,CUI1,CUI2,label
0,Links List,Heavy Chain Deposition Disease,0
1,Term (temporal),Childhood Fibrillary Astrocytoma,0
2,Different,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3,Human papilloma virus infection,BRCA2 Syndrome,0
4,Common (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
5,Determined by,Microcystic meningioma,0
6,Chemical Association,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7,Ibrutinib,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8,Childhood Lymphoma,Unresectable Rhabdomyosarcoma,0
9,Definitely Related to Intervention,Diffuse malignant mesothelioma,0
10,Poverty,Uterine Cancer,0
11,How Much Distress Itching,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12,13q12,Acute lymphadenitis,0
13,Head - Component of Device,Undifferentiated Endocervical Sarcoma,0
14,suggestion,Kaposi's sarcoma of extrahepatic bile duct,0
15,Ulceration,Leptomeningeal sarcoma,0
16,Etiology aspects,Human Papillomavirus-Related Carcinoma,0
17,biopsy characteristics,Tonsillar Carcinoma,0
18,Onset of (contextual qualifier),Platinum-Resistant Lung Small Cell Carcinoma,0
19,research subject screening,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20,Malignant Meningioma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21,Therapeutic procedure,Blepharal carcinoma,0
22,Common (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23,Have Shortness of Breath question,Adenocarcinoma of the prostate metastatic,0
24,Adrenocortical carcinoma,Intestinal Metaplasia of Bladder Urothelium,0
25,Adult Non-Hodgkin Lymphoma,Multiple Skull Base Meningiomas,0
26,In Cerebrospinal Fluid,Stage II Carcinoma of Penis,0
27,Subependymal Giant Cell Astrocytoma,Cherubism,0
28,Obesity,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
29,Multifocal,FIGO Stage IVA Ovarian Cancer,0
30,Affecting,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
31,Back,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
32,Personal appearance,Cartilaginous exostosis,0
33,Lifetime,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
34,Gingiva,Benign tumor of eyelid,0
35,30%,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
36,Primary malignant neoplasm,Human Papillomavirus-Related Carcinoma,0
37,Malignant Neoplasms,Trabecular adenocarcinoma,0
38,Study of epidemiology,Mixed astrocytoma-ependymoma,0
39,Remaining,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
40,Low Grade,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
41,Shin,Intraepithelial Melanocytic Hyperplasia,0
42,Protruding,Cerebral Primitive Neuroectodermal Tumor,0
43,20s,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
44,Cell Device,Human Papillomavirus-Related Carcinoma,0
45,Classification,Familial Adenomatous Polyposis Associated Medulloblastoma,0
46,Ability,Stage IV Childhood Non-Hodgkin Lymphoma,0
47,Unexplained weight loss,Tubal Hyperplasia,0
48,Usual,Kaposi's sarcoma of extrahepatic bile duct,0
49,Benign Neoplasm,Colorectal Neuroendocrine Tumor G2,0
50,Rare Diseases,Clinical Stage I Cutaneous Melanoma AJCC v8,0
51,combination - answer to question,Cartilaginous exostosis,0
52,Variable (uniformity),Gallbladder Adenocarcinoma,0
53,Usually,Larynx carcinoma recurrent,0
54,Back structure,Blepharal carcinoma,0
55,white blood cell type,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
56,Hemangioma,Mucinous adenocarcinoma gastric,0
57,Symptoms aspect,Benign tumor of eyelid,0
58,Smear - instruction imperative,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
59,Portion of urine,Adult Acute Eosinophilic Leukemia,0
60,Numbers,Recurrent Testicular Lymphoma,0
61,peripheral blood,Recurrent Uveal Melanoma,0
62,School Grade,Mucinous adenocarcinoma gastric,0
63,Malignant epithelioma,Refractory Barrett Esophagus,0
64,Very,Stage 0 Penile Cancer AJCC v8,0
65,Third,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
66,Source,Pancreatic Intraepithelial Neoplasia-3,0
67,Experimental Finding,Airway Hemangioma,0
68,Geographic Locations,Thyroid Hurthle Cell Carcinoma,0
69,Infection,ROSE Cluster 3,0
70,Entity Determiner - specific,Rhabdomyosarcoma with ganglionic differentiation,0
71,Removed,Ampulla of Vater Tubular Adenoma,0
72,Genetic,High Grade Glandular Intraepithelial Neoplasia,0
73,Specimen Source Codes - Tube,Localized Ewing Sarcoma,0
74,Latin America,Recurrent Uveal Melanoma,0
75,best (quality),Stage IB Pancreatic Cancer AJCC v8,0
76,Assortment,Mucinous adenocarcinoma gastric,0
77,Including (qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
78,low exposure,Acantholytic squamous cell carcinoma,0
79,Measures,Localized Askin Tumor,0
80,Malignant Neoplasms,Neonatal leukemia,0
81,Deeply,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
82,Cervix Uteri,Splenic Manifestation of Hairy Cell Leukemia,0
83,Involvement with,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
84,Case unit dose,Recurrent Rhabdomyosarcoma,0
85,Affect (mental function),Ampulla of Vater Tubular Adenoma,0
86,Form:Finding:Point in time:{Setting}:Document:{Role},Spermatocytic seminoma,0
87,>5,Mixed astrocytoma-ependymoma,0
88,Occur (action),Acantholytic squamous cell carcinoma,0
89,MOSTLY,Noninfiltrating Intraductal Carcinoma,0
90,Etiology aspects,Refractory Ependymoma,0
91,Treating,Nasal cavity carcinoma,0
92,Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
93,Breast Cancer Type 1 Susceptibility Protein Measurement,Engraftment syndrome,0
94,Condition,Vaginal Adenoma,0
95,Recombinant Immune Globulin,Unresectable Rhabdomyosarcoma,0
96,Body structure,Metaplastic carcinoma of breast,0
97,Daily Living,Grade 3a Malignant Neoplasm,0
98,Device Cord,Anaplastic large cell lymphoma,0
99,Covers (device),Papillary cystic tumor,0
100,High,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
101,Undescended testis (body structure),Liver Lymphangioma,0
102,Personal appearance,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
103,Representation (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
104,Family illness,Vaginal Adenoma,0
105,Zone,Undifferentiated Endocervical Sarcoma,0
106,Present,Congenital hamartoma,0
107,Persons,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
108,Definition,Lipoma of small intestine,0
109,Death NOS,Vaginal Adenoma,0
110,Nasal sinus,embryonal rhabdomyosarcoma of prostate,0
111,Malignant - descriptor,Choroid Epithelioid Cell Melanoma,0
112,Muscle Contraction,embryonal rhabdomyosarcoma of prostate,0
113,1000000,Engraftment syndrome,0
114,Include (action),Blood Vessel Tumors,0
115,Worker,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
116,Occur (action),Squamous cell carcinoma of lip,0
117,Colon <insect>,Pleomorphic adenoma of parotid gland,0
118,Malignant neoplasm of skin,Testicular cancer metastatic,0
119,Microvolt,Vaginal Adenoma,0
120,Meaning,Mucinous adenocarcinoma gastric,0
121,Membrane Device,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
122,foreign,Malignant neoplasm of choroid,0
123,Biomaterial Treatment,Congenital hamartoma,0
124,described,ROSE Cluster 3,0
125,Smear - instruction imperative,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
126,Lead,Papillary squamous cell carcinoma,0
127,Unknown GENC,Thymic Atypical Carcinoid Tumor,0
128,Penetration,FIGO Stage II Ovarian Cancer,0
129,leukemia,Locally Advanced Squamous Cell Carcinoma,0
130,Vaginal wall,Peripheral primitive neuroectodermal tumor of soft tissue,0
131,Responsible to,Bladder adenocarcinoma stage IV,0
132,Disease,Leptomeningeal sarcoma,0
133,Yolk Sac Tumor,Benign Apocrine Neoplasm,0
134,Weight Loss,Liver Cavernous Hemangioma,0
135,Bone marrow aspiration procedure,Type II Endometrial Adenocarcinoma,0
136,Occurrence,Noninfiltrating Intraductal Carcinoma,0
137,risk factors - observation list,Pancreatic carcinoma,0
138,Obesity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
139,Microplate Well,Angiosarcoma of liver,0
140,regional,Type II Endometrial Adenocarcinoma,0
141,Malignant Bone Neoplasm,Secondary malignant neoplasm of lymph node,0
142,Gestational trophoblastic disease,Mixed astrocytoma-ependymoma,0
143,True primary (qualifier value),Refractory Ependymoma,0
144,Frequently,Secondary malignant neoplasm of lymph node,0
145,Linear,Uterine Cancer,0
146,Liver Flavor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
147,Antimicrobial Intermediate Susceptibility Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
148,Initially,Pilocytic astrocytoma of cerebellum,0
149,Time,sarcoma of spinal cord,0
150,Line Unit of Length,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
151,depend,Stage I Adult Non-Hodgkin Lymphoma,0
152,Type - attribute,mucinous adenocarcinoma of gallbladder,0
153,Condition:Find:Pt:^Patient:Nom,Stage IV Penile Cancer AJCC v7,0
154,Hardness,Refractory Barrett Esophagus,0
155,Pediculus humanus capitis (eukaryote),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
156,Cancer Genus,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
157,Ductal Breast Carcinoma,Recurrent Primary Lymphoma of Bone,0
158,Communicable Diseases,Unresectable Rhabdomyosarcoma,0
159,Including (qualifier),Childhood Lymphoma,0
160,Arising,Thyroid Hurthle Cell Carcinoma,0
161,Resolution,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
162,radiotherapeutic,Childhood Central Nervous System Ganglioneuroblastoma,0
163,How Often Nausea,Small Intestinal Villous Adenoma,0
164,Preventive intent,Female Breast Carcinoma,0
165,Special,Noninfiltrating Intraductal Carcinoma,0
166,Grains,Mixed astrocytoma-ependymoma,0
167,Elderly (population group),Deep Leiomyoma,0
168,Small,Trichilemmocarcinoma,0
169,Phonation,Endometrial Small Cell Carcinoma,0
170,With intensity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
171,Collagen,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
172,Specimen Source Codes - tumor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
173,Inspiration function,Clinical Stage I Cutaneous Melanoma AJCC v8,0
174,risk factors,Acantholytic squamous cell carcinoma,0
175,Occur (action),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
176,Sweating,Acantholytic squamous cell carcinoma,0
177,Make - Instruction Imperative,Metastatic Lung Small Cell Carcinoma,0
178,Sufficient,Congenital hamartoma,0
179,Biomaterial Treatment,Liver Lymphangioma,0
180,Duct (organ) structure,Melanomatosis,0
181,Smear - instruction imperative,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
182,Classification,Locally Advanced Epithelioid Hemangioendothelioma,0
183,Tumor Antigens,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
184,Free of (attribute),Thymic Clear Cell Carcinoma,0
185,Phase,Anaplastic large cell lymphoma,0
186,New Zealand Rabbits,Precursor B-lymphoblastic lymphoma stage II,0
187,shared attribute,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
188,Following,Childhood Central Nervous System Immature Teratoma,0
189,Retinoic Acid Response Element,FIGO Stage IVA Ovarian Cancer,0
190,Anterior thoracic region,Neonatal leukemia,0
191,Physical findings,Clinical Stage I Cutaneous Melanoma AJCC v8,0
192,Often - answer to question,Non-Metastatic Gestational Trophoblastic Tumor,0
193,Presentation,Refractory Bladder Carcinoma,0
194,Painful intercourse female,Cervical Squamous Intraepithelial Neoplasia,0
195,Arising,Clinical Stage I Cutaneous Melanoma AJCC v8,0
196,Square Mile,Lipoma of small intestine,0
197,Bayer Visual Acuity Changes Grade 3,Acantholytic squamous cell carcinoma,0
198,Aspects of disease screening,Ectomesenchymal Chondromyxoid Tumor,0
199,Indication of (contextual qualifier),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
200,Muscle Tissue,Childhood Extragonadal Malignant Germ Cell Tumor,0
201,Liver,Brain Tumor,0
202,Adult Non-Hodgkin Lymphoma,Unicystic ameloblastoma,0
203,Cell Count,Benign Carotid Body Paraganglioma,0
204,Site,Malignant Testicular Sertoli Cell Tumor,0
205,Group A (qualifier value),Tumorlet,0
206,Blood Circulation,Anterior Urethral Malignant Neoplasm,0
207,Females,Liver Lymphangioma,0
208,Diagnosis,Papillary squamous cell carcinoma,0
209,Unit device,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
210,Pilocytic Astrocytoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
211,Associated topography,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
212,high - ActExposureLevelCode,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
213,Third revision,Blepharal carcinoma,0
214,shared attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
215,Benign,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
216,Organ,Microcystic meningioma,0
217,<90,Unicystic ameloblastoma,0
218,Childhood Rhabdomyosarcoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
219,Therapeutic radiology procedure,Plexosarcoma,0
220,Pineal germinoma,Diffuse malignant mesothelioma,0
221,Academic degree,Adenocarcinoma,0
222,Red Blood Cell Count measurement,Anterior Urethral Malignant Neoplasm,0
223,Supportive assistance,Tonsillar Carcinoma,0
224,Skin,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
225,Then,Granular Cell Leiomyosarcoma,0
226,Positive Selection,Adult Anaplastic Oligodendroglioma,0
227,Malignant Vaginal Neoplasm,Urethral Carcinoma,0
228,Diffuse,Clinical Stage I Cutaneous Melanoma AJCC v8,0
229,Peritoneum,Female Breast Carcinoma,0
230,Cumulative,Acinar cell carcinoma of pancreas,0
231,month,Clonal Hematopoiesis of Indeterminate Potential,0
232,Painless,Undifferentiated Endocervical Sarcoma,0
233,increasing incidence,Xeroderma pigmentosum,0
234,Occurrence,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
235,Carcinoma of lung,Epithelioid Sarcoma NCI Grade 3,0
236,second (number),Transitional cell carcinoma,0
237,One,Intestinal Metaplasia of Bladder Urothelium,0
238,Frequently,Primary Cutaneous Plasmablastic Lymphoma,0
239,prevention aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
240,Eye Color,Central Nervous System Yolk Sac Tumor,0
241,Condition:Find:Pt:^Patient:Nom,Refractory Ependymoma,0
242,Stomach,Vaginal Adenoma,0
243,Neck,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
244,Lung,Multiple Skull Base Meningiomas,0
245,Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
246,Melanins,Adult Alveolar Soft Part Sarcoma,0
247,Cyst,Acute Undifferentiated Leukemia,0
248,Unconscious State,Cervical Squamous Intraepithelial Neoplasia,0
249,Upper arm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
250,Decision,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
251,Long Term Survivorship,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
252,Specific qualifier value,FIGO Stage IVA Ovarian Cancer,0
253,Long-term Follow-up,Acute Undifferentiated Leukemia,0
254,Major <insect>,Blepharal carcinoma,0
255,Extrinsic,Primary Cutaneous Plasmablastic Lymphoma,0
256,Behavior:-:Point in time:^Patient:-,Placental aromatase deficiency,0
257,3+ Score,Non-Metastatic Gestational Trophoblastic Tumor,0
258,Phenomenon,Clinical Stage I Cutaneous Melanoma AJCC v8,0
259,Base - General Qualifier,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
260,Pain,Nasal cavity carcinoma,0
261,Containing (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
262,Small,Mixed astrocytoma-ependymoma,0
263,Cell Count,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
264,bony process,Engraftment syndrome,0
265,Body part,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
266,Area,Stage IV Colorectal Cancer AJCC v8,0
267,Deep (qualifier value),Choroid Epithelioid Cell Melanoma,0
268,Smoking,Stage I Adult Non-Hodgkin Lymphoma,0
269,Including (qualifier),Neonatal leukemia,0
270,To,Engraftment syndrome,0
271,Case (situation),Localized Askin Tumor,0
272,Pleomorphic,Mucosal Melanoma,0
273,Pressure (finding),sarcoma of spinal cord,0
274,Treating,Stage 0 Lip Carcinoma,0
275,Stop brand of fluoride,Bladder squamous cell carcinoma stage I,0
276,Males,Malignant Testicular Sertoli Cell Tumor,0
277,eTMF Content Model Code,Cartilaginous exostosis,0
278,Prostate,clear cell adenocarcinoma of gallbladder,0
279,Etiology aspects,Mucinous adenocarcinoma gastric,0
280,Neoplasms,Hodgkin lymphoma,0
281,More,Refractory Ependymoma,0
282,Unknown,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
283,Complete,Benign Anal Granular Cell Tumor,0
284,Known,Type II Endometrial Adenocarcinoma,0
285,Followed by,Hereditary corneal dystrophy,0
286,Repair,papillary carcinoma of penis,0
287,Surface of bone,Advanced Uterine Corpus Carcinosarcoma,0
288,Lactation,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
289,Joints,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
290,Providing presence (regime/therapy),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
291,Frequently,Metastatic Lung Small Cell Carcinoma,0
292,Percent of Abnormal Cells,Collecting Duct Carcinoma of the Kidney,0
293,Nutrients,Benign Anal Granular Cell Tumor,0
294,Removed,Localized Ewing Sarcoma,0
295,Classification,Cerebral Primitive Neuroectodermal Tumor,0
296,Manufactured sign,Astrocytoma of brain,0
297,International Classification of Disease for Oncology,Mucosal Melanoma,0
298,transmission process,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
299,Glycation End Products,Testicular cancer metastatic,0
300,SLC6A2 protein,Thyroid Hurthle Cell Carcinoma,0
301,Tryptophanase,Colorectal High Grade B-Cell Lymphoma,0
302,How Much Distress Vomiting,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
303,17th century,Chondrosarcoma,0
304,Options,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
305,Semilunar fold of fauces,Cancer of Urinary Tract,0
306,biopsy characteristics,Malignant melanoma of eyelid,0
307,Pharmacotherapy,Female Breast Carcinoma,0
308,Medullary - body parts,Cerebral Primitive Neuroectodermal Tumor,0
309,Roman Numeral III,Cherubism,0
310,Shortness of breath:-:Point in time:^Patient:-,sarcoma of spinal cord,0
311,Absent,Thyroid Hurthle Cell Carcinoma,0
312,Malignant Neoplasms,Activated B-cell type diffuse large B-cell lymphoma,0
313,Pineal gland,Giant cell angiofibroma,0
314,Epithelium of vagina,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
315,Classification,Botryoid-Type Embryonal Rhabdomyosarcoma,0
316,shared attribute,Engraftment syndrome,0
317,Manufactured form,Fibroadenoma of breast,0
318,Hormone replacement therapy,Benign squamous cell tumor,0
319,Involvement with,Refractory Bladder Carcinoma,0
320,Bone Marrow,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
321,Tumor Suppressor Genes,Childhood Lung Non-Small Cell Carcinoma,0
322,Well defined,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
323,Smooth muscle (tissue),Childhood Lymphoma,0
324,Event Seriousness - Significant,Vaginal Adenoid Cystic Carcinoma,0
325,Oral cavity,Acute Undifferentiated Leukemia,0
326,Telencephalon,Locally Advanced Epithelioid Hemangioendothelioma,0
327,Diagnosis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
328,Administration procedure,Ovarian germ cell choriocarcinoma stage IV,0
329,Make - Instruction Imperative,Childhood Fibrillary Astrocytoma,0
330,Grade,clear cell adenocarcinoma of gallbladder,0
331,Retained,Small cell neuroendocrine carcinoma of bladder,0
332,Involvement with,Metastatic Malignant Neoplasm in the Sellar Region,0
333,Fertility Domain,Adenocarcinoma of duodenum,0
334,200,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
335,Bothered by Vomiting,Maxillary Sinus Adenoid Cystic Carcinoma,0
336,3+ Score,Recurrent Uveal Melanoma,0
337,Science of Morphology,Hereditary corneal dystrophy,0
338,Newly Diagnosed Childhood Ependymoma,Fibroadenoma of breast,0
339,Image Feature,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
340,Mass,Benign tumor of eyelid,0
341,Affect (mental function),Fourth Ventricle and Brain Stem Ependymal Tumor,0
342,Tumor cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
343,65,Acantholytic squamous cell carcinoma,0
344,Levels (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
345,Firstly,Liver Lymphangioma,0
346,Vascular,Thymic Clear Cell Carcinoma,0
347,Response (statement),Bladder squamous cell carcinoma stage I,0
348,Liver,Gallbladder Adenocarcinoma,0
349,Negation,Small Intestinal Villous Adenoma,0
350,Neuroglia,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
351,Blink Reflexes,Botryoid-Type Embryonal Rhabdomyosarcoma,0
352,fish - non-drug agent,Intestinal Metaplasia of Bladder Urothelium,0
353,Tonsil,Recurrent Testicular Lymphoma,0
354,Skeletal bone,Recurrent Testicular Lymphoma,0
355,To,Liver Lymphangioma,0
356,Present,FIGO Stage IVA Ovarian Cancer,0
357,Lung,adenosquamous carcinoma of breast,0
358,Malignant neoplasm of soft tissue,Transitional cell carcinoma,0
359,B-Lymphocytes,Cystadenocarcinoma,0
360,Malignant Neoplasms,Malignant neoplasm of thalamus,0
361,Smudge cell,Refractory Barrett Esophagus,0
362,History of tobacco use,Trichilemmocarcinoma,0
363,Rating (action),Childhood Lymphoma,0
364,Natural Killer Cells,Diffuse malignant mesothelioma,0
365,Lymph,High Grade Glandular Intraepithelial Neoplasia,0
366,Changing,Carcinoma ex pleomorphic adenoma of parotid gland,0
367,Site of,Multiple Endocrine Neoplasia,0
368,Usual Severity Sweats,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
369,Wound Healing,Astrocytoma of brain,0
370,Varies,Astrocytoma of brain,0
371,Person Name,Small intestine carcinoma,0
372,Stem of Organ,Acute Undifferentiated Leukemia,0
373,Soluble (qualifier),Intraepithelial Melanocytic Hyperplasia,0
374,Extravasation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
375,Usual,Testicular cancer metastatic,0
376,Name (property) (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
377,second (number),Thyroid carcinoma,0
378,Both ovaries,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
379,Polycythemia,Pancreatic carcinoma,0
380,include - SetOperator,FIGO Stage IVA Ovarian Cancer,0
381,mesodermal,papillary carcinoma of penis,0
382,Immunoglobulin Heavy Chain Variable Domain,Maxillary Sinus Adenocarcinoma,0
383,cell growth,embryonal rhabdomyosarcoma of prostate,0
384,Point,Collecting Duct Carcinoma of the Kidney,0
385,Chest Pain,Maxillary Sinus Adenocarcinoma,0
386,Less Than,Benign squamous cell tumor,0
387,newly,Xeroderma pigmentosum,0
388,Cystitis,Human Papillomavirus-Related Carcinoma,0
389,Lymphoid system structure,Diffuse malignant mesothelioma,0
390,Percent of Bacteria,Epithelioid Sarcoma NCI Grade 3,0
391,include - SetOperator,Angiosarcoma of liver,0
392,Characteristics,Unresectable Rhabdomyosarcoma,0
393,algorithm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
394,Malignant Neoplasms,Diffuse malignant mesothelioma,0
395,therapeutic aspects,Botryoid-Type Embryonal Rhabdomyosarcoma,0
396,Offspring,Gallbladder Adenocarcinoma,0
397,Used by,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
398,Chemotherapy,Recurrent Rhabdomyosarcoma,0
399,Primary,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
400,genetic risk factors,Secondary malignant neoplasm of lymph node,0
401,BRCA1 wt Allele,Placental aromatase deficiency,0
402,Liver and Intrahepatic Biliary Tract Carcinoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
403,Tumor Necrosis Factor Receptor Superfamily Member 8,Benign squamous cell tumor,0
404,With shape,Carcinoma of urinary bladder,0
405,90%,Childhood Thyroid Gland Follicular Carcinoma,0
406,Part of,Adult Anaplastic Oligodendroglioma,0
407,Fever symptoms (finding),Collecting Duct Carcinoma of the Kidney,0
408,Worse,Benign squamous cell tumor,0
409,Entity,Choroid Epithelioid Cell Melanoma,0
410,Site of,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
411,Range,Diffuse malignant mesothelioma,0
412,Fatigue,Undifferentiated Endocervical Sarcoma,0
413,Fatigue,Testicular cancer metastatic,0
414,Oral epithelium (specimen),Carcinoma,0
415,Body part,Malignant melanoma of eyelid,0
416,North America,Vaginal Adenoma,0
417,Descent,Mucinous adenocarcinoma gastric,0
418,Often - answer to question,Unicystic ameloblastoma,0
419,Evidence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
420,Decision,Adult Acute Eosinophilic Leukemia,0
421,Treating,Recurrent Diffuse Intrinsic Pontine Glioma,0
422,Hiatal Hernia,Uterine Cancer,0
423,Mechanism Component of Device,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
424,Used by,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
425,Gene Cluster Text Format,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
426,2+ Score,Leiomyoma of Gallbladder,0
427,One,Pancreatic Intraepithelial Neoplasia-3,0
428,Glioblastoma Multiforme Pathway,Vaginal Adenoid Cystic Carcinoma,0
429,Stomach structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
430,Malignant neoplasm of skin,Gallbladder adenoma,0
431,Pressure (property),Malignant melanoma of eyelid,0
432,66,Intestinal Metaplasia of Bladder Urothelium,0
433,Gastroesophageal reflux disease,Basal Cell Ameloblastoma,0
434,fluid - substance,Cerebral Primitive Neuroectodermal Tumor,0
435,Primary malignant neoplasm,Anaplastic large cell lymphoma,0
436,Rare,Hemangioma,0
437,Aspects of signs,Lipoma of small intestine,0
438,Confirmed by,Malignant Testicular Sertoli Cell Tumor,0
439,Position of phenotypic abnormality,Methotrexate-Associated Hodgkin Lymphoma,0
440,Abdominal mass,Refractory Bladder Carcinoma,0
441,Make - Instruction Imperative,Childhood Lymphoma,0
442,Teratoma,Advanced Uterine Corpus Carcinosarcoma,0
443,Manufactured form,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
444,Cerebrum,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
445,therapeutic aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
446,2+ Score,benign mature teratoma of pancreas,0
447,Primary,Platinum-Resistant Lung Small Cell Carcinoma,0
448,Testicular mass,Benign squamous cell tumor,0
449,Type A,Mastocytosis,0
450,associated disease,Transitional cell carcinoma,0
451,Type A,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
452,include - SetOperator,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
453,Raised,Grade 3a Malignant Neoplasm,0
454,Overall,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
455,Enlargement procedure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
456,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Ichthyosis,0
457,Age at cancer Dx:Number:Point in time:Cancer.To be specified in another part of the message:Quantitative,Intraepithelial Melanocytic Hyperplasia,0
458,Reflux,Choroid Necrotic Melanoma,0
459,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
460,Three,Mixed astrocytoma-ependymoma,0
461,Development,Urethral Carcinoma,0
462,Mammal liver preparation,Transitional cell carcinoma,0
463,Viola tricolor extract,Leptomeningeal sarcoma,0
464,primary tumor,Clonal Hematopoiesis of Indeterminate Potential,0
465,Covered (qualifier value),Advanced Uterine Corpus Carcinosarcoma,0
466,Incidence Rate,Colorectal Neuroendocrine Tumor G2,0
467,Primary,Carcinoma,0
468,Table Cell Horizontal Align - left,Malignant Neoplasm with Regional Lymph Node Involvement,0
469,Certain (qualifier value),Splenic Manifestation of Hairy Cell Leukemia,0
470,Radiation Oncologists,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
471,Lesion,non-Hodgkin's lymphoma of spleen,0
472,Salivary Gland Neoplasms,Malignant neoplasm of thalamus,0
473,Increased cerebrospinal fluid production,Refractory WHO Grade III Glioma,0
474,Alcohol consumption,Peripheral primitive neuroectodermal tumor of soft tissue,0
475,Family (taxonomic),Stage IB Pancreatic Cancer AJCC v8,0
476,Occurrence Indicator,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
477,Urine,Human Papillomavirus-Related Carcinoma,0
478,Tobacco smoking behavior,Peripheral primitive neuroectodermal tumor of soft tissue,0
479,Poliosis,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
480,Squamous Epithelial Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
481,Occurrence,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
482,Seventh,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
483,acute,Liver Lymphangioma,0
484,Speaking (activity),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
485,Common (qualifier value),papillary carcinoma of penis,0
486,Grade,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
487,Removing (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
488,Brain,Heavy Chain Deposition Disease,0
489,Manufactured form,Childhood Anaplastic Large Cell Lymphoma,0
490,Chromosome band,Stage III Cutaneous Melanoma AJCC v6,0
491,Benign Teratoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
492,Greeks,Benign Ovarian Thecoma,0
493,1000000,Benign neoplasm of thorax,0
494,Narrowed structure,Liver Lymphangioma,0
495,A Codes,Mixed astrocytoma-ependymoma,0
496,Bone marrow: lymphocytes (finding),Malignant Neoplasm with Regional Lymph Node Involvement,0
497,SLC35G1 gene,Nasal cavity carcinoma,0
498,Tumor cells,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
499,Sharing (Social Behavior),Low Grade Squamous Intraepithelial Neoplasia,0
500,Shortened,Hodgkin Disease,0
501,Spreading (qualifier value),Mucinous adenocarcinoma gastric,0
502,Pure Spanish horse breed (organism),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
503,Surgery specialty,Localized Askin Tumor,0
504,Pleural Effusion,Intraepithelial Melanocytic Hyperplasia,0
505,Specific qualifier value,Human Papillomavirus-Related Carcinoma,0
506,Abnormal,Pancreatic carcinoma,0
507,Oils,Cervical Fibroepithelial Polyp,0
508,Male population group,Cervical Adenomyoma,0
509,Dictionary [Publication Type],Small intestine carcinoma,0
510,PSA Level Less than Two,Leiomyoma of Gallbladder,0
511,Squamous cell carcinoma - category,Childhood Extragonadal Malignant Germ Cell Tumor,0
512,peripheral blood,Acute Undifferentiated Leukemia,0
513,Family member,Cervical Adenomyoma,0
514,Including (qualifier),Endometrial Small Cell Carcinoma,0
515,Malignant Neoplasms,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
516,Poorly differentiated,Melanomatosis,0
517,United States,FIGO Stage IVA Ovarian Cancer,0
518,Complete,Mucosal Melanoma,0
519,Has difficulty doing (qualifier value),Malignant melanoma of eyelid,0
520,Neoplasms,Spongiotic dermatitis,0
521,day,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
522,Fever symptoms (finding),Uterine Cancer,0
523,Form of bone,Bladder Neuroendocrine Neoplasm,0
524,mesodermal,Mucinous adenocarcinoma gastric,0
525,Greater than one,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
526,Two,Central Nervous System Yolk Sac Tumor,0
527,Chest,Pancreatic Endocrine Carcinoma,0
528,Secondary Neoplasm,Benign Anal Granular Cell Tumor,0
529,Cancer Other,papillary carcinoma of penis,0
530,Image Feature,Undifferentiated Endocervical Sarcoma,0
531,Most,Malignant melanoma of eyelid,0
532,Prognostic Factors,Adult Hepatocellular Carcinoma,0
533,Female Phenotype,Childhood Central Nervous System Ganglioneuroblastoma,0
534,2+,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
535,Duct Device,Precursor B-lymphoblastic lymphoma stage II,0
536,Administration procedure,adenoid cystic carcinoma of lung,0
537,Chew (administration method),Diffuse malignant mesothelioma,0
538,Including (qualifier),Malignant neoplasm of thalamus,0
539,Call (Instruction),Localized Malignant Neoplasm,0
540,Round cell tumor,FIGO Stage IVA Ovarian Cancer,0
541,shared attribute,Acantholytic squamous cell carcinoma,0
542,Infrequent,Refractory Barrett Esophagus,0
543,Fasting Status Indicator,embryonal rhabdomyosarcoma of prostate,0
544,therapeutic aspects,Adult Alveolar Soft Part Sarcoma,0
545,Lymphatic System,Congenital hamartoma,0
546,Name Given at Birth,Stage IB Pancreatic Cancer AJCC v8,0
547,Blue color,Tonsillar Carcinoma,0
548,Sample Range,Benign Anal Granular Cell Tumor,0
549,Much,Maxillary Sinus Adenoid Cystic Carcinoma,0
550,Cover - action,Stage IV Penile Cancer AJCC v7,0
551,Fast Growing,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
552,Together,Xeroderma pigmentosum,0
553,Case unit dose,Hereditary Diffuse Gastric Adenocarcinoma,0
554,Treating,Blepharal carcinoma,0
555,NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
556,Cord - Body Parts,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
557,Affecting,Chondrosarcoma,0
558,Medical Imaging,Childhood Central Nervous System Ganglioneuroblastoma,0
559,Primary malignant neoplasm,Cervical Squamous Intraepithelial Neoplasia,0
560,Treatment Epoch,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
561,Second edition,Acute Undifferentiated Leukemia,0
562,Physical Medical Procedure,Unicystic ameloblastoma,0
563,Personal appearance,squamous cell carcinoma of the thyroid gland,0
564,Molecular Mass,Stage IV Colorectal Cancer AJCC v8,0
565,Complication Aspects,Cervical Fibroepithelial Polyp,0
566,Tumor Mass,Nasal cavity carcinoma,0
567,Headache,Refractory Bladder Carcinoma,0
568,Cardiac Lead Procedure,Primary Cutaneous Plasmablastic Lymphoma,0
569,Concept model domain,Cerebral Primitive Neuroectodermal Tumor,0
570,Usual Severity Itching,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
571,GORAB gene,Basal Cell Ameloblastoma,0
572,Unknown GENC,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
573,risk factors,Melanomatosis,0
574,treatment - ActInformationManagementReason,Acute Undifferentiated Leukemia,0
575,Cyclin A,Malignant neoplasm of olfactory nerve,0
576,Participation Type - origin,Type II Endometrial Adenocarcinoma,0
577,Primary malignant neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
578,Primary,Hyperplasia of pituitary gland,0
579,incidence of cases,Botryoid-Type Embryonal Rhabdomyosarcoma,0
580,Spreading (qualifier value),Pancreatic carcinoma,0
581,Cardiovascular system,Adult Acute Eosinophilic Leukemia,0
582,Specimen Source Codes - tumor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
583,Drain device,Choroid Necrotic Melanoma,0
584,Therapeutic radiology procedure,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
585,Tired,GIANT PIGMENTED HAIRY NEVUS,0
586,Shortness of Breath Visual Analogue Scale,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
587,risk factors,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
588,Blood Vessel,Clinical Stage I Cutaneous Melanoma AJCC v8,0
589,Pediculus humanus capitis (eukaryote),Childhood Lymphoma,0
590,Occurrence,Malignant melanoma of eyelid,0
591,Include (action),Uterine Cancer,0
592,Including (qualifier),ROSE Cluster 3,0
593,True primary (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
594,Major,Astrocytoma of brain,0
595,Most,Bladder Neuroendocrine Neoplasm,0
596,Form:Finding:Point in time:{Setting}:Document:{Role},Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
597,per second,Extra-Adrenal Paraganglioma,0
598,Study Variable,Trabecular adenocarcinoma,0
599,Prevalence aspects,Thymoma malignant recurrent,0
600,Occur (action),Adult Anaplastic Oligodendroglioma,0
601,Unknown,Methotrexate-Associated Hodgkin Lymphoma,0
602,100%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
603,Occurrence Indicator,Intraepithelial Melanocytic Hyperplasia,0
604,Participation Type - origin,Anaplastic large cell lymphoma,0
605,Mechanism Component of Device,Childhood Fibrillary Astrocytoma,0
606,Tests (qualifier value),Clinical Stage I Cutaneous Melanoma AJCC v8,0
607,Most,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
608,Along edge (qualifier value),Liver Cavernous Hemangioma,0
609,Firstly,Carcinomatosis of peritoneal cavity,0
610,3+ Score,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
611,Occur (action),Maxillary Sinus Adenocarcinoma,0
612,Occur (action),Stage III Cutaneous Melanoma AJCC v6,0
613,Diagnosis Study,Activated B-cell type diffuse large B-cell lymphoma,0
614,Various patch test substance,FIGO Stage IVA Ovarian Cancer,0
615,Have Weight Loss,Granular Cell Leiomyosarcoma,0
616,Cancer Genus,Brain Ependymoma,0
617,Precancerous Conditions,Funisitis (disorder),0
618,Connective Tissue,Malignant Testicular Sertoli Cell Tumor,0
619,Individual,Locally Advanced Carcinoma,0
620,Residential flat,clear cell adenocarcinoma of gallbladder,0
621,Hyperplastic Polyp,Anterior Urethral Malignant Neoplasm,0
622,Internal,Hodgkin lymphoma,0
623,Rocky,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
624,Glioma,Cervical Fibroepithelial Polyp,0
625,Pregnancy,Stage IB Pancreatic Cancer AJCC v8,0
626,Decision,papillary carcinoma of penis,0
627,acute,Papillary cystic tumor,0
628,Include (action),Stage II Hepatocellular Carcinoma AJCC v8,0
629,More Often than Once a Day,Spongiotic dermatitis,0
630,year,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
631,Chemotherapy,Acantholytic squamous cell carcinoma,0
632,Early stage,Tonsillar Carcinoma,0
633,Secondary Neoplasm,Acantholytic squamous cell carcinoma,0
634,Increased,Small cell neuroendocrine carcinoma of bladder,0
635,Naive Pregerminal Center B-Lymphocyte,Adrenal Rest Tumor,0
636,Retinoic Acid Response Element,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
637,First Intercourse,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
638,CDISC SEND Tumor Findings Results Terminology,Spongiotic dermatitis,0
639,Reduction (chemical),Cerebral Primitive Neuroectodermal Tumor,0
640,High,Childhood Lung Non-Small Cell Carcinoma,0
641,Rare,Multiple Endocrine Neoplasia,0
642,Biogenic Amines,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
643,Two,Uterine Cancer,0
644,Areas <moth>,Leptomeningeal sarcoma,0
645,Obesity,Kaposi's sarcoma of extrahepatic bile duct,0
646,unknown vaccine or immune globulin,papillary carcinoma of penis,0
647,Surgical extraction,Carcinoma of urinary bladder,0
648,Greater Than,Astrocytoma of brain,0
649,Present,Vaginal Adenoid Cystic Carcinoma,0
650,Subtype (attribute),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
651,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,sarcoma of spinal cord,0
652,Males,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
653,Symptoms,Liver Lymphangioma,0
654,Negation,Refractory Bladder Carcinoma,0
655,Squamous cell carcinoma - category,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
656,Lung,Recurrent Uveal Melanoma,0
657,Squamous Epithelial Cells,Stage I Adult Non-Hodgkin Lymphoma,0
658,Neoplasms,Collecting Duct Carcinoma of the Kidney,0
659,Time,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
660,Pituitary Gland,Adult Anaplastic Oligodendroglioma,0
661,metaplastic cell transformation,Papillary squamous cell carcinoma,0
662,Diameter (qualifier value),Cervical Adenomyoma,0
663,transport (device),Precursor B-lymphoblastic lymphoma stage II,0
664,Skin lesion,Pancreatic carcinoma,0
665,Endocrine Cells,Malignant Testicular Sertoli Cell Tumor,0
666,A Codes,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
667,Skin Specimen,Type II Endometrial Adenocarcinoma,0
668,avoidance,Microcystic meningioma,0
669,Etoposide,FIGO Stage II Ovarian Cancer,0
670,Small,Methotrexate-Associated Hodgkin Lymphoma,0
671,Greasy skin,Thyroid Hurthle Cell Carcinoma,0
672,Skin Angiosarcoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
673,Base - General Qualifier,embryonal rhabdomyosarcoma of prostate,0
674,Relationships,Primary Cutaneous Plasmablastic Lymphoma,0
675,Feelings,adenoid cystic carcinoma of lung,0
676,Togo,FIGO Stage II Ovarian Cancer,0
677,Relational and Item-Specific Encoding Task,Methotrexate-Associated Hodgkin Lymphoma,0
678,Mucous Membrane,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
679,Presentation,Squamous cell carcinoma of lip,0
680,Referring,Benign tumor of eyelid,0
681,Odontogenic Tumors,Malignant melanoma of eyelid,0
682,Used by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
683,Weight Loss,Thymic Clear Cell Carcinoma,0
684,Skull,Type II Endometrial Adenocarcinoma,0
685,Body site,Grade 3a Malignant Neoplasm,0
686,Appearance,Type II Endometrial Adenocarcinoma,0
687,Magnetic Resonance Imaging,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
688,Cancer Genus,Malignant Neoplasm of Lung - Multiple Primary Sites,0
689,include - SetOperator,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
690,Developed Countries,Diffuse malignant mesothelioma,0
691,Location,sarcoma of spinal cord,0
692,Internal,Peripheral primitive neuroectodermal tumor of soft tissue,0
693,Squamous Epithelial Cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
694,Hepatitis C,FIGO Stage II Ovarian Cancer,0
695,Case unit dose,Human Papillomavirus-Related Carcinoma,0
696,Complete Trisomy 21 Syndrome,Hereditary Diffuse Gastric Adenocarcinoma,0
697,Smear - instruction imperative,Non-Metastatic Gestational Trophoblastic Tumor,0
698,Immature,Ovarian germ cell choriocarcinoma stage IV,0
699,Epithelium of large intestine,Fibroadenoma of breast,0
700,Procedure Domain,Airway Hemangioma,0
701,The Sun,Localized Ewing Sarcoma,0
702,Type - attribute,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
703,Inguinal part of abdomen,Bladder squamous cell carcinoma stage I,0
704,Separate,Mucinous adenocarcinoma gastric,0
705,Heterogeneity,Testicular cancer metastatic,0
706,Perianal Squamous Intraepithelial Neoplasia,Carcinoma ex pleomorphic adenoma of parotid gland,0
707,Topical form corticosteroids,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
708,Fever,Human Papillomavirus-Related Carcinoma,0
709,Financial Account,Methotrexate-Associated Hodgkin Lymphoma,0
710,Person Observer,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
711,Set scale,Fibroadenoma of breast,0
712,Used by,Cervical Fibroepithelial Polyp,0
713,Often - answer to question,Testicular cancer metastatic,0
714,Disease,Familial Adenomatous Polyposis Associated Medulloblastoma,0
715,NCI CTEP SDC Melanoma Sub-Category Terminology,Unfavorable Non-Hodgkin Lymphoma,0
716,melanoma,Unicystic ameloblastoma,0
717,Classification,embryonal rhabdomyosarcoma of prostate,0
718,Endometrial biopsy,Brain Tumor,0
719,Renal Cell Carcinoma,Human Papillomavirus-Related Carcinoma,0
720,FAT1 wt Allele,Thyroid Hurthle Cell Carcinoma,0
721,Person present,Botryoid-Type Embryonal Rhabdomyosarcoma,0
722,Surface of cervix,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
723,Manufactured form,Carcinoma ex pleomorphic adenoma of parotid gland,0
724,intent,Bladder adenocarcinoma stage IV,0
725,Determined by,Benign Anal Granular Cell Tumor,0
726,Rare,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
727,Benign melanocytic nevus,Unresectable Rhabdomyosarcoma,0
728,Contain (action),Childhood Central Nervous System Ganglioneuroblastoma,0
729,Cell Count,Stage III Cutaneous Melanoma AJCC v6,0
730,Hypokinesia,embryonal rhabdomyosarcoma of prostate,0
731,Nodule,Malignant melanoma of eyelid,0
732,Biological Response Modifiers,Trabecular adenocarcinoma,0
733,Cause of death:Find:Pt:^Patient:Nom,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
734,Effective,Placental aromatase deficiency,0
735,Ultrasonic,Adult Hepatocellular Carcinoma,0
736,Feature,Vaginal Adenoma,0
737,Approximate,Unfavorable Non-Hodgkin Lymphoma,0
738,Only - dosing instruction fragment,Platinum-Resistant Lung Small Cell Carcinoma,0
739,Primary malignant neoplasm of lung,Trichilemmocarcinoma,0
740,Surgical extraction,Vaginal Adenoid Cystic Carcinoma,0
741,Condition,Benign Anal Granular Cell Tumor,0
742,Spreading (qualifier value),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
743,Brain Neoplasms,Locally Advanced Epithelioid Hemangioendothelioma,0
744,Tryptophanase,Mucinous adenocarcinoma gastric,0
745,Relative Survival,Recurrent Primary Lymphoma of Bone,0
746,To,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
747,metaplastic cell transformation,Human Papillomavirus-Related Carcinoma,0
748,Term Birth,Benign tumor of eyelid,0
749,Use - dosing instruction imperative,Lipoma of small intestine,0
750,Removed,Methotrexate-Associated Hodgkin Lymphoma,0
751,Subtype (attribute),Female Breast Carcinoma,0
752,Often - answer to question,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
753,combination - answer to question,Anterior Urethral Malignant Neoplasm,0
754,high - ActExposureLevelCode,Hyperplasia of pituitary gland,0
755,Specimen Source Codes - Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
756,Lymph,Cerebral Primitive Neuroectodermal Tumor,0
757,IPSS Risk Category High,Vaginal Adenoid Cystic Carcinoma,0
758,Treating,Cancer of Urinary Tract,0
759,Malignant neoplasm of kidney,Refractory Bladder Carcinoma,0
760,Formation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
761,Dyspnea,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
762,Borg Category-Ratio 10 Perceived Exertion Score 5,Female Breast Carcinoma,0
763,Lung,Digestive System Hodgkin Lymphoma,0
764,40%,Diffuse malignant mesothelioma,0
765,Component object,Familial Adenomatous Polyposis Associated Medulloblastoma,0
766,World Health Organization,Extracranial Neuroblastoma,0
767,More Often than Once a Day,Cancer of Urinary Tract,0
768,Western World,Heavy Chain Deposition Disease,0
769,Nose Diseases,Neoplasms,0
770,foreign,Maxillary Sinus Adenocarcinoma,0
771,Togo,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
772,Used by,Stage III Adult Immunoblastic Lymphoma,0
773,Splenomegaly,Placental aromatase deficiency,0
774,Anatomic Structure,Intestinal Metaplasia of Bladder Urothelium,0
775,Genitalia,Pancreatic Intraepithelial Neoplasia-3,0
776,Enneking High Surgical Grade,Human Papillomavirus-Related Carcinoma,0
777,Causing,Blood Vessel Tumors,0
778,Frequently,Xeroderma pigmentosum,0
779,Account number:Identifier:Point in time:^Patient:Nominal,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
780,Immune System Finding,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
781,Diagnostic Imaging,Stage IB Lung Cancer AJCC v7,0
782,floor (object),Recurrent Uveal Melanoma,0
783,Effectiveness,Colorectal Neuroendocrine Tumor G2,0
784,Mutation Abnormality,Mucinous adenocarcinoma gastric,0
785,% volume (qualifier value),Diffuse malignant mesothelioma,0
786,200,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
787,Vasopressin (USP),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
788,Childhood Myelodysplastic Syndrome,Acinar cell carcinoma of pancreas,0
789,Diagnosis,Cancer of Urinary Tract,0
790,Worsening pattern,Female Breast Carcinoma,0
791,Diagnosis Study,Fourth Ventricle and Brain Stem Ependymal Tumor,0
792,Treatment Epoch,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
793,Adult Diffuse Large B-Cell Lymphoma,Recurrent Rhabdomyosarcoma,0
794,Scheme,embryonal rhabdomyosarcoma of prostate,0
795,Manufactured form,Liver Lymphangioma,0
796,risk factors - observation list,Noninfiltrating Intraductal Carcinoma,0
797,Screening Study,Adult Brain Stem Mixed Glioma,0
798,Cessation of life,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
799,Immature Cell Count (laboratory procedure),FIGO Stage IVA Ovarian Cancer,0
800,Advanced phase,Cervical Fibroepithelial Polyp,0
801,Mature,Neonatal leukemia,0
802,N+ (tumor staging),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
803,Magnetic Resonance Imaging,FIGO Stage II Ovarian Cancer,0
804,Tonsil,Metaplastic carcinoma of breast,0
805,Presentation,Acute Undifferentiated Leukemia,0
806,Hormones,Cartilaginous exostosis,0
807,Age,Malignant neoplasm of olfactory nerve,0
808,Family member,Intraepithelial Melanocytic Hyperplasia,0
809,Smear - instruction imperative,Basal Cell Ameloblastoma,0
810,Form:Finding:Point in time:{Setting}:Document:{Role},Endometrial Small Cell Carcinoma,0
811,Behavior:-:Point in time:^Patient:-,Diffuse malignant mesothelioma,0
812,Few,Adult Hepatocellular Carcinoma,0
813,Including (qualifier),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
814,Account number:Identifier:Point in time:^Patient:Nominal,Breast Ductal Adenoma,0
815,Leads (device),Adult Anaplastic Oligodendroglioma,0
816,Count of entities,Recurrent Uveal Melanoma,0
817,Common Specifications in HL7 V3 Publishing,Adenocarcinoma of the prostate metastatic,0
818,Hereditary,Malignant Testicular Sertoli Cell Tumor,0
819,Diagnosis Study,Childhood Central Nervous System Ganglioneuroblastoma,0
820,Smear test,Kaposi's sarcoma of extrahepatic bile duct,0
821,Hodgkin Disease,Pancreatic carcinoma,0
822,Characteristics,Refractory Ependymoma,0
823,Disease,Botryoid-Type Embryonal Rhabdomyosarcoma,0
824,Lymphoproliferation,Hair nevus,0
825,NCI CTEP SDC Melanoma Sub-Category Terminology,Basal Cell Ameloblastoma,0
826,Approximate,Thyroid Hurthle Cell Carcinoma,0
827,Occur (action),Multiple Skull Base Meningiomas,0
828,Admission Level of Care Code - Improved,Malignant Testicular Sertoli Cell Tumor,0
829,Solar Erythema,Grade 3a Malignant Neoplasm,0
830,Tryptophanase,Anaplastic large cell lymphoma,0
831,Growth action,Refractory Barrett Esophagus,0
832,Retinoic Acid Response Element,Locally Advanced Epithelioid Hemangioendothelioma,0
833,Acquired Name,Benign squamous cell tumor,0
834,1000000,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
835,Frequently,Human Papillomavirus-Related Carcinoma,0
836,Adult human body,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
837,Removed,Female Breast Carcinoma,0
838,Certain (qualifier value),Malignant Neoplasm of Lung - Multiple Primary Sites,0
839,Japan,Peripheral primitive neuroectodermal tumor of soft tissue,0
840,Angiolymphoid hyperplasia,Botryoid-Type Embryonal Rhabdomyosarcoma,0
841,Occur (action),Stage IB Pancreatic Cancer AJCC v8,0
842,Estimated,embryonal rhabdomyosarcoma of prostate,0
843,Cells,Papillary squamous cell carcinoma,0
844,Process,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
845,Lifetime,Intraepithelial Melanocytic Hyperplasia,0
846,Thymic Tissue,Advanced Uterine Corpus Carcinosarcoma,0
847,Togo,Maxillary Sinus Adenocarcinoma,0
848,Fertility Agents,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
849,Singular,Heavy Chain Deposition Disease,0
850,Neoplasms by Site,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
851,Half,Liver Lymphangioma,0
852,status - In progress,FIGO Stage II Ovarian Cancer,0
853,Manufactured form,Pilocytic astrocytoma of cerebellum,0
854,Anterior portion of neck,FIGO Stage IVA Ovarian Cancer,0
855,Death (finding),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
856,Including (qualifier),Adult Fibrolamellar Carcinoma,0
857,Cosmetics,Pancreatic Endocrine Carcinoma,0
858,nonmyeloablative allogeneic hematopoietic stem cell transplantation,Basal Cell Ameloblastoma,0
859,Value Above Reference Range,Small cell neuroendocrine carcinoma of bladder,0
860,Males,Refractory Barrett Esophagus,0
861,Qualitative form,Metastatic Carcinoma in the Lung,0
862,Carcinoma,Cancer of Urinary Tract,0
863,radioactive iodine,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
864,Females,Cartilaginous exostosis,0
865,Etiology aspects,Acantholytic squamous cell carcinoma,0
866,Group A (qualifier value),Spongiotic dermatitis,0
867,High Risk Acute Leukemia,BRCA2 Syndrome,0
868,Virus,Cartilaginous exostosis,0
869,Publications,Kaposi's sarcoma of extrahepatic bile duct,0
870,United States,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
871,Genetic Risk,Stage IB Pancreatic Cancer AJCC v8,0
872,Bounded by,Ovarian germ cell choriocarcinoma stage IV,0
873,Liquid substance,Benign neoplasm of eye,0
874,Benign Neoplasm,Undifferentiated Neuroblastoma,0
875,Cell Count,BRCA2 Syndrome,0
876,What subject filter - Result,Localized Askin Tumor,0
877,GORAB gene,Pancreatic carcinoma,0
878,Entity,Stage IV Colorectal Cancer AJCC v8,0
879,Changing,Extracranial Neuroblastoma,0
880,Experimental Result,Mucinous cystadenofibroma,0
881,Intracranial,Testicular cancer metastatic,0
882,Subtype (attribute),Botryoid-Type Embryonal Rhabdomyosarcoma,0
883,Tryptophanase,Tubal Hyperplasia,0
884,Occurrence,Platinum-Resistant Lung Small Cell Carcinoma,0
885,Aggressive course,Grade 3a Malignant Neoplasm,0
886,Aromatase,Adrenal Rest Tumor,0
887,VARIOUS DRUG CLASSES IN ATC,Squamous cell carcinoma of lip,0
888,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
889,T-Lymphocyte,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
890,Fallopian Tubes,Mucinous cystadenofibroma,0
891,Symptoms,Stage IV Childhood Non-Hodgkin Lymphoma,0
892,Bacteria present,Cervical Fibroepithelial Polyp,0
893,Increased,Intracortical osteosarcoma,0
894,Sarcoma,Xeroderma pigmentosum,0
895,Poverty,Pancreatic carcinoma,0
896,Drop - Unit of Volume,Cancer of Urinary Tract,0
897,Obesity,Blepharal carcinoma,0
898,operate <remove>,FIGO Stage IVA Ovarian Cancer,0
899,Did not receive therapy or drug for,Adult Hepatocellular Carcinoma,0
900,Occur (action),Localized Ewing Sarcoma,0
901,*Type - Kind of quantity,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
902,Chemotherapy,Carcinoma of submandibular gland,0
903,Primary malignant neoplasm,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
904,Body structure,Bladder squamous cell carcinoma stage I,0
905,Definitely Related to Intervention,Tubal Hyperplasia,0
906,therapeutic aspects,Parathyroid Gland Adenocarcinoma,0
907,High,Locally Advanced Soft Tissue Sarcoma,0
908,Appearance of eyelid,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
909,Tissue Specimen Code,Cervical Squamous Intraepithelial Neoplasia,0
910,Systemic disease,Stage III Cutaneous Melanoma AJCC v6,0
911,Mutation,Multiple Endocrine Neoplasia,0
912,Floor - story of building,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
913,High,Stage III Adult Immunoblastic Lymphoma,0
914,Include (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
915,Shapes,Liver Lymphangioma,0
916,Increased,Fibroadenoma of breast,0
917,Testis,adenosquamous carcinoma of breast,0
918,Gait normal,Refractory Barrett Esophagus,0
919,Bile duct carcinoma,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
920,Cancer Genus,Colorectal High Grade B-Cell Lymphoma,0
921,Body tissue,Central Nervous System Yolk Sac Tumor,0
922,Drop (unit of presentation),Intraepithelial Melanocytic Hyperplasia,0
923,Term (temporal),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
924,Secretory Vesicles,Small cell neuroendocrine carcinoma of bladder,0
925,Definition,Kaposi's sarcoma of extrahepatic bile duct,0
926,70%,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
927,Body tissue,Central Nervous System Yolk Sac Tumor,0
928,Tumor stage,Brain Tumor,0
929,Sounding,Spermatocytic seminoma,0
930,Qualitative form,Acute Undifferentiated Leukemia,0
931,combination - answer to question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
932,Septicemia,Splenic Manifestation of Hairy Cell Leukemia,0
933,Therapeutic radiology procedure,Cerebral hemangioma,0
934,Hemoptysis,Maxillary Sinus Adenoid Cystic Carcinoma,0
935,Togo,Nasal cavity carcinoma,0
936,Diffuse,Kaposi's sarcoma of skin,0
937,Inguinal part of abdomen,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
938,Mental association,Malignant Testicular Sertoli Cell Tumor,0
939,Concern,Ovarian Dermoid Cyst with Secondary Carcinoma,0
940,Rare,Mixed astrocytoma-ependymoma,0
941,Pain NOS,Anaplastic large cell lymphoma,0
942,Breast Feeding,Malignant neoplasm of gallbladder,0
943,Disease,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
944,Significant,Mucinous neoplasm,0
945,Group A (blood group),Adrenal Rest Tumor,0
946,Human body,Stage III Cutaneous Melanoma AJCC v6,0
947,Reflecting,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
948,Rhabdomyosarcoma,Melanomatosis,0
949,Sectioning technique,Splenic Manifestation of Hairy Cell Leukemia,0
950,Erythrocytes,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
951,Documented,Metastatic Carcinoma in the Lung,0
952,Sharing (Social Behavior),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
953,Stomach Carcinoma,FIGO Stage IVA Ovarian Cancer,0
954,Help document,Basal Cell Ameloblastoma,0
955,Menopause,Recurrent Uveal Melanoma,0
956,Occur (action),Bladder squamous cell carcinoma stage I,0
957,Chemotherapy Regimen,Advanced Uterine Corpus Carcinosarcoma,0
958,Time,Cerebral hemangioma,0
959,Apply,Kaposi's sarcoma of extrahepatic bile duct,0
960,Neoplasms,Colorectal High Grade B-Cell Lymphoma,0
961,Manufactured form,Neonatal leukemia,0
962,Classification of information,Serous cystadenocarcinoma ovary,0
963,Radiation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
964,Antibiotics,ROSE Cluster 3,0
965,Thyroid Neoplasm,Ovarian germ cell choriocarcinoma stage IV,0
966,Childhood Ependymoma,Ovarian germ cell choriocarcinoma stage IV,0
967,Dyspareunia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
968,head of bed,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
969,Recommendation,Testicular cancer metastatic,0
970,Macrophage count,Acantholytic squamous cell carcinoma,0
971,Singular,FIGO Stage II Ovarian Cancer,0
972,majority,Choroid Necrotic Melanoma,0
973,Tumor of exocrine pancreas,Precursor B-lymphoblastic lymphoma stage II,0
974,Spinal Cord Injuries,Human Papillomavirus-Related Carcinoma,0
975,System (unit of presentation),Spongiotic dermatitis,0
976,Suspected qualifier,clear cell adenocarcinoma of gallbladder,0
977,Decision,gliosarcoma,0
978,rapid diagnosis,Recurrent Uveal Melanoma,0
979,Used by,Cervical Fibroepithelial Polyp,0
980,Frequently,Stage IB Lung Cancer AJCC v7,0
981,pharmacotherapeutic,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
982,Exposure to asbestos,Neonatal leukemia,0
983,Tissue Specimen Code,Kaposi's sarcoma of extrahepatic bile duct,0
984,dendritic spine neck,Recurrent Primary Lymphoma of Bone,0
985,Albumins,Airway Hemangioma,0
986,Adult Lymphoma,Benign Anal Granular Cell Tumor,0
987,Gastrointestinal tract structure,Blepharal carcinoma,0
988,Bothered by Night Sweats,Extra-Adrenal Paraganglioma,0
989,Testis present,Stage IV Penile Cancer AJCC v7,0
990,Stem of Organ,Bladder squamous cell carcinoma stage I,0
991,Show,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
992,Occur (action),Childhood Thyroid Gland Follicular Carcinoma,0
993,Hemopoietic stem cell transplant,Childhood Central Nervous System Ganglioneuroblastoma,0
994,Experimental Result,Tongue Alveolar Soft Part Sarcoma,0
995,Neuroendocrine Tumors,Chronic Myelomonocytic Leukemia-2,0
996,Symptoms aspect,Anterior Urethral Malignant Neoplasm,0
997,Blood,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
998,Head - Component of Device,Pancreatic Endocrine Carcinoma,0
999,Mixed (qualifier value),Microcystic meningioma,0
1000,Malignant Neoplasms,Liver Lymphangioma,0
1001,Lymphoma,Peripheral primitive neuroectodermal tumor of soft tissue,0
1002,Nursing interventions,Ovarian germ cell choriocarcinoma stage IV,0
1003,Skin,Endometrial Small Cell Carcinoma,0
1004,High,Human Papillomavirus-Related Carcinoma,0
1005,Time (foundation metadata concept),Brain Tumor,0
1006,Oncogene ErbB2,Fibroadenoma of breast,0
1007,Esthesia,ROSE Cluster 3,0
1008,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,Refractory Barrett Esophagus,0
1009,Polyp of large intestine,Childhood Lung Non-Small Cell Carcinoma,0
1010,Surgical service,Parathyroid Gland Adenocarcinoma,0
1011,Determined by,Bladder squamous cell carcinoma stage I,0
1012,Cell positive for CD34 antigen,Thymic Clear Cell Carcinoma,0
1013,Duplicate,Stage 0 Lip Carcinoma,0
1014,tuber cinereum,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1015,Time,Basal Cell Ameloblastoma,0
1016,Symptoms aspect,Adult Acute Eosinophilic Leukemia,0
1017,Population Median,Stage IB Pancreatic Cancer AJCC v8,0
1018,Either,Recurrent Testicular Lymphoma,0
1019,Antibiotics for systemic use,Stage IB Pancreatic Cancer AJCC v8,0
1020,Congenital phimosis,Localized Ewing Sarcoma,0
1021,Localized,Acute lymphadenitis,0
1022,Child,Human Papillomavirus-Related Carcinoma,0
1023,Frequently,Thyroid Hurthle Cell Carcinoma,0
1024,Adult Glioblastoma,Bladder adenocarcinoma stage IV,0
1025,Lymphoid Tissue,Contact dermatitis due to alkali,0
1026,Percent normal,Recurrent Testicular Lymphoma,0
1027,Stomach Carcinoma,ALK positive large B-cell lymphoma,0
1028,Published Comment,Intracortical osteosarcoma,0
1029,Occur (action),Refractory Ependymoma,0
1030,Usual,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1031,Gestational trophoblastic disease,Benign squamous cell tumor,0
1032,Reduced,Unfavorable Non-Hodgkin Lymphoma,0
1033,Techniques,FIGO Stage IVA Ovarian Cancer,0
1034,CEL gene,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1035,british,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1036,Approach,Refractory Ependymoma,0
1037,leukemia,Intestinal Neuroendocrine Carcinoma,0
1038,lobe,Childhood Anaplastic Large Cell Lymphoma,0
1039,1000000,Human Papillomavirus-Related Carcinoma,0
1040,Usual,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1041,Occurrence Indicator,Recurrent Rhabdomyosarcoma,0
1042,Characteristics,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1043,Pain,Malignant melanoma of eyelid,0
1044,Human Papilloma Virus Vaccine,Medulloblastoma,0
1045,Togo,adenosquamous carcinoma of breast,0
1046,low confidentiality,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1047,Anterior portion of neck,Basal Cell Ameloblastoma,0
1048,radiotherapeutic,Colorectal Neuroendocrine Tumor G2,0
1049,Africa,Unicystic ameloblastoma,0
1050,Adulthood,Recurrent Testicular Lymphoma,0
1051,2+ Score,Carcinoma of urinary bladder,0
1052,colon function,Precursor B-lymphoblastic lymphoma stage II,0
1053,High Level,Pilocytic astrocytoma of cerebellum,0
1054,Only - dosing instruction fragment,Extra-Adrenal Paraganglioma,0
1055,Include (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
1056,Usually,Benign squamous cell tumor,0
1057,Constant (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1058,include - SetOperator,Childhood Central Nervous System Ganglioneuroblastoma,0
1059,Neoplasm Metastasis,Acute Undifferentiated Leukemia,0
1060,Adult human body,Benign squamous cell tumor,0
1061,Derived value,Toxic Epidermal Necrolysis,0
1062,red Patches,Hyperplasia of pituitary gland,0
1063,Homo sapiens,Primary Cutaneous Plasmablastic Lymphoma,0
1064,Group A (blood group),Diffuse malignant mesothelioma,0
1065,Entity Determiner - specific,Uterine Cancer,0
1066,Abnormal result,Testicular cancer metastatic,0
1067,Known,Clonal Hematopoiesis of Indeterminate Potential,0
1068,allowing,Extra-Adrenal Paraganglioma,0
1069,Autumn,Microcystic meningioma,0
1070,Intestines,Spermatocytic seminoma,0
1071,Meaning,Bladder squamous cell carcinoma stage I,0
1072,Cell Count,sarcoma of spinal cord,0
1073,Hepatic Involvement,Bladder adenocarcinoma stage IV,0
1074,Assortment,Angiosarcoma of liver,0
1075,Tissue Specimen Code,Intraepithelial Melanocytic Hyperplasia,0
1076,Present,Adult Acute Eosinophilic Leukemia,0
1077,Indication of (contextual qualifier),Benign squamous cell tumor,0
1078,Type of complication:Type:Pt:^Patient:Nom,Mixed parotid tumor,0
1079,Dental Cavity Lining,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1080,risk factors - observation list,Cystadenocarcinoma,0
1081,Spreading (qualifier value),Neonatal leukemia,0
1082,Infrequent,Childhood Choriocarcinoma,0
1083,Cancer Genus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1084,Germ,Serous cystadenocarcinoma ovary,0
1085,Mental blocking,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1086,Joints,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1087,Vaginal (intended site),Recurrent Uveal Melanoma,0
1088,Physical findings,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1089,EPO protein,Refractory Barrett Esophagus,0
1090,10%,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
1091,Sometimes,FIGO Stage II Ovarian Cancer,0
1092,Hematology+Oncology,Engraftment syndrome,0
1093,Help document,embryonal rhabdomyosarcoma of prostate,0
1094,Mixed Neoplasm,Multiple Skull Base Meningiomas,0
1095,combination of objects,Benign Apocrine Neoplasm,0
1096,Lymphocyte Activation,Cervical Squamous Intraepithelial Neoplasia,0
1097,Rest,Pancreatic Intraepithelial Neoplasia-3,0
1098,Cervix carcinoma,Small intestine carcinoma,0
1099,Logical Condition,Medulloblastoma,0
1100,Four,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1101,Common Specifications in HL7 V3 Publishing,Blepharal carcinoma,0
1102,Due to,Mucinous cystadenofibroma,0
1103,Less Than,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1104,Primary mucinous cystadenocarcinoma of lung,Recurrent Testicular Lymphoma,0
1105,Evaluation procedure,Stage 0 Lip Carcinoma,0
1106,Back,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1107,Administration procedure,Type II Endometrial Adenocarcinoma,0
1108,Poor - grade value,Diffuse malignant mesothelioma,0
1109,IPSS Risk Category Low,Bladder adenocarcinoma stage IV,0
1110,Inferior,Choroid Necrotic Melanoma,0
1111,Persons,Cartilaginous exostosis,0
1112,Process (qualifier value),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
1113,Onset of (contextual qualifier),Locally Advanced Carcinoma,0
1114,treatment options,Adult Anaplastic Oligodendroglioma,0
1115,Retraction (finding),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1116,Hematology procedure,Breast Ductal Adenoma,0
1117,Rare,Mixed astrocytoma-ependymoma,0
1118,Exogenous Factors,Cervical Fibroepithelial Polyp,0
1119,Retinoic Acid Response Element,Ovarian germ cell choriocarcinoma stage IV,0
1120,Body structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1121,Manufactured form,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1122,Identical,Thyroid Hurthle Cell Carcinoma,0
1123,Cause of Death,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1124,New Zealand Rabbits,Microcystic meningioma,0
1125,Singular,Lipoma of small intestine,0
1126,Carcinoma,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1127,Common (qualifier value),Tongue Alveolar Soft Part Sarcoma,0
1128,Form:Finding:Point in time:{Setting}:Document:{Role},Ovarian germ cell choriocarcinoma stage IV,0
1129,Fever,Refractory Barrett Esophagus,0
1130,Chromosomal translocation,Cancer of Urinary Tract,0
1131,Immune,Refractory Bladder Carcinoma,0
1132,Advanced phase,Noninfiltrating Intraductal Carcinoma,0
1133,Primary malignant neoplasm,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1134,Recurrence (disease attribute),Recurrent Uveal Melanoma,0
1135,Chemotherapy Regimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1136,Urine looks dark,Recurrent Uveal Melanoma,0
1137,Full,squamous cell carcinoma of the thyroid gland,0
1138,Blood Circulation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1139,Biological Transport,Clonal Hematopoiesis of Indeterminate Potential,0
1140,Adult Ependymoma,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
1141,Hormone replacement therapy,Pancreatic carcinoma,0
1142,Cause of Death,Refractory Ependymoma,0
1143,Benzene,Refractory Ependymoma,0
1144,Feature,Malignant neoplasm of thalamus,0
1145,Blood Vessel,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1146,Qualitative form,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1147,depend,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1148,Treatment Effectiveness,Nasal cavity carcinoma,0
1149,low confidentiality,Melanomatosis,0
1150,History of previous events,Localized Askin Tumor,0
1151,Leading,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1152,MOSTLY,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1153,Slow,Thyroid Hurthle Cell Carcinoma,0
1154,4+ Answer to question,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
1155,Administration procedure,Stage III Cutaneous Melanoma AJCC v6,0
1156,Light Microscopy,Acute Undifferentiated Leukemia,0
1157,Weight measurement scales,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1158,Body Site Modifier - Lower,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1159,Usual,gliosarcoma,0
1160,Possible,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1161,Medical Imaging,Clonal Hematopoiesis of Indeterminate Potential,0
1162,antibiotics,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1163,Delta (difference),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1164,cancer risk,Refractory Bladder Carcinoma,0
1165,Lymphocyte,Peripheral primitive neuroectodermal tumor of soft tissue,0
1166,Occurrence Indicator,Adult Acute Eosinophilic Leukemia,0
1167,Olfactory system,Ovarian germ cell choriocarcinoma stage IV,0
1168,Irregular,Testicular cancer metastatic,0
1169,Take,Adult Hepatocellular Carcinoma,0
1170,Exception - Property or Attribute,FIGO Stage IVA Ovarian Cancer,0
1171,Pharmaceutical Preparations,Small cell neuroendocrine carcinoma of bladder,0
1172,Dorsal,Malignant Testicular Sertoli Cell Tumor,0
1173,Qualitative form,Ichthyosis,0
1174,Pure Spanish horse breed (organism),Refractory Bladder Carcinoma,0
1175,Treating,Airway Hemangioma,0
1176,Itchiness,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1177,Thyroid Gland Tissue,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1178,Diagnosis Study,Refractory Bladder Carcinoma,0
1179,Leakage,Stage IV Childhood Non-Hodgkin Lymphoma,0
1180,unknown vaccine or immune globulin,Brain Tumor,0
1181,Exposure to radiation,Childhood Central Nervous System Ganglioneuroblastoma,0
1182,therapeutic aspects,High Grade Glandular Intraepithelial Neoplasia,0
1183,Usual Severity Vomiting,Splenic Manifestation of Hairy Cell Leukemia,0
1184,Prostate,Splenic Manifestation of Hairy Cell Leukemia,0
1185,Inferior esophageal sphincter structure,Giant cell angiofibroma,0
1186,High Mitosis-Karyorrhexis Index,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1187,Formation,Benign squamous cell tumor,0
1188,Base - General Qualifier,Small cell neuroendocrine carcinoma of bladder,0
1189,Medical Device Emits Smoke,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1190,Pathological Dilatation,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1191,Biomaterial Treatment,Adult Acute Eosinophilic Leukemia,0
1192,Diffuse Large B-Cell Lymphoma,Intestinal Neuroendocrine Carcinoma,0
1193,Latch Device,Childhood Choriocarcinoma,0
1194,eTMF Content Model Code,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1195,To,Vaginal Adenoid Cystic Carcinoma,0
1196,Science of Morphology,Basal Cell Ameloblastoma,0
1197,Causing,Malignant Neoplasm with Regional Lymph Node Involvement,0
1198,Uterus,Medulloblastoma,0
1199,Females,Choroid Epithelioid Cell Melanoma,0
1200,Pruritus,Non-Metastatic Gestational Trophoblastic Tumor,0
1201,Hematological Disease,Basal Cell Ameloblastoma,0
1202,Body cavities,Cancer of Urinary Tract,0
1203,SPINK5 gene,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
1204,Signet ring cell,Locally Advanced Carcinoma,0
1205,Have Shortness of Breath question,Childhood Central Nervous System Immature Teratoma,0
1206,Autosomal hereditary disorder,Metastatic Lung Neuroendocrine Neoplasm,0
1207,Five-year Survival Rate,Squamous cell carcinoma of lip,0
1208,Sore to touch,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
1209,Occurrence Indicator,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1210,Formation,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1211,Solid Dose Form,Stage IB Lung Cancer AJCC v7,0
1212,Negation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1213,Present,Platinum-Resistant Lung Small Cell Carcinoma,0
1214,Science of Etiology,Acute Undifferentiated Leukemia,0
1215,Abnormal Cell Count,Engraftment syndrome,0
1216,Secretory Vesicles,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1217,Immunotherapy,Colorectal High Grade B-Cell Lymphoma,0
1218,respiratory,Cystadenocarcinoma,0
1219,Tentorium cerebelli,Splenic Manifestation of Hairy Cell Leukemia,0
1220,Ultrasonics (sound),Childhood Fibrillary Astrocytoma,0
1221,Status post,Unresectable Rhabdomyosarcoma,0
1222,Immunotherapy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1223,Occurrence,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1224,Occur (action),gliosarcoma,0
1225,diagnosis aspect,Childhood Central Nervous System Ganglioneuroblastoma,0
1226,Four,Carcinomatosis of peritoneal cavity,0
1227,low confidentiality,Chest Wall Fibromatosis,0
1228,1000000,ROSE Cluster 3,0
1229,Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1230,Treating,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1231,CD44 wt Allele,FIGO Stage II Ovarian Cancer,0
1232,Malignant neoplasm of testis,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1233,Characteristics,embryonal rhabdomyosarcoma of prostate,0
1234,Muscle (organ),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1235,Pharmacotherapy,Chondrosarcoma,0
1236,True,Recurrent Testicular Lymphoma,0
1237,To,Precursor B-lymphoblastic lymphoma stage II,0
1238,Common Specifications in HL7 V3 Publishing,Unresectable Rhabdomyosarcoma,0
1239,Examination,Gallbladder Adenocarcinoma,0
1240,Difficulty walking,Refractory Ependymoma,0
1241,Compressing (action),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
1242,Gland,Adult Brain Stem Mixed Glioma,0
1243,Common Specifications in HL7 V3 Publishing,Engraftment syndrome,0
1244,Biological Response Modifiers,Refractory Barrett Esophagus,0
1245,Progress,Hyperplasia of pituitary gland,0
1246,Biopsy,Stage I Adult Non-Hodgkin Lymphoma,0
1247,Lacking,Cervical Adenomyoma,0
1248,Secondary to,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1249,Common (qualifier value),Metastatic Ductal Breast Carcinoma,0
1250,diagnosis aspect,Tonsillar Carcinoma,0
1251,World,Malignant neoplasm of choroid,0
1252,Sunburn,Kaposi's sarcoma of extrahepatic bile duct,0
1253,Skin,sarcoma of spinal cord,0
1254,Milliampere second,Carcinomatosis of peritoneal cavity,0
1255,Exploratory incision,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1256,800,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1257,survival aspects,GIANT PIGMENTED HAIRY NEVUS,0
1258,combination - answer to question,Airway Hemangioma,0
1259,Singular,Thyroid Hurthle Cell Carcinoma,0
1260,Lower lip structure,Thyroid carcinoma,0
1261,Sarcoma - category (morphologic abnormality),Endometrial Small Cell Carcinoma,0
1262,Adult Pilocytic Astrocytoma,Bladder Neuroendocrine Neoplasm,0
1263,Adrenal Cortex Hormones,Hyperplasia of pituitary gland,0
1264,include - SetOperator,Cancer of Urinary Tract,0
1265,Malignant neoplasm of soft tissue,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1266,[AA000] INTRODUCTION,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
1267,shared attribute,Platinum-Resistant Lung Small Cell Carcinoma,0
1268,Myasthenia Gravis,Stage III Cutaneous Melanoma AJCC v6,0
1269,Structure of collecting tubule,FIGO Stage II Ovarian Cancer,0
1270,IPSS Risk Category High,embryonal rhabdomyosarcoma of prostate,0
1271,CDISC SEND Tumor Findings Results Terminology,Malignant melanoma of eyelid,0
1272,Ionizing radiation,Giant cell angiofibroma,0
1273,second (number),Noninfiltrating Intraductal Carcinoma,0
1274,Tired,Non-Hodgkin Lymphoma During Pregnancy,0
1275,Cause of death:Find:Pt:^Patient:Nom,Squamous cell carcinoma of lip,0
1276,Include (action),Cervical Squamous Intraepithelial Neoplasia,0
1277,serotonin secretion,Malignant neoplasm of thalamus,0
1278,Child,Stage III Cutaneous Melanoma AJCC v6,0
1279,Thrombopoietin,Recurrent Testicular Lymphoma,0
1280,treatment - ActInformationManagementReason,Mucinous adenocarcinoma gastric,0
1281,Estimated,Adult Hepatocellular Carcinoma,0
1282,SPACA9 gene,Secondary malignant neoplasm of lymph node,0
1283,Grouping,Ovarian germ cell choriocarcinoma stage IV,0
1284,radiotherapeutic,FIGO Stage IVA Ovarian Cancer,0
1285,1000000,Tumorlet,0
1286,Mast Cell Count,Acute Undifferentiated Leukemia,0
1287,Rectum,Gallbladder Adenocarcinoma,0
1288,Primary operation,Fibroadenoma of breast,0
1289,Neoplastic disease,Localized Ewing Sarcoma,0
1290,Plasma,Localized Malignant Neoplasm,0
1291,Derivation,Basal Cell Ameloblastoma,0
1292,How Often Weight Loss,Digestive System Hodgkin Lymphoma,0
1293,Adult Glioblastoma,Refractory Bladder Carcinoma,0
1294,depend,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1295,Genus Homo,Small cell neuroendocrine carcinoma of bladder,0
1296,Root body part,Benign squamous cell tumor,0
1297,Neuroglia,Type II Endometrial Adenocarcinoma,0
1298,Cystic,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1299,PCYT1A wt Allele,Platinum-Resistant Lung Small Cell Carcinoma,0
1300,Hypoalbuminemia,ROSE Cluster 3,0
1301,Tumor stage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1302,Advanced phase,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1303,Mild pain,Digestive System Hodgkin Lymphoma,0
1304,Surgical advancement - action,Locally Advanced Squamous Cell Carcinoma,0
1305,Forecast of outcome,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1306,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
1307,Immune System Finding,Splenic Manifestation of Hairy Cell Leukemia,0
1308,common types,Malignant neoplasm of olfactory nerve,0
1309,65+,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1310,Adenocarcinoma,Stage I Adult Non-Hodgkin Lymphoma,0
1311,Case (situation),Digestive System Hodgkin Lymphoma,0
1312,Nicotiana,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1313,leukemia,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
1314,stem cell factor receptor activity,Basal Cell Ameloblastoma,0
1315,Neoplasms,Refractory Ependymoma,0
1316,VARIOUS DRUG CLASSES IN ATC,Carcinoma,0
1317,Tissue Growth,Intestinal Metaplasia of Bladder Urothelium,0
1318,Personal appearance,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1319,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Rhabdomyosarcoma with ganglionic differentiation,0
1320,Negation,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
1321,Smaller,Stage I Adult Non-Hodgkin Lymphoma,0
1322,Disease remission,Epithelioid Sarcoma NCI Grade 3,0
1323,Complete Trisomy 21 Syndrome,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1324,Recurrence,Digestive System Hodgkin Lymphoma,0
1325,Including (qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1326,Specimen Source Codes - tumor,Pancreatic Endocrine Carcinoma,0
1327,Number of birth,Clonal Hematopoiesis of Indeterminate Potential,0
1328,Fever,Small cell neuroendocrine carcinoma of bladder,0
1329,Tryptophanase,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1330,Growth abnormality,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1331,Specimen Source Codes - tumor,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1332,Annual,Mucinous neoplasm,0
1333,pharmacotherapeutic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1334,Blood,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1335,Usual Severity Itching,Adenocarcinoma,0
1336,Sinus - general anatomical term,Low Grade Squamous Intraepithelial Neoplasia,0
1337,Combined,Diffuse malignant mesothelioma,0
1338,inflammatory,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1339,Cisplatin,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1340,Blood,Xeroderma pigmentosum,0
1341,Diameter (qualifier value),Microcystic meningioma,0
1342,Proton Pump Inhibitors [MoA],Tubal Hyperplasia,0
1343,pharmacotherapeutic,Childhood Extragonadal Malignant Germ Cell Tumor,0
1344,Fine needle aspiration biopsy,Adenocarcinoma,0
1345,Persons,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1346,10%,Mucinous cystadenofibroma,0
1347,Child,Kaposi's sarcoma of extrahepatic bile duct,0
1348,Specimen Source Codes - tumor,Acinar cell carcinoma of pancreas,0
1349,cell transformation,Transitional cell carcinoma,0
1350,Chemotherapy Regimen,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1351,Eye protection,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1352,Biopsy,Prostate Lymphoma,0
1353,Rapid,Stage II Hepatocellular Carcinoma AJCC v8,0
1354,include - SetOperator,Recurrent Testicular Lymphoma,0
1355,Estrogen Receptor Measurement,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1356,Malignancy,Recurrent Testicular Lymphoma,0
1357,Related personal status,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1358,Histopathology,Non-Metastatic Gestational Trophoblastic Tumor,0
1359,Tumor Cell Invasion,Locally Advanced Squamous Cell Carcinoma,0
1360,Plumbum metallicum,Breast Apocrine Adenoma,0
1361,To,Small intestine carcinoma,0
1362,Very rare,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1363,Consequence of,Adult Alveolar Soft Part Sarcoma,0
1364,Patients,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1365,International Classification of Disease for Oncology,Digestive System Hodgkin Lymphoma,0
1366,Sexually active,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1367,Concept model domain,Adult Alveolar Soft Part Sarcoma,0
1368,Have Pain,Splenic Manifestation of Hairy Cell Leukemia,0
1369,Death (finding),Recurrent Uveal Melanoma,0
1370,T lymphocyte marker,Endometrial Small Cell Carcinoma,0
1371,Symptoms,Primary Cutaneous Plasmablastic Lymphoma,0
1372,To,Engraftment syndrome,0
1373,Neoplasms,Female Breast Carcinoma,0
1374,2+ Score,Vaginal Adenoma,0
1375,Blood group A (finding),Tongue Alveolar Soft Part Sarcoma,0
1376,Child,Cerebral Primitive Neuroectodermal Tumor,0
1377,Reduced,ROSE Cluster 3,0
1378,Colon structure (body structure),Benign neoplasm of thorax,0
1379,Cessation of life,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
1380,Percent (qualifier value),Testicular cancer metastatic,0
1381,Therapeutic procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1382,Shortness of Breath Visual Analogue Scale,Rhabdomyosarcoma with ganglionic differentiation,0
1383,Covers (device),Stage IB Pancreatic Cancer AJCC v8,0
1384,International Classification of Diseases,Multiple Skull Base Meningiomas,0
1385,Upper urinary tract structure,Colorectal High Grade B-Cell Lymphoma,0
1386,Decade,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1387,Swollen Lymph Node,Vaginal Adenoma,0
1388,Indication of (contextual qualifier),Leiomyoma of Gallbladder,0
1389,Young Child [Disease/Finding],Squamous cell carcinoma of lip,0
1390,2+,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1391,Extension,Cancer of Urinary Tract,0
1392,Name,Benign neoplasm of thorax,0
1393,Symptoms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1394,Persons,Cancer of Urinary Tract,0
1395,Mutation,Metastatic Ductal Breast Carcinoma,0
1396,day,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1397,Exposure to radiation,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1398,include - SetOperator,Stage III Cutaneous Melanoma AJCC v6,0
1399,Used by,Angiosarcoma of liver,0
1400,Urethral Carcinoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1401,shared attribute,Squamous cell carcinoma of lip,0
1402,Sepsis,Metaplastic carcinoma of breast,0
1403,Placement action,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
1404,Skin,Refractory Bladder Carcinoma,0
1405,Skin Specimen,Benign squamous cell tumor,0
1406,International Classification of Disease for Oncology,Gallbladder adenoma,0
1407,Mammal liver preparation,Splenic Manifestation of Hairy Cell Leukemia,0
1408,Risk,Diffuse malignant mesothelioma,0
1409,Linear,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
1410,Time (foundation metadata concept),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1411,List,Adult Acute Eosinophilic Leukemia,0
1412,Including (qualifier),Squamous cell carcinoma of lip,0
1413,Did not receive therapy or drug for,Metastatic Neoplasm to the Gallbladder,0
1414,Australia,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1415,Increase,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1416,Body Parts - Canal,Microcystic meningioma,0
1417,Call (Instruction),Anterior Urethral Malignant Neoplasm,0
1418,Lung,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1419,Therapeutic radiology procedure,ROSE Cluster 3,0
1420,Drop British,Mucinous neoplasm,0
1421,member,adenosquamous carcinoma of breast,0
1422,peripheral blood,papillary carcinoma of penis,0
1423,Numerous,Small cell neuroendocrine carcinoma of bladder,0
1424,Period (temporal qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1425,include - SetOperator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1426,Out (direction),Collecting Duct Carcinoma of the Kidney,0
1427,Used by,Vaginal Adenoma,0
1428,Togo,Anterior Urethral Malignant Neoplasm,0
1429,Skin Erosion,Hyperplasia of pituitary gland,0
1430,Females,Acute lymphadenitis,0
1431,Viola tricolor,Intraepithelial Melanocytic Hyperplasia,0
1432,Obesity,Stage III Adult Immunoblastic Lymphoma,0
1433,consider,Stage IB Lung Cancer AJCC v7,0
1434,Active License,embryonal rhabdomyosarcoma of prostate,0
1435,Cessation of life,Cancer of Urinary Tract,0
1436,Clinical Observation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1437,Nerve,Blepharal carcinoma,0
1438,Metastasis,Cartilaginous exostosis,0
1439,Include (action),Refractory Ependymoma,0
1440,Colon <insect>,Deep Leiomyoma,0
1441,Skeletal bone,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1442,Lymphocyte component of blood,Locally Advanced Squamous Cell Carcinoma,0
1443,Human body structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1444,90%,Adult Acute Eosinophilic Leukemia,0
1445,Biologic Development,High Grade Glandular Intraepithelial Neoplasia,0
1446,Tobacco smoking behavior,Intraepithelial Melanocytic Hyperplasia,0
1447,Early,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1448,Mutation,Bladder squamous cell carcinoma stage I,0
1449,How Often Weight Loss,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1450,Neoplasm Metastasis,Parathyroid Gland Adenocarcinoma,0
1451,Immature,Kaposi's sarcoma of skin,0
1452,Active License,Bladder Neuroendocrine Neoplasm,0
1453,Blood,Larynx carcinoma recurrent,0
1454,Symptoms aspect,Metastatic Lung Small Cell Carcinoma,0
1455,Common (qualifier value),Adenocarcinoma,0
1456,Face,Blepharal carcinoma,0
1457,Sweating,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1458,avoidance,Extracranial Neuroblastoma,0
1459,Presentation,Metastatic Lung Neuroendocrine Neoplasm,0
1460,Diagnosis Study,Refractory Bladder Carcinoma,0
1461,Exposure to,Stage III Cutaneous Melanoma AJCC v6,0
1462,Neoplasms,non-Hodgkin's lymphoma of spleen,0
1463,Clear,Undifferentiated Neuroblastoma,0
1464,low exposure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1465,Cell Count,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1466,Therapeutic procedure,Recurrent Uveal Melanoma,0
1467,Divide,Placental aromatase deficiency,0
1468,Cell Count,Multiple Endocrine Neoplasia,0
1469,depend,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1470,CDISC SEND Tumor Findings Results Terminology,Xeroderma pigmentosum,0
1471,Cause of death:Find:Pt:^Patient:Nom,Neoplasms,0
1472,Retraction (finding),Extra-abdominal fibromatosis,0
1473,Known,Primary Cutaneous Plasmablastic Lymphoma,0
1474,Mass,Benign Apocrine Neoplasm,0
1475,Physical findings,Benign Anal Granular Cell Tumor,0
1476,Intermediate Mitosis-Karyorrhexis Index,Squamous cell carcinoma of lip,0
1477,Malignant Neoplasms,Localized Ewing Sarcoma,0
1478,Cellular Debris,Childhood Central Nervous System Ganglioneuroblastoma,0
1479,Aim,Childhood Central Nervous System Ganglioneuroblastoma,0
1480,combination of objects,Small Intestinal Villous Adenoma,0
1481,Relative (related person),benign mature teratoma of pancreas,0
1482,Human body,Ichthyosis,0
1483,Body tissue,Basal Cell Ameloblastoma,0
1484,Numerous,Platinum-Resistant Lung Small Cell Carcinoma,0
1485,Therapeutic radiology procedure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1486,United States,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1487,Acetaminophen [EPC],Stage III Adult Immunoblastic Lymphoma,0
1488,Ultra-violet,Acute Undifferentiated Leukemia,0
1489,Body Site Modifier - Lower,Methotrexate-Associated Hodgkin Lymphoma,0
1490,Primary operation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1491,Engraftment syndrome,Nasal cavity carcinoma,0
1492,In situ,Grade 1 Clear Cell Renal Cell Carcinoma,0
1493,+2,Breast Ductal Adenoma,0
1494,Acid reflux,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1495,How Often Vomiting,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1496,Benign neoplasm of paraganglion,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
1497,Mixed Cell Morphology,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
1498,Occurrence,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1499,Primary operation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1500,Entity Determiner - specific,Ampulla of Vater Tubular Adenoma,0
1501,Cells,Hodgkin Disease,0
1502,Active,Choroid Epithelioid Cell Melanoma,0
1503,Absent,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1504,Funds,Benign tumor of eyelid,0
1505,Transection (procedure),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1506,Occur (action),sarcoma of spinal cord,0
1507,Unmarried,Refractory Bladder Carcinoma,0
1508,Malignant - descriptor,Localized Ewing Sarcoma,0
1509,Free of (attribute),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1510,Occur (action),Kaposi's sarcoma of extrahepatic bile duct,0
1511,Feelings,Atypical Lobular Breast Hyperplasia,0
1512,Pediatrics,Chronic Myelomonocytic Leukemia-2,0
1513,Person Observer,Vaginal Adenoma,0
1514,Experimental Result,Stage IB Lung Cancer AJCC v7,0
1515,63,Granular Cell Leiomyosarcoma,0
1516,Togo,Benign squamous cell tumor,0
1517,Paraneoplastic Syndromes,FIGO Stage IVA Ovarian Cancer,0
1518,Dust,Lung Mucinous Cystadenoma,0
1519,Class,Clonal Hematopoiesis of Indeterminate Potential,0
1520,Most,Nasal cavity carcinoma,0
1521,N not otherwise specified Antibody,Cervical Squamous Intraepithelial Neoplasia,0
1522,Proximal,Mucinous adenocarcinoma gastric,0
1523,Squamocolumnar junction of cervix,Intestinal Metaplasia of Bladder Urothelium,0
1524,Rating (action),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1525,Eye,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1526,Immune System Finding,Pilocytic astrocytoma of cerebellum,0
1527,Fever symptoms (finding),Engraftment syndrome,0
1528,Surgical aspects,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1529,Screening procedure,Type II Endometrial Adenocarcinoma,0
1530,Operative Surgical Procedures,Stage 0 Lip Carcinoma,0
1531,Palatine Tonsil,Chronic Myelomonocytic Leukemia-2,0
1532,+2,Low Grade Squamous Intraepithelial Neoplasia,0
1533,Cardiac Lead Procedure,Xeroderma pigmentosum,0
1534,Severe (severity modifier),BRCA2 Syndrome,0
1535,Image Feature,Medulloblastoma,0
1536,Time,Ichthyosis,0
1537,Papillomavirus,Localized Askin Tumor,0
1538,respiratory,Pancreatic Intraepithelial Neoplasia-3,0
1539,Place,Small cell neuroendocrine carcinoma of bladder,0
1540,Rating (action),Hodgkin lymphoma,0
1541,2+,Splenic Manifestation of Hairy Cell Leukemia,0
1542,Weight measurement scales,Uterine Cancer,0
1543,Bone Marrow,Thyroid Hurthle Cell Carcinoma,0
1544,Therapeutic procedure,Digestive System Hodgkin Lymphoma,0
1545,year,Acute Undifferentiated Leukemia,0
1546,Less Than,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1547,Neoplasms,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
1548,Science of Etiology,Spermatocytic seminoma,0
1549,Heart,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
1550,Call (Instruction),Small cell neuroendocrine carcinoma of bladder,0
1551,spindle assembly checkpoint,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1552,Decrease,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1553,include - SetOperator,Digestive System Hodgkin Lymphoma,0
1554,per year,clear cell adenocarcinoma of gallbladder,0
1555,Call (Instruction),Carcinoma of urinary bladder,0
1556,Presentation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1557,African race,Malignant melanoma of eyelid,0
1558,Excessive,Type II Endometrial Adenocarcinoma,0
1559,Internal,Occult Lung Adenosquamous Carcinoma,0
1560,Medical Imaging,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1561,Percent of Abnormal Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1562,Including (qualifier),Cherubism,0
1563,Stage 3B,Adult Acute Eosinophilic Leukemia,0
1564,Cessation of life,Cancer of Urinary Tract,0
1565,Young Adult,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1566,Tired,Cervical Fibroepithelial Polyp,0
1567,alpha 1-Antitrypsin Deficiency,Acantholytic squamous cell carcinoma,0
1568,Dependent - ability,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
1569,West Haven Hepatic Encephalopathy Grade 3,Atypical Lobular Breast Hyperplasia,0
1570,Primary operation,Intraepithelial Melanocytic Hyperplasia,0
1571,Chemotherapy,Acinar cell carcinoma of pancreas,0
1572,Science of Morphology,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1573,Neoplasm Metastasis,Recurrent Testicular Lymphoma,0
1574,General surgery specialty,Stage III Adult Immunoblastic Lymphoma,0
1575,Beginning,Unresectable Rhabdomyosarcoma,0
1576,GUCY2C wt Allele,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1577,Breast Carcinoma,Tonsillar Carcinoma,0
1578,Case unit dose,Cancer of Urinary Tract,0
1579,Eye,Occult Lung Adenosquamous Carcinoma,0
1580,Specimen Type - Serum,Tubal Hyperplasia,0
1581,Cancer Genus,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1582,Endocrine Cells,malignant lymphoma of pancreatic lymph nodes,0
1583,Human body structure,Lung squamous cell carcinoma stage I,0
1584,Homo sapiens,Neonatal leukemia,0
1585,Table Cell Horizontal Align - left,Leiomyoma of Gallbladder,0
1586,survival aspects,Colorectal cancer,0
1587,Laboratory Procedures,Xeroderma pigmentosum,0
1588,Table Cell Horizontal Align - left,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1589,To,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1590,More,Testicular cancer metastatic,0
1591,Decrease,Pancreatic Endocrine Carcinoma,0
1592,Medical Imaging,Refractory Barrett Esophagus,0
1593,Formation,Refractory Ependymoma,0
1594,Intermediate Mitosis-Karyorrhexis Index,Adult Hepatocellular Carcinoma,0
1595,Absence (morphologic abnormality),Childhood Central Nervous System Ganglioneuroblastoma,0
1596,Talpidae,Adult Alveolar Soft Part Sarcoma,0
1597,Melanoma Pathway,Benign Anal Granular Cell Tumor,0
1598,Pure Spanish horse breed (organism),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1599,Primary malignant neoplasm,Splenic Manifestation of Hairy Cell Leukemia,0
1600,Usual,Choroid Necrotic Melanoma,0
1601,Controlling (action),Acute lymphadenitis,0
1602,Experimental Result,Kaposi's sarcoma of extrahepatic bile duct,0
1603,100%,Gallbladder Adenocarcinoma,0
1604,Ephrin Type-B Receptor 1,Benign squamous cell tumor,0
1605,10%,Endometrial Small Cell Carcinoma,0
1606,Time (foundation metadata concept),Human Papillomavirus-Related Carcinoma,0
1607,More Often than Once a Day,FIGO Stage IVA Ovarian Cancer,0
1608,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1609,Sometimes,Giant cell angiofibroma,0
1610,Affecting,Mucinous adenocarcinoma gastric,0
1611,Only - dosing instruction fragment,Airway Hemangioma,0
1612,per second,Mucinous adenocarcinoma gastric,0
1613,Antimicrobial Intermediate Susceptibility Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1614,Western Europe,Intraepithelial Melanocytic Hyperplasia,0
1615,Breaking down,Xeroderma pigmentosum,0
1616,Severities,Childhood Anaplastic Large Cell Lymphoma,0
1617,Limited stage (cancer stage),Methotrexate-Associated Hodgkin Lymphoma,0
1618,Referring,Mucinous adenocarcinoma gastric,0
1619,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1620,Tryptophanase,non-Hodgkin's lymphoma of spleen,0
1621,III (suffix),Extra-abdominal fibromatosis,0
1622,Decreased,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1623,Presentation,Thyroid Hurthle Cell Carcinoma,0
1624,Surgical aspects,Extra-abdominal fibromatosis,0
1625,Cessation of life,Werner Syndrome,0
1626,Following,Grade 3a Malignant Neoplasm,0
1627,Apply,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
1628,2+,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1629,Lung,Kaposi's sarcoma of skin,0
1630,Slightly (qualifier value),Adult Hepatocellular Carcinoma,0
1631,Limited (extensiveness),Anterior Urethral Malignant Neoplasm,0
1632,Togo,Liver Lymphangioma,0
1633,>90,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1634,Infiltration,Bladder Neuroendocrine Neoplasm,0
1635,Body Fluids,Hodgkin lymphoma,0
1636,Forecast of outcome,Small cell neuroendocrine carcinoma of bladder,0
1637,Empty (qualifier),Undifferentiated Endocervical Sarcoma,0
1638,Vaginal,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1639,Suspected diagnosis,Anaplastic large cell lymphoma,0
1640,mole changes,Unicystic ameloblastoma,0
1641,Singular,Metastatic Lung Neuroendocrine Neoplasm,0
1642,Two,Benign tumor of eyelid,0
1643,Homo sapiens,Choroid Epithelioid Cell Melanoma,0
1644,MOSTLY,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1645,Malignant - descriptor,Congenital hamartoma,0
1646,milliliter,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1647,Cessation of life,Cerebral Primitive Neuroectodermal Tumor,0
1648,Group A (qualifier value),Thymic Clear Cell Carcinoma,0
1649,Visible,Localized Askin Tumor,0
1650,Type - attribute,Refractory Ependymoma,0
1651,Contain (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1652,Primary,Diffuse malignant mesothelioma,0
1653,Scaling,Adult Alveolar Soft Part Sarcoma,0
1654,Code,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1655,Result,Breast Apocrine Adenoma,0
1656,Language Ability - Sign,Epithelioid Sarcoma NCI Grade 3,0
1657,Placenta,Papillary squamous cell carcinoma,0
1658,Follicle,FIGO Stage II Ovarian Cancer,0
1659,survive,Colorectal High Grade B-Cell Lymphoma,0
1660,Frequently,Brain Tumor,0
1661,Tissue Growth,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1662,Progress,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1663,Life Threatening,Squamous cell carcinoma of lip,0
1664,Tryptophanase,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1665,How Often Weight Loss,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1666,Weight decreased,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1667,Name (property) (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1668,Treating,Refractory Ependymoma,0
1669,Olfactory Mucosa,Small Intestinal Villous Adenoma,0
1670,therapeutic aspects,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1671,Patient Reported Outcome Stem,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1672,Extracellular Vesicles,Metastatic Lung Small Cell Carcinoma,0
1673,First (number),Germinoma,0
1674,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Recurrent Testicular Lymphoma,0
1675,Five,Cervical Fibroepithelial Polyp,0
1676,Magnetic Resonance Imaging Study File,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1677,Mathematical Factor,FIGO Stage IVA Ovarian Cancer,0
1678,Small,Benign neoplasm of thorax,0
1679,Skin Specimen,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1680,second (number),Recurrent Primary Lymphoma of Bone,0
1681,Consistency,Choroid Epithelioid Cell Melanoma,0
1682,Two,Maxillary Sinus Adenoid Cystic Carcinoma,0
1683,In Blood,Digestive System Hodgkin Lymphoma,0
1684,Approximate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1685,Including (qualifier),Papillary squamous cell carcinoma,0
1686,Group Object,Diffuse malignant mesothelioma,0
1687,Frequently,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1688,Manufactured sign,Uterine Cancer,0
1689,survival aspects,Primary Cutaneous Plasmablastic Lymphoma,0
1690,Extent of disease,Multiple Skull Base Meningiomas,0
1691,Death Related to Adverse Event,Serous cystadenocarcinoma ovary,0
1692,Enzyme (disposition),Childhood Lymphoma,0
1693,survival aspects,papillary carcinoma of penis,0
1694,Plumbum metallicum,Mucosal Melanoma,0
1695,Golden retriever,Adenocarcinoma of duodenum,0
1696,Tryptophanase,Childhood Central Nervous System Ganglioneuroblastoma,0
1697,peripheral blood,Mucosal Melanoma,0
1698,Including (qualifier),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1699,Problems - What subject filter,Tonsillar Carcinoma,0
1700,Cancer Genus,Epithelioid Sarcoma NCI Grade 3,0
1701,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1702,Vocal cord structure,Locally Advanced Epithelioid Hemangioendothelioma,0
1703,activate - Data Operation,Cervical Adenomyoma,0
1704,In Urine,Brain Ependymoma,0
1705,Decrease,Clonal Hematopoiesis of Indeterminate Potential,0
1706,Smear test,Hodgkin Disease,0
1707,Often - answer to question,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1708,Appearance,Cervical Fibroepithelial Polyp,0
1709,cell growth,Testicular cancer metastatic,0
1710,Mammal liver preparation,Pancreatic carcinoma,0
1711,dependent,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1712,Leading,Recurrent Testicular Lymphoma,0
1713,Body structure,Acantholytic squamous cell carcinoma,0
1714,Smaller,Malignant Neoplasm with Regional Lymph Node Involvement,0
1715,Presumed Benign,Benign neoplasm of thorax,0
1716,Increased risk for cancer,Type II Endometrial Adenocarcinoma,0
1717,red Patches,Basal Cell Ameloblastoma,0
1718,One,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1719,Symptoms aspect,BRCA2 Syndrome,0
1720,Stomach,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1721,Brain Neoplasms,Thyroid Hurthle Cell Carcinoma,0
1722,Form:Finding:Point in time:{Setting}:Document:{Role},Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1723,Copy (object),Cherubism,0
1724,Geographic Locations,Pancreatic Intraepithelial Neoplasia-3,0
1725,First (number),Advanced Lung Carcinoma,0
1726,Melanocytic nevus,Xeroderma pigmentosum,0
1727,intent,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1728,+2,Childhood Central Nervous System Ganglioneuroblastoma,0
1729,Term Birth,High Grade Glandular Intraepithelial Neoplasia,0
1730,Combined,Recurrent Testicular Lymphoma,0
1731,Device Motor,adenoid cystic carcinoma of lung,0
1732,Retinoic Acid Response Element,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1733,Removed,Hodgkin Disease,0
1734,Spreading (qualifier value),Bladder squamous cell carcinoma stage I,0
1735,Microplate Well,embryonal rhabdomyosarcoma of prostate,0
1736,Unmarried person,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1737,Point,Benign Anal Granular Cell Tumor,0
1738,Positive Finding,Recurrent Rhabdomyosarcoma,0
1739,Human papilloma virus infection,Nasal cavity carcinoma,0
1740,Occur (action),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1741,Neoplasms,Larynx carcinoma recurrent,0
1742,Scar Tissue,Anterior Urethral Malignant Neoplasm,0
1743,To,Angiosarcoma of liver,0
1744,Ultrasonic,clear cell adenocarcinoma of gallbladder,0
1745,Togo,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1746,Formation,Human Papillomavirus-Related Carcinoma,0
1747,depend,Refractory Barrett Esophagus,0
1748,Weight Loss,Breast Apocrine Adenoma,0
1749,Location,Breast Ductal Adenoma,0
1750,Biological Response Modifiers,Childhood Central Nervous System Ganglioneuroblastoma,0
1751,Result,Metastatic Ductal Breast Carcinoma,0
1752,Chemotherapy,Mucinous cystadenofibroma,0
1753,PSA Level Less than Two,Acute Undifferentiated Leukemia,0
1754,Rare,Squamous cell carcinoma of lip,0
1755,Packaging Case,Breast Ductal Adenoma,0
1756,Hyperlink,Airway Hemangioma,0
1757,Mass of body structure,clear cell adenocarcinoma of gallbladder,0
1758,Aspects of disease screening,Malignant Neoplasm with Regional Lymph Node Involvement,0
1759,Before,Stage 0 Penile Cancer AJCC v8,0
1760,Science of Anatomy,Human Papillomavirus-Related Carcinoma,0
1761,Rare,Toxic Epidermal Necrolysis,0
1762,Immature,Advanced Uterine Corpus Carcinosarcoma,0
1763,Formation,Rhabdomyosarcoma with ganglionic differentiation,0
1764,Hospice and Palliative Care Nursing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1765,Blood,Benign squamous cell tumor,0
1766,Used by,Kaposi's sarcoma of skin,0
1767,Li-Fraumeni Syndrome,Microcystic meningioma,0
1768,Order (taxonomic),Female Breast Carcinoma,0
1769,H2 receptor blockers,Hemangioma,0
1770,Death (finding),Unicystic ameloblastoma,0
1771,Milliampere second,Kaposi's sarcoma of skin,0
1772,shared attribute,Trabecular adenocarcinoma,0
1773,Testing,Placental aromatase deficiency,0
1774,Form of muscle,ICHTHYOSIS,0
1775,Smear - instruction imperative,Cerebral Primitive Neuroectodermal Tumor,0
1776,potential,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1777,Experimental Result,mucinous adenocarcinoma of gallbladder,0
1778,Cervical lymph node group,Precursor B-lymphoblastic lymphoma stage II,0
1779,BRCA1 protein,Necrotizing Funisitis,0
1780,National origin,Recurrent Primary Lymphoma of Bone,0
1781,Homo sapiens,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1782,Taxonomic,Type II Endometrial Adenocarcinoma,0
1783,insensitivity,Recurrent Uveal Melanoma,0
1784,Skin,Localized Malignant Neoplasm,0
1785,Cervix carcinoma,Testicular cancer metastatic,0
1786,Childhood Lymphoma,Testicular cancer metastatic,0
1787,Fever,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1788,Qualitative form,mucinous adenocarcinoma of gallbladder,0
1789,Genetic,Splenic Manifestation of Hairy Cell Leukemia,0
1790,Limited stage (cancer stage),Collecting Duct Carcinoma of the Kidney,0
1791,Malignant Vaginal Neoplasm,Small Intestinal Villous Adenoma,0
1792,Woman,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1793,removal technique,Benign Anal Granular Cell Tumor,0
1794,Affecting,mucinous adenocarcinoma of gallbladder,0
1795,Behavior,Larynx carcinoma recurrent,0
1796,Stop (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
1797,Often - answer to question,Mucinous adenocarcinoma gastric,0
1798,research subject screening,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1799,Fraction of,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1800,Course,Cerebral Primitive Neuroectodermal Tumor,0
1801,Diagnosis,Bladder squamous cell carcinoma stage I,0
1802,Desiccation,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1803,Treating,Malignant neoplasm of thalamus,0
1804,Reported Term,Acinar cell carcinoma of pancreas,0
1805,Lymph,Diffuse malignant mesothelioma,0
1806,Arising in,Pancreatic Intraepithelial Neoplasia-3,0
1807,T prime,Giant cell angiofibroma,0
1808,Unknown,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1809,Function (attribute),Botryoid-Type Embryonal Rhabdomyosarcoma,0
1810,Aspects of signs,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1811,Unknown,Secondary malignant neoplasm of lymph node,0
1812,Classical (qualifier value),Localized Ewing Sarcoma,0
1813,Urinary Bladder,Recurrent Uveal Melanoma,0
1814,Line Unit of Length,Localized Ewing Sarcoma,0
1815,Beginning,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1816,Classification,Stage III Cutaneous Melanoma AJCC v6,0
1817,Telephone Extension Number,Metastatic Kidney Carcinoma,0
1818,Usual,Occult Lung Adenosquamous Carcinoma,0
1819,Include (action),Cervical Fibroepithelial Polyp,0
1820,American College of Cardiology/American Heart Association Lesion Complexity Score A,Malignant Testicular Sertoli Cell Tumor,0
1821,Treatment Epoch,Papillary squamous cell carcinoma,0
1822,Endometrial scraping,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1823,Cover (physical object),Benign squamous cell tumor,0
1824,Absent,Placental aromatase deficiency,0
1825,Togo,Stage 0 Penile Cancer AJCC v8,0
1826,Grade IV Childhood Astrocytic Neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1827,Rare Diseases,Childhood Central Nervous System Ganglioneuroblastoma,0
1828,Clinical Study Case,Stage I Colon Neuroendocrine Tumor AJCC v8,0
1829,symbol,Medulloblastoma,0
1830,Including (qualifier),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
1831,Colon structure (body structure),Childhood Fibrillary Astrocytoma,0
1832,Needs,Stage IB Pancreatic Cancer AJCC v8,0
1833,To,Peripheral primitive neuroectodermal tumor of soft tissue,0
1834,Classification,Malignant melanoma of eyelid,0
1835,Spreading (qualifier value),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1836,Cancer Genus,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1837,Arsenic measurement,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1838,Most,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1839,How Often Weight Loss,Localized Ewing Sarcoma,0
1840,Histologic type,High Grade Glandular Intraepithelial Neoplasia,0
1841,Treatment Epoch,Mucinous adenocarcinoma gastric,0
1842,Formation,Squamous cell carcinoma of lip,0
1843,Pisum sativum (pea) extract,Recurrent Uveal Melanoma,0
1844,Qualitative form,Melanomatosis,0
1845,Sun Exposure,Trabecular adenocarcinoma,0
1846,Percent (qualifier value),FIGO Stage IVA Ovarian Cancer,0
1847,Recommendation,Benign squamous cell tumor,0
1848,Usually,Diffuse malignant mesothelioma,0
1849,Indication,Diffuse malignant mesothelioma,0
1850,Intercellular Junctions,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1851,Include (action),Maxillary Sinus Adenoid Cystic Carcinoma,0
1852,Replacement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1853,metastatic qualifier,Localized Ewing Sarcoma,0
1854,1000000,Metaplastic carcinoma of breast,0
1855,Mass of body region,Metastatic Malignant Neoplasm in the Sellar Region,0
1856,various other intestinal adsorbents in ATC,Melanomatosis,0
1857,melanoma,Activated B-cell type diffuse large B-cell lymphoma,0
1858,Malignant Neoplasms,Childhood Central Nervous System Immature Teratoma,0
1859,Involvement with,Leptomeningeal sarcoma,0
1860,<90,Recurrent Uveal Melanoma,0
1861,Pages,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
1862,Symptoms,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1863,Feel Tired question,Giant cell angiofibroma,0
1864,Fever,Endometrial Small Cell Carcinoma,0
1865,Immune system,Metastatic Lung Neuroendocrine Neoplasm,0
1866,Aspects of disease screening,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1867,Togo,Stage III Cutaneous Melanoma AJCC v6,0
1868,Stent,Ovarian germ cell choriocarcinoma stage IV,0
1869,Primary malignant neoplasm,Bladder adenocarcinoma stage IV,0
1870,Smear test,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1871,Process,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1872,Aspect - Kind of quantity,Non-Metastatic Gestational Trophoblastic Tumor,0
1873,Normal,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
1874,Pediculus humanus capitis (eukaryote),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1875,Classical Hodgkin's Lymphoma,Precursor B-lymphoblastic lymphoma stage II,0
1876,Status post,Fibroadenoma of breast,0
1877,Obesity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1878,spells (neurological symptom),Adult Hepatocellular Carcinoma,0
1879,Duct system,Splenic Manifestation of Hairy Cell Leukemia,0
1880,Physical findings,Adult Acute Eosinophilic Leukemia,0
1881,Highest,Kaposi's sarcoma of skin,0
1882,Formation,Clonal Hematopoiesis of Indeterminate Potential,0
1883,Childhood Alveolar Rhabdomyosarcoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1884,Sometimes,Metastatic Neoplasm to the Gallbladder,0
1885,Papillomavirus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1886,2+ Score,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1887,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Childhood Lymphoma,0
1888,Account number:Identifier:Point in time:^Patient:Nominal,Localized Malignant Neoplasm,0
1889,Experimental Result,Intracortical osteosarcoma,0
1890,Interventional procedure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1891,Manifest,Low Grade Squamous Intraepithelial Neoplasia,0
1892,Protective Clothing,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1893,shared attribute,Choroid Epithelioid Cell Melanoma,0
1894,2000,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1895,General Health:Find:Pt:^Patient:Ord,Diffuse malignant mesothelioma,0
1896,Use of,Cancer of Urinary Tract,0
1897,Cell Count,Ampulla of Vater Tubular Adenoma,0
1898,Smear - instruction imperative,Acute Undifferentiated Leukemia,0
1899,Container status - Identified,Angiosarcoma of liver,0
1900,Treating,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
1901,Call (Instruction),Acute Undifferentiated Leukemia,0
1902,Intention - mental process,Atypical Mesothelial Hyperplasia,0
1903,Xeroderma Pigmentosum,Neonatal leukemia,0
1904,Basis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1905,The Sun,Malignant Testicular Sertoli Cell Tumor,0
1906,Large,Endometrial Small Cell Carcinoma,0
1907,Deoxyribonucleic Acid Measurement,Benign tumor of eyelid,0
1908,bony process,Intraepithelial Melanocytic Hyperplasia,0
1909,Count of entities,Squamous cell carcinoma of lip,0
1910,Array Feature,Kaposi's sarcoma of extrahepatic bile duct,0
1911,United States,Angiosarcoma of liver,0
1912,Ultrasonics (sound),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1913,Ephrin Type-B Receptor 1,High Grade Glandular Intraepithelial Neoplasia,0
1914,Child,Stage IB Pancreatic Cancer AJCC v8,0
1915,Biopsy,Carcinomatosis of peritoneal cavity,0
1916,Cell Differentiation process,Stage III Cutaneous Melanoma AJCC v6,0
1917,Adult,Recurrent Uveal Melanoma,0
1918,Spreading (qualifier value),Malignant neoplasm of gallbladder,0
1919,Singular,Benign Anal Granular Cell Tumor,0
1920,Two,Mucinous adenocarcinoma gastric,0
1921,Immature,Unicystic ameloblastoma,0
1922,Therapeutic radiology procedure,Kaposi's sarcoma of skin,0
1923,set (group),Stage IV Penile Cancer AJCC v7,0
1924,Taxonomic,Placental aromatase deficiency,0
1925,Increased tendency to bruise,Undifferentiated Endocervical Sarcoma,0
1926,Only - dosing instruction fragment,Type II Endometrial Adenocarcinoma,0
1927,Medications,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1928,Occurrence,Undifferentiated Endocervical Sarcoma,0
1929,Including (qualifier),Adult Fibrolamellar Carcinoma,0
1930,Did not receive therapy or drug for,Epithelioid Sarcoma NCI Grade 3,0
1931,Angioma,Chest Wall Fibromatosis,0
1932,Conditional,Metastatic Malignant Neoplasm in the Sellar Region,0
1933,Hereditary,Primary Cutaneous Plasmablastic Lymphoma,0
1934,Macrophage Activation Syndrome,Childhood Anaplastic Large Cell Lymphoma,0
1935,drug companies,Noninfiltrating Intraductal Carcinoma,0
1936,Heterogeneity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1937,Operative Surgical Procedures,Adult Hepatocellular Carcinoma,0
1938,Residue on Palate,Malignant neoplasm of choroid,0
1939,Skin lesion,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1940,Feel Pain,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
1941,Reported Term,Chondrosarcoma,0
1942,Treating,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1943,Deterioration of status,Neoplasms,0
1944,Does stand alone,Carcinoma of urinary bladder,0
1945,Tryptophanase,clear cell adenocarcinoma of gallbladder,0
1946,Contain (action),Locally Advanced Carcinoma,0
1947,Reported Term,Digestive System Hodgkin Lymphoma,0
1948,Case (situation),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1949,Adult Glioblastoma,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1950,Chemotherapy Regimen,Engraftment syndrome,0
1951,Interventional procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1952,Absence (morphologic abnormality),Acute lymphadenitis,0
1953,Trachea (moth),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1954,Malignant melanoma of eye,Malignant melanoma of eyelid,0
1955,Reporting,Benign tumor of eyelid,0
1956,Blood group antibody I,Type II Endometrial Adenocarcinoma,0
1957,radiotherapeutic,Childhood Fibrillary Astrocytoma,0
1958,90%,Microcystic meningioma,0
1959,include - SetOperator,Plexosarcoma,0
1960,Progestins,Undifferentiated Endocervical Sarcoma,0
1961,Spreading (qualifier value),Multiple Skull Base Meningiomas,0
1962,>40 years,Basal Cell Ameloblastoma,0
1963,Normal menstruation - observation,Neonatal leukemia,0
1964,Symptoms,Lipoma of small intestine,0
1965,Process (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1966,Two,Chronic Myelomonocytic Leukemia-2,0
1967,member,clear cell adenocarcinoma of gallbladder,0
1968,N+ (tumor staging),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1969,30%,Locally Advanced Carcinoma,0
1970,Second Suffix,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1971,Point in time,Spindle Cell Melanoma,0
1972,National origin,Recurrent Testicular Lymphoma,0
1973,Grouped (qualifier value),Cancer of Urinary Tract,0
1974,Associated with,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
1975,User Group,Nasal cavity carcinoma,0
1976,Lung,Lung squamous cell carcinoma stage I,0
1977,Perianal Squamous Intraepithelial Neoplasia,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1978,Symptoms aspect,Metastatic Lung Neuroendocrine Neoplasm,0
1979,various antiinfectives and antiseptics for local oral treatment,Anterior Urethral Malignant Neoplasm,0
1980,Cell Count,Kaposi's sarcoma of extrahepatic bile duct,0
1981,Sharing (Social Behavior),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
1982,Hypertensive disease,Advanced Uterine Corpus Carcinosarcoma,0
1983,Vaginal Sarcoma,Undifferentiated Endocervical Sarcoma,0
1984,Subgroup A Nepoviruses,Acute Undifferentiated Leukemia,0
1985,Patients,Acute Undifferentiated Leukemia,0
1986,Plumbum metallicum,Cervical Adenomyoma,0
1987,Probable diagnosis,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1988,Arterial system,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1989,Often - answer to question,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1990,Term (temporal),Childhood Central Nervous System Ganglioneuroblastoma,0
1991,Narrow,Childhood Lymphoma,0
1992,Premalignant,Cartilaginous exostosis,0
1993,Over (spatial),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1994,Most,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1995,Descending,Squamous cell carcinoma of lip,0
1996,Carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1997,Combined,Vaginal Adenoma,0
1998,sequelae aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1999,Rest,Kaposi's sarcoma of extrahepatic bile duct,0
2000,Common (qualifier value),Human Papillomavirus-Related Carcinoma,0
2001,Liver Flavor,Childhood Thyroid Gland Follicular Carcinoma,0
2002,Occurrence Indicator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2003,Personal appearance,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2004,Biologic Development,embryonal rhabdomyosarcoma of prostate,0
2005,Symptoms,Choroid Epithelioid Cell Melanoma,0
2006,Common (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2007,Appearance Distress Question,Cerebral hemangioma,0
2008,Classical Hodgkin's Lymphoma,Cartilaginous exostosis,0
2009,Swelling,Ovarian germ cell choriocarcinoma stage IV,0
2010,Magnetic Resonance Imaging Study File,Digestive System Hodgkin Lymphoma,0
2011,Protein Glycosylation,Funisitis (disorder),0
2012,Females,Stage III Adult Immunoblastic Lymphoma,0
2013,Percent (qualifier value),Liver Cavernous Hemangioma,0
2014,Cancer Other,Giant cell angiofibroma,0
2015,Academic degree,Colorectal High Grade B-Cell Lymphoma,0
2016,Pancreatic Cancer Pathway,Medulloblastoma,0
2017,Salvage Therapy,Angiosarcoma of liver,0
2018,How Much Distress Weight Loss,Vaginal Adenoma,0
2019,Pharyngeal area structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2020,CD96 gene,Chest Wall Fibromatosis,0
2021,Low Level,Mixed astrocytoma-ependymoma,0
2022,Often - answer to question,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2023,Iodides,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2024,Retinoic Acid Response Element,Engraftment syndrome,0
2025,Sequence Data Type,Neonatal leukemia,0
2026,Adamantinoma,Mucosal Melanoma,0
2027,Person 1,Microcystic meningioma,0
2028,Papillary Thyroid Carcinoma Pathway,Ovarian Carcinoid Tumor,0
2029,Continuance of life,malignant lymphoma of pancreatic lymph nodes,0
2030,Malignant - descriptor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2031,Functional Relationship,FIGO Stage IVA Ovarian Cancer,0
2032,Disease,Recurrent Primary Lymphoma of Bone,0
2033,risk factors - observation list,Nasal cavity carcinoma,0
2034,Skin Pigmentation Disorder,Intestinal Metaplasia of Bladder Urothelium,0
2035,Formation,Occult Lung Adenosquamous Carcinoma,0
2036,Five,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2037,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Gallbladder Adenocarcinoma,0
2038,Logical Condition,Human Papillomavirus-Related Carcinoma,0
2039,risk factors,Non-Metastatic Gestational Trophoblastic Tumor,0
2040,Chew (administration method),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
2041,Stem cells,Locally Advanced Squamous Cell Carcinoma,0
2042,IPSS Risk Category High,Extra-Adrenal Paraganglioma,0
2043,Urine,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2044,Evaluation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2045,Death (finding),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2046,Normal,Lipoma of small intestine,0
2047,Development,Cerebral hemangioma,0
2048,majority,Xeroderma pigmentosum,0
2049,Specific qualifier value,Thymic Clear Cell Carcinoma,0
2050,Classification,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2051,Show,Childhood Fibrillary Astrocytoma,0
2052,Recommendation,Mucinous adenocarcinoma gastric,0
2053,Neoplasms,Adult Brain Stem Mixed Glioma,0
2054,Melanocytic nevus,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2055,Mandible,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2056,Females,Childhood Central Nervous System Ganglioneuroblastoma,0
2057,Protection,Ovarian Carcinoid Tumor,0
2058,Wound Healing,Metastatic Malignant Neoplasm in the Sellar Region,0
2059,Tobacco smoking behavior,Carcinoma of urinary bladder,0
2060,Lymphoid organ structure,Localized Malignant Neoplasm,0
2061,SLC6A2 wt Allele,Recurrent Uveal Melanoma,0
2062,Lymphocyte component of blood,Adult Alveolar Soft Part Sarcoma,0
2063,Cultured Cell Line,Small Intestinal Villous Adenoma,0
2064,Long Variable,Spongiotic dermatitis,0
2065,1+ Score,Transitional cell carcinoma,0
2066,Tetrachloroethylene,Fibroadenoma of breast,0
2067,Hemorrhagic,Chest Wall Fibromatosis,0
2068,Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2069,Pediculus (eukaryote),Anaplastic large cell lymphoma,0
2070,Lead,Kaposi's sarcoma of extrahepatic bile duct,0
2071,Cell Count,Melanomatosis,0
2072,In the past,Hereditary Diffuse Gastric Adenocarcinoma,0
2073,Arising,Engraftment syndrome,0
2074,South,Bladder squamous cell carcinoma stage I,0
2075,Usually,Noninfiltrating Intraductal Carcinoma,0
2076,Widening,Localized Askin Tumor,0
2077,Decision,Adult Acute Eosinophilic Leukemia,0
2078,Age at menopause,FIGO Stage IVA Ovarian Cancer,0
2079,How Much Distress Pain,Adult Alveolar Soft Part Sarcoma,0
2080,Lung,Malignant Testicular Sertoli Cell Tumor,0
2081,Formation,Pancreatic carcinoma,0
2082,Progress,FIGO Stage II Ovarian Cancer,0
2083,Cancer Biology,FIGO Stage II Ovarian Cancer,0
2084,True Control Status,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2085,unknown vaccine or immune globulin,Intraepithelial Melanocytic Hyperplasia,0
2086,Hematologic Tests,Refractory Bladder Carcinoma,0
2087,Myeloproliferation,FIGO Stage II Ovarian Cancer,0
2088,Borg Category-Ratio 10 Perceived Exertion Score 5,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2089,International Classification of Diseases,Adult Acute Eosinophilic Leukemia,0
2090,High Risk Acute Leukemia,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2091,Follicular thyroid carcinoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2092,Neck Pain Score 2,Periosteal Osteosarcoma,0
2093,Contain (action),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2094,Complete,Mixed astrocytoma-ependymoma,0
2095,Traumatic injury,Colorectal High Grade B-Cell Lymphoma,0
2096,Poverty,Hyperplasia of pituitary gland,0
2097,Nevus,Engraftment syndrome,0
2098,Type - attribute,Intracortical osteosarcoma,0
2099,Lymphadenopathy,Acinar cell carcinoma of pancreas,0
2100,Imbrication (procedure),Trichilemmocarcinoma,0
2101,Human body,Stage IB Pancreatic Cancer AJCC v8,0
2102,Make - Instruction Imperative,Airway Hemangioma,0
2103,Breast Cancer Type 1 Susceptibility Protein Measurement,Stage II Carcinoma of Penis,0
2104,Used by,Cystadenocarcinoma,0
2105,Epstein-Barr Virus,Blepharal carcinoma,0
2106,treatment - ActInformationManagementReason,Stage I Colon Neuroendocrine Tumor AJCC v8,0
2107,Medical Devices,Malignant melanoma of eyelid,0
2108,preference,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
2109,Malignant neoplasm of pancreas,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2110,Management procedure,adenoid cystic carcinoma of lung,0
2111,include - SetOperator,Mucinous adenocarcinoma gastric,0
2112,Adrenal Cortex,Extracranial Neuroblastoma,0
2113,Legal Adult,Extracranial Neuroblastoma,0
2114,growth aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
2115,per year,Ichthyoses,0
2116,genetic risk factors,Mixed parotid tumor,0
2117,PREVENT (product),Locally Advanced Soft Tissue Sarcoma,0
2118,Biological Response Modifier Therapy,Unresectable Rhabdomyosarcoma,0
2119,Excision,Intraepithelial Melanocytic Hyperplasia,0
2120,Ductal,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2121,Ethanol,Xeroderma pigmentosum,0
2122,Etiology,Adult Acute Eosinophilic Leukemia,0
2123,To,Kaposi's sarcoma of extrahepatic bile duct,0
2124,Immediate,Localized Ewing Sarcoma,0
2125,Carcinoma of bladder,FIGO Stage II Ovarian Cancer,0
2126,Muscle (organ),Pilocytic astrocytoma of cerebellum,0
2127,Magnetic Resonance Imaging,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2128,Cutaneous Melanoma,Nasal cavity carcinoma,0
2129,Age of Onset,Carcinoma of urinary bladder,0
2130,Often - answer to question,Chondrosarcoma,0
2131,Surgery specialty,Type II Endometrial Adenocarcinoma,0
2132,Severe (severity modifier),Benign squamous cell tumor,0
2133,suggestion,Bladder squamous cell carcinoma stage I,0
2134,Formation,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
2135,Central Nervous System Neoplasms,Unicystic ameloblastoma,0
2136,Negation,Atypical Lobular Breast Hyperplasia,0
2137,Vagina Carcinoma,Benign squamous cell tumor,0
2138,Consistency,squamous cell carcinoma of the thyroid gland,0
2139,Account number:Identifier:Point in time:^Patient:Nominal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2140,Including (qualifier),Xeroderma pigmentosum,0
2141,Delta (difference),Engraftment syndrome,0
2142,Limited Walking Ability,Mixed astrocytoma-ependymoma,0
2143,Severe (severity modifier),Blepharal carcinoma,0
2144,Cell Count,malignant lymphoma of pancreatic lymph nodes,0
2145,Filter - medical device,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2146,Carcinomatosis of peritoneal cavity,Melanomatosis,0
2147,Changing,Carcinoma of submandibular gland,0
2148,Sebum,Chronic Myelomonocytic Leukemia-2,0
2149,Table - furniture,Collecting Duct Carcinoma of the Kidney,0
2150,Type - attribute,benign mature teratoma of pancreas,0
2151,White blood cell count normal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2152,Slow,Endometrial Small Cell Carcinoma,0
2153,Cells,Benign tumor of eyelid,0
2154,Thought,Maxillary Sinus Adenoid Cystic Carcinoma,0
2155,Surrounding (qualifier value),Malignant neoplasm of gallbladder,0
2156,Pigmentary Change in Skin,Tongue Alveolar Soft Part Sarcoma,0
2157,800,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2158,Sequence Data Type,Metastatic Ductal Breast Carcinoma,0
2159,gene therapy,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
2160,Experimental Organism Basal Cell Carcinoma,Parathyroid Gland Adenocarcinoma,0
2161,2+ Score,Periosteal Osteosarcoma,0
2162,Line Unit of Length,Carcinoma of urinary bladder,0
2163,Tryptophanase,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2164,diagnosis aspect,Melanomatosis,0
2165,Current (present time),Metastatic Neoplasm to the Gallbladder,0
2166,Age,Basal Cell Ameloblastoma,0
2167,Meaning,Lung squamous cell carcinoma stage I,0
2168,Main,Childhood Lung Non-Small Cell Carcinoma,0
2169,Characterization,Stage IB Pancreatic Cancer AJCC v8,0
2170,Condyloma,Benign Anal Granular Cell Tumor,0
2171,Standard Treatment,Intraepithelial Melanocytic Hyperplasia,0
2172,Spreading (qualifier value),Ovarian Carcinoid Tumor,0
2173,Feel Tired question,Childhood Lymphoma,0
2174,Cystic,Fibroadenoma of breast,0
2175,Scar Tissue,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2176,Biomaterial Treatment,Cervical Squamous Intraepithelial Neoplasia,0
2177,Gender,Occult Lung Adenosquamous Carcinoma,0
2178,Testing,Stage 0 Penile Cancer AJCC v8,0
2179,Persons,Stage III Cutaneous Melanoma AJCC v6,0
2180,65,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2181,Tears body substance,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2182,Local disease,Methotrexate-Associated Hodgkin Lymphoma,0
2183,Network,Diffuse malignant mesothelioma,0
2184,Aggressive course,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2185,Lymphoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2186,Cell Count,Benign Anal Granular Cell Tumor,0
2187,Others - Allergy,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
2188,Case (situation),Neoplasms,0
2189,Arising,Carcinoma of urinary bladder,0
2190,Type - attribute,Recurrent Uveal Melanoma,0
2191,Type of vessel,Digestive System Hodgkin Lymphoma,0
2192,Direct (qualifier),Xeroderma pigmentosum,0
2193,Symptoms aspect,Grade 3a Malignant Neoplasm,0
2194,Age at menopause:Time:Point in time:^Patient:Quantitative,Carcinoma ex pleomorphic adenoma of parotid gland,0
2195,Aim,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2196,Primitive,Childhood Anaplastic Large Cell Lymphoma,0
2197,Genetic Heterogeneity,Benign tumor of eyelid,0
2198,Carcinoma in Situ,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2199,Manufactured form,Type II Endometrial Adenocarcinoma,0
2200,Image Feature,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2201,Supportive assistance,Grade 3a Malignant Neoplasm,0
2202,Adult human body,Lipoma of small intestine,0
2203,Medulloblastoma,Precursor B-lymphoblastic lymphoma stage II,0
2204,Continuance of life,Stage III Adult Immunoblastic Lymphoma,0
2205,Leading,Mucinous adenocarcinoma gastric,0
2206,High risk of,Stage IV Colorectal Cancer AJCC v8,0
2207,described,Anterior Urethral Malignant Neoplasm,0
2208,Thin (qualifier value),Endometrial Small Cell Carcinoma,0
2209,Science of Etiology,Mixed parotid tumor,0
2210,Population Group,Tonsillar Carcinoma,0
2211,GUCY2C wt Allele,Locally Advanced Carcinoma,0
2212,Secondary Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
2213,Togo,Blood Vessel Tumors,0
2214,Often - answer to question,Epithelioid Sarcoma NCI Grade 3,0
2215,Type A,Testicular cancer metastatic,0
2216,What subject filter - Result,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2217,Lead,Mucinous adenocarcinoma gastric,0
2218,More,ROSE Cluster 3,0
2219,Abdominal Cavity,Bladder adenocarcinoma stage IV,0
2220,Specimen Source Codes - tumor,Uterine Cancer,0
2221,Liquid substance,Childhood Anaplastic Large Cell Lymphoma,0
2222,Type A,Vaginal Adenoma,0
2223,Left sided,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2224,unknown vaccine or immune globulin,Mucosal Melanoma,0
2225,Localized skin lesion,Cerebral hemangioma,0
2226,risk factors,Stage IV Penile Cancer AJCC v7,0
2227,Goes <invertebrate>,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2228,Neoplasms,Peripheral primitive neuroectodermal tumor of soft tissue,0
2229,PREMATURE CHROMATID SEPARATION TRAIT,Heavy Chain Deposition Disease,0
2230,Skin pigmentation - finding,Digestive System Hodgkin Lymphoma,0
2231,Improving (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2232,Linear,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2233,Infection,Carcinoma,0
2234,Metastatic to,Localized Ewing Sarcoma,0
2235,Chemotherapy Regimen,GIANT PIGMENTED HAIRY NEVUS,0
2236,Carcinoma,Small intestine carcinoma,0
2237,Image Feature,Melanomatosis,0
2238,Device system,Recurrent Uveal Melanoma,0
2239,solid Ovarian mass,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2240,Smooth muscle (tissue),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2241,Cavern,Refractory Ependymoma,0
2242,protrusion,Stage IV Penile Cancer AJCC v7,0
2243,Mass of body region,Acute Undifferentiated Leukemia,0
2244,Entity Determiner - specific,Peripheral primitive neuroectodermal tumor of soft tissue,0
2245,Analysis of substances,Peripheral primitive neuroectodermal tumor of soft tissue,0
2246,Surface,Stage IV Colorectal Cancer AJCC v8,0
2247,Biopsy,Hemangioma,0
2248,Immune system,Maxillary Sinus Adenoid Cystic Carcinoma,0
2249,Retinoids,Benign Anal Granular Cell Tumor,0
2250,Chemotherapy,Cerebral hemangioma,0
2251,Does carry,Cervical Squamous Intraepithelial Neoplasia,0
2252,Certain (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
2253,Name (property) (qualifier value),Diffuse malignant mesothelioma,0
2254,Skin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2255,Including (qualifier),Engraftment syndrome,0
2256,Natural,Peripheral primitive neuroectodermal tumor of soft tissue,0
2257,Neoplastic disease of uncertain behavior,Peripheral primitive neuroectodermal tumor of soft tissue,0
2258,65,Trabecular adenocarcinoma,0
2259,Publications,Lipoma of small intestine,0
2260,Manifest,Thymic Clear Cell Carcinoma,0
2261,Fluid behavior,Breast Apocrine Adenoma,0
2262,Disseminated Malignant Neoplasm,Squamous cell carcinoma of lip,0
2263,Certain (qualifier value),Adult Hepatocellular Carcinoma,0
2264,Morning,Acute lymphadenitis,0
2265,Result,Pancreatic Endocrine Carcinoma,0
2266,Aspects of signs,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
2267,Entity Determiner - specific,Extracranial Neuroblastoma,0
2268,Present,Pancreatic carcinoma,0
2269,Cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2270,United States,Benign Anal Granular Cell Tumor,0
2271,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2272,Fever symptoms (finding),Tonsillar Carcinoma,0
2273,Classification of information,Digestive System Hodgkin Lymphoma,0
2274,Increased,Localized Askin Tumor,0
2275,Less Than,Cervical Adenomyoma,0
2276,Ovulation,Lipoma of small intestine,0
2277,Severe (severity modifier),Occult Lung Adenosquamous Carcinoma,0
2278,Lip and Oral Cavity Carcinoma,Vaginal Adenoid Cystic Carcinoma,0
2279,Poliosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2280,How Much Distress Weight Loss,Kaposi's sarcoma of extrahepatic bile duct,0
2281,Surgery specialty,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
2282,Context,Unicystic ameloblastoma,0
2283,Plumbum metallicum,Intracortical osteosarcoma,0
2284,Two,Choroid Necrotic Melanoma,0
2285,Aspects of signs,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2286,shared attribute,Choroid Epithelioid Cell Melanoma,0
2287,low confidentiality,Stage IV Colorectal Cancer AJCC v8,0
2288,Adenocarcinoma of large intestine,Diffuse malignant mesothelioma,0
2289,Malignant - descriptor,Acute lymphadenitis,0
2290,Common Specifications in HL7 V3 Publishing,FIGO Stage II Ovarian Cancer,0
2291,What subject filter - Result,Hyperplasia of pituitary gland,0
2292,Not Otherwise Specified,Localized Askin Tumor,0
2293,Capsule (unit of presentation),Atypical Mesothelial Hyperplasia,0
2294,3+ Score,Hair nevus,0
2295,Specimen Source Codes - Mucus,Medulloblastoma,0
2296,Usually,Splenic Manifestation of Hairy Cell Leukemia,0
2297,Usual Severity Sweats,FIGO Stage II Ovarian Cancer,0
2298,English Language,Cerebral Primitive Neuroectodermal Tumor,0
2299,Usually,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2300,Eighth,Benign neoplasm of eye,0
2301,Positron-Emission Tomography,Stage III Cutaneous Melanoma AJCC v6,0
2302,Thyroid Gland,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2303,Formation,Pleomorphic adenoma of parotid gland,0
2304,Carcinoid Tumor,Recurrent Testicular Lymphoma,0
2305,Ultrasonography,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2306,National origin,Digestive System Hodgkin Lymphoma,0
2307,Manufactured form,Recurrent Diffuse Intrinsic Pontine Glioma,0
2308,french race,Refractory Bladder Carcinoma,0
2309,Birth defects diagnosis:Find:Pt:^Patient:Nar,Liver Cavernous Hemangioma,0
2310,*Type - Kind of quantity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2311,Term Birth,Endometrial Small Cell Carcinoma,0
2312,True primary (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2313,skin color,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2314,Groups,Primary Cutaneous Plasmablastic Lymphoma,0
2315,Perform,Localized Askin Tumor,0
2316,Therapeutic procedure,Spindle Cell Melanoma,0
2317,seen,Mastocytosis,0
2318,MYOT gene,Female Breast Carcinoma,0
2319,Expiration,Liver Lymphangioma,0
2320,Response (communication),Female Breast Carcinoma,0
2321,Immunotherapy,Tonsillar Carcinoma,0
2322,Rare,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2323,Malignant - descriptor,Diffuse malignant mesothelioma,0
2324,Neoplasms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2325,Term (lexical),Uterine Cancer,0
2326,Sarcoma,Cerebral Primitive Neuroectodermal Tumor,0
2327,Manufactured sign,Tongue Alveolar Soft Part Sarcoma,0
2328,Pelvic pain female,Intestinal Metaplasia of Bladder Urothelium,0
2329,Niobium,Unicystic ameloblastoma,0
2330,Primary malignant neoplasm,Pilocytic astrocytoma of cerebellum,0
2331,Burkina Faso,Testicular cancer metastatic,0
2332,Skin Specimen,Metastatic Lung Neuroendocrine Neoplasm,0
2333,HLA Class II Histocompatibility Antigen Gamma Chain,Primary Cutaneous Plasmablastic Lymphoma,0
2334,Females,Transitional cell carcinoma,0
2335,Early,Recurrent Uveal Melanoma,0
2336,Common Specifications in HL7 V3 Publishing,Stage IV Penile Cancer AJCC v7,0
2337,Intestines,Hodgkin lymphoma,0
2338,Tooth root structure,Neonatal leukemia,0
2339,Body site,Recurrent Testicular Lymphoma,0
2340,therapeutic aspects,Trabecular adenocarcinoma,0
2341,Europe,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2342,Characteristics,FIGO Stage II Ovarian Cancer,0
2343,Associated with,Squamous cell carcinoma of lip,0
2344,Ultraviolet Light Sterilization,Fibroadenoma of breast,0
2345,Primary malignant neoplasm,Childhood Lung Non-Small Cell Carcinoma,0
2346,Young,Cerebral Primitive Neuroectodermal Tumor,0
2347,Science of Statistics,Stage IB Pancreatic Cancer AJCC v8,0
2348,List,Cerebral Primitive Neuroectodermal Tumor,0
2349,Fever symptoms (finding),Squamous cell carcinoma of lip,0
2350,Diet Code Specification Type - Preference,FIGO Stage IVA Ovarian Cancer,0
2351,Occurrence Indicator,Thymoma malignant recurrent,0
2352,Intestines,Gallbladder adenoma,0
2353,Early,Gallbladder Adenocarcinoma,0
2354,Congenital phimosis,Digestive System Hodgkin Lymphoma,0
2355,include - SetOperator,Gallbladder Adenocarcinoma,0
2356,Fatal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2357,Array Feature,Choroid Necrotic Melanoma,0
2358,Major,Childhood Lung Non-Small Cell Carcinoma,0
2359,Childhood Lymphoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2360,Cure (remedy),Stage IB Lung Cancer AJCC v7,0
2361,Device system,Childhood Central Nervous System Ganglioneuroblastoma,0
2362,*Type - Kind of quantity,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2363,Myelodysplastic Syndrome,Intraepithelial Melanocytic Hyperplasia,0
2364,Present,Gallbladder Adenocarcinoma,0
2365,Pancreatic carcinoma,Fibroadenoma of breast,0
2366,Categories,Benign neoplasm of eye,0
2367,Main,Medulloblastoma,0
2368,Oral region,Stage I Colon Neuroendocrine Tumor AJCC v8,0
2369,year,Colorectal Neuroendocrine Tumor G2,0
2370,Atypical,Cerebral Primitive Neuroectodermal Tumor,0
2371,Type - attribute,Benign Ovarian Thecoma,0
2372,Chemotherapy,Cerebral hemangioma,0
2373,Pain,Brain Tumor,0
2374,Adult Classical Hodgkin Lymphoma,Acantholytic squamous cell carcinoma,0
2375,Most,Unicystic ameloblastoma,0
2376,Age,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2377,Melanoma Pathway,Choroid Epithelioid Cell Melanoma,0
2378,Mathematical Operator,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2379,Relative Survival,Malignant neoplasm of thalamus,0
2380,Combined,FIGO Stage II Ovarian Cancer,0
2381,Vision,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2382,Active License,non-Hodgkin's lymphoma of spleen,0
2383,Clinical,Vaginal Adenoid Cystic Carcinoma,0
2384,Adult human body,Digestive System Hodgkin Lymphoma,0
2385,Hollow shape,Gallbladder Adenocarcinoma,0
2386,Submandibular,Splenic Manifestation of Hairy Cell Leukemia,0
2387,Treatment Epoch,Fibroadenoma of breast,0
2388,First (number),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2389,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Locally Advanced Squamous Cell Carcinoma,0
2390,Malignant Neoplasms,Giant cell angiofibroma,0
2391,Squamous Epithelial Cells,Mucinous adenocarcinoma gastric,0
2392,Derivation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2393,Five-year Survival Rate,Trabecular adenocarcinoma,0
2394,Small,Microcystic meningioma,0
2395,Occurrence,Intestinal Metaplasia of Bladder Urothelium,0
2396,Alcohol consumption,Malignant Neoplasm with Regional Lymph Node Involvement,0
2397,Percent of Abnormal Cells,papillary carcinoma of penis,0
2398,Body structure,Unicystic ameloblastoma,0
2399,Neuroendocrine Tumors,Airway Hemangioma,0
2400,Case (situation),Platinum-Resistant Lung Small Cell Carcinoma,0
2401,Sore to touch,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2402,Manufactured sign,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2403,Accepted,Familial Hemophagocytic Lymphocytosis,0
2404,Obesity,Carcinomatosis of peritoneal cavity,0
2405,Drop British,Trichilemmocarcinoma,0
2406,Cancer Genus,Neonatal leukemia,0
2407,First sign,Locally Advanced Squamous Cell Carcinoma,0
2408,Type of complication,Type II Endometrial Adenocarcinoma,0
2409,95,Stage 0 Penile Cancer AJCC v8,0
2410,include - SetOperator,Cerebral Primitive Neuroectodermal Tumor,0
2411,Negation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2412,What subject filter - Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2413,Good,Methotrexate-Associated Hodgkin Lymphoma,0
2414,Basis - conceptual entity,Cervical Squamous Intraepithelial Neoplasia,0
2415,Suspected qualifier,Stage III Cutaneous Melanoma AJCC v6,0
2416,Blue color,Childhood Fibrillary Astrocytoma,0
2417,Retinoic Acid Response Element,Spindle Cell Melanoma,0
2418,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Acinar cell carcinoma of pancreas,0
2419,Eye,Cervical Squamous Intraepithelial Neoplasia,0
2420,Oral,Localized Askin Tumor,0
2421,80%,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2422,Qualitative form,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2423,Frequently,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2424,Chest wall pain,Childhood Lymphoma,0
2425,African race,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2426,200,Malignant Testicular Sertoli Cell Tumor,0
2427,Return to (contextual qualifier) (qualifier value),Xeroderma pigmentosum,0
2428,Present,Breast Ductal Adenoma,0
2429,Gait normal,Gallbladder adenoma,0
2430,Patterns,Adenocarcinoma,0
2431,Common Specifications in HL7 V3 Publishing,Locally Advanced Soft Tissue Sarcoma,0
2432,Median Statistical Measurement,Serous cystadenocarcinoma ovary,0
2433,Known,Werner Syndrome,0
2434,Call (Instruction),Squamous cell carcinoma of lip,0
2435,Sharing (Social Behavior),Chronic Myelomonocytic Leukemia-2,0
2436,diagnosis aspect,Malignant melanoma of eyelid,0
2437,French Catheter Gauge,Brain Tumor,0
2438,transport (device),Ovarian Dermoid Cyst with Secondary Carcinoma,0
2439,Breaking down,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2440,Main,Liver Cavernous Hemangioma,0
2441,Value Above Reference Range,Xeroderma pigmentosum,0
2442,Possible diagnosis,Mucinous adenocarcinoma gastric,0
2443,List,Childhood Thyroid Gland Follicular Carcinoma,0
2444,Assortment,Benign Anal Granular Cell Tumor,0
2445,Value Above Reference Range,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2446,Imaging Techniques,Urethral Carcinoma,0
2447,North America,Methotrexate-Associated Hodgkin Lymphoma,0
2448,Contain (action),Localized Askin Tumor,0
2449,Fracture,Neonatal leukemia,0
2450,Surgery specialty,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2451,United States Military Commissioned Officer O4,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2452,Biliary Tract Cancer,Unresectable Rhabdomyosarcoma,0
2453,Condition,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2454,lymph nodes,Transitional cell carcinoma,0
2455,Teratoma,Benign Ovarian Thecoma,0
2456,What subject filter - Result,Ovarian germ cell choriocarcinoma stage IV,0
2457,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2458,Comfort,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2459,Name (property) (qualifier value),Medulloblastoma,0
2460,Qualitative form,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2461,Neoplasms,Spermatocytic seminoma,0
2462,Stomach,Adult Acute Eosinophilic Leukemia,0
2463,Outward,Metastatic Carcinoma in the Lung,0
2464,Nodulus cerebelli,Chondrosarcoma,0
2465,Attenuated by (contextual qualifier),Chondrosarcoma,0
2466,risk factors,Benign tumor of eyelid,0
2467,Cells,Locally Advanced Carcinoma,0
2468,Rare,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
2469,Initially,Colorectal High Grade B-Cell Lymphoma,0
2470,Unknown GENC,FIGO Stage II Ovarian Cancer,0
2471,Favorable,Malignant neoplasm of gallbladder,0
2472,Brain,Bladder squamous cell carcinoma stage I,0
2473,National origin,Kaposi's sarcoma of extrahepatic bile duct,0
2474,Operative Surgical Procedures,High Grade Glandular Intraepithelial Neoplasia,0
2475,2+ Score,ROSE Cluster 3,0
2476,Relationships,Pilocytic astrocytoma of cerebellum,0
2477,Non-invasive,Serous cystadenocarcinoma ovary,0
2478,With frequency,Lipoma of small intestine,0
2479,>90,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2480,Therapeutic procedure,Refractory Barrett Esophagus,0
2481,Interventional procedure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2482,What subject filter - Result,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2483,Pathology,Ovarian germ cell choriocarcinoma stage IV,0
2484,Risk,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2485,Therapeutic procedure,Leiomyoma of Gallbladder,0
2486,Primary malignant neoplasm,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
2487,<50,Intestinal Neuroendocrine Carcinoma,0
2488,Meningitis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2489,Usual Severity Sweats,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2490,Constipation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2491,Main,Cerebral Primitive Neuroectodermal Tumor,0
2492,Aerosol Dose Form,benign mature teratoma of pancreas,0
2493,combination of objects,Ovarian Carcinoid Tumor,0
2494,Reduction procedure,Benign neoplasm of thorax,0
2495,Infrequent,Metastatic Neoplasm to the Gallbladder,0
2496,Experimental Result,Giant cell angiofibroma,0
2497,Rate,Colorectal High Grade B-Cell Lymphoma,0
2498,Special,Human Papillomavirus-Related Carcinoma,0
2499,Cervix carcinoma,Occult Lung Adenosquamous Carcinoma,0
2500,Togo,Recurrent Testicular Lymphoma,0
2501,Cells,Trichilemmocarcinoma,0
2502,Broken skin,Melanomatosis,0
2503,Platelets Product,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2504,Pancreas,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2505,Better than Others,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2506,Qualitative form,Engraftment syndrome,0
2507,Progress,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2508,Tryptophanase,FIGO Stage IVA Ovarian Cancer,0
2509,Color change,Adult Acute Eosinophilic Leukemia,0
2510,Common Specifications in HL7 V3 Publishing,Papillary squamous cell carcinoma,0
2511,Nausea Visual Analogue Scale,Nasal cavity carcinoma,0
2512,Intestines,Ovarian germ cell choriocarcinoma stage IV,0
2513,Anorexia,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2514,Including (qualifier),Cerebral Primitive Neuroectodermal Tumor,0
2515,Survival Rate,Digestive System Hodgkin Lymphoma,0
2516,Presence (property),Benign neoplasm of eye,0
2517,therapeutic aspects,Lipoma of small intestine,0
2518,School Grade,Hodgkin Disease,0
2519,Enlargement procedure,Mucinous adenocarcinoma gastric,0
2520,Neuroglia,Brain Tumor,0
2521,Precipitating Factors,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2522,Proximal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2523,Symptoms aspect,Cervical Fibroepithelial Polyp,0
2524,Genetic Heterogeneity,Stage I Colon Neuroendocrine Tumor AJCC v8,0
2525,Astrocytoma,Undifferentiated Neuroblastoma,0
2526,Pesticides,Lipoma of small intestine,0
2527,Rest,Bladder adenocarcinoma stage IV,0
2528,Childhood Lymphoma,Acute Undifferentiated Leukemia,0
2529,Obesity,Refractory Barrett Esophagus,0
2530,kidneys and collecting system,Occult Lung Adenosquamous Carcinoma,0
2531,Body tissue,Engraftment syndrome,0
2532,spinal,Angiosarcoma of liver,0
2533,Derivative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2534,described,Malignant melanoma of eyelid,0
2535,Cell Count,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2536,Object Attribute,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2537,Gastrointestinal Leak NOS,Stage I Adult Non-Hodgkin Lymphoma,0
2538,Ductal Carcinoma,Papillary squamous cell carcinoma,0
2539,Biomaterial Treatment,Unfavorable Non-Hodgkin Lymphoma,0
2540,fluid - substance,Stage I Adult Non-Hodgkin Lymphoma,0
2541,Three,Basal Cell Ameloblastoma,0
2542,Sunlight,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2543,New Zealand,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2544,Mean Percent of Normal,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2545,Second edition,Squamous cell carcinoma of lip,0
2546,Relationships,Vaginal Adenoid Cystic Carcinoma,0
2547,Negation,Granular Cell Leiomyosarcoma,0
2548,Neck,Stage III Cutaneous Melanoma AJCC v6,0
2549,risk factors,Diffuse malignant mesothelioma,0
2550,Affect (mental function),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2551,NCI CTEP SDC Melanoma Sub-Category Terminology,Chronic Myelomonocytic Leukemia-2,0
2552,Does carry,Testicular cancer metastatic,0
2553,Cancer Genus,Brain Tumor,0
2554,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Chondrosarcoma,0
2555,Malignant Neoplasms,Diffuse malignant mesothelioma,0
2556,Free (available (qualifier)),Clinical Stage I Cutaneous Melanoma AJCC v8,0
2557,Risk,Splenic Manifestation of Hairy Cell Leukemia,0
2558,Malignant neoplasm of liver,FIGO Stage II Ovarian Cancer,0
2559,POEMS Syndrome,Adult Alveolar Soft Part Sarcoma,0
2560,SLC6A2 protein,Lipoma of small intestine,0
2561,survival aspects,Malignant neoplasm of subglottis,0
2562,Ephrin Type-B Receptor 1,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2563,Polypeptide Hormones,Gallbladder Adenocarcinoma,0
2564,Responsible to,Tongue Alveolar Soft Part Sarcoma,0
2565,Frequently,Colorectal High Grade B-Cell Lymphoma,0
2566,Hormone Therapy,Type II Endometrial Adenocarcinoma,0
2567,Malignant Neoplasms,clear cell adenocarcinoma of gallbladder,0
2568,Secreted,Stage IV Penile Cancer AJCC v7,0
2569,Money or percentage indicator - Percentage,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
2570,Set of regional lymph nodes,Liver Lymphangioma,0
2571,transport (device),Thymic Clear Cell Carcinoma,0
2572,Childhood Alveolar Soft Part Sarcoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2573,International Classification of Diseases,adenosquamous carcinoma of breast,0
2574,Speaking (activity),Unicystic ameloblastoma,0
2575,Experimental Result,Sarcomatoid Renal Cell Carcinoma,0
2576,How Much Distress Sweats,FIGO Stage IVA Ovarian Cancer,0
2577,Tumor stage,Angiosarcoma of liver,0
2578,Morphology,Keratoderma,0
2579,Classification,Liver Cavernous Hemangioma,0
2580,physiological aspects,Papillary squamous cell carcinoma,0
2581,Usually Need Help from Another Person for Reach,Adult Hepatocellular Carcinoma,0
2582,Minerals,FIGO Stage II Ovarian Cancer,0
2583,Two,Digestive System Hodgkin Lymphoma,0
2584,Lymphadenopathy,Contact dermatitis due to alkali,0
2585,respiratory gaseous exchange in organisms,Vaginal Adenoid Cystic Carcinoma,0
2586,Usually,Stage III Cutaneous Melanoma AJCC v6,0
2587,Classification,Undifferentiated Endocervical Sarcoma,0
2588,Inflammatory Breast Carcinoma,Extracranial Neuroblastoma,0
2589,Ks Antibody,Granular Cell Leiomyosarcoma,0
2590,Important,Malignant neoplasm of choroid,0
2591,Squamous cell carcinoma,Benign tumor of eyelid,0
2592,Surgery specialty,Nasal cavity carcinoma,0
2593,Various patch test substance,Chondrosarcoma,0
2594,Biomaterial Treatment,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2595,Domain (area of knowledge),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2596,Administration procedure,Kaposi's sarcoma of extrahepatic bile duct,0
2597,Ovary,embryonal rhabdomyosarcoma of prostate,0
2598,Including (qualifier),Papillary squamous cell carcinoma,0
2599,Proto-Oncogene Proteins B-raf,Trabecular adenocarcinoma,0
2600,Formation,Splenic Manifestation of Hairy Cell Leukemia,0
2601,Transformation,Engraftment syndrome,0
2602,Involvement with,Undifferentiated Neuroblastoma,0
2603,gene therapy,Stage II Carcinoma of Penis,0
2604,Normal,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2605,Colorectal Carcinoma,Kaposi's sarcoma of skin,0
2606,Estimated,Medulloblastoma,0
2607,Assessed,Recurrent Uveal Melanoma,0
2608,Notable,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2609,Vaginal (intended site),Female Breast Carcinoma,0
2610,Left sided,Stage II Carcinoma of Penis,0
2611,shared attribute,Thymic Clear Cell Carcinoma,0
2612,Usual Severity Pain,Epithelioid Sarcoma NCI Grade 3,0
2613,Occurrence,Neoplasms,0
2614,Array Feature,Digestive System Hodgkin Lymphoma,0
2615,Specimen Source Codes - tumor,Cerebral Primitive Neuroectodermal Tumor,0
2616,Ocular orbit,Giant cell angiofibroma,0
2617,76,Stage III Cutaneous Melanoma AJCC v6,0
2618,Fever,Mucinous adenocarcinoma gastric,0
2619,Persons,Childhood Thyroid Gland Follicular Carcinoma,0
2620,Study Subject,Childhood Lymphoma,0
2621,Cure (remedy),Benign Anal Granular Cell Tumor,0
2622,Neutral - answer to question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2623,Biomaterial Treatment,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2624,treatment - ActInformationManagementReason,Necrotizing Funisitis,0
2625,Physical findings,Unresectable Rhabdomyosarcoma,0
2626,Worried,Toxic Epidermal Necrolysis,0
2627,1960s,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2628,Negative Surgical Margin,Kaposi's sarcoma of skin,0
2629,How Often Shortness of Breath,Stage I Adult Non-Hodgkin Lymphoma,0
2630,Paraganglioma,Xeroderma pigmentosum,0
2631,Morphology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2632,+2,Non-Metastatic Gestational Trophoblastic Tumor,0
2633,Congenital meningocele,Childhood Anaplastic Large Cell Lymphoma,0
2634,Histologic,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2635,Agreement,Mucinous adenocarcinoma gastric,0
2636,Have Weight Loss,gliosarcoma,0
2637,Diagnosis Study,Anaplastic large cell lymphoma,0
2638,Case unit dose,embryonal rhabdomyosarcoma of prostate,0
2639,diagnosis aspect,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2640,Left sided,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2641,Widening,Stage 0 Penile Cancer AJCC v8,0
2642,Packaging Case,Diffuse malignant mesothelioma,0
2643,Total thymectomy,Multiple Skull Base Meningiomas,0
2644,Circumscribe (action),Chronic Myelomonocytic Leukemia-2,0
2645,Fasting Status Indicator,Stage III Cutaneous Melanoma AJCC v6,0
2646,Abdominal bloating,Kaposi's sarcoma of extrahepatic bile duct,0
2647,defects aspect,Cartilaginous exostosis,0
2648,Lip structure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2649,Contrast Media,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2650,risk factors,Leptomeningeal sarcoma,0
2651,Umbilical stump observable,Clonal Hematopoiesis of Indeterminate Potential,0
2652,Third revision,Gallbladder Adenocarcinoma,0
2653,depend,Digestive System Hodgkin Lymphoma,0
2654,Decision,Secondary malignant neoplasm of lymph node,0
2655,Including (qualifier),Mucinous adenocarcinoma gastric,0
2656,cell growth,Kaposi's sarcoma of skin,0
2657,Therapeutic radiology procedure,Neonatal leukemia,0
2658,Symptoms,Refractory Ependymoma,0
2659,general population,Recurrent Testicular Lymphoma,0
2660,Occurrence Indicator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2661,Guarded prognosis,Heavy Chain Deposition Disease,0
2662,Cellular infiltrate,Stage III Adult Immunoblastic Lymphoma,0
2663,risk factors - observation list,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2664,Common Specifications in HL7 V3 Publishing,Vaginal Adenoma,0
2665,Methods aspects,Xeroderma pigmentosum,0
2666,Young Adult,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2667,Fever symptoms (finding),Adenocarcinoma of the prostate metastatic,0
2668,Pressure - action,Thymic Clear Cell Carcinoma,0
2669,Inflammatory Bowel Diseases,Recurrent Testicular Lymphoma,0
2670,1000000,Adult Acute Eosinophilic Leukemia,0
2671,Adult human body,mucinous adenocarcinoma of gallbladder,0
2672,Body tissue,Melanomatosis,0
2673,Nose,Unicystic ameloblastoma,0
2674,Type A,Acantholytic squamous cell carcinoma,0
2675,year,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2676,Constant (qualifier),Hodgkin Disease,0
2677,Childhood Lymphoma,Small cell neuroendocrine carcinoma of bladder,0
2678,shared attribute,benign mature teratoma of pancreas,0
2679,Administration procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2680,Ultrasonic,Endometrial Small Cell Carcinoma,0
2681,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Human Papillomavirus-Related Carcinoma,0
2682,Genus Homo,Thyroid Hurthle Cell Carcinoma,0
2683,Smoking,Rhabdomyosarcoma with ganglionic differentiation,0
2684,Cancer Etiology,Hodgkin lymphoma,0
2685,In Blood,Benign neoplasm of thorax,0
2686,Used by,Methotrexate-Associated Hodgkin Lymphoma,0
2687,Percent (qualifier value),Cervical Squamous Intraepithelial Neoplasia,0
2688,Transection (procedure),Neonatal leukemia,0
2689,2000,Recurrent Rhabdomyosarcoma,0
2690,Historical aspects qualifier,Benign Anal Granular Cell Tumor,0
2691,Skin,Liver Lymphangioma,0
2692,Neoadjuvant Therapy,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2693,Skin Specimen,Intestinal Metaplasia of Bladder Urothelium,0
2694,PXN wt Allele,Anaplastic large cell lymphoma,0
2695,Manufactured form,Brain Tumor,0
2696,Myasthenia Gravis,Intestinal Metaplasia of Bladder Urothelium,0
2697,Face,Cervical Adenomyoma,0
2698,Vocal cord structure,Cancer of Urinary Tract,0
2699,Including (qualifier),Intracortical osteosarcoma,0
2700,Growth,Localized Askin Tumor,0
2701,Childhood Teratoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2702,Historical aspects qualifier,Childhood Thyroid Gland Follicular Carcinoma,0
2703,Major,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2704,Result,Refractory Ependymoma,0
2705,Site of primary lesion,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2706,Frequently,Unfavorable Non-Hodgkin Lymphoma,0
2707,Often - answer to question,embryonal rhabdomyosarcoma of prostate,0
2708,Organ,Unicystic ameloblastoma,0
2709,Therapeutic procedure,Diffuse malignant mesothelioma,0
2710,Neoplasms,Chondrosarcoma,0
2711,Usual,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2712,NR0B1 wt Allele,Stage I Colon Neuroendocrine Tumor AJCC v8,0
2713,Continuance of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2714,3+ Answer to Question,Transitional cell carcinoma,0
2715,Removed,Splenic Manifestation of Hairy Cell Leukemia,0
2716,Back Pain,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2717,Antifungal Antibiotics,Cancer of Urinary Tract,0
2718,Possibly Related to Intervention,Intestinal Metaplasia of Bladder Urothelium,0
2719,Tobacco smoking behavior,FIGO Stage II Ovarian Cancer,0
2720,Main,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2721,Blood Vessel,Parathyroid Gland Adenocarcinoma,0
2722,Neoplasm Metastasis,Pilocytic astrocytoma of cerebellum,0
2723,Genes,Mucinous adenocarcinoma gastric,0
2724,Financial Account,Testicular cancer metastatic,0
2725,Rare,Liver Cavernous Hemangioma,0
2726,risk factors - observation list,Stage IB Lung Cancer AJCC v7,0
2727,Common (qualifier value),Cherubism,0
2728,Interventional procedure,Chondrosarcoma,0
2729,Cessation of life,Recurrent Testicular Lymphoma,0
2730,Base - General Qualifier,Recurrent Uveal Melanoma,0
2731,Count of entities,Thymic Clear Cell Carcinoma,0
2732,Location of Oral Residue Following Swallowing,FIGO Stage IVA Ovarian Cancer,0
2733,Lymphoid Cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2734,Tumor cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2735,low,Testicular cancer metastatic,0
2736,Tissue damage,Ectomesenchymal Chondromyxoid Tumor,0
2737,Possible,Basal Cell Ameloblastoma,0
2738,High Level,embryonal rhabdomyosarcoma of prostate,0
2739,Gestational trophoblastic disease,Hemangioma,0
2740,Symptoms,Epithelioid Sarcoma NCI Grade 3,0
2741,Folded structure,Primary Cutaneous Plasmablastic Lymphoma,0
2742,Combined,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
2743,Ovarian Cysts,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2744,Singular,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2745,Leg,Locally Advanced Soft Tissue Sarcoma,0
2746,sex,Uterine Cancer,0
2747,Fever symptoms (finding),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
2748,Monoclonal Gammapathies,Vaginal Adenoid Cystic Carcinoma,0
2749,Neoplastic disease,Uterine Cancer,0
2750,Accident due to exposure to weather conditions,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2751,Diabetes Mellitus,Uterine Cancer,0
2752,Known,BRCA2 Syndrome,0
2753,Diagnosis,Gallbladder Adenocarcinoma,0
2754,Grade,Chest Wall Fibromatosis,0
2755,Articular system,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2756,Biomaterial Treatment,Stage III Adult Immunoblastic Lymphoma,0
2757,Used by,Cerebral Primitive Neuroectodermal Tumor,0
2758,Plasma Product,Bladder Neuroendocrine Neoplasm,0
2759,Malignant Neoplasms,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2760,Daily,Refractory Barrett Esophagus,0
2761,Distant,Intraepithelial Melanocytic Hyperplasia,0
2762,Different,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2763,Target Awareness - partial,Tongue Alveolar Soft Part Sarcoma,0
2764,Diagnostic Imaging,Locally Advanced Squamous Cell Carcinoma,0
2765,Abdominal mass,Recurrent Uveal Melanoma,0
2766,Human body,Carcinoma,0
2767,Screening,Neoplasms,0
2768,Negation,Serous cystadenocarcinoma ovary,0
2769,200,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2770,The Sun,Cerebral Primitive Neuroectodermal Tumor,0
2771,Interferes with,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2772,Hereditary Diffuse Gastric Cancer,Metaplastic carcinoma of breast,0
2773,Biological Response Modifiers,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2774,Case unit dose,Cancer of Urinary Tract,0
2775,Males,Anterior Urethral Malignant Neoplasm,0
2776,Type - attribute,Maxillary Sinus Adenoid Cystic Carcinoma,0
2777,Human Papillomavirus,Carcinomatosis of peritoneal cavity,0
2778,Due to,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
2779,Lymphoid system structure,Peripheral primitive neuroectodermal tumor of soft tissue,0
2780,Cover - action,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2781,Contain (action),Ovarian germ cell choriocarcinoma stage IV,0
2782,Secondary Neoplasm,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2783,Ameloblasts,mucinous adenocarcinoma of gallbladder,0
2784,More,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2785,anatomical layer,Neonatal leukemia,0
2786,Malignant Neoplasms,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2787,Two,Unfavorable Non-Hodgkin Lymphoma,0
2788,Involvement with,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2789,Human papillomavirus 16,Recurrent Diffuse Intrinsic Pontine Glioma,0
2790,Division (action),Stage III Adult Immunoblastic Lymphoma,0
2791,NCI CTEP SDC Melanoma Sub-Category Terminology,Kaposi's sarcoma of skin,0
2792,To,Stage IB Pancreatic Cancer AJCC v8,0
2793,Skin tanning,Diffuse malignant mesothelioma,0
2794,Sore to touch,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2795,Natural,Mixed astrocytoma-ependymoma,0
2796,Most,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2797,physiological aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2798,Disease remission,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
2799,Tissue Specimen Code,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2800,Type - attribute,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2801,Intestines,Basal Cell Ameloblastoma,0
2802,Lymphocyte,Kaposi's sarcoma of skin,0
2803,Cells,ROSE Cluster 3,0
2804,1000000,clear cell adenocarcinoma of gallbladder,0
2805,fibroma,Cervical Fibroepithelial Polyp,0
2806,Type - attribute,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2807,Age of Onset,Benign squamous cell tumor,0
2808,intrathecal chemotherapy,Chondrosarcoma,0
2809,Pharmacotherapy,Recurrent Testicular Lymphoma,0
2810,Milliampere second,Adenoma,0
2811,Case unit dose,Adult Alveolar Soft Part Sarcoma,0
2812,Treating,Recurrent Testicular Lymphoma,0
2813,Treatment Epoch,Liver Cavernous Hemangioma,0
2814,Tumor Mass,Malignant Neoplasm with Regional Lymph Node Involvement,0
2815,Thinking,Kaposi's sarcoma of extrahepatic bile duct,0
2816,Rare,embryonal rhabdomyosarcoma of prostate,0
2817,Special,Human Papillomavirus-Related Carcinoma,0
2818,Stomach,Colorectal Neuroendocrine Tumor G2,0
2819,Anorexia,Recurrent Uveal Melanoma,0
2820,Increased,Bladder adenocarcinoma stage IV,0
2821,Persons,Thymic Clear Cell Carcinoma,0
2822,diagnosis aspect,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2823,Vulva,Metastatic Lung Neuroendocrine Neoplasm,0
2824,Human body,Neonatal leukemia,0
2825,Viola <angiosperm>,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
2826,Receive,Extra-Adrenal Paraganglioma,0
2827,Combined,Locally Advanced Epithelioid Hemangioendothelioma,0
2828,Polypeptide Hormones,Tubal Hyperplasia,0
2829,Common Specifications in HL7 V3 Publishing,Mixed astrocytoma-ependymoma,0
2830,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Benign Anal Granular Cell Tumor,0
2831,Feelings,embryonal rhabdomyosarcoma of prostate,0
2832,Epithelial cell count (procedure),Benign squamous cell tumor,0
2833,Treatment Epoch,Giant cell angiofibroma,0
2834,Pediculus (eukaryote),Adult Alveolar Soft Part Sarcoma,0
2835,Term (temporal),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2836,include - SetOperator,de novo Myelodysplastic Syndrome,0
2837,Liver,Stage I Colon Neuroendocrine Tumor AJCC v8,0
2838,Type - attribute,Bladder squamous cell carcinoma stage I,0
2839,Skin Specimen,Carcinomatosis of peritoneal cavity,0
2840,cervical cancer,Breast Ductal Adenoma,0
2841,Frequently,Cerebral Primitive Neuroectodermal Tumor,0
2842,Dog family,Diffuse malignant mesothelioma,0
2843,Consistency,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2844,Labium,Kaposi's sarcoma of extrahepatic bile duct,0
2845,Childhood Lymphoma,Testicular cancer metastatic,0
2846,Plumbum metallicum,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2847,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2848,Feelings,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2849,Negation,Angiosarcoma of liver,0
2850,Brain part,Refractory Bladder Carcinoma,0
2851,Occur (action),Stage I Colon Neuroendocrine Tumor AJCC v8,0
2852,Lung,Hodgkin Disease,0
2853,Genetic Risk,Stage IB Pancreatic Cancer AJCC v8,0
2854,Chromosomes,Recurrent Testicular Lymphoma,0
2855,<3 (qualifier value),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2856,Neuroendocrine Tumors,Uterine Cancer,0
2857,Telencephalon,Melanomatosis,0
2858,Dietary Lead,Small Intestinal Villous Adenoma,0
2859,Location of Oral Residue Following Swallowing,Benign Apocrine Neoplasm,0
2860,device aspects,Brain Tumor,0
2861,potential,Uterine Cancer,0
2862,3+ Score,Type II Endometrial Adenocarcinoma,0
2863,biopsy characteristics,Malignant neoplasm of choroid,0
2864,Adverse Event Associated with Vascular,Cerebral Primitive Neuroectodermal Tumor,0
2865,Amount type - Percentage,Heavy Chain Deposition Disease,0
2866,Providing presence (regime/therapy),Hyperplasia of pituitary gland,0
2867,Biogenic Amines,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
2868,Infrequent,Vaginal Adenoma,0
2869,Usual,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2870,Molecular Mass,Collecting Duct Carcinoma of the Kidney,0
2871,Magnetic Resonance Imaging,Carcinomatosis of peritoneal cavity,0
2872,Area,Adult Acute Eosinophilic Leukemia,0
2873,Close,Metaplastic carcinoma of breast,0
2874,Togo,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2875,Well Differentiated,Atypical Mesothelial Hyperplasia,0
2876,Type - attribute,Refractory Bladder Carcinoma,0
2877,Tryptophanase,Childhood Anaplastic Large Cell Lymphoma,0
2878,Case unit dose,Sarcomatoid Renal Cell Carcinoma,0
2879,Cancer Genus,Xeroderma pigmentosum,0
2880,Malignant neoplasm of penis,Benign Anal Granular Cell Tumor,0
2881,Lymphoid Tissue,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2882,Certain (qualifier value),Mucinous adenocarcinoma,0
2883,Infected,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2884,Therapeutic procedure,Digestive System Hodgkin Lymphoma,0
2885,National origin,Choroid Necrotic Melanoma,0
2886,Etiology aspects,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2887,motor movement,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2888,Long,Cartilaginous exostosis,0
2889,Predominate,Localized Askin Tumor,0
2890,Pharmacotherapy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2891,United States,Anterior Urethral Malignant Neoplasm,0
2892,NCI CTEP SDC Melanoma Sub-Category Terminology,Human Papillomavirus-Related Carcinoma,0
2893,Socket Device,Childhood Anaplastic Large Cell Lymphoma,0
2894,PSA Level Less than Two,Methotrexate-Associated Hodgkin Lymphoma,0
2895,Symptoms aspect,Hodgkin Disease,0
2896,65+,Recurrent Rhabdomyosarcoma,0
2897,Skin,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2898,Qualitative form,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2899,Routine Contract,Engraftment syndrome,0
2900,Shoulder,Localized Ewing Sarcoma,0
2901,Decision,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2902,gene therapy,Angiosarcoma of liver,0
2903,Persons,embryonal rhabdomyosarcoma of prostate,0
2904,Swollen Lymph Node,Tumorlet,0
2905,Able (finding),Choroid Epithelioid Cell Melanoma,0
2906,Hair Diseases,Stage 0 Penile Cancer AJCC v8,0
2907,Levels (qualifier value),Stage 0 Penile Cancer AJCC v8,0
2908,Symptoms aspect,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
2909,Case (situation),Ovarian Dermoid Cyst with Secondary Carcinoma,0
2910,Cancer Genus,Childhood Lymphoma,0
2911,Spreading (qualifier value),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2912,per year,Refractory Ependymoma,0
2913,Woman,Pancreatic carcinoma,0
2914,Form:Finding:Point in time:{Setting}:Document:{Role},Thyroid carcinoma,0
2915,diagnosis aspect,Childhood Lung Non-Small Cell Carcinoma,0
2916,Immunoproliferative Disorders,Astrocytoma of brain,0
2917,20%,Childhood Central Nervous System Ganglioneuroblastoma,0
2918,Small cell carcinoma of lung,Mucinous adenocarcinoma gastric,0
2919,Iodides,Anaplastic large cell lymphoma,0
2920,Physicians,Parathyroid Gland Adenocarcinoma,0
2921,Neck,Cancer of Urinary Tract,0
2922,Usual Severity Vomiting,Breast Ductal Adenoma,0
2923,Chemotherapy Regimen,Noninfiltrating Intraductal Carcinoma,0
2924,Term (lexical),Mucinous adenocarcinoma gastric,0
2925,Intestines,Stage I Colon Neuroendocrine Tumor AJCC v8,0
2926,Neoplasm Metastasis,FIGO Stage II Ovarian Cancer,0
2927,Groups,Papillary squamous cell carcinoma,0
2928,Decreased vascular flow,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2929,Occurrence Indicator,Tonsillar Carcinoma,0
2930,Life,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2931,Etiology,Xeroderma pigmentosum,0
2932,New,Kaposi's sarcoma of extrahepatic bile duct,0
2933,Small,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2934,Approximate,Localized Ewing Sarcoma,0
2935,Confirmation,High Grade Glandular Intraepithelial Neoplasia,0
2936,Smaller,Intestinal Neuroendocrine Carcinoma,0
2937,Term (lexical),Angiosarcoma of liver,0
2938,Decreasing,Engraftment syndrome,0
2939,diagnosis aspect,Xeroderma pigmentosum,0
2940,Help document,Rhabdomyosarcoma with ganglionic differentiation,0
2941,Concentration measurement,Metaplastic carcinoma of breast,0
2942,Combined,Stage 0 Penile Cancer AJCC v8,0
2943,Venous system,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2944,X-Ray Computed Tomography,Papillary squamous cell carcinoma,0
2945,Malignant neoplasm of soft tissue,Pancreatic Endocrine Carcinoma,0
2946,Dietary Lead,Human Papillomavirus-Related Carcinoma,0
2947,Forecast of outcome,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2948,Primary malignant neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2949,20%,Cartilaginous exostosis,0
2950,Cover - action,Melanomatosis,0
2951,Known,Adult Alveolar Soft Part Sarcoma,0
2952,Numerous,Unresectable Rhabdomyosarcoma,0
2953,Therapeutic procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2954,Type - attribute,Stage IB Pancreatic Cancer AJCC v8,0
2955,Table Cell Horizontal Align - left,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2956,Wealthy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2957,Formation,Liver Lymphangioma,0
2958,Infertility study,FIGO Stage II Ovarian Cancer,0
2959,Occur (action),Breast Ductal Adenoma,0
2960,Stomach,Recurrent Uveal Melanoma,0
2961,Nodular (qualifier value),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
2962,SPINK5 gene,Childhood Central Nervous System Ganglioneuroblastoma,0
2963,Lymphoma,Adenocarcinoma,0
2964,Severe (severity modifier),Bladder Neuroendocrine Neoplasm,0
2965,body system,Type II Endometrial Adenocarcinoma,0
2966,B-Cell Lymphomas,Malignant melanoma of eyelid,0
2967,Retinoic Acid Response Element,Recurrent Rhabdomyosarcoma,0
2968,How Often Weight Loss,Adrenal Rest Tumor,0
2969,Highest,Metaplastic carcinoma of breast,0
2970,Pharmacotherapy,Fibroadenoma of breast,0
2971,Often - answer to question,Malignant neoplasm of olfactory nerve,0
2972,Clinical Trials,Clonal Hematopoiesis of Indeterminate Potential,0
2973,Weight decreased,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2974,Firstly,High Grade Glandular Intraepithelial Neoplasia,0
2975,Abdominal Pain,Thymic Clear Cell Carcinoma,0
2976,shared attribute,Hereditary Diffuse Gastric Adenocarcinoma,0
2977,To,Intraepithelial Melanocytic Hyperplasia,0
2978,Living Alone,embryonal rhabdomyosarcoma of prostate,0
2979,Covered (qualifier value),Refractory Barrett Esophagus,0
2980,Individual,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
2981,Then,Chest Wall Fibromatosis,0
2982,Location,Localized Ewing Sarcoma,0
2983,Laboratory method,Recurrent Rhabdomyosarcoma,0
2984,Prolonged menses,Cervical Squamous Intraepithelial Neoplasia,0
2985,Site,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2986,Fluid behavior,Benign Anal Granular Cell Tumor,0
2987,Sometimes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2988,Entity Determiner - specific,Breast Apocrine Adenoma,0
2989,Ephrin Type-B Receptor 1,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2990,Specimen Source Codes - Respiratory,Intraepithelial Melanocytic Hyperplasia,0
2991,Capillary Leak Syndrome,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2992,Chemicals,Mucinous cystadenofibroma,0
2993,Intervention regimes,Tonsillar Carcinoma,0
2994,set (group),Gallbladder Adenocarcinoma,0
2995,Condition:Find:Pt:^Patient:Nom,Recurrent Primary Lymphoma of Bone,0
2996,Ability to balance,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2997,Capillary vessel,Tonsillar Carcinoma,0
2998,Prognosis bad,Adult Anaplastic Oligodendroglioma,0
2999,Lymphoma,Epithelioid Sarcoma NCI Grade 3,0
3000,Weight Loss,Thyroid Hurthle Cell Carcinoma,0
3001,Malignant Vaginal Neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3002,heterochromatin domain,Leptomeningeal sarcoma,0
3003,Crystals,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3004,Operative Surgical Procedures,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3005,Kissing,Thymic Clear Cell Carcinoma,0
3006,Anterior,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3007,Common Specifications in HL7 V3 Publishing,Peripheral primitive neuroectodermal tumor of soft tissue,0
3008,Abnormal cell,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
3009,Elderly (population group),Thyroid Hurthle Cell Carcinoma,0
3010,Formation,High Grade Glandular Intraepithelial Neoplasia,0
3011,Occurrence,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3012,Malignant neoplasm of urinary bladder,Malignant Testicular Sertoli Cell Tumor,0
3013,Most,Diffuse malignant mesothelioma,0
3014,Basis - conceptual entity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3015,General surgery specialty,Occult Lung Adenosquamous Carcinoma,0
3016,Togo,Vaginal Adenoid Cystic Carcinoma,0
3017,Health,Precursor B-lymphoblastic lymphoma stage II,0
3018,Frequently,Childhood Central Nervous System Immature Teratoma,0
3019,Vaginal,Endometrial Small Cell Carcinoma,0
3020,Oral contraception,Thymic Clear Cell Carcinoma,0
3021,Account number:Identifier:Point in time:^Patient:Nominal,Fibroadenoma of breast,0
3022,Genus Anemia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3023,Illness (finding),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3024,Esophageal,Unicystic ameloblastoma,0
3025,99,Childhood Anaplastic Large Cell Lymphoma,0
3026,Code System Type - Internal,Vaginal Adenoma,0
3027,Endometrial Carcinoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
3028,cell type,adenosquamous carcinoma of breast,0
3029,Epidemic,Thyroid Hurthle Cell Carcinoma,0
3030,Liver Flavor,Vaginal Adenoid Cystic Carcinoma,0
3031,epithelial,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3032,government - ActInformationManagementReason,Kaposi's sarcoma of skin,0
3033,Ovarian Hyperstimulation Syndrome,Larynx carcinoma recurrent,0
3034,Ovary,Localized Ewing Sarcoma,0
3035,Asia,Thymoma malignant recurrent,0
3036,Well,Bladder squamous cell carcinoma stage I,0
3037,Immunization Programs,Cerebral hemangioma,0
3038,Telephone Extension Number,Liver Lymphangioma,0
3039,Known,Pilocytic astrocytoma of cerebellum,0
3040,Example,Liver Lymphangioma,0
3041,Platelet Glycoprotein 4,Non-Metastatic Gestational Trophoblastic Tumor,0
3042,low confidentiality,Spongiotic dermatitis,0
3043,Carbohydrates,Small cell neuroendocrine carcinoma of bladder,0
3044,Strong,Primary Cutaneous Plasmablastic Lymphoma,0
3045,Negation,FIGO Stage IVA Ovarian Cancer,0
3046,Autosomal recessive inheritance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3047,Chest wall structure,Platinum-Resistant Lung Small Cell Carcinoma,0
3048,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3049,Percent (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
3050,Five,Cancer of Urinary Tract,0
3051,Granulation Tissue,Ovarian germ cell choriocarcinoma stage IV,0
3052,treatment - ActInformationManagementReason,FIGO Stage II Ovarian Cancer,0
3053,Surrounding (qualifier value),Benign Carotid Body Paraganglioma,0
3054,Net (qualifier),Adenocarcinoma of the prostate metastatic,0
3055,Cerebrum,Human Papillomavirus-Related Carcinoma,0
3056,NCI CTEP SDC Melanoma Sub-Category Terminology,Malignant melanoma of eyelid,0
3057,Area,Engraftment syndrome,0
3058,Cause of death:Find:Pt:^Patient:Nom,Vaginal Adenoma,0
3059,Requirement,Neoplasms,0
3060,Large blood vessel structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3061,Workplace,Liver Lymphangioma,0
3062,Malignant Neoplasms,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3063,Carcinoma,adenosquamous carcinoma of breast,0
3064,Vaginal Hemorrhage,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3065,Common Specifications in HL7 V3 Publishing,Diffuse malignant mesothelioma,0
3066,Sore Throat,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3067,Muscle Tissue,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3068,various antiseptic throat preparations,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3069,Smear - instruction imperative,Leptomeningeal sarcoma,0
3070,Class,Liver Lymphangioma,0
3071,Slow,Benign Anal Granular Cell Tumor,0
3072,New Zealand,Advanced Uterine Corpus Carcinosarcoma,0
3073,Either,Xeroderma pigmentosum,0
3074,70%,Congenital hamartoma,0
3075,high - ActExposureLevelCode,Gallbladder Adenocarcinoma,0
3076,Fever,Tongue Alveolar Soft Part Sarcoma,0
3077,Age,Acute lymphadenitis,0
3078,International Statistical Classification of Diseases and Related Health Problems,Thyroid Hurthle Cell Carcinoma,0
3079,Haemoconcentration,Refractory Bladder Carcinoma,0
3080,Function Axis,Microcystic meningioma,0
3081,Clone Cells,Cartilaginous exostosis,0
3082,700,Thyroid Hurthle Cell Carcinoma,0
3083,Including (qualifier),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3084,Borg Category-Ratio 10 Perceived Exertion Score 5,Refractory Ependymoma,0
3085,Primary malignant neoplasm,Cartilaginous exostosis,0
3086,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Lipoma of small intestine,0
3087,Rating (action),Hemangioma,0
3088,International Classification of Diseases for Oncology,Metastatic Kidney Carcinoma,0
3089,More,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3090,Disease Screening,Recurrent Testicular Lymphoma,0
3091,/40,Lung Mucinous Cystadenoma,0
3092,Asthma Control Test Questionnaire,Malignant melanoma of eyelid,0
3093,Cancer Etiology,Pancreatic carcinoma,0
3094,Malignant Cell Count,clear cell adenocarcinoma of gallbladder,0
3095,Rare,Cervical Squamous Intraepithelial Neoplasia,0
3096,Soft Tissue Route of Drug Administration,Xeroderma pigmentosum,0
3097,Lymphatic System,Benign tumor of eyelid,0
3098,Malignant Cell Count,Childhood Fibrillary Astrocytoma,0
3099,Unit of radiation dose,Blood Vessel Tumors,0
3100,Actinic keratosis,Stage 0 Lip Carcinoma,0
3101,Able (finding),Small cell neuroendocrine carcinoma of bladder,0
3102,Biospecimen,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3103,World,Adult Alveolar Soft Part Sarcoma,0
3104,CEL gene,Benign Apocrine Neoplasm,0
3105,DNA,Nasal cavity carcinoma,0
3106,<90,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3107,Cystic,Locally Advanced Epithelioid Hemangioendothelioma,0
3108,HUGO Gene Nomenclature Committee,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3109,CEL gene,Childhood Fibrillary Astrocytoma,0
3110,Availability of,Choroid Epithelioid Cell Melanoma,0
3111,84,embryonal rhabdomyosarcoma of prostate,0
3112,Classification,Mucinous adenocarcinoma gastric,0
3113,Surgery specialty,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
3114,Poor oral hygiene,Childhood Central Nervous System Ganglioneuroblastoma,0
3115,Taxonomic,Tongue Alveolar Soft Part Sarcoma,0
3116,Only - dosing instruction fragment,Gallbladder Adenocarcinoma,0
3117,Area,Localized Askin Tumor,0
3118,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Human Papillomavirus-Related Carcinoma,0
3119,North America,Fourth Ventricle and Brain Stem Ependymal Tumor,0
3120,Symptoms aspect,Clonal Hematopoiesis of Indeterminate Potential,0
3121,Reported Term,Human Papillomavirus-Related Carcinoma,0
3122,Certain (qualifier value),Human Papillomavirus-Related Carcinoma,0
3123,Linear,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3124,Percent of Abnormal Cells,Human Papillomavirus-Related Carcinoma,0
3125,Lymphoma,Mixed parotid tumor,0
3126,United States,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3127,Biologic Development,Kaposi's sarcoma of extrahepatic bile duct,0
3128,Rate,Childhood Anaplastic Large Cell Lymphoma,0
3129,Tumor Mass,Recurrent Uveal Melanoma,0
3130,Times,Giant cell angiofibroma,0
3131,Certain (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
3132,Administrative Division,Adrenal Rest Tumor,0
3133,Person Observer,Cerebral Primitive Neuroectodermal Tumor,0
3134,Qualitative form,Ovarian germ cell choriocarcinoma stage IV,0
3135,Benign,Tubal Hyperplasia,0
3136,Glioblastoma,Plexosarcoma,0
3137,Major,FIGO Stage IVA Ovarian Cancer,0
3138,Pituitary Hormones,Benign Anal Granular Cell Tumor,0
3139,Location,Mucinous adenocarcinoma gastric,0
3140,With staging,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3141,Does turn (finding),Benign Anal Granular Cell Tumor,0
3142,per year,Refractory Ependymoma,0
3143,Rarely malignant,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3144,Formation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3145,Slow,Childhood Central Nervous System Ganglioneuroblastoma,0
3146,Major,FIGO Stage II Ovarian Cancer,0
3147,Needs,Pancreatic carcinoma,0
3148,CDISC SEND Tumor Findings Results Terminology,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3149,Offspring,Refractory Barrett Esophagus,0
3150,Expression procedure,Multiple Skull Base Meningiomas,0
3151,Greater Than,Uterine Cancer,0
3152,Carcinoma breast stage IV,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3153,Mass of body structure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3154,Present,Type II Endometrial Adenocarcinoma,0
3155,Responsible to,malignant lymphoma of pancreatic lymph nodes,0
3156,Comparison,Intraepithelial Melanocytic Hyperplasia,0
3157,Menopause present (finding),Recurrent Uveal Melanoma,0
3158,Country number,Kaposi's sarcoma of extrahepatic bile duct,0
3159,Occur (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3160,Pain,Refractory Bladder Carcinoma,0
3161,Color change,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3162,Sequence Arm,Advanced Lung Carcinoma,0
3163,human papilloma virus type 16,Cystadenocarcinoma,0
3164,Group A (qualifier value),adenoid cystic carcinoma of lung,0
3165,Anatomy aspects,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3166,+5,embryonal rhabdomyosarcoma of prostate,0
3167,Hereditary,Acute Undifferentiated Leukemia,0
3168,Aspects of signs,Germinoma,0
3169,Usually Need Help from Another Person for Arising,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3170,Body tissue,Neoplasms,0
3171,Medullary carcinoma of thyroid,Multiple Skull Base Meningiomas,0
3172,Neoplastic disease,Unicystic ameloblastoma,0
3173,Identified,Stage IB Pancreatic Cancer AJCC v8,0
3174,Test Method,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
3175,Basis - conceptual entity,Platinum-Resistant Lung Small Cell Carcinoma,0
3176,In addition to,Stage I Colon Neuroendocrine Tumor AJCC v8,0
3177,Term (temporal),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3178,Clonality,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3179,Child,Cerebral Primitive Neuroectodermal Tumor,0
3180,Neuroepithelial,Necrotizing Funisitis,0
3181,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3182,Entire dorsal spinal cord,Extracranial Neuroblastoma,0
3183,PSA Level Greater than Fifty,Multiple Endocrine Neoplasia,0
3184,Thick,Benign Anal Granular Cell Tumor,0
3185,Expression (foundation metadata concept),Squamous cell carcinoma of lip,0
3186,Negative,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3187,Childhood Hodgkin Lymphoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3188,Temporal Lobe,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3189,Impaired skin integrity,Epithelioid Sarcoma NCI Grade 3,0
3190,Smear - instruction imperative,Intracortical osteosarcoma,0
3191,Tobacco,Medulloblastoma,0
3192,Abdomen+,Benign neoplasm of eye,0
3193,Imaging Techniques,Stage IB Lung Cancer AJCC v7,0
3194,Talpidae,Stage II Hepatocellular Carcinoma AJCC v8,0
3195,Teens,Giant cell angiofibroma,0
3196,Radiation Ionizing Radiotherapy,Mucinous adenocarcinoma gastric,0
3197,North America,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3198,Cancer Genus,Undifferentiated Endocervical Sarcoma,0
3199,Period Circadian Protein Homolog 1,Heavy Chain Deposition Disease,0
3200,Family history,Placental aromatase deficiency,0
3201,Cause of Death,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3202,Hematology procedure,Kaposi's sarcoma of skin,0
3203,Africa,Tubal Hyperplasia,0
3204,Efficacy Study,Adult Acute Eosinophilic Leukemia,0
3205,Linear,Uterine Cancer,0
3206,Sufficiently defined concept definition status (core metadata concept),Localized Ewing Sarcoma,0
3207,Maintaining (action),Methotrexate-Associated Hodgkin Lymphoma,0
3208,In Blood,Intraepithelial Melanocytic Hyperplasia,0
3209,risk factors - observation list,Kaposi's sarcoma of extrahepatic bile duct,0
3210,Increasing,Refractory Barrett Esophagus,0
3211,peripheral blood,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
3212,Type - attribute,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3213,Standard Treatment,Intestinal Metaplasia of Bladder Urothelium,0
3214,Entity,Ichthyoses,0
3215,Poor function,Carcinoma of urinary bladder,0
3216,Pain Distress Question,Bladder squamous cell carcinoma stage I,0
3217,Diffuse Large B-Cell Lymphoma,Benign Anal Granular Cell Tumor,0
3218,Patient Discharge,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3219,Decade,carcinoma of middle ear,0
3220,Administration Method - Infiltrate,Uterine Cancer,0
3221,New,Bladder Neuroendocrine Neoplasm,0
3222,Chemotherapy Regimen,Xeroderma pigmentosum,0
3223,human herpesvirus 8,Low Grade Squamous Intraepithelial Neoplasia,0
3224,Specimen Source Codes - Mucus,Malignant melanoma of eyelid,0
3225,Blood Transfusion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3226,Time,Low Grade Squamous Intraepithelial Neoplasia,0
3227,Mutation,Pilocytic astrocytoma of cerebellum,0
3228,Cerebellum,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3229,Growth abnormality,Astrocytoma of brain,0
3230,What subject filter - Result,Undifferentiated Endocervical Sarcoma,0
3231,Physical findings,Thymic Atypical Carcinoid Tumor,0
3232,Most,Lipoma of small intestine,0
3233,Occurrence,Pancreatic Endocrine Carcinoma,0
3234,Tryptophanase,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
3235,Form of bone,Unicystic ameloblastoma,0
3236,Neoplasm Metastasis,Diffuse malignant mesothelioma,0
3237,Increase,Trichilemmocarcinoma,0
3238,Hormones,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3239,ca increase,Pancreatic Intraepithelial Neoplasia-3,0
3240,Felis catus,Stage IV Penile Cancer AJCC v7,0
3241,Contact with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3242,Relationships,Melanomatosis,0
3243,Manufactured form,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
3244,Injury due to exposure to external cause,Precursor B-lymphoblastic lymphoma stage II,0
3245,Secondary Neoplasm,Primary Cutaneous Plasmablastic Lymphoma,0
3246,Body Site Modifier - Lower,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
3247,Females,Lipoma of small intestine,0
3248,Epithelial ovarian cancer,Serous cystadenocarcinoma ovary,0
3249,Fever,Mixed parotid tumor,0
3250,Hemangioma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3251,Percent normal,Xeroderma pigmentosum,0
3252,KAT5 wt Allele,Placental aromatase deficiency,0
3253,include - SetOperator,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3254,Percent (qualifier value),Unicystic ameloblastoma,0
3255,Colorectal Carcinoma,Nasal cavity carcinoma,0
3256,Tobacco smoking behavior,Precursor B-lymphoblastic lymphoma stage II,0
3257,Incidence,Recurrent Testicular Lymphoma,0
3258,Salivary Glands,Liver Lymphangioma,0
3259,Either,Germinoma,0
3260,Administration procedure,Granular Cell Leiomyosarcoma,0
3261,Average of Value Derivation Technique,Cerebral Primitive Neuroectodermal Tumor,0
3262,Near,Thyroid Hurthle Cell Carcinoma,0
3263,Seed entity,Extra-abdominal fibromatosis,0
3264,Frequently,Small cell neuroendocrine carcinoma of bladder,0
3265,SMG1 wt Allele,Female Breast Carcinoma,0
3266,Pediculus (eukaryote),Extra-Adrenal Paraganglioma,0
3267,research subject screening,Localized Malignant Neoplasm,0
3268,Part of,Engraftment syndrome,0
3269,Symptoms aspect,Benign squamous cell tumor,0
3270,Fatigue,Uterine Cancer,0
3271,Group A (qualifier value),Gallbladder Adenocarcinoma,0
3272,Established,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3273,Ki67 Measurement,Cystadenocarcinoma,0
3274,Usual Severity Weight Loss,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3275,Hemorrhagic Fevers,Recurrent Uveal Melanoma,0
3276,Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3277,Cause of Death,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
3278,Skin,Childhood Anaplastic Large Cell Lymphoma,0
3279,Diagnosis,Undifferentiated Endocervical Sarcoma,0
3280,Bone Pain,Clonal Hematopoiesis of Indeterminate Potential,0
3281,Process (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3282,Unknown,Female Breast Carcinoma,0
3283,Less often,FIGO Stage IVA Ovarian Cancer,0
3284,Benign,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3285,95,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3286,Disease,Pancreatic Endocrine Carcinoma,0
3287,Feelings,Deep Leiomyoma,0
3288,Occurrence,Choroid Necrotic Melanoma,0
3289,Infrequent,Malignant neoplasm of olfactory nerve,0
3290,Include (action),Pancreatic Intraepithelial Neoplasia-3,0
3291,Injury due to exposure to external cause,clear cell adenocarcinoma of gallbladder,0
3292,Term (lexical),Recurrent Testicular Lymphoma,0
3293,Secondary Neoplasm,Pancreatic Endocrine Carcinoma,0
3294,Unknown GENC,Cancer of Urinary Tract,0
3295,Administration procedure,BRCA2 Syndrome,0
3296,Present,Gallbladder Adenocarcinoma,0
3297,Order (arrangement),Benign tumor of eyelid,0
3298,melanoma,Astrocytoma of brain,0
3299,Computed Tomography Study File,Malignant neoplasm of choroid,0
3300,Series - set of composite instances,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3301,degree of relationship - exchange,Bladder squamous cell carcinoma stage I,0
3302,Reported Term,Melanomatosis,0
3303,Symptoms,Familial Hemophagocytic Lymphocytosis,0
3304,Result,Malignant melanoma of eyelid,0
3305,combination of objects,Hodgkin lymphoma,0
3306,Aspect (characteristic),Familial Adenomatous Polyposis Associated Medulloblastoma,0
3307,include - SetOperator,Acute Undifferentiated Leukemia,0
3308,NCI CTEP SDC Melanoma Sub-Category Terminology,Breast Ductal Adenoma,0
3309,Small cell carcinoma of lung,Chest Wall Fibromatosis,0
3310,Case Study,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3311,Ultraviolet Rays,Diffuse malignant mesothelioma,0
3312,Slow,Nasal cavity carcinoma,0
3313,More,Multiple Skull Base Meningiomas,0
3314,Worse,BRCA2 Syndrome,0
3315,Target Lesion Identification,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3316,Undifferentiated Neuroblastoma,Undifferentiated Endocervical Sarcoma,0
3317,Carcinoma,gliosarcoma,0
3318,Uncontrolled,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3319,Form of uterus,gliosarcoma,0
3320,Lower - spatial qualifier,Human Papillomavirus-Related Carcinoma,0
3321,Medulloblastoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3322,Two,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3323,AKR1A1 wt Allele,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3324,Common (qualifier value),Tumorlet,0
3325,Centrocytic lymphoma,gliosarcoma,0
3326,Present,Hereditary Diffuse Gastric Adenocarcinoma,0
3327,Cervical Squamous Cell Carcinoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3328,Science of Etiology,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3329,Zone,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3330,TRIM33 wt Allele,Localized Ewing Sarcoma,0
3331,English Language,Pancreatic Intraepithelial Neoplasia-3,0
3332,Treatment Epoch,Stage IV Childhood Non-Hodgkin Lymphoma,0
3333,Less Than,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3334,Location of Oral Residue Following Swallowing,papillary carcinoma of penis,0
3335,Pharyngeal structure,Stage IB Pancreatic Cancer AJCC v8,0
3336,Pleomorphism,Ectomesenchymal Chondromyxoid Tumor,0
3337,Abnormal,Clonal Hematopoiesis of Indeterminate Potential,0
3338,Antibiotics,Thymic Atypical Carcinoid Tumor,0
3339,Spreading (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
3340,combination of objects,Stage IB Pancreatic Cancer AJCC v8,0
3341,Feelings,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
3342,Rare,Placental aromatase deficiency,0
3343,Percent of Abnormal Cells,Mucosal Melanoma,0
3344,World,Hemangioma,0
3345,Magnetic Resonance Imaging,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3346,Colorectal Cancer Pathway,Familial Hemophagocytic Lymphocytosis,0
3347,Case unit dose,Vaginal Adenoma,0
3348,Carrying,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3349,Operative Surgical Procedures,Testicular cancer metastatic,0
3350,Occur (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3351,Frequently,Neonatal leukemia,0
3352,Malignant neoplasm of urinary bladder,Kaposi's sarcoma of extrahepatic bile duct,0
3353,Cure (remedy),Undifferentiated Endocervical Sarcoma,0
3354,Fever,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3355,Scientific Study,Platinum-Resistant Lung Small Cell Carcinoma,0
3356,Y base,Recurrent Rhabdomyosarcoma,0
3357,How Much Distress Weight Loss,Vaginal Adenoma,0
3358,User Group,Testicular cancer metastatic,0
3359,Presentation,Tongue Alveolar Soft Part Sarcoma,0
3360,Two,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3361,Growth pattern,Atypical Lobular Breast Hyperplasia,0
3362,80%,Cerebral Primitive Neuroectodermal Tumor,0
3363,combination - answer to question,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3364,Persons,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
3365,Due to,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3366,artesunate,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3367,Normal pregnancy,Tubal Hyperplasia,0
3368,Pregnancy,Glomeruloid hemangioma,0
3369,Include (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3370,Administration procedure,Placental aromatase deficiency,0
3371,Usually Need Help from Another Person for Arising,Peripheral primitive neuroectodermal tumor of soft tissue,0
3372,IPSS Risk Category Low,Heavy Chain Deposition Disease,0
3373,Main,Benign Ovarian Thecoma,0
3374,Increasing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3375,Back Pain,Type II Endometrial Adenocarcinoma,0
3376,Catch - Finding of sensory dimension of pain,Stage III Cutaneous Melanoma AJCC v6,0
3377,Mediate,FIGO Stage II Ovarian Cancer,0
3378,Initially,Clonal Hematopoiesis of Indeterminate Potential,0
3379,Experimental Organism Basal Cell Carcinoma,sarcoma of spinal cord,0
3380,Child,Diffuse malignant mesothelioma,0
3381,Mature,Cerebral hemangioma,0
3382,DNA,Malignant Neoplasm with Regional Lymph Node Involvement,0
3383,English race,Carcinoma of submandibular gland,0
3384,Continuance of life,Squamous cell carcinoma of lip,0
3385,Include (action),Adenocarcinoma,0
3386,Choose (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
3387,Cornea,Atypical Lobular Breast Hyperplasia,0
3388,Before values,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3389,Less Than,Neonatal leukemia,0
3390,Manufactured form,Diffuse malignant mesothelioma,0
3391,Breast Carcinoma,Nasal cavity carcinoma,0
3392,Pelvic Pain,Adult Acute Eosinophilic Leukemia,0
3393,Include (action),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
3394,Image Feature,Childhood Fibrillary Astrocytoma,0
3395,Occurrence,Endometrial Small Cell Carcinoma,0
3396,Fourth,Intestinal Neuroendocrine Carcinoma,0
3397,Excision biopsy,Maxillary Sinus Adenocarcinoma,0
3398,1000000,Ovarian Carcinoid Tumor,0
3399,Decision,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3400,Left,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3401,Science of Etiology,Liver Lymphangioma,0
3402,Late,Metastatic Ductal Breast Carcinoma,0
3403,Glioblastoma Multiforme Pathway,Melanomatosis,0
3404,Edema,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3405,More,Pilocytic astrocytoma of cerebellum,0
3406,Management procedure,Lung squamous cell carcinoma stage I,0
3407,high - ActExposureLevelCode,Uterine Cancer,0
3408,Group A (blood group),Astrocytoma of brain,0
3409,Brain Neoplasms,Ovarian germ cell choriocarcinoma stage IV,0
3410,include - SetOperator,Anterior Urethral Malignant Neoplasm,0
3411,Responsible to,Melanomatosis,0
3412,Cardiac Arrest,Endometrial Small Cell Carcinoma,0
3413,Structure of left half of body,Adenocarcinoma,0
3414,Rate,Splenic Manifestation of Hairy Cell Leukemia,0
3415,Infection,Cervical Fibroepithelial Polyp,0
3416,Strikes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3417,Fishes,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3418,Tryptophanase,adenoid cystic carcinoma of lung,0
3419,Dietary Lead,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3420,Persons,Malignant Testicular Sertoli Cell Tumor,0
3421,Slide (glass microscope),Mucinous adenocarcinoma gastric,0
3422,Cure (remedy),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3423,Pleomorphic Xanthoastrocytoma,Malignant Testicular Sertoli Cell Tumor,0
3424,Progress,Refractory Ependymoma,0
3425,Offspring,Contact dermatitis due to alkali,0
3426,Injury due to exposure to external cause,Blepharal carcinoma,0
3427,Person Observer,Anterior Urethral Malignant Neoplasm,0
3428,suggestion,Malignant Neoplasm with Regional Lymph Node Involvement,0
3429,Optic Nerve,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3430,World,Transitional cell carcinoma,0
3431,Affect (mental function),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3432,gene therapy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3433,Term (lexical),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3434,Mass,Malignant Neoplasm with Regional Lymph Node Involvement,0
3435,Linear,Locally Advanced Squamous Cell Carcinoma,0
3436,Imaging Techniques,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3437,Image Feature,Adult Fibrolamellar Carcinoma,0
3438,Egg of order Phthiraptera,Adult Anaplastic Oligodendroglioma,0
3439,Severe (severity modifier),Atypical Mesothelial Hyperplasia,0
3440,Weight decreased,Recurrent Uveal Melanoma,0
3441,radiotherapeutic,ICHTHYOSIS,0
3442,Nucleotide Excision Repair,Metastatic Lung Small Cell Carcinoma,0
3443,Mesenchymal Cell Neoplasm,Leiomyoma of Gallbladder,0
3444,Adult Children,gliosarcoma,0
3445,Primary malignant neoplasm,Adult Acute Eosinophilic Leukemia,0
3446,Spreading (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3447,Body Site Modifier - Lower,Cancer of Urinary Tract,0
3448,Mesenchymal Stem Cells,Stage IV Penile Cancer AJCC v7,0
3449,various other intestinal adsorbents in ATC,Refractory Ependymoma,0
3450,Night sweats,Childhood Fibrillary Astrocytoma,0
3451,Stage Grouping,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3452,Cyst,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3453,Genital infection,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
3454,Pleomorphism (morphologic abnormality),High Grade Salivary Gland Mucoepidermoid Carcinoma,0
3455,Pediatric Neoplasm,Thyroid Hurthle Cell Carcinoma,0
3456,Array Feature,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3457,Diagnostic Imaging,Malignant Testicular Sertoli Cell Tumor,0
3458,Negation,Type II Endometrial Adenocarcinoma,0
3459,Leads (device),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3460,Interstitial Fluid,Chondrosarcoma,0
3461,White blood cell count normal,Mucinous adenocarcinoma gastric,0
3462,Dysuria,Stage 0 Penile Cancer AJCC v8,0
3463,PSA Level Greater than Fifty,Benign tumor of eyelid,0
3464,HLA Complex,Unicystic ameloblastoma,0
3465,Fibroid Tumor,Melanomatosis,0
3466,activate biological process,Methotrexate-Associated Hodgkin Lymphoma,0
3467,risk factors,Carcinoma of urinary bladder,0
3468,Net (qualifier),Malignant neoplasm of choroid,0
3469,Follicle,adenoid cystic carcinoma of lung,0
3470,presently,Angiosarcoma of liver,0
3471,Rare,Epithelioid Sarcoma NCI Grade 3,0
3472,Primary malignant neoplasm,Ovarian germ cell choriocarcinoma stage IV,0
3473,Usually,Blood Vessel Tumors,0
3474,Associated with,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3475,various other agents for local oral treatment in ATC,Metastatic Lung Small Cell Carcinoma,0
3476,Death NOS,Cancer of Urinary Tract,0
3477,Exposure to ionizing radiation,High Grade Glandular Intraepithelial Neoplasia,0
3478,99,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
3479,Inguinal region,Blood Vessel Tumors,0
3480,Only - dosing instruction fragment,Adenocarcinoma of the prostate metastatic,0
3481,Northern Europe,Astrocytoma of brain,0
3482,Possibly Related to Intervention,Non-Hodgkin Lymphoma During Pregnancy,0
3483,consideration,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3484,Carcinoma of larynx,Uterine Cancer,0
3485,63,Maxillary Sinus Adenocarcinoma,0
3486,Papillary Thyroid Carcinoma Pathway,Primary Cutaneous Plasmablastic Lymphoma,0
3487,Can Do Very Little,High Grade Glandular Intraepithelial Neoplasia,0
3488,Liver Flavor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3489,Early,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3490,Congenital qualifier,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3491,Tissue Specimen Code,squamous cell carcinoma of the thyroid gland,0
3492,Calcium Channel Blockers,Cancer of Urinary Tract,0
3493,Mobility aid,embryonal rhabdomyosarcoma of prostate,0
3494,Spreading (qualifier value),Kaposi's sarcoma of skin,0
3495,Due to,Locally Advanced Squamous Cell Carcinoma,0
3496,Germ cell tumor,Diffuse malignant mesothelioma,0
3497,Taxonomic,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3498,Liver,Childhood Lung Non-Small Cell Carcinoma,0
3499,Abnormal Reference Range,Maxillary Sinus Adenocarcinoma,0
3500,Related personal status,Recurrent Testicular Lymphoma,0
3501,Late,Bladder adenocarcinoma stage IV,0
3502,Symptoms,Lipoma of small intestine,0
3503,Known,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3504,Sexually Transmitted Diseases,Carcinoma ex pleomorphic adenoma of parotid gland,0
3505,Occur (action),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
3506,Active,FIGO Stage IVA Ovarian Cancer,0
3507,Affect (mental function),Chondrosarcoma,0
3508,Anterior,adenosquamous carcinoma of breast,0
3509,Account number:Identifier:Point in time:^Patient:Nominal,Rhabdomyosarcoma with ganglionic differentiation,0
3510,Weight decreased,Childhood Choriocarcinoma,0
3511,Prognosis:Find:Pt:^Patient:Nom,FIGO Stage IVA Ovarian Cancer,0
3512,Object Class,Benign Carotid Body Paraganglioma,0
3513,3+ Answer to Question,BRCA2 Syndrome,0
3514,Jack Device,Granular Cell Leiomyosarcoma,0
3515,Group A (qualifier value),Squamous cell carcinoma of lip,0
3516,Arranged (transportation),Cervical Fibroepithelial Polyp,0
3517,Cell Count,Clonal Hematopoiesis of Indeterminate Potential,0
3518,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3519,Part of,Mucinous neoplasm,0
3520,Treating,Undifferentiated Neuroblastoma,0
3521,Usually,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3522,Manufactured sign,Locally Advanced Carcinoma,0
3523,Rare,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3524,Infiltration Route of Drug Administration,gliosarcoma,0
3525,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Uterine Cancer,0
3526,Mathematical Operator,Locally Advanced Epithelioid Hemangioendothelioma,0
3527,Transformation,Unicystic ameloblastoma,0
3528,Obesity,Gallbladder Adenocarcinoma,0
3529,treatment - ActInformationManagementReason,Stage IB Pancreatic Cancer AJCC v8,0
3530,Vagina Carcinoma,Vaginal Adenoma,0
3531,Indexes,Uterine Cancer,0
3532,lobe,Lipoma of small intestine,0
3533,Much,Brain Ependymoma,0
3534,Cure (remedy),Adult Acute Eosinophilic Leukemia,0
3535,use of ultrasonography,Adult Alveolar Soft Part Sarcoma,0
3536,Unintentional,Stage II Hepatocellular Carcinoma AJCC v8,0
3537,Response to treatment,Chronic Myelomonocytic Leukemia-2,0
3538,Malignant Neoplasms,Precursor B-lymphoblastic lymphoma stage II,0
3539,Beginning,Tubal Hyperplasia,0
3540,Cervical lymph node group,Astrocytoma of brain,0
3541,Stensen's duct,Mucosal Melanoma,0
3542,Childhood Lymphoma,malignant lymphoma of pancreatic lymph nodes,0
3543,Does carry,Childhood Anaplastic Large Cell Lymphoma,0
3544,Qualitative form,Localized Askin Tumor,0
3545,Drain number:ID:Pt:^Patient:Nom,Noninfiltrating Intraductal Carcinoma,0
3546,Usual Severity Vomiting,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3547,Aggressive course,Hodgkin lymphoma,0
3548,How Often Weight Loss,Adult Alveolar Soft Part Sarcoma,0
3549,entry - cluster,Bladder adenocarcinoma stage IV,0
3550,Tobacco smoking behavior,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3551,Lymphatic System,Choroid Epithelioid Cell Melanoma,0
3552,Mean Percent of Normal,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3553,Hereditary Diseases,Thymic Clear Cell Carcinoma,0
3554,Body part,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3555,Lung,Undifferentiated Endocervical Sarcoma,0
3556,Germ cell tumor,Stage III Cutaneous Melanoma AJCC v6,0
3557,Support,Maxillary Sinus Adenoid Cystic Carcinoma,0
3558,Rosette formation,Bladder squamous cell carcinoma stage I,0
3559,Palmitic Acid,Cervical Fibroepithelial Polyp,0
3560,Dyspnea,Periosteal Osteosarcoma,0
3561,Numbers,papillary carcinoma of penis,0
3562,Mature Lymphocyte,Recurrent Testicular Lymphoma,0
3563,Egg of order Phthiraptera,Peripheral primitive neuroectodermal tumor of soft tissue,0
3564,Responsible to,Benign Anal Granular Cell Tumor,0
3565,Alcohols,Airway Hemangioma,0
3566,Pax (eukaryote),Carcinoma of urinary bladder,0
3567,Therapeutic procedure,Maxillary Sinus Adenocarcinoma,0
3568,Long Variable,Chest Wall Fibromatosis,0
3569,Cell Invasion,Stage III Cutaneous Melanoma AJCC v6,0
3570,Pharmacologic Substance,Hodgkin lymphoma,0
3571,Diffuse Large B-Cell Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3572,World Health Organization,Plexosarcoma,0
3573,International Classification of Diseases for Oncology,Recurrent Uveal Melanoma,0
3574,Retained,Diffuse malignant mesothelioma,0
3575,Spreading (qualifier value),Non-Metastatic Gestational Trophoblastic Tumor,0
3576,In Blood,Adenocarcinoma,0
3577,insensitivity,Chondrosarcoma,0
3578,Cessation of life,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3579,White Blood Cell Count procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3580,Occur (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3581,Family history,Childhood Anaplastic Large Cell Lymphoma,0
3582,Diagnostic Neoplasm Staging,Kaposi's sarcoma of extrahepatic bile duct,0
3583,Affect (mental function),Malignant melanoma of eyelid,0
3584,Notch Receptor Intracellular Domain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3585,Retraction (finding),Ovarian germ cell choriocarcinoma stage IV,0
3586,Rare,Recurrent Testicular Lymphoma,0
3587,Name (property) (qualifier value),Acute lymphadenitis,0
3588,Administration procedure,FIGO Stage IVA Ovarian Cancer,0
3589,Enhance (action),Malignant Testicular Sertoli Cell Tumor,0
3590,Mohs Surgery,Intestinal Neuroendocrine Carcinoma,0
3591,Malignant - descriptor,gliosarcoma,0
3592,Susceptible,Carcinoma,0
3593,Increasing,Recurrent Testicular Lymphoma,0
3594,Malignant - descriptor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3595,Diagnostic Imaging,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3596,Maxilla,Kaposi's sarcoma of extrahepatic bile duct,0
3597,Version,Colorectal Neuroendocrine Tumor G2,0
3598,Infrequent,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3599,Main,FIGO Stage IVA Ovarian Cancer,0
3600,Sometimes,Basal Cell Ameloblastoma,0
3601,Dyspareunia,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3602,Fibromatosis,embryonal rhabdomyosarcoma of prostate,0
3603,Present,Childhood Fibrillary Astrocytoma,0
3604,Smear - instruction imperative,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3605,Air (substance),mucinous adenocarcinoma of gallbladder,0
3606,Defense,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3607,HER-2-neu peptide vaccine,Intraepithelial Melanocytic Hyperplasia,0
3608,Administrative Division,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3609,Pain Distress Question,Contact dermatitis due to alkali,0
3610,Genetic,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3611,Two,Benign Anal Granular Cell Tumor,0
3612,Both ovaries,Adult Acute Eosinophilic Leukemia,0
3613,Symptoms,Small intestine carcinoma,0
3614,Referring,Astrocytoma of brain,0
3615,Ovary,Atypical Lobular Breast Hyperplasia,0
3616,Techniques,Cerebral Primitive Neuroectodermal Tumor,0
3617,Hematogenous spread,Melanomatosis,0
3618,NCI CTEP SDC Adrenal Cancer Sub-Category Terminology,Undifferentiated Endocervical Sarcoma,0
3619,Subtype (attribute),Nasal cavity carcinoma,0
3620,Persons,Thymic Clear Cell Carcinoma,0
3621,Rare,Stage II Carcinoma of Penis,0
3622,Include (action),Platinum-Resistant Lung Small Cell Carcinoma,0
3623,Personal appearance,clear cell adenocarcinoma of gallbladder,0
3624,Constant (qualifier),Digestive System Hodgkin Lymphoma,0
3625,Death (finding),Cervical Adenomyoma,0
3626,Include (action),Hereditary Diffuse Gastric Adenocarcinoma,0
3627,Main,Familial Hemophagocytic Lymphocytosis,0
3628,Extrinsic,Carcinoma of urinary bladder,0
3629,Gram per Deciliter,Diffuse malignant mesothelioma,0
3630,Classification of information,Anterior Urethral Malignant Neoplasm,0
3631,Case (situation),Cystadenocarcinoma,0
3632,More,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3633,Malignant - descriptor,Kaposi's sarcoma of extrahepatic bile duct,0
3634,Amount type - Percentage,Advanced Uterine Corpus Carcinosarcoma,0
3635,Less Than,Diffuse malignant mesothelioma,0
3636,Five-year Survival Rate,Refractory Barrett Esophagus,0
3637,Misdiagnosis,Non-Metastatic Gestational Trophoblastic Tumor,0
3638,Impaired skin integrity,Hodgkin lymphoma,0
3639,Adenocarcinoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3640,Object Class,Benign Carotid Body Paraganglioma,0
3641,Iris <angiosperm>,Type II Endometrial Adenocarcinoma,0
3642,Proline,Localized Ewing Sarcoma,0
3643,Inferior,Non-Metastatic Gestational Trophoblastic Tumor,0
3644,Most,Benign Apocrine Neoplasm,0
3645,depend,sarcoma of spinal cord,0
3646,Positive Charge,Childhood Thyroid Gland Follicular Carcinoma,0
3647,Primary,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3648,Local,Primary Cutaneous Plasmablastic Lymphoma,0
3649,Use of,Small cell neuroendocrine carcinoma of bladder,0
3650,status - In progress,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3651,Histologic,Stage III Adult Immunoblastic Lymphoma,0
3652,Adult Diffuse Large B-Cell Lymphoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3653,Ligaments,Kaposi's sarcoma of extrahepatic bile duct,0
3654,Cold Sensation,Pleomorphic adenoma of parotid gland,0
3655,Sharing (Social Behavior),Occult Lung Adenosquamous Carcinoma,0
3656,Severe Extremity Pain,Stage III Cutaneous Melanoma AJCC v6,0
3657,Fever,Intraepithelial Melanocytic Hyperplasia,0
3658,Code,Werner Syndrome,0
3659,Including (qualifier),Liver Lymphangioma,0
3660,Condition,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3661,Fever symptoms (finding),Trabecular adenocarcinoma,0
3662,Thymic epithelial tumor,Refractory Barrett Esophagus,0
3663,Unintentional Material Aspiration,benign mature teratoma of pancreas,0
3664,Subtype (attribute),Funisitis (disorder),0
3665,Death (finding),Childhood Lymphoma,0
3666,Common (qualifier value),Medulloblastoma,0
3667,Continuance of life,Kaposi's sarcoma of extrahepatic bile duct,0
3668,Body site,Acantholytic squamous cell carcinoma,0
3669,Feature,Rhabdomyosarcoma with ganglionic differentiation,0
3670,Ascites,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3671,Primary,Microcystic meningioma,0
3672,include - SetOperator,Vaginal Adenoma,0
3673,Aggressive behavior,Benign neoplasm of eye,0
3674,Confusion,Microcystic meningioma,0
3675,Same,Stage IB Lung Cancer AJCC v7,0
3676,Lifetime,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3677,Qualitative form,Giant cell angiofibroma,0
3678,Diffuse Large B-Cell Lymphoma,Digestive System Hodgkin Lymphoma,0
3679,Average,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
3680,Cancer of Lip,Carcinoma of urinary bladder,0
3681,Chewing,Stage 0 Lip Carcinoma,0
3682,Case (situation),Heavy Chain Deposition Disease,0
3683,Have Weight Loss,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3684,N+ (tumor staging),FIGO Stage II Ovarian Cancer,0
3685,Greater,Angiosarcoma of liver,0
3686,Smaller,Locally Advanced Epithelioid Hemangioendothelioma,0
3687,Adrenal Cancer,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3688,atypia morphology,Malignant Neoplasm with Regional Lymph Node Involvement,0
3689,Financial Account,embryonal rhabdomyosarcoma of prostate,0
3690,Specialized Stand Alone Plan - Vision,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3691,Melanocytic nevus,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3692,Sharing (Social Behavior),Ovarian Dermoid Cyst with Secondary Carcinoma,0
3693,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3694,Osteoporosis,Chest Wall Fibromatosis,0
3695,Physical shape,Tonsillar Carcinoma,0
3696,Pancreas,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3697,Body part,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3698,Time,Malignant neoplasm of subglottis,0
3699,Formation,Familial Hemophagocytic Lymphocytosis,0
3700,Fatigue,Stage II Carcinoma of Penis,0
3701,Abnormal cell,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3702,common types,FIGO Stage IVA Ovarian Cancer,0
3703,Detached,Pilocytic astrocytoma of cerebellum,0
3704,Carcinoma of lung,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3705,VARIOUS DRUG CLASSES IN ATC,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3706,Aggressive course,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3707,Pale feces (finding),Placental aromatase deficiency,0
3708,Immune system,Endometrial Small Cell Carcinoma,0
3709,Primary malignant neoplasm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3710,Left,Angiosarcoma of liver,0
3711,diagnosis aspect,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3712,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
3713,High,Giant cell angiofibroma,0
3714,Diagnosis Study,Testicular cancer metastatic,0
3715,Type A,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3716,Mutation,Acinar cell carcinoma of pancreas,0
3717,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
3718,A Codes,Stage IV Colorectal Cancer AJCC v8,0
3719,Australia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3720,Presence (property),Lung squamous cell carcinoma stage I,0
3721,Related personal status,Mixed astrocytoma-ependymoma,0
3722,Reaching,benign mature teratoma of pancreas,0
3723,Decreasing,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3724,shared attribute,Mixed astrocytoma-ependymoma,0
3725,therapeutic aspects,Precursor B-lymphoblastic lymphoma stage II,0
3726,Base of the Brain,Mucinous adenocarcinoma gastric,0
3727,Primary,Blepharal carcinoma,0
3728,Skin Specimen,Hodgkin lymphoma,0
3729,Smoking,Papillary squamous cell carcinoma,0
3730,High Level,Intracortical osteosarcoma,0
3731,Spreading (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
3732,Identified,Malignant melanoma of eyelid,0
3733,Feel Tired question,Intraepithelial Melanocytic Hyperplasia,0
3734,Occur (action),Metastatic Malignant Neoplasm in the Sellar Region,0
3735,Fibrous,Intraepithelial Melanocytic Hyperplasia,0
3736,Blood flow,Anaplastic large cell lymphoma,0
3737,Name (property) (qualifier value),FIGO Stage II Ovarian Cancer,0
3738,Platelet Glycoprotein 4,Intestinal Metaplasia of Bladder Urothelium,0
3739,Ultraviolet Light Sterilization,Pancreatic Intraepithelial Neoplasia-3,0
3740,International Classification of Disease for Oncology,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3741,Death (finding),Carcinoma ex pleomorphic adenoma of parotid gland,0
3742,80%,ROSE Cluster 3,0
3743,Immature Lymphocytes Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3744,Nervous system structure,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3745,Person 1,Hair nevus,0
3746,Precision - second,Pancreatic Endocrine Carcinoma,0
3747,Urine looks dark,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3748,Peripheral T-Cell Lymphoma,Malignant melanoma of eyelid,0
3749,AKR1A1 wt Allele,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3750,Two,Intestinal Metaplasia of Bladder Urothelium,0
3751,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3752,Before,Primary Cutaneous Plasmablastic Lymphoma,0
3753,Carcinoma,Mucinous adenocarcinoma gastric,0
3754,Covers (device),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3755,Pap smear,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3756,Options,Heavy Chain Deposition Disease,0
3757,Biopsy,Recurrent Testicular Lymphoma,0
3758,Diabetes,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3759,high - ActExposureLevelCode,Human Papillomavirus-Related Carcinoma,0
3760,Poor function,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3761,Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3762,Acquired lymphangioma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3763,Active License,Benign Anal Granular Cell Tumor,0
3764,65+,Liver Lymphangioma,0
3765,respiratory,Metastatic Lung Neuroendocrine Neoplasm,0
3766,Formation,Stage IB Pancreatic Cancer AJCC v8,0
3767,Body tissue,Metastatic Malignant Neoplasm in the Sellar Region,0
3768,Well Differentiated,Recurrent Rhabdomyosarcoma,0
3769,Neuroectodermal Tumor,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3770,Adverse Event Associated with Vascular,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3771,<90,Adenocarcinoma of duodenum,0
3772,Malignant - descriptor,Breast Apocrine Adenoma,0
3773,Etiology,Metastatic Neoplasm to the Gallbladder,0
3774,Tryptophanase,Congenital hamartoma,0
3775,Neoplasm Metastasis,Secondary malignant neoplasm of lymph node,0
3776,False Discovery Rate,Pancreatic Intraepithelial Neoplasia-3,0
3777,avoidance,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3778,Sensation quality,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
3779,Basis - conceptual entity,Tubal Hyperplasia,0
3780,Malignant Neoplasms,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3781,Therapeutic radiology procedure,Refractory Ependymoma,0
3782,Tryptophanase,Kaposi's sarcoma of extrahepatic bile duct,0
3783,Armpit,Cartilaginous exostosis,0
3784,Gland,Localized Malignant Neoplasm,0
3785,Cavitation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3786,Biopsy,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
3787,Example,Stage I Adult Non-Hodgkin Lymphoma,0
3788,High Mitosis-Karyorrhexis Index,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3789,Overall Publication Type,Plexosarcoma,0
3790,Feature,Metaplastic carcinoma of breast,0
3791,Family,Localized Askin Tumor,0
3792,Etiology aspects,Mucosal Melanoma,0
3793,Specimen Source Codes - tumor,Adult Anaplastic Oligodendroglioma,0
3794,Oral (intended site),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3795,What subject filter - Result,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3796,Third grade in elementary school,Maxillary Sinus Adenocarcinoma,0
3797,Location,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3798,Togo,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3799,Melanoma Pathway,Intestinal Metaplasia of Bladder Urothelium,0
3800,Observation of color of skin,Mucinous adenocarcinoma gastric,0
3801,treatment - ActInformationManagementReason,Melanomatosis,0
3802,Throat,Choroid Epithelioid Cell Melanoma,0
3803,Usual Severity Shortness of Breath,Hemangioma,0
3804,Admixture,Cancer of Urinary Tract,0
3805,Enlarged,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3806,Infection,Intracortical osteosarcoma,0
3807,Germ,Endometrial Small Cell Carcinoma,0
3808,Supportive assistance,Bladder adenocarcinoma stage IV,0
3809,Metastasis,Cancer of Urinary Tract,0
3810,seen,Ovarian Carcinoid Tumor,0
3811,Nearly,Acute Undifferentiated Leukemia,0
3812,60%,Stage 0 Lip Carcinoma,0
3813,General surgery specialty,Bladder adenocarcinoma stage IV,0
3814,Area,Childhood Central Nervous System Immature Teratoma,0
3815,Screening,Precursor B-lymphoblastic lymphoma stage II,0
3816,Condition,Malignant neoplasm of choroid,0
3817,MOSTLY,Atypical Mesothelial Hyperplasia,0
3818,Evaluation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3819,Lymphoid Cells,Acantholytic squamous cell carcinoma,0
3820,Including (qualifier),Recurrent Uveal Melanoma,0
3821,Pelvic Pain,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
3822,Appearance,Astrocytoma of brain,0
3823,Death (finding),Neonatal leukemia,0
3824,Present,squamous cell carcinoma of the thyroid gland,0
3825,Age,Stage I Colon Neuroendocrine Tumor AJCC v8,0
3826,Second Primary Cancers,Multiple Endocrine Neoplasia,0
3827,Skin Pigmentation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3828,pathologic fistula,Childhood Extragonadal Malignant Germ Cell Tumor,0
3829,Adrenal Gland Pheochromocytoma,Undifferentiated Endocervical Sarcoma,0
3830,PCYT1A wt Allele,Carcinoma ex pleomorphic adenoma of parotid gland,0
3831,Lung,Pancreatic Intraepithelial Neoplasia-3,0
3832,Squamous cell carcinoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3833,Etiology aspects,Tongue Alveolar Soft Part Sarcoma,0
3834,Lethal,Cervical Fibroepithelial Polyp,0
3835,More,Non-Metastatic Gestational Trophoblastic Tumor,0
3836,geographic population,Intestinal Metaplasia of Bladder Urothelium,0
3837,SLC6A2 protein,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3838,Clear,Chronic Myelomonocytic Leukemia-2,0
3839,Manufactured form,Extra-abdominal fibromatosis,0
3840,Rate,Mucosal Melanoma,0
3841,Suspected diagnosis,Astrocytoma of brain,0
3842,Case (situation),Platinum-Resistant Lung Small Cell Carcinoma,0
3843,+2,Intraepithelial Melanocytic Hyperplasia,0
3844,Collections (publication),Cerebral Primitive Neuroectodermal Tumor,0
3845,Lymphocyte production,Unicystic ameloblastoma,0
3846,include - SetOperator,Nasal cavity carcinoma,0
3847,Overall,Mucinous cystadenofibroma,0
3848,Togo,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3849,Assortment,Female Breast Carcinoma,0
3850,Finding,Neoplasms,0
3851,Third,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3852,Science of Etiology,Recurrent Uveal Melanoma,0
3853,<90,Intestinal Neuroendocrine Carcinoma,0
3854,Histology,Undifferentiated Endocervical Sarcoma,0
3855,Hemopoietic tissue,Melanomatosis,0
3856,Data Type - Point In Time,Fourth Ventricle and Brain Stem Ependymal Tumor,0
3857,Togo,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
3858,Hodgkin Disease,Precursor B-lymphoblastic lymphoma stage II,0
3859,Long Variable,Refractory Bladder Carcinoma,0
3860,Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3861,Administration procedure,Intestinal Metaplasia of Bladder Urothelium,0
3862,Odontogenic Epithelium,Small cell neuroendocrine carcinoma of bladder,0
3863,Occur (action),Refractory Ependymoma,0
3864,Group A (blood group),BRCA2 Syndrome,0
3865,Race,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3866,Form:Finding:Point in time:{Setting}:Document:{Role},Mucosal Melanoma,0
3867,Palmitic Acid,Locally Advanced Squamous Cell Carcinoma,0
3868,Tumor Mass,Extra-abdominal fibromatosis,0
3869,Lung,Acantholytic squamous cell carcinoma,0
3870,Morphology,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3871,Tanning of leather,Noninfiltrating Intraductal Carcinoma,0
3872,Brain,Nasal cavity carcinoma,0
3873,Differential Diagnosis,Adult Alveolar Soft Part Sarcoma,0
3874,High risk of,mucinous adenocarcinoma of gallbladder,0
3875,Malignant Neoplasms,Brain Ependymoma,0
3876,Kit device,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3877,Age,Extra-abdominal fibromatosis,0
3878,Small Cell Lung Cancer Pathway,Childhood Fibrillary Astrocytoma,0
3879,Azacitidine,Granular Cell Leiomyosarcoma,0
3880,potential,Female Breast Carcinoma,0
3881,Surgical aspects,Epithelioid Sarcoma NCI Grade 3,0
3882,Beginning,Malignant neoplasm of gallbladder,0
3883,Unknown GENC,Sarcomatoid Renal Cell Carcinoma,0
3884,Mast Cell Count,Cervical Adenomyoma,0
3885,Confirmed by,Localized Malignant Neoplasm,0
3886,Often - answer to question,Liver Cavernous Hemangioma,0
3887,Excision,Pancreatic carcinoma,0
3888,Therapeutic procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3889,Malignant neoplasm of breast,BRCA2 Syndrome,0
3890,Gram per Deciliter,Giant cell angiofibroma,0
3891,Food,Intraepithelial Melanocytic Hyperplasia,0
3892,High,Pancreatic carcinoma,0
3893,Well Being Visual Analogue Scale,Metastatic Lung Neuroendocrine Neoplasm,0
3894,Sex Cord-Stromal Tumor,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3895,Links List,Anaplastic large cell lymphoma,0
3896,Urinary system,Gallbladder Adenocarcinoma,0
3897,Include (action),Melanomatosis,0
3898,Treating,Liver Lymphangioma,0
3899,Others - Allergy,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3900,Persons,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3901,Tissue Specimen Code,Pancreatic carcinoma,0
3902,Administration procedure,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
3903,Histopathologic Grade,Intestinal Metaplasia of Bladder Urothelium,0
3904,Soft Tissue Route of Drug Administration,Mucinous adenocarcinoma gastric,0
3905,High risk of,Cerebral Primitive Neuroectodermal Tumor,0
3906,Diagnosis,Basal Cell Ameloblastoma,0
3907,Therapeutic procedure,Human Papillomavirus-Related Carcinoma,0
3908,Primary,Stage IB Pancreatic Cancer AJCC v8,0
3909,900,Brain Ependymoma,0
3910,Before,Acantholytic squamous cell carcinoma,0
3911,Statistical mean,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3912,MOSTLY,Acute lymphadenitis,0
3913,Glioblastoma Multiforme Pathway,Ichthyosis,0
3914,Possibly Related to Intervention,Breast Ductal Adenoma,0
3915,59,Metastatic Lung Small Cell Carcinoma,0
3916,Condition:Find:Pt:^Patient:Nom,FIGO Stage IVA Ovarian Cancer,0
3917,Used by,Childhood Central Nervous System Ganglioneuroblastoma,0
3918,Southern Europe,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3919,Adult Subependymal Giant Cell Astrocytoma,Hyperplasia of pituitary gland,0
3920,Case unit dose,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3921,Case unit dose,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
3922,Skin tanning,Primary Cutaneous Plasmablastic Lymphoma,0
3923,Following,Mixed astrocytoma-ependymoma,0
3924,Most,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3925,Endothelial Cells,Blepharal carcinoma,0
3926,Lineage,Stage I Colon Neuroendocrine Tumor AJCC v8,0
3927,artesunate,Colorectal cancer,0
3928,Pallor of skin,Lipoma of small intestine,0
3929,How Often Weight Loss,High Grade Glandular Intraepithelial Neoplasia,0
3930,1000000,FIGO Stage IVA Ovarian Cancer,0
3931,Body tissue,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3932,depend,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3933,Forecast of outcome,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3934,Relative to,Acute Undifferentiated Leukemia,0
3935,Smooth Muscle Tumor,Chronic Myelomonocytic Leukemia-2,0
3936,Skin,mucinous adenocarcinoma of gallbladder,0
3937,Striated muscle cell,Testicular cancer metastatic,0
3938,Negation,Cerebral Primitive Neuroectodermal Tumor,0
3939,Experimental Result,Human Papillomavirus-Related Carcinoma,0
3940,Spinal Cord,Cervical Fibroepithelial Polyp,0
3941,Lung,Vaginal Adenoid Cystic Carcinoma,0
3942,described,FIGO Stage IVA Ovarian Cancer,0
3943,Adenocarcinoma,Blood Vessel Tumors,0
3944,Illness: Cannot describe symptoms,Mucinous adenocarcinoma gastric,0
3945,Breast Feeding,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3946,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Lipoma of small intestine,0
3947,Fever,gliosarcoma,0
3948,Sequence Data Type,Squamous cell carcinoma of lip,0
3949,Tubal Ligation,Blepharal carcinoma,0
3950,Confirmation,mucinous adenocarcinoma of gallbladder,0
3951,White blood cells urine (lab test),Diffuse malignant mesothelioma,0
3952,shared attribute,Liver Cavernous Hemangioma,0
3953,Formation,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3954,Therapeutic immunosuppression,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3955,Include (action),Intraepithelial Melanocytic Hyperplasia,0
3956,True Control Status,Gallbladder Adenocarcinoma,0
3957,month,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3958,Damage,Recurrent Diffuse Intrinsic Pontine Glioma,0
3959,Disease remission,Spindle Cell Melanoma,0
3960,Operative Surgical Procedures,Xeroderma pigmentosum,0
3961,Code System Type - Internal,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3962,1000000,Ectomesenchymal Chondromyxoid Tumor,0
3963,Nodulus cerebelli,Thyroid Hurthle Cell Carcinoma,0
3964,Orbital region,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3965,WHO tumor classification,Locally Advanced Soft Tissue Sarcoma,0
3966,Designated,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3967,Solid Neoplasm,Acute Undifferentiated Leukemia,0
3968,Count of entities,Uterine Cancer,0
3969,Melanoma Pathway,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3970,Condition,Intracortical osteosarcoma,0
3971,Transmitted by,BRCA2 Syndrome,0
3972,Histologic,Funisitis (disorder),0
3973,Closed,papillary carcinoma of penis,0
3974,99,Cerebral Primitive Neuroectodermal Tumor,0
3975,New,Primary Cutaneous Plasmablastic Lymphoma,0
3976,Oral cavity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3977,Magnetic Resonance Imaging Study File,Lipoma of small intestine,0
3978,Primary malignant neoplasm,Heavy Chain Deposition Disease,0
3979,Malignant - descriptor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3980,Medulloepithelioma,Vaginal Adenoma,0
3981,Act Relationship Subset - previous,Metastatic Neoplasm to the Gallbladder,0
3982,Medications:-:Point in time:^Patient:-,Trabecular adenocarcinoma,0
3983,Disease,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
3984,To,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
3985,removal technique,Hodgkin Disease,0
3986,Increase,Gallbladder Adenocarcinoma,0
3987,Process (qualifier value),Benign Ovarian Thecoma,0
3988,Rating (action),Ampulla of Vater Tubular Adenoma,0
3989,Incomplete spinal cord injury,Adenoma,0
3990,physiological aspects,Childhood Extragonadal Malignant Germ Cell Tumor,0
3991,Beginning,Blepharal carcinoma,0
3992,Infrequent,Metaplastic carcinoma of breast,0
3993,Base - General Qualifier,Mucinous adenocarcinoma gastric,0
3994,Including (qualifier),Childhood Fibrillary Astrocytoma,0
3995,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3996,Secondary Neoplasm,Malignant Neoplasm with Regional Lymph Node Involvement,0
3997,Mesenchymal Cell Neoplasm,Hair nevus,0
3998,Symptoms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3999,Participation Type - origin,adenosquamous carcinoma of breast,0
4000,Very,Intestinal Neuroendocrine Carcinoma,0
4001,Status post,Stage III Cutaneous Melanoma AJCC v6,0
4002,metastatic qualifier,Unfavorable Non-Hodgkin Lymphoma,0
4003,Benign tumor of salivary gland,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4004,Cell secretion,sarcoma of spinal cord,0
4005,Diagnosis Study,Transitional cell carcinoma,0
4006,Have Difficulty Swallowing,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4007,Common (qualifier value),Tonsillar Carcinoma,0
4008,Gonadal structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4009,Group Object,papillary carcinoma of penis,0
4010,Cancer Histology,Metastatic Carcinoma in the Lung,0
4011,Sodium Chloride,Spermatocytic seminoma,0
4012,{Setting},Thyroid Hurthle Cell Carcinoma,0
4013,Form of breast,Localized Askin Tumor,0
4014,obsolete,Trichilemmocarcinoma,0
4015,Infrequent,Maxillary Sinus Adenoid Cystic Carcinoma,0
4016,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Endometrial Small Cell Carcinoma,0
4017,shared attribute,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4018,Tissue Growth,Childhood Lymphoma,0
4019,Image Feature,Recurrent Uveal Melanoma,0
4020,Human papilloma virus infection,Undifferentiated Endocervical Sarcoma,0
4021,Affecting,Childhood Anaplastic Large Cell Lymphoma,0
4022,2+,Recurrent Testicular Lymphoma,0
4023,Medical Device Emits Smoke,Adult Hepatocellular Carcinoma,0
4024,Term (temporal),mucinous adenocarcinoma of gallbladder,0
4025,Often - answer to question,High Grade Glandular Intraepithelial Neoplasia,0
4026,Removed,Brain Ependymoma,0
4027,General health,Localized Ewing Sarcoma,0
4028,Rest,Unfavorable Non-Hodgkin Lymphoma,0
4029,Poor - qualifier,Malignant melanoma of eyelid,0
4030,risk factors - observation list,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4031,Polypeptide Hormones,Testicular cancer metastatic,0
4032,Type - attribute,Plexosarcoma,0
4033,How Much Distress Sweats,Refractory Barrett Esophagus,0
4034,research subject screening,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4035,How Often Felt Normal question,Cancer of Urinary Tract,0
4036,Present,Malignant melanoma of eyelid,0
4037,Formation,Childhood Extragonadal Malignant Germ Cell Tumor,0
4038,dendritic spine neck,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4039,Face,Low Grade Squamous Intraepithelial Neoplasia,0
4040,treatment - ActInformationManagementReason,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
4041,described,Malignant neoplasm of subglottis,0
4042,Secretory Vesicles,Benign Anal Granular Cell Tumor,0
4043,Lip and Oral Cavity Carcinoma,Hyperplasia of pituitary gland,0
4044,neural,Granular Cell Leiomyosarcoma,0
4045,Aim,Malignant Testicular Sertoli Cell Tumor,0
4046,Known,Engraftment syndrome,0
4047,Primary malignant neoplasm,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4048,Occur (action),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4049,Site,Extra-Adrenal Paraganglioma,0
4050,1960s,Low Grade Squamous Intraepithelial Neoplasia,0
4051,Leukemia,malignant lymphoma of pancreatic lymph nodes,0
4052,Absent,Human Papillomavirus-Related Carcinoma,0
4053,Back,ROSE Cluster 3,0
4054,Malignant Neoplasms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4055,Subject Risk,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4056,device aspects,Localized Askin Tumor,0
4057,Advanced phase,Engraftment syndrome,0
4058,Wounds and Injuries,Childhood Central Nervous System Ganglioneuroblastoma,0
4059,Rhabdomyosarcoma,Childhood Extragonadal Malignant Germ Cell Tumor,0
4060,Physical Appearance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4061,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4062,Weight Loss,Extra-abdominal fibromatosis,0
4063,Symptoms aspect,Breast Ductal Adenoma,0
4064,Case (situation),Bladder squamous cell carcinoma stage I,0
4065,How Much Distress Cough,Cerebral hemangioma,0
4066,NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology,Childhood Central Nervous System Ganglioneuroblastoma,0
4067,Make - Instruction Imperative,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4068,Surrounding (qualifier value),Mixed astrocytoma-ependymoma,0
4069,Adult Non-Hodgkin Lymphoma,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
4070,shared attribute,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
4071,Tests (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4072,regional,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4073,Local,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4074,Use of,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4075,Extent of disease,Acantholytic squamous cell carcinoma,0
4076,Most,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
4077,Cure (remedy),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4078,Treatment Epoch,Benign Apocrine Neoplasm,0
4079,Referring,Platinum-Resistant Lung Small Cell Carcinoma,0
4080,Palliative Care,Adult Hepatocellular Carcinoma,0
4081,Science of Etiology,Digestive System Hodgkin Lymphoma,0
4082,B-Cell Activation,Refractory Ependymoma,0
4083,Thyroid carcinoma,Malignant neoplasm of thalamus,0
4084,morphological,Unresectable Rhabdomyosarcoma,0
4085,Malignant Neoplasms,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4086,Coitus,Congenital hamartoma,0
4087,laparoscopy (therapeutic),Gallbladder Adenocarcinoma,0
4088,400,Mastocytosis,0
4089,Weight decreased,Chronic Myelomonocytic Leukemia-2,0
4090,Completely - dosing instruction fragment,Advanced Uterine Corpus Carcinosarcoma,0
4091,second (number),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
4092,Definitely Related to Intervention,Undifferentiated Neuroblastoma,0
4093,Possibly Related to Intervention,Melanomatosis,0
4094,FDA Establishment Activity Terminology,Ampulla of Vater Tubular Adenoma,0
4095,Togo,Acantholytic squamous cell carcinoma,0
4096,Malignant tumor of cervix,Contact dermatitis due to alkali,0
4097,intrathecal chemotherapy,Refractory Ependymoma,0
4098,Germ Layers,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4099,Human body,Bladder Neuroendocrine Neoplasm,0
4100,United States,Low Grade Squamous Intraepithelial Neoplasia,0
4101,System,Thyroid Hurthle Cell Carcinoma,0
4102,Bleomycin,Carcinoma of submandibular gland,0
4103,63,Peripheral primitive neuroectodermal tumor of soft tissue,0
4104,Tissue damage,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4105,Mass,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4106,Site of,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4107,Prominent,Multiple Endocrine Neoplasia,0
4108,include - SetOperator,Vaginal Adenoma,0
4109,Known,Grade 3a Malignant Neoplasm,0
4110,Risk,clear cell adenocarcinoma of gallbladder,0
4111,Type - attribute,Refractory Barrett Esophagus,0
4112,To,Hemangioma,0
4113,Vaginal,Giant cell angiofibroma,0
4114,Object Relationship,Metastatic Neoplasm to the Gallbladder,0
4115,United States Military Commissioned Officer O4,Recurrent Uveal Melanoma,0
4116,Brain,Stage IB Pancreatic Cancer AJCC v8,0
4117,Manufactured form,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4118,Japan,Benign squamous cell tumor,0
4119,Descent,Malignant neoplasm of olfactory nerve,0
4120,Containing (qualifier),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4121,Human Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4122,Occurrence Indicator,Noninfiltrating Intraductal Carcinoma,0
4123,DNA Damage,Cerebral hemangioma,0
4124,Adult,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4125,Premalignant,Carcinoma,0
4126,Referring,Serous cystadenocarcinoma ovary,0
4127,Status post,Peripheral primitive neuroectodermal tumor of soft tissue,0
4128,31,Choroid Necrotic Melanoma,0
4129,Case unit dose,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4130,False Discovery Rate,Transitional cell carcinoma,0
4131,Etiology aspects,Adult Alveolar Soft Part Sarcoma,0
4132,Cytologic,Tonsillar Carcinoma,0
4133,Manufactured form,Adult Fibrolamellar Carcinoma,0
4134,Surgery specialty,Locally Advanced Squamous Cell Carcinoma,0
4135,mole changes,Neoplasms,0
4136,Weight decreased,Keratoderma,0
4137,Part of,Stage III Cutaneous Melanoma AJCC v6,0
4138,Supportive assistance,Localized Askin Tumor,0
4139,Hollow shape,FIGO Stage IVA Ovarian Cancer,0
4140,Woman,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4141,biopsy characteristics,Anterior Urethral Malignant Neoplasm,0
4142,*Type - Kind of quantity,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4143,Term Birth,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4144,Tissue Specimen Code,Basal Cell Ameloblastoma,0
4145,Distal (qualifier value),clear cell adenocarcinoma of gallbladder,0
4146,Malignant neoplasm of penis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4147,Granulocyte component of blood,Mucinous neoplasm,0
4148,Precancerous Conditions,Stage IV Childhood Non-Hodgkin Lymphoma,0
4149,Often - answer to question,FIGO Stage IVA Ovarian Cancer,0
4150,Factory,Gallbladder adenoma,0
4151,Present,Nasal cavity carcinoma,0
4152,Cessation of life,Mucinous adenocarcinoma gastric,0
4153,With intensity,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4154,Tumor site,Extra-Adrenal Paraganglioma,0
4155,International Statistical Classification of Diseases and Related Health Problems,Stage III Adult Immunoblastic Lymphoma,0
4156,6000,FIGO Stage II Ovarian Cancer,0
4157,Participation Type - origin,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4158,Involvement with,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4159,Form:Finding:Point in time:{Setting}:Document:{Role},Pancreatic carcinoma,0
4160,76,Melanomatosis,0
4161,Inguinal part of abdomen,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4162,Invasive,Ovarian germ cell choriocarcinoma stage IV,0
4163,Anatomic structures,Advanced Uterine Corpus Carcinosarcoma,0
4164,Tissue Specimen Code,Carcinoma of urinary bladder,0
4165,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,clear cell adenocarcinoma of gallbladder,0
4166,Term (temporal),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4167,risk factors - observation list,sarcoma of spinal cord,0
4168,Etiology aspects,Localized Askin Tumor,0
4169,Formations,Localized Ewing Sarcoma,0
4170,Cells,Stage III Cutaneous Melanoma AJCC v6,0
4171,Circumscribe (action),Vaginal Adenoid Cystic Carcinoma,0
4172,High Level,Leptomeningeal sarcoma,0
4173,Probably,Giant cell angiofibroma,0
4174,Morphology,Pancreatic carcinoma,0
4175,Distal (qualifier value),Malignant melanoma of eyelid,0
4176,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Hyperplasia of pituitary gland,0
4177,Hematologic Tests,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4178,Cheek structure,Malignant neoplasm of thalamus,0
4179,Formation,Benign neoplasm of eye,0
4180,Embryonic Development,Stage III Cutaneous Melanoma AJCC v6,0
4181,Useful,Granular Cell Leiomyosarcoma,0
4182,Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4183,Name,Stage III Cutaneous Melanoma AJCC v6,0
4184,Associated with,Colorectal cancer,0
4185,Only - dosing instruction fragment,Giant cell angiofibroma,0
4186,Used by,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
4187,Multiplication,Brain Ependymoma,0
4188,Cancer Genus,Unicystic ameloblastoma,0
4189,Definitely Related to Intervention,Female Breast Carcinoma,0
4190,Asia,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4191,Obesity,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4192,Lymphoma,Kaposi's sarcoma of extrahepatic bile duct,0
4193,common types,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4194,Extension,Uterine Cancer,0
4195,Surgical repair,Placental aromatase deficiency,0
4196,New,BRCA2 Syndrome,0
4197,Means,Childhood Anaplastic Large Cell Lymphoma,0
4198,Males,Adenocarcinoma of the prostate metastatic,0
4199,Stage Grouping,Congenital hamartoma,0
4200,Factor,Locally Advanced Squamous Cell Carcinoma,0
4201,Digital Content Category,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4202,CEL gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4203,Infrequent,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4204,mole changes,Ampulla of Vater Tubular Adenoma,0
4205,Device Motor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4206,Adipose tissue,squamous cell carcinoma of the thyroid gland,0
4207,Good,Choroid Necrotic Melanoma,0
4208,Classic Histology,Medulloblastoma,0
4209,shared attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4210,Has difficulty doing (qualifier value),Female Breast Carcinoma,0
4211,Young Adult,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4212,combination of objects,Benign Anal Granular Cell Tumor,0
4213,Legal Adult,Xeroderma pigmentosum,0
4214,Science of Etiology,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4215,Numbers,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4216,Burkitt Lymphoma,Kaposi's sarcoma of extrahepatic bile duct,0
4217,Down Syndrome,Peripheral primitive neuroectodermal tumor of soft tissue,0
4218,Orbit (brand of fungicide),Spermatocytic seminoma,0
4219,Cavitation,Intestinal Metaplasia of Bladder Urothelium,0
4220,Professional guide,Melanomatosis,0
4221,More,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4222,<3 (qualifier value),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4223,One,BRCA2 Syndrome,0
4224,veterans alcoholism screening test (VAST),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
4225,Hyperlink,Breast Ductal Adenoma,0
4226,Myeloma Proteins,FIGO Stage IVA Ovarian Cancer,0
4227,Sixty,Mixed astrocytoma-ependymoma,0
4228,Headache,Benign tumor of eyelid,0
4229,Pancreatic Hormones,Nasal cavity carcinoma,0
4230,size,Small cell neuroendocrine carcinoma of bladder,0
4231,Nine,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4232,Chemotherapy,Childhood Fibrillary Astrocytoma,0
4233,Bilateral,Benign tumor of eyelid,0
4234,Subject Risk,BRCA2 Syndrome,0
4235,Togo,Chest Wall Fibromatosis,0
4236,Treating,benign mature teratoma of pancreas,0
4237,Hollow shape,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4238,Physical findings,Melanomatosis,0
4239,Taxonomic,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4240,Packaging Case,Maxillary Sinus Adenoid Cystic Carcinoma,0
4241,Primary malignant neoplasm,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4242,control aspects,squamous cell carcinoma of the thyroid gland,0
4243,Formation,Non-Metastatic Gestational Trophoblastic Tumor,0
4244,Spreading (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
4245,Malignant Cell Count,Trabecular adenocarcinoma,0
4246,Continuance of life,Melanomatosis,0
4247,Include (action),FIGO Stage II Ovarian Cancer,0
4248,Hepatic Involvement,BRCA2 Syndrome,0
4249,Thin (qualifier value),adenoid cystic carcinoma of lung,0
4250,Gland,Gallbladder Adenocarcinoma,0
4251,Involvement with,Stage IV Penile Cancer AJCC v7,0
4252,Histology Procedure,Endometrial Small Cell Carcinoma,0
4253,year,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
4254,Average,Sarcomatoid Renal Cell Carcinoma,0
4255,Late,Vaginal Adenoid Cystic Carcinoma,0
4256,Disease Outcome,Intraepithelial Melanocytic Hyperplasia,0
4257,Type A,Low Grade Squamous Intraepithelial Neoplasia,0
4258,Usually,Atypical Lobular Breast Hyperplasia,0
4259,ancestors,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4260,AKR1A1 wt Allele,Pancreatic Intraepithelial Neoplasia-3,0
4261,condom use,Colorectal High Grade B-Cell Lymphoma,0
4262,Common (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
4263,Growth abnormality,Primary Cutaneous Plasmablastic Lymphoma,0
4264,shared attribute,embryonal rhabdomyosarcoma of prostate,0
4265,Term (temporal),Localized Ewing Sarcoma,0
4266,Liver,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
4267,RBC count low,Atypical Lobular Breast Hyperplasia,0
4268,survival aspects,Heavy Chain Deposition Disease,0
4269,physiological aspects,Testicular cancer metastatic,0
4270,Tract,Stage III Adult Immunoblastic Lymphoma,0
4271,per year,Small intestine carcinoma,0
4272,Hemorrhage,Stage 0 Lip Carcinoma,0
4273,Death (finding),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4274,Only - dosing instruction fragment,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4275,Entity Name Part Type - given,Squamous cell carcinoma of lip,0
4276,General surgery specialty,Childhood Lung Non-Small Cell Carcinoma,0
4277,NCI CTEP SDC Melanoma Sub-Category Terminology,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4278,Symptoms aspect,Choroid Necrotic Melanoma,0
4279,Disease,Endometrial Small Cell Carcinoma,0
4280,Chemotherapy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4281,Sequence Data Type,Precursor B-lymphoblastic lymphoma stage II,0
4282,Patient Discharge,Intraepithelial Melanocytic Hyperplasia,0
4283,Cessation of life,Non-Metastatic Gestational Trophoblastic Tumor,0
4284,Spinal Cord,Extracranial Neuroblastoma,0
4285,Relational and Item-Specific Encoding Task,Localized Malignant Neoplasm,0
4286,Function Axis,Endometrial Small Cell Carcinoma,0
4287,Data (eukaryote),Benign Anal Granular Cell Tumor,0
4288,Removing (action),Occult Lung Adenosquamous Carcinoma,0
4289,Usually,Mixed astrocytoma-ependymoma,0
4290,Hoods,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4291,BRCA2 protein,Bladder adenocarcinoma stage IV,0
4292,Lynch Syndrome,Anterior Urethral Malignant Neoplasm,0
4293,Analysis,Digestive System Hodgkin Lymphoma,0
4294,Collection (action),Female Breast Carcinoma,0
4295,Form:Finding:Point in time:{Setting}:Document:{Role},Primary Cutaneous Plasmablastic Lymphoma,0
4296,Response to treatment,Blepharal carcinoma,0
4297,Average of Value Derivation Technique,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4298,EntityNameUseR2 <temporary>,Human Papillomavirus-Related Carcinoma,0
4299,Membrane,Platinum-Resistant Lung Small Cell Carcinoma,0
4300,Orbital,Mixed astrocytoma-ependymoma,0
4301,Eye,Cancer of Urinary Tract,0
4302,Liver carcinoma,Malignant Testicular Sertoli Cell Tumor,0
4303,Decrease,Cervical Adenomyoma,0
4304,diagnostic image,Stage III Cutaneous Melanoma AJCC v6,0
4305,Most,Mastocytosis,0
4306,Status post,Refractory Barrett Esophagus,0
4307,English race,Cerebral Primitive Neuroectodermal Tumor,0
4308,Persons,Stage IB Lung Cancer AJCC v7,0
4309,Peritoneal Surface Malignancy,Mucinous adenocarcinoma gastric,0
4310,Inflammation,non-Hodgkin's lymphoma of spleen,0
4311,Chemotherapy Regimen,Recurrent Testicular Lymphoma,0
4312,Age at diagnosis,Trabecular adenocarcinoma,0
4313,Precursor,Vaginal Adenoma,0
4314,High Grade Astrocytic Tumor,High Grade Glandular Intraepithelial Neoplasia,0
4315,Shortened,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4316,Bacteria present,Bladder squamous cell carcinoma stage I,0
4317,Dropping,Non-Metastatic Gestational Trophoblastic Tumor,0
4318,Others - Allergy,Refractory Bladder Carcinoma,0
4319,35,Malignant melanoma of eyelid,0
4320,Very,Medulloblastoma,0
4321,Followed by,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4322,Oral cavity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4323,Surgery specialty,Hodgkin lymphoma,0
4324,Group A (blood group),Digestive System Hodgkin Lymphoma,0
4325,Net (qualifier),non-Hodgkin's lymphoma of spleen,0
4326,Tentorium cerebelli,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4327,Count of entities,Squamous cell carcinoma of lip,0
4328,Presentation,squamous cell carcinoma of the thyroid gland,0
4329,include - SetOperator,Papillary cystic tumor,0
4330,betel quid,Breast Ductal Adenoma,0
4331,Body tissue,Stage III Cutaneous Melanoma AJCC v6,0
4332,To,Gallbladder Adenocarcinoma,0
4333,Rest,Small cell neuroendocrine carcinoma of bladder,0
4334,Case (situation),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4335,Genitalia,Bladder squamous cell carcinoma stage I,0
4336,Cause of death:Find:Pt:^Patient:Nom,Tonsillar Carcinoma,0
4337,SLC35G1 gene,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4338,Associated with,Intraepithelial Melanocytic Hyperplasia,0
4339,Reported Term,Childhood Anaplastic Large Cell Lymphoma,0
4340,Usually,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4341,Use - dosing instruction imperative,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
4342,Continuance of life,FIGO Stage IVA Ovarian Cancer,0
4343,Enlarged,Recurrent Primary Lymphoma of Bone,0
4344,therapeutic aspects,Diffuse malignant mesothelioma,0
4345,Subgroup A Nepoviruses,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4346,Responsible to,Splenic Manifestation of Hairy Cell Leukemia,0
4347,Estimated,Peripheral primitive neuroectodermal tumor of soft tissue,0
4348,Original,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
4349,french race,Stage IB Pancreatic Cancer AJCC v8,0
4350,Science of Etiology,Carcinoma ex pleomorphic adenoma of parotid gland,0
4351,Tryptophanase,non-Hodgkin's lymphoma of spleen,0
4352,Subject Risk,Diffuse malignant mesothelioma,0
4353,Most,Type II Endometrial Adenocarcinoma,0
4354,Leads (device),Plexosarcoma,0
4355,Liquid substance,Malignant neoplasm of olfactory nerve,0
4356,Lymphatic System,Recurrent Testicular Lymphoma,0
4357,Childhood Leukemia,FIGO Stage IVA Ovarian Cancer,0
4358,0%,Benign tumor of eyelid,0
4359,Malignant Neoplasms,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4360,Clinician,Acantholytic squamous cell carcinoma,0
4361,Definitely Related to Intervention,Childhood Lymphoma,0
4362,Frequency of Pain Question,BRCA2 Syndrome,0
4363,Skin,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4364,Urothelium,Refractory Barrett Esophagus,0
4365,Cell Count,Undifferentiated Endocervical Sarcoma,0
4366,Eighth,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4367,Biopsy,Advanced Uterine Corpus Carcinosarcoma,0
4368,Type A,Ichthyosis,0
4369,Image Feature,Acantholytic squamous cell carcinoma,0
4370,Cancer Genus,Mucinous adenocarcinoma gastric,0
4371,Lower - spatial qualifier,Stage II Hepatocellular Carcinoma AJCC v8,0
4372,<90,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4373,ATLAS Score Clinical Classification,Cartilaginous exostosis,0
4374,Immune System Part,Refractory Bladder Carcinoma,0
4375,Tissue Specimen Code,Benign Anal Granular Cell Tumor,0
4376,Retinoic Acid Response Element,Stage IB Pancreatic Cancer AJCC v8,0
4377,Vestigium,Localized Askin Tumor,0
4378,Legal Adult,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4379,Continuous,Spongiotic dermatitis,0
4380,Amount type - Percentage,Mucinous adenocarcinoma gastric,0
4381,Cure (remedy),Extracranial Neuroblastoma,0
4382,Time,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
4383,Adult Classical Hodgkin Lymphoma,Leiomyoma of Gallbladder,0
4384,Numbers,Anterior Urethral Malignant Neoplasm,0
4385,Version (morphologic abnormality),Cartilaginous exostosis,0
4386,shared attribute,Malignant Testicular Sertoli Cell Tumor,0
4387,Epithelium of vagina,Bladder adenocarcinoma stage IV,0
4388,Administration procedure,Melanomatosis,0
4389,Contain (action),Benign neoplasm of eye,0
4390,Cancer Genus,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4391,Back Pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4392,Categories,Adult Hepatocellular Carcinoma,0
4393,Disease,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4394,aspects of adverse effects,Vaginal Adenoma,0
4395,Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire,clear cell adenocarcinoma of gallbladder,0
4396,Pain,Female Breast Carcinoma,0
4397,include - SetOperator,Localized Ewing Sarcoma,0
4398,Including (qualifier),Papillary squamous cell carcinoma,0
4399,Well Differentiated,Kaposi's sarcoma of extrahepatic bile duct,0
4400,Common Specifications in HL7 V3 Publishing,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
4401,BRCA2 gene,Refractory Bladder Carcinoma,0
4402,Usually,Leptomeningeal sarcoma,0
4403,Pancreas,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
4404,Gross (qualifier value),Choroid Epithelioid Cell Melanoma,0
4405,Skeletal bone,Parathyroid Gland Adenocarcinoma,0
4406,Retinoic Acid Response Element,Mucinous adenocarcinoma gastric,0
4407,Epithelial ovarian cancer,FIGO Stage IVA Ovarian Cancer,0
4408,Third,Nasal cavity carcinoma,0
4409,chapter,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4410,Infrequent,Anterior Urethral Malignant Neoplasm,0
4411,Symptoms aspect,Melanomatosis,0
4412,Rate,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4413,Negation,Necrotizing Funisitis,0
4414,Only - dosing instruction fragment,Refractory Ependymoma,0
4415,Derivative,squamous cell carcinoma of the thyroid gland,0
4416,Malignant Neoplasms,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4417,One,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4418,Greater,Adult Acute Eosinophilic Leukemia,0
4419,NIN gene,Grade 3a Malignant Neoplasm,0
4420,Firstly,Carcinoma of urinary bladder,0
4421,Fever symptoms (finding),Mucinous adenocarcinoma gastric,0
4422,2+ Score,Thymic Atypical Carcinoid Tumor,0
4423,Cell Count,Childhood Central Nervous System Ganglioneuroblastoma,0
4424,AKR1A1 wt Allele,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4425,Linear,Localized Ewing Sarcoma,0
4426,Woman,Refractory Bladder Carcinoma,0
4427,Bottom,Sarcomatoid Renal Cell Carcinoma,0
4428,Primary malignant neoplasm,Nasal cavity carcinoma,0
4429,Palmitic Acid,Cartilaginous exostosis,0
4430,/hour,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
4431,In Blood,Papillary squamous cell carcinoma,0
4432,Obstructed,Recurrent Primary Lymphoma of Bone,0
4433,Uterus,Stage I Adult Non-Hodgkin Lymphoma,0
4434,Most,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4435,Molecular Mass,Cerebral hemangioma,0
4436,Tissue Specimen Code,Angiosarcoma of liver,0
4437,Tryptophanase,Stage I Adult Non-Hodgkin Lymphoma,0
4438,Malignant Head and Neck Neoplasm,Stage IV Colorectal Cancer AJCC v8,0
4439,Type - attribute,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
4440,Similarity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4441,Diagnosis,ROSE Cluster 3,0
4442,Swollen Lymph Node,Cervical Fibroepithelial Polyp,0
4443,various other agents for local oral treatment in ATC,Localized Askin Tumor,0
4444,Australia,mucinous adenocarcinoma of gallbladder,0
4445,Cause of death.secondary:Find:Pt:^Patient:Nom,Gallbladder Adenocarcinoma,0
4446,Make - Instruction Imperative,Thyroid Hurthle Cell Carcinoma,0
4447,Type A,GIANT PIGMENTED HAIRY NEVUS,0
4448,Term (lexical),Squamous cell carcinoma of lip,0
4449,700,Recurrent Uveal Melanoma,0
4450,Involvement with,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4451,Well Differentiated,Squamous cell carcinoma of lip,0
4452,size,Tubal Hyperplasia,0
4453,Individual,squamous cell carcinoma of the thyroid gland,0
4454,Special,Stage IV Childhood Non-Hodgkin Lymphoma,0
4455,Platelets Product,Human Papillomavirus-Related Carcinoma,0
4456,Morphology,Stage III Adult Immunoblastic Lymphoma,0
4457,Risk,Childhood Central Nervous System Ganglioneuroblastoma,0
4458,Cell Count,Stage III Cutaneous Melanoma AJCC v6,0
4459,Only - dosing instruction fragment,Pancreatic Intraepithelial Neoplasia-3,0
4460,Science of Etiology,Neoplasms,0
4461,Patient Outcome,Stage II Carcinoma of Penis,0
4462,MM genotype,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
4463,Leukemia,Melanomatosis,0
4464,Appearance,Anterior Urethral Malignant Neoplasm,0
4465,Smoking,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4466,Palmitic Acid,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4467,Definition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4468,Negation,Nasal cavity carcinoma,0
4469,Sarcoma - category (morphologic abnormality),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4470,Autosomal dominant hereditary disorder,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4471,Squamous cell carcinoma - category,Fibroadenoma of breast,0
4472,Qualitative form,Neonatal leukemia,0
4473,Appearance,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4474,Patient Problem,Recurrent Uveal Melanoma,0
4475,Major <insect>,Hodgkin lymphoma,0
4476,Genus Homo,Refractory Ependymoma,0
4477,Feature,Thyroid Hurthle Cell Carcinoma,0
4478,Body Regions,Malignant Neoplasm with Regional Lymph Node Involvement,0
4479,Weight decreased,Bladder squamous cell carcinoma stage I,0
4480,Science of Etiology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4481,Common Specifications in HL7 V3 Publishing,Angiosarcoma of liver,0
4482,Aspects of signs,Plexosarcoma,0
4483,Stomach structure,Malignant neoplasm of thalamus,0
4484,Bone Marrow,FIGO Stage IVA Ovarian Cancer,0
4485,To,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
4486,Old,Malignant Testicular Sertoli Cell Tumor,0
4487,Togo,Malignant neoplasm of choroid,0
4488,Science of Etiology,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4489,Premalignant,Neonatal leukemia,0
4490,Disease,Squamous cell carcinoma of lip,0
4491,Bloating,Breast Ductal Adenoma,0
4492,Etiology aspects,Extra-abdominal fibromatosis,0
4493,Common (qualifier value),Mucinous adenocarcinoma gastric,0
4494,include - SetOperator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4495,Trauma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4496,Tryptophanase,Diffuse malignant mesothelioma,0
4497,Genes,Tonsillar Carcinoma,0
4498,Contain (action),Childhood Fibrillary Astrocytoma,0
4499,Nicotiana,Brain Tumor,0
4500,Further,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
4501,Glycation End Products,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4502,Feelings,Localized Ewing Sarcoma,0
4503,Five-year Survival Rate,Benign squamous cell tumor,0
4504,pharmacotherapeutic,Larynx carcinoma recurrent,0
4505,Show,Kaposi's sarcoma of skin,0
4506,Liver Flavor,Transitional cell carcinoma,0
4507,radiotherapeutic,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4508,pharmacotherapeutic,Mucinous adenocarcinoma gastric,0
4509,Dangerousness,Small Intestinal Villous Adenoma,0
4510,Cells,adenoid cystic carcinoma of lung,0
4511,Case unit dose,Deep Leiomyoma,0
4512,Complication,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4513,Part Dosing Unit,Stage III Cutaneous Melanoma AJCC v6,0
4514,Cessation of life,Lung Mucinous Cystadenoma,0
4515,Lead,Testicular cancer metastatic,0
4516,Primary malignant neoplasm,Diffuse malignant mesothelioma,0
4517,Enlargement procedure,Kaposi's sarcoma of extrahepatic bile duct,0
4518,Benign Neoplasm,Mucinous adenocarcinoma gastric,0
4519,Histologic,Liver Lymphangioma,0
4520,History,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4521,Superior mediastinum,clear cell adenocarcinoma of gallbladder,0
4522,Stage,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4523,Bone Infection,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4524,Tryptophanase,squamous cell carcinoma of the thyroid gland,0
4525,Severe (severity modifier),Mucosal Melanoma,0
4526,Continuance of life,Metastatic Carcinoma in the Lung,0
4527,Nuclear (nucleus),Non-Metastatic Gestational Trophoblastic Tumor,0
4528,Linear,Colorectal Neuroendocrine Tumor G2,0
4529,Screening,Locally Advanced Squamous Cell Carcinoma,0
4530,Pharmacotherapy,BRCA2 Syndrome,0
4531,Firstly,Congenital hamartoma,0
4532,Occur (action),Thyroid Hurthle Cell Carcinoma,0
4533,Methods aspects,Fibroadenoma of breast,0
4534,Lymphoma,Type II Endometrial Adenocarcinoma,0
4535,Third grade in elementary school,Ichthyosis,0
4536,Tanning of leather,Refractory Ependymoma,0
4537,Malignant Neoplasms,Tongue Alveolar Soft Part Sarcoma,0
4538,Valid,Refractory Barrett Esophagus,0
4539,Experimental Result,Clonal Hematopoiesis of Indeterminate Potential,0
4540,Affect (mental function),Splenic Manifestation of Hairy Cell Leukemia,0
4541,Representation (action),Pancreatic Intraepithelial Neoplasia-3,0
4542,Rare Diseases,Tonsillar Carcinoma,0
4543,Overall Publication Type,Digestive System Hodgkin Lymphoma,0
4544,Did not receive therapy or drug for,non-Hodgkin's lymphoma of spleen,0
4545,Feelings,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4546,Cancer Genus,Acantholytic squamous cell carcinoma,0
4547,Kinked,Hereditary Diffuse Gastric Adenocarcinoma,0
4548,Less Than,Central Nervous System Anaplastic Large Cell Lymphoma,0
4549,Manufactured form,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4550,Malignant neoplasm of thyroid,Blepharal carcinoma,0
4551,Neoplasms,Advanced Lung Carcinoma,0
4552,Primary malignant neoplasm,Recurrent Testicular Lymphoma,0
4553,Smallest,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4554,Complication Aspects,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4555,Nail plate,Female Breast Carcinoma,0
4556,include - SetOperator,FIGO Stage II Ovarian Cancer,0
4557,Tissue Growth,Cancer of Urinary Tract,0
4558,Usually,Cancer of Urinary Tract,0
4559,Followed by,Malignant neoplasm of subglottis,0
4560,Abnormal Reference Range,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4561,How Often Weight Loss,Stage III Cutaneous Melanoma AJCC v6,0
4562,Most,Plexosarcoma,0
4563,Medications:-:Point in time:^Patient:-,Metastatic Malignant Neoplasm in the Sellar Region,0
4564,pharmacotherapeutic,Stage IB Lung Cancer AJCC v7,0
4565,FOXO1 gene,Childhood Choriocarcinoma,0
4566,suffix,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4567,Infrequent,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4568,Prostate,Heavy Chain Deposition Disease,0
4569,Malignant neoplasm of mouth,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
4570,Congenital Abnormality,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4571,Linear,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4572,Category Type,Metaplastic carcinoma of breast,0
4573,shared attribute,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4574,Oral contraception,Platinum-Resistant Lung Small Cell Carcinoma,0
4575,Cancer Genus,Vaginal Adenoma,0
4576,National origin,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
4577,Firstly,Methotrexate-Associated Hodgkin Lymphoma,0
4578,Neoplasms,Human Papillomavirus-Related Carcinoma,0
4579,Wounds - qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
4580,Clear,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4581,Group A (blood group),Endometrial Small Cell Carcinoma,0
4582,Lung,Chondrosarcoma,0
4583,Event Seriousness - Significant,Epithelioid Sarcoma NCI Grade 3,0
4584,Excision,Fibroadenoma of breast,0
4585,Human body structure,Peripheral primitive neuroectodermal tumor of soft tissue,0
4586,International Statistical Classification of Diseases and Related Health Problems,Malignant neoplasm of thalamus,0
4587,Screening procedure,Malignant neoplasm of subglottis,0
4588,Disc - Body Part,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
4589,Chemotherapy Regimen,Unfavorable Non-Hodgkin Lymphoma,0
4590,Common Specifications in HL7 V3 Publishing,FIGO Stage II Ovarian Cancer,0
4591,Barrett Esophagus,Localized Askin Tumor,0
4592,survival aspects,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4593,Marketing basis - Transitional,Human Papillomavirus-Related Carcinoma,0
4594,Data operation - complete,Cervical Fibroepithelial Polyp,0
4595,Biomaterial Treatment,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4596,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4597,Melanoma Pathway,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4598,Intravenous,Malignant Neoplasm with Regional Lymph Node Involvement,0
4599,Percent (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4600,Vomiting,clear cell adenocarcinoma of gallbladder,0
4601,Togo,Medulloblastoma,0
4602,risk factors - observation list,Acantholytic squamous cell carcinoma,0
4603,Leg,clear cell adenocarcinoma of gallbladder,0
4604,Code System Type - Internal,Stage III Cutaneous Melanoma AJCC v6,0
4605,Upper Extremity,Localized Ewing Sarcoma,0
4606,Vaginal Neoplasms,Neonatal leukemia,0
4607,Logical Condition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4608,Family (taxonomic),Gallbladder Adenocarcinoma,0
4609,Appearance Distress Question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4610,Used by,Locally Advanced Epithelioid Hemangioendothelioma,0
4611,include - SetOperator,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4612,structure,Cerebral Primitive Neuroectodermal Tumor,0
4613,American College of Cardiology/American Heart Association Lesion Complexity Score C,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4614,Ichthyoses,Intracortical osteosarcoma,0
4615,Sweat,Bladder adenocarcinoma stage IV,0
4616,Elderly (population group),Recurrent Uveal Melanoma,0
4617,Group A (blood group),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4618,Hereditary Diffuse Gastric Cancer,Stage IV Penile Cancer AJCC v7,0
4619,Chemotherapy Regimen,Human Papillomavirus-Related Carcinoma,0
4620,Human body,Malignant neoplasm of olfactory nerve,0
4621,Include (action),Cherubism,0
4622,Catabolism,Lipoma of small intestine,0
4623,*Activity (kind of quantity),Contact dermatitis due to alkali,0
4624,Fibrolamellar Hepatocellular Carcinoma,Non-Metastatic Gestational Trophoblastic Tumor,0
4625,Sweat,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4626,Array Feature,Endometrial Small Cell Carcinoma,0
4627,Abdominal Cavity,Glomeruloid hemangioma,0
4628,Compartments [PK],Intestinal Neuroendocrine Carcinoma,0
4629,External exotoses,Trichilemmocarcinoma,0
4630,Singular,FIGO Stage IVA Ovarian Cancer,0
4631,Togo,Stage IV Penile Cancer AJCC v7,0
4632,Abnormal cell,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4633,various antiinfectives and antiseptics for local oral treatment,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4634,Abdominal Cavity,Intestinal Metaplasia of Bladder Urothelium,0
4635,Effectiveness,Peripheral primitive neuroectodermal tumor of soft tissue,0
4636,How Often Weight Loss,mucinous adenocarcinoma of gallbladder,0
4637,High risk of,Heavy Chain Deposition Disease,0
4638,Symptoms aspect,Maxillary Sinus Adenocarcinoma,0
4639,Additional,Vaginal Adenoma,0
4640,second (number),Squamous cell carcinoma of lip,0
4641,Excision,Stage 0 Penile Cancer AJCC v8,0
4642,Age-Years,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4643,Pharmacotherapy,Non-Metastatic Gestational Trophoblastic Tumor,0
4644,Academic degree,Benign Anal Granular Cell Tumor,0
4645,Make - Instruction Imperative,Testicular cancer metastatic,0
4646,Type A,Recurrent Primary Lymphoma of Bone,0
4647,New Zealand,Recurrent Uveal Melanoma,0
4648,Options,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4649,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4650,Cause of death.underlying,Periosteal Osteosarcoma,0
4651,Microvolt,Diffuse malignant mesothelioma,0
4652,Malignant - descriptor,FIGO Stage II Ovarian Cancer,0
4653,Sharing (Social Behavior),Carcinoma,0
4654,Case unit dose,embryonal rhabdomyosarcoma of prostate,0
4655,Malignant neoplasm of breast,Stage III Cutaneous Melanoma AJCC v6,0
4656,Persons,Neoplasms,0
4657,Chemotherapy Regimen,benign mature teratoma of pancreas,0
4658,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Recurrent Diffuse Intrinsic Pontine Glioma,0
4659,To,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4660,Pharmacotherapy,Uterine Cancer,0
4661,1000000,Prostate Lymphoma,0
4662,Blood,Hodgkin lymphoma,0
4663,Specimen Source Codes - tumor,Pancreatic carcinoma,0
4664,Pathologic,Cancer of Urinary Tract,0
4665,consider,Transitional cell carcinoma,0
4666,SPINK5 gene,Metastatic Kidney Carcinoma,0
4667,Leading,Splenic Manifestation of Hairy Cell Leukemia,0
4668,Orthologous Gene,Pleomorphic adenoma of parotid gland,0
4669,Difficult (qualifier value),Neoplasms,0
4670,Known,Carcinoma,0
4671,Affect (mental function),Anterior Urethral Malignant Neoplasm,0
4672,depend,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4673,Feelings,Gallbladder Adenocarcinoma,0
4674,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Mucinous adenocarcinoma,0
4675,Malignant Neoplasms,Necrotizing Funisitis,0
4676,Presentation,Malignant melanoma of eyelid,0
4677,Status post,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4678,Anatomy aspects,Cartilaginous exostosis,0
4679,Usual Severity Itching,Cerebral Primitive Neuroectodermal Tumor,0
4680,described,Vaginal Adenoid Cystic Carcinoma,0
4681,Small cell carcinoma of lung,FIGO Stage IVA Ovarian Cancer,0
4682,Two,Mucinous adenocarcinoma gastric,0
4683,Telephone Extension Number,Mucinous adenocarcinoma gastric,0
4684,Process (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
4685,Most,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
4686,Neoplasm Metastasis,Ovarian germ cell choriocarcinoma stage IV,0
4687,Times,Chest Wall Fibromatosis,0
4688,Science of Etiology,Mixed astrocytoma-ependymoma,0
4689,Greeks,Childhood Central Nervous System Ganglioneuroblastoma,0
4690,Negation,Stage III Cutaneous Melanoma AJCC v6,0
4691,Molecular Mass,Refractory Bladder Carcinoma,0
4692,Malignant Neoplasms,Breast Ductal Adenoma,0
4693,Abnormal cell,Spongiotic dermatitis,0
4694,Several,Locally Advanced Epithelioid Hemangioendothelioma,0
4695,1+ Score,Secondary malignant neoplasm of lymph node,0
4696,Classification of information,Localized Ewing Sarcoma,0
4697,Japanese language,FIGO Stage II Ovarian Cancer,0
4698,Condition:Find:Pt:^Patient:Nom,Adrenal Rest Tumor,0
4699,Biologic Development,Localized Malignant Neoplasm,0
4700,Protocols documentation,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
4701,survival aspects,Non-Metastatic Gestational Trophoblastic Tumor,0
4702,Mass of body region,Primary Cutaneous Plasmablastic Lymphoma,0
4703,Body part,High Grade Glandular Intraepithelial Neoplasia,0
4704,Act Relationship Subset - previous,Melanomatosis,0
4705,Medial collateral ligament,Carcinoma of submandibular gland,0
4706,Primary malignant neoplasm of endometrium,Benign Anal Granular Cell Tumor,0
4707,Less Than,Adult Hepatocellular Carcinoma,0
4708,Saint Lucia,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4709,removal technique,Rhabdomyosarcoma with ganglionic differentiation,0
4710,International Classification of Diseases,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
4711,Tired,Type II Endometrial Adenocarcinoma,0
4712,Approximate,Tubal Hyperplasia,0
4713,Low Back Pain,Mucinous cystadenofibroma,0
4714,Logical Condition,Tumorlet,0
4715,Malignant neoplasm of ovary,Nasal cavity carcinoma,0
4716,Initial Usage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4717,Process (qualifier value),Hodgkin lymphoma,0
4718,Chemotherapy Regimen,Maxillary Sinus Adenoid Cystic Carcinoma,0
4719,include - SetOperator,Trabecular adenocarcinoma,0
4720,First (number),Anterior Urethral Malignant Neoplasm,0
4721,Hematopoietic Neoplasms,Metastatic Lung Small Cell Carcinoma,0
4722,Smear - instruction imperative,Gallbladder Adenocarcinoma,0
4723,Pharmaceutical Preparations,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4724,Common Specifications in HL7 V3 Publishing,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4725,Account number:Identifier:Point in time:^Patient:Nominal,clear cell adenocarcinoma of gallbladder,0
4726,Malignant Vaginal Neoplasm,embryonal rhabdomyosarcoma of prostate,0
4727,Anal (qualifier value),Childhood Fibrillary Astrocytoma,0
4728,Extreme Response,Congenital hamartoma,0
4729,Body tissue,Methotrexate-Associated Hodgkin Lymphoma,0
4730,Emotional,Maxillary Sinus Adenoid Cystic Carcinoma,0
4731,Shortness of Breath Visual Analogue Scale,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4732,Common (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4733,Third,Occult Lung Adenosquamous Carcinoma,0
4734,Observation Interpretation - intermediate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4735,SLC35G1 gene,Stage III Cutaneous Melanoma AJCC v6,0
4736,Endocrine Cells,Benign tumor of eyelid,0
4737,Including (qualifier),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4738,N not otherwise specified Antibody,Maxillary Sinus Adenocarcinoma,0
4739,Case (situation),Funisitis (disorder),0
4740,Deglutition Disorders,Childhood Anaplastic Large Cell Lymphoma,0
4741,Lesion,Pancreatic carcinoma,0
4742,Taken,Lipoma of small intestine,0
4743,Out (direction),Cerebral Primitive Neuroectodermal Tumor,0
4744,Characterization,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4745,3+ Score,Extra-abdominal fibromatosis,0
4746,Location,gliosarcoma,0
4747,metastatic qualifier,Refractory Barrett Esophagus,0
4748,Covers (device),Engraftment syndrome,0
4749,Axilla,Carcinoma of submandibular gland,0
4750,Administration procedure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4751,Very High Level,Unresectable Rhabdomyosarcoma,0
4752,Methods aspects,FIGO Stage IVA Ovarian Cancer,0
4753,Qualitative form,embryonal rhabdomyosarcoma of prostate,0
4754,Platelets Product,Pancreatic carcinoma,0
4755,Myeloid,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4756,Glioblastoma Multiforme,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4757,Lacrimal gland structure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4758,Etiology,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4759,Colonic Polyps,Cerebral Primitive Neuroectodermal Tumor,0
4760,Greater,FIGO Stage II Ovarian Cancer,0
4761,High Mitotic Activity,mucinous adenocarcinoma of gallbladder,0
4762,Infrequent,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4763,EPRS gene,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4764,NCI CTEP SDC Astrocytoma,Astrocytoma of brain,0
4765,Term (temporal),Metastatic Lung Small Cell Carcinoma,0
4766,treatment - ActInformationManagementReason,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4767,Tears body substance,Parathyroid Gland Adenocarcinoma,0
4768,Estrogens,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4769,Classes - encounter,ROSE Cluster 3,0
4770,Item Collection,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
4771,Disease Screening,Recurrent Testicular Lymphoma,0
4772,Beginning,Testicular cancer metastatic,0
4773,Congenital ichthyosis,Malignant neoplasm of thalamus,0
4774,*Type - Kind of quantity,Malignant neoplasm of subglottis,0
4775,Nerve,Pancreatic Intraepithelial Neoplasia-3,0
4776,Most,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4777,Orbital content,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4778,Science of Etiology,Stage III Cutaneous Melanoma AJCC v6,0
4779,Estimated,Kaposi's sarcoma of skin,0
4780,Diagnostic Imaging,Metastatic Carcinoma in the Lung,0
4781,Manufactured form,Liver Lymphangioma,0
4782,Neoplasms,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4783,Treatment Epoch,Adult Acute Eosinophilic Leukemia,0
4784,Contain (action),papillary carcinoma of penis,0
4785,Low Grade,Mucinous adenocarcinoma,0
4786,Freezing,Low Grade Squamous Intraepithelial Neoplasia,0
4787,Cell Count,Cartilaginous exostosis,0
4788,Immune System Finding,Engraftment syndrome,0
4789,Sufficiently defined concept definition status (core metadata concept),Precursor B-lymphoblastic lymphoma stage II,0
4790,Adult Lymphoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4791,Abnormal Cell Count,Malignant neoplasm of thalamus,0
4792,Varies,Mucinous adenocarcinoma gastric,0
4793,Hemochromatosis,Methotrexate-Associated Hodgkin Lymphoma,0
4794,Leading,Stage III Adult Immunoblastic Lymphoma,0
4795,Increase,Unfavorable Non-Hodgkin Lymphoma,0
4796,morphological,Stage III Cutaneous Melanoma AJCC v6,0
4797,Include (action),Stage III Cutaneous Melanoma AJCC v6,0
4798,Death (finding),Localized Askin Tumor,0
4799,Version (morphologic abnormality),Mixed parotid tumor,0
4800,Disease,Diffuse malignant mesothelioma,0
4801,Approach,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4802,Togo,Angiosarcoma of liver,0
4803,Therapeutic procedure,Unfavorable Non-Hodgkin Lymphoma,0
4804,Frequently,Adenocarcinoma of duodenum,0
4805,Staining (finding),Adenocarcinoma of the prostate metastatic,0
4806,Fertility Agents,clear cell adenocarcinoma of gallbladder,0
4807,Males,Grade 1 Clear Cell Renal Cell Carcinoma,0
4808,Formation,Refractory Bladder Carcinoma,0
4809,United States,Platinum-Resistant Lung Small Cell Carcinoma,0
4810,Symptoms aspect,benign mature teratoma of pancreas,0
4811,Gram per Deciliter,Adult Anaplastic Oligodendroglioma,0
4812,soft tissue,Small cell neuroendocrine carcinoma of bladder,0
4813,Manual pelvic examination (procedure),Stage I Colon Neuroendocrine Tumor AJCC v8,0
4814,Low Level,FIGO Stage IVA Ovarian Cancer,0
4815,Primary malignant neoplasm,Unicystic ameloblastoma,0
4816,Case unit dose,Localized Ewing Sarcoma,0
4817,Presentation,Extracranial Neuroblastoma,0
4818,Therapeutic procedure,High Grade Glandular Intraepithelial Neoplasia,0
4819,Abdominal hysterectomy,Refractory Bladder Carcinoma,0
4820,Connective Tissue,Splenic Manifestation of Hairy Cell Leukemia,0
4821,Particle,Choroid Epithelioid Cell Melanoma,0
4822,Tumor cells,High Grade Glandular Intraepithelial Neoplasia,0
4823,Five-year Survival Rate,Basal Cell Ameloblastoma,0
4824,Malignant neoplasm of breast,Nasal cavity carcinoma,0
4825,Determined by,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4826,Endodermal,Endometrial Small Cell Carcinoma,0
4827,Autosomal dominant inheritance,Pancreatic carcinoma,0
4828,Does stand alone,Recurrent Uveal Melanoma,0
4829,per year,Epithelioid Sarcoma NCI Grade 3,0
4830,More,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4831,Treating,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
4832,Involvement with,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4833,Controlled by,Malignant melanoma of eyelid,0
4834,Affecting,Human Papillomavirus-Related Carcinoma,0
4835,Rare Diseases,squamous cell carcinoma of the thyroid gland,0
4836,Injury due to exposure to external cause,Metastatic Lung Neuroendocrine Neoplasm,0
4837,Positive,Breast Ductal Adenoma,0
4838,Negative Number,High Grade Glandular Intraepithelial Neoplasia,0
4839,Adolescent (age group),Small cell neuroendocrine carcinoma of bladder,0
4840,Followed by,Testicular cancer metastatic,0
4841,Biological Response Modifiers,Childhood Lymphoma,0
4842,Metastatic to,Tongue Alveolar Soft Part Sarcoma,0
4843,Pharmacotherapy,Adenocarcinoma of the prostate metastatic,0
4844,Collection (action),Trabecular adenocarcinoma,0
4845,Type - attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4846,Pleural effusion disorder,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4847,Condition:Find:Pt:^Patient:Nom,Cherubism,0
4848,Physical findings,Small Intestinal Villous Adenoma,0
4849,Anabolism,Malignant neoplasm of thalamus,0
4850,Stomach structure,Benign neoplasm of eye,0
4851,Extrinsic,embryonal rhabdomyosarcoma of prostate,0
4852,Cell Count,Gallbladder adenoma,0
4853,Destruction (action),Cancer of Urinary Tract,0
4854,LMNA wt Allele,Methotrexate-Associated Hodgkin Lymphoma,0
4855,Primary malignant neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4856,World Health Organization,Peripheral primitive neuroectodermal tumor of soft tissue,0
4857,Pap smear,Diffuse malignant mesothelioma,0
4858,Brain part,Peripheral primitive neuroectodermal tumor of soft tissue,0
4859,include - SetOperator,Papillary squamous cell carcinoma,0
4860,Thickened,squamous cell carcinoma of the thyroid gland,0
4861,Childhood Extracranial Germ Cell Tumor,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
4862,Laboratory Procedures,Unresectable Rhabdomyosarcoma,0
4863,Primary malignant neoplasm,Diffuse malignant mesothelioma,0
4864,Before,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4865,Distention,Grade 1 Clear Cell Renal Cell Carcinoma,0
4866,Call (Instruction),Malignant Neoplasm with Regional Lymph Node Involvement,0
4867,various allergen extracts,Unresectable Rhabdomyosarcoma,0
4868,Cancer Etiology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4869,Double eyelid,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4870,Spreading (qualifier value),adenoid cystic carcinoma of lung,0
4871,Malignant epithelioma,Intracortical osteosarcoma,0
4872,Chemotherapy,Stage IV Childhood Non-Hodgkin Lymphoma,0
4873,Hyperplasia,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4874,Stage Grouping,Primary Cutaneous Plasmablastic Lymphoma,0
4875,Together,Xeroderma pigmentosum,0
4876,Difficulty walking,Neonatal leukemia,0
4877,Asleep,Bladder Neuroendocrine Neoplasm,0
4878,Occur (action),Recurrent Testicular Lymphoma,0
4879,Include (action),Human Papillomavirus-Related Carcinoma,0
4880,Blood Circulation,Metastatic Lung Neuroendocrine Neoplasm,0
4881,Type - attribute,Recurrent Uveal Melanoma,0
4882,Surgical aspects,Familial Hemophagocytic Lymphocytosis,0
4883,Chemotherapy,Clonal Hematopoiesis of Indeterminate Potential,0
4884,Tests (qualifier value),Squamous cell carcinoma of lip,0
4885,month,FIGO Stage IVA Ovarian Cancer,0
4886,product,Neonatal leukemia,0
4887,Excision,Malignant Neoplasm with Regional Lymph Node Involvement,0
4888,shared attribute,Ectomesenchymal Chondromyxoid Tumor,0
4889,Occurrence Indicator,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4890,Retinoic Acid Response Element,Thyroid Hurthle Cell Carcinoma,0
4891,Physical findings,Liver Lymphangioma,0
4892,Sacrifice,Mucinous adenocarcinoma gastric,0
4893,Regurgitation,Undifferentiated Endocervical Sarcoma,0
4894,Evidence,Benign squamous cell tumor,0
4895,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4896,Gram per Deciliter,Intestinal Metaplasia of Bladder Urothelium,0
4897,Anterior portion of neck,embryonal rhabdomyosarcoma of prostate,0
4898,Trial Screening,Spongiotic dermatitis,0
4899,Cancer Genus,Lipoma of small intestine,0
4900,Only - dosing instruction fragment,Clonal Hematopoiesis of Indeterminate Potential,0
4901,Bone Pain,Adult Anaplastic Oligodendroglioma,0
4902,List,Liver Lymphangioma,0
4903,Table Rules - groups,Non-Metastatic Gestational Trophoblastic Tumor,0
4904,Lymphoma,Engraftment syndrome,0
4905,Child,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
4906,Bio-Informatics,Adult Alveolar Soft Part Sarcoma,0
4907,Body structure,Childhood Fibrillary Astrocytoma,0
4908,Vital (qualifier value),Testicular cancer metastatic,0
4909,Oral,Kaposi's sarcoma of skin,0
4910,Symptoms,Astrocytoma of brain,0
4911,seconds,Xeroderma pigmentosum,0
4912,Have Weight Loss,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4913,Science of Etiology,Tonsillar Carcinoma,0
4914,Walled,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4915,National origin,adenosquamous carcinoma of breast,0
4916,Times,FIGO Stage II Ovarian Cancer,0
4917,Complication,Testicular cancer metastatic,0
4918,Usually Need Help from Another Person for Arising,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4919,Growth action,mucinous adenocarcinoma of gallbladder,0
4920,Representation (action),Microcystic meningioma,0
4921,include - SetOperator,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4922,Central,Childhood Lymphoma,0
4923,Discharge,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4924,health and disease,BRCA2 Syndrome,0
4925,year,Malignant melanoma of eyelid,0
4926,Left,Undifferentiated Endocervical Sarcoma,0
4927,Contact with,Adenocarcinoma,0
4928,Major <insect>,Mastocytosis,0
4929,Macrophage Activation Syndrome,Human Papillomavirus-Related Carcinoma,0
4930,Colon structure (body structure),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
4931,Function Axis,Adult Brain Stem Mixed Glioma,0
4932,Adult Hodgkin Lymphoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4933,Often - answer to question,Cancer of Urinary Tract,0
4934,Most,Methotrexate-Associated Hodgkin Lymphoma,0
4935,Number of birth,Platinum-Resistant Lung Small Cell Carcinoma,0
4936,Second Suffix,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4937,Life Expectancy,Vaginal Adenoma,0
4938,Infected,Cancer of Urinary Tract,0
4939,Removing (action),Undifferentiated Neuroblastoma,0
4940,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
4941,Cells,Pancreatic Intraepithelial Neoplasia-3,0
4942,Involvement with,embryonal rhabdomyosarcoma of prostate,0
4943,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Transitional cell carcinoma,0
4944,Greater than one,Thyroid Hurthle Cell Carcinoma,0
4945,Include (action),Basal Cell Ameloblastoma,0
4946,Abdominal Cavity,Stage III Cutaneous Melanoma AJCC v6,0
4947,Stage IV Breast Cancer AJCC v6 and v7,Ichthyosis,0
4948,Base - General Qualifier,Childhood Fibrillary Astrocytoma,0
4949,NCI CTEP SDC Wilms Tumor Sub-Category Terminology,Adrenal Rest Tumor,0
4950,Very High Level,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4951,Infant,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
4952,Neuroendocrine Tumors,FIGO Stage II Ovarian Cancer,0
4953,G2 stage (tumor staging),Stage IV Colorectal Cancer AJCC v8,0
4954,Removed,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4955,Tryptophanase,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4956,Non-Seminomatous Lesion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4957,Term Birth,Necrotizing Funisitis,0
4958,Appearance,Recurrent Testicular Lymphoma,0
4959,Disease,Microcystic meningioma,0
4960,How Often Felt Normal question,GIANT PIGMENTED HAIRY NEVUS,0
4961,Important,Anaplastic large cell lymphoma,0
4962,Type A,Metastatic Ductal Breast Carcinoma,0
4963,Symptoms,Trabecular adenocarcinoma,0
4964,Colorectal Carcinoma,Basal Cell Ameloblastoma,0
4965,The Sun,Human Papillomavirus-Related Carcinoma,0
4966,Class,Localized Ewing Sarcoma,0
4967,Asia,Thyroid Hurthle Cell Carcinoma,0
4968,Order (arrangement),Splenic Manifestation of Hairy Cell Leukemia,0
4969,Occurrence,adenosquamous carcinoma of breast,0
4970,Childhood Leukemia,Adult Acute Eosinophilic Leukemia,0
4971,Affect (mental function),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4972,General surgery specialty,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4973,Genetic syndrome,FIGO Stage IVA Ovarian Cancer,0
4974,Occurrence Indicator,Digestive System Hodgkin Lymphoma,0
4975,Smaller,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4976,Screens (device),Recurrent Primary Lymphoma of Bone,0
4977,Providing (action),Stage III Cutaneous Melanoma AJCC v6,0
4978,International Statistical Classification of Diseases and Related Health Problems,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4979,Lower - spatial qualifier,Benign squamous cell tumor,0
4980,Japan,Pancreatic Intraepithelial Neoplasia-3,0
4981,Time,Thymic Clear Cell Carcinoma,0
4982,Testing,Granular Cell Leiomyosarcoma,0
4983,second (number),Stage IV Penile Cancer AJCC v7,0
4984,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4985,Human body structure,Type II Endometrial Adenocarcinoma,0
4986,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4987,Cyclophosphamide,non-Hodgkin's lymphoma of spleen,0
4988,Infiltration Route of Drug Administration,Undifferentiated Neuroblastoma,0
4989,Adenoma,Splenic Manifestation of Hairy Cell Leukemia,0
4990,Body structure,Papillary cystic tumor,0
4991,Age at diagnosis:Time:Pt:^Patient:Qn,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4992,Success,Giant cell angiofibroma,0
4993,*Type - Kind of quantity,Thymic Clear Cell Carcinoma,0
4994,Adult Hodgkin Lymphoma,Atypical Lobular Breast Hyperplasia,0
4995,Swelling,Undifferentiated Neuroblastoma,0
4996,Cell Count,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4997,Adult Subependymal Giant Cell Astrocytoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4998,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4999,Prevention Study,Malignant Neoplasm with Regional Lymph Node Involvement,0
5000,Monocytes,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5001,List,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5002,Medical Device Emits Smoke,Cerebral hemangioma,0
5003,Cells,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5004,Web Site,Undifferentiated Neuroblastoma,0
5005,Ultrasonography,Mucinous adenocarcinoma gastric,0
5006,Present,Xeroderma pigmentosum,0
5007,Pancreas part,Low Grade Squamous Intraepithelial Neoplasia,0
5008,Most,Locally Advanced Carcinoma,0
5009,Malignant Neoplasms,Gallbladder Adenocarcinoma,0
5010,Primary,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5011,Middle,Female Breast Carcinoma,0
5012,Cancer Genus,Recurrent Uveal Melanoma,0
5013,Usually Need Help from Another Person for Reach,Kaposi's sarcoma of skin,0
5014,2+ Score,Stage IV Penile Cancer AJCC v7,0
5015,Specimen Source Codes - tumor,Diffuse malignant mesothelioma,0
5016,Tryptophanase,squamous cell carcinoma of the thyroid gland,0
5017,Neoplasms,Uterine Cancer,0
5018,Death Related to Adverse Event,Xeroderma pigmentosum,0
5019,Targeted Therapy,Stage III Cutaneous Melanoma AJCC v6,0
5020,United States,Transitional cell carcinoma,0
5021,Weight Loss,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5022,CDISC SEND Tumor Findings Results Terminology,Endometrial Small Cell Carcinoma,0
5023,Retrobulbar Route of Drug Administration,Testicular cancer metastatic,0
5024,Disease Screening,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5025,FAT1 wt Allele,Cartilaginous exostosis,0
5026,1870s,adenosquamous carcinoma of breast,0
5027,Appearance Distress Question,Thyroid Hurthle Cell Carcinoma,0
5028,Abnormal host response,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5029,Person 3,Lipoma of small intestine,0
5030,Entire great blood vessel (organ),sarcoma of spinal cord,0
5031,Value Above Reference Range,Xeroderma pigmentosum,0
5032,Contract agreement,Neonatal leukemia,0
5033,More Often than Once a Day,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5034,Count of entities,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5035,Sacrifice,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5036,physiological aspects,Recurrent Testicular Lymphoma,0
5037,*Type - Kind of quantity,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5038,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5039,Cell Device,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5040,include - SetOperator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5041,Areas <moth>,Undifferentiated Endocervical Sarcoma,0
5042,Metastatic Neoplasm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5043,Metaplastic carcinoma of breast,Locally Advanced Soft Tissue Sarcoma,0
5044,Formation,Carcinoma of urinary bladder,0
5045,risk factors,Unicystic ameloblastoma,0
5046,Percent of Abnormal Cells,Blepharal carcinoma,0
5047,70%,Cartilaginous exostosis,0
5048,Better,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5049,Treatment Epoch,Childhood Central Nervous System Ganglioneuroblastoma,0
5050,Short Value,Malignant melanoma of eyelid,0
5051,melanocyte,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5052,>5,Blood Vessel Tumors,0
5053,Diabetes,Acute Undifferentiated Leukemia,0
5054,Array Feature,Peripheral primitive neuroectodermal tumor of soft tissue,0
5055,High,Locally Advanced Carcinoma,0
5056,Pediculus (eukaryote),Small cell neuroendocrine carcinoma of bladder,0
5057,Adult Soft Tissue Sarcoma,Malignant neoplasm of olfactory nerve,0
5058,Pain Distress Question,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5059,Nicotiana,Stage III Cutaneous Melanoma AJCC v6,0
5060,pharmacotherapeutic,Localized Malignant Neoplasm,0
5061,Amount type - Percentage,Basal Cell Ameloblastoma,0
5062,diagnosis aspect,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5063,Malignant - descriptor,FIGO Stage II Ovarian Cancer,0
5064,cell growth,Malignant neoplasm of gallbladder,0
5065,Cancer Other,Methotrexate-Associated Hodgkin Lymphoma,0
5066,Third,Adult Acute Eosinophilic Leukemia,0
5067,Type - attribute,Primary Cutaneous Plasmablastic Lymphoma,0
5068,Endometrial Carcinoma,Pancreatic carcinoma,0
5069,Occurrence Indicator,Cervical Squamous Intraepithelial Neoplasia,0
5070,Ricin poisoning,BRCA2 Syndrome,0
5071,Beds,Vaginal Adenoid Cystic Carcinoma,0
5072,Significant,Malignant neoplasm of choroid,0
5073,1+ Score,Acute lymphadenitis,0
5074,Axis,Peripheral primitive neuroectodermal tumor of soft tissue,0
5075,Cervical Intraepithelial Neoplasia,Testicular cancer metastatic,0
5076,Several,Squamous cell carcinoma of lip,0
5077,AMINO ACIDS/PROTEINS,Intraepithelial Melanocytic Hyperplasia,0
5078,Persons,Low Grade Squamous Intraepithelial Neoplasia,0
5079,Microplate Well,Intraepithelial Melanocytic Hyperplasia,0
5080,Stable status,Plexosarcoma,0
5081,Adult human body,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5082,Often - answer to question,Neoplasms,0
5083,Count of entities,Methotrexate-Associated Hodgkin Lymphoma,0
5084,Difficult (qualifier value),Fibroadenoma of breast,0
5085,Object Class,Testicular cancer metastatic,0
5086,Arrested progression,Ovarian Carcinoid Tumor,0
5087,CDISC SEND Tumor Findings Results Terminology,Platinum-Resistant Lung Small Cell Carcinoma,0
5088,Value Above Reference Range,Trichilemmocarcinoma,0
5089,*Type - Kind of quantity,Intraepithelial Melanocytic Hyperplasia,0
5090,Chronic inflammation,Unresectable Rhabdomyosarcoma,0
5091,Make - Instruction Imperative,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5092,Continuance of life,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5093,System - kit,Testicular cancer metastatic,0
5094,Epithelial Cells,Recurrent Uveal Melanoma,0
5095,Administration procedure,Peripheral primitive neuroectodermal tumor of soft tissue,0
5096,Liver Flavor,Pancreatic Intraepithelial Neoplasia-3,0
5097,Rubbery,adenosquamous carcinoma of breast,0
5098,Consistency,Deep Leiomyoma,0
5099,Front of neck,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5100,Sarcoma,Bladder adenocarcinoma stage IV,0
5101,Thick,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5102,20%,Benign Anal Granular Cell Tumor,0
5103,Aspect (characteristic),Mixed parotid tumor,0
5104,Loss of Appetite question,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5105,Inhibition,Benign Carotid Body Paraganglioma,0
5106,Anterior chest wall structure,sarcoma of spinal cord,0
5107,Associated topography,Engraftment syndrome,0
5108,body system,Uterine Cancer,0
5109,Electromagnetic Fields,Parathyroid Gland Adenocarcinoma,0
5110,Symptoms aspect,Childhood Anaplastic Large Cell Lymphoma,0
5111,Recurrence,Metastatic Kidney Carcinoma,0
5112,leukemia,Stage IV Colorectal Cancer AJCC v8,0
5113,Internal,Undifferentiated Neuroblastoma,0
5114,Liquid substance,Xeroderma pigmentosum,0
5115,treatment - ActInformationManagementReason,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5116,Data Transformation,Cervical Fibroepithelial Polyp,0
5117,Autoimmune Diseases,Pilocytic astrocytoma of cerebellum,0
5118,Result,Benign Carotid Body Paraganglioma,0
5119,Neoplasm Metastasis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5120,Mutation Abnormality,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5121,therapeutic aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5122,Xeroderma Pigmentosum,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5123,Active,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5124,South,Squamous cell carcinoma of lip,0
5125,Therapeutic radiology procedure,Hemangioma,0
5126,Beginning,Type II Endometrial Adenocarcinoma,0
5127,Abdominal Cavity,squamous cell carcinoma of the thyroid gland,0
5128,All extremities,Giant cell angiofibroma,0
5129,50%,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5130,Malignant lymphoma,Squamous cell carcinoma of lip,0
5131,Characterization,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
5132,BRCA2 Protein,Stage IV Colorectal Cancer AJCC v8,0
5133,Cover (physical object),Recurrent Uveal Melanoma,0
5134,Reflecting,FIGO Stage II Ovarian Cancer,0
5135,early disease,Childhood Fibrillary Astrocytoma,0
5136,Exposure to radiation,Extra-Adrenal Paraganglioma,0
5137,Pathogenic organism,Choroid Necrotic Melanoma,0
5138,Use of,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5139,Most,Localized Ewing Sarcoma,0
5140,Laryngeal part,Breast Apocrine Adenoma,0
5141,Swollen Lymph Node,Melanomatosis,0
5142,Can Do Very Little,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5143,Mode of inheritance,Hair nevus,0
5144,N not otherwise specified Antibody,Benign squamous cell tumor,0
5145,To,Recurrent Uveal Melanoma,0
5146,More,Childhood Fibrillary Astrocytoma,0
5147,Certainties,Noninfiltrating Intraductal Carcinoma,0
5148,Local disease,Acute lymphadenitis,0
5149,Primary malignant neoplasm,Pancreatic Endocrine Carcinoma,0
5150,Containing (qualifier),Intraepithelial Melanocytic Hyperplasia,0
5151,Germ Layers,Contact dermatitis due to alkali,0
5152,Body tissue,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5153,Structure of primordial sex cell,Stage IB Pancreatic Cancer AJCC v8,0
5154,Carbon Dioxide,Recurrent Testicular Lymphoma,0
5155,Common Specifications in HL7 V3 Publishing,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5156,SLC6A2 wt Allele,Intestinal Metaplasia of Bladder Urothelium,0
5157,3+ Answer to Question,Digestive System Hodgkin Lymphoma,0
5158,GIVEN,Endometrial Small Cell Carcinoma,0
5159,Serving,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5160,Teens,Carcinoma of urinary bladder,0
5161,Usually Need Help from Another Person for Reach,clear cell adenocarcinoma of gallbladder,0
5162,Decision,Human Papillomavirus-Related Carcinoma,0
5163,aggressive cancer,Stage 0 Penile Cancer AJCC v8,0
5164,Never (frequency),Spindle Cell Melanoma,0
5165,Tumor site,Benign squamous cell tumor,0
5166,Image Feature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5167,High Risk Acute Leukemia,Undifferentiated Neuroblastoma,0
5168,Cerebrum,Small cell neuroendocrine carcinoma of bladder,0
5169,peripheral blood,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5170,True primary (qualifier value),Refractory WHO Grade III Glioma,0
5171,Result,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
5172,include - SetOperator,Deep Leiomyoma,0
5173,Age,Hodgkin lymphoma,0
5174,63,Undifferentiated Neuroblastoma,0
5175,Dental Enamel,Nasal cavity carcinoma,0
5176,Benign,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5177,Primary,Xeroderma pigmentosum,0
5178,include - SetOperator,Placental aromatase deficiency,0
5179,Net (qualifier),Mucinous neoplasm,0
5180,Administration procedure,Astrocytoma of brain,0
5181,Life Threatening or Disabling Adverse Event,Mixed astrocytoma-ependymoma,0
5182,shared attribute,embryonal rhabdomyosarcoma of prostate,0
5183,Entity Determiner - specific,Unfavorable Non-Hodgkin Lymphoma,0
5184,Elderly (population group),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5185,Mammary Gland Parenchyma,Localized Askin Tumor,0
5186,Telephone Extension Number,Carcinoma of urinary bladder,0
5187,Process,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5188,2+ Score,Childhood Central Nervous System Ganglioneuroblastoma,0
5189,Combined,Pancreatic Intraepithelial Neoplasia-3,0
5190,Western Europe,Chronic Myelomonocytic Leukemia-2,0
5191,Minor (person),Stage III Cutaneous Melanoma AJCC v6,0
5192,Fertility Agents,benign mature teratoma of pancreas,0
5193,Upper aerodigestive tract,Papillary squamous cell carcinoma,0
5194,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5195,Times,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5196,Oral cavity,Trabecular adenocarcinoma,0
5197,Derivation,Acute Undifferentiated Leukemia,0
5198,Tumor stage,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5199,IPSS Risk Category High,Papillary squamous cell carcinoma,0
5200,Stomach,Cervical Fibroepithelial Polyp,0
5201,Treating,Malignant neoplasm of thalamus,0
5202,Examination,Vaginal Adenoid Cystic Carcinoma,0
5203,60%,Blepharal carcinoma,0
5204,Body tissue,Childhood Thyroid Gland Follicular Carcinoma,0
5205,PREVENT (product),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5206,Fasting,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5207,Usual,Trichilemmocarcinoma,0
5208,Diagnosis,Squamous cell carcinoma of lip,0
5209,Inferior,Gallbladder adenoma,0
5210,Common (qualifier value),Mastocytosis,0
5211,Frequently,Mastocytosis,0
5212,Nerve Tissue,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5213,Facial edema,FIGO Stage II Ovarian Cancer,0
5214,radiotherapeutic,Acute Undifferentiated Leukemia,0
5215,Breathing Distress Question,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5216,Congenital Abnormality,Malignant melanoma of eyelid,0
5217,More,Colorectal High Grade B-Cell Lymphoma,0
5218,Rest,FIGO Stage IVA Ovarian Cancer,0
5219,How Often Vomiting,Brain Tumor,0
5220,Diagnosis Study,Hyperplasia of pituitary gland,0
5221,Abnormally high,Stage III Cutaneous Melanoma AJCC v6,0
5222,Prevalence aspects,Cartilaginous exostosis,0
5223,Often - answer to question,Stage II Hepatocellular Carcinoma AJCC v8,0
5224,Age,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5225,Three,Benign Apocrine Neoplasm,0
5226,Treating,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5227,Respiration,Refractory Barrett Esophagus,0
5228,Due to,Refractory Barrett Esophagus,0
5229,Disease,Female Breast Carcinoma,0
5230,How Much Distress Itching,Cancer of Urinary Tract,0
5231,Form:Finding:Point in time:{Setting}:Document:{Role},Benign Ovarian Thecoma,0
5232,Study,Astrocytoma of brain,0
5233,Primary,Mucinous adenocarcinoma gastric,0
5234,Unmarried person,Locally Advanced Carcinoma,0
5235,More,High Grade Glandular Intraepithelial Neoplasia,0
5236,Sectioning technique,Astrocytoma of brain,0
5237,Body tissue,Trichilemmocarcinoma,0
5238,Including (qualifier),malignant lymphoma of pancreatic lymph nodes,0
5239,Intermediate,Cherubism,0
5240,Manufactured form,Acinar cell carcinoma of pancreas,0
5241,Pediculus humanus capitis (eukaryote),Digestive System Hodgkin Lymphoma,0
5242,Disorder of lymph node,Diffuse malignant mesothelioma,0
5243,Togo,Adult Alveolar Soft Part Sarcoma,0
5244,Time,Childhood Choriocarcinoma,0
5245,2+ Score,Trabecular adenocarcinoma,0
5246,Malignant neoplasm of endometrium,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5247,Primary malignant neoplasm,Splenic Manifestation of Hairy Cell Leukemia,0
5248,Did not receive therapy or drug for,Methotrexate-Associated Hodgkin Lymphoma,0
5249,Accounting (activity),Recurrent Testicular Lymphoma,0
5250,Germ,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5251,Abdomen,Low Grade Squamous Intraepithelial Neoplasia,0
5252,body system,Heavy Chain Deposition Disease,0
5253,Central Minus,Cherubism,0
5254,radiotherapeutic,Intraepithelial Melanocytic Hyperplasia,0
5255,DNA Breaks,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5256,BRCA1 protein,Fibroadenoma of breast,0
5257,Togo,sarcoma of spinal cord,0
5258,Enneking Low Surgical Grade,Refractory Barrett Esophagus,0
5259,Make - Instruction Imperative,Endometrial Small Cell Carcinoma,0
5260,Case unit dose,Adult Acute Eosinophilic Leukemia,0
5261,Human body,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5262,combination - answer to question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5263,various other nasal preparations in ATC,Undifferentiated Neuroblastoma,0
5264,Esophageal,Colorectal High Grade B-Cell Lymphoma,0
5265,Infection,Xeroderma pigmentosum,0
5266,Swab,Thymic Clear Cell Carcinoma,0
5267,Erythrocytes,Adult Alveolar Soft Part Sarcoma,0
5268,include - SetOperator,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
5269,Occur (action),Metastatic Carcinoma in the Lung,0
5270,Occurrence,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5271,Fraction of,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
5272,Neuroendocrine Tumors,Kaposi's sarcoma of skin,0
5273,Feelings,Neonatal leukemia,0
5274,Smear - instruction imperative,Small Intestinal Villous Adenoma,0
5275,Occur (action),Kaposi's sarcoma of extrahepatic bile duct,0
5276,Malignant Neoplasms,Hyperplasia of pituitary gland,0
5277,United States,Cancer of Urinary Tract,0
5278,Abnormal uterine bleeding,Unresectable Rhabdomyosarcoma,0
5279,Head and neck structure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5280,Short Value,Trichilemmocarcinoma,0
5281,Oropharyngeal,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5282,Occurrence Indicator,Engraftment syndrome,0
5283,gemcitabine,FIGO Stage II Ovarian Cancer,0
5284,Stem of Organ,Benign squamous cell tumor,0
5285,ICD-9,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5286,treatment options,Lung squamous cell carcinoma stage I,0
5287,Increased risk,Malignant Neoplasm with Regional Lymph Node Involvement,0
5288,Group A (qualifier value),Localized Ewing Sarcoma,0
5289,primary tumor,Kaposi's sarcoma of skin,0
5290,Headache,ROSE Cluster 3,0
5291,Severe (severity modifier),Unicystic ameloblastoma,0
5292,Life threatening - Event Consequence,Acute lymphadenitis,0
5293,Beginning,Peripheral primitive neuroectodermal tumor of soft tissue,0
5294,Version,Benign Anal Granular Cell Tumor,0
5295,Pregnancy,Acantholytic squamous cell carcinoma,0
5296,low confidentiality,Tubal Hyperplasia,0
5297,Associated with,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5298,Known,Angiosarcoma of liver,0
5299,Cellular fibroma,benign mature teratoma of pancreas,0
5300,Oral cavity,Nasal cavity carcinoma,0
5301,include - SetOperator,Chest Wall Fibromatosis,0
5302,Bone Marrow Cells,Ichthyoses,0
5303,To,Localized Ewing Sarcoma,0
5304,transport (device),Recurrent Testicular Lymphoma,0
5305,Similarity,Peripheral primitive neuroectodermal tumor of soft tissue,0
5306,Primary,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5307,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,FIGO Stage IVA Ovarian Cancer,0
5308,Room of building - Study,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5309,Aggressive course,Stage 0 Lip Carcinoma,0
5310,Referral placed,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5311,Lymphoid Tissue,Basal Cell Ameloblastoma,0
5312,High risk,Acantholytic squamous cell carcinoma,0
5313,Adenocarcinoma of pancreas,Malignant neoplasm of olfactory nerve,0
5314,Smear - instruction imperative,Astrocytoma of brain,0
5315,Aggressive course,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5316,Mus,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5317,Bone Tissue,Benign neoplasm of eye,0
5318,Most,Ovarian germ cell choriocarcinoma stage IV,0
5319,described,ROSE Cluster 3,0
5320,Preventive intent,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5321,Neoplasms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5322,International Statistical Classification of Diseases and Related Health Problems,Localized Malignant Neoplasm,0
5323,Diagnosis Study,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5324,brain cell,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5325,Subcutaneous Tissue,Undifferentiated Neuroblastoma,0
5326,Tryptophanase,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5327,Person Name,Gallbladder Adenocarcinoma,0
5328,Seizures,Vaginal Adenoid Cystic Carcinoma,0
5329,Comparison,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
5330,macromolecule,Childhood Thyroid Gland Follicular Carcinoma,0
5331,Major,Colorectal Neuroendocrine Tumor G2,0
5332,Frequently,embryonal rhabdomyosarcoma of prostate,0
5333,Specific qualifier value,Kaposi's sarcoma of skin,0
5334,risk factors - observation list,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5335,Free of (attribute),Familial Adenomatous Polyposis Associated Medulloblastoma,0
5336,*Type - Kind of quantity,Urethral Carcinoma,0
5337,Retinoic Acid Response Element,Microcystic meningioma,0
5338,Time,Chondrosarcoma,0
5339,Smear - instruction imperative,Cerebral Primitive Neuroectodermal Tumor,0
5340,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Stage II Hepatocellular Carcinoma AJCC v8,0
5341,High Mitosis-Karyorrhexis Index,de novo Myelodysplastic Syndrome,0
5342,Unique,Localized Ewing Sarcoma,0
5343,Concept model range (foundation metadata concept),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
5344,Sweat Glands,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5345,Plumbum metallicum,Stage II Hepatocellular Carcinoma AJCC v8,0
5346,Disease remission,Childhood Choriocarcinoma,0
5347,Referring,Neoplasms,0
5348,More,Undifferentiated Endocervical Sarcoma,0
5349,Togo,FIGO Stage II Ovarian Cancer,0
5350,Sunlight,Hyperplasia of pituitary gland,0
5351,NBL1 gene,Malignant melanoma of eyelid,0
5352,Person Name,Mucinous neoplasm,0
5353,High risk of,Recurrent Testicular Lymphoma,0
5354,Malignant Neoplasms,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5355,Targeted Therapy,FIGO Stage II Ovarian Cancer,0
5356,Neoplasms,Nasal cavity carcinoma,0
5357,Occurrence,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5358,Parameterized Data Type - Set,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
5359,pharmacotherapeutic,Leiomyoma of Gallbladder,0
5360,Common Specifications in HL7 V3 Publishing,Mixed astrocytoma-ependymoma,0
5361,Pruritus,Diffuse malignant mesothelioma,0
5362,Hyperplasia,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
5363,Bone Tissue,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5364,Form:Finding:Point in time:{Setting}:Document:{Role},Vaginal Adenoid Cystic Carcinoma,0
5365,Age at menopause,Type II Endometrial Adenocarcinoma,0
5366,Definition,Hemangioma,0
5367,In situ neoplasm (morphology),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5368,Following,mucinous adenocarcinoma of gallbladder,0
5369,Natural immunosuppression,Intraepithelial Melanocytic Hyperplasia,0
5370,Increase in size since previous mammogram,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5371,Pharyngeal structure,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5372,Negative Number,Human Papillomavirus-Related Carcinoma,0
5373,Include (action),Periosteal Osteosarcoma,0
5374,geographic population,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5375,Symptoms,Breast Ductal Adenoma,0
5376,Case (situation),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
5377,Surgery specialty,Refractory WHO Grade III Glioma,0
5378,Critical,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5379,Call (Instruction),Colorectal cancer,0
5380,Common (qualifier value),Diffuse malignant mesothelioma,0
5381,PSA Level Less than Two,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5382,Part of,Clonal Hematopoiesis of Indeterminate Potential,0
5383,Antimicrobial Susceptibility Result,Locally Advanced Carcinoma,0
5384,Arsenic measurement,Tongue Alveolar Soft Part Sarcoma,0
5385,Half,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5386,{Setting},Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5387,Cervical Squamous Cell Carcinoma,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5388,Lower - spatial qualifier,Cancer of Urinary Tract,0
5389,treatment - ActInformationManagementReason,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5390,World,Bladder adenocarcinoma stage IV,0
5391,Milliampere second,Benign Apocrine Neoplasm,0
5392,Togo,Colorectal High Grade B-Cell Lymphoma,0
5393,Histologic,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5394,Two,FIGO Stage IVA Ovarian Cancer,0
5395,Count of entities,embryonal rhabdomyosarcoma of prostate,0
5396,mesodermal,Childhood Central Nervous System Ganglioneuroblastoma,0
5397,Pluripotent,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5398,Neoplasms,Trabecular adenocarcinoma,0
5399,Immune System Processes,Endometrial Small Cell Carcinoma,0
5400,Necrotic changes (finding),Refractory Bladder Carcinoma,0
5401,Linear,Small intestine carcinoma,0
5402,Four,Adenocarcinoma of duodenum,0
5403,predictive factor,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5404,The Cancer Genome Atlas,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5405,Gastrointestinal tract structure,Thymic Clear Cell Carcinoma,0
5406,Carcinoma,papillary carcinoma of penis,0
5407,Inguinal region,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5408,Bone Marrow,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
5409,Frequently,Parathyroid Gland Adenocarcinoma,0
5410,Cancer Genus,squamous cell carcinoma of the thyroid gland,0
5411,Disease Response,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
5412,Round shape,Intestinal Metaplasia of Bladder Urothelium,0
5413,Function (attribute),non-Hodgkin's lymphoma of spleen,0
5414,Affecting,Hereditary Diffuse Gastric Adenocarcinoma,0
5415,Affecting,Mucinous adenocarcinoma gastric,0
5416,Most,Bladder adenocarcinoma stage IV,0
5417,Appearance,Acantholytic squamous cell carcinoma,0
5418,Cell Device,Stage III Cutaneous Melanoma AJCC v6,0
5419,Benign tumor of salivary gland,embryonal rhabdomyosarcoma of prostate,0
5420,Old age,Mucinous adenocarcinoma gastric,0
5421,Histologic,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5422,Upper jaw region,Squamous cell carcinoma of lip,0
5423,Class,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5424,morphological,Intraepithelial Melanocytic Hyperplasia,0
5425,Manufactured form,Epithelioid Sarcoma NCI Grade 3,0
5426,Population Group,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5427,Act Relationship Type - occurrence,Childhood Thyroid Gland Follicular Carcinoma,0
5428,Location of Oral Residue Following Swallowing,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5429,PAX3 gene,Benign tumor of eyelid,0
5430,Homo sapiens,Cervical Fibroepithelial Polyp,0
5431,Law enforcement arrest,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5432,Translocation of object,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5433,Pharmacotherapy,Type II Endometrial Adenocarcinoma,0
5434,Call (Instruction),Primary Cutaneous Plasmablastic Lymphoma,0
5435,75,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5436,Proline measurement,Lipoma of small intestine,0
5437,Clinical Study Case,ROSE Cluster 3,0
5438,Known,Cerebral Primitive Neuroectodermal Tumor,0
5439,Act Mood - intent,Rhabdomyosarcoma with ganglionic differentiation,0
5440,Premature aging syndrome,Larynx carcinoma recurrent,0
5441,Tobacco smoking behavior,Maxillary Sinus Adenoid Cystic Carcinoma,0
5442,Cancer Genus,Lipoma of small intestine,0
5443,Abnormal Reference Range,ROSE Cluster 3,0
5444,Prostate,Mucinous adenocarcinoma gastric,0
5445,Brain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5446,Greater Than,Mucinous neoplasm,0
5447,High,Childhood Central Nervous System Ganglioneuroblastoma,0
5448,Usually,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5449,200,Kaposi's sarcoma of extrahepatic bile duct,0
5450,health and disease,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5451,Frequently,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
5452,combination - answer to question,adenoid cystic carcinoma of lung,0
5453,Malignant Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5454,Pathological Dilatation,Childhood Central Nervous System Ganglioneuroblastoma,0
5455,Percent (qualifier value),Chest Wall Fibromatosis,0
5456,Manufactured form,Gallbladder Adenocarcinoma,0
5457,Mass of body region,Lipoma of small intestine,0
5458,Range,Refractory Bladder Carcinoma,0
5459,Negation,Astrocytoma of brain,0
5460,Medical Imaging,Acantholytic squamous cell carcinoma,0
5461,95,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5462,Worsening pattern,Chronic Myelomonocytic Leukemia-2,0
5463,Structure of cortex of kidney,Refractory Bladder Carcinoma,0
5464,various other agents for local oral treatment in ATC,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5465,artesunate,embryonal rhabdomyosarcoma of prostate,0
5466,Childhood Non-Hodgkin Lymphoma,Cancer of Urinary Tract,0
5467,Most,Cartilaginous exostosis,0
5468,Fever,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5469,World,sarcoma of spinal cord,0
5470,Unconscious State,Stage II Carcinoma of Penis,0
5471,Autosome,Recurrent Testicular Lymphoma,0
5472,Body tissue,Non-Metastatic Gestational Trophoblastic Tumor,0
5473,Head,Tonsillar Carcinoma,0
5474,Operative Surgical Procedures,Refractory Bladder Carcinoma,0
5475,Floor (anatomic),Bladder adenocarcinoma stage IV,0
5476,Chemotherapy Regimen,Neonatal leukemia,0
5477,Specimen obtained by fine needle aspiration procedure,Collecting Duct Carcinoma of the Kidney,0
5478,United States Military Commissioned Officer O4,Liver Lymphangioma,0
5479,Secondary Neoplasm,Endometrial Small Cell Carcinoma,0
5480,cancer classification,Engraftment syndrome,0
5481,Polycythemia Vera,Benign tumor of eyelid,0
5482,Skin Specimen,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5483,More Often than Once a Day,Digestive System Hodgkin Lymphoma,0
5484,Effect,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5485,Diagnosis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5486,Frequently,Congenital hamartoma,0
5487,shared attribute,Unicystic ameloblastoma,0
5488,CDISC Relationship Class,Locally Advanced Carcinoma,0
5489,Classification,Extra-abdominal fibromatosis,0
5490,How Often Felt Normal question,Transitional cell carcinoma,0
5491,Present,Maxillary Sinus Adenoid Cystic Carcinoma,0
5492,Fetal,Epithelioid Sarcoma NCI Grade 3,0
5493,Call (Instruction),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5494,Diagnostic Imaging,Refractory Barrett Esophagus,0
5495,Primary,Metastatic Neoplasm to the Gallbladder,0
5496,growth aspects,Cervical Fibroepithelial Polyp,0
5497,Online Mendelian Inheritance In Man,Epithelioid Sarcoma NCI Grade 3,0
5498,Along edge (qualifier value),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5499,Bony,Stage IB Pancreatic Cancer AJCC v8,0
5500,Persons,Acantholytic squamous cell carcinoma,0
5501,Classification,Metaplastic carcinoma of breast,0
5502,Precancerous Conditions,Extra-abdominal fibromatosis,0
5503,Form of nose,Engraftment syndrome,0
5504,Classification,Nasal cavity carcinoma,0
5505,Taxonomic,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5506,Family,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5507,Cells,Congenital hamartoma,0
5508,Qualitative form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5509,Pharyngeal structure,adenoid cystic carcinoma of lung,0
5510,VIPR1 wt Allele,Stage 0 Penile Cancer AJCC v8,0
5511,Night sweats,Kaposi's sarcoma of skin,0
5512,Portion of urine,squamous cell carcinoma of the thyroid gland,0
5513,IPSS Risk Category High,Ovarian germ cell choriocarcinoma stage IV,0
5514,Chemotherapy Regimen,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5515,Decision,Fourth Ventricle and Brain Stem Ependymal Tumor,0
5516,cns lymphoma,Malignant neoplasm of gallbladder,0
5517,Ovulation,Benign squamous cell tumor,0
5518,Singular,embryonal rhabdomyosarcoma of prostate,0
5519,Family member,Precursor B-lymphoblastic lymphoma stage II,0
5520,Hemorrhage,Advanced Uterine Corpus Carcinosarcoma,0
5521,Carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5522,Uterine Fibroids,Stage IB Pancreatic Cancer AJCC v8,0
5523,Body Site Modifier - Lower,Clonal Hematopoiesis of Indeterminate Potential,0
5524,Pink color,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
5525,Glioma,Acantholytic squamous cell carcinoma,0
5526,Much,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5527,Specimen Source Codes - tumor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5528,Case (situation),Papillary squamous cell carcinoma,0
5529,Characterization,FIGO Stage II Ovarian Cancer,0
5530,Genetic,Intraepithelial Melanocytic Hyperplasia,0
5531,Treatment intent,Atypical Lobular Breast Hyperplasia,0
5532,Name (property) (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5533,Levator palpebrae superioris structure,Rhabdomyosarcoma with ganglionic differentiation,0
5534,Symptoms aspect,Metastatic Malignant Neoplasm in the Sellar Region,0
5535,Bone Marrow,Kaposi's sarcoma of skin,0
5536,Table Rules - groups,Refractory Barrett Esophagus,0
5537,Fever,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5538,Trachea (moth),Spongiotic dermatitis,0
5539,Fluid overload,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5540,Infrequent,Parathyroid Gland Adenocarcinoma,0
5541,Mesenchymal Stem Cells,Werner Syndrome,0
5542,Birth defects diagnosis:Find:Pt:^Patient:Nar,Localized Askin Tumor,0
5543,GDF15 protein,Recurrent Uveal Melanoma,0
5544,Intention - mental process,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5545,Malignant - descriptor,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5546,Common (qualifier value),Engraftment syndrome,0
5547,Subtype (attribute),Adult Alveolar Soft Part Sarcoma,0
5548,dendritic spine neck,Malignant neoplasm of olfactory nerve,0
5549,Species,Hemangioma,0
5550,biopsy characteristics,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5551,Evaluation,Stage 0 Penile Cancer AJCC v8,0
5552,growth aspects,Benign Anal Granular Cell Tumor,0
5553,failed,Lipoma of small intestine,0
5554,320,Recurrent Testicular Lymphoma,0
5555,To,Malignant neoplasm of choroid,0
5556,Diagnosis,Squamous cell carcinoma of lip,0
5557,PDGFRA gene,Hereditary Diffuse Gastric Adenocarcinoma,0
5558,cell growth,Recurrent Testicular Lymphoma,0
5559,Group A (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5560,Malignant Neoplasms,Stage II Carcinoma of Penis,0
5561,Structure of subclavian vein,Angiosarcoma of liver,0
5562,radiotherapeutic,Localized Malignant Neoplasm,0
5563,Special,sarcoma of spinal cord,0
5564,Cone-Rod Dystrophy 2,Refractory Barrett Esophagus,0
5565,Injury cause:Type:Point in time:^Patient:Nominal,Pancreatic carcinoma,0
5566,Occurrence,Malignant neoplasm of olfactory nerve,0
5567,Retinoic Acid Response Element,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5568,Five-year Survival Rate,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5569,Melanocytic nevus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5570,Mass of neck,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5571,therapeutic aspects,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5572,Due to,mucinous adenocarcinoma of gallbladder,0
5573,Intraperitoneal,Tongue Alveolar Soft Part Sarcoma,0
5574,Target Awareness - partial,Atypical Lobular Breast Hyperplasia,0
5575,various other intestinal adsorbents in ATC,Recurrent Testicular Lymphoma,0
5576,CD69 protein,Childhood Anaplastic Large Cell Lymphoma,0
5577,structure,adenosquamous carcinoma of breast,0
5578,Widening,Thymic Clear Cell Carcinoma,0
5579,Ovary,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
5580,Followed by,Chest Wall Fibromatosis,0
5581,transcription factor activity,Benign tumor of eyelid,0
5582,diagnosis aspect,Hemangioma,0
5583,Benign,Xeroderma pigmentosum,0
5584,Daily Living,Hereditary Diffuse Gastric Adenocarcinoma,0
5585,Bilateral salpingectomy with oophorectomy,Endometrial Small Cell Carcinoma,0
5586,Including (qualifier),Malignant melanoma of eyelid,0
5587,Common Specifications in HL7 V3 Publishing,Trabecular adenocarcinoma,0
5588,Ethanol,Intraepithelial Melanocytic Hyperplasia,0
5589,Urinary tract,Contact dermatitis due to alkali,0
5590,Greeks,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5591,Target Awareness - partial,clear cell adenocarcinoma of gallbladder,0
5592,Related personal status,Chest Wall Fibromatosis,0
5593,Singular,Malignant melanoma of eyelid,0
5594,Tryptophanase,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5595,Malignant - descriptor,Cerebral hemangioma,0
5596,Toxic Epidermal Necrolysis,Melanomatosis,0
5597,Science of Etiology,Carcinoma,0
5598,Formed,Vaginal Adenoid Cystic Carcinoma,0
5599,High Grade Cervical Squamous Intraepithelial Neoplasia,Adult Alveolar Soft Part Sarcoma,0
5600,Type - attribute,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5601,Form:Finding:Point in time:{Setting}:Document:{Role},Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5602,Body tissue,Hereditary Diffuse Gastric Adenocarcinoma,0
5603,Entity Determiner - specific,Stage IV Penile Cancer AJCC v7,0
5604,High risk of,Mucosal Melanoma,0
5605,Occurrence,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5606,3+ Score,Cervical Fibroepithelial Polyp,0
5607,Term (lexical),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5608,Usually,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
5609,Natural History,Malignant neoplasm of subglottis,0
5610,Occur (action),High Grade Glandular Intraepithelial Neoplasia,0
5611,Toxic Epidermal Necrolysis,Colorectal High Grade B-Cell Lymphoma,0
5612,Sample Range,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5613,Person Name,Platinum-Resistant Lung Small Cell Carcinoma,0
5614,Human body,Adult Acute Eosinophilic Leukemia,0
5615,Reside,Human Papillomavirus-Related Carcinoma,0
5616,kill - ActRelationshipJoin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5617,Blood group A (finding),Nasal cavity carcinoma,0
5618,Abnormal Virilization,Tonsillar Carcinoma,0
5619,Biomaterial Treatment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5620,Malignant Childhood Neoplasm,Peripheral primitive neuroectodermal tumor of soft tissue,0
5621,Type - attribute,Carcinoma of urinary bladder,0
5622,Immature Lymphocytes Measurement,Refractory Barrett Esophagus,0
5623,Third revision,Unresectable Rhabdomyosarcoma,0
5624,Left sided,Refractory Barrett Esophagus,0
5625,Salivary Glands,embryonal rhabdomyosarcoma of prostate,0
5626,Neoplastic disease,Benign squamous cell tumor,0
5627,New,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5628,pharmacotherapeutic,Familial Hemophagocytic Lymphocytosis,0
5629,Previously Treated Childhood Rhabdomyosarcoma,Childhood Lymphoma,0
5630,Surgical aspects,Pancreatic carcinoma,0
5631,Often - answer to question,Recurrent Testicular Lymphoma,0
5632,Singular,Tonsillar Carcinoma,0
5633,More,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5634,Both ovaries,Granular Cell Leiomyosarcoma,0
5635,Result,Maxillary Sinus Adenoid Cystic Carcinoma,0
5636,Never (frequency),Digestive System Hodgkin Lymphoma,0
5637,Myeloproliferative disease,Type II Endometrial Adenocarcinoma,0
5638,Experimental Result,gliosarcoma,0
5639,20%,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5640,Diagnosis,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5641,Progress,mucinous adenocarcinoma of gallbladder,0
5642,risk factors - observation list,Adenocarcinoma of duodenum,0
5643,Classical Hodgkin's Lymphoma,Thymic Clear Cell Carcinoma,0
5644,SLC35G1 gene,Nasal cavity carcinoma,0
5645,Trial Screening,Pancreatic Intraepithelial Neoplasia-3,0
5646,ethnic european,Engraftment syndrome,0
5647,Adult Lymphoma,Acantholytic squamous cell carcinoma,0
5648,Tryptophanase,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5649,Smaller,Occult Lung Adenosquamous Carcinoma,0
5650,Increase,Benign Anal Granular Cell Tumor,0
5651,diagnosis aspect,Xeroderma pigmentosum,0
5652,Adult human body,Fourth Ventricle and Brain Stem Ependymal Tumor,0
5653,Relationships,Advanced Uterine Corpus Carcinosarcoma,0
5654,Associated with,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5655,Domain (area of knowledge),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5656,Malignant Neoplasms,Low Grade Squamous Intraepithelial Neoplasia,0
5657,Human Papillomavirus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5658,All,Splenic Manifestation of Hairy Cell Leukemia,0
5659,Qualitative form,Blepharal carcinoma,0
5660,Skin,Mixed parotid tumor,0
5661,status - In progress,Cervical Squamous Intraepithelial Neoplasia,0
5662,Persons,Medulloblastoma,0
5663,Include (action),Mucinous adenocarcinoma gastric,0
5664,Numbness,Vaginal Adenoma,0
5665,Specimen Source Codes - tumor,Benign tumor of eyelid,0
5666,Tryptophanase,FIGO Stage II Ovarian Cancer,0
5667,Histopathological aspects,Giant cell angiofibroma,0
5668,Risk,Vaginal Adenoid Cystic Carcinoma,0
5669,Hour,Adenocarcinoma,0
5670,Cervical lymph node group,High Grade Glandular Intraepithelial Neoplasia,0
5671,Melanoma Pathway,Malignant neoplasm of olfactory nerve,0
5672,Alcohols,Refractory Bladder Carcinoma,0
5673,Vaginal neoplasia,Stage II Carcinoma of Penis,0
5674,Valid,Undifferentiated Endocervical Sarcoma,0
5675,Removed,Breast Ductal Adenoma,0
5676,Hematologic Neoplasms,Ichthyosis,0
5677,Frequently,Clonal Hematopoiesis of Indeterminate Potential,0
5678,Financial Account,embryonal rhabdomyosarcoma of prostate,0
5679,Worse,Metastatic Carcinoma in the Lung,0
5680,Immune System Processes,Kaposi's sarcoma of extrahepatic bile duct,0
5681,Optic Chiasms,Mastocytosis,0
5682,Sample Range,Childhood Fibrillary Astrocytoma,0
5683,Basis - conceptual entity,Stage IV Penile Cancer AJCC v7,0
5684,Color,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5685,100%,Stage 0 Penile Cancer AJCC v8,0
5686,Type - attribute,Kaposi's sarcoma of extrahepatic bile duct,0
5687,Age at menopause,Acantholytic squamous cell carcinoma,0
5688,consider,Splenic Manifestation of Hairy Cell Leukemia,0
5689,Primary malignant neoplasm,FIGO Stage IVA Ovarian Cancer,0
5690,Biomaterial Treatment,Brain Tumor,0
5691,epithelial,Carcinomatosis of peritoneal cavity,0
5692,Ancestry-Informative Marker,Advanced Lung Carcinoma,0
5693,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Refractory Ependymoma,0
5694,Infiltration (procedure),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5695,Activation action,Stage 0 Penile Cancer AJCC v8,0
5696,Developed Countries,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5697,Negative - answer,Childhood Anaplastic Large Cell Lymphoma,0
5698,Vaginal neoplasia,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5699,Occurrence,Unicystic ameloblastoma,0
5700,Including (qualifier),Cancer of Urinary Tract,0
5701,Case (situation),Thyroid Hurthle Cell Carcinoma,0
5702,Imaging Techniques,Malignant neoplasm of olfactory nerve,0
5703,Aspect (characteristic),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5704,Affecting,Mucosal Melanoma,0
5705,Mammary Gland Parenchyma,Locally Advanced Carcinoma,0
5706,Radiotherapy Research,Bladder adenocarcinoma stage IV,0
5707,size,Unfavorable Non-Hodgkin Lymphoma,0
5708,Symptoms aspect,Benign Ovarian Thecoma,0
5709,Wall of colon,Stage IV Colorectal Cancer AJCC v8,0
5710,<3 (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5711,Heartburn,Low Grade Squamous Intraepithelial Neoplasia,0
5712,Cancer Genus,Metastatic Kidney Carcinoma,0
5713,Adult Pilocytic Astrocytoma,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5714,Anterior portion of neck,Placental aromatase deficiency,0
5715,Most,Papillary squamous cell carcinoma,0
5716,Deglutition,Stage IB Pancreatic Cancer AJCC v8,0
5717,various allergen extracts,Benign Anal Granular Cell Tumor,0
5718,Occurrence Indicator,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
5719,Critical,Occult Lung Adenosquamous Carcinoma,0
5720,School Grade,Neonatal leukemia,0
5721,Beginning,Digestive System Hodgkin Lymphoma,0
5722,Liver Flavor,Thyroid Hurthle Cell Carcinoma,0
5723,therapeutic aspects,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5724,Complication,Cervical Adenomyoma,0
5725,Microscopes,Acute Undifferentiated Leukemia,0
5726,Removed,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5727,Increased,Astrocytoma of brain,0
5728,Hand,Astrocytoma of brain,0
5729,Then,Acute Undifferentiated Leukemia,0
5730,Connective Tissue,Placental aromatase deficiency,0
5731,Cancer Genus,embryonal rhabdomyosarcoma of prostate,0
5732,Lymphoma,Recurrent Testicular Lymphoma,0
5733,Long,Intraepithelial Melanocytic Hyperplasia,0
5734,Upper,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
5735,Inguinal region,Low Grade Squamous Intraepithelial Neoplasia,0
5736,Most,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5737,Ability,Precursor B-lymphoblastic lymphoma stage II,0
5738,Process (qualifier value),Mixed parotid tumor,0
5739,Affecting,Childhood Central Nervous System Ganglioneuroblastoma,0
5740,Primary malignant neoplasm,Blood Vessel Tumors,0
5741,Cosmetic surgery,Anterior Urethral Malignant Neoplasm,0
5742,Multiple malignancy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5743,Needs,Precursor B-lymphoblastic lymphoma stage II,0
5744,diagnosis aspect,Chondrosarcoma,0
5745,Ulceration,embryonal rhabdomyosarcoma of prostate,0
5746,Occurrence Indicator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5747,To,Adult Hepatocellular Carcinoma,0
5748,Sacral dysgenesis,Small cell neuroendocrine carcinoma of bladder,0
5749,Tryptophanase,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5750,Uncontrolled,Congenital hamartoma,0
5751,Protocol Agent,Adult Fibrolamellar Carcinoma,0
5752,Damage,adenosquamous carcinoma of breast,0
5753,operate <remove>,Malignant Testicular Sertoli Cell Tumor,0
5754,Common (qualifier value),Metastatic Malignant Neoplasm in the Sellar Region,0
5755,Offspring,embryonal rhabdomyosarcoma of prostate,0
5756,Exposure to,Stage IV Colorectal Cancer AJCC v8,0
5757,Occurrence,Xeroderma pigmentosum,0
5758,Usual,Testicular cancer metastatic,0
5759,Lock - Remote control command,High Grade Glandular Intraepithelial Neoplasia,0
5760,Childhood Lymphoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5761,Superkingdom (taxonomic category),Occult Lung Adenosquamous Carcinoma,0
5762,Ulcer,Malignant melanoma of eyelid,0
5763,Unknown,Cervical Squamous Intraepithelial Neoplasia,0
5764,Row (arrangement),Hodgkin Disease,0
5765,Tissue Growth,mucinous adenocarcinoma of gallbladder,0
5766,Exons,Cervical Fibroepithelial Polyp,0
5767,Widening,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5768,lymph nodes,Cerebral hemangioma,0
5769,Include (action),Thymic Clear Cell Carcinoma,0
5770,Precision - temporal,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5771,59,Recurrent Uveal Melanoma,0
5772,shared attribute,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
5773,Numerous,Diffuse malignant mesothelioma,0
5774,1960s,Engraftment syndrome,0
5775,Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5776,Cause of death.underlying,Breast Ductal Adenoma,0
5777,Usual Severity Sweats,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5778,Three,Tonsillar Carcinoma,0
5779,Sample Mean,Liver Lymphangioma,0
5780,Rapid,Refractory Bladder Carcinoma,0
5781,Secondary to,Malignant melanoma of eyelid,0
5782,Usual,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5783,Malignant Vaginal Neoplasm,Xeroderma pigmentosum,0
5784,Often - answer to question,Undifferentiated Endocervical Sarcoma,0
5785,Desiccation,Testicular cancer metastatic,0
5786,per year,Acute lymphadenitis,0
5787,Locally,Human Papillomavirus-Related Carcinoma,0
5788,<90,Spongiotic dermatitis,0
5789,Take,Female Breast Carcinoma,0
5790,solid substance,Recurrent Uveal Melanoma,0
5791,Involvement with,Basal Cell Ameloblastoma,0
5792,Dilated,Locally Advanced Carcinoma,0
5793,Coding Subtest (WISC-V),non-Hodgkin's lymphoma of spleen,0
5794,Common (qualifier value),Breast Ductal Adenoma,0
5795,Manufactured form,FIGO Stage IVA Ovarian Cancer,0
5796,Including (qualifier),Kaposi's sarcoma of extrahepatic bile duct,0
5797,Dominant,Adenocarcinoma of the prostate metastatic,0
5798,Version,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5799,Frequently,benign mature teratoma of pancreas,0
5800,Definitely Related to Intervention,Testicular cancer metastatic,0
5801,Occur (action),Blepharal carcinoma,0
5802,Abnormal Reference Range,Thymic Clear Cell Carcinoma,0
5803,One,Recurrent Uveal Melanoma,0
5804,Diagnosis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5805,Males,Endometrial Small Cell Carcinoma,0
5806,Males,Splenic Manifestation of Hairy Cell Leukemia,0
5807,General surgery specialty,Mucinous adenocarcinoma,0
5808,Use of,mucinous adenocarcinoma of gallbladder,0
5809,Gait normal,Recurrent Primary Lymphoma of Bone,0
5810,Future,Diffuse malignant mesothelioma,0
5811,Decision,Chest Wall Fibromatosis,0
5812,One,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5813,risk factors - observation list,Squamous cell carcinoma of lip,0
5814,Stable status,Blood Vessel Tumors,0
5815,Mixed Tumor,Benign neoplasm of thorax,0
5816,Surgical aspects,Ichthyosis,0
5817,Curative - procedure intent,Metastatic Malignant Neoplasm in the Sellar Region,0
5818,Occurrence,Giant cell angiofibroma,0
5819,Tryptophanase,FIGO Stage II Ovarian Cancer,0
5820,Surgical extraction,Colorectal cancer,0
5821,Building caretaker,Thymic Atypical Carcinoid Tumor,0
5822,Type - attribute,Intraepithelial Melanocytic Hyperplasia,0
5823,Bone Pain,Acute Undifferentiated Leukemia,0
5824,Spreading (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5825,SLC6A2 wt Allele,Kaposi's sarcoma of extrahepatic bile duct,0
5826,Location of Pharyngeal Residue Following Swallowing,Fourth Ventricle and Brain Stem Ependymal Tumor,0
5827,Combined,Malignant Testicular Sertoli Cell Tumor,0
5828,Chemical or Textual Reference to Actual Test or Parameter,Metastatic Ductal Breast Carcinoma,0
5829,Weight Loss,Metaplastic carcinoma of breast,0
5830,Functional,Engraftment syndrome,0
5831,Lumpectomy of breast,Childhood Central Nervous System Ganglioneuroblastoma,0
5832,Spreading (qualifier value),Kaposi's sarcoma of skin,0
5833,Corner Minus,Advanced Uterine Corpus Carcinosarcoma,0
5834,Egg of order Phthiraptera,de novo Myelodysplastic Syndrome,0
5835,Vaginal wall,Childhood Extragonadal Malignant Germ Cell Tumor,0
5836,Life,Ectomesenchymal Chondromyxoid Tumor,0
5837,Multiplication,Placental aromatase deficiency,0
5838,Have Shortness of Breath question,Benign Anal Granular Cell Tumor,0
5839,Cancer Etiology,Lipoma of small intestine,0
5840,Management procedure,Stage I Adult Non-Hodgkin Lymphoma,0
5841,Pancreatic Cancer Pathway,Werner Syndrome,0
5842,Specimen Source Codes - Respiratory,Benign neoplasm of thorax,0
5843,Cancer Genus,Blood Vessel Tumors,0
5844,Present,Angiosarcoma of liver,0
5845,Asians,Malignant Neoplasm with Regional Lymph Node Involvement,0
5846,Variant,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5847,Togo,Lipoma of small intestine,0
5848,How Often Sweats,BRCA2 Syndrome,0
5849,Second edition,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
5850,General surgery specialty,Occult Lung Adenosquamous Carcinoma,0
5851,Synonym,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
5852,Science of Etiology,Benign Carotid Body Paraganglioma,0
5853,Weight Loss,Thyroid Hurthle Cell Carcinoma,0
5854,Rare,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5855,Diabetes,Chronic Myelomonocytic Leukemia-2,0
5856,Malignant neoplasm of soft tissue,Mucinous adenocarcinoma gastric,0
5857,Approximate,Undifferentiated Neuroblastoma,0
5858,seen,Recurrent Primary Lymphoma of Bone,0
5859,Patch (unit of presentation),Benign Ovarian Thecoma,0
5860,Polypeptide Hormones,Stage II Carcinoma of Penis,0
5861,trends qualifier,Cancer of Urinary Tract,0
5862,FLT3LG wt Allele,Choroid Epithelioid Cell Melanoma,0
5863,Code,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5864,Feel Tired question,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5865,Most,Acute Undifferentiated Leukemia,0
5866,Rare,Choroid Necrotic Melanoma,0
5867,Negation,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5868,Blood Platelets,Chest Wall Fibromatosis,0
5869,Mumps virus,Cartilaginous exostosis,0
5870,Volume (publication),Childhood Lung Non-Small Cell Carcinoma,0
5871,Derived value,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
5872,Singular,Refractory Barrett Esophagus,0
5873,Disruptive,Adult Alveolar Soft Part Sarcoma,0
5874,Occur (action),Congenital hamartoma,0
5875,<90,Squamous cell carcinoma of lip,0
5876,Estimated,Neoplasms,0
5877,Asia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5878,95,Female Breast Carcinoma,0
5879,1+,Benign Anal Granular Cell Tumor,0
5880,Call (Instruction),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5881,Malignant Neoplasms,Astrocytoma of brain,0
5882,Anal Sex,Stage IV Childhood Non-Hodgkin Lymphoma,0
5883,Adult human body,Colorectal High Grade B-Cell Lymphoma,0
5884,TP53 gene,Acantholytic squamous cell carcinoma,0
5885,pre-surgery,Engraftment syndrome,0
5886,IPSS Risk Category High,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5887,Lung,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5888,Group A (qualifier value),Childhood Fibrillary Astrocytoma,0
5889,Connective Tissue,Uterine Cancer,0
5890,Cancer Genus,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
5891,Edema,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5892,Benign Neoplasm,Bladder adenocarcinoma stage IV,0
5893,Deep (qualifier value),Peripheral primitive neuroectodermal tumor of soft tissue,0
5894,status - In progress,papillary carcinoma of penis,0
5895,Hearing,High Grade Glandular Intraepithelial Neoplasia,0
5896,History of present illness,Airway Hemangioma,0
5897,Science of Etiology,Refractory Ependymoma,0
5898,Leg,Metastatic Lung Small Cell Carcinoma,0
5899,IPSS Risk Category High,Lipoma of small intestine,0
5900,Persons,Granular Cell Leiomyosarcoma,0
5901,Infection,Benign Anal Granular Cell Tumor,0
5902,Nephroblastoma,Kaposi's sarcoma of skin,0
5903,One,Kaposi's sarcoma of extrahepatic bile duct,0
5904,melanocyte,Diffuse malignant mesothelioma,0
5905,Set (Psychology),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
5906,Include (action),Precursor B-lymphoblastic lymphoma stage II,0
5907,Exposure to,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5908,Embryonal Rhabdomyosarcoma,Thyroid carcinoma,0
5909,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Giant cell angiofibroma,0
5910,What subject filter - Result,benign mature teratoma of pancreas,0
5911,Body tissue,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5912,bacteria aspects,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5913,Abnormally high,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5914,Liver carcinoma,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
5915,Aryepiglottic fold structure,Carcinoma,0
5916,Approximate,Stage II Carcinoma of Penis,0
5917,Medical,Choroid Necrotic Melanoma,0
5918,Surgical aspects,Stage IB Pancreatic Cancer AJCC v8,0
5919,Mass,Refractory Bladder Carcinoma,0
5920,Contraceptives,Endometrial Small Cell Carcinoma,0
5921,Paraganglioma,Angiosarcoma of liver,0
5922,Secondary Cause of Death,Stage IB Lung Cancer AJCC v7,0
5923,Good,Pancreatic Intraepithelial Neoplasia-3,0
5924,Uncertainty,FIGO Stage II Ovarian Cancer,0
5925,Specimen Source Codes - tumor,Localized Ewing Sarcoma,0
5926,Including (qualifier),Carcinoma of urinary bladder,0
5927,World Health Organization,Colorectal cancer,0
5928,CD40LG wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5929,Certain (qualifier value),Undifferentiated Neuroblastoma,0
5930,Old,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
5931,Supportive assistance,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
5932,Logical Condition,Non-Metastatic Gestational Trophoblastic Tumor,0
5933,Benign Teratoma,Methotrexate-Associated Hodgkin Lymphoma,0
5934,Case unit dose,Medulloblastoma,0
5935,Options,Acute Undifferentiated Leukemia,0
5936,A Codes,clear cell adenocarcinoma of gallbladder,0
5937,Hearing Loss,ROSE Cluster 3,0
5938,Involvement with,Refractory Ependymoma,0
5939,Possibly Related to Intervention,Ichthyoses,0
5940,therapeutic aspects,Intracortical osteosarcoma,0
5941,Frequently,Childhood Fibrillary Astrocytoma,0
5942,TNFRSF8 Positive,Giant cell angiofibroma,0
5943,Tumor cells,Malignant melanoma of eyelid,0
5944,Fixation - action,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5945,Hypoalbuminemia,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5946,Science of Etiology,Female Breast Carcinoma,0
5947,Include (action),Leptomeningeal sarcoma,0
5948,Living quarters,Acantholytic squamous cell carcinoma,0
5949,Occur (action),Type II Endometrial Adenocarcinoma,0
5950,70%,FIGO Stage II Ovarian Cancer,0
5951,Adjacent,Clonal Hematopoiesis of Indeterminate Potential,0
5952,Structure of tubal tonsil,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5953,seconds,ROSE Cluster 3,0
5954,pharmacotherapeutic,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5955,Round cell tumor,Mucinous adenocarcinoma gastric,0
5956,10%,Locally Advanced Soft Tissue Sarcoma,0
5957,Frequently,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5958,Negative Number,Stage I Adult Non-Hodgkin Lymphoma,0
5959,Extension,Ovarian germ cell choriocarcinoma stage IV,0
5960,macrophage,Benign squamous cell tumor,0
5961,Probability,Plexosarcoma,0
5962,Contrast Media,Acantholytic squamous cell carcinoma,0
5963,status - In progress,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5964,Affect (mental function),Primary Cutaneous Plasmablastic Lymphoma,0
5965,Set of muscles,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5966,Area,Cystadenocarcinoma,0
5967,Base Pair Unit,Malignant Neoplasm with Regional Lymph Node Involvement,0
5968,BRCA1 protein,Malignant neoplasm of thalamus,0
5969,Occurrence Indicator,Spindle Cell Melanoma,0
5970,Human papilloma virus infection,Choroid Epithelioid Cell Melanoma,0
5971,Two,Advanced Uterine Corpus Carcinosarcoma,0
5972,Surrounding (qualifier value),Childhood Central Nervous System Immature Teratoma,0
5973,Common (qualifier value),clear cell adenocarcinoma of gallbladder,0
5974,Signs and Symptoms,Stage IB Pancreatic Cancer AJCC v8,0
5975,TP53 gene,Tumorlet,0
5976,Often - answer to question,Blepharal carcinoma,0
5977,Severe (severity modifier),Maxillary Sinus Adenoid Cystic Carcinoma,0
5978,FAMILIAL ADENOMATOUS POLYPOSIS,Splenic Manifestation of Hairy Cell Leukemia,0
5979,Common Specifications in HL7 V3 Publishing,Bladder adenocarcinoma stage IV,0
5980,Term (temporal),Breast Ductal Adenoma,0
5981,Vision,Mucinous adenocarcinoma gastric,0
5982,Presence (property),Low Grade Squamous Intraepithelial Neoplasia,0
5983,Two,Adult Acute Eosinophilic Leukemia,0
5984,other medicated shampoos in ATC,Intestinal Metaplasia of Bladder Urothelium,0
5985,Age of Onset,Chronic Myelomonocytic Leukemia-2,0
5986,With shape,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5987,Group A (qualifier value),papillary carcinoma of penis,0
5988,Retinoic Acid Response Element,Mixed astrocytoma-ependymoma,0
5989,Basis - conceptual entity,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5990,Target Lesion Identification,Thyroid Hurthle Cell Carcinoma,0
5991,Group A (blood group),Type II Endometrial Adenocarcinoma,0
5992,Personal appearance,Metastatic Ductal Breast Carcinoma,0
5993,Specific qualifier value,Anaplastic large cell lymphoma,0
5994,Science of Statistics,Adrenal Rest Tumor,0
5995,Present,Recurrent Rhabdomyosarcoma,0
5996,Diagnosis Study,Ovarian germ cell choriocarcinoma stage IV,0
5997,Skeletal bone,Recurrent Testicular Lymphoma,0
5998,Categories,Spongiotic dermatitis,0
5999,Europe,Refractory Ependymoma,0
6000,English race,Placental aromatase deficiency,0
6001,75,Benign Ovarian Thecoma,0
6002,Body tissue,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6003,Scab,Malignant neoplasm of gallbladder,0
6004,Smear - instruction imperative,Xeroderma pigmentosum,0
6005,HL7PublishingSubSection <practice>,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6006,Vagina,Malignant Neoplasm with Regional Lymph Node Involvement,0
6007,Structure of parenchyma of lung,Malignant melanoma of eyelid,0
6008,Obesity,Endometrial Small Cell Carcinoma,0
6009,Various patch test substance,Benign Anal Granular Cell Tumor,0
6010,End,papillary carcinoma of penis,0
6011,low,Localized Ewing Sarcoma,0
6012,Layer of dermis,Breast Ductal Adenoma,0
6013,Include (action),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6014,Treating,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6015,Covers (device),Cherubism,0
6016,Pain,Adult Brain Stem Mixed Glioma,0
6017,Three,Medulloblastoma,0
6018,Treating,Localized Malignant Neoplasm,0
6019,Cause of Death,Mixed astrocytoma-ependymoma,0
6020,Group A (blood group),Type II Endometrial Adenocarcinoma,0
6021,Hydatidiform Mole,Low Grade Squamous Intraepithelial Neoplasia,0
6022,Fever,Malignant melanoma of eyelid,0
6023,Fan (physical object),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6024,Taken,High Grade Glandular Intraepithelial Neoplasia,0
6025,Half,Squamous cell carcinoma of lip,0
6026,Tryptophanase,Nasal cavity carcinoma,0
6027,include - SetOperator,Atypical Lobular Breast Hyperplasia,0
6028,Constant (qualifier),Undifferentiated Endocervical Sarcoma,0
6029,Malignant neoplasm of skin,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
6030,per year,Localized Ewing Sarcoma,0
6031,Numbers,Acute Undifferentiated Leukemia,0
6032,Normal,Tonsillar Carcinoma,0
6033,Skin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6034,Widespread,Papillary squamous cell carcinoma,0
6035,Portion of urine,Serous cystadenocarcinoma ovary,0
6036,Clinical,Liver Lymphangioma,0
6037,Human body,Childhood Central Nervous System Immature Teratoma,0
6038,Treating,Uterine Cancer,0
6039,Two,Metastatic Ductal Breast Carcinoma,0
6040,Persons,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6041,Diagnosis,Neonatal leukemia,0
6042,Odontogenesis,Adenocarcinoma,0
6043,How Often Weight Loss,Recurrent Testicular Lymphoma,0
6044,Version,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6045,Malignant neoplasm of lung,Recurrent Primary Lymphoma of Bone,0
6046,B-Lymphocytes,FIGO Stage II Ovarian Cancer,0
6047,radiotherapeutic,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6048,Paraneoplastic Syndromes,Grade 3a Malignant Neoplasm,0
6049,Taxonomic,Carcinoma of urinary bladder,0
6050,High risk,Refractory Bladder Carcinoma,0
6051,Lymphoma,Lipoma of small intestine,0
6052,Chemotherapy Regimen,Cartilaginous exostosis,0
6053,Obesity,Methotrexate-Associated Hodgkin Lymphoma,0
6054,Back structure,Mucinous adenocarcinoma gastric,0
6055,Solid Dose Form,Liver Lymphangioma,0
6056,Known,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6057,Ankle,Cerebral hemangioma,0
6058,PSA Level Greater than Fifty,Periosteal Osteosarcoma,0
6059,Occur (action),Undifferentiated Neuroblastoma,0
6060,Neurons,Female Breast Carcinoma,0
6061,In Urine,Ichthyosis,0
6062,Abnormal Reference Range,de novo Myelodysplastic Syndrome,0
6063,Hereditary Diseases,Splenic Manifestation of Hairy Cell Leukemia,0
6064,Most,Endometrial Small Cell Carcinoma,0
6065,Skin Specimen,Mucinous adenocarcinoma gastric,0
6066,Tumor Mass,Metastatic Lung Small Cell Carcinoma,0
6067,Malignant neoplasm of lung,Benign squamous cell tumor,0
6068,Genetic Selection,Acute Undifferentiated Leukemia,0
6069,Diagnosis,Refractory Barrett Esophagus,0
6070,radiotherapeutic,Acute lymphadenitis,0
6071,Have Sweats,Childhood Lymphoma,0
6072,Bladder Cancer Pathway,Hyperplasia of pituitary gland,0
6073,Autosomal recessive inheritance,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6074,Valid,Trabecular adenocarcinoma,0
6075,Malignant Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
6076,Organ,Mucinous cystadenofibroma,0
6077,Experimental Result,Occult Lung Adenosquamous Carcinoma,0
6078,Posterior cord syndrome,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6079,Precision - second,Hyperplasia of pituitary gland,0
6080,Cell Proliferation,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
6081,Presence of cells,Multiple Skull Base Meningiomas,0
6082,Togo,Metaplastic carcinoma of breast,0
6083,Population Median,Tongue Alveolar Soft Part Sarcoma,0
6084,Referring,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6085,Reported Term,Malignant Neoplasm with Regional Lymph Node Involvement,0
6086,Late stage,Choroid Necrotic Melanoma,0
6087,Class (taxonomic),Hodgkin Disease,0
6088,Perianal,Spindle Cell Melanoma,0
6089,Usual,Stage IV Childhood Non-Hodgkin Lymphoma,0
6090,Cardiovascular system,Carcinoma ex pleomorphic adenoma of parotid gland,0
6091,Granulomatous,Diffuse malignant mesothelioma,0
6092,Cardiovascular System Part,Unfavorable Non-Hodgkin Lymphoma,0
6093,Renal collecting tube,Intraepithelial Melanocytic Hyperplasia,0
6094,Derivation,Childhood Fibrillary Astrocytoma,0
6095,Negation,Stage III Cutaneous Melanoma AJCC v6,0
6096,research subject screening,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6097,Table Cell Horizontal Align - left,Astrocytoma of brain,0
6098,therapeutic aspects,Cervical Fibroepithelial Polyp,0
6099,Alcohol consumption,Digestive System Hodgkin Lymphoma,0
6100,Accumulation of fluid,Small cell neuroendocrine carcinoma of bladder,0
6101,anatomical layer,Benign Anal Granular Cell Tumor,0
6102,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6103,Bladder Continence Question,Heavy Chain Deposition Disease,0
6104,Biologic Development,Nasal cavity carcinoma,0
6105,Appearance,Peripheral primitive neuroectodermal tumor of soft tissue,0
6106,Upper,Colorectal High Grade B-Cell Lymphoma,0
6107,change (in) bowel movements,Precursor B-lymphoblastic lymphoma stage II,0
6108,Malignant - descriptor,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6109,Veins,FIGO Stage IVA Ovarian Cancer,0
6110,Administration procedure,Blepharal carcinoma,0
6111,Qualitative form,gliosarcoma,0
6112,Anatomic Site,Refractory Ependymoma,0
6113,Usual Severity Sweats,Intraepithelial Melanocytic Hyperplasia,0
6114,Function (attribute),Refractory Ependymoma,0
6115,Intraepidermal vesicles,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6116,Case unit dose,Pilocytic astrocytoma of cerebellum,0
6117,Formation,Human Papillomavirus-Related Carcinoma,0
6118,Increase,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6119,Onset of (contextual qualifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
6120,Endocrine Cells,Engraftment syndrome,0
6121,Females,Maxillary Sinus Adenoid Cystic Carcinoma,0
6122,Average,FIGO Stage IVA Ovarian Cancer,0
6123,Shortened,Malignant Testicular Sertoli Cell Tumor,0
6124,Intravascular line,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6125,Possible diagnosis,Keratoderma,0
6126,Probability,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6127,Occurrence,Intestinal Neuroendocrine Carcinoma,0
6128,Variable (uniformity),Trichilemmocarcinoma,0
6129,Neuroepithelial Cells,Metaplastic carcinoma of breast,0
6130,Appearance Distress Question,Splenic Manifestation of Hairy Cell Leukemia,0
6131,Fused structure,Kaposi's sarcoma of skin,0
6132,utilization qualifier,Female Breast Carcinoma,0
6133,Analysis,Malignant neoplasm of olfactory nerve,0
6134,Social group,Mucinous adenocarcinoma gastric,0
6135,Cancer Genus,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
6136,Smear - instruction imperative,Childhood Fibrillary Astrocytoma,0
6137,Route of Administration - Mucous Membrane,Stage 0 Penile Cancer AJCC v8,0
6138,Cancer Remission,FIGO Stage II Ovarian Cancer,0
6139,Intention - mental process,Methotrexate-Associated Hodgkin Lymphoma,0
6140,treatment - ActInformationManagementReason,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6141,Cardiac Lead Procedure,Recurrent Testicular Lymphoma,0
6142,Ectoderm,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
6143,Biopsy,Cerebral Primitive Neuroectodermal Tumor,0
6144,Polypeptide Hormones,Acute lymphadenitis,0
6145,Name,Mixed astrocytoma-ependymoma,0
6146,ovarian neoplasm,adenosquamous carcinoma of breast,0
6147,Type - attribute,Choroid Necrotic Melanoma,0
6148,Risk,Chondrosarcoma,0
6149,Diagnosis Study,Adrenal Rest Tumor,0
6150,End,High Grade Glandular Intraepithelial Neoplasia,0
6151,oncology field,Transitional cell carcinoma,0
6152,Falls,Recurrent Diffuse Intrinsic Pontine Glioma,0
6153,Usual Severity Weight Loss,Advanced Lung Carcinoma,0
6154,Variety (taxon),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
6155,Pharmacokinetics: Excretion,Childhood Anaplastic Large Cell Lymphoma,0
6156,Derived value,Pancreatic Endocrine Carcinoma,0
6157,Skin,Occult Lung Adenosquamous Carcinoma,0
6158,Malignant neoplasm of gallbladder,FIGO Stage II Ovarian Cancer,0
6159,Container status - Identified,Benign Anal Granular Cell Tumor,0
6160,bacteria aspects,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6161,Microscopes,Benign Anal Granular Cell Tumor,0
6162,risk factors - observation list,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
6163,Primary malignant neoplasm,Angiosarcoma of liver,0
6164,Reported Term,Refractory Ependymoma,0
6165,Edema,Benign tumor of eyelid,0
6166,sex,Liver Cavernous Hemangioma,0
6167,Back structure,Adult Alveolar Soft Part Sarcoma,0
6168,Fever,Nasal cavity carcinoma,0
6169,Responsible to,Recurrent Uveal Melanoma,0
6170,radiotherapeutic,Cartilaginous exostosis,0
6171,Melanins,Stage IB Pancreatic Cancer AJCC v8,0
6172,Type - attribute,Bladder adenocarcinoma stage IV,0
6173,Time,Childhood Fibrillary Astrocytoma,0
6174,Pass (indicator),Precursor B-lymphoblastic lymphoma stage II,0
6175,Continuous,Squamous cell carcinoma of lip,0
6176,CYREN gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6177,Medications:-:Point in time:^Patient:-,Benign squamous cell tumor,0
6178,Multilaminar epithelium,Intraepithelial Melanocytic Hyperplasia,0
6179,Covers (device),FIGO Stage IVA Ovarian Cancer,0
6180,VIPR1 wt Allele,Fibroadenoma of breast,0
6181,Include (action),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6182,Qualitative form,Congenital hamartoma,0
6183,Major <insect>,Carcinoma of urinary bladder,0
6184,Rating (action),Testicular cancer metastatic,0
6185,Combined,Squamous cell carcinoma of lip,0
6186,Death (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6187,Group A (blood group),Locally Advanced Epithelioid Hemangioendothelioma,0
6188,Asia,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6189,Part,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6190,National Human Genome Research Institute (U.S.),Platinum-Resistant Lung Small Cell Carcinoma,0
6191,Affecting,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6192,Pharmacotherapy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6193,PREVENT (product),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6194,Excision,Basal Cell Ameloblastoma,0
6195,growth aspects,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6196,chance,Low Grade Squamous Intraepithelial Neoplasia,0
6197,Polypeptide Hormones,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6198,Removed,Localized Malignant Neoplasm,0
6199,Greater than one,Malignant melanoma of eyelid,0
6200,Clone Cells,Adult Fibrolamellar Carcinoma,0
6201,CDISC SDTM Route of Administration Terminology,Intracortical osteosarcoma,0
6202,Early,sarcoma of spinal cord,0
6203,Tumor Mass,FIGO Stage II Ovarian Cancer,0
6204,Certain (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
6205,Lymphadenopathy,Testicular cancer metastatic,0
6206,Descending,embryonal rhabdomyosarcoma of prostate,0
6207,Tanning of leather,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6208,80%,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6209,Approximate,Female Breast Carcinoma,0
6210,Basal cell carcinoma,Refractory WHO Grade III Glioma,0
6211,Tumor Mass,Endometrial Small Cell Carcinoma,0
6212,Diffuse Large B-Cell Lymphoma,Childhood Central Nervous System Ganglioneuroblastoma,0
6213,Include (action),Testicular cancer metastatic,0
6214,Childhood diseases,Benign Apocrine Neoplasm,0
6215,described,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6216,English race,Adult Hepatocellular Carcinoma,0
6217,shared attribute,Kaposi's sarcoma of skin,0
6218,Peeling of skin,Vaginal Adenoma,0
6219,Targeted Therapy,Adrenal Rest Tumor,0
6220,Numerous,Carcinoma of urinary bladder,0
6221,Mucous Membrane,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6222,Death (finding),Non-Metastatic Gestational Trophoblastic Tumor,0
6223,Greater,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6224,Structure of choroid plexus,Metastatic Neoplasm to the Gallbladder,0
6225,Time (foundation metadata concept),Acinar cell carcinoma of pancreas,0
6226,Trauma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6227,Containing (qualifier),Acantholytic squamous cell carcinoma,0
6228,Country number:Find:Pt:^Patient:Nom,Ovarian germ cell choriocarcinoma stage IV,0
6229,Swyer Syndrome,Tongue Alveolar Soft Part Sarcoma,0
6230,Often - answer to question,Localized Askin Tumor,0
6231,Neuronal heterotopia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6232,Specific qualifier value,Splenic Manifestation of Hairy Cell Leukemia,0
6233,Increase,Extra-abdominal fibromatosis,0
6234,Chorioamnionitis,mucinous adenocarcinoma of gallbladder,0
6235,Test - temporal region,Cervical Squamous Intraepithelial Neoplasia,0
6236,cell type,Intestinal Metaplasia of Bladder Urothelium,0
6237,75,Refractory Ependymoma,0
6238,Along edge (qualifier value),Peripheral primitive neuroectodermal tumor of soft tissue,0
6239,Spatial Frequency,Intracortical osteosarcoma,0
6240,Presence (property),Pancreatic Intraepithelial Neoplasia-3,0
6241,diagnosis aspect,Granular Cell Leiomyosarcoma,0
6242,60%,Engraftment syndrome,0
6243,Most Recent,Bladder adenocarcinoma stage IV,0
6244,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6245,non-recurrent,Lipoma of small intestine,0
6246,Sebaceous Glands,Breast Ductal Adenoma,0
6247,Group A (blood group),Childhood Central Nervous System Ganglioneuroblastoma,0
6248,include - SetOperator,Noninfiltrating Intraductal Carcinoma,0
6249,35,Nasal cavity carcinoma,0
6250,Males,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6251,Including (qualifier),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6252,Risk,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6253,Confirmation,Female Breast Carcinoma,0
6254,Graph Node,Maxillary Sinus Adenocarcinoma,0
6255,Hypesthesia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6256,peripheral blood,Engraftment syndrome,0
6257,Subject Risk,Testicular cancer metastatic,0
6258,Including (qualifier),Vaginal Adenoma,0
6259,risk factors,Kaposi's sarcoma of skin,0
6260,Used by,Fibroadenoma of breast,0
6261,Operative Surgical Procedures,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6262,gene therapy,adenoid cystic carcinoma of lung,0
6263,Numbers,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6264,Oral region,Endometrial Small Cell Carcinoma,0
6265,Oral cavity,clear cell adenocarcinoma of gallbladder,0
6266,Condition,Endometrial Small Cell Carcinoma,0
6267,Common (qualifier value),Spongiotic dermatitis,0
6268,Primary malignant neoplasm,Extra-Adrenal Paraganglioma,0
6269,Salivary Glands,adenoid cystic carcinoma of lung,0
6270,Cystadenocarcinoma,Cancer of Urinary Tract,0
6271,Medical Device Material Separation,Undifferentiated Endocervical Sarcoma,0
6272,Complete,Cervical Fibroepithelial Polyp,0
6273,Frequently,Anterior Urethral Malignant Neoplasm,0
6274,Seminoma,Refractory Ependymoma,0
6275,Gonadal structure,Acantholytic squamous cell carcinoma,0
6276,Fever,Ovarian germ cell choriocarcinoma stage IV,0
6277,Etiology aspects,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
6278,Disease,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6279,Most,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6280,Obesity,Deep Leiomyoma,0
6281,Diagnosis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6282,Publishing,embryonal rhabdomyosarcoma of prostate,0
6283,Skin Specimen,Metastatic Malignant Neoplasm in the Sellar Region,0
6284,analysis aspect,Contact dermatitis due to alkali,0
6285,Young Adult,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6286,Cells,mucinous adenocarcinoma of gallbladder,0
6287,Cell Count,Neonatal leukemia,0
6288,Tissue Specimen Code,Female Breast Carcinoma,0
6289,Body part,Ovarian Carcinoid Tumor,0
6290,Melanins,Cerebral Primitive Neuroectodermal Tumor,0
6291,Statistical Prevalence,Deep Leiomyoma,0
6292,Person Observer,Platinum-Resistant Lung Small Cell Carcinoma,0
6293,Covered (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
6294,Multiply - dosing instruction fragment,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6295,Less Than,Collecting Duct Carcinoma of the Kidney,0
6296,Vascular Neoplasms,papillary carcinoma of penis,0
6297,Smear - instruction imperative,Undifferentiated Endocervical Sarcoma,0
6298,Administration procedure,Childhood Central Nervous System Ganglioneuroblastoma,0
6299,Mass of body structure,Malignant melanoma of eyelid,0
6300,floor (object),Malignant Testicular Sertoli Cell Tumor,0
6301,Genitourinary system,Recurrent Testicular Lymphoma,0
6302,Moved from,Kaposi's sarcoma of skin,0
6303,Nicotiana tabacum,Papillary squamous cell carcinoma,0
6304,Surgery specialty,Malignant melanoma of eyelid,0
6305,Severe (severity modifier),Locally Advanced Soft Tissue Sarcoma,0
6306,Biomaterial Treatment,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6307,Occurrence Indicator,Liver Lymphangioma,0
6308,Environmental risk factor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6309,75,Human Papillomavirus-Related Carcinoma,0
6310,Singular,Recurrent Testicular Lymphoma,0
6311,pharmacotherapeutic,Placental aromatase deficiency,0
6312,Specimen Source Codes - tumor,Adult Anaplastic Oligodendroglioma,0
6313,Screening Study,Recurrent Uveal Melanoma,0
6314,Singular,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6315,Either,Adult Anaplastic Oligodendroglioma,0
6316,Administration procedure,Thymic Clear Cell Carcinoma,0
6317,Slightly Able,BRCA2 Syndrome,0
6318,Benign,Recurrent Testicular Lymphoma,0
6319,Abnormal Reference Range,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6320,Type - attribute,Blood Vessel Tumors,0
6321,Result,Metastatic Ductal Breast Carcinoma,0
6322,Simulate composite resin,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6323,Primary malignant neoplasm,Intracortical osteosarcoma,0
6324,hearing impairment,Tongue Alveolar Soft Part Sarcoma,0
6325,Epstein-Barr Virus,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6326,Carcinoma of lung,Stage IV Childhood Non-Hodgkin Lymphoma,0
6327,Weight Loss,clear cell adenocarcinoma of gallbladder,0
6328,Primary operation,Maxillary Sinus Adenoid Cystic Carcinoma,0
6329,United States,Vaginal Adenoma,0
6330,Neoplasms,Testicular cancer metastatic,0
6331,Negation,Stage I Adult Non-Hodgkin Lymphoma,0
6332,Malignant Neoplasms,Adult Fibrolamellar Carcinoma,0
6333,Indeterminate,Localized Ewing Sarcoma,0
6334,Infratentorial,Metastatic Lung Small Cell Carcinoma,0
6335,Affecting,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
6336,Neoplasms,Acantholytic squamous cell carcinoma,0
6337,Variety (taxon),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6338,Growth,Kaposi's sarcoma of extrahepatic bile duct,0
6339,Chemotherapy Regimen,Recurrent Uveal Melanoma,0
6340,Spreading (qualifier value),Fibroadenoma of breast,0
6341,Malignant neoplasm of pancreas,Ovarian germ cell choriocarcinoma stage IV,0
6342,Low Back Pain,Leptomeningeal sarcoma,0
6343,Medical Devices,Periosteal Osteosarcoma,0
6344,Hodgkin Disease,gliosarcoma,0
6345,World Health Organization,Intestinal Metaplasia of Bladder Urothelium,0
6346,Qualitative form,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6347,EHD1 wt Allele,FIGO Stage IVA Ovarian Cancer,0
6348,Mechanism Component of Device,Xeroderma pigmentosum,0
6349,Steroids,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6350,skin color,GIANT PIGMENTED HAIRY NEVUS,0
6351,Ephrin Type-B Receptor 1,Bladder adenocarcinoma stage IV,0
6352,Feelings,Carcinoma of urinary bladder,0
6353,Case (situation),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6354,Usually,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6355,Chemotherapy Regimen,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6356,Precision - temporal,Xeroderma pigmentosum,0
6357,Thigh structure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6358,Liver and Intrahepatic Biliary Tract Carcinoma,adenoid cystic carcinoma of lung,0
6359,Extrinsic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6360,Contrast,Female Breast Carcinoma,0
6361,corticosteroids cream,Diffuse malignant mesothelioma,0
6362,HL7PublishingSubSection <practice>,Bladder squamous cell carcinoma stage I,0
6363,combination - answer to question,Adult Alveolar Soft Part Sarcoma,0
6364,Chemotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6365,Term Birth,Benign Anal Granular Cell Tumor,0
6366,Formation,Microcystic meningioma,0
6367,Relational and Item-Specific Encoding Task,Breast Ductal Adenoma,0
6368,10%,Locally Advanced Squamous Cell Carcinoma,0
6369,Poor - qualifier,Advanced Lung Carcinoma,0
6370,Lower eyelid,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6371,Removed,Childhood Central Nervous System Immature Teratoma,0
6372,Liver Cirrhosis,Intestinal Neuroendocrine Carcinoma,0
6373,Mesenchymal Stem Cells,Vaginal Adenoma,0
6374,Pharmacotherapy,Stage II Hepatocellular Carcinoma AJCC v8,0
6375,Helping Behavior,Kaposi's sarcoma of extrahepatic bile duct,0
6376,Entity,Splenic Manifestation of Hairy Cell Leukemia,0
6377,0%,Nasal cavity carcinoma,0
6378,Before values,Recurrent Rhabdomyosarcoma,0
6379,antibody (non-specific) abnormal,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6380,Specimen Source Codes - tumor,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6381,Clear fluid,Malignant neoplasm of subglottis,0
6382,Confirmed by,Refractory Ependymoma,0
6383,Financial Account,Vaginal Adenoma,0
6384,Mass,adenoid cystic carcinoma of lung,0
6385,Did not receive therapy or drug for,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6386,Original,Mucinous adenocarcinoma gastric,0
6387,Obesity,Leiomyoma of Gallbladder,0
6388,Synonym (core metadata concept),FIGO Stage IVA Ovarian Cancer,0
6389,Cerebral cortex,Recurrent Testicular Lymphoma,0
6390,Malignant neoplasm of penis,adenoid cystic carcinoma of lung,0
6391,Involvement with,Granular Cell Leiomyosarcoma,0
6392,Lysergic acid diethylamide measurement,Type II Endometrial Adenocarcinoma,0
6393,Treatment Epoch,Intraepithelial Melanocytic Hyperplasia,0
6394,Papillary,Nasal cavity carcinoma,0
6395,Worse,Recurrent Uveal Melanoma,0
6396,Limited (extensiveness),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
6397,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6398,Skin Specimen,Childhood Fibrillary Astrocytoma,0
6399,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,BRCA2 Syndrome,0
6400,Disease,Cancer of Urinary Tract,0
6401,High risk of,Breast Apocrine Adenoma,0
6402,metastatic qualifier,Undifferentiated Endocervical Sarcoma,0
6403,1000000,Giant cell angiofibroma,0
6404,Lymphoma,Locally Advanced Epithelioid Hemangioendothelioma,0
6405,Bone Pain,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6406,Undifferentiated Sex,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6407,Adult Pilocytic Astrocytoma,Methotrexate-Associated Hodgkin Lymphoma,0
6408,Artificial (qualifier value),Human Papillomavirus-Related Carcinoma,0
6409,Science of Etiology,Acute lymphadenitis,0
6410,Myasthenia Gravis,Astrocytoma of brain,0
6411,Classes - encounter,Locally Advanced Epithelioid Hemangioendothelioma,0
6412,Confirmed by,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6413,Malignant - descriptor,Recurrent Rhabdomyosarcoma,0
6414,Talpidae,Contact dermatitis due to alkali,0
6415,photoreactivating enzyme activity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6416,World Health Organization,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6417,atypia morphology,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6418,Male population group,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6419,Obesity,Stage IV Colorectal Cancer AJCC v8,0
6420,operate <remove>,Intestinal Metaplasia of Bladder Urothelium,0
6421,Primary operation,Neoplasms,0
6422,Approximate,Clonal Hematopoiesis of Indeterminate Potential,0
6423,Liver,Advanced Uterine Corpus Carcinosarcoma,0
6424,What subject filter - Result,FIGO Stage IVA Ovarian Cancer,0
6425,What subject filter - Result,Non-Hodgkin Lymphoma During Pregnancy,0
6426,Including (qualifier),Adenocarcinoma,0
6427,Tryptophanase,Stage IB Pancreatic Cancer AJCC v8,0
6428,Driven,Stage 0 Penile Cancer AJCC v8,0
6429,Psyche structure,Mucinous adenocarcinoma gastric,0
6430,CEL gene,Refractory Barrett Esophagus,0
6431,Esophageal,Vaginal Adenoid Cystic Carcinoma,0
6432,Concept Relationship,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6433,Ganglioneuroblastoma,Giant cell angiofibroma,0
6434,Time,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6435,Etiology aspects,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6436,Encode (action),Acute Undifferentiated Leukemia,0
6437,Feel Tired question,Acute lymphadenitis,0
6438,Screening procedure,Childhood Thyroid Gland Follicular Carcinoma,0
6439,Surgical aspects,Childhood Thyroid Gland Follicular Carcinoma,0
6440,Visual Impairment,Blepharal carcinoma,0
6441,English [International Organization for Standardization 639-1 code en] language reference set,Stage IV Penile Cancer AJCC v7,0
6442,Qualitative form,Breast Apocrine Adenoma,0
6443,Good,High Grade Glandular Intraepithelial Neoplasia,0
6444,Abdomen,BRCA2 Syndrome,0
6445,Experimental Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6446,Sharing (Social Behavior),Carcinoma of urinary bladder,0
6447,Adult Non-Hodgkin Lymphoma,Localized Ewing Sarcoma,0
6448,Onset of (contextual qualifier),Adult Hepatocellular Carcinoma,0
6449,Condition,Refractory Ependymoma,0
6450,Liquid Tumor,Spongiotic dermatitis,0
6451,Beginning,Benign Anal Granular Cell Tumor,0
6452,Abnormally high,Stage I Colon Neuroendocrine Tumor AJCC v8,0
6453,Occurrence,Refractory Bladder Carcinoma,0
6454,Growth,Benign tumor of eyelid,0
6455,Early,ICHTHYOSIS,0
6456,Lymphocyte component of blood,Liver Lymphangioma,0
6457,Form:Finding:Point in time:{Setting}:Document:{Role},Thyroid Hurthle Cell Carcinoma,0
6458,Term Birth,Benign tumor of eyelid,0
6459,Near,Kaposi's sarcoma of skin,0
6460,Feelings,Multiple Skull Base Meningiomas,0
6461,Protein complex,Female Breast Carcinoma,0
6462,Primary,Localized Malignant Neoplasm,0
6463,Neuroglia,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6464,Pelvic pain female,Recurrent Testicular Lymphoma,0
6465,antibiotics,Fourth Ventricle and Brain Stem Ependymal Tumor,0
6466,History of present illness,Low Grade Squamous Intraepithelial Neoplasia,0
6467,Present,FIGO Stage IVA Ovarian Cancer,0
6468,Spreading (qualifier value),Choroid Necrotic Melanoma,0
6469,Increased,Vaginal Adenoid Cystic Carcinoma,0
6470,Term (temporal),Localized Malignant Neoplasm,0
6471,Resulting in,Human Papillomavirus-Related Carcinoma,0
6472,Including (qualifier),Acantholytic squamous cell carcinoma,0
6473,Type - attribute,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6474,ovarian,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6475,Sometimes,Diffuse malignant mesothelioma,0
6476,Papanicolaou Test,Gallbladder Adenocarcinoma,0
6477,Combined,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6478,Unknown,FIGO Stage II Ovarian Cancer,0
6479,Xp,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6480,Site of,Childhood Central Nervous System Immature Teratoma,0
6481,other medicated shampoos in ATC,Acantholytic squamous cell carcinoma,0
6482,Oral cavity,Anaplastic large cell lymphoma,0
6483,Continuous,Heavy Chain Deposition Disease,0
6484,2+ Score,Cervical Fibroepithelial Polyp,0
6485,Adult Teratoma,Childhood Fibrillary Astrocytoma,0
6486,Cover - action,Acantholytic squamous cell carcinoma,0
6487,800,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6488,Occurrence,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6489,Sunscreening Agents,FIGO Stage II Ovarian Cancer,0
6490,Very Much,Neoplasms,0
6491,Primary operation,Squamous cell carcinoma of lip,0
6492,Urine looks dark,Refractory Glioma,0
6493,Case (situation),ROSE Cluster 3,0
6494,Disease Screening,Splenic Manifestation of Hairy Cell Leukemia,0
6495,Palmitic Acid,Intraepithelial Melanocytic Hyperplasia,0
6496,Malignant Neoplasms,Sarcomatoid Renal Cell Carcinoma,0
6497,Manufactured form,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6498,Sharing (Social Behavior),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6499,treatment - ActInformationManagementReason,BRCA2 Syndrome,0
6500,Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6501,Meaning,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6502,Permutation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6503,MILDLY,Human Papillomavirus-Related Carcinoma,0
6504,Term (lexical),Childhood Fibrillary Astrocytoma,0
6505,Cicatrix,Acantholytic squamous cell carcinoma,0
6506,Negation,Splenic Manifestation of Hairy Cell Leukemia,0
6507,Cancer Genus,Spongiotic dermatitis,0
6508,depend,Pancreatic Intraepithelial Neoplasia-3,0
6509,Protocol - answer to question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6510,True primary (qualifier value),Multiple Skull Base Meningiomas,0
6511,Make - Instruction Imperative,GIANT PIGMENTED HAIRY NEVUS,0
6512,Sore sensation,Carcinoma ex pleomorphic adenoma of parotid gland,0
6513,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Adult Hepatocellular Carcinoma,0
6514,Carcinoma,Uterine Cancer,0
6515,spinal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6516,To,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6517,Chemicals,Parathyroid Gland Adenocarcinoma,0
6518,Definitive,Ectomesenchymal Chondromyxoid Tumor,0
6519,Obese build,Gallbladder Adenocarcinoma,0
6520,biopsy characteristics,Hyperplasia of pituitary gland,0
6521,Links List,Anaplastic large cell lymphoma,0
6522,per second,Blepharal carcinoma,0
6523,Curative - procedure intent,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6524,Retrobulbar space (body structure),squamous cell carcinoma of the thyroid gland,0
6525,Continuance of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6526,Source (property) (qualifier value),Testicular cancer metastatic,0
6527,Combined,Localized Askin Tumor,0
6528,Aspects of signs,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6529,Ependymoblastoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6530,Data operation - complete,Metastatic Ductal Breast Carcinoma,0
6531,Mixed Salivary Gland Tumor,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
6532,Chemotherapy Regimen,Ovarian Carcinoid Tumor,0
6533,Weight Loss,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6534,Circulating,Brain Ependymoma,0
6535,Poverty,Squamous cell carcinoma of lip,0
6536,Beginning,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6537,Neoplastic disease,BRCA2 Syndrome,0
6538,Togo,Recurrent Testicular Lymphoma,0
6539,Togo,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6540,Primary malignant neoplasm,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6541,Neoplasms,Squamous cell carcinoma of lip,0
6542,Individual,Benign Anal Granular Cell Tumor,0
6543,Common (qualifier value),Lung squamous cell carcinoma stage I,0
6544,Smear - instruction imperative,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6545,Tubal Ligation,Stage I Adult Non-Hodgkin Lymphoma,0
6546,various antiinfectives and antiseptics for local oral treatment,Acute Undifferentiated Leukemia,0
6547,Mass of body structure,Stage IB Lung Cancer AJCC v7,0
6548,Painless,Stage 0 Lip Carcinoma,0
6549,Formation,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6550,Cure (remedy),Locally Advanced Soft Tissue Sarcoma,0
6551,Leg,BRCA2 Syndrome,0
6552,Base - General Qualifier,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6553,Well,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6554,Pleomorphic,Peripheral primitive neuroectodermal tumor of soft tissue,0
6555,Anemia,Benign squamous cell tumor,0
6556,include - SetOperator,Stage I Adult Non-Hodgkin Lymphoma,0
6557,N not otherwise specified Antibody,Ovarian Carcinoid Tumor,0
6558,Most,Grade 1 Clear Cell Renal Cell Carcinoma,0
6559,RBM12 gene,Thymic Clear Cell Carcinoma,0
6560,Containing (qualifier),Bladder squamous cell carcinoma stage I,0
6561,Bacteria,Hereditary Diffuse Gastric Adenocarcinoma,0
6562,Formation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6563,Chemotherapy,Chondrosarcoma,0
6564,Condition:Find:Pt:^Patient:Nom,Vaginal Adenoid Cystic Carcinoma,0
6565,Adult human body,Childhood Anaplastic Large Cell Lymphoma,0
6566,Skull,Recurrent Diffuse Intrinsic Pontine Glioma,0
6567,Acquired (qualifier value),FIGO Stage IVA Ovarian Cancer,0
6568,South Korea,Benign Apocrine Neoplasm,0
6569,Common Specifications in HL7 V3 Publishing,Hemangioma,0
6570,Ulcer,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6571,Make - Instruction Imperative,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6572,genetic risk factors,Malignant Neoplasm with Regional Lymph Node Involvement,0
6573,Cell (compartment),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6574,World Health Organization,Bladder squamous cell carcinoma stage I,0
6575,Usual Severity Weight Loss,GIANT PIGMENTED HAIRY NEVUS,0
6576,Publishing,Malignant neoplasm of subglottis,0
6577,GORAB gene,Primary Cutaneous Plasmablastic Lymphoma,0
6578,Publications,Localized Malignant Neoplasm,0
6579,lymph nodes,Diffuse malignant mesothelioma,0
6580,Route of Administration - Mucous Membrane,Squamous cell carcinoma of lip,0
6581,various other intestinal adsorbents in ATC,Fibroadenoma of breast,0
6582,SMIM10L2A gene,Bladder squamous cell carcinoma stage I,0
6583,Occur (action),Hereditary corneal dystrophy,0
6584,Name,Metastatic Lung Neuroendocrine Neoplasm,0
6585,Dermis,Neonatal leukemia,0
6586,Leukemia,Vaginal Adenoid Cystic Carcinoma,0
6587,Neoplasms,Stage I Colon Neuroendocrine Tumor AJCC v8,0
6588,High Grade Astrocytic Tumor,Microcystic meningioma,0
6589,Adult human body,Human Papillomavirus-Related Carcinoma,0
6590,Nervous system structure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6591,Severe (severity modifier),Gallbladder adenoma,0
6592,Nasal sinus,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6593,60%,embryonal rhabdomyosarcoma of prostate,0
6594,Pelvic Pain,Locally Advanced Carcinoma,0
6595,3+ Score,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6596,Nasal (intended site),Bladder squamous cell carcinoma stage I,0
6597,Future,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6598,Usual,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6599,Include (action),Kaposi's sarcoma of extrahepatic bile duct,0
6600,Drop measurement,Basal Cell Ameloblastoma,0
6601,Megakaryocyte Count,Cervical Fibroepithelial Polyp,0
6602,Neoplasms,Extra-Adrenal Paraganglioma,0
6603,Anaphylactic shock,Benign tumor of eyelid,0
6604,Lung,Contact dermatitis due to alkali,0
6605,Sacrifice,Peripheral primitive neuroectodermal tumor of soft tissue,0
6606,Universal - VocabularyDomainQualifier,papillary carcinoma of penis,0
6607,Scrotum,Stage III Adult Immunoblastic Lymphoma,0
6608,Scheme,Mucinous adenocarcinoma gastric,0
6609,Common (qualifier value),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6610,Qualitative form,Type II Endometrial Adenocarcinoma,0
6611,Infrequent,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6612,Choroid,Recurrent Testicular Lymphoma,0
6613,Decision,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
6614,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Undifferentiated Leukemia,0
6615,What subject filter - Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6616,bacteria aspects,FIGO Stage IVA Ovarian Cancer,0
6617,Removed,Locally Advanced Carcinoma,0
6618,Hemoptysis,Adult Brain Stem Mixed Glioma,0
6619,Nearly,Methotrexate-Associated Hodgkin Lymphoma,0
6620,Second Suffix,Testicular cancer metastatic,0
6621,4+ Answer to question,Stage III Cutaneous Melanoma AJCC v6,0
6622,Tired,Pancreatic Endocrine Carcinoma,0
6623,Term (lexical),Melanomatosis,0
6624,Malignant Neoplasms,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
6625,Black color,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6626,Two,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6627,Term (temporal),Ichthyosis,0
6628,Part of,Unresectable Rhabdomyosarcoma,0
6629,Esophageal,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6630,point - UnitsOfMeasure,Small intestine carcinoma,0
6631,Palate,Mixed parotid tumor,0
6632,Development,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
6633,Occur (action),Ichthyoses,0
6634,Lower - spatial qualifier,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
6635,Abdomen+,Low Grade Squamous Intraepithelial Neoplasia,0
6636,Precision - characteristic,adenoid cystic carcinoma of lung,0
6637,Common Specifications in HL7 V3 Publishing,Chest Wall Fibromatosis,0
6638,Reparative closure,FIGO Stage IVA Ovarian Cancer,0
6639,Malignant neoplasm of endometrium,Trichilemmocarcinoma,0
6640,Type A,Ovarian germ cell choriocarcinoma stage IV,0
6641,Cancer Genus,Locally Advanced Epithelioid Hemangioendothelioma,0
6642,Class (taxonomic),gliosarcoma,0
6643,Visual Impairment,Gallbladder adenoma,0
6644,Average of Value Derivation Technique,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6645,Infrequent,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
6646,Encounter due to tobacco use,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6647,color additive,Childhood Lymphoma,0
6648,Non-Small Cell Lung Carcinoma,Childhood Fibrillary Astrocytoma,0
6649,Spinal Cord,Colorectal Neuroendocrine Tumor G2,0
6650,Entity,Squamous cell carcinoma of lip,0
6651,Singular,Heavy Chain Deposition Disease,0
6652,Filter (function),Occult Lung Adenosquamous Carcinoma,0
6653,Clavien-Dindo Grade II,Metaplastic carcinoma of breast,0
6654,Fever,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6655,About The Same,Stage 0 Lip Carcinoma,0
6656,Bruising,Bladder squamous cell carcinoma stage I,0
6657,Exposure to,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6658,Tobacco smoking behavior,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6659,Related personal status,Recurrent Testicular Lymphoma,0
6660,Lymphoid organ structure,Familial Hemophagocytic Lymphocytosis,0
6661,Excision,Mixed astrocytoma-ependymoma,0
6662,90%,Recurrent Testicular Lymphoma,0
6663,Bothered by Vomiting,Cystadenocarcinoma,0
6664,Value Above Reference Range,Female Breast Carcinoma,0
6665,2+ Score,Airway Hemangioma,0
6666,Tryptophanase,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6667,various antiseptic throat preparations,Intraepithelial Melanocytic Hyperplasia,0
6668,Evidence,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6669,Replaced by,Kaposi's sarcoma of extrahepatic bile duct,0
6670,United States,Bladder squamous cell carcinoma stage I,0
6671,Case (situation),Benign Anal Granular Cell Tumor,0
6672,Antifungal Antibiotics,Primary Cutaneous Plasmablastic Lymphoma,0
6673,Sample Range,Mucinous adenocarcinoma gastric,0
6674,Case unit dose,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6675,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Splenic Manifestation of Hairy Cell Leukemia,0
6676,Certain (qualifier value),Spermatocytic seminoma,0
6677,Descending,Malignant melanoma of eyelid,0
6678,Shortened,Vaginal Adenoid Cystic Carcinoma,0
6679,Immunoglobulins,Pancreatic carcinoma,0
6680,Symptoms aspect,Leiomyoma of Gallbladder,0
6681,Adenocarcinoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6682,Primary malignant neoplasm,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6683,Options,FIGO Stage II Ovarian Cancer,0
6684,Adult Glioblastoma,Diffuse malignant mesothelioma,0
6685,76,FIGO Stage IVA Ovarian Cancer,0
6686,E-Cadherin,Gallbladder Adenocarcinoma,0
6687,Retina,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6688,SLC6A2 protein,Ovarian germ cell choriocarcinoma stage IV,0
6689,Fever,Low Grade Squamous Intraepithelial Neoplasia,0
6690,Have Weight Loss,Carcinomatosis of peritoneal cavity,0
6691,Marketing basis - Transitional,Metaplastic carcinoma of breast,0
6692,Poor - grade value,Epithelioid Sarcoma NCI Grade 3,0
6693,Surgical extraction,Malignant Testicular Sertoli Cell Tumor,0
6694,Dorsal,Thymic Atypical Carcinoid Tumor,0
6695,Body Fluid Discharge,Multiple Endocrine Neoplasia,0
6696,Adult Rhabdomyosarcoma,Thymic Atypical Carcinoid Tumor,0
6697,Specific qualifier value,Refractory Barrett Esophagus,0
6698,Sample Range,Ovarian germ cell choriocarcinoma stage IV,0
6699,Cancer Genus,Vaginal Adenoid Cystic Carcinoma,0
6700,Skin Pigmentation,Periosteal Osteosarcoma,0
6701,Location,Benign neoplasm of eye,0
6702,Capillary vessel,clear cell adenocarcinoma of gallbladder,0
6703,Specimen Source Codes - tumor,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6704,Negation,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6705,Symptoms aspect,Extra-abdominal fibromatosis,0
6706,Etiology aspects,Unresectable Rhabdomyosarcoma,0
6707,Thyroid carcinoma,Nasal cavity carcinoma,0
6708,Bacterial shell rot,Gallbladder Adenocarcinoma,0
6709,Body part,FIGO Stage IVA Ovarian Cancer,0
6710,Treatment Epoch,Mucinous adenocarcinoma gastric,0
6711,Singular,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6712,Lymphatic Capillaries,Hereditary Diffuse Gastric Adenocarcinoma,0
6713,Common (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6714,Occur (action),Low Grade Squamous Intraepithelial Neoplasia,0
6715,Analysis,Anterior Urethral Malignant Neoplasm,0
6716,Usually,Methotrexate-Associated Hodgkin Lymphoma,0
6717,40%,gliosarcoma,0
6718,include - SetOperator,Adenocarcinoma,0
6719,Tissue Specimen Code,benign mature teratoma of pancreas,0
6720,Form of uterus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6721,status - In progress,Squamous cell carcinoma of lip,0
6722,Adult Lymphoma,Mucinous adenocarcinoma gastric,0
6723,Neoplasms,Engraftment syndrome,0
6724,Involvement with,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6725,alone - group size,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6726,Orbital region,Carcinoma ex pleomorphic adenoma of parotid gland,0
6727,Primary malignant neoplasm,Giant cell angiofibroma,0
6728,Case (situation),Cerebral Primitive Neuroectodermal Tumor,0
6729,Person 1,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6730,Gastroesophageal Reflux Disease,Anterior Urethral Malignant Neoplasm,0
6731,Therapeutic procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6732,Pancreas,Stage III Adult Immunoblastic Lymphoma,0
6733,Fatigue,Type II Endometrial Adenocarcinoma,0
6734,Related personal status,Epithelioid Sarcoma NCI Grade 3,0
6735,depend,Malignant melanoma of eyelid,0
6736,Actinic keratosis,Refractory Ependymoma,0
6737,Melanins,Vaginal Adenoid Cystic Carcinoma,0
6738,Asians,Noninfiltrating Intraductal Carcinoma,0
6739,Several,FIGO Stage IVA Ovarian Cancer,0
6740,Aspects of signs,Cancer of Urinary Tract,0
6741,Occlusion of artery (disorder),Bladder squamous cell carcinoma stage I,0
6742,Object Class,Endometrial Small Cell Carcinoma,0
6743,Tears body substance,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
6744,Antibiotics,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6745,Classification of information,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6746,Linear,Adenocarcinoma of duodenum,0
6747,Worse,Placental aromatase deficiency,0
6748,Referring,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
6749,Chemotherapy,Malignant Testicular Sertoli Cell Tumor,0
6750,Primary malignant neoplasm,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
6751,Experimental Result,Extracranial Neuroblastoma,0
6752,60%,Maxillary Sinus Adenocarcinoma,0
6753,Pediatric Neoplasm,Bladder adenocarcinoma stage IV,0
6754,Call (Instruction),Gallbladder adenoma,0
6755,Ultrasonography,mucinous adenocarcinoma of gallbladder,0
6756,Mutation,Diffuse malignant mesothelioma,0
6757,Genes,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6758,Sunlight,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6759,Neoplasm Metastasis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6760,Carcinoma,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6761,Blast Cell,Kaposi's sarcoma of skin,0
6762,High Risk Acute Leukemia,Microcystic meningioma,0
6763,Then,Type II Endometrial Adenocarcinoma,0
6764,Neoplasms,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6765,System (unit of presentation),Stage IV Childhood Non-Hodgkin Lymphoma,0
6766,Tissue Specimen Code,Stage IV Childhood Non-Hodgkin Lymphoma,0
6767,Decreasing,Lipoma of small intestine,0
6768,Frequently,Digestive System Hodgkin Lymphoma,0
6769,Sometimes,non-Hodgkin's lymphoma of spleen,0
6770,Genetic,Serous cystadenocarcinoma ovary,0
6771,Family history,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6772,Stress,Peripheral primitive neuroectodermal tumor of soft tissue,0
6773,Telencephalon,papillary carcinoma of penis,0
6774,Treatment intent,Refractory Ependymoma,0
6775,Containing (qualifier),Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
6776,Descent,Carcinoma of urinary bladder,0
6777,Mixed (qualifier value),Glomeruloid hemangioma,0
6778,T prime,Ichthyosis,0
6779,Etiology aspects,Colorectal cancer,0
6780,Usual Severity Weight Loss,Neonatal leukemia,0
6781,Examination,Acantholytic squamous cell carcinoma,0
6782,thymocyte,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6783,Examination,Carcinoma of urinary bladder,0
6784,Tissue Type Code - Basal cell carcinoma,Human Papillomavirus-Related Carcinoma,0
6785,Etiology,Childhood Lymphoma,0
6786,Autosomal dominant hereditary disorder,Adenocarcinoma,0
6787,Very High Level,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6788,Anatomic Site,Periosteal Osteosarcoma,0
6789,Obesity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6790,Common Specifications in HL7 V3 Publishing,Brain Tumor,0
6791,Abdominal Cavity,Tonsillar Carcinoma,0
6792,Within,Mucinous adenocarcinoma gastric,0
6793,Negation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6794,Primary,Adult Hepatocellular Carcinoma,0
6795,Term (lexical),Primary Cutaneous Plasmablastic Lymphoma,0
6796,Childhood Non-Hodgkin Lymphoma,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
6797,biopsy characteristics,Fibroadenoma of breast,0
6798,Common (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6799,Support,Mucinous adenocarcinoma gastric,0
6800,Blood group antibody I,Breast Ductal Adenoma,0
6801,Skin fold,Ovarian Carcinoid Tumor,0
6802,Renal pelvis,Stage I Adult Non-Hodgkin Lymphoma,0
6803,Few minutes,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6804,Thoracic Duct,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
6805,Operation excision,Low Grade Squamous Intraepithelial Neoplasia,0
6806,Age,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6807,Before,Placental aromatase deficiency,0
6808,Smear - instruction imperative,Kaposi's sarcoma of extrahepatic bile duct,0
6809,Areas <moth>,High Grade Glandular Intraepithelial Neoplasia,0
6810,shared attribute,Recurrent Uveal Melanoma,0
6811,Papillary transitional cell carcinoma,Bladder squamous cell carcinoma stage I,0
6812,Leads (device),Engraftment syndrome,0
6813,Macrophage Activation Syndrome,Cerebral Primitive Neuroectodermal Tumor,0
6814,Endocrine Cells,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6815,Structure of isthmus of thyroid gland,Carcinomatosis of peritoneal cavity,0
6816,Intervention regimes,Medulloblastoma,0
6817,Reported Term,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6818,Fallopian Tubes,Pancreatic Intraepithelial Neoplasia-3,0
6819,melanoma,Localized Askin Tumor,0
6820,Cells,Nasal cavity carcinoma,0
6821,Control function,Blepharal carcinoma,0
6822,Laboratory Procedures,Airway Hemangioma,0
6823,Diagnosis,Acute Undifferentiated Leukemia,0
6824,Togo,Maxillary Sinus Adenoid Cystic Carcinoma,0
6825,Frequently,Blood Vessel Tumors,0
6826,Contain (action),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6827,Due to,Cartilaginous exostosis,0
6828,fluid ounce,Papillary squamous cell carcinoma,0
6829,Thymus Gland,Thymic Clear Cell Carcinoma,0
6830,Able (finding),mucinous adenocarcinoma of gallbladder,0
6831,Ultrasonic Shockwave,Primary Cutaneous Plasmablastic Lymphoma,0
6832,35,Intestinal Metaplasia of Bladder Urothelium,0
6833,Ovary,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6834,Pharmacotherapy,Stage III Cutaneous Melanoma AJCC v6,0
6835,Unmarried person,Childhood Anaplastic Large Cell Lymphoma,0
6836,Endometrial biopsy,Liver Lymphangioma,0
6837,Measurement,Liver Lymphangioma,0
6838,Manufactured form,Malignant melanoma of eyelid,0
6839,Nipples,Heavy Chain Deposition Disease,0
6840,Probability,Squamous cell carcinoma of lip,0
6841,Following,Liver Lymphangioma,0
6842,Genes,Extra-Adrenal Paraganglioma,0
6843,Lymphocyte,Recurrent Uveal Melanoma,0
6844,Decision,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6845,Smear - instruction imperative,Adult Hepatocellular Carcinoma,0
6846,Spreading (qualifier value),Thymic Clear Cell Carcinoma,0
6847,Monitor Device,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6848,Diffuse Large B-Cell Lymphoma,Benign squamous cell tumor,0
6849,Plasma,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
6850,Sometimes,Anterior Urethral Malignant Neoplasm,0
6851,heart inflammation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6852,Brain,Microcystic meningioma,0
6853,various other agents for local oral treatment in ATC,Medulloblastoma,0
6854,Case unit dose,Blepharal carcinoma,0
6855,Neoadjuvant Therapy Clinical Trial Setting,Cerebral Primitive Neuroectodermal Tumor,0
6856,Pediculus (eukaryote),Microcystic meningioma,0
6857,Extrinsic,Cancer of Urinary Tract,0
6858,Screening,Uterine Cancer,0
6859,Severe (severity modifier),papillary carcinoma of penis,0
6860,Oral (intended site),FIGO Stage IVA Ovarian Cancer,0
6861,gene therapy,Adult Acute Eosinophilic Leukemia,0
6862,PSA Level Less than Two,Choroid Epithelioid Cell Melanoma,0
6863,7.2,Recurrent Primary Lymphoma of Bone,0
6864,Term (lexical),Type II Endometrial Adenocarcinoma,0
6865,Benign Neoplasm,Blepharal carcinoma,0
6866,Comprehension,Acantholytic squamous cell carcinoma,0
6867,*Type - Kind of quantity,Acute Undifferentiated Leukemia,0
6868,Case (situation),Heavy Chain Deposition Disease,0
6869,Age of Onset,Colorectal High Grade B-Cell Lymphoma,0
6870,Togo,Localized Ewing Sarcoma,0
6871,North America,Nasal cavity carcinoma,0
6872,Childhood Non-Hodgkin Lymphoma,Chondrosarcoma,0
6873,35,Kaposi's sarcoma of extrahepatic bile duct,0
6874,Occurrence,Extracranial Neuroblastoma,0
6875,Histocompatibility Testing,Mixed astrocytoma-ependymoma,0
6876,Unknown,Childhood Central Nervous System Ganglioneuroblastoma,0
6877,ferric oxide,Unresectable Rhabdomyosarcoma,0
6878,Plant Roots,Malignant Testicular Sertoli Cell Tumor,0
6879,Milliampere second,Bladder Neuroendocrine Neoplasm,0
6880,Negation,Refractory Ependymoma,0
6881,Tissue Specimen Code,Neonatal leukemia,0
6882,Secondary Neoplasm,Acantholytic squamous cell carcinoma,0
6883,Part of,Angiosarcoma of liver,0
6884,Horns,Neoplasms,0
6885,Often - answer to question,Thymic Clear Cell Carcinoma,0
6886,Vagina,Trichilemmocarcinoma,0
6887,Neoplasms,Adult Hepatocellular Carcinoma,0
6888,Due to,Benign Apocrine Neoplasm,0
6889,Occurrence Indicator,Refractory Barrett Esophagus,0
6890,Abdomen,Refractory Ependymoma,0
6891,Usual Severity Weight Loss,Testicular cancer metastatic,0
6892,Microvolt,Precursor B-lymphoblastic lymphoma stage II,0
6893,World,Tubal Hyperplasia,0
6894,Male Phenotype,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6895,Group A (qualifier value),Spongiotic dermatitis,0
6896,Dorsal,Kaposi's sarcoma of extrahepatic bile duct,0
6897,Africa,Advanced Lung Carcinoma,0
6898,Cancer Other,Childhood Thyroid Gland Follicular Carcinoma,0
6899,treatment - ActInformationManagementReason,Uterine Cancer,0
6900,Decade,Clonal Hematopoiesis of Indeterminate Potential,0
6901,Rate,Kaposi's sarcoma of skin,0
6902,risk factors,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
6903,Main,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6904,Leakage,Localized Ewing Sarcoma,0
6905,risk factors,Unresectable Rhabdomyosarcoma,0
6906,include - SetOperator,Metaplastic carcinoma of breast,0
6907,Square Mile,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6908,Symptoms aspect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6909,1+ Score,Medulloblastoma,0
6910,Hormonal Contraception,Leptomeningeal sarcoma,0
6911,Geographic Locations,Vaginal Adenoma,0
6912,Adverse Event Associated with Syndromes,Lung Inflammatory Myofibroblastic Tumor,0
6913,Average,Recurrent Uveal Melanoma,0
6914,Abdomen,Peripheral primitive neuroectodermal tumor of soft tissue,0
6915,complex (molecular entity),Kaposi's sarcoma of extrahepatic bile duct,0
6916,Hypothalamic hamartomas,Unicystic ameloblastoma,0
6917,Occurrence,Kaposi's sarcoma of extrahepatic bile duct,0
6918,Premalignant,Bladder adenocarcinoma stage IV,0
6919,Diagnosis,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
6920,Cause of Death,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6921,Support,mucinous adenocarcinoma of gallbladder,0
6922,Colorectal Carcinoma,embryonal rhabdomyosarcoma of prostate,0
6923,Much,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6924,Non-Small Cell Lung Carcinoma,Peripheral primitive neuroectodermal tumor of soft tissue,0
6925,Known,Stage III Cutaneous Melanoma AJCC v6,0
6926,Location of Pharyngeal Residue Following Swallowing,Chondrosarcoma,0
6927,Physical findings,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6928,year,Thyroid Hurthle Cell Carcinoma,0
6929,Take,Refractory Barrett Esophagus,0
6930,Support,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6931,Severe (severity modifier),embryonal rhabdomyosarcoma of prostate,0
6932,Growth,Localized Ewing Sarcoma,0
6933,Usually,Childhood Central Nervous System Ganglioneuroblastoma,0
6934,Cessation of life,Central Nervous System Anaplastic Large Cell Lymphoma,0
6935,Administration procedure,Benign neoplasm of eye,0
6936,Then,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6937,Immature cells,Lung squamous cell carcinoma stage I,0
6938,Dental caries,Recurrent Testicular Lymphoma,0
6939,Growth abnormality,Vaginal Adenoid Cystic Carcinoma,0
6940,Common (qualifier value),Gastric Diffuse Large B-Cell Lymphoma,0
6941,United States,Uterine Cancer,0
6942,Pelvic cavity structure,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
6943,triclocarban,Malignant melanoma of eyelid,0
6944,Manual pelvic examination (procedure),Non-Metastatic Gestational Trophoblastic Tumor,0
6945,Administration procedure,Stage III Cutaneous Melanoma AJCC v6,0
6946,United States,Benign Carotid Body Paraganglioma,0
6947,Blood,Xeroderma pigmentosum,0
6948,Chemotherapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6949,Proliferation (morphologic abnormality),Bladder adenocarcinoma stage IV,0
6950,Science of Etiology,Cartilaginous exostosis,0
6951,Primary malignant neoplasm,Medulloblastoma,0
6952,Gastric Gastrointestinal Stromal Tumor,Pilocytic astrocytoma of cerebellum,0
6953,Term (lexical),Botryoid-Type Embryonal Rhabdomyosarcoma,0
6954,Skin,Benign squamous cell tumor,0
6955,Only - dosing instruction fragment,Pancreatic Intraepithelial Neoplasia-3,0
6956,Deterioration of status,Lung Mucinous Cystadenoma,0
6957,Nasolacrimal duct structure,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6958,Hydatidiform Mole,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6959,Feelings,Splenic Manifestation of Hairy Cell Leukemia,0
6960,Classification,Neoplasms,0
6961,United States,Locally Advanced Carcinoma,0
6962,Singular,Acute Undifferentiated Leukemia,0
6963,Exposure to,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6964,Suspected qualifier,Trabecular adenocarcinoma,0
6965,During,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
6966,Progress,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6967,Therapeutic procedure,Airway Hemangioma,0
6968,Malignant neoplasm of pancreas,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6969,Linear,Choroid Epithelioid Cell Melanoma,0
6970,Structure of lower lobe of lung,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
6971,contents - HtmlLinkType,Ichthyoses,0
6972,Perfusion (procedure),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6973,Usual,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6974,Talc,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6975,Beginning,Human Papillomavirus-Related Carcinoma,0
6976,Fibrous nodule,Pancreatic Intraepithelial Neoplasia-3,0
6977,High Mitosis-Karyorrhexis Index,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6978,Skin,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6979,500,Mucosal Melanoma,0
6980,Recommendation,Spermatocytic seminoma,0
6981,percent positive cells,Precursor B-lymphoblastic lymphoma stage II,0
6982,Exist,sarcoma of spinal cord,0
6983,90%,Acute Undifferentiated Leukemia,0
6984,Person Name,Intracortical osteosarcoma,0
6985,Materials,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6986,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Unresectable Rhabdomyosarcoma,0
6987,Malignant neoplasm of ovary,Leptomeningeal sarcoma,0
6988,Ultraviolet Light Sterilization,Human Papillomavirus-Related Carcinoma,0
6989,hormone problem,Acute Undifferentiated Leukemia,0
6990,Have Sweats,Stage IV Penile Cancer AJCC v7,0
6991,size,FIGO Stage II Ovarian Cancer,0
6992,Lymphocyte,Astrocytoma of brain,0
6993,Beginning,Metaplastic carcinoma of breast,0
6994,Primary operation,Kaposi's sarcoma of extrahepatic bile duct,0
6995,Case unit dose,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6996,Fatigue,Stage IB Pancreatic Cancer AJCC v8,0
6997,apply - action,Vaginal Adenoma,0
6998,Active,Chronic Myelomonocytic Leukemia-2,0
6999,As Much as Desired,Cerebral Primitive Neuroectodermal Tumor,0
7000,Portion of urine,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7001,Possible diagnosis,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7002,Vulva,Collecting Duct Carcinoma of the Kidney,0
7003,Pediculus (eukaryote),Cervical Squamous Intraepithelial Neoplasia,0
7004,Common (qualifier value),FIGO Stage IVA Ovarian Cancer,0
7005,*Type - Kind of quantity,Colorectal cancer,0
7006,Gastrointestinal tract structure,Undifferentiated Endocervical Sarcoma,0
7007,Aggressive behavior,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
7008,Life,Astrocytoma of brain,0
7009,Malignant neoplasm of thyroid,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7010,Assisted (qualifier value),Noninfiltrating Intraductal Carcinoma,0
7011,Application (Document),Botryoid-Type Embryonal Rhabdomyosarcoma,0
7012,Spreading (qualifier value),Fibroadenoma of breast,0
7013,Oral cavity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7014,Glandular,Vaginal Adenoid Cystic Carcinoma,0
7015,Immune,Ichthyosis,0
7016,Lymphoma,GIANT PIGMENTED HAIRY NEVUS,0
7017,Often - answer to question,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7018,Diagnosis Study,Familial Hemophagocytic Lymphocytosis,0
7019,World Health Organization,Chest Wall Fibromatosis,0
7020,In Urine,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
7021,Asymptomatic Diseases,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
7022,How Much Distress Itching,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7023,Worsening pattern,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7024,Use of,Brain Tumor,0
7025,cell type,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7026,Deposition,Cancer of Urinary Tract,0
7027,Pruritus,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
7028,Sunlight,Undifferentiated Neuroblastoma,0
7029,71,Cartilaginous exostosis,0
7030,CEL gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7031,20%,Cervical Fibroepithelial Polyp,0
7032,Count of entities,Squamous cell carcinoma of lip,0
7033,Following,Anterior Urethral Malignant Neoplasm,0
7034,Cell division,Cancer of Urinary Tract,0
7035,Togo,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7036,Primary malignant neoplasm,Unresectable Rhabdomyosarcoma,0
7037,Areas <moth>,Mastocytosis,0
7038,Western Europe,Adult Fibrolamellar Carcinoma,0
7039,Characteristics,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
7040,Main,Bladder adenocarcinoma stage IV,0
7041,Often - answer to question,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7042,New,Benign Anal Granular Cell Tumor,0
7043,Cell Count,Splenic Manifestation of Hairy Cell Leukemia,0
7044,Include (action),Diffuse malignant mesothelioma,0
7045,Pelvic Pain,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7046,Young,Malignant melanoma of eyelid,0
7047,Classical Hodgkin's Lymphoma,Vaginal Adenoma,0
7048,adaptive,Metastatic Ductal Breast Carcinoma,0
7049,Term Birth,Cervical Fibroepithelial Polyp,0
7050,status - In progress,Engraftment syndrome,0
7051,Diagnosis,FIGO Stage II Ovarian Cancer,0
7052,Application procedure,BRCA2 Syndrome,0
7053,Lymphoma,Extracranial Neuroblastoma,0
7054,Obesity,Cancer of Urinary Tract,0
7055,Degree or extent,Mucosal Melanoma,0
7056,Togo,Thyroid Hurthle Cell Carcinoma,0
7057,Malignant Neoplasms,Pancreatic carcinoma,0
7058,Include (action),sarcoma of spinal cord,0
7059,Neoplasm Metastasis,Benign tumor of eyelid,0
7060,Call (Instruction),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7061,Oral cavity,Methotrexate-Associated Hodgkin Lymphoma,0
7062,Liquid substance,Benign squamous cell tumor,0
7063,Surgery specialty,Carcinomatosis of peritoneal cavity,0
7064,Average of Value Derivation Technique,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7065,Stomach,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7066,Formation,Pancreatic Intraepithelial Neoplasia-3,0
7067,Australia,Thymic Clear Cell Carcinoma,0
7068,Less Than,Benign Apocrine Neoplasm,0
7069,Scab,Squamous cell carcinoma of lip,0
7070,Evaluation procedure,Liver Lymphangioma,0
7071,How Much Distress Weight Loss,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7072,Person Name,Chondrosarcoma,0
7073,Pelvic pain female,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7074,Covered (qualifier value),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
7075,Free (available (qualifier)),Malignant neoplasm of olfactory nerve,0
7076,Symptoms,Rhabdomyosarcoma with ganglionic differentiation,0
7077,H NOS Antibodies,Acantholytic squamous cell carcinoma,0
7078,shared attribute,Melanomatosis,0
7079,Pathological Dilatation,FIGO Stage II Ovarian Cancer,0
7080,Lower jaw region,Intraepithelial Melanocytic Hyperplasia,0
7081,Abnormal vaginal bleeding,Primary Cutaneous Plasmablastic Lymphoma,0
7082,Effective,Hereditary Diffuse Gastric Adenocarcinoma,0
7083,Mechanism (attribute),Maxillary Sinus Adenoid Cystic Carcinoma,0
7084,Chickenpox Vaccine,Methotrexate-Associated Hodgkin Lymphoma,0
7085,Known,BRCA2 Syndrome,0
7086,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7087,Neoplasms,Childhood Central Nervous System Immature Teratoma,0
7088,Expression (foundation metadata concept),Recurrent Uveal Melanoma,0
7089,Observed,Melanomatosis,0
7090,depend,Unfavorable Non-Hodgkin Lymphoma,0
7091,Person 2,Metastatic Neoplasm to the Gallbladder,0
7092,Professional guide,Adenocarcinoma of duodenum,0
7093,Follow-Up Report,Familial Hemophagocytic Lymphocytosis,0
7094,Common Specifications in HL7 V3 Publishing,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7095,Swelling,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7096,Easy bleeding,Giant cell angiofibroma,0
7097,Case unit dose,Locally Advanced Soft Tissue Sarcoma,0
7098,Building process,Benign tumor of eyelid,0
7099,Human Cells,Tongue Alveolar Soft Part Sarcoma,0
7100,95,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7101,Aggressive Non-Hodgkin Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7102,Collagen Type III,Adult Hepatocellular Carcinoma,0
7103,Malignant neoplasm of urinary bladder,Acute Undifferentiated Leukemia,0
7104,Exposure to Agent Orange,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7105,Poly(ADP-ribose) Polymerases,Kaposi's sarcoma of extrahepatic bile duct,0
7106,Formation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7107,Case (situation),Breast Ductal Adenoma,0
7108,Treating,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7109,Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7110,brain shape,Intraepithelial Melanocytic Hyperplasia,0
7111,Egg of order Phthiraptera,Mucinous adenocarcinoma gastric,0
7112,TP53 protein,Adult Alveolar Soft Part Sarcoma,0
7113,Therapeutic procedure,Heavy Chain Deposition Disease,0
7114,Science of Morphology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7115,Wall of lymphatic vessel,Acute Undifferentiated Leukemia,0
7116,Skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7117,body system,Extra-abdominal fibromatosis,0
7118,History of present illness,Blepharal carcinoma,0
7119,Palmitic Acid,Childhood Anaplastic Large Cell Lymphoma,0
7120,Most,Cerebral Primitive Neuroectodermal Tumor,0
7121,Enneking High Surgical Grade,Carcinoma of urinary bladder,0
7122,Twice (Numerical Qualifier),Advanced Uterine Corpus Carcinosarcoma,0
7123,Vagina Carcinoma,mucinous adenocarcinoma of gallbladder,0
7124,medication - HL7 publishing domain,Recurrent Testicular Lymphoma,0
7125,Treatment Epoch,Refractory Bladder Carcinoma,0
7126,Short,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7127,Body structure,Undifferentiated Endocervical Sarcoma,0
7128,Diagnosis,Acinar cell carcinoma of pancreas,0
7129,include - SetOperator,Nasal cavity carcinoma,0
7130,Very Much,BRCA2 Syndrome,0
7131,Malignant Neoplasms,gliosarcoma,0
7132,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7133,Manufactured sign,Nasal cavity carcinoma,0
7134,Biomaterial Treatment,Recurrent Uveal Melanoma,0
7135,Cells,Toxic Epidermal Necrolysis,0
7136,Most,Benign Apocrine Neoplasm,0
7137,Blood Vessel,Splenic Manifestation of Hairy Cell Leukemia,0
7138,Cause of Death,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7139,General health,FIGO Stage II Ovarian Cancer,0
7140,Rating (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7141,Known,Noninfiltrating Intraductal Carcinoma,0
7142,Frequently,Cancer of Urinary Tract,0
7143,Biological Response Modifiers,Refractory Glioma,0
7144,True Control Status,Undifferentiated Endocervical Sarcoma,0
7145,Pelvic Pain,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7146,Uncontrolled,Stage IB Pancreatic Cancer AJCC v8,0
7147,Angiofibroma,Engraftment syndrome,0
7148,Array Feature,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7149,exception - ResponseLevel,Mucinous adenocarcinoma gastric,0
7150,Artificial Airways,Nasal cavity carcinoma,0
7151,Cessation of life,Undifferentiated Endocervical Sarcoma,0
7152,Contrast,Benign Carotid Body Paraganglioma,0
7153,Coding,Uterine Cancer,0
7154,Offspring,Benign neoplasm of eye,0
7155,described,Colorectal High Grade B-Cell Lymphoma,0
7156,Chemotherapy,Acantholytic squamous cell carcinoma,0
7157,Pharmacotherapy,Intraepithelial Melanocytic Hyperplasia,0
7158,year,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7159,GUCY2C protein,Ichthyosis,0
7160,Divide,Xeroderma pigmentosum,0
7161,Hereditary,Diffuse malignant mesothelioma,0
7162,First (number),Fibroadenoma of breast,0
7163,Lip structure,Nasal cavity carcinoma,0
7164,Make - Instruction Imperative,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7165,Pain,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7166,Cell Device,Anaplastic large cell lymphoma,0
7167,Result,Childhood Anaplastic Large Cell Lymphoma,0
7168,Human Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
7169,Primary malignant neoplasm of bladder,Childhood Anaplastic Large Cell Lymphoma,0
7170,Cavitation,Hereditary corneal dystrophy,0
7171,Usual,Basal Cell Ameloblastoma,0
7172,Complete Pharyngeal Contraction,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7173,Adult human body,Undifferentiated Endocervical Sarcoma,0
7174,therapeutic aspects,embryonal rhabdomyosarcoma of prostate,0
7175,Myeloid,Liver Lymphangioma,0
7176,One,Spongiotic dermatitis,0
7177,Hair follicle structure,Locally Advanced Epithelioid Hemangioendothelioma,0
7178,Africa,Refractory Bladder Carcinoma,0
7179,erbB-2 Receptor,embryonal rhabdomyosarcoma of prostate,0
7180,Primary operation,Pancreatic carcinoma,0
7181,CSNK1D wt Allele,Adult Acute Eosinophilic Leukemia,0
7182,Head - Component of Device,Squamous cell carcinoma of lip,0
7183,Bacteria,Anterior Urethral Malignant Neoplasm,0
7184,Known,clear cell adenocarcinoma of gallbladder,0
7185,Histopathologic Grade differentiation,Cervical Adenomyoma,0
7186,Complete excision,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7187,development aspects,Grade 1 Clear Cell Renal Cell Carcinoma,0
7188,Pain,Multiple Skull Base Meningiomas,0
7189,Lymphoid Tissue,Trabecular adenocarcinoma,0
7190,Tissue Specimen Code,Acantholytic squamous cell carcinoma,0
7191,cell type,Malignant Testicular Sertoli Cell Tumor,0
7192,Frequently,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7193,per year,Locally Advanced Soft Tissue Sarcoma,0
7194,Sequence Arm,Testicular cancer metastatic,0
7195,Name (property) (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7196,Manufactured form,Recurrent Primary Lymphoma of Bone,0
7197,Front of neck,Human Papillomavirus-Related Carcinoma,0
7198,Intravascular line,Benign squamous cell tumor,0
7199,Pelvic cavity structure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7200,Most,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7201,Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal,Malignant neoplasm of thalamus,0
7202,Childhood Burkitt Lymphoma,Fourth Ventricle and Brain Stem Ependymal Tumor,0
7203,Non-Small Cell Lung Carcinoma,Mixed astrocytoma-ependymoma,0
7204,Value Above Reference Range,Thymoma malignant recurrent,0
7205,Silicon Dioxide,Mucinous cystadenofibroma,0
7206,Firstly,Adenocarcinoma of duodenum,0
7207,Rating (action),Malignant neoplasm of choroid,0
7208,Right,Localized Ewing Sarcoma,0
7209,Research Activities,Urethral Carcinoma,0
7210,Progress,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7211,Survival Rate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7212,Glandular,embryonal rhabdomyosarcoma of prostate,0
7213,Congenital qualifier,Cartilaginous exostosis,0
7214,Offspring,Angiosarcoma of liver,0
7215,2+ Score,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7216,Vagina,Liver Lymphangioma,0
7217,year,Carcinoma of urinary bladder,0
7218,Decrease,Childhood Fibrillary Astrocytoma,0
7219,Metastatic Neoplasm,Gallbladder Adenocarcinoma,0
7220,Usually,Diffuse malignant mesothelioma,0
7221,Common (qualifier value),Bladder adenocarcinoma stage IV,0
7222,Before,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7223,Including (qualifier),Recurrent Primary Lymphoma of Bone,0
7224,Function (attribute),Clonal Hematopoiesis of Indeterminate Potential,0
7225,Including (qualifier),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
7226,Term Birth,Engraftment syndrome,0
7227,Referring,Transitional cell carcinoma,0
7228,Dietary Lead,Ampulla of Vater Tubular Adenoma,0
7229,Detected (finding),Benign neoplasm of eye,0
7230,Use of,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7231,therapeutic aspects,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7232,Progress,Tongue Alveolar Soft Part Sarcoma,0
7233,How Often Sweats,Benign Carotid Body Paraganglioma,0
7234,Offspring,Thyroid Hurthle Cell Carcinoma,0
7235,Child,Kaposi's sarcoma of extrahepatic bile duct,0
7236,Less Than,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7237,Neoplasms,Type II Endometrial Adenocarcinoma,0
7238,Malignant - descriptor,Nasal cavity carcinoma,0
7239,Squamous cell carcinoma,Childhood Central Nervous System Ganglioneuroblastoma,0
7240,Removing (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7241,Secondary Neoplasm,Human Papillomavirus-Related Carcinoma,0
7242,Aldosterone,Werner Syndrome,0
7243,Used by,Hereditary Diffuse Gastric Adenocarcinoma,0
7244,Abnormal Cell Count,Nasal cavity carcinoma,0
7245,Treatment Epoch,Benign Anal Granular Cell Tumor,0
7246,Reaching,Undifferentiated Endocervical Sarcoma,0
7247,Gene Mutation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7248,Specialized Stand Alone Plan - Vision,Recurrent Testicular Lymphoma,0
7249,High Mitosis-Karyorrhexis Index,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7250,General health,Angiosarcoma of liver,0
7251,Usual,Digestive System Hodgkin Lymphoma,0
7252,lymph nodes,Hereditary corneal dystrophy,0
7253,Various patch test substance,squamous cell carcinoma of the thyroid gland,0
7254,Cancer Genus,Fourth Ventricle and Brain Stem Ependymal Tumor,0
7255,Pain,Stage III Cutaneous Melanoma AJCC v6,0
7256,Affecting,FIGO Stage IVA Ovarian Cancer,0
7257,Different,Refractory Ependymoma,0
7258,Malignant Childhood Neoplasm,Neonatal leukemia,0
7259,Statistical Prevalence,Stage I Colon Neuroendocrine Tumor AJCC v8,0
7260,Causing,Colorectal High Grade B-Cell Lymphoma,0
7261,Occurrence,Stage IV Colorectal Cancer AJCC v8,0
7262,Providing presence (regime/therapy),Anterior Urethral Malignant Neoplasm,0
7263,Possible,Giant cell angiofibroma,0
7264,Unintentional,Locally Advanced Squamous Cell Carcinoma,0
7265,Administration procedure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7266,Common Specifications in HL7 V3 Publishing,Neonatal leukemia,0
7267,factor A,GIANT PIGMENTED HAIRY NEVUS,0
7268,More,Cerebral hemangioma,0
7269,Useful,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7270,Germ Cells,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7271,Food allergenic extracts,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7272,Beginning,BRCA2 Syndrome,0
7273,Lymphoma,Hodgkin Disease,0
7274,Human Papilloma Virus Vaccine,Chest Wall Fibromatosis,0
7275,Delta (difference),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7276,Tests (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
7277,Childhood Embryonal Rhabdomyosarcoma,Cancer of Urinary Tract,0
7278,Hemorrhage,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7279,Clear,Low Grade Squamous Intraepithelial Neoplasia,0
7280,Symptoms aspect,Blepharal carcinoma,0
7281,Common Specifications in HL7 V3 Publishing,Occult Lung Adenosquamous Carcinoma,0
7282,factor A,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7283,Abnormal degeneration,sarcoma of spinal cord,0
7284,Result,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7285,Smell Perception,Undifferentiated Endocervical Sarcoma,0
7286,Swelling,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7287,Assisted (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
7288,status - In progress,Splenic Manifestation of Hairy Cell Leukemia,0
7289,Oropharyngeal,Mixed astrocytoma-ependymoma,0
7290,Cell Count,Precursor B-lymphoblastic lymphoma stage II,0
7291,Rating (action),Nasal cavity carcinoma,0
7292,Benign melanocytic nevus,Recurrent Testicular Lymphoma,0
7293,Malignant neoplasm of thyroid,non-Hodgkin's lymphoma of spleen,0
7294,High Level,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7295,Pleomorphic carcinoma,Kaposi's sarcoma of skin,0
7296,Carcinoma of lung,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7297,day,Vaginal Adenoma,0
7298,Compressing (action),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7299,Leukocytes,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7300,Process,Secondary malignant neoplasm of lymph node,0
7301,Aspects of signs,Brain Tumor,0
7302,Including (qualifier),Engraftment syndrome,0
7303,Pharmacotherapy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7304,Times,Malignant neoplasm of subglottis,0
7305,Personal appearance,Non-Metastatic Gestational Trophoblastic Tumor,0
7306,Enlargement procedure,Benign Carotid Body Paraganglioma,0
7307,Immune system,BRCA2 Syndrome,0
7308,Form:Finding:Point in time:{Setting}:Document:{Role},High Grade Glandular Intraepithelial Neoplasia,0
7309,MUTYH gene,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7310,Blood Vessel,Metaplastic carcinoma of breast,0
7311,Malignant Childhood Neoplasm,Stage IV Penile Cancer AJCC v7,0
7312,Cell secretion,Neonatal leukemia,0
7313,Traumatic injury,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7314,Measurement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7315,Cancer Remission,Adult Hepatocellular Carcinoma,0
7316,Presumed,ROSE Cluster 3,0
7317,Rare,embryonal rhabdomyosarcoma of prostate,0
7318,Cancer Genus,benign mature teratoma of pancreas,0
7319,Science of Etiology,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7320,Abdominal Distension,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7321,Smudge Cell Count,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7322,Glycoproteins,Acantholytic squamous cell carcinoma,0
7323,40%,Localized Ewing Sarcoma,0
7324,Differentiation,Cancer of Urinary Tract,0
7325,Targeted Therapy,Recurrent Primary Lymphoma of Bone,0
7326,Left,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7327,Reported Term,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7328,chapter,Adult Alveolar Soft Part Sarcoma,0
7329,To,Ectomesenchymal Chondromyxoid Tumor,0
7330,Geographic Locations,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7331,Name (property) (qualifier value),Chest Wall Fibromatosis,0
7332,Specific qualifier value,Intraepithelial Melanocytic Hyperplasia,0
7333,Pediculus humanus capitis (eukaryote),Thymoma malignant recurrent,0
7334,Thrombocythemia,Stage III Cutaneous Melanoma AJCC v6,0
7335,Disseminated,Spongiotic dermatitis,0
7336,Both ovaries,Choroid Necrotic Melanoma,0
7337,Form:Finding:Point in time:{Setting}:Document:{Role},clear cell adenocarcinoma of gallbladder,0
7338,Obesity,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7339,Subtype (attribute),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7340,Partial,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7341,Binding (Molecular Function),Cervical Fibroepithelial Polyp,0
7342,High risk of,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7343,Anatomic Site,Non-Metastatic Gestational Trophoblastic Tumor,0
7344,Offspring,Clonal Hematopoiesis of Indeterminate Potential,0
7345,Surgical aspects,Human Papillomavirus-Related Carcinoma,0
7346,Slightly Agree,Colorectal High Grade B-Cell Lymphoma,0
7347,overview,Splenic Manifestation of Hairy Cell Leukemia,0
7348,Carcinoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7349,Direct type of relationship,Cherubism,0
7350,Severe (severity modifier),Non-Metastatic Gestational Trophoblastic Tumor,0
7351,Bone pain,Granular Cell Leiomyosarcoma,0
7352,Science of Etiology,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7353,Analysis,Adrenal Rest Tumor,0
7354,Part,Metastatic Lung Neuroendocrine Neoplasm,0
7355,Neoplasms,Liver Lymphangioma,0
7356,various other nasal preparations in ATC,Chest Wall Fibromatosis,0
7357,Type - attribute,Acute Undifferentiated Leukemia,0
7358,therapeutic aspects,Malignant neoplasm of thalamus,0
7359,Cystadenoma,Primary Cutaneous Plasmablastic Lymphoma,0
7360,Time (foundation metadata concept),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7361,Case Study,Intraepithelial Melanocytic Hyperplasia,0
7362,Type - attribute,Chest Wall Fibromatosis,0
7363,Cervical lymph node group,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7364,Therapeutic radiology procedure,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
7365,Major,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7366,Table Cell Horizontal Align - left,Refractory Barrett Esophagus,0
7367,Bladder Neoplasm,Childhood Thyroid Gland Follicular Carcinoma,0
7368,Vaginal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7369,Smoking,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7370,Two,Trichilemmocarcinoma,0
7371,Reported Term,Serous cystadenocarcinoma ovary,0
7372,Diagnosis Study,embryonal rhabdomyosarcoma of prostate,0
7373,Abdomen,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7374,Secondary to,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
7375,Stratified squamous epithelium,Placental aromatase deficiency,0
7376,Administration procedure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7377,Obesity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7378,Upper gastrointestinal tract series,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7379,disease transmission,Thyroid Hurthle Cell Carcinoma,0
7380,Location,Thyroid Hurthle Cell Carcinoma,0
7381,Epithelial ovarian cancer,Hodgkin Disease,0
7382,Cancer Genus,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7383,SLC6A2 protein,Childhood Lung Non-Small Cell Carcinoma,0
7384,PSA Level Less than Two,Pilocytic astrocytoma of cerebellum,0
7385,Occur (action),Malignant neoplasm of subglottis,0
7386,Weight Loss,Bladder squamous cell carcinoma stage I,0
7387,80%,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7388,Limb structure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7389,Sarcoma - category (morphologic abnormality),Acute lymphadenitis,0
7390,First sign,Lung squamous cell carcinoma stage I,0
7391,Lymphocyte component of blood,Digestive System Hodgkin Lymphoma,0
7392,Dietary Lead,Lipoma of small intestine,0
7393,Term Birth,Digestive System Hodgkin Lymphoma,0
7394,Surgery specialty,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7395,High risk,Mastocytosis,0
7396,gene therapy,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7397,Make - Instruction Imperative,Acantholytic squamous cell carcinoma,0
7398,Beginning,gliosarcoma,0
7399,Generic Role,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7400,white blood cell type,Refractory Barrett Esophagus,0
7401,Symptoms,Adult Hepatocellular Carcinoma,0
7402,Treatment Epoch,Splenic Manifestation of Hairy Cell Leukemia,0
7403,Healed,Stage IB Pancreatic Cancer AJCC v8,0
7404,Possible diagnosis,Xeroderma pigmentosum,0
7405,Vaginal Hemorrhage,Tubal Hyperplasia,0
7406,Bronchi,Carcinomatosis of peritoneal cavity,0
7407,Therapeutic procedure,Childhood Central Nervous System Immature Teratoma,0
7408,Singular,Benign Carotid Body Paraganglioma,0
7409,Greatly,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7410,Only - dosing instruction fragment,Adrenal Rest Tumor,0
7411,Including (qualifier),Testicular cancer metastatic,0
7412,Experimental Result,Mucinous adenocarcinoma gastric,0
7413,Science of Etiology,Methotrexate-Associated Hodgkin Lymphoma,0
7414,Symptoms aspect,Liver Lymphangioma,0
7415,High,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7416,diagnosis aspect,Recurrent Uveal Melanoma,0
7417,Related personal status,mucinous adenocarcinoma of gallbladder,0
7418,Microplate Well,gliosarcoma,0
7419,Togo,Female Breast Carcinoma,0
7420,Involvement with,Cervical Fibroepithelial Polyp,0
7421,Infection caused by Helicobacter pylori,Thyroid Hurthle Cell Carcinoma,0
7422,Occur (action),Adult Anaplastic Oligodendroglioma,0
7423,Basal Cell Carcinoma Pathway,Primary Cutaneous Plasmablastic Lymphoma,0
7424,Closed,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7425,Call (Instruction),Stage III Cutaneous Melanoma AJCC v6,0
7426,Organ,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7427,Abnormal cell,embryonal rhabdomyosarcoma of prostate,0
7428,epithelial,Engraftment syndrome,0
7429,Common Specifications in HL7 V3 Publishing,Adult Acute Eosinophilic Leukemia,0
7430,Follicular,Extra-abdominal fibromatosis,0
7431,What subject filter - Result,Rhabdomyosarcoma with ganglionic differentiation,0
7432,Incised wound,Occult Lung Adenosquamous Carcinoma,0
7433,Rapid,Colorectal High Grade B-Cell Lymphoma,0
7434,Referral placed,Chest Wall Fibromatosis,0
7435,% of total,Adult Hepatocellular Carcinoma,0
7436,Intestines,Advanced Lung Carcinoma,0
7437,Social group,Human Papillomavirus-Related Carcinoma,0
7438,Hypertensive disease,Fourth Ventricle and Brain Stem Ependymal Tumor,0
7439,Statistical Prevalence,Congenital hamartoma,0
7440,Chemotherapy Regimen,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
7441,Abnormally high,Grade 3a Malignant Neoplasm,0
7442,Non-Clinical Gestation Trial Phase,Locally Advanced Soft Tissue Sarcoma,0
7443,Malignant Neoplasms,Kaposi's sarcoma of extrahepatic bile duct,0
7444,Individual,Cartilaginous exostosis,0
7445,Aspects of signs,Xeroderma pigmentosum,0
7446,Occurrence Indicator,Cervical Adenomyoma,0
7447,pharmacotherapeutic,Splenic Manifestation of Hairy Cell Leukemia,0
7448,Related personal status,Gallbladder Adenocarcinoma,0
7449,Decision,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7450,Pharmaceutical Preparations,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7451,Neuroendocrine Tumors,Metaplastic carcinoma of breast,0
7452,Gland,Diffuse malignant mesothelioma,0
7453,Percent of Abnormal Cells,Childhood Central Nervous System Ganglioneuroblastoma,0
7454,Etiology aspects,Benign squamous cell tumor,0
7455,Death NOS,Benign neoplasm of thorax,0
7456,Categories,Childhood Central Nervous System Ganglioneuroblastoma,0
7457,Primary,Mucinous adenocarcinoma gastric,0
7458,Central Nervous System,Basal Cell Ameloblastoma,0
7459,Age,Recurrent Testicular Lymphoma,0
7460,Sunscreening Agents,Placental aromatase deficiency,0
7461,Options,Cancer of Urinary Tract,0
7462,View Tunnel,Refractory Ependymoma,0
7463,Symptoms,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7464,Part Dosing Unit,Lipoma of small intestine,0
7465,Coding,FIGO Stage IVA Ovarian Cancer,0
7466,Eating,Adult Alveolar Soft Part Sarcoma,0
7467,Including (qualifier),Spindle Cell Melanoma,0
7468,Intraepithelial Neoplasia,Malignant neoplasm of gallbladder,0
7469,Area,Hemangioma,0
7470,Retinoic Acid Response Element,BRCA2 Syndrome,0
7471,Testis,Metaplastic carcinoma of breast,0
7472,Common (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
7473,Various patch test substance,Xeroderma pigmentosum,0
7474,Medulla Oblongata,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7475,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Stage IV Childhood Non-Hodgkin Lymphoma,0
7476,Renal Cell Carcinoma,Malignant neoplasm of subglottis,0
7477,Coding,Testicular cancer metastatic,0
7478,Selenite,Localized Askin Tumor,0
7479,Cure (remedy),Melanomatosis,0
7480,Low Mitosis-Karyorrhexis Index,Diffuse malignant mesothelioma,0
7481,Common (qualifier value),ROSE Cluster 3,0
7482,Antibiotics,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7483,Affecting,Funisitis (disorder),0
7484,Trauma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7485,status - In progress,Acantholytic squamous cell carcinoma,0
7486,Red blood cells,Neonatal leukemia,0
7487,Valid,Fibroadenoma of breast,0
7488,Life Expectancy Less than Five Years,Kaposi's sarcoma of extrahepatic bile duct,0
7489,Hereditary,Medulloblastoma,0
7490,Have Weight Loss,Childhood Fibrillary Astrocytoma,0
7491,Body structure,Papillary squamous cell carcinoma,0
7492,Reduced,mucinous adenocarcinoma of gallbladder,0
7493,Diagnosis Study,Recurrent Uveal Melanoma,0
7494,Cells,Leptomeningeal sarcoma,0
7495,Net (qualifier),Malignant Neoplasm of Lung - Multiple Primary Sites,0
7496,Tryptophanase,Tonsillar Carcinoma,0
7497,Female of child bearing age,Necrotizing Funisitis,0
7498,PSA Level Less than Two,Nasal cavity carcinoma,0
7499,Response process,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
7500,Patient Reported Outcome Stem,Peripheral primitive neuroectodermal tumor of soft tissue,0
7501,First (number),Spongiotic dermatitis,0
7502,Include (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7503,Anatomic Site,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7504,Groups,squamous cell carcinoma of the thyroid gland,0
7505,Immunotherapy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7506,suggestion,Mucinous adenocarcinoma gastric,0
7507,Common (qualifier value),Metaplastic carcinoma of breast,0
7508,Biospecimen,Astrocytoma of brain,0
7509,Acute leukemia,Intraepithelial Melanocytic Hyperplasia,0
7510,Clothing,Childhood Lymphoma,0
7511,Leukemic Cells Measurement,embryonal rhabdomyosarcoma of prostate,0
7512,Singular,FIGO Stage IVA Ovarian Cancer,0
7513,Mass of body region,Collecting Duct Carcinoma of the Kidney,0
7514,section sample,Chondrosarcoma,0
7515,Discover,FIGO Stage II Ovarian Cancer,0
7516,Botswana,Intestinal Metaplasia of Bladder Urothelium,0
7517,Percent normal,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7518,Dysuria,Melanomatosis,0
7519,Primary malignant neoplasm,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7520,Pharmaceutical Preparations,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7521,Science of Etiology,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
7522,Etiology aspects,Lung squamous cell carcinoma stage I,0
7523,United States,Blood Vessel Tumors,0
7524,Enzyme (disposition),Small Intestinal Villous Adenoma,0
7525,Rare,Non-Metastatic Gestational Trophoblastic Tumor,0
7526,Qualitative form,Carcinoma,0
7527,Biological Response Modifiers,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7528,Spreading (qualifier value),Malignant melanoma of eyelid,0
7529,Covers (device),Bladder adenocarcinoma stage IV,0
7530,Death (finding),Metastatic Kidney Carcinoma,0
7531,Malignant Neoplasms,Hemangioma,0
7532,Pharmacotherapy,Astrocytoma of brain,0
7533,Benign Neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7534,Squamous cell carcinoma,Maxillary Sinus Adenocarcinoma,0
7535,Primary malignant neoplasm,benign mature teratoma of pancreas,0
7536,Including (qualifier),Diffuse malignant mesothelioma,0
7537,85,Childhood Thyroid Gland Follicular Carcinoma,0
7538,Congenital Abnormality,Small Intestinal Villous Adenoma,0
7539,Burkina Faso,Maxillary Sinus Adenoid Cystic Carcinoma,0
7540,Persons,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7541,Disease,Advanced Uterine Corpus Carcinosarcoma,0
7542,Person Name,Blood Vessel Tumors,0
7543,Tobacco smoking behavior,Neoplasms,0
7544,Tail,Medulloblastoma,0
7545,Case (situation),Malignant Neoplasm with Regional Lymph Node Involvement,0
7546,Frequently,Splenic Manifestation of Hairy Cell Leukemia,0
7547,Ultraviolet Light Sterilization,Clonal Hematopoiesis of Indeterminate Potential,0
7548,therapeutic aspects,Benign neoplasm of eye,0
7549,high - ActExposureLevelCode,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
7550,3+ Answer to Question,embryonal rhabdomyosarcoma of prostate,0
7551,Low Level,Malignant Neoplasm with Regional Lymph Node Involvement,0
7552,Major,Mucinous neoplasm,0
7553,Patient observation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7554,Occurrence Indicator,de novo Myelodysplastic Syndrome,0
7555,newly,Benign neoplasm of eye,0
7556,Death NOS,Refractory Bladder Carcinoma,0
7557,Etiology aspects,Grade 3a Malignant Neoplasm,0
7558,Common Specifications in HL7 V3 Publishing,Benign Carotid Body Paraganglioma,0
7559,Rating (action),Extra-abdominal fibromatosis,0
7560,Common Specifications in HL7 V3 Publishing,Bladder Neuroendocrine Neoplasm,0
7561,combination of objects,Adult Fibrolamellar Carcinoma,0
7562,Case unit dose,Localized Malignant Neoplasm,0
7563,Central Nervous System,Deep Leiomyoma,0
7564,Dysgerminoma,Undifferentiated Endocervical Sarcoma,0
7565,Skin cell,Gallbladder Adenocarcinoma,0
7566,Common (qualifier value),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7567,Including (qualifier),Refractory Ependymoma,0
7568,cervical cancer,Anaplastic large cell lymphoma,0
7569,Night sweats,Malignant melanoma of eyelid,0
7570,Main,Cervical Squamous Intraepithelial Neoplasia,0
7571,Critical,Metastatic Lung Small Cell Carcinoma,0
7572,Mucosal Melanoma,Malignant neoplasm of subglottis,0
7573,White color,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
7574,Myeloid Cells,Cervical Squamous Intraepithelial Neoplasia,0
7575,Adult Burkitt Lymphoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7576,Adult Lymphoma,Uterine Cancer,0
7577,Impaired skin integrity,Anaplastic large cell lymphoma,0
7578,Telephone Extension Number,Parathyroid Gland Adenocarcinoma,0
7579,Notable,Human Papillomavirus-Related Carcinoma,0
7580,various other agents for local oral treatment in ATC,Human Papillomavirus-Related Carcinoma,0
7581,Antidepressant Measurement,Mucinous neoplasm,0
7582,Management procedure,Intraepithelial Melanocytic Hyperplasia,0
7583,Feelings,Granular Cell Leiomyosarcoma,0
7584,Frequently,Benign Anal Granular Cell Tumor,0
7585,AKR1A1 wt Allele,Xeroderma pigmentosum,0
7586,Classification of information,Plexosarcoma,0
7587,Gland,Stage IB Pancreatic Cancer AJCC v8,0
7588,Call (Instruction),Chronic Myelomonocytic Leukemia-2,0
7589,Surface of skin,Brain Tumor,0
7590,Operative Surgical Procedures,Digestive System Hodgkin Lymphoma,0
7591,Body tissue,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7592,Others - Allergy,Childhood Cerebellar Neoplasm,0
7593,Rapid,Trichilemmocarcinoma,0
7594,American College of Cardiology/American Heart Association Lesion Complexity Score C,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7595,Symptoms,Benign Anal Granular Cell Tumor,0
7596,Surgery specialty,Cancer of Urinary Tract,0
7597,History of previous events,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7598,various antiinfectives and antiseptics for local oral treatment,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7599,Measurement,Benign squamous cell tumor,0
7600,high - ActExposureLevelCode,Lung squamous cell carcinoma stage I,0
7601,Only - dosing instruction fragment,Recurrent Testicular Lymphoma,0
7602,Tumor site,Localized Askin Tumor,0
7603,Legal Adult,Endometrial Small Cell Carcinoma,0
7604,Surgical Replantation,Xeroderma pigmentosum,0
7605,Damage,Undifferentiated Endocervical Sarcoma,0
7606,Gram per Deciliter,Stage IV Colorectal Cancer AJCC v8,0
7607,BRCA2 protein,Splenic Manifestation of Hairy Cell Leukemia,0
7608,Often - answer to question,Non-Metastatic Gestational Trophoblastic Tumor,0
7609,Exostosis,Papillary squamous cell carcinoma,0
7610,Diagnosis Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7611,Dental caries,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7612,shared attribute,Bladder adenocarcinoma stage IV,0
7613,Heterogeneity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7614,Tumor Mass,Parathyroid Gland Adenocarcinoma,0
7615,United States Military Commissioned Officer O4,Blepharal carcinoma,0
7616,Include (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7617,2+,Neonatal leukemia,0
7618,Werner Syndrome,Malignant Testicular Sertoli Cell Tumor,0
7619,Vagina,FIGO Stage II Ovarian Cancer,0
7620,Infection of bone,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7621,include - SetOperator,Gallbladder adenoma,0
7622,Present,Leptomeningeal sarcoma,0
7623,Image Feature,Primary Cutaneous Plasmablastic Lymphoma,0
7624,Known,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7625,Occurrence Indicator,Airway Hemangioma,0
7626,Biopsy,Cervical Fibroepithelial Polyp,0
7627,High,non-Hodgkin's lymphoma of spleen,0
7628,SLC6A2 wt Allele,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7629,Consequence of,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
7630,Reporting,benign mature teratoma of pancreas,0
7631,Classification of information,Liver Lymphangioma,0
7632,Benign,Atypical Lobular Breast Hyperplasia,0
7633,Acute leukemia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7634,TARSAL-CARPAL COALITION SYNDROME,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7635,The Sun,Chest Wall Fibromatosis,0
7636,Patient need for (contextual qualifier),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7637,Mucous body substance,Bladder squamous cell carcinoma stage I,0
7638,Five-year Survival Rate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7639,Abundance,Pancreatic Intraepithelial Neoplasia-3,0
7640,Complication Aspects,Stage IV Childhood Non-Hodgkin Lymphoma,0
7641,Cancer Genus,Xeroderma pigmentosum,0
7642,biopsy characteristics,FIGO Stage II Ovarian Cancer,0
7643,North America,FIGO Stage II Ovarian Cancer,0
7644,Varies,FIGO Stage IVA Ovarian Cancer,0
7645,newly,Endometrial Small Cell Carcinoma,0
7646,Dietary Factors,Peripheral primitive neuroectodermal tumor of soft tissue,0
7647,Pelvic Pain,Squamous cell carcinoma of lip,0
7648,radiotherapeutic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7649,Togo,Liver Lymphangioma,0
7650,Descent,Type II Endometrial Adenocarcinoma,0
7651,Etiology aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7652,Deletion Mutation,Cystadenocarcinoma,0
7653,Malignant Neoplasms,Cerebral Primitive Neuroectodermal Tumor,0
7654,Histology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7655,Neuroendocrine Tumors,Cervical Fibroepithelial Polyp,0
7656,Skin lesion,Childhood Anaplastic Large Cell Lymphoma,0
7657,Tumor cells,Non-Hodgkin Lymphoma During Pregnancy,0
7658,Platelet Glycoprotein 4,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7659,Social Role,Thymoma malignant recurrent,0
7660,therapeutic aspects,Colorectal Neuroendocrine Tumor G2,0
7661,Hereditary Nonpolyposis Colorectal Cancer,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7662,Rating (action),Human Papillomavirus-Related Carcinoma,0
7663,Related personal status,Benign neoplasm of thorax,0
7664,Cells,Adult Hepatocellular Carcinoma,0
7665,Cancer Genus,Low Grade Squamous Intraepithelial Neoplasia,0
7666,Sweating,Childhood Fibrillary Astrocytoma,0
7667,>90,Chronic Myelomonocytic Leukemia-2,0
7668,Highest,Fibroadenoma of breast,0
7669,Type - attribute,Ichthyosis,0
7670,Choriocarcinoma,ICHTHYOSIS,0
7671,Lymphocyte component of blood,FIGO Stage IVA Ovarian Cancer,0
7672,Different,Childhood Anaplastic Large Cell Lymphoma,0
7673,Ependyma,Airway Hemangioma,0
7674,Grade three rank,Metastatic Lung Small Cell Carcinoma,0
7675,Fever,Leptomeningeal sarcoma,0
7676,Vaginal Sarcoma,Acute Undifferentiated Leukemia,0
7677,Malignant Neoplasms,Cervical Squamous Intraepithelial Neoplasia,0
7678,Cells,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
7679,Occur (action),Thyroid Hurthle Cell Carcinoma,0
7680,Cells,Bladder squamous cell carcinoma stage I,0
7681,Negative Surgical Margin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7682,Usually Need Help from Another Person for Reach,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7683,Occur (action),Spongiotic dermatitis,0
7684,Net (qualifier),Carcinoma of urinary bladder,0
7685,Receive,Refractory WHO Grade III Glioma,0
7686,intrathecal chemotherapy,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
7687,Category Type,Stage I Adult Non-Hodgkin Lymphoma,0
7688,Biomaterial Treatment,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
7689,Common Specifications in HL7 V3 Publishing,Childhood Central Nervous System Ganglioneuroblastoma,0
7690,Severe (severity modifier),Pancreatic carcinoma,0
7691,Causing,Fibroadenoma of breast,0
7692,Operative Surgical Procedures,Breast Ductal Adenoma,0
7693,Similarity,Recurrent Uveal Melanoma,0
7694,North America,Recurrent Uveal Melanoma,0
7695,Chest,Testicular cancer metastatic,0
7696,CEL gene,Low Grade Squamous Intraepithelial Neoplasia,0
7697,Usual,BRCA2 Syndrome,0
7698,size,Benign Anal Granular Cell Tumor,0
7699,Manifestation of,Kaposi's sarcoma of extrahepatic bile duct,0
7700,Vaginal wall,Breast Ductal Adenoma,0
7701,% volume (qualifier value),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7702,Lymphocyte component of blood,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7703,Subgroup A Nepoviruses,Congenital hamartoma,0
7704,Combined,Basal Cell Ameloblastoma,0
7705,Neoplasms,Giant cell angiofibroma,0
7706,include - SetOperator,Kaposi's sarcoma of extrahepatic bile duct,0
7707,Canis familiaris,Carcinomatosis of peritoneal cavity,0
7708,Crystal - human material,Undifferentiated Neuroblastoma,0
7709,In Blood,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7710,Malignant neoplasm of skin,Stage I Adult Non-Hodgkin Lymphoma,0
7711,Main,Cervical Squamous Intraepithelial Neoplasia,0
7712,Exposure to radiation,Colorectal High Grade B-Cell Lymphoma,0
7713,Chemotherapy,Metastatic Lung Small Cell Carcinoma,0
7714,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Carcinomatosis of peritoneal cavity,0
7715,Benign,Choroid Epithelioid Cell Melanoma,0
7716,Cancer Genus,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7717,Tissue Specimen Code,Stage IV Childhood Non-Hodgkin Lymphoma,0
7718,ultrasound device,Congenital hamartoma,0
7719,Structure of ciliary ganglion,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7720,Primary,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7721,Childhood Lymphoma,Childhood Anaplastic Large Cell Lymphoma,0
7722,Due to,Metastatic Lung Small Cell Carcinoma,0
7723,Two,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7724,Cancer,Stage III Adult Immunoblastic Lymphoma,0
7725,Study Site,benign mature teratoma of pancreas,0
7726,Night sweats,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7727,Flank Pain,Mucinous adenocarcinoma gastric,0
7728,cell growth,ALK positive large B-cell lymphoma,0
7729,Elderly (population group),Bladder adenocarcinoma stage IV,0
7730,Associated topography,Childhood Choriocarcinoma,0
7731,Largest,Human Papillomavirus-Related Carcinoma,0
7732,Childhood Myelodysplastic Syndrome,Benign Apocrine Neoplasm,0
7733,Degree Unit of Plane Angle,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7734,Human papilloma virus infection,Angiosarcoma of liver,0
7735,risk factors - observation list,FIGO Stage II Ovarian Cancer,0
7736,Tissue Specimen Code,Adult Anaplastic Oligodendroglioma,0
7737,Etiology aspects,Atypical Mesothelial Hyperplasia,0
7738,Decreasing,Benign neoplasm of eye,0
7739,Widening,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7740,Involvement with,Childhood Lung Non-Small Cell Carcinoma,0
7741,Spinal Cord,Stage III Cutaneous Melanoma AJCC v6,0
7742,Female Reproductive System,Grade 3a Malignant Neoplasm,0
7743,Biological Transport,Refractory Bladder Carcinoma,0
7744,Neck,Bladder Neuroendocrine Neoplasm,0
7745,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7746,Occurrence Indicator,Localized Askin Tumor,0
7747,Treating,Refractory Bladder Carcinoma,0
7748,Flushing,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7749,One,Pilocytic astrocytoma of cerebellum,0
7750,Unconscious State,Central Nervous System Yolk Sac Tumor,0
7751,Males,Occult Lung Adenosquamous Carcinoma,0
7752,Metabolic Syndrome X,Adult Hepatocellular Carcinoma,0
7753,Mild (qualifier value),Nasal cavity carcinoma,0
7754,Astrocytes,Primary Cutaneous Plasmablastic Lymphoma,0
7755,Management Occupations,Primary Cutaneous Plasmablastic Lymphoma,0
7756,Body part,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7757,Array Feature,Medulloblastoma,0
7758,Forecast of outcome,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7759,Component object,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7760,PSA Level Less than Two,Cerebral hemangioma,0
7761,Bone Marrow,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7762,Low Back Pain,Acute Undifferentiated Leukemia,0
7763,Platelet Glycoprotein 4,Pancreatic Intraepithelial Neoplasia-3,0
7764,Spreading (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7765,Human papillomavirus 16,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7766,Neonatal (qualifier value),Thymic Clear Cell Carcinoma,0
7767,Adult Ependymoma,Contact dermatitis due to alkali,0
7768,Third revision,Brain Tumor,0
7769,Progress,Benign squamous cell tumor,0
7770,Shapes,Engraftment syndrome,0
7771,Set of short ciliary nerves,Benign squamous cell tumor,0
7772,Usual,Familial Hemophagocytic Lymphocytosis,0
7773,Eyelid structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7774,Two,Precursor B-lymphoblastic lymphoma stage II,0
7775,Carcinoma of lung,Non-Hodgkin Lymphoma During Pregnancy,0
7776,human AVP protein,Small intestine carcinoma,0
7777,Irritation,Benign Anal Granular Cell Tumor,0
7778,In Blood,Atypical Mesothelial Hyperplasia,0
7779,Heart,Ovarian germ cell choriocarcinoma stage IV,0
7780,Symptoms,BRCA2 Syndrome,0
7781,Immune System Processes,Adult Acute Eosinophilic Leukemia,0
7782,Order (document),Stage 0 Penile Cancer AJCC v8,0
7783,Therapeutic procedure,Sarcomatoid Renal Cell Carcinoma,0
7784,Singular,sarcoma of spinal cord,0
7785,Multiple Myeloma,Precursor B-lymphoblastic lymphoma stage II,0
7786,2+ Score,Lung squamous cell carcinoma stage I,0
7787,Frequently,Refractory Ependymoma,0
7788,Mutation,Endometrial Small Cell Carcinoma,0
7789,Referring,Kaposi's sarcoma of skin,0
7790,Elderly (population group),Chronic Myelomonocytic Leukemia-2,0
7791,Pain control,Extra-abdominal fibromatosis,0
7792,Mental concentration,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7793,Five,Unresectable Rhabdomyosarcoma,0
7794,Menopause,embryonal rhabdomyosarcoma of prostate,0
7795,shared attribute,Chest Wall Fibromatosis,0
7796,Cancer Genus,embryonal rhabdomyosarcoma of prostate,0
7797,data type - ratio,Bladder squamous cell carcinoma stage I,0
7798,Very,Extra-Adrenal Paraganglioma,0
7799,Mathematical Factor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7800,Result,Mucinous cystadenofibroma,0
7801,stage,Periosteal Osteosarcoma,0
7802,Tissue damage,benign mature teratoma of pancreas,0
7803,Laser plant,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7804,Carcinoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7805,Specimen Source Codes - Lesion,Benign neoplasm of eye,0
7806,Diffuse Large B-Cell Lymphoma,Acantholytic squamous cell carcinoma,0
7807,Seizures,Breast Apocrine Adenoma,0
7808,Progress,Hereditary corneal dystrophy,0
7809,ovarian,Clonal Hematopoiesis of Indeterminate Potential,0
7810,1000000,Cerebral Primitive Neuroectodermal Tumor,0
7811,Less Than,Astrocytoma of brain,0
7812,West (direction),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7813,Age-Years,Undifferentiated Neuroblastoma,0
7814,Exposure to,Vaginal Adenoma,0
7815,*Type - Kind of quantity,Anterior Urethral Malignant Neoplasm,0
7816,Debris,Cervical Adenomyoma,0
7817,Spreading (qualifier value),Refractory Bladder Carcinoma,0
7818,Connect,Benign squamous cell tumor,0
7819,Common (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
7820,Low Mitosis-Karyorrhexis Index,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7821,Skin,Malignant Testicular Sertoli Cell Tumor,0
7822,Tumor Mass,Stage III Adult Immunoblastic Lymphoma,0
7823,Common Specifications in HL7 V3 Publishing,adenosquamous carcinoma of breast,0
7824,Chemotherapy Regimen,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7825,Treatment Epoch,Stage 0 Lip Carcinoma,0
7826,melanoma,Anaplastic large cell lymphoma,0
7827,Occur (action),papillary carcinoma of penis,0
7828,peripheral blood,Kaposi's sarcoma of extrahepatic bile duct,0
7829,Beginning,Cancer of Urinary Tract,0
7830,Affect (mental function),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7831,Usually Need Help from Another Person for Reach,Acute Undifferentiated Leukemia,0
7832,>90,Unfavorable Non-Hodgkin Lymphoma,0
7833,Affecting,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7834,Reproduction,Keratoderma,0
7835,Spreading (qualifier value),Localized Malignant Neoplasm,0
7836,Page (document),Unfavorable Non-Hodgkin Lymphoma,0
7837,Leading,Mucinous adenocarcinoma,0
7838,Greater,Cerebral Primitive Neuroectodermal Tumor,0
7839,GUCY2C wt Allele,Colorectal cancer,0
7840,International Aspects,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7841,Daily,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7842,PDGFRB gene,Locally Advanced Squamous Cell Carcinoma,0
7843,Compressed structure,Leiomyoma of Gallbladder,0
7844,75,Grade 3a Malignant Neoplasm,0
7845,Complication,Type II Endometrial Adenocarcinoma,0
7846,Urine,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7847,Blood Vessel,Spermatocytic seminoma,0
7848,year,Adrenal Rest Tumor,0
7849,Birthmark,Small intestine carcinoma,0
7850,Cell Count,Cancer of Urinary Tract,0
7851,Glycation End Products,Undifferentiated Endocervical Sarcoma,0
7852,Portion of urine,Diffuse malignant mesothelioma,0
7853,Cervical dysplasia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7854,Low Back Pain,Thyroid Hurthle Cell Carcinoma,0
7855,Brain,Transitional cell carcinoma,0
7856,First (number),Squamous cell carcinoma of lip,0
7857,Including (qualifier),Clinical Stage I Cutaneous Melanoma AJCC v8,0
7858,Infrequent,Carcinoma of urinary bladder,0
7859,Overall Publication Type,Recurrent Primary Lymphoma of Bone,0
7860,Treating,Endometrial Small Cell Carcinoma,0
7861,Adult human body,Mixed parotid tumor,0
7862,Blood,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7863,Tanning of leather,Thyroid Hurthle Cell Carcinoma,0
7864,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
7865,Infrequent,Pancreatic Intraepithelial Neoplasia-3,0
7866,Mass,Astrocytoma of brain,0
7867,84,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7868,Risk,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7869,<50,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7870,Senile Plaques,Leiomyoma of Gallbladder,0
7871,Hematologic Tests,Recurrent Uveal Melanoma,0
7872,Papillary serous cystadenocarcinoma,Endometrial Small Cell Carcinoma,0
7873,Cicatrix,carcinoma of middle ear,0
7874,N not otherwise specified Antibody,Granular Cell Leiomyosarcoma,0
7875,Person 1,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7876,First (number),Undifferentiated Endocervical Sarcoma,0
7877,Referring,Nasal cavity carcinoma,0
7878,Leading,Nasal cavity carcinoma,0
7879,Relational and Item-Specific Encoding Task,Cervical Fibroepithelial Polyp,0
7880,Injection of therapeutic agent,sarcoma of spinal cord,0
7881,World Health Organization,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7882,Screening for cancer,Xeroderma pigmentosum,0
7883,Benign Smooth Muscle Neoplasm,Acantholytic squamous cell carcinoma,0
7884,Different,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7885,Common Specifications in HL7 V3 Publishing,embryonal rhabdomyosarcoma of prostate,0
7886,Shortness of breath:-:Point in time:^Patient:-,Refractory Bladder Carcinoma,0
7887,Usually Need Help from Another Person for Reach,Anterior Urethral Malignant Neoplasm,0
7888,include - SetOperator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7889,Tryptophanase,Metastatic Carcinoma in the Lung,0
7890,Malignant neoplasm of duodenum,mucinous adenocarcinoma of gallbladder,0
7891,New,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7892,1000000,Refractory Bladder Carcinoma,0
7893,biopsy characteristics,Peripheral primitive neuroectodermal tumor of soft tissue,0
7894,Decision,Refractory Ependymoma,0
7895,Site of,Localized Ewing Sarcoma,0
7896,All of the Time,Spindle Cell Melanoma,0
7897,Delayed Puberty,Mucinous adenocarcinoma,0
7898,bony process,sarcoma of spinal cord,0
7899,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Mucinous adenocarcinoma gastric,0
7900,Type - attribute,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
7901,Feelings,Stage IB Pancreatic Cancer AJCC v8,0
7902,Imbrication (procedure),Vaginal Adenoma,0
7903,Adult Lymphoma,Clonal Hematopoiesis of Indeterminate Potential,0
7904,Adult human body,Malignant Testicular Sertoli Cell Tumor,0
7905,Intestines,Refractory Ependymoma,0
7906,Uveal melanoma,Lipoma of small intestine,0
7907,Measures (attribute),Adult Hepatocellular Carcinoma,0
7908,Detection,clear cell adenocarcinoma of gallbladder,0
7909,Body structure,Benign squamous cell tumor,0
7910,Appearance,clear cell adenocarcinoma of gallbladder,0
7911,Congenital defects,Kaposi's sarcoma of extrahepatic bile duct,0
7912,device aspects,Benign tumor of eyelid,0
7913,Tryptophanase,Astrocytoma of brain,0
7914,cell type,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7915,Evaluation,GIANT PIGMENTED HAIRY NEVUS,0
7916,newly,Carcinoma,0
7917,Biomaterial Treatment,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7918,Expected,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7919,Morphology,Childhood Choriocarcinoma,0
7920,Type A,Benign Anal Granular Cell Tumor,0
7921,Character String Data Type,Giant cell angiofibroma,0
7922,Salivary Glands,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7923,Tryptophanase,Type II Endometrial Adenocarcinoma,0
7924,Bladder Continence Question,Cervical Adenomyoma,0
7925,Induce (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
7926,Occurrence,Angiosarcoma of liver,0
7927,80%,Recurrent Primary Lymphoma of Bone,0
7928,Stage Grouping,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7929,Squamous cell carcinoma - category,Collecting Duct Carcinoma of the Kidney,0
7930,Tryptophanase,Mixed astrocytoma-ependymoma,0
7931,Superkingdom (taxonomic category),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7932,Good,Stage 0 Lip Carcinoma,0
7933,Tryptophanase,Maxillary Sinus Adenocarcinoma,0
7934,Embryonal Rhabdomyosarcoma,Airway Hemangioma,0
7935,All nervous tissue,Leiomyoma of Gallbladder,0
7936,Infection,Diffuse malignant mesothelioma,0
7937,Overlap,Chest Wall Fibromatosis,0
7938,Lymphocyte,Malignant melanoma of eyelid,0
7939,AS virus,Recurrent Primary Lymphoma of Bone,0
7940,Family history,Intestinal Metaplasia of Bladder Urothelium,0
7941,Common Specifications in HL7 V3 Publishing,Diffuse malignant mesothelioma,0
7942,borderline ovarian tumor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7943,Affect (mental function),Xeroderma pigmentosum,0
7944,Common Specifications in HL7 V3 Publishing,Fourth Ventricle and Brain Stem Ependymal Tumor,0
7945,What subject filter - Result,Carcinoma ex pleomorphic adenoma of parotid gland,0
7946,Logical Condition,Localized Askin Tumor,0
7947,General surgery specialty,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7948,Spreading (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7949,Malignant - descriptor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7950,Case (situation),Cherubism,0
7951,Late,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7952,Treatment Epoch,Secondary malignant neoplasm of lymph node,0
7953,Account number:Identifier:Point in time:^Patient:Nominal,Type II Endometrial Adenocarcinoma,0
7954,Chemotherapy Regimen,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
7955,Interstitial Route of Drug Administration,Cervical Fibroepithelial Polyp,0
7956,Study Element,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7957,Arising in,Bladder squamous cell carcinoma stage I,0
7958,Organ Transplantation,Placental aromatase deficiency,0
7959,Cancer Genus,papillary carcinoma of penis,0
7960,Ventricle,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7961,One,Bladder adenocarcinoma stage IV,0
7962,Section - Geographic Area,Gallbladder Adenocarcinoma,0
7963,Interpretation Process,Acantholytic squamous cell carcinoma,0
7964,List,Gallbladder Adenocarcinoma,0
7965,Visit,Intraepithelial Melanocytic Hyperplasia,0
7966,Exclude,Splenic Manifestation of Hairy Cell Leukemia,0
7967,Multiple Myeloma,Kaposi's sarcoma of extrahepatic bile duct,0
7968,Therapeutic radiology procedure,Clonal Hematopoiesis of Indeterminate Potential,0
7969,Electrolyte [EPC],Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7970,95,Trabecular adenocarcinoma,0
7971,Body structure,Brain Tumor,0
7972,Morphology,Acute Undifferentiated Leukemia,0
7973,Publishing,Localized Malignant Neoplasm,0
7974,Childhood Lymphoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7975,Tryptophanase,FIGO Stage IVA Ovarian Cancer,0
7976,Colon structure (body structure),Secondary malignant neoplasm of lymph node,0
7977,Body tissue,Diffuse malignant mesothelioma,0
7978,Distal (qualifier value),Benign neoplasm of eye,0
7979,Effectiveness,Papillary squamous cell carcinoma,0
7980,other medicated shampoos in ATC,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7981,Side,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7982,United States,Metaplastic carcinoma of breast,0
7983,Unknown GENC,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7984,Upper,Female Breast Carcinoma,0
7985,IPSS Risk Category High,Maxillary Sinus Adenoid Cystic Carcinoma,0
7986,United States,Adenocarcinoma,0
7987,1980s,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
7988,Two,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
7989,High risk of,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7990,Established,Neonatal leukemia,0
7991,Persons,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7992,Main,Benign neoplasm of eye,0
7993,Persistent,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
7994,Case (situation),ROSE Cluster 3,0
7995,Forecast of outcome,Intraepithelial Melanocytic Hyperplasia,0
7996,treatment - ActInformationManagementReason,Diffuse malignant mesothelioma,0
7997,Intervention regimes,Childhood Thyroid Gland Follicular Carcinoma,0
7998,Occurrence,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7999,Fungal,Primary Cutaneous Plasmablastic Lymphoma,0
8000,Symptoms,FIGO Stage IVA Ovarian Cancer,0
8001,Poverty,Refractory Ependymoma,0
8002,Occur (action),Anterior Urethral Malignant Neoplasm,0
8003,Lung diseases,Stage IB Pancreatic Cancer AJCC v8,0
8004,Infrequent,Thymic Clear Cell Carcinoma,0
8005,Adult Teratoma,High Grade Glandular Intraepithelial Neoplasia,0
8006,Primary,Medulloblastoma,0
8007,Metastatic malignant neoplasm to brain,Chest Wall Fibromatosis,0
8008,Serous,Engraftment syndrome,0
8009,diagnosis aspect,sarcoma of spinal cord,0
8010,Often - answer to question,Pleomorphic adenoma of parotid gland,0
8011,cell transformation,Larynx carcinoma recurrent,0
8012,Neoadjuvant Therapy Clinical Trial Setting,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8013,Separate,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8014,research,Chronic Myelomonocytic Leukemia-2,0
8015,Surgical aspects,Stage I Colon Neuroendocrine Tumor AJCC v8,0
8016,Symptoms,adenoid cystic carcinoma of lung,0
8017,Reside,Malignant melanoma of eyelid,0
8018,10%,Childhood Central Nervous System Ganglioneuroblastoma,0
8019,Greater Than,Heavy Chain Deposition Disease,0
8020,Have Been Coughing,Brain Tumor,0
8021,Slow,Intestinal Metaplasia of Bladder Urothelium,0
8022,United States,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
8023,Html Link Type - index,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8024,Astrocytes,Metastatic Kidney Carcinoma,0
8025,Woman,Benign tumor of eyelid,0
8026,Give - dosing instruction imperative,Benign neoplasm of thorax,0
8027,Person Observer,Mixed astrocytoma-ependymoma,0
8028,development aspects,Primary Cutaneous Plasmablastic Lymphoma,0
8029,Carcinoid Tumor,Intestinal Neuroendocrine Carcinoma,0
8030,Decreasing,Mixed parotid tumor,0
8031,Cervical Atlas,Localized Askin Tumor,0
8032,Surgical aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8033,Known,Occult Lung Adenosquamous Carcinoma,0
8034,Neoplasms,Endometrial Small Cell Carcinoma,0
8035,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8036,Woman,embryonal rhabdomyosarcoma of prostate,0
8037,Persons,Congenital hamartoma,0
8038,Injury due to exposure to external cause,Locally Advanced Soft Tissue Sarcoma,0
8039,Beginning,Fibroadenoma of breast,0
8040,Peritoneum,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8041,Social Networks,Hodgkin Disease,0
8042,Hematologic Tests,Diffuse malignant mesothelioma,0
8043,Liver carcinoma,Trichilemmocarcinoma,0
8044,Blood,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8045,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8046,Precision - characteristic,Platinum-Resistant Lung Small Cell Carcinoma,0
8047,various allergen extracts,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8048,Tryptophanase,Clonal Hematopoiesis of Indeterminate Potential,0
8049,Etiology aspects,Pancreatic Intraepithelial Neoplasia-3,0
8050,General surgery specialty,Stage IB Lung Cancer AJCC v7,0
8051,Occurrence Indicator,Peripheral primitive neuroectodermal tumor of soft tissue,0
8052,Techniques,Hemangioma,0
8053,Primary malignant neoplasm,Uterine Cancer,0
8054,1.1,Localized Askin Tumor,0
8055,Recommendation,Adenocarcinoma,0
8056,Diagnosis Study,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8057,900,squamous cell carcinoma of the thyroid gland,0
8058,Per Millimeter,gliosarcoma,0
8059,H/O: malignant neoplasm,Stage IV Colorectal Cancer AJCC v8,0
8060,Long-term,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8061,british,Pancreatic Intraepithelial Neoplasia-3,0
8062,Groups,Childhood Fibrillary Astrocytoma,0
8063,metaplastic cell transformation,Extra-abdominal fibromatosis,0
8064,Disease,Granular Cell Leiomyosarcoma,0
8065,pharmacotherapeutic,Malignant neoplasm of subglottis,0
8066,Microscopes,Recurrent Rhabdomyosarcoma,0
8067,Severe (severity modifier),embryonal rhabdomyosarcoma of prostate,0
8068,Event Seriousness - Significant,Localized Malignant Neoplasm,0
8069,Subgroup,Malignant melanoma of eyelid,0
8070,Band form,FIGO Stage II Ovarian Cancer,0
8071,Occurrence Indicator,Trichilemmocarcinoma,0
8072,External lower lip,Maxillary Sinus Adenoid Cystic Carcinoma,0
8073,N+ (tumor staging),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8074,Symptoms aspect,Medulloblastoma,0
8075,Formation,Kaposi's sarcoma of extrahepatic bile duct,0
8076,*Type - Kind of quantity,Low Grade Squamous Intraepithelial Neoplasia,0
8077,Transitional cell morphology,Neoplasms,0
8078,Anterior portion of neck,Unicystic ameloblastoma,0
8079,Myalgia,Nasal cavity carcinoma,0
8080,Result,Bladder squamous cell carcinoma stage I,0
8081,Tobacco smoking behavior,Heavy Chain Deposition Disease,0
8082,Uvea,Sarcomatoid Renal Cell Carcinoma,0
8083,Possible diagnosis,Clonal Hematopoiesis of Indeterminate Potential,0
8084,Smear - instruction imperative,Serous cystadenocarcinoma ovary,0
8085,Sporadically,Endometrial Small Cell Carcinoma,0
8086,Meaning,Malignant neoplasm of gallbladder,0
8087,Drugs used in migraine prophylaxis,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
8088,Loss of appetite (finding),Chondrosarcoma,0
8089,Include (action),Heavy Chain Deposition Disease,0
8090,Lymphocyte,Undifferentiated Neuroblastoma,0
8091,Minor (value),Malignant neoplasm of gallbladder,0
8092,Overall,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
8093,Derivation,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8094,Small,Stage I Colon Neuroendocrine Tumor AJCC v8,0
8095,Include (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
8096,Often - answer to question,Pancreatic carcinoma,0
8097,Lymphocyte component of blood,Localized Malignant Neoplasm,0
8098,Confirmed by,Human Papillomavirus-Related Carcinoma,0
8099,Adult Angiosarcoma,Metastatic Kidney Carcinoma,0
8100,Overall,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8101,CDISC SDTM Procedure Terminology,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
8102,Active,Trabecular adenocarcinoma,0
8103,Face,Refractory Ependymoma,0
8104,Esophagus,Adult Acute Eosinophilic Leukemia,0
8105,Occurrence Indicator,Xeroderma pigmentosum,0
8106,Vertebral column,Acute Undifferentiated Leukemia,0
8107,Overall Publication Type,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8108,Disease,Platinum-Resistant Lung Small Cell Carcinoma,0
8109,Areas <moth>,Diffuse malignant mesothelioma,0
8110,Malignant neoplasm of urinary bladder,Recurrent Uveal Melanoma,0
8111,Solid,Adenocarcinoma,0
8112,Referring,Locally Advanced Carcinoma,0
8113,*Type - Kind of quantity,FIGO Stage II Ovarian Cancer,0
8114,Smear - instruction imperative,Testicular cancer metastatic,0
8115,Solid,Methotrexate-Associated Hodgkin Lymphoma,0
8116,Microscopic,Benign Carotid Body Paraganglioma,0
8117,Usual,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
8118,Insecticides,Splenic Manifestation of Hairy Cell Leukemia,0
8119,Immature Cell Count (laboratory procedure),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8120,Time,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8121,Skin,Melanomatosis,0
8122,Publications,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8123,Neoplasm Metastasis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8124,Literature,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8125,pharmacotherapeutic,Pancreatic Intraepithelial Neoplasia-3,0
8126,preference,Chronic Myelomonocytic Leukemia-2,0
8127,Most,Melanomatosis,0
8128,Often - answer to question,Metastatic Ductal Breast Carcinoma,0
8129,Dosing Days to Detection,Stage 0 Penile Cancer AJCC v8,0
8130,Process (qualifier value),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
8131,Most,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8132,veterans alcoholism screening test (VAST),Kaposi's sarcoma of extrahepatic bile duct,0
8133,Survival Rate,Mucinous adenocarcinoma gastric,0
8134,Pale color,Mucinous adenocarcinoma,0
8135,Adult Alveolar Soft Part Sarcoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8136,Symptoms aspect,Acute Undifferentiated Leukemia,0
8137,Very High Level,FIGO Stage II Ovarian Cancer,0
8138,Odontogenesis,Intraepithelial Melanocytic Hyperplasia,0
8139,One,Mucinous adenocarcinoma gastric,0
8140,Only - dosing instruction fragment,Ovarian Carcinoid Tumor,0
8141,site-specific telomere resolvase activity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8142,Europe,Testicular cancer metastatic,0
8143,IPSS Risk Category High,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8144,Malignant Neoplasms,papillary carcinoma of penis,0
8145,Case unit dose,Refractory WHO Grade III Glioma,0
8146,Fatigue,Childhood Extragonadal Malignant Germ Cell Tumor,0
8147,75,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8148,Males,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8149,Hematuria,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8150,*Type - Kind of quantity,adenosquamous carcinoma of breast,0
8151,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Stage IV Penile Cancer AJCC v7,0
8152,cell type,clear cell adenocarcinoma of gallbladder,0
8153,Affecting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8154,Guide device,Type II Endometrial Adenocarcinoma,0
8155,status - In progress,Kaposi's sarcoma of extrahepatic bile duct,0
8156,Cessation of life,Rhabdomyosarcoma with ganglionic differentiation,0
8157,Most,Melanomatosis,0
8158,Administration Method - Infiltrate,Stage IV Colorectal Cancer AJCC v8,0
8159,Hormonal,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8160,solid substance,Diffuse malignant mesothelioma,0
8161,Gait normal,embryonal rhabdomyosarcoma of prostate,0
8162,90%,Familial Hemophagocytic Lymphocytosis,0
8163,CEL gene,Neonatal leukemia,0
8164,Frequently,Adult Alveolar Soft Part Sarcoma,0
8165,Tissue Specimen Code,Acute Undifferentiated Leukemia,0
8166,65,Pancreatic carcinoma,0
8167,Following,Metastatic Malignant Neoplasm in the Sellar Region,0
8168,Name,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8169,65,Medulloblastoma,0
8170,Greater,Stage IV Childhood Non-Hodgkin Lymphoma,0
8171,Age at menopause,Mucinous adenocarcinoma,0
8172,Histopathologic Grade differentiation,Kaposi's sarcoma of skin,0
8173,Major <insect>,Undifferentiated Endocervical Sarcoma,0
8174,Epithelioma,gliosarcoma,0
8175,Breaking down,Malignant Neoplasm with Regional Lymph Node Involvement,0
8176,Extraction,Type II Endometrial Adenocarcinoma,0
8177,Hematologic Neoplasms,Hodgkin lymphoma,0
8178,Neck,Localized Askin Tumor,0
8179,Primary malignant neoplasm,Refractory Barrett Esophagus,0
8180,Confirmation,Chest Wall Fibromatosis,0
8181,Child,Childhood Central Nervous System Ganglioneuroblastoma,0
8182,invasive cancer,Clonal Hematopoiesis of Indeterminate Potential,0
8183,Third ventricle structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8184,Problems - What subject filter,Uterine Cancer,0
8185,Electromagnetic Fields,Low Grade Squamous Intraepithelial Neoplasia,0
8186,Anabolism,Angiosarcoma of liver,0
8187,Blood Proteins,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8188,Characterization,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8189,CEL gene,embryonal rhabdomyosarcoma of prostate,0
8190,Macrophage Activation Syndrome,Recurrent Primary Lymphoma of Bone,0
8191,Involvement with,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
8192,Risk,Diffuse malignant mesothelioma,0
8193,Bloating,squamous cell carcinoma of the thyroid gland,0
8194,Mass of body structure,Stage IV Colorectal Cancer AJCC v8,0
8195,Certain (qualifier value),Mucinous adenocarcinoma gastric,0
8196,Geographic Locations,Intestinal Metaplasia of Bladder Urothelium,0
8197,Frequently,Recurrent Primary Lymphoma of Bone,0
8198,Body Excretions,Recurrent Primary Lymphoma of Bone,0
8199,Human papilloma virus infection,Cartilaginous exostosis,0
8200,Plasma Cells,Malignant melanoma of eyelid,0
8201,Rare,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8202,Primary sclerosing cholangitis,Localized Askin Tumor,0
8203,Affecting,Mixed astrocytoma-ependymoma,0
8204,Classification,Stage II Carcinoma of Penis,0
8205,Complete Trisomy 21 Syndrome,Bladder adenocarcinoma stage IV,0
8206,Major,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8207,Disease Outbreaks,Angiosarcoma of liver,0
8208,Either,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8209,include - SetOperator,Tonsillar Carcinoma,0
8210,Manufactured sign,Benign Carotid Body Paraganglioma,0
8211,Slight (qualifier value),Mixed astrocytoma-ependymoma,0
8212,Colon structure (body structure),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8213,65+,Squamous cell carcinoma of lip,0
8214,Related personal status,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8215,Common Specifications in HL7 V3 Publishing,Childhood Choriocarcinoma,0
8216,Smear - instruction imperative,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8217,Time,Localized Malignant Neoplasm,0
8218,Inflammation,Nasal cavity carcinoma,0
8219,Percent of Abnormal Cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8220,Present,Kaposi's sarcoma of extrahepatic bile duct,0
8221,Cicatrix,Rhabdomyosarcoma with ganglionic differentiation,0
8222,Pap smear,Mixed parotid tumor,0
8223,Related personal status,Diffuse malignant mesothelioma,0
8224,Tryptophanase,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8225,Term (temporal),Diffuse malignant mesothelioma,0
8226,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Uterine Cancer,0
8227,Lymphocyte Count measurement,Fibroadenoma of breast,0
8228,2+ Score,Recurrent Testicular Lymphoma,0
8229,Ewings sarcoma,Tonsillar Carcinoma,0
8230,Precision - second,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8231,Diagnosis Study,Childhood Fibrillary Astrocytoma,0
8232,Malignant Neoplasms,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8233,Experimental Result,Type II Endometrial Adenocarcinoma,0
8234,Numerous,Recurrent Uveal Melanoma,0
8235,One,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8236,shared attribute,malignant lymphoma of pancreatic lymph nodes,0
8237,Discharge,FIGO Stage IVA Ovarian Cancer,0
8238,Data operation - complete,Kaposi's sarcoma of extrahepatic bile duct,0
8239,Rate,Undifferentiated Endocervical Sarcoma,0
8240,lymphatic cancer,Diffuse malignant mesothelioma,0
8241,Childhood Non-Hodgkin Lymphoma,Splenic Manifestation of Hairy Cell Leukemia,0
8242,Poles,Medulloblastoma,0
8243,Change -- procedure,Basal Cell Ameloblastoma,0
8244,high - ActExposureLevelCode,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
8245,Woman,Stage IB Lung Cancer AJCC v7,0
8246,Supportive assistance,Kaposi's sarcoma of skin,0
8247,Very Much,Platinum-Resistant Lung Small Cell Carcinoma,0
8248,Relate - vinyl resin,Stage IV Childhood Non-Hodgkin Lymphoma,0
8249,Bladder Cancer Pathway,FIGO Stage II Ovarian Cancer,0
8250,Tryptophanase,Choroid Necrotic Melanoma,0
8251,Chromosomes,Benign Ovarian Thecoma,0
8252,Body tissue,Undifferentiated Neuroblastoma,0
8253,Result,adenosquamous carcinoma of breast,0
8254,site-specific telomere resolvase activity,Mucinous cystadenofibroma,0
8255,List,Urethral Carcinoma,0
8256,Substance,Metaplastic carcinoma of breast,0
8257,Foreskin of penis,mucinous adenocarcinoma of gallbladder,0
8258,include - SetOperator,Hodgkin Disease,0
8259,Mucoepidermoid Carcinoma,Localized Ewing Sarcoma,0
8260,Aspects of signs,BRCA2 Syndrome,0
8261,Breast Feeding,Angiosarcoma of liver,0
8262,Mutation Abnormality,Acute lymphadenitis,0
8263,CD44 wt Allele,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8264,Cancer Genus,Refractory WHO Grade III Glioma,0
8265,Manufactured form,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8266,Histology aspects,Multiple Skull Base Meningiomas,0
8267,Tests (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
8268,Biopsy,Vaginal Adenoma,0
8269,Precancerous Conditions,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8270,United States,Malignant Testicular Sertoli Cell Tumor,0
8271,Physical shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8272,Lymphoid Cell Count,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8273,Bladder Continence Question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8274,All of the Time,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8275,Pallor,Intraepithelial Melanocytic Hyperplasia,0
8276,Problems - What subject filter,Peripheral primitive neuroectodermal tumor of soft tissue,0
8277,Secretory Vesicles,non-Hodgkin's lymphoma of spleen,0
8278,UV Radiation,Atypical Lobular Breast Hyperplasia,0
8279,General surgery specialty,Hereditary Diffuse Gastric Adenocarcinoma,0
8280,high - ActExposureLevelCode,Unresectable Rhabdomyosarcoma,0
8281,To,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8282,Occur (action),Intraepithelial Melanocytic Hyperplasia,0
8283,Common (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8284,various antiseptic throat preparations,Mucinous adenocarcinoma,0
8285,Females,BRCA2 Syndrome,0
8286,Classes - encounter,Peripheral primitive neuroectodermal tumor of soft tissue,0
8287,Malignant Neoplasms,Recurrent Testicular Lymphoma,0
8288,800,Methotrexate-Associated Hodgkin Lymphoma,0
8289,N not otherwise specified Antibody,Ovarian germ cell choriocarcinoma stage IV,0
8290,Cell secretion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8291,Form:Finding:Point in time:{Setting}:Document:{Role},Lipoma of small intestine,0
8292,Apply,Acantholytic squamous cell carcinoma,0
8293,Nevus,Cerebral Primitive Neuroectodermal Tumor,0
8294,competitive advantage,Heavy Chain Deposition Disease,0
8295,Type - attribute,Unicystic ameloblastoma,0
8296,In addition to,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8297,The Sun,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
8298,Medical Drop,Metaplastic carcinoma of breast,0
8299,Genus Axis,Small intestine carcinoma,0
8300,Ductal Breast Carcinoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8301,Therapeutic radiology procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8302,diagnostic procedure,Maxillary Sinus Adenoid Cystic Carcinoma,0
8303,Body Fluids,Anaplastic large cell lymphoma,0
8304,Rare Diseases,Testicular cancer metastatic,0
8305,shared attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8306,Usual Severity Weight Loss,Stage III Cutaneous Melanoma AJCC v6,0
8307,Certain (qualifier value),Familial Hemophagocytic Lymphocytosis,0
8308,Adenolymphoma,Cerebral Primitive Neuroectodermal Tumor,0
8309,Occurrence Indicator,Stage IV Childhood Non-Hodgkin Lymphoma,0
8310,Life,Digestive System Hodgkin Lymphoma,0
8311,Before,Mixed astrocytoma-ependymoma,0
8312,Congenital MeSH qualifier,Pancreatic Intraepithelial Neoplasia-3,0
8313,Pathogenic organism,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8314,Cessation of life,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
8315,Effective,Cartilaginous exostosis,0
8316,Stop (qualifier value),Chest Wall Fibromatosis,0
8317,Black race,Refractory Bladder Carcinoma,0
8318,Call (Instruction),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8319,Near,Brain Tumor,0
8320,Loss of Appetite question,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8321,Negation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8322,Sacrifice,Splenic Manifestation of Hairy Cell Leukemia,0
8323,Nervous system problem,Adenocarcinoma,0
8324,Endoscopy (procedure),Low Grade Squamous Intraepithelial Neoplasia,0
8325,Muscle of arm,Ichthyoses,0
8326,Early disease stage,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8327,active (HL7 RoleLink),Undifferentiated Endocervical Sarcoma,0
8328,Importance Rating Score 0,Gallbladder Adenocarcinoma,0
8329,Type A,Papillary squamous cell carcinoma,0
8330,2+,Digestive System Hodgkin Lymphoma,0
8331,Involvement with,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8332,Occurrence,Advanced Uterine Corpus Carcinosarcoma,0
8333,Formation,Digestive System Hodgkin Lymphoma,0
8334,Frequently,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
8335,How Much Distress Shortness of Breath,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8336,Known,Childhood Central Nervous System Ganglioneuroblastoma,0
8337,75,Testicular cancer metastatic,0
8338,contextual factors,malignant lymphoma of pancreatic lymph nodes,0
8339,Percent of Abnormal Cells,Stage I Adult Non-Hodgkin Lymphoma,0
8340,Astrocytes,Tubal Hyperplasia,0
8341,Upper arm,Metastatic Carcinoma in the Lung,0
8342,Togo,Nasal cavity carcinoma,0
8343,Characterization,Splenic Manifestation of Hairy Cell Leukemia,0
8344,Patients,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8345,Thymus <angiosperm>,Human Papillomavirus-Related Carcinoma,0
8346,Adult human body,Trabecular adenocarcinoma,0
8347,Web Site,Maxillary Sinus Adenocarcinoma,0
8348,Occurrence,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8349,shared attribute,Carcinoma of urinary bladder,0
8350,Slightly (qualifier value),FIGO Stage II Ovarian Cancer,0
8351,Chorioamnionitis,Chest Wall Fibromatosis,0
8352,Germ Cells,Thymic Atypical Carcinoid Tumor,0
8353,Spinal Cord,Bladder adenocarcinoma stage IV,0
8354,Squamous cell carcinoma - category,Platinum-Resistant Lung Small Cell Carcinoma,0
8355,Cerebral hemisphere structure (body structure),Bladder squamous cell carcinoma stage I,0
8356,Main,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8357,Intercellular Junctions,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8358,various other agents for local oral treatment in ATC,Mastocytosis,0
8359,depend,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8360,Pain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8361,Solid,Benign squamous cell tumor,0
8362,Immune System Finding,Acute Undifferentiated Leukemia,0
8363,Similarity,Locally Advanced Epithelioid Hemangioendothelioma,0
8364,Back structure,Diffuse malignant mesothelioma,0
8365,Chemotherapy,ROSE Cluster 3,0
8366,evaporation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8367,>40 years,Periosteal Osteosarcoma,0
8368,School Grade,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8369,Morning,Acantholytic squamous cell carcinoma,0
8370,Various patch test substance,Malignant Testicular Sertoli Cell Tumor,0
8371,low confidentiality,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8372,Main,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8373,Contain (action),Non-Metastatic Gestational Trophoblastic Tumor,0
8374,Time,Kaposi's sarcoma of extrahepatic bile duct,0
8375,Covers (device),Stage IV Colorectal Cancer AJCC v8,0
8376,Type - attribute,clear cell adenocarcinoma of gallbladder,0
8377,Version,Liver Lymphangioma,0
8378,Affect (mental function),Intraepithelial Melanocytic Hyperplasia,0
8379,analysis aspect,squamous cell carcinoma of the thyroid gland,0
8380,Order (taxonomic),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8381,Cover (physical object),Malignant Neoplasm with Regional Lymph Node Involvement,0
8382,Neoplastic disease,Anterior Urethral Malignant Neoplasm,0
8383,Metastatic Neoplasm,Undifferentiated Endocervical Sarcoma,0
8384,Name,Gallbladder Adenocarcinoma,0
8385,Diagnosis,Intestinal Metaplasia of Bladder Urothelium,0
8386,Used by,Adult Acute Eosinophilic Leukemia,0
8387,Colon structure (body structure),Female Breast Carcinoma,0
8388,Radiation Ionizing Radiotherapy,Hereditary Diffuse Gastric Adenocarcinoma,0
8389,Bothered by Vomiting,Thymoma malignant recurrent,0
8390,Symptoms aspect,Locally Advanced Epithelioid Hemangioendothelioma,0
8391,Bayer Corneal Epitheliopathy Grade 3,Benign Apocrine Neoplasm,0
8392,Numerous,Female Breast Carcinoma,0
8393,Head and Neck Carcinoma,Mucinous adenocarcinoma gastric,0
8394,International Statistical Classification of Diseases and Related Health Problems,Tubal Hyperplasia,0
8395,Upper Respiratory Infections,Xeroderma pigmentosum,0
8396,With shape,Type II Endometrial Adenocarcinoma,0
8397,Duct (organ) structure,Squamous cell carcinoma of lip,0
8398,Include (action),Benign Anal Granular Cell Tumor,0
8399,Southern Europe,Anterior Urethral Malignant Neoplasm,0
8400,epithelial,Necrotizing Funisitis,0
8401,Primary,sarcoma of spinal cord,0
8402,week,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8403,Very high,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8404,Therapeutic radiology procedure,FIGO Stage II Ovarian Cancer,0
8405,Variety (taxon),Neonatal leukemia,0
8406,Tanning of leather,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8407,follow-up,Refractory Barrett Esophagus,0
8408,Publishing,Benign neoplasm of thorax,0
8409,Eyelash,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8410,Qualitative form,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8411,Etiology aspects,Anterior Urethral Malignant Neoplasm,0
8412,Medical History,Liver Cavernous Hemangioma,0
8413,Most Recent,Colorectal cancer,0
8414,Skin reaction,adenosquamous carcinoma of breast,0
8415,Route,Maxillary Sinus Adenocarcinoma,0
8416,Soft,Microcystic meningioma,0
8417,Improved,Acute Undifferentiated Leukemia,0
8418,Choose (action),Malignant melanoma of eyelid,0
8419,Well,Locally Advanced Squamous Cell Carcinoma,0
8420,BRCA2 protein,Extracranial Neuroblastoma,0
8421,Primary malignant neoplasm,Clonal Hematopoiesis of Indeterminate Potential,0
8422,High Level,Cancer of Urinary Tract,0
8423,Obstruction,Spindle Cell Melanoma,0
8424,Cardiac Lead Procedure,Endometrial Small Cell Carcinoma,0
8425,Surface of skin,Cervical Squamous Intraepithelial Neoplasia,0
8426,Cells,Microcystic meningioma,0
8427,IV number:ID:Pt:^Patient:Nom,Cancer of Urinary Tract,0
8428,Symptoms aspect,FIGO Stage II Ovarian Cancer,0
8429,Flow,Ovarian germ cell choriocarcinoma stage IV,0
8430,Molecular Mass,Spongiotic dermatitis,0
8431,Phimosis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8432,Common (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8433,Tiredness Visual Analogue Scale,Liver Lymphangioma,0
8434,Negation,Cerebral Primitive Neuroectodermal Tumor,0
8435,Array Feature,clear cell adenocarcinoma of gallbladder,0
8436,Table Cell Horizontal Align - left,Locally Advanced Carcinoma,0
8437,Side of head,Tonsillar Carcinoma,0
8438,Tired,Squamous cell carcinoma of lip,0
8439,Symptoms aspect,BRCA2 Syndrome,0
8440,Occurrence,Acute Undifferentiated Leukemia,0
8441,Concept Attribute,Low Grade Squamous Intraepithelial Neoplasia,0
8442,Mass of body structure,Lipoma of small intestine,0
8443,High Mitosis-Karyorrhexis Index,Locally Advanced Epithelioid Hemangioendothelioma,0
8444,Decision,Recurrent Uveal Melanoma,0
8445,Confirmed by,FIGO Stage II Ovarian Cancer,0
8446,Form:Finding:Point in time:{Setting}:Document:{Role},Nasal cavity carcinoma,0
8447,Pharmacotherapy,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8448,Have Weight Loss,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8449,Diagnosis of exclusion,Cartilaginous exostosis,0
8450,Recent,Kaposi's sarcoma of skin,0
8451,Grade three rank,Stage III Adult Immunoblastic Lymphoma,0
8452,Most,High Grade Glandular Intraepithelial Neoplasia,0
8453,Have Itch,Metastatic Carcinoma in the Lung,0
8454,Including (qualifier),Precursor B-lymphoblastic lymphoma stage II,0
8455,High Mitosis-Karyorrhexis Index,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8456,More common in males,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8457,Hematopoietic stem cells,Splenic Manifestation of Hairy Cell Leukemia,0
8458,Tooth Wear,Recurrent Testicular Lymphoma,0
8459,Usually,Recurrent Testicular Lymphoma,0
8460,Head,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
8461,Colon <insect>,ROSE Cluster 3,0
8462,Geographic Locations,Recurrent Primary Lymphoma of Bone,0
8463,Extent of disease,Nasal cavity carcinoma,0
8464,Formation,FIGO Stage IVA Ovarian Cancer,0
8465,Malignant Neoplasms,Refractory Barrett Esophagus,0
8466,Sneezing,Anterior Urethral Malignant Neoplasm,0
8467,Precision - second,Bladder squamous cell carcinoma stage I,0
8468,eTMF Content Model Code,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8469,Primary,squamous cell carcinoma of the thyroid gland,0
8470,removal technique,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8471,High,Mucinous adenocarcinoma gastric,0
8472,Increase,Tubal Hyperplasia,0
8473,oligodendroglioma,Brain Tumor,0
8474,Study Variable,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8475,metastatic qualifier,Childhood Choriocarcinoma,0
8476,Geographic Locations,FIGO Stage IVA Ovarian Cancer,0
8477,Present,Breast Ductal Adenoma,0
8478,*Type - Kind of quantity,sarcoma of spinal cord,0
8479,Cell Device,Diffuse malignant mesothelioma,0
8480,Application procedure,Airway Hemangioma,0
8481,treatment - ActInformationManagementReason,Microcystic meningioma,0
8482,CD44 wt Allele,Adult Acute Eosinophilic Leukemia,0
8483,Known,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8484,Mass,Malignant melanoma of eyelid,0
8485,Elderly (population group),Mixed astrocytoma-ependymoma,0
8486,Head - Component of Device,Non-Metastatic Gestational Trophoblastic Tumor,0
8487,Developed Countries,Childhood Central Nervous System Ganglioneuroblastoma,0
8488,Electromagnetic Fields,Adenocarcinoma,0
8489,Approximate,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
8490,Occurrence Indicator,Clonal Hematopoiesis of Indeterminate Potential,0
8491,Telephone Extension Number,Cartilaginous exostosis,0
8492,Integumentary scale,Undifferentiated Endocervical Sarcoma,0
8493,Disruptive,Localized Askin Tumor,0
8494,In Cerebrospinal Fluid,Colorectal High Grade B-Cell Lymphoma,0
8495,Individual,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8496,Condition:Find:Pt:^Patient:Nom,Cerebral Primitive Neuroectodermal Tumor,0
8497,Neonatal Abstinence Syndrome,Brain Ependymoma,0
8498,Neuroendocrine Tumors,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8499,Synonym (core metadata concept),Localized Ewing Sarcoma,0
8500,Entity Determiner - specific,Microcystic meningioma,0
8501,Covers (device),Childhood Fibrillary Astrocytoma,0
8502,Estimated,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8503,shared attribute,Benign Apocrine Neoplasm,0
8504,Time (foundation metadata concept),GIANT PIGMENTED HAIRY NEVUS,0
8505,Primary malignant neoplasm,Extra-Adrenal Paraganglioma,0
8506,Biopsy,Mucinous adenocarcinoma gastric,0
8507,Receptors,Microcystic meningioma,0
8508,Dryness of eye,Mixed astrocytoma-ependymoma,0
8509,Pruritus,Basal Cell Ameloblastoma,0
8510,Type - attribute,Kaposi's sarcoma of skin,0
8511,Frequently,Stage IV Colorectal Cancer AJCC v8,0
8512,Scaling,Recurrent Testicular Lymphoma,0
8513,84,Localized Malignant Neoplasm,0
8514,Fluid behavior,Benign Apocrine Neoplasm,0
8515,Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider},Locally Advanced Epithelioid Hemangioendothelioma,0
8516,Case (situation),Cartilaginous exostosis,0
8517,Togo,Cervical Fibroepithelial Polyp,0
8518,Have Itch,Noninfiltrating Intraductal Carcinoma,0
8519,Somalia,Breast Ductal Adenoma,0
8520,Treating,Refractory Bladder Carcinoma,0
8521,Blood group antibody I,mucinous adenocarcinoma of gallbladder,0
8522,Sometimes,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
8523,Cancer Genus,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8524,Early,Intraepithelial Melanocytic Hyperplasia,0
8525,described,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8526,Presentation,Extra-Adrenal Paraganglioma,0
8527,With staging,Carcinoma,0
8528,Surgery specialty,Recurrent Uveal Melanoma,0
8529,Hodgkin Disease,Ovarian germ cell choriocarcinoma stage IV,0
8530,Pharmacotherapy,Colorectal Neuroendocrine Tumor G2,0
8531,Hypertensive disease,Larynx carcinoma recurrent,0
8532,Experimental Result,Medulloblastoma,0
8533,biopsy characteristics,Maxillary Sinus Adenoid Cystic Carcinoma,0
8534,Child 7,Pancreatic Endocrine Carcinoma,0
8535,Blood Vessel,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
8536,Major <insect>,Pancreatic carcinoma,0
8537,ethnic european,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8538,Decreasing,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8539,Include (action),Chronic Myelomonocytic Leukemia-2,0
8540,Occur (action),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8541,Relationships,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8542,Down Syndrome,Sarcomatoid Renal Cell Carcinoma,0
8543,Sore skin,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8544,Orchiectomy,Chest Wall Fibromatosis,0
8545,2+,Giant cell angiofibroma,0
8546,Tests (qualifier value),Adult Alveolar Soft Part Sarcoma,0
8547,Lymphatic vessel,Spongiotic dermatitis,0
8548,other medicated shampoos in ATC,Adrenal Rest Tumor,0
8549,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8550,analysis aspect,Liver Lymphangioma,0
8551,include - SetOperator,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8552,Pharmacotherapy,Digestive System Hodgkin Lymphoma,0
8553,Vaccination,Unicystic ameloblastoma,0
8554,Financial Account,Carcinomatosis of peritoneal cavity,0
8555,Examination finding,Neonatal leukemia,0
8556,Chemotherapy,Liver Lymphangioma,0
8557,Communicable Diseases,Human Papillomavirus-Related Carcinoma,0
8558,Confirmed by,Refractory Barrett Esophagus,0
8559,Sunlight,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8560,World,Acute Undifferentiated Leukemia,0
8561,Germ cell tumor,Recurrent Uveal Melanoma,0
8562,Tumor cells,Giant cell angiofibroma,0
8563,Unintentional,Occult Lung Adenosquamous Carcinoma,0
8564,Ear structure,Ovarian Carcinoid Tumor,0
8565,Age at menopause:Time:Point in time:^Patient:Quantitative,Leiomyoma of Gallbladder,0
8566,Northern Europe,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8567,Cure (remedy),Testicular cancer metastatic,0
8568,High Mitosis-Karyorrhexis Index,Stage III Cutaneous Melanoma AJCC v6,0
8569,Histocompatibility Testing,Kaposi's sarcoma of extrahepatic bile duct,0
8570,Relationships,Primary Cutaneous Plasmablastic Lymphoma,0
8571,Usually Need Help from Another Person for Arising,Malignant melanoma of eyelid,0
8572,Classification of information,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8573,Target Lesion Identification,Microcystic meningioma,0
8574,RBC count low,Extracranial Neuroblastoma,0
8575,Case unit dose,Type II Endometrial Adenocarcinoma,0
8576,Muscle damage,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
8577,Widespread Disease,Congenital hamartoma,0
8578,Referring,Granular Cell Leiomyosarcoma,0
8579,Abdominal colic,Chronic Myelomonocytic Leukemia-2,0
8580,Etiology aspects,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8581,Family member,Recurrent Uveal Melanoma,0
8582,geographic population,Small cell neuroendocrine carcinoma of bladder,0
8583,Out (direction),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8584,No status change,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8585,cervical cancer,Squamous cell carcinoma of lip,0
8586,Oral region,Blepharal carcinoma,0
8587,Type - attribute,sarcoma of spinal cord,0
8588,Smear - instruction imperative,Benign Anal Granular Cell Tumor,0
8589,pharmacotherapeutic,Intraepithelial Melanocytic Hyperplasia,0
8590,Value Above Reference Range,Stage IV Childhood Non-Hodgkin Lymphoma,0
8591,Obesity,Unfavorable Non-Hodgkin Lymphoma,0
8592,Primary Malignant Liver Neoplasm,Tonsillar Carcinoma,0
8593,Immunotherapy,Kaposi's sarcoma of extrahepatic bile duct,0
8594,Qualitative form,Intracortical osteosarcoma,0
8595,How Often Itching,Acinar cell carcinoma of pancreas,0
8596,Diagnosis,Thymic Atypical Carcinoid Tumor,0
8597,T-Cell Lymphoma,Diffuse malignant mesothelioma,0
8598,Biomaterial Treatment,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8599,Liver Flavor,sarcoma of spinal cord,0
8600,Smear - instruction imperative,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8601,How Much Distress Weight Loss,Non-Metastatic Gestational Trophoblastic Tumor,0
8602,Bibliographic Reference,Adenocarcinoma of the prostate metastatic,0
8603,Diffuse Large B-Cell Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8604,Endodermal,Anterior Urethral Malignant Neoplasm,0
8605,Inguinal region,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8606,Vascular,Neoplasms,0
8607,Adult human body,Non-Metastatic Gestational Trophoblastic Tumor,0
8608,Tobacco,Mucinous adenocarcinoma gastric,0
8609,Chemicals,Larynx carcinoma recurrent,0
8610,To,Childhood Central Nervous System Immature Teratoma,0
8611,gene therapy,Locally Advanced Carcinoma,0
8612,Together,Adult Alveolar Soft Part Sarcoma,0
8613,Infrequent,Intestinal Metaplasia of Bladder Urothelium,0
8614,BONE CARIES,Cartilaginous exostosis,0
8615,Slightly Able,Splenic Manifestation of Hairy Cell Leukemia,0
8616,Non-Small Cell Lung Carcinoma,Stage II Carcinoma of Penis,0
8617,Therapeutic radiology procedure,Tongue Alveolar Soft Part Sarcoma,0
8618,A Codes,Mucosal Melanoma,0
8619,Benign Neoplasm,Localized Ewing Sarcoma,0
8620,Adult,Bladder squamous cell carcinoma stage I,0
8621,Medical Device Emits Smoke,Epithelioid Sarcoma NCI Grade 3,0
8622,Deletion (action),Intraepithelial Melanocytic Hyperplasia,0
8623,Logical Condition,Non-Metastatic Gestational Trophoblastic Tumor,0
8624,Involvement with,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8625,Late,Carcinoma of urinary bladder,0
8626,Relational and Item-Specific Encoding Task,Grade 1 Clear Cell Renal Cell Carcinoma,0
8627,white blood cell type,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8628,operate <remove>,Refractory Bladder Carcinoma,0
8629,Lymphoma,Childhood Anaplastic Large Cell Lymphoma,0
8630,Device system,Endometrial Small Cell Carcinoma,0
8631,Structure of retroorbital region,Stage IB Pancreatic Cancer AJCC v8,0
8632,Old,Acantholytic squamous cell carcinoma,0
8633,diagnosis aspect,Mucinous cystadenofibroma,0
8634,Screening,Squamous cell carcinoma of lip,0
8635,Treating,Refractory Ependymoma,0
8636,Childhood Neuroblastoma,FIGO Stage II Ovarian Cancer,0
8637,Clear fluid,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8638,Form:Finding:Point in time:{Setting}:Document:{Role},Childhood Lung Non-Small Cell Carcinoma,0
8639,Location,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8640,Moveable,Xeroderma pigmentosum,0
8641,Medications:-:Point in time:^Patient:-,Intraepithelial Melanocytic Hyperplasia,0
8642,Dysplasia,Peripheral primitive neuroectodermal tumor of soft tissue,0
8643,Tryptophanase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8644,To,Non-Hodgkin Lymphoma During Pregnancy,0
8645,Autosomal recessive inheritance,Metastatic Malignant Neoplasm in the Sellar Region,0
8646,Primary malignant neoplasm,Breast Apocrine Adenoma,0
8647,mast cell,squamous cell carcinoma of the thyroid gland,0
8648,Symptoms,Unfavorable Non-Hodgkin Lymphoma,0
8649,Caucasians,Stage IV Penile Cancer AJCC v7,0
8650,Testis,Astrocytoma of brain,0
8651,Worsening pattern,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
8652,Skin,Granular Cell Leiomyosarcoma,0
8653,Lacking,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8654,Adenocarcinoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
8655,shared attribute,Metastatic Ductal Breast Carcinoma,0
8656,Status post,Cancer of Urinary Tract,0
8657,+5,FIGO Stage II Ovarian Cancer,0
8658,Recommendation,Cancer of Urinary Tract,0
8659,Specimen Source Codes - Infiltrate,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8660,Only - dosing instruction fragment,Medulloblastoma,0
8661,H NOS Antibodies,Squamous cell carcinoma of lip,0
8662,Frequently,Intestinal Metaplasia of Bladder Urothelium,0
8663,Beginning,FIGO Stage II Ovarian Cancer,0
8664,survival aspects,Acinar cell carcinoma of pancreas,0
8665,Overall Publication Type,Localized Ewing Sarcoma,0
8666,Referring,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8667,Percent of Abnormal Cells,Mastocytosis,0
8668,Mental Recall,FIGO Stage II Ovarian Cancer,0
8669,20%,Heavy Chain Deposition Disease,0
8670,Skin,Cervical Fibroepithelial Polyp,0
8671,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Fourth Ventricle and Brain Stem Ependymal Tumor,0
8672,Referral placed,Stage IV Colorectal Cancer AJCC v8,0
8673,Adult human body,Chronic Myelomonocytic Leukemia-2,0
8674,Account number:Identifier:Point in time:^Patient:Nominal,Kaposi's sarcoma of skin,0
8675,Part,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8676,Human body structure,Airway Hemangioma,0
8677,Increased,Locally Advanced Squamous Cell Carcinoma,0
8678,Immunotherapy,Papillary squamous cell carcinoma,0
8679,Condyloma,Cervical Adenomyoma,0
8680,54,High Grade Glandular Intraepithelial Neoplasia,0
8681,Bladder Neoplasm,Bladder squamous cell carcinoma stage I,0
8682,Human body structure,Melanomatosis,0
8683,Decreased,Low Grade Squamous Intraepithelial Neoplasia,0
8684,Detectable,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8685,Same,Female Breast Carcinoma,0
8686,Malignant epithelioma,Stage IB Pancreatic Cancer AJCC v8,0
8687,Removed,Cervical Squamous Intraepithelial Neoplasia,0
8688,National origin,Ichthyoses,0
8689,brain cell,Refractory Barrett Esophagus,0
8690,Lymphocyte component of blood,Ichthyoses,0
8691,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
8692,Sarcoma,Atypical Lobular Breast Hyperplasia,0
8693,Smear - instruction imperative,Anterior Urethral Malignant Neoplasm,0
8694,Weight Loss,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8695,Shortness of breath:-:Point in time:^Patient:-,Pilocytic astrocytoma of cerebellum,0
8696,Sometimes,Acute lymphadenitis,0
8697,High Mitosis-Karyorrhexis Index,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8698,Reduction procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8699,Location of Pharyngeal Residue Following Swallowing,Xeroderma pigmentosum,0
8700,Cancer Genus,Carcinoma of urinary bladder,0
8701,Form:Finding:Point in time:{Setting}:Document:{Role},Childhood Anaplastic Large Cell Lymphoma,0
8702,set (group),Childhood Central Nervous System Immature Teratoma,0
8703,Abdominal Cavity,Nasal cavity carcinoma,0
8704,Malignant Neoplasms,Childhood Central Nervous System Ganglioneuroblastoma,0
8705,Condition:Find:Pt:^Patient:Nom,Unfavorable Non-Hodgkin Lymphoma,0
8706,Known,Childhood Choriocarcinoma,0
8707,Chemotherapy Regimen,Mixed astrocytoma-ependymoma,0
8708,therapeutic aspects,Kaposi's sarcoma of skin,0
8709,Standard (qualifier),Recurrent Diffuse Intrinsic Pontine Glioma,0
8710,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Trabecular adenocarcinoma,0
8711,Pathogenic organism,Benign squamous cell tumor,0
8712,Classification of information,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8713,Acute Undifferentiated Leukemia,Werner Syndrome,0
8714,Account number:Identifier:Point in time:^Patient:Nominal,Extra-abdominal fibromatosis,0
8715,include - SetOperator,Cervical Fibroepithelial Polyp,0
8716,Diagnosis,Tumorlet,0
8717,Major <insect>,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8718,Malignant Neoplasms,Trabecular adenocarcinoma,0
8719,Injection procedure,Metaplastic carcinoma of breast,0
8720,radiotherapeutic,Melanomatosis,0
8721,Disease Response,Stage IB Pancreatic Cancer AJCC v8,0
8722,Levels (qualifier value),Gallbladder Adenocarcinoma,0
8723,Derived value,embryonal rhabdomyosarcoma of prostate,0
8724,Case (situation),Ichthyosis,0
8725,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Spermatocytic seminoma,0
8726,Associated with,Hereditary Diffuse Gastric Adenocarcinoma,0
8727,CD34 Measurement,Splenic Manifestation of Hairy Cell Leukemia,0
8728,diagnosis aspect,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8729,Sarcomatous Component Present,Primary Cutaneous Plasmablastic Lymphoma,0
8730,Benign melanocytic nevus,Endometrial Small Cell Carcinoma,0
8731,Patient Reported Outcome Stem,Peripheral primitive neuroectodermal tumor of soft tissue,0
8732,Subject Risk,embryonal rhabdomyosarcoma of prostate,0
8733,Most,mucinous adenocarcinoma of gallbladder,0
8734,Physical findings,Pancreatic carcinoma,0
8735,Healthy,Adult Alveolar Soft Part Sarcoma,0
8736,include - SetOperator,Cervical Squamous Intraepithelial Neoplasia,0
8737,Have Been Vomiting,Nasal cavity carcinoma,0
8738,Very Much,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8739,Dermatologist,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8740,Neoplasms,Benign tumor of eyelid,0
8741,Overall Publication Type,Unicystic ameloblastoma,0
8742,Abdomen,Adult Hepatocellular Carcinoma,0
8743,solid substance,Stage III Cutaneous Melanoma AJCC v6,0
8744,Study Site,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
8745,Adapt (substance),Hereditary corneal dystrophy,0
8746,Monoclonal Gammopathy of Undetermined Significance,Refractory Barrett Esophagus,0
8747,World,Chest Wall Fibromatosis,0
8748,Sepsis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8749,Adult human body,sarcoma of spinal cord,0
8750,Population Group,squamous cell carcinoma of the thyroid gland,0
8751,Primary operation,Hodgkin lymphoma,0
8752,Changing,Intraepithelial Melanocytic Hyperplasia,0
8753,Australia,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8754,1+ Score,Stage III Adult Immunoblastic Lymphoma,0
8755,Smear - instruction imperative,Engraftment syndrome,0
8756,Better,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8757,Disease,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8758,Inguinal part of abdomen,Spermatocytic seminoma,0
8759,Squamous cell carcinoma - category,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8760,criteria,Malignant Neoplasm with Regional Lymph Node Involvement,0
8761,regional,FIGO Stage II Ovarian Cancer,0
8762,Substance amount,Recurrent Uveal Melanoma,0
8763,Dental caries,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8764,VARIOUS DRUG CLASSES IN ATC,Central Nervous System Anaplastic Large Cell Lymphoma,0
8765,risk factors,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8766,Severe Extremity Pain,benign mature teratoma of pancreas,0
8767,Specimen Source Codes - Mucus,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
8768,Limited stage (cancer stage),Metaplastic carcinoma of breast,0
8769,Loss of Appetite question,Thyroid Hurthle Cell Carcinoma,0
8770,Characteristics,Localized Askin Tumor,0
8771,mole changes,Fibroadenoma of breast,0
8772,3+ Answer to Question,Benign Carotid Body Paraganglioma,0
8773,Vagina Carcinoma,ALK positive large B-cell lymphoma,0
8774,Area,Cerebral Primitive Neuroectodermal Tumor,0
8775,Females,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8776,N not otherwise specified Antibody,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8777,Etiology aspects,Pancreatic carcinoma,0
8778,Occurrence,Acantholytic squamous cell carcinoma,0
8779,Growth rate,Pleomorphic adenoma of parotid gland,0
8780,high - ActExposureLevelCode,Cerebral hemangioma,0
8781,include - SetOperator,Basal Cell Ameloblastoma,0
8782,What subject filter - Result,Cerebral Primitive Neuroectodermal Tumor,0
8783,Sunscreening Agents,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8784,Neoplasms,Adult Hepatocellular Carcinoma,0
8785,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
8786,Well,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
8787,Consistency,Localized Ewing Sarcoma,0
8788,pharmacotherapeutic,Airway Hemangioma,0
8789,Diagnosis,Childhood Fibrillary Astrocytoma,0
8790,Manufactured sign,Cerebral Primitive Neuroectodermal Tumor,0
8791,Attack behavior,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8792,Cicatrix,Periosteal Osteosarcoma,0
8793,Lymphatic,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8794,development aspects,Platinum-Resistant Lung Small Cell Carcinoma,0
8795,shared attribute,Peripheral primitive neuroectodermal tumor of soft tissue,0
8796,International Statistical Classification of Diseases and Related Health Problems,Basal Cell Ameloblastoma,0
8797,Case unit dose,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8798,Form:Finding:Point in time:{Setting}:Document:{Role},Funisitis (disorder),0
8799,Tumor type,FIGO Stage IVA Ovarian Cancer,0
8800,High risk of,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8801,United States,Acute Undifferentiated Leukemia,0
8802,therapeutic aspects,Cancer of Urinary Tract,0
8803,Erythrocytes,mucinous adenocarcinoma of gallbladder,0
8804,Pale color,Tongue Alveolar Soft Part Sarcoma,0
8805,Normal,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8806,Sectioning technique,Malignant neoplasm of gallbladder,0
8807,Urinary Diversion,FIGO Stage IVA Ovarian Cancer,0
8808,Mass of body structure,Childhood Central Nervous System Immature Teratoma,0
8809,Benign Neoplasm,Mucinous adenocarcinoma gastric,0
8810,{Setting},Benign tumor of eyelid,0
8811,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,embryonal rhabdomyosarcoma of prostate,0
8812,Qualitative form,Cancer of Urinary Tract,0
8813,Reported By,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8814,Form:Finding:Point in time:{Setting}:Document:{Role},clear cell adenocarcinoma of gallbladder,0
8815,Relationships,Malignant neoplasm of subglottis,0
8816,Immunosuppression,GIANT PIGMENTED HAIRY NEVUS,0
8817,Occur (action),Thymic Atypical Carcinoid Tumor,0
8818,Gamma globulin,Tonsillar Carcinoma,0
8819,Biomaterial Treatment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8820,Surgery specialty,clear cell adenocarcinoma of gallbladder,0
8821,biomedical tube device,Carcinoma,0
8822,Sunlight,Cervical Fibroepithelial Polyp,0
8823,Often - answer to question,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8824,Colon <insect>,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
8825,low exposure,Refractory Ependymoma,0
8826,Net (qualifier),Malignant neoplasm of choroid,0
8827,Itchiness,Childhood Central Nervous System Ganglioneuroblastoma,0
8828,Numerous,BRCA2 Syndrome,0
8829,What subject filter - Result,ALK positive large B-cell lymphoma,0
8830,Malignant Neoplasms,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8831,Current (present time),Hemangioma,0
8832,Genetic Marker Expression,Testicular cancer metastatic,0
8833,Damage,Plexosarcoma,0
8834,Tube - unit dose,Stage II Hepatocellular Carcinoma AJCC v8,0
8835,Body Fluids,Rhabdomyosarcoma with ganglionic differentiation,0
8836,Better,Metastatic Lung Small Cell Carcinoma,0
8837,Stomach structure,Ovarian germ cell choriocarcinoma stage IV,0
8838,Process,Childhood Central Nervous System Ganglioneuroblastoma,0
8839,Count of entities,Recurrent Uveal Melanoma,0
8840,Now (temporal qualifier),Recurrent Uveal Melanoma,0
8841,Zone,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
8842,Including (qualifier),Colorectal High Grade B-Cell Lymphoma,0
8843,Decision,Bladder squamous cell carcinoma stage I,0
8844,Form:Finding:Point in time:{Setting}:Document:{Role},Platinum-Resistant Lung Small Cell Carcinoma,0
8845,Metastatic Neoplasm,Stage IB Pancreatic Cancer AJCC v8,0
8846,FAP protein,Placental aromatase deficiency,0
8847,physiological aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8848,Response Likelihood,Malignant neoplasm of olfactory nerve,0
8849,Risk,Unfavorable Non-Hodgkin Lymphoma,0
8850,Easy,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8851,Primary,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8852,Giant Cell Fibroblastoma,Anterior Urethral Malignant Neoplasm,0
8853,Control function,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8854,Fever,Malignant neoplasm of olfactory nerve,0
8855,Adult Liposarcoma,benign mature teratoma of pancreas,0
8856,Malignant neoplasm of skin,Choroid Epithelioid Cell Melanoma,0
8857,Malignant neoplasm of soft tissue,Kaposi's sarcoma of skin,0
8858,CDISC SEND Tumor Findings Results Terminology,Grade 1 Clear Cell Renal Cell Carcinoma,0
8859,Most,Malignant Testicular Sertoli Cell Tumor,0
8860,Eye,BRCA2 Syndrome,0
8861,Coughing,Refractory WHO Grade III Glioma,0
8862,To,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8863,Adenocarcinoma,Squamous cell carcinoma of lip,0
8864,Etiology aspects,Human Papillomavirus-Related Carcinoma,0
8865,Symptomatic,Adult Acute Eosinophilic Leukemia,0
8866,Increased tendency to bruise,Werner Syndrome,0
8867,Condition:Find:Pt:^Patient:Nom,Metastatic Lung Small Cell Carcinoma,0
8868,Approach,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8869,Neoplasms,Splenic Manifestation of Hairy Cell Leukemia,0
8870,Continuance of life,Testicular cancer metastatic,0
8871,Primary,Blood Vessel Tumors,0
8872,Approximate,Bladder adenocarcinoma stage IV,0
8873,PSA Level Less than Two,Trabecular adenocarcinoma,0
8874,Skull,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8875,Body tissue,Locally Advanced Carcinoma,0
8876,Contrast,Breast Apocrine Adenoma,0
8877,disease markers,Undifferentiated Neuroblastoma,0
8878,Risk,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8879,Benign neoplasm of uterus,Carcinomatosis of peritoneal cavity,0
8880,Cell Shape,Nasal cavity carcinoma,0
8881,Numerous,Xeroderma pigmentosum,0
8882,Hair Specimen,Human Papillomavirus-Related Carcinoma,0
8883,Medulla,Malignant melanoma of eyelid,0
8884,Malignant Neoplasms,Stage IB Pancreatic Cancer AJCC v8,0
8885,Inguinal part of abdomen,Splenic Manifestation of Hairy Cell Leukemia,0
8886,Use of,Undifferentiated Endocervical Sarcoma,0
8887,risk factors - observation list,Benign Carotid Body Paraganglioma,0
8888,Linear,Benign neoplasm of eye,0
8889,Male population group,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8890,Persons,Chondrosarcoma,0
8891,Early,Adult Alveolar Soft Part Sarcoma,0
8892,Organ,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8893,Involvement with,FIGO Stage IVA Ovarian Cancer,0
8894,Retinoic Acid Response Element,Medulloblastoma,0
8895,Most,Acute Undifferentiated Leukemia,0
8896,Hematological Disease,Metaplastic carcinoma of breast,0
8897,Cessation of life,Placental aromatase deficiency,0
8898,Involvement with,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8899,Removing (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8900,CEL gene,benign mature teratoma of pancreas,0
8901,Histopathologic Grade,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8902,Sodium Cation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8903,Top (position),Undifferentiated Endocervical Sarcoma,0
8904,65+,Pilocytic astrocytoma of cerebellum,0
8905,Thymus Neoplasms,Splenic Manifestation of Hairy Cell Leukemia,0
8906,Breast Feeding,Undifferentiated Endocervical Sarcoma,0
8907,Techniques,FIGO Stage IVA Ovarian Cancer,0
8908,Neoplasms,Malignant neoplasm of olfactory nerve,0
8909,Plasma Cells,Refractory Bladder Carcinoma,0
8910,Stem of Organ,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8911,With shape,Nasal cavity carcinoma,0
8912,Basis - conceptual entity,Melanomatosis,0
8913,Singular,Intracortical osteosarcoma,0
8914,Biomaterial Treatment,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8915,Pentaerythritol Tetranitrate,Lipoma of small intestine,0
8916,trend,Colorectal High Grade B-Cell Lymphoma,0
8917,Room of building - Study,Chronic Myelomonocytic Leukemia-2,0
8918,50%,Benign Anal Granular Cell Tumor,0
8919,Chemotherapy Drugs Adminstered,Thymic Atypical Carcinoid Tumor,0
8920,Base - General Qualifier,Acantholytic squamous cell carcinoma,0
8921,Permutation,Intraepithelial Melanocytic Hyperplasia,0
8922,Nasal (intended site),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8923,Longitudinal Studies,BRCA2 Syndrome,0
8924,Characteristics,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8925,Widening,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8926,Observation Interpretation - intermediate,Blepharal carcinoma,0
8927,Cell Count,Stage IB Pancreatic Cancer AJCC v8,0
8928,Leading,Mucinous adenocarcinoma gastric,0
8929,Woman,Chronic Myelomonocytic Leukemia-2,0
8930,Common (qualifier value),Chronic Myelomonocytic Leukemia-2,0
8931,Uncertain - Response,FIGO Stage II Ovarian Cancer,0
8932,Deterioration of status,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8933,Type - attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8934,High,Trichilemmocarcinoma,0
8935,Beginning,Ovarian germ cell choriocarcinoma stage IV,0
8936,Severe Extremity Pain,Vaginal Adenoid Cystic Carcinoma,0
8937,To,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8938,Type A,clear cell adenocarcinoma of gallbladder,0
8939,Body Site Modifier - Lower,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8940,Malignant neoplasm of lung,Tonsillar Carcinoma,0
8941,Call (Instruction),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8942,Adult human body,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8943,Malignant epithelioma,Squamous cell carcinoma of lip,0
8944,Primary malignant neoplasm,Pancreatic Endocrine Carcinoma,0
8945,Old,Atypical Mesothelial Hyperplasia,0
8946,Linear,Kaposi's sarcoma of extrahepatic bile duct,0
8947,Extension,Blepharal carcinoma,0
8948,Body structure,Peripheral primitive neuroectodermal tumor of soft tissue,0
8949,Aluminum measurement,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8950,Esophagus,Adult Acute Eosinophilic Leukemia,0
8951,65+,Endometrial Small Cell Carcinoma,0
8952,Data Compression,Benign Anal Granular Cell Tumor,0
8953,Body surface,Refractory Ependymoma,0
8954,Childhood Diffuse Large B-Cell Lymphoma,Refractory Bladder Carcinoma,0
8955,Cell surface,Airway Hemangioma,0
8956,Stem of Organ,Larynx carcinoma recurrent,0
8957,Chemotherapy Regimen,Xeroderma pigmentosum,0
8958,Tissue Specimen Code,Unicystic ameloblastoma,0
8959,Childhood Lymphoma,Adenocarcinoma,0
8960,Chemotherapy,Localized Ewing Sarcoma,0
8961,Treated with,High Grade Glandular Intraepithelial Neoplasia,0
8962,Malignant Neoplasms,Refractory Ependymoma,0
8963,Neoplasm of subglottis,Endometrial Small Cell Carcinoma,0
8964,Arising in,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8965,Cover (physical object),Stage IB Pancreatic Cancer AJCC v8,0
8966,unknown vaccine or immune globulin,Stage I Adult Non-Hodgkin Lymphoma,0
8967,Surgery specialty,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8968,Domain (area of knowledge),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8969,Result,Leptomeningeal sarcoma,0
8970,Aspiration-action,Adult Alveolar Soft Part Sarcoma,0
8971,2+ Score,Cerebral Primitive Neuroectodermal Tumor,0
8972,Type - attribute,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8973,To,Advanced Lung Carcinoma,0
8974,Barite,non-Hodgkin's lymphoma of spleen,0
8975,Skin Erosion,Digestive System Hodgkin Lymphoma,0
8976,CDISC Findings Class,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8977,Hollow shape,FIGO Stage II Ovarian Cancer,0
8978,Resolution,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8979,Structure of lumen of body system,Brain Tumor,0
8980,bony process,FIGO Stage II Ovarian Cancer,0
8981,Manufactured form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8982,Tryptophanase,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8983,Fasting,Refractory Ependymoma,0
8984,Blastoma,Blood Vessel Tumors,0
8985,Child,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8986,Primary malignant neoplasm,Placental aromatase deficiency,0
8987,Therapy Object (animal model),Refractory Bladder Carcinoma,0
8988,Feel Tired question,Kaposi's sarcoma of extrahepatic bile duct,0
8989,Type - attribute,Childhood Central Nervous System Ganglioneuroblastoma,0
8990,Most,Kaposi's sarcoma of skin,0
8991,Appearance of breast,Fibroadenoma of breast,0
8992,Lymphatic,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8993,Cessation of life,Childhood Central Nervous System Ganglioneuroblastoma,0
8994,Vaginal Neoplasms,FIGO Stage II Ovarian Cancer,0
8995,Affecting,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8996,common types,Localized Askin Tumor,0
8997,Therapeutic procedure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8998,To,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8999,Leukocytes,Mixed astrocytoma-ependymoma,0
9000,Rare,adenoid cystic carcinoma of lung,0
9001,Granulocytes Product,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9002,Group A (blood group),Pancreatic carcinoma,0
9003,Presentation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9004,Fatigue,Necrotizing Funisitis,0
9005,Has property,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9006,combination - answer to question,Squamous cell carcinoma of lip,0
9007,Hematochezia,Breast Ductal Adenoma,0
9008,Neoplasms,Mucinous adenocarcinoma gastric,0
9009,Distant,Ichthyoses,0
9010,Count of entities,Pilocytic astrocytoma of cerebellum,0
9011,Benign Neoplasm,Locally Advanced Soft Tissue Sarcoma,0
9012,Metastatic to,Pancreatic Intraepithelial Neoplasia-3,0
9013,Covered (qualifier value),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
9014,Physical Activity Measurement,Benign neoplasm of eye,0
9015,treatment - ActInformationManagementReason,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9016,Leukemia,Ovarian germ cell choriocarcinoma stage IV,0
9017,Growth action,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9018,Statistical Prevalence,Ichthyosis,0
9019,Childhood Acute Megakaryoblastic Leukemia,Carcinoma of submandibular gland,0
9020,Include (action),Intraepithelial Melanocytic Hyperplasia,0
9021,Diagnosis Study,Heavy Chain Deposition Disease,0
9022,Does swallow,Recurrent Primary Lymphoma of Bone,0
9023,Cell Count,Fibroadenoma of breast,0
9024,Present,Intraepithelial Melanocytic Hyperplasia,0
9025,Polypeptide Hormones,Secondary malignant neoplasm of lymph node,0
9026,Reside,Contact dermatitis due to alkali,0
9027,Body tissue,Brain Ependymoma,0
9028,Cells,Small intestine carcinoma,0
9029,Malignant neoplasm of brain,Unicystic ameloblastoma,0
9030,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Rhabdomyosarcoma,0
9031,Neuroectodermal Tumor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9032,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
9033,Mixed (qualifier value),Human Papillomavirus-Related Carcinoma,0
9034,Common Specifications in HL7 V3 Publishing,Diffuse malignant mesothelioma,0
9035,Acral,FIGO Stage IVA Ovarian Cancer,0
9036,Woman,Spermatocytic seminoma,0
9037,IPSS Risk Category Low,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
9038,Neoplasms,Benign Anal Granular Cell Tumor,0
9039,Coding,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9040,National Cancer Institute,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9041,animal allergen extracts,Childhood Central Nervous System Ganglioneuroblastoma,0
9042,Most,Maxillary Sinus Adenoid Cystic Carcinoma,0
9043,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9044,Biopsy,Breast Apocrine Adenoma,0
9045,Greater,Mucinous cystadenofibroma,0
9046,Primary malignant neoplasm of appendix,Gallbladder Adenocarcinoma,0
9047,Metastatic malignant neoplasm to brain,Spongiotic dermatitis,0
9048,Main,Nasal cavity carcinoma,0
9049,Age,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9050,Sore skin,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9051,Approximate,Stage III Adult Immunoblastic Lymphoma,0
9052,Firstly,Stage 0 Lip Carcinoma,0
9053,Simian virus 40,FIGO Stage IVA Ovarian Cancer,0
9054,Check ligament,Malignant neoplasm of subglottis,0
9055,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
9056,*Type - Kind of quantity,Stage 0 Penile Cancer AJCC v8,0
9057,Curettage procedure,Ectomesenchymal Chondromyxoid Tumor,0
9058,Normal,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9059,cell type,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9060,include - SetOperator,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
9061,Anatomic Site,Hemangioma,0
9062,Lung,Ampulla of Vater Tubular Adenoma,0
9063,Rate,Intestinal Metaplasia of Bladder Urothelium,0
9064,Woolly hair nevus,Noninfiltrating Intraductal Carcinoma,0
9065,Age at diagnosis:Time:Pt:^Patient:Qn,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9066,Nuclear pleomorphism,Malignant melanoma of eyelid,0
9067,Point in time,FIGO Stage IVA Ovarian Cancer,0
9068,Excision,Heavy Chain Deposition Disease,0
9069,Include (action),Acute lymphadenitis,0
9070,Magnetic Resonance Imaging,Brain Tumor,0
9071,pharmacotherapeutic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9072,Retinoic Acid Response Element,Stage III Adult Immunoblastic Lymphoma,0
9073,GDF15 protein,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9074,Beginning,Kaposi's sarcoma of skin,0
9075,Mental association,Breast Ductal Adenoma,0
9076,Poor function,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9077,Cessation of life,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
9078,Usual,Locally Advanced Carcinoma,0
9079,Including (qualifier),Childhood Fibrillary Astrocytoma,0
9080,Pruritus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9081,Senility,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9082,Simple,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9083,Chemotherapy Regimen,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9084,Fever symptoms (finding),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9085,Etiology aspects,Xeroderma pigmentosum,0
9086,Variant,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9087,User Group,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9088,Diagnosis Study,Vaginal Adenoid Cystic Carcinoma,0
9089,Pelvic cavity structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9090,Macrophage Activation Syndrome,Unfavorable Non-Hodgkin Lymphoma,0
9091,Etiology aspects,High Grade Glandular Intraepithelial Neoplasia,0
9092,Point,Squamous cell carcinoma of lip,0
9093,risk factors - observation list,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
9094,Squamous cell carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9095,Easy bleeding,Maxillary Sinus Adenoid Cystic Carcinoma,0
9096,radiotherapeutic,Bladder adenocarcinoma stage IV,0
9097,Smell Perception,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9098,Feature,Carcinomatosis of peritoneal cavity,0
9099,Previous,Digestive System Hodgkin Lymphoma,0
9100,Elbow,Stage IB Lung Cancer AJCC v7,0
9101,Brain Neoplasms,GIANT PIGMENTED HAIRY NEVUS,0
9102,Muscle (organ),Xeroderma pigmentosum,0
9103,Woman,Mucinous adenocarcinoma,0
9104,Leg,Type II Endometrial Adenocarcinoma,0
9105,Term (lexical),Botryoid-Type Embryonal Rhabdomyosarcoma,0
9106,Easy,Stage 0 Penile Cancer AJCC v8,0
9107,Spreading (qualifier value),Stage II Fallopian Tube Cancer,0
9108,Blood group A (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9109,shared attribute,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9110,Congenital Abnormality,Unicystic ameloblastoma,0
9111,>90,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9112,Metastatic Disease Clinical Trial Setting,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9113,lymph nodes,Mixed astrocytoma-ependymoma,0
9114,Smear - instruction imperative,Benign Anal Granular Cell Tumor,0
9115,Marrow plasma cell,Extracranial Neuroblastoma,0
9116,Severe Extremity Pain,Multiple Endocrine Neoplasia,0
9117,Most,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9118,Parotid swelling,Unicystic ameloblastoma,0
9119,combination - answer to question,Neonatal leukemia,0
9120,Adipocytes,embryonal rhabdomyosarcoma of prostate,0
9121,Nasal bone structure,Ovarian Carcinoid Tumor,0
9122,Cell Count,Lipoma of small intestine,0
9123,Symptoms aspect,Refractory Bladder Carcinoma,0
9124,Part,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9125,Cover - action,Advanced Uterine Corpus Carcinosarcoma,0
9126,Call (Instruction),Thymic Clear Cell Carcinoma,0
9127,various allergen extracts,Platinum-Resistant Lung Small Cell Carcinoma,0
9128,Only - dosing instruction fragment,Uterine Cancer,0
9129,Malignant neoplasm of soft tissue,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9130,Neoplasms,Thymic Atypical Carcinoid Tumor,0
9131,Case (situation),Ovarian Dermoid Cyst with Secondary Carcinoma,0
9132,Body structure,High Grade Glandular Intraepithelial Neoplasia,0
9133,Manufactured sign,Human Papillomavirus-Related Carcinoma,0
9134,Close,Stage I Colon Neuroendocrine Tumor AJCC v8,0
9135,Tobacco smoking behavior,Refractory Barrett Esophagus,0
9136,To,Mucinous adenocarcinoma gastric,0
9137,Tumor site,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9138,Aspects of signs,Brain Ependymoma,0
9139,Include (action),Bladder squamous cell carcinoma stage I,0
9140,Leading,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9141,Brain Neoplasms,FIGO Stage IVA Ovarian Cancer,0
9142,Second Primary Cancers,Testicular cancer metastatic,0
9143,Negation,Primary Cutaneous Plasmablastic Lymphoma,0
9144,Slight (qualifier value),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9145,Hepatitis C virus,Advanced Lung Carcinoma,0
9146,Chemotherapy Regimen,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9147,Inferior,BRCA2 Syndrome,0
9148,French-American-British Classification,ROSE Cluster 3,0
9149,operate <remove>,Mixed astrocytoma-ependymoma,0
9150,Adult,Cancer of Urinary Tract,0
9151,monomer,Pancreatic carcinoma,0
9152,Part,Cervical Adenomyoma,0
9153,Enlargement procedure,Xeroderma pigmentosum,0
9154,radiotherapeutic,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9155,Egg of order Phthiraptera,Vaginal Adenoid Cystic Carcinoma,0
9156,Worsening pattern,High Grade Glandular Intraepithelial Neoplasia,0
9157,Biogenic Amines,Undifferentiated Endocervical Sarcoma,0
9158,Bilateral cataracts (disorder),Placental aromatase deficiency,0
9159,Referral placed,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9160,More,non-Hodgkin's lymphoma of spleen,0
9161,Skin Specimen,Malignant melanoma of eyelid,0
9162,Late,Neonatal leukemia,0
9163,pars nervosa of hypophysis,ROSE Cluster 3,0
9164,Reported Term,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9165,Include (action),Endometrial Small Cell Carcinoma,0
9166,Both ovaries,benign mature teratoma of pancreas,0
9167,Medulloblastoma,Metastatic Malignant Neoplasm in the Sellar Region,0
9168,Therapeutic procedure,Intestinal Metaplasia of Bladder Urothelium,0
9169,CDISC SEND Tumor Findings Results Terminology,Non-Metastatic Gestational Trophoblastic Tumor,0
9170,Contrast,Larynx carcinoma recurrent,0
9171,Ulceration,Lipoma of small intestine,0
9172,Females,Benign squamous cell tumor,0
9173,Benign,Splenic Manifestation of Hairy Cell Leukemia,0
9174,Uterine Corpus Sarcoma,Congenital hamartoma,0
9175,Web Site,Adenocarcinoma of the prostate metastatic,0
9176,Malignant Neoplasms,Microcystic meningioma,0
9177,Squamous cell carcinoma,FIGO Stage IVA Ovarian Cancer,0
9178,Primary operation,Small cell neuroendocrine carcinoma of bladder,0
9179,Area,Stage IB Pancreatic Cancer AJCC v8,0
9180,Used by,Peripheral primitive neuroectodermal tumor of soft tissue,0
9181,Histopathologic Grade,Peripheral primitive neuroectodermal tumor of soft tissue,0
9182,Polyglandular Type I Autoimmune Syndrome,Colorectal High Grade B-Cell Lymphoma,0
9183,ethnic european,Recurrent Primary Lymphoma of Bone,0
9184,Benign,Stage IV Penile Cancer AJCC v7,0
9185,Serum Calcium Level,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9186,Type A,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9187,Requirement,Stage IV Childhood Non-Hodgkin Lymphoma,0
9188,combination of objects,Benign neoplasm of thorax,0
9189,Smear - instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9190,Life,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9191,Linear,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9192,risk factors - observation list,Refractory Ependymoma,0
9193,Differentiation,Diffuse malignant mesothelioma,0
9194,Operative Surgical Procedures,Cervical Adenomyoma,0
9195,Consortium or Network,FIGO Stage II Ovarian Cancer,0
9196,Rare,Placental aromatase deficiency,0
9197,Term Source,Cervical Fibroepithelial Polyp,0
9198,Skin Specimen,Brain Ependymoma,0
9199,Act Mood - intent,Periosteal Osteosarcoma,0
9200,Therapeutic procedure,Liver Lymphangioma,0
9201,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9202,Experimental Result,Locally Advanced Soft Tissue Sarcoma,0
9203,Carcinoma,Multiple Skull Base Meningiomas,0
9204,Classification of information,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9205,Fighting,Kaposi's sarcoma of extrahepatic bile duct,0
9206,Nose,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9207,Spreading (qualifier value),Malignant Neoplasm of Lung - Multiple Primary Sites,0
9208,diagnosis aspect,Endometrial Small Cell Carcinoma,0
9209,Obesity,Stage III Cutaneous Melanoma AJCC v6,0
9210,seen,Localized Ewing Sarcoma,0
9211,Percent of Abnormal Cells,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9212,Greater,Adult Acute Eosinophilic Leukemia,0
9213,Decision,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9214,Papillomavirus,Advanced Uterine Corpus Carcinosarcoma,0
9215,CLEC4D gene,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9216,Upper surface of body of first segment of coccyx,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9217,Adenocarcinoma of large intestine,Cervical Fibroepithelial Polyp,0
9218,Lymphocyte,Plexosarcoma,0
9219,Sequence Data Type,Squamous cell carcinoma of lip,0
9220,Thyroid hormone (disposition),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9221,Primary operation,BRCA2 Syndrome,0
9222,Clinical,Diffuse malignant mesothelioma,0
9223,Metastatic Disease Clinical Trial Setting,Engraftment syndrome,0
9224,Human body,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9225,Tissue Specimen Code,Cancer of Urinary Tract,0
9226,include - SetOperator,Recurrent Primary Lymphoma of Bone,0
9227,Thymus Gland,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9228,Bloody,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9229,Tract,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9230,Swollen Lymph Node,Adult Acute Eosinophilic Leukemia,0
9231,Interruption,Unicystic ameloblastoma,0
9232,Leading,FIGO Stage II Ovarian Cancer,0
9233,Disease,Hemangioma,0
9234,Pediatrics,BRCA2 Syndrome,0
9235,3+ Score,Squamous cell carcinoma of lip,0
9236,Squamous Epithelial Cells,Maxillary Sinus Adenocarcinoma,0
9237,Tryptophanase,Kaposi's sarcoma of extrahepatic bile duct,0
9238,Woman,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9239,Slightly (qualifier value),Locally Advanced Carcinoma,0
9240,Persistent embryonic structure,Hodgkin lymphoma,0
9241,Malignant Neoplasms,Spermatocytic seminoma,0
9242,Type - attribute,Childhood Central Nervous System Ganglioneuroblastoma,0
9243,Isolate - microorganism,Multiple Skull Base Meningiomas,0
9244,Penetrance,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9245,Include (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9246,Pancreatitis,Gallbladder Adenocarcinoma,0
9247,Chorionic Gonadotropin,Stage III Cutaneous Melanoma AJCC v6,0
9248,Persons,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9249,Esthesia,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9250,Operative Surgical Procedures,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9251,Togo,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9252,Benign Neoplasm,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9253,Retinoic Acid Response Element,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9254,Young,Benign squamous cell tumor,0
9255,Common Specifications in HL7 V3 Publishing,Xeroderma pigmentosum,0
9256,Condition,Extracranial Neuroblastoma,0
9257,Previous,Methotrexate-Associated Hodgkin Lymphoma,0
9258,Occurrence,Type II Endometrial Adenocarcinoma,0
9259,high - ActExposureLevelCode,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9260,Type A,Childhood Central Nervous System Ganglioneuroblastoma,0
9261,Limited stage (cancer stage),Anaplastic large cell lymphoma,0
9262,<50,Malignant neoplasm of thalamus,0
9263,Hematological Disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9264,Excision,Stage IB Pancreatic Cancer AJCC v8,0
9265,majority,Pancreatic Intraepithelial Neoplasia-3,0
9266,Sedentary,Papillary cystic tumor,0
9267,Call (Instruction),Lung squamous cell carcinoma stage I,0
9268,Unmarried person,Chronic Myelomonocytic Leukemia-2,0
9269,30%,Peripheral primitive neuroectodermal tumor of soft tissue,0
9270,90%,Vaginal Adenoid Cystic Carcinoma,0
9271,other medicated shampoos in ATC,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9272,High Level,Squamous cell carcinoma of lip,0
9273,Ovary,Benign neoplasm of eye,0
9274,Upper,Urethral Carcinoma,0
9275,Lower jaw region,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9276,Poor - grade value,Localized Askin Tumor,0
9277,Frequently,Uterine Cancer,0
9278,Tunnel structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9279,newly,Extra-abdominal fibromatosis,0
9280,Disease Screening,Malignant neoplasm of gallbladder,0
9281,Pain NOS,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
9282,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Carcinoma of urinary bladder,0
9283,Absent,Refractory Ependymoma,0
9284,N+ (tumor staging),Familial Hemophagocytic Lymphocytosis,0
9285,status - In progress,mucinous adenocarcinoma of gallbladder,0
9286,Form of bone,Bladder Neuroendocrine Neoplasm,0
9287,To,Vaginal Adenoid Cystic Carcinoma,0
9288,Test - temporal region,Pancreatic Endocrine Carcinoma,0
9289,Etiology aspects,Hereditary Diffuse Gastric Adenocarcinoma,0
9290,Areas <moth>,Lipoma of small intestine,0
9291,Lymphoma,Locally Advanced Squamous Cell Carcinoma,0
9292,subscriber - self,Refractory Ependymoma,0
9293,Cancer Genus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9294,Condition:Find:Pt:^Patient:Nom,Locally Advanced Epithelioid Hemangioendothelioma,0
9295,Transection (procedure),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9296,Continuance of life,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9297,Forecast of outcome,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9298,Diabetes Mellitus,Kaposi's sarcoma of extrahepatic bile duct,0
9299,Elements,Ovarian germ cell choriocarcinoma stage IV,0
9300,Bilateral salpingectomy with oophorectomy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9301,Include (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9302,Disease,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9303,Mucous Membrane,Intestinal Neuroendocrine Carcinoma,0
9304,various allergen extracts,Mucinous adenocarcinoma,0
9305,Vaginal (intended site),Familial Hemophagocytic Lymphocytosis,0
9306,epithelial,Splenic Manifestation of Hairy Cell Leukemia,0
9307,high - ActExposureLevelCode,clear cell adenocarcinoma of gallbladder,0
9308,Tryptophanase,Basal Cell Ameloblastoma,0
9309,Group A (blood group),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9310,Genetic Markers,clear cell adenocarcinoma of gallbladder,0
9311,BRCA2 protein,Cancer of Urinary Tract,0
9312,Experimental Result,Benign neoplasm of thorax,0
9313,year,Bladder Neuroendocrine Neoplasm,0
9314,Inguinal part of abdomen,Malignant neoplasm of choroid,0
9315,Entity Determiner - specific,Refractory Barrett Esophagus,0
9316,Blood Cells,Female Breast Carcinoma,0
9317,Family (taxonomic),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9318,Taxonomic,Astrocytoma of brain,0
9319,Benign,Epithelioid Sarcoma NCI Grade 3,0
9320,Food allergenic extracts,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9321,Togo,Small cell neuroendocrine carcinoma of bladder,0
9322,Phenotype determination,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9323,Diagnostic Imaging,Engraftment syndrome,0
9324,Structure of parenchyma of lung,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9325,Observation of reflex,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
9326,Known,High Grade Glandular Intraepithelial Neoplasia,0
9327,Sarcoma,Microcystic meningioma,0
9328,depend,Nasal cavity carcinoma,0
9329,Evidence,Endometrial Small Cell Carcinoma,0
9330,Human body,Type II Endometrial Adenocarcinoma,0
9331,Aggressive course,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9332,Crystal Present Or Absent (lab procedure),Type II Endometrial Adenocarcinoma,0
9333,One,Giant cell angiofibroma,0
9334,Head,Intraepithelial Melanocytic Hyperplasia,0
9335,Usual,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
9336,Males,Metastatic Lung Small Cell Carcinoma,0
9337,Patient Condition Code - Stable,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9338,Shoulder,Refractory Ependymoma,0
9339,Complete excision,Noninfiltrating Intraductal Carcinoma,0
9340,therapeutic aspects,Uterine Cancer,0
9341,Cerebral Cavernous Hemangioma,Breast Ductal Adenoma,0
9342,bony process,Colorectal High Grade B-Cell Lymphoma,0
9343,Meningeal cluster,Mixed astrocytoma-ependymoma,0
9344,Classification of information,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9345,treatment - ActInformationManagementReason,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
9346,Very high,Congenital hamartoma,0
9347,Back,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9348,Cancer Genus,Adenocarcinoma,0
9349,Subject -direct target,Testicular cancer metastatic,0
9350,Weight decreased,Digestive System Hodgkin Lymphoma,0
9351,Five,mucinous adenocarcinoma of gallbladder,0
9352,Vomiting,Mucosal Melanoma,0
9353,One,Xeroderma pigmentosum,0
9354,Massive,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
9355,Spreading (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
9356,Combined,Stage III Cutaneous Melanoma AJCC v6,0
9357,Logical Condition,Mixed astrocytoma-ependymoma,0
9358,shared attribute,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9359,Treating,Stage IV Penile Cancer AJCC v7,0
9360,BRCA2 protein,Childhood Fibrillary Astrocytoma,0
9361,Offspring,Human Papillomavirus-Related Carcinoma,0
9362,Term Birth,Gallbladder Adenocarcinoma,0
9363,Nursing interventions,Diffuse malignant mesothelioma,0
9364,Common (qualifier value),Maxillary Sinus Adenoid Cystic Carcinoma,0
9365,diagnosis aspect,Giant cell angiofibroma,0
9366,Form:Finding:Point in time:{Setting}:Document:{Role},Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9367,Spreading (qualifier value),non-Hodgkin's lymphoma of spleen,0
9368,Leading,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9369,Malignant - descriptor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9370,Persons,Trichilemmocarcinoma,0
9371,International Statistical Classification of Diseases and Related Health Problems,Cervical Squamous Intraepithelial Neoplasia,0
9372,Different,Cancer of Urinary Tract,0
9373,Positron-Emission Tomography,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9374,Negation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9375,Tryptophanase,Recurrent Uveal Melanoma,0
9376,To,Stage III Cutaneous Melanoma AJCC v6,0
9377,Expiration,Mucinous adenocarcinoma gastric,0
9378,Combined,Mucinous adenocarcinoma gastric,0
9379,Cutaneous Melanoma,Cervical Adenomyoma,0
9380,Severe Extremity Pain,Cerebral Primitive Neuroectodermal Tumor,0
9381,Advanced phase,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9382,Pharmaceutical Preparations,Neonatal leukemia,0
9383,Localized,Fibroadenoma of breast,0
9384,T-Lymphocyte,Thymic Clear Cell Carcinoma,0
9385,Cystoscopy,FIGO Stage II Ovarian Cancer,0
9386,Human Cells,Refractory Glioma,0
9387,Give - dosing instruction imperative,Blepharal carcinoma,0
9388,Vaginal neoplasia,Transitional cell carcinoma,0
9389,Coitus,Platinum-Resistant Lung Small Cell Carcinoma,0
9390,Chemotherapy,Mucosal Melanoma,0
9391,United States,Refractory Ependymoma,0
9392,Usual,Tongue Alveolar Soft Part Sarcoma,0
9393,Intraocular,Pilocytic astrocytoma of cerebellum,0
9394,Lymphocyte,Engraftment syndrome,0
9395,Family (taxonomic),Carcinoma ex pleomorphic adenoma of parotid gland,0
9396,CEL gene,mucinous adenocarcinoma of gallbladder,0
9397,Thickened,Female Breast Carcinoma,0
9398,Publications,Thymic Clear Cell Carcinoma,0
9399,Subject Risk,Cervical Squamous Intraepithelial Neoplasia,0
9400,Part of,Methotrexate-Associated Hodgkin Lymphoma,0
9401,dendritic spine neck,Cartilaginous exostosis,0
9402,Back structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9403,Malignant neoplasm of urinary bladder,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9404,Partial larynx,Intraepithelial Melanocytic Hyperplasia,0
9405,Cardiovascular system,Cherubism,0
9406,Name (property) (qualifier value),Localized Askin Tumor,0
9407,100%,Microcystic meningioma,0
9408,To,Human Papillomavirus-Related Carcinoma,0
9409,Blood Cells,Malignant melanoma of eyelid,0
9410,Ependymoma,Bladder Neuroendocrine Neoplasm,0
9411,Two,Splenic Manifestation of Hairy Cell Leukemia,0
9412,Present,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9413,Smear - instruction imperative,Squamous cell carcinoma of lip,0
9414,Distant,Adult Hepatocellular Carcinoma,0
9415,Measurement,Metaplastic carcinoma of breast,0
9416,Measured Tumor Identification,Small cell neuroendocrine carcinoma of bladder,0
9417,Cervical Squamous Cell Carcinoma,Familial Hemophagocytic Lymphocytosis,0
9418,Secondary Neoplasm,Kaposi's sarcoma of skin,0
9419,Swollen Lymph Node,Ovarian germ cell choriocarcinoma stage IV,0
9420,Related personal status,Peripheral primitive neuroectodermal tumor of soft tissue,0
9421,Version,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9422,Array Feature,Engraftment syndrome,0
9423,Primitive,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9424,Tissue Type Code - Basal cell carcinoma,Thyroid Hurthle Cell Carcinoma,0
9425,STS gene,Stage II Carcinoma of Penis,0
9426,Appearance Distress Question,Female Breast Carcinoma,0
9427,Grouped (foundation metadata concept),Low Grade Squamous Intraepithelial Neoplasia,0
9428,Location of Oral Residue Following Swallowing,Periosteal Osteosarcoma,0
9429,Sore skin,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9430,Concept History,Adult Alveolar Soft Part Sarcoma,0
9431,Vitamin supplementation,Benign tumor of eyelid,0
9432,Pediculus humanus capitis (eukaryote),Chronic Myelomonocytic Leukemia-2,0
9433,Glioblastoma Multiforme,Trabecular adenocarcinoma,0
9434,Accepted,Pancreatic Intraepithelial Neoplasia-3,0
9435,Present,Adult Alveolar Soft Part Sarcoma,0
9436,General surgery specialty,Acute Undifferentiated Leukemia,0
9437,Small,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
9438,Control function,Benign tumor of eyelid,0
9439,Diarrhea,Metastatic Lung Small Cell Carcinoma,0
9440,Best Case Imputation Technique,Low Grade Squamous Intraepithelial Neoplasia,0
9441,survival aspects,Benign Apocrine Neoplasm,0
9442,Asians,ROSE Cluster 3,0
9443,Condition:Find:Pt:^Patient:Nom,Intestinal Metaplasia of Bladder Urothelium,0
9444,Recurrence,Trabecular adenocarcinoma,0
9445,Pharmacotherapy,Childhood Lung Non-Small Cell Carcinoma,0
9446,Condylomata Acuminata,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9447,Chemotherapy,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9448,Often - answer to question,ROSE Cluster 3,0
9449,Moveable,Cancer of Urinary Tract,0
9450,Eating,Childhood Fibrillary Astrocytoma,0
9451,survival aspects,Nasal cavity carcinoma,0
9452,Apply (instruction),FIGO Stage II Ovarian Cancer,0
9453,section sample,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9454,Age of onset of symptoms:Time:Pt:^Patient:Qn,Contact dermatitis due to alkali,0
9455,Name (property) (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9456,Linear,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9457,Arsenic,Colorectal cancer,0
9458,Human body structure,Undifferentiated Endocervical Sarcoma,0
9459,Aspects of disease screening,Benign squamous cell tumor,0
9460,Fatigue,Melanomatosis,0
9461,Table Rules - groups,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9462,diagnosis aspect,Stage III Cutaneous Melanoma AJCC v6,0
9463,Aberrant,Malignant neoplasm of olfactory nerve,0
9464,Therapeutic radiology procedure,Chronic Myelomonocytic Leukemia-2,0
9465,Usually Need Help from Another Person for Arising,FIGO Stage II Ovarian Cancer,0
9466,Antibodies,Melanomatosis,0
9467,Name (property) (qualifier value),Small Intestinal Villous Adenoma,0
9468,Life,adenosquamous carcinoma of breast,0
9469,treatment - ActInformationManagementReason,High Grade Glandular Intraepithelial Neoplasia,0
9470,Pain,Squamous cell carcinoma of lip,0
9471,800,Intestinal Metaplasia of Bladder Urothelium,0
9472,Case Study,Pleomorphic adenoma of parotid gland,0
9473,Probable diagnosis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9474,Difficulty walking,Acute Undifferentiated Leukemia,0
9475,Esophagitis,Chondrosarcoma,0
9476,Operative Surgical Procedures,Cervical Squamous Intraepithelial Neoplasia,0
9477,Organ,Thymic Atypical Carcinoid Tumor,0
9478,Manual pelvic examination (procedure),Acute Undifferentiated Leukemia,0
9479,Leukemic Cells Measurement,Human Papillomavirus-Related Carcinoma,0
9480,Skeletal bone,Collecting Duct Carcinoma of the Kidney,0
9481,Older Population,Mucinous adenocarcinoma gastric,0
9482,Child,Fibroadenoma of breast,0
9483,Infection,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9484,Feelings,clear cell adenocarcinoma of gallbladder,0
9485,Cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9486,Pain,Breast Ductal Adenoma,0
9487,Metastasis,Malignant Neoplasm with Regional Lymph Node Involvement,0
9488,Intrinsic origin,Advanced Uterine Corpus Carcinosarcoma,0
9489,Human body,Pancreatic carcinoma,0
9490,To,Metastatic Lung Neuroendocrine Neoplasm,0
9491,Cell Count,Stage IB Pancreatic Cancer AJCC v8,0
9492,International Classification of Disease for Oncology,Stage II Carcinoma of Penis,0
9493,Cell Communication,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9494,Exact (qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9495,Secondary to,Refractory Bladder Carcinoma,0
9496,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Undifferentiated Leukemia,0
9497,Disease,Vaginal Adenoid Cystic Carcinoma,0
9498,Volume Measurement,Adult Anaplastic Oligodendroglioma,0
9499,Observed,Nasal cavity carcinoma,0
9500,Limited (extensiveness),Colorectal High Grade B-Cell Lymphoma,0
9501,100%,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9502,Decision,Intestinal Metaplasia of Bladder Urothelium,0
9503,granulocyte,Recurrent Primary Lymphoma of Bone,0
9504,Frequently,Cervical Squamous Intraepithelial Neoplasia,0
9505,Palmitic Acid,Fourth Ventricle and Brain Stem Ependymal Tumor,0
9506,Administration type,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9507,Dysgerminoma,Hereditary Diffuse Gastric Adenocarcinoma,0
9508,Greater than one,Ichthyoses,0
9509,Possibly Related to Intervention,Mixed parotid tumor,0
9510,Relationships,Endometrial Small Cell Carcinoma,0
9511,Scientific Study,Astrocytoma of brain,0
9512,Room of building - Study,Stage IV Childhood Non-Hodgkin Lymphoma,0
9513,Type A,Unfavorable Non-Hodgkin Lymphoma,0
9514,Persons,Benign Anal Granular Cell Tumor,0
9515,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage 0 Penile Cancer AJCC v8,0
9516,Professional Occupation,Hodgkin Disease,0
9517,Human body,Refractory Glioma,0
9518,Childhood Leukemia,Refractory Barrett Esophagus,0
9519,Chemotherapy,Localized Ewing Sarcoma,0
9520,Include (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9521,physiological aspects,Maxillary Sinus Adenocarcinoma,0
9522,CDISC SDTM Route of Administration Terminology,Childhood Central Nervous System Ganglioneuroblastoma,0
9523,Count of entities,Locally Advanced Squamous Cell Carcinoma,0
9524,Neoplasm Metastasis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9525,Benzene,Mixed astrocytoma-ependymoma,0
9526,What subject filter - Result,Mixed astrocytoma-ependymoma,0
9527,ABCB1 protein,Childhood Fibrillary Astrocytoma,0
9528,Blood Cells,Melanomatosis,0
9529,Type A,Maxillary Sinus Adenocarcinoma,0
9530,Adenocarcinoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9531,Carcinoma,Stage IB Pancreatic Cancer AJCC v8,0
9532,leukemia,BRCA2 Syndrome,0
9533,Defense,Refractory Bladder Carcinoma,0
9534,Ameloblasts,Benign Anal Granular Cell Tumor,0
9535,Subtype (attribute),adenoid cystic carcinoma of lung,0
9536,Chemotherapy Regimen,FIGO Stage II Ovarian Cancer,0
9537,Classification of information,Low Grade Squamous Intraepithelial Neoplasia,0
9538,Squamous cell carcinoma,Clonal Hematopoiesis of Indeterminate Potential,0
9539,Sensation quality,Bladder adenocarcinoma stage IV,0
9540,Benign Neoplasm,Squamous cell carcinoma of lip,0
9541,Common Specifications in HL7 V3 Publishing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9542,Egg of order Phthiraptera,Cervical Fibroepithelial Polyp,0
9543,Currarino triad,Uterine Cancer,0
9544,Togo,Mucinous adenocarcinoma gastric,0
9545,Abdomen,Cartilaginous exostosis,0
9546,shared attribute,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
9547,Unspecified,Chronic Myelomonocytic Leukemia-2,0
9548,Asia,clear cell adenocarcinoma of gallbladder,0
9549,Anatomic Site,Malignant neoplasm of subglottis,0
9550,Symptoms aspect,Vaginal Adenoid Cystic Carcinoma,0
9551,Numerous,Stage III Adult Immunoblastic Lymphoma,0
9552,Call (Instruction),Benign squamous cell tumor,0
9553,Dura Mater,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9554,Embryonic Development,Pancreatic Intraepithelial Neoplasia-3,0
9555,Benign Neoplasm,Malignant neoplasm of gallbladder,0
9556,Coitus,Splenic Manifestation of Hairy Cell Leukemia,0
9557,Bloating,Acute Undifferentiated Leukemia,0
9558,Skin Specimen,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9559,various antiinfectives and antiseptics for local oral treatment,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9560,Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9561,Antifungal Antibiotics,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9562,Full,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9563,Does play,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
9564,High Level,Neoplasms,0
9565,Morphology,Childhood Central Nervous System Immature Teratoma,0
9566,Count of entities,Hodgkin lymphoma,0
9567,Scientific Publication,Endometrial Small Cell Carcinoma,0
9568,Ichthyosis,Extra-Adrenal Paraganglioma,0
9569,Used by,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9570,Point,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9571,Persons,Benign neoplasm of thorax,0
9572,CYREN gene,Gallbladder Adenocarcinoma,0
9573,European race,Malignant neoplasm of olfactory nerve,0
9574,Overall,Stage I Colon Neuroendocrine Tumor AJCC v8,0
9575,International Classification of Diseases for Oncology,Ectomesenchymal Chondromyxoid Tumor,0
9576,Including (qualifier),Locally Advanced Carcinoma,0
9577,Glioma,Testicular cancer metastatic,0
9578,Human body structure,Leptomeningeal sarcoma,0
9579,Person Observer,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
9580,Use of,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
9581,Malignant Neoplasms,Type II Endometrial Adenocarcinoma,0
9582,Woman,Nasal cavity carcinoma,0
9583,Olfactory Epithelium,Advanced Uterine Corpus Carcinosarcoma,0
9584,Neoplasms,Angiosarcoma of liver,0
9585,Recurrent infections,Refractory Barrett Esophagus,0
9586,Malignant neoplasm of large intestine,Blepharal carcinoma,0
9587,2+ Score,Recurrent Uveal Melanoma,0
9588,Transection (procedure),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9589,Tumor type,FIGO Stage II Ovarian Cancer,0
9590,Nervous system structure,Refractory Barrett Esophagus,0
9591,shared attribute,Pilocytic astrocytoma of cerebellum,0
9592,Both ovaries,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9593,Confirmed by,Diffuse malignant mesothelioma,0
9594,Containing (qualifier),Lipoma of small intestine,0
9595,Location of Oral Residue Following Swallowing,GIANT PIGMENTED HAIRY NEVUS,0
9596,Procedural approach,FIGO Stage IVA Ovarian Cancer,0
9597,Impaired skin integrity,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9598,Arising in,Cerebral Primitive Neuroectodermal Tumor,0
9599,Used by,Placental aromatase deficiency,0
9600,risk factors - observation list,Blepharal carcinoma,0
9601,More,Brain Tumor,0
9602,Tumor cells,Blepharal carcinoma,0
9603,Tryptophanase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9604,Have Weight Loss,Stage IV Childhood Non-Hodgkin Lymphoma,0
9605,Beginning,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9606,PREVENT (product),benign mature teratoma of pancreas,0
9607,Patient Reported Outcome Stem,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9608,Analysis of substances,FIGO Stage IVA Ovarian Cancer,0
9609,Volume (publication),Human Papillomavirus-Related Carcinoma,0
9610,eTMF Content Model Code,Adult Alveolar Soft Part Sarcoma,0
9611,Chronic inflammation,Kaposi's sarcoma of extrahepatic bile duct,0
9612,In Blood,FIGO Stage II Ovarian Cancer,0
9613,Cancer Genus,Stage I Adult Non-Hodgkin Lymphoma,0
9614,Obese build,Childhood Thyroid Gland Follicular Carcinoma,0
9615,Occur (action),Human Papillomavirus-Related Carcinoma,0
9616,Manufactured sign,Stage IV Penile Cancer AJCC v7,0
9617,per second,Locally Advanced Carcinoma,0
9618,Symptoms aspect,Angiosarcoma of liver,0
9619,Reported Term,FIGO Stage IVA Ovarian Cancer,0
9620,Call (Instruction),Undifferentiated Endocervical Sarcoma,0
9621,Malignant - descriptor,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9622,Highest,Malignant melanoma of eyelid,0
9623,Formations,Xeroderma pigmentosum,0
9624,Subject Risk,Atypical Mesothelial Hyperplasia,0
9625,Prognosis:Find:Pt:^Patient:Nom,Recurrent Testicular Lymphoma,0
9626,Melanoma Pathway,Atypical Lobular Breast Hyperplasia,0
9627,Thinking,Gallbladder Adenocarcinoma,0
9628,Negation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9629,Tryptophanase,clear cell adenocarcinoma of gallbladder,0
9630,Variant,Cerebral Primitive Neuroectodermal Tumor,0
9631,False Discovery Rate,Adult Hepatocellular Carcinoma,0
9632,Subtype (attribute),Cervical Fibroepithelial Polyp,0
9633,include - SetOperator,Hereditary Diffuse Gastric Adenocarcinoma,0
9634,Poor - qualifier,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9635,Severe Extremity Pain,Human Papillomavirus-Related Carcinoma,0
9636,Affect (mental function),Astrocytoma of brain,0
9637,More,Mucinous adenocarcinoma gastric,0
9638,Pharmacologic Substance,Stage III Cutaneous Melanoma AJCC v6,0
9639,Evidence,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
9640,Basis - conceptual entity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9641,Feelings,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9642,Smear - instruction imperative,Acute Undifferentiated Leukemia,0
9643,Malignant Female Reproductive System Neoplasm,Locally Advanced Epithelioid Hemangioendothelioma,0
9644,Screening - general NOS (finding),Metaplastic carcinoma of breast,0
9645,Percent of Abnormal Cells,Heavy Chain Deposition Disease,0
9646,Linear,Malignant melanoma of eyelid,0
9647,Most,Papillary squamous cell carcinoma,0
9648,site-specific telomere resolvase activity,Benign Carotid Body Paraganglioma,0
9649,OVARIAN SWELLING,Stage IB Pancreatic Cancer AJCC v8,0
9650,Common (qualifier value),Type II Endometrial Adenocarcinoma,0
9651,week,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9652,Administration procedure,Angiosarcoma of liver,0
9653,Due to,Diffuse malignant mesothelioma,0
9654,Usual Severity Shortness of Breath,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9655,Reference Object,Undifferentiated Endocervical Sarcoma,0
9656,Rare Diseases,Hodgkin lymphoma,0
9657,Associated with,Gallbladder Adenocarcinoma,0
9658,Case unit dose,Hodgkin Disease,0
9659,65,Thyroid Hurthle Cell Carcinoma,0
9660,Pain,Acantholytic squamous cell carcinoma,0
9661,To,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9662,Internal,BRCA2 Syndrome,0
9663,Laparotomy,Adult Alveolar Soft Part Sarcoma,0
9664,Form:Finding:Point in time:{Setting}:Document:{Role},Intracortical osteosarcoma,0
9665,Dysuria,Thyroid Hurthle Cell Carcinoma,0
9666,survive,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9667,year,ROSE Cluster 3,0
9668,Pelvis,Digestive System Hodgkin Lymphoma,0
9669,Body tissue,Unicystic ameloblastoma,0
9670,Laser Device Component,Primary Cutaneous Plasmablastic Lymphoma,0
9671,Call (Instruction),Chondrosarcoma,0
9672,Common Specifications in HL7 V3 Publishing,gliosarcoma,0
9673,Academic degree,Tonsillar Carcinoma,0
9674,Fusion procedure,Carcinomatosis of peritoneal cavity,0
9675,Condition,Kaposi's sarcoma of skin,0
9676,Specimen,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9677,Morphology,Carcinoma of urinary bladder,0
9678,Unknown,Refractory Bladder Carcinoma,0
9679,Chemotherapy,Stage III Adult Immunoblastic Lymphoma,0
9680,Science of Morphology,Cancer of Urinary Tract,0
9681,Diagnosis Study,Ovarian Carcinoid Tumor,0
9682,Hyperlink,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9683,English [International Organization for Standardization 639-1 code en] language reference set,Malignant melanoma of eyelid,0
9684,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9685,Term Birth,Nasal cavity carcinoma,0
9686,Percent of Abnormal Cells,Cartilaginous exostosis,0
9687,Have Itch,Cervical Squamous Intraepithelial Neoplasia,0
9688,Very Much,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9689,Personal appearance,Xeroderma pigmentosum,0
9690,Relationships,Recurrent Uveal Melanoma,0
9691,Type - attribute,Pancreatic carcinoma,0
9692,100%,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9693,chapter,Childhood Choriocarcinoma,0
9694,Skeletal bone,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
9695,Formation,Stage I Adult Non-Hodgkin Lymphoma,0
9696,Appearance,Localized Askin Tumor,0
9697,Shortened,Refractory Barrett Esophagus,0
9698,Administration occupational activities,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9699,Malignant neoplasm of large intestine,Metaplastic carcinoma of breast,0
9700,Medical Device Emits Smoke,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9701,Carcinoma,Childhood Fibrillary Astrocytoma,0
9702,Average,Carcinoma of urinary bladder,0
9703,Factor,Necrotizing Funisitis,0
9704,Surface,Deep Leiomyoma,0
9705,Hypotension,Refractory Ependymoma,0
9706,Nine,Adrenal Rest Tumor,0
9707,Oral cavity,Small cell neuroendocrine carcinoma of bladder,0
9708,Pain,Adult Hepatocellular Carcinoma,0
9709,Basis - conceptual entity,Adenocarcinoma of the prostate metastatic,0
9710,MALIGNANT benign,Benign tumor of eyelid,0
9711,Pelvic Pain,Noninfiltrating Intraductal Carcinoma,0
9712,Physical findings,Blood Vessel Tumors,0
9713,Occurrence Indicator,Spermatocytic seminoma,0
9714,Parameterized Data Type - Set,FIGO Stage II Ovarian Cancer,0
9715,Contain (action),Intraepithelial Melanocytic Hyperplasia,0
9716,Cell Count,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9717,>90,Undifferentiated Endocervical Sarcoma,0
9718,Intraventricular,Thymic Clear Cell Carcinoma,0
9719,Neoplasm Metastasis,Peripheral primitive neuroectodermal tumor of soft tissue,0
9720,Clinical Trials,Peripheral primitive neuroectodermal tumor of soft tissue,0
9721,Biological Response Modifier Therapy,adenoid cystic carcinoma of lung,0
9722,second (number),Type II Endometrial Adenocarcinoma,0
9723,31,Thymic Clear Cell Carcinoma,0
9724,1+ Score,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9725,Dangerousness,Trichilemmocarcinoma,0
9726,Solid,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9727,Tryptophanase,Benign Anal Granular Cell Tumor,0
9728,Age,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9729,Malignant Neoplasms,Metastatic Ductal Breast Carcinoma,0
9730,Pharmacotherapy,Extra-Adrenal Paraganglioma,0
9731,Normal tissue morphology,Kaposi's sarcoma of extrahepatic bile duct,0
9732,Lymphocyte production,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9733,Occurrence Indicator,Ovarian germ cell choriocarcinoma stage IV,0
9734,Medical History,Squamous cell carcinoma of lip,0
9735,Singular,Acute Undifferentiated Leukemia,0
9736,Pressure- physical agent,adenoid cystic carcinoma of lung,0
9737,Late,Malignant melanoma of eyelid,0
9738,Known,Childhood Fibrillary Astrocytoma,0
9739,research subject screening,Fibroadenoma of breast,0
9740,diagnosis aspect,Congenital hamartoma,0
9741,Symptoms aspect,Stage IB Pancreatic Cancer AJCC v8,0
9742,Pressure (property),Clonal Hematopoiesis of Indeterminate Potential,0
9743,Abdominal wall structure,Benign Carotid Body Paraganglioma,0
9744,Uterine Corpus Sarcoma,Multiple Skull Base Meningiomas,0
9745,Medical Devices,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9746,Malignant lymphoma,sarcoma of spinal cord,0
9747,Low Risk,Tonsillar Carcinoma,0
9748,Occurrence Indicator,Rhabdomyosarcoma with ganglionic differentiation,0
9749,Slightly (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
9750,Benign Neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
9751,Neurofibromatosis 1,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
9752,Use of,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9753,Frequently,Primary Cutaneous Plasmablastic Lymphoma,0
9754,Subtype (attribute),Adult Acute Eosinophilic Leukemia,0
9755,Cell Count,Sarcomatoid Renal Cell Carcinoma,0
9756,Role,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9757,Icterus,Benign Apocrine Neoplasm,0
9758,Male population group,Acute Undifferentiated Leukemia,0
9759,Part,Stage III Cutaneous Melanoma AJCC v6,0
9760,Have Weight Loss,Type II Endometrial Adenocarcinoma,0
9761,Childhood Lymphoma,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9762,Type A,Metastatic Lung Neuroendocrine Neoplasm,0
9763,Aspects of disease screening,Spindle Cell Melanoma,0
9764,Antimicrobial Intermediate Susceptibility Result,Splenic Manifestation of Hairy Cell Leukemia,0
9765,Biomaterial Treatment,Stage IV Childhood Non-Hodgkin Lymphoma,0
9766,+2,Carcinoma of urinary bladder,0
9767,Numerous,Adrenal Rest Tumor,0
9768,What subject filter - Result,Blood Vessel Tumors,0
9769,Lung,Trichilemmocarcinoma,0
9770,Less Than,Adenocarcinoma of duodenum,0
9771,Medications:-:Point in time:^Patient:-,Carcinoma of urinary bladder,0
9772,Firstly,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9773,Diagnosis Study,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9774,Neoplasm Metastasis,clear cell adenocarcinoma of gallbladder,0
9775,Growth action,Adult Acute Eosinophilic Leukemia,0
9776,Usually Need Help from Another Person for Arising,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9777,Body tissue,Bladder Neuroendocrine Neoplasm,0
9778,Ability,Cherubism,0
9779,Including (qualifier),Hodgkin Disease,0
9780,Comment,Mixed astrocytoma-ependymoma,0
9781,27,Childhood Central Nervous System Ganglioneuroblastoma,0
9782,Primary malignant neoplasm,Intestinal Metaplasia of Bladder Urothelium,0
9783,In Urine,Localized Askin Tumor,0
9784,Used by,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9785,combination - answer to question,Unfavorable Non-Hodgkin Lymphoma,0
9786,Blood group antibody I,Chest Wall Fibromatosis,0
9787,Diagnosis,Lung squamous cell carcinoma stage I,0
9788,Name,Anaplastic large cell lymphoma,0
9789,Sunscreening Agents,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9790,Tryptophanase,Malignant neoplasm of subglottis,0
9791,Worsening pattern,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9792,Occur (action),Undifferentiated Endocervical Sarcoma,0
9793,Used by,Liver Lymphangioma,0
9794,Orbital region,Cervical Fibroepithelial Polyp,0
9795,Breast,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9796,Present,Adult Alveolar Soft Part Sarcoma,0
9797,Absent,Stage III Adult Immunoblastic Lymphoma,0
9798,Immune,Malignant neoplasm of olfactory nerve,0
9799,Associated with,Childhood Thyroid Gland Follicular Carcinoma,0
9800,Lung,Adult Alveolar Soft Part Sarcoma,0
9801,Body tissue,Unfavorable Non-Hodgkin Lymphoma,0
9802,Sequence Arm,Primary Cutaneous Plasmablastic Lymphoma,0
9803,Type A,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9804,Only - dosing instruction fragment,Tonsillar Carcinoma,0
9805,Transection (procedure),benign mature teratoma of pancreas,0
9806,Area,Stage IB Lung Cancer AJCC v7,0
9807,nonspecific,Cervical Adenomyoma,0
9808,Neuroblastoma,Uterine Cancer,0
9809,Gastrointestinal Stromal Tumors,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9810,Neoplasms,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9811,Frequently,Testicular cancer metastatic,0
9812,Including (qualifier),Urethral Carcinoma,0
9813,Back structure,Lipoma of small intestine,0
9814,Platelet Glycoprotein 4,Unicystic ameloblastoma,0
9815,Diagnosis,Malignant neoplasm of subglottis,0
9816,Skin symptom,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9817,Spreading (qualifier value),Collecting Duct Carcinoma of the Kidney,0
9818,Dermoid Cyst,Placental aromatase deficiency,0
9819,Mutation,de novo Myelodysplastic Syndrome,0
9820,ovarian neoplasm,Cancer of Urinary Tract,0
9821,Cells,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9822,Chemotherapy,Neonatal leukemia,0
9823,Weight Loss,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9824,Embryonic Development,Cervical Squamous Intraepithelial Neoplasia,0
9825,Lung,Pancreatic Intraepithelial Neoplasia-3,0
9826,Better than Others,Thymoma malignant recurrent,0
9827,Biological Response Modifiers,Central Nervous System Anaplastic Large Cell Lymphoma,0
9828,Lymphadenopathy,Refractory Ependymoma,0
9829,Child,Human Papillomavirus-Related Carcinoma,0
9830,Usually,Cervical Squamous Intraepithelial Neoplasia,0
9831,Tryptophanase,Trichilemmocarcinoma,0
9832,Human Papilloma Virus Vaccine,Benign squamous cell tumor,0
9833,Killing,Refractory Ependymoma,0
9834,Average of Value Derivation Technique,Stage II Carcinoma of Penis,0
9835,analysis aspect,Pleomorphic adenoma of parotid gland,0
9836,Science of Etiology,High Grade Glandular Intraepithelial Neoplasia,0
9837,Combined,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9838,Personal appearance,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
9839,Intestines,Spongiotic dermatitis,0
9840,metaplastic cell transformation,Acantholytic squamous cell carcinoma,0
9841,Tryptophanase,malignant lymphoma of pancreatic lymph nodes,0
9842,research,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9843,Males,Gallbladder Adenocarcinoma,0
9844,Location of Pharyngeal Residue Following Swallowing,Metastatic Lung Neuroendocrine Neoplasm,0
9845,3+ Answer to Question,Periosteal Osteosarcoma,0
9846,Biopsy,Malignant Testicular Sertoli Cell Tumor,0
9847,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
9848,In Blood,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
9849,various allergen extracts,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9850,<50,Small intestine carcinoma,0
9851,Function Axis,Localized Ewing Sarcoma,0
9852,Malignant neoplasm of skin,Recurrent Diffuse Intrinsic Pontine Glioma,0
9853,More,Cartilaginous exostosis,0
9854,Disruptive,Thymic Clear Cell Carcinoma,0
9855,Male population group,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9856,Most,Tubal Hyperplasia,0
9857,Carcinoma of lung,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9858,Causing,mucinous adenocarcinoma of gallbladder,0
9859,Etiology aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9860,Human Papillomavirus Positive,Funisitis (disorder),0
9861,Noma,Metastatic Neoplasm to the Gallbladder,0
9862,Colorectal Cancer,Locally Advanced Soft Tissue Sarcoma,0
9863,Face (spatial concept),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9864,Two,Breast Ductal Adenoma,0
9865,Infection,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9866,Back structure,Cerebral Primitive Neuroectodermal Tumor,0
9867,Essential,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9868,Term (lexical),adenosquamous carcinoma of breast,0
9869,Source,Refractory Bladder Carcinoma,0
9870,Hollow shape,Refractory Ependymoma,0
9871,South,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9872,Antibiotics for systemic use,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9873,Including (qualifier),Stage II Hepatocellular Carcinoma AJCC v8,0
9874,Approximate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9875,Anemia,Epithelioid Sarcoma NCI Grade 3,0
9876,Occur (action),Localized Ewing Sarcoma,0
9877,+2,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9878,Removed,Non-Metastatic Gestational Trophoblastic Tumor,0
9879,Aluminum measurement,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9880,BRCA1 protein,Localized Ewing Sarcoma,0
9881,Operative Surgical Procedures,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9882,Administration procedure,Cystadenocarcinoma,0
9883,Dyspnea,Cervical Fibroepithelial Polyp,0
9884,Age at diagnosis,Liver Cavernous Hemangioma,0
9885,mast cell,Cancer of Urinary Tract,0
9886,Additional,Benign Carotid Body Paraganglioma,0
9887,Occurrence Indicator,Blepharal carcinoma,0
9888,Ovarian Carcinoma,Benign tumor of eyelid,0
9889,Area,Digestive System Hodgkin Lymphoma,0
9890,Entity Determiner - specific,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9891,Area,Human Papillomavirus-Related Carcinoma,0
9892,Lung,BRCA2 Syndrome,0
9893,Capsule (unit of presentation),Thyroid Hurthle Cell Carcinoma,0
9894,Classification of information,Basal Cell Ameloblastoma,0
9895,Tired,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9896,In Blood,Acantholytic squamous cell carcinoma,0
9897,Removed,Tonsillar Carcinoma,0
9898,Have Weight Loss,Female Breast Carcinoma,0
9899,Publications,Intestinal Metaplasia of Bladder Urothelium,0
9900,Carcinoma,Colorectal Neuroendocrine Tumor G2,0
9901,To,Angiosarcoma of liver,0
9902,risk factors,FIGO Stage IVA Ovarian Cancer,0
9903,Core needle biopsy,Benign tumor of eyelid,0
9904,Skin tanning,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9905,Occurrence,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9906,Appearance,Squamous cell carcinoma of lip,0
9907,PSA Level Less than Two,Benign Anal Granular Cell Tumor,0
9908,Better than Others,Adult Anaplastic Oligodendroglioma,0
9909,Name,Splenic Manifestation of Hairy Cell Leukemia,0
9910,Occur (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9911,95,Malignant melanoma of eyelid,0
9912,Reduced,Kaposi's sarcoma of extrahepatic bile duct,0
9913,Balance,non-Hodgkin's lymphoma of spleen,0
9914,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage III Cutaneous Melanoma AJCC v6,0
9915,second (number),ROSE Cluster 3,0
9916,Acquired phimosis,Blepharal carcinoma,0
9917,High,Squamous cell carcinoma of lip,0
9918,Immune system,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9919,Related personal status,Adult Alveolar Soft Part Sarcoma,0
9920,Lifetime Risk,Secondary malignant neoplasm of lymph node,0
9921,Bone Marrow,Recurrent Rhabdomyosarcoma,0
9922,Reverse,gliosarcoma,0
9923,include - SetOperator,Colorectal High Grade B-Cell Lymphoma,0
9924,Benign Neoplasm,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9925,Time,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9926,Elderly (population group),Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
9927,Cause of death:Find:Pt:^Patient:Nom,Benign squamous cell tumor,0
9928,Worsening pattern,Refractory Ependymoma,0
9929,Unknown GENC,Malignant neoplasm of gallbladder,0
9930,Occur (action),Cartilaginous exostosis,0
9931,Metastasis,Parathyroid Gland Adenocarcinoma,0
9932,Average,Squamous cell carcinoma of lip,0
9933,Childhood Extracranial Germ Cell Tumor,Stage II Hepatocellular Carcinoma AJCC v8,0
9934,Goiter,Cancer of Urinary Tract,0
9935,Organ,Metaplastic carcinoma of breast,0
9936,Manufactured sign,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9937,soft tissue,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9938,Standard of Care,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
9939,*Type - Kind of quantity,clear cell adenocarcinoma of gallbladder,0
9940,Specific qualifier value,Rhabdomyosarcoma with ganglionic differentiation,0
9941,Disease,Parathyroid Gland Adenocarcinoma,0
9942,Breast tissue sample,Childhood Extragonadal Malignant Germ Cell Tumor,0
9943,Lymphangitis,Pancreatic Endocrine Carcinoma,0
9944,Damage,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9945,health and disease,Thyroid Hurthle Cell Carcinoma,0
9946,Generations,Undifferentiated Endocervical Sarcoma,0
9947,Basal Cell Carcinoma Pathway,Gallbladder adenoma,0
9948,*Type - Kind of quantity,Maxillary Sinus Adenoid Cystic Carcinoma,0
9949,Duodenal Cancer,Stage III Cutaneous Melanoma AJCC v6,0
9950,Pelvic Pain,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9951,Source,Stage I Colon Neuroendocrine Tumor AJCC v8,0
9952,Bone structure of rib,Ichthyosis,0
9953,West Haven Hepatic Encephalopathy Grade 3,Mixed astrocytoma-ependymoma,0
9954,Dyspnea,Parathyroid Gland Adenocarcinoma,0
9955,GDF15 protein,Stage 0 Penile Cancer AJCC v8,0
9956,Catch - Finding of sensory dimension of pain,Type II Endometrial Adenocarcinoma,0
9957,Two,Spindle Cell Melanoma,0
9958,Lymphocyte,Tongue Alveolar Soft Part Sarcoma,0
9959,Malignant Cell Count,Cystadenocarcinoma,0
9960,cell growth,Contact dermatitis due to alkali,0
9961,Togo,Childhood Central Nervous System Ganglioneuroblastoma,0
9962,Including (qualifier),Endometrial Small Cell Carcinoma,0
9963,Gases,Mucosal Melanoma,0
9964,Frequently,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9965,Occur (action),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9966,CHURC1 gene,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9967,Probability,Recurrent Testicular Lymphoma,0
9968,Dorsal,Intestinal Metaplasia of Bladder Urothelium,0
9969,Spreading (qualifier value),Mastocytosis,0
9970,Course,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
9971,radiotherapeutic,Plexosarcoma,0
9972,SLC35G1 gene,Metaplastic carcinoma of breast,0
9973,Cell Count,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
9974,Oral (intended site),Childhood Central Nervous System Ganglioneuroblastoma,0
9975,Greater,Giant cell angiofibroma,0
9976,breast.duct,adenosquamous carcinoma of breast,0
9977,Chemotherapy Regimen,Engraftment syndrome,0
9978,Lower (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9979,American College of Cardiology/American Heart Association Lesion Complexity Score C,Advanced Uterine Corpus Carcinosarcoma,0
9980,Childhood diseases,Carcinoma of urinary bladder,0
9981,Therapeutic procedure,Stage I Adult Non-Hodgkin Lymphoma,0
9982,Certain (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9983,6/3,benign mature teratoma of pancreas,0
9984,Malignant Neoplasms,Melanomatosis,0
9985,Mathematical Factor,Localized Malignant Neoplasm,0
9986,treatment - ActInformationManagementReason,Acute lymphadenitis,0
9987,Rare,Cerebral Primitive Neuroectodermal Tumor,0
9988,Biogenic Amines,sarcoma of spinal cord,0
9989,International Statistical Classification of Diseases and Related Health Problems,Undifferentiated Endocervical Sarcoma,0
9990,Lacking,Childhood Lung Non-Small Cell Carcinoma,0
9991,Rating (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
9992,Headache,Acute lymphadenitis,0
9993,>5,Stage III Cutaneous Melanoma AJCC v6,0
9994,To,squamous cell carcinoma of the thyroid gland,0
9995,Treatment Epoch,Methotrexate-Associated Hodgkin Lymphoma,0
9996,Occurrence Indicator,embryonal rhabdomyosarcoma of prostate,0
9997,Disease,Kaposi's sarcoma of skin,0
9998,Result,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
9999,Anatomic Site,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
10000,Increased risk for cancer,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10001,combination of objects,Extra-Adrenal Paraganglioma,0
10002,Operative Surgical Procedures,Malignant melanoma of eyelid,0
10003,Place - dosing instruction imperative,Recurrent Uveal Melanoma,0
10004,Base - General Qualifier,Diffuse malignant mesothelioma,0
10005,Reciprocal translocation,Endometrial Small Cell Carcinoma,0
10006,Occurrence,Refractory Barrett Esophagus,0
10007,Growth action,Refractory Ependymoma,0
10008,treatment - ActInformationManagementReason,Stage 0 Lip Carcinoma,0
10009,ovarian,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10010,structure,Recurrent Testicular Lymphoma,0
10011,Cessation of life,Kaposi's sarcoma of extrahepatic bile duct,0
10012,Diagnosis Study,Metastatic Ductal Breast Carcinoma,0
10013,Lymphangioma,Stage IB Lung Cancer AJCC v7,0
10014,Infant,Adult Alveolar Soft Part Sarcoma,0
10015,Line Specimen,Maxillary Sinus Adenocarcinoma,0
10016,Occurrence,Childhood Central Nervous System Ganglioneuroblastoma,0
10017,Anaplastic astrocytoma,Recurrent Uveal Melanoma,0
10018,Agreement,Benign squamous cell tumor,0
10019,Providing presence (regime/therapy),Childhood Cerebellar Neoplasm,0
10020,Used by,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
10021,Pedunculated Lesion,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10022,Epithelial proliferation,Carcinoma ex pleomorphic adenoma of parotid gland,0
10023,Heart failure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10024,Substance,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10025,Due to,Endometrial Small Cell Carcinoma,0
10026,Subject is Randomized,malignant lymphoma of pancreatic lymph nodes,0
10027,Science of Etiology,Localized Askin Tumor,0
10028,Hemorrhage,Engraftment syndrome,0
10029,fluid - substance,Acantholytic squamous cell carcinoma,0
10030,Diagnosis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10031,Seventh,Lung Mucinous Cystadenoma,0
10032,Central,Testicular cancer metastatic,0
10033,Menopause,Undifferentiated Endocervical Sarcoma,0
10034,dendritic spine neck,Thymic Clear Cell Carcinoma,0
10035,newly,Splenic Manifestation of Hairy Cell Leukemia,0
10036,65,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10037,Coitus,mucinous adenocarcinoma of gallbladder,0
10038,Cancer Genus,Female Breast Carcinoma,0
10039,Neoplasms,Mixed parotid tumor,0
10040,Occurrence Indicator,Localized Ewing Sarcoma,0
10041,Upper,Kaposi's sarcoma of extrahepatic bile duct,0
10042,Extraction,Intraepithelial Melanocytic Hyperplasia,0
10043,How Often Weight Loss,Stage III Cutaneous Melanoma AJCC v6,0
10044,Entire endocrine gland,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10045,Manufactured form,Acantholytic squamous cell carcinoma,0
10046,Carcinoid Tumor,Tonsillar Carcinoma,0
10047,Late,Testicular cancer metastatic,0
10048,Body structure,Blepharal carcinoma,0
10049,Abdominal bloating,Undifferentiated Endocervical Sarcoma,0
10050,Management Occupations,Brain Tumor,0
10051,Iodides,Undifferentiated Neuroblastoma,0
10052,Personal appearance,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10053,Malignant neoplasm of ampulla of Vater,Malignant Neoplasm of Lung - Multiple Primary Sites,0
10054,shared attribute,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10055,True primary (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
10056,Involvement with,Childhood Central Nervous System Ganglioneuroblastoma,0
10057,Percent (qualifier value),Thyroid Hurthle Cell Carcinoma,0
10058,Halitosis,BRCA2 Syndrome,0
10059,memory b cell,Stage IV Childhood Non-Hodgkin Lymphoma,0
10060,Neoplasm Metastasis,Refractory Ependymoma,0
10061,Use of,Maxillary Sinus Adenocarcinoma,0
10062,Germ-Line Mutation,Mucinous adenocarcinoma gastric,0
10063,respiratory gaseous exchange in organisms,Tongue Alveolar Soft Part Sarcoma,0
10064,Lymphoid,Peripheral primitive neuroectodermal tumor of soft tissue,0
10065,Body tissue,Recurrent Primary Lymphoma of Bone,0
10066,Person Name,Angiosarcoma of liver,0
10067,Risk,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10068,Two,Giant cell angiofibroma,0
10069,Changing,Locally Advanced Squamous Cell Carcinoma,0
10070,Biomaterial Treatment,Cerebral hemangioma,0
10071,Second edition,Pleomorphic adenoma of parotid gland,0
10072,Childhood Atypical Teratoid/Rhabdoid Tumor,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10073,90%,Granular Cell Leiomyosarcoma,0
10074,Persistent embryonic structure,Childhood Central Nervous System Ganglioneuroblastoma,0
10075,bony process,Cerebral Primitive Neuroectodermal Tumor,0
10076,Cells,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10077,Plasma,Stage III Adult Immunoblastic Lymphoma,0
10078,Spreading (qualifier value),Brain Ependymoma,0
10079,Therapeutic procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10080,Good,Blepharal carcinoma,0
10081,Several,Cerebral Primitive Neuroectodermal Tumor,0
10082,Anatomic Site,Type II Endometrial Adenocarcinoma,0
10083,Occurrence Indicator,Splenic Manifestation of Hairy Cell Leukemia,0
10084,Skin Specimen,Advanced Lung Carcinoma,0
10085,Time (foundation metadata concept),Lung Mucinous Cystadenoma,0
10086,Frequently,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10087,Basal cell carcinoma,Stage II Hepatocellular Carcinoma AJCC v8,0
10088,Pancreas part,Spongiotic dermatitis,0
10089,A Codes,gliosarcoma,0
10090,Lack of exercise finding,Intestinal Metaplasia of Bladder Urothelium,0
10091,Prior Chemotherapy,Hyperplasia of pituitary gland,0
10092,Exposure to radiation,Acantholytic squamous cell carcinoma,0
10093,Malignant neoplasm of larynx,Low Grade Squamous Intraepithelial Neoplasia,0
10094,parent,Female Breast Carcinoma,0
10095,Hormonal,Tongue Alveolar Soft Part Sarcoma,0
10096,Therapeutic procedure,Blepharal carcinoma,0
10097,Malignant Neoplasms,Gallbladder Adenocarcinoma,0
10098,Pharmacotherapy,Occult Lung Adenosquamous Carcinoma,0
10099,Squamous cell carcinoma - category,Human Papillomavirus-Related Carcinoma,0
10100,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Pilocytic astrocytoma of cerebellum,0
10101,Organ,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
10102,Immune System Finding,Extra-Adrenal Paraganglioma,0
10103,Definitive,Childhood Fibrillary Astrocytoma,0
10104,various other nasal preparations in ATC,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10105,Blood,Pancreatic Intraepithelial Neoplasia-3,0
10106,Nature,Small cell neuroendocrine carcinoma of bladder,0
10107,General surgery specialty,Kaposi's sarcoma of extrahepatic bile duct,0
10108,Importance Rating Score 0,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10109,Treating,non-Hodgkin's lymphoma of spleen,0
10110,More,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10111,Removal of bladder,Unicystic ameloblastoma,0
10112,Financial Account,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10113,United States Military Commissioned Officer O4,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10114,Malignant Childhood Neoplasm,Adult Acute Eosinophilic Leukemia,0
10115,Ingestible alcohol,Undifferentiated Endocervical Sarcoma,0
10116,spinal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10117,Location of Pharyngeal Residue Following Swallowing,Localized Askin Tumor,0
10118,Cells,Toxic Epidermal Necrolysis,0
10119,Insect Bite Specimen Code,Extra-Adrenal Paraganglioma,0
10120,Pruritus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10121,Derivative,Thymic Clear Cell Carcinoma,0
10122,Following,Gallbladder Adenocarcinoma,0
10123,Classical Hodgkin's Lymphoma,Malignant melanoma of eyelid,0
10124,Location,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10125,white blood cell type,Digestive System Hodgkin Lymphoma,0
10126,Lymphoma,Splenic Manifestation of Hairy Cell Leukemia,0
10127,Much,Testicular cancer metastatic,0
10128,Myoepithelial,Intraepithelial Melanocytic Hyperplasia,0
10129,Smear - instruction imperative,Stage III Adult Immunoblastic Lymphoma,0
10130,leukemia,Recurrent Uveal Melanoma,0
10131,Limited stage (cancer stage),Microcystic meningioma,0
10132,Immunotherapy,Primary Cutaneous Plasmablastic Lymphoma,0
10133,brain cell,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10134,Sequence Arm,Benign neoplasm of eye,0
10135,Developed Countries,Colorectal Mucin Poor Hyperplastic Polyp,0
10136,Bone structure of coccyx,Choroid Epithelioid Cell Melanoma,0
10137,1+ Score,Malignant Testicular Sertoli Cell Tumor,0
10138,Neoplasm Metastasis,Extra-abdominal fibromatosis,0
10139,Qualitative form,adenoid cystic carcinoma of lung,0
10140,Duct (organ) structure,Placental aromatase deficiency,0
10141,Event-Free Survival,Benign Anal Granular Cell Tumor,0
10142,Compress (Compression Algorithm),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10143,Tooth root structure,Bladder adenocarcinoma stage IV,0
10144,Tryptophanase,Metastatic Ductal Breast Carcinoma,0
10145,Human body structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10146,Treating,Benign squamous cell tumor,0
10147,Affecting,Clonal Hematopoiesis of Indeterminate Potential,0
10148,Group A (blood group),Colorectal cancer,0
10149,Others - Allergy,Cervical Adenomyoma,0
10150,Offspring,Non-Metastatic Gestational Trophoblastic Tumor,0
10151,20%,Trichilemmocarcinoma,0
10152,Fasciola hepatica infection,Engraftment syndrome,0
10153,Ancestry-Informative Marker,Atypical Mesothelial Hyperplasia,0
10154,Skin,Carcinoma of urinary bladder,0
10155,Experimental Result,Cartilaginous exostosis,0
10156,Endocrine system,Mucosal Melanoma,0
10157,Menstruation,Stage I Colon Neuroendocrine Tumor AJCC v8,0
10158,Night sweats,Anterior Urethral Malignant Neoplasm,0
10159,Group A (blood group),Malignant neoplasm of gallbladder,0
10160,Hematopoietic Neoplasms,Stage III Cutaneous Melanoma AJCC v6,0
10161,Common Specifications in HL7 V3 Publishing,Stage IV Childhood Non-Hodgkin Lymphoma,0
10162,Protocol Agent,Trabecular adenocarcinoma,0
10163,Shapes,Atypical Mesothelial Hyperplasia,0
10164,Tryptophanase,Thymic Clear Cell Carcinoma,0
10165,Stem cells,Colorectal cancer,0
10166,Dangerousness,Breast Ductal Adenoma,0
10167,Subject Risk,Benign neoplasm of eye,0
10168,Cancer Genus,Stage II Carcinoma of Penis,0
10169,Facial swelling (finding),Recurrent Testicular Lymphoma,0
10170,Tryptophanase,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10171,biopsy characteristics,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10172,Cancer Genus,Mastocytosis,0
10173,95,FIGO Stage II Ovarian Cancer,0
10174,Broken skin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10175,Qualitative form,ICHTHYOSIS,0
10176,Manufactured sign,Splenic Manifestation of Hairy Cell Leukemia,0
10177,Recommendation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10178,Primary,Liver Cavernous Hemangioma,0
10179,Mode of inheritance,Kaposi's sarcoma of extrahepatic bile duct,0
10180,Fibrosis Assessment,Neonatal leukemia,0
10181,P450-aromatase Deficiency,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10182,Pruritus,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10183,Occurrence,Localized Askin Tumor,0
10184,Term Birth,Locally Advanced Soft Tissue Sarcoma,0
10185,Vagina Carcinoma,Metaplastic carcinoma of breast,0
10186,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Xeroderma pigmentosum,0
10187,High Level,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
10188,Dental Enamel,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10189,Histologic,Maxillary Sinus Adenoid Cystic Carcinoma,0
10190,Singular,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10191,Childhood Lymphoma,Refractory Bladder Carcinoma,0
10192,Kidney Infection,Grade 3a Malignant Neoplasm,0
10193,Infiltration (procedure),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10194,Malignant neoplasm of large intestine,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10195,Body structure,Ovarian germ cell choriocarcinoma stage IV,0
10196,Taxonomic,Ovarian germ cell choriocarcinoma stage IV,0
10197,International Classification of Disease for Oncology,Placental aromatase deficiency,0
10198,Five,Hereditary Diffuse Gastric Adenocarcinoma,0
10199,English [International Organization for Standardization 639-1 code en] language reference set,Type II Endometrial Adenocarcinoma,0
10200,history (of) disease family,FIGO Stage II Ovarian Cancer,0
10201,Childhood Ependymoma,Angiosarcoma of liver,0
10202,Container status - Identified,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
10203,Aspects of signs,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10204,trophoblast,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10205,Diameter (qualifier value),embryonal rhabdomyosarcoma of prostate,0
10206,Healthy,Locally Advanced Squamous Cell Carcinoma,0
10207,Brain part,Anterior Urethral Malignant Neoplasm,0
10208,Bone structure of cranium,clear cell adenocarcinoma of gallbladder,0
10209,Common Specifications in HL7 V3 Publishing,Transitional cell carcinoma,0
10210,Specific qualifier value,Kaposi's sarcoma of skin,0
10211,Imaging Techniques,FIGO Stage II Ovarian Cancer,0
10212,Tumor cells,Primary Cutaneous Plasmablastic Lymphoma,0
10213,Platelet Glycoprotein 4,Intestinal Metaplasia of Bladder Urothelium,0
10214,Greater,Plexosarcoma,0
10215,Sternum,Malignant neoplasm of thalamus,0
10216,Presence (property),Testicular cancer metastatic,0
10217,Adult Hodgkin Lymphoma,Granular Cell Leiomyosarcoma,0
10218,Primary malignant neoplasm,Chest Wall Fibromatosis,0
10219,Mass of body region,Cervical Squamous Intraepithelial Neoplasia,0
10220,Often - answer to question,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10221,Persons,Stage IB Lung Cancer AJCC v7,0
10222,Bladder Continence Question,Digestive System Hodgkin Lymphoma,0
10223,Laboratory Procedures,Carcinomatosis of peritoneal cavity,0
10224,<50,Benign neoplasm of eye,0
10225,Often - answer to question,Carcinoma of urinary bladder,0
10226,One,FIGO Stage II Ovarian Cancer,0
10227,One,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10228,Known,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10229,Adapt (substance),Lipoma of small intestine,0
10230,Malignant Neoplasms,Locally Advanced Epithelioid Hemangioendothelioma,0
10231,Intersex,Mixed astrocytoma-ependymoma,0
10232,Smear - instruction imperative,Collecting Duct Carcinoma of the Kidney,0
10233,Appearance,Locally Advanced Squamous Cell Carcinoma,0
10234,Fever,Parathyroid Gland Adenocarcinoma,0
10235,Dominant,Childhood Fibrillary Astrocytoma,0
10236,TNM Staging System,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10237,Radiotherapy Research,embryonal rhabdomyosarcoma of prostate,0
10238,50%,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
10239,Pediculus (eukaryote),Human Papillomavirus-Related Carcinoma,0
10240,Usage,Cancer of Urinary Tract,0
10241,vascular transport,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10242,Call (Instruction),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10243,Negation,embryonal rhabdomyosarcoma of prostate,0
10244,Approximate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10245,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10246,Providing (action),mucinous adenocarcinoma of gallbladder,0
10247,Accounting (activity),Pancreatic carcinoma,0
10248,Australia,Stage III Cutaneous Melanoma AJCC v6,0
10249,Cell Count,Acute Undifferentiated Leukemia,0
10250,year,Heavy Chain Deposition Disease,0
10251,Indication of (contextual qualifier),Localized Askin Tumor,0
10252,Vagina,Cancer of Urinary Tract,0
10253,various antiinfectives and antiseptics for local oral treatment,Acantholytic squamous cell carcinoma,0
10254,Surrounding (qualifier value),Congenital hamartoma,0
10255,Term (lexical),Recurrent Uveal Melanoma,0
10256,Chief complaint (finding),Mixed astrocytoma-ependymoma,0
10257,National origin,Hereditary Diffuse Gastric Adenocarcinoma,0
10258,Group A (blood group),Benign neoplasm of thorax,0
10259,Aggressive behavior,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10260,Abnormal Cell Count,Adenocarcinoma,0
10261,classical example,Cerebral Primitive Neuroectodermal Tumor,0
10262,Myasthenia Gravis,Undifferentiated Endocervical Sarcoma,0
10263,Stage,Pancreatic Endocrine Carcinoma,0
10264,Painless,Spongiotic dermatitis,0
10265,Psyche structure,Malignant melanoma of eyelid,0
10266,Intestines,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10267,Congenital defects,Malignant Testicular Sertoli Cell Tumor,0
10268,described,sarcoma of spinal cord,0
10269,Admission Level of Care Code - Improved,Splenic Manifestation of Hairy Cell Leukemia,0
10270,Choriocarcinoma,Vaginal Adenoid Cystic Carcinoma,0
10271,United States Military Commissioned Officer O4,Diffuse malignant mesothelioma,0
10272,Adult human body,Pancreatic carcinoma,0
10273,Vaccinated at,Epithelioid Sarcoma NCI Grade 3,0
10274,Ascites,Atypical Lobular Breast Hyperplasia,0
10275,*Type - Kind of quantity,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10276,Entity Determiner - specific,Brain Tumor,0
10277,Type A,Intraepithelial Melanocytic Hyperplasia,0
10278,Science of Etiology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10279,diagnosis aspect,Choroid Necrotic Melanoma,0
10280,Health,Uterine Cancer,0
10281,How Often Itching,Benign Carotid Body Paraganglioma,0
10282,Ability,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10283,Alpha-fetoprotein level - finding,Stage III Cutaneous Melanoma AJCC v6,0
10284,Endoscopy (procedure),Advanced Uterine Corpus Carcinosarcoma,0
10285,Lesion,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10286,Radiofrequency Ablation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10287,Carcinoma of lung,Squamous cell carcinoma of lip,0
10288,Skin,clear cell adenocarcinoma of gallbladder,0
10289,Human Papillomavirus,Uterine Cancer,0
10290,Confirmed by,Mucinous adenocarcinoma gastric,0
10291,United States,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10292,Birth,Peripheral primitive neuroectodermal tumor of soft tissue,0
10293,Tumor cells,Hereditary Diffuse Gastric Adenocarcinoma,0
10294,Out (direction),squamous cell carcinoma of the thyroid gland,0
10295,Occur (action),Diffuse malignant mesothelioma,0
10296,Intestines,Female Breast Carcinoma,0
10297,Population Mean,Childhood Fibrillary Astrocytoma,0
10298,Melanocytic nevus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10299,Cartilage,Nasal cavity carcinoma,0
10300,International Aspects,Diffuse malignant mesothelioma,0
10301,How Much Distress Weight Loss,Benign tumor of eyelid,0
10302,More,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
10303,Syphilis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10304,40%,Diffuse malignant mesothelioma,0
10305,35,Multiple Skull Base Meningiomas,0
10306,Case unit dose,sarcoma of spinal cord,0
10307,Physical Medical Procedure,Carcinoma of urinary bladder,0
10308,Dominant,Acantholytic squamous cell carcinoma,0
10309,Surgery specialty,Kaposi's sarcoma of skin,0
10310,CDISC SDTM Procedure Terminology,embryonal rhabdomyosarcoma of prostate,0
10311,Array Feature,Testicular cancer metastatic,0
10312,Blood,Localized Ewing Sarcoma,0
10313,70%,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10314,Male,Acantholytic squamous cell carcinoma,0
10315,Cosmetic surgery specialty,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
10316,Cell (compartment),High Grade Salivary Gland Mucoepidermoid Carcinoma,0
10317,Including (qualifier),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
10318,Togo,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10319,United States,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
10320,Direct (qualifier),Localized Malignant Neoplasm,0
10321,Medical service,BRCA2 Syndrome,0
10322,Contain (action),Adult Alveolar Soft Part Sarcoma,0
10323,Chemicals,Cervical Fibroepithelial Polyp,0
10324,Human papilloma virus infection,Periosteal Osteosarcoma,0
10325,Skin,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10326,Obese build,Stage I Adult Non-Hodgkin Lymphoma,0
10327,risk factors - observation list,Benign Anal Granular Cell Tumor,0
10328,Neuroglia,Metastatic Neoplasm to the Gallbladder,0
10329,Human Papillomavirus,Cancer of Urinary Tract,0
10330,Specific qualifier value,Stage III Cutaneous Melanoma AJCC v6,0
10331,Time (foundation metadata concept),Stage 0 Penile Cancer AJCC v8,0
10332,Precision - temporal,Stage 0 Penile Cancer AJCC v8,0
10333,Body tissue,Mucinous adenocarcinoma,0
10334,Cerebral hemisphere structure (body structure),Kaposi's sarcoma of skin,0
10335,Sun Exposure,Cherubism,0
10336,General surgery specialty,Stage II Hepatocellular Carcinoma AJCC v8,0
10337,Array Feature,Recurrent Testicular Lymphoma,0
10338,Occurrence Indicator,Cervical Squamous Intraepithelial Neoplasia,0
10339,Disease,Giant cell angiofibroma,0
10340,Second edition,Localized Malignant Neoplasm,0
10341,Flowers,Stage I Colon Neuroendocrine Tumor AJCC v8,0
10342,Increase,Liver Lymphangioma,0
10343,70%,Engraftment syndrome,0
10344,Tobacco smoking behavior,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10345,Bacteria,Acantholytic squamous cell carcinoma,0
10346,Tryptophanase,Benign squamous cell tumor,0
10347,Preventable,Xeroderma pigmentosum,0
10348,Subgroup A Nepoviruses,Adult Acute Eosinophilic Leukemia,0
10349,include - SetOperator,Spongiotic dermatitis,0
10350,Primary malignant neoplasm,FIGO Stage IVA Ovarian Cancer,0
10351,IPSS Risk Category Low,Contact dermatitis due to alkali,0
10352,To,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10353,Cell Count,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10354,Cervical dysplasia,Kaposi's sarcoma of skin,0
10355,Divide,Hyperplasia of pituitary gland,0
10356,Categories,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10357,How Often Felt Normal question,FIGO Stage IVA Ovarian Cancer,0
10358,Penis carcinoma,Stage IV Colorectal Cancer AJCC v8,0
10359,Little NOS,Childhood Fibrillary Astrocytoma,0
10360,Compression - action,Kaposi's sarcoma of extrahepatic bile duct,0
10361,PODXL protein,Type II Endometrial Adenocarcinoma,0
10362,Uterine Cancer,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10363,Continuance of life,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10364,Site of,Uterine Cancer,0
10365,Sometimes,Stage III Adult Immunoblastic Lymphoma,0
10366,Experimental Result,Melanomatosis,0
10367,Administration procedure,Childhood Lung Non-Small Cell Carcinoma,0
10368,In Urine,Adult Hepatocellular Carcinoma,0
10369,Child,embryonal rhabdomyosarcoma of prostate,0
10370,Cell Count,Atypical Lobular Breast Hyperplasia,0
10371,Tumor Subtype,Astrocytoma of brain,0
10372,Abdomen+,Childhood Fibrillary Astrocytoma,0
10373,Immunization,Tonsillar Carcinoma,0
10374,Helper-Inducer T-Lymphocyte,Maxillary Sinus Adenocarcinoma,0
10375,regional,adenoid cystic carcinoma of lung,0
10376,Aging,Localized Ewing Sarcoma,0
10377,Asia,Anaplastic large cell lymphoma,0
10378,Specimen Source Codes - tumor,adenosquamous carcinoma of breast,0
10379,Malignant neoplasm of oropharynx,Airway Hemangioma,0
10380,Fever,Methotrexate-Associated Hodgkin Lymphoma,0
10381,Consistency,Clonal Hematopoiesis of Indeterminate Potential,0
10382,Structure of parenchyma of lung,Contact dermatitis due to alkali,0
10383,include - SetOperator,Undifferentiated Endocervical Sarcoma,0
10384,Sacrifice,Recurrent Testicular Lymphoma,0
10385,N+ (tumor staging),adenoid cystic carcinoma of lung,0
10386,Central Nervous System,Carcinomatosis of peritoneal cavity,0
10387,Changed status,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10388,Offspring,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10389,Often - answer to question,Neonatal leukemia,0
10390,More,Malignant melanoma of eyelid,0
10391,Fever,Chest Wall Fibromatosis,0
10392,Metastatic Disease Clinical Trial Setting,Stage 0 Lip Carcinoma,0
10393,Petal,Carcinoma of urinary bladder,0
10394,Dyspareunia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10395,SHORT STATURE,Giant cell angiofibroma,0
10396,Oral (intended site),Advanced Uterine Corpus Carcinosarcoma,0
10397,Extrinsic,Human Papillomavirus-Related Carcinoma,0
10398,Nausea,Female Breast Carcinoma,0
10399,Urinary Bladder,Digestive System Hodgkin Lymphoma,0
10400,Excretory function,Vaginal Adenoid Cystic Carcinoma,0
10401,Area,Xeroderma pigmentosum,0
10402,Food allergenic extracts,Vaginal Adenoma,0
10403,Loss of Appetite question,Grade 1 Clear Cell Renal Cell Carcinoma,0
10404,Negation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10405,Adverse effects,Adult Alveolar Soft Part Sarcoma,0
10406,Location of Oral Residue Following Swallowing,Vaginal Adenoma,0
10407,Stomach structure,Brain Ependymoma,0
10408,Glioma,Choroid Epithelioid Cell Melanoma,0
10409,Medical Device Emits Smoke,Liver Lymphangioma,0
10410,Data Transformation,Anterior Urethral Malignant Neoplasm,0
10411,include - SetOperator,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10412,Eyelid structure,Benign squamous cell tumor,0
10413,Pelvic Pain,Unicystic ameloblastoma,0
10414,Most,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10415,Diabetes Mellitus,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
10416,Name,Stage II Hepatocellular Carcinoma AJCC v8,0
10417,Sometimes,Localized Malignant Neoplasm,0
10418,During,Maxillary Sinus Adenocarcinoma,0
10419,Retinoic Acid Response Element,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10420,Class (taxonomic),Intestinal Metaplasia of Bladder Urothelium,0
10421,Mass of body region,non-Hodgkin's lymphoma of spleen,0
10422,risk factors,Unicystic ameloblastoma,0
10423,Universal - VocabularyDomainQualifier,Pancreatic carcinoma,0
10424,Anus,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
10425,research subject screening,Engraftment syndrome,0
10426,Similarity,Human Papillomavirus-Related Carcinoma,0
10427,Malignant Neoplasms,Locally Advanced Epithelioid Hemangioendothelioma,0
10428,Inguinal part of abdomen,clear cell adenocarcinoma of gallbladder,0
10429,A Codes,High Grade Glandular Intraepithelial Neoplasia,0
10430,Secretory Vesicles,Acantholytic squamous cell carcinoma,0
10431,Painful intercourse female,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10432,Squamocolumnar junction of cervix,Intracortical osteosarcoma,0
10433,Brain Neoplasms,Anterior Urethral Malignant Neoplasm,0
10434,Common (qualifier value),Granular Cell Leiomyosarcoma,0
10435,majority,Childhood Lymphoma,0
10436,Dermatitis,Cerebral Primitive Neuroectodermal Tumor,0
10437,Usual Severity Weight Loss,Carcinoma ex pleomorphic adenoma of parotid gland,0
10438,Decision,Refractory WHO Grade III Glioma,0
10439,eTMF Content Model Code,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10440,2+ Score,Chondrosarcoma,0
10441,Five-year Survival Rate,Extra-Adrenal Paraganglioma,0
10442,Early,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10443,High risk of,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10444,Neoplasm Metastasis,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10445,Malignant Neoplasms,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10446,Minor (person),Recurrent Primary Lymphoma of Bone,0
10447,How Much Distress Nausea,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10448,Including (qualifier),Testicular cancer metastatic,0
10449,Woman,FIGO Stage IVA Ovarian Cancer,0
10450,Human embryo,Malignant melanoma of eyelid,0
10451,Common Specifications in HL7 V3 Publishing,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
10452,Unit of Measure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10453,1960s,Breast Apocrine Adenoma,0
10454,Mass,Benign tumor of eyelid,0
10455,Tissue Specimen Code,Neoplasms,0
10456,Loss of Appetite question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10457,mesenchymal,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10458,Medications,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
10459,How Much Distress Pain,Malignant Testicular Sertoli Cell Tumor,0
10460,Cessation of life,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10461,Western World,Acantholytic squamous cell carcinoma,0
10462,Slow,Refractory Bladder Carcinoma,0
10463,Firstly,Cancer of Urinary Tract,0
10464,Statistical mean,Cervical Fibroepithelial Polyp,0
10465,Most Recent,Locally Advanced Soft Tissue Sarcoma,0
10466,Affect (mental function),Tumorlet,0
10467,90%,Contact dermatitis due to alkali,0
10468,Plants,Mixed parotid tumor,0
10469,Blood Platelets,Tonsillar Carcinoma,0
10470,Risk,Cancer of Urinary Tract,0
10471,How Often Shortness of Breath,Diffuse malignant mesothelioma,0
10472,Case unit dose,Anaplastic large cell lymphoma,0
10473,>90,Multiple Skull Base Meningiomas,0
10474,Include (action),Lung Inflammatory Myofibroblastic Tumor,0
10475,Function (attribute),Malignant neoplasm of subglottis,0
10476,Image Feature,Refractory Barrett Esophagus,0
10477,Diagnosis Study,Stage IB Lung Cancer AJCC v7,0
10478,Long-term,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10479,Appearance,Neonatal leukemia,0
10480,Neck,Unfavorable Non-Hodgkin Lymphoma,0
10481,depend,Benign squamous cell tumor,0
10482,Form:Finding:Point in time:{Setting}:Document:{Role},FIGO Stage II Ovarian Cancer,0
10483,Probability,Localized Askin Tumor,0
10484,Metastasis,Intraepithelial Melanocytic Hyperplasia,0
10485,Subject Risk,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10486,Tired,Recurrent Testicular Lymphoma,0
10487,Africa,Cancer of Urinary Tract,0
10488,Megakaryoblast Cell Count,Multiple Endocrine Neoplasia,0
10489,Thickened,Intraepithelial Melanocytic Hyperplasia,0
10490,Body structure,Childhood Anaplastic Large Cell Lymphoma,0
10491,Call (Instruction),Intestinal Metaplasia of Bladder Urothelium,0
10492,Including (qualifier),Acute Undifferentiated Leukemia,0
10493,Membrane Glycoproteins,Ichthyosis,0
10494,Basis - conceptual entity,Nasal cavity carcinoma,0
10495,status - In progress,sarcoma of spinal cord,0
10496,Direct type of relationship,embryonal rhabdomyosarcoma of prostate,0
10497,Worse,Metastatic Ductal Breast Carcinoma,0
10498,mucus layer,Female Breast Carcinoma,0
10499,Dyspnea,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10500,Process (qualifier value),Mucinous adenocarcinoma,0
10501,Pediatric,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10502,Tobacco smoking behavior,Stage 0 Penile Cancer AJCC v8,0
10503,Fibroid Tumor,Stage IV Penile Cancer AJCC v7,0
10504,geographic population,Tongue Alveolar Soft Part Sarcoma,0
10505,Manufactured form,Lipoma of small intestine,0
10506,Near,Cervical Squamous Intraepithelial Neoplasia,0
10507,Location,mucinous adenocarcinoma of gallbladder,0
10508,Sclera,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10509,National origin,Mastocytosis,0
10510,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Acute Undifferentiated Leukemia,0
10511,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
10512,Greeks,Stage 0 Lip Carcinoma,0
10513,Posterior Pituitary Hormone Drug Class,Splenic Manifestation of Hairy Cell Leukemia,0
10514,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Diffuse Intrinsic Pontine Glioma,0
10515,Mean Percent of Normal,Adult Hepatocellular Carcinoma,0
10516,Infection,Squamous cell carcinoma of lip,0
10517,Simpson Grade 3,FIGO Stage IVA Ovarian Cancer,0
10518,Malignancy,Pancreatic Intraepithelial Neoplasia-3,0
10519,Occur (action),Metastatic Ductal Breast Carcinoma,0
10520,Decrease,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10521,Embryonic tissue,embryonal rhabdomyosarcoma of prostate,0
10522,Late,Medulloblastoma,0
10523,Anaplastic thyroid carcinoma,Anaplastic large cell lymphoma,0
10524,Main,Chest Wall Fibromatosis,0
10525,Associated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10526,Primary malignant neoplasm,Carcinoma of urinary bladder,0
10527,Parenchyma,Engraftment syndrome,0
10528,ADCY10 gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10529,Vaginal (intended site),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10530,Sexual Partners,Cancer of Urinary Tract,0
10531,Manufactured form,Mucinous adenocarcinoma gastric,0
10532,Specimen Source Codes - tumor,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10533,Continuance of life,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10534,Presentation,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10535,Adrenal Gland Neoplasms,Anterior Urethral Malignant Neoplasm,0
10536,Dilated,Transitional cell carcinoma,0
10537,Screening - general (procedure),benign mature teratoma of pancreas,0
10538,AKR1A1 wt Allele,Benign Anal Granular Cell Tumor,0
10539,Abnormally high,Benign Anal Granular Cell Tumor,0
10540,Version,Metaplastic carcinoma of breast,0
10541,West Haven Hepatic Encephalopathy Grade 3,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10542,Squamous Epithelial Cells,Intracortical osteosarcoma,0
10543,Usual,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
10544,CDISC SEND Tumor Findings Results Terminology,Metastatic Lung Neuroendocrine Neoplasm,0
10545,Dilated,Type II Endometrial Adenocarcinoma,0
10546,Vagina,Cervical Fibroepithelial Polyp,0
10547,Aggressive behavior,Engraftment syndrome,0
10548,Component object,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
10549,Thymus Gland,Thyroid Hurthle Cell Carcinoma,0
10550,shared attribute,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10551,Usual Severity Weight Loss,Heavy Chain Deposition Disease,0
10552,Subtype (attribute),Botryoid-Type Embryonal Rhabdomyosarcoma,0
10553,Cancer Genus,Anterior Urethral Malignant Neoplasm,0
10554,Formation,non-Hodgkin's lymphoma of spleen,0
10555,Experimental Result,Locally Advanced Soft Tissue Sarcoma,0
10556,Cancer Genus,carcinoma of middle ear,0
10557,Associated with,Diffuse malignant mesothelioma,0
10558,Probable diagnosis,Adult Acute Eosinophilic Leukemia,0
10559,Reporting,Recurrent Primary Lymphoma of Bone,0
10560,Skin lesion,Ovarian germ cell choriocarcinoma stage IV,0
10561,Operation excision,Adult Acute Eosinophilic Leukemia,0
10562,65,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10563,Lacrimal sac,squamous cell carcinoma of the thyroid gland,0
10564,More,High Grade Glandular Intraepithelial Neoplasia,0
10565,per second,Acantholytic squamous cell carcinoma,0
10566,Used by,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10567,Malignant Central Nervous System Neoplasm,Malignant melanoma of eyelid,0
10568,Obesity,Rhabdomyosarcoma with ganglionic differentiation,0
10569,Cancer of Lip,Mucinous adenocarcinoma gastric,0
10570,Often - answer to question,Childhood Anaplastic Large Cell Lymphoma,0
10571,>90,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
10572,Characteristics,Recurrent Uveal Melanoma,0
10573,Platelet Glycoprotein 4,Undifferentiated Endocervical Sarcoma,0
10574,Negation,Brain Tumor,0
10575,Cover (physical object),Intraepithelial Melanocytic Hyperplasia,0
10576,More,Acute Undifferentiated Leukemia,0
10577,Progress,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10578,Immunotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10579,Further,Carcinoma of urinary bladder,0
10580,Smoking,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10581,Tryptophanase,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10582,Body part,Recurrent Testicular Lymphoma,0
10583,Include (action),embryonal rhabdomyosarcoma of prostate,0
10584,Involvement with,High Grade Glandular Intraepithelial Neoplasia,0
10585,Pituitary Gland,Liver Lymphangioma,0
10586,diagnosis aspect,Stage IB Pancreatic Cancer AJCC v8,0
10587,Approach,Rhabdomyosarcoma with ganglionic differentiation,0
10588,Specimen Source Codes - tumor,Uterine Cancer,0
10589,High,Adult Alveolar Soft Part Sarcoma,0
10590,Subject Risk,Type II Endometrial Adenocarcinoma,0
10591,Personal appearance,Neonatal leukemia,0
10592,N+ (tumor staging),Botryoid-Type Embryonal Rhabdomyosarcoma,0
10593,Diabetes Mellitus,Malignant melanoma of eyelid,0
10594,Hidrocystoma,Adult Alveolar Soft Part Sarcoma,0
10595,Formation,Mastocytosis,0
10596,Process (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10597,spindle assembly checkpoint,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10598,Childhood Neuroblastoma,Tongue Alveolar Soft Part Sarcoma,0
10599,More,Hereditary Diffuse Gastric Adenocarcinoma,0
10600,*Type - Kind of quantity,Lipoma of small intestine,0
10601,metaplastic,Thyroid Hurthle Cell Carcinoma,0
10602,various antiinfectives and antiseptics for local oral treatment,Benign Anal Granular Cell Tumor,0
10603,Pleural effusion fluid,Neoplasms,0
10604,Techniques,Advanced Uterine Corpus Carcinosarcoma,0
10605,Fever,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10606,Orbital region,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10607,Scientific Control,Transitional cell carcinoma,0
10608,Usual Severity Itching,Stage IB Lung Cancer AJCC v7,0
10609,Strong,Splenic Manifestation of Hairy Cell Leukemia,0
10610,Classification,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10611,Science of Etiology,Xeroderma pigmentosum,0
10612,Occurrence,Gallbladder Adenocarcinoma,0
10613,Type - attribute,FIGO Stage IVA Ovarian Cancer,0
10614,Severe (severity modifier),Malignant Testicular Sertoli Cell Tumor,0
10615,Only - dosing instruction fragment,Atypical Lobular Breast Hyperplasia,0
10616,Pressure - action,Noninfiltrating Intraductal Carcinoma,0
10617,Sometimes,Trabecular adenocarcinoma,0
10618,Including (qualifier),Parathyroid Gland Adenocarcinoma,0
10619,Age,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10620,Include (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10621,70%,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10622,Specific qualifier value,Maxillary Sinus Adenocarcinoma,0
10623,Followed by,Recurrent Testicular Lymphoma,0
10624,Capillary Action,GIANT PIGMENTED HAIRY NEVUS,0
10625,Neoplasms,Extracranial Neuroblastoma,0
10626,Group A (qualifier value),Medulloblastoma,0
10627,Primary,Fibroadenoma of breast,0
10628,Primary malignant neoplasm,Thymic Atypical Carcinoid Tumor,0
10629,Gait normal,Multiple Skull Base Meningiomas,0
10630,Dyspnea,Intestinal Metaplasia of Bladder Urothelium,0
10631,Primary malignant neoplasm,Refractory Bladder Carcinoma,0
10632,Death Rate,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
10633,Age of Onset,Vaginal Adenoma,0
10634,Neurofibromatosis 1,Unresectable Rhabdomyosarcoma,0
10635,Central Nervous System Embryonal Neoplasm,Ovarian germ cell choriocarcinoma stage IV,0
10636,North America,Chondrosarcoma,0
10637,Immune system,Unresectable Rhabdomyosarcoma,0
10638,Leukemia (category),Ovarian germ cell choriocarcinoma stage IV,0
10639,Indexes,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10640,Formation,Low Grade Squamous Intraepithelial Neoplasia,0
10641,Anterior,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
10642,Representation (action),Splenic Manifestation of Hairy Cell Leukemia,0
10643,Hemorrhage,Basal Cell Ameloblastoma,0
10644,Organ,Carcinoma of urinary bladder,0
10645,Platelet-Derived Growth Factor Receptor Alpha,Cervical Fibroepithelial Polyp,0
10646,Type A,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10647,Primary operation,Extra-Adrenal Paraganglioma,0
10648,Descent,Microcystic meningioma,0
10649,Protection Element Attribute,Acantholytic squamous cell carcinoma,0
10650,Miss - Title,Medulloblastoma,0
10651,Body Fluids,adenoid cystic carcinoma of lung,0
10652,Classification,Uterine Cancer,0
10653,Third revision,Hyperplasia of pituitary gland,0
10654,Oral,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10655,Mass of body structure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10656,Usual Severity Weight Loss,Peripheral primitive neuroectodermal tumor of soft tissue,0
10657,week,Mucosal Melanoma,0
10658,Genetic,Lipoma of small intestine,0
10659,Stem cell transplant,Werner Syndrome,0
10660,Vascular,Recurrent Uveal Melanoma,0
10661,3+ Score,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10662,Drug Administration Routes,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10663,Malignant Neoplasms,Angiosarcoma of liver,0
10664,Etiology aspects,Stage III Cutaneous Melanoma AJCC v6,0
10665,Anogenital region,Mixed astrocytoma-ependymoma,0
10666,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Childhood Lung Non-Small Cell Carcinoma,0
10667,Skin,Cartilaginous exostosis,0
10668,Proliferation (morphologic abnormality),Ovarian germ cell choriocarcinoma stage IV,0
10669,Melanoma Pathway,Localized Askin Tumor,0
10670,Cancer Genus,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10671,Administration procedure,Hereditary Diffuse Gastric Adenocarcinoma,0
10672,Prophylactic treatment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10673,Treating,Atypical Lobular Breast Hyperplasia,0
10674,Personal appearance,Cervical Adenomyoma,0
10675,Cause of Death,Mucinous cystadenofibroma,0
10676,Involvement with,Larynx carcinoma recurrent,0
10677,Initially,Human Papillomavirus-Related Carcinoma,0
10678,Widening,Adult Alveolar Soft Part Sarcoma,0
10679,Include (action),Acute Undifferentiated Leukemia,0
10680,CEL gene,Kaposi's sarcoma of extrahepatic bile duct,0
10681,Therapeutic radiology procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
10682,Lung,Melanomatosis,0
10683,shared attribute,Low Grade Squamous Intraepithelial Neoplasia,0
10684,biologic degeneration,Malignant neoplasm of thalamus,0
10685,Include (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
10686,Ki-1+ Anaplastic Large Cell Lymphoma,Endometrial Small Cell Carcinoma,0
10687,Monitor Device,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10688,Mass of body region,Melanomatosis,0
10689,Chemotherapy Regimen,Thyroid carcinoma,0
10690,Site,Hodgkin lymphoma,0
10691,Cancer Genus,Cerebral Primitive Neuroectodermal Tumor,0
10692,Two,Hyperplasia of pituitary gland,0
10693,Conventional Treatment,Malignant neoplasm of olfactory nerve,0
10694,SERPINA3 wt Allele,Peripheral primitive neuroectodermal tumor of soft tissue,0
10695,Nasal turbinate bone structure,Recurrent Uveal Melanoma,0
10696,Used by,Kaposi's sarcoma of skin,0
10697,Decrease,Neonatal leukemia,0
10698,Affecting,Acantholytic squamous cell carcinoma,0
10699,Fever,Leptomeningeal sarcoma,0
10700,active (HL7 RoleLink),Acute Undifferentiated Leukemia,0
10701,Affecting,Adenocarcinoma of duodenum,0
10702,Specimen Type - Genital,Human Papillomavirus-Related Carcinoma,0
10703,Human body structure,clear cell adenocarcinoma of gallbladder,0
10704,Solid Dose Form,Acantholytic squamous cell carcinoma,0
10705,Common (qualifier value),Type II Endometrial Adenocarcinoma,0
10706,Due to,Malignant Testicular Sertoli Cell Tumor,0
10707,Exposure to toxin,Malignant melanoma of eyelid,0
10708,Age,Carcinoma of urinary bladder,0
10709,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Intraepithelial Melanocytic Hyperplasia,0
10710,Tissue Specimen Code,Metaplastic carcinoma of breast,0
10711,Family history,Melanomatosis,0
10712,Chemical or Textual Reference to Actual Test or Parameter,Vaginal Adenoma,0
10713,Human body,Digestive System Hodgkin Lymphoma,0
10714,Tumor type,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10715,Primary malignant neoplasm,Childhood Choriocarcinoma,0
10716,Fifth,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10717,Caucasians,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10718,chance,Benign tumor of eyelid,0
10719,structure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
10720,Pelvic Pain,Undifferentiated Neuroblastoma,0
10721,Line Specimen,Endometrial Small Cell Carcinoma,0
10722,Height / growth measure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10723,Disease,embryonal rhabdomyosarcoma of prostate,0
10724,Frequently,Granular Cell Leiomyosarcoma,0
10725,Precision - second,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10726,Qualitative form,Engraftment syndrome,0
10727,Lifetime,Basal Cell Ameloblastoma,0
10728,Diagnosis,Recurrent Rhabdomyosarcoma,0
10729,Entity Determiner - specific,Digestive System Hodgkin Lymphoma,0
10730,Similarity,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
10731,Pelvis,Localized Ewing Sarcoma,0
10732,APC gene,Occult Lung Adenosquamous Carcinoma,0
10733,per year,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10734,Geographic Locations,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10735,PSA Level Less than Five,Bladder squamous cell carcinoma stage I,0
10736,Painless,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10737,Bothered by Night Sweats,Vaginal Adenoma,0
10738,Type - attribute,Localized Ewing Sarcoma,0
10739,To,Xeroderma pigmentosum,0
10740,Intestines,Benign tumor of eyelid,0
10741,Low Mitosis-Karyorrhexis Index,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10742,BRCA1 protein,Maxillary Sinus Adenocarcinoma,0
10743,Tissue of central nervous system,Blepharal carcinoma,0
10744,Operative Surgical Procedures,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10745,Class,Metastatic Carcinoma in the Lung,0
10746,survival aspects,Splenic Manifestation of Hairy Cell Leukemia,0
10747,Spinal Cord,Hodgkin Disease,0
10748,Artificial cardiac pacemaker,Grade 3a Malignant Neoplasm,0
10749,Cessation of life,Nasal cavity carcinoma,0
10750,Occur (action),Acute Undifferentiated Leukemia,0
10751,Affecting,Digestive System Hodgkin Lymphoma,0
10752,epithelial,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10753,Usual,Platinum-Resistant Lung Small Cell Carcinoma,0
10754,General surgery specialty,Recurrent Primary Lymphoma of Bone,0
10755,Numerous,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10756,Show,malignant lymphoma of pancreatic lymph nodes,0
10757,Genetic Markers,Female Breast Carcinoma,0
10758,Varies,Spermatocytic seminoma,0
10759,Time (foundation metadata concept),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10760,Manufactured sign,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10761,Science of Statistics,Transitional cell carcinoma,0
10762,Impaired skin integrity,Cervical Fibroepithelial Polyp,0
10763,include - SetOperator,Heavy Chain Deposition Disease,0
10764,White Blood Cell Count procedure,Small cell neuroendocrine carcinoma of bladder,0
10765,During,Recurrent Primary Lymphoma of Bone,0
10766,Mean Percent of Normal,Malignant neoplasm of olfactory nerve,0
10767,Location,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10768,Trial Screening,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10769,Involvement with,Recurrent Testicular Lymphoma,0
10770,Major <insect>,adenoid cystic carcinoma of lung,0
10771,Account number:Identifier:Point in time:^Patient:Nominal,Acantholytic squamous cell carcinoma,0
10772,Others - Allergy,Cartilaginous exostosis,0
10773,Neutral pH,Lipoma of small intestine,0
10774,Frequently,Vaginal Adenoma,0
10775,Due to,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10776,Risk,FIGO Stage II Ovarian Cancer,0
10777,Lymphadenopathy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
10778,Associated with,Bladder adenocarcinoma stage IV,0
10779,Coding,Nasal cavity carcinoma,0
10780,melanoma,Pancreatic carcinoma,0
10781,Poverty,Cervical Squamous Intraepithelial Neoplasia,0
10782,SPINK5 gene,adenoid cystic carcinoma of lung,0
10783,Tears - SpecimenType,Stage IB Lung Cancer AJCC v7,0
10784,Exist,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10785,Acute Undifferentiated Leukemia,Carcinoma of urinary bladder,0
10786,PELVIS irradiation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10787,60%,Stage III Cutaneous Melanoma AJCC v6,0
10788,Glycation End Products,Cancer of Urinary Tract,0
10789,Diagnosis,Vaginal Adenoid Cystic Carcinoma,0
10790,European Union Notified Body,Bladder squamous cell carcinoma stage I,0
10791,Malignant Neoplasms,Squamous cell carcinoma of lip,0
10792,dendritic spine neck,Refractory Barrett Esophagus,0
10793,Dual,Benign Ovarian Thecoma,0
10794,Bloating,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10795,Conditioning (Psychology),Diffuse malignant mesothelioma,0
10796,Pancreatic Hormones,Granular Cell Leiomyosarcoma,0
10797,Enneking High Surgical Grade,Pancreatic carcinoma,0
10798,Coating (film),Stage IV Penile Cancer AJCC v7,0
10799,Ulcer,Localized Askin Tumor,0
10800,Childhood Germ Cell Tumor,Pancreatic Intraepithelial Neoplasia-3,0
10801,400,Trabecular adenocarcinoma,0
10802,Skin,Benign squamous cell tumor,0
10803,Decision,Malignant Neoplasm with Regional Lymph Node Involvement,0
10804,Skeletal bone,Nasal cavity carcinoma,0
10805,Aggressive course,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10806,Primary malignant neoplasm,Intraepithelial Melanocytic Hyperplasia,0
10807,Tumor Mass,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10808,Nasal (intended site),Botryoid-Type Embryonal Rhabdomyosarcoma,0
10809,Previous,Metastatic Ductal Breast Carcinoma,0
10810,Rapid,Childhood Lymphoma,0
10811,Therapeutic radiology procedure,Testicular cancer metastatic,0
10812,Supernumerary,Stage IB Pancreatic Cancer AJCC v8,0
10813,Initial (abbreviation),Familial Hemophagocytic Lymphocytosis,0
10814,Common Specifications in HL7 V3 Publishing,Tongue Alveolar Soft Part Sarcoma,0
10815,Volume,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10816,Filter (function),Clinical Stage I Cutaneous Melanoma AJCC v8,0
10817,biopsy characteristics,Ichthyoses,0
10818,Urine,Breast Apocrine Adenoma,0
10819,Name (property) (qualifier value),Gallbladder adenoma,0
10820,Histocompatibility Testing,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10821,Presentation,Granular Cell Leiomyosarcoma,0
10822,Dyspnea,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
10823,Occurrence,Fibroadenoma of breast,0
10824,Grade IV Childhood Astrocytic Neoplasm,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10825,Enneking High Surgical Grade,Choroid Necrotic Melanoma,0
10826,removal technique,Advanced Uterine Corpus Carcinosarcoma,0
10827,Deeply - dosing instruction fragment,papillary carcinoma of penis,0
10828,Lead,Cervical Adenomyoma,0
10829,Most,Carcinoma,0
10830,Associated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10831,Cell Count,Locally Advanced Squamous Cell Carcinoma,0
10832,Collection (action),malignant lymphoma of pancreatic lymph nodes,0
10833,curettage specimen,Stage III Adult Immunoblastic Lymphoma,0
10834,Primary malignant neoplasm,Stage IV Penile Cancer AJCC v7,0
10835,melanoma,Pancreatic Intraepithelial Neoplasia-3,0
10836,Benign,Recurrent Uveal Melanoma,0
10837,Young,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10838,Participation Type - origin,Childhood Central Nervous System Ganglioneuroblastoma,0
10839,Stem cell transplant,Thymoma malignant recurrent,0
10840,Parotid salivary apparatus,Hodgkin Disease,0
10841,Malignant Central Nervous System Neoplasm,Pilocytic astrocytoma of cerebellum,0
10842,survival aspects,ICHTHYOSIS,0
10843,Connect,Acute Undifferentiated Leukemia,0
10844,Infrequent,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10845,Onset of Action,Mucinous adenocarcinoma gastric,0
10846,Case unit dose,Leptomeningeal sarcoma,0
10847,To,Heavy Chain Deposition Disease,0
10848,SLC6A2 protein,Childhood Lung Non-Small Cell Carcinoma,0
10849,PIMREG gene,Mucinous cystadenofibroma,0
10850,Kilosecond,Cervical Fibroepithelial Polyp,0
10851,PSA Level Less than Five,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10852,Ephrin Type-B Receptor 1,Neonatal leukemia,0
10853,Symptoms aspect,Refractory Ependymoma,0
10854,Heart,Acute lymphadenitis,0
10855,3+ Score,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10856,Platelet Glycoprotein 4,Stage 0 Penile Cancer AJCC v8,0
10857,Feel Tired question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10858,Ultraviolet Rays,Colorectal High Grade B-Cell Lymphoma,0
10859,risk factors,Intraepithelial Melanocytic Hyperplasia,0
10860,>65 years,Locally Advanced Squamous Cell Carcinoma,0
10861,Occurrence,Thyroid carcinoma,0
10862,Categories,Cerebral Primitive Neuroectodermal Tumor,0
10863,Ratio,Undifferentiated Neuroblastoma,0
10864,Proteins,Childhood Anaplastic Large Cell Lymphoma,0
10865,How Often Weight Loss,Refractory Barrett Esophagus,0
10866,Extra-location,Undifferentiated Endocervical Sarcoma,0
10867,Paintings,Mixed astrocytoma-ependymoma,0
10868,Metastatic Neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
10869,Common (qualifier value),Colorectal Neuroendocrine Tumor G2,0
10870,Targeted Therapy,Cancer of Urinary Tract,0
10871,Compleat Liquid Nutrition,Ovarian Carcinoid Tumor,0
10872,Primary,Anterior Urethral Malignant Neoplasm,0
10873,Adverse Event by CTCAE Category,Tongue Alveolar Soft Part Sarcoma,0
10874,Consistency,Uterine Cancer,0
10875,Survival Rate,Medulloblastoma,0
10876,Involvement with,Choroid Epithelioid Cell Melanoma,0
10877,Physical shape,Cervical Squamous Intraepithelial Neoplasia,0
10878,Experimental Organism Anal Sac Gland,Splenic Manifestation of Hairy Cell Leukemia,0
10879,Aspects of signs,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10880,Fasting,Human Papillomavirus-Related Carcinoma,0
10881,Repair,Medulloblastoma,0
10882,Adult human body,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10883,Benign,Benign Carotid Body Paraganglioma,0
10884,Often - answer to question,Lung squamous cell carcinoma stage I,0
10885,Full,Cervical Fibroepithelial Polyp,0
10886,Application Context,Testicular cancer metastatic,0
10887,Treated with,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10888,How Much Distress Weight Loss,Ichthyosis,0
10889,Fragment of (qualifier value),Malignant neoplasm of subglottis,0
10890,Upon - dosing instruction fragment,Unicystic ameloblastoma,0
10891,Have Been Vomiting,Choroid Necrotic Melanoma,0
10892,How Much Distress Vomiting,Liver Lymphangioma,0
10893,Name (property) (qualifier value),Neonatal leukemia,0
10894,Metastatic Disease Clinical Trial Setting,Primary Cutaneous Plasmablastic Lymphoma,0
10895,Infrequent,Benign Anal Granular Cell Tumor,0
10896,Infant,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10897,Tumor cells,Digestive System Hodgkin Lymphoma,0
10898,Carcinoma,High Grade Glandular Intraepithelial Neoplasia,0
10899,VARIOUS DRUG CLASSES IN ATC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10900,Specimen Source Codes - tumor,Carcinomatosis of peritoneal cavity,0
10901,North America,Childhood Central Nervous System Ganglioneuroblastoma,0
10902,Eyelid Diseases,Multiple Skull Base Meningiomas,0
10903,Linear,Adenocarcinoma of the prostate metastatic,0
10904,Frequently,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
10905,1+ Score,Adenocarcinoma of duodenum,0
10906,Make - Instruction Imperative,Refractory Bladder Carcinoma,0
10907,Prevalence aspects,Kaposi's sarcoma of extrahepatic bile duct,0
10908,Pelvis+,Bladder adenocarcinoma stage IV,0
10909,Face (spatial concept),Multiple Skull Base Meningiomas,0
10910,Medical,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10911,Epithelial ovarian cancer,de novo Myelodysplastic Syndrome,0
10912,Anemia,Digestive System Hodgkin Lymphoma,0
10913,Problems - What subject filter,adenoid cystic carcinoma of lung,0
10914,Overall,Refractory WHO Grade III Glioma,0
10915,3+ Score,Stage IV Childhood Non-Hodgkin Lymphoma,0
10916,Type - attribute,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
10917,Weight decreased,Stage IB Pancreatic Cancer AJCC v8,0
10918,Symptoms,carcinoma of middle ear,0
10919,Call (Instruction),Adenocarcinoma,0
10920,growth aspects,adenosquamous carcinoma of breast,0
10921,Mammal liver preparation,Fibroadenoma of breast,0
10922,Include (action),Spongiotic dermatitis,0
10923,Bone structure of cranium,Small Intestinal Villous Adenoma,0
10924,Scientific Publication,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10925,Support,Stage III Cutaneous Melanoma AJCC v6,0
10926,Diagnosis,Recurrent Testicular Lymphoma,0
10927,+2,Childhood Fibrillary Astrocytoma,0
10928,Appearance,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
10929,Oncogene Fusion,Diffuse malignant mesothelioma,0
10930,Back Pain,Extracranial Neuroblastoma,0
10931,Capecitabine/Cisplatin Regimen,Methotrexate-Associated Hodgkin Lymphoma,0
10932,Redness,Bladder Neuroendocrine Neoplasm,0
10933,Often - answer to question,Angiosarcoma of liver,0
10934,Offspring,Bladder adenocarcinoma stage IV,0
10935,Plasma,Neoplasms,0
10936,Imaging Techniques,Intraepithelial Melanocytic Hyperplasia,0
10937,Diagnosis,Ovarian germ cell choriocarcinoma stage IV,0
10938,Changing,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10939,Cancer Other,Acute Undifferentiated Leukemia,0
10940,Descending,Recurrent Primary Lymphoma of Bone,0
10941,Line Unit of Length,Female Breast Carcinoma,0
10942,Body part,Kaposi's sarcoma of extrahepatic bile duct,0
10943,various other intestinal adsorbents in ATC,Malignant melanoma of eyelid,0
10944,CD69 wt Allele,Splenic Manifestation of Hairy Cell Leukemia,0
10945,Include (action),Undifferentiated Endocervical Sarcoma,0
10946,Genetic syndrome,embryonal rhabdomyosarcoma of prostate,0
10947,Pap smear,Advanced Uterine Corpus Carcinosarcoma,0
10948,Asia,Diffuse malignant mesothelioma,0
10949,Feature,Malignant neoplasm of gallbladder,0
10950,Presence (property),Kaposi's sarcoma of skin,0
10951,Type A,Stage IB Pancreatic Cancer AJCC v8,0
10952,Result,Benign tumor of eyelid,0
10953,Reflex motion descriptor,Adult Hepatocellular Carcinoma,0
10954,Patients,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10955,Progress,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10956,melanocyte,Benign squamous cell tumor,0
10957,Tryptophanase,Endometrial Small Cell Carcinoma,0
10958,Negation,Mucinous adenocarcinoma gastric,0
10959,Either,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10960,Often - answer to question,mucinous adenocarcinoma of gallbladder,0
10961,Abnormal result,Blepharal carcinoma,0
10962,International Medical Terminology,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10963,Urinary Bladder,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10964,Following,Childhood Fibrillary Astrocytoma,0
10965,Less often,Acantholytic squamous cell carcinoma,0
10966,combination - answer to question,Stage IV Penile Cancer AJCC v7,0
10967,control aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
10968,Sharing (Social Behavior),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10969,Include (action),Precursor B-lymphoblastic lymphoma stage II,0
10970,Beginning,Tonsillar Carcinoma,0
10971,Parenchyma,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10972,International Classification of Disease for Oncology,Refractory Ependymoma,0
10973,Firstly,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10974,research subject screening,Mucinous adenocarcinoma gastric,0
10975,Radiation,Childhood Fibrillary Astrocytoma,0
10976,Increased,Breast Ductal Adenoma,0
10977,Twice (Numerical Qualifier),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10978,Range,Human Papillomavirus-Related Carcinoma,0
10979,Uterus,Stage I Adult Non-Hodgkin Lymphoma,0
10980,Ulcerative Colitis,Metaplastic carcinoma of breast,0
10981,Finding related to focusing,Lung squamous cell carcinoma stage I,0
10982,Follow,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10983,Disease Screening,Mucinous adenocarcinoma gastric,0
10984,Cells,Cancer of Urinary Tract,0
10985,Pharmacotherapy,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10986,Beginning,Locally Advanced Carcinoma,0
10987,Known,Engraftment syndrome,0
10988,Infected,Thymoma malignant recurrent,0
10989,Breast tissue sample,Low Grade Squamous Intraepithelial Neoplasia,0
10990,Lung,Spermatocytic seminoma,0
10991,Kininogenase,Childhood Choriocarcinoma,0
10992,Packaging Case,BRCA2 Syndrome,0
10993,Usual Severity Sweats,Nasal cavity carcinoma,0
10994,Five,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10995,Classification,Peripheral primitive neuroectodermal tumor of soft tissue,0
10996,Treating,Platinum-Resistant Lung Small Cell Carcinoma,0
10997,Brain Neoplasms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10998,Play,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10999,Estimated,ROSE Cluster 3,0
11000,Taxonomic,Vaginal Adenoma,0
11001,Most,Maxillary Sinus Adenoid Cystic Carcinoma,0
11002,Normal,Placental aromatase deficiency,0
11003,status - In progress,Blepharal carcinoma,0
11004,Age at menopause:Time:Point in time:^Patient:Quantitative,Digestive System Hodgkin Lymphoma,0
11005,Squamous cell carcinoma - category,Chronic Myelomonocytic Leukemia-2,0
11006,Primary malignant neoplasm,Kaposi's sarcoma of extrahepatic bile duct,0
11007,One,Undifferentiated Endocervical Sarcoma,0
11008,Retinoic Acid Response Element,Carcinoma of urinary bladder,0
11009,Antibiotics,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11010,shared attribute,Stage IV Penile Cancer AJCC v7,0
11011,Space - property,Malignant neoplasm of choroid,0
11012,Blood group A (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11013,Cryptorchidism,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11014,Structure of arteriole,FIGO Stage II Ovarian Cancer,0
11015,Occurrence,Carcinoma of urinary bladder,0
11016,Secondary Neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11017,Lower (action),Pilocytic astrocytoma of cerebellum,0
11018,Compression - action,Benign neoplasm of eye,0
11019,cell type,Extra-Adrenal Paraganglioma,0
11020,Therapeutic procedure,Benign squamous cell tumor,0
11021,Severe Extremity Pain,Malignant melanoma of eyelid,0
11022,Malignant Neoplasms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11023,Common (qualifier value),Grade 3a Malignant Neoplasm,0
11024,Specimen Source Codes - Tears,Type II Endometrial Adenocarcinoma,0
11025,Finding of hormone level,Splenic Manifestation of Hairy Cell Leukemia,0
11026,Primary,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11027,2+ Score,Collecting Duct Carcinoma of the Kidney,0
11028,status - In progress,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11029,Experimental Result,Locally Advanced Epithelioid Hemangioendothelioma,0
11030,True primary (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11031,include - SetOperator,Neoplasms,0
11032,Corner Plus,Stage III Cutaneous Melanoma AJCC v6,0
11033,Symptoms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11034,Screening procedure,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
11035,Internal medicine specialty,Cerebral Primitive Neuroectodermal Tumor,0
11036,Dental caries,Carcinoma of submandibular gland,0
11037,Fusion procedure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11038,Hematology (discipline),Ovarian germ cell choriocarcinoma stage IV,0
11039,Treating,Adult Hepatocellular Carcinoma,0
11040,System,Multiple Skull Base Meningiomas,0
11041,Immune,Stage II Carcinoma of Penis,0
11042,Known,Non-Metastatic Gestational Trophoblastic Tumor,0
11043,consideration,Astrocytoma of brain,0
11044,Therapeutic procedure,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
11045,Sufficiently defined concept definition status (core metadata concept),Melanomatosis,0
11046,CD5L wt Allele,Kaposi's sarcoma of skin,0
11047,Congenital Abnormality,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11048,Etiology aspects,Kaposi's sarcoma of skin,0
11049,Back structure,Chondrosarcoma,0
11050,Common Specifications in HL7 V3 Publishing,Vaginal Adenoma,0
11051,Type - attribute,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11052,Due to,Localized Ewing Sarcoma,0
11053,Primary malignant neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11054,Occurrence Indicator,High Grade Glandular Intraepithelial Neoplasia,0
11055,Beginning,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11056,300,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11057,Cell Count,Fibroadenoma of breast,0
11058,Abnormal cell,Tonsillar Carcinoma,0
11059,Enlarged,Localized Ewing Sarcoma,0
11060,Goes <invertebrate>,adenoid cystic carcinoma of lung,0
11061,operate <remove>,non-Hodgkin's lymphoma of spleen,0
11062,Less Than,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11063,Secretory Vesicles,Stage 0 Penile Cancer AJCC v8,0
11064,One,Tubal Hyperplasia,0
11065,Intestines,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11066,Indication of (contextual qualifier),BRCA2 Syndrome,0
11067,One,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11068,3+ Answer to Question,Ichthyosis,0
11069,Study,Childhood Central Nervous System Ganglioneuroblastoma,0
11070,Negative Surgical Margin,Colorectal High Grade B-Cell Lymphoma,0
11071,Initial Usage,Hereditary Diffuse Gastric Adenocarcinoma,0
11072,Therapeutic procedure,Pancreatic Intraepithelial Neoplasia-3,0
11073,Biopsy,Kaposi's sarcoma of extrahepatic bile duct,0
11074,Patients,Bladder squamous cell carcinoma stage I,0
11075,Similarity,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11076,Including (qualifier),Cerebral Primitive Neuroectodermal Tumor,0
11077,DUOXA1 gene,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11078,Sarcoma of soft tissue,Pancreatic Endocrine Carcinoma,0
11079,include - SetOperator,Unicystic ameloblastoma,0
11080,Manufactured form,Adult Alveolar Soft Part Sarcoma,0
11081,Scientific Publication,Astrocytoma of brain,0
11082,Obesity,Colorectal cancer,0
11083,Include (action),Astrocytoma of brain,0
11084,United States,Localized Ewing Sarcoma,0
11085,Coughing,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11086,Abnormally high,Primary Cutaneous Plasmablastic Lymphoma,0
11087,Occurrence,Bladder adenocarcinoma stage IV,0
11088,Formation,FIGO Stage II Ovarian Cancer,0
11089,biopsy characteristics,Extracranial Neuroblastoma,0
11090,Associated with,FIGO Stage IVA Ovarian Cancer,0
11091,Germ cell tumor,Acute Undifferentiated Leukemia,0
11092,Body tissue,Pilocytic astrocytoma of cerebellum,0
11093,Malignant neoplasm of lung,Childhood Extragonadal Malignant Germ Cell Tumor,0
11094,Age at menopause,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
11095,Chemotherapy Regimen,Type II Endometrial Adenocarcinoma,0
11096,Near,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11097,How Often Felt Normal question,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11098,Chicken laying egg for human food,Stage III Adult Immunoblastic Lymphoma,0
11099,gastrointestinal,Heavy Chain Deposition Disease,0
11100,Include (action),Malignant Testicular Sertoli Cell Tumor,0
11101,Basis - conceptual entity,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11102,Comparison,FIGO Stage II Ovarian Cancer,0
11103,Urinary Bladder,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
11104,Common Specifications in HL7 V3 Publishing,Kaposi's sarcoma of extrahepatic bile duct,0
11105,<50,Thyroid Hurthle Cell Carcinoma,0
11106,Irritation - emotion,Melanomatosis,0
11107,Late,Familial Hemophagocytic Lymphocytosis,0
11108,Including (qualifier),Extra-Adrenal Paraganglioma,0
11109,Manufactured form,Vaginal Adenoid Cystic Carcinoma,0
11110,Including (qualifier),Clonal Hematopoiesis of Indeterminate Potential,0
11111,Body part,Vaginal Adenoma,0
11112,Etiology aspects,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11113,Loss of appetite (finding),Metaplastic carcinoma of breast,0
11114,Skeletal bone,Adult Anaplastic Oligodendroglioma,0
11115,various other nasal preparations in ATC,Carcinoma of submandibular gland,0
11116,Ultrasonic Shockwave,Undifferentiated Endocervical Sarcoma,0
11117,2+ Score,Tonsillar Carcinoma,0
11118,survive,Bladder Neuroendocrine Neoplasm,0
11119,Blood,Chest Wall Fibromatosis,0
11120,Symptoms aspect,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11121,Illness: Cannot describe symptoms,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11122,Blast (physical force),Stage IV Childhood Non-Hodgkin Lymphoma,0
11123,genome sequencing,Mucinous adenocarcinoma gastric,0
11124,Cell Differentiation process,GIANT PIGMENTED HAIRY NEVUS,0
11125,*Type - Kind of quantity,Blood Vessel Tumors,0
11126,hand - unit of measure,Benign tumor of eyelid,0
11127,risk factors,Giant cell angiofibroma,0
11128,Pancreatic carcinoma,Childhood Extragonadal Malignant Germ Cell Tumor,0
11129,Study,Anterior Urethral Malignant Neoplasm,0
11130,Probability,Refractory Barrett Esophagus,0
11131,Treating,Endometrial Small Cell Carcinoma,0
11132,cell growth,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11133,Unknown,Prostate Lymphoma,0
11134,Teens,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11135,cell transformation,Localized Malignant Neoplasm,0
11136,Oral cavity,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11137,filter information process,Bladder adenocarcinoma stage IV,0
11138,Suspected qualifier,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11139,risk factors - observation list,Familial Hemophagocytic Lymphocytosis,0
11140,Overall Well Being,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11141,Supportive assistance,Intestinal Neuroendocrine Carcinoma,0
11142,Malignant Neoplasms,squamous cell carcinoma of the thyroid gland,0
11143,Known,Unfavorable Non-Hodgkin Lymphoma,0
11144,Importance Weight,Pilocytic astrocytoma of cerebellum,0
11145,Relationships,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
11146,Involvement with,Methotrexate-Associated Hodgkin Lymphoma,0
11147,Skeletal system,Undifferentiated Endocervical Sarcoma,0
11148,Patient currently pregnant,Cerebral hemangioma,0
11149,Nearly,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
11150,Growth action,Engraftment syndrome,0
11151,Present,Primary Cutaneous Plasmablastic Lymphoma,0
11152,Drink (dietary substance),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11153,Macrophage count,Thymic Clear Cell Carcinoma,0
11154,Ultrasonic,FIGO Stage IVA Ovarian Cancer,0
11155,Lung,Locally Advanced Squamous Cell Carcinoma,0
11156,Central,Malignant neoplasm of choroid,0
11157,Usually Need Help from Another Person for Arising,Heavy Chain Deposition Disease,0
11158,Osteosarcoma of bone,Mucinous adenocarcinoma,0
11159,Sufficient,Serous cystadenocarcinoma ovary,0
11160,Immune System Finding,malignant lymphoma of pancreatic lymph nodes,0
11161,Interventional procedure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11162,include - SetOperator,Splenic Manifestation of Hairy Cell Leukemia,0
11163,3+ Score,Type II Endometrial Adenocarcinoma,0
11164,Increased,Bladder adenocarcinoma stage IV,0
11165,Neoplastic disease,Kaposi's sarcoma of skin,0
11166,Array Feature,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
11167,Childhood Lymphoma,FIGO Stage IVA Ovarian Cancer,0
11168,Targeted Therapy,Intestinal Neuroendocrine Carcinoma,0
11169,Acute Undifferentiated Leukemia,Lipoma of small intestine,0
11170,Classification,gliosarcoma,0
11171,List,Splenic Manifestation of Hairy Cell Leukemia,0
11172,Activation action,Acantholytic squamous cell carcinoma,0
11173,dependent,Ampulla of Vater Tubular Adenoma,0
11174,Urethra part,Benign Ovarian Thecoma,0
11175,Reduced,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11176,Spreading (qualifier value),embryonal rhabdomyosarcoma of prostate,0
11177,Order (action),Airway Hemangioma,0
11178,Condition,Colorectal Neuroendocrine Tumor G2,0
11179,Malignant neoplasm of thyroid,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11180,To,Blood Vessel Tumors,0
11181,Large,Kaposi's sarcoma of extrahepatic bile duct,0
11182,incidence of cases,Undifferentiated Endocervical Sarcoma,0
11183,Irregular,Ectomesenchymal Chondromyxoid Tumor,0
11184,factor A,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11185,radiotherapeutic,Metastatic Carcinoma in the Lung,0
11186,Case (situation),Kaposi's sarcoma of skin,0
11187,10%,Bladder Neuroendocrine Neoplasm,0
11188,Administration procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11189,Uterine Fibroids,Occult Lung Adenosquamous Carcinoma,0
11190,Experimental Result,Cervical Fibroepithelial Polyp,0
11191,Reduced,Maxillary Sinus Adenoid Cystic Carcinoma,0
11192,Togo,Vaginal Adenoid Cystic Carcinoma,0
11193,Malignant neoplasm of pancreas,Occult Lung Adenosquamous Carcinoma,0
11194,Communicable Diseases,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11195,Colon <insect>,Papillary squamous cell carcinoma,0
11196,Communication Contact,Precursor B-lymphoblastic lymphoma stage II,0
11197,Include (action),Mastocytosis,0
11198,Abnormal coordination,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11199,Digestive Enzymes,Childhood Fibrillary Astrocytoma,0
11200,Firstly,Placental aromatase deficiency,0
11201,Skin Specimen,Secondary malignant neoplasm of lymph node,0
11202,Malignant Neoplasms,Stage 0 Lip Carcinoma,0
11203,Clone,Small cell neuroendocrine carcinoma of bladder,0
11204,Therapeutic procedure,Astrocytoma of brain,0
11205,Type A,Breast Ductal Adenoma,0
11206,multiple pathologies,Multiple Endocrine Neoplasia,0
11207,Referring,Liver Cavernous Hemangioma,0
11208,Entity,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11209,Obesity,Non-Hodgkin Lymphoma During Pregnancy,0
11210,World Health Organization,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11211,Northern Europe,Pilocytic astrocytoma of cerebellum,0
11212,Disease Screening,Lipoma of small intestine,0
11213,Combined,Deep Leiomyoma,0
11214,Hepatitis,Mucinous adenocarcinoma gastric,0
11215,Location of Pharyngeal Residue Following Swallowing,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11216,Type A,Platinum-Resistant Lung Small Cell Carcinoma,0
11217,Magnetic Resonance Imaging,embryonal rhabdomyosarcoma of prostate,0
11218,Supine Position,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11219,Disease,Human Papillomavirus-Related Carcinoma,0
11220,Fever symptoms (finding),Fibroadenoma of breast,0
11221,Cirrhosis,Mucinous adenocarcinoma gastric,0
11222,Healthy,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11223,During,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11224,Lymphoid neoplasm,ICHTHYOSIS,0
11225,Complete Pharyngeal Contraction,Neoplasms,0
11226,Most,Gallbladder Adenocarcinoma,0
11227,risk factors,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11228,Similarity,Mucosal Melanoma,0
11229,Thyroid Gland,Bladder Neuroendocrine Neoplasm,0
11230,Malignant Neoplasms,Transitional cell carcinoma,0
11231,Species,Rhabdomyosarcoma with ganglionic differentiation,0
11232,physiological aspects,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11233,Age,Type II Endometrial Adenocarcinoma,0
11234,Cancer Genus,Cartilaginous exostosis,0
11235,Skin cell,Thyroid Hurthle Cell Carcinoma,0
11236,Count of entities,Metaplastic carcinoma of breast,0
11237,Severe (severity modifier),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11238,status - In progress,Refractory Barrett Esophagus,0
11239,Accidental Falls,Carcinoma of submandibular gland,0
11240,Formations,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
11241,century,mucinous adenocarcinoma of gallbladder,0
11242,Areas <moth>,Malignant neoplasm of subglottis,0
11243,Term (temporal),Female Breast Carcinoma,0
11244,Nausea,Kaposi's sarcoma of skin,0
11245,described,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11246,Surface of skin,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11247,Occurrence Indicator,Adrenal Rest Tumor,0
11248,Prognostic Factors,FIGO Stage IVA Ovarian Cancer,0
11249,Glandular stomach,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11250,Established,Recurrent Primary Lymphoma of Bone,0
11251,Spreading (qualifier value),Childhood Central Nervous System Immature Teratoma,0
11252,Cell Device,Hemangioma,0
11253,Persons,Medulloblastoma,0
11254,Smoking,Kaposi's sarcoma of skin,0
11255,Dietary Lead,Mixed astrocytoma-ependymoma,0
11256,Tissue Specimen Code,Locally Advanced Carcinoma,0
11257,Experimental Result,Malignant melanoma of eyelid,0
11258,What subject filter - Result,Fibroadenoma of breast,0
11259,Multiple Myeloma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11260,Cell Device,Localized Askin Tumor,0
11261,Negation,squamous cell carcinoma of the thyroid gland,0
11262,Malignant Neoplasms,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11263,Carbohydrate nutrients,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11264,Well Differentiated,Diffuse malignant mesothelioma,0
11265,Greater,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11266,Several,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
11267,System - kit,Colorectal cancer,0
11268,Base - General Qualifier,Grade 3a Malignant Neoplasm,0
11269,Unknown,Refractory Barrett Esophagus,0
11270,True primary (qualifier value),Small cell neuroendocrine carcinoma of bladder,0
11271,Poor function,Mixed parotid tumor,0
11272,In addition to,Melanomatosis,0
11273,Abnormally high,Cervical Adenomyoma,0
11274,Smaller,Localized Askin Tumor,0
11275,Designated,Recurrent Rhabdomyosarcoma,0
11276,Spread by direct extension,Recurrent Primary Lymphoma of Bone,0
11277,mucosa-associated lymphoid tissue,Collecting Duct Carcinoma of the Kidney,0
11278,Rate,Bladder Neuroendocrine Neoplasm,0
11279,Widening,Cervical Squamous Intraepithelial Neoplasia,0
11280,Smear - instruction imperative,Plexosarcoma,0
11281,active (HL7 RoleLink),Mucinous adenocarcinoma gastric,0
11282,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
11283,Body tissue,Xeroderma pigmentosum,0
11284,True Control Status,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11285,Use of,Female Breast Carcinoma,0
11286,Tissue Specimen Code,embryonal rhabdomyosarcoma of prostate,0
11287,Surgical aspects,Breast Apocrine Adenoma,0
11288,Treating,Mixed astrocytoma-ependymoma,0
11289,Distention of blood vessel,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11290,Capillary Action,Anterior Urethral Malignant Neoplasm,0
11291,Abdominal Cavity,Engraftment syndrome,0
11292,Entity Determiner - specific,Primary Cutaneous Plasmablastic Lymphoma,0
11293,General surgery specialty,Granular Cell Leiomyosarcoma,0
11294,Including (qualifier),Metastatic Lung Neuroendocrine Neoplasm,0
11295,Pharyngeal structure,Splenic Manifestation of Hairy Cell Leukemia,0
11296,disease history,Epithelioid Sarcoma NCI Grade 3,0
11297,Tobacco smoking behavior,Recurrent Uveal Melanoma,0
11298,60%,Brain Tumor,0
11299,associated disease,Stage IB Lung Cancer AJCC v7,0
11300,Survival Rate,Localized Askin Tumor,0
11301,2+ Score,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11302,peritoneal,Malignant neoplasm of olfactory nerve,0
11303,Breast tissue sample,Recurrent Uveal Melanoma,0
11304,chance,Intestinal Metaplasia of Bladder Urothelium,0
11305,soft tissue,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11306,Have Pain,Malignant Testicular Sertoli Cell Tumor,0
11307,alone - group size,Acantholytic squamous cell carcinoma,0
11308,tumor growth,Childhood Central Nervous System Ganglioneuroblastoma,0
11309,Type - attribute,papillary carcinoma of penis,0
11310,Neuroglia,Hereditary Diffuse Gastric Adenocarcinoma,0
11311,Malignant Neoplasms,Stage I Adult Non-Hodgkin Lymphoma,0
11312,Neoplasms,Adenocarcinoma of duodenum,0
11313,Structure of Wharton's jelly,Gallbladder adenoma,0
11314,Diagnosis Study,Extracranial Neuroblastoma,0
11315,Derivation,Engraftment syndrome,0
11316,Cancer Genus,Metastatic Carcinoma in the Lung,0
11317,Buildup,Platinum-Resistant Lung Small Cell Carcinoma,0
11318,Entity Determiner - specific,Breast Ductal Adenoma,0
11319,Main,Medulloblastoma,0
11320,Malignant Neoplasms,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11321,/40,Grade 1 Clear Cell Renal Cell Carcinoma,0
11322,Country number:Find:Pt:^Patient:Nom,Cancer of Urinary Tract,0
11323,What subject filter - Result,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11324,Occur (action),Endometrial Small Cell Carcinoma,0
11325,Neoplasm Metastasis,FIGO Stage II Ovarian Cancer,0
11326,Myoepithelial,Liver Lymphangioma,0
11327,Tonsil,Locally Advanced Soft Tissue Sarcoma,0
11328,Mesenchymal Stem Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11329,Most,FIGO Stage IVA Ovarian Cancer,0
11330,Treating,Malignant neoplasm of choroid,0
11331,Specimen Source Codes - tumor,Stage IB Lung Cancer AJCC v7,0
11332,Dysuria,Heavy Chain Deposition Disease,0
11333,Major <insect>,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
11334,LATS1 gene,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11335,Body tissue,Malignant Neoplasm with Regional Lymph Node Involvement,0
11336,How Often Constipation,Type II Endometrial Adenocarcinoma,0
11337,Term (lexical),Squamous cell carcinoma of lip,0
11338,Night sweats,Precursor B-lymphoblastic lymphoma stage II,0
11339,Mutation,Human Papillomavirus-Related Carcinoma,0
11340,Confirm,Stage IB Lung Cancer AJCC v7,0
11341,Special,Mucosal Melanoma,0
11342,Assortment,Refractory Ependymoma,0
11343,Salivary Gland Neoplasms,Pleomorphic adenoma of parotid gland,0
11344,Cosmetic procedure,benign mature teratoma of pancreas,0
11345,RMS,Malignant neoplasm of gallbladder,0
11346,Order (record artifact),Mixed astrocytoma-ependymoma,0
11347,Dropping,Astrocytoma of brain,0
11348,Females,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11349,Malignant Carcinoid Syndrome,Benign neoplasm of thorax,0
11350,Stage Grouping,Kaposi's sarcoma of skin,0
11351,Biomaterial Treatment,Ichthyosis,0
11352,30%,Uterine Cancer,0
11353,Result,Familial Hemophagocytic Lymphocytosis,0
11354,Term Birth,Malignant melanoma of eyelid,0
11355,Before values,Leptomeningeal sarcoma,0
11356,Killing,Type II Endometrial Adenocarcinoma,0
11357,Gene Mutation,Astrocytoma of brain,0
11358,Pharyngeal structure,clear cell adenocarcinoma of gallbladder,0
11359,Disease,Metastatic Ductal Breast Carcinoma,0
11360,Precipitating Factors,Testicular cancer metastatic,0
11361,shared attribute,Clonal Hematopoiesis of Indeterminate Potential,0
11362,Upper Respiratory Infections,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11363,Retinoic Acid Response Element,Blepharal carcinoma,0
11364,Decision,Mixed parotid tumor,0
11365,Pleomorphic,Chondrosarcoma,0
11366,Malignant neoplasm of lung,Maxillary Sinus Adenocarcinoma,0
11367,Lobe of cerebellum,Congenital hamartoma,0
11368,Ability,Intraepithelial Melanocytic Hyperplasia,0
11369,Type A,Neoplasms,0
11370,Location of Oral Residue Following Swallowing,Non-Hodgkin Lymphoma During Pregnancy,0
11371,Stromal Invasion,Bladder adenocarcinoma stage IV,0
11372,Tests (qualifier value),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11373,Astrocytoma,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11374,Surgical aspects,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11375,Call (Instruction),benign mature teratoma of pancreas,0
11376,Abdomen,FIGO Stage IVA Ovarian Cancer,0
11377,Common (qualifier value),Childhood Lymphoma,0
11378,Spreading (qualifier value),Childhood Thyroid Gland Follicular Carcinoma,0
11379,Hematopoietic Neoplasms,Endometrial Small Cell Carcinoma,0
11380,Male population group,Trichilemmocarcinoma,0
11381,Fallopian Tubes,Vaginal Adenoid Cystic Carcinoma,0
11382,Lymphocyte,Gallbladder Adenocarcinoma,0
11383,Left,Low Grade Squamous Intraepithelial Neoplasia,0
11384,Species,Transitional cell carcinoma,0
11385,Alleles,Adenocarcinoma,0
11386,Abnormal Reference Range,Multiple Skull Base Meningiomas,0
11387,Face (spatial concept),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11388,Neoplasm Metastasis,Neonatal leukemia,0
11389,Adult Anaplastic Oligodendroglioma,Undifferentiated Endocervical Sarcoma,0
11390,Part of,Refractory Bladder Carcinoma,0
11391,Obese build,Benign Anal Granular Cell Tumor,0
11392,Congenital MeSH qualifier,Chronic Myelomonocytic Leukemia-2,0
11393,Multiple sexual contacts,Cerebral Primitive Neuroectodermal Tumor,0
11394,Lung,Unresectable Rhabdomyosarcoma,0
11395,Primary,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11396,Severe (severity modifier),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11397,Contain (action),Childhood Fibrillary Astrocytoma,0
11398,Chemotherapy,Splenic Manifestation of Hairy Cell Leukemia,0
11399,Sunlight,Ovarian Carcinoid Tumor,0
11400,Adenocarcinoma,Adult Alveolar Soft Part Sarcoma,0
11401,Abnormal Reference Range,Carcinoma ex pleomorphic adenoma of parotid gland,0
11402,Neuroendocrine Tumors,Peripheral primitive neuroectodermal tumor of soft tissue,0
11403,Used by,Locally Advanced Squamous Cell Carcinoma,0
11404,Administration procedure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11405,Neoplasm Metastasis,Thymic Clear Cell Carcinoma,0
11406,Usually,Mucosal Melanoma,0
11407,Fever,Refractory Bladder Carcinoma,0
11408,Diabetes Mellitus,Carcinomatosis of peritoneal cavity,0
11409,Surrounding (qualifier value),Testicular cancer metastatic,0
11410,Species,Metastatic Malignant Neoplasm in the Sellar Region,0
11411,Component object,Benign Carotid Body Paraganglioma,0
11412,Hematology+Oncology,Pancreatic Endocrine Carcinoma,0
11413,Milliampere second,Choroid Necrotic Melanoma,0
11414,Cells,Neoplasms,0
11415,Junonia,Advanced Lung Carcinoma,0
11416,Specific qualifier value,Localized Askin Tumor,0
11417,American College of Cardiology/American Heart Association Lesion Complexity Score C,Low Grade Squamous Intraepithelial Neoplasia,0
11418,Thymoma,Acute Undifferentiated Leukemia,0
11419,Administration procedure,Kaposi's sarcoma of skin,0
11420,Neurofibromatosis 1,Stage II Carcinoma of Penis,0
11421,Logical Condition,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
11422,Aggressive course,Localized Askin Tumor,0
11423,Condition,Malignant neoplasm of subglottis,0
11424,Usual,Intestinal Metaplasia of Bladder Urothelium,0
11425,development aspects,Intestinal Metaplasia of Bladder Urothelium,0
11426,clinical aspects,Uterine Cancer,0
11427,Common (qualifier value),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
11428,Known,FIGO Stage IVA Ovarian Cancer,0
11429,100%,papillary carcinoma of penis,0
11430,Elements,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11431,Divide,Malignant Testicular Sertoli Cell Tumor,0
11432,Advanced phase,Carcinomatosis of peritoneal cavity,0
11433,glottis,Hodgkin lymphoma,0
11434,Rate,Pancreatic carcinoma,0
11435,Etiology aspects,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11436,Interferes with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11437,Malignant neoplasm of lung,Atypical Lobular Breast Hyperplasia,0
11438,Acinar Cell Carcinoma,Benign Apocrine Neoplasm,0
11439,Capsule Dosing Unit,Adult Brain Stem Mixed Glioma,0
11440,Cancer Genus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11441,Occurrence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11442,63,Stage III Cutaneous Melanoma AJCC v6,0
11443,Followed by,Acantholytic squamous cell carcinoma,0
11444,Lymphocyte,Grade 1 Clear Cell Renal Cell Carcinoma,0
11445,Main,Undifferentiated Endocervical Sarcoma,0
11446,Estrogen (disposition),Diffuse malignant mesothelioma,0
11447,Occurrence,Adult Hepatocellular Carcinoma,0
11448,Infection,malignant lymphoma of pancreatic lymph nodes,0
11449,MOSTLY,Cervical Squamous Intraepithelial Neoplasia,0
11450,Usual,Primary Cutaneous Plasmablastic Lymphoma,0
11451,Possible,Metastatic Kidney Carcinoma,0
11452,Primary malignant neoplasm,Benign neoplasm of thorax,0
11453,Within,adenosquamous carcinoma of breast,0
11454,Death (finding),Recurrent Testicular Lymphoma,0
11455,Age,Thymoma malignant recurrent,0
11456,Type - attribute,Malignant neoplasm of subglottis,0
11457,Times,Anterior Urethral Malignant Neoplasm,0
11458,Name (property) (qualifier value),Precursor B-lymphoblastic lymphoma stage II,0
11459,Medical,Benign Anal Granular Cell Tumor,0
11460,Self,Colorectal cancer,0
11461,Malaise,Bladder Neuroendocrine Neoplasm,0
11462,Acquired phimosis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11463,Containing (qualifier),GIANT PIGMENTED HAIRY NEVUS,0
11464,History of previous events,Diffuse malignant mesothelioma,0
11465,Have Weight Loss,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11466,Bone marrow biopsy,Cerebral Primitive Neuroectodermal Tumor,0
11467,Device system,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11468,Code,Clonal Hematopoiesis of Indeterminate Potential,0
11469,Logical Condition,Spongiotic dermatitis,0
11470,Factor,Kaposi's sarcoma of skin,0
11471,Infiltrative Tumor Margin,Xeroderma pigmentosum,0
11472,Dilate procedure,Medulloblastoma,0
11473,Traumatic injury,Thyroid Hurthle Cell Carcinoma,0
11474,Anorexia,Adenocarcinoma of the prostate metastatic,0
11475,Two,de novo Myelodysplastic Syndrome,0
11476,Tumor grade G3,Benign Ovarian Thecoma,0
11477,Second Suffix,Bladder adenocarcinoma stage IV,0
11478,year,Multiple Endocrine Neoplasia,0
11479,Screening procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11480,Table Cell Horizontal Align - left,adenosquamous carcinoma of breast,0
11481,Intracranial Hypertension,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11482,Alcohol consumption,Hodgkin Disease,0
11483,Male population group,gliosarcoma,0
11484,Genitalia,Gallbladder Adenocarcinoma,0
11485,Family history,Adenocarcinoma of the prostate metastatic,0
11486,Negative Charge,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11487,Ectodermal,Human Papillomavirus-Related Carcinoma,0
11488,T-Lymphocytopenia,Locally Advanced Epithelioid Hemangioendothelioma,0
11489,Tetraploidy,Bladder Neuroendocrine Neoplasm,0
11490,Nose,Chondrosarcoma,0
11491,Feelings,Bladder Neuroendocrine Neoplasm,0
11492,Vomiting,clear cell adenocarcinoma of gallbladder,0
11493,Including (qualifier),malignant lymphoma of pancreatic lymph nodes,0
11494,Cancer Genus,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11495,Including (qualifier),Locally Advanced Epithelioid Hemangioendothelioma,0
11496,protein body,Hair nevus,0
11497,Occurrence Indicator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11498,Retinoic acid syndrome,Diffuse malignant mesothelioma,0
11499,Rate,Cervical Adenomyoma,0
11500,Primary malignant neoplasm,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11501,Dorsal,Airway Hemangioma,0
11502,Chemotherapy,Carcinoma ex pleomorphic adenoma of parotid gland,0
11503,Family history,Intestinal Metaplasia of Bladder Urothelium,0
11504,Female Phenotype,High Grade Glandular Intraepithelial Neoplasia,0
11505,Immune System Finding,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11506,Can Do Very Little,Splenic Manifestation of Hairy Cell Leukemia,0
11507,Female Reproductive System,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
11508,CD5L wt Allele,Locally Advanced Squamous Cell Carcinoma,0
11509,Occurrence Indicator,Anterior Urethral Malignant Neoplasm,0
11510,Aim (idea),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11511,Occurrence,Cystadenocarcinoma,0
11512,Range,Cerebral hemangioma,0
11513,Increase,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11514,Stem cell transplant,Intraepithelial Melanocytic Hyperplasia,0
11515,Weight Loss,Hodgkin lymphoma,0
11516,Retinoic Acid Response Element,Type II Endometrial Adenocarcinoma,0
11517,Persons,Acute Undifferentiated Leukemia,0
11518,Skin,Cerebral hemangioma,0
11519,peripheral blood,Mastocytosis,0
11520,Intravascular line,Benign neoplasm of eye,0
11521,Initially,Acantholytic squamous cell carcinoma,0
11522,XK wt Allele,Cervical Squamous Intraepithelial Neoplasia,0
11523,Following,Locally Advanced Squamous Cell Carcinoma,0
11524,treatment options,Brain Tumor,0
11525,Geographic Locations,Breast Ductal Adenoma,0
11526,Symptoms,Intestinal Metaplasia of Bladder Urothelium,0
11527,Sometimes,malignant lymphoma of pancreatic lymph nodes,0
11528,Related personal status,Breast Ductal Adenoma,0
11529,Array Feature,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11530,/40,Mucinous adenocarcinoma gastric,0
11531,Take,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11532,Hodgkin Disease,Benign Apocrine Neoplasm,0
11533,Endocrine Gland Neoplasms,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11534,Cause of death.underlying,Female Breast Carcinoma,0
11535,Deterioration of status,Kaposi's sarcoma of skin,0
11536,Antiretroviral Therapy,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11537,Optical filter,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11538,Trial Screening,Human Papillomavirus-Related Carcinoma,0
11539,Definition,Chronic Myelomonocytic Leukemia-2,0
11540,Singular,Transitional cell carcinoma,0
11541,Derivation,Pancreatic carcinoma,0
11542,Occurrence,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11543,Body part,Clonal Hematopoiesis of Indeterminate Potential,0
11544,Location of Oral Residue Following Swallowing,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11545,Diagnosis,Hyperplasia of pituitary gland,0
11546,Adenocarcinoma,Stage III Adult Immunoblastic Lymphoma,0
11547,Fever symptoms (finding),Spongiotic dermatitis,0
11548,Part Dosing Unit,Mixed parotid tumor,0
11549,Half,Bladder adenocarcinoma stage IV,0
11550,Body part,embryonal rhabdomyosarcoma of prostate,0
11551,Malignant Neoplasms,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11552,Group A (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11553,Precision - second,BRCA2 Syndrome,0
11554,Referring,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11555,Adult Hodgkin Lymphoma,Splenic Manifestation of Hairy Cell Leukemia,0
11556,bony process,Localized Ewing Sarcoma,0
11557,Genetic Risk,Stage III Cutaneous Melanoma AJCC v6,0
11558,Have Sweats,Giant cell angiofibroma,0
11559,Number of birth,Granular Cell Leiomyosarcoma,0
11560,Time,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11561,Generic Role,Childhood Lymphoma,0
11562,Body tissue,Kaposi's sarcoma of extrahepatic bile duct,0
11563,Tests (qualifier value),Testicular cancer metastatic,0
11564,Cancer Genus,Squamous cell carcinoma of lip,0
11565,Risk,Anterior Urethral Malignant Neoplasm,0
11566,Property (attribute),Childhood Central Nervous System Immature Teratoma,0
11567,Due to,Breast Ductal Adenoma,0
11568,Bilateral salpingectomy with oophorectomy,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11569,Chemotherapy,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
11570,Lung,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
11571,Exogenous Factors,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11572,Red color,Blepharal carcinoma,0
11573,Surgical repair,Intraepithelial Melanocytic Hyperplasia,0
11574,Filters,Astrocytoma of brain,0
11575,Event Seriousness - Significant,Cerebral hemangioma,0
11576,Hormonal Contraception,Kaposi's sarcoma of skin,0
11577,radiotherapeutic,Ichthyosis,0
11578,Approach,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11579,Firstly,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11580,Financial Account,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11581,Cardiovascular System Part,Mixed astrocytoma-ependymoma,0
11582,Fourth ventricle structure,Prostate Lymphoma,0
11583,Patient Condition Code - Stable,Intracortical osteosarcoma,0
11584,Specimen,Squamous cell carcinoma of lip,0
11585,Time (foundation metadata concept),Stage I Colon Neuroendocrine Tumor AJCC v8,0
11586,NCI CTEP SDC Melanoma Sub-Category Terminology,Benign neoplasm of thorax,0
11587,Areas <moth>,Stage III Cutaneous Melanoma AJCC v6,0
11588,Red Blood Cell Count measurement,Cervical Squamous Intraepithelial Neoplasia,0
11589,Infection,Cancer of Urinary Tract,0
11590,Connect,Acute Undifferentiated Leukemia,0
11591,Long-term,Stage III Adult Immunoblastic Lymphoma,0
11592,Formation,High Grade Glandular Intraepithelial Neoplasia,0
11593,Removed,Ichthyosis,0
11594,Most,Transitional cell carcinoma,0
11595,Morphology,Mixed astrocytoma-ependymoma,0
11596,Gastric (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
11597,year,Pancreatic carcinoma,0
11598,Packed cell volume increased,Benign Anal Granular Cell Tumor,0
11599,Symptoms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11600,Extent of disease,Localized Askin Tumor,0
11601,Hormonal,Intracortical osteosarcoma,0
11602,Notable,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11603,Appearance Distress Question,Intracortical osteosarcoma,0
11604,Males,Gallbladder Adenocarcinoma,0
11605,Act Reason - Error,Thyroid Hurthle Cell Carcinoma,0
11606,cardiovascular disorder risk,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11607,Pale feces (finding),mucinous adenocarcinoma of gallbladder,0
11608,Homo sapiens,Sarcomatoid Renal Cell Carcinoma,0
11609,Weight measurement scales,Malignant neoplasm of subglottis,0
11610,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Benign squamous cell tumor,0
11611,Child,Bladder squamous cell carcinoma stage I,0
11612,Tryptophanase,Unicystic ameloblastoma,0
11613,Most,Recurrent Uveal Melanoma,0
11614,Location of Oral Residue Following Swallowing,Benign neoplasm of thorax,0
11615,Scientific Control,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
11616,Pregnancy,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11617,Five-year Survival Rate,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11618,Precancerous Conditions,Benign squamous cell tumor,0
11619,60%,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11620,Four,Liver Lymphangioma,0
11621,Mass of body structure,Primary Cutaneous Plasmablastic Lymphoma,0
11622,>90,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11623,Primary malignant neoplasm,Astrocytoma of brain,0
11624,More,Werner Syndrome,0
11625,Frequently,Pleomorphic adenoma of parotid gland,0
11626,Hematologic Neoplasms,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
11627,Prognosis:Find:Pt:^Patient:Nom,Childhood Cerebellar Neoplasm,0
11628,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11629,Fever symptoms (finding),embryonal rhabdomyosarcoma of prostate,0
11630,Patch Dosing Unit,Childhood Thyroid Gland Follicular Carcinoma,0
11631,size,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11632,Call (Instruction),Carcinoma of urinary bladder,0
11633,Flushing,Funisitis (disorder),0
11634,Retinoic Acid Response Element,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11635,Surgical reduction,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11636,Prognosis:Find:Pt:^Patient:Nom,Kaposi's sarcoma of extrahepatic bile duct,0
11637,Night sweats,Anaplastic large cell lymphoma,0
11638,Genetic Heterogeneity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11639,Time,Cervical Squamous Intraepithelial Neoplasia,0
11640,Mucous Membrane,Benign squamous cell tumor,0
11641,Human Study Subject,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11642,Only - dosing instruction fragment,Clonal Hematopoiesis of Indeterminate Potential,0
11643,Long Variable,Adult Brain Stem Mixed Glioma,0
11644,Type - attribute,Colorectal Neuroendocrine Tumor G2,0
11645,Presentation,Acantholytic squamous cell carcinoma,0
11646,Average of Value Derivation Technique,Endometrial Small Cell Carcinoma,0
11647,Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11648,PGAP3 gene,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11649,Contrast Media,Benign tumor of eyelid,0
11650,Pain Distress Question,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11651,Healthy,benign mature teratoma of pancreas,0
11652,Males,Vaginal Adenoma,0
11653,Weight decreased,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11654,Local disease,Adenocarcinoma,0
11655,Leads (device),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
11656,Malignant neoplasm of skin,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
11657,Highest,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
11658,Skin,Benign squamous cell tumor,0
11659,size,Angiosarcoma of liver,0
11660,Location of Oral Residue Following Swallowing,Cerebral Primitive Neuroectodermal Tumor,0
11661,Specimen Source Codes - Macrophages,Cervical Fibroepithelial Polyp,0
11662,Often - answer to question,Stage IB Pancreatic Cancer AJCC v8,0
11663,Cancer Remission,Thymic Clear Cell Carcinoma,0
11664,Genetic Risk,Adult Alveolar Soft Part Sarcoma,0
11665,Midline (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11666,Sodium Tetradecyl Sulfate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11667,Occur (action),Platinum-Resistant Lung Small Cell Carcinoma,0
11668,Usual Severity Vomiting,Mixed parotid tumor,0
11669,Base - General Qualifier,Stage I Adult Non-Hodgkin Lymphoma,0
11670,Together,Kaposi's sarcoma of extrahepatic bile duct,0
11671,Office Visits,Astrocytoma of brain,0
11672,Code,embryonal rhabdomyosarcoma of prostate,0
11673,pharmacotherapeutic,Lung Mucinous Cystadenoma,0
11674,leukemia,Hair nevus,0
11675,Therapeutic radiology procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11676,Asians,Acantholytic squamous cell carcinoma,0
11677,cell activation,squamous cell carcinoma of the thyroid gland,0
11678,Tissue Specimen Code,embryonal rhabdomyosarcoma of prostate,0
11679,Moved from,Ovarian germ cell choriocarcinoma stage IV,0
11680,Gestational,Childhood Cerebellar Neoplasm,0
11681,Neuroendocrine Tumors,Bladder adenocarcinoma stage IV,0
11682,Deficiency of sulfatase,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11683,Symptoms aspect,Spermatocytic seminoma,0
11684,Second Suffix,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11685,Upper,Refractory Barrett Esophagus,0
11686,dendritic spine neck,Precursor B-lymphoblastic lymphoma stage II,0
11687,Result,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11688,Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11689,Ectodermal,Female Breast Carcinoma,0
11690,Place,Carcinomatosis of peritoneal cavity,0
11691,Endoscopy of stomach,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11692,Snake bite (morphologic abnormality),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11693,Immunoglobulin M,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11694,Specimen Source Codes - Lesion,Periosteal Osteosarcoma,0
11695,Two,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11696,Malignant - descriptor,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11697,Manufactured form,Airway Hemangioma,0
11698,Pancreas,Tubal Hyperplasia,0
11699,Treatment Epoch,Pancreatic carcinoma,0
11700,Divide,Angiosarcoma of liver,0
11701,Antineoplastic Agents,Pancreatic carcinoma,0
11702,Gland,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11703,Term Birth,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11704,Negative Finding,Airway Hemangioma,0
11705,biopsy characteristics,Stage IV Colorectal Cancer AJCC v8,0
11706,Symptoms aspect,Bladder adenocarcinoma stage IV,0
11707,Classification of information,Lipoma of small intestine,0
11708,Slow Growing,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11709,Contain (action),Airway Hemangioma,0
11710,Completely Able,Localized Ewing Sarcoma,0
11711,Active,Vaginal Adenoid Cystic Carcinoma,0
11712,Mathematical Factor,Neonatal leukemia,0
11713,Inflammatory cell,Refractory Ependymoma,0
11714,Multiple Myeloma,gliosarcoma,0
11715,Occurrence Indicator,Benign Anal Granular Cell Tumor,0
11716,Nose,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11717,Beginning,Metastatic Kidney Carcinoma,0
11718,Antibodies,Type II Endometrial Adenocarcinoma,0
11719,Abdominal Cavity,Digestive System Hodgkin Lymphoma,0
11720,Tumor cells,Refractory Barrett Esophagus,0
11721,Scientist,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11722,Rare,Engraftment syndrome,0
11723,macrophage,Hodgkin Disease,0
11724,Frequently,Tongue Alveolar Soft Part Sarcoma,0
11725,Financial Account,Testicular cancer metastatic,0
11726,2+ Score,Xeroderma pigmentosum,0
11727,include - SetOperator,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11728,Nevus,Brain Ependymoma,0
11729,Firstly,Type II Endometrial Adenocarcinoma,0
11730,Diagnosis,Stage IV Childhood Non-Hodgkin Lymphoma,0
11731,Loss of appetite (finding),Liver Lymphangioma,0
11732,Location of Pharyngeal Residue Following Swallowing,Collecting Duct Carcinoma of the Kidney,0
11733,Group A (qualifier value),Neoplasms,0
11734,Tumor Mass,Localized Ewing Sarcoma,0
11735,Separate,Melanomatosis,0
11736,Cell Count,Blood Vessel Tumors,0
11737,Tumor grade G3,Breast Ductal Adenoma,0
11738,Family,Locally Advanced Soft Tissue Sarcoma,0
11739,Often - answer to question,Astrocytoma of brain,0
11740,Diagnosis,Malignant neoplasm of gallbladder,0
11741,Night sweats,Xeroderma pigmentosum,0
11742,potential,Bladder squamous cell carcinoma stage I,0
11743,Mass of body structure,Splenic Manifestation of Hairy Cell Leukemia,0
11744,Most,Benign neoplasm of thorax,0
11745,Surgery specialty,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
11746,Mesenchymal Stem Cells,Splenic Manifestation of Hairy Cell Leukemia,0
11747,Lead,Nasal cavity carcinoma,0
11748,General surgery specialty,Digestive System Hodgkin Lymphoma,0
11749,estrogen receptor alpha,Adult Hepatocellular Carcinoma,0
11750,Relationships,Colorectal Neuroendocrine Tumor G2,0
11751,therapeutic aspects,Intraepithelial Melanocytic Hyperplasia,0
11752,Togo,Vaginal Adenoid Cystic Carcinoma,0
11753,Feet,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11754,84,Cerebral Primitive Neuroectodermal Tumor,0
11755,Present,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11756,Agenesis of corpus callosum,Secondary malignant neoplasm of lymph node,0
11757,Primary malignant neoplasm,Childhood Fibrillary Astrocytoma,0
11758,Divide,Vaginal Adenoma,0
11759,Science of Etiology,Benign neoplasm of eye,0
11760,pharmacotherapeutic,Acantholytic squamous cell carcinoma,0
11761,Occurrence,Refractory Barrett Esophagus,0
11762,Woman,Malignant melanoma of eyelid,0
11763,Birth,Refractory Barrett Esophagus,0
11764,Abdomen,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11765,Exist,Metastatic Kidney Carcinoma,0
11766,Area,Chest Wall Fibromatosis,0
11767,3+ Score,Malignant melanoma of eyelid,0
11768,Poor - qualifier,Brain Tumor,0
11769,Manufactured form,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11770,Symptoms,Pleomorphic adenoma of parotid gland,0
11771,Malignant neoplasm of endometrium,Cervical Squamous Intraepithelial Neoplasia,0
11772,Short Value,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11773,failed,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11774,Pathway (interactions),Ovarian Dermoid Cyst with Secondary Carcinoma,0
11775,Adenocarcinoma,Recurrent Testicular Lymphoma,0
11776,Widening,Recurrent Testicular Lymphoma,0
11777,Childhood Neuroblastoma,Pleomorphic adenoma of parotid gland,0
11778,Common (qualifier value),Hereditary Diffuse Gastric Adenocarcinoma,0
11779,Nervous system structure,Childhood Anaplastic Large Cell Lymphoma,0
11780,59,Bladder Neuroendocrine Neoplasm,0
11781,Line Unit of Length,Human Papillomavirus-Related Carcinoma,0
11782,Representation (action),Germinoma,0
11783,General surgery specialty,Vaginal Adenoma,0
11784,shared attribute,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11785,physiological aspects,clear cell adenocarcinoma of gallbladder,0
11786,Overgrowth,Benign Apocrine Neoplasm,0
11787,Carcinoma of bladder,Benign Apocrine Neoplasm,0
11788,primary tumor,Cancer of Urinary Tract,0
11789,General surgery specialty,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11790,FAT1 wt Allele,Small cell neuroendocrine carcinoma of bladder,0
11791,Distant,Familial Hemophagocytic Lymphocytosis,0
11792,New,Recurrent Uveal Melanoma,0
11793,Occurrence,Engraftment syndrome,0
11794,Fibrosis,Splenic Manifestation of Hairy Cell Leukemia,0
11795,Secondary Neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11796,Smell Perception,Nasal cavity carcinoma,0
11797,Early,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11798,PREVENT (product),Acantholytic squamous cell carcinoma,0
11799,Physical findings,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11800,Cutaneous Melanoma,Refractory Barrett Esophagus,0
11801,Antibodies,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11802,Waldeyer's ring,Undifferentiated Endocervical Sarcoma,0
11803,Malignant - descriptor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11804,Adult Germ Cell Tumor,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11805,Type - attribute,Choroid Necrotic Melanoma,0
11806,Genes,Neonatal leukemia,0
11807,Slight (qualifier value),Acute Undifferentiated Leukemia,0
11808,Primary,Thyroid Hurthle Cell Carcinoma,0
11809,Malignant Neoplasms,FIGO Stage II Ovarian Cancer,0
11810,Female Reproductive System,Lipoma of small intestine,0
11811,Tumor grade G3,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
11812,types of infections,Refractory Ependymoma,0
11813,Room of building - Study,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11814,Apply (administration method),Bladder adenocarcinoma stage IV,0
11815,Extrinsic,Tubal Hyperplasia,0
11816,Death NOS,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11817,Lacrimal gland structure,Acute Undifferentiated Leukemia,0
11818,Certain (qualifier value),Kaposi's sarcoma of skin,0
11819,Tryptophanase,Cervical Fibroepithelial Polyp,0
11820,Records,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11821,controversy,ROSE Cluster 3,0
11822,Including (qualifier),Thymic Clear Cell Carcinoma,0
11823,Microcyst,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11824,Mathematical Operator,Tonsillar Carcinoma,0
11825,Immature Platelet,Occult Lung Adenosquamous Carcinoma,0
11826,Diagnostic Neoplasm Staging,Type II Endometrial Adenocarcinoma,0
11827,Case (situation),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11828,General surgery specialty,Intraepithelial Melanocytic Hyperplasia,0
11829,Death (finding),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11830,Immune system,Intestinal Metaplasia of Bladder Urothelium,0
11831,Ovulation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11832,Type A,embryonal rhabdomyosarcoma of prostate,0
11833,Cure (remedy),Chondrosarcoma,0
11834,Multifocal,Spongiotic dermatitis,0
11835,Skin Specimen,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
11836,Role,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11837,Logical Condition,Undifferentiated Endocervical Sarcoma,0
11838,Immune System Finding,Pilocytic astrocytoma of cerebellum,0
11839,Prior Medication Usage,Locally Advanced Epithelioid Hemangioendothelioma,0
11840,Malignant Neoplasms,Metastatic Lung Neuroendocrine Neoplasm,0
11841,Negation,Ovarian germ cell choriocarcinoma stage IV,0
11842,contextual factors,Refractory Bladder Carcinoma,0
11843,Qualitative form,Stage II Carcinoma of Penis,0
11844,Circulating Tumor Cell Count,Mixed parotid tumor,0
11845,Bruising,Recurrent Uveal Melanoma,0
11846,Ovarian Carcinoma,Female Breast Carcinoma,0
11847,Alcohol consumption,Cerebral hemangioma,0
11848,Spreading (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
11849,Cauda Equina,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11850,Complication Aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11851,Fatigue,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11852,Sometimes,Advanced Uterine Corpus Carcinosarcoma,0
11853,Tumor type,Childhood Fibrillary Astrocytoma,0
11854,Together,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11855,Live - Specimen Condition,Cervical Fibroepithelial Polyp,0
11856,Smear - instruction imperative,Stage III Cutaneous Melanoma AJCC v6,0
11857,Specimen Source Codes - tumor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11858,98,Peripheral primitive neuroectodermal tumor of soft tissue,0
11859,One,Trabecular adenocarcinoma,0
11860,Spreading (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
11861,Epidemiology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11862,What subject filter - Result,Gallbladder Adenocarcinoma,0
11863,Manufactured form,Adenocarcinoma,0
11864,A Codes,Childhood Fibrillary Astrocytoma,0
11865,Gram per Deciliter,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11866,Excision,Digestive System Hodgkin Lymphoma,0
11867,Pleural Effusion,Non-Metastatic Gestational Trophoblastic Tumor,0
11868,Auditory pitch,Carcinoma,0
11869,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
11870,Decision,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11871,chance,Precursor B-lymphoblastic lymphoma stage II,0
11872,Male population group,Refractory Barrett Esophagus,0
11873,Stratified squamous epithelium,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11874,Young,adenosquamous carcinoma of breast,0
11875,Blood Products Laboratory Testing,Unfavorable Non-Hodgkin Lymphoma,0
11876,Swollen Lymph Node,Recurrent Testicular Lymphoma,0
11877,Often - answer to question,Choroid Necrotic Melanoma,0
11878,Analysis,Uterine Cancer,0
11879,Variety (taxon),Unicystic ameloblastoma,0
11880,Sacrifice,Refractory Ependymoma,0
11881,Progestins,Cervical Adenomyoma,0
11882,Usual,Hemangioma,0
11883,TP53 wt Allele,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11884,Biopsy,Melanomatosis,0
11885,One,Localized Ewing Sarcoma,0
11886,Symptoms,Chest Wall Fibromatosis,0
11887,Bone Marrow,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
11888,Immunoglobulin complex location,Locally Advanced Epithelioid Hemangioendothelioma,0
11889,Environment,Squamous cell carcinoma of lip,0
11890,Aggressive malignancies,Malignant neoplasm of subglottis,0
11891,Partial,Placental aromatase deficiency,0
11892,Definitely Related to Intervention,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11893,therapeutic aspects,Giant cell angiofibroma,0
11894,3+ Answer to Question,sarcoma of spinal cord,0
11895,Benign,Breast Ductal Adenoma,0
11896,Subject Risk,Bladder adenocarcinoma stage IV,0
11897,various other nasal preparations in ATC,Trabecular adenocarcinoma,0
11898,Age,Childhood Central Nervous System Ganglioneuroblastoma,0
11899,Blood Vessel,Testicular cancer metastatic,0
11900,Genetic syndrome,Ovarian germ cell choriocarcinoma stage IV,0
11901,United States,Acantholytic squamous cell carcinoma,0
11902,aromatase activity,Ovarian germ cell choriocarcinoma stage IV,0
11903,Superkingdom (taxonomic category),Metastatic Neoplasm to the Gallbladder,0
11904,contact exposure to arsenic (history),Unfavorable Non-Hodgkin Lymphoma,0
11905,Location of Oral Residue Following Swallowing,Tonsillar Carcinoma,0
11906,Certainties,Acute Undifferentiated Leukemia,0
11907,Qualitative form,Small Intestinal Villous Adenoma,0
11908,Diagnostic Imaging,Engraftment syndrome,0
11909,Old age,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11910,include - SetOperator,Stage I Colon Neuroendocrine Tumor AJCC v8,0
11911,Increased,Adult Hepatocellular Carcinoma,0
11912,eTMF Content Model Code,Localized Ewing Sarcoma,0
11913,Decreasing,Peripheral primitive neuroectodermal tumor of soft tissue,0
11914,Frequently,Metaplastic carcinoma of breast,0
11915,Operative Surgical Procedures,Recurrent Testicular Lymphoma,0
11916,Angiomatous,Thymic Clear Cell Carcinoma,0
11917,Talpidae,Lipoma of small intestine,0
11918,Carcinoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11919,Togo,Benign squamous cell tumor,0
11920,Enhance (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11921,Cells,Localized Ewing Sarcoma,0
11922,Lymphoproliferation,Medulloblastoma,0
11923,Liver and Intrahepatic Biliary Tract Carcinoma,Cystadenocarcinoma,0
11924,Malignant - descriptor,Neoplasms,0
11925,chronic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11926,Anatomic Site,Anterior Urethral Malignant Neoplasm,0
11927,Formation,Uterine Cancer,0
11928,Aggressive course,Refractory Barrett Esophagus,0
11929,Blood Vessel,Cerebral Primitive Neuroectodermal Tumor,0
11930,foreign,Hodgkin lymphoma,0
11931,Destruction (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11932,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11933,Body tissue,Tongue Alveolar Soft Part Sarcoma,0
11934,Procedure (set of actions),Multiple Endocrine Neoplasia,0
11935,per year,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11936,Cystic duct structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11937,Pediculus humanus capitis (eukaryote),Adenocarcinoma,0
11938,Body tissue,Angiosarcoma of liver,0
11939,Australia,Digestive System Hodgkin Lymphoma,0
11940,Bone pain,Low Grade Squamous Intraepithelial Neoplasia,0
11941,Left,Non-Metastatic Gestational Trophoblastic Tumor,0
11942,Obese build,Cerebral Primitive Neuroectodermal Tumor,0
11943,Point Name,Pilocytic astrocytoma of cerebellum,0
11944,Drop British,de novo Myelodysplastic Syndrome,0
11945,Varicella Virus Vaccine Live (Oka-Merck) strain,Bladder adenocarcinoma stage IV,0
11946,Carcinoma in Situ,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
11947,Data Compression,Cancer of Urinary Tract,0
11948,Follow-up status,Benign Apocrine Neoplasm,0
11949,Exhibits as Topic,Choroid Necrotic Melanoma,0
11950,FAT1 wt Allele,Choroid Necrotic Melanoma,0
11951,Often - answer to question,Malignant Testicular Sertoli Cell Tumor,0
11952,Cell secretion,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11953,Web Site,Colorectal High Grade B-Cell Lymphoma,0
11954,Disease,Astrocytoma of brain,0
11955,Cough Frequency,Recurrent Uveal Melanoma,0
11956,Vomiting,Vaginal Adenoma,0
11957,Palatine Tonsil,squamous cell carcinoma of the thyroid gland,0
11958,research subject screening,Acute Undifferentiated Leukemia,0
11959,Enlarged,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11960,Chemotherapy,Carcinoma of urinary bladder,0
11961,Increase,Mucinous adenocarcinoma gastric,0
11962,Malignant neoplasm of lung,Metaplastic carcinoma of breast,0
11963,In Blood,Cystadenocarcinoma,0
11964,Aggressive behavior,Pancreatic Intraepithelial Neoplasia-3,0
11965,radiotherapeutic,Heavy Chain Deposition Disease,0
11966,Health,Melanomatosis,0
11967,Brain,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11968,Often - answer to question,Pancreatic carcinoma,0
11969,Diagnosis Study,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
11970,Bruising,Unicystic ameloblastoma,0
11971,Categories,FIGO Stage II Ovarian Cancer,0
11972,Add - instruction imperative,Chronic Myelomonocytic Leukemia-2,0
11973,seconds,clear cell adenocarcinoma of gallbladder,0
11974,Treating,Recurrent Testicular Lymphoma,0
11975,China,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11976,Well,Extracranial Neuroblastoma,0
11977,Oral,Anterior Urethral Malignant Neoplasm,0
11978,treatment - ActInformationManagementReason,Benign Carotid Body Paraganglioma,0
11979,65+,Small cell neuroendocrine carcinoma of bladder,0
11980,Parenchyma,Keratoderma,0
11981,intent,Choroid Necrotic Melanoma,0
11982,Radiating to,Refractory Bladder Carcinoma,0
11983,Decision,Mucosal Melanoma,0
11984,HLA Class II Histocompatibility Antigen Gamma Chain,Malignant neoplasm of choroid,0
11985,Infrequent,Acantholytic squamous cell carcinoma,0
11986,Organ,Malignant melanoma of eyelid,0
11987,True primary (qualifier value),Pleomorphic adenoma of parotid gland,0
11988,Chronic myeloproliferative disorder,Fibroadenoma of breast,0
11989,PSA Level Less than Five,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11990,Condition:Find:Pt:^Patient:Nom,Endometrial Small Cell Carcinoma,0
11991,Therapy Object (animal model),Adenocarcinoma,0
11992,Approved,Cervical Squamous Intraepithelial Neoplasia,0
11993,Most,Carcinomatosis of peritoneal cavity,0
11994,Hematopoietic stem cells,Benign Apocrine Neoplasm,0
11995,Division (surgical procedure),Cervical Squamous Intraepithelial Neoplasia,0
11996,Classical Hodgkin's Lymphoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11997,Ibrutinib,Peripheral primitive neuroectodermal tumor of soft tissue,0
11998,Persons,Benign Anal Granular Cell Tumor,0
11999,Stomach structure,Cervical Fibroepithelial Polyp,0
12000,Hemangioma,Pancreatic Intraepithelial Neoplasia-3,0
12001,Type - attribute,Rhabdomyosarcoma with ganglionic differentiation,0
12002,Percent normal,Adult Acute Eosinophilic Leukemia,0
12003,Foreskin of penis,Grade 3a Malignant Neoplasm,0
12004,Changed status,Clonal Hematopoiesis of Indeterminate Potential,0
12005,Evaluation procedure,Digestive System Hodgkin Lymphoma,0
12006,Contain (action),Unfavorable Non-Hodgkin Lymphoma,0
12007,Woman,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12008,Frequently,Low Grade Squamous Intraepithelial Neoplasia,0
12009,Two,Stage III Adult Immunoblastic Lymphoma,0
12010,Bilateral complete salpingectomy,Refractory Barrett Esophagus,0
12011,Mandible,adenoid cystic carcinoma of lung,0
12012,treatment - ActInformationManagementReason,Secondary malignant neoplasm of lymph node,0
12013,combination - answer to question,Recurrent Uveal Melanoma,0
12014,Diagnostic Imaging,Pilocytic astrocytoma of cerebellum,0
12015,Thrombocythemia,Cherubism,0
12016,Group A (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
12017,Active License,Primary Cutaneous Plasmablastic Lymphoma,0
12018,Leading,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12019,Blood Platelets,Liver Cavernous Hemangioma,0
12020,Feature,Malignant melanoma of eyelid,0
12021,High,Heavy Chain Deposition Disease,0
12022,Moved to,Localized Askin Tumor,0
12023,Color,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12024,Anterior mediastinum,Malignant melanoma of eyelid,0
12025,include - SetOperator,BRCA2 Syndrome,0
12026,Veins,Tonsillar Carcinoma,0
12027,Histology,Adult Alveolar Soft Part Sarcoma,0
12028,1+,Gallbladder Adenocarcinoma,0
12029,Standard (document),Childhood Central Nervous System Ganglioneuroblastoma,0
12030,64,Recurrent Rhabdomyosarcoma,0
12031,2+,Blepharal carcinoma,0
12032,More,Female Breast Carcinoma,0
12033,Persons,BRCA2 Syndrome,0
12034,Area,gliosarcoma,0
12035,Type A,Spermatocytic seminoma,0
12036,Statistical Significance,Astrocytoma of brain,0
12037,Offspring,Kaposi's sarcoma of extrahepatic bile duct,0
12038,various other nasal preparations in ATC,Benign Anal Granular Cell Tumor,0
12039,Extreme,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12040,Sustained,Xeroderma pigmentosum,0
12041,Pediculus humanus capitis (eukaryote),Thyroid Hurthle Cell Carcinoma,0
12042,Medical Imaging,Refractory Ependymoma,0
12043,DNA,Metaplastic carcinoma of breast,0
12044,patient is female,Multiple Endocrine Neoplasia,0
12045,therapeutic aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
12046,Usually,Malignant melanoma of eyelid,0
12047,Ovarian Carcinoma,Lung squamous cell carcinoma stage I,0
12048,Feature,Hereditary Diffuse Gastric Adenocarcinoma,0
12049,Down Syndrome,Liver Lymphangioma,0
12050,Primary malignant neoplasm,Cerebral Primitive Neuroectodermal Tumor,0
12051,Rare,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12052,Distention of blood vessel,Choroid Epithelioid Cell Melanoma,0
12053,BRCA2 gene,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12054,pharmacotherapeutic,High Grade Glandular Intraepithelial Neoplasia,0
12055,Family (taxonomic),Spermatocytic seminoma,0
12056,Stem cell transplant,Mucinous adenocarcinoma,0
12057,Infrequent,Childhood Anaplastic Large Cell Lymphoma,0
12058,Bloating,Pancreatic carcinoma,0
12059,Infrequent,Mucinous adenocarcinoma gastric,0
12060,Dietary Arsenic,Childhood Central Nervous System Ganglioneuroblastoma,0
12061,Common Specifications in HL7 V3 Publishing,Vaginal Adenoid Cystic Carcinoma,0
12062,Fever,Bladder adenocarcinoma stage IV,0
12063,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
12064,Primary malignant neoplasm,Adult Anaplastic Oligodendroglioma,0
12065,Transformation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12066,Hematuria,Chronic Myelomonocytic Leukemia-2,0
12067,Result,Xeroderma pigmentosum,0
12068,Pentaerythritol Tetranitrate,Gallbladder Adenocarcinoma,0
12069,Surgical aspects,Peripheral primitive neuroectodermal tumor of soft tissue,0
12070,Case unit dose,Spindle Cell Melanoma,0
12071,Act Mood - intent,Transitional cell carcinoma,0
12072,Including (qualifier),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12073,IPSS Risk Category High,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12074,per day,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12075,Togo,Recurrent Testicular Lymphoma,0
12076,Dorsal,Acute lymphadenitis,0
12077,Death (finding),Gallbladder Adenocarcinoma,0
12078,Widening,Mastocytosis,0
12079,Geographic Locations,Cervical Squamous Intraepithelial Neoplasia,0
12080,Methods,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12081,Malignant Neoplasms,Chronic Myelomonocytic Leukemia-2,0
12082,diagnosis aspect,Vaginal Adenoid Cystic Carcinoma,0
12083,Left,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
12084,Pale color saturation,Uterine Cancer,0
12085,Survival Rate,Epithelioid Sarcoma NCI Grade 3,0
12086,Mother (person),Metastatic Carcinoma in the Lung,0
12087,treatment - ActInformationManagementReason,Vaginal Adenoma,0
12088,Taken,Stage 0 Lip Carcinoma,0
12089,Group Object,Stage IV Childhood Non-Hodgkin Lymphoma,0
12090,Anorectal,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12091,Neoplastic disease,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12092,Occurrence,Localized Askin Tumor,0
12093,Macrophage Activation Syndrome,Malignant Testicular Sertoli Cell Tumor,0
12094,Area,Periosteal Osteosarcoma,0
12095,Person Observer,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12096,Formation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12097,Dyspareunia,Testicular cancer metastatic,0
12098,Inflammatory Breast Carcinoma,Metaplastic carcinoma of breast,0
12099,Several,Cervical Fibroepithelial Polyp,0
12100,Infantile Colic,Kaposi's sarcoma of extrahepatic bile duct,0
12101,bony process,Diffuse malignant mesothelioma,0
12102,Unit of radiation dose,High Grade Glandular Intraepithelial Neoplasia,0
12103,Endocervical epithelium,Anaplastic large cell lymphoma,0
12104,Burkina Faso,FIGO Stage II Ovarian Cancer,0
12105,Dento-alveolar joint,Undifferentiated Endocervical Sarcoma,0
12106,Obese build,Ovarian germ cell choriocarcinoma stage IV,0
12107,Smaller,Pleomorphic adenoma of parotid gland,0
12108,Similarity,Female Breast Carcinoma,0
12109,Type - attribute,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12110,Better,Unicystic ameloblastoma,0
12111,Term Birth,Mucinous cystadenofibroma,0
12112,One,Colorectal High Grade B-Cell Lymphoma,0
12113,Well,Cervical Squamous Intraepithelial Neoplasia,0
12114,83,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12115,Egg of order Phthiraptera,Low Grade Squamous Intraepithelial Neoplasia,0
12116,Diabetes Mellitus,Nasal cavity carcinoma,0
12117,treatment - ActInformationManagementReason,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12118,Mathematical Operator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12119,Most,Stage III Adult Immunoblastic Lymphoma,0
12120,Approximate,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12121,Cholangiocarcinoma,Endometrial Small Cell Carcinoma,0
12122,Probability,Bladder adenocarcinoma stage IV,0
12123,Referral placed,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12124,Genes,Thymoma malignant recurrent,0
12125,Type - attribute,Benign Apocrine Neoplasm,0
12126,Squamous cell carcinoma,Unresectable Rhabdomyosarcoma,0
12127,PSA Level Greater than Fifty,Congenital hamartoma,0
12128,Classification,Unresectable Rhabdomyosarcoma,0
12129,Plasma,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12130,Clavien-Dindo Grade III,Refractory Bladder Carcinoma,0
12131,Common (qualifier value),Adult Alveolar Soft Part Sarcoma,0
12132,pharmacotherapeutic,Uterine Cancer,0
12133,Daily Living,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12134,Form:Finding:Point in time:{Setting}:Document:{Role},Cervical Squamous Intraepithelial Neoplasia,0
12135,morphological,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
12136,Proteins,Placental aromatase deficiency,0
12137,Malignant Childhood Neoplasm,ROSE Cluster 3,0
12138,Tumor stage,Localized Malignant Neoplasm,0
12139,Problems - What subject filter,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
12140,Tissue Specimen Code,Childhood Thyroid Gland Follicular Carcinoma,0
12141,Disease Management,Childhood Anaplastic Large Cell Lymphoma,0
12142,Code,Stage IB Pancreatic Cancer AJCC v8,0
12143,Togo,ROSE Cluster 3,0
12144,Type A,Recurrent Uveal Melanoma,0
12145,Due to,Nasal cavity carcinoma,0
12146,Chemotherapy,Benign Apocrine Neoplasm,0
12147,PSA Level Greater than Fifty,Chest Wall Fibromatosis,0
12148,Malignant tumor of colon,Refractory Barrett Esophagus,0
12149,Malignant Neoplasms,Advanced Uterine Corpus Carcinosarcoma,0
12150,SMG1 wt Allele,Tubal Hyperplasia,0
12151,shared attribute,Intraepithelial Melanocytic Hyperplasia,0
12152,MYOT gene,Occult Lung Adenosquamous Carcinoma,0
12153,Acute monocytic leukemia,Adenocarcinoma,0
12154,Endocrine Cells,Childhood Lymphoma,0
12155,Often - answer to question,Adult Acute Eosinophilic Leukemia,0
12156,Coding,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12157,Occurrence Indicator,Gallbladder Adenocarcinoma,0
12158,Compleat Liquid Nutrition,malignant lymphoma of pancreatic lymph nodes,0
12159,Throat,Gallbladder Adenocarcinoma,0
12160,chronic,Benign Apocrine Neoplasm,0
12161,Simpson Grade 3,Mucinous adenocarcinoma gastric,0
12162,Common Specifications in HL7 V3 Publishing,Stage IV Penile Cancer AJCC v7,0
12163,Hormonal,Vaginal Adenoma,0
12164,How Much Distress Sweats,Type II Endometrial Adenocarcinoma,0
12165,Burkina Faso,Hereditary Diffuse Gastric Adenocarcinoma,0
12166,Person 1,Engraftment syndrome,0
12167,Dependent - ability,Cervical Squamous Intraepithelial Neoplasia,0
12168,Minor salivary gland structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12169,Intrinsic origin,Intraepithelial Melanocytic Hyperplasia,0
12170,Account number:Identifier:Point in time:^Patient:Nominal,adenosquamous carcinoma of breast,0
12171,Universities,Human Papillomavirus-Related Carcinoma,0
12172,Case unit dose,Malignant melanoma of eyelid,0
12173,Basis - conceptual entity,Stage IB Pancreatic Cancer AJCC v8,0
12174,Qualitative form,sarcoma of spinal cord,0
12175,United States,ROSE Cluster 3,0
12176,Cerebellum,Breast Ductal Adenoma,0
12177,Two,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12178,Abnormal Reference Range,Childhood Central Nervous System Ganglioneuroblastoma,0
12179,Biological Response Modifiers,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12180,Constant (qualifier),Colorectal High Grade B-Cell Lymphoma,0
12181,Non-Small Cell Lung Carcinoma,Atypical Lobular Breast Hyperplasia,0
12182,Progress,Adult Alveolar Soft Part Sarcoma,0
12183,apply - action,Malignant Neoplasm with Regional Lymph Node Involvement,0
12184,Filter - medical device,Astrocytoma of brain,0
12185,Mechanism (attribute),Nasal cavity carcinoma,0
12186,Malignant neoplasm of soft tissue,Stage IV Childhood Non-Hodgkin Lymphoma,0
12187,Probability,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12188,Africa,Mucinous adenocarcinoma gastric,0
12189,Component object,Cartilaginous exostosis,0
12190,Half,Squamous cell carcinoma of lip,0
12191,Manufactured sign,Spongiotic dermatitis,0
12192,Five,Digestive System Hodgkin Lymphoma,0
12193,Eating,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12194,Retinoic Acid Response Element,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12195,Case unit dose,clear cell adenocarcinoma of gallbladder,0
12196,Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions,Intestinal Metaplasia of Bladder Urothelium,0
12197,Structure of spermatogenic epithelium,clear cell adenocarcinoma of gallbladder,0
12198,immunoglobulin activity,Giant cell angiofibroma,0
12199,Broken skin,Refractory WHO Grade III Glioma,0
12200,Alphabet,Engraftment syndrome,0
12201,Immune System Processes,Refractory Ependymoma,0
12202,Moll's gland cyst,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12203,Melanoma Pathway,Pancreatic Intraepithelial Neoplasia-3,0
12204,Lung,Malignant Neoplasm with Regional Lymph Node Involvement,0
12205,Immature Lymphocytes Measurement,Tonsillar Carcinoma,0
12206,biopsy characteristics,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12207,Leg,clear cell adenocarcinoma of gallbladder,0
12208,white blood cell type,FIGO Stage II Ovarian Cancer,0
12209,other medicated shampoos in ATC,Kaposi's sarcoma of skin,0
12210,Most,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12211,Multiple Myeloma,Childhood Thyroid Gland Follicular Carcinoma,0
12212,Southern Europe,Diffuse malignant mesothelioma,0
12213,One,Locally Advanced Carcinoma,0
12214,Pelvic Pain,adenosquamous carcinoma of breast,0
12215,Marketing basis - Transitional,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12216,MOSTLY,Metastatic Ductal Breast Carcinoma,0
12217,Breast Cancer Type 1 Susceptibility Protein Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12218,Primary,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12219,site,mucinous adenocarcinoma of gallbladder,0
12220,Three,Giant cell angiofibroma,0
12221,Covers (device),Platinum-Resistant Lung Small Cell Carcinoma,0
12222,Usual,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12223,Immature,Brain Tumor,0
12224,Have Been Coughing,Squamous cell carcinoma of lip,0
12225,Proton pump inhibitors for peptic ulcer and GORD,Nasal cavity carcinoma,0
12226,Common (qualifier value),Recurrent Uveal Melanoma,0
12227,Smear - instruction imperative,Leptomeningeal sarcoma,0
12228,Appearance,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12229,Agreement,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12230,N not otherwise specified Antibody,Cervical Fibroepithelial Polyp,0
12231,Triggered by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12232,Cell Device,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12233,Main,Medulloblastoma,0
12234,Life Expectancy Less than Five Years,Locally Advanced Soft Tissue Sarcoma,0
12235,Cell (compartment),FIGO Stage IVA Ovarian Cancer,0
12236,Present,Pancreatic Intraepithelial Neoplasia-3,0
12237,Weather,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12238,Neonatal Abstinence Syndrome,FIGO Stage IVA Ovarian Cancer,0
12239,Lymphatic Spread,Stage II Hepatocellular Carcinoma AJCC v8,0
12240,Classical Hodgkin's Lymphoma,Localized Ewing Sarcoma,0
12241,Science of Etiology,Intestinal Metaplasia of Bladder Urothelium,0
12242,Bladder Continence Question,Breast Apocrine Adenoma,0
12243,Major <insect>,Stage III Cutaneous Melanoma AJCC v6,0
12244,Base - General Qualifier,Pancreatic carcinoma,0
12245,Line Unit of Length,Hodgkin Disease,0
12246,ETV5 gene,Breast Ductal Adenoma,0
12247,Tears - SpecimenType,Pilocytic astrocytoma of cerebellum,0
12248,Preoperative,Bladder squamous cell carcinoma stage I,0
12249,Primary malignant neoplasm,Chest Wall Fibromatosis,0
12250,Symptoms aspect,Carcinoma of submandibular gland,0
12251,Removed,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12252,Used by,Blood Vessel Tumors,0
12253,Human Cells,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12254,Diabetes Mellitus,Intracortical osteosarcoma,0
12255,Characteristics,Endometrial Small Cell Carcinoma,0
12256,Clinical Observation,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12257,2+ Score,Locally Advanced Soft Tissue Sarcoma,0
12258,Formed,Astrocytoma of brain,0
12259,Nearly,Pancreatic carcinoma,0
12260,biopsy characteristics,Anaplastic large cell lymphoma,0
12261,Classification,clear cell adenocarcinoma of gallbladder,0
12262,Common Specifications in HL7 V3 Publishing,Refractory Barrett Esophagus,0
12263,Neither Satisfied nor Dissatisfied,Malignant neoplasm of thalamus,0
12264,Carcinoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12265,Beds,Benign Carotid Body Paraganglioma,0
12266,Extrinsic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12267,Alphabet,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12268,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12269,Common (qualifier value),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12270,Congenital ichthyosis,Human Papillomavirus-Related Carcinoma,0
12271,Digital Content Category,Angiosarcoma of liver,0
12272,Tryptophanase,Maxillary Sinus Adenoid Cystic Carcinoma,0
12273,Ovary,Pilocytic astrocytoma of cerebellum,0
12274,Report (document),Childhood Anaplastic Large Cell Lymphoma,0
12275,How Much Distress Shortness of Breath,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12276,Adapt (substance),Mucosal Melanoma,0
12277,Main,Small Intestinal Villous Adenoma,0
12278,Fever symptoms (finding),Mixed parotid tumor,0
12279,cancer immunology,Precursor B-lymphoblastic lymphoma stage II,0
12280,Type - attribute,Vaginal Adenoid Cystic Carcinoma,0
12281,health and disease,Localized Malignant Neoplasm,0
12282,Cancer Etiology,mucinous adenocarcinoma of gallbladder,0
12283,Metastatic Disease Clinical Trial Setting,FIGO Stage IVA Ovarian Cancer,0
12284,Embryonic Development,Low Grade Squamous Intraepithelial Neoplasia,0
12285,Usually,Transitional cell carcinoma,0
12286,70%,Sarcomatoid Renal Cell Carcinoma,0
12287,Bayer Visual Acuity Changes Grade 3,Recurrent Uveal Melanoma,0
12288,contact exposure to arsenic (history),Recurrent Rhabdomyosarcoma,0
12289,family of origin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12290,Highest,Non-Metastatic Gestational Trophoblastic Tumor,0
12291,subscriber - self,Neonatal leukemia,0
12292,transmission process,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12293,shared attribute,Anterior Urethral Malignant Neoplasm,0
12294,Special,Vaginal Adenoid Cystic Carcinoma,0
12295,polyps,Advanced Lung Carcinoma,0
12296,High,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12297,Long-term,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12298,Sex Cord-Stromal Tumor,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
12299,migrated,Lipoma of small intestine,0
12300,CDH1 gene,Mucinous adenocarcinoma gastric,0
12301,How Much Distress Sweats,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12302,second (number),Mucinous adenocarcinoma gastric,0
12303,Covers (device),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12304,Diffuse,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12305,Tobacco smoking behavior,FIGO Stage IVA Ovarian Cancer,0
12306,Derivative,High Grade Glandular Intraepithelial Neoplasia,0
12307,Communicable Diseases,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12308,Age,Squamous cell carcinoma of lip,0
12309,Sometimes,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12310,Call (Instruction),Peripheral primitive neuroectodermal tumor of soft tissue,0
12311,Rate,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
12312,Surgery specialty,Epithelioid Sarcoma NCI Grade 3,0
12313,peripheral blood,Pleomorphic adenoma of parotid gland,0
12314,Unlikely,Mixed parotid tumor,0
12315,Symptoms aspect,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12316,treatment - ActInformationManagementReason,Female Breast Carcinoma,0
12317,Diagnosis,Xeroderma pigmentosum,0
12318,Specimen Source Codes - Tube,Childhood Thyroid Gland Follicular Carcinoma,0
12319,Type - attribute,Maxillary Sinus Adenoid Cystic Carcinoma,0
12320,Common (qualifier value),Clinical Stage I Cutaneous Melanoma AJCC v8,0
12321,Surrounding (qualifier value),Endometrial Small Cell Carcinoma,0
12322,Nursing interventions,Angiosarcoma of liver,0
12323,Class,Atypical Lobular Breast Hyperplasia,0
12324,Eating,Angiosarcoma of liver,0
12325,Cardiac Lead Procedure,Medulloblastoma,0
12326,Including (qualifier),Extra-Adrenal Paraganglioma,0
12327,Most,Leptomeningeal sarcoma,0
12328,Body tissue,Vaginal Adenoid Cystic Carcinoma,0
12329,Mucoepidermoid Carcinoma,Locally Advanced Epithelioid Hemangioendothelioma,0
12330,Neoplasms,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12331,Major <insect>,Heavy Chain Deposition Disease,0
12332,Treating,Stage II Hepatocellular Carcinoma AJCC v8,0
12333,therapeutic aspects,Metastatic Carcinoma in the Lung,0
12334,Delight,Female Breast Carcinoma,0
12335,Fatigue,Childhood Central Nervous System Immature Teratoma,0
12336,Oral region,Ovarian germ cell choriocarcinoma stage IV,0
12337,Reported Term,Unicystic ameloblastoma,0
12338,combination - answer to question,Unfavorable Non-Hodgkin Lymphoma,0
12339,Pharmaceutical Preparations,Thyroid Hurthle Cell Carcinoma,0
12340,To,Mixed astrocytoma-ependymoma,0
12341,Radiological Exposure Device,FIGO Stage IVA Ovarian Cancer,0
12342,Large,Engraftment syndrome,0
12343,Pale color saturation,FIGO Stage II Ovarian Cancer,0
12344,Mechanism Component of Device,Gallbladder Adenocarcinoma,0
12345,Bladder Continence Question,Metaplastic carcinoma of breast,0
12346,Descent,Methotrexate-Associated Hodgkin Lymphoma,0
12347,Both ovaries,Malignant Neoplasm with Regional Lymph Node Involvement,0
12348,Heightened,Acute Undifferentiated Leukemia,0
12349,Resolution,Cervical Fibroepithelial Polyp,0
12350,Secondary Neoplasm,Trichilemmocarcinoma,0
12351,Offspring,ROSE Cluster 3,0
12352,Increased,Diffuse malignant mesothelioma,0
12353,Frequently,Localized Malignant Neoplasm,0
12354,To,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12355,See,Kaposi's sarcoma of extrahepatic bile duct,0
12356,Smaller,Refractory Bladder Carcinoma,0
12357,Treating,Liver Cavernous Hemangioma,0
12358,Skin Erosion,Pancreatic Intraepithelial Neoplasia-3,0
12359,Age of onset of symptoms:Time:Pt:^Patient:Qn,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12360,New,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
12361,Yolk Sac Tumor,FIGO Stage II Ovarian Cancer,0
12362,More,Malignant melanoma of eyelid,0
12363,Merkel cell carcinoma,non-Hodgkin's lymphoma of spleen,0
12364,Qualitative form,Stage II Carcinoma of Penis,0
12365,Include (action),Adenocarcinoma of the prostate metastatic,0
12366,Cell Count,embryonal rhabdomyosarcoma of prostate,0
12367,Diagnostic Imaging,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
12368,seen,Intraepithelial Melanocytic Hyperplasia,0
12369,Invasive Ductal Breast Carcinoma,Recurrent Uveal Melanoma,0
12370,Collections (publication),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12371,High Grade Ovarian Serous Adenocarcinoma,Small Intestinal Villous Adenoma,0
12372,Cerebral hemisphere structure (body structure),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
12373,active (HL7 RoleLink),Recurrent Uveal Melanoma,0
12374,To,Ectomesenchymal Chondromyxoid Tumor,0
12375,ovarian,Placental aromatase deficiency,0
12376,Ethanol,BRCA2 Syndrome,0
12377,Taxonomic,Cartilaginous exostosis,0
12378,Cancer Genus,Locally Advanced Soft Tissue Sarcoma,0
12379,Operative Surgical Procedures,Intestinal Neuroendocrine Carcinoma,0
12380,Occurrence Indicator,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12381,status - In progress,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12382,Rectum,Cerebral hemangioma,0
12383,Favorable,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12384,Mammal liver preparation,Carcinoma,0
12385,include - SetOperator,Childhood Thyroid Gland Follicular Carcinoma,0
12386,Abnormally high,Localized Ewing Sarcoma,0
12387,Treating,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12388,Specimen Source Codes - tumor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12389,Tissue Specimen Code,Engraftment syndrome,0
12390,Color,Pilocytic astrocytoma of cerebellum,0
12391,Tumor cells,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12392,Diagnosis Study,Basal Cell Ameloblastoma,0
12393,Center of town,Unresectable Rhabdomyosarcoma,0
12394,Sequence Data Type,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12395,Smaller,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12396,Body tissue,Locally Advanced Epithelioid Hemangioendothelioma,0
12397,year,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
12398,Phenomenon,Kaposi's sarcoma of extrahepatic bile duct,0
12399,Chronic inflammation,Mucinous cystadenofibroma,0
12400,Specific qualifier value,Deep Leiomyoma,0
12401,Lymphadenopathy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12402,Cancer Genus,Breast Ductal Adenoma,0
12403,other medicated shampoos in ATC,Thymoma malignant recurrent,0
12404,Term Source,Congenital hamartoma,0
12405,Carcinoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12406,Only - dosing instruction fragment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12407,Central,FIGO Stage IVA Ovarian Cancer,0
12408,Cells,non-Hodgkin's lymphoma of spleen,0
12409,Inguinal part of abdomen,Malignant neoplasm of gallbladder,0
12410,Toxic Epidermal Necrolysis,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12411,Adult Lymphoma,Testicular cancer metastatic,0
12412,Epithelial ovarian cancer,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12413,Edema,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12414,Primary malignant neoplasm,Benign Ovarian Thecoma,0
12415,Symptoms aspect,Anaplastic large cell lymphoma,0
12416,Primary malignant neoplasm,Refractory Barrett Esophagus,0
12417,*Type - Kind of quantity,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
12418,Irregular,Choroid Necrotic Melanoma,0
12419,Loss of Appetite question,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
12420,year,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12421,Soft,Cervical Fibroepithelial Polyp,0
12422,CD69 protein,Larynx carcinoma recurrent,0
12423,Neoplasm Metastasis,Unresectable Rhabdomyosarcoma,0
12424,International Classification of Disease for Oncology,Benign Anal Granular Cell Tumor,0
12425,Breast tissue sample,Xeroderma pigmentosum,0
12426,Physical findings,Angiosarcoma of liver,0
12427,Third revision,Benign squamous cell tumor,0
12428,Confirmed by,Larynx carcinoma recurrent,0
12429,Sweat Glands,Astrocytoma of brain,0
12430,In Blood,Adult Alveolar Soft Part Sarcoma,0
12431,Targeted Therapy,Pancreatic Endocrine Carcinoma,0
12432,Catch - Finding of sensory dimension of pain,Bladder Neuroendocrine Neoplasm,0
12433,Fluid behavior,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12434,Primary malignant neoplasm,Lipoma of small intestine,0
12435,Disruptive,Unicystic ameloblastoma,0
12436,Embryo,Funisitis (disorder),0
12437,System - kit,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12438,Type A,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12439,Severe Extremity Pain,Adult Acute Eosinophilic Leukemia,0
12440,Specimen Source Codes - Genital,Recurrent Uveal Melanoma,0
12441,Trial Screening,Advanced Uterine Corpus Carcinosarcoma,0
12442,phosphoethanolamine,Recurrent Testicular Lymphoma,0
12443,mesenchymal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12444,Value Above Reference Range,Malignant melanoma of eyelid,0
12445,1+,Cervical Squamous Intraepithelial Neoplasia,0
12446,Basal cell carcinoma,FIGO Stage II Ovarian Cancer,0
12447,High Mitosis-Karyorrhexis Index,Tubal Hyperplasia,0
12448,3+ Answer to Question,Small intestine carcinoma,0
12449,Rare,Recurrent Primary Lymphoma of Bone,0
12450,lymph nodes,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12451,VARIOUS DRUG CLASSES IN ATC,non-Hodgkin's lymphoma of spleen,0
12452,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Stage II Hepatocellular Carcinoma AJCC v8,0
12453,Intellectual scale,Malignant neoplasm of subglottis,0
12454,Much,Anterior Urethral Malignant Neoplasm,0
12455,Interferes with,Human Papillomavirus-Related Carcinoma,0
12456,Organ,FIGO Stage IVA Ovarian Cancer,0
12457,Prophylactic behavior,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12458,Latin America,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12459,Frequently,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
12460,Historical - ParameterizedDataType,Locally Advanced Carcinoma,0
12461,Cardiovascular system,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12462,Pith - plant part,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
12463,Folded structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12464,Carcinoid Tumor,FIGO Stage IVA Ovarian Cancer,0
12465,Ameloblastoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12466,Ovarian Carcinoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12467,Case (situation),Thymic Atypical Carcinoid Tumor,0
12468,Web Site,gliosarcoma,0
12469,Cells,Stage 0 Penile Cancer AJCC v8,0
12470,Togo,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
12471,Due to,Thyroid Hurthle Cell Carcinoma,0
12472,Upper back structure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12473,Usual,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12474,Fishes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12475,Medical service,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12476,Age Factors,Undifferentiated Endocervical Sarcoma,0
12477,Make - Instruction Imperative,Adenocarcinoma of the prostate metastatic,0
12478,Type A,Nasal cavity carcinoma,0
12479,Togo,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12480,lymph nodes,Childhood Central Nervous System Ganglioneuroblastoma,0
12481,Congenital Abnormality,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12482,Embryonal Rhabdomyosarcoma,Acantholytic squamous cell carcinoma,0
12483,Aggressive course,Recurrent Testicular Lymphoma,0
12484,Confusion,Gallbladder Adenocarcinoma,0
12485,31,Malignant neoplasm of thalamus,0
12486,Including (qualifier),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12487,Bone Pain,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
12488,Version,Nasal cavity carcinoma,0
12489,Referring,Choroid Epithelioid Cell Melanoma,0
12490,Dorsal,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12491,Geographic Locations,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12492,Beginning,Primary Cutaneous Plasmablastic Lymphoma,0
12493,Virus,Stage IB Pancreatic Cancer AJCC v8,0
12494,Occurrence Indicator,Cervical Squamous Intraepithelial Neoplasia,0
12495,To,Cerebral Primitive Neuroectodermal Tumor,0
12496,Physical findings,Stage III Adult Immunoblastic Lymphoma,0
12497,VARIOUS DRUG CLASSES IN ATC,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12498,Human papilloma virus infection,Intraepithelial Melanocytic Hyperplasia,0
12499,Malignant Vaginal Neoplasm,Localized Ewing Sarcoma,0
12500,Image Feature,Diffuse malignant mesothelioma,0
12501,Tryptophanase,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12502,Adult Lymphoma,Acantholytic squamous cell carcinoma,0
12503,Squamous,Human Papillomavirus-Related Carcinoma,0
12504,Symptoms aspect,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12505,Vaginal intraepithelial neoplasia,Maxillary Sinus Adenoid Cystic Carcinoma,0
12506,Before,Mixed astrocytoma-ependymoma,0
12507,Five,Stage III Cutaneous Melanoma AJCC v6,0
12508,Woman,Thymic Clear Cell Carcinoma,0
12509,Manufactured form,Nasal cavity carcinoma,0
12510,Trimethoprim-Sulfamethoxazole Combination,gliosarcoma,0
12511,Nicotiana tabacum,adenoid cystic carcinoma of lung,0
12512,Name,Gallbladder Adenocarcinoma,0
12513,Pharyngeal structure,Refractory Barrett Esophagus,0
12514,XK wt Allele,FIGO Stage II Ovarian Cancer,0
12515,include - SetOperator,Parathyroid Gland Adenocarcinoma,0
12516,Renal Cell Carcinoma,Hereditary corneal dystrophy,0
12517,Time (foundation metadata concept),Recurrent Testicular Lymphoma,0
12518,Removed,Adult Brain Stem Mixed Glioma,0
12519,Fever,Cervical Squamous Intraepithelial Neoplasia,0
12520,Dryness (characteristic),Digestive System Hodgkin Lymphoma,0
12521,Urinary Bladder,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12522,NCI CTEP SDC Astrocytoma,Pancreatic Intraepithelial Neoplasia-3,0
12523,Infertility,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12524,Low Level,Metastatic Ductal Breast Carcinoma,0
12525,1980s,Collecting Duct Carcinoma of the Kidney,0
12526,Ulceration,Uterine Cancer,0
12527,How Much Distress Weight Loss,Refractory Bladder Carcinoma,0
12528,Type - attribute,Secondary malignant neoplasm of lymph node,0
12529,Age,Cervical Fibroepithelial Polyp,0
12530,Fallopian Tubes,Stage II Carcinoma of Penis,0
12531,Singular,Low Grade Squamous Intraepithelial Neoplasia,0
12532,Known,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12533,Associated with,Localized Askin Tumor,0
12534,Usual Severity Shortness of Breath,Acute Undifferentiated Leukemia,0
12535,Tryptophanase,Methotrexate-Associated Hodgkin Lymphoma,0
12536,shared attribute,Cervical Fibroepithelial Polyp,0
12537,Weight decreased,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12538,Initially,Stage II Carcinoma of Penis,0
12539,Partial,Hereditary corneal dystrophy,0
12540,Factor,Type II Endometrial Adenocarcinoma,0
12541,Common (qualifier value),Chronic Myelomonocytic Leukemia-2,0
12542,Back structure,Cerebral Primitive Neuroectodermal Tumor,0
12543,Morbidity - disease rate,Acute Undifferentiated Leukemia,0
12544,Body tissue,Heavy Chain Deposition Disease,0
12545,Have Shortness of Breath question,Benign Anal Granular Cell Tumor,0
12546,Sensation quality,Liver Cavernous Hemangioma,0
12547,Basis - conceptual entity,Vaginal Adenoma,0
12548,brain shape,Colorectal High Grade B-Cell Lymphoma,0
12549,Term (temporal),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12550,Clonality,FIGO Stage IVA Ovarian Cancer,0
12551,Fever,Fibroadenoma of breast,0
12552,Cartilage,adenoid cystic carcinoma of lung,0
12553,Classification,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12554,10%,Larynx carcinoma recurrent,0
12555,Individual,Stage III Adult Immunoblastic Lymphoma,0
12556,Account number:Identifier:Point in time:^Patient:Nominal,Advanced Uterine Corpus Carcinosarcoma,0
12557,Cerebellum,Maxillary Sinus Adenocarcinoma,0
12558,Nevus,Xeroderma pigmentosum,0
12559,member,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12560,Major,Cancer of Urinary Tract,0
12561,Therapeutic radiology procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12562,ovarian,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12563,Malignant Neoplasms,Vaginal Adenoma,0
12564,Treating,Benign Anal Granular Cell Tumor,0
12565,Clinical,Stage I Adult Non-Hodgkin Lymphoma,0
12566,Mathematical Operator,Stage III Cutaneous Melanoma AJCC v6,0
12567,Sex Behavior,Locally Advanced Carcinoma,0
12568,Secondary Neoplasm,Localized Askin Tumor,0
12569,Along edge (qualifier value),Mastocytosis,0
12570,Affecting,Diffuse malignant mesothelioma,0
12571,Examination,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12572,Primary malignant neoplasm,Mucinous cystadenofibroma,0
12573,Urinary Bladder,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12574,Dietary Factors,Cerebral Primitive Neuroectodermal Tumor,0
12575,/40,Germinoma,0
12576,Smear - instruction imperative,Malignant neoplasm of olfactory nerve,0
12577,Cure (remedy),Extra-abdominal fibromatosis,0
12578,Including (qualifier),Contact dermatitis due to alkali,0
12579,Corner Minus,Medulloblastoma,0
12580,Type - attribute,Localized Malignant Neoplasm,0
12581,Body tissue,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12582,Histology Procedure,Xeroderma pigmentosum,0
12583,Appearance,Giant cell angiofibroma,0
12584,Social group,Mucinous adenocarcinoma gastric,0
12585,Reported Term,Testicular cancer metastatic,0
12586,Two,Pilocytic astrocytoma of cerebellum,0
12587,Body Fluids,Cerebral Primitive Neuroectodermal Tumor,0
12588,Special,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12589,Concept model domain,ROSE Cluster 3,0
12590,Structure of Wharton's jelly,Intestinal Neuroendocrine Carcinoma,0
12591,Contain (action),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12592,Point Name,squamous cell carcinoma of the thyroid gland,0
12593,Needs,Refractory Barrett Esophagus,0
12594,Disease,Benign Apocrine Neoplasm,0
12595,Aromatase deficiency,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12596,Very Much,mucinous adenocarcinoma of gallbladder,0
12597,Two,Neonatal leukemia,0
12598,Tobacco use,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12599,site-specific telomere resolvase activity,Female Breast Carcinoma,0
12600,Common Cold,Atypical Lobular Breast Hyperplasia,0
12601,Unmarried,Hereditary Diffuse Gastric Adenocarcinoma,0
12602,Deoxyribonucleic Acid Measurement,Recurrent Uveal Melanoma,0
12603,various antiseptic throat preparations,Lipoma of small intestine,0
12604,Abdominal bloating,Childhood Anaplastic Large Cell Lymphoma,0
12605,Papillomaviridae,Malignant Neoplasm with Regional Lymph Node Involvement,0
12606,Numerous,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12607,Human body structure,Pancreatic carcinoma,0
12608,Consistent with,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12609,Therapeutic procedure,Mucinous adenocarcinoma gastric,0
12610,Abdomen,Type II Endometrial Adenocarcinoma,0
12611,Second Suffix,Refractory Bladder Carcinoma,0
12612,Type 3,embryonal rhabdomyosarcoma of prostate,0
12613,Hematoxylin and eosin stain method,Fibroadenoma of breast,0
12614,Loss of Appetite question,Cancer of Urinary Tract,0
12615,No Application Type,Intraepithelial Melanocytic Hyperplasia,0
12616,1+ Score,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12617,Cells,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
12618,Erythropoietin,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12619,BRCA2 gene,Testicular cancer metastatic,0
12620,Biogenic Amines,Astrocytoma of brain,0
12621,Incidental Findings,Malignant Neoplasm with Regional Lymph Node Involvement,0
12622,oncology field,Kaposi's sarcoma of skin,0
12623,Bone neoplasms,Carcinoma of submandibular gland,0
12624,risk factors,Vaginal Adenoma,0
12625,include - SetOperator,Diffuse malignant mesothelioma,0
12626,Organ,Vaginal Adenoma,0
12627,Therapeutic procedure,Childhood Central Nervous System Ganglioneuroblastoma,0
12628,Breast Carcinoma,Advanced Uterine Corpus Carcinosarcoma,0
12629,Common Specifications in HL7 V3 Publishing,Epithelioid Sarcoma NCI Grade 3,0
12630,Apply,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12631,Reported Term,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12632,Childhood Hodgkin Lymphoma,Xeroderma pigmentosum,0
12633,Ursidae Family,Metastatic Lung Neuroendocrine Neoplasm,0
12634,Growth action,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12635,Treated with,Diffuse malignant mesothelioma,0
12636,Smear - instruction imperative,Colorectal Neuroendocrine Tumor G2,0
12637,Physical assessment findings,Hereditary Diffuse Gastric Adenocarcinoma,0
12638,PSA Level Greater than Fifty,Splenic Manifestation of Hairy Cell Leukemia,0
12639,Including (qualifier),Recurrent Rhabdomyosarcoma,0
12640,IGHV@ gene cluster,Angiosarcoma of liver,0
12641,Individual,Acute Undifferentiated Leukemia,0
12642,use of ultrasonography,Mucinous adenocarcinoma gastric,0
12643,combination of objects,FIGO Stage IVA Ovarian Cancer,0
12644,Shell - Animal skin appendage,Splenic Manifestation of Hairy Cell Leukemia,0
12645,Lesion,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12646,23,Carcinoma,0
12647,Patient Outcome - Died,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12648,Blood,Acute Undifferentiated Leukemia,0
12649,Unknown GENC,Adult Hepatocellular Carcinoma,0
12650,Moved from,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12651,Common (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
12652,Over (spatial),Locally Advanced Carcinoma,0
12653,year,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12654,A Codes,Stage IB Pancreatic Cancer AJCC v8,0
12655,Smoking,Giant cell angiofibroma,0
12656,radioactive iodine,Mixed parotid tumor,0
12657,Cyst,Carcinomatosis of peritoneal cavity,0
12658,Simple,Benign Anal Granular Cell Tumor,0
12659,Asthma Control Test Questionnaire,Breast Ductal Adenoma,0
12660,Occurrence Indicator,Stage III Cutaneous Melanoma AJCC v6,0
12661,Malignant neoplasm of larynx,Cancer of Urinary Tract,0
12662,Five-year Survival Rate,FIGO Stage II Ovarian Cancer,0
12663,Sarcoma - category (morphologic abnormality),Type II Endometrial Adenocarcinoma,0
12664,newly,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12665,Therapeutic radiology procedure,Anterior Urethral Malignant Neoplasm,0
12666,CYREN gene,embryonal rhabdomyosarcoma of prostate,0
12667,Following,Endometrial Small Cell Carcinoma,0
12668,Increase,Thymic Clear Cell Carcinoma,0
12669,Brain Stem,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12670,Aspects of signs,Congenital hamartoma,0
12671,Injury of integument,Angiosarcoma of liver,0
12672,Benign neoplasm of paraganglion,Cancer of Urinary Tract,0
12673,Adult human body,Primary Cutaneous Plasmablastic Lymphoma,0
12674,Pharyngitis,Unresectable Rhabdomyosarcoma,0
12675,Numbers,Adult Acute Eosinophilic Leukemia,0
12676,75,Trabecular adenocarcinoma,0
12677,Mass of body structure,Adult Anaplastic Oligodendroglioma,0
12678,Togo,Cerebral hemangioma,0
12679,Human Cells,Refractory Ependymoma,0
12680,Cover (physical object),Mucinous adenocarcinoma,0
12681,Including (qualifier),Trabecular adenocarcinoma,0
12682,User Group,Thymic Clear Cell Carcinoma,0
12683,Occur (action),Granular Cell Leiomyosarcoma,0
12684,Punctum,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12685,cell growth pattern,Kaposi's sarcoma of skin,0
12686,Absent,Breast Ductal Adenoma,0
12687,Tissue Specimen Code,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12688,curettage specimen,Blepharal carcinoma,0
12689,Improvement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12690,Hemoptysis,Nasal cavity carcinoma,0
12691,Surgical aspects,Brain Ependymoma,0
12692,Enneking Low Surgical Grade,FIGO Stage II Ovarian Cancer,0
12693,Procedure (set of actions),Thymic Clear Cell Carcinoma,0
12694,Spreading (qualifier value),Tongue Alveolar Soft Part Sarcoma,0
12695,Before,Airway Hemangioma,0
12696,Person Name,Brain Tumor,0
12697,Common Specifications in HL7 V3 Publishing,Refractory Bladder Carcinoma,0
12698,Males,Stage III Cutaneous Melanoma AJCC v6,0
12699,Blood Cells,Locally Advanced Epithelioid Hemangioendothelioma,0
12700,Asia,Anterior Urethral Malignant Neoplasm,0
12701,{Setting},Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
12702,Human body,Adult Alveolar Soft Part Sarcoma,0
12703,Malignant neoplasm of skin,Tumorlet,0
12704,Kidney Tubules,Diffuse malignant mesothelioma,0
12705,Fever symptoms (finding),Botryoid-Type Embryonal Rhabdomyosarcoma,0
12706,Neoplasms,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
12707,Consistency,Intestinal Metaplasia of Bladder Urothelium,0
12708,Palmitic Acid,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12709,Known,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12710,Etiology aspects,Localized Ewing Sarcoma,0
12711,Histamine H2 Receptor Antagonists [MoA],Engraftment syndrome,0
12712,Population Group,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12713,Ductal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12714,Provide (product),Lipoma of small intestine,0
12715,Most,Malignant melanoma of eyelid,0
12716,Aspects of signs,Cancer of Urinary Tract,0
12717,40%,Chronic Myelomonocytic Leukemia-2,0
12718,Precision - temporal,Carcinomatosis of peritoneal cavity,0
12719,Process,Ovarian Carcinoid Tumor,0
12720,Seminoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12721,Intestines,Endometrial Small Cell Carcinoma,0
12722,Case (situation),Carcinoma of urinary bladder,0
12723,Very good,Adult Fibrolamellar Carcinoma,0
12724,Medications,Digestive System Hodgkin Lymphoma,0
12725,3+ Score,Endometrial Small Cell Carcinoma,0
12726,Mean Percent of Normal,Cervical Fibroepithelial Polyp,0
12727,Rare,Childhood Fibrillary Astrocytoma,0
12728,How Much Distress Weight Loss,Mucinous adenocarcinoma gastric,0
12729,Covers (device),Grade 3a Malignant Neoplasm,0
12730,Hypothalamic structure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12731,Small cell carcinoma of lung,Benign neoplasm of eye,0
12732,Germ Cells,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12733,Type 3,Gallbladder Adenocarcinoma,0
12734,depend,Papillary squamous cell carcinoma,0
12735,Laser-generated electromagnetic radiation,Leiomyoma of Gallbladder,0
12736,Stomach structure,Childhood Central Nervous System Ganglioneuroblastoma,0
12737,X-Ray Computed Tomography,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12738,Therapeutic radiology procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12739,Asleep,Extra-Adrenal Paraganglioma,0
12740,Disease Screening,Human Papillomavirus-Related Carcinoma,0
12741,Malignant Childhood Neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12742,Classic Histology,Hemangioma,0
12743,Structure of mucous membrane of nose,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12744,Categories,Carcinoma ex pleomorphic adenoma of parotid gland,0
12745,Brain part,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12746,Kidney,Childhood Lymphoma,0
12747,CD5L wt Allele,Angiosarcoma of liver,0
12748,Hereditary,Benign neoplasm of thorax,0
12749,Diagnosis Study,Liver Cavernous Hemangioma,0
12750,Feelings,Digestive System Hodgkin Lymphoma,0
12751,high - ActExposureLevelCode,Vaginal Adenoid Cystic Carcinoma,0
12752,High Grade Astrocytic Tumor,Cerebral hemangioma,0
12753,Melanoma Pathway,embryonal rhabdomyosarcoma of prostate,0
12754,Humoralism,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12755,Index,Locally Advanced Carcinoma,0
12756,Histology Procedure,Thymic Atypical Carcinoid Tumor,0
12757,Include (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12758,Cover (physical object),Colorectal High Grade B-Cell Lymphoma,0
12759,Common Specifications in HL7 V3 Publishing,Thymic Clear Cell Carcinoma,0
12760,Participation Type - origin,Neonatal leukemia,0
12761,Males,Chest Wall Fibromatosis,0
12762,Endothelial Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12763,Tumor type,Congenital hamartoma,0
12764,Type A,Benign Carotid Body Paraganglioma,0
12765,Type A,Intraepithelial Melanocytic Hyperplasia,0
12766,How Much Distress Difficulty Swallowing,Stage I Colon Neuroendocrine Tumor AJCC v8,0
12767,Neuroendocrine Tumors,Multiple Skull Base Meningiomas,0
12768,Benign Neoplasm,Occult Lung Adenosquamous Carcinoma,0
12769,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Airway Hemangioma,0
12770,diagnosis aspect,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12771,Characteristics,malignant lymphoma of pancreatic lymph nodes,0
12772,Type - attribute,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12773,Sufficiently defined concept definition status (core metadata concept),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12774,Due to,Recurrent Testicular Lymphoma,0
12775,Diagnosis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12776,Qualitative form,Splenic Manifestation of Hairy Cell Leukemia,0
12777,Poor - grade value,Stage II Carcinoma of Penis,0
12778,Recurrent fevers,Endometrial Small Cell Carcinoma,0
12779,Common (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
12780,Case unit dose,adenoid cystic carcinoma of lung,0
12781,Treating,Stage III Cutaneous Melanoma AJCC v6,0
12782,Old,Localized Malignant Neoplasm,0
12783,Racial group,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12784,Entity Determiner - specific,Gallbladder adenoma,0
12785,Epithelial cell count (procedure),Ovarian germ cell choriocarcinoma stage IV,0
12786,Cystoscopy,Refractory Bladder Carcinoma,0
12787,various other agents for local oral treatment in ATC,Primary Cutaneous Plasmablastic Lymphoma,0
12788,Performed,Childhood Choriocarcinoma,0
12789,Gastrointestinal tract structure,Recurrent Testicular Lymphoma,0
12790,Divide,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
12791,Diagnosis,Undifferentiated Endocervical Sarcoma,0
12792,Deterioration of status,Anterior Urethral Malignant Neoplasm,0
12793,Death NOS,Recurrent Rhabdomyosarcoma,0
12794,Removal of bladder,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
12795,Metastatic to,Metaplastic carcinoma of breast,0
12796,Transmitted by,embryonal rhabdomyosarcoma of prostate,0
12797,Administration procedure,Melanomatosis,0
12798,Physical findings,Leiomyoma of Gallbladder,0
12799,Worsening pattern,Adenocarcinoma,0
12800,Symptoms aspect,Engraftment syndrome,0
12801,Human papilloma virus infection,Acute Undifferentiated Leukemia,0
12802,Direct Extension,Benign squamous cell tumor,0
12803,Numbers,Multiple Skull Base Meningiomas,0
12804,radiotherapeutic,Thyroid Hurthle Cell Carcinoma,0
12805,Benign Neoplasm,Stage IB Pancreatic Cancer AJCC v8,0
12806,Life Expectancy Less than Ten Years,Blood Vessel Tumors,0
12807,Formation,Hereditary Diffuse Gastric Adenocarcinoma,0
12808,Testing,Pancreatic carcinoma,0
12809,Lower urinary tract,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12810,English Language,Granular Cell Leiomyosarcoma,0
12811,Term Birth,Acantholytic squamous cell carcinoma,0
12812,Extrinsic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12813,Negation,Recurrent Uveal Melanoma,0
12814,per second,Endometrial Small Cell Carcinoma,0
12815,Include (action),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12816,Representation (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12817,Secondary malignant neoplasm of lymph nodes of neck,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12818,Togo,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12819,Precancerous Conditions,Type II Endometrial Adenocarcinoma,0
12820,Primitive,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
12821,Body tissue,adenoid cystic carcinoma of lung,0
12822,Skeletal bone,Recurrent Testicular Lymphoma,0
12823,Plasma Product,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12824,Retinoic Acid Response Element,Uterine Cancer,0
12825,Negation,Carcinoma of urinary bladder,0
12826,Fourth ventricle structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12827,Adult Lymphoma,Prostate Lymphoma,0
12828,In Urine,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12829,Occurrence Indicator,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12830,Pharmaceutical Preparations,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12831,Operation excision,Malignant melanoma of eyelid,0
12832,80%,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12833,Fetal Tissue,Uterine Cancer,0
12834,Physical shape,Metastatic Malignant Neoplasm in the Sellar Region,0
12835,CDISC ADAS-Cog - Commands Summary Score,Vaginal Adenoid Cystic Carcinoma,0
12836,Inspiration function,Type II Endometrial Adenocarcinoma,0
12837,Sometimes,Thyroid Hurthle Cell Carcinoma,0
12838,Forecast of outcome,Peripheral primitive neuroectodermal tumor of soft tissue,0
12839,At risk of disease,Type II Endometrial Adenocarcinoma,0
12840,Thyroid cancer,Kaposi's sarcoma of extrahepatic bile duct,0
12841,Removed,Benign Anal Granular Cell Tumor,0
12842,Affect (mental function),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
12843,Lymphoid Tissue,Malignant melanoma of eyelid,0
12844,Known,Cartilaginous exostosis,0
12845,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Stage III Cutaneous Melanoma AJCC v6,0
12846,Pain NOS,FIGO Stage IVA Ovarian Cancer,0
12847,*Type - Kind of quantity,Breast Apocrine Adenoma,0
12848,Fever,Breast Ductal Adenoma,0
12849,Domain (area of knowledge),Transitional cell carcinoma,0
12850,Secondary Neoplasm,Uterine Cancer,0
12851,2+,Xeroderma pigmentosum,0
12852,How Much Distress Shortness of Breath,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12853,High Risk Acute Leukemia,Microcystic meningioma,0
12854,Weight decreased,Ovarian Carcinoid Tumor,0
12855,Including (qualifier),Epithelioid Sarcoma NCI Grade 3,0
12856,peripheral blood,Ovarian germ cell choriocarcinoma stage IV,0
12857,Surgical aspects,Type II Endometrial Adenocarcinoma,0
12858,Rating (action),Contact dermatitis due to alkali,0
12859,lymph nodes,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12860,High risk,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12861,treatment - ActInformationManagementReason,Cancer of Urinary Tract,0
12862,Fresh Water,Endometrial Small Cell Carcinoma,0
12863,Percent normal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12864,International Classification of Diseases for Oncology,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12865,Type of device,Tubal Hyperplasia,0
12866,Two,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12867,growth aspects,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
12868,Pleomorphism (morphologic abnormality),Refractory Bladder Carcinoma,0
12869,Accumulation,Benign tumor of eyelid,0
12870,Contain (action),Maxillary Sinus Adenocarcinoma,0
12871,Common Specifications in HL7 V3 Publishing,Cervical Fibroepithelial Polyp,0
12872,Overall Publication Type,benign mature teratoma of pancreas,0
12873,Nicotiana,Breast Ductal Adenoma,0
12874,Circulating,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12875,diagnosis aspect,Vaginal Adenoid Cystic Carcinoma,0
12876,Established,Benign Anal Granular Cell Tumor,0
12877,Regular,Giant cell angiofibroma,0
12878,Treatment Epoch,Stage IB Pancreatic Cancer AJCC v8,0
12879,Organ,Airway Hemangioma,0
12880,Infrequent,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12881,Removed,Leiomyoma of Gallbladder,0
12882,Skin lesion,Carcinomatosis of peritoneal cavity,0
12883,Empty (qualifier),Uterine Cancer,0
12884,Array Feature,FIGO Stage IVA Ovarian Cancer,0
12885,Usual Severity Weight Loss,Cervical Adenomyoma,0
12886,Term Birth,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12887,Precision - second,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12888,Diagnosis,Recurrent Primary Lymphoma of Bone,0
12889,Remetinostat,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12890,Keratoderma,Testicular cancer metastatic,0
12891,HLA Complex,Leiomyoma of Gallbladder,0
12892,Reduction procedure,Pancreatic Intraepithelial Neoplasia-3,0
12893,Supernumerary,Digestive System Hodgkin Lymphoma,0
12894,various allergen extracts,Stage I Colon Neuroendocrine Tumor AJCC v8,0
12895,Neoplasms,Malignant melanoma of eyelid,0
12896,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12897,Fatigue,Malignant neoplasm of subglottis,0
12898,Removed,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12899,Trial Screening,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12900,10%,Atypical Mesothelial Hyperplasia,0
12901,Name,Intraepithelial Melanocytic Hyperplasia,0
12902,Occurrence Indicator,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12903,Beginning,Bladder adenocarcinoma stage IV,0
12904,high - ActExposureLevelCode,Neoplasms,0
12905,Pelvis,Recurrent Diffuse Intrinsic Pontine Glioma,0
12906,100%,Mucinous neoplasm,0
12907,Male population group,Malignant Testicular Sertoli Cell Tumor,0
12908,Body tissue,Xeroderma pigmentosum,0
12909,Tissue Specimen Code,Grade 3a Malignant Neoplasm,0
12910,Post Device,Pancreatic Intraepithelial Neoplasia-3,0
12911,Specimen Type - Macrophages,Acantholytic squamous cell carcinoma,0
12912,Merkel cell carcinoma,Recurrent Uveal Melanoma,0
12913,Cell (compartment),Benign Carotid Body Paraganglioma,0
12914,Specialized Stand Alone Plan - Vision,papillary carcinoma of penis,0
12915,Cancer Genus,Diffuse malignant mesothelioma,0
12916,biopsy characteristics,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12917,More,Benign squamous cell tumor,0
12918,Aggressive behavior,Kaposi's sarcoma of extrahepatic bile duct,0
12919,Electromagnetic Radiation,Bladder adenocarcinoma stage IV,0
12920,Subject Risk,Cervical Squamous Intraepithelial Neoplasia,0
12921,Biologic Development,Hodgkin Disease,0
12922,Specimen Source Codes - Respiratory,Leiomyoma of Gallbladder,0
12923,symbol - solid dosage form,Benign squamous cell tumor,0
12924,Manufactured form,Stage IV Colorectal Cancer AJCC v8,0
12925,Malignant - descriptor,Advanced Uterine Corpus Carcinosarcoma,0
12926,Beginning,Intestinal Metaplasia of Bladder Urothelium,0
12927,Surface,Acute Undifferentiated Leukemia,0
12928,How Often Felt Normal question,Thymic Clear Cell Carcinoma,0
12929,Infrequent,Cancer of Urinary Tract,0
12930,Primitive Streak,Mixed astrocytoma-ependymoma,0
12931,pharmacotherapeutic,Parathyroid Gland Adenocarcinoma,0
12932,Hyperviscosity syndrome,Adrenal Rest Tumor,0
12933,Tumor Mass,Acinar cell carcinoma of pancreas,0
12934,Occurrence Indicator,Ichthyosis,0
12935,Disseminated Malignant Neoplasm,Papillary cystic tumor,0
12936,Capillary Leak Syndrome,Anaplastic large cell lymphoma,0
12937,Preventive monitoring,Malignant neoplasm of olfactory nerve,0
12938,Immunotherapy,Malignant Testicular Sertoli Cell Tumor,0
12939,Asians,Familial Hemophagocytic Lymphocytosis,0
12940,white blood cell type,BRCA2 Syndrome,0
12941,Hematopoietic stem cells,Melanomatosis,0
12942,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
12943,Spreading (qualifier value),Neonatal leukemia,0
12944,Time (foundation metadata concept),Recurrent Uveal Melanoma,0
12945,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Undifferentiated Endocervical Sarcoma,0
12946,Oncologists,Stage IB Lung Cancer AJCC v7,0
12947,Hematopoietic Neoplasms,Rhabdomyosarcoma with ganglionic differentiation,0
12948,Common Specifications in HL7 V3 Publishing,Papillary squamous cell carcinoma,0
12949,Toilet seat,Hereditary corneal dystrophy,0
12950,Cone-Rod Dystrophy 2,Recurrent Testicular Lymphoma,0
12951,Duct (organ) structure,Malignant Testicular Sertoli Cell Tumor,0
12952,Process,Vaginal Adenoid Cystic Carcinoma,0
12953,Ultrasonic Shockwave,FIGO Stage IVA Ovarian Cancer,0
12954,Epidermis,Malignant melanoma of eyelid,0
12955,Person Name,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12956,Disruptive,Type II Endometrial Adenocarcinoma,0
12957,American College of Cardiology/American Heart Association Lesion Complexity Score C,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12958,1+ Score,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
12959,Feel Tired question,Bladder squamous cell carcinoma stage I,0
12960,Orbit (brand of fungicide),benign mature teratoma of pancreas,0
12961,Pelvic Pain,Cerebral hemangioma,0
12962,per year,Carcinoma of urinary bladder,0
12963,Before,Malignant neoplasm of thalamus,0
12964,1+ Score,Gallbladder Adenocarcinoma,0
12965,Help document,Epithelioid Sarcoma NCI Grade 3,0
12966,Interventional procedure,Stage IV Childhood Non-Hodgkin Lymphoma,0
12967,Tryptophanase,Plexosarcoma,0
12968,Thinking,Gallbladder adenoma,0
12969,Clinical Trials,Localized Askin Tumor,0
12970,Including (qualifier),Advanced Uterine Corpus Carcinosarcoma,0
12971,Prognosis:Find:Pt:^Patient:Nom,Transitional cell carcinoma,0
12972,To,Lung squamous cell carcinoma stage I,0
12973,Human body structure,Acute Undifferentiated Leukemia,0
12974,Experimental Result,Childhood Cerebellar Neoplasm,0
12975,Second Suffix,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12976,CEL gene,Malignant melanoma of eyelid,0
12977,How Much Distress Weight Loss,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12978,NIN gene,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12979,Neoplasms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12980,combination of objects,Refractory Ependymoma,0
12981,shared attribute,Acantholytic squamous cell carcinoma,0
12982,Gram per Deciliter,non-Hodgkin's lymphoma of spleen,0
12983,Area,Mucinous adenocarcinoma,0
12984,shared attribute,Stage IB Pancreatic Cancer AJCC v8,0
12985,Knowledge,Recurrent Rhabdomyosarcoma,0
12986,Treating,Hereditary Diffuse Gastric Adenocarcinoma,0
12987,Symptoms,Benign squamous cell tumor,0
12988,Treatment Epoch,Thymic Clear Cell Carcinoma,0
12989,Major <insect>,Leptomeningeal sarcoma,0
12990,Malignant neoplasm of thymus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12991,Gallbladder Carcinoma,Angiosarcoma of liver,0
12992,Always (frequency),High Grade Glandular Intraepithelial Neoplasia,0
12993,Tissue Specimen Code,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
12994,development aspects,Mastocytosis,0
12995,IPSS Risk Category Low,Malignant Testicular Sertoli Cell Tumor,0
12996,Divide,FIGO Stage II Ovarian Cancer,0
12997,Certainties,Grade 3a Malignant Neoplasm,0
12998,Mechanism (attribute),Plexosarcoma,0
12999,Histogenic Process,Acinar cell carcinoma of pancreas,0
13000,Science of Morphology,Childhood Extragonadal Malignant Germ Cell Tumor,0
13001,Visual Analog Scale,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13002,Surgical aspects,Clonal Hematopoiesis of Indeterminate Potential,0
13003,Vagina,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
13004,Used by,Lipoma of small intestine,0
13005,Dust,Adult Fibrolamellar Carcinoma,0
13006,Symptoms aspect,ALK positive large B-cell lymphoma,0
13007,Bladder Continence Question,Localized Malignant Neoplasm,0
13008,Togo,Childhood Cerebellar Neoplasm,0
13009,Abnormal Reference Range,Basal Cell Ameloblastoma,0
13010,Referring,Ovarian germ cell choriocarcinoma stage IV,0
13011,*Relative,Unresectable Rhabdomyosarcoma,0
13012,Chemotherapy Regimen,Digestive System Hodgkin Lymphoma,0
13013,Physical findings,Lipoma of small intestine,0
13014,month,Cervical Fibroepithelial Polyp,0
13015,Feelings,Diffuse malignant mesothelioma,0
13016,Microscopes,Mucinous adenocarcinoma gastric,0
13017,structure,Advanced Lung Carcinoma,0
13018,Known,Malignant Testicular Sertoli Cell Tumor,0
13019,Symptom severity level,Intraepithelial Melanocytic Hyperplasia,0
13020,Personal appearance,Lipoma of small intestine,0
13021,Occurrence Indicator,Stage III Adult Immunoblastic Lymphoma,0
13022,low exposure,Locally Advanced Epithelioid Hemangioendothelioma,0
13023,Adult,Liver Cavernous Hemangioma,0
13024,Either,Neonatal leukemia,0
13025,Cessation of life,Cancer of Urinary Tract,0
13026,Including (qualifier),Thymic Clear Cell Carcinoma,0
13027,Hereditary Diseases,Benign squamous cell tumor,0
13028,Skeletal bone,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13029,Occurrence Indicator,Intraepithelial Melanocytic Hyperplasia,0
13030,Anatomic Site,Unicystic ameloblastoma,0
13031,Malignant Neoplasms,Malignant neoplasm of subglottis,0
13032,Smear - instruction imperative,Airway Hemangioma,0
13033,GUCY2C protein,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13034,More,Stage III Cutaneous Melanoma AJCC v6,0
13035,Life Threatening,Acantholytic squamous cell carcinoma,0
13036,Role,Childhood Thyroid Gland Follicular Carcinoma,0
13037,Obese build,Mucinous cystadenofibroma,0
13038,Primary malignant neoplasm of endometrium,Cancer of Urinary Tract,0
13039,Polypeptide Hormones,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13040,During,Diffuse malignant mesothelioma,0
13041,BRCA2 gene,Squamous cell carcinoma of lip,0
13042,Vomiting,Mastocytosis,0
13043,To,Blepharal carcinoma,0
13044,Back structure,Malignant neoplasm of subglottis,0
13045,Skin Pigmentation,Childhood Fibrillary Astrocytoma,0
13046,More common in women,Colorectal Neuroendocrine Tumor G2,0
13047,Classification,Adult Alveolar Soft Part Sarcoma,0
13048,Sex Behavior,Mucinous adenocarcinoma gastric,0
13049,Retinoic Acid Response Element,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13050,Characteristics,Maxillary Sinus Adenocarcinoma,0
13051,majority,FIGO Stage II Ovarian Cancer,0
13052,How Much Distress Pain,Childhood Central Nervous System Ganglioneuroblastoma,0
13053,Cover - action,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13054,pharmacotherapeutic,Carcinoma,0
13055,Cardiomyopathy,Hereditary corneal dystrophy,0
13056,Agent,Unfavorable Non-Hodgkin Lymphoma,0
13057,Hematopoietic stem cells,FIGO Stage II Ovarian Cancer,0
13058,Treating,Placental aromatase deficiency,0
13059,Diagnosis Study,Heavy Chain Deposition Disease,0
13060,research,adenoid cystic carcinoma of lung,0
13061,shared attribute,Adult Alveolar Soft Part Sarcoma,0
13062,Oral region,Non-Metastatic Gestational Trophoblastic Tumor,0
13063,Referring,Childhood Fibrillary Astrocytoma,0
13064,Symptoms,Precursor B-lymphoblastic lymphoma stage II,0
13065,Artificial Airways,Fibroadenoma of breast,0
13066,Make - Instruction Imperative,Heavy Chain Deposition Disease,0
13067,Support,Refractory Ependymoma,0
13068,Symptoms aspect,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13069,Offspring,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13070,Mutation Abnormality,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13071,Emotions,Chest Wall Fibromatosis,0
13072,Include (action),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
13073,Treatment Epoch,Pancreatic Endocrine Carcinoma,0
13074,Natural History,Cervical Fibroepithelial Polyp,0
13075,Skeletal muscle structure,Acute lymphadenitis,0
13076,Ichthyoses,Benign squamous cell tumor,0
13077,Slight (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
13078,Malignant epithelioma,Unfavorable Non-Hodgkin Lymphoma,0
13079,Change -- procedure,Locally Advanced Squamous Cell Carcinoma,0
13080,Cancer Genus,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13081,Occurrence Indicator,Platinum-Resistant Lung Small Cell Carcinoma,0
13082,Skin Specimen,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13083,Suspected qualifier,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13084,bony process,Splenic Manifestation of Hairy Cell Leukemia,0
13085,Filter (function),Medulloblastoma,0
13086,biopsy characteristics,Tumorlet,0
13087,Weight decreased,Cartilaginous exostosis,0
13088,Surgical patch,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13089,Abnormal cell,Stage IB Lung Cancer AJCC v7,0
13090,Analysis of substances,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13091,Average of Value Derivation Technique,Intestinal Metaplasia of Bladder Urothelium,0
13092,Neoplasms,Mixed astrocytoma-ependymoma,0
13093,Pigment cell,Localized Ewing Sarcoma,0
13094,Spreading (qualifier value),Cystadenocarcinoma,0
13095,control substance,Colorectal Neuroendocrine Tumor G2,0
13096,Childhood Hodgkin Lymphoma,Acantholytic squamous cell carcinoma,0
13097,teratologic,Brain Ependymoma,0
13098,Concept History,Cervical Adenomyoma,0
13099,High risk of,BRCA2 Syndrome,0
13100,Stomach,Metastatic Carcinoma in the Lung,0
13101,Sahara,Endometrial Small Cell Carcinoma,0
13102,Aggressive course,Cystadenocarcinoma,0
13103,Firstly,Breast Ductal Adenoma,0
13104,Epidermis,Basal Cell Ameloblastoma,0
13105,Symptoms aspect,adenosquamous carcinoma of breast,0
13106,Elevated,Engraftment syndrome,0
13107,Sex Cord-Stromal Tumor,Colorectal Neuroendocrine Tumor G2,0
13108,Areas <moth>,Recurrent Testicular Lymphoma,0
13109,Logical Condition,non-Hodgkin's lymphoma of spleen,0
13110,Publications,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13111,Categories,Testicular cancer metastatic,0
13112,How Often Shortness of Breath,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13113,Account number:Identifier:Point in time:^Patient:Nominal,Adult Brain Stem Mixed Glioma,0
13114,Neuroendocrine Tumors,Mucinous adenocarcinoma gastric,0
13115,Administration procedure,Adult Acute Eosinophilic Leukemia,0
13116,Carcinoid Tumor,Collecting Duct Carcinoma of the Kidney,0
13117,Patient need for (contextual qualifier),Localized Askin Tumor,0
13118,diagnosis aspect,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13119,Thymus <angiosperm>,Contact dermatitis due to alkali,0
13120,Present,Splenic Manifestation of Hairy Cell Leukemia,0
13121,Solid Dose Form,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13122,Histology Procedure,Neonatal leukemia,0
13123,Philadelphia Chromosome,Advanced Lung Carcinoma,0
13124,Base - General Qualifier,BRCA2 Syndrome,0
13125,Bayer Corneal Epitheliopathy Grade 3,Endometrial Small Cell Carcinoma,0
13126,Childhood Diffuse Large B-Cell Lymphoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13127,respiratory,Mucinous adenocarcinoma gastric,0
13128,Localized,Cancer of Urinary Tract,0
13129,chance,Intestinal Metaplasia of Bladder Urothelium,0
13130,Ancestry-Informative Marker,Stage III Cutaneous Melanoma AJCC v6,0
13131,Precursor Cell Lymphoblastic Leukemia Lymphoma,Squamous cell carcinoma of lip,0
13132,Oropharyngeal,Malignant melanoma of eyelid,0
13133,application of research,Mixed parotid tumor,0
13134,Metastasis,Ovarian germ cell choriocarcinoma stage IV,0
13135,Slow,embryonal rhabdomyosarcoma of prostate,0
13136,Adult Medulloblastoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13137,Known,Leptomeningeal sarcoma,0
13138,Decision,Benign tumor of eyelid,0
13139,Common Specifications in HL7 V3 Publishing,Hodgkin lymphoma,0
13140,Homo sapiens,Vaginal Adenoid Cystic Carcinoma,0
13141,Age of Onset,Benign Anal Granular Cell Tumor,0
13142,Most,Benign Anal Granular Cell Tumor,0
13143,Breast Carcinoma,Pancreatic Intraepithelial Neoplasia-3,0
13144,Early,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13145,Arising,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
13146,Case (situation),Breast Ductal Adenoma,0
13147,Episodic,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13148,Usually Need Help from Another Person for Arising,Small cell neuroendocrine carcinoma of bladder,0
13149,Congenital melanocytic nevus,Contact dermatitis due to alkali,0
13150,Therapeutic procedure,Localized Ewing Sarcoma,0
13151,Pediculus (eukaryote),Malignant Neoplasm with Regional Lymph Node Involvement,0
13152,Malignant neoplasm of ovary,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13153,Exertion,Serous cystadenocarcinoma ovary,0
13154,Net (qualifier),Stage IV Childhood Non-Hodgkin Lymphoma,0
13155,Subject Risk,Locally Advanced Carcinoma,0
13156,Males,Brain Tumor,0
13157,Current (present time),Childhood Lung Non-Small Cell Carcinoma,0
13158,Derivation,Kaposi's sarcoma of extrahepatic bile duct,0
13159,Spreading (qualifier value),Benign tumor of eyelid,0
13160,Medulla Oblongata,Nasal cavity carcinoma,0
13161,Replacement - supply,Bladder adenocarcinoma stage IV,0
13162,Arsenic measurement,Stage IB Pancreatic Cancer AJCC v8,0
13163,Neuromuscular,Extracranial Neuroblastoma,0
13164,Human papillomavirus typing (procedure),Female Breast Carcinoma,0
13165,Binding action,Precursor B-lymphoblastic lymphoma stage II,0
13166,SLC5A5 protein,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13167,depend,Transitional cell carcinoma,0
13168,Condition,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13169,DNA index 2,Bladder squamous cell carcinoma stage I,0
13170,Internal,Collecting Duct Carcinoma of the Kidney,0
13171,Relationships,Peripheral primitive neuroectodermal tumor of soft tissue,0
13172,Common Cold,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13173,Ulceration,Mixed astrocytoma-ependymoma,0
13174,Including (qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13175,chapter,Contact dermatitis due to alkali,0
13176,Relationships,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13177,Usually,Bladder Neuroendocrine Neoplasm,0
13178,Macrophage count,Thymic Clear Cell Carcinoma,0
13179,How Often Nausea,embryonal rhabdomyosarcoma of prostate,0
13180,Feature,FIGO Stage II Ovarian Cancer,0
13181,Slight (qualifier value),Occult Lung Adenosquamous Carcinoma,0
13182,Obesity,Stage IB Pancreatic Cancer AJCC v8,0
13183,Milliampere second,Malignant Testicular Sertoli Cell Tumor,0
13184,treatment - ActInformationManagementReason,Xeroderma pigmentosum,0
13185,Surrounding (qualifier value),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
13186,Togo,Larynx carcinoma recurrent,0
13187,Operative Surgical Procedures,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13188,Head and neck structure,Mucinous cystadenofibroma,0
13189,Taxonomic,Malignant Testicular Sertoli Cell Tumor,0
13190,Pruritus,Peripheral primitive neuroectodermal tumor of soft tissue,0
13191,Blood,Atypical Mesothelial Hyperplasia,0
13192,Internal,Hodgkin Disease,0
13193,Case unit dose,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13194,Certainties,Engraftment syndrome,0
13195,Visible,Tonsillar Carcinoma,0
13196,Tryptophanase,Diffuse malignant mesothelioma,0
13197,Specimen Source Codes - tumor,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
13198,Label (document),Pancreatic Intraepithelial Neoplasia-3,0
13199,Peeling of skin,Thymic Atypical Carcinoid Tumor,0
13200,Ulcer,Malignant neoplasm of thalamus,0
13201,Divide,Benign neoplasm of thorax,0
13202,Malignant neoplasm of brain,FIGO Stage II Ovarian Cancer,0
13203,Fever,Ampulla of Vater Tubular Adenoma,0
13204,Used by,Malignant melanoma of eyelid,0
13205,Sharing (Social Behavior),clear cell adenocarcinoma of gallbladder,0
13206,New,Digestive System Hodgkin Lymphoma,0
13207,combination of objects,Acantholytic squamous cell carcinoma,0
13208,One,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13209,Medical History,Acute Undifferentiated Leukemia,0
13210,Chemotherapy,Metaplastic carcinoma of breast,0
13211,Discover,Anterior Urethral Malignant Neoplasm,0
13212,Skin,Pancreatic Intraepithelial Neoplasia-3,0
13213,Site,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13214,Human gene,squamous cell carcinoma of the thyroid gland,0
13215,Abnormally high,Stage I Adult Non-Hodgkin Lymphoma,0
13216,How Often Felt Normal question,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13217,Similarity,Stage III Cutaneous Melanoma AJCC v6,0
13218,DNA,Endometrial Small Cell Carcinoma,0
13219,Optical filter,Benign neoplasm of thorax,0
13220,Have Itch,Acantholytic squamous cell carcinoma,0
13221,Ultrasonic Shockwave,Acantholytic squamous cell carcinoma,0
13222,1960s,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13223,Nervous system structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13224,Decision,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13225,Tryptophanase,Adult Anaplastic Oligodendroglioma,0
13226,Anterior mediastinum,Childhood Central Nervous System Ganglioneuroblastoma,0
13227,Used by,Carcinoma of urinary bladder,0
13228,Exophytic,sarcoma of spinal cord,0
13229,status - In progress,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13230,Providing (action),Adult Alveolar Soft Part Sarcoma,0
13231,shared attribute,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13232,Mucous body substance,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13233,Human body,Carcinomatosis of peritoneal cavity,0
13234,Genetic Markers,Malignant melanoma of eyelid,0
13235,leukemia,Benign Carotid Body Paraganglioma,0
13236,Central African Republic,Colorectal High Grade B-Cell Lymphoma,0
13237,Telephone Extension Number,Unfavorable Non-Hodgkin Lymphoma,0
13238,Usual Severity Pain,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13239,Infiltration Route of Drug Administration,Refractory WHO Grade III Glioma,0
13240,High Level,Advanced Uterine Corpus Carcinosarcoma,0
13241,Mumps,Refractory Barrett Esophagus,0
13242,Urinary Diversion,Stage III Adult Immunoblastic Lymphoma,0
13243,Entity Determiner - specific,ROSE Cluster 3,0
13244,Epithelium,Type II Endometrial Adenocarcinoma,0
13245,Lower (action),Refractory Bladder Carcinoma,0
13246,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Recurrent Uveal Melanoma,0
13247,N not otherwise specified Antibody,Childhood Lymphoma,0
13248,Specimen Source Codes - tumor,Non-Metastatic Gestational Trophoblastic Tumor,0
13249,World,Unresectable Rhabdomyosarcoma,0
13250,Milliampere second,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13251,Risk,Anaplastic large cell lymphoma,0
13252,Result,FIGO Stage IVA Ovarian Cancer,0
13253,Approximate,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13254,Hematologic Tests,Hereditary corneal dystrophy,0
13255,Negation,Childhood Lymphoma,0
13256,Tubular adenoma,Hereditary Diffuse Gastric Adenocarcinoma,0
13257,Low Mitosis-Karyorrhexis Index,Unresectable Rhabdomyosarcoma,0
13258,Changed status,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13259,Stomach Diseases,Funisitis (disorder),0
13260,Adult human body,Thyroid Hurthle Cell Carcinoma,0
13261,Both ovaries,Breast Ductal Adenoma,0
13262,Manufactured form,Basal Cell Ameloblastoma,0
13263,30%,Spermatocytic seminoma,0
13264,Telephone Extension Number,Intraepithelial Melanocytic Hyperplasia,0
13265,Relationships,Benign Anal Granular Cell Tumor,0
13266,Chronic Lymphocytic Leukemia,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13267,Rare,Squamous cell carcinoma of lip,0
13268,Increase,Vaginal Adenoid Cystic Carcinoma,0
13269,Common Specifications in HL7 V3 Publishing,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13270,Psyche structure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13271,Good,Anaplastic large cell lymphoma,0
13272,Skin tag,Methotrexate-Associated Hodgkin Lymphoma,0
13273,Spleen,Thyroid Hurthle Cell Carcinoma,0
13274,Most,Malignant melanoma of eyelid,0
13275,2+,Pleomorphic adenoma of parotid gland,0
13276,Term (lexical),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13277,Cancer Genus,Adult Hepatocellular Carcinoma,0
13278,Feature,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13279,Water,Melanomatosis,0
13280,Africa,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
13281,80%,Benign squamous cell tumor,0
13282,Treating,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13283,Term (lexical),Undifferentiated Endocervical Sarcoma,0
13284,Cutaneous Route of Drug Administration,Recurrent Uveal Melanoma,0
13285,Prostate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13286,Rare,Metastatic Malignant Neoplasm in the Sellar Region,0
13287,Derived value,Ovarian Carcinoid Tumor,0
13288,Papillary transitional cell neoplasm of low malignant potential,Malignant neoplasm of thalamus,0
13289,Anorexia,Diffuse malignant mesothelioma,0
13290,Distant,Malignant neoplasm of gallbladder,0
13291,Therapeutic procedure,FIGO Stage IVA Ovarian Cancer,0
13292,Avitaminosis,Metastatic Lung Neuroendocrine Neoplasm,0
13293,Imaging Techniques,Vaginal Adenoid Cystic Carcinoma,0
13294,Science of Etiology,FIGO Stage II Ovarian Cancer,0
13295,Occurrence,Refractory Ependymoma,0
13296,General surgery specialty,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13297,Screening procedure,Type II Endometrial Adenocarcinoma,0
13298,rituximab,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13299,Reduced,Cervical Squamous Intraepithelial Neoplasia,0
13300,Very large,Recurrent Primary Lymphoma of Bone,0
13301,Childhood Non-Hodgkin Lymphoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13302,Females,Undifferentiated Neuroblastoma,0
13303,Contain (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13304,Pediatric,High Grade Glandular Intraepithelial Neoplasia,0
13305,General surgery specialty,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13306,Analysis,Female Breast Carcinoma,0
13307,Brain part,Adrenal Rest Tumor,0
13308,chronic,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13309,Manufactured sign,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13310,True primary (qualifier value),squamous cell carcinoma of the thyroid gland,0
13311,Reported Term,Placental aromatase deficiency,0
13312,Replaced by,Leiomyoma of Gallbladder,0
13313,Type A,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13314,polyps,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13315,Posterior Spinal Artery Syndrome,Larynx carcinoma recurrent,0
13316,Vegetables,Bladder adenocarcinoma stage IV,0
13317,IPSS Risk Category High,Kaposi's sarcoma of skin,0
13318,Skin,Kaposi's sarcoma of extrahepatic bile duct,0
13319,Chemotherapy,Squamous cell carcinoma of lip,0
13320,Pleomorphic,Cerebral Primitive Neuroectodermal Tumor,0
13321,New,Basal Cell Ameloblastoma,0
13322,common types,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13323,100%,Stage IB Lung Cancer AJCC v7,0
13324,Result,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13325,To,Heavy Chain Deposition Disease,0
13326,Qualitative form,Pilocytic astrocytoma of cerebellum,0
13327,<3 (qualifier value),Cancer of Urinary Tract,0
13328,N+ (tumor staging),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13329,Michigan alcoholism screening test,Liver Cavernous Hemangioma,0
13330,Sacrococcygeal teratoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13331,A1CF wt Allele,adenosquamous carcinoma of breast,0
13332,How Much Distress Itching,Malignant melanoma of eyelid,0
13333,stage,Benign neoplasm of thorax,0
13334,Concept model range (foundation metadata concept),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
13335,Dysuria,Diffuse malignant mesothelioma,0
13336,Drop measurement,Benign squamous cell tumor,0
13337,Science of Statistics,FIGO Stage II Ovarian Cancer,0
13338,Progress,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13339,Characteristics,Engraftment syndrome,0
13340,Separate,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
13341,Smoking,Lung squamous cell carcinoma stage I,0
13342,Mediate,Malignant Testicular Sertoli Cell Tumor,0
13343,Disease,Refractory Barrett Esophagus,0
13344,Ascites,Tonsillar Carcinoma,0
13345,Lipomatosis,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13346,Vascular,Childhood Extragonadal Malignant Germ Cell Tumor,0
13347,SLC6A2 protein,gliosarcoma,0
13348,Retinoic Acid Response Element,Blepharal carcinoma,0
13349,International Aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13350,Persons,Congenital hamartoma,0
13351,Subtype (attribute),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
13352,Drop measurement,Non-Metastatic Gestational Trophoblastic Tumor,0
13353,Cough Frequency,Intracortical osteosarcoma,0
13354,Used by,de novo Myelodysplastic Syndrome,0
13355,Child,Stage IB Lung Cancer AJCC v7,0
13356,Subgroup A Nepoviruses,Serous cystadenocarcinoma ovary,0
13357,Frequently,Stage III Cutaneous Melanoma AJCC v6,0
13358,ultrasound device,Stage IB Lung Cancer AJCC v7,0
13359,Anorexia,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13360,Common (qualifier value),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13361,Prophylactic behavior,Undifferentiated Endocervical Sarcoma,0
13362,Most,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13363,Abnormal,Benign Anal Granular Cell Tumor,0
13364,Human body,Non-Metastatic Gestational Trophoblastic Tumor,0
13365,Cell Count,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13366,trauma qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
13367,combination of objects,Adult Hepatocellular Carcinoma,0
13368,Flattened,Malignant neoplasm of subglottis,0
13369,Combined,Non-Metastatic Gestational Trophoblastic Tumor,0
13370,Sufficiently defined concept definition status (core metadata concept),Medulloblastoma,0
13371,Completely - dosing instruction fragment,Breast Ductal Adenoma,0
13372,Skeletal,Leptomeningeal sarcoma,0
13373,History of present illness,Malignant neoplasm of subglottis,0
13374,Weight decreased,Pancreatic Intraepithelial Neoplasia-3,0
13375,Abnormal cell,Anaplastic large cell lymphoma,0
13376,Abdomen+,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
13377,Rare Diseases,Noninfiltrating Intraductal Carcinoma,0
13378,Aggressive behavior,Breast Ductal Adenoma,0
13379,Case (situation),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13380,Skin,High Grade Glandular Intraepithelial Neoplasia,0
13381,treatment - ActInformationManagementReason,Breast Ductal Adenoma,0
13382,Secondary Neoplasm,Benign Anal Granular Cell Tumor,0
13383,Age of Onset,Astrocytoma of brain,0
13384,Therapeutic procedure,Mucinous adenocarcinoma,0
13385,Age,Malignant neoplasm of gallbladder,0
13386,CDISC SEND Tumor Findings Results Terminology,Diffuse malignant mesothelioma,0
13387,Early stage,Unicystic ameloblastoma,0
13388,Tumor Mass,Liver Lymphangioma,0
13389,Call (Instruction),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
13390,Pleural effusion fluid,Lipoma of small intestine,0
13391,Retinoic Acid Response Element,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13392,Malignant Neoplasms,Rhabdomyosarcoma with ganglionic differentiation,0
13393,Sequence of Planned Assessment Schedule,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13394,Including (qualifier),Ovarian germ cell choriocarcinoma stage IV,0
13395,Simple,Periosteal Osteosarcoma,0
13396,pharmacotherapeutic,Type II Endometrial Adenocarcinoma,0
13397,59,Heavy Chain Deposition Disease,0
13398,Duplicate,Bladder adenocarcinoma stage IV,0
13399,High Level,Grade 3a Malignant Neoplasm,0
13400,Autoimmune Diseases,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13401,Procedure (set of actions),Malignant neoplasm of subglottis,0
13402,Leads (device),Diffuse malignant mesothelioma,0
13403,Iodides,ICHTHYOSIS,0
13404,Scalp structure,Splenic Manifestation of Hairy Cell Leukemia,0
13405,Chromosomes,Melanomatosis,0
13406,Lung,Cerebral Primitive Neuroectodermal Tumor,0
13407,Common (qualifier value),Heavy Chain Deposition Disease,0
13408,IMPA1 gene,Plexosarcoma,0
13409,contagion,FIGO Stage II Ovarian Cancer,0
13410,Affect (mental function),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13411,Lymphoma,Acute Undifferentiated Leukemia,0
13412,Immune system,Chest Wall Fibromatosis,0
13413,immunoglobulin complex location,Angiosarcoma of liver,0
13414,Breast,Testicular cancer metastatic,0
13415,Clear cell carcinoma of lung,FIGO Stage II Ovarian Cancer,0
13416,Togo,Kaposi's sarcoma of skin,0
13417,Thrombocythemia,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13418,Treatment Epoch,Cerebral Primitive Neuroectodermal Tumor,0
13419,PSA Level Less than Five,Extra-Adrenal Paraganglioma,0
13420,Rare,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13421,Antibiotic Resistance,Bladder Neuroendocrine Neoplasm,0
13422,To,mucinous adenocarcinoma of gallbladder,0
13423,Smaller,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13424,Pancreas,Intraepithelial Melanocytic Hyperplasia,0
13425,Treating,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13426,Blue - answer to question,Human Papillomavirus-Related Carcinoma,0
13427,Mechanism Component of Device,Cervical Adenomyoma,0
13428,Bone Pain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13429,Stem of plant,Xeroderma pigmentosum,0
13430,Cancer Genus,Acute Undifferentiated Leukemia,0
13431,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13432,Taxonomic,Placental aromatase deficiency,0
13433,Linear,Human Papillomavirus-Related Carcinoma,0
13434,Reaching,Glomeruloid hemangioma,0
13435,Characteristics,Malignant Testicular Sertoli Cell Tumor,0
13436,Jaw,Stage IV Colorectal Cancer AJCC v8,0
13437,Obese build,Melanomatosis,0
13438,Following,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13439,Loss of appetite (finding),Mixed astrocytoma-ependymoma,0
13440,CDISC SEND Tumor Findings Results Terminology,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13441,Palm thickening,Pleomorphic adenoma of parotid gland,0
13442,Life Expectancy Less than Twenty Years,Locally Advanced Squamous Cell Carcinoma,0
13443,Negation,Engraftment syndrome,0
13444,Person Observer,Liver Lymphangioma,0
13445,Including (qualifier),Angiosarcoma of liver,0
13446,How Much Distress Itching,Secondary malignant neoplasm of lymph node,0
13447,Beginning,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13448,Diagnosis Study,Thymic Atypical Carcinoid Tumor,0
13449,Absence (morphologic abnormality),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13450,What subject filter - Result,Locally Advanced Squamous Cell Carcinoma,0
13451,True primary (qualifier value),Extra-abdominal fibromatosis,0
13452,Clone,Peripheral primitive neuroectodermal tumor of soft tissue,0
13453,Assisted (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
13454,Did not receive therapy or drug for,benign mature teratoma of pancreas,0
13455,site-specific telomere resolvase activity,Angiosarcoma of liver,0
13456,Pain,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13457,Image Feature,FIGO Stage II Ovarian Cancer,0
13458,Poverty,Carcinoma ex pleomorphic adenoma of parotid gland,0
13459,Lymphoma,Gallbladder Adenocarcinoma,0
13460,Condition:Find:Pt:^Patient:Nom,Adult Alveolar Soft Part Sarcoma,0
13461,Grouped (qualifier value),Hodgkin Disease,0
13462,Oral region,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13463,Common Specifications in HL7 V3 Publishing,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13464,Proteins,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13465,Adult human body,Malignant melanoma of eyelid,0
13466,fluid - substance,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13467,Chronic inflammation,Cartilaginous exostosis,0
13468,Breast,Gallbladder Adenocarcinoma,0
13469,shared attribute,squamous cell carcinoma of the thyroid gland,0
13470,Stroma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13471,Risk,Carcinomatosis of peritoneal cavity,0
13472,Mass of body region,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13473,Class (taxonomic),Stage III Adult Immunoblastic Lymphoma,0
13474,Lumpectomy of breast,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
13475,Qualitative form,Multiple Skull Base Meningiomas,0
13476,Surgery specialty,Adult Alveolar Soft Part Sarcoma,0
13477,Bothered by Nausea,Undifferentiated Endocervical Sarcoma,0
13478,Encounter,Benign tumor of eyelid,0
13479,Historical - DataType,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13480,Type A,Stage II Hepatocellular Carcinoma AJCC v8,0
13481,Muscle Tissue,Stage IV Penile Cancer AJCC v7,0
13482,Derivation,Giant cell angiofibroma,0
13483,Therapeutic procedure,Diffuse malignant mesothelioma,0
13484,Common (qualifier value),Digestive System Hodgkin Lymphoma,0
13485,Always (frequency),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13486,Block (unit of presentation),Human Papillomavirus-Related Carcinoma,0
13487,common types,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13488,Increased erythropoietin,Diffuse malignant mesothelioma,0
13489,per year,Pleomorphic adenoma of parotid gland,0
13490,Treating,Kaposi's sarcoma of extrahepatic bile duct,0
13491,Goiter,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13492,Walls of a building,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13493,Feature,Stage III Cutaneous Melanoma AJCC v6,0
13494,Usual Severity Shortness of Breath,Advanced Uterine Corpus Carcinosarcoma,0
13495,Subject Risk,Occult Lung Adenosquamous Carcinoma,0
13496,Bothered by Night Sweats,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13497,Multiple Endocrine Neoplasia,Benign Anal Granular Cell Tumor,0
13498,Value Above Reference Range,Giant cell angiofibroma,0
13499,Mass of body structure,Cerebral hemangioma,0
13500,Including (qualifier),Noninfiltrating Intraductal Carcinoma,0
13501,Malignant Neoplasms,Grade 3a Malignant Neoplasm,0
13502,Poor - qualifier,Mixed astrocytoma-ependymoma,0
13503,Genus Cygnus,Bladder adenocarcinoma stage IV,0
13504,85,Medulloblastoma,0
13505,Nature,papillary carcinoma of penis,0
13506,Endometrium,malignant lymphoma of pancreatic lymph nodes,0
13507,Bone pain,Peripheral primitive neuroectodermal tumor of soft tissue,0
13508,Cartilage,Childhood Fibrillary Astrocytoma,0
13509,Confirmed by,benign mature teratoma of pancreas,0
13510,Most,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13511,During,Adult Acute Eosinophilic Leukemia,0
13512,Advance -- medical device,Pilocytic astrocytoma of cerebellum,0
13513,Removed,Mucinous cystadenofibroma,0
13514,Platelets,Type II Endometrial Adenocarcinoma,0
13515,Often - answer to question,Tongue Alveolar Soft Part Sarcoma,0
13516,Subglottis structure,Type II Endometrial Adenocarcinoma,0
13517,Site of,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13518,Tumor Mass,Stage 0 Penile Cancer AJCC v8,0
13519,Ascites,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13520,control aspects,papillary carcinoma of penis,0
13521,Liver,Blepharal carcinoma,0
13522,Persons,Extra-Adrenal Paraganglioma,0
13523,Specimen Source Codes - tumor,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13524,Qualitative form,Ampulla of Vater Tubular Adenoma,0
13525,therapeutic aspects,clear cell adenocarcinoma of gallbladder,0
13526,Thymus Neoplasms,Epithelioid Sarcoma NCI Grade 3,0
13527,liposarcoma,FIGO Stage II Ovarian Cancer,0
13528,Biomaterial Treatment,Brain Tumor,0
13529,Constant (qualifier),Uterine Cancer,0
13530,per second,Chronic Myelomonocytic Leukemia-2,0
13531,Frequently,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13532,filter information process,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13533,Physical findings,Malignant Neoplasm with Regional Lymph Node Involvement,0
13534,Childhood Non-Hodgkin Lymphoma,Heavy Chain Deposition Disease,0
13535,Cell Count,Childhood Anaplastic Large Cell Lymphoma,0
13536,Injury due to exposure to external cause,Benign Anal Granular Cell Tumor,0
13537,Science of Etiology,Maxillary Sinus Adenoid Cystic Carcinoma,0
13538,Pancreas,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13539,Hormonal,Pancreatic Intraepithelial Neoplasia-3,0
13540,Dorsal,Malignant neoplasm of olfactory nerve,0
13541,Vascular,Gallbladder adenoma,0
13542,Midline (qualifier value),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13543,Pancreatitis,Splenic Manifestation of Hairy Cell Leukemia,0
13544,therapeutic aspects,gliosarcoma,0
13545,Primary,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13546,Usually,Adult Hepatocellular Carcinoma,0
13547,Source,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13548,Serum,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13549,Skin,Thyroid Hurthle Cell Carcinoma,0
13550,Manufactured form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13551,Treatment Epoch,non-Hodgkin's lymphoma of spleen,0
13552,Unexplained weight loss,Childhood Central Nervous System Ganglioneuroblastoma,0
13553,Hodgkin Disease,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13554,Organ,Stage I Adult Non-Hodgkin Lymphoma,0
13555,Most,Diffuse malignant mesothelioma,0
13556,Genetic Risk,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13557,fluid - substance,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13558,Skin,Colorectal cancer,0
13559,Togo,Melanomatosis,0
13560,Ultrasonography,Vaginal Adenoid Cystic Carcinoma,0
13561,Object Class,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13562,Thought,Neonatal leukemia,0
13563,Tissue Specimen Code,Tonsillar Carcinoma,0
13564,Rattus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13565,Curative - procedure intent,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13566,treatment - ActInformationManagementReason,Spongiotic dermatitis,0
13567,Pelvic Pain,Cancer of Urinary Tract,0
13568,Symptoms,Uterine Cancer,0
13569,Togo,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13570,Including (qualifier),Localized Askin Tumor,0
13571,Human body structure,Recurrent Testicular Lymphoma,0
13572,Forecast of outcome,Brain Tumor,0
13573,Including (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13574,Spinal Cord,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13575,Endocrine system,malignant lymphoma of pancreatic lymph nodes,0
13576,Sarcoma,Childhood Lung Non-Small Cell Carcinoma,0
13577,Part of,Congenital hamartoma,0
13578,Concept History,Peripheral primitive neuroectodermal tumor of soft tissue,0
13579,Derivation,Mucinous adenocarcinoma gastric,0
13580,SLC6A2 protein,Uterine Cancer,0
13581,More,Lung Inflammatory Myofibroblastic Tumor,0
13582,Cessation of life,Periosteal Osteosarcoma,0
13583,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
13584,Brain,Contact dermatitis due to alkali,0
13585,include - SetOperator,Trabecular adenocarcinoma,0
13586,Lower - spatial qualifier,Gallbladder Adenocarcinoma,0
13587,Asbestos,Ovarian germ cell choriocarcinoma stage IV,0
13588,Myeloid neoplasm,Hodgkin lymphoma,0
13589,National origin,Endometrial Small Cell Carcinoma,0
13590,Lymphocyte,Spindle Cell Melanoma,0
13591,Prognosis:Find:Pt:^Patient:Nom,Chondrosarcoma,0
13592,Unmarried person,Adenocarcinoma,0
13593,Formation,Anterior Urethral Malignant Neoplasm,0
13594,Negation,Cervical Fibroepithelial Polyp,0
13595,treatment - ActInformationManagementReason,Refractory Bladder Carcinoma,0
13596,Poor - grade value,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13597,per year,Breast Ductal Adenoma,0
13598,Formation,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13599,Abnormal Reference Range,Stage I Colon Neuroendocrine Tumor AJCC v8,0
13600,Pharmacotherapy,Acute Undifferentiated Leukemia,0
13601,Respiratory tract structure,Intestinal Neuroendocrine Carcinoma,0
13602,Favorable,Hemangioma,0
13603,Ulcer,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13604,Scientific Study,Childhood Central Nervous System Ganglioneuroblastoma,0
13605,analysis aspect,Vaginal Adenoid Cystic Carcinoma,0
13606,Reduced,Mucinous cystadenofibroma,0
13607,Chemotherapy,Spongiotic dermatitis,0
13608,Tumor cells,Childhood Central Nervous System Ganglioneuroblastoma,0
13609,Death (finding),GIANT PIGMENTED HAIRY NEVUS,0
13610,Skin lesion,Parathyroid Gland Adenocarcinoma,0
13611,white blood cell type,Recurrent Rhabdomyosarcoma,0
13612,Tumor type,Localized Malignant Neoplasm,0
13613,Cell Device,Locally Advanced Carcinoma,0
13614,Specimen Type - Macrophages,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13615,North America,Refractory Ependymoma,0
13616,adaptive,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13617,Papillomaviridae,Mucinous adenocarcinoma gastric,0
13618,Offspring,Benign neoplasm of thorax,0
13619,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Acute Undifferentiated Leukemia,0
13620,Microbial anatomical capsule structure,Endometrial Small Cell Carcinoma,0
13621,Motor Neuron and Pancreas Homeobox Protein 1,Bladder adenocarcinoma stage IV,0
13622,inflammatory,clear cell adenocarcinoma of gallbladder,0
13623,Cancer Genus,Vaginal Adenoid Cystic Carcinoma,0
13624,Cancer Other,Digestive System Hodgkin Lymphoma,0
13625,risk factors - observation list,Adult Anaplastic Oligodendroglioma,0
13626,combination - answer to question,Gallbladder Adenocarcinoma,0
13627,AS virus,embryonal rhabdomyosarcoma of prostate,0
13628,Localized,BRCA2 Syndrome,0
13629,Associated with,Childhood Thyroid Gland Follicular Carcinoma,0
13630,2+ Score,Heavy Chain Deposition Disease,0
13631,Small,FIGO Stage II Ovarian Cancer,0
13632,Usual Severity Weight Loss,Spongiotic dermatitis,0
13633,Including (qualifier),Acantholytic squamous cell carcinoma,0
13634,Stem cell transplant,Stage III Cutaneous Melanoma AJCC v6,0
13635,Abnormal increase in number,Cartilaginous exostosis,0
13636,Similarity,Chest Wall Fibromatosis,0
13637,Occurrence,Squamous cell carcinoma of lip,0
13638,Usual,Undifferentiated Endocervical Sarcoma,0
13639,Fever symptoms (finding),Heavy Chain Deposition Disease,0
13640,300,Ampulla of Vater Tubular Adenoma,0
13641,Negation,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13642,treatment - ActInformationManagementReason,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13643,More,Noninfiltrating Intraductal Carcinoma,0
13644,Painful intercourse female,Thyroid Hurthle Cell Carcinoma,0
13645,Adult Lymphoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13646,Therapeutic radiology procedure,Mucinous cystadenofibroma,0
13647,Promegakaryocytes,Splenic Manifestation of Hairy Cell Leukemia,0
13648,Seventh,Neoplasms,0
13649,Leading,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13650,Pleomorphic Xanthoastrocytoma,Activated B-cell type diffuse large B-cell lymphoma,0
13651,Worsening pattern,Endometrial Small Cell Carcinoma,0
13652,How Much Distress Vomiting,Adrenal Rest Tumor,0
13653,>5,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13654,Microplate Well,Malignant Testicular Sertoli Cell Tumor,0
13655,Involvement with,Acute lymphadenitis,0
13656,High grade (lymphoma grade) (finding),Metastatic Malignant Neoplasm in the Sellar Region,0
13657,Human papillomavirus 16,Adenocarcinoma,0
13658,Back structure,Vaginal Adenoma,0
13659,Location,Cervical Squamous Intraepithelial Neoplasia,0
13660,CD244 wt Allele,Endometrial Small Cell Carcinoma,0
13661,Adult Lymphoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13662,Benign,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13663,liter,Fourth Ventricle and Brain Stem Ependymal Tumor,0
13664,Body surface,Localized Ewing Sarcoma,0
13665,Ovarian Follicle,Intracortical osteosarcoma,0
13666,Rapid,Childhood Extragonadal Malignant Germ Cell Tumor,0
13667,Occurrence,Adult Hepatocellular Carcinoma,0
13668,Contribution,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13669,Response to treatment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13670,Human body structure,Splenic Manifestation of Hairy Cell Leukemia,0
13671,40%,Malignant neoplasm of choroid,0
13672,Early,Acantholytic squamous cell carcinoma,0
13673,Present,squamous cell carcinoma of the thyroid gland,0
13674,History,Breast Ductal Adenoma,0
13675,Only a Little,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13676,Three,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13677,Referring,Liver Cavernous Hemangioma,0
13678,Testicular Germ Cell Tumor,Malignant neoplasm of subglottis,0
13679,Structure of great blood vessel (organ),Recurrent Testicular Lymphoma,0
13680,System,Non-Metastatic Gestational Trophoblastic Tumor,0
13681,Lower - spatial qualifier,Larynx carcinoma recurrent,0
13682,True primary (qualifier value),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13683,Acute lymphocytic leukemia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13684,red Patches,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13685,White color,Locally Advanced Soft Tissue Sarcoma,0
13686,Response to treatment,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13687,Post Device,Recurrent Testicular Lymphoma,0
13688,Frequently,Astrocytoma of brain,0
13689,Malignant Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13690,Rating (action),Liver Lymphangioma,0
13691,eTMF Content Model Code,benign mature teratoma of pancreas,0
13692,Childhood Germ Cell Tumor,Clonal Hematopoiesis of Indeterminate Potential,0
13693,Lateral ventricle structure,Engraftment syndrome,0
13694,High Mitosis-Karyorrhexis Index,Cerebral Primitive Neuroectodermal Tumor,0
13695,Physical findings,Digestive System Hodgkin Lymphoma,0
13696,biopsy characteristics,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13697,N not otherwise specified Antibody,Ovarian germ cell choriocarcinoma stage IV,0
13698,Block Unit of Distance,Adult Alveolar Soft Part Sarcoma,0
13699,Most,Acute Undifferentiated Leukemia,0
13700,Bladder Continence Question,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13701,Condition,Congenital hamartoma,0
13702,Breast,Benign Anal Granular Cell Tumor,0
13703,Environmental risk factor,Carcinomatosis of peritoneal cavity,0
13704,Primary,Stage I Colon Neuroendocrine Tumor AJCC v8,0
13705,per year,Intraepithelial Melanocytic Hyperplasia,0
13706,N+ (tumor staging),Peripheral primitive neuroectodermal tumor of soft tissue,0
13707,Chemotherapy,mucinous adenocarcinoma of gallbladder,0
13708,Leading,Papillary cystic tumor,0
13709,Lower (action),Lipoma of small intestine,0
13710,Polymerization,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13711,Sharing (Social Behavior),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13712,Decreasing,Diffuse malignant mesothelioma,0
13713,Name,Intestinal Metaplasia of Bladder Urothelium,0
13714,Adolescent (age group),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13715,<3 (qualifier value),Chest Wall Fibromatosis,0
13716,Family history,Localized Ewing Sarcoma,0
13717,Human body,Digestive System Hodgkin Lymphoma,0
13718,Type of Form,Malignant Testicular Sertoli Cell Tumor,0
13719,treatment - ActInformationManagementReason,Benign neoplasm of eye,0
13720,Symptoms,Collecting Duct Carcinoma of the Kidney,0
13721,Bone marrow aspiration procedure,Childhood Anaplastic Large Cell Lymphoma,0
13722,treatment options,Neonatal leukemia,0
13723,Mathematical Operator,Diffuse malignant mesothelioma,0
13724,Biospecimen,Stage II Carcinoma of Penis,0
13725,Symptom:Find:Pt:^Patient:Nom,Chest Wall Fibromatosis,0
13726,Participation Type - origin,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13727,melanoma,ALK positive large B-cell lymphoma,0
13728,Tumor Mass,Carcinoma of urinary bladder,0
13729,Cessation of life,Adult Acute Eosinophilic Leukemia,0
13730,True primary (qualifier value),Ichthyosis,0
13731,Smear - instruction imperative,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
13732,Forecast of outcome,Adult Acute Eosinophilic Leukemia,0
13733,Lung,Stage III Cutaneous Melanoma AJCC v6,0
13734,Negation,Neoplasms,0
13735,Complete Agreement,Angiosarcoma of liver,0
13736,CEL gene,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13737,Old,Bladder squamous cell carcinoma stage I,0
13738,Primary malignant neoplasm,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13739,diagnosis aspect,Malignant Neoplasm with Regional Lymph Node Involvement,0
13740,Smear - instruction imperative,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13741,MYELODYSPLASTIC SYNDROME,Recurrent Uveal Melanoma,0
13742,Result,Vaginal Adenoma,0
13743,Rapid,Childhood Fibrillary Astrocytoma,0
13744,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Human Papillomavirus-Related Carcinoma,0
13745,Make - Instruction Imperative,Squamous cell carcinoma of lip,0
13746,Characterization,Stage II Fallopian Tube Cancer,0
13747,Special,Cervical Fibroepithelial Polyp,0
13748,Malignant neoplasm of brain,Secondary malignant neoplasm of lymph node,0
13749,Pruritus,Vaginal Adenoid Cystic Carcinoma,0
13750,To,Basal Cell Ameloblastoma,0
13751,Prior Chemotherapy,Pancreatic Endocrine Carcinoma,0
13752,Togo,Medulloblastoma,0
13753,Internal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13754,Biological Response Modifiers,Kaposi's sarcoma of extrahepatic bile duct,0
13755,English race,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13756,Occurrence,Intraepithelial Melanocytic Hyperplasia,0
13757,size,Pilocytic astrocytoma of cerebellum,0
13758,Development,Malignant neoplasm of thalamus,0
13759,Categories,Localized Ewing Sarcoma,0
13760,Tissue Specimen Code,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
13761,Usual,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13762,Practice Experience,Tonsillar Carcinoma,0
13763,Biological Response Modifier Therapy,Diffuse malignant mesothelioma,0
13764,Areas <moth>,Tonsillar Carcinoma,0
13765,One,Type II Endometrial Adenocarcinoma,0
13766,leukemia,FIGO Stage IVA Ovarian Cancer,0
13767,therapeutic aspects,papillary carcinoma of penis,0
13768,Skin,Human Papillomavirus-Related Carcinoma,0
13769,Spreading (qualifier value),Acute Undifferentiated Leukemia,0
13770,Example,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13771,% volume (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13772,Type A,ROSE Cluster 3,0
13773,Smear - instruction imperative,Epithelioid Sarcoma NCI Grade 3,0
13774,Color,Pancreatic Intraepithelial Neoplasia-3,0
13775,Lacking,Fibroadenoma of breast,0
13776,Biomaterial Treatment,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
13777,Pharmacotherapy,Heavy Chain Deposition Disease,0
13778,CDISC SEND Body System Terminology,Chest Wall Fibromatosis,0
13779,Sequence Data Type,Chondrosarcoma,0
13780,To,Neoplasms,0
13781,Ephrin Type-B Receptor 1,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
13782,Different,Human Papillomavirus-Related Carcinoma,0
13783,Grouping,Childhood Fibrillary Astrocytoma,0
13784,Age at diagnosis:Time:Pt:^Patient:Qn,papillary carcinoma of penis,0
13785,How Much Distress Weight Loss,Recurrent Uveal Melanoma,0
13786,Adult Soft Tissue Sarcoma,Kaposi's sarcoma of extrahepatic bile duct,0
13787,Five,FIGO Stage II Ovarian Cancer,0
13788,Soft Tissue Neoplasms,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13789,advanced disease,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13790,Supratentorial,Papillary squamous cell carcinoma,0
13791,Adult Diffuse Large B-Cell Lymphoma,Bladder squamous cell carcinoma stage I,0
13792,3+ Score,Mucinous neoplasm,0
13793,Sex Cord-Stromal Tumor,Intraepithelial Melanocytic Hyperplasia,0
13794,Usual,malignant lymphoma of pancreatic lymph nodes,0
13795,fluid - substance,clear cell adenocarcinoma of gallbladder,0
13796,Percent normal,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13797,N+ (tumor staging),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13798,Area,Deep Leiomyoma,0
13799,Epithelioma,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13800,Immunoproliferative Disorders,embryonal rhabdomyosarcoma of prostate,0
13801,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Mastocytosis,0
13802,Adrenal Cortical Adenoma,Childhood Central Nervous System Immature Teratoma,0
13803,Pathology,Acantholytic squamous cell carcinoma,0
13804,Classification of information,ROSE Cluster 3,0
13805,Logical Condition,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
13806,Removed,Cancer of Urinary Tract,0
13807,IPSS Risk Category Low,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13808,Increased erythropoietin,Cerebral Primitive Neuroectodermal Tumor,0
13809,Symptoms aspect,Liver Lymphangioma,0
13810,Neoplasms,Microcystic meningioma,0
13811,Often - answer to question,Melanomatosis,0
13812,Tumor Mass,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13813,Destruction (action),Breast Ductal Adenoma,0
13814,Osteosarcoma,Non-Metastatic Gestational Trophoblastic Tumor,0
13815,Percent of Abnormal Cells,Angiosarcoma of liver,0
13816,Covers (device),Female Breast Carcinoma,0
13817,shared attribute,Hodgkin lymphoma,0
13818,Reaching,Acute lymphadenitis,0
13819,Primary malignant neoplasm,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
13820,status - In progress,Malignant Testicular Sertoli Cell Tumor,0
13821,Swollen Lymph Node,Vaginal Adenoma,0
13822,health and disease,Type II Endometrial Adenocarcinoma,0
13823,Case (situation),non-Hodgkin's lymphoma of spleen,0
13824,Histopathology,Digestive System Hodgkin Lymphoma,0
13825,Representation (action),Intraepithelial Melanocytic Hyperplasia,0
13826,Small Cell Lung Cancer Pathway,Cervical Squamous Intraepithelial Neoplasia,0
13827,Antibiotics,Malignant neoplasm of choroid,0
13828,various antiinfectives and antiseptics for local oral treatment,Bladder squamous cell carcinoma stage I,0
13829,Serious,gliosarcoma,0
13830,Population Group,Malignant melanoma of eyelid,0
13831,Comprehension,Adult Anaplastic Oligodendroglioma,0
13832,Treating,Thymoma malignant recurrent,0
13833,Physical findings,FIGO Stage II Ovarian Cancer,0
13834,MYELODYSPLASTIC SYNDROME,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
13835,Genetic,Childhood Central Nervous System Ganglioneuroblastoma,0
13836,cervical cancer,Low Grade Squamous Intraepithelial Neoplasia,0
13837,Cancer Genus,Mucinous adenocarcinoma gastric,0
13838,1+ Score,Clonal Hematopoiesis of Indeterminate Potential,0
13839,Primary malignant neoplasm,Stage 0 Penile Cancer AJCC v8,0
13840,International Classification of Disease for Oncology,Mucinous adenocarcinoma,0
13841,Abdomen+,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13842,Mass Effect,Anterior Urethral Malignant Neoplasm,0
13843,Diagnosis,Bladder adenocarcinoma stage IV,0
13844,Adenocarcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13845,Ovary,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13846,Basis - conceptual entity,FIGO Stage II Ovarian Cancer,0
13847,Infrequent,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13848,More,Anterior Urethral Malignant Neoplasm,0
13849,With shape,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13850,include - SetOperator,Stage III Adult Immunoblastic Lymphoma,0
13851,Type - attribute,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13852,Group A (qualifier value),Diffuse malignant mesothelioma,0
13853,Brain,Stage IB Pancreatic Cancer AJCC v8,0
13854,Tests (qualifier value),Airway Hemangioma,0
13855,Containing (qualifier),Platinum-Resistant Lung Small Cell Carcinoma,0
13856,Partial,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13857,Call (Instruction),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13858,Specimen Source Codes - tumor,Type II Endometrial Adenocarcinoma,0
13859,other medicated shampoos in ATC,Squamous cell carcinoma of lip,0
13860,Transitory,Stage II Carcinoma of Penis,0
13861,Operative Surgical Procedures,Acute Undifferentiated Leukemia,0
13862,Version (morphologic abnormality),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13863,Person Name,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
13864,Cells,Stage I Adult Non-Hodgkin Lymphoma,0
13865,Classification,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13866,Growth action,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13867,physiological aspects,Non-Hodgkin Lymphoma During Pregnancy,0
13868,Persons,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13869,Concept model range (foundation metadata concept),Endometrial Small Cell Carcinoma,0
13870,Thyroid carcinoma,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
13871,Most,Recurrent Uveal Melanoma,0
13872,Experimental Organism Basal Cell Carcinoma,Leptomeningeal sarcoma,0
13873,Ability,Carcinoma of urinary bladder,0
13874,Raised,ROSE Cluster 3,0
13875,human MUC1 protein,Carcinoma of submandibular gland,0
13876,Inch Unit of Length,Carcinoma of urinary bladder,0
13877,Less Than,Intestinal Neuroendocrine Carcinoma,0
13878,melanoma,Nasal cavity carcinoma,0
13879,Geographic state,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13880,Present,Benign squamous cell tumor,0
13881,Primary,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13882,Manufactured form,Thymic Clear Cell Carcinoma,0
13883,omit,Liver Lymphangioma,0
13884,pharmacotherapeutic,Malignant Testicular Sertoli Cell Tumor,0
13885,Lymphoma,Type II Endometrial Adenocarcinoma,0
13886,60%,Digestive System Hodgkin Lymphoma,0
13887,solid substance,Stage II Fallopian Tube Cancer,0
13888,Cardiac Lead Procedure,Primary Cutaneous Plasmablastic Lymphoma,0
13889,Occur (action),Malignant Neoplasm with Regional Lymph Node Involvement,0
13890,Greater,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13891,Togo,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
13892,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13893,Epithelial cell count (procedure),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13894,Palliative Care,Stage III Adult Immunoblastic Lymphoma,0
13895,Negation,Adenocarcinoma,0
13896,Common (qualifier value),Cervical Fibroepithelial Polyp,0
13897,Malignant tumor of cervix,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13898,Have Weight Loss,Tonsillar Carcinoma,0
13899,Smear - instruction imperative,Kaposi's sarcoma of skin,0
13900,Greater,Gallbladder adenoma,0
13901,United States,Larynx carcinoma recurrent,0
13902,To,Acute lymphadenitis,0
13903,Frequently,Advanced Uterine Corpus Carcinosarcoma,0
13904,Used by,embryonal rhabdomyosarcoma of prostate,0
13905,Support,embryonal rhabdomyosarcoma of prostate,0
13906,Involvement with,Nasal cavity carcinoma,0
13907,include - SetOperator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13908,Splitting,Kaposi's sarcoma of skin,0
13909,Similarity,Multiple Skull Base Meningiomas,0
13910,Have Weight Loss,Non-Metastatic Gestational Trophoblastic Tumor,0
13911,Often - answer to question,Platinum-Resistant Lung Small Cell Carcinoma,0
13912,Cure (remedy),Mixed astrocytoma-ependymoma,0
13913,Neoplasms,Stage IV Childhood Non-Hodgkin Lymphoma,0
13914,Coloring Excipient,Refractory Bladder Carcinoma,0
13915,CDISC SDTM Procedure Terminology,clear cell adenocarcinoma of gallbladder,0
13916,Etiology aspects,Pancreatic Endocrine Carcinoma,0
13917,Count of entities,Benign Carotid Body Paraganglioma,0
13918,Congenital Abnormality,Liver Cavernous Hemangioma,0
13919,Occurrence Indicator,Cerebral Primitive Neuroectodermal Tumor,0
13920,Function Axis,Basal Cell Ameloblastoma,0
13921,More Often than Once a Day,Testicular cancer metastatic,0
13922,status - In progress,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13923,Spreading (qualifier value),Germinoma,0
13924,Take,Blepharal carcinoma,0
13925,Embryonic tissue,Liver Lymphangioma,0
13926,Experimental Result,Precursor B-lymphoblastic lymphoma stage II,0
13927,Mixed Salivary Gland Tumor,Refractory Barrett Esophagus,0
13928,Genetic Predisposition to Disease,Pancreatic carcinoma,0
13929,Direct (qualifier),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13930,DNA,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13931,Proton Pump Inhibitors,Gallbladder adenoma,0
13932,To,Rhabdomyosarcoma with ganglionic differentiation,0
13933,Lymphocyte,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13934,Increased frequency of micturition,Childhood Choriocarcinoma,0
13935,Front of neck,Refractory Ependymoma,0
13936,Sebaceous Glands,Deep Leiomyoma,0
13937,Form:Finding:Point in time:{Setting}:Document:{Role},Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13938,Specialized,Funisitis (disorder),0
13939,Two,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13940,Statistical mean,Stage I Adult Non-Hodgkin Lymphoma,0
13941,Asia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13942,Self,Noninfiltrating Intraductal Carcinoma,0
13943,Frequently,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13944,Manufactured sign,Adenocarcinoma,0
13945,Immune,Kaposi's sarcoma of skin,0
13946,Neoplasms,Angiosarcoma of liver,0
13947,include - SetOperator,Atypical Lobular Breast Hyperplasia,0
13948,Back Pain,Maxillary Sinus Adenoid Cystic Carcinoma,0
13949,Specimen Source Codes - Respiratory,Stage III Cutaneous Melanoma AJCC v6,0
13950,Tryptophanase,Trichilemmocarcinoma,0
13951,peripheral blood,Xeroderma pigmentosum,0
13952,Call (Instruction),Type II Endometrial Adenocarcinoma,0
13953,Neoplasm Metastasis,Granular Cell Leiomyosarcoma,0
13954,Have Pain,Astrocytoma of brain,0
13955,Negation,Locally Advanced Squamous Cell Carcinoma,0
13956,Less often,Engraftment syndrome,0
13957,Fungus (lab result),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13958,Human body,Papillary squamous cell carcinoma,0
13959,Including (qualifier),Methotrexate-Associated Hodgkin Lymphoma,0
13960,Not Applicable,Locally Advanced Squamous Cell Carcinoma,0
13961,Physician:Identifier:Point in time:^Patient:Nominal,Testicular cancer metastatic,0
13962,PSA Level Greater than Fifty,non-Hodgkin's lymphoma of spleen,0
13963,Shortened,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13964,fluid - substance,Childhood Central Nervous System Immature Teratoma,0
13965,Categories,Angiosarcoma of liver,0
13966,Malignant Neoplasms,Adenocarcinoma of the prostate metastatic,0
13967,Homo sapiens,Human Papillomavirus-Related Carcinoma,0
13968,Diagnosis,Mucinous adenocarcinoma gastric,0
13969,Benign,Pancreatic carcinoma,0
13970,Often - answer to question,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
13971,Never (frequency),Childhood Lymphoma,0
13972,20%,Leiomyoma of Gallbladder,0
13973,Biological Response Modifiers,Acute Undifferentiated Leukemia,0
13974,Color change,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13975,Spreading (qualifier value),sarcoma of spinal cord,0
13976,Primary malignant neoplasm,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13977,Spreading (qualifier value),Liver Lymphangioma,0
13978,Obesity,Benign tumor of eyelid,0
13979,Protons,clear cell adenocarcinoma of gallbladder,0
13980,Pressure (finding),Type II Endometrial Adenocarcinoma,0
13981,National origin,Diffuse malignant mesothelioma,0
13982,Cerebrum,de novo Myelodysplastic Syndrome,0
13983,Location of Pharyngeal Residue Following Swallowing,Benign Anal Granular Cell Tumor,0
13984,One,Cerebral hemangioma,0
13985,Frequently,Refractory Barrett Esophagus,0
13986,Affect (mental function),Locally Advanced Soft Tissue Sarcoma,0
13987,size,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13988,Pelvic Pain,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13989,Hypesthesia,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13990,Mass of body structure,squamous cell carcinoma of the thyroid gland,0
13991,Distention of blood vessel,FIGO Stage IVA Ovarian Cancer,0
13992,Neck,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13993,Sharing (Social Behavior),Benign neoplasm of eye,0
13994,Further,Digestive System Hodgkin Lymphoma,0
13995,Make - Instruction Imperative,Hereditary Diffuse Gastric Adenocarcinoma,0
13996,Benign Vascular Neoplasm,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13997,Manufactured form,Digestive System Hodgkin Lymphoma,0
13998,Round shape,Metastatic Neoplasm to the Gallbladder,0
13999,Mammal liver preparation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14000,Adult Classical Hodgkin Lymphoma,Undifferentiated Endocervical Sarcoma,0
14001,Weight decreased,Hyperplasia of pituitary gland,0
14002,Pisum sativum,Astrocytoma of brain,0
14003,Conventional (Clear Cell) Renal Cell Carcinoma,Bladder adenocarcinoma stage IV,0
14004,Symptoms,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
14005,Woman,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14006,Pyelonephritis,Thymic Clear Cell Carcinoma,0
14007,Group A (blood group),Recurrent Uveal Melanoma,0
14008,Symptoms aspect,Squamous cell carcinoma of lip,0
14009,Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
14010,Treatment Epoch,Mucosal Melanoma,0
14011,Not Applicable,Trichilemmocarcinoma,0
14012,Type A,Thymic Clear Cell Carcinoma,0
14013,Sometimes,Cerebral Primitive Neuroectodermal Tumor,0
14014,Tryptophanase,Carcinoma of submandibular gland,0
14015,Neuroendocrine Tumors,clear cell adenocarcinoma of gallbladder,0
14016,stage,Tumorlet,0
14017,Cancer Genus,Benign Carotid Body Paraganglioma,0
14018,Death (finding),Secondary malignant neoplasm of lymph node,0
14019,Ability,Chest Wall Fibromatosis,0
14020,Recurrent infections,Stage III Cutaneous Melanoma AJCC v6,0
14021,Injury due to exposure to external cause,Cancer of Urinary Tract,0
14022,Sarcoma of soft tissue,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14023,Pediculus humanus capitis (eukaryote),Unicystic ameloblastoma,0
14024,CD69 wt Allele,Childhood Anaplastic Large Cell Lymphoma,0
14025,biopsy characteristics,Leptomeningeal sarcoma,0
14026,Formation,Small Intestinal Villous Adenoma,0
14027,Then,Adenocarcinoma of the prostate metastatic,0
14028,Reported,Benign Anal Granular Cell Tumor,0
14029,Cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
14030,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14031,Imaging Techniques,Intraepithelial Melanocytic Hyperplasia,0
14032,Symptoms aspect,mucinous adenocarcinoma of gallbladder,0
14033,biopsy characteristics,Recurrent Primary Lymphoma of Bone,0
14034,General surgery specialty,Airway Hemangioma,0
14035,Severe (severity modifier),Clinical Stage I Cutaneous Melanoma AJCC v8,0
14036,Malignant - descriptor,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14037,Bladder Neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14038,Immunotherapy,Squamous cell carcinoma of lip,0
14039,Group A (blood group),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
14040,Process,Giant cell angiofibroma,0
14041,Human Cells,Mucinous adenocarcinoma gastric,0
14042,Operative Surgical Procedures,Malignant melanoma of eyelid,0
14043,Occurrence,Clonal Hematopoiesis of Indeterminate Potential,0
14044,Act Relationship Subset - previous,Hereditary corneal dystrophy,0
14045,Mass of body structure,Type II Endometrial Adenocarcinoma,0
14046,Increase,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14047,First (number),Childhood Central Nervous System Ganglioneuroblastoma,0
14048,Removing (action),Bladder adenocarcinoma stage IV,0
14049,Example,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14050,Decision,ICHTHYOSIS,0
14051,Increased risk for cancer,Mixed astrocytoma-ependymoma,0
14052,Airway structure,Advanced Lung Carcinoma,0
14053,Study Site,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
14054,Eye lid,Undifferentiated Endocervical Sarcoma,0
14055,Known,Acute Undifferentiated Leukemia,0
14056,How Often Shortness of Breath,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14057,Patient Reported Outcome Stem,Extra-Adrenal Paraganglioma,0
14058,Viral,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14059,Aspects of disease screening,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14060,Following,Undifferentiated Endocervical Sarcoma,0
14061,Lower (action),Pancreatic carcinoma,0
14062,+5,Intestinal Metaplasia of Bladder Urothelium,0
14063,Highest,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14064,Slightly Agree,Recurrent Uveal Melanoma,0
14065,Biopsy,Recurrent Uveal Melanoma,0
14066,What subject filter - Result,Endometrial Small Cell Carcinoma,0
14067,Two,Thymic Clear Cell Carcinoma,0
14068,Aspect - Kind of quantity,Human Papillomavirus-Related Carcinoma,0
14069,Compresses (device),Airway Hemangioma,0
14070,Rest,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14071,Fatal,embryonal rhabdomyosarcoma of prostate,0
14072,Most,Familial Adenomatous Polyposis Associated Medulloblastoma,0
14073,Human body structure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14074,Capillary vessel,Unicystic ameloblastoma,0
14075,Immune system,Testicular cancer metastatic,0
14076,Five-year Survival Rate,embryonal rhabdomyosarcoma of prostate,0
14077,Unique,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14078,Colorectal Cancer Pathway,Ichthyosis,0
14079,Persons,Benign Carotid Body Paraganglioma,0
14080,Long,Tonsillar Carcinoma,0
14081,Sharing (Social Behavior),Carcinomatosis of peritoneal cavity,0
14082,Medical Device Emits Smoke,Familial Adenomatous Polyposis Associated Medulloblastoma,0
14083,Occurrence,Metastatic Carcinoma in the Lung,0
14084,Overall,papillary carcinoma of penis,0
14085,Usually,Adult Hepatocellular Carcinoma,0
14086,Report (document),Rhabdomyosarcoma with ganglionic differentiation,0
14087,pharmacotherapeutic,Acute Undifferentiated Leukemia,0
14088,Evidence,Acute lymphadenitis,0
14089,Clouded consciousness,Childhood Fibrillary Astrocytoma,0
14090,Malignant neoplasm of ovary,Recurrent Testicular Lymphoma,0
14091,Adult Lymphoma,Necrotizing Funisitis,0
14092,Stomach,Refractory Barrett Esophagus,0
14093,Person Observer,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14094,Early,Maxillary Sinus Adenoid Cystic Carcinoma,0
14095,Biomaterial Treatment,Endometrial Small Cell Carcinoma,0
14096,Lymphoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14097,Fatal,Stage IB Pancreatic Cancer AJCC v8,0
14098,Malignant Neoplasms,Female Breast Carcinoma,0
14099,Integumentary scale,Astrocytoma of brain,0
14100,European race,Unicystic ameloblastoma,0
14101,Helpful,Malignant neoplasm of thalamus,0
14102,early detection of cervical cancer,squamous cell carcinoma of the thyroid gland,0
14103,Difficulty walking,ROSE Cluster 3,0
14104,Human Age Group,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14105,Classes - encounter,Papillary cystic tumor,0
14106,Third grade in elementary school,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14107,Neck,Undifferentiated Endocervical Sarcoma,0
14108,Consistency,Spermatocytic seminoma,0
14109,Initial (abbreviation),Refractory Ependymoma,0
14110,Deterioration of status,clear cell adenocarcinoma of gallbladder,0
14111,True primary (qualifier value),Transitional cell carcinoma,0
14112,Solid Neoplasm,Xeroderma pigmentosum,0
14113,Melanoma Pathway,Hodgkin Disease,0
14114,Form:Finding:Point in time:{Setting}:Document:{Role},Malignant Neoplasm with Regional Lymph Node Involvement,0
14115,Tryptophanase,Childhood Central Nervous System Ganglioneuroblastoma,0
14116,American College of Cardiology/American Heart Association Lesion Complexity Score C,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
14117,Pathological Dilatation,Precursor B-lymphoblastic lymphoma stage II,0
14118,Complication Aspects,Testicular cancer metastatic,0
14119,Occur (action),Benign squamous cell tumor,0
14120,Retinoic Acid Response Element,Pancreatic Intraepithelial Neoplasia-3,0
14121,Complete Agreement,Refractory Ependymoma,0
14122,Liver Flavor,Colorectal Neuroendocrine Tumor G2,0
14123,Out (direction),Metastatic Kidney Carcinoma,0
14124,Case (situation),Splenic Manifestation of Hairy Cell Leukemia,0
14125,Very,Localized Askin Tumor,0
14126,Sarcoma - category (morphologic abnormality),Precursor B-lymphoblastic lymphoma stage II,0
14127,Poverty,Gallbladder Adenocarcinoma,0
14128,Megakaryoblasts,embryonal rhabdomyosarcoma of prostate,0
14129,Seventh,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14130,Early,Uterine Cancer,0
14131,Trial Screening,Non-Metastatic Gestational Trophoblastic Tumor,0
14132,Morphology,Thymic Clear Cell Carcinoma,0
14133,Estimated,Metastatic Lung Small Cell Carcinoma,0
14134,radiotherapeutic,Metastatic Malignant Neoplasm in the Sellar Region,0
14135,Combined,Thymic Clear Cell Carcinoma,0
14136,dendritic spine neck,Refractory Ependymoma,0
14137,Histopathological aspects,Benign tumor of eyelid,0
14138,Obese build,Pancreatic carcinoma,0
14139,Body structure,Lipoma of small intestine,0
14140,Stress,Lung squamous cell carcinoma stage I,0
14141,combination of objects,Engraftment syndrome,0
14142,Frequently,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14143,Hardness,Type II Endometrial Adenocarcinoma,0
14144,Adult Lymphoma,embryonal rhabdomyosarcoma of prostate,0
14145,Embryonic Development,Recurrent Rhabdomyosarcoma,0
14146,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
14147,Females,Grade 3a Malignant Neoplasm,0
14148,Hereditary Diseases,Ovarian Carcinoid Tumor,0
14149,Chemotherapy,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14150,Solid Dose Form,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14151,70%,Rhabdomyosarcoma with ganglionic differentiation,0
14152,Malignant neoplasm of thyroid,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14153,Skeletal bone,Medulloblastoma,0
14154,Divide,Rhabdomyosarcoma with ganglionic differentiation,0
14155,Loss of appetite (finding),Malignant melanoma of eyelid,0
14156,Covers (device),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14157,Relationships,Unicystic ameloblastoma,0
14158,Most,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
14159,Physical Appearance,Benign Carotid Body Paraganglioma,0
14160,Chemotherapy Regimen,Childhood Fibrillary Astrocytoma,0
14161,Divide,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14162,Throat,Undifferentiated Endocervical Sarcoma,0
14163,Interstitial Fluid,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14164,Surgical aspects,Digestive System Hodgkin Lymphoma,0
14165,Duct (organ) structure,Diffuse malignant mesothelioma,0
14166,Human Papillomavirus Positive,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14167,Poliosis,Small Intestinal Villous Adenoma,0
14168,Somatic mutation,Locally Advanced Carcinoma,0
14169,Common (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14170,PER1 gene,Kaposi's sarcoma of extrahepatic bile duct,0
14171,Effect,Hodgkin Disease,0
14172,Adult Non-Hodgkin Lymphoma,Cervical Squamous Intraepithelial Neoplasia,0
14173,Growth,non-Hodgkin's lymphoma of spleen,0
14174,Occur (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
14175,Back,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14176,Confirmation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14177,Comparison,Acute lymphadenitis,0
14178,Call (Instruction),Refractory Barrett Esophagus,0
14179,Heartburn,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14180,How Much Distress Constipation,Vaginal Adenoid Cystic Carcinoma,0
14181,Sunlight,Bladder adenocarcinoma stage IV,0
14182,More Often than Once a Day,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14183,Most,Transitional cell carcinoma,0
14184,Reclassified,Chest Wall Fibromatosis,0
14185,Histologic type,Refractory Glioma,0
14186,Loss of appetite (finding),Ovarian Dermoid Cyst with Secondary Carcinoma,0
14187,Infrequent,Breast Apocrine Adenoma,0
14188,white blood cell type,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14189,Involvement with,Localized Ewing Sarcoma,0
14190,Stage 3 lower case b,clear cell adenocarcinoma of gallbladder,0
14191,Renal Cell Carcinoma,clear cell adenocarcinoma of gallbladder,0
14192,risk factors,Cerebral Primitive Neuroectodermal Tumor,0
14193,Occurrence Indicator,Stage II Hepatocellular Carcinoma AJCC v8,0
14194,Rare,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14195,Covered (qualifier value),Necrotizing Funisitis,0
14196,predictive factor,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14197,Lesion,Refractory Barrett Esophagus,0
14198,Type - attribute,Acantholytic squamous cell carcinoma,0
14199,Physical findings,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
14200,Elevated,Blepharal carcinoma,0
14201,Tryptophanase,Cancer of Urinary Tract,0
14202,Adult Hodgkin Lymphoma,sarcoma of spinal cord,0
14203,Hemorrhage,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
14204,Top (position),Splenic Manifestation of Hairy Cell Leukemia,0
14205,Age,Intraepithelial Melanocytic Hyperplasia,0
14206,Blood Circulation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14207,Late stage,Kaposi's sarcoma of skin,0
14208,Present,Low Grade Squamous Intraepithelial Neoplasia,0
14209,Chest Pain,Mucinous adenocarcinoma gastric,0
14210,Symptoms aspect,Urethral Carcinoma,0
14211,Present,Benign Anal Granular Cell Tumor,0
14212,Complete,Acute Undifferentiated Leukemia,0
14213,include - SetOperator,Atypical Lobular Breast Hyperplasia,0
14214,Slow Growing,Parathyroid Gland Adenocarcinoma,0
14215,Liquid substance,Benign tumor of eyelid,0
14216,Cessation of life,Localized Askin Tumor,0
14217,Tract,Diffuse malignant mesothelioma,0
14218,Large,Type II Endometrial Adenocarcinoma,0
14219,Cessation of life,Diffuse malignant mesothelioma,0
14220,Human body structure,ROSE Cluster 3,0
14221,Retinoic Acid Response Element,Mastocytosis,0
14222,Person Name,Endometrial Small Cell Carcinoma,0
14223,Blood Cells,Thymic Clear Cell Carcinoma,0
14224,Infiltration,Engraftment syndrome,0
14225,Often - answer to question,Ovarian germ cell choriocarcinoma stage IV,0
14226,Primary malignant neoplasm,Childhood Anaplastic Large Cell Lymphoma,0
14227,Often - answer to question,Acute Undifferentiated Leukemia,0
14228,Adipose tissue,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14229,Location of Pharyngeal Residue Following Swallowing,Trichilemmocarcinoma,0
14230,Cultured Cell Line,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14231,lymphatic cancer,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14232,Financial Account,adenosquamous carcinoma of breast,0
14233,Pharmaceutical Preparations,FIGO Stage II Ovarian Cancer,0
14234,Mass,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14235,Examination of skin,Melanomatosis,0
14236,Affect (mental function),Blepharal carcinoma,0
14237,Primary malignant neoplasm of lung,Clonal Hematopoiesis of Indeterminate Potential,0
14238,Worse,Bladder adenocarcinoma stage IV,0
14239,Morphology,Peripheral primitive neuroectodermal tumor of soft tissue,0
14240,New Zealand,Atypical Lobular Breast Hyperplasia,0
14241,Management Occupations,Recurrent Testicular Lymphoma,0
14242,Device tip (physical object),Kaposi's sarcoma of skin,0
14243,Continuance of life,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14244,ITGBL1 gene,Localized Malignant Neoplasm,0
14245,Groups,Lipoma of small intestine,0
14246,Rate,Occult Lung Adenosquamous Carcinoma,0
14247,Category Type,Kaposi's sarcoma of extrahepatic bile duct,0
14248,Hepatitis B,Multiple Skull Base Meningiomas,0
14249,Internal medicine specialty,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14250,Has difficulty doing (qualifier value),Locally Advanced Carcinoma,0
14251,Persons,Chondrosarcoma,0
14252,Form:Finding:Point in time:{Setting}:Document:{Role},Carcinoma of urinary bladder,0
14253,Subject Risk,Cartilaginous exostosis,0
14254,Duplicate,Female Breast Carcinoma,0
14255,Referring,Vaginal Adenoma,0
14256,Testis,Stage III Cutaneous Melanoma AJCC v6,0
14257,Body part,squamous cell carcinoma of the thyroid gland,0
14258,Numbers,Collecting Duct Carcinoma of the Kidney,0
14259,Fever,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
14260,Body tissue,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
14261,cell growth,Brain Tumor,0
14262,depend,Ichthyosis,0
14263,Juice,Kaposi's sarcoma of skin,0
14264,Etiology aspects,Stage II Carcinoma of Penis,0
14265,Diagnosis Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14266,Frequently,Small cell neuroendocrine carcinoma of bladder,0
14267,Population at Risk,Malignant Testicular Sertoli Cell Tumor,0
14268,Diabetes Mellitus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14269,Body cavities,Intestinal Neuroendocrine Carcinoma,0
14270,Cure (remedy),Cancer of Urinary Tract,0
14271,Widespread,Malignant Testicular Sertoli Cell Tumor,0
14272,Infrequent,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14273,month,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14274,IV number:ID:Pt:^Patient:Nom,Secondary malignant neoplasm of lymph node,0
14275,Nodule,Benign Carotid Body Paraganglioma,0
14276,SLC6A2 wt Allele,Heavy Chain Deposition Disease,0
14277,Increase,Melanomatosis,0
14278,Race,Microcystic meningioma,0
14279,Increase,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
14280,Occurrence Indicator,Carcinomatosis of peritoneal cavity,0
14281,Hypotension,Malignant Testicular Sertoli Cell Tumor,0
14282,55,Kaposi's sarcoma of skin,0
14283,Mass of body structure,Carcinomatosis of peritoneal cavity,0
14284,survival aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14285,Death (finding),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14286,Foreskin of penis,Localized Askin Tumor,0
14287,Lymphangioma,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14288,high - ActExposureLevelCode,Squamous cell carcinoma of lip,0
14289,Damage,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14290,Administration procedure,Refractory Bladder Carcinoma,0
14291,MALIGNANT benign,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14292,Body tissue,Squamous cell carcinoma of lip,0
14293,Local,Stage IB Lung Cancer AJCC v7,0
14294,Eyelash,Angiosarcoma of liver,0
14295,Rare,Stage I Adult Non-Hodgkin Lymphoma,0
14296,Primary malignant neoplasm,Carcinoma of urinary bladder,0
14297,gene therapy,Colorectal High Grade B-Cell Lymphoma,0
14298,Neuroectodermal Tumor,Malignant melanoma of eyelid,0
14299,Domain (area of knowledge),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
14300,Biomaterial Treatment,Acantholytic squamous cell carcinoma,0
14301,1+ Score,Splenic Manifestation of Hairy Cell Leukemia,0
14302,Examination of pharynx,Type II Endometrial Adenocarcinoma,0
14303,Reproductive History,Non-Metastatic Gestational Trophoblastic Tumor,0
14304,A Codes,Central Nervous System Yolk Sac Tumor,0
14305,Genes,Adult Acute Eosinophilic Leukemia,0
14306,Clinical trial protocol,Adult Hepatocellular Carcinoma,0
14307,Cerebral hemisphere structure (body structure),Recurrent Testicular Lymphoma,0
14308,Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14309,Measures,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14310,Presence of cells,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
14311,photoreactivating enzyme activity,Pancreatic Intraepithelial Neoplasia-3,0
14312,Diagnosis,Colorectal Neuroendocrine Tumor G2,0
14313,Qualitative form,Peripheral primitive neuroectodermal tumor of soft tissue,0
14314,Relationships,Unfavorable Non-Hodgkin Lymphoma,0
14315,CYP19A1 wt Allele,Malignant melanoma of eyelid,0
14316,mouth swelling,Uterine Cancer,0
14317,Indolent Non-Hodgkin Lymphoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14318,Negative Selection,Childhood Anaplastic Large Cell Lymphoma,0
14319,68,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14320,Inflammatory Myofibroblastic Tumor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14321,Departure - action,Non-Metastatic Gestational Trophoblastic Tumor,0
14322,diagnosis aspect,Splenic Manifestation of Hairy Cell Leukemia,0
14323,World Health Organization,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14324,various antiseptic throat preparations,Serous cystadenocarcinoma ovary,0
14325,Hematologic Tests,Blood Vessel Tumors,0
14326,Including (qualifier),Malignant neoplasm of gallbladder,0
14327,Include (action),Childhood Central Nervous System Ganglioneuroblastoma,0
14328,Cure (remedy),Metaplastic carcinoma of breast,0
14329,diagnosis aspect,Pancreatic Intraepithelial Neoplasia-3,0
14330,Have Been Vomiting,Intraepithelial Melanocytic Hyperplasia,0
14331,Very Much,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14332,Secretory Vesicles,Trabecular adenocarcinoma,0
14333,True primary (qualifier value),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
14334,Usual,Colorectal High Grade B-Cell Lymphoma,0
14335,Obstructed,Metaplastic carcinoma of breast,0
14336,Orchitis,Childhood Fibrillary Astrocytoma,0
14337,Unknown GENC,Giant cell angiofibroma,0
14338,Both ovaries,Bladder adenocarcinoma stage IV,0
14339,parent,Type II Endometrial Adenocarcinoma,0
14340,Cancer Other,Chest Wall Fibromatosis,0
14341,primary tumor,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
14342,Linear,Benign tumor of eyelid,0
14343,Narrow face,Serous cystadenocarcinoma ovary,0
14344,Skeletal bone,Noninfiltrating Intraductal Carcinoma,0
14345,Negation,Platinum-Resistant Lung Small Cell Carcinoma,0
14346,Include (action),ROSE Cluster 3,0
14347,Internal,Tonsillar Carcinoma,0
14348,Cumulative Survival Rate,High Grade Glandular Intraepithelial Neoplasia,0
14349,Ability,BRCA2 Syndrome,0
14350,Abnormal,Chondrosarcoma,0
14351,Both ovaries,Unfavorable Non-Hodgkin Lymphoma,0
14352,Face,Astrocytoma of brain,0
14353,Central African Republic,Thymic Clear Cell Carcinoma,0
14354,Disease,Tongue Alveolar Soft Part Sarcoma,0
14355,Lymphoma,Chondrosarcoma,0
14356,mucus layer,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14357,Sweat,Adult Hepatocellular Carcinoma,0
14358,Facial swelling (finding),Malignant melanoma of eyelid,0
14359,Common (qualifier value),Benign squamous cell tumor,0
14360,Congenital phimosis,Stage IV Penile Cancer AJCC v7,0
14361,Mucosa-Associated Lymphoid Tissue Lymphoma,Stage III Cutaneous Melanoma AJCC v6,0
14362,Entity Determiner - specific,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
14363,Including (qualifier),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14364,Personal appearance,Stage II Hepatocellular Carcinoma AJCC v8,0
14365,Symptoms,Carcinomatosis of peritoneal cavity,0
14366,Major <insect>,Carcinoma of urinary bladder,0
14367,Therapeutic procedure,Chondrosarcoma,0
14368,Rate,Tonsillar Carcinoma,0
14369,Clinical,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
14370,Affecting,Metaplastic carcinoma of breast,0
14371,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14372,Diagnosis,Adenocarcinoma of duodenum,0
14373,Have Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
14374,Numerous,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14375,Account number:Identifier:Point in time:^Patient:Nominal,Blepharal carcinoma,0
14376,Definitive,Female Breast Carcinoma,0
14377,Hemorrhage,Malignant neoplasm of subglottis,0
14378,spinal,Refractory Ependymoma,0
14379,Leg,Heavy Chain Deposition Disease,0
14380,Brain part,Spindle Cell Melanoma,0
14381,Occurrence Indicator,Hemangioma,0
14382,Highest,Localized Askin Tumor,0
14383,Cancer Registry,Acantholytic squamous cell carcinoma,0
14384,Exposure to,Malignant neoplasm of subglottis,0
14385,Array Feature,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14386,Tired,GIANT PIGMENTED HAIRY NEVUS,0
14387,50%,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14388,Carcinoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
14389,Ultrasonography,Thymic Clear Cell Carcinoma,0
14390,Due to,Non-Metastatic Gestational Trophoblastic Tumor,0
14391,Definitely Related to Intervention,Non-Metastatic Gestational Trophoblastic Tumor,0
14392,Cell Count,Adult Alveolar Soft Part Sarcoma,0
14393,3+ Score,Thyroid Hurthle Cell Carcinoma,0
14394,Malignant neoplasm of urinary bladder,Advanced Lung Carcinoma,0
14395,English race,Choroid Necrotic Melanoma,0
14396,Occurrence Indicator,Spongiotic dermatitis,0
14397,Vitamin Deficiency,Splenic Manifestation of Hairy Cell Leukemia,0
14398,Risk,Recurrent Uveal Melanoma,0
14399,Icterus,Thyroid Hurthle Cell Carcinoma,0
14400,High,Serous cystadenocarcinoma ovary,0
14401,Skin,Refractory Ependymoma,0
14402,Cerebral hemisphere structure (body structure),Malignant Neoplasm of Lung - Multiple Primary Sites,0
14403,Including (qualifier),Splenic Manifestation of Hairy Cell Leukemia,0
14404,Togo,Placental aromatase deficiency,0
14405,structure,Hodgkin lymphoma,0
14406,CDISC SEND Body System Terminology,Angiosarcoma of liver,0
14407,Positron-Emission Tomography,Acantholytic squamous cell carcinoma,0
14408,Definition,Localized Ewing Sarcoma,0
14409,Neuropil,Stage IB Pancreatic Cancer AJCC v8,0
14410,Removed,Cancer of Urinary Tract,0
14411,3+ Score,Undifferentiated Endocervical Sarcoma,0
14412,Folded structure,Medulloblastoma,0
14413,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14414,potential,Blood Vessel Tumors,0
14415,Obesity,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14416,Cancer Genus,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14417,Entity Determiner - specific,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14418,See,Astrocytoma of brain,0
14419,Biogenic Amines,Refractory Barrett Esophagus,0
14420,Similarity,Hereditary Diffuse Gastric Adenocarcinoma,0
14421,Clinical Study Case,Recurrent Testicular Lymphoma,0
14422,low exposure,Airway Hemangioma,0
14423,criteria,Gallbladder Adenocarcinoma,0
14424,Age-Years,Fourth Ventricle and Brain Stem Ependymal Tumor,0
14425,Togo,Localized Malignant Neoplasm,0
14426,Ethanol,Refractory Bladder Carcinoma,0
14427,Act Mood - intent,Endometrial Small Cell Carcinoma,0
14428,Name,Nasal cavity carcinoma,0
14429,Negative Finding,Cartilaginous exostosis,0
14430,Coughing,Kaposi's sarcoma of skin,0
14431,Sodium Chloride,Stage II Hepatocellular Carcinoma AJCC v8,0
14432,Chemotherapy Regimen,Refractory Barrett Esophagus,0
14433,Cell Count,Nasal cavity carcinoma,0
14434,2+ Score,Intraepithelial Melanocytic Hyperplasia,0
14435,Blood flow,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14436,*Type - Kind of quantity,FIGO Stage IVA Ovarian Cancer,0
14437,diagnosis aspect,Bladder squamous cell carcinoma stage I,0
14438,How Often Weight Loss,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14439,Glioma,Malignant Neoplasm with Regional Lymph Node Involvement,0
14440,Qualitative form,Epithelioid Sarcoma NCI Grade 3,0
14441,Poor - grade value,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14442,Normal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14443,Better than Others,Carcinomatosis of peritoneal cavity,0
14444,How Often Sweats,Digestive System Hodgkin Lymphoma,0
14445,Category Type,Chronic Myelomonocytic Leukemia-2,0
14446,Benign,Bladder Neuroendocrine Neoplasm,0
14447,Biological Response Modifier Therapy,Trichilemmocarcinoma,0
14448,Smaller,Kaposi's sarcoma of skin,0
14449,Only - dosing instruction fragment,Pancreatic carcinoma,0
14450,Pharmaceutical Preparations,Adenocarcinoma of the prostate metastatic,0
14451,Act Class - investigation,Anaplastic large cell lymphoma,0
14452,World Health Organization,benign mature teratoma of pancreas,0
14453,Cell Device,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14454,Prophylactic behavior,Xeroderma pigmentosum,0
14455,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14456,Muscle (organ),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14457,Eye foreign bodies,Carcinoma of submandibular gland,0
14458,Seventh,Locally Advanced Epithelioid Hemangioendothelioma,0
14459,Symptoms,Bladder squamous cell carcinoma stage I,0
14460,Metastasis,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14461,Specimen Source Codes - tumor,papillary carcinoma of penis,0
14462,Corticosteroid [EPC],Locally Advanced Carcinoma,0
14463,Abnormal size,Refractory Barrett Esophagus,0
14464,risk factors,Thyroid Hurthle Cell Carcinoma,0
14465,Illness: Cannot describe symptoms,Maxillary Sinus Adenoid Cystic Carcinoma,0
14466,Most,Stage III Adult Immunoblastic Lymphoma,0
14467,Common Specifications in HL7 V3 Publishing,Mucinous cystadenofibroma,0
14468,Microscopic description,Placental aromatase deficiency,0
14469,Involvement with,Larynx carcinoma recurrent,0
14470,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Chest Wall Fibromatosis,0
14471,Lymphatic Capillaries,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14472,Symptoms aspect,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
14473,diagnosis aspect,Liver Lymphangioma,0
14474,Closed,Breast Ductal Adenoma,0
14475,Specimen Source Codes - Lesion,Undifferentiated Endocervical Sarcoma,0
14476,site-specific telomere resolvase activity,Thyroid Hurthle Cell Carcinoma,0
14477,Overall,Cervical Fibroepithelial Polyp,0
14478,Gastrointestinal tract structure,Neoplasms,0
14479,Recombinant Erythropoietin,Granular Cell Leiomyosarcoma,0
14480,Life threatening - Event Consequence,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14481,Two,Cervical Fibroepithelial Polyp,0
14482,Surrounding (qualifier value),Childhood Thyroid Gland Follicular Carcinoma,0
14483,Retraction (finding),Refractory Barrett Esophagus,0
14484,Special,Breast Ductal Adenoma,0
14485,Frequently,Mucinous cystadenofibroma,0
14486,Table Cell Vertical Align - middle,Vaginal Adenoid Cystic Carcinoma,0
14487,Therapeutic procedure,Adult Acute Eosinophilic Leukemia,0
14488,Separated from cohabitee,papillary carcinoma of penis,0
14489,Base - General Qualifier,Multiple Skull Base Meningiomas,0
14490,Certain (qualifier value),Brain Tumor,0
14491,Subtype (attribute),ICHTHYOSIS,0
14492,Biological Transport,Choroid Necrotic Melanoma,0
14493,How Often Weight Loss,Medulloblastoma,0
14494,International Statistical Classification of Diseases and Related Health Problems,FIGO Stage IVA Ovarian Cancer,0
14495,Stroma,non-Hodgkin's lymphoma of spleen,0
14496,Negation,Benign Anal Granular Cell Tumor,0
14497,Cervical Intraepithelial Neoplasia,Brain Ependymoma,0
14498,glycosylation,Melanomatosis,0
14499,Shortened,Chronic Myelomonocytic Leukemia-2,0
14500,Science of Statistics,Digestive System Hodgkin Lymphoma,0
14501,Back Pain,Testicular cancer metastatic,0
14502,Category Type,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14503,Edema,Heavy Chain Deposition Disease,0
14504,Common Specifications in HL7 V3 Publishing,Localized Askin Tumor,0
14505,Human body,Extracranial Neuroblastoma,0
14506,Malignant Neoplasms,Cervical Squamous Intraepithelial Neoplasia,0
14507,Science of Etiology,Stage IV Childhood Non-Hodgkin Lymphoma,0
14508,Smear - instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14509,Disease,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
14510,100%,Intraepithelial Melanocytic Hyperplasia,0
14511,Occurrence,Recurrent Rhabdomyosarcoma,0
14512,Examined,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14513,Human Cells,Diffuse malignant mesothelioma,0
14514,chapter,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14515,85,gliosarcoma,0
14516,Sometimes,Unfavorable Non-Hodgkin Lymphoma,0
14517,Neuroblastoma,Childhood Fibrillary Astrocytoma,0
14518,Mental association,Thymic Clear Cell Carcinoma,0
14519,B-Lymphocytes,clear cell adenocarcinoma of gallbladder,0
14520,Occurrence Indicator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14521,Color change,Necrotizing Funisitis,0
14522,Lymphocyte,Extra-Adrenal Paraganglioma,0
14523,Brain,Collecting Duct Carcinoma of the Kidney,0
14524,Ovary,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14525,Childhood Embryonal Rhabdomyosarcoma,Microcystic meningioma,0
14526,Biomaterial Treatment,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
14527,Neoplasms,Small cell neuroendocrine carcinoma of bladder,0
14528,Serous Membrane,Kaposi's sarcoma of extrahepatic bile duct,0
14529,Including (qualifier),embryonal rhabdomyosarcoma of prostate,0
14530,Togo,Medulloblastoma,0
14531,Posterior cerebral commissure,Acute lymphadenitis,0
14532,Including (qualifier),Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
14533,Followed by,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14534,Cancer Genus,Benign neoplasm of thorax,0
14535,risk factors,Precursor B-lymphoblastic lymphoma stage II,0
14536,Tumor Subtype,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14537,Bladder Neoplasm,Heavy Chain Deposition Disease,0
14538,Diagnosis Study,Malignant melanoma of eyelid,0
14539,Content Creation Date,Acantholytic squamous cell carcinoma,0
14540,Decrease in appetite,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14541,Exposure to,Cancer of Urinary Tract,0
14542,Malignant - descriptor,Unicystic ameloblastoma,0
14543,include - SetOperator,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14544,Childhood Solid Neoplasm,Cerebral Primitive Neuroectodermal Tumor,0
14545,Firstly,Hodgkin lymphoma,0
14546,Main,Benign neoplasm of eye,0
14547,Cancer Genus,Malignant melanoma of eyelid,0
14548,mast-,Squamous cell carcinoma of lip,0
14549,Vagina,Undifferentiated Endocervical Sarcoma,0
14550,Occurrence,Refractory Bladder Carcinoma,0
14551,Location,Testicular cancer metastatic,0
14552,Malignant Epithelial Cell,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
14553,Circulatory System Process,FIGO Stage IVA Ovarian Cancer,0
14554,Network Device,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14555,Hemorrhage,Human Papillomavirus-Related Carcinoma,0
14556,Natural History,Recurrent Primary Lymphoma of Bone,0
14557,Followed by,Noninfiltrating Intraductal Carcinoma,0
14558,Liver Flavor,Transitional cell carcinoma,0
14559,Weight Loss,Thyroid Hurthle Cell Carcinoma,0
14560,Cancer Genus,Acute lymphadenitis,0
14561,Function (attribute),Cervical Adenomyoma,0
14562,Vaginal (intended site),Mucinous adenocarcinoma gastric,0
14563,Integral Membrane Proteins,Stage II Carcinoma of Penis,0
14564,Obese build,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14565,risk factors - observation list,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14566,Dietary Lead,Childhood Central Nervous System Ganglioneuroblastoma,0
14567,Account number:Identifier:Point in time:^Patient:Nominal,Precursor B-lymphoblastic lymphoma stage II,0
14568,Therapeutic procedure,Cartilaginous exostosis,0
14569,Second Suffix,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
14570,Usual Severity Itching,Undifferentiated Endocervical Sarcoma,0
14571,Specific qualifier value,Blepharal carcinoma,0
14572,Therapeutic radiology procedure,Human Papillomavirus-Related Carcinoma,0
14573,Probably,Squamous cell carcinoma of lip,0
14574,Glandular stomach,Breast Ductal Adenoma,0
14575,Main,Colorectal Neuroendocrine Tumor G2,0
14576,Chemotherapy,FIGO Stage II Ovarian Cancer,0
14577,Etiology aspects,FIGO Stage IVA Ovarian Cancer,0
14578,Communicable Diseases,Locally Advanced Carcinoma,0
14579,Geographic Locations,Female Breast Carcinoma,0
14580,95,Childhood Lymphoma,0
14581,Malignant neoplasm of skin,Malignant neoplasm of choroid,0
14582,800,Fourth Ventricle and Brain Stem Ependymal Tumor,0
14583,Common (qualifier value),Cherubism,0
14584,Common Specifications in HL7 V3 Publishing,Unfavorable Non-Hodgkin Lymphoma,0
14585,Covered (qualifier value),Xeroderma pigmentosum,0
14586,Cancer Registry,Carcinomatosis of peritoneal cavity,0
14587,Superfamily,Ovarian germ cell choriocarcinoma stage IV,0
14588,combination of objects,Spongiotic dermatitis,0
14589,Contain (action),Undifferentiated Endocervical Sarcoma,0
14590,Lung,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
14591,Body tissue,Leiomyoma of Gallbladder,0
14592,Pharmacotherapy,Adenocarcinoma of duodenum,0
14593,Body part,clear cell adenocarcinoma of gallbladder,0
14594,Sex Cord-Stromal Tumor,Hodgkin lymphoma,0
14595,Heart Ventricle,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14596,Closure,Refractory Barrett Esophagus,0
14597,diagnosis aspect,High Grade Glandular Intraepithelial Neoplasia,0
14598,leukemia,Fourth Ventricle and Brain Stem Ependymal Tumor,0
14599,Data operation - complete,Leptomeningeal sarcoma,0
14600,Isolation procedure,Vaginal Adenoid Cystic Carcinoma,0
14601,Disease,Cervical Squamous Intraepithelial Neoplasia,0
14602,Condition:Find:Pt:^Patient:Nom,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14603,Including (qualifier),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14604,Knowledge,adenosquamous carcinoma of breast,0
14605,peritoneal,Unicystic ameloblastoma,0
14606,shared attribute,FIGO Stage II Ovarian Cancer,0
14607,Usual Severity Itching,Adult Hepatocellular Carcinoma,0
14608,How Often Weight Loss,Benign Anal Granular Cell Tumor,0
14609,Result,Carcinomatosis of peritoneal cavity,0
14610,Area,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
14611,Precursor Cell Lymphoblastic Leukemia Lymphoma,Bladder adenocarcinoma stage IV,0
14612,Lymphocyte component of blood,Small cell neuroendocrine carcinoma of bladder,0
14613,Have Shortness of Breath question,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14614,Common Specifications in HL7 V3 Publishing,Melanomatosis,0
14615,Back Pain,Intraepithelial Melanocytic Hyperplasia,0
14616,Comparison,Locally Advanced Squamous Cell Carcinoma,0
14617,Qualitative form,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14618,Male population group,embryonal rhabdomyosarcoma of prostate,0
14619,Forecast of outcome,Ichthyosis,0
14620,Neoplastic Glandular Cell,Uterine Cancer,0
14621,Empty (qualifier),BRCA2 Syndrome,0
14622,Glioblastoma Multiforme,Papillary squamous cell carcinoma,0
14623,Similarity,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14624,Esophagitis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14625,Numbness,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14626,associated disease,Pancreatic carcinoma,0
14627,Mole,Acute Undifferentiated Leukemia,0
14628,Person Name,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14629,As Much as Desired,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
14630,Usually Need Help from Another Person for Arising,Peripheral primitive neuroectodermal tumor of soft tissue,0
14631,Divide,Childhood Central Nervous System Ganglioneuroblastoma,0
14632,How Much Distress Weight Loss,Adult Fibrolamellar Carcinoma,0
14633,Bothered by Vomiting,Diffuse malignant mesothelioma,0
14634,Cerebral hemisphere structure (body structure),Pancreatic Endocrine Carcinoma,0
14635,Symptoms,Intestinal Metaplasia of Bladder Urothelium,0
14636,Epithelial cell count (procedure),Metastatic Lung Small Cell Carcinoma,0
14637,Decade,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14638,Hereditary,clear cell adenocarcinoma of gallbladder,0
14639,How Much Distress Pain,Vaginal Adenoma,0
14640,Adult,Benign tumor of eyelid,0
14641,Occur (action),Type II Endometrial Adenocarcinoma,0
14642,Obesity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14643,Present,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14644,Slightly Agree,Digestive System Hodgkin Lymphoma,0
14645,Form:Finding:Point in time:{Setting}:Document:{Role},Ovarian Dermoid Cyst with Secondary Carcinoma,0
14646,Axilla,Fibroadenoma of breast,0
14647,Glia <plant>,Kaposi's sarcoma of extrahepatic bile duct,0
14648,Similarity,Acute Undifferentiated Leukemia,0
14649,Due to,Adult Acute Eosinophilic Leukemia,0
14650,Diagnosis,Acinar cell carcinoma of pancreas,0
14651,Neck,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14652,Offspring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14653,Automobile Driving,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14654,Patients,Basal Cell Ameloblastoma,0
14655,Blood Circulation,Squamous cell carcinoma of lip,0
14656,Primary malignant neoplasm,Endometrial Small Cell Carcinoma,0
14657,Spreading (qualifier value),Benign Carotid Body Paraganglioma,0
14658,% index,Advanced Uterine Corpus Carcinosarcoma,0
14659,Deoxyribonucleic Acid Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14660,Pigment cell,Melanomatosis,0
14661,Drug Administration Routes,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
14662,Entity Determiner - specific,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14663,<50,Malignant melanoma of eyelid,0
14664,Term Birth,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14665,Child,Squamous cell carcinoma of lip,0
14666,Lymphocyte,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
14667,Malignant neoplasm of breast,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14668,Bronchoconstriction [PE],Benign Carotid Body Paraganglioma,0
14669,Staging system,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14670,Carcinoma,Human Papillomavirus-Related Carcinoma,0
14671,Blood,Metastatic Carcinoma in the Lung,0
14672,Abdominal Cavity,Gallbladder Adenocarcinoma,0
14673,Malignant Neoplasms,Hair nevus,0
14674,unknown vaccine or immune globulin,Cancer of Urinary Tract,0
14675,Body part,Ovarian germ cell choriocarcinoma stage IV,0
14676,Linear,Locally Advanced Squamous Cell Carcinoma,0
14677,High Level,Refractory Barrett Esophagus,0
14678,Times,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
14679,Stomach structure,Acinar cell carcinoma of pancreas,0
14680,Worsening pattern,Malignant melanoma of eyelid,0
14681,Concept model domain,Airway Hemangioma,0
14682,Does stand alone,Choroid Necrotic Melanoma,0
14683,Details,Engraftment syndrome,0
14684,DNA Repair,Medulloblastoma,0
14685,Common (qualifier value),Recurrent Testicular Lymphoma,0
14686,include - SetOperator,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14687,Operative Surgical Procedures,Digestive System Hodgkin Lymphoma,0
14688,Covered (qualifier value),Childhood Lung Non-Small Cell Carcinoma,0
14689,Smoking,Primary Cutaneous Plasmablastic Lymphoma,0
14690,Pharmacotherapy,Refractory Barrett Esophagus,0
14691,Taxonomic,Ovarian germ cell choriocarcinoma stage IV,0
14692,Type - attribute,Cervical Fibroepithelial Polyp,0
14693,Genomics,Vaginal Adenoid Cystic Carcinoma,0
14694,System (unit of presentation),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14695,Superior mediastinum,Benign tumor of eyelid,0
14696,Negative - answer,Locally Advanced Carcinoma,0
14697,Biological Response Modifiers,Tongue Alveolar Soft Part Sarcoma,0
14698,Prognosis bad,Hair nevus,0
14699,Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14700,Malignant Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14701,Pelvic pain female,Locally Advanced Epithelioid Hemangioendothelioma,0
14702,Sometimes,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
14703,Cancer Genus,Primary Cutaneous Plasmablastic Lymphoma,0
14704,Digital Content Category,Localized Malignant Neoplasm,0
14705,Tired,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14706,Young Adult,Kaposi's sarcoma of skin,0
14707,How Much Distress Shortness of Breath,Serous cystadenocarcinoma ovary,0
14708,Type - attribute,Localized Askin Tumor,0
14709,Pseudotumor,Small intestine carcinoma,0
14710,Sunlight,gliosarcoma,0
14711,Front of neck,Unicystic ameloblastoma,0
14712,Term (lexical),Diffuse malignant mesothelioma,0
14713,Recommendation,Adult Alveolar Soft Part Sarcoma,0
14714,2+,Xeroderma pigmentosum,0
14715,Congenital chromosomal disease,Multiple Skull Base Meningiomas,0
14716,Column (arrangement),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
14717,Trial Subject Replacement,Adult Alveolar Soft Part Sarcoma,0
14718,Support,Peripheral primitive neuroectodermal tumor of soft tissue,0
14719,Therapeutic radiology procedure,Multiple Skull Base Meningiomas,0
14720,Throat,Fourth Ventricle and Brain Stem Ependymal Tumor,0
14721,Second edition,Peripheral primitive neuroectodermal tumor of soft tissue,0
14722,lobe,Adenocarcinoma,0
14723,Malignant neoplasm of lung,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14724,Experimental Result,Uterine Cancer,0
14725,Treatment Epoch,Tonsillar Carcinoma,0
14726,Degree Unit of Plane Angle,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14727,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Maxillary Sinus Adenoid Cystic Carcinoma,0
14728,Occurrence,Childhood Extragonadal Malignant Germ Cell Tumor,0
14729,Diagnosis Study,embryonal rhabdomyosarcoma of prostate,0
14730,Occurrence Indicator,Breast Ductal Adenoma,0
14731,Main,Cervical Adenomyoma,0
14732,diagnosis aspect,Giant cell angiofibroma,0
14733,Sarcoma - category (morphologic abnormality),Stage 0 Lip Carcinoma,0
14734,CDISC SEND Tumor Findings Results Terminology,Extracranial Neuroblastoma,0
14735,Hormone Therapy,FIGO Stage II Ovarian Cancer,0
14736,Sounds device,Necrotizing Funisitis,0
14737,Pelvic pain female,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14738,Manufactured form,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14739,Rare,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14740,survive,Endometrial Small Cell Carcinoma,0
14741,Poverty,Endometrial Small Cell Carcinoma,0
14742,Malignant Childhood Neoplasm,Mixed astrocytoma-ependymoma,0
14743,Intersex,Colorectal cancer,0
14744,How Much Distress Pain,Breast Ductal Adenoma,0
14745,Qualitative form,Female Breast Carcinoma,0
14746,Pelvic pain female,malignant lymphoma of pancreatic lymph nodes,0
14747,Morning,Diffuse malignant mesothelioma,0
14748,Observation Interpretation - intermediate,Cancer of Urinary Tract,0
14749,Area,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14750,therapeutic aspects,Cervical Fibroepithelial Polyp,0
14751,Version (morphologic abnormality),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14752,Operative Surgical Procedures,Choroid Necrotic Melanoma,0
14753,Separate,Digestive System Hodgkin Lymphoma,0
14754,Family history,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14755,Pediculus (eukaryote),Thymic Clear Cell Carcinoma,0
14756,Sunlight,Thymic Clear Cell Carcinoma,0
14757,More Often than Once a Day,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14758,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
14759,set (group),Botryoid-Type Embryonal Rhabdomyosarcoma,0
14760,Operation excision,Childhood Fibrillary Astrocytoma,0
14761,Occur (action),Malignant melanoma of eyelid,0
14762,Html Link Type - index,Malignant melanoma of eyelid,0
14763,Specific qualifier value,Metaplastic carcinoma of breast,0
14764,Hepatitis C Virus Infection,Ovarian germ cell choriocarcinoma stage IV,0
14765,Result,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14766,Often - answer to question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14767,Form:Finding:Point in time:{Setting}:Document:{Role},Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14768,Atypical,Kaposi's sarcoma of extrahepatic bile duct,0
14769,Most,Melanomatosis,0
14770,Appearance,Cancer of Urinary Tract,0
14771,Main,Blepharal carcinoma,0
14772,body system,Digestive System Hodgkin Lymphoma,0
14773,Biopsy,Mixed astrocytoma-ependymoma,0
14774,combination of objects,papillary carcinoma of penis,0
14775,NCI CTEP SDC Melanoma Sub-Category Terminology,Benign Ovarian Thecoma,0
14776,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Brain Tumor,0
14777,Person Name,Non-Hodgkin Lymphoma During Pregnancy,0
14778,Normal,Malignant melanoma of eyelid,0
14779,Cause of death.underlying,Thymoma malignant recurrent,0
14780,Type A,Benign Apocrine Neoplasm,0
14781,Increased Immunologic Activity [PE],Bladder adenocarcinoma stage IV,0
14782,Breaking down,Carcinoma of urinary bladder,0
14783,Endocrine Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14784,Bothered by Vomiting,Malignant Neoplasm with Regional Lymph Node Involvement,0
14785,Neuroectodermal Tumor,Adult Fibrolamellar Carcinoma,0
14786,Headache,Bladder squamous cell carcinoma stage I,0
14787,Mathematical Operator,Ovarian germ cell choriocarcinoma stage IV,0
14788,Derivation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14789,newly,Cartilaginous exostosis,0
14790,Pilot Projects,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14791,Term (lexical),Unicystic ameloblastoma,0
14792,Immune,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14793,Colon structure (body structure),Pilocytic astrocytoma of cerebellum,0
14794,Prebone tissue,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14795,Weight Loss,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
14796,Tumor cells,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14797,Ultraviolet Rays,Adult Alveolar Soft Part Sarcoma,0
14798,Operative Surgical Procedures,Metaplastic carcinoma of breast,0
14799,Smear - instruction imperative,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14800,Purple,Intraepithelial Melanocytic Hyperplasia,0
14801,Unified - Type of Agreement,Acute Undifferentiated Leukemia,0
14802,Life Expectancy Less than Twenty Years,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14803,50%,Metastatic Ductal Breast Carcinoma,0
14804,therapeutic aspects,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14805,Cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14806,Scientific Publication,Breast Ductal Adenoma,0
14807,operate <remove>,Testicular cancer metastatic,0
14808,Specimen Source Codes - Respiratory,Endometrial Small Cell Carcinoma,0
14809,treatment - ActInformationManagementReason,Nasal cavity carcinoma,0
14810,Version (morphologic abnormality),Stage III Cutaneous Melanoma AJCC v6,0
14811,Distal (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14812,Change in voice (finding),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14813,Radiotherapy Research,Recurrent Primary Lymphoma of Bone,0
14814,Occur (action),Metastatic Lung Neuroendocrine Neoplasm,0
14815,Most,Gallbladder Adenocarcinoma,0
14816,Science of Etiology,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
14817,consider,Benign squamous cell tumor,0
14818,Skin Specimen,papillary carcinoma of penis,0
14819,Study Control,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
14820,diagnosis aspect,Medulloblastoma,0
14821,Body tissue,FIGO Stage II Ovarian Cancer,0
14822,Gait normal,malignant lymphoma of pancreatic lymph nodes,0
14823,CD34 gene,Squamous cell carcinoma of lip,0
14824,Type - attribute,Xeroderma pigmentosum,0
14825,Extrinsic,Refractory Glioma,0
14826,65+,Stage III Cutaneous Melanoma AJCC v6,0
14827,Age of Onset,Malignant melanoma of eyelid,0
14828,Adult human body,Stage IB Pancreatic Cancer AJCC v8,0
14829,cell growth,Adult Hepatocellular Carcinoma,0
14830,Observation of attack,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14831,Clear,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
14832,<90,Acantholytic squamous cell carcinoma,0
14833,0%,Extracranial Neuroblastoma,0
14834,antibiotics,Blood Vessel Tumors,0
14835,Chemotherapy Regimen,Platinum-Resistant Lung Small Cell Carcinoma,0
14836,growth aspects,Heavy Chain Deposition Disease,0
14837,Including (qualifier),Metastatic Carcinoma in the Lung,0
14838,20%,Splenic Manifestation of Hairy Cell Leukemia,0
14839,Hodgkin Disease,Acantholytic squamous cell carcinoma,0
14840,Inferior Colliculus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14841,Malignant neoplasm of submandibular gland,Locally Advanced Carcinoma,0
14842,Occur (action),Adult Anaplastic Oligodendroglioma,0
14843,Clinical Effectiveness,Xeroderma pigmentosum,0
14844,Chemotherapy Regimen,Breast Ductal Adenoma,0
14845,Tumor cells,Choroid Epithelioid Cell Melanoma,0
14846,TRANSCRIPTION FACTOR,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14847,Science of Etiology,Collecting Duct Carcinoma of the Kidney,0
14848,Survival Rate,Type II Endometrial Adenocarcinoma,0
14849,Common (qualifier value),Neonatal leukemia,0
14850,SLC6A2 wt Allele,Childhood Anaplastic Large Cell Lymphoma,0
14851,Feel Tired question,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14852,Cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14853,Disease,Diffuse malignant mesothelioma,0
14854,Etiology aspects,Childhood Anaplastic Large Cell Lymphoma,0
14855,Epithelioid and spindle cell nevus,ROSE Cluster 3,0
14856,insensitivity,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14857,Cancer Genus,Stage 0 Penile Cancer AJCC v8,0
14858,year,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
14859,Cancer Genus,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14860,year,Basal Cell Ameloblastoma,0
14861,Cultured Cell Line,Medulloblastoma,0
14862,Tumor cells,Xeroderma pigmentosum,0
14863,Plant Roots,Undifferentiated Endocervical Sarcoma,0
14864,Frequently,Clonal Hematopoiesis of Indeterminate Potential,0
14865,Pruritus,FIGO Stage II Ovarian Cancer,0
14866,Changed status,Unicystic ameloblastoma,0
14867,Breast Carcinoma,Angiosarcoma of liver,0
14868,Acquisition (action),Anterior Urethral Malignant Neoplasm,0
14869,antigen binding,Kaposi's sarcoma of extrahepatic bile duct,0
14870,Persons,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14871,Common (qualifier value),Digestive System Hodgkin Lymphoma,0
14872,Complete Trisomy 21 Syndrome,Human Papillomavirus-Related Carcinoma,0
14873,soft tissue,Pancreatic carcinoma,0
14874,Tryptophanase,Collecting Duct Carcinoma of the Kidney,0
14875,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14876,Cells,Thyroid Hurthle Cell Carcinoma,0
14877,Fatigue,Localized Askin Tumor,0
14878,Characteristics,Unfavorable Non-Hodgkin Lymphoma,0
14879,Patient Reported Outcome Stem,Hodgkin Disease,0
14880,Less Than,Malignant melanoma of eyelid,0
14881,Yellow complexion,Medulloblastoma,0
14882,Xeroderma Pigmentosum,Localized Malignant Neoplasm,0
14883,Firm,Atypical Lobular Breast Hyperplasia,0
14884,Behavior,Brain Tumor,0
14885,Surgical aspects,Neoplasms,0
14886,Approximate,Pilocytic astrocytoma of cerebellum,0
14887,Second Suffix,Angiosarcoma of liver,0
14888,brain cell,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14889,Surgical aspects,Refractory Bladder Carcinoma,0
14890,Both ovaries,Benign tumor of eyelid,0
14891,Lead,Bladder Neuroendocrine Neoplasm,0
14892,Feel Tired question,Melanomatosis,0
14893,Make - Instruction Imperative,Cervical Adenomyoma,0
14894,pharmacotherapeutic,Liver Cavernous Hemangioma,0
14895,Well,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14896,Vaginal,Benign Ovarian Thecoma,0
14897,Injury due to exposure to external cause,Malignant neoplasm of thalamus,0
14898,Sometimes,Bladder squamous cell carcinoma stage I,0
14899,majority,Kaposi's sarcoma of skin,0
14900,Adult,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
14901,Basis - conceptual entity,Carcinoma ex pleomorphic adenoma of parotid gland,0
14902,Affecting,Deep Leiomyoma,0
14903,Neoplasms,Metaplastic carcinoma of breast,0
14904,Salivary Gland Tissue,Kaposi's sarcoma of skin,0
14905,Bone marrow: lymphocytes (finding),Childhood Lymphoma,0
14906,Decision,Lung squamous cell carcinoma stage I,0
14907,Obesity,Kaposi's sarcoma of skin,0
14908,Main,Small intestine carcinoma,0
14909,Occurrence,Carcinoma,0
14910,Dominant,Angiosarcoma of liver,0
14911,Ploidies,Acute Undifferentiated Leukemia,0
14912,Morphology,Testicular cancer metastatic,0
14913,Epithelial ovarian cancer,Placental aromatase deficiency,0
14914,Science of Statistics,Small Intestinal Villous Adenoma,0
14915,Often - answer to question,Female Breast Carcinoma,0
14916,Asia,Astrocytoma of brain,0
14917,Side,Locally Advanced Epithelioid Hemangioendothelioma,0
14918,Symptoms aspect,Mucinous adenocarcinoma gastric,0
14919,Mohs Surgery,Carcinoma of urinary bladder,0
14920,Disease,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14921,Vomiting,Adult Fibrolamellar Carcinoma,0
14922,Negative Surgical Margin,Stage IB Pancreatic Cancer AJCC v8,0
14923,Colon structure (body structure),Childhood Lymphoma,0
14924,Providing presence (regime/therapy),Cervical Adenomyoma,0
14925,Include (action),Benign Anal Granular Cell Tumor,0
14926,Biopsy,Intestinal Metaplasia of Bladder Urothelium,0
14927,various antiseptic throat preparations,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14928,Diabetes,Adult Hepatocellular Carcinoma,0
14929,shared attribute,Malignant Neoplasm with Regional Lymph Node Involvement,0
14930,Myelodysplastic Syndrome,Recurrent Uveal Melanoma,0
14931,indolent,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
14932,Affecting,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14933,Tests (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
14934,Covers (device),Localized Ewing Sarcoma,0
14935,Borg Category-Ratio 10 Perceived Exertion Score 5,ROSE Cluster 3,0
14936,Death (finding),Splenic Manifestation of Hairy Cell Leukemia,0
14937,Include (action),Mucinous cystadenofibroma,0
14938,Basis - conceptual entity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14939,include - SetOperator,Cancer of Urinary Tract,0
14940,Include (action),Metaplastic carcinoma of breast,0
14941,gastrointestinal,Diffuse malignant mesothelioma,0
14942,seen,Carcinomatosis of peritoneal cavity,0
14943,Social group,Hyperplasia of pituitary gland,0
14944,Tissue specific,Mucinous adenocarcinoma gastric,0
14945,CDISC SEND Tumor Findings Results Terminology,Locally Advanced Epithelioid Hemangioendothelioma,0
14946,Manual pelvic examination (procedure),Transitional cell carcinoma,0
14947,Entity Name Part Qualifier - birth,Malignant neoplasm of olfactory nerve,0
14948,VARIOUS DRUG CLASSES IN ATC,Mixed parotid tumor,0
14949,X-Ray Computed Tomography,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
14950,classic behavior,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14951,Tissue Specimen Code,Pancreatic carcinoma,0
14952,Treating,Testicular cancer metastatic,0
14953,Malignant neoplasm of skin,Childhood Lung Non-Small Cell Carcinoma,0
14954,Examination of cells,Mastocytosis,0
14955,Acquired Name,Fibroadenoma of breast,0
14956,Adult human body,Intestinal Metaplasia of Bladder Urothelium,0
14957,Group Object,Uterine Cancer,0
14958,photoreactivating enzyme activity,Localized Malignant Neoplasm,0
14959,Epithelial Cells,Hereditary Diffuse Gastric Adenocarcinoma,0
14960,To,Refractory Barrett Esophagus,0
14961,cell type,Pancreatic Intraepithelial Neoplasia-3,0
14962,Increase,Pancreatic carcinoma,0
14963,Science of Etiology,Splenic Manifestation of Hairy Cell Leukemia,0
14964,second (number),Clonal Hematopoiesis of Indeterminate Potential,0
14965,Anatomic Site,Localized Ewing Sarcoma,0
14966,Social group,Acantholytic squamous cell carcinoma,0
14967,Case (situation),Cancer of Urinary Tract,0
14968,Times,GIANT PIGMENTED HAIRY NEVUS,0
14969,Recent,Liver Lymphangioma,0
14970,Presence of cells,Carcinomatosis of peritoneal cavity,0
14971,Deafness,Diffuse malignant mesothelioma,0
14972,Completely - dosing instruction fragment,squamous cell carcinoma of the thyroid gland,0
14973,Time,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
14974,Carcinoma of bladder,Ovarian germ cell choriocarcinoma stage IV,0
14975,Diagnostic Imaging,Recurrent Uveal Melanoma,0
14976,Glioblastoma Multiforme,Heavy Chain Deposition Disease,0
14977,high - ActExposureLevelCode,Secondary malignant neoplasm of lymph node,0
14978,Common Specifications in HL7 V3 Publishing,Cartilaginous exostosis,0
14979,Sodium Cation,sarcoma of spinal cord,0
14980,Case unit dose,Ichthyoses,0
14981,Epithelial cell count (procedure),Pancreatic Intraepithelial Neoplasia-3,0
14982,Increasing,Thyroid Hurthle Cell Carcinoma,0
14983,Case (situation),Mucosal Melanoma,0
14984,How Often Weight Loss,FIGO Stage II Ovarian Cancer,0
14985,63,Lung Mucinous Cystadenoma,0
14986,Initially,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14987,Back,Bladder adenocarcinoma stage IV,0
14988,Endocervical epithelium,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14989,During,Metaplastic carcinoma of breast,0
14990,common types,Stage IB Lung Cancer AJCC v7,0
14991,Diagnosis,Ovarian Carcinoid Tumor,0
14992,Changing,Undifferentiated Endocervical Sarcoma,0
14993,Cirrhosis,Angiosarcoma of liver,0
14994,veterans alcoholism screening test (VAST),FIGO Stage II Ovarian Cancer,0
14995,>90,Blepharal carcinoma,0
14996,combination of objects,Carcinoma of urinary bladder,0
14997,Arising,Deep Leiomyoma,0
14998,Oral Sex,Intraepithelial Melanocytic Hyperplasia,0
14999,Sometimes,Metaplastic carcinoma of breast,0
15000,Therapeutic procedure,Fibroadenoma of breast,0
15001,Area,Astrocytoma of brain,0
15002,Group A (blood group),FIGO Stage II Ovarian Cancer,0
15003,Usual,Melanomatosis,0
15004,Rare,Intracortical osteosarcoma,0
15005,Common (qualifier value),Stage III Cutaneous Melanoma AJCC v6,0
15006,User Group,Undifferentiated Endocervical Sarcoma,0
15007,Gait normal,Stage III Cutaneous Melanoma AJCC v6,0
15008,Event Seriousness - Significant,Non-Hodgkin Lymphoma During Pregnancy,0
15009,Ovarian Carcinoma,Familial Hemophagocytic Lymphocytosis,0
15010,(City) Block,Type II Endometrial Adenocarcinoma,0
15011,Person Observer,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15012,allowing,Occult Lung Adenosquamous Carcinoma,0
15013,Pharmaceutical Preparations,Leptomeningeal sarcoma,0
15014,Patients,Stage IB Pancreatic Cancer AJCC v8,0
15015,Outlines (document),Thymic Clear Cell Carcinoma,0
15016,cell growth,Splenic Manifestation of Hairy Cell Leukemia,0
15017,Blood Vessel,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15018,Cancer Genus,Advanced Lung Carcinoma,0
15019,+5,Vaginal Adenoid Cystic Carcinoma,0
15020,bony process,Thymoma malignant recurrent,0
15021,Natural Killer Cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15022,Shallow,Blepharal carcinoma,0
15023,Irritants,Female Breast Carcinoma,0
15024,Most,Liver Lymphangioma,0
15025,CEL gene,clear cell adenocarcinoma of gallbladder,0
15026,Project,Occult Lung Adenosquamous Carcinoma,0
15027,Administration procedure,Type II Endometrial Adenocarcinoma,0
15028,Percent normal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15029,Patient Monitoring,Ovarian germ cell choriocarcinoma stage IV,0
15030,Adult Lymphoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15031,Specimen Source Codes - tumor,Fibroadenoma of breast,0
15032,Bartholin Glands,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15033,Show,Digestive System Hodgkin Lymphoma,0
15034,Human Papillomavirus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15035,A Codes,Grade 3a Malignant Neoplasm,0
15036,/40,Digestive System Hodgkin Lymphoma,0
15037,Room of building - Study,Malignant Testicular Sertoli Cell Tumor,0
15038,Occurrence,Neoplasms,0
15039,High risk,Melanomatosis,0
15040,Cartilage,Germinoma,0
15041,Negation,Refractory Bladder Carcinoma,0
15042,melanocyte,Squamous cell carcinoma of lip,0
15043,Type - attribute,FIGO Stage IVA Ovarian Cancer,0
15044,Genes,Astrocytoma of brain,0
15045,Neoplasm Metastasis,Squamous cell carcinoma of lip,0
15046,Central neuroblastoma,Mucinous adenocarcinoma gastric,0
15047,B-Lymphocytes,squamous cell carcinoma of the thyroid gland,0
15048,700,Vaginal Adenoid Cystic Carcinoma,0
15049,Special,BRCA2 Syndrome,0
15050,Treatment Epoch,Ampulla of Vater Tubular Adenoma,0
15051,Malignant tumor of peritoneum,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15052,History of previous events,Locally Advanced Carcinoma,0
15053,Occurrence,Astrocytoma of brain,0
15054,Call (Instruction),Malignant neoplasm of subglottis,0
15055,Septum - general anatomical term,Mixed astrocytoma-ependymoma,0
15056,Timepoint,Serous cystadenocarcinoma ovary,0
15057,Breathing Distress Question,Acute Undifferentiated Leukemia,0
15058,Hormonal,Benign tumor of eyelid,0
15059,Chemotherapy Regimen,Microcystic meningioma,0
15060,Subependymal Giant Cell Astrocytoma,Refractory Ependymoma,0
15061,Body Site Modifier - Lower,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15062,Subcategory,Intraepithelial Melanocytic Hyperplasia,0
15063,incomplete spinal cord injury,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15064,Used by,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15065,Standard Treatment,Intestinal Neuroendocrine Carcinoma,0
15066,Present,Sarcomatoid Renal Cell Carcinoma,0
15067,Chicken laying egg for human food,Malignant melanoma of eyelid,0
15068,Diagnosis,Small intestine carcinoma,0
15069,abnormal growth by tissue,Ovarian Carcinoid Tumor,0
15070,Estrogen [EPC],Childhood Thyroid Gland Follicular Carcinoma,0
15071,Decision,Hereditary Diffuse Gastric Adenocarcinoma,0
15072,Present,Noninfiltrating Intraductal Carcinoma,0
15073,Adult human body,Extracranial Neuroblastoma,0
15074,Cessation of life,Adult Alveolar Soft Part Sarcoma,0
15075,Metastasis,Recurrent Uveal Melanoma,0
15076,Prenatal care,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15077,Major salivary gland structure,Thyroid Hurthle Cell Carcinoma,0
15078,Act Mood - intent,Funisitis (disorder),0
15079,84,Adult Fibrolamellar Carcinoma,0
15080,Physiological Processes,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15081,Treatment Epoch,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15082,How Much Distress Shortness of Breath,Mucinous adenocarcinoma gastric,0
15083,Unmarried,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15084,Togo,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15085,Help document,Kaposi's sarcoma of extrahepatic bile duct,0
15086,99,FIGO Stage II Ovarian Cancer,0
15087,Mammal liver preparation,Cerebral Primitive Neuroectodermal Tumor,0
15088,epithelial,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15089,Cartilage,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
15090,Abdominal Cavity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15091,Function Axis,Neonatal leukemia,0
15092,New,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15093,Feelings,Xeroderma pigmentosum,0
15094,inflammatory,Localized Malignant Neoplasm,0
15095,Slightly Able,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15096,Brain,Hereditary corneal dystrophy,0
15097,Form:Finding:Point in time:{Setting}:Document:{Role},Pancreatic carcinoma,0
15098,Benign Neoplasm,Platinum-Resistant Lung Small Cell Carcinoma,0
15099,german race,Liver Lymphangioma,0
15100,Glioblastoma Multiforme Pathway,Locally Advanced Squamous Cell Carcinoma,0
15101,Condition:Find:Pt:^Patient:Nom,Malignant neoplasm of thalamus,0
15102,Thick,embryonal rhabdomyosarcoma of prostate,0
15103,Occupations,sarcoma of spinal cord,0
15104,Young,Recurrent Rhabdomyosarcoma,0
15105,Human Papillomavirus Positive,Intestinal Metaplasia of Bladder Urothelium,0
15106,Financial Account,Squamous cell carcinoma of lip,0
15107,Cyst,Kaposi's sarcoma of extrahepatic bile duct,0
15108,More,Locally Advanced Soft Tissue Sarcoma,0
15109,Human body,Female Breast Carcinoma,0
15110,Containing (qualifier),Thymic Clear Cell Carcinoma,0
15111,Metastatic Neoplasm,Uterine Cancer,0
15112,Overall,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15113,Lymphocyte,papillary carcinoma of penis,0
15114,Salivary Glands,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15115,Radiation,Acute lymphadenitis,0
15116,Present,Undifferentiated Neuroblastoma,0
15117,seen,Blood Vessel Tumors,0
15118,Limited stage (cancer stage),Childhood Central Nervous System Immature Teratoma,0
15119,Vomiting,Breast Ductal Adenoma,0
15120,Prognosis:Find:Pt:^Patient:Nom,adenoid cystic carcinoma of lung,0
15121,trauma qualifier,Intraepithelial Melanocytic Hyperplasia,0
15122,Diet poor,Benign Apocrine Neoplasm,0
15123,Infrequent,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15124,Operative Surgical Procedures,Diffuse malignant mesothelioma,0
15125,second (number),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15126,Including (qualifier),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
15127,Anterior portion of neck,Medulloblastoma,0
15128,Near,Unfavorable Non-Hodgkin Lymphoma,0
15129,Known,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
15130,Manufactured form,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15131,English Language,Adrenal Rest Tumor,0
15132,Hour Times Percent,FIGO Stage II Ovarian Cancer,0
15133,Goes <invertebrate>,Xeroderma pigmentosum,0
15134,Cover - action,Thymic Atypical Carcinoid Tumor,0
15135,Vaginal intraepithelial neoplasia,Maxillary Sinus Adenocarcinoma,0
15136,Mass of skin,Childhood Lymphoma,0
15137,TRIM33 gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15138,Physical Examination,Melanomatosis,0
15139,occurrence characteristics,Refractory Ependymoma,0
15140,Body part,Blood Vessel Tumors,0
15141,Divide,Mixed astrocytoma-ependymoma,0
15142,/40,Undifferentiated Neuroblastoma,0
15143,Benign Neoplasm,Kaposi's sarcoma of skin,0
15144,Fatigue,Leptomeningeal sarcoma,0
15145,Parotid Gland,Squamous cell carcinoma of lip,0
15146,Process,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15147,High Mitosis-Karyorrhexis Index,Recurrent Uveal Melanoma,0
15148,Dysuria,Childhood Fibrillary Astrocytoma,0
15149,1000000,Maxillary Sinus Adenoid Cystic Carcinoma,0
15150,Type - attribute,Fibroadenoma of breast,0
15151,Abdominal Cavity,Digestive System Hodgkin Lymphoma,0
15152,Subtype (attribute),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15153,Glia <plant>,embryonal rhabdomyosarcoma of prostate,0
15154,Decision,Testicular cancer metastatic,0
15155,Definitely Related to Intervention,carcinoma of middle ear,0
15156,Granuloma,Digestive System Hodgkin Lymphoma,0
15157,Hemangioma,Localized Askin Tumor,0
15158,Medical service,Stage IB Pancreatic Cancer AJCC v8,0
15159,Hollings Cancer Center,Pleomorphic adenoma of parotid gland,0
15160,Specimen Source Codes - Macrophages,Acute Undifferentiated Leukemia,0
15161,Did not receive therapy or drug for,Mucinous neoplasm,0
15162,Melanoma Pathway,Xeroderma pigmentosum,0
15163,General surgery specialty,Diffuse malignant mesothelioma,0
15164,Including (qualifier),Melanomatosis,0
15165,Rare,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15166,Plasma cell dyscrasia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15167,Screening Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15168,Stem cell transplant,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15169,pharmacotherapeutic,Ovarian germ cell choriocarcinoma stage IV,0
15170,Gait normal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15171,Body tissue,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
15172,Net (qualifier),Splenic Manifestation of Hairy Cell Leukemia,0
15173,Dermatitis,Choroid Necrotic Melanoma,0
15174,Scientific Control,Pleomorphic adenoma of parotid gland,0
15175,Involvement with,Intestinal Neuroendocrine Carcinoma,0
15176,BRCA1 protein,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15177,To,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15178,3+ Answer to Question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15179,Responsible to,Intraepithelial Melanocytic Hyperplasia,0
15180,Radiotherapy Research,Benign squamous cell tumor,0
15181,Adult Lymphoma,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
15182,Language Ability - Sign,Cartilaginous exostosis,0
15183,Two,Non-Metastatic Gestational Trophoblastic Tumor,0
15184,Neuroglia,Localized Malignant Neoplasm,0
15185,Different,Undifferentiated Endocervical Sarcoma,0
15186,Males,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15187,A Codes,Refractory Ependymoma,0
15188,various antiseptic throat preparations,Spongiotic dermatitis,0
15189,Exposure to,Colorectal Mucin Poor Hyperplastic Polyp,0
15190,Good,Extracranial Neuroblastoma,0
15191,English [International Organization for Standardization 639-1 code en] language reference set,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15192,NCI CTEP SDC Melanoma Sub-Category Terminology,Pancreatic Intraepithelial Neoplasia-3,0
15193,Mixed (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15194,Prognosis bad,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15195,Tumor cells,mucinous adenocarcinoma of gallbladder,0
15196,Anatomic Site,Hemangioma,0
15197,Antibiotics for systemic use,Chest Wall Fibromatosis,0
15198,Increased risk,ROSE Cluster 3,0
15199,cure of disease,adenoid cystic carcinoma of lung,0
15200,Dairy Cream,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15201,Result,Lung Mucinous Cystadenoma,0
15202,Enneking High Surgical Grade,Undifferentiated Endocervical Sarcoma,0
15203,Congenital Abnormality,Carcinoma,0
15204,Pharmacotherapy,Benign Carotid Body Paraganglioma,0
15205,School Grade,Melanomatosis,0
15206,Symptoms aspect,Engraftment syndrome,0
15207,Adolescent (age group),Collecting Duct Carcinoma of the Kidney,0
15208,Cell Count,Adenocarcinoma,0
15209,Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15210,Complete,Unfavorable Non-Hodgkin Lymphoma,0
15211,survival aspects,Choroid Epithelioid Cell Melanoma,0
15212,Determined by,Mucinous adenocarcinoma gastric,0
15213,Appearance,Stage III Adult Immunoblastic Lymphoma,0
15214,Usual Severity Nausea,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15215,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15216,Mean Percent of Normal,Carcinoma of urinary bladder,0
15217,Name,Stage IB Pancreatic Cancer AJCC v8,0
15218,Image Feature,Uterine Cancer,0
15219,Base - General Qualifier,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15220,Different,Thymic Clear Cell Carcinoma,0
15221,Chemotherapy,Childhood Extragonadal Malignant Germ Cell Tumor,0
15222,Homo sapiens,Type II Endometrial Adenocarcinoma,0
15223,International Classification of Diseases for Oncology,Squamous cell carcinoma of lip,0
15224,Breast Cancer Type 1 Susceptibility Protein Measurement,Advanced Lung Carcinoma,0
15225,Inflammatory Bowel Diseases,Occult Lung Adenosquamous Carcinoma,0
15226,Often - answer to question,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15227,Swelling,Endometrial Small Cell Carcinoma,0
15228,KRT17 wt Allele,Thymic Clear Cell Carcinoma,0
15229,Adult Acute Megakaryoblastic Leukemia,Mucinous adenocarcinoma gastric,0
15230,shared attribute,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15231,Process,Intraepithelial Melanocytic Hyperplasia,0
15232,Clear,Thymoma malignant recurrent,0
15233,Case (situation),Low Grade Squamous Intraepithelial Neoplasia,0
15234,Dual,Recurrent Uveal Melanoma,0
15235,Ovary,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15236,Risk,embryonal rhabdomyosarcoma of prostate,0
15237,Carrying,Kaposi's sarcoma of skin,0
15238,Collagen Type I,FIGO Stage IVA Ovarian Cancer,0
15239,Death (finding),Cystadenocarcinoma,0
15240,Occur (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15241,Active License,Carcinoma of urinary bladder,0
15242,Brain,Carcinoma of urinary bladder,0
15243,Include (action),Advanced Lung Carcinoma,0
15244,Poor - grade value,Basal Cell Ameloblastoma,0
15245,incidence of cases,Fibroadenoma of breast,0
15246,Cause of death:Find:Pt:^Patient:Nom,Engraftment syndrome,0
15247,Type - attribute,Recurrent Testicular Lymphoma,0
15248,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
15249,Back structure,Adult Hepatocellular Carcinoma,0
15250,Medical History,Epithelioid Sarcoma NCI Grade 3,0
15251,GDF15 protein,Cancer of Urinary Tract,0
15252,Pancreatic carcinoma,Rhabdomyosarcoma with ganglionic differentiation,0
15253,Occurrence,Carcinoma of urinary bladder,0
15254,Body Fluids,Squamous cell carcinoma of lip,0
15255,Group A (qualifier value),Carcinoma,0
15256,ACACA wt Allele,Colorectal Neuroendocrine Tumor G2,0
15257,Diagnosis Study,Primary Cutaneous Plasmablastic Lymphoma,0
15258,veterans alcoholism screening test (VAST),Collecting Duct Carcinoma of the Kidney,0
15259,consider,Cerebral Primitive Neuroectodermal Tumor,0
15260,Fasting Status Indicator,Bladder adenocarcinoma stage IV,0
15261,T-Cell Development,Astrocytoma of brain,0
15262,How Often Felt Normal question,Chondrosarcoma,0
15263,Presentation,Tonsillar Carcinoma,0
15264,Pancreas,ICHTHYOSIS,0
15265,Carcinoma,Stage IV Penile Cancer AJCC v7,0
15266,Anatomic Site,Malignant neoplasm of choroid,0
15267,Operative Surgical Procedures,Childhood Central Nervous System Ganglioneuroblastoma,0
15268,Tissue injury,Metastatic Lung Small Cell Carcinoma,0
15269,Cancer Genus,Peripheral primitive neuroectodermal tumor of soft tissue,0
15270,Surgery specialty,Extracranial Neuroblastoma,0
15271,Present,Stage I Adult Non-Hodgkin Lymphoma,0
15272,Cells,Thyroid Hurthle Cell Carcinoma,0
15273,Pacemaker ECG Assessment,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
15274,diagnosis aspect,Recurrent Testicular Lymphoma,0
15275,Death (finding),Epithelioid Sarcoma NCI Grade 3,0
15276,Cell secretion,Localized Askin Tumor,0
15277,Only - dosing instruction fragment,Hyperplasia of pituitary gland,0
15278,Lead,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15279,Occurrence Indicator,Benign tumor of eyelid,0
15280,device aspects,Uterine Cancer,0
15281,Virus,Chronic Myelomonocytic Leukemia-2,0
15282,Cardiac Lead Procedure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15283,Malignant Neoplasms,Vaginal Adenoma,0
15284,2+,Secondary malignant neoplasm of lymph node,0
15285,CDISC SEND Tumor Findings Results Terminology,Fibroadenoma of breast,0
15286,Reported Term,Bladder squamous cell carcinoma stage I,0
15287,Percent of Abnormal Cells,Endometrial Small Cell Carcinoma,0
15288,Increase,FIGO Stage IVA Ovarian Cancer,0
15289,Uterine Fibroids,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
15290,Firstly,Transitional cell carcinoma,0
15291,Entire primordial sex cell,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15292,Human body,Atypical Lobular Breast Hyperplasia,0
15293,Diagnosis Study,Intraepithelial Melanocytic Hyperplasia,0
15294,Lung,non-Hodgkin's lymphoma of spleen,0
15295,shared attribute,Cartilaginous exostosis,0
15296,Analysis of substances,Urethral Carcinoma,0
15297,Related personal status,Uterine Cancer,0
15298,Status post,Metastatic Neoplasm to the Gallbladder,0
15299,Detection,Childhood Anaplastic Large Cell Lymphoma,0
15300,Characteristics,Recurrent Testicular Lymphoma,0
15301,75,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15302,Tumor site:Anat:Pt:Specimen:Nom,Adult Alveolar Soft Part Sarcoma,0
15303,Known,Platinum-Resistant Lung Small Cell Carcinoma,0
15304,First (number),Thymic Atypical Carcinoid Tumor,0
15305,Susceptibility (property) (qualifier value),Colorectal cancer,0
15306,Hematuria,Breast Ductal Adenoma,0
15307,Disease,Breast Ductal Adenoma,0
15308,bony process,FIGO Stage IVA Ovarian Cancer,0
15309,Usually,Cerebral Primitive Neuroectodermal Tumor,0
15310,Intestines,Adult Fibrolamellar Carcinoma,0
15311,Biomaterial Treatment,Recurrent Rhabdomyosarcoma,0
15312,contextual factors,embryonal rhabdomyosarcoma of prostate,0
15313,Pregnancy,Localized Askin Tumor,0
15314,month,Undifferentiated Neuroblastoma,0
15315,Oropharyngeal Carcinoma,Locally Advanced Epithelioid Hemangioendothelioma,0
15316,Neuron spine,malignant lymphoma of pancreatic lymph nodes,0
15317,One,Pilocytic astrocytoma of cerebellum,0
15318,Percent of Bacteria,Mastocytosis,0
15319,<90,Precursor B-lymphoblastic lymphoma stage II,0
15320,Smear test,Adult Alveolar Soft Part Sarcoma,0
15321,Biogenic Amines,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15322,Analysis,Type II Endometrial Adenocarcinoma,0
15323,Togo,Cartilaginous exostosis,0
15324,Growth action,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15325,Birth defects diagnosis:Find:Pt:^Patient:Nar,malignant lymphoma of pancreatic lymph nodes,0
15326,Result,Parathyroid Gland Adenocarcinoma,0
15327,Base - General Qualifier,gliosarcoma,0
15328,various other nasal preparations in ATC,Intestinal Neuroendocrine Carcinoma,0
15329,VIPR1 wt Allele,Unicystic ameloblastoma,0
15330,Involvement with,FIGO Stage II Ovarian Cancer,0
15331,Affect (mental function),Gallbladder Adenocarcinoma,0
15332,Prophylactic behavior,Chest Wall Fibromatosis,0
15333,Skin,Pleomorphic adenoma of parotid gland,0
15334,Fever,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15335,International Classification of Diseases for Oncology,Type II Endometrial Adenocarcinoma,0
15336,Pelvis,Testicular cancer metastatic,0
15337,Feature,Cerebral Primitive Neuroectodermal Tumor,0
15338,Substance amount,Malignant Neoplasm with Regional Lymph Node Involvement,0
15339,Sarcoma - category (morphologic abnormality),BRCA2 Syndrome,0
15340,Present,Hodgkin lymphoma,0
15341,Shapes,Thymic Atypical Carcinoid Tumor,0
15342,Affecting,Cervical Squamous Intraepithelial Neoplasia,0
15343,Human body,Stage IB Lung Cancer AJCC v7,0
15344,Rating (action),Vaginal Adenoma,0
15345,Nodulus cerebelli,Recurrent Uveal Melanoma,0
15346,How Often Vomiting,Refractory Barrett Esophagus,0
15347,Cancer/Testis Antigen,Mucinous adenocarcinoma gastric,0
15348,human AVP protein,Angiosarcoma of liver,0
15349,Syndrome,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
15350,Primary malignant neoplasm,Benign squamous cell tumor,0
15351,Large,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15352,Medications,Granular Cell Leiomyosarcoma,0
15353,Firstly,sarcoma of spinal cord,0
15354,Including (qualifier),Benign Anal Granular Cell Tumor,0
15355,Significant,Childhood Lymphoma,0
15356,Row (arrangement),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15357,Pilocytic Astrocytoma,Diffuse malignant mesothelioma,0
15358,*Type - Kind of quantity,Epithelioid Sarcoma NCI Grade 3,0
15359,fluid - substance,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15360,Rare,Low Grade Squamous Intraepithelial Neoplasia,0
15361,Risk,Epithelioid Sarcoma NCI Grade 3,0
15362,Simple,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15363,Certain (qualifier value),Malignant neoplasm of thalamus,0
15364,Reduced,Plexosarcoma,0
15365,Removing (action),Refractory Bladder Carcinoma,0
15366,Overall Publication Type,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15367,Set (Psychology),Noninfiltrating Intraductal Carcinoma,0
15368,Thyroid Gland,Maxillary Sinus Adenocarcinoma,0
15369,Hormone replacement therapy,Thymic Atypical Carcinoid Tumor,0
15370,Chemotherapy Regimen,Kaposi's sarcoma of skin,0
15371,Infrequent,Recurrent Rhabdomyosarcoma,0
15372,Decision,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15373,Solitary leiomyoma,Refractory Ependymoma,0
15374,CD69 protein,mucinous adenocarcinoma of gallbladder,0
15375,Squamous cell carcinoma - category,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15376,Sufficiently defined concept definition status (core metadata concept),Airway Hemangioma,0
15377,Used by,Clonal Hematopoiesis of Indeterminate Potential,0
15378,Tryptophanase,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15379,Oropharyngeal Carcinoma,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
15380,Iris (Eye),Neonatal leukemia,0
15381,Retinoic Acid Response Element,Cervical Squamous Intraepithelial Neoplasia,0
15382,combination of objects,Ovarian germ cell choriocarcinoma stage IV,0
15383,Blood capillaries,Refractory Bladder Carcinoma,0
15384,Life Threatening,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15385,Spreading (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15386,Recommendation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15387,Limited Lifting Ability,Childhood Anaplastic Large Cell Lymphoma,0
15388,Limited component (foundation metadata concept),Stage IV Colorectal Cancer AJCC v8,0
15389,Computed Tomography Study File,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15390,Occurrence,Breast Apocrine Adenoma,0
15391,Structure of germinal center of lymph node,embryonal rhabdomyosarcoma of prostate,0
15392,Known,Recurrent Uveal Melanoma,0
15393,Function (attribute),Metastatic Lung Small Cell Carcinoma,0
15394,Personal appearance,adenoid cystic carcinoma of lung,0
15395,Biogenic Amines,Kaposi's sarcoma of skin,0
15396,Spleen,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15397,shared attribute,Small Intestinal Villous Adenoma,0
15398,Aspects of signs,Engraftment syndrome,0
15399,Include (action),Cerebral hemangioma,0
15400,Most,Advanced Uterine Corpus Carcinosarcoma,0
15401,Type - attribute,Chest Wall Fibromatosis,0
15402,Europe,Nasal cavity carcinoma,0
15403,Increase,Nasal cavity carcinoma,0
15404,liposarcoma,Atypical Lobular Breast Hyperplasia,0
15405,Confirmation,Larynx carcinoma recurrent,0
15406,International Classification of Diseases for Oncology,Vaginal Adenoma,0
15407,shared attribute,High Grade Glandular Intraepithelial Neoplasia,0
15408,Exposure to,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15409,Sweating,Refractory Glioma,0
15410,Science of Etiology,Neoplasms,0
15411,Subgroup,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
15412,Common Specifications in HL7 V3 Publishing,Cervical Squamous Intraepithelial Neoplasia,0
15413,Skeletal bone,Benign Anal Granular Cell Tumor,0
15414,Aspects of disease screening,Squamous cell carcinoma of lip,0
15415,Lymphoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15416,Microcyst,Collecting Duct Carcinoma of the Kidney,0
15417,Dysplasia,Acute Undifferentiated Leukemia,0
15418,Unknown,Methotrexate-Associated Hodgkin Lymphoma,0
15419,Tumor cells,adenosquamous carcinoma of breast,0
15420,Set of nose hairs,Adenocarcinoma of duodenum,0
15421,Include (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15422,treatment options,Intraepithelial Melanocytic Hyperplasia,0
15423,Including (qualifier),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15424,Plasma,Melanomatosis,0
15425,Human body,Localized Ewing Sarcoma,0
15426,Table Cell Horizontal Align - left,Undifferentiated Endocervical Sarcoma,0
15427,FAT1 wt Allele,Benign Anal Granular Cell Tumor,0
15428,Very high,Precursor B-lymphoblastic lymphoma stage II,0
15429,Presence (property),Ovarian Dermoid Cyst with Secondary Carcinoma,0
15430,combination of objects,High Grade Glandular Intraepithelial Neoplasia,0
15431,System One,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15432,Balance (substance),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15433,/mm3,Malignant Neoplasm with Regional Lymph Node Involvement,0
15434,CDISC SEND Tumor Findings Results Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15435,Inguinal region,Low Grade Squamous Intraepithelial Neoplasia,0
15436,Options,Atypical Lobular Breast Hyperplasia,0
15437,Diagnosis Study,Methotrexate-Associated Hodgkin Lymphoma,0
15438,Togo,Recurrent Primary Lymphoma of Bone,0
15439,Fibrous,Bladder Neuroendocrine Neoplasm,0
15440,Abnormal host response,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15441,Regulation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15442,Rate,Hyperplasia of pituitary gland,0
15443,Arsenic measurement,Necrotizing Funisitis,0
15444,Treating,Cervical Fibroepithelial Polyp,0
15445,Known,Spongiotic dermatitis,0
15446,Infrequent,Serous cystadenocarcinoma ovary,0
15447,Response (communication),Engraftment syndrome,0
15448,Management Occupations,Carcinoma,0
15449,Group A (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
15450,Scalp structure,Adrenal Rest Tumor,0
15451,Contusions,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15452,Slow progression,Recurrent Testicular Lymphoma,0
15453,Alcohols,Choroid Necrotic Melanoma,0
15454,Intestines,Carcinoma of urinary bladder,0
15455,Seven-Day Report,Atypical Mesothelial Hyperplasia,0
15456,Digital Content Category,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15457,Complete Agreement,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15458,Body cavities,Grade 3a Malignant Neoplasm,0
15459,Colorectal Cancer Pathway,Acute lymphadenitis,0
15460,solid substance,Testicular cancer metastatic,0
15461,Including (qualifier),Cancer of Urinary Tract,0
15462,Outlines (document),BRCA2 Syndrome,0
15463,Infrequent,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
15464,Imaging Techniques,Prostate Lymphoma,0
15465,Response to treatment,Thymic Clear Cell Carcinoma,0
15466,Detection,Neonatal leukemia,0
15467,Building structure,Trichilemmocarcinoma,0
15468,Abnormal result,Stage II Carcinoma of Penis,0
15469,Healthy,Digestive System Hodgkin Lymphoma,0
15470,Pelvis,Pilocytic astrocytoma of cerebellum,0
15471,30%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15472,To,Recurrent Testicular Lymphoma,0
15473,various other intestinal adsorbents in ATC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15474,Levels (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15475,0%,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15476,diagnosis aspect,squamous cell carcinoma of the thyroid gland,0
15477,Part,Malignant neoplasm of thalamus,0
15478,Bowen's Disease,Stage 0 Penile Cancer AJCC v8,0
15479,Major,FIGO Stage II Ovarian Cancer,0
15480,Lymphocyte component of blood,Acute Undifferentiated Leukemia,0
15481,LATS1 wt Allele,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15482,erythropoietin activity,Refractory Barrett Esophagus,0
15483,Greater,Recurrent Testicular Lymphoma,0
15484,Malignant neoplasm of soft tissue,Low Grade Squamous Intraepithelial Neoplasia,0
15485,newly,Acantholytic squamous cell carcinoma,0
15486,Body tissue,Blepharal carcinoma,0
15487,Rare Diseases,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15488,include - SetOperator,FIGO Stage IVA Ovarian Cancer,0
15489,Smaller,Blood Vessel Tumors,0
15490,Logical Condition,Colorectal High Grade B-Cell Lymphoma,0
15491,Occurrence Indicator,Choroid Epithelioid Cell Melanoma,0
15492,Occurrence Indicator,Recurrent Primary Lymphoma of Bone,0
15493,Diabetes Mellitus,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15494,Absence (morphologic abnormality),Thyroid Hurthle Cell Carcinoma,0
15495,Subgroup A Nepoviruses,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15496,Small intestine carcinoma,Collecting Duct Carcinoma of the Kidney,0
15497,Blast count procedure,Bladder squamous cell carcinoma stage I,0
15498,Reaction,Tonsillar Carcinoma,0
15499,Tumor tissue sample,Uterine Cancer,0
15500,Problems - What subject filter,Anterior Urethral Malignant Neoplasm,0
15501,History,Adenocarcinoma of the prostate metastatic,0
15502,Late,Grade 3a Malignant Neoplasm,0
15503,0%,Recurrent Testicular Lymphoma,0
15504,Web Site,Mastocytosis,0
15505,SUSPENSORY,Human Papillomavirus-Related Carcinoma,0
15506,Retinoic Acid Response Element,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15507,peripheral blood,FIGO Stage IVA Ovarian Cancer,0
15508,Pancreatic Cyst,Bladder adenocarcinoma stage IV,0
15509,Alternative,BRCA2 Syndrome,0
15510,Non-Small Cell Lung Carcinoma,Mastocytosis,0
15511,chance,Stage I Adult Non-Hodgkin Lymphoma,0
15512,bony process,Metaplastic carcinoma of breast,0
15513,Form:Finding:Point in time:{Setting}:Document:{Role},Stage III Gastric Neuroendocrine Tumor AJCC v8,0
15514,Study,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15515,Average,Cerebral hemangioma,0
15516,Presentation,Pleomorphic adenoma of parotid gland,0
15517,size,Larynx carcinoma recurrent,0
15518,Have Itch,Bladder Neuroendocrine Neoplasm,0
15519,Group A (blood group),Fibroadenoma of breast,0
15520,Occur (action),High Grade Glandular Intraepithelial Neoplasia,0
15521,Leading,Pilocytic astrocytoma of cerebellum,0
15522,Nictitating Membrane,Thyroid Hurthle Cell Carcinoma,0
15523,World,Atypical Lobular Breast Hyperplasia,0
15524,<90,Papillary cystic tumor,0
15525,Treatment Epoch,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15526,Hereditary Diseases,Childhood Cerebellar Neoplasm,0
15527,System (unit of presentation),Recurrent Testicular Lymphoma,0
15528,shared attribute,Neonatal leukemia,0
15529,Primary,Benign Anal Granular Cell Tumor,0
15530,Hormonal Contraception,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15531,Clouded consciousness,Peripheral primitive neuroectodermal tumor of soft tissue,0
15532,Definitely Related to Intervention,Benign Anal Granular Cell Tumor,0
15533,Ability,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15534,Tumor Mass,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
15535,Infrequent,Multiple Skull Base Meningiomas,0
15536,Concept model range (foundation metadata concept),Giant cell angiofibroma,0
15537,Abdomen,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15538,Intercellular Junctions,Noninfiltrating Intraductal Carcinoma,0
15539,Weight Loss,Thymic Atypical Carcinoid Tumor,0
15540,Singular,Childhood Lung Non-Small Cell Carcinoma,0
15541,Academic degree,Basal Cell Ameloblastoma,0
15542,Human body structure,Carcinoma,0
15543,potential,Cancer of Urinary Tract,0
15544,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Metastatic Malignant Neoplasm in the Sellar Region,0
15545,Squamous cell carcinoma - category,Chronic Myelomonocytic Leukemia-2,0
15546,Skin,Intestinal Metaplasia of Bladder Urothelium,0
15547,Designated Blood Product Donation,Refractory Ependymoma,0
15548,Pale feces (finding),Cerebral Primitive Neuroectodermal Tumor,0
15549,Plasma,Rhabdomyosarcoma with ganglionic differentiation,0
15550,Shapes,malignant lymphoma of pancreatic lymph nodes,0
15551,Rosette formation,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15552,High,Digestive System Hodgkin Lymphoma,0
15553,Including (qualifier),Blepharal carcinoma,0
15554,Immunotherapy,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15555,Within,Astrocytoma of brain,0
15556,*Type - Kind of quantity,Hodgkin Disease,0
15557,High Level,Blepharal carcinoma,0
15558,More,Adenocarcinoma,0
15559,Chemotherapy,Anaplastic large cell lymphoma,0
15560,ovarian,Malignant neoplasm of thalamus,0
15561,Back structure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15562,Make - Instruction Imperative,sarcoma of spinal cord,0
15563,Fever,Adult Alveolar Soft Part Sarcoma,0
15564,Retinoid [EPC],Astrocytoma of brain,0
15565,Both ovaries,Methotrexate-Associated Hodgkin Lymphoma,0
15566,Turner Syndrome,Acantholytic squamous cell carcinoma,0
15567,Gland,Thyroid Hurthle Cell Carcinoma,0
15568,Known,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15569,Population Group,Clonal Hematopoiesis of Indeterminate Potential,0
15570,Screening,Squamous cell carcinoma of lip,0
15571,Moveable,Breast Ductal Adenoma,0
15572,Fracture,Malignant Neoplasm with Regional Lymph Node Involvement,0
15573,Tobacco user,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15574,Forecast of outcome,High Grade Glandular Intraepithelial Neoplasia,0
15575,To,Nasal cavity carcinoma,0
15576,Present,Squamous cell carcinoma of lip,0
15577,Poor - qualifier,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15578,World Health Organization,FIGO Stage II Ovarian Cancer,0
15579,Change in voice (finding),Central Nervous System Anaplastic Large Cell Lymphoma,0
15580,Odontogenic Epithelium,Cancer of Urinary Tract,0
15581,Most,Bladder adenocarcinoma stage IV,0
15582,Administration procedure,Undifferentiated Neuroblastoma,0
15583,Symptoms,Maxillary Sinus Adenocarcinoma,0
15584,Antigens,Extra-Adrenal Paraganglioma,0
15585,Glioblastoma,Ovarian germ cell choriocarcinoma stage IV,0
15586,Peripheral Nerves,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15587,15-19,Stage III Adult Immunoblastic Lymphoma,0
15588,Occurrence,Type II Endometrial Adenocarcinoma,0
15589,Extension,Neoplasms,0
15590,Cell Device,Anterior Urethral Malignant Neoplasm,0
15591,Fatigue,Papillary squamous cell carcinoma,0
15592,Adolescent (age group),Mucinous adenocarcinoma gastric,0
15593,Frequently,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15594,Numerous,Thymic Atypical Carcinoid Tumor,0
15595,Disease Screening,Localized Malignant Neoplasm,0
15596,Logical Condition,Plexosarcoma,0
15597,Data Transformation,Thyroid Hurthle Cell Carcinoma,0
15598,Mass of skin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15599,melanoma,Pleomorphic adenoma of parotid gland,0
15600,Vaginal Neoplasms,Tongue Alveolar Soft Part Sarcoma,0
15601,Imbrication (procedure),Malignant neoplasm of gallbladder,0
15602,Tumor Mass,Mucosal Melanoma,0
15603,Fatigue,Placental aromatase deficiency,0
15604,Relate - vinyl resin,Melanomatosis,0
15605,radiotherapeutic,Female Breast Carcinoma,0
15606,Intraocular (intended site),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15607,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Intraepithelial Melanocytic Hyperplasia,0
15608,Intravascular line,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15609,Skin,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15610,Massive,Adult Acute Eosinophilic Leukemia,0
15611,Science of Etiology,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15612,Specific qualifier value,Chondrosarcoma,0
15613,Low Level,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15614,Use of,Undifferentiated Endocervical Sarcoma,0
15615,photoreactivating enzyme activity,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15616,Endometrial Carcinoma,Non-Hodgkin Lymphoma During Pregnancy,0
15617,utilization qualifier,Adult Acute Eosinophilic Leukemia,0
15618,Case unit dose,Thymic Atypical Carcinoid Tumor,0
15619,Childhood Lymphoma,Tonsillar Carcinoma,0
15620,+2,Cerebral hemangioma,0
15621,Run-in Period,Malignant Neoplasm with Regional Lymph Node Involvement,0
15622,Malignant tumor of colon,Childhood Lymphoma,0
15623,Prevalence aspects,Airway Hemangioma,0
15624,Germ cell tumor,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15625,Body Weight,Metastatic Lung Small Cell Carcinoma,0
15626,Cessation of life,Endometrial Small Cell Carcinoma,0
15627,Availability of,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15628,Feel Pain,Stage III Adult Immunoblastic Lymphoma,0
15629,body system,Contact dermatitis due to alkali,0
15630,Treating,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15631,Referring,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15632,Primary malignant neoplasm,Recurrent Testicular Lymphoma,0
15633,Abdominal bloating,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15634,Due to,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15635,Malignant - descriptor,Carcinoma ex pleomorphic adenoma of parotid gland,0
15636,*Type - Kind of quantity,Recurrent Testicular Lymphoma,0
15637,Percent (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15638,Neuroglia,Papillary squamous cell carcinoma,0
15639,Malignant Neoplasms,Cervical Fibroepithelial Polyp,0
15640,Malignant Central Nervous System Neoplasm,Choroid Necrotic Melanoma,0
15641,pharmacotherapeutic,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15642,Adult Hodgkin Lymphoma,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
15643,Occurrence Indicator,Carcinoma ex pleomorphic adenoma of parotid gland,0
15644,Increase,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
15645,Financial Account,Advanced Uterine Corpus Carcinosarcoma,0
15646,WHO Central Nervous System Grade III,Thyroid Hurthle Cell Carcinoma,0
15647,Usual Severity Weight Loss,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15648,Offspring,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15649,Recommendation,Bladder squamous cell carcinoma stage I,0
15650,First sign,Recurrent Rhabdomyosarcoma,0
15651,low,Heavy Chain Deposition Disease,0
15652,Collection (action),Nasal cavity carcinoma,0
15653,Anterior,Mucinous adenocarcinoma gastric,0
15654,Science of Etiology,Vaginal Adenoma,0
15655,Post,Lipoma of small intestine,0
15656,Therapeutic radiology procedure,Metaplastic carcinoma of breast,0
15657,Esthesia,Cerebral Primitive Neuroectodermal Tumor,0
15658,Mutation,Intracortical osteosarcoma,0
15659,Cancer Genus,Recurrent Rhabdomyosarcoma,0
15660,Subject Risk,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15661,Lymphoma,Maxillary Sinus Adenocarcinoma,0
15662,Malignant neoplasm of thymus,Grade 3a Malignant Neoplasm,0
15663,high throughput analysis,Malignant neoplasm of thalamus,0
15664,Treating,Melanomatosis,0
15665,Large,Fibroadenoma of breast,0
15666,Pharmacotherapy,Benign Apocrine Neoplasm,0
15667,Posterolateral,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15668,intent,ROSE Cluster 3,0
15669,Surgical service,FIGO Stage II Ovarian Cancer,0
15670,Most Recent,Kaposi's sarcoma of skin,0
15671,Loss of appetite (finding),Fourth Ventricle and Brain Stem Ependymal Tumor,0
15672,Most,clear cell adenocarcinoma of gallbladder,0
15673,Chest Pain,Basal Cell Ameloblastoma,0
15674,All of the Time,Glomeruloid hemangioma,0
15675,Genus Homo,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15676,Childhood,Stage I Adult Non-Hodgkin Lymphoma,0
15677,Organ,Type II Endometrial Adenocarcinoma,0
15678,4+ Answer to question,Malignant melanoma of eyelid,0
15679,Erythropoiesis,Chest Wall Fibromatosis,0
15680,Term Birth,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15681,CDISC SEND Tumor Findings Results Terminology,Thyroid Hurthle Cell Carcinoma,0
15682,Rare,Locally Advanced Epithelioid Hemangioendothelioma,0
15683,Togo,Splenic Manifestation of Hairy Cell Leukemia,0
15684,Smaller,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15685,Usual Severity Weight Loss,Prostate Lymphoma,0
15686,Structure of germinal center of lymph node,Medulloblastoma,0
15687,Occur (action),Cervical Fibroepithelial Polyp,0
15688,Primary malignant neoplasm,Adult Hepatocellular Carcinoma,0
15689,Malignant neoplasm of skin,Splenic Manifestation of Hairy Cell Leukemia,0
15690,Benign,Bladder squamous cell carcinoma stage I,0
15691,Usual Severity Weight Loss,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15692,Pulmonary aspiration,Liver Lymphangioma,0
15693,Membrane,High Grade Glandular Intraepithelial Neoplasia,0
15694,Usually,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15695,Malignancy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15696,Treatment Epoch,Maxillary Sinus Adenocarcinoma,0
15697,Primary malignant neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15698,Carcinoma of lung,Astrocytoma of brain,0
15699,Analysis,Metastatic Neoplasm to the Gallbladder,0
15700,Including (qualifier),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15701,Blood,Hereditary Diffuse Gastric Adenocarcinoma,0
15702,Common (qualifier value),Recurrent Primary Lymphoma of Bone,0
15703,Retained,Ichthyosis,0
15704,Fever,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15705,Referring,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
15706,Comparison,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
15707,Areas <moth>,Fibroadenoma of breast,0
15708,Surface,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15709,Taxonomic,Malignant melanoma of eyelid,0
15710,Sometimes,Refractory Barrett Esophagus,0
15711,Call (Instruction),Stage IV Penile Cancer AJCC v7,0
15712,development aspects,Adult Hepatocellular Carcinoma,0
15713,Extrinsic,Benign Anal Granular Cell Tumor,0
15714,Often - answer to question,Malignant neoplasm of thalamus,0
15715,Hemopoietic tissue,Microcystic meningioma,0
15716,Pigment cell,Benign Apocrine Neoplasm,0
15717,Sunscreening Agents,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15718,Mass of body structure,Intraepithelial Melanocytic Hyperplasia,0
15719,Invasive Ductal Breast Carcinoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15720,Squamous,adenoid cystic carcinoma of lung,0
15721,*Type - Kind of quantity,Childhood Fibrillary Astrocytoma,0
15722,One,High Grade Glandular Intraepithelial Neoplasia,0
15723,Version (morphologic abnormality),High Grade Glandular Intraepithelial Neoplasia,0
15724,Treatment Epoch,Stage 0 Penile Cancer AJCC v8,0
15725,Manufactured form,Pleomorphic adenoma of parotid gland,0
15726,incidence of cases,Familial Hemophagocytic Lymphocytosis,0
15727,Biologic Development,Carcinomatosis of peritoneal cavity,0
15728,Human body,Pilocytic astrocytoma of cerebellum,0
15729,Common Specifications in HL7 V3 Publishing,Bladder adenocarcinoma stage IV,0
15730,320,embryonal rhabdomyosarcoma of prostate,0
15731,With texture,Benign neoplasm of eye,0
15732,Body cavities,Melanomatosis,0
15733,Name,Splenic Manifestation of Hairy Cell Leukemia,0
15734,Talpidae,Metastatic Neoplasm to the Gallbladder,0
15735,1+,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15736,Less Than,Melanomatosis,0
15737,Account number:Identifier:Point in time:^Patient:Nominal,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
15738,Table Rules - groups,Diffuse malignant mesothelioma,0
15739,IPSS Risk Category Low,Choroid Necrotic Melanoma,0
15740,Human body structure,Ovarian germ cell choriocarcinoma stage IV,0
15741,Nicotiana,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15742,Highest,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
15743,85,Extra-abdominal fibromatosis,0
15744,Abdominal bloating,Locally Advanced Squamous Cell Carcinoma,0
15745,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15746,Cancer Genus,Thymic Clear Cell Carcinoma,0
15747,Tumor size,Benign Anal Granular Cell Tumor,0
15748,Parotid Neoplasms,FIGO Stage II Ovarian Cancer,0
15749,Occurrence,Cerebral hemangioma,0
15750,Mechanism (attribute),adenoid cystic carcinoma of lung,0
15751,severe reaction,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15752,Derived value,Choroid Necrotic Melanoma,0
15753,AMACR wt Allele,Adult Anaplastic Oligodendroglioma,0
15754,Approximate,Type II Endometrial Adenocarcinoma,0
15755,Childhood Lymphoma,Recurrent Uveal Melanoma,0
15756,Togo,Benign tumor of eyelid,0
15757,Adrenal mass,Anterior Urethral Malignant Neoplasm,0
15758,gene therapy,Ovarian germ cell choriocarcinoma stage IV,0
15759,Surgery specialty,Peripheral primitive neuroectodermal tumor of soft tissue,0
15760,Easy bleeding,Heavy Chain Deposition Disease,0
15761,Carcinoma of lung,Undifferentiated Endocervical Sarcoma,0
15762,Primary malignant neoplasm of lung,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15763,Malignant neoplasm of appendix,Undifferentiated Neuroblastoma,0
15764,Neoplastic disease,Neonatal leukemia,0
15765,Noninvasive,Multiple Skull Base Meningiomas,0
15766,Minor (person),Tubal Hyperplasia,0
15767,Nervous system structure,Heavy Chain Deposition Disease,0
15768,Additional,Refractory Ependymoma,0
15769,Neoplastic disease,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15770,Infarction,Unresectable Rhabdomyosarcoma,0
15771,Malignant neoplasm of oropharynx,Choroid Necrotic Melanoma,0
15772,Contusions,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15773,All of the Time,Stage III Cutaneous Melanoma AJCC v6,0
15774,Progress,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15775,And/Or,Benign Anal Granular Cell Tumor,0
15776,Associated with,Childhood Central Nervous System Ganglioneuroblastoma,0
15777,Never (frequency),Ichthyoses,0
15778,Approximate,Collecting Duct Carcinoma of the Kidney,0
15779,Circulating blood,Leptomeningeal sarcoma,0
15780,body system,Methotrexate-Associated Hodgkin Lymphoma,0
15781,Time,de novo Myelodysplastic Syndrome,0
15782,shared attribute,Mucinous cystadenofibroma,0
15783,Direct (qualifier),Adult Acute Eosinophilic Leukemia,0
15784,Total,FIGO Stage IVA Ovarian Cancer,0
15785,Disease,Cerebral Primitive Neuroectodermal Tumor,0
15786,Seizures,Engraftment syndrome,0
15787,Tumor Mass,Colorectal cancer,0
15788,Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
15789,Complication Aspects,Kaposi's sarcoma of skin,0
15790,Scaling,Carcinoma,0
15791,Child,embryonal rhabdomyosarcoma of prostate,0
15792,Pleomorphic,Stage III Cutaneous Melanoma AJCC v6,0
15793,65+,Melanomatosis,0
15794,What subject filter - Result,Liver Cavernous Hemangioma,0
15795,Sometimes,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15796,Delta (difference),Medulloblastoma,0
15797,Human body,Carcinoma,0
15798,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Stage III Cutaneous Melanoma AJCC v6,0
15799,Back,Digestive System Hodgkin Lymphoma,0
15800,Tube - unit dose,adenosquamous carcinoma of breast,0
15801,Sample Range,Engraftment syndrome,0
15802,Tryptophanase,Fibroadenoma of breast,0
15803,Metastatic Neoplasm,Congenital hamartoma,0
15804,Morphology,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15805,Group A (blood group),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15806,Approximate,Benign tumor of eyelid,0
15807,Newly Diagnosed Childhood Ependymoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15808,Sharing (Social Behavior),Atypical Lobular Breast Hyperplasia,0
15809,metastatic qualifier,FIGO Stage IVA Ovarian Cancer,0
15810,Sometimes,Kaposi's sarcoma of extrahepatic bile duct,0
15811,Measures,Small cell neuroendocrine carcinoma of bladder,0
15812,Symptoms,Stage III Adult Immunoblastic Lymphoma,0
15813,Primary,FIGO Stage IVA Ovarian Cancer,0
15814,Taken,Benign Anal Granular Cell Tumor,0
15815,Data Change Date,Tonsillar Carcinoma,0
15816,Benign,Vaginal Adenoid Cystic Carcinoma,0
15817,Mass of body region,Methotrexate-Associated Hodgkin Lymphoma,0
15818,Case unit dose,Diffuse malignant mesothelioma,0
15819,Mammal liver preparation,Localized Ewing Sarcoma,0
15820,Benign,Benign neoplasm of thorax,0
15821,Percent normal,Transitional cell carcinoma,0
15822,Delta (difference),Toxic Epidermal Necrolysis,0
15823,Age,Testicular cancer metastatic,0
15824,Back Pain,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15825,Prophylactic behavior,Melanomatosis,0
15826,How Often Shortness of Breath,Hodgkin Disease,0
15827,Areas <moth>,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15828,Five-year Survival Rate,Benign Anal Granular Cell Tumor,0
15829,Childhood Embryonal Rhabdomyosarcoma,Bladder squamous cell carcinoma stage I,0
15830,Hodgkin Disease,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
15831,Symptoms,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15832,Malignant Neoplasms,Colorectal Neuroendocrine Tumor G2,0
15833,Follicular thyroid carcinoma,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
15834,Person Name,Mixed astrocytoma-ependymoma,0
15835,Patient observation,Mucinous adenocarcinoma gastric,0
15836,83,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15837,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Nasal cavity carcinoma,0
15838,Not Otherwise Specified,Childhood Central Nervous System Ganglioneuroblastoma,0
15839,Complication Aspects,Fibroadenoma of breast,0
15840,radiotherapeutic,Congenital hamartoma,0
15841,Adult Hodgkin Lymphoma,Mucinous adenocarcinoma,0
15842,Congenital Disorders,Locally Advanced Soft Tissue Sarcoma,0
15843,Sharing (Social Behavior),Uterine Cancer,0
15844,Main,Childhood Lung Non-Small Cell Carcinoma,0
15845,Aspect - Kind of quantity,benign mature teratoma of pancreas,0
15846,Adult Lymphoma,Locally Advanced Soft Tissue Sarcoma,0
15847,Smear - instruction imperative,Cancer of Urinary Tract,0
15848,Cancer Genus,Ichthyosis,0
15849,<3 (qualifier value),Medulloblastoma,0
15850,Surgery specialty,Giant cell angiofibroma,0
15851,Less Than,Mucinous adenocarcinoma gastric,0
15852,Enlarged,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15853,Operative Surgical Procedures,Human Papillomavirus-Related Carcinoma,0
15854,Including (qualifier),clear cell adenocarcinoma of gallbladder,0
15855,Better,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15856,2+ Score,Refractory Ependymoma,0
15857,Optimistic,Childhood Anaplastic Large Cell Lymphoma,0
15858,Analysis of substances,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15859,Salivary Gland Neoplasms,Digestive System Hodgkin Lymphoma,0
15860,Time (foundation metadata concept),Refractory Ependymoma,0
15861,Incidence,Methotrexate-Associated Hodgkin Lymphoma,0
15862,Polypeptide Hormones,Localized Ewing Sarcoma,0
15863,Enzymes,Adult Alveolar Soft Part Sarcoma,0
15864,North America,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15865,Almost All of the Time,Platinum-Resistant Lung Small Cell Carcinoma,0
15866,white blood cell type,Trabecular adenocarcinoma,0
15867,Cellular Debris,Nasal cavity carcinoma,0
15868,Known,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15869,Occur (action),Stage IB Lung Cancer AJCC v7,0
15870,Damage,Cerebral Primitive Neuroectodermal Tumor,0
15871,cervical cancer,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15872,Non-small cell carcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15873,Large,Platinum-Resistant Lung Small Cell Carcinoma,0
15874,Canis familiaris,Endometrial Small Cell Carcinoma,0
15875,Hemorrhage,Cervical Squamous Intraepithelial Neoplasia,0
15876,Occurrence,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15877,Entity Determiner - specific,Localized Askin Tumor,0
15878,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Human Papillomavirus-Related Carcinoma,0
15879,Therapeutic procedure,Adenocarcinoma of the prostate metastatic,0
15880,Rare,Locally Advanced Squamous Cell Carcinoma,0
15881,Control function,Digestive System Hodgkin Lymphoma,0
15882,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15883,Adamantinoma,Stage II Carcinoma of Penis,0
15884,Male population group,Adult Alveolar Soft Part Sarcoma,0
15885,Enhance (action),FIGO Stage II Ovarian Cancer,0
15886,Benign neoplasm of paraganglion,Engraftment syndrome,0
15887,New Zealand Rabbits,Endometrial Small Cell Carcinoma,0
15888,shared attribute,Malignant melanoma of eyelid,0
15889,Class (taxonomic),Anterior Urethral Malignant Neoplasm,0
15890,Pleura,Stage 0 Penile Cancer AJCC v8,0
15891,2+ Score,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15892,Measured,Spongiotic dermatitis,0
15893,Irritant behavior,Stage 0 Lip Carcinoma,0
15894,Including (qualifier),Intestinal Metaplasia of Bladder Urothelium,0
15895,bony process,Hyperplasia of pituitary gland,0
15896,Source,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
15897,Oral region,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15898,Very Much,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15899,Adrenal Cortical Adenoma,Childhood Fibrillary Astrocytoma,0
15900,operate <remove>,Cancer of Urinary Tract,0
15901,Invasive Carcinoma,Transitional cell carcinoma,0
15902,Laboratory,Acute Undifferentiated Leukemia,0
15903,Solid,Malignant Neoplasm with Regional Lymph Node Involvement,0
15904,95,Medulloblastoma,0
15905,Cerebrum,Stage III Adult Immunoblastic Lymphoma,0
15906,Effective,Human Papillomavirus-Related Carcinoma,0
15907,Occurrence,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15908,Is an only child,Kaposi's sarcoma of skin,0
15909,Malignant Squamous Cell Neoplasm,Plexosarcoma,0
15910,Low Grade,Recurrent Testicular Lymphoma,0
15911,Primary,Trabecular adenocarcinoma,0
15912,Minor (person),Adenocarcinoma of the prostate metastatic,0
15913,Group A (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15914,adjectives,Bladder squamous cell carcinoma stage I,0
15915,Seminoma,Chest Wall Fibromatosis,0
15916,SLC6A2 wt Allele,Thymic Atypical Carcinoid Tumor,0
15917,Less Than,Adult Alveolar Soft Part Sarcoma,0
15918,Call (Instruction),Locally Advanced Soft Tissue Sarcoma,0
15919,Third,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15920,Five,Mucinous adenocarcinoma gastric,0
15921,Difficulty walking,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15922,Linear,Granular Cell Leiomyosarcoma,0
15923,Doses of vaccine,Cerebral Primitive Neuroectodermal Tumor,0
15924,Absence (morphologic abnormality),Undifferentiated Endocervical Sarcoma,0
15925,Definitely Related to Intervention,Anaplastic large cell lymphoma,0
15926,Include (action),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
15927,Primary malignant neoplasm,Lung Inflammatory Myofibroblastic Tumor,0
15928,Experimental Result,Recurrent Primary Lymphoma of Bone,0
15929,Poor function,Unresectable Rhabdomyosarcoma,0
15930,Symptoms aspect,benign mature teratoma of pancreas,0
15931,Include (action),Malignant Neoplasm with Regional Lymph Node Involvement,0
15932,Use of,Extra-Adrenal Paraganglioma,0
15933,Urinary Diversion,Testicular cancer metastatic,0
15934,Vaginal intraepithelial neoplasia,Localized Askin Tumor,0
15935,Skin condition (observable entity),Grade 3a Malignant Neoplasm,0
15936,Chemicals,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15937,Brain part,Spongiotic dermatitis,0
15938,Percent (qualifier value),Vaginal Adenoma,0
15939,risk factors,Intestinal Metaplasia of Bladder Urothelium,0
15940,Hematuria,Methotrexate-Associated Hodgkin Lymphoma,0
15941,Condition,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15942,Item Collection,Digestive System Hodgkin Lymphoma,0
15943,Asia,Undifferentiated Endocervical Sarcoma,0
15944,Group A (blood group),Astrocytoma of brain,0
15945,device aspects,Colorectal cancer,0
15946,Including (qualifier),ALK positive large B-cell lymphoma,0
15947,Used by,Hodgkin lymphoma,0
15948,Does play,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
15949,Volume Measurement,Fibroadenoma of breast,0
15950,Chest wall structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15951,Presentation,Undifferentiated Endocervical Sarcoma,0
15952,Most,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15953,Aggressive behavior,Childhood Central Nervous System Immature Teratoma,0
15954,1000000,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15955,66,Stage III Adult Immunoblastic Lymphoma,0
15956,Term Birth,Undifferentiated Neuroblastoma,0
15957,Ultraviolet Rays,Splenic Manifestation of Hairy Cell Leukemia,0
15958,Together,Nasal cavity carcinoma,0
15959,W stress,Basal Cell Ameloblastoma,0
15960,Targeted Therapy,Mucinous adenocarcinoma gastric,0
15961,World,Vaginal Adenoma,0
15962,Normal,Cervical Fibroepithelial Polyp,0
15963,Process,Congenital hamartoma,0
15964,Neoplasms,Metaplastic carcinoma of breast,0
15965,shared attribute,Malignant melanoma of eyelid,0
15966,Procedure (set of actions),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15967,brain shape,Gallbladder adenoma,0
15968,Cause of death:Find:Pt:^Patient:Nom,Blood Vessel Tumors,0
15969,Case Study,Refractory Barrett Esophagus,0
15970,International Classification of Diseases for Oncology,clear cell adenocarcinoma of gallbladder,0
15971,Bacteria present,Female Breast Carcinoma,0
15972,Problems - What subject filter,Adult Hepatocellular Carcinoma,0
15973,Malignant Neoplasms,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
15974,Time,Malignant Neoplasm with Regional Lymph Node Involvement,0
15975,Microvolt,Malignant neoplasm of gallbladder,0
15976,Skin lesion,Malignant melanoma of eyelid,0
15977,Togo,Non-Metastatic Gestational Trophoblastic Tumor,0
15978,Administration procedure,Thyroid Hurthle Cell Carcinoma,0
15979,Sleeping Pills,Advanced Lung Carcinoma,0
15980,Case unit dose,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15981,Scaly skin,Pancreatic carcinoma,0
15982,development aspects,Fibroadenoma of breast,0
15983,Line Specimen,Localized Ewing Sarcoma,0
15984,Neoplasm Metastasis,Splenic Manifestation of Hairy Cell Leukemia,0
15985,Cardiac Lead Procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15986,Spreading (qualifier value),Metastatic Neoplasm to the Gallbladder,0
15987,Egg of order Phthiraptera,Cervical Squamous Intraepithelial Neoplasia,0
15988,Biological Transport,Stage IB Lung Cancer AJCC v7,0
15989,Mediate,Colorectal High Grade B-Cell Lymphoma,0
15990,Paraneoplastic Syndromes,gliosarcoma,0
15991,Oral cavity,Acute Undifferentiated Leukemia,0
15992,Extrinsic,Glomeruloid hemangioma,0
15993,Renal Cell Carcinoma Pathway,Benign Anal Granular Cell Tumor,0
15994,World,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15995,Referral placed,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
15996,AKT1S1 gene,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15997,Current (present time),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15998,Genetic,Breast Ductal Adenoma,0
15999,therapeutic aspects,Ovarian germ cell choriocarcinoma stage IV,0
16000,Tubal Ligation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16001,Advanced phase,Metastatic Lung Neuroendocrine Neoplasm,0
16002,Mass of body structure,Localized Ewing Sarcoma,0
16003,French language,Fibroadenoma of breast,0
16004,Pitch - substance,papillary carcinoma of penis,0
16005,Monitor,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16006,Singular,Refractory Bladder Carcinoma,0
16007,Most,Maxillary Sinus Adenoid Cystic Carcinoma,0
16008,Known,Benign neoplasm of thorax,0
16009,Age of Onset,Intraepithelial Melanocytic Hyperplasia,0
16010,Sex Behavior,Breast Ductal Adenoma,0
16011,Immature,Benign Anal Granular Cell Tumor,0
16012,International Classification of Diseases,Thyroid Hurthle Cell Carcinoma,0
16013,Common (qualifier value),Basal Cell Ameloblastoma,0
16014,7.2,Breast Apocrine Adenoma,0
16015,Pharyngeal structure,Secondary malignant neoplasm of lymph node,0
16016,point - UnitsOfMeasure,Cervical Adenomyoma,0
16017,Qualitative form,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16018,Linear,Recurrent Primary Lymphoma of Bone,0
16019,Characterization,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16020,Call (Instruction),Thyroid Hurthle Cell Carcinoma,0
16021,Array Feature,Carcinoma of submandibular gland,0
16022,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16023,What subject filter - Result,Choroid Epithelioid Cell Melanoma,0
16024,Negation,Nasal cavity carcinoma,0
16025,Condition:Find:Pt:^Patient:Nom,Splenic Manifestation of Hairy Cell Leukemia,0
16026,Feel Tired question,Human Papillomavirus-Related Carcinoma,0
16027,PREVENT (product),FIGO Stage IVA Ovarian Cancer,0
16028,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
16029,High Risk Acute Leukemia,Vaginal Adenoma,0
16030,Personal appearance,Benign Anal Granular Cell Tumor,0
16031,Usually,Liver Lymphangioma,0
16032,Mechanism (attribute),Activated B-cell type diffuse large B-cell lymphoma,0
16033,Large,Advanced Lung Carcinoma,0
16034,Condition,Granular Cell Leiomyosarcoma,0
16035,Medical Devices,Non-Metastatic Gestational Trophoblastic Tumor,0
16036,Most,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16037,Neoplasms,Clonal Hematopoiesis of Indeterminate Potential,0
16038,lymph nodes,Stage I Colon Neuroendocrine Tumor AJCC v8,0
16039,1980s,Benign squamous cell tumor,0
16040,<90,Kaposi's sarcoma of skin,0
16041,To,Peripheral primitive neuroectodermal tumor of soft tissue,0
16042,Blood Vessel,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16043,Togo,Benign Anal Granular Cell Tumor,0
16044,Immature,Anterior Urethral Malignant Neoplasm,0
16045,Affect (mental function),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
16046,Adverse Event Associated with Vascular,Stage 0 Lip Carcinoma,0
16047,To,Low Grade Squamous Intraepithelial Neoplasia,0
16048,Future,Thymoma malignant recurrent,0
16049,Valid,Leiomyoma of Gallbladder,0
16050,T-Cell Receptor,Locally Advanced Epithelioid Hemangioendothelioma,0
16051,Tumor type,squamous cell carcinoma of the thyroid gland,0
16052,Minor (value),FIGO Stage II Ovarian Cancer,0
16053,Feelings,Anterior Urethral Malignant Neoplasm,0
16054,Including (qualifier),Endometrial Small Cell Carcinoma,0
16055,Released (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16056,Tumor Suppression,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16057,Woman,ROSE Cluster 3,0
16058,Chemotherapy Regimen,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16059,Plasma Cells,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
16060,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16061,Duct (organ) structure,Rhabdomyosarcoma with ganglionic differentiation,0
16062,Function (attribute),Benign Apocrine Neoplasm,0
16063,depend,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16064,Glioblastoma,Brain Tumor,0
16065,Skin Specimen,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16066,Shortness of breath:-:Point in time:^Patient:-,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16067,Malignant tumor of colon,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
16068,Antibodies,Nasal cavity carcinoma,0
16069,Fibrous connective tissue,Splenic Manifestation of Hairy Cell Leukemia,0
16070,combination - answer to question,Stage III Cutaneous Melanoma AJCC v6,0
16071,Beginning,Adrenal Rest Tumor,0
16072,Chemotherapy,Intraepithelial Melanocytic Hyperplasia,0
16073,Estrogens,Recurrent Testicular Lymphoma,0
16074,Paraganglioma,Adenocarcinoma of duodenum,0
16075,Screening procedure,Atypical Mesothelial Hyperplasia,0
16076,Good,High Grade Glandular Intraepithelial Neoplasia,0
16077,Enlargement procedure,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16078,Term (temporal),Xeroderma pigmentosum,0
16079,Tree Node,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16080,PSA Level Greater than Fifty,Xeroderma pigmentosum,0
16081,Left sided,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16082,CYREN gene,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16083,Characterization,Undifferentiated Neuroblastoma,0
16084,Carcinoma of bladder,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
16085,Frequently,de novo Myelodysplastic Syndrome,0
16086,Science of Etiology,Stage IB Pancreatic Cancer AJCC v8,0
16087,Concept model domain,Cervical Adenomyoma,0
16088,Microscopic description,Spongiotic dermatitis,0
16089,Interventional procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16090,Current (present time),Botryoid-Type Embryonal Rhabdomyosarcoma,0
16091,CD69 wt Allele,sarcoma of spinal cord,0
16092,shared attribute,Ovarian germ cell choriocarcinoma stage IV,0
16093,Cerebral Cavernous Hemangioma,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16094,Cutaneous Melanoma,Cerebral Primitive Neuroectodermal Tumor,0
16095,Closed,Xeroderma pigmentosum,0
16096,Table Cell Horizontal Align - left,Giant cell angiofibroma,0
16097,Elevated alpha-fetoprotein,Childhood Cerebellar Neoplasm,0
16098,Vomiting,Carcinoma ex pleomorphic adenoma of parotid gland,0
16099,Financial Account,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16100,Delta (difference),Clinical Stage I Cutaneous Melanoma AJCC v8,0
16101,Occurrence,Diffuse malignant mesothelioma,0
16102,Treated with,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
16103,Including (qualifier),Vaginal Adenoma,0
16104,Histological Techniques,Stage IB Pancreatic Cancer AJCC v8,0
16105,Adult,Metastatic Ductal Breast Carcinoma,0
16106,unknown vaccine or immune globulin,Stage I Adult Non-Hodgkin Lymphoma,0
16107,Occurrence Indicator,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16108,Specimen Source Codes - Serum,Localized Ewing Sarcoma,0
16109,Usual Severity Shortness of Breath,Carcinoma,0
16110,Relationship by association,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
16111,90 - 100%,Melanomatosis,0
16112,Medications,Adenocarcinoma,0
16113,Respiration,Refractory Ependymoma,0
16114,High risk of,gliosarcoma,0
16115,Spreading (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
16116,Administration procedure,Malignant neoplasm of thalamus,0
16117,Cartilage,Stage III Cutaneous Melanoma AJCC v6,0
16118,ADCY10 gene,Thymic Atypical Carcinoid Tumor,0
16119,Cell Device,Metastatic Malignant Neoplasm in the Sellar Region,0
16120,Primary malignant neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16121,Positioning Attribute,Mastocytosis,0
16122,Togo,Carcinoma of urinary bladder,0
16123,Conditional,Endometrial Small Cell Carcinoma,0
16124,Location of Oral Residue Following Swallowing,Grade 3a Malignant Neoplasm,0
16125,Adult human body,Adult Anaplastic Oligodendroglioma,0
16126,Public Domain,Angiosarcoma of liver,0
16127,Chemotherapy Regimen,Platinum-Resistant Lung Small Cell Carcinoma,0
16128,Confirmed by,Cervical Fibroepithelial Polyp,0
16129,Bone Marrow,Primary Cutaneous Plasmablastic Lymphoma,0
16130,Measurement,Medulloblastoma,0
16131,Kidney Tubules,Uterine Cancer,0
16132,Cause of Death,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16133,Body tissue,Unresectable Rhabdomyosarcoma,0
16134,Therapeutic procedure,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16135,Category Type,Ectomesenchymal Chondromyxoid Tumor,0
16136,Biomaterial Treatment,Recurrent Testicular Lymphoma,0
16137,Frequently,Malignant melanoma of eyelid,0
16138,Bone Growth,Toxic Epidermal Necrolysis,0
16139,Study Variable,Airway Hemangioma,0
16140,Sound - physical agent,Undifferentiated Neuroblastoma,0
16141,melanocyte,Childhood Central Nervous System Immature Teratoma,0
16142,Acetic Acid,non-Hodgkin's lymphoma of spleen,0
16143,Average of Value Derivation Technique,Adult Brain Stem Mixed Glioma,0
16144,Poor - grade value,Multiple Skull Base Meningiomas,0
16145,Both ovaries,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16146,Rare,Human Papillomavirus-Related Carcinoma,0
16147,diagnosis aspect,Leiomyoma of Gallbladder,0
16148,Symptoms,Refractory Ependymoma,0
16149,As Much as Desired,Blepharal carcinoma,0
16150,Endogenous,Adult Acute Eosinophilic Leukemia,0
16151,risk factors,embryonal rhabdomyosarcoma of prostate,0
16152,Referring,Bladder Neuroendocrine Neoplasm,0
16153,Subject Risk,Tonsillar Carcinoma,0
16154,Abnormal Cell Count,Nasal cavity carcinoma,0
16155,Chemotherapy,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16156,Birth,Stage 0 Penile Cancer AJCC v8,0
16157,Act Relationship Subset - previous,Mucosal Melanoma,0
16158,Leads (device),GIANT PIGMENTED HAIRY NEVUS,0
16159,Numbers,Malignant neoplasm of olfactory nerve,0
16160,Simple,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16161,Array Feature,Non-Metastatic Gestational Trophoblastic Tumor,0
16162,Pharmacotherapy,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16163,Type - attribute,Small cell neuroendocrine carcinoma of bladder,0
16164,List,Clonal Hematopoiesis of Indeterminate Potential,0
16165,Treatment Epoch,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16166,Functional disorder,Malignant melanoma of eyelid,0
16167,Experimental Result,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
16168,Often - answer to question,Angiosarcoma of liver,0
16169,Mixed Tumor,adenoid cystic carcinoma of lung,0
16170,various antiseptic throat preparations,Platinum-Resistant Lung Small Cell Carcinoma,0
16171,medication - HL7 publishing domain,Digestive System Hodgkin Lymphoma,0
16172,Junction Device,Cartilaginous exostosis,0
16173,Complication Aspects,Vaginal Adenoid Cystic Carcinoma,0
16174,Including (qualifier),Low Grade Squamous Intraepithelial Neoplasia,0
16175,Occurrence Indicator,Stage IB Lung Cancer AJCC v7,0
16176,Age,Thyroid Hurthle Cell Carcinoma,0
16177,Class (taxonomic),Carcinoma of urinary bladder,0
16178,Rapid,Gallbladder adenoma,0
16179,Have Itch,Stage III Cutaneous Melanoma AJCC v6,0
16180,MS gene,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16181,T-Cell Receptor,Metastatic Carcinoma in the Lung,0
16182,Body Site Modifier - Lower,Maxillary Sinus Adenocarcinoma,0
16183,Qualitative form,Stage I Colon Neuroendocrine Tumor AJCC v8,0
16184,Item Collection,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16185,Usual Severity Cough,Basal Cell Ameloblastoma,0
16186,risk factors,Acantholytic squamous cell carcinoma,0
16187,End,clear cell adenocarcinoma of gallbladder,0
16188,Immunoproliferative Disorders,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16189,Type - attribute,Ovarian germ cell choriocarcinoma stage IV,0
16190,Tryptophanase,Localized Ewing Sarcoma,0
16191,Cells,clear cell adenocarcinoma of gallbladder,0
16192,Symptoms,Papillary squamous cell carcinoma,0
16193,Aspects of signs,Lung Inflammatory Myofibroblastic Tumor,0
16194,What subject filter - Result,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16195,Surgery specialty,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16196,Occurrence Indicator,Adult Alveolar Soft Part Sarcoma,0
16197,Neoplasms,Uterine Cancer,0
16198,Used by,embryonal rhabdomyosarcoma of prostate,0
16199,Guide device,squamous cell carcinoma of the thyroid gland,0
16200,Equine laminitis,Bladder Neuroendocrine Neoplasm,0
16201,Often - answer to question,Locally Advanced Carcinoma,0
16202,Responsible to,Adult Fibrolamellar Carcinoma,0
16203,Cell Differentiation process,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16204,Set (Psychology),Stage III Cutaneous Melanoma AJCC v6,0
16205,Useful,Xeroderma pigmentosum,0
16206,Immunoglobulin Heavy Chain Variable Domain,Acantholytic squamous cell carcinoma,0
16207,Nucleated Thrombocyte Count,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16208,Rating (action),squamous cell carcinoma of the thyroid gland,0
16209,Take,Benign neoplasm of thorax,0
16210,Nasopharynx,Bladder adenocarcinoma stage IV,0
16211,Specific qualifier value,Female Breast Carcinoma,0
16212,NCI CTEP SDC Osteosarcoma Sub-Category Terminology,Pilocytic astrocytoma of cerebellum,0
16213,40%,adenosquamous carcinoma of breast,0
16214,Preventive monitoring,Cerebral Primitive Neuroectodermal Tumor,0
16215,United States Military Commissioned Officer O4,Transitional cell carcinoma,0
16216,<3 (qualifier value),FIGO Stage IVA Ovarian Cancer,0
16217,Slow Growing,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16218,60%,Non-Metastatic Gestational Trophoblastic Tumor,0
16219,Breast,Kaposi's sarcoma of skin,0
16220,Organ,Brain Tumor,0
16221,burrow wound,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
16222,Ephrin Type-B Receptor 1,Astrocytoma of brain,0
16223,Mathematical Operator,Refractory Bladder Carcinoma,0
16224,Process,Low Grade Squamous Intraepithelial Neoplasia,0
16225,Fibrous layer,Testicular cancer metastatic,0
16226,Related personal status,Thymic Clear Cell Carcinoma,0
16227,radiotherapeutic,Blepharal carcinoma,0
16228,Treatment Epoch,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16229,Surgery specialty,mucinous adenocarcinoma of gallbladder,0
16230,Ability,Benign tumor of eyelid,0
16231,Esophageal,Stage II Hepatocellular Carcinoma AJCC v8,0
16232,Stop brand of fluoride,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16233,shared attribute,Intraepithelial Melanocytic Hyperplasia,0
16234,Skin Specimen,Benign tumor of eyelid,0
16235,Neoplasms,Intestinal Metaplasia of Bladder Urothelium,0
16236,Line Specimen,Intestinal Metaplasia of Bladder Urothelium,0
16237,Infrequent,Recurrent Primary Lymphoma of Bone,0
16238,To,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16239,pharmacotherapeutic,Adult Acute Eosinophilic Leukemia,0
16240,status - In progress,Cartilaginous exostosis,0
16241,low exposure,Prostate Lymphoma,0
16242,lymph nodes,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16243,Young,Benign squamous cell tumor,0
16244,Case unit dose,non-Hodgkin's lymphoma of spleen,0
16245,Childhood Ganglioneuroblastoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16246,Veins,Stage IB Lung Cancer AJCC v7,0
16247,Chemotherapy Regimen,Heavy Chain Deposition Disease,0
16248,Benign Neoplasm,Digestive System Hodgkin Lymphoma,0
16249,On (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
16250,Elective procedure,Tonsillar Carcinoma,0
16251,Carcinoma,Liver Lymphangioma,0
16252,Unknown GENC,Stage IB Lung Cancer AJCC v7,0
16253,Surgical aspects,Recurrent Testicular Lymphoma,0
16254,Computed Tomography Study File,Kaposi's sarcoma of extrahepatic bile duct,0
16255,Marketing basis - Transitional,Leiomyoma of Gallbladder,0
16256,Risk,Benign squamous cell tumor,0
16257,Pressure - action,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
16258,Classification,Refractory Bladder Carcinoma,0
16259,Hemorrhage,Cervical Fibroepithelial Polyp,0
16260,Maturity of Progression,Malignant melanoma of eyelid,0
16261,Treatment Epoch,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16262,Account number:Identifier:Point in time:^Patient:Nominal,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16263,seconds,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16264,Genital system,Basal Cell Ameloblastoma,0
16265,Persons,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
16266,Large,Pleomorphic adenoma of parotid gland,0
16267,Referring,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16268,Linear,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16269,Mirror,Testicular cancer metastatic,0
16270,IPSS Risk Category High,Diffuse malignant mesothelioma,0
16271,Primary,Bladder Neuroendocrine Neoplasm,0
16272,Age,Intraepithelial Melanocytic Hyperplasia,0
16273,Cause of death:Find:Pt:^Patient:Nom,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16274,Leading,Lipoma of small intestine,0
16275,Five,Medulloblastoma,0
16276,Rare,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16277,Time (foundation metadata concept),Medulloblastoma,0
16278,Aggressive Non-Hodgkin Lymphoma,Transitional cell carcinoma,0
16279,Primary,Maxillary Sinus Adenocarcinoma,0
16280,Infective cystitis,Human Papillomavirus-Related Carcinoma,0
16281,Human body structure,mucinous adenocarcinoma of gallbladder,0
16282,Extension,Chronic Myelomonocytic Leukemia-2,0
16283,pregnancy related,Human Papillomavirus-Related Carcinoma,0
16284,Post,Localized Askin Tumor,0
16285,Same,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16286,Chemical Association,Adenocarcinoma,0
16287,Therapeutic procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16288,Include (action),clear cell adenocarcinoma of gallbladder,0
16289,Etiology,Blepharal carcinoma,0
16290,Site of,Blepharal carcinoma,0
16291,Adenocarcinoma of pancreas,Malignant neoplasm of olfactory nerve,0
16292,Different,Non-Metastatic Gestational Trophoblastic Tumor,0
16293,Hemorrhage,BRCA2 Syndrome,0
16294,Young,Neonatal leukemia,0
16295,Antibiotics,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16296,Shiny,Astrocytoma of brain,0
16297,Occurrence,Peripheral primitive neuroectodermal tumor of soft tissue,0
16298,Cosmetic procedure,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16299,Line Specimen,Cerebral hemangioma,0
16300,90%,Childhood Lymphoma,0
16301,Cell (compartment),Malignant Neoplasm with Regional Lymph Node Involvement,0
16302,Melanoma Pathway,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16303,Malignant Neoplasms,adenoid cystic carcinoma of lung,0
16304,biomedical tube device,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16305,Activities,Ovarian Carcinoid Tumor,0
16306,Imaging Techniques,Cerebral Primitive Neuroectodermal Tumor,0
16307,High risk,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16308,Primary malignant neoplasm,BRCA2 Syndrome,0
16309,Cell Device,Extra-abdominal fibromatosis,0
16310,Ductal Carcinoma,Endometrial Small Cell Carcinoma,0
16311,Fast Growing,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16312,Contraceptives,Malignant melanoma of eyelid,0
16313,Leads (device),embryonal rhabdomyosarcoma of prostate,0
16314,Complete,embryonal rhabdomyosarcoma of prostate,0
16315,10%,Testicular cancer metastatic,0
16316,Diagnosis,Benign tumor of eyelid,0
16317,Morning,Undifferentiated Endocervical Sarcoma,0
16318,Account number:Identifier:Point in time:^Patient:Nominal,Stage III Cutaneous Melanoma AJCC v6,0
16319,Malignant Female Reproductive System Neoplasm,Benign squamous cell tumor,0
16320,biopsy characteristics,Tonsillar Carcinoma,0
16321,Pancreatic Intraductal Papillary Mucinous Neoplasm,FIGO Stage IVA Ovarian Cancer,0
16322,Factor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16323,Sarcoma of soft tissue,Liver Lymphangioma,0
16324,Before values,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16325,Acute monocytic leukemia,Kaposi's sarcoma of skin,0
16326,god,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16327,Dysplasia,Cystadenocarcinoma,0
16328,Type - attribute,Thyroid Hurthle Cell Carcinoma,0
16329,Specimen Source Codes - Macrophages,Undifferentiated Endocervical Sarcoma,0
16330,Prognosis:Find:Pt:^Patient:Nom,FIGO Stage II Ovarian Cancer,0
16331,High Level,Collecting Duct Carcinoma of the Kidney,0
16332,During,Ovarian germ cell choriocarcinoma stage IV,0
16333,treatment - ActInformationManagementReason,Stage 0 Lip Carcinoma,0
16334,N+ (tumor staging),Benign tumor of eyelid,0
16335,Location of Oral Residue Following Swallowing,Central Nervous System Anaplastic Large Cell Lymphoma,0
16336,described,adenoid cystic carcinoma of lung,0
16337,Australia,Unresectable Rhabdomyosarcoma,0
16338,International Classification of Diseases for Oncology,Neonatal leukemia,0
16339,Vaginal Sarcoma,Periosteal Osteosarcoma,0
16340,Five-year Survival Rate,Mixed astrocytoma-ependymoma,0
16341,Flank (surface region),Mucinous cystadenofibroma,0
16342,Feel Tired question,Bladder adenocarcinoma stage IV,0
16343,Affecting,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16344,Vaginal intraepithelial neoplasia,embryonal rhabdomyosarcoma of prostate,0
16345,Known,Pilocytic astrocytoma of cerebellum,0
16346,Different,Female Breast Carcinoma,0
16347,Injury due to exposure to external cause,Diffuse malignant mesothelioma,0
16348,Red Blood Cell Count measurement,Bladder adenocarcinoma stage IV,0
16349,low exposure,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16350,Malignant neoplasm of skin,Neonatal leukemia,0
16351,IPSS Risk Category High,Type II Endometrial Adenocarcinoma,0
16352,high - ActExposureLevelCode,Bladder squamous cell carcinoma stage I,0
16353,Lacking,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16354,pharmacotherapeutic,Type II Endometrial Adenocarcinoma,0
16355,Circulating blood,Small cell neuroendocrine carcinoma of bladder,0
16356,Adipocytes,Blood Vessel Tumors,0
16357,Others - Allergy,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16358,Smaller,Benign Apocrine Neoplasm,0
16359,Human Papillomavirus Positive,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
16360,Numbers,Melanomatosis,0
16361,Young Adult,Locally Advanced Epithelioid Hemangioendothelioma,0
16362,Complication,Stage II Carcinoma of Penis,0
16363,Childhood Lymphoma,Acantholytic squamous cell carcinoma,0
16364,Abnormally high,Intraepithelial Melanocytic Hyperplasia,0
16365,Examination of pharynx,Vaginal Adenoid Cystic Carcinoma,0
16366,Pain,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16367,Sequence Data Type,Digestive System Hodgkin Lymphoma,0
16368,Neoplasm Metastasis,Endometrial Small Cell Carcinoma,0
16369,Spreading (qualifier value),Papillary squamous cell carcinoma,0
16370,Immunoproliferative Disorders,Endometrial Small Cell Carcinoma,0
16371,Stem of plant,Non-Metastatic Gestational Trophoblastic Tumor,0
16372,Feelings,Lipoma of small intestine,0
16373,Adolescent (age group),Transitional cell carcinoma,0
16374,Disease,Kaposi's sarcoma of extrahepatic bile duct,0
16375,List,Malignant neoplasm of olfactory nerve,0
16376,International Classification of Diseases for Oncology,Benign squamous cell tumor,0
16377,disease transmission qualifier,Cancer of Urinary Tract,0
16378,Stem cell transplant,Childhood Lymphoma,0
16379,Tumor Mass,Kaposi's sarcoma of skin,0
16380,Certain (qualifier value),Fourth Ventricle and Brain Stem Ependymal Tumor,0
16381,Virus,Anaplastic large cell lymphoma,0
16382,Evidence,Refractory Ependymoma,0
16383,Primary malignant neoplasm,sarcoma of spinal cord,0
16384,Progress,Human Papillomavirus-Related Carcinoma,0
16385,Average of Value Derivation Technique,Ichthyosis,0
16386,Name Given at Birth,Peripheral primitive neuroectodermal tumor of soft tissue,0
16387,Firstly,Leiomyoma of Gallbladder,0
16388,Cells,Giant cell angiofibroma,0
16389,+2,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16390,Percent normal,mucinous adenocarcinoma of gallbladder,0
16391,Occur (action),Intraepithelial Melanocytic Hyperplasia,0
16392,Feelings,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16393,Vomiting,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16394,Cystic teratoma,Mucinous cystadenofibroma,0
16395,Include (action),Blepharal carcinoma,0
16396,*Type - Kind of quantity,Splenic Manifestation of Hairy Cell Leukemia,0
16397,Pathogenic organism,embryonal rhabdomyosarcoma of prostate,0
16398,Operation excision,Kaposi's sarcoma of extrahepatic bile duct,0
16399,Aspects of signs,Astrocytoma of brain,0
16400,Fever,Placental aromatase deficiency,0
16401,How Often Weight Loss,Cancer of Urinary Tract,0
16402,Surface of cervix,Undifferentiated Neuroblastoma,0
16403,Referring,Noninfiltrating Intraductal Carcinoma,0
16404,Biopsy,Endometrial Small Cell Carcinoma,0
16405,Either,Mucinous adenocarcinoma gastric,0
16406,Type - attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16407,Frequently,Choroid Necrotic Melanoma,0
16408,Biological Response Modifiers,Neoplasms,0
16409,Poor - qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
16410,How Much Distress Weight Loss,Maxillary Sinus Adenocarcinoma,0
16411,Stage,Brain Ependymoma,0
16412,Similarity,Unicystic ameloblastoma,0
16413,Pharmacotherapy,Locally Advanced Soft Tissue Sarcoma,0
16414,Neoplastic disease,Congenital hamartoma,0
16415,Symptoms aspect,Testicular cancer metastatic,0
16416,Sensation quality,Low Grade Squamous Intraepithelial Neoplasia,0
16417,shared attribute,Localized Malignant Neoplasm,0
16418,SLC5A5 gene,Refractory Ependymoma,0
16419,SERPINA3 protein,Werner Syndrome,0
16420,Body tissue,Benign Apocrine Neoplasm,0
16421,Immune system,Malignant Testicular Sertoli Cell Tumor,0
16422,Breast,Choroid Necrotic Melanoma,0
16423,Treatment intent,Metastatic Lung Small Cell Carcinoma,0
16424,Classification of information,Childhood Fibrillary Astrocytoma,0
16425,Extent of disease,FIGO Stage IVA Ovarian Cancer,0
16426,Q13,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16427,Cell (compartment),Intraepithelial Melanocytic Hyperplasia,0
16428,Aggressive behavior,Engraftment syndrome,0
16429,Therapeutic radiology procedure,Malignant neoplasm of choroid,0
16430,Neoplastic Glandular Cell,Melanomatosis,0
16431,Only - dosing instruction fragment,Undifferentiated Neuroblastoma,0
16432,65,Stage I Adult Non-Hodgkin Lymphoma,0
16433,Diagnosis,BRCA2 Syndrome,0
16434,oncology field,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16435,New Zealand Rabbits,Colorectal cancer,0
16436,Occur (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16437,Supratentorial Embryonal Tumor,Diffuse malignant mesothelioma,0
16438,Event Seriousness - Significant,clear cell adenocarcinoma of gallbladder,0
16439,66,Non-Metastatic Gestational Trophoblastic Tumor,0
16440,Occurrence Indicator,Endometrial Small Cell Carcinoma,0
16441,Early,Transitional cell carcinoma,0
16442,Case (situation),Stage IV Childhood Non-Hodgkin Lymphoma,0
16443,Malignant Neoplasms,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16444,Stage Grouping,Giant cell angiofibroma,0
16445,site-specific telomere resolvase activity,clear cell adenocarcinoma of gallbladder,0
16446,Free (available (qualifier)),Locally Advanced Squamous Cell Carcinoma,0
16447,Fallopian Tubes,Malignant neoplasm of thalamus,0
16448,Prolonged,Low Grade Squamous Intraepithelial Neoplasia,0
16449,white blood cell type,Leptomeningeal sarcoma,0
16450,Tissue Specimen Code,Choroid Necrotic Melanoma,0
16451,2+ Score,Peripheral primitive neuroectodermal tumor of soft tissue,0
16452,Death (finding),Kaposi's sarcoma of extrahepatic bile duct,0
16453,Time,Malignant Testicular Sertoli Cell Tumor,0
16454,Occurrence Indicator,Localized Malignant Neoplasm,0
16455,Homo sapiens,Neonatal leukemia,0
16456,Symptoms,Peripheral primitive neuroectodermal tumor of soft tissue,0
16457,Beginning,Chronic Myelomonocytic Leukemia-2,0
16458,Measured,Trichilemmocarcinoma,0
16459,Simpson Grade 3,Type II Endometrial Adenocarcinoma,0
16460,Body structure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16461,Clear,Bladder squamous cell carcinoma stage I,0
16462,Term (lexical),ROSE Cluster 3,0
16463,Tissue Specimen Code,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16464,Systemic disease,benign mature teratoma of pancreas,0
16465,risk factors,Maxillary Sinus Adenoid Cystic Carcinoma,0
16466,Squamous cell carcinoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16467,Location of Pharyngeal Residue Following Swallowing,Malignant neoplasm of gallbladder,0
16468,Never (frequency),Kaposi's sarcoma of extrahepatic bile duct,0
16469,66,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16470,Specific qualifier value,Adult Brain Stem Mixed Glioma,0
16471,Coating (film),Human Papillomavirus-Related Carcinoma,0
16472,Together,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16473,Gastrointestinal tract structure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16474,Cell Count,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16475,Melanocytic nevus of skin,Human Papillomavirus-Related Carcinoma,0
16476,Australia,Maxillary Sinus Adenoid Cystic Carcinoma,0
16477,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16478,Nearly,Digestive System Hodgkin Lymphoma,0
16479,Mild (qualifier value),Unicystic ameloblastoma,0
16480,Fasting,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16481,ethnic european,Cervical Fibroepithelial Polyp,0
16482,Function Axis,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16483,Therapeutic tactile stimulation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16484,Polypeptide Hormones,Squamous cell carcinoma of lip,0
16485,Tubal Ligation,Undifferentiated Endocervical Sarcoma,0
16486,Increase,Undifferentiated Neuroblastoma,0
16487,shared attribute,Undifferentiated Neuroblastoma,0
16488,Survival Rate,Brain Tumor,0
16489,Love,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16490,Presentation,Childhood Anaplastic Large Cell Lymphoma,0
16491,Relationships,Recurrent Testicular Lymphoma,0
16492,Etiology aspects,Benign neoplasm of thorax,0
16493,Application Context,Metastatic Malignant Neoplasm in the Sellar Region,0
16494,Body part,Refractory Bladder Carcinoma,0
16495,Anatomic Site,Mucinous neoplasm,0
16496,Childhood Diffuse Large B-Cell Lymphoma,Recurrent Testicular Lymphoma,0
16497,Sequence Arm,Mucosal Melanoma,0
16498,dendritic spine neck,Clonal Hematopoiesis of Indeterminate Potential,0
16499,Tooth structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16500,Severe (severity modifier),Neoplasms,0
16501,Result,Placental aromatase deficiency,0
16502,Development,FIGO Stage IVA Ovarian Cancer,0
16503,Possible diagnosis,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16504,Areas <moth>,Metastatic Lung Neuroendocrine Neoplasm,0
16505,Mass of body structure,Medulloblastoma,0
16506,Characterization,Stage III Adult Immunoblastic Lymphoma,0
16507,Death NOS,Angiosarcoma of liver,0
16508,Formation,Female Breast Carcinoma,0
16509,DOCK1 gene,embryonal rhabdomyosarcoma of prostate,0
16510,include - SetOperator,Endometrial Small Cell Carcinoma,0
16511,Geographic Locations,Cartilaginous exostosis,0
16512,Usual,Testicular cancer metastatic,0
16513,Latin America,Maxillary Sinus Adenocarcinoma,0
16514,1+,Mucinous adenocarcinoma gastric,0
16515,Renal Cell Carcinoma Pathway,Pancreatic Endocrine Carcinoma,0
16516,Diagnosis,Small intestine carcinoma,0
16517,Exclusion,embryonal rhabdomyosarcoma of prostate,0
16518,enzyme activity,Childhood Fibrillary Astrocytoma,0
16519,Light Emitting Diode Device,Localized Ewing Sarcoma,0
16520,Dependent for dressing,Vaginal Adenoid Cystic Carcinoma,0
16521,Divide,Childhood Central Nervous System Ganglioneuroblastoma,0
16522,Spreading (qualifier value),FIGO Stage IVA Ovarian Cancer,0
16523,Vision,Refractory Barrett Esophagus,0
16524,Cystoscopy,Acantholytic squamous cell carcinoma,0
16525,Speaking (activity),Refractory Glioma,0
16526,Group A (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16527,Nausea,Colorectal cancer,0
16528,gene therapy,Stage II Fallopian Tube Cancer,0
16529,vulvovaginal,Hodgkin lymphoma,0
16530,Occur (action),Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16531,pharmacotherapeutic,Digestive System Hodgkin Lymphoma,0
16532,Liver,Colorectal cancer,0
16533,Decision,Recurrent Primary Lymphoma of Bone,0
16534,Progress,Benign neoplasm of thorax,0
16535,Formation,Transitional cell carcinoma,0
16536,Old,Intracortical osteosarcoma,0
16537,Surgical aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16538,Workers,Intracortical osteosarcoma,0
16539,Occurrence,Localized Ewing Sarcoma,0
16540,84,Blood Vessel Tumors,0
16541,Structure of great blood vessel (organ),Carcinoma of submandibular gland,0
16542,Togo,Astrocytoma of brain,0
16543,Limited stage (cancer stage),sarcoma of spinal cord,0
16544,Occur (action),Stage IB Lung Cancer AJCC v7,0
16545,Leading,Adenocarcinoma of duodenum,0
16546,Most,Occult Lung Adenosquamous Carcinoma,0
16547,Vaginal (intended site),Squamous cell carcinoma of lip,0
16548,Number of birth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16549,Usual Severity Weight Loss,Localized Malignant Neoplasm,0
16550,Body Fluids,Blepharal carcinoma,0
16551,Derived value,ALK positive large B-cell lymphoma,0
16552,biopsy characteristics,Benign neoplasm of thorax,0
16553,Areas <moth>,Chest Wall Fibromatosis,0
16554,Free of (attribute),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
16555,Person 1,Benign Carotid Body Paraganglioma,0
16556,Unexplained weight loss,Small cell neuroendocrine carcinoma of bladder,0
16557,Tryptophanase,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
16558,Multiple Myeloma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16559,Positive Selection,Childhood Anaplastic Large Cell Lymphoma,0
16560,Dyspnea,Mucinous cystadenofibroma,0
16561,Recurrence,Testicular cancer metastatic,0
16562,Umbilical stump observable,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16563,white blood cell type,Squamous cell carcinoma of lip,0
16564,Overall Well Being,Type II Endometrial Adenocarcinoma,0
16565,Case unit dose,Undifferentiated Neuroblastoma,0
16566,How Much Distress Weight Loss,Carcinoma of urinary bladder,0
16567,1960s,Localized Askin Tumor,0
16568,Malignant neoplasm of large intestine,Testicular cancer metastatic,0
16569,Negation,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
16570,Include (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
16571,<50,Breast Apocrine Adenoma,0
16572,Natures,FIGO Stage IVA Ovarian Cancer,0
16573,Following,Intraepithelial Melanocytic Hyperplasia,0
16574,Present,Brain Tumor,0
16575,Have Diarrhea,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
16576,Younger child,Stage IB Pancreatic Cancer AJCC v8,0
16577,Protection,Fourth Ventricle and Brain Stem Ependymal Tumor,0
16578,Approximate,Malignant neoplasm of olfactory nerve,0
16579,therapeutic aspects,Cervical Fibroepithelial Polyp,0
16580,Hematopoietic Neoplasms,Congenital hamartoma,0
16581,Trial Screening,Intracortical osteosarcoma,0
16582,Tryptophanase,Endometrial Small Cell Carcinoma,0
16583,Term Birth,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16584,Europe,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16585,Asia,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16586,Include (action),BRCA2 Syndrome,0
16587,Far East,Angiosarcoma of liver,0
16588,What subject filter - Result,Cerebral Primitive Neuroectodermal Tumor,0
16589,Average of Value Derivation Technique,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16590,Over (spatial),adenoid cystic carcinoma of lung,0
16591,High risk,Recurrent Rhabdomyosarcoma,0
16592,Melanocytic nevus,Deep Leiomyoma,0
16593,risk factors,Recurrent Uveal Melanoma,0
16594,research subject screening,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16595,therapeutic aspects,Testicular cancer metastatic,0
16596,Artificial Airways,Splenic Manifestation of Hairy Cell Leukemia,0
16597,Space - property,Type II Endometrial Adenocarcinoma,0
16598,Vaginal intraepithelial neoplasia,Malignant melanoma of eyelid,0
16599,biopsy characteristics,Granular Cell Leiomyosarcoma,0
16600,Proliferation (morphologic abnormality),Hodgkin Disease,0
16601,betel quid,Peripheral primitive neuroectodermal tumor of soft tissue,0
16602,Organ,Stage II Fallopian Tube Cancer,0
16603,Status post,Female Breast Carcinoma,0
16604,combination - answer to question,Pancreatic carcinoma,0
16605,Treating,Mucinous adenocarcinoma gastric,0
16606,Talpidae,Heavy Chain Deposition Disease,0
16607,Endocrine Cells,Recurrent Testicular Lymphoma,0
16608,Appearance,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16609,Third revision,Splenic Manifestation of Hairy Cell Leukemia,0
16610,Beginning,Stage IV Penile Cancer AJCC v7,0
16611,Age at menopause:Time:Point in time:^Patient:Quantitative,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
16612,seconds,Refractory Bladder Carcinoma,0
16613,World,Cartilaginous exostosis,0
16614,Often - answer to question,Intestinal Metaplasia of Bladder Urothelium,0
16615,United States,Localized Askin Tumor,0
16616,Treatment Epoch,Malignant neoplasm of thalamus,0
16617,With shape,Cerebral Primitive Neuroectodermal Tumor,0
16618,Malignant Neoplasms,Refractory Ependymoma,0
16619,Digestive Enzymes,Trichilemmocarcinoma,0
16620,Time,Stage I Adult Non-Hodgkin Lymphoma,0
16621,Disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16622,Cystic,Unresectable Rhabdomyosarcoma,0
16623,Pesticides,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
16624,Neoplasms,Recurrent Uveal Melanoma,0
16625,Malignant Neoplasms,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
16626,Cell Lineage,FIGO Stage IVA Ovarian Cancer,0
16627,Sore Throat,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16628,<90,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16629,include - SetOperator,Diffuse malignant mesothelioma,0
16630,Occurrence Indicator,Breast Ductal Adenoma,0
16631,Boat dock,Methotrexate-Associated Hodgkin Lymphoma,0
16632,Linear,Metastatic Lung Small Cell Carcinoma,0
16633,Most,Bladder adenocarcinoma stage IV,0
16634,Unconscious State,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16635,Worse,Digestive System Hodgkin Lymphoma,0
16636,Symptoms aspect,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16637,Childhood Medulloblastoma,Ectomesenchymal Chondromyxoid Tumor,0
16638,Condition:Find:Pt:^Patient:Nom,Endometrial Small Cell Carcinoma,0
16639,Short,Intraepithelial Melanocytic Hyperplasia,0
16640,Binding action,Extra-abdominal fibromatosis,0
16641,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16642,To,Engraftment syndrome,0
16643,Include (action),Cancer of Urinary Tract,0
16644,Cancer Genus,Rhabdomyosarcoma with ganglionic differentiation,0
16645,First (number),Tonsillar Carcinoma,0
16646,Usual Severity Itching,Bladder adenocarcinoma stage IV,0
16647,Including (qualifier),Carcinomatosis of peritoneal cavity,0
16648,Prevalence aspects,Non-Metastatic Gestational Trophoblastic Tumor,0
16649,Medical Device Emits Smoke,Cerebral Primitive Neuroectodermal Tumor,0
16650,site-specific telomere resolvase activity,Blood Vessel Tumors,0
16651,Treated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16652,Associated topography,Childhood Fibrillary Astrocytoma,0
16653,Asians,adenoid cystic carcinoma of lung,0
16654,NCI CTEP SDC Melanoma Sub-Category Terminology,Mixed parotid tumor,0
16655,Pharmacotherapy,Malignant melanoma of eyelid,0
16656,Bone Marrow,Maxillary Sinus Adenocarcinoma,0
16657,Retinoic Acid Response Element,Malignant Neoplasm of Lung - Multiple Primary Sites,0
16658,Malignant neoplasm of thyroid,Cervical Squamous Intraepithelial Neoplasia,0
16659,Occurrence,Astrocytoma of brain,0
16660,Stem of plant,Lipoma of small intestine,0
16661,Diagnosis,Secondary malignant neoplasm of lymph node,0
16662,Retinoic Acid Response Element,Stage IB Pancreatic Cancer AJCC v8,0
16663,Common Specifications in HL7 V3 Publishing,Granular Cell Leiomyosarcoma,0
16664,Primary malignant neoplasm of lung,Localized Askin Tumor,0
16665,Representation (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
16666,CEL gene,Basal Cell Ameloblastoma,0
16667,Functional Relationship,Adenocarcinoma,0
16668,Minor (value),Primary Cutaneous Plasmablastic Lymphoma,0
16669,Hemangioma,Stage II Fallopian Tube Cancer,0
16670,Tumor Mass,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
16671,Previous,Small Intestinal Villous Adenoma,0
16672,Numbers,Carcinomatosis of peritoneal cavity,0
16673,Togo,Recurrent Uveal Melanoma,0
16674,Triggered by,Low Grade Squamous Intraepithelial Neoplasia,0
16675,Problems - What subject filter,Female Breast Carcinoma,0
16676,Data Transformation,Atypical Lobular Breast Hyperplasia,0
16677,Physical Medical Procedure,Advanced Uterine Corpus Carcinosarcoma,0
16678,LYMPHOID Cancers,Giant cell angiofibroma,0
16679,intent,Mucinous cystadenofibroma,0
16680,Surgical reduction,Colorectal Neuroendocrine Tumor G2,0
16681,Platelet Glycoprotein 4,Liver Lymphangioma,0
16682,Blood Platelets,Stage II Hepatocellular Carcinoma AJCC v8,0
16683,Togo,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16684,Net (qualifier),Ovarian Dermoid Cyst with Secondary Carcinoma,0
16685,Empty (qualifier),Carcinoma of urinary bladder,0
16686,Concept model domain,Diffuse malignant mesothelioma,0
16687,Soft Tissue Route of Drug Administration,Intraepithelial Melanocytic Hyperplasia,0
16688,Provide (product),Benign Anal Granular Cell Tumor,0
16689,consider,Cancer of Urinary Tract,0
16690,Squamous cell carcinoma,Metastatic Lung Small Cell Carcinoma,0
16691,100%,Plexosarcoma,0
16692,Therapeutic radiology procedure,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16693,Usually Need Help from Another Person for Reach,Precursor B-lymphoblastic lymphoma stage II,0
16694,Absence (morphologic abnormality),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16695,Extrinsic,Intracortical osteosarcoma,0
16696,Usual,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
16697,Pale feces (finding),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16698,Body structure,Nasal cavity carcinoma,0
16699,Include (action),Human Papillomavirus-Related Carcinoma,0
16700,consider,Breast Ductal Adenoma,0
16701,Plaque (lesion),Gallbladder adenoma,0
16702,primary tumor,Brain Tumor,0
16703,Body part,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16704,shared attribute,Carcinomatosis of peritoneal cavity,0
16705,Adult,Heavy Chain Deposition Disease,0
16706,Breast Cancer Type 1 Susceptibility Protein Measurement,Intestinal Metaplasia of Bladder Urothelium,0
16707,Beginning,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16708,Precision - characteristic,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16709,Immature Lymphocytes Measurement,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16710,Diagnostic Imaging,Tonsillar Carcinoma,0
16711,Up,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16712,Blood Vessel,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16713,Characteristics,Breast Ductal Adenoma,0
16714,Surgical service,Undifferentiated Endocervical Sarcoma,0
16715,ALLERGENS IDENTIFIED:PRESENCE OR IDENTITY:POINT IN TIME:SERUM:NOMINAL,BRCA2 Syndrome,0
16716,LYMPHOID Cancers,Malignant melanoma of eyelid,0
16717,Xeroderma Pigmentosum,Undifferentiated Endocervical Sarcoma,0
16718,To,Maxillary Sinus Adenoid Cystic Carcinoma,0
16719,Continuance of life,Mixed astrocytoma-ependymoma,0
16720,Organ,Blepharal carcinoma,0
16721,Fluid behavior,Adult Acute Eosinophilic Leukemia,0
16722,Early Therapy,Prostate Lymphoma,0
16723,Diagnosis,Cerebral Primitive Neuroectodermal Tumor,0
16724,10%,Maxillary Sinus Adenoid Cystic Carcinoma,0
16725,Upper,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16726,peripheral blood,Refractory Ependymoma,0
16727,Growth,Medulloblastoma,0
16728,Head,Precursor B-lymphoblastic lymphoma stage II,0
16729,Three,Refractory Ependymoma,0
16730,Abdomen distended,Leiomyoma of Gallbladder,0
16731,Neoplasm Metastasis,Airway Hemangioma,0
16732,Abnormal cell,Malignant melanoma of eyelid,0
16733,More,Kaposi's sarcoma of extrahepatic bile duct,0
16734,peripheral blood,Gastric Diffuse Large B-Cell Lymphoma,0
16735,Aerosols,Benign Ovarian Thecoma,0
16736,Process (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16737,Subject Risk,Lipoma of small intestine,0
16738,Thyroid Neoplasm,Engraftment syndrome,0
16739,ancestors,Basal Cell Ameloblastoma,0
16740,To,Cervical Adenomyoma,0
16741,Tumor cells,Astrocytoma of brain,0
16742,Communicable Diseases,Diffuse malignant mesothelioma,0
16743,Mobility aid,Female Breast Carcinoma,0
16744,Drinking Water,clear cell adenocarcinoma of gallbladder,0
16745,Coloring Excipient,Bladder squamous cell carcinoma stage I,0
16746,Alcohol consumption,Thyroid Hurthle Cell Carcinoma,0
16747,Comparison,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16748,True Control Status,Carcinoma of urinary bladder,0
16749,Usual Severity Pain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16750,Common Specifications in HL7 V3 Publishing,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16751,House (environment),Intestinal Metaplasia of Bladder Urothelium,0
16752,diagnostic image,Benign neoplasm of thorax,0
16753,Diagnosis Study,Fibroadenoma of breast,0
16754,Tumor site,Malignant neoplasm of choroid,0
16755,Thyroid carcinoma,Liver Lymphangioma,0
16756,Childhood Lymphoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16757,Combined Modality Therapy,Thymic Clear Cell Carcinoma,0
16758,Specific qualifier value,Benign Carotid Body Paraganglioma,0
16759,Malignant neoplasm of pancreas,Leptomeningeal sarcoma,0
16760,Icterus,FIGO Stage II Ovarian Cancer,0
16761,Case (situation),Ovarian Carcinoid Tumor,0
16762,*Type - Kind of quantity,Bladder adenocarcinoma stage IV,0
16763,Chest,Cartilaginous exostosis,0
16764,Cell of Claudius,Bladder squamous cell carcinoma stage I,0
16765,Well,Mucinous adenocarcinoma gastric,0
16766,Cord - Body Parts,Diffuse malignant mesothelioma,0
16767,Malignant - descriptor,Childhood Fibrillary Astrocytoma,0
16768,Iodides,Ovarian germ cell choriocarcinoma stage IV,0
16769,Surrounding (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16770,Abdomen+,Metastatic Neoplasm to the Gallbladder,0
16771,Benign,Childhood Lymphoma,0
16772,Proteins,Benign Carotid Body Paraganglioma,0
16773,What subject filter - Result,Occult Lung Adenosquamous Carcinoma,0
16774,Connecticut,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16775,Have Pain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16776,Person Observer,Heavy Chain Deposition Disease,0
16777,Muscle (organ),Locally Advanced Soft Tissue Sarcoma,0
16778,Case (situation),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16779,Together,Vaginal Adenoid Cystic Carcinoma,0
16780,Population Group,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16781,Progress,Mixed astrocytoma-ependymoma,0
16782,More,Benign squamous cell tumor,0
16783,Benign melanocytic nevus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16784,Physical shape,Mixed astrocytoma-ependymoma,0
16785,International Aspects,Squamous cell carcinoma of lip,0
16786,Occur (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16787,Respiration,Locally Advanced Epithelioid Hemangioendothelioma,0
16788,Neoplasms,Extra-Adrenal Paraganglioma,0
16789,Increase,papillary carcinoma of penis,0
16790,Cancer Other,Hodgkin lymphoma,0
16791,Representation (action),Werner Syndrome,0
16792,Treating,Tonsillar Carcinoma,0
16793,Medial,sarcoma of spinal cord,0
16794,Decision,Airway Hemangioma,0
16795,Primary malignant neoplasm,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16796,Organ,Kaposi's sarcoma of extrahepatic bile duct,0
16797,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
16798,What subject filter - Result,Kaposi's sarcoma of skin,0
16799,Antibiotic throat preparations,Female Breast Carcinoma,0
16800,Arranged (transportation),Malignant Neoplasm with Regional Lymph Node Involvement,0
16801,Early disease stage,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16802,Unintentional,Recurrent Primary Lymphoma of Bone,0
16803,Show,Astrocytoma of brain,0
16804,Surgical service,Unresectable Rhabdomyosarcoma,0
16805,First (number),Human Papillomavirus-Related Carcinoma,0
16806,Tonsillar Carcinoma,Testicular cancer metastatic,0
16807,Population Group,Pilocytic astrocytoma of cerebellum,0
16808,75,Multiple Skull Base Meningiomas,0
16809,Changed status,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16810,Abnormal Cell Count,Maxillary Sinus Adenoid Cystic Carcinoma,0
16811,Fever symptoms (finding),Malignant melanoma of eyelid,0
16812,Dana-Farber/Harvard Cancer Center,Mastocytosis,0
16813,Type A,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16814,Decreasing,Vaginal Adenoid Cystic Carcinoma,0
16815,Common (qualifier value),Cherubism,0
16816,Usually,Advanced Lung Carcinoma,0
16817,Occur (action),Acute Undifferentiated Leukemia,0
16818,Malignant Neoplasms,Cancer of Urinary Tract,0
16819,Digestion,Childhood Central Nervous System Ganglioneuroblastoma,0
16820,Carcinoma,Gallbladder Adenocarcinoma,0
16821,Range,Intraepithelial Melanocytic Hyperplasia,0
16822,Mutation Abnormality,FIGO Stage IVA Ovarian Cancer,0
16823,Malignant Neoplasms,Non-Hodgkin Lymphoma During Pregnancy,0
16824,Therapy Object (animal model),FIGO Stage IVA Ovarian Cancer,0
16825,Infrequent,Primary Cutaneous Plasmablastic Lymphoma,0
16826,Common (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
16827,20%,Pancreatic carcinoma,0
16828,Poor function,clear cell adenocarcinoma of gallbladder,0
16829,described,clear cell adenocarcinoma of gallbladder,0
16830,Include (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16831,80%,Epithelioid Sarcoma NCI Grade 3,0
16832,Entity Name Part Qualifier - birth,Endometrial Small Cell Carcinoma,0
16833,Designated Blood Product Donation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16834,Flat shape,Secondary malignant neoplasm of lymph node,0
16835,Nervous system structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16836,Tired,Anterior Urethral Malignant Neoplasm,0
16837,Down Syndrome,Liver Lymphangioma,0
16838,Effectiveness,Lipoma of small intestine,0
16839,Persons,Lipoma of small intestine,0
16840,Financial Account,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16841,Percent (qualifier value),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
16842,Acetic Acids,Ovarian germ cell choriocarcinoma stage IV,0
16843,Severe (severity modifier),Spermatocytic seminoma,0
16844,Biomaterial Treatment,Adenocarcinoma,0
16845,Science of Etiology,Trabecular adenocarcinoma,0
16846,Pitcairn Island,Hodgkin Disease,0
16847,Chest Pain,benign mature teratoma of pancreas,0
16848,VARIOUS DRUG CLASSES IN ATC,Brain Ependymoma,0
16849,Does stand alone,mucinous adenocarcinoma of gallbladder,0
16850,Weight decreased,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16851,Africa,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16852,Squamous cell carcinoma - category,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16853,Treatment intent,Ichthyosis,0
16854,T-Lymphocytopenia,Hereditary Diffuse Gastric Adenocarcinoma,0
16855,New bone formation (morphologic abnormality),Atypical Mesothelial Hyperplasia,0
16856,Mixed Cell Morphology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16857,Preventive intent,Tongue Alveolar Soft Part Sarcoma,0
16858,Hereditary Diseases,Hereditary Diffuse Gastric Adenocarcinoma,0
16859,Result,clear cell adenocarcinoma of gallbladder,0
16860,Disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16861,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,de novo Myelodysplastic Syndrome,0
16862,Esophageal Stricture,Nasal cavity carcinoma,0
16863,Tumor Mass,Tonsillar Carcinoma,0
16864,Characterization,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16865,Obesity,clear cell adenocarcinoma of gallbladder,0
16866,Neurofibromatosis 2,Squamous cell carcinoma of lip,0
16867,Diffuse Large B-Cell Lymphoma,Testicular cancer metastatic,0
16868,Median (qualifier value),Cervical Squamous Intraepithelial Neoplasia,0
16869,Chromosomes,Endometrial Small Cell Carcinoma,0
16870,Science of Statistics,Uterine Cancer,0
16871,Linear,Stage IB Pancreatic Cancer AJCC v8,0
16872,Symptoms aspect,clear cell adenocarcinoma of gallbladder,0
16873,Bacteria,Human Papillomavirus-Related Carcinoma,0
16874,How Often Itching,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16875,Subgroup,Childhood Fibrillary Astrocytoma,0
16876,Patient observation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16877,Occurrence,Maxillary Sinus Adenoid Cystic Carcinoma,0
16878,Daily Living,Acantholytic squamous cell carcinoma,0
16879,diagnosis aspect,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16880,history (of) disease family,Microcystic meningioma,0
16881,Never (frequency),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16882,Subtype (attribute),Ovarian Dermoid Cyst with Secondary Carcinoma,0
16883,Lymphoma,Mixed parotid tumor,0
16884,Brain Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
16885,Malignant tumor of cervix,FIGO Stage IVA Ovarian Cancer,0
16886,Common (qualifier value),Fibroadenoma of breast,0
16887,Age - 16,Recurrent Testicular Lymphoma,0
16888,Often - answer to question,Chest Wall Fibromatosis,0
16889,Flank Pain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16890,Symptoms,Pancreatic Intraepithelial Neoplasia-3,0
16891,Astrocytoma,Bladder adenocarcinoma stage IV,0
16892,ASIP wt Allele,Carcinoma of urinary bladder,0
16893,Therapeutic radiology procedure,Refractory Ependymoma,0
16894,Vaginal (intended site),Microcystic meningioma,0
16895,Antigens,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16896,Continuance of life,Refractory Ependymoma,0
16897,Etiology,Epithelioid Sarcoma NCI Grade 3,0
16898,Condition,Cancer of Urinary Tract,0
16899,Five-year Survival Rate,Serous cystadenocarcinoma ovary,0
16900,Visual Impairment,Multiple Endocrine Neoplasia,0
16901,body system,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
16902,Spreading (qualifier value),Metastatic Neoplasm to the Gallbladder,0
16903,Manufactured form,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16904,Nodule,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16905,Known,Diffuse malignant mesothelioma,0
16906,Shortness of Breath Visual Analogue Scale,Plexosarcoma,0
16907,Cause of death.underlying,Carcinoma of urinary bladder,0
16908,treatment - ActInformationManagementReason,Giant cell angiofibroma,0
16909,Term (temporal),Squamous cell carcinoma of lip,0
16910,>90,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16911,Percent of Abnormal Cells,Malignant Neoplasm of Lung - Multiple Primary Sites,0
16912,Lymphocyte component of blood,Diffuse malignant mesothelioma,0
16913,To,Childhood Lung Non-Small Cell Carcinoma,0
16914,Histology aspects,Parathyroid Gland Adenocarcinoma,0
16915,Aggressive behavior,Human Papillomavirus-Related Carcinoma,0
16916,Optic Nerve Glioma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16917,Occurrence Indicator,Cancer of Urinary Tract,0
16918,Human Cells,Melanomatosis,0
16919,Network,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
16920,Entity Determiner - specific,ROSE Cluster 3,0
16921,How Much Distress Sweats,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16922,Cessation of life,Childhood Anaplastic Large Cell Lymphoma,0
16923,Eye lid,FIGO Stage IVA Ovarian Cancer,0
16924,*Type - Kind of quantity,Uterine Cancer,0
16925,Eye,Stage II Carcinoma of Penis,0
16926,Occurrence Indicator,Breast Apocrine Adenoma,0
16927,Used by,Clonal Hematopoiesis of Indeterminate Potential,0
16928,General surgery specialty,Childhood Central Nervous System Ganglioneuroblastoma,0
16929,Exist,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
16930,Cancer Genus,Ectomesenchymal Chondromyxoid Tumor,0
16931,Abdominal Cavity,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16932,Human Papilloma Virus Vaccine,Gallbladder Adenocarcinoma,0
16933,1000000,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16934,Persons,Stage III Cutaneous Melanoma AJCC v6,0
16935,Picture,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16936,Weight measurement scales,Childhood Fibrillary Astrocytoma,0
16937,Object Class,Cerebral Primitive Neuroectodermal Tumor,0
16938,Treatment Effectiveness,Pleomorphic adenoma of parotid gland,0
16939,Relationships,Cerebral hemangioma,0
16940,Retinoic Acid Response Element,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
16941,classical example,Refractory Barrett Esophagus,0
16942,Infrequent,Refractory Bladder Carcinoma,0
16943,Treating,Peripheral primitive neuroectodermal tumor of soft tissue,0
16944,NCI CTEP SDC Thyroid Cancer Sub-Category Terminology,Refractory Bladder Carcinoma,0
16945,Exposure to radiation,FIGO Stage II Ovarian Cancer,0
16946,Including (qualifier),Melanomatosis,0
16947,Disks (device),Locally Advanced Epithelioid Hemangioendothelioma,0
16948,Delayed Puberty,Stage II Hepatocellular Carcinoma AJCC v8,0
16949,What subject filter - Result,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16950,Tryptophanase,Chest Wall Fibromatosis,0
16951,Qualitative form,Unicystic ameloblastoma,0
16952,Upper,Benign squamous cell tumor,0
16953,Frequently,Stage IV Penile Cancer AJCC v7,0
16954,Gastrectomy,Metastatic Neoplasm to the Gallbladder,0
16955,Cerebrospinal Fluid,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16956,Contribution,gliosarcoma,0
16957,Abnormally high,Childhood Fibrillary Astrocytoma,0
16958,god,FIGO Stage IVA Ovarian Cancer,0
16959,Persons,Occult Lung Adenosquamous Carcinoma,0
16960,Increased,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16961,Decision,Benign Apocrine Neoplasm,0
16962,Science of Etiology,Brain Tumor,0
16963,1000000,FIGO Stage IVA Ovarian Cancer,0
16964,Hydrocephalus,Recurrent Rhabdomyosarcoma,0
16965,Death (finding),Unresectable Rhabdomyosarcoma,0
16966,Common Specifications in HL7 V3 Publishing,Splenic Manifestation of Hairy Cell Leukemia,0
16967,Usually,Acute Undifferentiated Leukemia,0
16968,Count of entities,Mixed astrocytoma-ependymoma,0
16969,Experimental Result,Metaplastic carcinoma of breast,0
16970,Adult Diffuse Large B-Cell Lymphoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16971,Rectal examination,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16972,shared attribute,Adult Alveolar Soft Part Sarcoma,0
16973,per second,Metastatic Malignant Neoplasm in the Sellar Region,0
16974,Development,Microcystic meningioma,0
16975,Childhood Non-Hodgkin Lymphoma,Carcinoma,0
16976,Classification,Unfavorable Non-Hodgkin Lymphoma,0
16977,Levels (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
16978,Bone Marrow,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16979,Primary malignant neoplasm,adenosquamous carcinoma of breast,0
16980,Secondary Neoplasm,Localized Ewing Sarcoma,0
16981,Ewings sarcoma,Cervical Squamous Intraepithelial Neoplasia,0
16982,Paired box protein Pax-3,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16983,Different,Recurrent Testicular Lymphoma,0
16984,Component object,Benign Anal Granular Cell Tumor,0
16985,Blood Cells,Benign Anal Granular Cell Tumor,0
16986,Radiology Specialty,Fibroadenoma of breast,0
16987,Document Body,Kaposi's sarcoma of skin,0
16988,Dosing Days to Detection,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16989,Providing presence (regime/therapy),Adult Acute Eosinophilic Leukemia,0
16990,Cancer Genus,Cerebral Primitive Neuroectodermal Tumor,0
16991,seen,Funisitis (disorder),0
16992,Earache,Recurrent Rhabdomyosarcoma,0
16993,morphological,Sarcomatoid Renal Cell Carcinoma,0
16994,Cell Count,Brain Tumor,0
16995,Carcinoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16996,Malignant Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16997,low exposure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
16998,One,Intraepithelial Melanocytic Hyperplasia,0
16999,Body tissue patch material,Lipoma of small intestine,0
17000,Exist,Ichthyosis,0
17001,VARIOUS DRUG CLASSES IN ATC,Adult Alveolar Soft Part Sarcoma,0
17002,anaphylaxis,Malignant neoplasm of subglottis,0
17003,65+,FIGO Stage II Ovarian Cancer,0
17004,per year,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17005,Aim,Adult Acute Eosinophilic Leukemia,0
17006,Various patch test substance,Endometrial Small Cell Carcinoma,0
17007,Most,Childhood Lymphoma,0
17008,bony process,Adenocarcinoma,0
17009,Disease,Multiple Skull Base Meningiomas,0
17010,Stomach structure,Unfavorable Non-Hodgkin Lymphoma,0
17011,Ovarian Germ Cell Tumor,Mucinous adenocarcinoma gastric,0
17012,Type - attribute,Stage IV Penile Cancer AJCC v7,0
17013,Category Type,Malignant neoplasm of gallbladder,0
17014,Gonadal Dysgenesis,Benign tumor of eyelid,0
17015,Apocrine Glands,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
17016,Time (foundation metadata concept),Ovarian Dermoid Cyst with Secondary Carcinoma,0
17017,Affect (mental function),Metaplastic carcinoma of breast,0
17018,Pancreas part,Larynx carcinoma recurrent,0
17019,Rare,Maxillary Sinus Adenoid Cystic Carcinoma,0
17020,Usually,Testicular cancer metastatic,0
17021,Contain (action),Malignant melanoma of eyelid,0
17022,Containing (qualifier),Trichilemmocarcinoma,0
17023,potential,Uterine Cancer,0
17024,Rating (action),Colorectal cancer,0
17025,Reported Term,Peripheral primitive neuroectodermal tumor of soft tissue,0
17026,Excision,Malignant melanoma of eyelid,0
17027,Organ,Liver Lymphangioma,0
17028,Males,Female Breast Carcinoma,0
17029,World Health Organization,Stage II Hepatocellular Carcinoma AJCC v8,0
17030,Tumor cells,Trabecular adenocarcinoma,0
17031,Dorsal,Neonatal leukemia,0
17032,Therapeutic radiology procedure,Metaplastic carcinoma of breast,0
17033,Symptoms aspect,Childhood Fibrillary Astrocytoma,0
17034,Stage Grouping,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17035,Usually Need Help from Another Person for Reach,Recurrent Uveal Melanoma,0
17036,Death (finding),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17037,Skin,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
17038,Togo,Localized Malignant Neoplasm,0
17039,various other nasal preparations in ATC,sarcoma of spinal cord,0
17040,Hematopoiesis,benign mature teratoma of pancreas,0
17041,Involvement with,Heavy Chain Deposition Disease,0
17042,Infrequent,Lipoma of small intestine,0
17043,Pruritus,Cervical Squamous Intraepithelial Neoplasia,0
17044,Palmitic Acid,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17045,High Risk Acute Leukemia,Xeroderma pigmentosum,0
17046,Increase,sarcoma of spinal cord,0
17047,Dorsal,Neonatal leukemia,0
17048,Nevus,benign mature teratoma of pancreas,0
17049,Often - answer to question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17050,Basis - conceptual entity,Intraepithelial Melanocytic Hyperplasia,0
17051,Usually Need Help from Another Person for Reach,Unresectable Rhabdomyosarcoma,0
17052,Life Expectancy Less than Ten Years,Uterine Cancer,0
17053,Physical findings,Digestive System Hodgkin Lymphoma,0
17054,Including (qualifier),Recurrent Primary Lymphoma of Bone,0
17055,Malignant Head and Neck Neoplasm,Unfavorable Non-Hodgkin Lymphoma,0
17056,Drop (unit of presentation),Stage III Cutaneous Melanoma AJCC v6,0
17057,Approximate,Endometrial Small Cell Carcinoma,0
17058,Estrogen [EPC],Stage III Adult Immunoblastic Lymphoma,0
17059,Children only,Stage III Adult Immunoblastic Lymphoma,0
17060,Proprietary Name,Vaginal Adenoma,0
17061,Disease Screening,Malignant neoplasm of subglottis,0
17062,Linear,Platinum-Resistant Lung Small Cell Carcinoma,0
17063,Age,Benign Carotid Body Paraganglioma,0
17064,Manufactured form,embryonal rhabdomyosarcoma of prostate,0
17065,Difficult (qualifier value),Hemangioma,0
17066,Including (qualifier),Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
17067,Known,Stage III Cutaneous Melanoma AJCC v6,0
17068,Adult,Testicular cancer metastatic,0
17069,Pain,Pleomorphic adenoma of parotid gland,0
17070,peripheral blood,Cancer of Urinary Tract,0
17071,Molecular Mass,Gallbladder Adenocarcinoma,0
17072,Persons,Refractory Ependymoma,0
17073,Different,Larynx carcinoma recurrent,0
17074,Involvement with,Methotrexate-Associated Hodgkin Lymphoma,0
17075,Result,Primary Cutaneous Plasmablastic Lymphoma,0
17076,Taxonomic,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17077,Manufactured sign,Bladder adenocarcinoma stage IV,0
17078,Advanced phase,Chondrosarcoma,0
17079,Associated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17080,Bladder Neoplasm,mucinous adenocarcinoma of gallbladder,0
17081,International Statistical Classification of Diseases and Related Health Problems,Refractory Ependymoma,0
17082,Progestins,Breast Ductal Adenoma,0
17083,Young Adult,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17084,Used by,Type II Endometrial Adenocarcinoma,0
17085,Representation (action),Stage III Adult Immunoblastic Lymphoma,0
17086,Contents,Xeroderma pigmentosum,0
17087,Empty (qualifier),Keratoderma,0
17088,Form:Finding:Point in time:{Setting}:Document:{Role},Botryoid-Type Embryonal Rhabdomyosarcoma,0
17089,Disease Management,Benign Anal Granular Cell Tumor,0
17090,Endocrine Cells,Acantholytic squamous cell carcinoma,0
17091,Soft Tissue Route of Drug Administration,squamous cell carcinoma of the thyroid gland,0
17092,Separate,Splenic Manifestation of Hairy Cell Leukemia,0
17093,Hodgkin Disease,Stage 0 Penile Cancer AJCC v8,0
17094,Singular,Carcinoma of urinary bladder,0
17095,Often - answer to question,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17096,Adult Pilocytic Astrocytoma,Ovarian germ cell choriocarcinoma stage IV,0
17097,Atypical ductal hyperplasia (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17098,Metastatic Disease Clinical Trial Setting,Liver Cavernous Hemangioma,0
17099,Symptoms,Ampulla of Vater Tubular Adenoma,0
17100,Lower - spatial qualifier,Stage II Carcinoma of Penis,0
17101,76,Mucinous adenocarcinoma gastric,0
17102,Medical Device Emits Smoke,Intracortical osteosarcoma,0
17103,Present,Lipoma of small intestine,0
17104,Bayer Visual Acuity Changes Grade 3,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17105,Body part,Stage IB Pancreatic Cancer AJCC v8,0
17106,Physical findings,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17107,Body tissue,Colorectal High Grade B-Cell Lymphoma,0
17108,Five-year Survival Rate,Localized Malignant Neoplasm,0
17109,Metastatic to,Kaposi's sarcoma of skin,0
17110,SLC6A2 protein,Liver Lymphangioma,0
17111,Esthesia,Malignant melanoma of eyelid,0
17112,Solid organ transplant,Vaginal Adenoid Cystic Carcinoma,0
17113,Approximate,Placental aromatase deficiency,0
17114,Rare,BRCA2 Syndrome,0
17115,Togo,Stage I Adult Non-Hodgkin Lymphoma,0
17116,More,FIGO Stage II Ovarian Cancer,0
17117,Cancer Genus,Engraftment syndrome,0
17118,Has focus,Breast Ductal Adenoma,0
17119,SLC6A2 protein,FIGO Stage II Ovarian Cancer,0
17120,Excision,Secondary malignant neoplasm of lymph node,0
17121,Slow Growing,Gallbladder Adenocarcinoma,0
17122,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17123,Brain,Acute Undifferentiated Leukemia,0
17124,Tired,Bladder Neuroendocrine Neoplasm,0
17125,Premalignant,Choroid Epithelioid Cell Melanoma,0
17126,Relationships,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17127,Malignant Neoplasms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17128,Metastatic Disease Clinical Trial Setting,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17129,Heterogeneity,Contact dermatitis due to alkali,0
17130,Case (situation),Endometrial Small Cell Carcinoma,0
17131,Adult Hodgkin Lymphoma,Localized Ewing Sarcoma,0
17132,Metastasis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17133,Gait normal,Low Grade Squamous Intraepithelial Neoplasia,0
17134,classical example,Pilocytic astrocytoma of cerebellum,0
17135,MNX1 gene,Metastatic Ductal Breast Carcinoma,0
17136,Tumor cells,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
17137,Heart,Ichthyosis,0
17138,Nicotiana tabacum,Benign neoplasm of eye,0
17139,Line Specimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17140,Therapeutic radiology procedure,Mucinous neoplasm,0
17141,Response to treatment,Carcinoma,0
17142,How Much Distress Weight Loss,Stage IV Childhood Non-Hodgkin Lymphoma,0
17143,Case unit dose,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17144,Imaging Techniques,Childhood Extragonadal Malignant Germ Cell Tumor,0
17145,Occurrence,Funisitis (disorder),0
17146,Cell division,Keratoderma,0
17147,At risk of infection,Small intestine carcinoma,0
17148,Painless,Hemangioma,0
17149,Tired,Mucinous neoplasm,0
17150,Family history,Metaplastic carcinoma of breast,0
17151,Presentation,Leptomeningeal sarcoma,0
17152,Package Type Not Applicable,Choroid Necrotic Melanoma,0
17153,Head,Childhood Anaplastic Large Cell Lymphoma,0
17154,Sufficient,Uterine Cancer,0
17155,Adult Non-Hodgkin Lymphoma,Platinum-Resistant Lung Small Cell Carcinoma,0
17156,Smear test,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17157,Ability,Malignant neoplasm of choroid,0
17158,3+ Score,Localized Ewing Sarcoma,0
17159,Cancer Genus,Human Papillomavirus-Related Carcinoma,0
17160,Australia,Adenocarcinoma of the prostate metastatic,0
17161,Base - General Qualifier,Malignant melanoma of eyelid,0
17162,Eye,Localized Askin Tumor,0
17163,Blood Vessel,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
17164,Frequencies (time pattern),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17165,Intestines,Brain Ependymoma,0
17166,Index,Lipoma of small intestine,0
17167,Woman,gliosarcoma,0
17168,Long-term,Refractory Glioma,0
17169,Data operation - complete,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17170,Mutation,Pancreatic Endocrine Carcinoma,0
17171,Neoplasms,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
17172,Hematuria,Carcinoma ex pleomorphic adenoma of parotid gland,0
17173,high-risk group,Leiomyoma of Gallbladder,0
17174,Embryo,Digestive System Hodgkin Lymphoma,0
17175,Skin tanning,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17176,section sample,Mucinous adenocarcinoma gastric,0
17177,Include (action),Pancreatic carcinoma,0
17178,Old,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
17179,Sweat gland cyst,Stage III Cutaneous Melanoma AJCC v6,0
17180,PSA Level Less than Five,Clonal Hematopoiesis of Indeterminate Potential,0
17181,Lymphocyte,Astrocytoma of brain,0
17182,Descending,Metastatic Kidney Carcinoma,0
17183,Feature,Mixed astrocytoma-ependymoma,0
17184,Primary malignant neoplasm,Vaginal Adenoma,0
17185,Occur (action),Adult Hepatocellular Carcinoma,0
17186,Area,Cancer of Urinary Tract,0
17187,Left sided,Childhood Central Nervous System Ganglioneuroblastoma,0
17188,Carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17189,Absence of Signs or Symptoms,Intracortical osteosarcoma,0
17190,Thyroid Gland,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17191,Cancer Genus,Malignant Neoplasm with Regional Lymph Node Involvement,0
17192,Reported Term,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17193,Changing,Adenocarcinoma of the prostate metastatic,0
17194,use of ultrasonography,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17195,Infertility risk,Xeroderma pigmentosum,0
17196,Lymphocyte,Digestive System Hodgkin Lymphoma,0
17197,Vision:-:Point in time:^Patient:-,Kaposi's sarcoma of skin,0
17198,Infrequent,Diffuse malignant mesothelioma,0
17199,New Zealand Rabbits,Stage IV Childhood Non-Hodgkin Lymphoma,0
17200,Chemotherapy Regimen,Stage IB Pancreatic Cancer AJCC v8,0
17201,Followed by,Tonsillar Carcinoma,0
17202,Anterior chest wall structure,Localized Malignant Neoplasm,0
17203,Second edition,Keratoderma,0
17204,Section - Geographic Area,Benign Anal Granular Cell Tumor,0
17205,Parenchyma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17206,Main,Basal Cell Ameloblastoma,0
17207,Imaging Techniques,gliosarcoma,0
17208,Second edition,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17209,Immunotherapy for cancer,Diffuse malignant mesothelioma,0
17210,include - SetOperator,Recurrent Testicular Lymphoma,0
17211,Sometimes,Malignant neoplasm of gallbladder,0
17212,Operative Surgical Procedures,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17213,Mutation,Blepharal carcinoma,0
17214,Diagnosis Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17215,PSA Level Less than Two,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17216,6/3,Collecting Duct Carcinoma of the Kidney,0
17217,Human body structure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17218,Nursing interventions,Medulloblastoma,0
17219,Main,Kaposi's sarcoma of skin,0
17220,Blood,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17221,Mammal liver preparation,Anterior Urethral Malignant Neoplasm,0
17222,Plant nodule,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17223,include - SetOperator,Locally Advanced Soft Tissue Sarcoma,0
17224,Often - answer to question,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17225,Cancer/Testis Antigen,Clonal Hematopoiesis of Indeterminate Potential,0
17226,Shortness of breath:-:Point in time:^Patient:-,Clonal Hematopoiesis of Indeterminate Potential,0
17227,therapeutic aspects,benign mature teratoma of pancreas,0
17228,Persons,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
17229,Non-invasive,Platinum-Resistant Lung Small Cell Carcinoma,0
17230,Entity Determiner - specific,Recurrent Testicular Lymphoma,0
17231,Blood group A (finding),Grade 1 Clear Cell Renal Cell Carcinoma,0
17232,Metastatic Neoplasm,Brain Tumor,0
17233,Abnormal,Brain Tumor,0
17234,Lung,Malignant melanoma of eyelid,0
17235,Affecting,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17236,Painless,adenoid cystic carcinoma of lung,0
17237,Drop - Unit of Volume,FIGO Stage IVA Ovarian Cancer,0
17238,Grade,Bladder squamous cell carcinoma stage I,0
17239,Injury due to exposure to external cause,Xeroderma pigmentosum,0
17240,Cornea,Benign Anal Granular Cell Tumor,0
17241,Subtype (attribute),Carcinomatosis of peritoneal cavity,0
17242,Benign melanocytic nevus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17243,Tryptophanase,Kaposi's sarcoma of extrahepatic bile duct,0
17244,Uterine Cancer,Carcinomatosis of peritoneal cavity,0
17245,Buildup,Stage IV Colorectal Cancer AJCC v8,0
17246,Common (qualifier value),Metastatic Neoplasm to the Gallbladder,0
17247,Present,FIGO Stage IVA Ovarian Cancer,0
17248,High risk,Acantholytic squamous cell carcinoma,0
17249,As Much as Desired,Localized Ewing Sarcoma,0
17250,Abnormal Cell Count,Childhood Choriocarcinoma,0
17251,TableCellVerticalAlign - bottom,Gallbladder Adenocarcinoma,0
17252,Chemotherapy,Benign Anal Granular Cell Tumor,0
17253,Tumor cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17254,Tissue Growth,Type II Endometrial Adenocarcinoma,0
17255,Usual,Hodgkin lymphoma,0
17256,Abnormal cell,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17257,Tests (qualifier value),non-Hodgkin's lymphoma of spleen,0
17258,Microplate Well,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17259,Death Related to Adverse Event,Breast Ductal Adenoma,0
17260,Benign,Stage II Carcinoma of Penis,0
17261,diagnosis aspect,Malignant Neoplasm with Regional Lymph Node Involvement,0
17262,North America,Basal Cell Ameloblastoma,0
17263,Primary malignant neoplasm,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17264,Cell Lineage,Malignant neoplasm of thalamus,0
17265,Low probability,Epithelioid Sarcoma NCI Grade 3,0
17266,Case unit dose,Adult Alveolar Soft Part Sarcoma,0
17267,Bodily secretions,Gallbladder Adenocarcinoma,0
17268,More Often than Once a Day,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17269,risk factors,Intraepithelial Melanocytic Hyperplasia,0
17270,Calcium Channel Antagonists [MoA],Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17271,intent,mucinous adenocarcinoma of gallbladder,0
17272,Occurrence,Testicular cancer metastatic,0
17273,Grade,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
17274,Carcinoma of bladder,Chest Wall Fibromatosis,0
17275,Childhood Non-Hodgkin Lymphoma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17276,Negation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17277,Excision,Ovarian Carcinoid Tumor,0
17278,Aspects of signs,Malignant neoplasm of subglottis,0
17279,Recipient,Recurrent Uveal Melanoma,0
17280,International Classification of Disease for Oncology,Cervical Fibroepithelial Polyp,0
17281,Classical (qualifier value),Mucinous adenocarcinoma gastric,0
17282,95,Chronic Myelomonocytic Leukemia-2,0
17283,include - SetOperator,Digestive System Hodgkin Lymphoma,0
17284,Case unit dose,Localized Ewing Sarcoma,0
17285,Special,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17286,therapeutic aspects,Cerebral Primitive Neuroectodermal Tumor,0
17287,10%,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17288,Genetic,Sarcomatoid Renal Cell Carcinoma,0
17289,Burkina Faso,Childhood Central Nervous System Ganglioneuroblastoma,0
17290,Aspects of signs,Liver Lymphangioma,0
17291,68,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17292,Europe,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17293,Definition,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17294,Involvement with,Fibroadenoma of breast,0
17295,CDISC SEND Tumor Findings Results Terminology,Childhood Fibrillary Astrocytoma,0
17296,Greater,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
17297,Common Specifications in HL7 V3 Publishing,ROSE Cluster 3,0
17298,Malignant Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17299,Walls of a building,Thyroid Hurthle Cell Carcinoma,0
17300,Lymphatic vessel,Transitional cell carcinoma,0
17301,To,Stage III Cutaneous Melanoma AJCC v6,0
17302,Sarcoma - category (morphologic abnormality),Vaginal Adenoma,0
17303,How Often Weight Loss,Metaplastic carcinoma of breast,0
17304,Nicotiana tabacum,Refractory Barrett Esophagus,0
17305,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
17306,Tryptophanase,Hereditary Diffuse Gastric Adenocarcinoma,0
17307,Dependent for dressing,Stage IV Childhood Non-Hodgkin Lymphoma,0
17308,Rating (action),Necrotizing Funisitis,0
17309,Acute Myeloid Leukemia Pathway,Childhood Lymphoma,0
17310,% of total,Advanced Lung Carcinoma,0
17311,Juvenile Myelomonocytic Leukemia,Benign squamous cell tumor,0
17312,Occurrence Indicator,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17313,Aim,Occult Lung Adenosquamous Carcinoma,0
17314,Child,Hemangioma,0
17315,Term (lexical),Cancer of Urinary Tract,0
17316,Togo,Acute Undifferentiated Leukemia,0
17317,Infratentorial,Benign squamous cell tumor,0
17318,Fatigue,Splenic Manifestation of Hairy Cell Leukemia,0
17319,% index,Extracranial Neuroblastoma,0
17320,Malignant Neoplasms,Acantholytic squamous cell carcinoma,0
17321,Often - answer to question,Stage III Cutaneous Melanoma AJCC v6,0
17322,risk factors - observation list,Refractory Ependymoma,0
17323,Primary malignant neoplasm,Metastatic Carcinoma in the Lung,0
17324,various antiseptic throat preparations,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17325,Monocyte count procedure,Lung squamous cell carcinoma stage I,0
17326,Negation,Carcinoma of urinary bladder,0
17327,Monoclonal Antibodies,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17328,Oral,Benign squamous cell tumor,0
17329,Malignant - descriptor,Melanomatosis,0
17330,High Mitosis-Karyorrhexis Index,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17331,Muscle Tissue,Metastatic Lung Small Cell Carcinoma,0
17332,Block (unit of measure),Metastatic Kidney Carcinoma,0
17333,Cold Temperature,Hereditary corneal dystrophy,0
17334,Premalignant Cell,Neoplasms,0
17335,abnormal growth by tissue,Localized Askin Tumor,0
17336,Physical shape,Anterior Urethral Malignant Neoplasm,0
17337,Squamous cell carcinoma,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
17338,Adult Classical Hodgkin Lymphoma,Mucinous neoplasm,0
17339,Foot British,FIGO Stage II Ovarian Cancer,0
17340,use of ultrasonography,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17341,Section - Geographic Area,Kaposi's sarcoma of skin,0
17342,Cover - action,High Grade Glandular Intraepithelial Neoplasia,0
17343,Person Observer,Platinum-Resistant Lung Small Cell Carcinoma,0
17344,Etiology aspects,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17345,Deep Resection Margin,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17346,various other intestinal adsorbents in ATC,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17347,Human body,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17348,Ursidae Family,Extra-Adrenal Paraganglioma,0
17349,Skin,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17350,Consistency,ICHTHYOSIS,0
17351,Eye protection,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17352,2+ Score,Leptomeningeal sarcoma,0
17353,Widening,Stage IV Childhood Non-Hodgkin Lymphoma,0
17354,Persons,benign mature teratoma of pancreas,0
17355,Usual,Childhood Central Nervous System Ganglioneuroblastoma,0
17356,shared attribute,Digestive System Hodgkin Lymphoma,0
17357,Skin,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17358,Tumor Mass,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17359,Type - attribute,Localized Ewing Sarcoma,0
17360,Poor - qualifier,Localized Ewing Sarcoma,0
17361,Reactive fibrous tissue proliferation,Intracortical osteosarcoma,0
17362,diagnosis aspect,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17363,Rest,Unicystic ameloblastoma,0
17364,ERBB2 gene,Malignant neoplasm of olfactory nerve,0
17365,Togo,Malignant Testicular Sertoli Cell Tumor,0
17366,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Mixed astrocytoma-ependymoma,0
17367,physiological aspects,Endometrial Small Cell Carcinoma,0
17368,Cardiac Lead Procedure,Cerebral hemangioma,0
17369,Singular,Localized Malignant Neoplasm,0
17370,Abnormal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17371,various other agents for local oral treatment in ATC,Kaposi's sarcoma of skin,0
17372,Virus Diseases,Adenocarcinoma,0
17373,Metastasis,Nasal cavity carcinoma,0
17374,Good,Recurrent Testicular Lymphoma,0
17375,Generalization (Psychology),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17376,Increase,Digestive System Hodgkin Lymphoma,0
17377,Spreading (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
17378,Cause of death.underlying,Hyperplasia of pituitary gland,0
17379,Stromal Cells,Thymic Atypical Carcinoid Tumor,0
17380,Rating (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17381,Include (action),Testicular cancer metastatic,0
17382,Respiratory organs,Adenocarcinoma,0
17383,Affecting,Anterior Urethral Malignant Neoplasm,0
17384,Occurrence,Uterine Cancer,0
17385,Type - attribute,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17386,Gram per Deciliter,Mucinous neoplasm,0
17387,Pancreas,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17388,Elbow joint structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17389,<50,Bladder adenocarcinoma stage IV,0
17390,Together,Adult Hepatocellular Carcinoma,0
17391,Manufactured sign,FIGO Stage IVA Ovarian Cancer,0
17392,Affecting,Medulloblastoma,0
17393,Qualitative form,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17394,Mode of inheritance,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17395,Occurrence,Peripheral primitive neuroectodermal tumor of soft tissue,0
17396,radiotherapeutic,Stage II Carcinoma of Penis,0
17397,Bilateral complete salpingectomy,Unicystic ameloblastoma,0
17398,Body tissue,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17399,Atypical Teratoid Rhabdoid Tumor,Medulloblastoma,0
17400,Personal appearance,Hodgkin lymphoma,0
17401,Multiple malignancy,Kaposi's sarcoma of extrahepatic bile duct,0
17402,Aluminum measurement,Small Intestinal Villous Adenoma,0
17403,Life threatening - Event Consequence,Diffuse malignant mesothelioma,0
17404,Topical Corticosteroid Therapy,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17405,Logical Condition,Astrocytoma of brain,0
17406,Term (lexical),Melanomatosis,0
17407,treatment - ActInformationManagementReason,Primary Cutaneous Plasmablastic Lymphoma,0
17408,Abnormal increase in number,Extracranial Neuroblastoma,0
17409,Spreading (qualifier value),Extra-abdominal fibromatosis,0
17410,Presentation,Adult Hepatocellular Carcinoma,0
17411,Symptoms aspect,embryonal rhabdomyosarcoma of prostate,0
17412,Skin Pigmentation,Cervical Squamous Intraepithelial Neoplasia,0
17413,winter,Primary Cutaneous Plasmablastic Lymphoma,0
17414,Scar Tissue,Low Grade Squamous Intraepithelial Neoplasia,0
17415,Time (foundation metadata concept),Anterior Urethral Malignant Neoplasm,0
17416,removal technique,Human Papillomavirus-Related Carcinoma,0
17417,Singular,Adenocarcinoma,0
17418,Variety (taxon),Giant cell angiofibroma,0
17419,Malignant Neoplasms,BRCA2 Syndrome,0
17420,Cancer Genus,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17421,Basis - conceptual entity,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
17422,Precursor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17423,2+ Score,Pleomorphic adenoma of parotid gland,0
17424,Actual Aspiration,Diffuse malignant mesothelioma,0
17425,Qualitative form,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17426,Dimple,Childhood Fibrillary Astrocytoma,0
17427,Increased,Testicular cancer metastatic,0
17428,*Type - Kind of quantity,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
17429,Greeks,Colorectal Neuroendocrine Tumor G2,0
17430,Logical Condition,Acute lymphadenitis,0
17431,10%,Recurrent Uveal Melanoma,0
17432,N not otherwise specified Antibody,Astrocytoma of brain,0
17433,Dermatologist,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17434,Manufactured form,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17435,Medical History,Malignant neoplasm of choroid,0
17436,Science of Etiology,Mucinous neoplasm,0
17437,Third,Congenital hamartoma,0
17438,Togo,Recurrent Testicular Lymphoma,0
17439,Blood Cell Count,Advanced Lung Carcinoma,0
17440,Vulva,Unresectable Rhabdomyosarcoma,0
17441,Cardiac Lead Procedure,Benign Apocrine Neoplasm,0
17442,Concept model range (foundation metadata concept),Maxillary Sinus Adenocarcinoma,0
17443,Symptoms,Platinum-Resistant Lung Small Cell Carcinoma,0
17444,Main,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17445,Back structure,Intraepithelial Melanocytic Hyperplasia,0
17446,Grouped (foundation metadata concept),Cerebral hemangioma,0
17447,Infection,Bladder squamous cell carcinoma stage I,0
17448,2+ Score,Localized Ewing Sarcoma,0
17449,Condition:Find:Pt:^Patient:Nom,Pancreatic carcinoma,0
17450,Pharmaceutical Preparations,Localized Askin Tumor,0
17451,Etiology aspects,Undifferentiated Neuroblastoma,0
17452,Physical Examination,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17453,Physical Inactivity,Grade 3a Malignant Neoplasm,0
17454,Include (action),Recurrent Uveal Melanoma,0
17455,Aggressive Non-Hodgkin Lymphoma,Melanomatosis,0
17456,>5,Heavy Chain Deposition Disease,0
17457,Curative - procedure intent,Metastatic Carcinoma in the Lung,0
17458,Ten,Chest Wall Fibromatosis,0
17459,Neoplasms,Funisitis (disorder),0
17460,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17461,Have Constipation,Adenocarcinoma,0
17462,Squamous cell carcinoma,Lung squamous cell carcinoma stage I,0
17463,Progress,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
17464,Radiology studies,Blood Vessel Tumors,0
17465,Fine needle aspiration biopsy,Cancer of Urinary Tract,0
17466,Percent Activity,Hereditary Diffuse Gastric Adenocarcinoma,0
17467,Pharmacotherapy,Uterine Cancer,0
17468,Anorexia,Granular Cell Leiomyosarcoma,0
17469,Vertebrates,Refractory Ependymoma,0
17470,Chemotherapy,Diffuse malignant mesothelioma,0
17471,Precaution Code - Confused,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17472,Current (present time),Spermatocytic seminoma,0
17473,Ovary,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17474,Contrast Media,Adenocarcinoma,0
17475,Name,Ovarian germ cell choriocarcinoma stage IV,0
17476,Cardiac Lead Procedure,Central Nervous System Anaplastic Large Cell Lymphoma,0
17477,10%,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17478,Subgroup,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17479,To,Mucinous adenocarcinoma gastric,0
17480,Basis - conceptual entity,Cancer of Urinary Tract,0
17481,rituximab,Anterior Urethral Malignant Neoplasm,0
17482,One,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17483,Taxonomic,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17484,ovarian neoplasm,Extra-abdominal fibromatosis,0
17485,T-Cell Development,Localized Askin Tumor,0
17486,Reaching,Mucinous neoplasm,0
17487,therapeutic aspects,Human Papillomavirus-Related Carcinoma,0
17488,Agreement,Hereditary Diffuse Gastric Adenocarcinoma,0
17489,Minor (value),Clinical Stage I Cutaneous Melanoma AJCC v8,0
17490,Most,Choroid Necrotic Melanoma,0
17491,GCFC2 gene,Ectomesenchymal Chondromyxoid Tumor,0
17492,Form:Finding:Point in time:{Setting}:Document:{Role},Hereditary Diffuse Gastric Adenocarcinoma,0
17493,Age of onset of symptoms:Time:Pt:^Patient:Qn,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17494,Benzene,Chondrosarcoma,0
17495,Reaching,embryonal rhabdomyosarcoma of prostate,0
17496,Night time,Recurrent Uveal Melanoma,0
17497,Weight Loss,Recurrent Testicular Lymphoma,0
17498,Administration occupational activities,Vaginal Adenoid Cystic Carcinoma,0
17499,Involvement with,Unfavorable Non-Hodgkin Lymphoma,0
17500,Dietary Lead,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17501,Abnormal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17502,Papillomaviridae,Acantholytic squamous cell carcinoma,0
17503,Thickened,Granular Cell Leiomyosarcoma,0
17504,Ultrasonics (sound),Clinical Stage I Cutaneous Melanoma AJCC v8,0
17505,Removed,Clonal Hematopoiesis of Indeterminate Potential,0
17506,Papanicolaou Test,Stage IV Penile Cancer AJCC v7,0
17507,Papanicolaou Test,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17508,Cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
17509,Five-year Survival Rate,Locally Advanced Carcinoma,0
17510,N+ (tumor staging),Kaposi's sarcoma of skin,0
17511,A Codes,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
17512,Before,Anterior Urethral Malignant Neoplasm,0
17513,Males,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
17514,Present,Angiosarcoma of liver,0
17515,Condylomata Acuminata,Medulloblastoma,0
17516,Klinefelter's syndrome - male with more than two X chromosomes,Nasal cavity carcinoma,0
17517,Predisposition -- attribute,Benign Anal Granular Cell Tumor,0
17518,Medical Imaging,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17519,production,Ovarian germ cell choriocarcinoma stage IV,0
17520,Grade three rank,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
17521,seen,Metaplastic carcinoma of breast,0
17522,Genitalia,Testicular cancer metastatic,0
17523,isolation aspects,Recurrent Uveal Melanoma,0
17524,Diagnosis,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
17525,Function (attribute),High Grade Salivary Gland Mucoepidermoid Carcinoma,0
17526,Tissue Specimen Code,Cervical Adenomyoma,0
17527,Human body,Squamous cell carcinoma of lip,0
17528,Containing (qualifier),Blood Vessel Tumors,0
17529,Tobacco smoking behavior,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17530,Primary malignant neoplasm,Parathyroid Gland Adenocarcinoma,0
17531,Person Name,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17532,Metastasis,Unresectable Rhabdomyosarcoma,0
17533,Primary malignant neoplasm,Airway Hemangioma,0
17534,Effect,Malignant melanoma of eyelid,0
17535,Including (qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17536,Item Collection,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17537,renaissance,Kaposi's sarcoma of skin,0
17538,Replacement - supply,Anterior Urethral Malignant Neoplasm,0
17539,Precursor,Malignant Neoplasm of Lung - Multiple Primary Sites,0
17540,Continuous,Metastatic Neoplasm to the Gallbladder,0
17541,Major,Localized Ewing Sarcoma,0
17542,Biological Processes,Benign neoplasm of eye,0
17543,Mesothelioma,Giant cell angiofibroma,0
17544,Case (situation),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17545,To,Heavy Chain Deposition Disease,0
17546,65+,ROSE Cluster 3,0
17547,>65 years,Mucinous adenocarcinoma gastric,0
17548,Abnormally high,Pancreatic Intraepithelial Neoplasia-3,0
17549,Type - attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17550,N+ (tumor staging),High Grade Glandular Intraepithelial Neoplasia,0
17551,Retinoic Acid Response Element,Type II Endometrial Adenocarcinoma,0
17552,chronic,Unicystic ameloblastoma,0
17553,Old age,Endometrial Small Cell Carcinoma,0
17554,Decrease,Benign Apocrine Neoplasm,0
17555,More,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17556,lymph nodes,Anaplastic large cell lymphoma,0
17557,animal allergen extracts,Benign squamous cell tumor,0
17558,3+ Score,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17559,Protein Digestion (research activity),Female Breast Carcinoma,0
17560,Manufactured form,Type II Endometrial Adenocarcinoma,0
17561,Administration occupational activities,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17562,risk factors - observation list,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17563,Cryptorchidism,Epithelioid Sarcoma NCI Grade 3,0
17564,Urinary Tract Infection,Type II Endometrial Adenocarcinoma,0
17565,Pale color,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17566,Prior Medication Usage,Refractory Ependymoma,0
17567,Estrogen (disposition),Familial Adenomatous Polyposis Associated Medulloblastoma,0
17568,Ectoderm,Atypical Lobular Breast Hyperplasia,0
17569,Used by,Multiple Skull Base Meningiomas,0
17570,Different,Vaginal Adenoma,0
17571,White Blood Cell Count procedure,Angiosarcoma of liver,0
17572,Malignant tumor of cervix,Locally Advanced Soft Tissue Sarcoma,0
17573,include - SetOperator,Splenic Manifestation of Hairy Cell Leukemia,0
17574,Containing (qualifier),Xeroderma pigmentosum,0
17575,Coding,malignant lymphoma of pancreatic lymph nodes,0
17576,Tumor cells,Vaginal Adenoma,0
17577,Occur (action),non-Hodgkin's lymphoma of spleen,0
17578,Classification,Anterior Urethral Malignant Neoplasm,0
17579,<3 (qualifier value),Maxillary Sinus Adenocarcinoma,0
17580,PSA Level Less than Two,Basal Cell Ameloblastoma,0
17581,Social Role,Intestinal Metaplasia of Bladder Urothelium,0
17582,Pediculus humanus capitis (eukaryote),Ovarian Dermoid Cyst with Secondary Carcinoma,0
17583,Two,Grade 3a Malignant Neoplasm,0
17584,Platelets,Kaposi's sarcoma of extrahepatic bile duct,0
17585,Thickened,squamous cell carcinoma of the thyroid gland,0
17586,Heterogeneity,sarcoma of spinal cord,0
17587,Result,Basal Cell Ameloblastoma,0
17588,Ulceration,Stage IB Lung Cancer AJCC v7,0
17589,suggestion,Metastatic Kidney Carcinoma,0
17590,Tissue Specimen Code,ROSE Cluster 3,0
17591,Primary,Benign tumor of eyelid,0
17592,Hyperlink,Breast Ductal Adenoma,0
17593,Common (qualifier value),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
17594,VIPR1 wt Allele,Trabecular adenocarcinoma,0
17595,findings aspects,Refractory Bladder Carcinoma,0
17596,Name,Blepharal carcinoma,0
17597,Strawberry nevus of skin,Cervical Squamous Intraepithelial Neoplasia,0
17598,Preventive intent,Pancreatic Endocrine Carcinoma,0
17599,Disease,Splenic Manifestation of Hairy Cell Leukemia,0
17600,Colon <insect>,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17601,Providing presence (regime/therapy),Unicystic ameloblastoma,0
17602,Primary malignant neoplasm,Refractory Ependymoma,0
17603,SPINK5 gene,Basal Cell Ameloblastoma,0
17604,Vagina Carcinoma,Low Grade Squamous Intraepithelial Neoplasia,0
17605,Increase,Thyroid Hurthle Cell Carcinoma,0
17606,Weight decreased,Recurrent Rhabdomyosarcoma,0
17607,Abnormally high,Gallbladder Adenocarcinoma,0
17608,Rapid,Noninfiltrating Intraductal Carcinoma,0
17609,include - SetOperator,Benign Apocrine Neoplasm,0
17610,98,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17611,Tumor cells,Cerebral Primitive Neuroectodermal Tumor,0
17612,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17613,Medical Devices,Nasal cavity carcinoma,0
17614,Brain Neoplasms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17615,Result,BRCA2 Syndrome,0
17616,Desmoplastic fibroblastoma,Non-Metastatic Gestational Trophoblastic Tumor,0
17617,Case (situation),Localized Ewing Sarcoma,0
17618,Stem of plant,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17619,Etiology aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17620,Better than Others,Neonatal leukemia,0
17621,Seventh,Trichilemmocarcinoma,0
17622,Patient Reported Outcome Stem,Ovarian germ cell choriocarcinoma stage IV,0
17623,Lymphoma cells,Breast Ductal Adenoma,0
17624,Birth,Recurrent Testicular Lymphoma,0
17625,Cosmetics,malignant lymphoma of pancreatic lymph nodes,0
17626,Devices,Refractory Bladder Carcinoma,0
17627,Usual,Secondary malignant neoplasm of lymph node,0
17628,PSA Level Greater than Fifty,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17629,Cancer Genus,Thymic Clear Cell Carcinoma,0
17630,shared attribute,Werner Syndrome,0
17631,Host (organism),Epithelioid Sarcoma NCI Grade 3,0
17632,System (unit of presentation),Atypical Lobular Breast Hyperplasia,0
17633,Poverty,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17634,In Blood,Xeroderma pigmentosum,0
17635,Various patch test substance,Mucinous adenocarcinoma gastric,0
17636,Chemotherapy,Childhood Fibrillary Astrocytoma,0
17637,Secondary to,Transitional cell carcinoma,0
17638,PSA Level Less than Two,Mucinous adenocarcinoma gastric,0
17639,Acute Myeloid Leukemia Pathway,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17640,Qualitative form,Hereditary corneal dystrophy,0
17641,Importance Rating Score 0,Astrocytoma of brain,0
17642,Intravascular line,Hereditary Diffuse Gastric Adenocarcinoma,0
17643,Etiology aspects,ROSE Cluster 3,0
17644,Manufactured sign,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17645,Barrett Esophagus,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17646,mouth swelling,Hemangioma,0
17647,Melanins,Childhood Anaplastic Large Cell Lymphoma,0
17648,Redness,Extra-Adrenal Paraganglioma,0
17649,Involvement with,Intraepithelial Melanocytic Hyperplasia,0
17650,Cell Device,Stage I Colon Neuroendocrine Tumor AJCC v8,0
17651,Five,Angiosarcoma of liver,0
17652,status - In progress,Pleomorphic adenoma of parotid gland,0
17653,Special,FIGO Stage IVA Ovarian Cancer,0
17654,Divide,Trabecular adenocarcinoma,0
17655,Basis - conceptual entity,Thyroid Hurthle Cell Carcinoma,0
17656,Effect,Lung Mucinous Cystadenoma,0
17657,Noma,Pancreatic carcinoma,0
17658,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
17659,Body tissue,Malignant Testicular Sertoli Cell Tumor,0
17660,Hematopoiesis,Endometrial Small Cell Carcinoma,0
17661,Specialized,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17662,Common (qualifier value),Childhood Lung Non-Small Cell Carcinoma,0
17663,Metastasis,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
17664,Left sided,BRCA2 Syndrome,0
17665,Sweating,Clonal Hematopoiesis of Indeterminate Potential,0
17666,N not otherwise specified Antibody,Angiosarcoma of liver,0
17667,high - ActExposureLevelCode,Kaposi's sarcoma of skin,0
17668,Accurate (qualifier),Adult Anaplastic Oligodendroglioma,0
17669,Cancer Genus,Ichthyoses,0
17670,Count of entities,Astrocytoma of brain,0
17671,Cohort Studies,Pancreatic Intraepithelial Neoplasia-3,0
17672,acinar cell adenocarcinoma of the pancreas,Uterine Cancer,0
17673,Known,Extracranial Neuroblastoma,0
17674,Platelets,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17675,Symptoms,Stage IV Penile Cancer AJCC v7,0
17676,Blood,Basal Cell Ameloblastoma,0
17677,Carrying,Mucinous neoplasm,0
17678,Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17679,Carcinoid Tumor,Locally Advanced Carcinoma,0
17680,False Discovery Rate,Female Breast Carcinoma,0
17681,Spherical shape,malignant lymphoma of pancreatic lymph nodes,0
17682,Talpidae,Advanced Lung Carcinoma,0
17683,Togo,Recurrent Testicular Lymphoma,0
17684,Symptoms aspect,Kaposi's sarcoma of skin,0
17685,Night sweats,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17686,Hemopoietic tissue,Stage 0 Penile Cancer AJCC v8,0
17687,Increased,Childhood Central Nervous System Ganglioneuroblastoma,0
17688,Adoptive Immunotherapy,High Grade Glandular Intraepithelial Neoplasia,0
17689,various other agents for local oral treatment in ATC,Recurrent Uveal Melanoma,0
17690,Mammal liver preparation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
17691,Mesothelial cell,Cervical Squamous Intraepithelial Neoplasia,0
17692,posterior fossa,Stage II Carcinoma of Penis,0
17693,Western Europe,embryonal rhabdomyosarcoma of prostate,0
17694,Females,Human Papillomavirus-Related Carcinoma,0
17695,Dependent for dressing,Thymic Clear Cell Carcinoma,0
17696,pharmacotherapeutic,Acantholytic squamous cell carcinoma,0
17697,HLA Class II Histocompatibility Antigen Gamma Chain,Uterine Cancer,0
17698,Human body,Refractory Barrett Esophagus,0
17699,Pigment cell,Breast Ductal Adenoma,0
17700,Multiply - dosing instruction fragment,Heavy Chain Deposition Disease,0
17701,Evidence,Hair nevus,0
17702,Diagnosis Study,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17703,Negative Surgical Margin,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17704,Include (action),Intestinal Metaplasia of Bladder Urothelium,0
17705,PREVENT (product),Malignant neoplasm of thalamus,0
17706,Established,Clonal Hematopoiesis of Indeterminate Potential,0
17707,parent,Tubal Hyperplasia,0
17708,Occurrence,Extra-abdominal fibromatosis,0
17709,Person Name,Kaposi's sarcoma of extrahepatic bile duct,0
17710,Tactile,Thymic Clear Cell Carcinoma,0
17711,Angioma,Melanomatosis,0
17712,Histology aspects,Tumorlet,0
17713,Mutation Abnormality,Cerebral hemangioma,0
17714,Three,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17715,*Type - Kind of quantity,Acantholytic squamous cell carcinoma,0
17716,Part of,Stage IV Penile Cancer AJCC v7,0
17717,Providing presence (regime/therapy),Stage IV Penile Cancer AJCC v7,0
17718,various antiinfectives and antiseptics for local oral treatment,Malignant melanoma of eyelid,0
17719,Percent normal,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17720,Combined,Childhood Anaplastic Large Cell Lymphoma,0
17721,Mass of body region,Recurrent Uveal Melanoma,0
17722,Exhibits as Topic,Blepharal carcinoma,0
17723,Pelvic Pain,Precursor B-lymphoblastic lymphoma stage II,0
17724,Occurrence,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17725,Mass of body structure,Splenic Manifestation of Hairy Cell Leukemia,0
17726,Notable,FIGO Stage II Ovarian Cancer,0
17727,Part of,BRCA2 Syndrome,0
17728,Affecting,Stage III Adult Immunoblastic Lymphoma,0
17729,Financial Account,Metastatic Malignant Neoplasm in the Sellar Region,0
17730,year,Splenic Manifestation of Hairy Cell Leukemia,0
17731,Occurrence Indicator,Extra-abdominal fibromatosis,0
17732,Upper jaw region,Cerebral Primitive Neuroectodermal Tumor,0
17733,described,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
17734,Congenital Abnormality,Multiple Skull Base Meningiomas,0
17735,Chemotherapy,Malignant neoplasm of olfactory nerve,0
17736,Rare,Locally Advanced Carcinoma,0
17737,Tumor Mass,Refractory Bladder Carcinoma,0
17738,Diagnosis,Testicular cancer metastatic,0
17739,chapter,embryonal rhabdomyosarcoma of prostate,0
17740,Remaining,Stage 0 Lip Carcinoma,0
17741,Treating,Liver Cavernous Hemangioma,0
17742,+2,Clonal Hematopoiesis of Indeterminate Potential,0
17743,Back Pain,Chest Wall Fibromatosis,0
17744,Image Feature,Type II Endometrial Adenocarcinoma,0
17745,Geographic state,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17746,Show,Locally Advanced Squamous Cell Carcinoma,0
17747,Immune System Finding,Hair nevus,0
17748,Dermatologic disorders,Astrocytoma of brain,0
17749,Rest,Multiple Skull Base Meningiomas,0
17750,Floor (anatomic),Microcystic meningioma,0
17751,Negative Surgical Margin,Neonatal leukemia,0
17752,Symptoms,Low Grade Squamous Intraepithelial Neoplasia,0
17753,Home environment,Carcinoma of submandibular gland,0
17754,Five-year Survival Rate,Kaposi's sarcoma of extrahepatic bile duct,0
17755,Definitely Related to Intervention,Kaposi's sarcoma of skin,0
17756,thiocolchicoside,Type II Endometrial Adenocarcinoma,0
17757,Painless,Heavy Chain Deposition Disease,0
17758,Plasma,Intestinal Metaplasia of Bladder Urothelium,0
17759,Therapeutic radiology procedure,Gallbladder adenoma,0
17760,Togo,Peripheral primitive neuroectodermal tumor of soft tissue,0
17761,Experimental Result,Digestive System Hodgkin Lymphoma,0
17762,Vision,adenoid cystic carcinoma of lung,0
17763,Enlargement procedure,Bladder squamous cell carcinoma stage I,0
17764,Frequently,Cancer of Urinary Tract,0
17765,Plasmacytoma,Plexosarcoma,0
17766,Malignant Head and Neck Neoplasm,Stage III Cutaneous Melanoma AJCC v6,0
17767,Affect (mental function),Malignant Neoplasm with Regional Lymph Node Involvement,0
17768,Therapy Object (animal model),Neonatal leukemia,0
17769,Body part,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17770,research subject screening,Plexosarcoma,0
17771,Magnetic Resonance Imaging Study File,Leiomyoma of Gallbladder,0
17772,Fever,Stage IV Childhood Non-Hodgkin Lymphoma,0
17773,Time (foundation metadata concept),Central Nervous System Yolk Sac Tumor,0
17774,Time (foundation metadata concept),Malignant melanoma of eyelid,0
17775,Urine looks dark,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17776,Northern Europe,Vaginal Adenoma,0
17777,Cancer Genus,Intraepithelial Melanocytic Hyperplasia,0
17778,Blood,Benign squamous cell tumor,0
17779,How Often Vomiting,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17780,Usual Severity Weight Loss,Primary Cutaneous Plasmablastic Lymphoma,0
17781,Type - attribute,Leptomeningeal sarcoma,0
17782,East,Acute Undifferentiated Leukemia,0
17783,Formation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17784,Penis carcinoma,Colorectal High Grade B-Cell Lymphoma,0
17785,GORAB gene,Bladder Neuroendocrine Neoplasm,0
17786,Symptoms,Adult Alveolar Soft Part Sarcoma,0
17787,Tryptophanase,Metastatic Kidney Carcinoma,0
17788,Very,Congenital hamartoma,0
17789,Ultraviolet Light Sterilization,Hodgkin lymphoma,0
17790,Tumor type,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17791,Chest,Recurrent Testicular Lymphoma,0
17792,diagnosis aspect,Endometrial Small Cell Carcinoma,0
17793,peripheral blood,Mixed astrocytoma-ependymoma,0
17794,Term (lexical),Heavy Chain Deposition Disease,0
17795,Decrease,Maxillary Sinus Adenocarcinoma,0
17796,Derived value,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17797,Estrogen [EPC],Pancreatic carcinoma,0
17798,Manufactured form,Fibroadenoma of breast,0
17799,risk factors - observation list,Carcinomatosis of peritoneal cavity,0
17800,Meningitis,GIANT PIGMENTED HAIRY NEVUS,0
17801,Abnormal cell,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
17802,Evidence,Intestinal Neuroendocrine Carcinoma,0
17803,Bothered by Night Sweats,Liver Cavernous Hemangioma,0
17804,Anterior thoracic region,Cerebral Primitive Neuroectodermal Tumor,0
17805,Benign Ovarian Neoplasm,Acantholytic squamous cell carcinoma,0
17806,Proliferation (morphologic abnormality),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17807,Including (qualifier),Stage III Cutaneous Melanoma AJCC v6,0
17808,Tryptophanase,Mucinous neoplasm,0
17809,Social Networks,Breast Ductal Adenoma,0
17810,How Often Weight Loss,Locally Advanced Squamous Cell Carcinoma,0
17811,Salivary Gland Tissue,Locally Advanced Carcinoma,0
17812,Occur (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17813,depend,Recurrent Testicular Lymphoma,0
17814,Malignant - descriptor,Stage I Colon Neuroendocrine Tumor AJCC v8,0
17815,Affecting,Mastocytosis,0
17816,Persons,Acantholytic squamous cell carcinoma,0
17817,Universal HL7CMETAttribution,clear cell adenocarcinoma of gallbladder,0
17818,Ductal,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17819,Sex Cord-Stromal Tumor,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
17820,development aspects,Mixed astrocytoma-ependymoma,0
17821,NCI CTEP SDC Endocrine Neoplasm Category Terminology,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
17822,Polyvinyl Chloride,Bladder adenocarcinoma stage IV,0
17823,Capsule Shape,Type II Endometrial Adenocarcinoma,0
17824,Usual,Anaplastic large cell lymphoma,0
17825,Manufactured form,malignant lymphoma of pancreatic lymph nodes,0
17826,Necrosis,Peripheral primitive neuroectodermal tumor of soft tissue,0
17827,Life,Microcystic meningioma,0
17828,Personal appearance,FIGO Stage II Ovarian Cancer,0
17829,Buccal smear procedure,Blood Vessel Tumors,0
17830,Excision,Maxillary Sinus Adenoid Cystic Carcinoma,0
17831,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17832,Reaching,Carcinoma of urinary bladder,0
17833,Subject Risk,Medulloblastoma,0
17834,Well Differentiated,Benign squamous cell tumor,0
17835,UV Radiation,Metastatic Neoplasm to the Gallbladder,0
17836,3+ Answer to Question,Small intestine carcinoma,0
17837,Ninein,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17838,Aspartic Acid Measurement,Liver Cavernous Hemangioma,0
17839,breast.duct,Central Nervous System Anaplastic Large Cell Lymphoma,0
17840,Histology,High Grade Glandular Intraepithelial Neoplasia,0
17841,Left sided,Rhabdomyosarcoma with ganglionic differentiation,0
17842,Human body structure,Tubal Hyperplasia,0
17843,Oral region,Giant cell angiofibroma,0
17844,Crowding,ROSE Cluster 3,0
17845,Derived value,Peripheral primitive neuroectodermal tumor of soft tissue,0
17846,Unspecified,Xeroderma pigmentosum,0
17847,Stem of Organ,Metaplastic carcinoma of breast,0
17848,United States Military Commissioned Officer O4,Rhabdomyosarcoma with ganglionic differentiation,0
17849,Tubular adenoma,Keratoderma,0
17850,Surgical reduction,Squamous cell carcinoma of lip,0
17851,Chromosomal deoxyribonucleic acid,Locally Advanced Squamous Cell Carcinoma,0
17852,Cessation of life,Human Papillomavirus-Related Carcinoma,0
17853,Group A (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
17854,Smoking,Basal Cell Ameloblastoma,0
17855,Ultrasonography,BRCA2 Syndrome,0
17856,Transitional cell morphology,Recurrent Testicular Lymphoma,0
17857,Human papillomavirus typing (procedure),Childhood Anaplastic Large Cell Lymphoma,0
17858,Biomaterial Treatment,Nasal cavity carcinoma,0
17859,Lesion,Stage 0 Penile Cancer AJCC v8,0
17860,Singular,malignant lymphoma of pancreatic lymph nodes,0
17861,Tryptophanase,Human Papillomavirus-Related Carcinoma,0
17862,Has focus,Giant cell angiofibroma,0
17863,Specific qualifier value,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17864,Common Specifications in HL7 V3 Publishing,Pancreatic Intraepithelial Neoplasia-3,0
17865,>5,Breast Ductal Adenoma,0
17866,Malignant - descriptor,Maxillary Sinus Adenocarcinoma,0
17867,Disease Response,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
17868,SHORT STATURE,Recurrent Rhabdomyosarcoma,0
17869,Substance amount,Metastatic Kidney Carcinoma,0
17870,Myeloid neoplasm,Secondary malignant neoplasm of lymph node,0
17871,artesunate,Recurrent Primary Lymphoma of Bone,0
17872,other medicated shampoos in ATC,Refractory Ependymoma,0
17873,Classification,Secondary malignant neoplasm of lymph node,0
17874,Observation of color of skin,Pancreatic Intraepithelial Neoplasia-3,0
17875,Treating,Acinar cell carcinoma of pancreas,0
17876,Symptoms aspect,Secondary malignant neoplasm of lymph node,0
17877,Abnormally high,Papillary squamous cell carcinoma,0
17878,Irritant (disposition),Female Breast Carcinoma,0
17879,Mean Percent of Normal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17880,shared attribute,clear cell adenocarcinoma of gallbladder,0
17881,Usually,Malignant neoplasm of thalamus,0
17882,Painful intercourse female,Kaposi's sarcoma of extrahepatic bile duct,0
17883,Cancer Genus,Adrenal Rest Tumor,0
17884,treatment - ActInformationManagementReason,Bladder squamous cell carcinoma stage I,0
17885,Nutrients,Metaplastic carcinoma of breast,0
17886,Diabetes Mellitus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17887,Delta (difference),Intestinal Metaplasia of Bladder Urothelium,0
17888,Then,Endometrial Small Cell Carcinoma,0
17889,Volume (publication),Ovarian germ cell choriocarcinoma stage IV,0
17890,Affecting,Anterior Urethral Malignant Neoplasm,0
17891,Cystoscopy,Stage I Adult Non-Hodgkin Lymphoma,0
17892,Recurrent Malignant Neoplasm,Benign neoplasm of thorax,0
17893,Created By,Kaposi's sarcoma of skin,0
17894,Categories,Intraepithelial Melanocytic Hyperplasia,0
17895,Affecting,Liver Lymphangioma,0
17896,Diagnosis,Nasal cavity carcinoma,0
17897,Clinical Study Follow-up,Human Papillomavirus-Related Carcinoma,0
17898,Immunization Domain,Benign Anal Granular Cell Tumor,0
17899,Americas Ethnicity,Chronic Myelomonocytic Leukemia-2,0
17900,treatment - ActInformationManagementReason,Multiple Skull Base Meningiomas,0
17901,Including (qualifier),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17902,Therapeutic radiology procedure,Acantholytic squamous cell carcinoma,0
17903,Room of building - Study,Undifferentiated Endocervical Sarcoma,0
17904,Support,FIGO Stage IVA Ovarian Cancer,0
17905,Function (attribute),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17906,March (month),Vaginal Adenoid Cystic Carcinoma,0
17907,Age of onset of symptoms:Time:Pt:^Patient:Qn,Cervical Squamous Intraepithelial Neoplasia,0
17908,Several,Airway Hemangioma,0
17909,Molecule,mucinous adenocarcinoma of gallbladder,0
17910,Reduced,Hereditary Diffuse Gastric Adenocarcinoma,0
17911,Including (qualifier),Diffuse malignant mesothelioma,0
17912,Classification,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17913,Pregnancy,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
17914,Adult human body,Thymic Clear Cell Carcinoma,0
17915,How Much Distress Itching,Childhood Cerebellar Neoplasm,0
17916,Specimen Source Codes - Respiratory,Mucinous adenocarcinoma gastric,0
17917,Sarcoma - category (morphologic abnormality),Refractory Bladder Carcinoma,0
17918,Most,Localized Ewing Sarcoma,0
17919,Specimen Source Codes - tumor,Granular Cell Leiomyosarcoma,0
17920,Worsening pattern,Localized Askin Tumor,0
17921,Medical Imaging,Neoplasms,0
17922,MYELODYSPLASTIC SYNDROME,Parathyroid Gland Adenocarcinoma,0
17923,Menopause present (finding),Heavy Chain Deposition Disease,0
17924,Lung,Kaposi's sarcoma of extrahepatic bile duct,0
17925,Organ,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17926,Science of Etiology,Type II Endometrial Adenocarcinoma,0
17927,Regular,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17928,Screening,Blood Vessel Tumors,0
17929,Present,Type II Endometrial Adenocarcinoma,0
17930,Part,Childhood Thyroid Gland Follicular Carcinoma,0
17931,Possibly Related to Intervention,Cancer of Urinary Tract,0
17932,Granulocytes Product,Splenic Manifestation of Hairy Cell Leukemia,0
17933,Unexplained weight loss,Atypical Mesothelial Hyperplasia,0
17934,Both kidneys,Thymic Clear Cell Carcinoma,0
17935,Series,FIGO Stage II Ovarian Cancer,0
17936,How Often Weight Loss,FIGO Stage II Ovarian Cancer,0
17937,shared attribute,Kaposi's sarcoma of extrahepatic bile duct,0
17938,Case unit dose,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
17939,B-Cell Receptor Complex,Childhood Lung Non-Small Cell Carcinoma,0
17940,Malignant Neoplasms,Acantholytic squamous cell carcinoma,0
17941,Usual,Neonatal leukemia,0
17942,Cervix Uteri,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17943,pharmacotherapeutic,gliosarcoma,0
17944,Name (property) (qualifier value),Noninfiltrating Intraductal Carcinoma,0
17945,Symptoms,Mixed astrocytoma-ependymoma,0
17946,Obsolete - EditStatus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17947,How Often Sweats,Chronic Myelomonocytic Leukemia-2,0
17948,Including (qualifier),Epithelioid Sarcoma NCI Grade 3,0
17949,Part,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17950,Drop (unit of presentation),Ovarian germ cell choriocarcinoma stage IV,0
17951,Body tissue,Bladder squamous cell carcinoma stage I,0
17952,Case (situation),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17953,Occipital,Stage 0 Lip Carcinoma,0
17954,Therapeutic radiology procedure,Necrotizing Funisitis,0
17955,Tumor Mass,Thymic Clear Cell Carcinoma,0
17956,Lamina Propria,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17957,Secondary to,Multiple Endocrine Neoplasia,0
17958,Population Group,Liver Lymphangioma,0
17959,include - SetOperator,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17960,Different,Cervical Squamous Intraepithelial Neoplasia,0
17961,Excision,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17962,analysis aspect,Cervical Fibroepithelial Polyp,0
17963,N+ (tumor staging),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17964,Metastatic Neoplasm,Medulloblastoma,0
17965,Group A (qualifier value),Extra-Adrenal Paraganglioma,0
17966,Woman,Acinar cell carcinoma of pancreas,0
17967,Purple,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17968,Purpose,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17969,Adverse effects,Giant cell angiofibroma,0
17970,Risk,Stage IV Childhood Non-Hodgkin Lymphoma,0
17971,Damage,Adult Alveolar Soft Part Sarcoma,0
17972,Slightly Able,Leptomeningeal sarcoma,0
17973,Science of Etiology,Malignant Testicular Sertoli Cell Tumor,0
17974,Clear,Giant cell angiofibroma,0
17975,Surgery specialty,Endometrial Small Cell Carcinoma,0
17976,Basis - conceptual entity,Benign Anal Granular Cell Tumor,0
17977,Subject Risk,Cystadenocarcinoma,0
17978,Term (lexical),Central Nervous System Yolk Sac Tumor,0
17979,Vasculature,Cerebral Primitive Neuroectodermal Tumor,0
17980,2+,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17981,Breathing Distress Question,Small intestine carcinoma,0
17982,Neoplasms,Neonatal leukemia,0
17983,Genitalia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17984,Sexual Partners,Pancreatic Intraepithelial Neoplasia-3,0
17985,Adult Rhabdomyosarcoma,Adult Hepatocellular Carcinoma,0
17986,Endometrial scraping,Bladder adenocarcinoma stage IV,0
17987,Common Specifications in HL7 V3 Publishing,Carcinoma of urinary bladder,0
17988,THPO wt Allele,Thyroid Hurthle Cell Carcinoma,0
17989,Nephron brand of racepinephrine hydrochloride,Human Papillomavirus-Related Carcinoma,0
17990,Image Feature,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17991,What subject filter - Result,Endometrial Small Cell Carcinoma,0
17992,Subject Risk,Xeroderma pigmentosum,0
17993,Lesion,Mucinous cystadenofibroma,0
17994,Five-year Survival Rate,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17995,Rate,Transitional cell carcinoma,0
17996,Vertebrates,Anterior Urethral Malignant Neoplasm,0
17997,Cultured Cell Line,Spongiotic dermatitis,0
17998,Benign neurologic neoplasms,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
17999,Grouped (foundation metadata concept),Vaginal Adenoma,0
18000,Residential flat,Endometrial Small Cell Carcinoma,0
18001,Needs,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
18002,Supportive assistance,Digestive System Hodgkin Lymphoma,0
18003,Include (action),Chest Wall Fibromatosis,0
18004,Either,Melanomatosis,0
18005,Carcinoma of bladder,Granular Cell Leiomyosarcoma,0
18006,Carcinoid Tumor,Atypical Lobular Breast Hyperplasia,0
18007,Usual,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18008,Malignant neoplasm of stomach,Vaginal Adenoma,0
18009,Common Specifications in HL7 V3 Publishing,Choroid Necrotic Melanoma,0
18010,Type A,Stage IV Childhood Non-Hodgkin Lymphoma,0
18011,Usually Need Help from Another Person for Arising,Lung squamous cell carcinoma stage I,0
18012,Total,Type II Endometrial Adenocarcinoma,0
18013,Base - General Qualifier,Stage 0 Lip Carcinoma,0
18014,Therapeutic procedure,Stage IB Lung Cancer AJCC v7,0
18015,Prevalence aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18016,Excision,clear cell adenocarcinoma of gallbladder,0
18017,Measures,Childhood Fibrillary Astrocytoma,0
18018,Purpose,Recurrent Primary Lymphoma of Bone,0
18019,Fever,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18020,Continuance of life,Thymic Atypical Carcinoid Tumor,0
18021,Better,Diffuse malignant mesothelioma,0
18022,Use of,Malignant melanoma of eyelid,0
18023,Malignant Neoplasms,Giant cell angiofibroma,0
18024,Target Awareness - partial,Kaposi's sarcoma of extrahepatic bile duct,0
18025,Case unit dose,BRCA2 Syndrome,0
18026,Midline (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18027,Frequently,Malignant Testicular Sertoli Cell Tumor,0
18028,1+ Score,Engraftment syndrome,0
18029,Weight decreased,Melanomatosis,0
18030,Major,Toxic Epidermal Necrolysis,0
18031,Placental Steroid Sulfatase Deficiency,Low Grade Squamous Intraepithelial Neoplasia,0
18032,Biopsy,FIGO Stage IVA Ovarian Cancer,0
18033,Hollow shape,Carcinomatosis of peritoneal cavity,0
18034,Blast Cell,Localized Askin Tumor,0
18035,Visual Accommodation,Cerebral Primitive Neuroectodermal Tumor,0
18036,Occur (action),Melanomatosis,0
18037,Increasing,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18038,Occur (action),Thymic Clear Cell Carcinoma,0
18039,Swollen Lymph Node,ROSE Cluster 3,0
18040,Factor,BRCA2 Syndrome,0
18041,In Blood,Intestinal Neuroendocrine Carcinoma,0
18042,Acquired Immunodeficiency Syndrome,Peripheral primitive neuroectodermal tumor of soft tissue,0
18043,Due to,Ovarian germ cell choriocarcinoma stage IV,0
18044,Very Much,Malignant Neoplasm of Lung - Multiple Primary Sites,0
18045,physiological aspects,Intestinal Metaplasia of Bladder Urothelium,0
18046,Medical service,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18047,Etiology aspects,Stage III Cutaneous Melanoma AJCC v6,0
18048,Gait normal,Benign tumor of eyelid,0
18049,inferiority,ROSE Cluster 3,0
18050,Supportive assistance,Chronic Myelomonocytic Leukemia-2,0
18051,Ingestible alcohol,Cancer of Urinary Tract,0
18052,Immune,Carcinoma of urinary bladder,0
18053,morphological,Parathyroid Gland Adenocarcinoma,0
18054,Tumor Mass,Squamous cell carcinoma of lip,0
18055,Eye,Carcinoma of urinary bladder,0
18056,Funisitis (disorder),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18057,Chest,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18058,How Often Vomiting,Low Grade Squamous Intraepithelial Neoplasia,0
18059,Usually,Occult Lung Adenosquamous Carcinoma,0
18060,Reported Term,Primary Cutaneous Plasmablastic Lymphoma,0
18061,Type A,Low Grade Squamous Intraepithelial Neoplasia,0
18062,Effusion of blood,Vaginal Adenoid Cystic Carcinoma,0
18063,Feature,Recurrent Testicular Lymphoma,0
18064,Surgical aspects,Female Breast Carcinoma,0
18065,Monitoring - action,Pancreatic carcinoma,0
18066,Slow,Intraepithelial Melanocytic Hyperplasia,0
18067,Qualitative form,Adult Hepatocellular Carcinoma,0
18068,Relationships,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18069,Medical,Carcinoma of urinary bladder,0
18070,Child,Hodgkin Disease,0
18071,Sufficiently defined concept definition status (core metadata concept),Botryoid-Type Embryonal Rhabdomyosarcoma,0
18072,Cancer Genus,Cervical Squamous Intraepithelial Neoplasia,0
18073,Togo,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18074,Alternative,Pancreatic Endocrine Carcinoma,0
18075,1980s,Tonsillar Carcinoma,0
18076,control aspects,Diffuse malignant mesothelioma,0
18077,Horse Melanoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18078,Fasting Status Indicator,Pancreatic carcinoma,0
18079,Apocrine Cell,Thyroid Hurthle Cell Carcinoma,0
18080,To,ROSE Cluster 3,0
18081,ISOLATE COMPOUND,Gallbladder Adenocarcinoma,0
18082,combination of objects,High Grade Glandular Intraepithelial Neoplasia,0
18083,Treatment intent,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18084,human MUC1 protein,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18085,Common (qualifier value),Anterior Urethral Malignant Neoplasm,0
18086,Age,Colorectal High Grade B-Cell Lymphoma,0
18087,1930s,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18088,Tumor cells,Refractory Barrett Esophagus,0
18089,Togo,Cervical Adenomyoma,0
18090,Infant,Hyperplasia of pituitary gland,0
18091,site-specific telomere resolvase activity,Mucinous adenocarcinoma gastric,0
18092,Tryptophanase,Stage III Adult Immunoblastic Lymphoma,0
18093,Certain (qualifier value),FIGO Stage II Ovarian Cancer,0
18094,Present,Recurrent Uveal Melanoma,0
18095,Term (lexical),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18096,Treated with,Recurrent Uveal Melanoma,0
18097,Name,Locally Advanced Epithelioid Hemangioendothelioma,0
18098,various antiseptic throat preparations,Mucinous cystadenofibroma,0
18099,United States Military Commissioned Officer O4,Malignant Testicular Sertoli Cell Tumor,0
18100,Frequently,Benign Anal Granular Cell Tumor,0
18101,How Often Weight Loss,Lipoma of small intestine,0
18102,Operative Surgical Procedures,Hodgkin Disease,0
18103,Certain (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18104,Resulting in,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
18105,Rate,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18106,What subject filter - Result,Recurrent Testicular Lymphoma,0
18107,Then,Cervical Squamous Intraepithelial Neoplasia,0
18108,Headache,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18109,Diagnosis,Cerebral hemangioma,0
18110,bony process,Carcinoma of urinary bladder,0
18111,Term Birth,FIGO Stage II Ovarian Cancer,0
18112,Characterization,papillary carcinoma of penis,0
18113,Bladder Infection,Childhood Central Nervous System Ganglioneuroblastoma,0
18114,Brain,Malignant melanoma of eyelid,0
18115,Levels (qualifier value),Refractory Bladder Carcinoma,0
18116,Proteins,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18117,Abnormal,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18118,Larynx,Unfavorable Non-Hodgkin Lymphoma,0
18119,Abdomen,Benign neoplasm of thorax,0
18120,French language,Pancreatic carcinoma,0
18121,Feel Tired question,Precursor B-lymphoblastic lymphoma stage II,0
18122,Cytologic,Cervical Fibroepithelial Polyp,0
18123,Cell (compartment),Recurrent Uveal Melanoma,0
18124,Class (taxonomic),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
18125,One,gliosarcoma,0
18126,Therapeutic radiology procedure,FIGO Stage II Ovarian Cancer,0
18127,Mass of body structure,Neoplasms,0
18128,Ability,Stage IB Pancreatic Cancer AJCC v8,0
18129,Thinking,Hodgkin Disease,0
18130,Oral cavity,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
18131,Cartilage,Liver Cavernous Hemangioma,0
18132,ACACA wt Allele,FIGO Stage II Ovarian Cancer,0
18133,Biopsy,Occult Lung Adenosquamous Carcinoma,0
18134,Body tissue,Undifferentiated Neuroblastoma,0
18135,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Familial Adenomatous Polyposis Associated Medulloblastoma,0
18136,Empty (qualifier),Leptomeningeal sarcoma,0
18137,Antibodies,FIGO Stage IVA Ovarian Cancer,0
18138,Major,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18139,Ability,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
18140,Disease,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
18141,Management procedure,FIGO Stage IVA Ovarian Cancer,0
18142,Malignant neoplasm of lung,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
18143,Fever symptoms (finding),Choroid Epithelioid Cell Melanoma,0
18144,Clinical Item,Gallbladder Adenocarcinoma,0
18145,Cessation of life,Refractory Ependymoma,0
18146,Thyroid cancer,Adult Alveolar Soft Part Sarcoma,0
18147,Make - Instruction Imperative,Acute Undifferentiated Leukemia,0
18148,Disease Outcome,Hodgkin lymphoma,0
18149,Occurrence Indicator,Locally Advanced Carcinoma,0
18150,Possible,Maxillary Sinus Adenocarcinoma,0
18151,Cell (compartment),Neoplasms,0
18152,Response Likelihood,Metastatic Carcinoma in the Lung,0
18153,70%,Vaginal Adenoid Cystic Carcinoma,0
18154,*Type - Kind of quantity,Mixed astrocytoma-ependymoma,0
18155,Rate,Malignant melanoma of eyelid,0
18156,More than 5 years,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18157,Negation,embryonal rhabdomyosarcoma of prostate,0
18158,Time,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18159,Sequence Data Type,Hemangioma,0
18160,3+ Answer to Question,Benign neoplasm of thorax,0
18161,Overall,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18162,Call (Instruction),Familial Adenomatous Polyposis Associated Medulloblastoma,0
18163,Headache,Placental aromatase deficiency,0
18164,Abnormal cell,Childhood Lymphoma,0
18165,Childhood Diffuse Large B-Cell Lymphoma,Childhood Anaplastic Large Cell Lymphoma,0
18166,One,Cystadenocarcinoma,0
18167,Tryptophanase,Locally Advanced Squamous Cell Carcinoma,0
18168,Biomaterial Treatment,Metaplastic carcinoma of breast,0
18169,Mutation,Refractory Barrett Esophagus,0
18170,Central,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18171,Tryptophanase,Microcystic meningioma,0
18172,Negation,Malignant melanoma of eyelid,0
18173,Brain,sarcoma of spinal cord,0
18174,90%,Anterior Urethral Malignant Neoplasm,0
18175,Physical Activity Measurement,Female Breast Carcinoma,0
18176,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18177,Section (object),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18178,Itchiness,Collecting Duct Carcinoma of the Kidney,0
18179,Malignant neoplasm of mouth,Nasal cavity carcinoma,0
18180,Aspects of signs,ROSE Cluster 3,0
18181,50%,Clonal Hematopoiesis of Indeterminate Potential,0
18182,Major <insect>,Malignant neoplasm of gallbladder,0
18183,Autoimmune Diseases,Thyroid Hurthle Cell Carcinoma,0
18184,Exposure to,Thymoma malignant recurrent,0
18185,growth aspects,Carcinoma,0
18186,Occurrence,Intestinal Neuroendocrine Carcinoma,0
18187,regional,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18188,Therapeutic procedure,Ectomesenchymal Chondromyxoid Tumor,0
18189,Clinical trial protocol document,Digestive System Hodgkin Lymphoma,0
18190,year,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
18191,M+ (tumor staging),Botryoid-Type Embryonal Rhabdomyosarcoma,0
18192,therapeutic aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
18193,Pleural effusion disorder,Lung squamous cell carcinoma stage I,0
18194,pharmacotherapeutic,Locally Advanced Carcinoma,0
18195,Occurrence Indicator,Intestinal Neuroendocrine Carcinoma,0
18196,Main,adenosquamous carcinoma of breast,0
18197,High Risk Acute Leukemia,Unresectable Rhabdomyosarcoma,0
18198,Historical aspects qualifier,Extra-Adrenal Paraganglioma,0
18199,Formation,Engraftment syndrome,0
18200,Vocal articulation,Pancreatic Intraepithelial Neoplasia-3,0
18201,Specific qualifier value,Adenocarcinoma,0
18202,Health,Pilocytic astrocytoma of cerebellum,0
18203,Packaging Case,Acute Undifferentiated Leukemia,0
18204,Patch - Extended Release Film,Lipoma of small intestine,0
18205,Smoking,Kaposi's sarcoma of extrahepatic bile duct,0
18206,Aspects of disease screening,Benign tumor of eyelid,0
18207,include - SetOperator,Epithelioid Sarcoma NCI Grade 3,0
18208,Cells,embryonal rhabdomyosarcoma of prostate,0
18209,Enneking Low Surgical Grade,Malignant melanoma of eyelid,0
18210,Cisplatin,Stage III Cutaneous Melanoma AJCC v6,0
18211,gastrointestinal gas,Clonal Hematopoiesis of Indeterminate Potential,0
18212,90%,Astrocytoma of brain,0
18213,survival aspects,Cervical Squamous Intraepithelial Neoplasia,0
18214,Fertility Agents,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18215,Gender,Thyroid Hurthle Cell Carcinoma,0
18216,Surgical Replantation,Anterior Urethral Malignant Neoplasm,0
18217,day,Type II Endometrial Adenocarcinoma,0
18218,Episode of,Spindle Cell Melanoma,0
18219,Skin,Chronic Myelomonocytic Leukemia-2,0
18220,Pediatric Neoplasm,Mastocytosis,0
18221,Occurrence Indicator,Urethral Carcinoma,0
18222,Function Axis,Blepharal carcinoma,0
18223,Taxonomic,Periosteal Osteosarcoma,0
18224,Cells,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18225,Mucous body substance,Medulloblastoma,0
18226,Stem of Organ,Hemangioma,0
18227,Uncomplicated,FIGO Stage IVA Ovarian Cancer,0
18228,Ectomesenchymal Chondromyxoid Tumor,mucinous adenocarcinoma of gallbladder,0
18229,European Viper,Cervical Fibroepithelial Polyp,0
18230,Pilocytic Astrocytoma,Thyroid carcinoma,0
18231,Communicable Diseases,Malignant Testicular Sertoli Cell Tumor,0
18232,Mass,Clonal Hematopoiesis of Indeterminate Potential,0
18233,Relationships,Pilocytic astrocytoma of cerebellum,0
18234,Hematologic Tests,Intraepithelial Melanocytic Hyperplasia,0
18235,Include (action),Neonatal leukemia,0
18236,Malignant neoplasm of larynx,Tonsillar Carcinoma,0
18237,Causing,Recurrent Primary Lymphoma of Bone,0
18238,row - Table,Extracranial Neuroblastoma,0
18239,Focal,Trichilemmocarcinoma,0
18240,Western World,Diffuse malignant mesothelioma,0
18241,High,Recurrent Uveal Melanoma,0
18242,Involvement with,Hereditary Diffuse Gastric Adenocarcinoma,0
18243,Molecular,Metaplastic carcinoma of breast,0
18244,Escherichia coli,Adult Hepatocellular Carcinoma,0
18245,Decision,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18246,Symptoms,Advanced Uterine Corpus Carcinosarcoma,0
18247,Site of,sarcoma of spinal cord,0
18248,Physical assessment findings,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18249,Obese build,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18250,Basis,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
18251,To,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18252,Early stage,FIGO Stage IVA Ovarian Cancer,0
18253,Lymphoma,Mucosal Melanoma,0
18254,Mechanism (attribute),Stage IV Childhood Non-Hodgkin Lymphoma,0
18255,Skin cell,Liver Lymphangioma,0
18256,Eye lid,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18257,Unusual,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18258,Ovary,embryonal rhabdomyosarcoma of prostate,0
18259,PSA Level Less than Two,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18260,Noninvasive,Localized Askin Tumor,0
18261,Meningocele,Placental aromatase deficiency,0
18262,National Cancer Institute,Human Papillomavirus-Related Carcinoma,0
18263,Radiation Oncologists,Angiosarcoma of liver,0
18264,unknown vaccine or immune globulin,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18265,Etiology aspects,Unfavorable Non-Hodgkin Lymphoma,0
18266,Thorotrast,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18267,Term (lexical),Pancreatic Intraepithelial Neoplasia-3,0
18268,Used by,Grade 3a Malignant Neoplasm,0
18269,Spreading (qualifier value),Pancreatic carcinoma,0
18270,Hydrocephalus,FIGO Stage IVA Ovarian Cancer,0
18271,M Protein,Undifferentiated Endocervical Sarcoma,0
18272,Common (qualifier value),Papillary squamous cell carcinoma,0
18273,Ability,Granular Cell Leiomyosarcoma,0
18274,Treating,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18275,Death NOS,Locally Advanced Squamous Cell Carcinoma,0
18276,Interventional procedure,Acute Undifferentiated Leukemia,0
18277,Mean Percent of Normal,Uterine Cancer,0
18278,In Blood,Atypical Mesothelial Hyperplasia,0
18279,Childhood Lymphoma,mucinous adenocarcinoma of gallbladder,0
18280,Act Class - investigation,Precursor B-lymphoblastic lymphoma stage II,0
18281,Lymphocyte component of blood,Metastatic Lung Neuroendocrine Neoplasm,0
18282,Human papilloma virus infection,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18283,Lead,Stage II Hepatocellular Carcinoma AJCC v8,0
18284,Retinal pigment epithelial cell,Recurrent Uveal Melanoma,0
18285,Removed,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18286,Tissue Specimen Code,Ovarian germ cell choriocarcinoma stage IV,0
18287,Leads (device),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18288,Associated topography,Stage I Adult Non-Hodgkin Lymphoma,0
18289,Within,Blood Vessel Tumors,0
18290,+5,Cerebral hemangioma,0
18291,Cessation of life,Squamous cell carcinoma of lip,0
18292,Usual Severity Vomiting,Maxillary Sinus Adenocarcinoma,0
18293,Uterus,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18294,Evidence,Benign tumor of eyelid,0
18295,Germ Cells,Stage III Cutaneous Melanoma AJCC v6,0
18296,Fetal Ultrasonography,Gastric Diffuse Large B-Cell Lymphoma,0
18297,Science of Etiology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18298,Vaginal clear cell adenocarcinoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18299,How Much Distress Weight Loss,Choroid Necrotic Melanoma,0
18300,Symptoms aspect,Breast Apocrine Adenoma,0
18301,Case (situation),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18302,Severe (severity modifier),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
18303,Squamous cell carcinoma,Engraftment syndrome,0
18304,Subject Risk,Intestinal Neuroendocrine Carcinoma,0
18305,Case (situation),Clonal Hematopoiesis of Indeterminate Potential,0
18306,year,Giant cell angiofibroma,0
18307,Feel Tired question,Stage III Cutaneous Melanoma AJCC v6,0
18308,Fish (substance),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18309,cell growth,Recurrent Testicular Lymphoma,0
18310,Malignant melanoma of vulva,Granular Cell Leiomyosarcoma,0
18311,Front of neck,Female Breast Carcinoma,0
18312,Occurrence,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
18313,Childhood Diffuse Large B-Cell Lymphoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18314,Diagnosis Study,Clonal Hematopoiesis of Indeterminate Potential,0
18315,Including (qualifier),Atypical Mesothelial Hyperplasia,0
18316,Substance,Hereditary Diffuse Gastric Adenocarcinoma,0
18317,Brain Neoplasms,Malignant Testicular Sertoli Cell Tumor,0
18318,Group A (blood group),Adult Acute Eosinophilic Leukemia,0
18319,Childbirth,Unfavorable Non-Hodgkin Lymphoma,0
18320,Infrequent,Nasal cavity carcinoma,0
18321,immune system development,Locally Advanced Squamous Cell Carcinoma,0
18322,Benign,ROSE Cluster 3,0
18323,59,ICHTHYOSIS,0
18324,Dental White Spot,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
18325,Lip structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18326,Introduction procedure,Benign Apocrine Neoplasm,0
18327,Valid,ROSE Cluster 3,0
18328,Cancer Genus,Liver Cavernous Hemangioma,0
18329,Unknown GENC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18330,PSA Level Greater than Fifty,Carcinomatosis of peritoneal cavity,0
18331,75,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18332,Humor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18333,Soft,Benign Carotid Body Paraganglioma,0
18334,United States,Cartilaginous exostosis,0
18335,Subject Risk,Benign squamous cell tumor,0
18336,Tumor cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
18337,Ability,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18338,Malignant Neoplasms,Female Breast Carcinoma,0
18339,Absent,Funisitis (disorder),0
18340,Percent normal,Malignant neoplasm of subglottis,0
18341,Cure (remedy),Carcinoma of urinary bladder,0
18342,Vaginal,Type II Endometrial Adenocarcinoma,0
18343,Child,Choroid Necrotic Melanoma,0
18344,Melanoma Pathway,Benign Anal Granular Cell Tumor,0
18345,Breast Carcinoma,Cancer of Urinary Tract,0
18346,Esthesia,Acute lymphadenitis,0
18347,Cell Count,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18348,Lesion,Human Papillomavirus-Related Carcinoma,0
18349,Result,Squamous cell carcinoma of lip,0
18350,Orbital region,Endometrial Small Cell Carcinoma,0
18351,Tumor Mass,Benign Carotid Body Paraganglioma,0
18352,Reduced,Adult Alveolar Soft Part Sarcoma,0
18353,Germinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18354,Fertility Agents,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18355,high - ActExposureLevelCode,FIGO Stage IVA Ovarian Cancer,0
18356,Topical surface,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18357,To,Acute lymphadenitis,0
18358,Combined,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
18359,Intention - mental process,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
18360,Therapeutic procedure,Leptomeningeal sarcoma,0
18361,Surgical aspects,Cerebral Primitive Neuroectodermal Tumor,0
18362,Smaller,Transitional cell carcinoma,0
18363,Image Feature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18364,low,Serous cystadenocarcinoma ovary,0
18365,Fatigue,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
18366,Molecular Mass,Stage III Cutaneous Melanoma AJCC v6,0
18367,Main,Childhood Cerebellar Neoplasm,0
18368,1000000,Chronic Myelomonocytic Leukemia-2,0
18369,pharmacotherapeutic,Secondary malignant neoplasm of lymph node,0
18370,Upper arm,Kaposi's sarcoma of skin,0
18371,Caucasoid Race,Benign squamous cell tumor,0
18372,Small,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18373,65+,Non-Metastatic Gestational Trophoblastic Tumor,0
18374,Usually,Intracortical osteosarcoma,0
18375,Feel Tired question,Hemangioma,0
18376,Squamous cell carcinoma of skin,Xeroderma pigmentosum,0
18377,900,Thymic Clear Cell Carcinoma,0
18378,Skin,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
18379,Interstitial Cells of Cajal,Thymic Clear Cell Carcinoma,0
18380,Therapeutic procedure,Familial Adenomatous Polyposis Associated Medulloblastoma,0
18381,Cells,Non-Metastatic Gestational Trophoblastic Tumor,0
18382,Chemotherapy,Bladder squamous cell carcinoma stage I,0
18383,Disease,Kaposi's sarcoma of extrahepatic bile duct,0
18384,Pancreas,Malignant neoplasm of choroid,0
18385,High risk of,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
18386,Lymphocyte component of blood,BRCA2 Syndrome,0
18387,Hemorrhage,Lung squamous cell carcinoma stage I,0
18388,50%,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
18389,Right,Clonal Hematopoiesis of Indeterminate Potential,0
18390,Endometrium,Papillary squamous cell carcinoma,0
18391,Disease,non-Hodgkin's lymphoma of spleen,0
18392,Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18393,Central Minus,Acantholytic squamous cell carcinoma,0
18394,Neoplasms,Heavy Chain Deposition Disease,0
18395,Involvement with,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18396,How Much Distress Weight Loss,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18397,Abnormal number of nucleoli,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18398,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18399,Drain device,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18400,Affecting,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18401,Sample Median,Human Papillomavirus-Related Carcinoma,0
18402,Swab specimen,Thymic Clear Cell Carcinoma,0
18403,Precaution Code - Confused,Intestinal Metaplasia of Bladder Urothelium,0
18404,Primary lymphoid organ,Pancreatic Endocrine Carcinoma,0
18405,Over (spatial),Adult Acute Eosinophilic Leukemia,0
18406,low exposure,Digestive System Hodgkin Lymphoma,0
18407,Usual Severity Sweats,Bladder squamous cell carcinoma stage I,0
18408,Congenital Abnormality,Advanced Uterine Corpus Carcinosarcoma,0
18409,high - ActExposureLevelCode,Chronic Myelomonocytic Leukemia-2,0
18410,Numerous,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18411,Present,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18412,Slightly Agree,Thymic Atypical Carcinoid Tumor,0
18413,Benign Neoplasm,Locally Advanced Soft Tissue Sarcoma,0
18414,Fever,Astrocytoma of brain,0
18415,Cardiovascular system,Stage I Colon Neuroendocrine Tumor AJCC v8,0
18416,Dry,Mucinous adenocarcinoma gastric,0
18417,Urinary Bladder,Type II Endometrial Adenocarcinoma,0
18418,pharmacotherapeutic,FIGO Stage IVA Ovarian Cancer,0
18419,Biopsy,Advanced Lung Carcinoma,0
18420,Concept model domain,Acinar cell carcinoma of pancreas,0
18421,Adenium obesum,Choroid Necrotic Melanoma,0
18422,Central neuroblastoma,Adult Acute Eosinophilic Leukemia,0
18423,Status post,Acute lymphadenitis,0
18424,Base - General Qualifier,Female Breast Carcinoma,0
18425,Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18426,Accessory,Gallbladder Adenocarcinoma,0
18427,Progress,Methotrexate-Associated Hodgkin Lymphoma,0
18428,Minor salivary gland structure,Vaginal Adenoid Cystic Carcinoma,0
18429,Reported Term,Mucinous adenocarcinoma,0
18430,Presence (property),Primary Cutaneous Plasmablastic Lymphoma,0
18431,Pathology report,Locally Advanced Soft Tissue Sarcoma,0
18432,Unit - NCI Thesaurus Property,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18433,PREVENT (product),FIGO Stage II Ovarian Cancer,0
18434,Exogenous Factors,GIANT PIGMENTED HAIRY NEVUS,0
18435,HLA Class II Histocompatibility Antigen Gamma Chain,Metastatic Carcinoma in the Lung,0
18436,Known,Spongiotic dermatitis,0
18437,Cell (compartment),Malignant neoplasm of choroid,0
18438,Procedure (set of actions),Cancer of Urinary Tract,0
18439,Acute Undifferentiated Leukemia,Keratoderma,0
18440,Death (finding),Stage IV Childhood Non-Hodgkin Lymphoma,0
18441,Metastatic Neoplasm,Pancreatic carcinoma,0
18442,Prophylactic behavior,Bladder squamous cell carcinoma stage I,0
18443,GDF15 protein,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18444,Etiology aspects,Ovarian germ cell choriocarcinoma stage IV,0
18445,Common (qualifier value),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
18446,Adult Cholangiocarcinoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18447,Large,Ovarian germ cell choriocarcinoma stage IV,0
18448,To,Pancreatic Intraepithelial Neoplasia-3,0
18449,Europe,Congenital hamartoma,0
18450,Brain,Testicular cancer metastatic,0
18451,melanocyte,Ichthyosis,0
18452,Including (qualifier),BRCA2 Syndrome,0
18453,Type - attribute,Undifferentiated Endocervical Sarcoma,0
18454,Orbit (brand of fungicide),Locally Advanced Soft Tissue Sarcoma,0
18455,Primary operation,Airway Hemangioma,0
18456,Separate,Cancer of Urinary Tract,0
18457,Object Class,Blood Vessel Tumors,0
18458,Confirmed by,Xeroderma pigmentosum,0
18459,Approximate,Placental aromatase deficiency,0
18460,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18461,Gene Cluster Text Format,clear cell adenocarcinoma of gallbladder,0
18462,Therapeutic procedure,Hereditary Diffuse Gastric Adenocarcinoma,0
18463,United States Military Commissioned Officer O4,Familial Adenomatous Polyposis Associated Medulloblastoma,0
18464,Subependymal Giant Cell Astrocytoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18465,consider,Ichthyosis,0
18466,Surface of brain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18467,Occur (action),Nasal cavity carcinoma,0
18468,Have Weight Loss,Giant cell angiofibroma,0
18469,Cell Invasion,Hereditary Diffuse Gastric Adenocarcinoma,0
18470,Abnormal cell,Advanced Uterine Corpus Carcinosarcoma,0
18471,Fifth,Stage 0 Penile Cancer AJCC v8,0
18472,Swallowing painful,Recurrent Uveal Melanoma,0
18473,Basis - conceptual entity,Liver Lymphangioma,0
18474,ocular sphere,Liver Cavernous Hemangioma,0
18475,Cow's milk,Extracranial Neuroblastoma,0
18476,Adverse Event Associated with Vascular,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
18477,Arm of chromosome,Adult Alveolar Soft Part Sarcoma,0
18478,What subject filter - Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18479,Cancer Genus,Childhood Fibrillary Astrocytoma,0
18480,Japan,Malignant melanoma of eyelid,0
18481,Left,Small Intestinal Villous Adenoma,0
18482,Sharing (Social Behavior),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
18483,Complete Agreement,Refractory Barrett Esophagus,0
18484,Type A,carcinoma of middle ear,0
18485,75,Squamous cell carcinoma of lip,0
18486,Neurons,Precursor B-lymphoblastic lymphoma stage II,0
18487,risk factors,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18488,Malignant Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18489,Abdominal hysterectomy,Extracranial Neuroblastoma,0
18490,BRCA2 gene,Hodgkin Disease,0
18491,International Classification of Diseases for Oncology,Uterine Cancer,0
18492,Occur (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18493,All,Splenic Manifestation of Hairy Cell Leukemia,0
18494,include - SetOperator,Gallbladder adenoma,0
18495,Neoplasms by Site,Refractory Barrett Esophagus,0
18496,include - SetOperator,Malignant neoplasm of thalamus,0
18497,Cell (compartment),Cancer of Urinary Tract,0
18498,Science of Etiology,Blood Vessel Tumors,0
18499,How Often Weight Loss,Benign Anal Granular Cell Tumor,0
18500,Occurrence Indicator,Diffuse malignant mesothelioma,0
18501,Chemotherapy,Chronic Myelomonocytic Leukemia-2,0
18502,Anaplasia,Cerebral Primitive Neuroectodermal Tumor,0
18503,Skeletal bone,Basal Cell Ameloblastoma,0
18504,Benign tumor of salivary gland,Childhood Lymphoma,0
18505,Surgery specialty,Mucinous neoplasm,0
18506,To,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18507,derivation calculation,clear cell adenocarcinoma of gallbladder,0
18508,Palatine Tonsil,Malignant neoplasm of gallbladder,0
18509,Death (finding),Uterine Cancer,0
18510,Etiology aspects,Childhood Central Nervous System Ganglioneuroblastoma,0
18511,Metastatic Neoplasm,Spongiotic dermatitis,0
18512,Occurrence,Acute lymphadenitis,0
18513,Doubling Time,Platinum-Resistant Lung Small Cell Carcinoma,0
18514,shared attribute,Unresectable Rhabdomyosarcoma,0
18515,Acute lymphocytic leukemia,Human Papillomavirus-Related Carcinoma,0
18516,Manipulation procedure,Chest Wall Fibromatosis,0
18517,Usual,Stage III Cutaneous Melanoma AJCC v6,0
18518,Case unit dose,Melanomatosis,0
18519,Melanocytic nevus,Adult Hepatocellular Carcinoma,0
18520,Cough,Malignant neoplasm of thalamus,0
18521,Feelings,Spongiotic dermatitis,0
18522,General Health:Find:Pt:^Patient:Ord,Spongiotic dermatitis,0
18523,Result,Chest Wall Fibromatosis,0
18524,Long Variable,Mucinous cystadenofibroma,0
18525,Occurrence Indicator,Maxillary Sinus Adenocarcinoma,0
18526,Hyperestrogenism,Undifferentiated Endocervical Sarcoma,0
18527,Data,Testicular cancer metastatic,0
18528,Feel Tired question,Kaposi's sarcoma of extrahepatic bile duct,0
18529,Nuclear hyperchromasia,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18530,59,Human Papillomavirus-Related Carcinoma,0
18531,Tissue Specimen Code,Diffuse malignant mesothelioma,0
18532,seen,Mixed astrocytoma-ependymoma,0
18533,Body site,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
18534,Sensitive,Human Papillomavirus-Related Carcinoma,0
18535,development aspects,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
18536,Decision,Locally Advanced Soft Tissue Sarcoma,0
18537,Borg Category-Ratio 10 Perceived Exertion Score 5,Neoplasms,0
18538,member,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18539,Removed,Low Grade Squamous Intraepithelial Neoplasia,0
18540,How Often Difficulty Swallowing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18541,Basis - conceptual entity,Cervical Fibroepithelial Polyp,0
18542,4+ Answer to question,Digestive System Hodgkin Lymphoma,0
18543,Very high,Thymoma malignant recurrent,0
18544,Liver carcinoma,Vaginal Adenoma,0
18545,Name (property) (qualifier value),Vaginal Adenoma,0
18546,Pieris rapae,Chest Wall Fibromatosis,0
18547,Cornea,Adult Alveolar Soft Part Sarcoma,0
18548,Pelvic Pain,Small cell neuroendocrine carcinoma of bladder,0
18549,*Type - Kind of quantity,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
18550,potential,Benign Ovarian Thecoma,0
18551,Testis,benign mature teratoma of pancreas,0
18552,regional,Metastatic Lung Small Cell Carcinoma,0
18553,Feel Tired question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18554,Rosa,Malignant neoplasm of choroid,0
18555,Leads (device),Recurrent Testicular Lymphoma,0
18556,Communicable Diseases,Stage III Cutaneous Melanoma AJCC v6,0
18557,Chronic myeloproliferative disorder,Congenital hamartoma,0
18558,Neoplasm Metastasis,Type II Endometrial Adenocarcinoma,0
18559,Study Control,Extra-abdominal fibromatosis,0
18560,Most,Benign tumor of eyelid,0
18561,+2,Gallbladder Adenocarcinoma,0
18562,Representation (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18563,Before values,Carcinoma ex pleomorphic adenoma of parotid gland,0
18564,Etiology aspects,Kaposi's sarcoma of skin,0
18565,Associated with,Acute Undifferentiated Leukemia,0
18566,Mass of body structure,Platinum-Resistant Lung Small Cell Carcinoma,0
18567,Testis present,adenosquamous carcinoma of breast,0
18568,Benign Neoplasm,Neonatal leukemia,0
18569,Disease remission,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18570,Involvement with,Malignant Testicular Sertoli Cell Tumor,0
18571,Lymphoma,Pancreatic Intraepithelial Neoplasia-3,0
18572,Early,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18573,Proliferation,Engraftment syndrome,0
18574,diagnosis aspect,Benign squamous cell tumor,0
18575,Common Specifications in HL7 V3 Publishing,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
18576,Ultra-violet,non-Hodgkin's lymphoma of spleen,0
18577,Group A (blood group),Acantholytic squamous cell carcinoma,0
18578,Beginning,Liver Lymphangioma,0
18579,Stellate,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
18580,Together,Intestinal Metaplasia of Bladder Urothelium,0
18581,Administration procedure,BRCA2 Syndrome,0
18582,Tissue Specimen Code,Malignant Neoplasm of Lung - Multiple Primary Sites,0
18583,Age-Years,Papillary squamous cell carcinoma,0
18584,described,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18585,Neoadjuvant Therapy,Unresectable Rhabdomyosarcoma,0
18586,Human papillomavirus types,Breast Apocrine Adenoma,0
18587,CDISC SEND Tumor Findings Results Terminology,Metastatic Carcinoma in the Lung,0
18588,Early disease stage,Refractory Barrett Esophagus,0
18589,Tumor cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18590,TP53 gene,Malignant Neoplasm of Lung - Multiple Primary Sites,0
18591,Malignant neoplasm of breast,Uterine Cancer,0
18592,Blood group A (finding),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18593,What subject filter - Result,Kaposi's sarcoma of extrahepatic bile duct,0
18594,Cause of Death,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18595,Human Cells,Placental aromatase deficiency,0
18596,Acute leukemia,Acute Undifferentiated Leukemia,0
18597,<50,Basal Cell Ameloblastoma,0
18598,Cancer Genus,Deep Leiomyoma,0
18599,How Much Distress Shortness of Breath,Chronic Myelomonocytic Leukemia-2,0
18600,Sharing (Social Behavior),Cherubism,0
18601,Call (Instruction),Extracranial Neuroblastoma,0
18602,Administration procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18603,Mediator brand of benfluorex hydrochloride,Peripheral primitive neuroectodermal tumor of soft tissue,0
18604,Remetinostat,sarcoma of spinal cord,0
18605,Distant,Recurrent Uveal Melanoma,0
18606,Peripheral,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18607,Tumor type,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18608,Disruptive,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18609,Hemorrhage,Cancer of Urinary Tract,0
18610,Upper arm,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18611,Disease Management,Primary Cutaneous Plasmablastic Lymphoma,0
18612,primary tumor,Digestive System Hodgkin Lymphoma,0
18613,Antibodies,Non-Metastatic Gestational Trophoblastic Tumor,0
18614,Frequently,Nasal cavity carcinoma,0
18615,Performed,Uterine Cancer,0
18616,Occurrence Indicator,Human Papillomavirus-Related Carcinoma,0
18617,Tumor Mass,Adult Acute Eosinophilic Leukemia,0
18618,Two,Squamous cell carcinoma of lip,0
18619,Prior Medication Usage,Vaginal Adenoid Cystic Carcinoma,0
18620,Adjacent,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18621,Changing,Stage IB Pancreatic Cancer AJCC v8,0
18622,Include (action),clear cell adenocarcinoma of gallbladder,0
18623,Money or percentage indicator - Percentage,Transitional cell carcinoma,0
18624,Tanning of leather,Hodgkin lymphoma,0
18625,10%,Acantholytic squamous cell carcinoma,0
18626,Type - attribute,Small Intestinal Villous Adenoma,0
18627,Rare,Type II Endometrial Adenocarcinoma,0
18628,Immunoproliferative Disorders,Stage I Adult Non-Hodgkin Lymphoma,0
18629,Togo,Metastatic Malignant Neoplasm in the Sellar Region,0
18630,Make - Instruction Imperative,Nasal cavity carcinoma,0
18631,Iodides,Metaplastic carcinoma of breast,0
18632,Malignant neoplasm of lung,Thymic Clear Cell Carcinoma,0
18633,Tumor cells,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
18634,Tissue damage,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18635,Offspring,Xeroderma pigmentosum,0
18636,Diagnostic Neoplasm Staging,Lung squamous cell carcinoma stage I,0
18637,Person 1,Multiple Skull Base Meningiomas,0
18638,Undifferentiated,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18639,Nausea Visual Analogue Scale,Chronic Myelomonocytic Leukemia-2,0
18640,Loss of Appetite question,Stage IB Pancreatic Cancer AJCC v8,0
18641,Small cell carcinoma of lung,Pancreatic carcinoma,0
18642,Histology,Lipoma of small intestine,0
18643,Critical,Placental aromatase deficiency,0
18644,thymocyte,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18645,Frequently,Endometrial Small Cell Carcinoma,0
18646,Inheritance,High Grade Glandular Intraepithelial Neoplasia,0
18647,Intestines,Stage III Cutaneous Melanoma AJCC v6,0
18648,Bronchoconstriction,Neoplasms,0
18649,Singular,Low Grade Squamous Intraepithelial Neoplasia,0
18650,Abnormal,Melanomatosis,0
18651,Incidence,Metastatic Neoplasm to the Gallbladder,0
18652,Numerous,Endometrial Small Cell Carcinoma,0
18653,TP53 gene,Mixed astrocytoma-ependymoma,0
18654,Lower - spatial qualifier,Bladder squamous cell carcinoma stage I,0
18655,Upper arm,squamous cell carcinoma of the thyroid gland,0
18656,Lung Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18657,Canada,de novo Myelodysplastic Syndrome,0
18658,Asia,Heavy Chain Deposition Disease,0
18659,Surgery specialty,Acute Undifferentiated Leukemia,0
18660,Wound Healing,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
18661,medication - HL7 publishing domain,Blood Vessel Tumors,0
18662,Neoplasms,Localized Askin Tumor,0
18663,Major salivary gland structure,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
18664,Often - answer to question,Refractory Glioma,0
18665,Aspects of signs,Benign tumor of eyelid,0
18666,Circulatory Process,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18667,Eyelid structure,Fourth Ventricle and Brain Stem Ependymal Tumor,0
18668,Tryptophanase,Intraepithelial Melanocytic Hyperplasia,0
18669,Compleat Liquid Nutrition,Deep Leiomyoma,0
18670,Mammals,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18671,Entity,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
18672,Post,ROSE Cluster 3,0
18673,Bone Marrow Transplantation,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18674,Specimen Source Codes - tumor,Acantholytic squamous cell carcinoma,0
18675,Indication of (contextual qualifier),Ovarian Dermoid Cyst with Secondary Carcinoma,0
18676,Range,Intestinal Metaplasia of Bladder Urothelium,0
18677,Benign Smooth Muscle Neoplasm,Childhood Central Nervous System Ganglioneuroblastoma,0
18678,Tryptophanase,Type II Endometrial Adenocarcinoma,0
18679,Tryptophanase,Stage III Cutaneous Melanoma AJCC v6,0
18680,Tissue Specimen Code,Carcinomatosis of peritoneal cavity,0
18681,subapical complex location,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18682,Walls of a building,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
18683,Abnormality of the face,Carcinoma,0
18684,Screening procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18685,Expanding,Stage 0 Lip Carcinoma,0
18686,Loss of appetite (finding),Adult Acute Eosinophilic Leukemia,0
18687,Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
18688,health and disease,Mastocytosis,0
18689,Administration procedure,Unresectable Rhabdomyosarcoma,0
18690,Vision,Acute lymphadenitis,0
18691,Prognosis:Find:Pt:^Patient:Nom,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18692,Type - attribute,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
18693,At risk of infection,Thyroid Hurthle Cell Carcinoma,0
18694,Benign disorder,Extra-abdominal fibromatosis,0
18695,Skin Erosion,Mucinous adenocarcinoma gastric,0
18696,More,Cerebral Primitive Neuroectodermal Tumor,0
18697,Areas <moth>,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18698,Mean Percent of Normal,Human Papillomavirus-Related Carcinoma,0
18699,CDISC SEND Body System Terminology,Diffuse malignant mesothelioma,0
18700,Persons,Human Papillomavirus-Related Carcinoma,0
18701,Renal Cell Carcinoma Pathway,Ichthyosis,0
18702,Pineal germinoma,Refractory Ependymoma,0
18703,Tryptophanase,Precursor B-lymphoblastic lymphoma stage II,0
18704,Papillomavirus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18705,bony process,Cervical Adenomyoma,0
18706,biopsy characteristics,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18707,Obese build,Childhood Thyroid Gland Follicular Carcinoma,0
18708,Rare,Refractory Barrett Esophagus,0
18709,Morphology,Benign tumor of eyelid,0
18710,Malignant Neoplasms,FIGO Stage IVA Ovarian Cancer,0
18711,Neoplasms by Site,Collecting Duct Carcinoma of the Kidney,0
18712,Vaginal neoplasia,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18713,depend,Squamous cell carcinoma of lip,0
18714,English race,BRCA2 Syndrome,0
18715,Specimen Source Codes - Genital,High Grade Glandular Intraepithelial Neoplasia,0
18716,Congestive heart failure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18717,disease transmission,Hereditary corneal dystrophy,0
18718,Reaching,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
18719,Tissue specific,Intraepithelial Melanocytic Hyperplasia,0
18720,Exertion,Gallbladder Adenocarcinoma,0
18721,Form:Finding:Point in time:{Setting}:Document:{Role},Urethral Carcinoma,0
18722,Li-Fraumeni Syndrome,Spongiotic dermatitis,0
18723,Kind of quantity - Frequency,Cerebral Primitive Neuroectodermal Tumor,0
18724,Smaller,Stage III Adult Immunoblastic Lymphoma,0
18725,Two,Uterine Cancer,0
18726,Usual Severity Nausea,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
18727,Histocompatibility Testing,Carcinoma of submandibular gland,0
18728,Form:Finding:Point in time:{Setting}:Document:{Role},Benign tumor of eyelid,0
18729,Time,Recurrent Testicular Lymphoma,0
18730,Secondary malignant neoplasm of lung,Heavy Chain Deposition Disease,0
18731,Science of Etiology,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18732,Class (taxonomic),Benign squamous cell tumor,0
18733,Night sweats,Human Papillomavirus-Related Carcinoma,0
18734,Part of,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18735,Musculature of limb,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18736,second (number),Stage III Cutaneous Melanoma AJCC v6,0
18737,Immune system,Localized Ewing Sarcoma,0
18738,Certain (qualifier value),Diffuse malignant mesothelioma,0
18739,shared attribute,Malignant melanoma of eyelid,0
18740,Human papilloma virus infection,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18741,Therapeutic radiology procedure,Astrocytoma of brain,0
18742,Therapeutic radiology procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18743,Lymphoid Tissue,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
18744,Biological Response Modifier Therapy,Liver Lymphangioma,0
18745,English [International Organization for Standardization 639-1 code en] language reference set,Chronic Myelomonocytic Leukemia-2,0
18746,Preventing (action),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18747,Pharmacotherapy,Cherubism,0
18748,bony process,Benign squamous cell tumor,0
18749,Has difficulty doing (qualifier value),malignant lymphoma of pancreatic lymph nodes,0
18750,Development,Small intestine carcinoma,0
18751,Surgical extraction,Keratoderma,0
18752,Numerous,Stage IB Pancreatic Cancer AJCC v8,0
18753,Time (foundation metadata concept),Hemangioma,0
18754,% live,Acute Undifferentiated Leukemia,0
18755,Cervix carcinoma,Colorectal Neuroendocrine Tumor G2,0
18756,Use of,Squamous cell carcinoma of lip,0
18757,Human Chorionic Gonadotropin,Tubal Hyperplasia,0
18758,Liver Flavor,Childhood Central Nervous System Ganglioneuroblastoma,0
18759,Age,Recurrent Uveal Melanoma,0
18760,bony process,Angiosarcoma of liver,0
18761,Data Transformation,Acute lymphadenitis,0
18762,Various patch test substance,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18763,Term (lexical),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18764,morphological,Malignant neoplasm of olfactory nerve,0
18765,Urinary tract,Endometrial Small Cell Carcinoma,0
18766,Levels (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
18767,Trial Screening,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
18768,Science of Etiology,Benign Apocrine Neoplasm,0
18769,Diagnostic radiologic examination,Bladder squamous cell carcinoma stage I,0
18770,Female,Congenital hamartoma,0
18771,Usual Severity Weight Loss,Mucinous adenocarcinoma gastric,0
18772,Skin Pigmentation,Chronic Myelomonocytic Leukemia-2,0
18773,SPINK5 gene,Clonal Hematopoiesis of Indeterminate Potential,0
18774,Polyglandular Type I Autoimmune Syndrome,Xeroderma pigmentosum,0
18775,Bathing,Bladder squamous cell carcinoma stage I,0
18776,Uterine Cancer,Small cell neuroendocrine carcinoma of bladder,0
18777,Injury due to exposure to external cause,Multiple Endocrine Neoplasia,0
18778,Abnormal Reference Range,Breast Apocrine Adenoma,0
18779,Digital Content Category,Stage III Adult Immunoblastic Lymphoma,0
18780,Biopsy,Trabecular adenocarcinoma,0
18781,Life Threatening or Disabling Adverse Event,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18782,Either,Recurrent Uveal Melanoma,0
18783,Chewing,sarcoma of spinal cord,0
18784,pump (device),Tongue Alveolar Soft Part Sarcoma,0
18785,Symptoms aspect,Engraftment syndrome,0
18786,Recurrent infections,Stage 0 Penile Cancer AJCC v8,0
18787,Stomach,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18788,Beginning,Metastatic Lung Neuroendocrine Neoplasm,0
18789,+5,Astrocytoma of brain,0
18790,Severe atopic dermatitis,Clonal Hematopoiesis of Indeterminate Potential,0
18791,Chemotherapy Regimen,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18792,Observation in research,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
18793,Important,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18794,Both kidneys,Astrocytoma of brain,0
18795,Recurrence,Neonatal leukemia,0
18796,Usual Severity Weight Loss,Gallbladder Adenocarcinoma,0
18797,Disruptive,Benign neoplasm of eye,0
18798,Characterization,Localized Askin Tumor,0
18799,Name (property) (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18800,Skin,Metastatic Lung Neuroendocrine Neoplasm,0
18801,Melanocytic nevus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18802,Physical findings,Rhabdomyosarcoma with ganglionic differentiation,0
18803,Sarcoma,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
18804,shared attribute,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18805,Laboratory Procedures,Fourth Ventricle and Brain Stem Ependymal Tumor,0
18806,Neoadjuvant Therapy Clinical Trial Setting,Anterior Urethral Malignant Neoplasm,0
18807,Cancer Biology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18808,How Much Distress Weight Loss,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18809,Ewings sarcoma,Cancer of Urinary Tract,0
18810,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Malignant Neoplasm with Regional Lymph Node Involvement,0
18811,point - UnitsOfMeasure,Neonatal leukemia,0
18812,Basis - conceptual entity,Metastatic Lung Small Cell Carcinoma,0
18813,Hormone Therapy,Unfavorable Non-Hodgkin Lymphoma,0
18814,Subtype (attribute),Maxillary Sinus Adenoid Cystic Carcinoma,0
18815,Primary,Carcinomatosis of peritoneal cavity,0
18816,various antiseptic throat preparations,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18817,diagnosis aspect,Stage IV Childhood Non-Hodgkin Lymphoma,0
18818,Binding Sites,Pancreatic Intraepithelial Neoplasia-3,0
18819,genetic aspects,Multiple Skull Base Meningiomas,0
18820,Cervix Uteri,Kaposi's sarcoma of extrahepatic bile duct,0
18821,*Type - Kind of quantity,Kaposi's sarcoma of skin,0
18822,therapeutic aspects,Methotrexate-Associated Hodgkin Lymphoma,0
18823,Appearance,Stage II Carcinoma of Penis,0
18824,Overall Publication Type,Locally Advanced Squamous Cell Carcinoma,0
18825,Over (spatial),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18826,Ephrin Type-B Receptor 1,Brain Ependymoma,0
18827,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18828,Term (lexical),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18829,Pediculus (eukaryote),Recurrent Testicular Lymphoma,0
18830,Definition,Acute Undifferentiated Leukemia,0
18831,20%,Ichthyoses,0
18832,Lingual tonsil,Rhabdomyosarcoma with ganglionic differentiation,0
18833,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
18834,Intellectual scale,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18835,Type - attribute,Tongue Alveolar Soft Part Sarcoma,0
18836,Age,Unfavorable Non-Hodgkin Lymphoma,0
18837,Abdomen distended,Locally Advanced Epithelioid Hemangioendothelioma,0
18838,Effective,Mixed parotid tumor,0
18839,Does carry,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18840,Benign neoplasm of paraganglion,Extra-Adrenal Paraganglioma,0
18841,insensitivity,Recurrent Testicular Lymphoma,0
18842,Wound Healing,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
18843,Pressure - action,Acute Undifferentiated Leukemia,0
18844,Disease,Undifferentiated Neuroblastoma,0
18845,Uncontrolled,Childhood Thyroid Gland Follicular Carcinoma,0
18846,International Classification of Disease,Pleomorphic adenoma of parotid gland,0
18847,10%,Anaplastic large cell lymphoma,0
18848,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18849,Administration procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
18850,2+ Score,Colorectal High Grade B-Cell Lymphoma,0
18851,Percent (qualifier value),Breast Ductal Adenoma,0
18852,International Classification of Diseases for Oncology,Digestive System Hodgkin Lymphoma,0
18853,Percent inhibition,gliosarcoma,0
18854,year,Unresectable Rhabdomyosarcoma,0
18855,To,Malignant neoplasm of thalamus,0
18856,Myasthenia Gravis,Childhood Lung Non-Small Cell Carcinoma,0
18857,Life threatening - Event Consequence,Squamous cell carcinoma of lip,0
18858,Packaging Case,Splenic Manifestation of Hairy Cell Leukemia,0
18859,30%,Neoplasms,0
18860,Ureter,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18861,Side,gliosarcoma,0
18862,Result,Anaplastic large cell lymphoma,0
18863,Recurrence,Neoplasms,0
18864,Infection,Localized Askin Tumor,0
18865,Observation - diagnostic procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18866,System - kit,embryonal rhabdomyosarcoma of prostate,0
18867,Biopsy,Trichilemmocarcinoma,0
18868,Abnormal Reference Range,Kaposi's sarcoma of skin,0
18869,Basis,Multiple Endocrine Neoplasia,0
18870,Lymphoma,Maxillary Sinus Adenoid Cystic Carcinoma,0
18871,Diagnosis Study,Choroid Epithelioid Cell Melanoma,0
18872,Most,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18873,Medical,Locally Advanced Carcinoma,0
18874,Numbers,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
18875,Cell (compartment),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18876,Extrinsic,Primary Cutaneous Plasmablastic Lymphoma,0
18877,Protein Turn,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18878,Translucent,Engraftment syndrome,0
18879,Immune System Processes,Recurrent Rhabdomyosarcoma,0
18880,Loss of appetite (finding),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18881,year,Childhood Fibrillary Astrocytoma,0
18882,Cover (physical object),Acute lymphadenitis,0
18883,Type A,Thymic Atypical Carcinoid Tumor,0
18884,Disease,Cystadenocarcinoma,0
18885,prior radiation therapy,Tonsillar Carcinoma,0
18886,Manufactured form,Xeroderma pigmentosum,0
18887,Thymoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18888,bony process,Endometrial Small Cell Carcinoma,0
18889,Recommendation,Lipoma of small intestine,0
18890,Term (temporal),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18891,Worse,Lipoma of small intestine,0
18892,Vulva,Benign Anal Granular Cell Tumor,0
18893,Severe Extremity Pain,gliosarcoma,0
18894,Rapid,Astrocytoma of brain,0
18895,Dorsal funiculus,Benign Anal Granular Cell Tumor,0
18896,week,Chondrosarcoma,0
18897,Proliferation,Intracortical osteosarcoma,0
18898,Base - General Qualifier,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18899,Lead,Refractory Bladder Carcinoma,0
18900,Dyspnea,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18901,Ability,Glomeruloid hemangioma,0
18902,Three,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18903,Present,Lipoma of small intestine,0
18904,Sunlight,Hereditary Diffuse Gastric Adenocarcinoma,0
18905,Neuron spine,Hodgkin Disease,0
18906,Epithelium,FIGO Stage IVA Ovarian Cancer,0
18907,Oral cavity,Primary Cutaneous Plasmablastic Lymphoma,0
18908,Tumor type,Mucinous adenocarcinoma gastric,0
18909,patient condition,Locally Advanced Soft Tissue Sarcoma,0
18910,Cell Count,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18911,Gram per Deciliter,Carcinomatosis of peritoneal cavity,0
18912,Neoplasms,Benign Anal Granular Cell Tumor,0
18913,Skin,Benign Anal Granular Cell Tumor,0
18914,Coughing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18915,Osteoporosis,Adrenal Rest Tumor,0
18916,Rare,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18917,Due to,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18918,radiotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18919,Gait normal,Recurrent Testicular Lymphoma,0
18920,Postmenopausal state,Melanomatosis,0
18921,vowels,Acute Undifferentiated Leukemia,0
18922,Count of entities,Kaposi's sarcoma of skin,0
18923,include - SetOperator,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
18924,Cluster,Mucinous adenocarcinoma gastric,0
18925,white blood cell type,Pancreatic carcinoma,0
18926,IPSS Risk Category High,Undifferentiated Endocervical Sarcoma,0
18927,United States,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
18928,seconds,Cerebral Primitive Neuroectodermal Tumor,0
18929,pharmacotherapeutic,Childhood Lung Non-Small Cell Carcinoma,0
18930,Chemotherapy Regimen,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18931,Affect (mental function),Tonsillar Carcinoma,0
18932,Mammal liver preparation,Liver Lymphangioma,0
18933,Monitor,Fibroadenoma of breast,0
18934,described,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18935,Woman,Pancreatic carcinoma,0
18936,Family history,Childhood Anaplastic Large Cell Lymphoma,0
18937,Large,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18938,Analysis of substances,Stage IV Colorectal Cancer AJCC v8,0
18939,Infective cystitis,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18940,Activities,Benign Apocrine Neoplasm,0
18941,Occurrence Indicator,Mixed astrocytoma-ependymoma,0
18942,Formation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18943,Treating,Childhood Lung Non-Small Cell Carcinoma,0
18944,Lymphoplasmacytoid Cell,Vaginal Adenoid Cystic Carcinoma,0
18945,30%,Nasal cavity carcinoma,0
18946,Type A,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
18947,radiotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18948,Pain,Recurrent Uveal Melanoma,0
18949,Chemotherapy Regimen,Refractory Bladder Carcinoma,0
18950,Generic Role,Adult Hepatocellular Carcinoma,0
18951,Present,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18952,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,FIGO Stage IVA Ovarian Cancer,0
18953,shared attribute,Benign tumor of eyelid,0
18954,respiratory,Breast Ductal Adenoma,0
18955,A Codes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18956,risk factors - observation list,Basal Cell Ameloblastoma,0
18957,Glandular,Stage III Cutaneous Melanoma AJCC v6,0
18958,How Much Distress Vomiting,Intracortical osteosarcoma,0
18959,Aspects of signs,Methotrexate-Associated Hodgkin Lymphoma,0
18960,Usual,Malignant melanoma of eyelid,0
18961,Disease,Stage IB Lung Cancer AJCC v7,0
18962,Cell (compartment),Primary Cutaneous Plasmablastic Lymphoma,0
18963,Family history,Multiple Endocrine Neoplasia,0
18964,Gland,Extracranial Neuroblastoma,0
18965,Spreading (qualifier value),Diffuse malignant mesothelioma,0
18966,radiotherapeutic,Malignant melanoma of eyelid,0
18967,Abnormal cellular component of blood,Precursor B-lymphoblastic lymphoma stage II,0
18968,geographic population,Diffuse malignant mesothelioma,0
18969,Term (temporal),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
18970,Benign,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18971,Spreading (qualifier value),Xeroderma pigmentosum,0
18972,Skeletal bone,Cervical Fibroepithelial Polyp,0
18973,Infection,Adenocarcinoma of duodenum,0
18974,Frequently,Gallbladder Adenocarcinoma,0
18975,Negation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18976,Poor - grade value,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
18977,Overall,Adrenal Rest Tumor,0
18978,Abnormal,Childhood Lymphoma,0
18979,Carcinoma of lung,Kaposi's sarcoma of extrahepatic bile duct,0
18980,Females,Undifferentiated Endocervical Sarcoma,0
18981,Natural History,Mucinous cystadenofibroma,0
18982,Group Object,Splenic Manifestation of Hairy Cell Leukemia,0
18983,Rating (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
18984,Malignant neoplasm of salivary gland,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18985,Percent (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
18986,Jaw,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
18987,Osteogenesis,Malignant melanoma of eyelid,0
18988,Adenomatous Polyposis Coli,Ichthyosis,0
18989,Discover,Mucinous neoplasm,0
18990,Official,Thyroid Hurthle Cell Carcinoma,0
18991,SERPINA3 protein,Childhood Lymphoma,0
18992,Fish Flavor,Kaposi's sarcoma of skin,0
18993,Balanced - adjective,Type II Endometrial Adenocarcinoma,0
18994,*Type - Kind of quantity,Carcinoma,0
18995,FAT1 wt Allele,Mucinous adenocarcinoma gastric,0
18996,Small,Hair nevus,0
18997,*Type - Kind of quantity,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
18998,Pressure- physical agent,Benign Anal Granular Cell Tumor,0
18999,Malignant Neoplasms,Engraftment syndrome,0
19000,Fetus,Cervical Squamous Intraepithelial Neoplasia,0
19001,Condition,Chest Wall Fibromatosis,0
19002,Human body structure,Contact dermatitis due to alkali,0
19003,35,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19004,Similarity,Hodgkin lymphoma,0
19005,Inguinal region,Acute Undifferentiated Leukemia,0
19006,Known,Pancreatic Intraepithelial Neoplasia-3,0
19007,Experimental Result,Pancreatic carcinoma,0
19008,Decrease,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19009,Known,Mucinous adenocarcinoma gastric,0
19010,Tissue Specimen Code,Hereditary Diffuse Gastric Adenocarcinoma,0
19011,Diagnosis,Digestive System Hodgkin Lymphoma,0
19012,Usual,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19013,68,Nasal cavity carcinoma,0
19014,Probable diagnosis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19015,Immunotherapy,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19016,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Cancer of Urinary Tract,0
19017,Tumor Mass,Liver Cavernous Hemangioma,0
19018,Worse,Intraepithelial Melanocytic Hyperplasia,0
19019,GDF15 protein,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19020,Pharmacotherapy,Malignant melanoma of eyelid,0
19021,Two,Cerebral hemangioma,0
19022,Screening Study,Kaposi's sarcoma of skin,0
19023,High Mitosis-Karyorrhexis Index,non-Hodgkin's lymphoma of spleen,0
19024,Fragments,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19025,Act Class - investigation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19026,Nutrients,Thymic Clear Cell Carcinoma,0
19027,Account number:Identifier:Point in time:^Patient:Nominal,Hodgkin Disease,0
19028,Distant,Adult Acute Eosinophilic Leukemia,0
19029,Completely Able,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19030,Malignant neoplasm of urinary bladder,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19031,Tired,Mucinous adenocarcinoma gastric,0
19032,Historical aspects qualifier,Medulloblastoma,0
19033,Intention - mental process,Peripheral primitive neuroectodermal tumor of soft tissue,0
19034,Occurrence Indicator,Digestive System Hodgkin Lymphoma,0
19035,Similarity,Refractory Barrett Esophagus,0
19036,Lung,Undifferentiated Neuroblastoma,0
19037,CEL gene,Stage IB Pancreatic Cancer AJCC v8,0
19038,Logical Condition,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19039,How Often Weight Loss,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19040,Body part,Pilocytic astrocytoma of cerebellum,0
19041,centimeter,Kaposi's sarcoma of extrahepatic bile duct,0
19042,Icterus,Engraftment syndrome,0
19043,Growth,Xeroderma pigmentosum,0
19044,Shortened,Kaposi's sarcoma of extrahepatic bile duct,0
19045,Human body structure,Transitional cell carcinoma,0
19046,Neoplasms,Childhood Fibrillary Astrocytoma,0
19047,diagnosis aspect,FIGO Stage II Ovarian Cancer,0
19048,Different,Familial Hemophagocytic Lymphocytosis,0
19049,Financial Account,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19050,Spreading (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19051,Surface Antigens,Chronic Myelomonocytic Leukemia-2,0
19052,Surgical aspects,Uterine Cancer,0
19053,Weight Loss,Ichthyoses,0
19054,Plumbum metallicum,Mucinous adenocarcinoma gastric,0
19055,Unknown GENC,Type II Endometrial Adenocarcinoma,0
19056,Good,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19057,Cells,Breast Ductal Adenoma,0
19058,Glomeruloid hemangioma,Tonsillar Carcinoma,0
19059,Inhibition,Granular Cell Leiomyosarcoma,0
19060,Tumor Mass,Nasal cavity carcinoma,0
19061,Location,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19062,Third grade in elementary school,Peripheral primitive neuroectodermal tumor of soft tissue,0
19063,NCI CTEP SDC Melanoma Sub-Category Terminology,Childhood Choriocarcinoma,0
19064,Linear,adenosquamous carcinoma of breast,0
19065,Swelling,Recurrent Uveal Melanoma,0
19066,Biological Response Modifiers,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19067,ethnic european,Benign tumor of eyelid,0
19068,Slow,Benign Anal Granular Cell Tumor,0
19069,Often - answer to question,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19070,Common Specifications in HL7 V3 Publishing,Mucosal Melanoma,0
19071,CD5L wt Allele,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19072,Stop (qualifier value),Gallbladder Adenocarcinoma,0
19073,DNA,Refractory Ependymoma,0
19074,Term (lexical),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19075,X-linked inheritance,Bladder adenocarcinoma stage IV,0
19076,Maxilla,Vaginal Adenoid Cystic Carcinoma,0
19077,Frequently,Gallbladder Adenocarcinoma,0
19078,1+ Score,High Grade Glandular Intraepithelial Neoplasia,0
19079,Symptoms,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19080,% Ercs,Plexosarcoma,0
19081,Prognosis:Find:Pt:^Patient:Nom,Stage 0 Penile Cancer AJCC v8,0
19082,Estimated,Basal Cell Ameloblastoma,0
19083,include - SetOperator,Stage III Adult Immunoblastic Lymphoma,0
19084,include - SetOperator,Neoplasms,0
19085,Smear - instruction imperative,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19086,Inguinal region,Carcinomatosis of peritoneal cavity,0
19087,Infected,Childhood Thyroid Gland Follicular Carcinoma,0
19088,Person 1,Colorectal High Grade B-Cell Lymphoma,0
19089,Count of entities,Parathyroid Gland Adenocarcinoma,0
19090,Well,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19091,Squamous cell carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19092,Pharmacotherapy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19093,Residue on Aryepiglottic Folds Following Swallowing,Undifferentiated Endocervical Sarcoma,0
19094,Study,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19095,Name (property) (qualifier value),Recurrent Uveal Melanoma,0
19096,Neck,FIGO Stage IVA Ovarian Cancer,0
19097,peripheral blood,embryonal rhabdomyosarcoma of prostate,0
19098,Klinefelter Syndrome,Primary Cutaneous Plasmablastic Lymphoma,0
19099,Abnormally high,Occult Lung Adenosquamous Carcinoma,0
19100,PSA Level Greater than Fifty,Uterine Cancer,0
19101,Version,Digestive System Hodgkin Lymphoma,0
19102,Lip structure,Refractory Ependymoma,0
19103,Pain Distress Question,Hodgkin lymphoma,0
19104,Hospital specialist,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19105,Intraepithelial Neoplasia,Benign Apocrine Neoplasm,0
19106,Possible,Ovarian germ cell choriocarcinoma stage IV,0
19107,Togo,gliosarcoma,0
19108,Percent of Abnormal Cells,Unfavorable Non-Hodgkin Lymphoma,0
19109,Often - answer to question,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19110,Bloating,Anterior Urethral Malignant Neoplasm,0
19111,1+ Score,Anterior Urethral Malignant Neoplasm,0
19112,Pages,Platinum-Resistant Lung Small Cell Carcinoma,0
19113,Skin Pigmentation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19114,Limited stage (cancer stage),Malignant neoplasm of subglottis,0
19115,Age,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19116,Small,Kaposi's sarcoma of extrahepatic bile duct,0
19117,Offspring,non-Hodgkin's lymphoma of spleen,0
19118,Statistical Significance,Squamous cell carcinoma of lip,0
19119,Reporting,Malignant melanoma of eyelid,0
19120,Hormone replacement therapy,Lipoma of small intestine,0
19121,Time (foundation metadata concept),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19122,Manufactured form,Adult Hepatocellular Carcinoma,0
19123,Knee,Sarcomatoid Renal Cell Carcinoma,0
19124,Central Nervous System Neoplasms,Pancreatic Intraepithelial Neoplasia-3,0
19125,Hemorrhage,Carcinoma of urinary bladder,0
19126,Childhood Hodgkin Lymphoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19127,Malignant neoplasm of large intestine,Nasal cavity carcinoma,0
19128,Ethanol,Medulloblastoma,0
19129,Financial Account,Mixed astrocytoma-ependymoma,0
19130,Trial Subject Replacement,Kaposi's sarcoma of extrahepatic bile duct,0
19131,Structure of germinal center of lymph node,Malignant neoplasm of subglottis,0
19132,Ultraviolet Rays,Spindle Cell Melanoma,0
19133,Respiratory System Finding,Granular Cell Leiomyosarcoma,0
19134,Non-Metastatic Childhood Soft Tissue Sarcoma,Colorectal cancer,0
19135,X-Ray Computed Tomography,Undifferentiated Endocervical Sarcoma,0
19136,Tissue Growth,Stage II Carcinoma of Penis,0
19137,Adenocarcinoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19138,90 - 100%,Diffuse malignant mesothelioma,0
19139,64,Acute Undifferentiated Leukemia,0
19140,Immature,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19141,% bound (qualifier value),Stage 0 Penile Cancer AJCC v8,0
19142,CD69 protein,Heavy Chain Deposition Disease,0
19143,Known,Endometrial Small Cell Carcinoma,0
19144,High Level,Unicystic ameloblastoma,0
19145,10%,Clonal Hematopoiesis of Indeterminate Potential,0
19146,Normal function,Occult Lung Adenosquamous Carcinoma,0
19147,Biomaterial Treatment,Adult Anaplastic Oligodendroglioma,0
19148,Primary,embryonal rhabdomyosarcoma of prostate,0
19149,North America,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19150,Physical findings,Malignant melanoma of eyelid,0
19151,Age of Onset,Mucinous adenocarcinoma,0
19152,2+ Score,Malignant Testicular Sertoli Cell Tumor,0
19153,Cancer Genus,Clonal Hematopoiesis of Indeterminate Potential,0
19154,Abdominal Pain,Brain Ependymoma,0
19155,Adult Non-Hodgkin Lymphoma,Stage IB Lung Cancer AJCC v7,0
19156,Second Look Surgery,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19157,Uveal melanoma,Primary Cutaneous Plasmablastic Lymphoma,0
19158,Targeted Therapy,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
19159,Sensory (qualifier value),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19160,capsule (pharmacologic),Mixed astrocytoma-ependymoma,0
19161,Bile Duct Diseases,Endometrial Small Cell Carcinoma,0
19162,Diagnostic Neoplasm Staging,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19163,Human body,Adult Acute Eosinophilic Leukemia,0
19164,pharmacotherapeutic,Splenic Manifestation of Hairy Cell Leukemia,0
19165,Omphalitis,Female Breast Carcinoma,0
19166,Stomach structure,Mixed astrocytoma-ependymoma,0
19167,Smear - instruction imperative,High Grade Glandular Intraepithelial Neoplasia,0
19168,Version,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19169,Squamous,Spongiotic dermatitis,0
19170,Eyelid structure,Multiple Skull Base Meningiomas,0
19171,Esophageal manometry,Digestive System Hodgkin Lymphoma,0
19172,Function (attribute),mucinous adenocarcinoma of gallbladder,0
19173,Most,Benign neoplasm of eye,0
19174,Diagnosis,malignant lymphoma of pancreatic lymph nodes,0
19175,Comparison,Malignant melanoma of eyelid,0
19176,protein body,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19177,Primary malignant neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19178,Survival Rate,Neoplasms,0
19179,Skin,Kaposi's sarcoma of skin,0
19180,Before values,Human Papillomavirus-Related Carcinoma,0
19181,Snake Bites,Locally Advanced Epithelioid Hemangioendothelioma,0
19182,Occur (action),Unicystic ameloblastoma,0
19183,Minor salivary gland structure,Uterine Cancer,0
19184,Childhood Non-Hodgkin Lymphoma,Recurrent Testicular Lymphoma,0
19185,Lymphoid,Extra-Adrenal Paraganglioma,0
19186,Body site,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19187,Tissue Growth,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19188,Oral (intended site),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19189,Location,Liver Lymphangioma,0
19190,Death (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19191,Name,Neonatal leukemia,0
19192,United States,Benign Carotid Body Paraganglioma,0
19193,Indication of (contextual qualifier),Intestinal Metaplasia of Bladder Urothelium,0
19194,How Much Distress Weight Loss,Vaginal Adenoid Cystic Carcinoma,0
19195,Symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19196,interstitial,FIGO Stage IVA Ovarian Cancer,0
19197,Involvement with,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19198,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Tongue Alveolar Soft Part Sarcoma,0
19199,Geographic Locations,Metastatic Carcinoma in the Lung,0
19200,Malignant Head and Neck Neoplasm,Benign Anal Granular Cell Tumor,0
19201,Myeloid Leukemia,Endometrial Small Cell Carcinoma,0
19202,Formation,Secondary malignant neoplasm of lymph node,0
19203,Make - Instruction Imperative,Toxic Epidermal Necrolysis,0
19204,Morphology,clear cell adenocarcinoma of gallbladder,0
19205,Smear - instruction imperative,Liver Lymphangioma,0
19206,Distant,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19207,20%,Cartilaginous exostosis,0
19208,Medical Drop,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19209,Ulceration,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
19210,Line Specimen,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
19211,Abnormal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19212,Early,Hereditary Diffuse Gastric Adenocarcinoma,0
19213,Web Site,Malignant neoplasm of thalamus,0
19214,Belgium,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
19215,Goes <invertebrate>,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
19216,Further,Benign tumor of eyelid,0
19217,Publications,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19218,Case (situation),Gallbladder Adenocarcinoma,0
19219,Ultraviolet Light Sterilization,Mixed astrocytoma-ependymoma,0
19220,What subject filter - Result,Methotrexate-Associated Hodgkin Lymphoma,0
19221,Neck of organ,Stage IV Childhood Non-Hodgkin Lymphoma,0
19222,Healthy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19223,Fever symptoms (finding),Fibroadenoma of breast,0
19224,Skin Specimen,Anterior Urethral Malignant Neoplasm,0
19225,Specimen Source Codes - Serum,Pancreatic Intraepithelial Neoplasia-3,0
19226,Stage Grouping,Cervical Fibroepithelial Polyp,0
19227,Manufactured sign,Low Grade Squamous Intraepithelial Neoplasia,0
19228,Human papillomavirus 11,Intraepithelial Melanocytic Hyperplasia,0
19229,Tumor Mass,Gallbladder Adenocarcinoma,0
19230,Chemotherapy,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19231,Local disease,Ichthyosis,0
19232,<3 (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19233,Study Site,Acute Undifferentiated Leukemia,0
19234,Overall Publication Type,High Grade Glandular Intraepithelial Neoplasia,0
19235,Urinary Bladder,Hyperplasia of pituitary gland,0
19236,Floor - story of building,Leiomyoma of Gallbladder,0
19237,Result,Non-Metastatic Gestational Trophoblastic Tumor,0
19238,dendritic spine neck,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19239,Lymphoid Tissue,Anaplastic large cell lymphoma,0
19240,Symptoms,Familial Adenomatous Polyposis Associated Medulloblastoma,0
19241,Name (property) (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
19242,Tests (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19243,Antibiotics,Stage IV Penile Cancer AJCC v7,0
19244,Macrophage Activation Syndrome,Spongiotic dermatitis,0
19245,Vasopressins,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19246,ovarian neoplasm,Stage IV Penile Cancer AJCC v7,0
19247,Surgical aspects,Testicular cancer metastatic,0
19248,Mutation,Unresectable Rhabdomyosarcoma,0
19249,Condition:Find:Pt:^Patient:Nom,Intestinal Neuroendocrine Carcinoma,0
19250,Better than Others,Malignant melanoma of eyelid,0
19251,Death NOS,Malignant Neoplasm with Regional Lymph Node Involvement,0
19252,Neonatal (qualifier value),Localized Askin Tumor,0
19253,Morphology,Rhabdomyosarcoma with ganglionic differentiation,0
19254,Metabolic Inhibition,Granular Cell Leiomyosarcoma,0
19255,Weight decreased,Extracranial Neuroblastoma,0
19256,Dependent for Toilet Use,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
19257,Persons,mucinous adenocarcinoma of gallbladder,0
19258,Specimen Source Codes - tumor,Nasal cavity carcinoma,0
19259,Form:Finding:Point in time:{Setting}:Document:{Role},Epithelioid Sarcoma NCI Grade 3,0
19260,Initially,Fibroadenoma of breast,0
19261,Usually,Occult Lung Adenosquamous Carcinoma,0
19262,Adult human body,Adult Fibrolamellar Carcinoma,0
19263,Basis - conceptual entity,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
19264,Persons,Adenocarcinoma of the prostate metastatic,0
19265,Severe (severity modifier),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19266,Series - set of composite instances,Mixed astrocytoma-ependymoma,0
19267,Comparison,Childhood Thyroid Gland Follicular Carcinoma,0
19268,Patterns,Cancer of Urinary Tract,0
19269,Extravasation,Childhood Central Nervous System Ganglioneuroblastoma,0
19270,Loss,Malignant neoplasm of olfactory nerve,0
19271,Known,BRCA2 Syndrome,0
19272,Uterine Fibroids,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19273,Abnormal,Tubal Hyperplasia,0
19274,Transitional epithelium,Chronic Myelomonocytic Leukemia-2,0
19275,Poor function,Anterior Urethral Malignant Neoplasm,0
19276,Subtype (attribute),gliosarcoma,0
19277,Report (document),Mucinous adenocarcinoma gastric,0
19278,Then,Chest Wall Fibromatosis,0
19279,Neoplasm Metastasis,Platinum-Resistant Lung Small Cell Carcinoma,0
19280,Recommendation,Engraftment syndrome,0
19281,Screening procedure,Bladder squamous cell carcinoma stage I,0
19282,Aspects of signs,Digestive System Hodgkin Lymphoma,0
19283,Function (attribute),Refractory Glioma,0
19284,Imaging Techniques,Diffuse malignant mesothelioma,0
19285,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Astrocytoma of brain,0
19286,Condyloma,Peripheral primitive neuroectodermal tumor of soft tissue,0
19287,Confirmed by,Malignant neoplasm of subglottis,0
19288,Urothelium,Vaginal Adenoid Cystic Carcinoma,0
19289,Act Mood - intent,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19290,Ethanol,Thyroid Hurthle Cell Carcinoma,0
19291,800,Adult Alveolar Soft Part Sarcoma,0
19292,Symptoms aspect,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19293,Epithelial cell count (procedure),Metastatic Lung Small Cell Carcinoma,0
19294,Cerebral Cavernous Hemangioma,Malignant Neoplasm of Lung - Multiple Primary Sites,0
19295,Containing (qualifier),embryonal rhabdomyosarcoma of prostate,0
19296,To,Acute Undifferentiated Leukemia,0
19297,Histopathology,Metastatic Neoplasm to the Gallbladder,0
19298,Live - Specimen Condition,Stage III Cutaneous Melanoma AJCC v6,0
19299,Two,Localized Malignant Neoplasm,0
19300,Distant,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19301,Degree or extent,Splenic Manifestation of Hairy Cell Leukemia,0
19302,PREVENT (product),Intraepithelial Melanocytic Hyperplasia,0
19303,Effectiveness,Cervical Squamous Intraepithelial Neoplasia,0
19304,Microplate Well,Diffuse malignant mesothelioma,0
19305,Include (action),Microcystic meningioma,0
19306,Late,Stage 0 Lip Carcinoma,0
19307,Supportive assistance,Primary Cutaneous Plasmablastic Lymphoma,0
19308,Occurrence Indicator,Mucinous adenocarcinoma gastric,0
19309,Cancer Genus,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
19310,Decision,Digestive System Hodgkin Lymphoma,0
19311,treatment - ActInformationManagementReason,Ovarian germ cell choriocarcinoma stage IV,0
19312,Body part,Thymic Clear Cell Carcinoma,0
19313,Mature Teratoma,Bladder adenocarcinoma stage IV,0
19314,Africa,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19315,2000,Tonsillar Carcinoma,0
19316,Present,Non-Metastatic Gestational Trophoblastic Tumor,0
19317,Usual,Neonatal leukemia,0
19318,20%,Chest Wall Fibromatosis,0
19319,Continuance of life,Chest Wall Fibromatosis,0
19320,Retinoic Acid Response Element,Clonal Hematopoiesis of Indeterminate Potential,0
19321,Back,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19322,Skin cell,Mucinous adenocarcinoma gastric,0
19323,DNA,Papillary squamous cell carcinoma,0
19324,Pale color,Ovarian Carcinoid Tumor,0
19325,Previously Treated Childhood Rhabdomyosarcoma,Methotrexate-Associated Hodgkin Lymphoma,0
19326,Example,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19327,Milk Specimen,squamous cell carcinoma of the thyroid gland,0
19328,Frequently,Vaginal Adenoid Cystic Carcinoma,0
19329,Usually Need Help from Another Person for Reach,Cartilaginous exostosis,0
19330,Smoking,Stage III Cutaneous Melanoma AJCC v6,0
19331,Tissue of urinary bladder,Neonatal leukemia,0
19332,Covers (device),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19333,CDH1 protein,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19334,Compleat Liquid Nutrition,Cerebral hemangioma,0
19335,Alcohol intake above recommended sensible limits,Melanomatosis,0
19336,Exposure to,Refractory Barrett Esophagus,0
19337,Child,Hemangioma,0
19338,Treatment Epoch,Endometrial Small Cell Carcinoma,0
19339,320,Xeroderma pigmentosum,0
19340,Testing,Malignant melanoma of eyelid,0
19341,SLC35G1 gene,Ovarian germ cell choriocarcinoma stage IV,0
19342,Receptors,Stage IB Pancreatic Cancer AJCC v8,0
19343,Lacrimal duct,Stage IB Pancreatic Cancer AJCC v8,0
19344,How Often Itching,Childhood Central Nervous System Ganglioneuroblastoma,0
19345,Deep Resection Margin,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19346,intramanchette transport,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19347,Affecting,adenoid cystic carcinoma of lung,0
19348,Usual,Benign Carotid Body Paraganglioma,0
19349,CEL gene,Kaposi's sarcoma of extrahepatic bile duct,0
19350,Females,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19351,Behaviorial Habits,Germinoma,0
19352,+5,Familial Adenomatous Polyposis Associated Medulloblastoma,0
19353,ovarian neoplasm,Serous cystadenocarcinoma ovary,0
19354,Malignant neoplasm of pancreas,Thyroid Hurthle Cell Carcinoma,0
19355,Associated topography,Hyperplasia of pituitary gland,0
19356,Two,Squamous cell carcinoma of lip,0
19357,Cancer Genus,Benign Anal Granular Cell Tumor,0
19358,Include (action),Gallbladder Adenocarcinoma,0
19359,Skin,Stage 0 Penile Cancer AJCC v8,0
19360,Skin tanning,Stage IB Pancreatic Cancer AJCC v8,0
19361,Process of secretion,Malignant neoplasm of subglottis,0
19362,Decrease,High Grade Glandular Intraepithelial Neoplasia,0
19363,Account number:Identifier:Point in time:^Patient:Nominal,Primary Cutaneous Plasmablastic Lymphoma,0
19364,Area,Cervical Squamous Intraepithelial Neoplasia,0
19365,Chamber (physical object),Cancer of Urinary Tract,0
19366,Procedures involving the use of pharmaceuticals,Ichthyosis,0
19367,Parenchyma,High Grade Glandular Intraepithelial Neoplasia,0
19368,shared attribute,Endometrial Small Cell Carcinoma,0
19369,Receptors,Stage II Carcinoma of Penis,0
19370,Patient Condition Code - Stable,Kaposi's sarcoma of extrahepatic bile duct,0
19371,Palmitic Acid,Human Papillomavirus-Related Carcinoma,0
19372,Established,Cerebral Primitive Neuroectodermal Tumor,0
19373,Class (taxonomic),Cerebral Primitive Neuroectodermal Tumor,0
19374,Skin Specimen,Carcinoma ex pleomorphic adenoma of parotid gland,0
19375,ETS Translocation Variant 5,sarcoma of spinal cord,0
19376,Breast Carcinoma,Pancreatic carcinoma,0
19377,Uveal melanoma,Diffuse malignant mesothelioma,0
19378,Vaginal (intended site),Chondrosarcoma,0
19379,Have Pain,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
19380,Local-Regional anatomy,Human Papillomavirus-Related Carcinoma,0
19381,Dangerousness,Pancreatic Intraepithelial Neoplasia-3,0
19382,contents - HtmlLinkType,FIGO Stage II Ovarian Cancer,0
19383,Including (qualifier),Primary Cutaneous Plasmablastic Lymphoma,0
19384,Age of onset of symptoms:Time:Pt:^Patient:Qn,Recurrent Testicular Lymphoma,0
19385,*Type - Kind of quantity,Familial Adenomatous Polyposis Associated Medulloblastoma,0
19386,Relative Survival,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19387,General surgery specialty,Malignant Testicular Sertoli Cell Tumor,0
19388,Most Recent,Malignant neoplasm of subglottis,0
19389,Genetic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19390,Human body structure,Malignant Testicular Sertoli Cell Tumor,0
19391,Hodgkin Disease,mucinous adenocarcinoma of gallbladder,0
19392,Present,Small cell neuroendocrine carcinoma of bladder,0
19393,Preventing (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
19394,Tired,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19395,Body part,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
19396,Sometimes,Low Grade Squamous Intraepithelial Neoplasia,0
19397,Area,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19398,Biomaterial Treatment,Recurrent Testicular Lymphoma,0
19399,Bands,Familial Hemophagocytic Lymphocytosis,0
19400,Platelet Glycoprotein 4,Mixed parotid tumor,0
19401,Manufactured form,Type II Endometrial Adenocarcinoma,0
19402,How Much Distress Vomiting,FIGO Stage IVA Ovarian Cancer,0
19403,Main,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19404,Lesion,Blood Vessel Tumors,0
19405,98,Lipoma of small intestine,0
19406,Bone Pain,Malignant Testicular Sertoli Cell Tumor,0
19407,Old,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19408,Large,Unicystic ameloblastoma,0
19409,Standard (qualifier),Undifferentiated Endocervical Sarcoma,0
19410,Acquired (qualifier value),Malignant Neoplasm of Lung - Multiple Primary Sites,0
19411,Occur (action),Engraftment syndrome,0
19412,Descent,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19413,2+,Mucosal Melanoma,0
19414,Progress,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19415,Known,FIGO Stage II Ovarian Cancer,0
19416,Vertebral column,Pilocytic astrocytoma of cerebellum,0
19417,Usually Need Help from Another Person for Eating,Angiosarcoma of liver,0
19418,Blood capillaries,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
19419,Local disease,Endometrial Small Cell Carcinoma,0
19420,Lichenification,Metastatic Neoplasm to the Gallbladder,0
19421,Cover - action,non-Hodgkin's lymphoma of spleen,0
19422,include - SetOperator,Chest Wall Fibromatosis,0
19423,2+ Score,Neoplasms,0
19424,anatomical layer,Stage 0 Penile Cancer AJCC v8,0
19425,Medical Device Emits Smoke,Nasal cavity carcinoma,0
19426,Disease Management,Giant cell angiofibroma,0
19427,Rare,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19428,Cardiac Lead Procedure,Stage IB Pancreatic Cancer AJCC v8,0
19429,Decision,Platinum-Resistant Lung Small Cell Carcinoma,0
19430,Headache,Xeroderma pigmentosum,0
19431,Lesion,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19432,Carcinogenesis,Benign Anal Granular Cell Tumor,0
19433,Occur (action),Secondary malignant neoplasm of lymph node,0
19434,Most,Pancreatic Intraepithelial Neoplasia-3,0
19435,Malignant neoplasm of soft tissue,Metastatic Malignant Neoplasm in the Sellar Region,0
19436,High Level,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19437,T prime,Intestinal Metaplasia of Bladder Urothelium,0
19438,Cell Count,Intestinal Metaplasia of Bladder Urothelium,0
19439,Pelvis+,Malignant melanoma of eyelid,0
19440,Standard (document),Cervical Squamous Intraepithelial Neoplasia,0
19441,Formation,Angiosarcoma of liver,0
19442,Positive,BRCA2 Syndrome,0
19443,CDISC SEND Tumor Findings Results Terminology,Epithelioid Sarcoma NCI Grade 3,0
19444,low confidentiality,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19445,Sharing (Social Behavior),FIGO Stage IVA Ovarian Cancer,0
19446,Specimen Source Codes - tumor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19447,Biopsy,Cervical Squamous Intraepithelial Neoplasia,0
19448,Publications,Hodgkin lymphoma,0
19449,Decision,Acute Undifferentiated Leukemia,0
19450,biopsy characteristics,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19451,Biomaterial Treatment,mucinous adenocarcinoma of gallbladder,0
19452,Negation,Angiosarcoma of liver,0
19453,Intermediate Mitosis-Karyorrhexis Index,Splenic Manifestation of Hairy Cell Leukemia,0
19454,Decision,Cartilaginous exostosis,0
19455,Five,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19456,High Grade Cervical Squamous Intraepithelial Neoplasia,Platinum-Resistant Lung Small Cell Carcinoma,0
19457,United States,Cystadenocarcinoma,0
19458,Root Mean Square,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19459,day,Spindle Cell Melanoma,0
19460,Formation,Extracranial Neuroblastoma,0
19461,Infrequent,Angiosarcoma of liver,0
19462,World Health Organization,Diffuse malignant mesothelioma,0
19463,Togo,Locally Advanced Epithelioid Hemangioendothelioma,0
19464,Five,Primary Cutaneous Plasmablastic Lymphoma,0
19465,Experimental Result,Breast Ductal Adenoma,0
19466,Dilate procedure,Acute Undifferentiated Leukemia,0
19467,Primary operation,Engraftment syndrome,0
19468,Overall Survival,Neonatal leukemia,0
19469,analysis aspect,FIGO Stage II Ovarian Cancer,0
19470,Abdominal bloating,Peripheral primitive neuroectodermal tumor of soft tissue,0
19471,low,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19472,Overall,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19473,3+ Score,Bladder adenocarcinoma stage IV,0
19474,Type A,Kaposi's sarcoma of extrahepatic bile duct,0
19475,Immune System Finding,Cerebral Primitive Neuroectodermal Tumor,0
19476,Line Specimen,Methotrexate-Associated Hodgkin Lymphoma,0
19477,Investigative Subject,Cancer of Urinary Tract,0
19478,Coding,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19479,Cells,adenoid cystic carcinoma of lung,0
19480,Screening Study,Chondrosarcoma,0
19481,Common (qualifier value),Angiosarcoma of liver,0
19482,Carcinoma of lung,mucinous adenocarcinoma of gallbladder,0
19483,Sexually Transmitted Diseases,Papillary squamous cell carcinoma,0
19484,eTMF Content Model Code,Cerebral hemangioma,0
19485,How Much Distress Weight Loss,Stage IV Colorectal Cancer AJCC v8,0
19486,Biomaterial Treatment,embryonal rhabdomyosarcoma of prostate,0
19487,Individual,Fibroadenoma of breast,0
19488,Effectiveness,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19489,Hepatitis B,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19490,Stop (qualifier value),Metastatic Malignant Neoplasm in the Sellar Region,0
19491,Biopsy,Chronic Myelomonocytic Leukemia-2,0
19492,Smaller,Hemangioma,0
19493,Ovary,FIGO Stage II Ovarian Cancer,0
19494,Muscle of orbit,Grade 3a Malignant Neoplasm,0
19495,Tumor Mass,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19496,Analysis of substances,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19497,Common (qualifier value),Mucinous adenocarcinoma gastric,0
19498,Male population group,Hodgkin Disease,0
19499,Deglutition Disorders,Stage III Cutaneous Melanoma AJCC v6,0
19500,Keloid,Tubal Hyperplasia,0
19501,include - SetOperator,Cervical Fibroepithelial Polyp,0
19502,Lymphoid leukemia,Liver Cavernous Hemangioma,0
19503,Known,Malignant neoplasm of gallbladder,0
19504,Unknown GENC,Acantholytic squamous cell carcinoma,0
19505,Location of Pharyngeal Residue Following Swallowing,Bladder adenocarcinoma stage IV,0
19506,Symptoms aspect,Carcinoma ex pleomorphic adenoma of parotid gland,0
19507,Intervention regimes,Acantholytic squamous cell carcinoma,0
19508,Relationships,Giant cell angiofibroma,0
19509,Along edge (qualifier value),Heavy Chain Deposition Disease,0
19510,Type - attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19511,Subject Risk,Childhood Thyroid Gland Follicular Carcinoma,0
19512,Most,Maxillary Sinus Adenocarcinoma,0
19513,Pain,Liver Lymphangioma,0
19514,Four,Gallbladder Adenocarcinoma,0
19515,Primary,Low Grade Squamous Intraepithelial Neoplasia,0
19516,Value Above Reference Range,Engraftment syndrome,0
19517,Liver,Angiosarcoma of liver,0
19518,Presentation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19519,Premalignant,Benign neoplasm of eye,0
19520,Anterior nares,Stage II Carcinoma of Penis,0
19521,metaplastic cell transformation,FIGO Stage IVA Ovarian Cancer,0
19522,Use - dosing instruction imperative,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19523,3+ Score,Acantholytic squamous cell carcinoma,0
19524,Reduction procedure,Carcinoma of urinary bladder,0
19525,Classification,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
19526,Name,Refractory Ependymoma,0
19527,American College of Cardiology/American Heart Association Lesion Complexity Score C,Benign Anal Granular Cell Tumor,0
19528,Sweat,Colorectal cancer,0
19529,Greater,sarcoma of spinal cord,0
19530,Always (frequency),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19531,Show,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19532,Digestive Enzymes,Giant cell angiofibroma,0
19533,Human Cells,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19534,Prostate,Larynx carcinoma recurrent,0
19535,Refractory Cytopenia of Childhood,Chondrosarcoma,0
19536,Specific qualifier value,Kaposi's sarcoma of extrahepatic bile duct,0
19537,Skin,Chronic Myelomonocytic Leukemia-2,0
19538,Gastrointestinal tract structure,Adult Alveolar Soft Part Sarcoma,0
19539,How Often Vomiting,Diffuse malignant mesothelioma,0
19540,Node - plant part,Acute lymphadenitis,0
19541,Malignant - descriptor,Microcystic meningioma,0
19542,Chemotherapy,Cerebral Primitive Neuroectodermal Tumor,0
19543,Body surface,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19544,Formations,malignant lymphoma of pancreatic lymph nodes,0
19545,Universal,Diffuse malignant mesothelioma,0
19546,Associated with,Carcinoma of urinary bladder,0
19547,THM gene,Melanomatosis,0
19548,Embryonic Development,Benign Anal Granular Cell Tumor,0
19549,Cancer Registry,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19550,Progress,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19551,Repeat Surgery,Thymic Clear Cell Carcinoma,0
19552,Bayer Visual Acuity Changes Grade 3,Mucinous adenocarcinoma gastric,0
19553,Division (action),Anterior Urethral Malignant Neoplasm,0
19554,First (number),Refractory Barrett Esophagus,0
19555,High,Heavy Chain Deposition Disease,0
19556,Pediatric Neoplasm,Stage IB Pancreatic Cancer AJCC v8,0
19557,Erythropoiesis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19558,Endocrine Gland Neoplasms,Malignant neoplasm of thalamus,0
19559,Neoplasms,Adult Acute Eosinophilic Leukemia,0
19560,Response (statement),Botryoid-Type Embryonal Rhabdomyosarcoma,0
19561,Diagnosis Study,Childhood Lymphoma,0
19562,shared attribute,FIGO Stage IVA Ovarian Cancer,0
19563,seen,Primary Cutaneous Plasmablastic Lymphoma,0
19564,Brain Neoplasms,Neonatal leukemia,0
19565,preference,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19566,Tissue Donors,Maxillary Sinus Adenocarcinoma,0
19567,Beginning,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
19568,Supratentorial Embryonal Tumor,Heavy Chain Deposition Disease,0
19569,Participation Type - origin,Vaginal Adenoma,0
19570,What subject filter - Result,Mucinous adenocarcinoma,0
19571,Source,Stage IB Pancreatic Cancer AJCC v8,0
19572,pharmacotherapeutic,Adenocarcinoma,0
19573,Large,Squamous cell carcinoma of lip,0
19574,Frequently,Malignant Neoplasm with Regional Lymph Node Involvement,0
19575,Determined by,Placental aromatase deficiency,0
19576,Occur (action),Mucinous adenocarcinoma gastric,0
19577,Infrequent,clear cell adenocarcinoma of gallbladder,0
19578,Genetic syndrome,Unfavorable Non-Hodgkin Lymphoma,0
19579,Brain Neoplasms,Unresectable Rhabdomyosarcoma,0
19580,Chemotherapy Regimen,Intestinal Metaplasia of Bladder Urothelium,0
19581,Adjacent,Astrocytoma of brain,0
19582,Occurrence Indicator,Diffuse malignant mesothelioma,0
19583,Neoadjuvant Therapy,Benign tumor of eyelid,0
19584,Several,Benign squamous cell tumor,0
19585,Term Birth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19586,Specimen Source Codes - Tube,Squamous cell carcinoma of lip,0
19587,Tryptophanase,Mucinous adenocarcinoma gastric,0
19588,Cessation of life,Recurrent Rhabdomyosarcoma,0
19589,Capsule Dosing Unit,squamous cell carcinoma of the thyroid gland,0
19590,Manufactured sign,Testicular cancer metastatic,0
19591,Used by,Stage III Cutaneous Melanoma AJCC v6,0
19592,Malignant neoplasm of salivary gland,Acantholytic squamous cell carcinoma,0
19593,Occurrence,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
19594,United States Food and Drug Administration,Astrocytoma of brain,0
19595,Aim (idea),Primary Cutaneous Plasmablastic Lymphoma,0
19596,Mass,Benign Anal Granular Cell Tumor,0
19597,Occurrence Indicator,Benign Anal Granular Cell Tumor,0
19598,Tumor cells,Childhood Central Nervous System Ganglioneuroblastoma,0
19599,Patient need for (contextual qualifier),Adenocarcinoma,0
19600,Three,Chronic Myelomonocytic Leukemia-2,0
19601,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19602,Usual Severity Vomiting,Diffuse malignant mesothelioma,0
19603,Blood Cells,Metaplastic carcinoma of breast,0
19604,Occurrence,Colorectal Neuroendocrine Tumor G2,0
19605,Spreading (qualifier value),Adenocarcinoma,0
19606,Blood Vessel,Multiple Skull Base Meningiomas,0
19607,Beginning,Intestinal Neuroendocrine Carcinoma,0
19608,Qualitative form,Adenocarcinoma of duodenum,0
19609,Thyroid Gland Tissue,Primary Cutaneous Plasmablastic Lymphoma,0
19610,Females,Malignant melanoma of eyelid,0
19611,Function (attribute),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19612,Filters,Recurrent Uveal Melanoma,0
19613,Science of Etiology,Ovarian germ cell choriocarcinoma stage IV,0
19614,Result,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19615,Persistent,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19616,Open,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19617,week,Extra-abdominal fibromatosis,0
19618,Circulatory System Process,Splenic Manifestation of Hairy Cell Leukemia,0
19619,Entity Determiner - specific,Benign neoplasm of thorax,0
19620,Malignant Head and Neck Neoplasm,Noninfiltrating Intraductal Carcinoma,0
19621,Surgical service,Nasal cavity carcinoma,0
19622,therapeutic aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19623,Risk,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19624,Categories,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19625,Including (qualifier),Vaginal Adenoma,0
19626,Pancreas,Tonsillar Carcinoma,0
19627,Abdominal mass,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19628,United States,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19629,Name (property) (qualifier value),Endometrial Small Cell Carcinoma,0
19630,Formation,Malignant neoplasm of subglottis,0
19631,Sounds device,Epithelioid Sarcoma NCI Grade 3,0
19632,Superkingdom (taxonomic category),Stage III Cutaneous Melanoma AJCC v6,0
19633,Main,Childhood Central Nervous System Ganglioneuroblastoma,0
19634,+5,Childhood Lung Non-Small Cell Carcinoma,0
19635,Tissue Specimen Code,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
19636,pemetrexed,FIGO Stage II Ovarian Cancer,0
19637,Possibly Related to Intervention,Childhood Extragonadal Malignant Germ Cell Tumor,0
19638,Malignant neoplasm of skin,Mixed astrocytoma-ependymoma,0
19639,Childhood Non-Hodgkin Lymphoma,Stage I Colon Neuroendocrine Tumor AJCC v8,0
19640,Metastatic Neoplasm,Kaposi's sarcoma of skin,0
19641,Formation,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19642,Occurrence Indicator,Stage IB Pancreatic Cancer AJCC v8,0
19643,Usual,Kaposi's sarcoma of skin,0
19644,Mathematical Factor,mucinous adenocarcinoma of gallbladder,0
19645,Two,Kaposi's sarcoma of skin,0
19646,Autosomal Recessive Disorder,Breast Ductal Adenoma,0
19647,Expression procedure,Neonatal leukemia,0
19648,65+,Unicystic ameloblastoma,0
19649,Neoplasm Metastasis,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19650,Biological Markers,Benign tumor of eyelid,0
19651,Urinary Diversion,Malignant neoplasm of olfactory nerve,0
19652,How Often Itching,Lung Mucinous Cystadenoma,0
19653,Term (lexical),Fibroadenoma of breast,0
19654,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Refractory Bladder Carcinoma,0
19655,Five-year Survival Rate,Locally Advanced Soft Tissue Sarcoma,0
19656,Patient Visit,Recurrent Rhabdomyosarcoma,0
19657,Flushing,Acute Undifferentiated Leukemia,0
19658,Sweating,ROSE Cluster 3,0
19659,Diagnosis,Stage III Adult Immunoblastic Lymphoma,0
19660,Non-Metastatic Childhood Soft Tissue Sarcoma,Stage IB Pancreatic Cancer AJCC v8,0
19661,History of present illness,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19662,Cancer Genus,Digestive System Hodgkin Lymphoma,0
19663,Disease,Adenocarcinoma of the prostate metastatic,0
19664,Color change,Type II Endometrial Adenocarcinoma,0
19665,chance,Carcinomatosis of peritoneal cavity,0
19666,Frequently,Breast Ductal Adenoma,0
19667,Natural History,Squamous cell carcinoma of lip,0
19668,pharmacotherapeutic,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19669,Surface of cervix,Engraftment syndrome,0
19670,Post,Vaginal Adenoid Cystic Carcinoma,0
19671,Root Mean Square,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19672,Japanese race,Cerebral Primitive Neuroectodermal Tumor,0
19673,Appearance,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19674,filter information process,Parathyroid Gland Adenocarcinoma,0
19675,Does move,Astrocytoma of brain,0
19676,Hodgkin Disease,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19677,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19678,Tryptophanase,adenoid cystic carcinoma of lung,0
19679,Synonym,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19680,Upper,Human Papillomavirus-Related Carcinoma,0
19681,majority,Adenocarcinoma of the prostate metastatic,0
19682,Juvenile,Pancreatic carcinoma,0
19683,Half,Mucinous adenocarcinoma gastric,0
19684,Have Weight Loss,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19685,Risk,Transitional cell carcinoma,0
19686,cell growth,Unresectable Rhabdomyosarcoma,0
19687,General surgery specialty,Cervical Fibroepithelial Polyp,0
19688,Lymphoma,Childhood Thyroid Gland Follicular Carcinoma,0
19689,Receive,FIGO Stage II Ovarian Cancer,0
19690,Regulatory Application,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19691,Occurrence,Melanomatosis,0
19692,Aplasia Cutis Congenita,Vaginal Adenoid Cystic Carcinoma,0
19693,Present,Squamous cell carcinoma of lip,0
19694,Therapeutic radiology procedure,Childhood Extragonadal Malignant Germ Cell Tumor,0
19695,High,Childhood Anaplastic Large Cell Lymphoma,0
19696,Return to (contextual qualifier) (qualifier value),Platinum-Resistant Lung Small Cell Carcinoma,0
19697,Shapes,Benign squamous cell tumor,0
19698,Following,Localized Askin Tumor,0
19699,Treatment Epoch,Carcinoma of urinary bladder,0
19700,Reflex action,Papillary squamous cell carcinoma,0
19701,Did not receive therapy or drug for,Mucinous adenocarcinoma,0
19702,Symptoms,Adult Alveolar Soft Part Sarcoma,0
19703,New,Stage III Cutaneous Melanoma AJCC v6,0
19704,SPINK5 gene,Malignant melanoma of eyelid,0
19705,Occurrence Indicator,Cervical Fibroepithelial Polyp,0
19706,Neurilemmoma,Extracranial Neuroblastoma,0
19707,Sunscreening Agents,Stage III Adult Immunoblastic Lymphoma,0
19708,Nevus,Malignant neoplasm of subglottis,0
19709,rapid diagnosis,Small cell neuroendocrine carcinoma of bladder,0
19710,+2,Carcinoma ex pleomorphic adenoma of parotid gland,0
19711,+2,Acantholytic squamous cell carcinoma,0
19712,Oral,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19713,More,Malignant neoplasm of subglottis,0
19714,Study Variable,Mucosal Melanoma,0
19715,biopsy characteristics,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19716,Lung,Metastatic Lung Small Cell Carcinoma,0
19717,Disease,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19718,What subject filter - Result,embryonal rhabdomyosarcoma of prostate,0
19719,Testis,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
19720,Common Specifications in HL7 V3 Publishing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19721,Significant,Nasal cavity carcinoma,0
19722,Supportive assistance,sarcoma of spinal cord,0
19723,Including (qualifier),Blepharal carcinoma,0
19724,Swallowing G-code,Lipoma of small intestine,0
19725,Circular,FIGO Stage II Ovarian Cancer,0
19726,Often - answer to question,Mastocytosis,0
19727,Aspects of congenital malformations,Localized Malignant Neoplasm,0
19728,Fall,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19729,Appearance,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19730,Compression,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
19731,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,Neoplasms,0
19732,cell type,Maxillary Sinus Adenoid Cystic Carcinoma,0
19733,Established,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19734,medication - HL7 publishing domain,Gallbladder adenoma,0
19735,Epithelial Cells,Pancreatic Intraepithelial Neoplasia-3,0
19736,Throat,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19737,stage,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19738,Varies,Intraepithelial Melanocytic Hyperplasia,0
19739,include - SetOperator,Primary Cutaneous Plasmablastic Lymphoma,0
19740,Decision,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19741,photoreactivating enzyme activity,Metastatic Kidney Carcinoma,0
19742,Death (finding),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19743,Negation,Adult Hepatocellular Carcinoma,0
19744,Sequence Data Type,Pancreatic carcinoma,0
19745,Body part,Precursor B-lymphoblastic lymphoma stage II,0
19746,Most,Vaginal Adenoma,0
19747,Type - attribute,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19748,Neoplasms,Liver Lymphangioma,0
19749,Singular,Carcinomatosis of peritoneal cavity,0
19750,Times,Cervical Squamous Intraepithelial Neoplasia,0
19751,Physical findings,Kaposi's sarcoma of extrahepatic bile duct,0
19752,Sample Mean,Recurrent Rhabdomyosarcoma,0
19753,<90,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
19754,Contrast,Papillary cystic tumor,0
19755,risk factors,Splenic Manifestation of Hairy Cell Leukemia,0
19756,Singular,Microcystic meningioma,0
19757,Show,Digestive System Hodgkin Lymphoma,0
19758,Lung,Engraftment syndrome,0
19759,shared attribute,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19760,International Classification of Disease for Oncology,Extracranial Neuroblastoma,0
19761,health and disease,papillary carcinoma of penis,0
19762,Metastatic Disease Clinical Trial Setting,Localized Malignant Neoplasm,0
19763,Filters,Thyroid Hurthle Cell Carcinoma,0
19764,NCI CTEP SDC Myeloma Sub-Category Terminology,Stage IB Pancreatic Cancer AJCC v8,0
19765,Subject Risk,Locally Advanced Carcinoma,0
19766,Category Type,Low Grade Squamous Intraepithelial Neoplasia,0
19767,Nuclear (incident type),Recurrent Uveal Melanoma,0
19768,Two,Thyroid Hurthle Cell Carcinoma,0
19769,Tissue Growth,Melanomatosis,0
19770,control substance,High Grade Glandular Intraepithelial Neoplasia,0
19771,<50,Ampulla of Vater Tubular Adenoma,0
19772,Stem of plant,Heavy Chain Deposition Disease,0
19773,Grade IV Childhood Astrocytic Neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19774,Aspects of signs,embryonal rhabdomyosarcoma of prostate,0
19775,Solid,Pancreatic carcinoma,0
19776,*Type - Kind of quantity,Refractory Ependymoma,0
19777,Fallopian Tubes,Anaplastic large cell lymphoma,0
19778,Carcinoma of lung,Spongiotic dermatitis,0
19779,Lung,Trichilemmocarcinoma,0
19780,Make - Instruction Imperative,Locally Advanced Squamous Cell Carcinoma,0
19781,Factor,Pancreatic carcinoma,0
19782,Characteristics,Cervical Fibroepithelial Polyp,0
19783,therapeutic aspects,Adult Hepatocellular Carcinoma,0
19784,How Often Sweats,embryonal rhabdomyosarcoma of prostate,0
19785,Encounter due to family history of leukemia,Granular Cell Leiomyosarcoma,0
19786,Observation in research,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19787,alone - group size,Splenic Manifestation of Hairy Cell Leukemia,0
19788,Removed,Congenital hamartoma,0
19789,kill - ActRelationshipJoin,Benign Anal Granular Cell Tumor,0
19790,Term Birth,papillary carcinoma of penis,0
19791,Pallor,Melanomatosis,0
19792,Body structure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19793,Human body,Carcinoma of urinary bladder,0
19794,Communicable Diseases,Hereditary Diffuse Gastric Adenocarcinoma,0
19795,Type A,Placental aromatase deficiency,0
19796,Obesity,benign mature teratoma of pancreas,0
19797,depend,Locally Advanced Soft Tissue Sarcoma,0
19798,Asia,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
19799,year,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
19800,Pelvic Pain,Carcinomatosis of peritoneal cavity,0
19801,Therapeutic procedure,BRCA2 Syndrome,0
19802,PROC wt Allele,Intraepithelial Melanocytic Hyperplasia,0
19803,Abdomen+,Kaposi's sarcoma of extrahepatic bile duct,0
19804,Often - answer to question,BRCA2 Syndrome,0
19805,100%,Human Papillomavirus-Related Carcinoma,0
19806,Surgery specialty,Refractory Barrett Esophagus,0
19807,Malignant neoplasm of soft tissue,Unresectable Rhabdomyosarcoma,0
19808,risk factors - observation list,Adult Hepatocellular Carcinoma,0
19809,year,Childhood Central Nervous System Ganglioneuroblastoma,0
19810,Rate,Stage IB Pancreatic Cancer AJCC v8,0
19811,vinyl chloride,Precursor B-lymphoblastic lymphoma stage II,0
19812,Togo,Epithelioid Sarcoma NCI Grade 3,0
19813,95,Endometrial Small Cell Carcinoma,0
19814,Pharmacotherapy,Malignant neoplasm of gallbladder,0
19815,Genes,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19816,Structure of venule,Recurrent Testicular Lymphoma,0
19817,pharmacotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19818,Common (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
19819,Cachexia,Adult Hepatocellular Carcinoma,0
19820,Before,Unicystic ameloblastoma,0
19821,Adult Lymphoma,Kaposi's sarcoma of extrahepatic bile duct,0
19822,negative regulation of biological process,Diffuse malignant mesothelioma,0
19823,0%,Papillary squamous cell carcinoma,0
19824,World Health Organization,Chronic Myelomonocytic Leukemia-2,0
19825,Age at diagnosis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19826,Brain,Endometrial Small Cell Carcinoma,0
19827,Behavior,Malignant Testicular Sertoli Cell Tumor,0
19828,Reported Term,Metastatic Malignant Neoplasm in the Sellar Region,0
19829,Target Lesion Identification,Heavy Chain Deposition Disease,0
19830,Death (finding),Vaginal Adenoma,0
19831,Glandular Pattern,Adult Alveolar Soft Part Sarcoma,0
19832,Fish (substance),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19833,Occur (action),Metastatic Carcinoma in the Lung,0
19834,Medical Device Emits Smoke,Hodgkin Disease,0
19835,Dry skin,Childhood Lung Non-Small Cell Carcinoma,0
19836,Scaly skin,Carcinoma of urinary bladder,0
19837,In Blood,Splenic Manifestation of Hairy Cell Leukemia,0
19838,Medications,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19839,Occur (action),Small Intestinal Villous Adenoma,0
19840,Pharmacotherapy,mucinous adenocarcinoma of gallbladder,0
19841,Time,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19842,combination - answer to question,Leiomyoma of Gallbladder,0
19843,Contiguous gene syndrome,Unfavorable Non-Hodgkin Lymphoma,0
19844,Diagnosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19845,Bodily secretions,Choroid Necrotic Melanoma,0
19846,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
19847,50%,Squamous cell carcinoma of lip,0
19848,Gene Mutation,Blepharal carcinoma,0
19849,Abnormally high,Testicular cancer metastatic,0
19850,Common Specifications in HL7 V3 Publishing,Localized Askin Tumor,0
19851,Microscopic,Cancer of Urinary Tract,0
19852,Classification,Benign neoplasm of thorax,0
19853,Surgical reduction,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19854,Stem cell transplant,Mucinous adenocarcinoma gastric,0
19855,Intravascular line,Mixed astrocytoma-ependymoma,0
19856,Hematopoietic stem cells,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19857,risk factors,Refractory Ependymoma,0
19858,Lymphatic duct,Female Breast Carcinoma,0
19859,Symptoms aspect,Localized Ewing Sarcoma,0
19860,Etiology,Childhood Fibrillary Astrocytoma,0
19861,Cartilage,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19862,Immune System Finding,Vaginal Adenoid Cystic Carcinoma,0
19863,MOSTLY,Metaplastic carcinoma of breast,0
19864,1960s,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19865,Manufactured form,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19866,Statistical Frequency,Angiosarcoma of liver,0
19867,Hypertensive disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19868,Biomaterial Treatment,Low Grade Squamous Intraepithelial Neoplasia,0
19869,Pharmacologic Substance,Microcystic meningioma,0
19870,Vision,Undifferentiated Endocervical Sarcoma,0
19871,Morphology,mucinous adenocarcinoma of gallbladder,0
19872,Cancer Genus,Melanomatosis,0
19873,Genetic Marker Expression,Mixed astrocytoma-ependymoma,0
19874,Adult Children,Malignant melanoma of eyelid,0
19875,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19876,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Pancreatic carcinoma,0
19877,Participation Type - origin,Grade 3a Malignant Neoplasm,0
19878,Americas Ethnicity,Adult Hepatocellular Carcinoma,0
19879,Offspring,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19880,Poor function,Recurrent Uveal Melanoma,0
19881,World Health Organization,Leiomyoma of Gallbladder,0
19882,One,FIGO Stage II Ovarian Cancer,0
19883,Persons,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19884,Risk,Lung squamous cell carcinoma stage I,0
19885,Interleukins,Mucinous neoplasm,0
19886,Colorectal Cancer,Xeroderma pigmentosum,0
19887,depend,Mucinous adenocarcinoma gastric,0
19888,Immunocompromised Host,Stage IB Pancreatic Cancer AJCC v8,0
19889,Hyperplastic Polyp,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19890,Additional,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19891,Specialized cell structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19892,Derived value,Mucinous adenocarcinoma gastric,0
19893,various other agents for local oral treatment in ATC,Recurrent Testicular Lymphoma,0
19894,Formation,Cervical Squamous Intraepithelial Neoplasia,0
19895,Ulcer,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19896,Time,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19897,CDISC SDTM Disease Outcome Terminology,Placental aromatase deficiency,0
19898,cancer-predisposing genes,Advanced Lung Carcinoma,0
19899,Scientific Publication,Localized Askin Tumor,0
19900,Pruritus,Small Intestinal Villous Adenoma,0
19901,Cause of death.underlying,Maxillary Sinus Adenocarcinoma,0
19902,Aspects of signs,Thymic Atypical Carcinoid Tumor,0
19903,Antibiotics,Stage IV Colorectal Cancer AJCC v8,0
19904,The Sun,Low Grade Squamous Intraepithelial Neoplasia,0
19905,Smoking,Acute lymphadenitis,0
19906,WHO Central Nervous System Grade II,Giant cell angiofibroma,0
19907,polyps,Diffuse malignant mesothelioma,0
19908,Occurrence,Stage IV Childhood Non-Hodgkin Lymphoma,0
19909,Hormone replacement therapy,Stage III Cutaneous Melanoma AJCC v6,0
19910,Group A (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
19911,Term (lexical),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19912,Body structure,Atypical Lobular Breast Hyperplasia,0
19913,Cystitis,Carcinomatosis of peritoneal cavity,0
19914,Ultraviolet Light Sterilization,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19915,chronic,Thyroid Hurthle Cell Carcinoma,0
19916,65+,FIGO Stage II Ovarian Cancer,0
19917,Immunotherapy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19918,photoreactivating enzyme activity,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19919,Surgery specialty,Squamous cell carcinoma of lip,0
19920,Referring,adenoid cystic carcinoma of lung,0
19921,Male population group,mucinous adenocarcinoma of gallbladder,0
19922,Treating,Pleomorphic adenoma of parotid gland,0
19923,More,Acute Undifferentiated Leukemia,0
19924,Slow,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19925,Html Link Type - index,Stage IB Pancreatic Cancer AJCC v8,0
19926,Often - answer to question,Vaginal Adenoma,0
19927,3+ Score,Kaposi's sarcoma of skin,0
19928,Type - attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19929,Blue - answer to question,Cerebral Primitive Neuroectodermal Tumor,0
19930,Neoplasms,Splenic Manifestation of Hairy Cell Leukemia,0
19931,Highest,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19932,Fever,Childhood Fibrillary Astrocytoma,0
19933,>5,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
19934,Feel Tired question,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19935,Togo,Xeroderma pigmentosum,0
19936,Metastatic Disease Clinical Trial Setting,Squamous cell carcinoma of lip,0
19937,The Sun,Acute Undifferentiated Leukemia,0
19938,Very Much,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19939,prior radiation therapy,BRCA2 Syndrome,0
19940,Methods aspects,Glomeruloid hemangioma,0
19941,Surgical aspects,Malignant Testicular Sertoli Cell Tumor,0
19942,Diagnosis Study,Precursor B-lymphoblastic lymphoma stage II,0
19943,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Locally Advanced Squamous Cell Carcinoma,0
19944,Neoplasms,Brain Tumor,0
19945,Diagnosis Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19946,Thin (qualifier value),Malignant melanoma of eyelid,0
19947,Term (lexical),Localized Askin Tumor,0
19948,>90,Intraepithelial Melanocytic Hyperplasia,0
19949,Call (Instruction),Localized Ewing Sarcoma,0
19950,Sequence Data Type,Bladder adenocarcinoma stage IV,0
19951,Spreading (qualifier value),Kaposi's sarcoma of skin,0
19952,Cessation of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19953,Known,Basal Cell Ameloblastoma,0
19954,lymph nodes,Thymic Clear Cell Carcinoma,0
19955,Tryptophanase,Acantholytic squamous cell carcinoma,0
19956,seen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19957,Malignant neoplasm of lung,malignant lymphoma of pancreatic lymph nodes,0
19958,Ability,Acantholytic squamous cell carcinoma,0
19959,Unification process,Benign Anal Granular Cell Tumor,0
19960,Cancer Registry,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19961,Response (communication),Benign Anal Granular Cell Tumor,0
19962,French Catheter Gauge,Advanced Uterine Corpus Carcinosarcoma,0
19963,Subtype (attribute),Primary Cutaneous Plasmablastic Lymphoma,0
19964,size,Non-Hodgkin Lymphoma During Pregnancy,0
19965,Excision,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19966,Fecal Impaction,Intestinal Metaplasia of Bladder Urothelium,0
19967,What subject filter - Result,Benign Anal Granular Cell Tumor,0
19968,Catch - Finding of sensory dimension of pain,Diffuse malignant mesothelioma,0
19969,Same,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19970,Breaking down,FIGO Stage IVA Ovarian Cancer,0
19971,Structure of parenchyma of lung,Hair nevus,0
19972,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Activated B-cell type diffuse large B-cell lymphoma,0
19973,Location,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19974,Negation,Female Breast Carcinoma,0
19975,Time (foundation metadata concept),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19976,Testis,Liver Cavernous Hemangioma,0
19977,Connective Tissue,Occult Lung Adenosquamous Carcinoma,0
19978,Medical service,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
19979,bony process,Locally Advanced Epithelioid Hemangioendothelioma,0
19980,Problems - What subject filter,Malignant melanoma of eyelid,0
19981,Skin,Stage 0 Penile Cancer AJCC v8,0
19982,Spreading (qualifier value),Undifferentiated Endocervical Sarcoma,0
19983,Mass of body region,Papillary squamous cell carcinoma,0
19984,Cell (compartment),Clonal Hematopoiesis of Indeterminate Potential,0
19985,Pharmacotherapy,Mucinous adenocarcinoma gastric,0
19986,Symptoms,papillary carcinoma of penis,0
19987,Tracheal aspiration,Granular Cell Leiomyosarcoma,0
19988,Coding,mucinous adenocarcinoma of gallbladder,0
19989,Cancer Genus,Malignant Testicular Sertoli Cell Tumor,0
19990,Mature,Engraftment syndrome,0
19991,lymph nodes,Secondary malignant neoplasm of lymph node,0
19992,Human body,Nasal cavity carcinoma,0
19993,Medullary carcinoma of thyroid,Melanomatosis,0
19994,Smear - instruction imperative,Malignant neoplasm of choroid,0
19995,Greater,Spermatocytic seminoma,0
19996,teratologic,Carcinoma of urinary bladder,0
19997,Nasal sinus,Metastatic Malignant Neoplasm in the Sellar Region,0
19998,shared attribute,FIGO Stage II Ovarian Cancer,0
19999,Randomization,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20000,Base - General Qualifier,Pancreatic carcinoma,0
20001,Wounds and Injuries,Vaginal Adenoma,0
20002,Cancer Genus,Primary Cutaneous Plasmablastic Lymphoma,0
20003,Left sided,Childhood Lymphoma,0
20004,Fever symptoms (finding),Human Papillomavirus-Related Carcinoma,0
20005,Term Birth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20006,Thin (qualifier value),Basal Cell Ameloblastoma,0
20007,Pleomorphic Xanthoastrocytoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20008,Cell Differentiation process,Engraftment syndrome,0
20009,Personal appearance,FIGO Stage IVA Ovarian Cancer,0
20010,risk factors,Digestive System Hodgkin Lymphoma,0
20011,Primary,Low Grade Squamous Intraepithelial Neoplasia,0
20012,Specific qualifier value,Hereditary Diffuse Gastric Adenocarcinoma,0
20013,Occurrence Indicator,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
20014,Abdomen,Adult Hepatocellular Carcinoma,0
20015,Noninvasive,Ovarian germ cell choriocarcinoma stage IV,0
20016,peripheral blood,BRCA2 Syndrome,0
20017,Manufactured form,Malignant neoplasm of thalamus,0
20018,Common (qualifier value),Stage III Adult Immunoblastic Lymphoma,0
20019,Growth,Benign squamous cell tumor,0
20020,Base - General Qualifier,Mucinous adenocarcinoma,0
20021,Lymphocyte,Refractory Bladder Carcinoma,0
20022,One,Human Papillomavirus-Related Carcinoma,0
20023,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
20024,Sequence of Planned Assessment Schedule,embryonal rhabdomyosarcoma of prostate,0
20025,Feature,Extracranial Neuroblastoma,0
20026,Squamous cell carcinoma,Giant cell angiofibroma,0
20027,In Blood,Melanomatosis,0
20028,Surgical aspects,Hyperplasia of pituitary gland,0
20029,Central nervous system tract structure,Recurrent Testicular Lymphoma,0
20030,Term Birth,Hodgkin Disease,0
20031,Mutation,Liver Lymphangioma,0
20032,Anatomic Site,Mucinous adenocarcinoma gastric,0
20033,+2,Epithelioid Sarcoma NCI Grade 3,0
20034,Germ cell tumor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20035,Orbital region,Hyperplasia of pituitary gland,0
20036,blood neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20037,Coding,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20038,Tumor Mass,Splenic Manifestation of Hairy Cell Leukemia,0
20039,Common (qualifier value),Benign neoplasm of eye,0
20040,Skin,Breast Ductal Adenoma,0
20041,Numerous,Cancer of Urinary Tract,0
20042,Type - attribute,Deep Leiomyoma,0
20043,physiological aspects,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20044,Alternating,Recurrent Uveal Melanoma,0
20045,leukemia,Multiple Endocrine Neoplasia,0
20046,Name Given at Birth,Heavy Chain Deposition Disease,0
20047,Common (qualifier value),Carcinoma of urinary bladder,0
20048,Pharyngitis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20049,Options,High Grade Glandular Intraepithelial Neoplasia,0
20050,Cancer Registry,Intraepithelial Melanocytic Hyperplasia,0
20051,Cause of death:Find:Pt:^Patient:Nom,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20052,Hereditary Diseases,Bladder adenocarcinoma stage IV,0
20053,Vaginal Neoplasms,Atypical Mesothelial Hyperplasia,0
20054,Acute Undifferentiated Leukemia,Bladder squamous cell carcinoma stage I,0
20055,Cell Proliferation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20056,Set scale,Adult Hepatocellular Carcinoma,0
20057,Osteophyte,Stage III Adult Immunoblastic Lymphoma,0
20058,Diagnosis Study,papillary carcinoma of penis,0
20059,Mucins,Papillary squamous cell carcinoma,0
20060,Percent of Bacteria,Giant cell angiofibroma,0
20061,Limited stage (cancer stage),Grade 3a Malignant Neoplasm,0
20062,Cataract,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20063,How Often Vomiting,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20064,Basis - conceptual entity,Acantholytic squamous cell carcinoma,0
20065,Mucosa-Associated Lymphoid Tissue Lymphoma,Stage 0 Penile Cancer AJCC v8,0
20066,solid substance,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20067,Dermoid Cyst,Mixed astrocytoma-ependymoma,0
20068,Tumor Progression,Malignant Neoplasm of Lung - Multiple Primary Sites,0
20069,99,Squamous cell carcinoma of lip,0
20070,South Korea,Cystadenocarcinoma,0
20071,low exposure,Refractory Ependymoma,0
20072,Sore Throat,Tongue Alveolar Soft Part Sarcoma,0
20073,Fluid behavior,Malignant neoplasm of subglottis,0
20074,Reduction (chemical),squamous cell carcinoma of the thyroid gland,0
20075,Manual pelvic examination (procedure),Bladder squamous cell carcinoma stage I,0
20076,2+ Score,Childhood Fibrillary Astrocytoma,0
20077,Fever,Stage III Adult Immunoblastic Lymphoma,0
20078,Alveolar Soft Part Sarcoma,Squamous cell carcinoma of lip,0
20079,Device Cord,Melanomatosis,0
20080,Dangerousness,Adenocarcinoma,0
20081,potential,Peripheral primitive neuroectodermal tumor of soft tissue,0
20082,aggressive cancer,Metaplastic carcinoma of breast,0
20083,Infiltration,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20084,Country,Squamous cell carcinoma of lip,0
20085,Used by,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20086,Common (qualifier value),Gallbladder Adenocarcinoma,0
20087,Age at diagnosis:Time:Pt:^Patient:Qn,Metastatic Carcinoma in the Lung,0
20088,Logical Condition,Primary Cutaneous Plasmablastic Lymphoma,0
20089,classic behavior,Kaposi's sarcoma of skin,0
20090,Granulocyte count,Pilocytic astrocytoma of cerebellum,0
20091,Qualitative form,Localized Malignant Neoplasm,0
20092,1+,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20093,Symptoms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20094,treatment - ActInformationManagementReason,Brain Tumor,0
20095,Rare,Basal Cell Ameloblastoma,0
20096,Tobacco smoking behavior,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20097,Fluid Balance,Maxillary Sinus Adenoid Cystic Carcinoma,0
20098,Eccrine Glands,ROSE Cluster 3,0
20099,Categories,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20100,Histopathologic Grade differentiation,Stage IV Colorectal Cancer AJCC v8,0
20101,Bound (value),Peripheral primitive neuroectodermal tumor of soft tissue,0
20102,Americas Ethnicity,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
20103,Classification,ROSE Cluster 3,0
20104,Often - answer to question,Brain Ependymoma,0
20105,Diagnosis,Malignant neoplasm of choroid,0
20106,Meningioma,Primary Cutaneous Plasmablastic Lymphoma,0
20107,failed,Neonatal leukemia,0
20108,United States Military Commissioned Officer O4,Chondrosarcoma,0
20109,Adult human body,Unresectable Rhabdomyosarcoma,0
20110,dendritic spine neck,Breast Apocrine Adenoma,0
20111,Usually,Peripheral primitive neuroectodermal tumor of soft tissue,0
20112,Woman,papillary carcinoma of penis,0
20113,Smudge cell,Basal Cell Ameloblastoma,0
20114,Generation (action),adenosquamous carcinoma of breast,0
20115,Biological Response Modifiers,Melanomatosis,0
20116,Flat shape,Airway Hemangioma,0
20117,Blood Vessel,Extra-Adrenal Paraganglioma,0
20118,How Much Distress Weight Loss,Chronic Myelomonocytic Leukemia-2,0
20119,Immune System Finding,Refractory Bladder Carcinoma,0
20120,Digestive Enzymes,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20121,shared attribute,Stage I Adult Non-Hodgkin Lymphoma,0
20122,Low Level,Acute lymphadenitis,0
20123,Feelings,Medulloblastoma,0
20124,Singular,Angiosarcoma of liver,0
20125,Common Specifications in HL7 V3 Publishing,Benign Anal Granular Cell Tumor,0
20126,Often - answer to question,Diffuse malignant mesothelioma,0
20127,Sometimes,Kaposi's sarcoma of extrahepatic bile duct,0
20128,Frequently,Engraftment syndrome,0
20129,Does stand alone,Clonal Hematopoiesis of Indeterminate Potential,0
20130,Drainage procedure,Stage II Carcinoma of Penis,0
20131,Most,Benign Apocrine Neoplasm,0
20132,treatment - ActInformationManagementReason,Central Nervous System Anaplastic Large Cell Lymphoma,0
20133,Possible diagnosis,Ovarian Carcinoid Tumor,0
20134,Togo,Refractory Bladder Carcinoma,0
20135,Bone Marrow Examination,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
20136,shared attribute,Adult Alveolar Soft Part Sarcoma,0
20137,How Often Diarrhea,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20138,Neuron spine,Squamous cell carcinoma of lip,0
20139,Specific qualifier value,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20140,Worse,Engraftment syndrome,0
20141,SLC6A2 protein,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20142,seen,Malignant melanoma of eyelid,0
20143,90%,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20144,Sustain,Non-Hodgkin Lymphoma During Pregnancy,0
20145,Certainties,Acantholytic squamous cell carcinoma,0
20146,Benign neoplasm of sweat gland,clear cell adenocarcinoma of gallbladder,0
20147,90%,Squamous cell carcinoma of lip,0
20148,Population Mean,BRCA2 Syndrome,0
20149,Occur (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20150,THM gene,Recurrent Uveal Melanoma,0
20151,Very high,High Grade Glandular Intraepithelial Neoplasia,0
20152,Square Mile,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20153,Medical Device Emits Smoke,Fourth Ventricle and Brain Stem Ependymal Tumor,0
20154,Cold Temperature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20155,Polypeptide Hormones,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20156,Manufactured sign,Bladder squamous cell carcinoma stage I,0
20157,Tumor type,Basal Cell Ameloblastoma,0
20158,Phimosis,Pancreatic carcinoma,0
20159,Urine,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
20160,Surveys,Liver Lymphangioma,0
20161,1960s,Refractory Bladder Carcinoma,0
20162,Cancer Genus,Colorectal High Grade B-Cell Lymphoma,0
20163,radiotherapeutic,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20164,Rare Diseases,Primary Cutaneous Plasmablastic Lymphoma,0
20165,Adult Rhabdomyosarcoma,Mucinous adenocarcinoma gastric,0
20166,Status post,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20167,Main,Acinar cell carcinoma of pancreas,0
20168,metastatic qualifier,Malignant neoplasm of olfactory nerve,0
20169,Physical shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20170,Cells,Colorectal Neuroendocrine Tumor G2,0
20171,To,Spongiotic dermatitis,0
20172,Two,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20173,Triggered by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
20174,3+ Score,papillary carcinoma of penis,0
20175,Alveolus,Cartilaginous exostosis,0
20176,Sore sensation,Acute Undifferentiated Leukemia,0
20177,Ovarian Carcinoma,Recurrent Uveal Melanoma,0
20178,Adult Diffuse Large B-Cell Lymphoma,Xeroderma pigmentosum,0
20179,Solid,Childhood Choriocarcinoma,0
20180,Secondary to,Hodgkin lymphoma,0
20181,Occurrence Indicator,Adult Hepatocellular Carcinoma,0
20182,0%,Fourth Ventricle and Brain Stem Ependymal Tumor,0
20183,diagnosis aspect,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20184,Mast Cell Count,Malignant Neoplasm of Lung - Multiple Primary Sites,0
20185,Cancer Registry,Clonal Hematopoiesis of Indeterminate Potential,0
20186,potential,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
20187,Distal (qualifier value),Cartilaginous exostosis,0
20188,Rare,Familial Adenomatous Polyposis Associated Medulloblastoma,0
20189,Glioblastoma Multiforme,Liver Lymphangioma,0
20190,Most,Childhood Anaplastic Large Cell Lymphoma,0
20191,Indication of (contextual qualifier),Acute Undifferentiated Leukemia,0
20192,Genes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20193,Pacemaker Procedure,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20194,Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20195,Make - Instruction Imperative,clear cell adenocarcinoma of gallbladder,0
20196,Gonadal Dysgenesis,Hereditary Diffuse Gastric Adenocarcinoma,0
20197,Body structure,Pancreatic carcinoma,0
20198,utilization qualifier,Malignant neoplasm of gallbladder,0
20199,Hepatitis C virus,Testicular cancer metastatic,0
20200,Active License,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20201,Type - attribute,Plexosarcoma,0
20202,Term Birth,Acantholytic squamous cell carcinoma,0
20203,Progress,Undifferentiated Endocervical Sarcoma,0
20204,Morbidity - disease rate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20205,Adult,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
20206,Fourth (suffix),malignant lymphoma of pancreatic lymph nodes,0
20207,Dorsal,Localized Malignant Neoplasm,0
20208,Circulating Neoplastic Cells,Small Intestinal Villous Adenoma,0
20209,Obesity,Malignant neoplasm of thalamus,0
20210,pharmacotherapeutic,Refractory Bladder Carcinoma,0
20211,Retinoic Acid Response Element,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20212,Old,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20213,Case (situation),Airway Hemangioma,0
20214,Imaging Techniques,Cervical Adenomyoma,0
20215,Did not receive therapy or drug for,Vaginal Adenoid Cystic Carcinoma,0
20216,incidence of cases,Unfavorable Non-Hodgkin Lymphoma,0
20217,Primary operation,Multiple Endocrine Neoplasia,0
20218,General surgery specialty,Squamous cell carcinoma of lip,0
20219,Long,Female Breast Carcinoma,0
20220,300,Acantholytic squamous cell carcinoma,0
20221,Shortness of breath:-:Point in time:^Patient:-,FIGO Stage II Ovarian Cancer,0
20222,development aspects,Mucinous adenocarcinoma gastric,0
20223,Medical Device Material Separation,Adult Alveolar Soft Part Sarcoma,0
20224,Last,Choroid Epithelioid Cell Melanoma,0
20225,Most,Metaplastic carcinoma of breast,0
20226,Back Pain,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20227,Scientific Publication,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20228,Symptoms,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20229,Chemotherapy Regimen,Giant cell angiofibroma,0
20230,Characteristics,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20231,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Pancreatic Endocrine Carcinoma,0
20232,Glycation End Products,Pancreatic carcinoma,0
20233,Pediatric,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20234,Appearance of breast,FIGO Stage IVA Ovarian Cancer,0
20235,Trial Screening,Airway Hemangioma,0
20236,Site of,Carcinoma of urinary bladder,0
20237,ovarian neoplasm,Type II Endometrial Adenocarcinoma,0
20238,Destruction (action),clear cell adenocarcinoma of gallbladder,0
20239,Manufactured form,Benign Anal Granular Cell Tumor,0
20240,Adult,Cartilaginous exostosis,0
20241,aggressive cancer,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
20242,Discover,Liver Lymphangioma,0
20243,Uterine Corpus Sarcoma,Squamous cell carcinoma of lip,0
20244,Yellow complexion,Cerebral Primitive Neuroectodermal Tumor,0
20245,System,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20246,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Choroid Necrotic Melanoma,0
20247,Usual,Childhood Central Nervous System Immature Teratoma,0
20248,Induce (action),Acute Undifferentiated Leukemia,0
20249,Cancer/Testis Antigen,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
20250,Histocompatibility Testing,Lipoma of small intestine,0
20251,Moist,Low Grade Squamous Intraepithelial Neoplasia,0
20252,Definitely Related to Intervention,Benign Anal Granular Cell Tumor,0
20253,Tobacco,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20254,Skin Specimen,Primary Cutaneous Plasmablastic Lymphoma,0
20255,Patient need for (contextual qualifier),Refractory Ependymoma,0
20256,Entity Determiner - specific,Stage III Adult Immunoblastic Lymphoma,0
20257,Manufactured form,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20258,Used by,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20259,radiotherapeutic,Childhood Fibrillary Astrocytoma,0
20260,Usual,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
20261,Case (situation),Diffuse malignant mesothelioma,0
20262,Symptoms,Localized Askin Tumor,0
20263,Five-year Survival Rate,Metastatic Lung Neuroendocrine Neoplasm,0
20264,Bothered by Night Sweats,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20265,Have Shortness of Breath question,Benign Anal Granular Cell Tumor,0
20266,Certainties,Extra-Adrenal Paraganglioma,0
20267,Male Gender,Digestive System Hodgkin Lymphoma,0
20268,Including (qualifier),Cartilaginous exostosis,0
20269,Sarcoma - category (morphologic abnormality),Botryoid-Type Embryonal Rhabdomyosarcoma,0
20270,Cells,Trichilemmocarcinoma,0
20271,Known,Heavy Chain Deposition Disease,0
20272,Hemopoietic tissue,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
20273,peripheral blood,Nasal cavity carcinoma,0
20274,Symptoms aspect,Metastatic Kidney Carcinoma,0
20275,year,Tongue Alveolar Soft Part Sarcoma,0
20276,Personal appearance,Acute lymphadenitis,0
20277,Malignant Neoplasms,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20278,IPSS Risk Category Low,Neoplasms,0
20279,Include (action),embryonal rhabdomyosarcoma of prostate,0
20280,Treated with,Papillary squamous cell carcinoma,0
20281,Melanoma Pathway,Stage III Cutaneous Melanoma AJCC v6,0
20282,Smaller,Stage IB Pancreatic Cancer AJCC v8,0
20283,Early stage,Metastatic Ductal Breast Carcinoma,0
20284,Volume,Metaplastic carcinoma of breast,0
20285,Case unit dose,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
20286,Approximate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20287,Pallor of skin,Adult Alveolar Soft Part Sarcoma,0
20288,What subject filter - Result,Kaposi's sarcoma of extrahepatic bile duct,0
20289,size,Thymic Clear Cell Carcinoma,0
20290,To,Spongiotic dermatitis,0
20291,Absent,Maxillary Sinus Adenocarcinoma,0
20292,Diagnosis Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20293,Retraction (finding),Carcinoma of urinary bladder,0
20294,Old,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20295,Have Itch,Human Papillomavirus-Related Carcinoma,0
20296,Visual Analog Pain Scale,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20297,Hepatobiliary System,Cervical Fibroepithelial Polyp,0
20298,Shapes,Ichthyosis,0
20299,Average of Value Derivation Technique,Collecting Duct Carcinoma of the Kidney,0
20300,Fatal,Mixed astrocytoma-ependymoma,0
20301,Aim,Thyroid Hurthle Cell Carcinoma,0
20302,Negation,FIGO Stage IVA Ovarian Cancer,0
20303,MOSTLY,Extra-Adrenal Paraganglioma,0
20304,Then,Chondrosarcoma,0
20305,Ovarian Carcinoma,Ichthyoses,0
20306,Tissue damage,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20307,Uterine Fibroids,Endometrial Small Cell Carcinoma,0
20308,Critical,Cartilaginous exostosis,0
20309,Neoplasms,Acute Undifferentiated Leukemia,0
20310,More,Familial Hemophagocytic Lymphocytosis,0
20311,Food,Anterior Urethral Malignant Neoplasm,0
20312,Similarity,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20313,Cervical lymph node group,FIGO Stage IVA Ovarian Cancer,0
20314,Grouped (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20315,Does turn (finding),Localized Askin Tumor,0
20316,Uncontrolled,Adult Acute Eosinophilic Leukemia,0
20317,To,Giant cell angiofibroma,0
20318,Weight decreased,Trabecular adenocarcinoma,0
20319,year,Cartilaginous exostosis,0
20320,Lasers,Thyroid Hurthle Cell Carcinoma,0
20321,Cell Count,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20322,Feel Tired question,Cancer of Urinary Tract,0
20323,Tumor cells,Kaposi's sarcoma of skin,0
20324,Ivory Coast,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20325,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20326,Known,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20327,Tumor Mass,Intraepithelial Melanocytic Hyperplasia,0
20328,Immature cells,Squamous cell carcinoma of lip,0
20329,parent,Locally Advanced Soft Tissue Sarcoma,0
20330,Most,Female Breast Carcinoma,0
20331,Reduced,Benign neoplasm of thorax,0
20332,Mixed Cell Morphology,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20333,Dysuria,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20334,abnormal growth by tissue,Undifferentiated Endocervical Sarcoma,0
20335,Ependymoma,Uterine Cancer,0
20336,Tissue Specimen Code,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20337,Numerous,Recurrent Testicular Lymphoma,0
20338,CEL gene,Kaposi's sarcoma of extrahepatic bile duct,0
20339,Include (action),Methotrexate-Associated Hodgkin Lymphoma,0
20340,Study Site,Mucinous neoplasm,0
20341,Three,Localized Ewing Sarcoma,0
20342,Pleural effusion fluid,Xeroderma pigmentosum,0
20343,Limb structure,Mucinous adenocarcinoma gastric,0
20344,Including (qualifier),embryonal rhabdomyosarcoma of prostate,0
20345,Generation (action),Primary Cutaneous Plasmablastic Lymphoma,0
20346,Adenocarcinoma,Benign neoplasm of eye,0
20347,English Language,Splenic Manifestation of Hairy Cell Leukemia,0
20348,Malignant Neoplasms,Thyroid carcinoma,0
20349,Rare,Pancreatic Intraepithelial Neoplasia-3,0
20350,include - SetOperator,Maxillary Sinus Adenocarcinoma,0
20351,Special,Vaginal Adenoid Cystic Carcinoma,0
20352,Phimosis,Recurrent Testicular Lymphoma,0
20353,Complication,Hodgkin Disease,0
20354,Disruption,embryonal rhabdomyosarcoma of prostate,0
20355,Blood Circulation,Breast Ductal Adenoma,0
20356,Presentation,Precursor B-lymphoblastic lymphoma stage II,0
20357,See,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20358,Growth action,Locally Advanced Soft Tissue Sarcoma,0
20359,melanoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20360,Evaluation,Gallbladder Adenocarcinoma,0
20361,Social Role,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20362,b cell differentiation,FIGO Stage II Ovarian Cancer,0
20363,Cancer Registry,Benign neoplasm of thorax,0
20364,Primary malignant neoplasm,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20365,Beginning,Localized Askin Tumor,0
20366,Togo,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
20367,Spreading (qualifier value),Cancer of Urinary Tract,0
20368,Needs,Bladder Neuroendocrine Neoplasm,0
20369,Forecast of outcome,Digestive System Hodgkin Lymphoma,0
20370,Did not receive therapy or drug for,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20371,Area,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20372,Infant,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20373,Involvement with,adenosquamous carcinoma of breast,0
20374,Lower (action),Astrocytoma of brain,0
20375,Involvement with,Precursor B-lymphoblastic lymphoma stage II,0
20376,One,mucinous adenocarcinoma of gallbladder,0
20377,Multiple Myeloma,Childhood Fibrillary Astrocytoma,0
20378,Lymphocyte component of blood,non-Hodgkin's lymphoma of spleen,0
20379,Peas - dietary,Refractory Barrett Esophagus,0
20380,ETV5 wt Allele,Uterine Cancer,0
20381,Specimen Source Codes - tumor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20382,Known,Human Papillomavirus-Related Carcinoma,0
20383,Stem cells,Small Intestinal Villous Adenoma,0
20384,Abdomen,Stage IB Lung Cancer AJCC v7,0
20385,Including (qualifier),Periosteal Osteosarcoma,0
20386,Entity,Bladder squamous cell carcinoma stage I,0
20387,Both ovaries,Chronic Myelomonocytic Leukemia-2,0
20388,protein complex location,Gallbladder Adenocarcinoma,0
20389,Biomaterial Treatment,Bladder Neuroendocrine Neoplasm,0
20390,Skeletal bone,Stage IV Colorectal Cancer AJCC v8,0
20391,Most,Pancreatic Intraepithelial Neoplasia-3,0
20392,Cancer Genus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20393,chronic,Prostate Lymphoma,0
20394,2+ Score,Acute lymphadenitis,0
20395,Time,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20396,Epithelioma,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20397,PSA Level Less than Five,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20398,Dorsal,Unfavorable Non-Hodgkin Lymphoma,0
20399,Menopause,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20400,Brain,Carcinomatosis of peritoneal cavity,0
20401,Smear - instruction imperative,Acantholytic squamous cell carcinoma,0
20402,Means,Secondary malignant neoplasm of lymph node,0
20403,include - SetOperator,Undifferentiated Endocervical Sarcoma,0
20404,Formation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20405,Disease,Granular Cell Leiomyosarcoma,0
20406,Exocrine Glands,Splenic Manifestation of Hairy Cell Leukemia,0
20407,Metastatic to,Anaplastic large cell lymphoma,0
20408,Endometrial Carcinoma,Extra-Adrenal Paraganglioma,0
20409,Calcarea sulphurica,Basal Cell Ameloblastoma,0
20410,Southern Europe,Lipoma of small intestine,0
20411,Negation,Larynx carcinoma recurrent,0
20412,Monitoring Device,Non-Metastatic Gestational Trophoblastic Tumor,0
20413,Often - answer to question,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20414,potential,Acute lymphadenitis,0
20415,Usually,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20416,Metaplastic carcinoma,Mixed astrocytoma-ependymoma,0
20417,Malignant neoplasm of lung,Acantholytic squamous cell carcinoma,0
20418,Aggressive behavior,Hyperplasia of pituitary gland,0
20419,Rating (action),Cervical Squamous Intraepithelial Neoplasia,0
20420,Symptoms,Anterior Urethral Malignant Neoplasm,0
20421,Very,Malignant neoplasm of subglottis,0
20422,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20423,Cardiovascular system,Type II Endometrial Adenocarcinoma,0
20424,Medical Device Emits Smoke,Chest Wall Fibromatosis,0
20425,Percent (qualifier value),Adult Anaplastic Oligodendroglioma,0
20426,Give - dosing instruction imperative,carcinoma of middle ear,0
20427,Face (spatial concept),Cancer of Urinary Tract,0
20428,risk factors,Small cell neuroendocrine carcinoma of bladder,0
20429,lymph nodes,Splenic Manifestation of Hairy Cell Leukemia,0
20430,Body structure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20431,Exposure to,Cervical Fibroepithelial Polyp,0
20432,Expiration,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
20433,Common Specifications in HL7 V3 Publishing,Gallbladder Adenocarcinoma,0
20434,Characterization,Engraftment syndrome,0
20435,Caucasoid Race,Localized Askin Tumor,0
20436,Operative Surgical Procedures,Benign neoplasm of thorax,0
20437,Weight decreased,Recurrent Uveal Melanoma,0
20438,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20439,Stomach Carcinoma,Microcystic meningioma,0
20440,Hematologic Tests,Malignant melanoma of eyelid,0
20441,Benign neoplasm of brain,Extracranial Neuroblastoma,0
20442,family of origin,Ovarian germ cell choriocarcinoma stage IV,0
20443,Symptoms,Testicular cancer metastatic,0
20444,Include (action),Werner Syndrome,0
20445,white blood cell type,Lipoma of small intestine,0
20446,Less Than,Blood Vessel Tumors,0
20447,Hormones,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20448,Weight Loss,Human Papillomavirus-Related Carcinoma,0
20449,High Level,Uterine Cancer,0
20450,Screening Study,FIGO Stage II Ovarian Cancer,0
20451,Categories,Splenic Manifestation of Hairy Cell Leukemia,0
20452,Percent (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
20453,United States Military Commissioned Officer O4,Liver Lymphangioma,0
20454,diagnosis aspect,Splenic Manifestation of Hairy Cell Leukemia,0
20455,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20456,N not otherwise specified Antibody,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20457,Tumor Mass,Chronic Myelomonocytic Leukemia-2,0
20458,Location of Oral Residue Following Swallowing,Mucinous adenocarcinoma,0
20459,Smear - instruction imperative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20460,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
20461,66,Kaposi's sarcoma of skin,0
20462,risk factors - observation list,Malignant neoplasm of subglottis,0
20463,Southern Europe,Extra-Adrenal Paraganglioma,0
20464,Stat (do immediately),Malignant neoplasm of gallbladder,0
20465,Males,Melanomatosis,0
20466,Tobacco smoking behavior,Cerebral Primitive Neuroectodermal Tumor,0
20467,bony process,Intraepithelial Melanocytic Hyperplasia,0
20468,Congenital Abnormality,Stage I Colon Neuroendocrine Tumor AJCC v8,0
20469,General surgery specialty,High Grade Glandular Intraepithelial Neoplasia,0
20470,Singular,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
20471,Identifier,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20472,Phase,Necrotizing Funisitis,0
20473,Unknown,Extra-Adrenal Paraganglioma,0
20474,Sunlight,Intestinal Metaplasia of Bladder Urothelium,0
20475,Chemotherapy,Basal Cell Ameloblastoma,0
20476,Pathogenesis,Malignant neoplasm of olfactory nerve,0
20477,Mutation Abnormality,Carcinoma,0
20478,Body tissue,Spongiotic dermatitis,0
20479,Glioblastoma,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20480,Neoplastic disease,Intraepithelial Melanocytic Hyperplasia,0
20481,Characteristics,Lung Mucinous Cystadenoma,0
20482,Dermis,Plexosarcoma,0
20483,Column (anatomic),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
20484,>90,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20485,Anorexia,Type II Endometrial Adenocarcinoma,0
20486,Human body structure,Benign Anal Granular Cell Tumor,0
20487,Collecting system,Xeroderma pigmentosum,0
20488,Common Specifications in HL7 V3 Publishing,Malignant melanoma of eyelid,0
20489,Blood Cells,Non-Metastatic Gestational Trophoblastic Tumor,0
20490,Primitive,Benign Anal Granular Cell Tumor,0
20491,FAT1 wt Allele,Locally Advanced Soft Tissue Sarcoma,0
20492,Before,Mucinous adenocarcinoma gastric,0
20493,Common (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
20494,Frequently,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20495,risk factors,Adult Hepatocellular Carcinoma,0
20496,Metaplasia,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20497,Experimental Result,Mixed astrocytoma-ependymoma,0
20498,Arteries,clear cell adenocarcinoma of gallbladder,0
20499,How Much Distress Weight Loss,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20500,Africa South of the Sahara,Blepharal carcinoma,0
20501,Pancreatic Cancer Pathway,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20502,Case unit dose,Gallbladder Adenocarcinoma,0
20503,Childhood Atypical Teratoid/Rhabdoid Tumor,Ichthyosis,0
20504,Nervous system structure,BRCA2 Syndrome,0
20505,Structure of thyroid follicle,Peripheral primitive neuroectodermal tumor of soft tissue,0
20506,Connective Tissue,Airway Hemangioma,0
20507,Neoplasms,Acantholytic squamous cell carcinoma,0
20508,Diabetes,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20509,Renal carcinoma,Familial Adenomatous Polyposis Associated Medulloblastoma,0
20510,Form:Finding:Point in time:{Setting}:Document:{Role},Benign Ovarian Thecoma,0
20511,Responsible to,Bladder squamous cell carcinoma stage I,0
20512,Drainage procedure,Malignant Testicular Sertoli Cell Tumor,0
20513,Symptoms,Carcinoma of submandibular gland,0
20514,Grade two rank,Stage II Hepatocellular Carcinoma AJCC v8,0
20515,NCI CTEP SDC Melanoma Sub-Category Terminology,Mucinous adenocarcinoma gastric,0
20516,Secondary hypercalcemia,Precursor B-lymphoblastic lymphoma stage II,0
20517,Fibroadenoma,Cancer of Urinary Tract,0
20518,Mechanism (attribute),Thymic Clear Cell Carcinoma,0
20519,Unknown GENC,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20520,Primary,Atypical Lobular Breast Hyperplasia,0
20521,Over (spatial),Serous cystadenocarcinoma ovary,0
20522,Critical,Chronic Myelomonocytic Leukemia-2,0
20523,Complete Trisomy 21 Syndrome,Bladder squamous cell carcinoma stage I,0
20524,Mixed Neoplasm,Locally Advanced Epithelioid Hemangioendothelioma,0
20525,Difficult (qualifier value),Astrocytoma of brain,0
20526,Main,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20527,Therapeutic procedure,Diffuse malignant mesothelioma,0
20528,Symptoms aspect,non-Hodgkin's lymphoma of spleen,0
20529,Symptoms,FIGO Stage IVA Ovarian Cancer,0
20530,Use of,Stage IV Penile Cancer AJCC v7,0
20531,Blast (physical force),Botryoid-Type Embryonal Rhabdomyosarcoma,0
20532,various other nasal preparations in ATC,Low Grade Squamous Intraepithelial Neoplasia,0
20533,Tissue Specimen Code,Leptomeningeal sarcoma,0
20534,Very,Fibroadenoma of breast,0
20535,General surgery specialty,Refractory Ependymoma,0
20536,Science of Etiology,Bladder squamous cell carcinoma stage I,0
20537,Medical pathologist,Locally Advanced Carcinoma,0
20538,granulocyte,Advanced Lung Carcinoma,0
20539,Term (lexical),Diffuse malignant mesothelioma,0
20540,Including (qualifier),Childhood Central Nervous System Ganglioneuroblastoma,0
20541,Male population group,Chest Wall Fibromatosis,0
20542,Devices,Testicular cancer metastatic,0
20543,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
20544,Functional,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20545,Kissing,Low Grade Squamous Intraepithelial Neoplasia,0
20546,Immune System Processes,Stage III Cutaneous Melanoma AJCC v6,0
20547,Stable status,Low Grade Squamous Intraepithelial Neoplasia,0
20548,Occurrence,Refractory Ependymoma,0
20549,Common Specifications in HL7 V3 Publishing,Atypical Mesothelial Hyperplasia,0
20550,Group A (qualifier value),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
20551,Pharmacologic Substance,Stage IV Colorectal Cancer AJCC v8,0
20552,Sufficiently defined concept definition status (core metadata concept),Advanced Lung Carcinoma,0
20553,Rapid,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20554,Type - attribute,Benign squamous cell tumor,0
20555,Pain,Stage III Cutaneous Melanoma AJCC v6,0
20556,Sometimes,Medulloblastoma,0
20557,Tumor Mass,Recurrent Testicular Lymphoma,0
20558,Body tissue,Breast Ductal Adenoma,0
20559,How Often Shortness of Breath,Metastatic Lung Small Cell Carcinoma,0
20560,Set (Psychology),Prostate Lymphoma,0
20561,Fever symptoms (finding),Blood Vessel Tumors,0
20562,<3 (qualifier value),Breast Ductal Adenoma,0
20563,Growth abnormality,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20564,Unconscious State,Primary Cutaneous Plasmablastic Lymphoma,0
20565,Area,Refractory Barrett Esophagus,0
20566,Trauma,Bladder adenocarcinoma stage IV,0
20567,Normal,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20568,Case (situation),Bladder squamous cell carcinoma stage I,0
20569,Benign,FIGO Stage II Ovarian Cancer,0
20570,Term (lexical),Acantholytic squamous cell carcinoma,0
20571,Compressed structure,Mucinous adenocarcinoma gastric,0
20572,Granulocyte component of blood,ROSE Cluster 3,0
20573,Phenazopyridine,Hodgkin Disease,0
20574,FAT1 wt Allele,Periosteal Osteosarcoma,0
20575,Surface of skin,Anaplastic large cell lymphoma,0
20576,melanoma,ROSE Cluster 3,0
20577,KIT gene,Colorectal High Grade B-Cell Lymphoma,0
20578,Academic degree,Adenocarcinoma,0
20579,Overall Publication Type,Childhood Choriocarcinoma,0
20580,seconds,Stage III Adult Immunoblastic Lymphoma,0
20581,Include (action),Spongiotic dermatitis,0
20582,Biological Response Modifier Therapy,Pancreatic carcinoma,0
20583,diagnosis aspect,Recurrent Uveal Melanoma,0
20584,omit,Hereditary corneal dystrophy,0
20585,Extrinsic,Acantholytic squamous cell carcinoma,0
20586,occurrence characteristics,Vaginal Adenoma,0
20587,immunologist,embryonal rhabdomyosarcoma of prostate,0
20588,How Often Felt Normal question,Undifferentiated Endocervical Sarcoma,0
20589,Tonsil,Maxillary Sinus Adenoid Cystic Carcinoma,0
20590,Chemicals,malignant lymphoma of pancreatic lymph nodes,0
20591,Skin,Metaplastic carcinoma of breast,0
20592,Body structure,Cancer of Urinary Tract,0
20593,Negation,Fourth Ventricle and Brain Stem Ependymal Tumor,0
20594,Inspiration function,Chronic Myelomonocytic Leukemia-2,0
20595,Person Name,Tonsillar Carcinoma,0
20596,Representation (action),Adult Fibrolamellar Carcinoma,0
20597,Domain (area of knowledge),Low Grade Squamous Intraepithelial Neoplasia,0
20598,Vasculature,Trabecular adenocarcinoma,0
20599,Cancer Genus,Carcinoma of urinary bladder,0
20600,status - In progress,Intracortical osteosarcoma,0
20601,Linear,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20602,Immature cells,Breast Ductal Adenoma,0
20603,List,FIGO Stage II Ovarian Cancer,0
20604,Togo,Carcinoma of urinary bladder,0
20605,90%,Cervical Fibroepithelial Polyp,0
20606,Diagnosis Study,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20607,Ability,Choroid Epithelioid Cell Melanoma,0
20608,Secretory Vesicles,Splenic Manifestation of Hairy Cell Leukemia,0
20609,Contrast Media,Anterior Urethral Malignant Neoplasm,0
20610,Diagnosis Study,Medulloblastoma,0
20611,Deletion 1p36,Leiomyoma of Gallbladder,0
20612,Epoetin Alfa,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
20613,Wound Healing,Atypical Lobular Breast Hyperplasia,0
20614,Skin Lymphangiosarcoma,Gallbladder Adenocarcinoma,0
20615,Clone,Epithelioid Sarcoma NCI Grade 3,0
20616,Hospitals,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20617,Tired,Xeroderma pigmentosum,0
20618,Couple (action),Malignant Testicular Sertoli Cell Tumor,0
20619,Chemotherapy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20620,Functional,Secondary malignant neoplasm of lymph node,0
20621,aspects of adverse effects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20622,Homo sapiens,Multiple Skull Base Meningiomas,0
20623,Groups,Cancer of Urinary Tract,0
20624,described,Childhood Extragonadal Malignant Germ Cell Tumor,0
20625,Renal carcinoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20626,Family,Human Papillomavirus-Related Carcinoma,0
20627,Qualitative form,Malignant neoplasm of subglottis,0
20628,diagnosis aspect,Stage IB Pancreatic Cancer AJCC v8,0
20629,Stroma,Malignant neoplasm of gallbladder,0
20630,Night sweats,Liver Cavernous Hemangioma,0
20631,Linear,Neonatal leukemia,0
20632,Female,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20633,Decision,Acantholytic squamous cell carcinoma,0
20634,Meaning,Neonatal leukemia,0
20635,Approximate,Rhabdomyosarcoma with ganglionic differentiation,0
20636,Usage,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20637,74,Intraepithelial Melanocytic Hyperplasia,0
20638,Arising,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
20639,Gene Mutant,FIGO Stage II Ovarian Cancer,0
20640,Radiation Ionizing Radiotherapy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20641,Less Than,Unfavorable Non-Hodgkin Lymphoma,0
20642,Hemangioma,Cervical Adenomyoma,0
20643,Weight decreased,Colorectal cancer,0
20644,High Mitosis-Karyorrhexis Index,Intestinal Neuroendocrine Carcinoma,0
20645,Distant,Cartilaginous exostosis,0
20646,fluid - substance,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20647,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Primary Cutaneous Plasmablastic Lymphoma,0
20648,Hormone Therapy,Gallbladder Adenocarcinoma,0
20649,Concept model domain,Vaginal Adenoma,0
20650,Histopathologic Grade,Metastatic Ductal Breast Carcinoma,0
20651,melanocyte,Refractory Barrett Esophagus,0
20652,One,Non-Metastatic Gestational Trophoblastic Tumor,0
20653,84,Multiple Skull Base Meningiomas,0
20654,New Zealand,Refractory Barrett Esophagus,0
20655,cell type,Childhood Cerebellar Neoplasm,0
20656,To,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20657,Organ,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20658,Follicular,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20659,combination of objects,Giant cell angiofibroma,0
20660,Free (available (qualifier)),Anaplastic large cell lymphoma,0
20661,Persons,Placental aromatase deficiency,0
20662,Code,Tongue Alveolar Soft Part Sarcoma,0
20663,consider,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20664,classical example,Splenic Manifestation of Hairy Cell Leukemia,0
20665,Back,Human Papillomavirus-Related Carcinoma,0
20666,Dysuria,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20667,Homo sapiens,Recurrent Uveal Melanoma,0
20668,Diffuse Large B-Cell Lymphoma,Prostate Lymphoma,0
20669,combination - answer to question,Recurrent Testicular Lymphoma,0
20670,style,Intraepithelial Melanocytic Hyperplasia,0
20671,Beginning,Childhood Choriocarcinoma,0
20672,100%,Malignant melanoma of eyelid,0
20673,Skin,Childhood Central Nervous System Ganglioneuroblastoma,0
20674,Rapid,Mixed astrocytoma-ependymoma,0
20675,Value Above Reference Range,Methotrexate-Associated Hodgkin Lymphoma,0
20676,Primary operation,Atypical Lobular Breast Hyperplasia,0
20677,Lymphocyte,Female Breast Carcinoma,0
20678,<3 (qualifier value),Localized Malignant Neoplasm,0
20679,Symptoms aspect,Metastatic Malignant Neoplasm in the Sellar Region,0
20680,Macrophage Activation Syndrome,Female Breast Carcinoma,0
20681,With shape,Diffuse malignant mesothelioma,0
20682,Appearance Distress Question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20683,Tryptophanase,Kaposi's sarcoma of skin,0
20684,Characteristics,Thymic Clear Cell Carcinoma,0
20685,Rapid,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20686,55,Undifferentiated Neuroblastoma,0
20687,Medical,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
20688,Financial Account,Precursor B-lymphoblastic lymphoma stage II,0
20689,Hospitalization,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20690,Central neuroblastoma,Recurrent Testicular Lymphoma,0
20691,Neoplasms,Recurrent Testicular Lymphoma,0
20692,Type - attribute,Angiosarcoma of liver,0
20693,Tissue Specimen Code,Non-Metastatic Gestational Trophoblastic Tumor,0
20694,National origin,Human Papillomavirus-Related Carcinoma,0
20695,Hyperestrogenism,Adult Anaplastic Oligodendroglioma,0
20696,aggressive cancer,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20697,Appearance Distress Question,Noninfiltrating Intraductal Carcinoma,0
20698,Six,Undifferentiated Endocervical Sarcoma,0
20699,lymph nodes,Brain Ependymoma,0
20700,Child,Congenital hamartoma,0
20701,peripheral blood,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20702,cell growth,Refractory Bladder Carcinoma,0
20703,Severe (severity modifier),Localized Ewing Sarcoma,0
20704,Animals,Childhood Extragonadal Malignant Germ Cell Tumor,0
20705,Body part,FIGO Stage IVA Ovarian Cancer,0
20706,Oral cavity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20707,Chemotherapy Regimen,Liver Cavernous Hemangioma,0
20708,Usually,Carcinomatosis of peritoneal cavity,0
20709,risk factors,Grade 1 Clear Cell Renal Cell Carcinoma,0
20710,Combined,Localized Malignant Neoplasm,0
20711,Malignant Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20712,Qualitative form,Splenic Manifestation of Hairy Cell Leukemia,0
20713,Skin Pigmentation,Cancer of Urinary Tract,0
20714,cell transformation,Serous cystadenocarcinoma ovary,0
20715,hiv-infection/aids,Angiosarcoma of liver,0
20716,Fertility Agents,Recurrent Testicular Lymphoma,0
20717,Presence (property),Familial Adenomatous Polyposis Associated Medulloblastoma,0
20718,Elements,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20719,Type A,Engraftment syndrome,0
20720,Benign,Adrenal Rest Tumor,0
20721,Logical Condition,Intraepithelial Melanocytic Hyperplasia,0
20722,Intimate (qualifier value),Atypical Mesothelial Hyperplasia,0
20723,How Often Sweats,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20724,Malignant neoplasm of gastrointestinal tract,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20725,Breast,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20726,Major <insect>,Squamous cell carcinoma of lip,0
20727,Neoplasms,FIGO Stage IVA Ovarian Cancer,0
20728,Procedure Domain,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20729,Make - Instruction Imperative,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
20730,Sacrococcygeal,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20731,Dietary Lead,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20732,Stem cell transplant,Cancer of Urinary Tract,0
20733,Including (qualifier),Uterine Cancer,0
20734,Occurrence,Endometrial Small Cell Carcinoma,0
20735,Chemotherapy Regimen,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20736,Affect (mental function),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20737,Exposure to,Splenic Manifestation of Hairy Cell Leukemia,0
20738,New,Chondrosarcoma,0
20739,Benign neoplasm of uterus,Epithelioid Sarcoma NCI Grade 3,0
20740,Mismatch Repair,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20741,Used by,mucinous adenocarcinoma of gallbladder,0
20742,Due to,Basal Cell Ameloblastoma,0
20743,Asia,Nasal cavity carcinoma,0
20744,All extremities,Malignant Neoplasm with Regional Lymph Node Involvement,0
20745,Bristol Stool Type 3,Granular Cell Leiomyosarcoma,0
20746,various other intestinal adsorbents in ATC,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20747,Rare,Kaposi's sarcoma of skin,0
20748,Lower - spatial qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
20749,Including (qualifier),BRCA2 Syndrome,0
20750,Skin,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20751,include - SetOperator,Liver Lymphangioma,0
20752,Disease,Metaplastic carcinoma of breast,0
20753,Leg,Toxic Epidermal Necrolysis,0
20754,Skin,Small cell neuroendocrine carcinoma of bladder,0
20755,Tobacco smoking behavior,Carcinoma ex pleomorphic adenoma of parotid gland,0
20756,Known,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20757,Large,Metastatic Lung Neuroendocrine Neoplasm,0
20758,Make - Instruction Imperative,Acute Undifferentiated Leukemia,0
20759,1000000,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20760,risk factors,Adrenal Rest Tumor,0
20761,clinical aspects,Ovarian germ cell choriocarcinoma stage IV,0
20762,Distal (qualifier value),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20763,Meaning,Recurrent Testicular Lymphoma,0
20764,Age,Hereditary Diffuse Gastric Adenocarcinoma,0
20765,Hair,Refractory Barrett Esophagus,0
20766,Negative Finding,Acute Undifferentiated Leukemia,0
20767,Linear,non-Hodgkin's lymphoma of spleen,0
20768,Diagnostic tests,clear cell adenocarcinoma of gallbladder,0
20769,Divide,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20770,Sore Throat,Gallbladder Adenocarcinoma,0
20771,Symptoms aspect,Childhood Central Nervous System Ganglioneuroblastoma,0
20772,Disorder of cellular component of blood,Stage IV Penile Cancer AJCC v7,0
20773,Chemotherapy Regimen,Thyroid Hurthle Cell Carcinoma,0
20774,Time,Familial Adenomatous Polyposis Associated Medulloblastoma,0
20775,Target Awareness - partial,Tongue Alveolar Soft Part Sarcoma,0
20776,Ovary,Metaplastic carcinoma of breast,0
20777,various allergen extracts,Tonsillar Carcinoma,0
20778,PSA Level Less than Two,Maxillary Sinus Adenoid Cystic Carcinoma,0
20779,skin color,Carcinoma ex pleomorphic adenoma of parotid gland,0
20780,Etiology aspects,Childhood Central Nervous System Ganglioneuroblastoma,0
20781,Night time,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20782,Cancer Other,Extra-Adrenal Paraganglioma,0
20783,therapeutic aspects,Occult Lung Adenosquamous Carcinoma,0
20784,Pancreatic Cancer Pathway,Kaposi's sarcoma of skin,0
20785,Targeted Therapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20786,Architecture,ROSE Cluster 3,0
20787,Specimen Source Codes - tumor,Tongue Alveolar Soft Part Sarcoma,0
20788,Have Been Vomiting,Recurrent Testicular Lymphoma,0
20789,metaplastic cell transformation,Pancreatic carcinoma,0
20790,PSA Level Less than Two,Stage I Colon Neuroendocrine Tumor AJCC v8,0
20791,Current (present time),Cervical Squamous Intraepithelial Neoplasia,0
20792,warming process,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20793,High Mitosis-Karyorrhexis Index,Cartilaginous exostosis,0
20794,Entity,Childhood Choriocarcinoma,0
20795,Hereditary,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20796,Childhood Myelodysplastic Syndrome,Spongiotic dermatitis,0
20797,Frequently,Benign Carotid Body Paraganglioma,0
20798,Tryptophanase,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20799,Focal,Anterior Urethral Malignant Neoplasm,0
20800,removal technique,Childhood Fibrillary Astrocytoma,0
20801,Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20802,*Type - Kind of quantity,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20803,Reported Term,Extra-Adrenal Paraganglioma,0
20804,Childhood Grade III Meningioma,Childhood Fibrillary Astrocytoma,0
20805,CDISC SEND Tumor Findings Results Terminology,Mixed parotid tumor,0
20806,Forecast of outcome,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
20807,Benign,embryonal rhabdomyosarcoma of prostate,0
20808,Vaginal,Malignant melanoma of eyelid,0
20809,oncology field,Pilocytic astrocytoma of cerebellum,0
20810,Specimen Source Codes - Lesion,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20811,Nodule,Kaposi's sarcoma of skin,0
20812,Form:Finding:Point in time:{Setting}:Document:{Role},Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20813,Divide,Basal Cell Ameloblastoma,0
20814,Beginning,Metaplastic carcinoma of breast,0
20815,prior radiation therapy,Recurrent Testicular Lymphoma,0
20816,Money or percentage indicator - Percentage,mucinous adenocarcinoma of gallbladder,0
20817,Involvement with,Mixed astrocytoma-ependymoma,0
20818,Present,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20819,Malignant Childhood Neoplasm,Refractory Bladder Carcinoma,0
20820,Targeted Therapy,Splenic Manifestation of Hairy Cell Leukemia,0
20821,Body tissue,Stage IV Colorectal Cancer AJCC v8,0
20822,High,Cervical Fibroepithelial Polyp,0
20823,+2,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20824,Therapeutic radiology procedure,Uterine Cancer,0
20825,Body tissue,Human Papillomavirus-Related Carcinoma,0
20826,Nodule,Granular Cell Leiomyosarcoma,0
20827,Date in time,embryonal rhabdomyosarcoma of prostate,0
20828,85,Benign squamous cell tumor,0
20829,Melanoma Pathway,Locally Advanced Carcinoma,0
20830,Chemicals,Undifferentiated Endocervical Sarcoma,0
20831,Derived value,FIGO Stage II Ovarian Cancer,0
20832,Medulla Oblongata,Pancreatic carcinoma,0
20833,Basis - conceptual entity,Endometrial Small Cell Carcinoma,0
20834,Multiply - dosing instruction fragment,Stage IB Lung Cancer AJCC v7,0
20835,Adult Diffuse Large B-Cell Lymphoma,Undifferentiated Neuroblastoma,0
20836,Covers (device),Medulloblastoma,0
20837,+2,Angiosarcoma of liver,0
20838,Benign neoplasm of breast,BRCA2 Syndrome,0
20839,Frequently,Nasal cavity carcinoma,0
20840,Main,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
20841,Chemotherapy Regimen,Testicular cancer metastatic,0
20842,dendritic spine neck,Squamous cell carcinoma of lip,0
20843,CD5L wt Allele,Stage 0 Penile Cancer AJCC v8,0
20844,Contain (action),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
20845,Blood,Stage III Cutaneous Melanoma AJCC v6,0
20846,Inactive - answer to question,Hereditary Diffuse Gastric Adenocarcinoma,0
20847,Plumbum metallicum,Primary Cutaneous Plasmablastic Lymphoma,0
20848,Childhood Teratoma,Intraepithelial Melanocytic Hyperplasia,0
20849,Cause of death:Find:Pt:^Patient:Nom,Malignant Testicular Sertoli Cell Tumor,0
20850,Surgical service,Heavy Chain Deposition Disease,0
20851,Hereditary,Malignant neoplasm of thalamus,0
20852,Times,Peripheral primitive neuroectodermal tumor of soft tissue,0
20853,Array Feature,Thymic Clear Cell Carcinoma,0
20854,Neoplasms,Gallbladder Adenocarcinoma,0
20855,Vaginal,Hodgkin lymphoma,0
20856,Intestinal metaplasia,Recurrent Uveal Melanoma,0
20857,Often - answer to question,Intestinal Metaplasia of Bladder Urothelium,0
20858,60%,Melanomatosis,0
20859,Result,Liver Cavernous Hemangioma,0
20860,Seizures,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
20861,Platelets,Benign Anal Granular Cell Tumor,0
20862,Tumor Mass,Localized Askin Tumor,0
20863,Skin cell,Malignant neoplasm of subglottis,0
20864,Near,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20865,Plumbum metallicum,Gallbladder Adenocarcinoma,0
20866,Personal appearance,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20867,Type A,Peripheral primitive neuroectodermal tumor of soft tissue,0
20868,Negation,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20869,Involvement with,Splenic Manifestation of Hairy Cell Leukemia,0
20870,Finding,Liver Cavernous Hemangioma,0
20871,Increase,Engraftment syndrome,0
20872,Five-year Survival Rate,Carcinomatosis of peritoneal cavity,0
20873,Stenting,Malignant neoplasm of subglottis,0
20874,shared attribute,Cancer of Urinary Tract,0
20875,Known,Endometrial Small Cell Carcinoma,0
20876,Lymphoma,BRCA2 Syndrome,0
20877,Two,Leptomeningeal sarcoma,0
20878,Dermatitis,Giant cell angiofibroma,0
20879,Code,Chest Wall Fibromatosis,0
20880,Exposure to,adenoid cystic carcinoma of lung,0
20881,Revealed,Female Breast Carcinoma,0
20882,Leads (device),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20883,unknown vaccine or immune globulin,Type II Endometrial Adenocarcinoma,0
20884,Tissue specific,FIGO Stage II Ovarian Cancer,0
20885,Arising in,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20886,Crystal deposition,Peripheral primitive neuroectodermal tumor of soft tissue,0
20887,Age-Years,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20888,Beginning,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
20889,Biopsy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20890,Type - attribute,Malignant neoplasm of thalamus,0
20891,Chemotherapy,Gallbladder Adenocarcinoma,0
20892,Togo,Cerebral hemangioma,0
20893,Include (action),Blood Vessel Tumors,0
20894,Referring,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20895,common types,Malignant neoplasm of gallbladder,0
20896,Smear - instruction imperative,Mastocytosis,0
20897,Death (finding),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20898,Subject Risk,Malignant Neoplasm with Regional Lymph Node Involvement,0
20899,Site of,Stage III Adult Immunoblastic Lymphoma,0
20900,Fever symptoms (finding),Congenital hamartoma,0
20901,High risk,Carcinoma,0
20902,Widening,Clonal Hematopoiesis of Indeterminate Potential,0
20903,Hereditary,Bladder Neuroendocrine Neoplasm,0
20904,Five,Extra-abdominal fibromatosis,0
20905,Primary,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20906,Thyroid Hormones,Refractory Barrett Esophagus,0
20907,Residue on Tongue,Intestinal Metaplasia of Bladder Urothelium,0
20908,Greater,Benign Carotid Body Paraganglioma,0
20909,Examination,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20910,Family history,Mucinous adenocarcinoma gastric,0
20911,Common (qualifier value),Xeroderma pigmentosum,0
20912,Neoplasms,Pilocytic astrocytoma of cerebellum,0
20913,Etiology aspects,Bladder squamous cell carcinoma stage I,0
20914,Inguinal region,Vaginal Adenoid Cystic Carcinoma,0
20915,Compression,Neoplasms,0
20916,Have Been Vomiting,Intestinal Metaplasia of Bladder Urothelium,0
20917,Onset of (contextual qualifier),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20918,depend,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
20919,Tissue of urinary bladder,Human Papillomavirus-Related Carcinoma,0
20920,Characteristics,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
20921,Granulocyte count,Mastocytosis,0
20922,Often - answer to question,Squamous cell carcinoma of lip,0
20923,Type A,FIGO Stage II Ovarian Cancer,0
20924,Several,Astrocytoma of brain,0
20925,Views survey,Ichthyoses,0
20926,Component object,FIGO Stage II Ovarian Cancer,0
20927,Science of Etiology,Malignant Testicular Sertoli Cell Tumor,0
20928,Painless,Bladder adenocarcinoma stage IV,0
20929,Science of Etiology,Bladder Neuroendocrine Neoplasm,0
20930,Transection (procedure),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20931,Delta (difference),Uterine Cancer,0
20932,Skin,Mixed parotid tumor,0
20933,Atypical proliferation,BRCA2 Syndrome,0
20934,Result,Multiple Skull Base Meningiomas,0
20935,Object Relationship,Refractory Ependymoma,0
20936,Primary malignant neoplasm,Nasal cavity carcinoma,0
20937,Cells,Mucinous adenocarcinoma gastric,0
20938,Risk,Recurrent Testicular Lymphoma,0
20939,CYREN gene,Mucinous adenocarcinoma gastric,0
20940,Chemotherapy,Mucinous adenocarcinoma gastric,0
20941,Enzymes,clear cell adenocarcinoma of gallbladder,0
20942,Colon structure (body structure),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20943,Cell Count,Childhood Fibrillary Astrocytoma,0
20944,Unintentional,Adult Anaplastic Oligodendroglioma,0
20945,Immune,Lung squamous cell carcinoma stage I,0
20946,Excision,Neonatal leukemia,0
20947,Myeloid Progenitor Cells,Carcinoma of urinary bladder,0
20948,Medical History,Ichthyosis,0
20949,Age-Years,Nasal cavity carcinoma,0
20950,Squamous cell carcinoma - category,Colorectal cancer,0
20951,Hereditary,Refractory Ependymoma,0
20952,Classification,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20953,Cultured Cell Line,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20954,Canada,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20955,Present,Locally Advanced Soft Tissue Sarcoma,0
20956,Spreading (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
20957,Vitamin B 12 Deficiency,Mucosal Melanoma,0
20958,Genes,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20959,research subject screening,Recurrent Primary Lymphoma of Bone,0
20960,Hormonal Contraception,Acantholytic squamous cell carcinoma,0
20961,Cessation of life,Cerebral Primitive Neuroectodermal Tumor,0
20962,Apply,mucinous adenocarcinoma of gallbladder,0
20963,Sibling,Multiple Endocrine Neoplasia,0
20964,Adenocarcinoma of large intestine,Gallbladder Adenocarcinoma,0
20965,Medical,clear cell adenocarcinoma of gallbladder,0
20966,Left,Bladder squamous cell carcinoma stage I,0
20967,Treating,Childhood Fibrillary Astrocytoma,0
20968,Bladder Cancer Pathway,Cervical Squamous Intraepithelial Neoplasia,0
20969,Greater than one,Hodgkin Disease,0
20970,Analysis of substances,High Grade Glandular Intraepithelial Neoplasia,0
20971,Cells,Digestive System Hodgkin Lymphoma,0
20972,Skin Specimen,Undifferentiated Endocervical Sarcoma,0
20973,Sometimes,Malignant melanoma of eyelid,0
20974,Two,Advanced Uterine Corpus Carcinosarcoma,0
20975,Diet Code Specification Type - Preference,Thymic Clear Cell Carcinoma,0
20976,True,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20977,Usual,Human Papillomavirus-Related Carcinoma,0
20978,Spreading (qualifier value),adenoid cystic carcinoma of lung,0
20979,Negation,Grade 3a Malignant Neoplasm,0
20980,Neoplastic disease,Methotrexate-Associated Hodgkin Lymphoma,0
20981,Death (finding),Digestive System Hodgkin Lymphoma,0
20982,Dietary Lead,Stage III Cutaneous Melanoma AJCC v6,0
20983,Involvement with,Vaginal Adenoid Cystic Carcinoma,0
20984,Witnesses,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20985,Glycation End Products,Tonsillar Carcinoma,0
20986,Malignant - descriptor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20987,Formation,Plexosarcoma,0
20988,Reduced,Adult Anaplastic Oligodendroglioma,0
20989,Term (temporal),Stage III Cutaneous Melanoma AJCC v6,0
20990,Lymphoma,FIGO Stage IVA Ovarian Cancer,0
20991,Occurrence,Bladder adenocarcinoma stage IV,0
20992,Uncontrolled,Carcinomatosis of peritoneal cavity,0
20993,Characteristics,Extracranial Neuroblastoma,0
20994,Plasma Product,Recurrent Testicular Lymphoma,0
20995,Negation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
20996,65+,Melanomatosis,0
20997,Sarcoma,Undifferentiated Endocervical Sarcoma,0
20998,Then,Adult Alveolar Soft Part Sarcoma,0
20999,Respiratory System Agents,non-Hodgkin's lymphoma of spleen,0
21000,Acquired Name,Cervical Fibroepithelial Polyp,0
21001,Right lymphatic duct,Undifferentiated Endocervical Sarcoma,0
21002,Case (situation),Human Papillomavirus-Related Carcinoma,0
21003,Animals,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
21004,Overall,Adult Anaplastic Oligodendroglioma,0
21005,Imaging Techniques,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21006,device aspects,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21007,Tissue membrane,Choroid Necrotic Melanoma,0
21008,Biomaterial Treatment,Grade 3a Malignant Neoplasm,0
21009,Usual Severity Weight Loss,papillary carcinoma of penis,0
21010,Abdomen+,Airway Hemangioma,0
21011,Benign,Benign squamous cell tumor,0
21012,In Blood,Stage IV Penile Cancer AJCC v7,0
21013,common types,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21014,Dorsal,ROSE Cluster 3,0
21015,Aim (idea),Anaplastic large cell lymphoma,0
21016,Adenoid Cystic Carcinoma,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
21017,*Type - Kind of quantity,Cerebral Primitive Neuroectodermal Tumor,0
21018,Pharyngeal structure,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21019,Constant (qualifier),Childhood Central Nervous System Immature Teratoma,0
21020,Brain Neoplasms,Hereditary Diffuse Gastric Adenocarcinoma,0
21021,Anorexia,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21022,Condition,Chronic Myelomonocytic Leukemia-2,0
21023,Weighing patient,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21024,Cutaneous,Advanced Lung Carcinoma,0
21025,Primary malignant neoplasm,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
21026,Make - Instruction Imperative,Adenocarcinoma of duodenum,0
21027,NCI CTEP SDC Melanoma Sub-Category Terminology,Cartilaginous exostosis,0
21028,Combined,Childhood Fibrillary Astrocytoma,0
21029,Females,Hyperplasia of pituitary gland,0
21030,ACTG2 wt Allele,Childhood Central Nervous System Immature Teratoma,0
21031,Frequently,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
21032,treatment - ActInformationManagementReason,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21033,To,Acantholytic squamous cell carcinoma,0
21034,Common Specifications in HL7 V3 Publishing,Unicystic ameloblastoma,0
21035,animal allergen extracts,Gallbladder Adenocarcinoma,0
21036,Have Weight Loss,Anterior Urethral Malignant Neoplasm,0
21037,Carcinoma,Stage III Cutaneous Melanoma AJCC v6,0
21038,Malignant neoplasm of stomach,Urethral Carcinoma,0
21039,Low Mitosis-Karyorrhexis Index,Endometrial Small Cell Carcinoma,0
21040,Physicians,Diffuse malignant mesothelioma,0
21041,shared attribute,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21042,Surgical aspects,Platinum-Resistant Lung Small Cell Carcinoma,0
21043,Cell (compartment),Vaginal Adenoid Cystic Carcinoma,0
21044,cancer risk,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21045,2+ Score,Metastatic Kidney Carcinoma,0
21046,treatment - ActInformationManagementReason,Adult Alveolar Soft Part Sarcoma,0
21047,include - SetOperator,sarcoma of spinal cord,0
21048,Togo,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21049,Radiological Exposure Device,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21050,Feel Pain,de novo Myelodysplastic Syndrome,0
21051,Occurrence Indicator,Anterior Urethral Malignant Neoplasm,0
21052,veterans alcoholism screening test (VAST),Mucinous neoplasm,0
21053,Childhood Lymphoma,Metaplastic carcinoma of breast,0
21054,seconds,Nasal cavity carcinoma,0
21055,Pancreatic carcinoma,Adenocarcinoma,0
21056,Two,Endometrial Small Cell Carcinoma,0
21057,Feel Pain,Digestive System Hodgkin Lymphoma,0
21058,Metastatic Neoplasm,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
21059,Patterns,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21060,include - SetOperator,Hereditary Diffuse Gastric Adenocarcinoma,0
21061,Lymphocyte,Malignant melanoma of eyelid,0
21062,Female,benign mature teratoma of pancreas,0
21063,Show,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21064,Contain (action),Plexosarcoma,0
21065,pharmacotherapeutic,Epithelioid Sarcoma NCI Grade 3,0
21066,CD69 wt Allele,High Grade Glandular Intraepithelial Neoplasia,0
21067,Frequency of Pain Question,Astrocytoma of brain,0
21068,7.2,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21069,Therapeutic procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21070,Entity Determiner - specific,clear cell adenocarcinoma of gallbladder,0
21071,Firstly,Benign tumor of eyelid,0
21072,Milk (body substance),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21073,Egg of order Phthiraptera,Pancreatic Intraepithelial Neoplasia-3,0
21074,Following,Colorectal High Grade B-Cell Lymphoma,0
21075,Process (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
21076,Shell (rigid covering),Mucosal Melanoma,0
21077,Benign Neoplasm,Carcinoma of submandibular gland,0
21078,Neoplasms by Site,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21079,Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21080,Shortened,Placental aromatase deficiency,0
21081,Abnormally high,Metastatic Malignant Neoplasm in the Sellar Region,0
21082,Epidermal cells,Brain Ependymoma,0
21083,> 2 years,Atypical Lobular Breast Hyperplasia,0
21084,Moist,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21085,Nose,Splenic Manifestation of Hairy Cell Leukemia,0
21086,Moved to,Cerebral Primitive Neuroectodermal Tumor,0
21087,Specimen Source Codes - tumor,Engraftment syndrome,0
21088,Pain,FIGO Stage IVA Ovarian Cancer,0
21089,Retinoic Acid Response Element,Mastocytosis,0
21090,*Type - Kind of quantity,Liver Cavernous Hemangioma,0
21091,Epithelial Cells,Female Breast Carcinoma,0
21092,High,Maxillary Sinus Adenocarcinoma,0
21093,Representation (action),Nasal cavity carcinoma,0
21094,Term (temporal),Diffuse malignant mesothelioma,0
21095,Mesothelial cell count,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21096,Congenital qualifier,Locally Advanced Epithelioid Hemangioendothelioma,0
21097,Thyroid carcinoma,Fibroadenoma of breast,0
21098,Egg of order Phthiraptera,Bladder adenocarcinoma stage IV,0
21099,To,Stage II Carcinoma of Penis,0
21100,Screening Study,Squamous cell carcinoma of lip,0
21101,Diagnosis,Maxillary Sinus Adenoid Cystic Carcinoma,0
21102,pathologic fistula,Locally Advanced Carcinoma,0
21103,Third,Extra-abdominal fibromatosis,0
21104,Following,mucinous adenocarcinoma of gallbladder,0
21105,Personal appearance,Acute lymphadenitis,0
21106,Categories,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
21107,Deoxyribonucleic Acid Measurement,Locally Advanced Squamous Cell Carcinoma,0
21108,Malignant neoplasm of ovary,Transitional cell carcinoma,0
21109,Including (qualifier),Intraepithelial Melanocytic Hyperplasia,0
21110,Life Threatening or Disabling Adverse Event,Ovarian germ cell choriocarcinoma stage IV,0
21111,Including (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21112,Physical shape,Basal Cell Ameloblastoma,0
21113,Diagnostic Imaging,Malignant neoplasm of gallbladder,0
21114,Agenesis of corpus callosum,Microcystic meningioma,0
21115,Sample Median,Acantholytic squamous cell carcinoma,0
21116,Include (action),Trabecular adenocarcinoma,0
21117,Cells,Cervical Squamous Intraepithelial Neoplasia,0
21118,Occurrence,Melanomatosis,0
21119,Contain (action),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
21120,Primary malignant neoplasm,Intraepithelial Melanocytic Hyperplasia,0
21121,Involvement with,Extracranial Neuroblastoma,0
21122,Symptoms,Intraepithelial Melanocytic Hyperplasia,0
21123,Form:Finding:Point in time:{Setting}:Document:{Role},Secondary malignant neoplasm of lymph node,0
21124,Hyperplasia,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21125,Tumor Mass,Vaginal Adenoma,0
21126,Cancer Genus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21127,Beginning,Squamous cell carcinoma of lip,0
21128,production,Cerebral Primitive Neuroectodermal Tumor,0
21129,Localized,Neoplasms,0
21130,diagnosis aspect,Stage III Cutaneous Melanoma AJCC v6,0
21131,Body structure,ICHTHYOSIS,0
21132,Group A (qualifier value),Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
21133,Vagina,mucinous adenocarcinoma of gallbladder,0
21134,Cancer Genus,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
21135,Concentration measurement,Cervical Fibroepithelial Polyp,0
21136,Administration procedure,Refractory Ependymoma,0
21137,Personal appearance,Intracortical osteosarcoma,0
21138,Location of Pharyngeal Residue Following Swallowing,Undifferentiated Endocervical Sarcoma,0
21139,campbell,Localized Askin Tumor,0
21140,Poverty,Carcinoma of urinary bladder,0
21141,Iodides,Necrotizing Funisitis,0
21142,Most,Bladder adenocarcinoma stage IV,0
21143,Involvement with,Diffuse malignant mesothelioma,0
21144,Rest,Melanomatosis,0
21145,Very,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21146,Night time,Refractory Bladder Carcinoma,0
21147,Does run (finding),Pancreatic carcinoma,0
21148,diagnostic accuracy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21149,Tryptophanase,embryonal rhabdomyosarcoma of prostate,0
21150,Group A (qualifier value),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
21151,Used by,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
21152,DNA,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21153,Include (action),Locally Advanced Epithelioid Hemangioendothelioma,0
21154,Therapeutic radiology procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21155,various allergen extracts,Childhood Fibrillary Astrocytoma,0
21156,Embryonic tissue,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21157,High Level,Malignant neoplasm of gallbladder,0
21158,Include (action),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21159,Platelets,Malignant melanoma of eyelid,0
21160,Body tissue,Unresectable Rhabdomyosarcoma,0
21161,Repaired,Recurrent Uveal Melanoma,0
21162,majority,Benign neoplasm of eye,0
21163,History,Engraftment syndrome,0
21164,Affecting,Recurrent Uveal Melanoma,0
21165,Family history,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21166,Poor - qualifier,Familial Hemophagocytic Lymphocytosis,0
21167,Recurrent infections,Thymic Clear Cell Carcinoma,0
21168,Root body part,Malignant neoplasm of thalamus,0
21169,Reported,Cervical Fibroepithelial Polyp,0
21170,Symptoms aspect,Clonal Hematopoiesis of Indeterminate Potential,0
21171,Including (qualifier),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
21172,Surface,Intraepithelial Melanocytic Hyperplasia,0
21173,Type - attribute,Mucinous adenocarcinoma gastric,0
21174,Present,Hereditary corneal dystrophy,0
21175,To,Splenic Manifestation of Hairy Cell Leukemia,0
21176,Endometrial biopsy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21177,Organ,Chronic Myelomonocytic Leukemia-2,0
21178,Referring,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
21179,Image Feature,Choroid Necrotic Melanoma,0
21180,2+ Score,Stage III Cutaneous Melanoma AJCC v6,0
21181,Diagnosis Study,Stage IB Pancreatic Cancer AJCC v8,0
21182,Primary lymphoid organ,Kaposi's sarcoma of extrahepatic bile duct,0
21183,Manufactured sign,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21184,survival aspects,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21185,Classification,sarcoma of spinal cord,0
21186,BRCA2 protein,Platinum-Resistant Lung Small Cell Carcinoma,0
21187,High Mitosis-Karyorrhexis Index,Methotrexate-Associated Hodgkin Lymphoma,0
21188,Age,Localized Malignant Neoplasm,0
21189,Participation Type - origin,Thymic Clear Cell Carcinoma,0
21190,What subject filter - Result,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21191,Pressure (property),Precursor B-lymphoblastic lymphoma stage II,0
21192,Sweat,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21193,Structure of lymphatic trunk,Malignant melanoma of eyelid,0
21194,Neoplasms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21195,Screening,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21196,Cause of death.underlying,Grade 3a Malignant Neoplasm,0
21197,Germ cell tumor,Malignant Testicular Sertoli Cell Tumor,0
21198,United States,Kaposi's sarcoma of skin,0
21199,Pesticides,Cancer of Urinary Tract,0
21200,peripheral blood,Adult Brain Stem Mixed Glioma,0
21201,Canada,Malignant neoplasm of choroid,0
21202,Result,Adult Hepatocellular Carcinoma,0
21203,Contain (action),Microcystic meningioma,0
21204,Definition,Unicystic ameloblastoma,0
21205,Aspects of disease screening,Ovarian Carcinoid Tumor,0
21206,shared attribute,Malignant Testicular Sertoli Cell Tumor,0
21207,other medicated shampoos in ATC,Endometrial Small Cell Carcinoma,0
21208,Breast,Female Breast Carcinoma,0
21209,Appearance,Recurrent Uveal Melanoma,0
21210,N not otherwise specified Antibody,Splenic Manifestation of Hairy Cell Leukemia,0
21211,filtration,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21212,Morbidity - disease rate,Stage IV Colorectal Cancer AJCC v8,0
21213,Body tissue,Childhood Thyroid Gland Follicular Carcinoma,0
21214,Breast Carcinoma,Stage IV Childhood Non-Hodgkin Lymphoma,0
21215,Capsule Shape,FIGO Stage IVA Ovarian Cancer,0
21216,Arising in,Benign neoplasm of thorax,0
21217,Negation,Metastatic Malignant Neoplasm in the Sellar Region,0
21218,Human body structure,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21219,Polyp of large intestine,Refractory Barrett Esophagus,0
21220,Blastoma,Adult Fibrolamellar Carcinoma,0
21221,Carcinoid Tumor,Recurrent Primary Lymphoma of Bone,0
21222,Location,Cervical Fibroepithelial Polyp,0
21223,Cell (compartment),Mucinous adenocarcinoma gastric,0
21224,Follow-Up Report,clear cell adenocarcinoma of gallbladder,0
21225,Most,Gallbladder Adenocarcinoma,0
21226,True,Recurrent Uveal Melanoma,0
21227,First (number),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
21228,Act Class - investigation,Pilocytic astrocytoma of cerebellum,0
21229,Affecting,Nasal cavity carcinoma,0
21230,Transitional cell morphology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21231,Vaginal Sarcoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21232,Retinoic Acid Response Element,Basal Cell Ameloblastoma,0
21233,Include (action),Recurrent Testicular Lymphoma,0
21234,Smear - instruction imperative,Larynx carcinoma recurrent,0
21235,melanocyte,Mucinous adenocarcinoma,0
21236,Screening - general (procedure),Stage I Adult Non-Hodgkin Lymphoma,0
21237,Etiology aspects,Acantholytic squamous cell carcinoma,0
21238,Neoplasms,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
21239,Immune system,Locally Advanced Soft Tissue Sarcoma,0
21240,Infected,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21241,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21242,Males,Adrenal Rest Tumor,0
21243,Increase,Fibroadenoma of breast,0
21244,Symptoms,Mucinous adenocarcinoma gastric,0
21245,Swallowing painful,Cerebral Primitive Neuroectodermal Tumor,0
21246,treatment - ActInformationManagementReason,Kaposi's sarcoma of skin,0
21247,Able (finding),Botryoid-Type Embryonal Rhabdomyosarcoma,0
21248,Specimen Source Codes - tumor,Type II Endometrial Adenocarcinoma,0
21249,Round shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21250,Hearing examination finding,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21251,Occurrence Indicator,Mucinous adenocarcinoma gastric,0
21252,Increased,Mixed astrocytoma-ependymoma,0
21253,Precision - characteristic,Acute Undifferentiated Leukemia,0
21254,Large,Mucinous adenocarcinoma gastric,0
21255,Interferes with,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21256,Secondary Neoplasm,Vaginal Adenoid Cystic Carcinoma,0
21257,Vomiting,Testicular cancer metastatic,0
21258,Rare,Recurrent Primary Lymphoma of Bone,0
21259,Body tissue,Breast Ductal Adenoma,0
21260,Common (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21261,Usual Severity Weight Loss,Tonsillar Carcinoma,0
21262,Malignant Neoplasms,Heavy Chain Deposition Disease,0
21263,3+ Answer to Question,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21264,What subject filter - Result,Stage II Carcinoma of Penis,0
21265,1960s,Cancer of Urinary Tract,0
21266,Occurrence Indicator,Lipoma of small intestine,0
21267,Person 1,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21268,various allergen extracts,Benign squamous cell tumor,0
21269,Palpebronasal fold,Adult Anaplastic Oligodendroglioma,0
21270,low,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21271,Patients,Acute Undifferentiated Leukemia,0
21272,Autoimmune Diseases,embryonal rhabdomyosarcoma of prostate,0
21273,Continuance of life,Blood Vessel Tumors,0
21274,Primary Malignant Liver Neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21275,Cessation of life,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21276,Neuroblastoma,Trichilemmocarcinoma,0
21277,Incidence,Melanomatosis,0
21278,More,Uterine Cancer,0
21279,Qualitative form,Digestive System Hodgkin Lymphoma,0
21280,year,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21281,Left sided,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21282,Usual Severity Weight Loss,Malignant neoplasm of thalamus,0
21283,Severe (severity modifier),Digestive System Hodgkin Lymphoma,0
21284,Availability of,Noninfiltrating Intraductal Carcinoma,0
21285,Malignant neoplasm of skin,Liver Lymphangioma,0
21286,Containing (qualifier),Unresectable Rhabdomyosarcoma,0
21287,diagnosis aspect,Childhood Fibrillary Astrocytoma,0
21288,*Type - Kind of quantity,Mucosal Melanoma,0
21289,Linear,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21290,Active License,Astrocytoma of brain,0
21291,Anterior,Adult Hepatocellular Carcinoma,0
21292,Arising,Carcinoma of submandibular gland,0
21293,Squamous,Adult Alveolar Soft Part Sarcoma,0
21294,Sore skin,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21295,Linear,Benign tumor of eyelid,0
21296,Togo,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21297,Contain (action),Pancreatic carcinoma,0
21298,Urinary tract,Transitional cell carcinoma,0
21299,Malignant Neoplasms,Testicular cancer metastatic,0
21300,Malignant neoplasm of kidney,mucinous adenocarcinoma of gallbladder,0
21301,SPINK5 gene,Central Nervous System Yolk Sac Tumor,0
21302,User Group,Benign Apocrine Neoplasm,0
21303,Term Birth,Benign Carotid Body Paraganglioma,0
21304,Tired,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21305,Pharmacotherapy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21306,Image Feature,Advanced Uterine Corpus Carcinosarcoma,0
21307,Tumor site,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21308,Tissue Specimen Code,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21309,Rare,Pleomorphic adenoma of parotid gland,0
21310,Ephrin Type-B Receptor 1,Mucinous neoplasm,0
21311,Distant,Recurrent Testicular Lymphoma,0
21312,Effective,Colorectal Neuroendocrine Tumor G2,0
21313,Generalized,Anaplastic large cell lymphoma,0
21314,Specimen Source Codes - tumor,Metaplastic carcinoma of breast,0
21315,Lifetime,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21316,Molecular Mass,Benign Anal Granular Cell Tumor,0
21317,Castor bean poisoning,Cervical Fibroepithelial Polyp,0
21318,Treating,Recurrent Uveal Melanoma,0
21319,Disorder of cellular component of blood,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21320,Development,Atypical Lobular Breast Hyperplasia,0
21321,lead increased,Recurrent Testicular Lymphoma,0
21322,Form:Finding:Point in time:{Setting}:Document:{Role},Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21323,Chromosome Aberrations,Gallbladder Adenocarcinoma,0
21324,Inferior Colliculus,Human Papillomavirus-Related Carcinoma,0
21325,various other intestinal adsorbents in ATC,BRCA2 Syndrome,0
21326,ovarian,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21327,Entity Determiner - specific,Nasal cavity carcinoma,0
21328,Removal of bladder,benign mature teratoma of pancreas,0
21329,Human body structure,BRCA2 Syndrome,0
21330,Out (direction),Occult Lung Adenosquamous Carcinoma,0
21331,Medications:-:Point in time:^Patient:-,Cerebral Primitive Neuroectodermal Tumor,0
21332,Tumor Mass,Stage III Cutaneous Melanoma AJCC v6,0
21333,Pediatric Neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21334,Negative,Colorectal cancer,0
21335,Flat shape,Mixed astrocytoma-ependymoma,0
21336,Hormonal,Squamous cell carcinoma of lip,0
21337,Research Activities,Advanced Uterine Corpus Carcinosarcoma,0
21338,Vaginal,Malignant melanoma of eyelid,0
21339,Including (qualifier),Bladder squamous cell carcinoma stage I,0
21340,Aggressive behavior,Malignant melanoma of eyelid,0
21341,Areas <moth>,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
21342,Usually,Medulloblastoma,0
21343,International Statistical Classification of Diseases and Related Health Problems,Gallbladder Adenocarcinoma,0
21344,Drop - Unit of Volume,Intraepithelial Melanocytic Hyperplasia,0
21345,depend,Adenocarcinoma,0
21346,Give - dosing instruction imperative,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21347,Application Dosing Unit,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21348,option - ActMoodPredicate,Stage III Cutaneous Melanoma AJCC v6,0
21349,DNA,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21350,P-Glycoproteins,Airway Hemangioma,0
21351,Including (qualifier),Tongue Alveolar Soft Part Sarcoma,0
21352,Post Device,Larynx carcinoma recurrent,0
21353,Biopsy,Lipoma of small intestine,0
21354,Treating,Bladder squamous cell carcinoma stage I,0
21355,theca cell,Benign squamous cell tumor,0
21356,Endocrine,Colorectal cancer,0
21357,Fine needle aspiration biopsy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21358,Icterus,Familial Hemophagocytic Lymphocytosis,0
21359,Version,Mucosal Melanoma,0
21360,Variable (uniformity),Metastatic Lung Small Cell Carcinoma,0
21361,diagnosis aspect,Hodgkin Disease,0
21362,Lung,Cystadenocarcinoma,0
21363,active (HL7 RoleLink),Thymic Atypical Carcinoid Tumor,0
21364,Fix,Benign Anal Granular Cell Tumor,0
21365,Cellular infiltrate,Malignant neoplasm of subglottis,0
21366,Intervention regimes,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21367,More,Methotrexate-Associated Hodgkin Lymphoma,0
21368,Glycation End Products,Childhood Central Nervous System Ganglioneuroblastoma,0
21369,More,Platinum-Resistant Lung Small Cell Carcinoma,0
21370,Numerous,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21371,Type of reconstruction,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21372,Infective cystitis,Chronic Myelomonocytic Leukemia-2,0
21373,Occur (action),Type II Endometrial Adenocarcinoma,0
21374,therapeutic aspects,Unfavorable Non-Hodgkin Lymphoma,0
21375,84,Vaginal Adenoma,0
21376,Childhood Leukemia,Endometrial Small Cell Carcinoma,0
21377,Very,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21378,Term (temporal),Benign Carotid Body Paraganglioma,0
21379,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
21380,Include (action),Undifferentiated Endocervical Sarcoma,0
21381,various other intestinal adsorbents in ATC,Metastatic Ductal Breast Carcinoma,0
21382,3+ Score,Human Papillomavirus-Related Carcinoma,0
21383,17th century,Human Papillomavirus-Related Carcinoma,0
21384,Original Regulatory Submission,Stage III Cutaneous Melanoma AJCC v6,0
21385,Leakage,Endometrial Small Cell Carcinoma,0
21386,Supportive assistance,Childhood Choriocarcinoma,0
21387,Etiology aspects,Locally Advanced Carcinoma,0
21388,Usual Severity Difficulty Swallowing,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21389,All extremities,Epithelioid Sarcoma NCI Grade 3,0
21390,Metastatic to,Vaginal Adenoma,0
21391,Impaired skin integrity,Werner Syndrome,0
21392,65,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21393,80%,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21394,Natures,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21395,Administration type,Cancer of Urinary Tract,0
21396,risk factors - observation list,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21397,Line Unit of Length,Human Papillomavirus-Related Carcinoma,0
21398,Mass of body structure,Childhood Central Nervous System Ganglioneuroblastoma,0
21399,Anemia,Cerebral Primitive Neuroectodermal Tumor,0
21400,Primitive Mesenchymal Cell,Malignant Testicular Sertoli Cell Tumor,0
21401,Five,Hodgkin lymphoma,0
21402,Time (foundation metadata concept),Acute Undifferentiated Leukemia,0
21403,Tumor cells,Cerebral Primitive Neuroectodermal Tumor,0
21404,Neoplasm Metastasis,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
21405,Rest,Non-Metastatic Gestational Trophoblastic Tumor,0
21406,Coding,Tonsillar Carcinoma,0
21407,What subject filter - Result,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
21408,Second Suffix,Extra-Adrenal Paraganglioma,0
21409,Mechanism (attribute),Vaginal Adenoma,0
21410,Negation,Multiple Skull Base Meningiomas,0
21411,Account number:Identifier:Point in time:^Patient:Nominal,Airway Hemangioma,0
21412,Loss of appetite (finding),Childhood Central Nervous System Ganglioneuroblastoma,0
21413,Screening procedure,Mucinous adenocarcinoma,0
21414,68,Thyroid Hurthle Cell Carcinoma,0
21415,Age of Onset,Pancreatic Intraepithelial Neoplasia-3,0
21416,PREVENT (product),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
21417,Similarity,Unresectable Rhabdomyosarcoma,0
21418,year,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21419,Usually,Stage IV Childhood Non-Hodgkin Lymphoma,0
21420,Cause of Death,Adult Alveolar Soft Part Sarcoma,0
21421,seen,Occult Lung Adenosquamous Carcinoma,0
21422,Followed by,Cancer of Urinary Tract,0
21423,Multiple Sclerosis,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21424,Common (qualifier value),Recurrent Testicular Lymphoma,0
21425,Physical findings,Clonal Hematopoiesis of Indeterminate Potential,0
21426,Sternum,Recurrent Testicular Lymphoma,0
21427,Eye,Intraepithelial Melanocytic Hyperplasia,0
21428,Nicotiana,Benign neoplasm of eye,0
21429,Lock Device,Melanomatosis,0
21430,Arising in,Papillary squamous cell carcinoma,0
21431,Malignant Neoplasms,Undifferentiated Neuroblastoma,0
21432,Treated with,Benign tumor of eyelid,0
21433,Affecting,Chest Wall Fibromatosis,0
21434,Togo,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21435,Mutation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21436,Usual Severity Weight Loss,Kaposi's sarcoma of extrahepatic bile duct,0
21437,Malignancy,Metastatic Neoplasm to the Gallbladder,0
21438,Main,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21439,Simpson Grade 2,Benign tumor of eyelid,0
21440,Type - attribute,Vaginal Adenoma,0
21441,Blood Platelets,Lipoma of small intestine,0
21442,Person Name,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21443,Previous,Diffuse malignant mesothelioma,0
21444,Neoplasms,BRCA2 Syndrome,0
21445,Crystal Device,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21446,History of previous events,Testicular cancer metastatic,0
21447,American College of Cardiology/American Heart Association Lesion Complexity Score C,Extra-Adrenal Paraganglioma,0
21448,Alveolar rhabdomyosarcoma,Malignant melanoma of eyelid,0
21449,Initially,Anterior Urethral Malignant Neoplasm,0
21450,Early,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21451,Warts,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21452,Abdominal hysterectomy,Acute lymphadenitis,0
21453,Infrequent,Serous cystadenocarcinoma ovary,0
21454,Estrogen (disposition),Kaposi's sarcoma of skin,0
21455,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
21456,Pharmacotherapy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21457,Electrical Current,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
21458,Base - General Qualifier,Hodgkin Disease,0
21459,Growth action,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
21460,Tissue Specimen Code,Colorectal Neuroendocrine Tumor G2,0
21461,Antibody Formation,sarcoma of spinal cord,0
21462,Type - attribute,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21463,Adult Gliosarcoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21464,Encounter due to being a donor,Mucinous adenocarcinoma,0
21465,Cancer Genus,Type II Endometrial Adenocarcinoma,0
21466,cervical cancer,Anaplastic large cell lymphoma,0
21467,Include (action),Pleomorphic adenoma of parotid gland,0
21468,Presence (property),Unicystic ameloblastoma,0
21469,Synonym (core metadata concept),Clinical Stage I Cutaneous Melanoma AJCC v8,0
21470,Malignant Neoplasms,Grade 3a Malignant Neoplasm,0
21471,Vaginal Melanoma,Benign Anal Granular Cell Tumor,0
21472,Stem of Organ,BRCA2 Syndrome,0
21473,Operative Surgical Procedures,Tonsillar Carcinoma,0
21474,Characterization,Recurrent Uveal Melanoma,0
21475,Leg,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21476,Proliferation (morphologic abnormality),Benign Ovarian Thecoma,0
21477,Psyche structure,ROSE Cluster 3,0
21478,Cell (compartment),Endometrial Small Cell Carcinoma,0
21479,Operative Surgical Procedures,Anaplastic large cell lymphoma,0
21480,Country,Trichilemmocarcinoma,0
21481,Sequence Data Type,Intestinal Metaplasia of Bladder Urothelium,0
21482,Axillary Lymph Node Involvement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21483,First (number),Stage III Cutaneous Melanoma AJCC v6,0
21484,Genetic Inheritance,FIGO Stage IVA Ovarian Cancer,0
21485,Heart Failure,Childhood Anaplastic Large Cell Lymphoma,0
21486,Exposure to Agent Orange,BRCA2 Syndrome,0
21487,*Type - Kind of quantity,Maxillary Sinus Adenoid Cystic Carcinoma,0
21488,Immunocompromised Host,Noninfiltrating Intraductal Carcinoma,0
21489,Neurofibromatosis 1,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21490,Absence (morphologic abnormality),Ovarian germ cell choriocarcinoma stage IV,0
21491,Tissue Specimen Code,Intestinal Metaplasia of Bladder Urothelium,0
21492,Contain (action),Refractory Bladder Carcinoma,0
21493,Pilocytic Astrocytoma,Spermatocytic seminoma,0
21494,various other nasal preparations in ATC,Splenic Manifestation of Hairy Cell Leukemia,0
21495,Abnormal Cell Count,Splenic Manifestation of Hairy Cell Leukemia,0
21496,Diet,Colorectal Neuroendocrine Tumor G2,0
21497,In situ,FIGO Stage IVA Ovarian Cancer,0
21498,Infective cystitis,Thyroid carcinoma,0
21499,Cervical lymph node group,Hyperplasia of pituitary gland,0
21500,Adult Myelodysplastic Syndrome,Engraftment syndrome,0
21501,Now (temporal qualifier),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21502,radiotherapeutic,Anterior Urethral Malignant Neoplasm,0
21503,Widening,High Grade Glandular Intraepithelial Neoplasia,0
21504,Timepoint,Intestinal Metaplasia of Bladder Urothelium,0
21505,900,Ichthyosis,0
21506,Name (property) (qualifier value),Benign neoplasm of thorax,0
21507,Abnormal result,Mastocytosis,0
21508,To,Platinum-Resistant Lung Small Cell Carcinoma,0
21509,Sunlight,Advanced Uterine Corpus Carcinosarcoma,0
21510,include - SetOperator,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21511,Source of radiation (attribute),Intestinal Neuroendocrine Carcinoma,0
21512,Slightly Able,Colorectal High Grade B-Cell Lymphoma,0
21513,Exertion,Unicystic ameloblastoma,0
21514,Endometrial Carcinoma,Localized Ewing Sarcoma,0
21515,Tissue Specimen Code,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21516,Inguinal region,Basal Cell Ameloblastoma,0
21517,African American,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21518,Poor - qualifier,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21519,Persons,Astrocytoma of brain,0
21520,Kidney,Rhabdomyosarcoma with ganglionic differentiation,0
21521,New,Localized Ewing Sarcoma,0
21522,Assisted (qualifier value),Xeroderma pigmentosum,0
21523,Portion of urine,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21524,>5,Peripheral primitive neuroectodermal tumor of soft tissue,0
21525,Linear,Childhood Fibrillary Astrocytoma,0
21526,Unknown GENC,Refractory Ependymoma,0
21527,Common (qualifier value),Gallbladder Adenocarcinoma,0
21528,Rating (action),Cervical Fibroepithelial Polyp,0
21529,Muscle Pain,Colorectal cancer,0
21530,WHO Central Nervous System Grade IV,Brain Tumor,0
21531,Isolated,Cancer of Urinary Tract,0
21532,Fever,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21533,Escape (mental process),Carcinomatosis of peritoneal cavity,0
21534,Squamous cell carcinoma - category,Carcinoma of urinary bladder,0
21535,Common (qualifier value),Bladder squamous cell carcinoma stage I,0
21536,Neoadjuvant Therapy,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
21537,Tryptophanase,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21538,Australia,Localized Askin Tumor,0
21539,PSA Level Less than Two,Rhabdomyosarcoma with ganglionic differentiation,0
21540,Occurrence,Gallbladder Adenocarcinoma,0
21541,In situ,Type II Endometrial Adenocarcinoma,0
21542,Malignant neoplasm of lung,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
21543,Acetaminophen,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21544,Smear - instruction imperative,Localized Askin Tumor,0
21545,survival aspects,Stage III Cutaneous Melanoma AJCC v6,0
21546,Evidence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21547,Stains,Benign neoplasm of eye,0
21548,Fasting,Tongue Alveolar Soft Part Sarcoma,0
21549,Result,Carcinoma of submandibular gland,0
21550,Correct (qualifier),Thymic Clear Cell Carcinoma,0
21551,Spreading (qualifier value),Childhood Lymphoma,0
21552,Medical History,FIGO Stage II Ovarian Cancer,0
21553,Tissue Specimen Code,Metaplastic carcinoma of breast,0
21554,Corner Plus,Mucinous adenocarcinoma gastric,0
21555,Lesion,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21556,Tumor Mass,Metastatic Lung Small Cell Carcinoma,0
21557,English race,Adult Acute Eosinophilic Leukemia,0
21558,Sore sensation,Pancreatic carcinoma,0
21559,World Health Organization,Squamous cell carcinoma of lip,0
21560,Classification of information,ICHTHYOSIS,0
21561,Malignant - descriptor,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21562,Gastrointestinal tract structure,Spindle Cell Melanoma,0
21563,Rating (action),Multiple Skull Base Meningiomas,0
21564,Pancreatic Hormones,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21565,Childhood Diffuse Large B-Cell Lymphoma,Digestive System Hodgkin Lymphoma,0
21566,Loss of Appetite question,Adult Fibrolamellar Carcinoma,0
21567,Eighth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21568,Malignant - descriptor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21569,Age at diagnosis,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21570,Organ,Benign neoplasm of eye,0
21571,risk factors - observation list,Stage II Carcinoma of Penis,0
21572,To,Stage III Adult Immunoblastic Lymphoma,0
21573,Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21574,Abnormally high,Recurrent Diffuse Intrinsic Pontine Glioma,0
21575,C3 gene,Benign squamous cell tumor,0
21576,Diagnosis,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21577,Regurgitation - mechanism,Malignant melanoma of eyelid,0
21578,Complete Agreement,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21579,Continuance of life,Locally Advanced Squamous Cell Carcinoma,0
21580,Togo,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21581,Separate,Localized Ewing Sarcoma,0
21582,Behavior,Metastatic Neoplasm to the Gallbladder,0
21583,Cause of Death,Maxillary Sinus Adenocarcinoma,0
21584,Body structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
21585,Name (property) (qualifier value),Childhood Anaplastic Large Cell Lymphoma,0
21586,Leading,Acantholytic squamous cell carcinoma,0
21587,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Undifferentiated Leukemia,0
21588,Rest,Adult Acute Eosinophilic Leukemia,0
21589,Site,Mixed parotid tumor,0
21590,Renal carcinoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21591,Type A,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
21592,depend,Breast Ductal Adenoma,0
21593,Age,Human Papillomavirus-Related Carcinoma,0
21594,Body Fluid Discharge,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21595,Affecting,Bladder adenocarcinoma stage IV,0
21596,Leading,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21597,Salivary Glands,Microcystic meningioma,0
21598,Lymphoma,FIGO Stage II Ovarian Cancer,0
21599,child survival,Central Nervous System Yolk Sac Tumor,0
21600,Involvement with,Medulloblastoma,0
21601,Excision,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21602,Surgical aspects,Uterine Cancer,0
21603,Five-year Survival Rate,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21604,International Foot,Squamous cell carcinoma of lip,0
21605,Make - Instruction Imperative,Localized Askin Tumor,0
21606,Hypothalamic structure,Stage IB Lung Cancer AJCC v7,0
21607,Glycation End Products,Endometrial Small Cell Carcinoma,0
21608,Case (situation),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21609,More,Cartilaginous exostosis,0
21610,Thyroid carcinoma,Stage III Cutaneous Melanoma AJCC v6,0
21611,Human body structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21612,Death (finding),Primary Cutaneous Plasmablastic Lymphoma,0
21613,Death (finding),Localized Malignant Neoplasm,0
21614,Disease remission,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
21615,Tumor cells,Splenic Manifestation of Hairy Cell Leukemia,0
21616,Relationships,Bladder Neuroendocrine Neoplasm,0
21617,Tissue Specimen Code,Peripheral primitive neuroectodermal tumor of soft tissue,0
21618,Antacids,Localized Askin Tumor,0
21619,Palatine Tonsil,Refractory Glioma,0
21620,Human body,mucinous adenocarcinoma of gallbladder,0
21621,Bulbomembranous Urethra,Tonsillar Carcinoma,0
21622,Breast Carcinoma,Advanced Lung Carcinoma,0
21623,Due to,papillary carcinoma of penis,0
21624,What subject filter - Result,Anterior Urethral Malignant Neoplasm,0
21625,Base of the Brain,Spermatocytic seminoma,0
21626,Freckles,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
21627,Vertebrates,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21628,Inguinal region,Squamous cell carcinoma of lip,0
21629,Negative Selection,Testicular cancer metastatic,0
21630,High Mitosis-Karyorrhexis Index,Carcinomatosis of peritoneal cavity,0
21631,Pleomorphism,Precursor B-lymphoblastic lymphoma stage II,0
21632,Meaning,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21633,Pericardial sac structure,Neoplasms,0
21634,Tissue Specimen Code,Liver Lymphangioma,0
21635,Throat,Low Grade Squamous Intraepithelial Neoplasia,0
21636,70%,Locally Advanced Squamous Cell Carcinoma,0
21637,Carcinoma with osteoclast-like giant cells,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21638,Early,Anterior Urethral Malignant Neoplasm,0
21639,Cancer Genus,Localized Ewing Sarcoma,0
21640,Location,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21641,Involvement with,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21642,Occur (action),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21643,Therapeutic radiology procedure,Bladder adenocarcinoma stage IV,0
21644,various antiseptic throat preparations,Non-Metastatic Gestational Trophoblastic Tumor,0
21645,Type - attribute,BRCA2 Syndrome,0
21646,Skin lesion,adenoid cystic carcinoma of lung,0
21647,Result,Cervical Squamous Intraepithelial Neoplasia,0
21648,Set of regional lymph nodes,Carcinomatosis of peritoneal cavity,0
21649,Coding Subtest (WAIS-IV),Adult Acute Eosinophilic Leukemia,0
21650,Suspected diagnosis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21651,Current (present time),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21652,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21653,Class,Neonatal leukemia,0
21654,70%,Tubal Hyperplasia,0
21655,Location,Recurrent Primary Lymphoma of Bone,0
21656,Cervix carcinoma,Maxillary Sinus Adenocarcinoma,0
21657,Exposure to,Spermatocytic seminoma,0
21658,nonspecific,clear cell adenocarcinoma of gallbladder,0
21659,Thyroid Gland,Cartilaginous exostosis,0
21660,40%,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21661,Diagnosis Study,Stage IB Lung Cancer AJCC v7,0
21662,African American,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21663,Support,Colorectal cancer,0
21664,Sweat,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21665,Blood Products Laboratory Testing,Cancer of Urinary Tract,0
21666,Immune,Benign neoplasm of thorax,0
21667,Primary malignant neoplasm,Lipoma of small intestine,0
21668,Name (property) (qualifier value),Mucinous cystadenofibroma,0
21669,Blood group antibody I,Transitional cell carcinoma,0
21670,Several,Heavy Chain Deposition Disease,0
21671,Requirement,FIGO Stage IVA Ovarian Cancer,0
21672,Tract,Metaplastic carcinoma of breast,0
21673,Complete,malignant lymphoma of pancreatic lymph nodes,0
21674,IPSS Risk Category High,Acinar cell carcinoma of pancreas,0
21675,American College of Cardiology/American Heart Association Lesion Complexity Score C,Stage IB Pancreatic Cancer AJCC v8,0
21676,Pelvic pain female,Recurrent Testicular Lymphoma,0
21677,adjectives,Bladder squamous cell carcinoma stage I,0
21678,Human body,Vaginal Adenoid Cystic Carcinoma,0
21679,Usually Need Help from Another Person for Reach,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21680,Name,embryonal rhabdomyosarcoma of prostate,0
21681,Body tissue,Extracranial Neuroblastoma,0
21682,History of - blood transfusion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21683,FDA Establishment Activity Terminology,Locally Advanced Squamous Cell Carcinoma,0
21684,Limited stage (cancer stage),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21685,Mass of body structure,Cancer of Urinary Tract,0
21686,Known,Grade 1 Clear Cell Renal Cell Carcinoma,0
21687,Common Specifications in HL7 V3 Publishing,Chronic Myelomonocytic Leukemia-2,0
21688,Screening,Refractory Ependymoma,0
21689,Occur (action),Hodgkin Disease,0
21690,Structure of minor calyx,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21691,To,Benign tumor of eyelid,0
21692,Advanced phase,Plexosarcoma,0
21693,>5,Digestive System Hodgkin Lymphoma,0
21694,Papillary thyroid carcinoma,Locally Advanced Squamous Cell Carcinoma,0
21695,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Childhood Central Nervous System Ganglioneuroblastoma,0
21696,Common (qualifier value),Benign Apocrine Neoplasm,0
21697,Tentorium <eukaryote>,Acantholytic squamous cell carcinoma,0
21698,Operative Surgical Procedures,Mucinous neoplasm,0
21699,To,Basal Cell Ameloblastoma,0
21700,Nasal cavity,Cartilaginous exostosis,0
21701,Concept model domain,FIGO Stage II Ovarian Cancer,0
21702,Cerebral hemisphere structure (body structure),Ovarian Dermoid Cyst with Secondary Carcinoma,0
21703,How Often Felt Normal question,Childhood Central Nervous System Ganglioneuroblastoma,0
21704,filtration,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21705,Usually,malignant lymphoma of pancreatic lymph nodes,0
21706,abnormal growth by tissue,Squamous cell carcinoma of lip,0
21707,Use of,Benign squamous cell tumor,0
21708,Common (qualifier value),Glomeruloid hemangioma,0
21709,Often - answer to question,adenoid cystic carcinoma of lung,0
21710,member,Gallbladder Adenocarcinoma,0
21711,Presentation,Intraepithelial Melanocytic Hyperplasia,0
21712,diagnosis aspect,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
21713,Base Pairing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21714,leukemia,Adult Acute Eosinophilic Leukemia,0
21715,Death (finding),Acute Undifferentiated Leukemia,0
21716,Feel Tired question,Diffuse malignant mesothelioma,0
21717,Lower lip structure,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
21718,Referring,Liver Lymphangioma,0
21719,Blood Cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21720,Ultraviolet Rays,Squamous cell carcinoma of lip,0
21721,Obesity,Ichthyosis,0
21722,Cells,Engraftment syndrome,0
21723,Woman,embryonal rhabdomyosarcoma of prostate,0
21724,Patient Reported Outcome,Larynx carcinoma recurrent,0
21725,Medicine,Engraftment syndrome,0
21726,Normal,Rhabdomyosarcoma with ganglionic differentiation,0
21727,Chemotherapy,Occult Lung Adenosquamous Carcinoma,0
21728,Frequently,Refractory Bladder Carcinoma,0
21729,Cover - action,Digestive System Hodgkin Lymphoma,0
21730,Definitely Related to Intervention,mucinous adenocarcinoma of gallbladder,0
21731,1+ Score,Cerebral Primitive Neuroectodermal Tumor,0
21732,Coding,Stage III Cutaneous Melanoma AJCC v6,0
21733,Hodgkin Disease,Contact dermatitis due to alkali,0
21734,Cessation of life,Engraftment syndrome,0
21735,Often - answer to question,Squamous cell carcinoma of lip,0
21736,PREVENT (product),mucinous adenocarcinoma of gallbladder,0
21737,Negation,Type II Endometrial Adenocarcinoma,0
21738,Tissue Growth,Cancer of Urinary Tract,0
21739,Carcinoma,Recurrent Testicular Lymphoma,0
21740,Canada,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21741,Usual Severity Weight Loss,Pilocytic astrocytoma of cerebellum,0
21742,50%,Human Papillomavirus-Related Carcinoma,0
21743,Patient observation,Pancreatic carcinoma,0
21744,Include (action),Thyroid Hurthle Cell Carcinoma,0
21745,What subject filter - Result,Vaginal Adenoma,0
21746,Neoplasms,Endometrial Small Cell Carcinoma,0
21747,Gonadal structure,Bladder squamous cell carcinoma stage I,0
21748,Arising in,Pancreatic carcinoma,0
21749,include - SetOperator,Undifferentiated Endocervical Sarcoma,0
21750,Benign Vascular Neoplasm,Ichthyosis,0
21751,Biomaterial Treatment,Medulloblastoma,0
21752,Occur (action),Carcinoma,0
21753,Tumor cells,Neoplasms,0
21754,Formed,FIGO Stage IVA Ovarian Cancer,0
21755,Genus equus,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21756,Malignant Neoplasms,Periosteal Osteosarcoma,0
21757,Sufficiently defined concept definition status (core metadata concept),Locally Advanced Epithelioid Hemangioendothelioma,0
21758,Pure Spanish horse breed (organism),Acantholytic squamous cell carcinoma,0
21759,PSA Level Less than Two,Giant cell angiofibroma,0
21760,<90,Malignant melanoma of eyelid,0
21761,Chemotherapy Regimen,Platinum-Resistant Lung Small Cell Carcinoma,0
21762,To,Non-Metastatic Gestational Trophoblastic Tumor,0
21763,Abdomen distended,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21764,abnormal growth by tissue,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21765,Common (qualifier value),embryonal rhabdomyosarcoma of prostate,0
21766,Areas <moth>,Cervical Squamous Intraepithelial Neoplasia,0
21767,Wild flowers,Unresectable Rhabdomyosarcoma,0
21768,radiotherapeutic,Refractory Barrett Esophagus,0
21769,10%,Methotrexate-Associated Hodgkin Lymphoma,0
21770,Variable (uniformity),Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
21771,Approximate,Uterine Cancer,0
21772,Brain part,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21773,Malignant Neoplasms,Refractory Barrett Esophagus,0
21774,Diagnosis,Kaposi's sarcoma of extrahepatic bile duct,0
21775,Illness: Cannot describe symptoms,Cartilaginous exostosis,0
21776,Tissue Specimen Code,Endometrial Small Cell Carcinoma,0
21777,Most,Intraepithelial Melanocytic Hyperplasia,0
21778,Dryness (characteristic),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21779,2+,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21780,Usually Need Help from Another Person for Arising,Carcinoma of urinary bladder,0
21781,Time (foundation metadata concept),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21782,Divide,Metastatic Neoplasm to the Gallbladder,0
21783,Secondary Neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21784,Wounds and Injuries,Platinum-Resistant Lung Small Cell Carcinoma,0
21785,Coding,Maxillary Sinus Adenoid Cystic Carcinoma,0
21786,Disease,Chest Wall Fibromatosis,0
21787,Abdominal Cavity,Cancer of Urinary Tract,0
21788,Example,Digestive System Hodgkin Lymphoma,0
21789,Contain (action),Bladder adenocarcinoma stage IV,0
21790,Component object,Multiple Skull Base Meningiomas,0
21791,Complete Pharyngeal Contraction,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21792,Benign melanocytic nevus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21793,<3 (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21794,Age at diagnosis:Time:Pt:^Patient:Qn,High Grade Glandular Intraepithelial Neoplasia,0
21795,Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21796,Result,Metastatic Ductal Breast Carcinoma,0
21797,Tissue Specimen Code,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21798,Meibomian Cyst,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21799,Publishing,Childhood Fibrillary Astrocytoma,0
21800,To,Pancreatic carcinoma,0
21801,Only - dosing instruction fragment,Hodgkin lymphoma,0
21802,Human Cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21803,Tickling sensation quality,Childhood Central Nervous System Ganglioneuroblastoma,0
21804,Togo,Pancreatic carcinoma,0
21805,Malignant Neoplasms,Cervical Fibroepithelial Polyp,0
21806,Screening - general NOS (finding),Acute Undifferentiated Leukemia,0
21807,Childhood Lymphoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21808,Arising,Giant cell angiofibroma,0
21809,Type - attribute,embryonal rhabdomyosarcoma of prostate,0
21810,Pediculus (eukaryote),Hodgkin lymphoma,0
21811,Numerous,Cartilaginous exostosis,0
21812,Feelings,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21813,Pituitary Gland,Angiosarcoma of liver,0
21814,Malignant neoplasm of skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21815,Tryptophanase,Adenocarcinoma of the prostate metastatic,0
21816,Esophageal,Recurrent Testicular Lymphoma,0
21817,Human Papillomavirus,Digestive System Hodgkin Lymphoma,0
21818,Tumor Cell Invasion,Mixed astrocytoma-ependymoma,0
21819,Cancer Genus,de novo Myelodysplastic Syndrome,0
21820,Aspects of disease screening,Recurrent Diffuse Intrinsic Pontine Glioma,0
21821,Secretory Vesicles,Refractory Barrett Esophagus,0
21822,Function Axis,Airway Hemangioma,0
21823,Type A,Benign Anal Granular Cell Tumor,0
21824,Small cell carcinoma of lung,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21825,Togo,Peripheral primitive neuroectodermal tumor of soft tissue,0
21826,Regulatory Application,Tonsillar Carcinoma,0
21827,Cells,Chronic Myelomonocytic Leukemia-2,0
21828,Vertebral column,BRCA2 Syndrome,0
21829,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21830,Observation of color of skin,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21831,Done (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
21832,Often - answer to question,Tonsillar Carcinoma,0
21833,Site of origin,mucinous adenocarcinoma of gallbladder,0
21834,Suspected diagnosis,Occult Lung Adenosquamous Carcinoma,0
21835,Adenocarcinoma of anal sac,Low Grade Squamous Intraepithelial Neoplasia,0
21836,N+ (tumor staging),Nasal cavity carcinoma,0
21837,3+ Score,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21838,Name,Thyroid Hurthle Cell Carcinoma,0
21839,Double eyelid,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21840,Concept model range (foundation metadata concept),Childhood Fibrillary Astrocytoma,0
21841,RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Metastatic Lung Neuroendocrine Neoplasm,0
21842,Contain (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21843,Neoplasms,Intestinal Metaplasia of Bladder Urothelium,0
21844,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21845,Probably,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21846,Manufactured sign,Vaginal Adenoma,0
21847,Number of birth,Gallbladder Adenocarcinoma,0
21848,VARIOUS DRUG CLASSES IN ATC,Recurrent Uveal Melanoma,0
21849,Surgical aspects,Liver Lymphangioma,0
21850,Ultraviolet Rays,Stage I Adult Non-Hodgkin Lymphoma,0
21851,exception - ResponseLevel,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21852,Histopathologic Grade,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21853,Injury wounds,Lung squamous cell carcinoma stage I,0
21854,Biomaterial Treatment,Trabecular adenocarcinoma,0
21855,Usual,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21856,Blood capillaries,Breast Ductal Adenoma,0
21857,Subject Risk,Adult Alveolar Soft Part Sarcoma,0
21858,Most,Small cell neuroendocrine carcinoma of bladder,0
21859,Talpidae,Malignant neoplasm of olfactory nerve,0
21860,To,Squamous cell carcinoma of lip,0
21861,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Primary Cutaneous Plasmablastic Lymphoma,0
21862,Cell Count,Hyperplasia of pituitary gland,0
21863,Treatment Epoch,Gallbladder adenoma,0
21864,Different,Metaplastic carcinoma of breast,0
21865,Negation,adenosquamous carcinoma of breast,0
21866,Inguinal part of abdomen,Stage III Cutaneous Melanoma AJCC v6,0
21867,Pass (indicator),Mucinous neoplasm,0
21868,pharmacotherapeutic,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21869,Lymphoid organ structure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21870,Present,Tubal Hyperplasia,0
21871,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21872,Rare,Airway Hemangioma,0
21873,Mixed Neoplasm,Lung Mucinous Cystadenoma,0
21874,Possible,Medulloblastoma,0
21875,Large,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21876,Out (direction),Adult Alveolar Soft Part Sarcoma,0
21877,International Aspects,malignant lymphoma of pancreatic lymph nodes,0
21878,Persons,embryonal rhabdomyosarcoma of prostate,0
21879,Providing presence (regime/therapy),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21880,Diagnosis,Bladder squamous cell carcinoma stage I,0
21881,Have Weight Loss,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21882,1+,Refractory Bladder Carcinoma,0
21883,Screening procedure,Cancer of Urinary Tract,0
21884,Combined,Pancreatic Intraepithelial Neoplasia-3,0
21885,85,Hodgkin lymphoma,0
21886,Include (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21887,Catch - Finding of sensory dimension of pain,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21888,Smear - instruction imperative,Childhood Anaplastic Large Cell Lymphoma,0
21889,LYMPHOID Cancers,Childhood Thyroid Gland Follicular Carcinoma,0
21890,Distal (qualifier value),Benign squamous cell tumor,0
21891,Sunscreening Agents,FIGO Stage IVA Ovarian Cancer,0
21892,Ancestry-Informative Marker,Nasal cavity carcinoma,0
21893,Metastatic Neoplasm,Spongiotic dermatitis,0
21894,Tryptophanase,Choroid Necrotic Melanoma,0
21895,penis,Malignant melanoma of eyelid,0
21896,Sequence Arm,adenosquamous carcinoma of breast,0
21897,Further,Engraftment syndrome,0
21898,Germ Layers,Trabecular adenocarcinoma,0
21899,Abnormal,Thymic Clear Cell Carcinoma,0
21900,Body structure,Thyroid Hurthle Cell Carcinoma,0
21901,English Language,Low Grade Squamous Intraepithelial Neoplasia,0
21902,Administration procedure,Stage IB Pancreatic Cancer AJCC v8,0
21903,Name (property) (qualifier value),Undifferentiated Endocervical Sarcoma,0
21904,Sore to touch,Metastatic Lung Neuroendocrine Neoplasm,0
21905,Survey Foot,Thymic Clear Cell Carcinoma,0
21906,Oligodendroglia,Benign tumor of eyelid,0
21907,Neoplasms,Metastatic Neoplasm to the Gallbladder,0
21908,Tissue Growth,Airway Hemangioma,0
21909,risk factors,Testicular cancer metastatic,0
21910,Diagnostic Imaging,ROSE Cluster 3,0
21911,Oral (intended site),Spongiotic dermatitis,0
21912,metaplastic cell transformation,Platinum-Resistant Lung Small Cell Carcinoma,0
21913,Diagnosis Study,adenoid cystic carcinoma of lung,0
21914,More,Mucinous adenocarcinoma gastric,0
21915,Non-Small Cell Lung Carcinoma,Deep Leiomyoma,0
21916,Malignant Neoplasms,Lipoma of small intestine,0
21917,European race,Hereditary Diffuse Gastric Adenocarcinoma,0
21918,Plumbum metallicum,Carcinoma of urinary bladder,0
21919,Vaginal,Benign tumor of eyelid,0
21920,Uveal melanoma,benign mature teratoma of pancreas,0
21921,Controlled by,Human Papillomavirus-Related Carcinoma,0
21922,potential,Basal Cell Ameloblastoma,0
21923,Skin Specimen,Stage IB Lung Cancer AJCC v7,0
21924,Term (temporal),Human Papillomavirus-Related Carcinoma,0
21925,Primary malignant neoplasm,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21926,Fibroid Tumor,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21927,Surgical aspects,Plexosarcoma,0
21928,Feature,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21929,OTULIN gene,Colorectal High Grade B-Cell Lymphoma,0
21930,Unmarried,Thyroid carcinoma,0
21931,Term (temporal),adenosquamous carcinoma of breast,0
21932,Specific qualifier value,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21933,Adult Lymphoma,Colorectal Neuroendocrine Tumor G2,0
21934,Sepsis (Invertebrate),Adult Alveolar Soft Part Sarcoma,0
21935,diagnosis aspect,Refractory Bladder Carcinoma,0
21936,per year,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21937,Confirmation,Keratoderma,0
21938,Hepatoblastoma,Cystadenocarcinoma,0
21939,Negation,Tonsillar Carcinoma,0
21940,Most,Malignant melanoma of eyelid,0
21941,Control function,de novo Myelodysplastic Syndrome,0
21942,Morphology,Metastatic Malignant Neoplasm in the Sellar Region,0
21943,Sometimes,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
21944,65,Pancreatic Intraepithelial Neoplasia-3,0
21945,Cervix Uteri,Recurrent Primary Lymphoma of Bone,0
21946,Problems - What subject filter,Squamous cell carcinoma of lip,0
21947,Further,adenoid cystic carcinoma of lung,0
21948,Breathing Distress Question,Benign Carotid Body Paraganglioma,0
21949,Human Cells,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21950,Most,Testicular cancer metastatic,0
21951,Classification,Stage III Adult Immunoblastic Lymphoma,0
21952,Data Type - Point In Time,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21953,Initially,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21954,Pelvic Pain,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
21955,Supportive assistance,Medulloblastoma,0
21956,Negation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21957,Occurrence Indicator,Tonsillar Carcinoma,0
21958,REMS Protocol,Diffuse malignant mesothelioma,0
21959,Weight Loss,Ovarian germ cell choriocarcinoma stage IV,0
21960,Surrounding (qualifier value),Type II Endometrial Adenocarcinoma,0
21961,Retinoic Acid Response Element,Splenic Manifestation of Hairy Cell Leukemia,0
21962,Biomaterial Treatment,Breast Ductal Adenoma,0
21963,radiotherapeutic,Heavy Chain Deposition Disease,0
21964,Anaplastic thyroid carcinoma,Extra-Adrenal Paraganglioma,0
21965,Primary malignant neoplasm,Xeroderma pigmentosum,0
21966,To,Metastatic Neoplasm to the Gallbladder,0
21967,Hematologic Tests,Heavy Chain Deposition Disease,0
21968,North America,Heavy Chain Deposition Disease,0
21969,Biomaterial Treatment,Testicular cancer metastatic,0
21970,Used by,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21971,Condition:Find:Pt:^Patient:Nom,Stage I Adult Non-Hodgkin Lymphoma,0
21972,High Grade Cervical Squamous Intraepithelial Neoplasia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21973,Part of,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21974,Splenomegaly,Malignant melanoma of eyelid,0
21975,Case unit dose,Refractory Bladder Carcinoma,0
21976,IPSS Risk Category High,Low Grade Squamous Intraepithelial Neoplasia,0
21977,intended - ParticipationSignature,FIGO Stage II Ovarian Cancer,0
21978,Lymphoid,Neonatal leukemia,0
21979,Measures,Heavy Chain Deposition Disease,0
21980,Term Birth,Cancer of Urinary Tract,0
21981,Average,Choroid Necrotic Melanoma,0
21982,Component object,Undifferentiated Endocervical Sarcoma,0
21983,Gait normal,Primary Cutaneous Plasmablastic Lymphoma,0
21984,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21985,pharmacotherapeutic,Familial Hemophagocytic Lymphocytosis,0
21986,shared attribute,Tonsillar Carcinoma,0
21987,Cells,Mucinous cystadenofibroma,0
21988,React,Spongiotic dermatitis,0
21989,Comparison,Ovarian germ cell choriocarcinoma stage IV,0
21990,Age at menopause:Time:Point in time:^Patient:Quantitative,Benign Ovarian Thecoma,0
21991,United States Military Commissioned Officer O4,Lung squamous cell carcinoma stage I,0
21992,Enhance (action),papillary carcinoma of penis,0
21993,Symptoms aspect,Digestive System Hodgkin Lymphoma,0
21994,Rapid,Metastatic Lung Neuroendocrine Neoplasm,0
21995,occurrence characteristics,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21996,<90,Intraepithelial Melanocytic Hyperplasia,0
21997,Degree Unit of Plane Angle,Acute Undifferentiated Leukemia,0
21998,<3 (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
21999,Anterior portion of neck,Heavy Chain Deposition Disease,0
22000,Striated muscle cell,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22001,Group Object,Localized Askin Tumor,0
22002,With shape,Bladder squamous cell carcinoma stage I,0
22003,BRCA2 gene,Blood Vessel Tumors,0
22004,Hormonal,Leptomeningeal sarcoma,0
22005,Colon <insect>,Xeroderma pigmentosum,0
22006,Lead,Mucosal Melanoma,0
22007,Physical shape,Carcinoma of submandibular gland,0
22008,Type - attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
22009,Ovary,Acantholytic squamous cell carcinoma,0
22010,Either,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22011,Orbital region,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22012,Intrinsic origin,Brain Tumor,0
22013,Exchange (clinical),Stage 0 Penile Cancer AJCC v8,0
22014,Eyelid structure,FIGO Stage II Ovarian Cancer,0
22015,Food Consumption,Clonal Hematopoiesis of Indeterminate Potential,0
22016,Line Unit of Length,Refractory Ependymoma,0
22017,Symptoms,Thymic Clear Cell Carcinoma,0
22018,biopsy characteristics,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22019,Non-Neoplastic Disorder,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
22020,Pharmacotherapy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22021,Multiple Myeloma,Childhood Central Nervous System Ganglioneuroblastoma,0
22022,Groups,Xeroderma pigmentosum,0
22023,Usually,Xeroderma pigmentosum,0
22024,Application Context,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22025,Body Site Modifier - Lower,Metastatic Lung Neuroendocrine Neoplasm,0
22026,Feel Nausea,Medulloblastoma,0
22027,Primary malignant neoplasm,Mixed astrocytoma-ependymoma,0
22028,Stem of plant,Thyroid Hurthle Cell Carcinoma,0
22029,Common (qualifier value),mucinous adenocarcinoma of gallbladder,0
22030,Body tissue,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22031,Regurgitates after swallowing,Type II Endometrial Adenocarcinoma,0
22032,Skin tanning,Adenocarcinoma,0
22033,Bladder Continence Question,Peripheral primitive neuroectodermal tumor of soft tissue,0
22034,bony process,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22035,Type A,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22036,Blood flow,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22037,Ability,clear cell adenocarcinoma of gallbladder,0
22038,Approximate,clear cell adenocarcinoma of gallbladder,0
22039,Carcinoma,Intraepithelial Melanocytic Hyperplasia,0
22040,Membrane Device,Lipoma of small intestine,0
22041,Adenoidal structure,Stage III Cutaneous Melanoma AJCC v6,0
22042,>5,Necrotizing Funisitis,0
22043,Medical Device Emits Smoke,Intestinal Neuroendocrine Carcinoma,0
22044,Malignant - descriptor,Intraepithelial Melanocytic Hyperplasia,0
22045,Skin,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22046,SLC6A2 protein,Benign Anal Granular Cell Tumor,0
22047,Metaplasia,Intraepithelial Melanocytic Hyperplasia,0
22048,Time,Refractory Bladder Carcinoma,0
22049,shared attribute,Extracranial Neuroblastoma,0
22050,Telling untruths,Childhood Fibrillary Astrocytoma,0
22051,Spectrum,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22052,Occur (action),Stage III Cutaneous Melanoma AJCC v6,0
22053,Accurate (qualifier),Carcinoma of submandibular gland,0
22054,Division (surgical procedure),Familial Adenomatous Polyposis Associated Medulloblastoma,0
22055,Growth action,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22056,Lymphoma,Ovarian germ cell choriocarcinoma stage IV,0
22057,Death (finding),Intracortical osteosarcoma,0
22058,ovarian neoplasm,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22059,Pale color saturation,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
22060,NCI Thesaurus Qualifier,Xeroderma pigmentosum,0
22061,Hematologic Neoplasms,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
22062,Tissue Specimen Code,Colorectal Neuroendocrine Tumor G2,0
22063,Malignant neoplasm of breast,Colorectal cancer,0
22064,Second edition,Metastatic Neoplasm to the Gallbladder,0
22065,Contain (action),mucinous adenocarcinoma of gallbladder,0
22066,peripheral blood,High Grade Glandular Intraepithelial Neoplasia,0
22067,Malignant neoplasm of breast,Unresectable Rhabdomyosarcoma,0
22068,Recent,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
22069,Gastrointestinal tract structure,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
22070,Pancreatic Cancer Pathway,Childhood Central Nervous System Ganglioneuroblastoma,0
22071,Singular,Intraepithelial Melanocytic Hyperplasia,0
22072,Anabolism,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22073,Probably,Undifferentiated Endocervical Sarcoma,0
22074,Symptoms,Choroid Necrotic Melanoma,0
22075,Malignant Neoplasms,Transitional cell carcinoma,0
22076,Disease,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22077,Less Than,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22078,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
22079,2+,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22080,Test Result,Chondrosarcoma,0
22081,Cystic,malignant lymphoma of pancreatic lymph nodes,0
22082,Fluid behavior,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22083,Early,Engraftment syndrome,0
22084,Pediculus (eukaryote),Fourth Ventricle and Brain Stem Ependymal Tumor,0
22085,Primary,Occult Lung Adenosquamous Carcinoma,0
22086,Greater,Adult Fibrolamellar Carcinoma,0
22087,Cells,BRCA2 Syndrome,0
22088,Cells,Mucinous adenocarcinoma gastric,0
22089,Subject Risk,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22090,Use of,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22091,Radioactive Seed Implant Dosing Unit,Human Papillomavirus-Related Carcinoma,0
22092,Cancer Genus,Advanced Lung Carcinoma,0
22093,Walled,Choroid Epithelioid Cell Melanoma,0
22094,Myoepithelioma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22095,Plasma,Contact dermatitis due to alkali,0
22096,Malignant neoplasm of liver,Benign neoplasm of thorax,0
22097,Pure Spanish horse breed (organism),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22098,Upper arm,Epithelioid Sarcoma NCI Grade 3,0
22099,Malignant tumor of exocrine pancreas,Localized Malignant Neoplasm,0
22100,Occur (action),Female Breast Carcinoma,0
22101,BEP protocol,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22102,Person Name,Kaposi's sarcoma of extrahepatic bile duct,0
22103,unknown vaccine or immune globulin,Gallbladder Adenocarcinoma,0
22104,Malignant neoplasm of ovary,Small cell neuroendocrine carcinoma of bladder,0
22105,To,Childhood Fibrillary Astrocytoma,0
22106,Molecular Mass,Trichilemmocarcinoma,0
22107,Biogenic Amines,Pancreatic Intraepithelial Neoplasia-3,0
22108,Manufactured sign,Funisitis (disorder),0
22109,Xeroderma Pigmentosum,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22110,Communicable Diseases,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
22111,Pallor,Engraftment syndrome,0
22112,Contraceptives,Kaposi's sarcoma of extrahepatic bile duct,0
22113,control substance,Familial Adenomatous Polyposis Associated Medulloblastoma,0
22114,Metastatic to,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22115,Determined by,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22116,growth aspects,Human Papillomavirus-Related Carcinoma,0
22117,Woman,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22118,Biological Response Modifier Therapy,Mucinous adenocarcinoma gastric,0
22119,Smooth muscle (tissue),Brain Ependymoma,0
22120,Small cell carcinoma of lung,Malignant melanoma of eyelid,0
22121,Primary,Astrocytoma of brain,0
22122,International Unit,Stage III Cutaneous Melanoma AJCC v6,0
22123,Benign Neoplasm,Thymic Atypical Carcinoid Tumor,0
22124,Site of,Cervical Squamous Intraepithelial Neoplasia,0
22125,risk factors,Unicystic ameloblastoma,0
22126,Value Above Reference Range,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22127,The Sun,Atypical Lobular Breast Hyperplasia,0
22128,Lymphadenopathy,papillary carcinoma of penis,0
22129,Myeloid,Astrocytoma of brain,0
22130,PSA Level Less than Five,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22131,Manufactured sign,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22132,CT of systems,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22133,Illness: Cannot describe symptoms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22134,Unmarried,Stage III Adult Immunoblastic Lymphoma,0
22135,Germ cell tumor,clear cell adenocarcinoma of gallbladder,0
22136,List,High Grade Glandular Intraepithelial Neoplasia,0
22137,Africa,Localized Malignant Neoplasm,0
22138,Adult Lymphoma,Astrocytoma of brain,0
22139,NCI CTEP SDC Mesothelioma Sub-Category Terminology,Atypical Mesothelial Hyperplasia,0
22140,combination of objects,Vaginal Adenoma,0
22141,Malignant - descriptor,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22142,Fusion-Negative Rhabdomyosarcoma,Malignant Testicular Sertoli Cell Tumor,0
22143,*Type - Kind of quantity,Periosteal Osteosarcoma,0
22144,Tired,Basal Cell Ameloblastoma,0
22145,Carcinoid Tumor,mucinous adenocarcinoma of gallbladder,0
22146,B-Cell Lymphomas,Cervical Squamous Intraepithelial Neoplasia,0
22147,Childhood Hodgkin Lymphoma,Acantholytic squamous cell carcinoma,0
22148,>90,Advanced Uterine Corpus Carcinosarcoma,0
22149,Entire elbow region,Type II Endometrial Adenocarcinoma,0
22150,Provide (product),Hereditary Diffuse Gastric Adenocarcinoma,0
22151,Beginning,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22152,Sometimes,Melanomatosis,0
22153,mole changes,Carcinoma of urinary bladder,0
22154,peripheral blood,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22155,Lifestyle changes,Gallbladder Adenocarcinoma,0
22156,Make - Instruction Imperative,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22157,Form of joint,Stage IV Childhood Non-Hodgkin Lymphoma,0
22158,SPINK5 gene,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22159,Only - dosing instruction fragment,Transitional cell carcinoma,0
22160,Beginning,Cerebral Primitive Neuroectodermal Tumor,0
22161,year,Adult Acute Eosinophilic Leukemia,0
22162,week,Cerebral Primitive Neuroectodermal Tumor,0
22163,Microscopes,Cancer of Urinary Tract,0
22164,More,Childhood Anaplastic Large Cell Lymphoma,0
22165,Feelings,Thyroid Hurthle Cell Carcinoma,0
22166,Type A,Endometrial Small Cell Carcinoma,0
22167,Unmarried,Uterine Cancer,0
22168,Taxonomic,Clonal Hematopoiesis of Indeterminate Potential,0
22169,risk factors - observation list,Benign Ovarian Thecoma,0
22170,Scab,Breast Ductal Adenoma,0
22171,Enhance (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22172,Orbital region,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22173,Secondary Neoplasm,Female Breast Carcinoma,0
22174,Tumor Mass,Stage III Adult Immunoblastic Lymphoma,0
22175,Person Name,Locally Advanced Squamous Cell Carcinoma,0
22176,Unexplained weight loss,High Grade Glandular Intraepithelial Neoplasia,0
22177,Referral placed,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22178,Same,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
22179,Primary malignant neoplasm,Localized Askin Tumor,0
22180,Upper arm,Gallbladder Adenocarcinoma,0
22181,1000000,clear cell adenocarcinoma of gallbladder,0
22182,Child,Pancreatic carcinoma,0
22183,Management Occupations,Benign tumor of eyelid,0
22184,Statistical Significance,Refractory Ependymoma,0
22185,Resulting in,Cervical Fibroepithelial Polyp,0
22186,Swelling,Childhood Central Nervous System Ganglioneuroblastoma,0
22187,Descending,Angiosarcoma of liver,0
22188,Metaplasia,Endometrial Small Cell Carcinoma,0
22189,Overweight,Granular Cell Leiomyosarcoma,0
22190,factor A,Metaplastic carcinoma of breast,0
22191,Early,Malignant neoplasm of thalamus,0
22192,South East Asian,Intestinal Metaplasia of Bladder Urothelium,0
22193,Symptoms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22194,Lymphoid Tissue,Locally Advanced Squamous Cell Carcinoma,0
22195,United States,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22196,Have Weight Loss,Heavy Chain Deposition Disease,0
22197,Body tissue,Pancreatic Intraepithelial Neoplasia-3,0
22198,Small cell carcinoma of lung,Recurrent Uveal Melanoma,0
22199,Egg of order Phthiraptera,Kaposi's sarcoma of extrahepatic bile duct,0
22200,IPSS Risk Category Low,Kaposi's sarcoma of skin,0
22201,How Often,embryonal rhabdomyosarcoma of prostate,0
22202,Include (action),Cervical Squamous Intraepithelial Neoplasia,0
22203,Vaginal Hemorrhage,BRCA2 Syndrome,0
22204,Hematopoietic Neoplasms,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22205,Tests (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
22206,Hormone (disposition),Unicystic ameloblastoma,0
22207,Germ cell tumor,Unicystic ameloblastoma,0
22208,Part of,Recurrent Primary Lymphoma of Bone,0
22209,Latin America,Stage IB Pancreatic Cancer AJCC v8,0
22210,Cell Device,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22211,Mechanism Component of Device,FIGO Stage IVA Ovarian Cancer,0
22212,Occurrence,Human Papillomavirus-Related Carcinoma,0
22213,True,Bladder Neuroendocrine Neoplasm,0
22214,Usual,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22215,Treatment Epoch,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22216,Poor - qualifier,Tubal Hyperplasia,0
22217,Swallowing:-:Point in time:^Patient:-,gliosarcoma,0
22218,Body tissue,Intestinal Metaplasia of Bladder Urothelium,0
22219,Neoplasm Metastasis,Stage I Adult Non-Hodgkin Lymphoma,0
22220,Result,Localized Ewing Sarcoma,0
22221,Biopsy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22222,Patient need for (contextual qualifier),Type II Endometrial Adenocarcinoma,0
22223,Childhood Gliosarcoma,Acantholytic squamous cell carcinoma,0
22224,Base - General Qualifier,Anaplastic large cell lymphoma,0
22225,Eighth,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22226,MOSTLY,Medulloblastoma,0
22227,Bile duct structure,ICHTHYOSIS,0
22228,Bone Marrow,Neoplasms,0
22229,Rare,clear cell adenocarcinoma of gallbladder,0
22230,Smoking,Nasal cavity carcinoma,0
22231,Abdomen+,Cervical Fibroepithelial Polyp,0
22232,rituximab,Stage IV Penile Cancer AJCC v7,0
22233,Mammary Gland Parenchyma,Human Papillomavirus-Related Carcinoma,0
22234,Class,Non-Metastatic Gestational Trophoblastic Tumor,0
22235,Percent (qualifier value),Clonal Hematopoiesis of Indeterminate Potential,0
22236,Rest,Metastatic Ductal Breast Carcinoma,0
22237,Subtype (attribute),Malignant Neoplasm with Regional Lymph Node Involvement,0
22238,Epithelium,Unfavorable Non-Hodgkin Lymphoma,0
22239,Affecting,Malignant melanoma of eyelid,0
22240,Very Much,Glomeruloid hemangioma,0
22241,3+ Score,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22242,Normal,malignant lymphoma of pancreatic lymph nodes,0
22243,Widening,Ovarian Carcinoid Tumor,0
22244,PSA Level Greater than Fifty,Medulloblastoma,0
22245,30%,Childhood Fibrillary Astrocytoma,0
22246,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Airway Hemangioma,0
22247,Immunotherapy,Tonsillar Carcinoma,0
22248,Linear,Localized Askin Tumor,0
22249,Salts,Chronic Myelomonocytic Leukemia-2,0
22250,Physical findings,Intraepithelial Melanocytic Hyperplasia,0
22251,Spreading (qualifier value),Testicular cancer metastatic,0
22252,Feel Tired question,Non-Metastatic Gestational Trophoblastic Tumor,0
22253,Pseudomyxoma Peritonei,Thyroid Hurthle Cell Carcinoma,0
22254,95,Cervical Squamous Intraepithelial Neoplasia,0
22255,Common (qualifier value),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
22256,breast.duct,Adult Alveolar Soft Part Sarcoma,0
22257,Treatment Effectiveness,Stage III Cutaneous Melanoma AJCC v6,0
22258,Life,Ovarian germ cell choriocarcinoma stage IV,0
22259,Scientific Study,Metaplastic carcinoma of breast,0
22260,Abdomen distended,Carcinomatosis of peritoneal cavity,0
22261,Characteristics,Recurrent Diffuse Intrinsic Pontine Glioma,0
22262,Have Itch,Unresectable Rhabdomyosarcoma,0
22263,90%,Ovarian germ cell choriocarcinoma stage IV,0
22264,PAGR1 wt Allele,Benign Anal Granular Cell Tumor,0
22265,interstitial,Malignant Neoplasm of Lung - Multiple Primary Sites,0
22266,Common Specifications in HL7 V3 Publishing,Trichilemmocarcinoma,0
22267,Cell Count,Xeroderma pigmentosum,0
22268,Numerous,Hodgkin lymphoma,0
22269,Common Specifications in HL7 V3 Publishing,Malignant Neoplasm with Regional Lymph Node Involvement,0
22270,Have Weight Loss,Thyroid Hurthle Cell Carcinoma,0
22271,To,Noninfiltrating Intraductal Carcinoma,0
22272,Lung,non-Hodgkin's lymphoma of spleen,0
22273,Include (action),Hodgkin Disease,0
22274,Nobel Prize,Tonsillar Carcinoma,0
22275,Greeks,embryonal rhabdomyosarcoma of prostate,0
22276,regional,Malignant melanoma of eyelid,0
22277,Tryptophanase,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22278,Ultrasonic,Granular Cell Leiomyosarcoma,0
22279,size,BRCA2 Syndrome,0
22280,More Often than Once a Day,gliosarcoma,0
22281,Female Phenotype,Testicular cancer metastatic,0
22282,Removal of bladder,Cystadenocarcinoma,0
22283,Screening Study,Refractory Glioma,0
22284,Storage Unit,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
22285,Symptoms,Low Grade Squamous Intraepithelial Neoplasia,0
22286,Probably,Unicystic ameloblastoma,0
22287,Job Status - Temporary,Adult Hepatocellular Carcinoma,0
22288,Hematologic Neoplasms,Rhabdomyosarcoma with ganglionic differentiation,0
22289,include - SetOperator,Malignant Testicular Sertoli Cell Tumor,0
22290,Smaller,Cervical Squamous Intraepithelial Neoplasia,0
22291,Colon <insect>,Bladder squamous cell carcinoma stage I,0
22292,Disease,Locally Advanced Soft Tissue Sarcoma,0
22293,Carrying,Extracranial Neuroblastoma,0
22294,Secondary to,Malignant neoplasm of thalamus,0
22295,Tanning of leather,malignant lymphoma of pancreatic lymph nodes,0
22296,Physical findings,squamous cell carcinoma of the thyroid gland,0
22297,80%,Mucinous neoplasm,0
22298,Chemotherapy,Contact dermatitis due to alkali,0
22299,How Much Distress Weight Loss,Noninfiltrating Intraductal Carcinoma,0
22300,Deoxyribonucleic Acid Measurement,Refractory Bladder Carcinoma,0
22301,Environmental risk factor,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22302,General surgery specialty,Recurrent Uveal Melanoma,0
22303,Increase in size since previous mammogram,Necrotizing Funisitis,0
22304,1000000,Squamous cell carcinoma of lip,0
22305,per year,Female Breast Carcinoma,0
22306,Sufficiently defined concept definition status (core metadata concept),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22307,Itchiness,Stage IV Colorectal Cancer AJCC v8,0
22308,Subject Risk,clear cell adenocarcinoma of gallbladder,0
22309,How Much Distress Itching,Primary Cutaneous Plasmablastic Lymphoma,0
22310,Etiology aspects,FIGO Stage IVA Ovarian Cancer,0
22311,Median (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
22312,majority,Undifferentiated Endocervical Sarcoma,0
22313,Tissue Specimen Code,Malignant neoplasm of choroid,0
22314,Location of Oral Residue Following Swallowing,Metastatic Ductal Breast Carcinoma,0
22315,Specimen Source Codes - Mucus,Extracranial Neuroblastoma,0
22316,Occur (action),Microcystic meningioma,0
22317,Occur (action),Stage IV Penile Cancer AJCC v7,0
22318,Thyroid carcinoma,Parathyroid Gland Adenocarcinoma,0
22319,Lymphohistiocytosis,Neoplasms,0
22320,Trauma,Leptomeningeal sarcoma,0
22321,Firstly,Refractory Barrett Esophagus,0
22322,Morphology,FIGO Stage IVA Ovarian Cancer,0
22323,Tobacco smoking behavior,Metastatic Neoplasm to the Gallbladder,0
22324,various allergen extracts,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22325,Air,Medulloblastoma,0
22326,Transurethral Resection,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22327,Specific qualifier value,Diffuse malignant mesothelioma,0
22328,PCYT1A wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22329,Process (qualifier value),mucinous adenocarcinoma of gallbladder,0
22330,Rate,Acute Undifferentiated Leukemia,0
22331,Glandular,Breast Ductal Adenoma,0
22332,Primary malignant neoplasm,Malignant melanoma of eyelid,0
22333,Treatment Epoch,Stage I Colon Neuroendocrine Tumor AJCC v8,0
22334,Nausea,Melanomatosis,0
22335,Then,Extracranial Neuroblastoma,0
22336,Malignant Neoplasms,Childhood Lung Non-Small Cell Carcinoma,0
22337,Prostate,Metastatic Malignant Neoplasm in the Sellar Region,0
22338,CEL gene,Larynx carcinoma recurrent,0
22339,Code,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22340,Tryptophanase,Benign Apocrine Neoplasm,0
22341,Patterns,Advanced Lung Carcinoma,0
22342,Specimen Source Codes - tumor,Stage III Cutaneous Melanoma AJCC v6,0
22343,Mass of body structure,Prostate Lymphoma,0
22344,Milliampere second,Cerebral Primitive Neuroectodermal Tumor,0
22345,Greece,Childhood Central Nervous System Ganglioneuroblastoma,0
22346,Science of Morphology,Medulloblastoma,0
22347,Rating (action),Small intestine carcinoma,0
22348,Involvement with,Thyroid carcinoma,0
22349,Abnormal Reference Range,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22350,Parenchyma,Rhabdomyosarcoma with ganglionic differentiation,0
22351,Immature Lymphocytes Measurement,Kaposi's sarcoma of extrahepatic bile duct,0
22352,Form:Finding:Point in time:{Setting}:Document:{Role},Extracranial Neuroblastoma,0
22353,Time,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
22354,Group Object,Extra-Adrenal Paraganglioma,0
22355,Hepatitis Viruses,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22356,Pickled food,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22357,Infrequent,Liver Lymphangioma,0
22358,Inspiration function,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22359,Call (Instruction),Kaposi's sarcoma of skin,0
22360,Lung,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
22361,Sole of Foot,ROSE Cluster 3,0
22362,CD5 Positive,Splenic Manifestation of Hairy Cell Leukemia,0
22363,Prognosis good,Stage 0 Penile Cancer AJCC v8,0
22364,Short Value,Mixed astrocytoma-ependymoma,0
22365,Follicle,Basal Cell Ameloblastoma,0
22366,Liver,Breast Ductal Adenoma,0
22367,Introduces,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22368,Limb structure,Bladder squamous cell carcinoma stage I,0
22369,Limited stage (cancer stage),Malignant Neoplasm with Regional Lymph Node Involvement,0
22370,Adenocarcinoma of large intestine,Noninfiltrating Intraductal Carcinoma,0
22371,Taking of swab,Pancreatic carcinoma,0
22372,Dysgerminoma,Bladder squamous cell carcinoma stage I,0
22373,CHURC1 gene,Colorectal cancer,0
22374,Neuroendocrine Tumors,Undifferentiated Endocervical Sarcoma,0
22375,Xeroderma Pigmentosum,BRCA2 Syndrome,0
22376,Nicotiana,Localized Askin Tumor,0
22377,Edema,Recurrent Testicular Lymphoma,0
22378,Undifferentiated,Stage III Cutaneous Melanoma AJCC v6,0
22379,best (quality),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22380,risk factors,Childhood Choriocarcinoma,0
22381,Insecticides,Mucinous adenocarcinoma gastric,0
22382,Food,Unresectable Rhabdomyosarcoma,0
22383,Left,Gallbladder Adenocarcinoma,0
22384,Mean Percent of Normal,Adult Brain Stem Mixed Glioma,0
22385,Occur (action),Squamous cell carcinoma of lip,0
22386,Combined,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22387,Treating,Squamous cell carcinoma of lip,0
22388,True primary (qualifier value),ICHTHYOSIS,0
22389,Blood,Undifferentiated Endocervical Sarcoma,0
22390,control substance,Localized Malignant Neoplasm,0
22391,Entity Name Part Qualifier - birth,clear cell adenocarcinoma of gallbladder,0
22392,biopsy characteristics,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22393,Often - answer to question,Vaginal Adenoid Cystic Carcinoma,0
22394,Patient Outcome,Kaposi's sarcoma of extrahepatic bile duct,0
22395,Abnormal cell,Endometrial Small Cell Carcinoma,0
22396,white blood cell type,Medulloblastoma,0
22397,Type - attribute,Microcystic meningioma,0
22398,Dietary Lead,Thymic Clear Cell Carcinoma,0
22399,Assortment,Mixed astrocytoma-ependymoma,0
22400,Possible diagnosis,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22401,Before,Mucinous cystadenofibroma,0
22402,Pancreas part,Spongiotic dermatitis,0
22403,Specimen Source Codes - tumor,Clonal Hematopoiesis of Indeterminate Potential,0
22404,Primary malignant neoplasm,Undifferentiated Endocervical Sarcoma,0
22405,combination of objects,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22406,Mechanism (attribute),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
22407,Glioma,Astrocytoma of brain,0
22408,Adverse Event Associated with Vascular,Endometrial Small Cell Carcinoma,0
22409,Mathematical Operator,Thymic Clear Cell Carcinoma,0
22410,Squamous Epithelial Cells,Stage I Colon Neuroendocrine Tumor AJCC v8,0
22411,Adult human body,FIGO Stage II Ovarian Cancer,0
22412,Sometimes,Intraepithelial Melanocytic Hyperplasia,0
22413,Skin Specimen,Metastatic Malignant Neoplasm in the Sellar Region,0
22414,Slow Growing Mass,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22415,Unmarried person,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22416,Exposure to radiation,High Grade Glandular Intraepithelial Neoplasia,0
22417,Play,Benign Apocrine Neoplasm,0
22418,National origin,Anterior Urethral Malignant Neoplasm,0
22419,Abnormal,Squamous cell carcinoma of lip,0
22420,Proliferation,High Grade Glandular Intraepithelial Neoplasia,0
22421,Ocular orbit,Adult Alveolar Soft Part Sarcoma,0
22422,Chromosomal translocation,Colorectal Neuroendocrine Tumor G2,0
22423,Pharmacotherapy,Mixed astrocytoma-ependymoma,0
22424,Transmitted by,Localized Malignant Neoplasm,0
22425,Skin,Stage 0 Lip Carcinoma,0
22426,Grade three rank,Spermatocytic seminoma,0
22427,Area,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22428,Lymphoid Tissue,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22429,Togo,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22430,Type - attribute,Thyroid Hurthle Cell Carcinoma,0
22431,Part of,Basal Cell Ameloblastoma,0
22432,Common (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
22433,Sex Behavior,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22434,Pharmacotherapy,Precursor B-lymphoblastic lymphoma stage II,0
22435,SELL protein,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
22436,Microscopes,Colorectal Neuroendocrine Tumor G2,0
22437,Light Microscopy,Diffuse malignant mesothelioma,0
22438,Lymphoma,Mucinous adenocarcinoma gastric,0
22439,Conditional,Digestive System Hodgkin Lymphoma,0
22440,Medical Imaging,Ectomesenchymal Chondromyxoid Tumor,0
22441,Long-term,Mucinous adenocarcinoma gastric,0
22442,High Risk Acute Leukemia,Ichthyosis,0
22443,melanoma,Activated B-cell type diffuse large B-cell lymphoma,0
22444,Dyspareunia,Adenocarcinoma,0
22445,Immunoglobulins,Noninfiltrating Intraductal Carcinoma,0
22446,NCI CTEP SDC Thyroid Cancer Sub-Category Terminology,Microcystic meningioma,0
22447,Abundance,Cervical Squamous Intraepithelial Neoplasia,0
22448,Thyroid hormone (disposition),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22449,High Level,squamous cell carcinoma of the thyroid gland,0
22450,Negation,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22451,Fungi,Carcinomatosis of peritoneal cavity,0
22452,False Discovery Rate,Locally Advanced Soft Tissue Sarcoma,0
22453,MALIGNANT benign,Undifferentiated Endocervical Sarcoma,0
22454,Ocular orbit,Childhood Anaplastic Large Cell Lymphoma,0
22455,Weight Loss,Acantholytic squamous cell carcinoma,0
22456,How Much Distress Shortness of Breath,Spongiotic dermatitis,0
22457,risk factors - observation list,FIGO Stage IVA Ovarian Cancer,0
22458,Large,Squamous cell carcinoma of lip,0
22459,Life Threatening,Type II Endometrial Adenocarcinoma,0
22460,Hemangioma,Carcinomatosis of peritoneal cavity,0
22461,Abdomen+,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22462,Back Pain,Chest Wall Fibromatosis,0
22463,Body part,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22464,Decision,Cervical Adenomyoma,0
22465,Long-term Follow-up,Stage I Adult Non-Hodgkin Lymphoma,0
22466,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22467,Call (Instruction),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
22468,Common (qualifier value),Unresectable Rhabdomyosarcoma,0
22469,Area,Angiosarcoma of liver,0
22470,status - In progress,Epithelioid Sarcoma NCI Grade 3,0
22471,Immunotherapy,Precursor B-lymphoblastic lymphoma stage II,0
22472,Incidence,Pilocytic astrocytoma of cerebellum,0
22473,Result,BRCA2 Syndrome,0
22474,Frequently,papillary carcinoma of penis,0
22475,Mass of body structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22476,Complex,Pancreatic Endocrine Carcinoma,0
22477,Lacking,Unfavorable Non-Hodgkin Lymphoma,0
22478,Scar Tissue,Localized Ewing Sarcoma,0
22479,Rarely malignant,Unresectable Rhabdomyosarcoma,0
22480,Decision,Kaposi's sarcoma of extrahepatic bile duct,0
22481,Inhaled air,Refractory Ependymoma,0
22482,United States,Cancer of Urinary Tract,0
22483,Targeted Therapy,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22484,Subtype (attribute),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22485,Volume,Endometrial Small Cell Carcinoma,0
22486,Experimental Result,Adult Hepatocellular Carcinoma,0
22487,cancer risk,Intestinal Metaplasia of Bladder Urothelium,0
22488,Gestational Trophoblastic Neoplasms,Cancer of Urinary Tract,0
22489,Fatigue,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
22490,Type - attribute,Unresectable Rhabdomyosarcoma,0
22491,Gestational trophoblastic disease,FIGO Stage II Ovarian Cancer,0
22492,Base - General Qualifier,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22493,Larynx,Acantholytic squamous cell carcinoma,0
22494,Often - answer to question,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22495,Individual,Refractory Bladder Carcinoma,0
22496,Surface of skin,Pilocytic astrocytoma of cerebellum,0
22497,Term Birth,Digestive System Hodgkin Lymphoma,0
22498,Childhood Extracranial Germ Cell Tumor,Angiosarcoma of liver,0
22499,Experimental Result,Mastocytosis,0
22500,Primary malignant neoplasm,Human Papillomavirus-Related Carcinoma,0
22501,New,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22502,Call (Instruction),Cancer of Urinary Tract,0
22503,Electromagnetic Spectrum,Clonal Hematopoiesis of Indeterminate Potential,0
22504,Malignant Vaginal Neoplasm,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22505,High expression,Breast Ductal Adenoma,0
22506,Stem of plant,Acute Undifferentiated Leukemia,0
22507,Cell (compartment),Squamous cell carcinoma of lip,0
22508,Form:Finding:Point in time:{Setting}:Document:{Role},embryonal rhabdomyosarcoma of prostate,0
22509,AIDS defining illness,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
22510,Disease susceptibility,Vaginal Adenoid Cystic Carcinoma,0
22511,Cell Count,Maxillary Sinus Adenocarcinoma,0
22512,Qualifier (concept),Astrocytoma of brain,0
22513,Free (available (qualifier)),Benign Anal Granular Cell Tumor,0
22514,Entity Determiner - specific,Lipoma of small intestine,0
22515,Growth,FIGO Stage II Ovarian Cancer,0
22516,Collection (action),Childhood Lymphoma,0
22517,Areas <moth>,Kaposi's sarcoma of extrahepatic bile duct,0
22518,Negation,Kaposi's sarcoma of skin,0
22519,Adult human body,Nasal cavity carcinoma,0
22520,Most,Malignant neoplasm of thalamus,0
22521,Surgery specialty,Cartilaginous exostosis,0
22522,Palpebral margin,Microcystic meningioma,0
22523,mole changes,Ichthyoses,0
22524,Low Back Pain,Non-Metastatic Gestational Trophoblastic Tumor,0
22525,Two,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22526,shared attribute,Colorectal Neuroendocrine Tumor G2,0
22527,Has difficulty doing (qualifier value),Cancer of Urinary Tract,0
22528,Including (qualifier),Stage IB Pancreatic Cancer AJCC v8,0
22529,10%,Stage IV Colorectal Cancer AJCC v8,0
22530,Lung,Metastatic Lung Neuroendocrine Neoplasm,0
22531,Old,Kaposi's sarcoma of skin,0
22532,Usually,Thymic Clear Cell Carcinoma,0
22533,Count of entities,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22534,Possible diagnosis,Human Papillomavirus-Related Carcinoma,0
22535,Ambient,embryonal rhabdomyosarcoma of prostate,0
22536,Childhood Non-Hodgkin Lymphoma,Papillary squamous cell carcinoma,0
22537,House mice,Digestive System Hodgkin Lymphoma,0
22538,1000000,Recurrent Uveal Melanoma,0
22539,Large,Acute Undifferentiated Leukemia,0
22540,Sequence Data Type,Prostate Lymphoma,0
22541,Study Site,Female Breast Carcinoma,0
22542,Pharyngitis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22543,Characteristics,Blepharal carcinoma,0
22544,Neoplastic Cell Transformation,Chronic Myelomonocytic Leukemia-2,0
22545,Negation,Adrenal Rest Tumor,0
22546,Blood Platelets,Refractory Bladder Carcinoma,0
22547,Mutation Abnormality,Hodgkin lymphoma,0
22548,Participation Type - origin,Human Papillomavirus-Related Carcinoma,0
22549,Decision,Undifferentiated Endocervical Sarcoma,0
22550,Type - attribute,Pilocytic astrocytoma of cerebellum,0
22551,Severe (severity modifier),Recurrent Rhabdomyosarcoma,0
22552,Count of entities,Splenic Manifestation of Hairy Cell Leukemia,0
22553,Skin,Stage IB Lung Cancer AJCC v7,0
22554,Status post,Atypical Mesothelial Hyperplasia,0
22555,Note (document),Undifferentiated Neuroblastoma,0
22556,Affecting,Human Papillomavirus-Related Carcinoma,0
22557,Primary malignant neoplasm,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
22558,Appearance,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22559,Urine,Kaposi's sarcoma of extrahepatic bile duct,0
22560,Common Specifications in HL7 V3 Publishing,Clonal Hematopoiesis of Indeterminate Potential,0
22561,Blood group antibody I,Blood Vessel Tumors,0
22562,Ninth,Liver Cavernous Hemangioma,0
22563,Fever,Adult Alveolar Soft Part Sarcoma,0
22564,Genus Homo,Locally Advanced Squamous Cell Carcinoma,0
22565,World,Pancreatic Intraepithelial Neoplasia-3,0
22566,include - SetOperator,Thyroid carcinoma,0
22567,Lip structure,Extracranial Neuroblastoma,0
22568,Out (direction),Benign neoplasm of thorax,0
22569,Management procedure,Cerebral Primitive Neuroectodermal Tumor,0
22570,Adverse Event Associated with Syndromes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22571,risk factors,embryonal rhabdomyosarcoma of prostate,0
22572,Ancestry-Informative Marker,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22573,Poor - grade value,Granular Cell Leiomyosarcoma,0
22574,Age,Stage II Carcinoma of Penis,0
22575,Pith - plant part,Mucinous adenocarcinoma gastric,0
22576,Primary malignant neoplasm,Papillary squamous cell carcinoma,0
22577,Testicular Neoplasms,Adult Acute Eosinophilic Leukemia,0
22578,Estrogens,Childhood Anaplastic Large Cell Lymphoma,0
22579,Mean Percent of Normal,Pancreatic Intraepithelial Neoplasia-3,0
22580,Cancer Genus,embryonal rhabdomyosarcoma of prostate,0
22581,Carcinoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22582,Usual Severity Pain,Carcinoma of urinary bladder,0
22583,Animals,Cerebral Primitive Neuroectodermal Tumor,0
22584,Stomach,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22585,bacteria aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22586,Distal (qualifier value),Bladder squamous cell carcinoma stage I,0
22587,Reinfection,clear cell adenocarcinoma of gallbladder,0
22588,Play,Bladder squamous cell carcinoma stage I,0
22589,Financial Account,FIGO Stage II Ovarian Cancer,0
22590,Imaging Techniques,Pancreatic Intraepithelial Neoplasia-3,0
22591,IPSS Risk Category High,squamous cell carcinoma of the thyroid gland,0
22592,Surgical aspects,Mucinous adenocarcinoma gastric,0
22593,Injury cause,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22594,Metastatic to,Localized Malignant Neoplasm,0
22595,Presentation,Diffuse malignant mesothelioma,0
22596,risk factors,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22597,Retinoic Acid Response Element,Refractory Bladder Carcinoma,0
22598,Dermatitis,Multiple Skull Base Meningiomas,0
22599,Primary operation,BRCA2 Syndrome,0
22600,Characteristics,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22601,Participation Type - origin,Childhood Central Nervous System Ganglioneuroblastoma,0
22602,BBS9 wt Allele,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22603,include - SetOperator,Mucosal Melanoma,0
22604,CEL gene,Methotrexate-Associated Hodgkin Lymphoma,0
22605,Base - General Qualifier,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22606,90%,Trichilemmocarcinoma,0
22607,Prophylactic behavior,Cerebral Primitive Neuroectodermal Tumor,0
22608,Gastroenterologist,Mucinous neoplasm,0
22609,Tactile,adenosquamous carcinoma of breast,0
22610,Crystal Structure,Nasal cavity carcinoma,0
22611,Adult Germ Cell Tumor,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22612,A Codes,Benign tumor of eyelid,0
22613,Rapid,Placental aromatase deficiency,0
22614,Symptoms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22615,Source,Werner Syndrome,0
22616,Tissue Specimen Code,Cancer of Urinary Tract,0
22617,Decision,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22618,melanoma,Human Papillomavirus-Related Carcinoma,0
22619,Pitch (deviation),Atypical Lobular Breast Hyperplasia,0
22620,FAT1 wt Allele,Peripheral primitive neuroectodermal tumor of soft tissue,0
22621,Including (qualifier),Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
22622,Empty (qualifier),Lipoma of small intestine,0
22623,Known,FIGO Stage II Ovarian Cancer,0
22624,treatment options,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
22625,Cervical Intraepithelial Neoplasia,Intraepithelial Melanocytic Hyperplasia,0
22626,Neoplasms,Vaginal Adenoid Cystic Carcinoma,0
22627,Adult,Type II Endometrial Adenocarcinoma,0
22628,trauma qualifier,Thymoma malignant recurrent,0
22629,cell-cell adhesion,Stage II Carcinoma of Penis,0
22630,Linear,Chest Wall Fibromatosis,0
22631,Lung,Stage IB Pancreatic Cancer AJCC v8,0
22632,Childhood Rhabdomyosarcoma,Gastric Diffuse Large B-Cell Lymphoma,0
22633,Young,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22634,Reported,Diffuse malignant mesothelioma,0
22635,Primary malignant neoplasm,Refractory Ependymoma,0
22636,Malignant neoplasm of thyroid,FIGO Stage II Ovarian Cancer,0
22637,other medicated shampoos in ATC,Metaplastic carcinoma of breast,0
22638,Frequently,Childhood Thyroid Gland Follicular Carcinoma,0
22639,Publications,Cerebral Primitive Neuroectodermal Tumor,0
22640,United States Military Commissioned Officer O4,Giant cell angiofibroma,0
22641,High,Keratoderma,0
22642,Unspecified,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22643,Retinoic Acid Response Element,Adult Anaplastic Oligodendroglioma,0
22644,What subject filter - Result,Stage IV Childhood Non-Hodgkin Lymphoma,0
22645,Intention - mental process,Tubal Hyperplasia,0
22646,Lifetime,papillary carcinoma of penis,0
22647,Class,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22648,Abnormal Cell Count,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22649,Dryness (characteristic),Grade 3a Malignant Neoplasm,0
22650,Anorexia,Childhood Fibrillary Astrocytoma,0
22651,Entity Determiner - specific,Intestinal Metaplasia of Bladder Urothelium,0
22652,35,Diffuse malignant mesothelioma,0
22653,Diffuse malignant lymphoma - centroblastic-centrocytic,Nasal cavity carcinoma,0
22654,Radiographic imaging procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22655,Eczema,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22656,cell type,Pancreatic Intraepithelial Neoplasia-3,0
22657,Primary malignant neoplasm of endometrium,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
22658,Occur (action),Mucinous adenocarcinoma gastric,0
22659,Lymphoma,Ovarian germ cell choriocarcinoma stage IV,0
22660,Known,Airway Hemangioma,0
22661,Symptoms,Mucosal Melanoma,0
22662,Pelvic Pain,Rhabdomyosarcoma with ganglionic differentiation,0
22663,spring (season),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22664,Common Specifications in HL7 V3 Publishing,Carcinomatosis of peritoneal cavity,0
22665,Compartment syndromes,Intestinal Neuroendocrine Carcinoma,0
22666,Vision,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22667,Treatment Epoch,Cerebral hemangioma,0
22668,Males,Diffuse malignant mesothelioma,0
22669,To,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22670,Dry,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22671,Fill,Peripheral primitive neuroectodermal tumor of soft tissue,0
22672,Occurrence,Splenic Manifestation of Hairy Cell Leukemia,0
22673,Medical Imaging,Malignant melanoma of eyelid,0
22674,common types,Intraepithelial Melanocytic Hyperplasia,0
22675,Diagnosis,Childhood Lung Non-Small Cell Carcinoma,0
22676,Plumbum metallicum,Nasal cavity carcinoma,0
22677,Immature Cell Count (laboratory procedure),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
22678,Urine,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22679,TONICS,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22680,Recommendation,Melanomatosis,0
22681,regional,Small cell neuroendocrine carcinoma of bladder,0
22682,Record - QueryRequestLimit,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22683,BLNK gene,Diffuse malignant mesothelioma,0
22684,Structure of thyroid parafollicular cell,Type II Endometrial Adenocarcinoma,0
22685,Skin,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22686,Skeletal bone,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22687,per year,Congenital hamartoma,0
22688,Teens,Undifferentiated Endocervical Sarcoma,0
22689,Linear,Human Papillomavirus-Related Carcinoma,0
22690,member,Hereditary Diffuse Gastric Adenocarcinoma,0
22691,Pain in scrotum,Leiomyoma of Gallbladder,0
22692,Part of,Advanced Lung Carcinoma,0
22693,Present,Stage III Cutaneous Melanoma AJCC v6,0
22694,Degree or extent,Digestive System Hodgkin Lymphoma,0
22695,Specific qualifier value,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22696,Pelvic cavity structure,Kaposi's sarcoma of extrahepatic bile duct,0
22697,Colorectal Cancer,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22698,Abdominal Cavity,Localized Ewing Sarcoma,0
22699,Variant,Granular Cell Leiomyosarcoma,0
22700,Primary malignant neoplasm,Metastatic Neoplasm to the Gallbladder,0
22701,Acquired phimosis,Benign Ovarian Thecoma,0
22702,Group A (blood group),Mucinous adenocarcinoma gastric,0
22703,Astrocytes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22704,Destruction (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22705,1000000,Pancreatic carcinoma,0
22706,Biological Response Modifiers,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22707,Reported Term,Benign tumor of eyelid,0
22708,Scaling,Fourth Ventricle and Brain Stem Ependymal Tumor,0
22709,eTMF Content Model Code,Intraepithelial Melanocytic Hyperplasia,0
22710,Contain (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
22711,Analysis,Uterine Cancer,0
22712,Administration procedure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22713,Common (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22714,Specific qualifier value,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22715,Salivary Glands,Unicystic ameloblastoma,0
22716,Gonadal structure,Thymic Clear Cell Carcinoma,0
22717,Record - QueryRequestLimit,Recurrent Testicular Lymphoma,0
22718,Reaching,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
22719,Local disease,Engraftment syndrome,0
22720,Lower (action),Recurrent Uveal Melanoma,0
22721,Surgical service,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22722,Family history,Mucinous cystadenofibroma,0
22723,Guide device,Low Grade Squamous Intraepithelial Neoplasia,0
22724,Myoepithelial,de novo Myelodysplastic Syndrome,0
22725,To,Unfavorable Non-Hodgkin Lymphoma,0
22726,Have Sweats,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
22727,Sequence Arm,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22728,Woman,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22729,Response process,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22730,Homo sapiens,Benign Anal Granular Cell Tumor,0
22731,Certain (qualifier value),ROSE Cluster 3,0
22732,Division (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22733,Dark brown,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22734,Undifferentiated Sex,Recurrent Testicular Lymphoma,0
22735,Permanent,Malignant Neoplasm of Lung - Multiple Primary Sites,0
22736,Experimental Result,Recurrent Testicular Lymphoma,0
22737,Context,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
22738,Formation,Grade 1 Clear Cell Renal Cell Carcinoma,0
22739,Biologic Development,Kaposi's sarcoma of skin,0
22740,Surgery specialty,Pancreatic Endocrine Carcinoma,0
22741,Geographic Locations,Recurrent Uveal Melanoma,0
22742,Symptoms,Endometrial Small Cell Carcinoma,0
22743,Methods,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22744,Gender Status - Intact,Mucinous adenocarcinoma gastric,0
22745,Malignant - descriptor,Refractory Ependymoma,0
22746,Human body,Testicular cancer metastatic,0
22747,Most,Mucinous adenocarcinoma,0
22748,include - SetOperator,Multiple Skull Base Meningiomas,0
22749,Sore skin,Chondrosarcoma,0
22750,Less Than,Intestinal Neuroendocrine Carcinoma,0
22751,Negative Charge,Refractory Bladder Carcinoma,0
22752,Set scale,Multiple Skull Base Meningiomas,0
22753,Order (record artifact),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22754,Medical service,Localized Askin Tumor,0
22755,Etiology aspects,Metastatic Neoplasm to the Gallbladder,0
22756,Group A (blood group),Chondrosarcoma,0
22757,Latin America,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22758,Thymus <angiosperm>,Cervical Squamous Intraepithelial Neoplasia,0
22759,Australia,Cartilaginous exostosis,0
22760,Use of,Larynx carcinoma recurrent,0
22761,Qualitative form,Stage II Carcinoma of Penis,0
22762,Therapeutic procedure,Malignant Neoplasm with Regional Lymph Node Involvement,0
22763,metastatic qualifier,Blepharal carcinoma,0
22764,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
22765,Better,Microcystic meningioma,0
22766,Predisposition -- attribute,Tongue Alveolar Soft Part Sarcoma,0
22767,Tumor stage,Low Grade Squamous Intraepithelial Neoplasia,0
22768,lymph nodes,Uterine Cancer,0
22769,Symptoms aspect,Hodgkin Disease,0
22770,Malignant Neoplasms,Stage III Cutaneous Melanoma AJCC v6,0
22771,Transitional cell morphology,Cancer of Urinary Tract,0
22772,Sound - physical agent,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22773,Patterns,Childhood Central Nervous System Ganglioneuroblastoma,0
22774,*Type - Kind of quantity,Multiple Skull Base Meningiomas,0
22775,Blood,Basal Cell Ameloblastoma,0
22776,World Health Organization,Acute Undifferentiated Leukemia,0
22777,Occur (action),Benign tumor of eyelid,0
22778,Tissue Specimen Code,Metastatic Malignant Neoplasm in the Sellar Region,0
22779,True primary (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22780,Foot,Refractory Ependymoma,0
22781,shared attribute,High Grade Glandular Intraepithelial Neoplasia,0
22782,Solid Dose Form,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
22783,Smear - instruction imperative,clear cell adenocarcinoma of gallbladder,0
22784,Occurrence Indicator,Xeroderma pigmentosum,0
22785,Stains,Undifferentiated Endocervical Sarcoma,0
22786,Involvement with,Peripheral primitive neuroectodermal tumor of soft tissue,0
22787,Secondary tumor site,Chest Wall Fibromatosis,0
22788,Uterine Corpus Sarcoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22789,Biogenic Amines,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22790,BRCA1 protein,Extracranial Neuroblastoma,0
22791,ovarian,Benign tumor of eyelid,0
22792,Rate,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22793,Reported Term,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22794,PERMANENT DEAFNESS,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22795,Estrogen (disposition),Hodgkin Disease,0
22796,Adult,Spongiotic dermatitis,0
22797,Units Of Measure - lumen,Localized Askin Tumor,0
22798,Identity,Cervical Squamous Intraepithelial Neoplasia,0
22799,Tumor cells,non-Hodgkin's lymphoma of spleen,0
22800,Presacral,Colorectal High Grade B-Cell Lymphoma,0
22801,To,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22802,Post Device,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22803,status - In progress,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22804,Hyalinizing trabecular adenoma,ROSE Cluster 3,0
22805,/40,Mucinous cystadenofibroma,0
22806,Lymphocyte component of blood,Contact dermatitis due to alkali,0
22807,>90,Hodgkin lymphoma,0
22808,Financial Account,Undifferentiated Endocervical Sarcoma,0
22809,Classification of information,Mucinous adenocarcinoma,0
22810,Abnormally high,Adult Alveolar Soft Part Sarcoma,0
22811,Coughing,Funisitis (disorder),0
22812,Abnormal Cell Count,Atypical Lobular Breast Hyperplasia,0
22813,Occurrence,sarcoma of spinal cord,0
22814,Transurethral Resection,Astrocytoma of brain,0
22815,First (number),Gallbladder Adenocarcinoma,0
22816,United States,Squamous cell carcinoma of lip,0
22817,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Extracranial Neuroblastoma,0
22818,Cerebellum,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
22819,Group A (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22820,Interventional procedure,Squamous cell carcinoma of lip,0
22821,Breeding,Digestive System Hodgkin Lymphoma,0
22822,Extreme,Human Papillomavirus-Related Carcinoma,0
22823,Neuron spine,Melanomatosis,0
22824,Treatment Epoch,Adult Anaplastic Oligodendroglioma,0
22825,Benign condition,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22826,Site,FIGO Stage IVA Ovarian Cancer,0
22827,Age,Cervical Squamous Intraepithelial Neoplasia,0
22828,Waste Products,Hyperplasia of pituitary gland,0
22829,brain cell,Liver Lymphangioma,0
22830,Occur (action),Childhood Central Nervous System Immature Teratoma,0
22831,Childhood Lymphoma,Angiosarcoma of liver,0
22832,Life Expectancy Less than Five Years,Localized Askin Tumor,0
22833,System,Plexosarcoma,0
22834,Coding,Carcinoma ex pleomorphic adenoma of parotid gland,0
22835,Worker,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22836,Improved - answer to question,Mucinous adenocarcinoma gastric,0
22837,PSA Level Greater than Fifty,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22838,Scientific Publication,Benign Anal Granular Cell Tumor,0
22839,Cancer Genus,Kaposi's sarcoma of skin,0
22840,Nausea,Spermatocytic seminoma,0
22841,Promotional Kit,Bladder adenocarcinoma stage IV,0
22842,Usually,Benign squamous cell tumor,0
22843,Mixed Cell Morphology,Mucinous adenocarcinoma gastric,0
22844,Back structure,Malignant Testicular Sertoli Cell Tumor,0
22845,Symptoms,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
22846,Percent of Abnormal Cells,papillary carcinoma of penis,0
22847,Very Much,Familial Hemophagocytic Lymphocytosis,0
22848,Changing,Carcinoma ex pleomorphic adenoma of parotid gland,0
22849,General surgery specialty,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22850,Young Adult,Tongue Alveolar Soft Part Sarcoma,0
22851,Differentiation,Multiple Skull Base Meningiomas,0
22852,Oral (intended site),Collecting Duct Carcinoma of the Kidney,0
22853,Epithelial ovarian cancer,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
22854,Form:Finding:Point in time:{Setting}:Document:{Role},Botryoid-Type Embryonal Rhabdomyosarcoma,0
22855,Adult,Acute Undifferentiated Leukemia,0
22856,Adult Lymphoma,FIGO Stage II Ovarian Cancer,0
22857,To,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
22858,Menstruation,Thyroid Hurthle Cell Carcinoma,0
22859,Long-term Follow-up,Gallbladder adenoma,0
22860,Severe Extremity Pain,Type II Endometrial Adenocarcinoma,0
22861,Mass of body region,Nasal cavity carcinoma,0
22862,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22863,Abnormal,Sarcomatoid Renal Cell Carcinoma,0
22864,intent,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22865,Entire ear,Unicystic ameloblastoma,0
22866,Associated with,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
22867,lymph nodes,Stage II Carcinoma of Penis,0
22868,Growth,Pancreatic carcinoma,0
22869,Fish Flavor,Neonatal leukemia,0
22870,Biological Response Modifier Therapy,Benign Anal Granular Cell Tumor,0
22871,Include (action),benign mature teratoma of pancreas,0
22872,Involvement with,Mixed astrocytoma-ependymoma,0
22873,Childhood Lymphoma,Colorectal High Grade B-Cell Lymphoma,0
22874,Fever,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22875,Overall Publication Type,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22876,Disease Progression,Acantholytic squamous cell carcinoma,0
22877,N+ (tumor staging),Congenital hamartoma,0
22878,Headache,clear cell adenocarcinoma of gallbladder,0
22879,Operative Surgical Procedures,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22880,Include (action),Melanomatosis,0
22881,Malignant - descriptor,Papillary squamous cell carcinoma,0
22882,Pancreas,Toxic Epidermal Necrolysis,0
22883,Administration procedure,Benign Anal Granular Cell Tumor,0
22884,Cover (physical object),Clinical Stage I Cutaneous Melanoma AJCC v8,0
22885,Asymptomatic,Undifferentiated Endocervical Sarcoma,0
22886,Carcinoma,Advanced Uterine Corpus Carcinosarcoma,0
22887,Molecular Mass,Melanomatosis,0
22888,metaplastic cell transformation,Non-Hodgkin Lymphoma During Pregnancy,0
22889,Call (Instruction),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22890,spells (neurological symptom),Cartilaginous exostosis,0
22891,Most,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22892,Diagnosis,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22893,System,Hemangioma,0
22894,Measures,Carcinoma of urinary bladder,0
22895,various allergen extracts,Cervical Fibroepithelial Polyp,0
22896,Laboratory Procedures,Colorectal Neuroendocrine Tumor G2,0
22897,Known,Bladder squamous cell carcinoma stage I,0
22898,Benign,Malignant neoplasm of choroid,0
22899,Present,Multiple Endocrine Neoplasia,0
22900,cancer genetics,FIGO Stage IVA Ovarian Cancer,0
22901,Data operation - complete,Airway Hemangioma,0
22902,Respiration,Childhood Central Nervous System Ganglioneuroblastoma,0
22903,Five,Metastatic Carcinoma in the Lung,0
22904,Only - dosing instruction fragment,Brain Tumor,0
22905,Therapeutic procedure,Stage III Cutaneous Melanoma AJCC v6,0
22906,Diagnosis Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22907,Usually,Cancer of Urinary Tract,0
22908,Hemorrhage,Acantholytic squamous cell carcinoma,0
22909,Clinical,Thymic Clear Cell Carcinoma,0
22910,Deterioration of status,Cervical Squamous Intraepithelial Neoplasia,0
22911,Small cell carcinoma of lung,Intestinal Neuroendocrine Carcinoma,0
22912,Person Observer,Childhood Central Nervous System Ganglioneuroblastoma,0
22913,Iodides,Methotrexate-Associated Hodgkin Lymphoma,0
22914,Cells panel,Benign tumor of eyelid,0
22915,Symptoms aspect,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22916,low exposure,Malignant melanoma of eyelid,0
22917,Maybe,Childhood Fibrillary Astrocytoma,0
22918,Caucasoid Race,Carcinoma of urinary bladder,0
22919,Adult Classical Hodgkin Lymphoma,Benign Anal Granular Cell Tumor,0
22920,Most,Clonal Hematopoiesis of Indeterminate Potential,0
22921,Protection,Angiosarcoma of liver,0
22922,Ephrin Type-B Receptor 1,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22923,Form:Finding:Point in time:{Setting}:Document:{Role},squamous cell carcinoma of the thyroid gland,0
22924,Numerous,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
22925,How Often Felt Normal question,Astrocytoma of brain,0
22926,Presentation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
22927,Usually,Benign Anal Granular Cell Tumor,0
22928,Nicotiana tabacum,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22929,Most,Testicular cancer metastatic,0
22930,Head - Component of Device,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22931,Histopathologic Grade,Stage III Cutaneous Melanoma AJCC v6,0
22932,Glioblastoma Multiforme Pathway,Low Grade Squamous Intraepithelial Neoplasia,0
22933,Common Specifications in HL7 V3 Publishing,Childhood Thyroid Gland Follicular Carcinoma,0
22934,Hodgkin Disease,Small cell neuroendocrine carcinoma of bladder,0
22935,Painless,Vaginal Adenoma,0
22936,Cancer Other,Recurrent Primary Lymphoma of Bone,0
22937,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22938,User Group,Carcinoma of submandibular gland,0
22939,Affecting,adenosquamous carcinoma of breast,0
22940,Growth,Choroid Necrotic Melanoma,0
22941,combination of objects,Intracortical osteosarcoma,0
22942,Case (situation),Kaposi's sarcoma of extrahepatic bile duct,0
22943,Bothered by Vomiting,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22944,Subtype (attribute),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
22945,Neoadjuvant Therapy,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
22946,Have Nausea,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22947,Manufactured sign,Engraftment syndrome,0
22948,Post Device,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22949,2+ Score,Malignant Neoplasm with Regional Lymph Node Involvement,0
22950,Interventional procedure,Digestive System Hodgkin Lymphoma,0
22951,Periungual fibroma,Childhood Fibrillary Astrocytoma,0
22952,Genetic,Adult Alveolar Soft Part Sarcoma,0
22953,Occur (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22954,Four,Ovarian germ cell choriocarcinoma stage IV,0
22955,Value Above Reference Range,Benign neoplasm of eye,0
22956,Interstitial Fluid,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
22957,System One,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22958,Skin,Gallbladder Adenocarcinoma,0
22959,Edema,Benign Anal Granular Cell Tumor,0
22960,Derivation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22961,Iris <mantid>,Type II Endometrial Adenocarcinoma,0
22962,Population Group,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22963,Smear test,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
22964,Intestines,Squamous cell carcinoma of lip,0
22965,Weight decreased,Low Grade Squamous Intraepithelial Neoplasia,0
22966,Medical Devices,Unresectable Rhabdomyosarcoma,0
22967,Females,High Grade Glandular Intraepithelial Neoplasia,0
22968,Experimental Result,adenoid cystic carcinoma of lung,0
22969,Current (present time),Bladder adenocarcinoma stage IV,0
22970,Section (object),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22971,Formation,FIGO Stage IVA Ovarian Cancer,0
22972,Dark color,Stage II Hepatocellular Carcinoma AJCC v8,0
22973,How Much Distress Vomiting,Refractory Ependymoma,0
22974,The Sun,Clonal Hematopoiesis of Indeterminate Potential,0
22975,Bothered by Night Sweats,Malignant neoplasm of gallbladder,0
22976,Genus Homo,FIGO Stage II Ovarian Cancer,0
22977,Vasculature,Ovarian germ cell choriocarcinoma stage IV,0
22978,Beginning,Atypical Lobular Breast Hyperplasia,0
22979,Related personal status,Thyroid Hurthle Cell Carcinoma,0
22980,per year,Spongiotic dermatitis,0
22981,Abdomen distended,Melanomatosis,0
22982,Hospital specialist,Unicystic ameloblastoma,0
22983,Respiratory System,malignant lymphoma of pancreatic lymph nodes,0
22984,CD244 protein,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
22985,biopsy characteristics,Cervical Squamous Intraepithelial Neoplasia,0
22986,Web Site,Acute Undifferentiated Leukemia,0
22987,Often - answer to question,Stage III Cutaneous Melanoma AJCC v6,0
22988,Leakage,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
22989,Definitely Related to Intervention,Basal Cell Ameloblastoma,0
22990,National origin,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22991,Oral region,Adult Alveolar Soft Part Sarcoma,0
22992,Science of Etiology,Anterior Urethral Malignant Neoplasm,0
22993,Frequently,Type II Endometrial Adenocarcinoma,0
22994,Greater,Childhood Extragonadal Malignant Germ Cell Tumor,0
22995,Review [Publication Type],Peripheral primitive neuroectodermal tumor of soft tissue,0
22996,Present,FIGO Stage II Ovarian Cancer,0
22997,Immune,Recurrent Testicular Lymphoma,0
22998,Abnormally high,Acute lymphadenitis,0
22999,Natures,Chondrosarcoma,0
23000,Arising in,sarcoma of spinal cord,0
23001,Laparoscopy,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23002,Contain (action),Acantholytic squamous cell carcinoma,0
23003,Experimental Result,embryonal rhabdomyosarcoma of prostate,0
23004,Survival Rate,Grade 3a Malignant Neoplasm,0
23005,Image Feature,Pancreatic carcinoma,0
23006,Treating,Stage III Cutaneous Melanoma AJCC v6,0
23007,Term (temporal),Human Papillomavirus-Related Carcinoma,0
23008,Neck,Grade 1 Clear Cell Renal Cell Carcinoma,0
23009,Malignant Neoplasms,FIGO Stage II Ovarian Cancer,0
23010,Inguinal region,Breast Ductal Adenoma,0
23011,Experimental Result,gliosarcoma,0
23012,Molecular Mass,Intestinal Metaplasia of Bladder Urothelium,0
23013,Abdomen,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23014,Formation,Colorectal High Grade B-Cell Lymphoma,0
23015,How Much Distress Weight Loss,Brain Ependymoma,0
23016,Antibody studies (procedure),Vaginal Adenoid Cystic Carcinoma,0
23017,Ability to Drive,Ovarian germ cell choriocarcinoma stage IV,0
23018,Room of building - Study,Clonal Hematopoiesis of Indeterminate Potential,0
23019,Basis - conceptual entity,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23020,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Hodgkin lymphoma,0
23021,Including (qualifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
23022,Does carry,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23023,Endocrine system,Microcystic meningioma,0
23024,Consistency,Clonal Hematopoiesis of Indeterminate Potential,0
23025,Hardness,Plexosarcoma,0
23026,Malignant Neoplasms,Malignant neoplasm of gallbladder,0
23027,Crowding,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23028,vascular inflammations,Thymic Clear Cell Carcinoma,0
23029,Old,Vaginal Adenoid Cystic Carcinoma,0
23030,Call (Instruction),Bladder adenocarcinoma stage IV,0
23031,Skin cell,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23032,Cancer Genus,Transitional cell carcinoma,0
23033,Feelings,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23034,Valid,ICHTHYOSIS,0
23035,Early Therapy,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23036,Data,Digestive System Hodgkin Lymphoma,0
23037,Antibiotic throat preparations,Chronic Myelomonocytic Leukemia-2,0
23038,Anatomic Structure,Unicystic ameloblastoma,0
23039,Include (action),Liver Cavernous Hemangioma,0
23040,Toxic Epidermal Necrolysis,Pancreatic carcinoma,0
23041,Papillary thyroid carcinoma,Basal Cell Ameloblastoma,0
23042,Unit of radiation dose,Bladder adenocarcinoma stage IV,0
23043,lymph nodes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23044,International Classification of Diseases,Female Breast Carcinoma,0
23045,Latin America,Adult Alveolar Soft Part Sarcoma,0
23046,Etiology,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23047,High Level,Mucinous adenocarcinoma gastric,0
23048,Myeloid Leukemia,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23049,Skin,Clonal Hematopoiesis of Indeterminate Potential,0
23050,Previous,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
23051,Infant,FIGO Stage II Ovarian Cancer,0
23052,Relationships,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
23053,Outlines (document),Stage II Hepatocellular Carcinoma AJCC v8,0
23054,System,Mucinous adenocarcinoma gastric,0
23055,Five,Malignant melanoma of eyelid,0
23056,Treating,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23057,Cessation of life,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23058,Page (document),Maxillary Sinus Adenoid Cystic Carcinoma,0
23059,Occur (action),Childhood Thyroid Gland Follicular Carcinoma,0
23060,Treating,Advanced Uterine Corpus Carcinosarcoma,0
23061,common types,Advanced Uterine Corpus Carcinosarcoma,0
23062,Pharmacotherapy,Stage IB Pancreatic Cancer AJCC v8,0
23063,Therapeutic procedure,Liver Lymphangioma,0
23064,Disease,Uterine Cancer,0
23065,Characterization,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23066,Immune,Vaginal Adenoid Cystic Carcinoma,0
23067,Examined,Lung squamous cell carcinoma stage I,0
23068,Manufactured form,Choroid Necrotic Melanoma,0
23069,therapeutic aspects,Stage IB Pancreatic Cancer AJCC v8,0
23070,Set (Psychology),Recurrent Testicular Lymphoma,0
23071,Image Feature,Stage II Carcinoma of Penis,0
23072,Type - attribute,Stage III Cutaneous Melanoma AJCC v6,0
23073,Adult Liposarcoma,Lipoma of small intestine,0
23074,Mutation,Small cell neuroendocrine carcinoma of bladder,0
23075,Frequently,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23076,Adult Classical Hodgkin Lymphoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23077,Specific qualifier value,Anterior Urethral Malignant Neoplasm,0
23078,Primary malignant neoplasm,Mixed parotid tumor,0
23079,Negative Charge,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23080,Ovarian mucinous tumor,Thymic Clear Cell Carcinoma,0
23081,Include (action),Mixed astrocytoma-ependymoma,0
23082,Known,Stage II Carcinoma of Penis,0
23083,Malignant Neoplasms,Low Grade Squamous Intraepithelial Neoplasia,0
23084,Psychotherapy,Mucinous adenocarcinoma,0
23085,Heightened,Digestive System Hodgkin Lymphoma,0
23086,Brain,Low Grade Squamous Intraepithelial Neoplasia,0
23087,Severe (severity modifier),Intracortical osteosarcoma,0
23088,Malignant tumor of colon,Breast Apocrine Adenoma,0
23089,Sometimes,Low Grade Squamous Intraepithelial Neoplasia,0
23090,Hydranencephaly with Renal Aplasia-Dysplasia,Carcinoma of urinary bladder,0
23091,3+ Score,Chondrosarcoma,0
23092,Average of Value Derivation Technique,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
23093,Specimen Source Codes - Pacemaker,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23094,Very,Acute Undifferentiated Leukemia,0
23095,Malignant - descriptor,Locally Advanced Epithelioid Hemangioendothelioma,0
23096,Formation,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23097,Ultrasonic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23098,Survival Rate,FIGO Stage II Ovarian Cancer,0
23099,Medical service,Intracortical osteosarcoma,0
23100,Frequently,Ichthyosis,0
23101,Hormonal,Hyperplasia of pituitary gland,0
23102,Gland,Blepharal carcinoma,0
23103,Specimen Type - Genital,Adult Alveolar Soft Part Sarcoma,0
23104,0%,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
23105,Lymphadenopathy,Benign tumor of eyelid,0
23106,Malignant Neoplasms,Stage III Cutaneous Melanoma AJCC v6,0
23107,Common (qualifier value),Atypical Mesothelial Hyperplasia,0
23108,Hypesthesia,Vaginal Adenoid Cystic Carcinoma,0
23109,Diagnosis,Malignant melanoma of eyelid,0
23110,AKR1A1 wt Allele,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23111,How Much Distress Cough,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23112,Mobility as a finding,Pancreatic carcinoma,0
23113,Cancer Registry,Ovarian Carcinoid Tumor,0
23114,Body part,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23115,Condition,Nasal cavity carcinoma,0
23116,Lymphoid Cell Count,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23117,Electromagnetic Spectrum,Neonatal leukemia,0
23118,Usually Need Help from Another Person for Arising,Unicystic ameloblastoma,0
23119,Metastasis,Nasal cavity carcinoma,0
23120,Several,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23121,Usually,FIGO Stage II Ovarian Cancer,0
23122,Body structure,Angiosarcoma of liver,0
23123,Literature,Refractory Ependymoma,0
23124,cervical cancer,Rhabdomyosarcoma with ganglionic differentiation,0
23125,Usual,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23126,In Urine,Digestive System Hodgkin Lymphoma,0
23127,Before values,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23128,Rare,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23129,Adult Hodgkin Lymphoma,Locally Advanced Carcinoma,0
23130,Household composition,Xeroderma pigmentosum,0
23131,Trial Screening,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23132,risk factors,Recurrent Uveal Melanoma,0
23133,Retinoic Acid Response Element,Recurrent Uveal Melanoma,0
23134,Detection,Precursor B-lymphoblastic lymphoma stage II,0
23135,Inguinal part of abdomen,Xeroderma pigmentosum,0
23136,Advance,squamous cell carcinoma of the thyroid gland,0
23137,Cells,Squamous cell carcinoma of lip,0
23138,Call (Instruction),Hyperplasia of pituitary gland,0
23139,depend,Ovarian germ cell choriocarcinoma stage IV,0
23140,Removed,adenosquamous carcinoma of breast,0
23141,Cancer Genus,Mixed astrocytoma-ependymoma,0
23142,Adult Lymphoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23143,Persons,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23144,Cancer Genus,Diffuse malignant mesothelioma,0
23145,Glioma,Secondary malignant neoplasm of lymph node,0
23146,Palpebronasal fold,Kaposi's sarcoma of extrahepatic bile duct,0
23147,Neuroendocrine Tumors,Adult Acute Eosinophilic Leukemia,0
23148,Experimental Finding,Benign Carotid Body Paraganglioma,0
23149,Known,Pilocytic astrocytoma of cerebellum,0
23150,Possibly Related to Intervention,Human Papillomavirus-Related Carcinoma,0
23151,Descending,Childhood Lymphoma,0
23152,Poverty,Congenital hamartoma,0
23153,Surgical aspects,Contact dermatitis due to alkali,0
23154,All of the Time,Stage III Cutaneous Melanoma AJCC v6,0
23155,Combined,Localized Askin Tumor,0
23156,shared attribute,Carcinoma of submandibular gland,0
23157,System (unit of presentation),Locally Advanced Soft Tissue Sarcoma,0
23158,Country,Primary Cutaneous Plasmablastic Lymphoma,0
23159,Process (qualifier value),Xeroderma pigmentosum,0
23160,70%,FIGO Stage IVA Ovarian Cancer,0
23161,shared attribute,Kaposi's sarcoma of skin,0
23162,Negation,Acantholytic squamous cell carcinoma,0
23163,described,Adenocarcinoma of the prostate metastatic,0
23164,Present,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23165,Act Relationship Type - occurrence,Bladder squamous cell carcinoma stage I,0
23166,Internal,Mucinous adenocarcinoma gastric,0
23167,Shock,Tongue Alveolar Soft Part Sarcoma,0
23168,Varies,FIGO Stage II Ovarian Cancer,0
23169,Object Class,Liver Cavernous Hemangioma,0
23170,Speaking (activity),Thymoma malignant recurrent,0
23171,Unmarried person,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23172,Science of Morphology,Female Breast Carcinoma,0
23173,Blood Vessel,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23174,Tumor Mass,Astrocytoma of brain,0
23175,Entity Determiner - specific,mucinous adenocarcinoma of gallbladder,0
23176,<3 (qualifier value),Benign Apocrine Neoplasm,0
23177,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23178,Liquid substance,Hemangioma,0
23179,List,Childhood Anaplastic Large Cell Lymphoma,0
23180,Fallopian Tubes,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23181,Classification of information,Malignant melanoma of eyelid,0
23182,Negation,Splenic Manifestation of Hairy Cell Leukemia,0
23183,Pancreas,Hodgkin lymphoma,0
23184,Malignant tumor of cervix,ROSE Cluster 3,0
23185,Supportive assistance,Basal Cell Ameloblastoma,0
23186,Tobacco,Hereditary Diffuse Gastric Adenocarcinoma,0
23187,Brain part,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
23188,800,Benign tumor of eyelid,0
23189,Common Specifications in HL7 V3 Publishing,Splenic Manifestation of Hairy Cell Leukemia,0
23190,status - In progress,Benign Anal Granular Cell Tumor,0
23191,Work,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
23192,Operative Surgical Procedures,Colorectal High Grade B-Cell Lymphoma,0
23193,CDISC SEND Tumor Findings Results Terminology,clear cell adenocarcinoma of gallbladder,0
23194,Jumping,Endometrial Small Cell Carcinoma,0
23195,Case (situation),Type II Endometrial Adenocarcinoma,0
23196,Area,Mixed astrocytoma-ependymoma,0
23197,Surgery specialty,Anaplastic large cell lymphoma,0
23198,Intermediate,Carcinoma of urinary bladder,0
23199,Abdomen,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
23200,Formation,High Grade Glandular Intraepithelial Neoplasia,0
23201,Appearance,Stage IB Pancreatic Cancer AJCC v8,0
23202,Palmitic Acid,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23203,Occur (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23204,59,Malignant neoplasm of olfactory nerve,0
23205,Nasal sinus,ICHTHYOSIS,0
23206,CDISC SEND Body System Terminology,Vaginal Adenoid Cystic Carcinoma,0
23207,Females,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23208,Including (qualifier),Acute Undifferentiated Leukemia,0
23209,Factor,Occult Lung Adenosquamous Carcinoma,0
23210,Weight Loss,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23211,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
23212,Recurrent urinary tract infection,Cerebral Primitive Neuroectodermal Tumor,0
23213,Medical,Digestive System Hodgkin Lymphoma,0
23214,eTMF Content Model Code,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
23215,year,Bladder adenocarcinoma stage IV,0
23216,Widening,Pancreatic Intraepithelial Neoplasia-3,0
23217,Skin,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23218,Times,Basal Cell Ameloblastoma,0
23219,Illness: Cannot describe symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23220,+5,Werner Syndrome,0
23221,Part of,Adult Acute Eosinophilic Leukemia,0
23222,Form:Finding:Point in time:{Setting}:Document:{Role},Blood Vessel Tumors,0
23223,Removed,Acute Undifferentiated Leukemia,0
23224,Often - answer to question,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23225,Two,Benign tumor of eyelid,0
23226,Fluid Leak,Colorectal Neuroendocrine Tumor G2,0
23227,Science of Etiology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23228,Alveolar,BRCA2 Syndrome,0
23229,Taste Perception,Testicular cancer metastatic,0
23230,Risk,Testicular cancer metastatic,0
23231,Tobacco,Engraftment syndrome,0
23232,Tryptophanase,Benign Apocrine Neoplasm,0
23233,To,Benign neoplasm of thorax,0
23234,Painless,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23235,Tryptophanase,Ovarian germ cell choriocarcinoma stage IV,0
23236,Have Weight Loss,FIGO Stage IVA Ovarian Cancer,0
23237,epithelial,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23238,Occurrence,Stage III Adult Immunoblastic Lymphoma,0
23239,Much,Undifferentiated Endocervical Sarcoma,0
23240,Science of genetics,Maxillary Sinus Adenoid Cystic Carcinoma,0
23241,Lymphocyte component of blood,Adrenal Rest Tumor,0
23242,Etiology aspects,Stage III Cutaneous Melanoma AJCC v6,0
23243,Disease,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23244,Biological Response Modifiers,Colorectal High Grade B-Cell Lymphoma,0
23245,Bacteria,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23246,Vertebral column,Pancreatic Intraepithelial Neoplasia-3,0
23247,Childhood Soft Tissue Sarcoma,Pancreatic carcinoma,0
23248,Section (object),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23249,Classical Hodgkin's Lymphoma,FIGO Stage II Ovarian Cancer,0
23250,morphological,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23251,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Bladder adenocarcinoma stage IV,0
23252,Keratoconjunctivitis Sicca,Kaposi's sarcoma of skin,0
23253,Excessive,Leiomyoma of Gallbladder,0
23254,Manifested by,Atypical Lobular Breast Hyperplasia,0
23255,Cure (remedy),Stage III Cutaneous Melanoma AJCC v6,0
23256,Tumor type,Recurrent Testicular Lymphoma,0
23257,include - SetOperator,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23258,Hereditary,Small intestine carcinoma,0
23259,Increase in size since previous mammogram,Stage IV Colorectal Cancer AJCC v8,0
23260,potential,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23261,<90,Papillary squamous cell carcinoma,0
23262,W stress,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23263,NCI CTEP SDC Gestational Trophoblastic Disease Sub-Category Terminology,Recurrent Uveal Melanoma,0
23264,Completely Able,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23265,Identifiable Class,Metastatic Ductal Breast Carcinoma,0
23266,Thyroid Gland Follicular Adenoma,Hereditary Diffuse Gastric Adenocarcinoma,0
23267,Genus Homo,Digestive System Hodgkin Lymphoma,0
23268,Face (spatial concept),Unfavorable Non-Hodgkin Lymphoma,0
23269,Retinoic Acid Response Element,Small Intestinal Villous Adenoma,0
23270,Form:Finding:Point in time:{Setting}:Document:{Role},Non-Metastatic Gestational Trophoblastic Tumor,0
23271,Acute Myeloid Leukemia Pathway,squamous cell carcinoma of the thyroid gland,0
23272,Count of entities,Recurrent Testicular Lymphoma,0
23273,High,Methotrexate-Associated Hodgkin Lymphoma,0
23274,Death (finding),Colorectal High Grade B-Cell Lymphoma,0
23275,combination - answer to question,Mixed astrocytoma-ependymoma,0
23276,Sweating,Glomeruloid hemangioma,0
23277,Uveal melanoma,Lung squamous cell carcinoma stage I,0
23278,Histologic,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23279,Decision,Human Papillomavirus-Related Carcinoma,0
23280,consideration,Papillary squamous cell carcinoma,0
23281,Site,Adult Hepatocellular Carcinoma,0
23282,Descending,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23283,Malignant neoplasm of breast,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23284,Basis - conceptual entity,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23285,Neuroendocrine Tumors,Cerebral Primitive Neuroectodermal Tumor,0
23286,Form:Finding:Point in time:{Setting}:Document:{Role},FIGO Stage IVA Ovarian Cancer,0
23287,Molecular Mass,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
23288,Occurrence Indicator,Malignant neoplasm of thalamus,0
23289,Occur (action),Nasal cavity carcinoma,0
23290,Body structure,Metaplastic carcinoma of breast,0
23291,Refrigeration,Benign Anal Granular Cell Tumor,0
23292,Frequently,Gallbladder Adenocarcinoma,0
23293,Seventh,Recurrent Testicular Lymphoma,0
23294,Sore sensation,Metastatic Lung Neuroendocrine Neoplasm,0
23295,Term Birth,Carcinoma,0
23296,Recurrence (disease attribute),Acute Undifferentiated Leukemia,0
23297,NMYC Gene Amplification dysfunction,Acute Undifferentiated Leukemia,0
23298,Usual,Type II Endometrial Adenocarcinoma,0
23299,Usual Severity Weight Loss,BRCA2 Syndrome,0
23300,gastrointestinal,Diffuse malignant mesothelioma,0
23301,Massive,Metastatic Kidney Carcinoma,0
23302,Males,Vaginal Adenoma,0
23303,Asians,Vaginal Adenoma,0
23304,Axis vertebra,Melanomatosis,0
23305,Rituxan,Breast Ductal Adenoma,0
23306,Plasma Product,embryonal rhabdomyosarcoma of prostate,0
23307,Often - answer to question,Engraftment syndrome,0
23308,Pale color saturation,Benign Anal Granular Cell Tumor,0
23309,nonmetastatic,Vaginal Adenoma,0
23310,Hereditary,Bladder squamous cell carcinoma stage I,0
23311,Family,Liver Cavernous Hemangioma,0
23312,Seventh,Spongiotic dermatitis,0
23313,Early,clear cell adenocarcinoma of gallbladder,0
23314,Most,Digestive System Hodgkin Lymphoma,0
23315,Childhood Hodgkin Lymphoma,Extracranial Neuroblastoma,0
23316,Occurrence,Metastatic Carcinoma in the Lung,0
23317,Chemicals,Localized Ewing Sarcoma,0
23318,radiotherapeutic,Squamous cell carcinoma of lip,0
23319,Rest,Intestinal Neuroendocrine Carcinoma,0
23320,seen,Vaginal Adenoma,0
23321,Women's Health,embryonal rhabdomyosarcoma of prostate,0
23322,Treatment intent,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23323,Cystic,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23324,Infrequent,Human Papillomavirus-Related Carcinoma,0
23325,High Risk Acute Leukemia,Melanomatosis,0
23326,Classification,Chronic Myelomonocytic Leukemia-2,0
23327,>90,Childhood Anaplastic Large Cell Lymphoma,0
23328,Mutation Abnormality,Liver Cavernous Hemangioma,0
23329,Broken skin,Intestinal Neuroendocrine Carcinoma,0
23330,potential,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23331,Failure (biologic function),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23332,Malignant Neoplasms,Childhood Fibrillary Astrocytoma,0
23333,Relationship by association,clear cell adenocarcinoma of gallbladder,0
23334,Case unit dose,Splenic Manifestation of Hairy Cell Leukemia,0
23335,Surgery specialty,Intestinal Neuroendocrine Carcinoma,0
23336,Well Differentiated Oligodendroglioma,Vaginal Adenoma,0
23337,Related personal status,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23338,Divide,Childhood Lymphoma,0
23339,Adenocarcinoma of pancreas,Trabecular adenocarcinoma,0
23340,All of the Time,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23341,Pediculus humanus capitis (eukaryote),Clinical Stage I Cutaneous Melanoma AJCC v8,0
23342,International Classification of Disease for Oncology,Unfavorable Non-Hodgkin Lymphoma,0
23343,Relocation of home or business,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23344,Adverse Event Associated with Vascular,Adult Alveolar Soft Part Sarcoma,0
23345,Case unit dose,Papillary squamous cell carcinoma,0
23346,Sharing (Social Behavior),Xeroderma pigmentosum,0
23347,Cancer Genus,Stage II Carcinoma of Penis,0
23348,Tissue Specimen Code,gliosarcoma,0
23349,Carcinoma,Spongiotic dermatitis,0
23350,Squamous Epithelial Cells,Pancreatic carcinoma,0
23351,Primary malignant neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23352,Neuroglia,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23353,risk factors - observation list,Malignant melanoma of eyelid,0
23354,Sample Range,Benign Carotid Body Paraganglioma,0
23355,Chemotherapy Regimen,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23356,Body part,Maxillary Sinus Adenoid Cystic Carcinoma,0
23357,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
23358,Carcinoma in Situ,Childhood Thyroid Gland Follicular Carcinoma,0
23359,International Classification of Diseases,Stage III Cutaneous Melanoma AJCC v6,0
23360,Bone marrow myeloid dysplasia,Colorectal cancer,0
23361,Transplantation of liver,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23362,Form:Finding:Point in time:{Setting}:Document:{Role},Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
23363,Face,Refractory Barrett Esophagus,0
23364,Offspring,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23365,include - SetOperator,Localized Ewing Sarcoma,0
23366,Symptoms,Stage IB Pancreatic Cancer AJCC v8,0
23367,various other nasal preparations in ATC,Lipoma of small intestine,0
23368,Cell Count,embryonal rhabdomyosarcoma of prostate,0
23369,Skeletal bone,Metastatic Lung Small Cell Carcinoma,0
23370,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23371,MOSTLY,Human Papillomavirus-Related Carcinoma,0
23372,North America,adenoid cystic carcinoma of lung,0
23373,800,Squamous cell carcinoma of lip,0
23374,Appearance Distress Question,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23375,Degree or extent,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23376,Adenocarcinoma,Breast Ductal Adenoma,0
23377,Usually,Advanced Lung Carcinoma,0
23378,Five,Anterior Urethral Malignant Neoplasm,0
23379,Adult human body,High Grade Glandular Intraepithelial Neoplasia,0
23380,Term (lexical),squamous cell carcinoma of the thyroid gland,0
23381,Occurrence Indicator,Digestive System Hodgkin Lymphoma,0
23382,Anatomic Site,Diffuse malignant mesothelioma,0
23383,Borg Category-Ratio 10 Perceived Exertion Score 5,Metastatic Neoplasm to the Gallbladder,0
23384,Third floor,Chronic Myelomonocytic Leukemia-2,0
23385,Five-year Survival Rate,Maxillary Sinus Adenocarcinoma,0
23386,Cicatrix,Diffuse malignant mesothelioma,0
23387,Type - attribute,Malignant melanoma of eyelid,0
23388,<50,Stage III Cutaneous Melanoma AJCC v6,0
23389,Definitely Related to Intervention,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23390,Different,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23391,Spectrum,Ichthyoses,0
23392,Cause of Death,Mucinous adenocarcinoma gastric,0
23393,Togo,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23394,Back structure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23395,40%,Breast Ductal Adenoma,0
23396,Common Specifications in HL7 V3 Publishing,Heavy Chain Deposition Disease,0
23397,Urticaria,Metastatic Lung Neuroendocrine Neoplasm,0
23398,Average,Intestinal Metaplasia of Bladder Urothelium,0
23399,Dysphagia,Parathyroid Gland Adenocarcinoma,0
23400,High Grade Ovarian Serous Adenocarcinoma,Maxillary Sinus Adenocarcinoma,0
23401,Stage,Stage IV Childhood Non-Hodgkin Lymphoma,0
23402,Suspected qualifier,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23403,Increase,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23404,Known,Cartilaginous exostosis,0
23405,Prophylactic treatment,Intestinal Metaplasia of Bladder Urothelium,0
23406,Type - attribute,Maxillary Sinus Adenoid Cystic Carcinoma,0
23407,Ultrasonography,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23408,Non-invasive,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23409,Value Above Reference Range,Trabecular adenocarcinoma,0
23410,Complete,Xeroderma pigmentosum,0
23411,Present,Human Papillomavirus-Related Carcinoma,0
23412,Localized,Deep Leiomyoma,0
23413,Including (qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23414,Very high,Stage IV Childhood Non-Hodgkin Lymphoma,0
23415,Involvement with,Vaginal Adenoid Cystic Carcinoma,0
23416,Usually,Leiomyoma of Gallbladder,0
23417,Operative Surgical Procedures,Digestive System Hodgkin Lymphoma,0
23418,Therapeutic procedure,Endometrial Small Cell Carcinoma,0
23419,Pelvic pain female,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23420,Dangerousness,Childhood Anaplastic Large Cell Lymphoma,0
23421,Enneking Low Surgical Grade,Spongiotic dermatitis,0
23422,Acute leukemia,Precursor B-lymphoblastic lymphoma stage II,0
23423,cancer risk,Mixed parotid tumor,0
23424,Geographic Locations,Blood Vessel Tumors,0
23425,Chemotherapy Regimen,Brain Tumor,0
23426,Name,Refractory Barrett Esophagus,0
23427,Out (direction),Breast Ductal Adenoma,0
23428,neck gland,Human Papillomavirus-Related Carcinoma,0
23429,Lymphatic System,Lipoma of small intestine,0
23430,Distant,Acute lymphadenitis,0
23431,Consortium or Network,Placental aromatase deficiency,0
23432,Aggressive malignancies,Stage II Hepatocellular Carcinoma AJCC v8,0
23433,Concept History,Malignant neoplasm of olfactory nerve,0
23434,System - kit,Refractory Ependymoma,0
23435,include - SetOperator,Type II Endometrial Adenocarcinoma,0
23436,Anabolism,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
23437,Major <insect>,ROSE Cluster 3,0
23438,Taxonomic,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
23439,Occurrence,Benign squamous cell tumor,0
23440,National Cancer Institute,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23441,AS virus,FIGO Stage IVA Ovarian Cancer,0
23442,Pruritus,Kaposi's sarcoma of extrahepatic bile duct,0
23443,200,Stage II Hepatocellular Carcinoma AJCC v8,0
23444,Survival Rate,Squamous cell carcinoma of lip,0
23445,Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23446,Ultrasonics (sound),Childhood Lymphoma,0
23447,Disease,Spermatocytic seminoma,0
23448,Decision,de novo Myelodysplastic Syndrome,0
23449,Increase,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23450,Ductal Breast Carcinoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23451,Therapeutic procedure,Cervical Fibroepithelial Polyp,0
23452,Approximate,papillary carcinoma of penis,0
23453,Dry,Thyroid Hurthle Cell Carcinoma,0
23454,Include (action),Stage II Hepatocellular Carcinoma AJCC v8,0
23455,Basis - conceptual entity,Childhood Anaplastic Large Cell Lymphoma,0
23456,Occurrence,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23457,Thymus <angiosperm>,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23458,Histology aspects,Gastric Diffuse Large B-Cell Lymphoma,0
23459,3+ Score,Malignant melanoma of eyelid,0
23460,Spreading (qualifier value),Mucosal Melanoma,0
23461,Recommendation,Cherubism,0
23462,Due to,Non-Metastatic Gestational Trophoblastic Tumor,0
23463,Blood Cells,Colorectal Neuroendocrine Tumor G2,0
23464,Benign Smooth Muscle Neoplasm,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23465,Increase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23466,Completely - dosing instruction fragment,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
23467,cell transformation,Endometrial Small Cell Carcinoma,0
23468,Case (situation),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23469,Body tissue,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
23470,Trial Screening,Kaposi's sarcoma of extrahepatic bile duct,0
23471,Feel Pain,Locally Advanced Epithelioid Hemangioendothelioma,0
23472,month,Locally Advanced Epithelioid Hemangioendothelioma,0
23473,Needs,non-Hodgkin's lymphoma of spleen,0
23474,Genus Homo,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23475,Obesity,Adrenal Rest Tumor,0
23476,Vomiting,Papillary squamous cell carcinoma,0
23477,Fever,Cervical Fibroepithelial Polyp,0
23478,seconds,Stage IB Lung Cancer AJCC v7,0
23479,<90,Adult Acute Eosinophilic Leukemia,0
23480,Mechanism Component of Device,Peripheral primitive neuroectodermal tumor of soft tissue,0
23481,Before,Hereditary corneal dystrophy,0
23482,Common Specifications in HL7 V3 Publishing,Colorectal cancer,0
23483,Lymphadenitis,Mucinous adenocarcinoma gastric,0
23484,Stem cell transplant,Recurrent Uveal Melanoma,0
23485,Taken,Squamous cell carcinoma of lip,0
23486,Adult human body,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23487,Arising in,Intraepithelial Melanocytic Hyperplasia,0
23488,Malignant Neoplasms,Refractory Barrett Esophagus,0
23489,Short,Recurrent Rhabdomyosarcoma,0
23490,Togo,Hodgkin lymphoma,0
23491,Benign,Astrocytoma of brain,0
23492,Endocrine Cells,Blood Vessel Tumors,0
23493,Relationships,Clonal Hematopoiesis of Indeterminate Potential,0
23494,Certain (qualifier value),Advanced Uterine Corpus Carcinosarcoma,0
23495,Science of Etiology,Carcinoma of urinary bladder,0
23496,Ninth,Hodgkin Disease,0
23497,structure,Hodgkin Disease,0
23498,IPSS Risk Category High,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23499,Reaching,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
23500,Males,Unresectable Rhabdomyosarcoma,0
23501,Grouping,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23502,Exposure to,Lipoma of small intestine,0
23503,Often - answer to question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23504,Usual Severity Weight Loss,adenoid cystic carcinoma of lung,0
23505,Disseminated Malignant Neoplasm,Childhood Central Nervous System Ganglioneuroblastoma,0
23506,combination of objects,Malignant Testicular Sertoli Cell Tumor,0
23507,Menstruation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23508,Screening,Human Papillomavirus-Related Carcinoma,0
23509,Immunoproliferative Disorders,squamous cell carcinoma of the thyroid gland,0
23510,Reported,Small intestine carcinoma,0
23511,Irritation (finding),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
23512,Unintentional,Chest Wall Fibromatosis,0
23513,Lung,Kaposi's sarcoma of skin,0
23514,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Small Intestinal Villous Adenoma,0
23515,Inguinal part of abdomen,Intraepithelial Melanocytic Hyperplasia,0
23516,Science of Etiology,Breast Apocrine Adenoma,0
23517,X-linked inheritance,Pilocytic astrocytoma of cerebellum,0
23518,Always (frequency),Localized Ewing Sarcoma,0
23519,Formation,Papillary squamous cell carcinoma,0
23520,Separated from cohabitee,Vaginal Adenoma,0
23521,Preventive intent,Microcystic meningioma,0
23522,Metastatic Neoplasm,Anterior Urethral Malignant Neoplasm,0
23523,QPCT wt Allele,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23524,Idle,ROSE Cluster 3,0
23525,Combined Modality Therapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23526,Shortness of Breath Visual Analogue Scale,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23527,Occurrence,Type II Endometrial Adenocarcinoma,0
23528,Primary malignant neoplasm,Hodgkin Disease,0
23529,Central Nervous System Neoplasms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23530,treatment - ActInformationManagementReason,Heavy Chain Deposition Disease,0
23531,Alkalies,Maxillary Sinus Adenocarcinoma,0
23532,Lymphatic vessel,Gallbladder Adenocarcinoma,0
23533,United States,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23534,Chemicals,Small cell neuroendocrine carcinoma of bladder,0
23535,Vomiting,Colorectal cancer,0
23536,Early,Digestive System Hodgkin Lymphoma,0
23537,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23538,Chest Wall Pain,Lung squamous cell carcinoma stage I,0
23539,Absence (morphologic abnormality),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23540,Palmitic Acid,Xeroderma pigmentosum,0
23541,Smear - instruction imperative,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23542,Five,Tumorlet,0
23543,Persistent,Bladder adenocarcinoma stage IV,0
23544,Blood group A (finding),Ichthyoses,0
23545,Good,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
23546,Reported Term,Undifferentiated Endocervical Sarcoma,0
23547,Complication,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23548,How Often Shortness of Breath,Stage IB Pancreatic Cancer AJCC v8,0
23549,Usual Severity Diarrhea,mucinous adenocarcinoma of gallbladder,0
23550,Melanoma Pathway,Adult Acute Eosinophilic Leukemia,0
23551,Cerebrum,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23552,Prognosis:Find:Pt:^Patient:Nom,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23553,Cessation of life,Undifferentiated Endocervical Sarcoma,0
23554,Human body structure,Unicystic ameloblastoma,0
23555,Kind of quantity - Taste,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23556,Negation,Bladder adenocarcinoma stage IV,0
23557,Screening,Refractory Ependymoma,0
23558,pathogenic aspects,embryonal rhabdomyosarcoma of prostate,0
23559,Genus Labia,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23560,Anorexia,Xeroderma pigmentosum,0
23561,Name,Mixed astrocytoma-ependymoma,0
23562,year,Leptomeningeal sarcoma,0
23563,gliosarcoma,Vaginal Adenoma,0
23564,Primary malignant neoplasm,Type II Endometrial Adenocarcinoma,0
23565,Often - answer to question,Glomeruloid hemangioma,0
23566,Beginning,Cancer of Urinary Tract,0
23567,Most of the time,Intraepithelial Melanocytic Hyperplasia,0
23568,Net (qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23569,Body part,BRCA2 Syndrome,0
23570,Biopsy,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23571,Ninein,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23572,Greater than one,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23573,Family history,Trichilemmocarcinoma,0
23574,Hematopoietic Neoplasms,Engraftment syndrome,0
23575,Pelvic pain female,mucinous adenocarcinoma of gallbladder,0
23576,Tryptophanase,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23577,Cancer Genus,Familial Hemophagocytic Lymphocytosis,0
23578,First (number),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23579,Body tissue,Malignant neoplasm of thalamus,0
23580,Successful,Noninfiltrating Intraductal Carcinoma,0
23581,Intellectual scale,Melanomatosis,0
23582,Nictitating Membrane,High Grade Glandular Intraepithelial Neoplasia,0
23583,risk factors - observation list,Adult Alveolar Soft Part Sarcoma,0
23584,Large,Acantholytic squamous cell carcinoma,0
23585,Arising in,Acinar cell carcinoma of pancreas,0
23586,Pediculus humanus capitis (eukaryote),mucinous adenocarcinoma of gallbladder,0
23587,More,Unicystic ameloblastoma,0
23588,Very High Level,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
23589,suffix,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
23590,Offspring,BRCA2 Syndrome,0
23591,Experimental Result,Bladder squamous cell carcinoma stage I,0
23592,Gravidity,Adult Hepatocellular Carcinoma,0
23593,Now (temporal qualifier),Unfavorable Non-Hodgkin Lymphoma,0
23594,Intermediate,Papillary squamous cell carcinoma,0
23595,Effectiveness,ROSE Cluster 3,0
23596,X-Ray Computed Tomography,Bladder adenocarcinoma stage IV,0
23597,Surgical aspects,Benign squamous cell tumor,0
23598,Ultrasonic Shockwave,Recurrent Testicular Lymphoma,0
23599,Tumor cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23600,Hereditary Diseases,sarcoma of spinal cord,0
23601,Northern Europe,Intracortical osteosarcoma,0
23602,As Much as Desired,Tongue Alveolar Soft Part Sarcoma,0
23603,Onset of (contextual qualifier),Maxillary Sinus Adenocarcinoma,0
23604,Progress,Thyroid Hurthle Cell Carcinoma,0
23605,Cancer Genus,Werner Syndrome,0
23606,History of previous events,Vaginal Adenoid Cystic Carcinoma,0
23607,Repaired,Intracortical osteosarcoma,0
23608,Usually,Xeroderma pigmentosum,0
23609,Cause of death.underlying,Adult Anaplastic Oligodendroglioma,0
23610,Mature,Stage III Adult Immunoblastic Lymphoma,0
23611,lobe,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23612,Night time,Stage II Hepatocellular Carcinoma AJCC v8,0
23613,Person Name,Hodgkin Disease,0
23614,Treatment Plan,Leiomyoma of Gallbladder,0
23615,Sun Exposure,Adult Hepatocellular Carcinoma,0
23616,Traumatic injury,Clonal Hematopoiesis of Indeterminate Potential,0
23617,What subject filter - Result,Stage II Hepatocellular Carcinoma AJCC v8,0
23618,Common (qualifier value),Metastatic Ductal Breast Carcinoma,0
23619,Body part,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23620,Hyperplasia,Metaplastic carcinoma of breast,0
23621,Followed by,Undifferentiated Endocervical Sarcoma,0
23622,United States,Localized Ewing Sarcoma,0
23623,Type A,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23624,Disease,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23625,Certainties,Squamous cell carcinoma of lip,0
23626,Anaplastic Oligodendroglioma,Adult Anaplastic Oligodendroglioma,0
23627,Pruritus,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
23628,Diagnostic Imaging,Stage 0 Penile Cancer AJCC v8,0
23629,PSA Level Less than Five,Cervical Fibroepithelial Polyp,0
23630,Possible,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23631,Negation,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
23632,Group A (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
23633,Pregnancy,Acute Undifferentiated Leukemia,0
23634,Process,Cervical Fibroepithelial Polyp,0
23635,Smear - instruction imperative,Adult Acute Eosinophilic Leukemia,0
23636,Negation,Mucinous adenocarcinoma gastric,0
23637,Deglutition,Endometrial Small Cell Carcinoma,0
23638,Account number:Identifier:Point in time:^Patient:Nominal,Unicystic ameloblastoma,0
23639,Spindle,Cerebral Primitive Neuroectodermal Tumor,0
23640,Contain (action),Benign Anal Granular Cell Tumor,0
23641,Platelet Glycoprotein 4,Neonatal leukemia,0
23642,X-Ray Computed Tomography,Lipoma of small intestine,0
23643,Early,Thyroid Hurthle Cell Carcinoma,0
23644,New,Epithelioid Sarcoma NCI Grade 3,0
23645,Within,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23646,Dual,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
23647,Lung,Mucinous cystadenofibroma,0
23648,Confirmed by,Kaposi's sarcoma of extrahepatic bile duct,0
23649,Body tissue,Malignant neoplasm of olfactory nerve,0
23650,survival aspects,Bladder squamous cell carcinoma stage I,0
23651,Type A,Malignant neoplasm of gallbladder,0
23652,IPSS Risk Category High,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23653,Africa,Fibroadenoma of breast,0
23654,Wound number:ID:Pt:^Patient:Nom,Hemangioma,0
23655,Fasting,Maxillary Sinus Adenocarcinoma,0
23656,Group A (blood group),Ovarian Dermoid Cyst with Secondary Carcinoma,0
23657,In Blood,Recurrent Primary Lymphoma of Bone,0
23658,Canada,Vaginal Adenoid Cystic Carcinoma,0
23659,Anus,Cerebral Primitive Neuroectodermal Tumor,0
23660,Feel Tired question,Pancreatic Intraepithelial Neoplasia-3,0
23661,BRCA2 protein,Medulloblastoma,0
23662,Fasting,Digestive System Hodgkin Lymphoma,0
23663,Elderly (population group),Mucinous adenocarcinoma gastric,0
23664,Blood Cells,Fibroadenoma of breast,0
23665,World,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23666,Diarrhea,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23667,Usual Severity Shortness of Breath,Unicystic ameloblastoma,0
23668,Diagnosis Study,Locally Advanced Epithelioid Hemangioendothelioma,0
23669,combination - answer to question,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23670,Extension,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23671,See,Astrocytoma of brain,0
23672,Either,Ichthyosis,0
23673,Diagnosis Study,Malignant Testicular Sertoli Cell Tumor,0
23674,Body structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23675,Linear,Platinum-Resistant Lung Small Cell Carcinoma,0
23676,Application (Document),Pancreatic carcinoma,0
23677,Able to Concentrate Question,Recurrent Uveal Melanoma,0
23678,Secondary Neoplasm,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
23679,Presentation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23680,Manufactured sign,Airway Hemangioma,0
23681,Hodgkin Disease,Undifferentiated Endocervical Sarcoma,0
23682,Surface of skin,Kaposi's sarcoma of skin,0
23683,Anatomic Site,Testicular cancer metastatic,0
23684,Derivative,Colorectal Neuroendocrine Tumor G2,0
23685,Associated with,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23686,Person Name,Vaginal Adenoid Cystic Carcinoma,0
23687,Free (available (qualifier)),Thymoma malignant recurrent,0
23688,Serum calcium measurement,Cystadenocarcinoma,0
23689,Tryptophanase,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23690,Lymphoid Tissue,Benign squamous cell tumor,0
23691,Ephrin Type-B Receptor 1,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23692,Sarcoidosis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23693,Occurrence Indicator,Fibroadenoma of breast,0
23694,Congenital Abnormality,Locally Advanced Epithelioid Hemangioendothelioma,0
23695,Nipples,Metaplastic carcinoma of breast,0
23696,Time,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23697,Infrequent,embryonal rhabdomyosarcoma of prostate,0
23698,Range,Hemangioma,0
23699,Malignant Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23700,Malignant neoplasm of stomach,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23701,Qualitative form,Ovarian Carcinoid Tumor,0
23702,Base,Heavy Chain Deposition Disease,0
23703,Treatment Epoch,Vaginal Adenoma,0
23704,Common Specifications in HL7 V3 Publishing,Vaginal Adenoma,0
23705,white blood cell type,Mucinous adenocarcinoma gastric,0
23706,Definitive,Endometrial Small Cell Carcinoma,0
23707,Negation,Metastatic Malignant Neoplasm in the Sellar Region,0
23708,Contain (action),Malignant melanoma of eyelid,0
23709,Subject - topic,Refractory Ependymoma,0
23710,Blood,Endometrial Small Cell Carcinoma,0
23711,Cover - action,Extra-Adrenal Paraganglioma,0
23712,International Classification of Disease for Oncology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23713,Patient need for (contextual qualifier),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23714,Precancerous Conditions,Locally Advanced Carcinoma,0
23715,World Health Organization,Benign neoplasm of eye,0
23716,AKR1A1 wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23717,low,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
23718,Involvement with,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23719,Lung,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23720,East,Familial Hemophagocytic Lymphocytosis,0
23721,Three,Primary Cutaneous Plasmablastic Lymphoma,0
23722,Pharmacotherapy,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23723,Pancreas,non-Hodgkin's lymphoma of spleen,0
23724,Feature,Angiosarcoma of liver,0
23725,Manufactured form,Malignant Neoplasm of Lung - Multiple Primary Sites,0
23726,Occur (action),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23727,Cardiac Lead Procedure,Intraepithelial Melanocytic Hyperplasia,0
23728,Lipoma,Malignant neoplasm of subglottis,0
23729,Pain NOS,Childhood Central Nervous System Ganglioneuroblastoma,0
23730,Document completion status - Documented,Multiple Endocrine Neoplasia,0
23731,Malignant neoplasm of lung,Localized Ewing Sarcoma,0
23732,PSA Level Less than Two,Gallbladder Adenocarcinoma,0
23733,Occurrence Indicator,adenosquamous carcinoma of breast,0
23734,Cell Differentiation process,Hemangioma,0
23735,oncology field,Blepharal carcinoma,0
23736,1+ Score,Giant cell angiofibroma,0
23737,Subtype (attribute),Astrocytoma of brain,0
23738,Molecular Mass,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23739,Odontogenic Tumors,Metastatic Ductal Breast Carcinoma,0
23740,Viruses ingredient,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23741,Administration procedure,Pancreatic Endocrine Carcinoma,0
23742,Location of Oral Residue Following Swallowing,FIGO Stage II Ovarian Cancer,0
23743,Bilateral complete salpingectomy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23744,Experimental Result,Splenic Manifestation of Hairy Cell Leukemia,0
23745,Others - Allergy,Kaposi's sarcoma of skin,0
23746,Sequela of disorder,Papillary cystic tumor,0
23747,chapter,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23748,Gonadal structure,Human Papillomavirus-Related Carcinoma,0
23749,Accounting (activity),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23750,High risk of,Squamous cell carcinoma of lip,0
23751,Further,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
23752,various allergen extracts,Angiosarcoma of liver,0
23753,Involvement with,Locally Advanced Squamous Cell Carcinoma,0
23754,Tryptophanase,Childhood Central Nervous System Immature Teratoma,0
23755,Extension,Heavy Chain Deposition Disease,0
23756,Percent Activity,Peripheral primitive neuroectodermal tumor of soft tissue,0
23757,FAT1 wt Allele,embryonal rhabdomyosarcoma of prostate,0
23758,Overall Publication Type,Nasal cavity carcinoma,0
23759,Form of uterus,Chondrosarcoma,0
23760,Adult Subependymal Giant Cell Astrocytoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23761,Population Group,Pilocytic astrocytoma of cerebellum,0
23762,Unknown,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23763,biopsy characteristics,Medulloblastoma,0
23764,Common (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23765,Reduction (chemical),Refractory Ependymoma,0
23766,various other agents for local oral treatment in ATC,Plexosarcoma,0
23767,Group A (blood group),Malignant Neoplasm with Regional Lymph Node Involvement,0
23768,Code,Melanomatosis,0
23769,throat cancer,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23770,Discover,Refractory WHO Grade III Glioma,0
23771,Leg,Placental aromatase deficiency,0
23772,potential,Trichilemmocarcinoma,0
23773,Correct (qualifier),Thymic Clear Cell Carcinoma,0
23774,Spreading (qualifier value),Cervical Squamous Intraepithelial Neoplasia,0
23775,Exostoses,Malignant neoplasm of olfactory nerve,0
23776,Percent of Abnormal Cells,Bladder squamous cell carcinoma stage I,0
23777,Usual,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23778,Treatment intent,Endometrial Small Cell Carcinoma,0
23779,Breast Carcinoma,Bladder Neuroendocrine Neoplasm,0
23780,rhinoplasty,Splenic Manifestation of Hairy Cell Leukemia,0
23781,Body Fluid Discharge,Cerebral Primitive Neuroectodermal Tumor,0
23782,Tired,Intestinal Neuroendocrine Carcinoma,0
23783,Diagnosis,Localized Ewing Sarcoma,0
23784,veterans alcoholism screening test (VAST),Peripheral primitive neuroectodermal tumor of soft tissue,0
23785,Decreasing,Xeroderma pigmentosum,0
23786,Fluid behavior,Testicular cancer metastatic,0
23787,Metastatic malignant neoplasm to brain,Endometrial Small Cell Carcinoma,0
23788,95,Testicular cancer metastatic,0
23789,Diagnostic Imaging,Acute Undifferentiated Leukemia,0
23790,Germ cell tumor,Acantholytic squamous cell carcinoma,0
23791,Premalignant,Medulloblastoma,0
23792,Interstitial Route of Drug Administration,Hyperplasia of pituitary gland,0
23793,Histologic type,FIGO Stage IVA Ovarian Cancer,0
23794,Surrounding (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
23795,Lip and Oral Cavity Carcinoma,Locally Advanced Carcinoma,0
23796,factor A,Clonal Hematopoiesis of Indeterminate Potential,0
23797,Combined,Stage III Cutaneous Melanoma AJCC v6,0
23798,Africa,Rhabdomyosarcoma with ganglionic differentiation,0
23799,Very,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23800,Cancer Genus,Recurrent Testicular Lymphoma,0
23801,Asbestos,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
23802,Disease Steps Questionnaire,Mixed astrocytoma-ependymoma,0
23803,radiotherapeutic,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23804,Cell Count,Xeroderma pigmentosum,0
23805,Line Specimen,Unresectable Rhabdomyosarcoma,0
23806,motor movement,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23807,Woman,Trabecular adenocarcinoma,0
23808,potential,Benign Ovarian Thecoma,0
23809,Type - attribute,Stage I Adult Non-Hodgkin Lymphoma,0
23810,Parameterized Data Type - Set,Human Papillomavirus-Related Carcinoma,0
23811,Surface,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23812,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23813,Referring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23814,Mass,Malignant Neoplasm of Lung - Multiple Primary Sites,0
23815,Feel Tired question,Acantholytic squamous cell carcinoma,0
23816,Scrofula,Benign Apocrine Neoplasm,0
23817,Uterus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
23818,Involvement with,Hemangioma,0
23819,Liver,Diffuse malignant mesothelioma,0
23820,Medical Imaging,Lipoma of small intestine,0
23821,Uterine Cancer,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23822,Mass of body structure,Heavy Chain Deposition Disease,0
23823,Extracellular Matrix,adenosquamous carcinoma of breast,0
23824,Large,Refractory Barrett Esophagus,0
23825,Have Itch,Vaginal Adenoid Cystic Carcinoma,0
23826,Common Cold,mucinous adenocarcinoma of gallbladder,0
23827,Endometrial scraping,Digestive System Hodgkin Lymphoma,0
23828,Management procedure,Metastatic Lung Neuroendocrine Neoplasm,0
23829,Poverty,Mixed parotid tumor,0
23830,Cutaneous (intended site),Non-Metastatic Gestational Trophoblastic Tumor,0
23831,Point Name,Refractory Ependymoma,0
23832,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Recurrent Rhabdomyosarcoma,0
23833,Cells,Refractory Barrett Esophagus,0
23834,Fever,Fourth Ventricle and Brain Stem Ependymal Tumor,0
23835,Low Mitosis-Karyorrhexis Index,Childhood Anaplastic Large Cell Lymphoma,0
23836,Well Differentiated,Adult Acute Eosinophilic Leukemia,0
23837,Management procedure,Localized Ewing Sarcoma,0
23838,Metastasis,Cervical Adenomyoma,0
23839,Child,Adult Acute Eosinophilic Leukemia,0
23840,Overall Publication Type,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23841,Surrounding (qualifier value),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23842,Intravascular line,Recurrent Testicular Lymphoma,0
23843,allowing,Peripheral primitive neuroectodermal tumor of soft tissue,0
23844,Asp snake,Testicular cancer metastatic,0
23845,Options,Non-Metastatic Gestational Trophoblastic Tumor,0
23846,Symptoms,Occult Lung Adenosquamous Carcinoma,0
23847,Skin tanning,Stage I Colon Neuroendocrine Tumor AJCC v8,0
23848,Tobacco,Collecting Duct Carcinoma of the Kidney,0
23849,Pathogenic organism,Low Grade Squamous Intraepithelial Neoplasia,0
23850,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23851,Frequently,Pancreatic Intraepithelial Neoplasia-3,0
23852,Plasma Cell Neoplasm,Carcinoma,0
23853,Clumped,FIGO Stage II Ovarian Cancer,0
23854,Primary,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23855,Include (action),gliosarcoma,0
23856,Slight (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23857,Symptoms aspect,embryonal rhabdomyosarcoma of prostate,0
23858,Abnormal Cell Count,Cartilaginous exostosis,0
23859,Biomaterial Treatment,Brain Tumor,0
23860,Overall,Small cell neuroendocrine carcinoma of bladder,0
23861,Human body structure,Intraepithelial Melanocytic Hyperplasia,0
23862,2+,Acute Undifferentiated Leukemia,0
23863,majority,Congenital hamartoma,0
23864,Containing (qualifier),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23865,Regimen - CHV concept,High Grade Glandular Intraepithelial Neoplasia,0
23866,Beginning,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23867,Sharing (Social Behavior),Cervical Adenomyoma,0
23868,Often - answer to question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23869,Group A (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
23870,A Codes,Endometrial Small Cell Carcinoma,0
23871,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Advanced Uterine Corpus Carcinosarcoma,0
23872,Biochemical Pathway,Cystadenocarcinoma,0
23873,Frequently,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23874,newly,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23875,Symptoms aspect,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23876,Divide,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23877,Synonym (core metadata concept),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
23878,Reported Term,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23879,Most,Childhood Central Nervous System Ganglioneuroblastoma,0
23880,Neoplasms,Carcinomatosis of peritoneal cavity,0
23881,Cell (compartment),Squamous cell carcinoma of lip,0
23882,Administration type,Bladder squamous cell carcinoma stage I,0
23883,Treatment Epoch,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23884,Malignant lymphangioma,Stage 0 Penile Cancer AJCC v8,0
23885,Speech,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23886,Metastatic to,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23887,Headache,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23888,Vision:-:Point in time:^Patient:-,Childhood Central Nervous System Ganglioneuroblastoma,0
23889,Human body,Nasal cavity carcinoma,0
23890,newly,Placental aromatase deficiency,0
23891,Cancer Genus,Neonatal leukemia,0
23892,Body structure,Refractory Ependymoma,0
23893,Often - answer to question,Adrenal Rest Tumor,0
23894,Form:Finding:Point in time:{Setting}:Document:{Role},Benign tumor of eyelid,0
23895,Form:Finding:Point in time:{Setting}:Document:{Role},Cystadenocarcinoma,0
23896,Expiration,Tongue Alveolar Soft Part Sarcoma,0
23897,Malignant neoplasm of liver,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
23898,Excessive,Kaposi's sarcoma of extrahepatic bile duct,0
23899,Providing presence (regime/therapy),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23900,True primary (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23901,Extension,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23902,lymph nodes,Recurrent Uveal Melanoma,0
23903,CYREN gene,ROSE Cluster 3,0
23904,Diabetes,Type II Endometrial Adenocarcinoma,0
23905,ovarian,Benign tumor of eyelid,0
23906,ethnic european,Xeroderma pigmentosum,0
23907,Fascia,Malignant melanoma of eyelid,0
23908,Units Of Measure - bel,Periosteal Osteosarcoma,0
23909,Decision,Intestinal Metaplasia of Bladder Urothelium,0
23910,Human body,Choroid Necrotic Melanoma,0
23911,20%,Precursor B-lymphoblastic lymphoma stage II,0
23912,Manufactured form,Cerebral Primitive Neuroectodermal Tumor,0
23913,Anatomical compartments,Benign squamous cell tumor,0
23914,year,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23915,Epithelium of vagina,Neonatal leukemia,0
23916,Rare,Maxillary Sinus Adenoid Cystic Carcinoma,0
23917,Back structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23918,Primary malignant neoplasm,Benign Apocrine Neoplasm,0
23919,various antiseptic throat preparations,Transitional cell carcinoma,0
23920,Count Dosing Unit,Malignant neoplasm of subglottis,0
23921,Diagnosis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23922,Array Feature,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23923,suggestion,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23924,Approximate,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23925,Structure of right thigh,Adult Alveolar Soft Part Sarcoma,0
23926,Gonadal structure,Mucinous adenocarcinoma,0
23927,Childhood Extracranial Germ Cell Tumor,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23928,One,Cerebral Primitive Neuroectodermal Tumor,0
23929,Not abnormal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23930,Code,Kaposi's sarcoma of skin,0
23931,Chemotherapy,Locally Advanced Carcinoma,0
23932,diagnosis aspect,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23933,Does swallow,adenosquamous carcinoma of breast,0
23934,Prevention Study,benign mature teratoma of pancreas,0
23935,Data Table,Testicular cancer metastatic,0
23936,Average,Metaplastic carcinoma of breast,0
23937,Transurethral Resection,Brain Tumor,0
23938,set (group),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23939,Amount type - Percentage,Human Papillomavirus-Related Carcinoma,0
23940,treatment - ActInformationManagementReason,Stage II Hepatocellular Carcinoma AJCC v8,0
23941,Known,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23942,New,ROSE Cluster 3,0
23943,Thyroid Hormones,Fibroadenoma of breast,0
23944,Malignancy,Malignant Testicular Sertoli Cell Tumor,0
23945,Ductal Breast Carcinoma,non-Hodgkin's lymphoma of spleen,0
23946,Most,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23947,Providing (action),Benign Anal Granular Cell Tumor,0
23948,Approximate,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23949,International Classification of Diseases for Oncology,Recurrent Uveal Melanoma,0
23950,Times,adenoid cystic carcinoma of lung,0
23951,Geographic Locations,Adult Acute Eosinophilic Leukemia,0
23952,Immunoglobulins,FIGO Stage II Ovarian Cancer,0
23953,Lymphocyte Activation,Stage III Cutaneous Melanoma AJCC v6,0
23954,Folded structure,ROSE Cluster 3,0
23955,Biomaterial Treatment,Occult Lung Adenosquamous Carcinoma,0
23956,Show,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
23957,Usual Severity Pain,Unfavorable Non-Hodgkin Lymphoma,0
23958,Approximate,Benign Apocrine Neoplasm,0
23959,Clinical Study Case,Childhood Lymphoma,0
23960,Usual,Malignant melanoma of eyelid,0
23961,Adrenal Glands,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23962,Formation,Uterine Cancer,0
23963,Symptoms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23964,growth aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23965,Smear - instruction imperative,Methotrexate-Associated Hodgkin Lymphoma,0
23966,Wound Healing,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23967,Common (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
23968,Lung,Pancreatic Intraepithelial Neoplasia-3,0
23969,CD44 wt Allele,Neonatal leukemia,0
23970,Appearance,Periosteal Osteosarcoma,0
23971,Symptoms aspect,High Grade Glandular Intraepithelial Neoplasia,0
23972,Greater than one,Benign Carotid Body Paraganglioma,0
23973,Related personal status,Childhood Fibrillary Astrocytoma,0
23974,Neoplasms,Undifferentiated Endocervical Sarcoma,0
23975,Most,Contact dermatitis due to alkali,0
23976,Country number,Malignant melanoma of eyelid,0
23977,*Type - Kind of quantity,Vaginal Adenoma,0
23978,Abundance,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23979,consider,Clonal Hematopoiesis of Indeterminate Potential,0
23980,Structure of lateral palpebral ligament,Liver Lymphangioma,0
23981,Often - answer to question,Carcinomatosis of peritoneal cavity,0
23982,Symptoms,Papillary squamous cell carcinoma,0
23983,Result,Thymoma malignant recurrent,0
23984,Biological Response Modifiers,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23985,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Engraftment syndrome,0
23986,Rare,Granular Cell Leiomyosarcoma,0
23987,Chemotherapy Regimen,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
23988,Lymphocyte component of blood,Spindle Cell Melanoma,0
23989,Manufactured form,Unresectable Rhabdomyosarcoma,0
23990,Neoplasms,Occult Lung Adenosquamous Carcinoma,0
23991,Rating (action),Engraftment syndrome,0
23992,Slightly Able,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23993,Mobility Ability,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23994,capsule (pharmacologic),Botryoid-Type Embryonal Rhabdomyosarcoma,0
23995,<90,Malignant neoplasm of choroid,0
23996,Beginning,Anterior Urethral Malignant Neoplasm,0
23997,Life Threatening or Disabling Adverse Event,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23998,Fever symptoms (finding),Liver Lymphangioma,0
23999,Myeloid Cells,Colorectal Neuroendocrine Tumor G2,0
24000,60%,Breast Ductal Adenoma,0
24001,Apply (instruction),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24002,Swallowing G-code,malignant lymphoma of pancreatic lymph nodes,0
24003,Time (foundation metadata concept),Childhood Central Nervous System Ganglioneuroblastoma,0
24004,Eye foreign bodies,Small intestine carcinoma,0
24005,Diabetes,Benign Carotid Body Paraganglioma,0
24006,Experimental Result,Type II Endometrial Adenocarcinoma,0
24007,Exposure to,Splenic Manifestation of Hairy Cell Leukemia,0
24008,Clinical Effectiveness,Refractory Bladder Carcinoma,0
24009,N+ (tumor staging),Multiple Skull Base Meningiomas,0
24010,Fresh (qualifier value),Childhood Choriocarcinoma,0
24011,Mean Percent of Normal,Unfavorable Non-Hodgkin Lymphoma,0
24012,Photon Correlation Spectroscopy,Female Breast Carcinoma,0
24013,Waste Products,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24014,Cell division,Xeroderma pigmentosum,0
24015,Pediatrics,Leptomeningeal sarcoma,0
24016,Experimental Result,Kaposi's sarcoma of skin,0
24017,Epithelial cell count (procedure),Botryoid-Type Embryonal Rhabdomyosarcoma,0
24018,Pharmacotherapy,Endometrial Small Cell Carcinoma,0
24019,Superkingdom (taxonomic category),Malignant neoplasm of thalamus,0
24020,Set scale,Thymic Clear Cell Carcinoma,0
24021,Smear - instruction imperative,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24022,Suspected diagnosis,Kaposi's sarcoma of extrahepatic bile duct,0
24023,Larynx,Vaginal Adenoid Cystic Carcinoma,0
24024,% volume (qualifier value),Benign squamous cell tumor,0
24025,Usual Severity Constipation,FIGO Stage II Ovarian Cancer,0
24026,Personal appearance,Cerebral hemangioma,0
24027,Encode (action),Thymic Clear Cell Carcinoma,0
24028,Followed by,Stage IV Penile Cancer AJCC v7,0
24029,Entity Determiner - specific,Blepharal carcinoma,0
24030,morphological,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24031,year,Pancreatic carcinoma,0
24032,Woman,Metaplastic carcinoma of breast,0
24033,Etiology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24034,Tract,Endometrial Small Cell Carcinoma,0
24035,Long Variable,Stage IV Colorectal Cancer AJCC v8,0
24036,survive,Neoplasms,0
24037,Compress (Compression Algorithm),Non-Hodgkin Lymphoma During Pregnancy,0
24038,Metastasis,Bladder Neuroendocrine Neoplasm,0
24039,Tryptophanase,Localized Askin Tumor,0
24040,20%,Localized Askin Tumor,0
24041,To,Basal Cell Ameloblastoma,0
24042,Carcinoma in Situ,Malignant neoplasm of olfactory nerve,0
24043,Person Name,Malignant neoplasm of thalamus,0
24044,Kaposi Sarcoma,Female Breast Carcinoma,0
24045,Hearing Loss,Kaposi's sarcoma of extrahepatic bile duct,0
24046,metastatic qualifier,Secondary malignant neoplasm of lymph node,0
24047,Air Filters,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24048,Structure of left half of body,Parathyroid Gland Adenocarcinoma,0
24049,Disease,Liver Lymphangioma,0
24050,Usual,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24051,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24052,Patient observation,Stage IV Childhood Non-Hodgkin Lymphoma,0
24053,Cell Device,Benign Apocrine Neoplasm,0
24054,Resolution,Female Breast Carcinoma,0
24055,High Mitosis-Karyorrhexis Index,Vaginal Adenoma,0
24056,Last,Xeroderma pigmentosum,0
24057,Hodgkin Disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24058,Shortness of Breath Visual Analogue Scale,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24059,Group A (qualifier value),Recurrent Primary Lymphoma of Bone,0
24060,Skin Specimen,Blepharal carcinoma,0
24061,<90,Acute Undifferentiated Leukemia,0
24062,Primary malignant neoplasm,Trichilemmocarcinoma,0
24063,radiotherapeutic,Xeroderma pigmentosum,0
24064,Pleomorphism,Primary Cutaneous Plasmablastic Lymphoma,0
24065,Tired,Cerebral Primitive Neuroectodermal Tumor,0
24066,Fasting,Pancreatic Intraepithelial Neoplasia-3,0
24067,Smell Perception,Malignant Neoplasm with Regional Lymph Node Involvement,0
24068,Negative Surgical Margin,Hodgkin lymphoma,0
24069,T-Lymphocyte,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24070,>90,Cancer of Urinary Tract,0
24071,Milliampere second,Epithelioid Sarcoma NCI Grade 3,0
24072,Medical Tent,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24073,Poor coordination,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24074,Progress,Intraepithelial Melanocytic Hyperplasia,0
24075,Attenuation,Refractory Ependymoma,0
24076,Version,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24077,Oral region,Female Breast Carcinoma,0
24078,Human papilloma virus infection,Locally Advanced Soft Tissue Sarcoma,0
24079,SERPINA3 wt Allele,Ichthyosis,0
24080,Widening,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24081,Back Pain,Ovarian germ cell choriocarcinoma stage IV,0
24082,Include (action),Splenic Manifestation of Hairy Cell Leukemia,0
24083,Abnormal,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
24084,What subject filter - Result,Acantholytic squamous cell carcinoma,0
24085,Cell (compartment),Extra-Adrenal Paraganglioma,0
24086,Pediatric,Stage III Cutaneous Melanoma AJCC v6,0
24087,Night sweats,Metaplastic carcinoma of breast,0
24088,Stem cell transplant,FIGO Stage II Ovarian Cancer,0
24089,Spread by direct extension,Malignant neoplasm of olfactory nerve,0
24090,Histopathologic Grade,Blood Vessel Tumors,0
24091,Gingiva,Malignant neoplasm of subglottis,0
24092,Medical Imaging,Nasal cavity carcinoma,0
24093,Diagnosis,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
24094,How Often Weight Loss,Childhood Central Nervous System Immature Teratoma,0
24095,Dictionaries as Topic,Benign Apocrine Neoplasm,0
24096,Dermatologic disorders,Bladder squamous cell carcinoma stage I,0
24097,Squamous cell carcinoma - category,Kaposi's sarcoma of skin,0
24098,Ultraviolet Rays,Acute Undifferentiated Leukemia,0
24099,Body part,Refractory Bladder Carcinoma,0
24100,Pharmacologic Substance,Adrenal Rest Tumor,0
24101,Skin Specimen,Type II Endometrial Adenocarcinoma,0
24102,Ovarian Carcinoma,Acute lymphadenitis,0
24103,Rattus norvegicus,papillary carcinoma of penis,0
24104,Extrinsic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24105,Including (qualifier),Childhood Central Nervous System Ganglioneuroblastoma,0
24106,Location of Pharyngeal Residue Following Swallowing,Adult Hepatocellular Carcinoma,0
24107,Soft Tissue Neoplasms,Adult Alveolar Soft Part Sarcoma,0
24108,Five-year Survival Rate,Recurrent Uveal Melanoma,0
24109,Pharmacotherapy,Intraepithelial Melanocytic Hyperplasia,0
24110,Most Recent,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
24111,Two,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24112,Name (property) (qualifier value),Grade 3a Malignant Neoplasm,0
24113,Pancreatic Neoplasm,Stage IV Childhood Non-Hodgkin Lymphoma,0
24114,50%,Liver Lymphangioma,0
24115,Acute Megakaryocytic Leukemias,gliosarcoma,0
24116,Qualitative form,Human Papillomavirus-Related Carcinoma,0
24117,United States Military Commissioned Officer O4,Benign squamous cell tumor,0
24118,artesunate,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
24119,Brain,Bladder adenocarcinoma stage IV,0
24120,Fever,Mixed astrocytoma-ependymoma,0
24121,Fatigue,Collecting Duct Carcinoma of the Kidney,0
24122,Human body,Tubal Hyperplasia,0
24123,Family Felidae,sarcoma of spinal cord,0
24124,To,Liver Lymphangioma,0
24125,geographic population,Metaplastic carcinoma of breast,0
24126,General surgery specialty,Recurrent Uveal Melanoma,0
24127,Frequency of Pain Question,FIGO Stage IVA Ovarian Cancer,0
24128,Genome,Necrotizing Funisitis,0
24129,Crystal - natural material,FIGO Stage IVA Ovarian Cancer,0
24130,Old,Mucinous adenocarcinoma gastric,0
24131,Malignant neoplasm of skin,FIGO Stage II Ovarian Cancer,0
24132,In Situ Follicular Neoplasia,Multiple Skull Base Meningiomas,0
24133,1000000,Locally Advanced Soft Tissue Sarcoma,0
24134,Oral cavity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24135,Biopsy,Clonal Hematopoiesis of Indeterminate Potential,0
24136,Cessation of life,clear cell adenocarcinoma of gallbladder,0
24137,Screening,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24138,Regular,Multiple Skull Base Meningiomas,0
24139,Usual Severity Itching,Locally Advanced Squamous Cell Carcinoma,0
24140,Stomach structure,Pancreatic Intraepithelial Neoplasia-3,0
24141,heirarchal root,Chest Wall Fibromatosis,0
24142,Diffuse Large B-Cell Lymphoma,Localized Ewing Sarcoma,0
24143,Used by,Blepharal carcinoma,0
24144,Accepted,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24145,ultrasound device,Gallbladder Adenocarcinoma,0
24146,ATG5 wt Allele,BRCA2 Syndrome,0
24147,HLA Class II Histocompatibility Antigen Gamma Chain,Thyroid Hurthle Cell Carcinoma,0
24148,Percent (qualifier value),Unresectable Rhabdomyosarcoma,0
24149,Running (physical activity),Melanomatosis,0
24150,Endocervical epithelium,Refractory Ependymoma,0
24151,Treating,Trabecular adenocarcinoma,0
24152,Frequently,Airway Hemangioma,0
24153,Similarity,Benign neoplasm of thorax,0
24154,Cell Count,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24155,Materials,Mucinous adenocarcinoma gastric,0
24156,Edema,Benign tumor of eyelid,0
24157,Embryonic Germ Cells,Medulloblastoma,0
24158,Carcinoma of supraglottis,Cancer of Urinary Tract,0
24159,Skin Specimen,Bladder squamous cell carcinoma stage I,0
24160,combination - answer to question,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24161,Decision,Cherubism,0
24162,Country number,Advanced Lung Carcinoma,0
24163,Observation - diagnostic procedure,Stage III Cutaneous Melanoma AJCC v6,0
24164,Completely Able,Thyroid carcinoma,0
24165,Information,Benign Apocrine Neoplasm,0
24166,leukemia,Extracranial Neuroblastoma,0
24167,Transformation,Mucinous adenocarcinoma gastric,0
24168,Cell Count,Diffuse malignant mesothelioma,0
24169,Mutation,Small Intestinal Villous Adenoma,0
24170,Lymphatic,Bladder Neuroendocrine Neoplasm,0
24171,Vomiting,Thymic Clear Cell Carcinoma,0
24172,To,Contact dermatitis due to alkali,0
24173,Headache,Medulloblastoma,0
24174,Procedures involving the use of pharmaceuticals,Blepharal carcinoma,0
24175,Cure (remedy),Kaposi's sarcoma of extrahepatic bile duct,0
24176,Population Mean,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24177,Further,Fourth Ventricle and Brain Stem Ependymal Tumor,0
24178,Classification,Ovarian germ cell choriocarcinoma stage IV,0
24179,Upper abdominal pain,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24180,Primary malignant neoplasm,Anterior Urethral Malignant Neoplasm,0
24181,Yellow complexion,Thymoma malignant recurrent,0
24182,mucus layer,squamous cell carcinoma of the thyroid gland,0
24183,Name,Cancer of Urinary Tract,0
24184,Throat,Trabecular adenocarcinoma,0
24185,Out (direction),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
24186,Wounds - qualifier,Childhood Fibrillary Astrocytoma,0
24187,Beginning,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24188,Rare Lesion,Splenic Manifestation of Hairy Cell Leukemia,0
24189,professional occupation status,Familial Adenomatous Polyposis Associated Medulloblastoma,0
24190,Human body structure,Recurrent Uveal Melanoma,0
24191,Common (qualifier value),Basal Cell Ameloblastoma,0
24192,Biomaterial Treatment,Testicular cancer metastatic,0
24193,Shortened,Stage IV Colorectal Cancer AJCC v8,0
24194,treatment options,Choroid Necrotic Melanoma,0
24195,IPSS Risk Category High,Mixed astrocytoma-ependymoma,0
24196,High,Benign Apocrine Neoplasm,0
24197,Pure Spanish horse breed (organism),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24198,rituximab,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24199,Update,Melanomatosis,0
24200,Lead,Bladder adenocarcinoma stage IV,0
24201,Histopathology,Recurrent Uveal Melanoma,0
24202,The Sun,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24203,Dependent - ability,Gallbladder adenoma,0
24204,Follow - dosing instruction imperative,Uterine Cancer,0
24205,World,Breast Apocrine Adenoma,0
24206,Divide,mucinous adenocarcinoma of gallbladder,0
24207,Therapeutic procedure,Small cell neuroendocrine carcinoma of bladder,0
24208,Carrying,Stage III Adult Immunoblastic Lymphoma,0
24209,Lymphatic System,Platinum-Resistant Lung Small Cell Carcinoma,0
24210,prevention aspects,Sarcomatoid Renal Cell Carcinoma,0
24211,Stem of plant,Unicystic ameloblastoma,0
24212,Malignant Neoplasms,Metastatic Lung Small Cell Carcinoma,0
24213,Numerous,Small cell neuroendocrine carcinoma of bladder,0
24214,Valid,FIGO Stage IVA Ovarian Cancer,0
24215,Skin,Recurrent Testicular Lymphoma,0
24216,Worse,Cerebral Primitive Neuroectodermal Tumor,0
24217,Uterus,Metastatic Ductal Breast Carcinoma,0
24218,Medical,Stage I Adult Non-Hodgkin Lymphoma,0
24219,More,Peripheral primitive neuroectodermal tumor of soft tissue,0
24220,Metastatic Neoplasm,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
24221,User Group,Recurrent Testicular Lymphoma,0
24222,Have Been Vomiting,Melanomatosis,0
24223,Spreading (qualifier value),Breast Ductal Adenoma,0
24224,Fever,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24225,Human patch material,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24226,Pathologic,Pilocytic astrocytoma of cerebellum,0
24227,Adult Myelodysplastic Syndrome,FIGO Stage II Ovarian Cancer,0
24228,Known,Intestinal Neuroendocrine Carcinoma,0
24229,Worse,Intraepithelial Melanocytic Hyperplasia,0
24230,Negation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24231,Medical service,FIGO Stage II Ovarian Cancer,0
24232,Interested,Precursor B-lymphoblastic lymphoma stage II,0
24233,Initially,Splenic Manifestation of Hairy Cell Leukemia,0
24234,Beginning,Testicular cancer metastatic,0
24235,Reported Term,Stage III Cutaneous Melanoma AJCC v6,0
24236,Call (Instruction),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
24237,Attachments (document),Fibroadenoma of breast,0
24238,Arising,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24239,Both ovaries,Tonsillar Carcinoma,0
24240,Dependent for bathing,Stage III Cutaneous Melanoma AJCC v6,0
24241,PSA Level Less than Two,Childhood Thyroid Gland Follicular Carcinoma,0
24242,Tissue Specimen Code,Carcinomatosis of peritoneal cavity,0
24243,68,Uterine Cancer,0
24244,Atlases,Spongiotic dermatitis,0
24245,Adenocarcinoma of pancreas,FIGO Stage IVA Ovarian Cancer,0
24246,AKR1A1 wt Allele,Multiple Skull Base Meningiomas,0
24247,Gene Deletion Abnormality,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24248,Macrophage Activation Syndrome,Liver Lymphangioma,0
24249,CD5L wt Allele,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24250,Evidence,Localized Askin Tumor,0
24251,Cystadenoma,Fourth Ventricle and Brain Stem Ependymal Tumor,0
24252,Deoxyribonucleic Acid Measurement,Recurrent Primary Lymphoma of Bone,0
24253,Schwann Cells,Intraepithelial Melanocytic Hyperplasia,0
24254,therapeutic aspects,Mixed astrocytoma-ependymoma,0
24255,Catch - Finding of sensory dimension of pain,Basal Cell Ameloblastoma,0
24256,pharmacotherapeutic,Acute Undifferentiated Leukemia,0
24257,Case unit dose,Adult Hepatocellular Carcinoma,0
24258,3+ Score,Anaplastic large cell lymphoma,0
24259,OTULIN gene,Maxillary Sinus Adenocarcinoma,0
24260,Include (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
24261,Sixty,Parathyroid Gland Adenocarcinoma,0
24262,Plasma,Childhood Central Nervous System Ganglioneuroblastoma,0
24263,Sweating,Benign neoplasm of thorax,0
24264,More Often than Once a Day,Stage IV Childhood Non-Hodgkin Lymphoma,0
24265,Malignant mesothelioma,Trabecular adenocarcinoma,0
24266,Nervous system structure,Maxillary Sinus Adenocarcinoma,0
24267,Childhood Brain Neoplasm,Spindle Cell Melanoma,0
24268,Malignant neoplasm of kidney,Cartilaginous exostosis,0
24269,To,Multiple Skull Base Meningiomas,0
24270,Mass,Secondary malignant neoplasm of lymph node,0
24271,To,Cystadenocarcinoma,0
24272,What subject filter - Result,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24273,Chest wall structure,Malignant Testicular Sertoli Cell Tumor,0
24274,Include (action),Localized Ewing Sarcoma,0
24275,Neoplasm Metastasis,Cancer of Urinary Tract,0
24276,Condition:Find:Pt:^Patient:Nom,Refractory Barrett Esophagus,0
24277,MOSTLY,benign mature teratoma of pancreas,0
24278,Body site,Stage IV Penile Cancer AJCC v7,0
24279,Kidney Tubules,Adenocarcinoma,0
24280,survival aspects,Blepharal carcinoma,0
24281,Therapeutic procedure,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24282,Seven,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24283,Mature,Acute Undifferentiated Leukemia,0
24284,Myeloproliferative disease,Bladder squamous cell carcinoma stage I,0
24285,Positive Number,Cerebral Primitive Neuroectodermal Tumor,0
24286,Generation (action),Chest Wall Fibromatosis,0
24287,Stromal Cells,Mixed astrocytoma-ependymoma,0
24288,Smear - instruction imperative,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24289,Poor appetite question,Pancreatic Intraepithelial Neoplasia-3,0
24290,Section - Geographic Area,Germinoma,0
24291,Damage,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24292,Small cell carcinoma of lung,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24293,Third,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24294,Adult human body,Astrocytoma of brain,0
24295,Population Group,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24296,PFDN5 gene,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24297,Common Specifications in HL7 V3 Publishing,Refractory Glioma,0
24298,Lymphocyte Count measurement,Cervical Squamous Intraepithelial Neoplasia,0
24299,Fraction of,Neonatal leukemia,0
24300,other medicated shampoos in ATC,Nasal cavity carcinoma,0
24301,pharmacotherapeutic,Mucinous adenocarcinoma gastric,0
24302,Cell Count,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24303,Better,Benign tumor of eyelid,0
24304,Complete excision,Benign Anal Granular Cell Tumor,0
24305,Cessation of life,Peripheral primitive neuroectodermal tumor of soft tissue,0
24306,risk factors - observation list,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24307,Involvement with,Metastatic Neoplasm to the Gallbladder,0
24308,Small cell carcinoma of lung,Unresectable Rhabdomyosarcoma,0
24309,Complete excision,Unicystic ameloblastoma,0
24310,Infant,Acantholytic squamous cell carcinoma,0
24311,Ameloblastoma,Mastocytosis,0
24312,Complicated,Stage IV Penile Cancer AJCC v7,0
24313,Table Cell Horizontal Align - left,Uterine Cancer,0
24314,Include (action),Stage III Cutaneous Melanoma AJCC v6,0
24315,Rare,Engraftment syndrome,0
24316,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
24317,Excision,Thymic Atypical Carcinoid Tumor,0
24318,Polypeptide Hormones,Werner Syndrome,0
24319,Chronic myeloproliferative disorder,Thymoma malignant recurrent,0
24320,Often - answer to question,mucinous adenocarcinoma of gallbladder,0
24321,Bladder Continence Question,Acute Undifferentiated Leukemia,0
24322,diagnosis aspect,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24323,Adult Diffuse Large B-Cell Lymphoma,mucinous adenocarcinoma of gallbladder,0
24324,How Much Distress Sweats,Digestive System Hodgkin Lymphoma,0
24325,Occurrence Indicator,Stage IB Lung Cancer AJCC v7,0
24326,Group A (blood group),ROSE Cluster 3,0
24327,Variety (taxon),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24328,Decision,sarcoma of spinal cord,0
24329,Squamous cell carcinoma,Human Papillomavirus-Related Carcinoma,0
24330,Determined by,BRCA2 Syndrome,0
24331,Neoplasms,Unresectable Rhabdomyosarcoma,0
24332,Type A,Liver Lymphangioma,0
24333,mesenchymal,Human Papillomavirus-Related Carcinoma,0
24334,Tissue Type Code - Basal cell carcinoma,Carcinomatosis of peritoneal cavity,0
24335,diagnosis aspect,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24336,Procedure findings:Finding:Point in time:^Patient:Narrative,Maxillary Sinus Adenocarcinoma,0
24337,Skin Erosion,Clonal Hematopoiesis of Indeterminate Potential,0
24338,Tryptophanase,Recurrent Testicular Lymphoma,0
24339,More,Undifferentiated Endocervical Sarcoma,0
24340,Volume 2,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24341,Manufactured form,Primary Cutaneous Plasmablastic Lymphoma,0
24342,Term Birth,Non-Metastatic Gestational Trophoblastic Tumor,0
24343,Specimen Source Codes - Lesion,Adult Brain Stem Mixed Glioma,0
24344,Seizures,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24345,Referring,Stage III Cutaneous Melanoma AJCC v6,0
24346,Pruritus,Maxillary Sinus Adenoid Cystic Carcinoma,0
24347,High,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
24348,100%,Mixed parotid tumor,0
24349,With shape,Bladder Neuroendocrine Neoplasm,0
24350,Pediculus (eukaryote),Metastatic Malignant Neoplasm in the Sellar Region,0
24351,Pylorus,Vaginal Adenoma,0
24352,Pure Spanish horse breed (organism),ICHTHYOSIS,0
24353,Superkingdom (taxonomic category),Recurrent Testicular Lymphoma,0
24354,Additional,adenoid cystic carcinoma of lung,0
24355,Operative Surgical Procedures,Diffuse malignant mesothelioma,0
24356,Used by,Liver Cavernous Hemangioma,0
24357,Present,Splenic Manifestation of Hairy Cell Leukemia,0
24358,Show,Uterine Cancer,0
24359,Yellow complexion,Undifferentiated Endocervical Sarcoma,0
24360,Smooth Muscle Tumor,FIGO Stage II Ovarian Cancer,0
24361,Consistency,BRCA2 Syndrome,0
24362,Surrounding (qualifier value),Cancer of Urinary Tract,0
24363,Dog family,Locally Advanced Epithelioid Hemangioendothelioma,0
24364,Skin Specimen,Recurrent Testicular Lymphoma,0
24365,FAT1 wt Allele,FIGO Stage II Ovarian Cancer,0
24366,Body cavities,Stage III Cutaneous Melanoma AJCC v6,0
24367,Value Above Reference Range,Congenital hamartoma,0
24368,Continuance of life,Adult Hepatocellular Carcinoma,0
24369,Call (Instruction),Digestive System Hodgkin Lymphoma,0
24370,therapeutic aspects,Stage III Cutaneous Melanoma AJCC v6,0
24371,Blood Circulation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24372,Determined by,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24373,Smear - instruction imperative,Astrocytoma of brain,0
24374,Did not receive therapy or drug for,Cancer of Urinary Tract,0
24375,Solid Dose Form,High Grade Glandular Intraepithelial Neoplasia,0
24376,Pharmacotherapy,Squamous cell carcinoma of lip,0
24377,In Blood,Benign neoplasm of thorax,0
24378,Body structure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24379,Group A (qualifier value),Locally Advanced Epithelioid Hemangioendothelioma,0
24380,Statistical Significance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24381,mucus layer,Colorectal Mucin Poor Hyperplastic Polyp,0
24382,Leukemic Cells Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24383,Adult Non-Hodgkin Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
24384,Skin,Non-Metastatic Gestational Trophoblastic Tumor,0
24385,Bone Marrow,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24386,Color change,Kaposi's sarcoma of extrahepatic bile duct,0
24387,Division (surgical procedure),Engraftment syndrome,0
24388,Further,Childhood Anaplastic Large Cell Lymphoma,0
24389,Curettage procedure,Noninfiltrating Intraductal Carcinoma,0
24390,Retinoic Acid Response Element,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
24391,Personal appearance,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24392,Most,malignant lymphoma of pancreatic lymph nodes,0
24393,Colorectal Carcinoma,Pilocytic astrocytoma of cerebellum,0
24394,Exist,Uterine Cancer,0
24395,Firstly,Kaposi's sarcoma of skin,0
24396,Outer cortex of kidney,Vaginal Adenoma,0
24397,Presence (property),FIGO Stage IVA Ovarian Cancer,0
24398,pharmacotherapeutic,Heavy Chain Deposition Disease,0
24399,LMOD1 gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24400,Occurrence,Malignant melanoma of eyelid,0
24401,Supportive assistance,Familial Hemophagocytic Lymphocytosis,0
24402,Cell (compartment),Trabecular adenocarcinoma,0
24403,brain cell,Unfavorable Non-Hodgkin Lymphoma,0
24404,Intraductal papillary mucinous neoplasm,Locally Advanced Soft Tissue Sarcoma,0
24405,Neonatal Deformity,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24406,Malignant Neoplasms,Microcystic meningioma,0
24407,Occur (action),Acantholytic squamous cell carcinoma,0
24408,Often - answer to question,Localized Askin Tumor,0
24409,Body Site Modifier - Lower,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24410,Cessation of life,Cervical Fibroepithelial Polyp,0
24411,Homo sapiens,Liver Cavernous Hemangioma,0
24412,Initial Usage,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24413,Very rare,Adult Hepatocellular Carcinoma,0
24414,Carcinoma,Brain Tumor,0
24415,Associated with,Anaplastic large cell lymphoma,0
24416,95,Non-Metastatic Gestational Trophoblastic Tumor,0
24417,Has difficulty doing (qualifier value),Chronic Myelomonocytic Leukemia-2,0
24418,Metastatic Neoplasm,Recurrent Testicular Lymphoma,0
24419,Worse,Spongiotic dermatitis,0
24420,Definitely Related to Intervention,GIANT PIGMENTED HAIRY NEVUS,0
24421,Unit,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24422,Signs and Symptoms,Bladder adenocarcinoma stage IV,0
24423,Malignant Central Nervous System Neoplasm,Botryoid-Type Embryonal Rhabdomyosarcoma,0
24424,Multiple Partners,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24425,Cancer Genus,Digestive System Hodgkin Lymphoma,0
24426,MYELODYSPLASTIC SYNDROME,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24427,seen,Mucinous adenocarcinoma gastric,0
24428,Bothered by Night Sweats,Methotrexate-Associated Hodgkin Lymphoma,0
24429,Sarcoma,Childhood Fibrillary Astrocytoma,0
24430,Chest Wall Pain,Grade 3a Malignant Neoplasm,0
24431,Biogenic Amines,Cancer of Urinary Tract,0
24432,Perfusion route,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24433,Specimen Source Codes - tumor,Refractory WHO Grade III Glioma,0
24434,Subject Risk,Digestive System Hodgkin Lymphoma,0
24435,Extravasation,Xeroderma pigmentosum,0
24436,Togo,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24437,Good,Mucinous neoplasm,0
24438,Neoplasms,Benign Apocrine Neoplasm,0
24439,Therapeutic radiology procedure,Heavy Chain Deposition Disease,0
24440,Offspring,non-Hodgkin's lymphoma of spleen,0
24441,Screening Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24442,Group A (blood group),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24443,Occurrence,Childhood Anaplastic Large Cell Lymphoma,0
24444,Histamine Antagonists,FIGO Stage II Ovarian Cancer,0
24445,Initially,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24446,seconds,Stage II Carcinoma of Penis,0
24447,Ciliary Body,Refractory Bladder Carcinoma,0
24448,Adult human body,Adult Alveolar Soft Part Sarcoma,0
24449,Connective Tissue,FIGO Stage II Ovarian Cancer,0
24450,factor A,Unicystic ameloblastoma,0
24451,Pressure (finding),Congenital hamartoma,0
24452,Uveal melanoma,Unresectable Rhabdomyosarcoma,0
24453,Mobility aid,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24454,Essential,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
24455,Qualitative form,Secondary malignant neoplasm of lymph node,0
24456,bony process,clear cell adenocarcinoma of gallbladder,0
24457,Disk Dosing Unit,Trabecular adenocarcinoma,0
24458,Occurrence,Locally Advanced Epithelioid Hemangioendothelioma,0
24459,Coding,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24460,Virus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24461,Tissue Specimen Code,Benign squamous cell tumor,0
24462,Qualitative form,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24463,Areas <moth>,ICHTHYOSIS,0
24464,Formation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24465,90%,Occult Lung Adenosquamous Carcinoma,0
24466,include - SetOperator,Intraepithelial Melanocytic Hyperplasia,0
24467,Cartilage,Medulloblastoma,0
24468,Make - Instruction Imperative,Adult Alveolar Soft Part Sarcoma,0
24469,Acute leukemia,embryonal rhabdomyosarcoma of prostate,0
24470,Pharmacotherapy,Intraepithelial Melanocytic Hyperplasia,0
24471,Alcohols,Metastatic Malignant Neoplasm in the Sellar Region,0
24472,Result,Thymic Atypical Carcinoid Tumor,0
24473,Condition,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24474,treatment - ActInformationManagementReason,Papillary cystic tumor,0
24475,Asia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24476,*Type - Kind of quantity,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24477,Domain (area of knowledge),Female Breast Carcinoma,0
24478,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
24479,Presentation,Cerebral hemangioma,0
24480,per year,Benign Apocrine Neoplasm,0
24481,Chemotherapy,Metaplastic carcinoma of breast,0
24482,Microscopy,Stage III Cutaneous Melanoma AJCC v6,0
24483,Tumor type,Small intestine carcinoma,0
24484,Local,Carcinoma of urinary bladder,0
24485,Malignant Neoplasms,Stage IV Colorectal Cancer AJCC v8,0
24486,Definition,Malignant Neoplasm with Regional Lymph Node Involvement,0
24487,Spur - plant part,FIGO Stage II Ovarian Cancer,0
24488,Neoplasms,embryonal rhabdomyosarcoma of prostate,0
24489,Response process,Ichthyoses,0
24490,900,Benign Anal Granular Cell Tumor,0
24491,CEL gene,High Grade Glandular Intraepithelial Neoplasia,0
24492,To,Undifferentiated Endocervical Sarcoma,0
24493,Formations,Kaposi's sarcoma of extrahepatic bile duct,0
24494,Easy,Diffuse malignant mesothelioma,0
24495,Tube - unit dose,FIGO Stage II Ovarian Cancer,0
24496,400,Chronic Myelomonocytic Leukemia-2,0
24497,Lower (action),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
24498,Appearance of eyelid,Clonal Hematopoiesis of Indeterminate Potential,0
24499,Well Differentiated,Splenic Manifestation of Hairy Cell Leukemia,0
24500,Bluish red color,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24501,Pilomyxoid astrocytoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24502,Soft Tissue Route of Drug Administration,Human Papillomavirus-Related Carcinoma,0
24503,Precursor Cell Lymphoblastic Leukemia Lymphoma,Uterine Cancer,0
24504,Epithelium,Intestinal Metaplasia of Bladder Urothelium,0
24505,Ingestible alcohol,Kaposi's sarcoma of extrahepatic bile duct,0
24506,100%,Thyroid Hurthle Cell Carcinoma,0
24507,Cytoplasm,Pleomorphic adenoma of parotid gland,0
24508,Screening procedure,Adult Alveolar Soft Part Sarcoma,0
24509,Growth,Non-Metastatic Gestational Trophoblastic Tumor,0
24510,Togo,Adult Anaplastic Oligodendroglioma,0
24511,Lacrimal canaliculus structure,Benign Apocrine Neoplasm,0
24512,CEL gene,Nasal cavity carcinoma,0
24513,Adult Lymphoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24514,40%,Bladder adenocarcinoma stage IV,0
24515,Analysis,Carcinoma of urinary bladder,0
24516,*Type - Kind of quantity,Refractory Barrett Esophagus,0
24517,Stem of Organ,Metaplastic carcinoma of breast,0
24518,Relationships,Hereditary Diffuse Gastric Adenocarcinoma,0
24519,Blood group antibody I,Precursor B-lymphoblastic lymphoma stage II,0
24520,Most,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
24521,Organ,Benign Anal Granular Cell Tumor,0
24522,Firstly,Cancer of Urinary Tract,0
24523,Name,Xeroderma pigmentosum,0
24524,risk factors,Precursor B-lymphoblastic lymphoma stage II,0
24525,Continuance of life,Malignant neoplasm of subglottis,0
24526,Case (situation),Recurrent Uveal Melanoma,0
24527,*Type - Kind of quantity,Familial Adenomatous Polyposis Associated Medulloblastoma,0
24528,shared attribute,BRCA2 Syndrome,0
24529,Epithelium,Childhood Fibrillary Astrocytoma,0
24530,Neoplasms,Childhood Cerebellar Neoplasm,0
24531,KIAA1549L gene,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24532,Taxonomic,Gallbladder adenoma,0
24533,Coding,Cherubism,0
24534,diagnosis aspect,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24535,Measurement,Recurrent Rhabdomyosarcoma,0
24536,World Health Organization,Pancreatic Endocrine Carcinoma,0
24537,Tissue specific,Localized Ewing Sarcoma,0
24538,Testing,Kaposi's sarcoma of extrahepatic bile duct,0
24539,Evidence,Stage IB Pancreatic Cancer AJCC v8,0
24540,Tumor cells,Benign squamous cell tumor,0
24541,Primary malignant neoplasm,Acantholytic squamous cell carcinoma,0
24542,Treated with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24543,combination - answer to question,Ampulla of Vater Tubular Adenoma,0
24544,Involvement with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24545,Hormone replacement therapy,Maxillary Sinus Adenoid Cystic Carcinoma,0
24546,Fever symptoms (finding),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
24547,Scientific Control,ROSE Cluster 3,0
24548,Increase,Gallbladder Adenocarcinoma,0
24549,Experimental Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24550,Devices,Localized Ewing Sarcoma,0
24551,Immune,Carcinoma of submandibular gland,0
24552,Abnormal Reference Range,Malignant Testicular Sertoli Cell Tumor,0
24553,appendiceal,Childhood Anaplastic Large Cell Lymphoma,0
24554,Dropping,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24555,survive,Cancer of Urinary Tract,0
24556,ASIP protein,Benign tumor of eyelid,0
24557,Surgical reduction,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24558,Manufactured form,Unicystic ameloblastoma,0
24559,Ectoderm,Periosteal Osteosarcoma,0
24560,Microplate Well,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24561,Premalignant Cell,Cerebral Primitive Neuroectodermal Tumor,0
24562,Togo,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
24563,Case unit dose,Malignant neoplasm of subglottis,0
24564,Digital Content Category,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24565,Serum,Recurrent Primary Lymphoma of Bone,0
24566,Component object,Tonsillar Carcinoma,0
24567,health and disease,Gallbladder adenoma,0
24568,Frequently,Endometrial Small Cell Carcinoma,0
24569,Sore to touch,Malignant neoplasm of gallbladder,0
24570,Urinary Bladder,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
24571,Chemotherapy,Squamous cell carcinoma of lip,0
24572,Liquid Tumor,Neonatal leukemia,0
24573,Only - dosing instruction fragment,Adult Alveolar Soft Part Sarcoma,0
24574,described,Adult Hepatocellular Carcinoma,0
24575,Characterization,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24576,Frequently,Ovarian germ cell choriocarcinoma stage IV,0
24577,Value Above Reference Range,Kaposi's sarcoma of extrahepatic bile duct,0
24578,respiratory gaseous exchange in organisms,Cancer of Urinary Tract,0
24579,Front of neck,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24580,Papillary,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24581,Squamous cell carcinoma,Airway Hemangioma,0
24582,Cerebrospinal Fluid,Tubal Hyperplasia,0
24583,combination - answer to question,Pancreatic Intraepithelial Neoplasia-3,0
24584,Pelvis+,Acantholytic squamous cell carcinoma,0
24585,Used by,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24586,year,Endometrial Small Cell Carcinoma,0
24587,Myasthenia Gravis,Occult Lung Adenosquamous Carcinoma,0
24588,depend,Locally Advanced Epithelioid Hemangioendothelioma,0
24589,Reduction (chemical),Chronic Myelomonocytic Leukemia-2,0
24590,New,Engraftment syndrome,0
24591,Case unit dose,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24592,History,Metastatic Lung Neuroendocrine Neoplasm,0
24593,Decreased,ROSE Cluster 3,0
24594,Frequently,Human Papillomavirus-Related Carcinoma,0
24595,Known,Botryoid-Type Embryonal Rhabdomyosarcoma,0
24596,Togo,Secondary malignant neoplasm of lymph node,0
24597,What subject filter - Result,Vaginal Adenoma,0
24598,Malignant neoplasm of ovary,Malignant neoplasm of olfactory nerve,0
24599,Most,Intestinal Neuroendocrine Carcinoma,0
24600,Adult human body,Human Papillomavirus-Related Carcinoma,0
24601,Reaching,Mucinous adenocarcinoma,0
24602,Sinus - general anatomical term,Locally Advanced Soft Tissue Sarcoma,0
24603,Group A (qualifier value),Adult Acute Eosinophilic Leukemia,0
24604,Original Regulatory Submission,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24605,shared attribute,Bladder adenocarcinoma stage IV,0
24606,Initial (abbreviation),FIGO Stage II Ovarian Cancer,0
24607,Weight decreased,Familial Hemophagocytic Lymphocytosis,0
24608,Subject Risk,Recurrent Rhabdomyosarcoma,0
24609,Infection,Pancreatic Endocrine Carcinoma,0
24610,Swollen Lymph Node,Malignant Testicular Sertoli Cell Tumor,0
24611,Chromosomal translocation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24612,Decision,Mixed astrocytoma-ependymoma,0
24613,Carcinoma,Astrocytoma of brain,0
24614,Multiple malignancy,Cervical Squamous Intraepithelial Neoplasia,0
24615,Swollen Lymph Node,Stage 0 Lip Carcinoma,0
24616,Recommendation,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24617,Epithelial Cells,Vaginal Adenoma,0
24618,Further,Mucinous adenocarcinoma gastric,0
24619,Improved - answer to question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24620,Arising,Splenic Manifestation of Hairy Cell Leukemia,0
24621,Blood Vessel,FIGO Stage II Ovarian Cancer,0
24622,Referral placed,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
24623,Kit Dosing Unit,Unicystic ameloblastoma,0
24624,Case unit dose,Malignant melanoma of eyelid,0
24625,Referring,Xeroderma pigmentosum,0
24626,Meaning,mucinous adenocarcinoma of gallbladder,0
24627,Childhood Neuroblastoma,embryonal rhabdomyosarcoma of prostate,0
24628,Cytogenetics,Liver Lymphangioma,0
24629,Teens,Hemangioma,0
24630,Painful intercourse female,Plexosarcoma,0
24631,Biomaterial Treatment,Melanomatosis,0
24632,Dependent for Toilet Use,Trichilemmocarcinoma,0
24633,Formation,Granular Cell Leiomyosarcoma,0
24634,Treating,Localized Askin Tumor,0
24635,Biological Response Modifiers,Benign Anal Granular Cell Tumor,0
24636,Type - attribute,Cancer of Urinary Tract,0
24637,Primary,Mucinous cystadenofibroma,0
24638,THM gene,Cancer of Urinary Tract,0
24639,Carcinoma,Metastatic Ductal Breast Carcinoma,0
24640,In Blood,Unfavorable Non-Hodgkin Lymphoma,0
24641,various other agents for local oral treatment in ATC,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24642,Cancer of Lip,Kaposi's sarcoma of extrahepatic bile duct,0
24643,Europe,Neoplasms,0
24644,Combined,Type II Endometrial Adenocarcinoma,0
24645,Primary malignant neoplasm,FIGO Stage IVA Ovarian Cancer,0
24646,Experimental Result,Peripheral primitive neuroectodermal tumor of soft tissue,0
24647,biopsy characteristics,Diffuse malignant mesothelioma,0
24648,Providing presence (regime/therapy),Recurrent Rhabdomyosarcoma,0
24649,Basis - conceptual entity,Funisitis (disorder),0
24650,Extrinsic,Adult Alveolar Soft Part Sarcoma,0
24651,Prostate,Carcinoma ex pleomorphic adenoma of parotid gland,0
24652,ASPM wt Allele,Bladder adenocarcinoma stage IV,0
24653,Tests (qualifier value),Refractory Ependymoma,0
24654,Medical Drop,FIGO Stage IVA Ovarian Cancer,0
24655,Most,Stage I Colon Neuroendocrine Tumor AJCC v8,0
24656,Beginning,Noninfiltrating Intraductal Carcinoma,0
24657,brain cell,Stage IB Pancreatic Cancer AJCC v8,0
24658,Code,Nasal cavity carcinoma,0
24659,therapeutic aspects,Endometrial Small Cell Carcinoma,0
24660,Histology aspects,Spongiotic dermatitis,0
24661,health and disease,Cancer of Urinary Tract,0
24662,Occurrence,Acute lymphadenitis,0
24663,Adult Non-Hodgkin Lymphoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24664,Common (qualifier value),adenosquamous carcinoma of breast,0
24665,Pigment cell,Malignant neoplasm of thalamus,0
24666,Negation,Undifferentiated Endocervical Sarcoma,0
24667,Childhood Soft Tissue Sarcoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24668,Leads (device),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24669,Ischemia,Thymic Clear Cell Carcinoma,0
24670,Epithelium,Periosteal Osteosarcoma,0
24671,Left,Benign Anal Granular Cell Tumor,0
24672,United States Military Commissioned Officer O4,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24673,Related personal status,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24674,Person Name,Secondary malignant neoplasm of lymph node,0
24675,*Type - Kind of quantity,Childhood Fibrillary Astrocytoma,0
24676,removal technique,Vaginal Adenoma,0
24677,Part,Mucinous adenocarcinoma gastric,0
24678,Epithelial Cells,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24679,Usual,Airway Hemangioma,0
24680,per year,Tongue Alveolar Soft Part Sarcoma,0
24681,Ability,Neonatal leukemia,0
24682,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,Gastric Diffuse Large B-Cell Lymphoma,0
24683,Partial,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24684,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24685,combination - answer to question,Locally Advanced Squamous Cell Carcinoma,0
24686,Difficult (qualifier value),Colorectal Neuroendocrine Tumor G2,0
24687,*Type - Kind of quantity,Adult Hepatocellular Carcinoma,0
24688,Cell Device,Benign squamous cell tumor,0
24689,Historical aspects qualifier,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24690,Certain (qualifier value),Metastatic Lung Small Cell Carcinoma,0
24691,Term (temporal),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24692,Sharing (Social Behavior),adenoid cystic carcinoma of lung,0
24693,Sarcoma - category (morphologic abnormality),Cherubism,0
24694,Reduction (chemical),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24695,Australia,Choroid Epithelioid Cell Melanoma,0
24696,Endometrial scraping,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24697,Does communicate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24698,Immunotherapy,Diffuse malignant mesothelioma,0
24699,Two,Squamous cell carcinoma of lip,0
24700,Abnormally high,Kaposi's sarcoma of extrahepatic bile duct,0
24701,Singular,Bladder Neuroendocrine Neoplasm,0
24702,Incidental,Spongiotic dermatitis,0
24703,entry - cluster,Transitional cell carcinoma,0
24704,65+,Metastatic Lung Neuroendocrine Neoplasm,0
24705,Embryonic tissue,Locally Advanced Soft Tissue Sarcoma,0
24706,Human body structure,Human Papillomavirus-Related Carcinoma,0
24707,Usually,Leiomyoma of Gallbladder,0
24708,Nervous system structure,Occult Lung Adenosquamous Carcinoma,0
24709,Uterus,Anaplastic large cell lymphoma,0
24710,put - instruction imperative,Localized Malignant Neoplasm,0
24711,Spreading (qualifier value),Xeroderma pigmentosum,0
24712,Transplanted organ,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
24713,Present,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24714,Comparison,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24715,Frequently,Extracranial Neuroblastoma,0
24716,Treating,Adenoma,0
24717,Present,Mucinous adenocarcinoma gastric,0
24718,Table Frame - above,Benign squamous cell tumor,0
24719,Screening procedure,mucinous adenocarcinoma of gallbladder,0
24720,Financial Account,Intraepithelial Melanocytic Hyperplasia,0
24721,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24722,Beginning,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24723,Numerous,Hereditary Diffuse Gastric Adenocarcinoma,0
24724,Swelling,Low Grade Squamous Intraepithelial Neoplasia,0
24725,How Often Itching,Noninfiltrating Intraductal Carcinoma,0
24726,Fragment,Localized Malignant Neoplasm,0
24727,Benign,Stage III Cutaneous Melanoma AJCC v6,0
24728,Financial Account,Engraftment syndrome,0
24729,Presentation,Anterior Urethral Malignant Neoplasm,0
24730,therapeutic aspects,Stage II Carcinoma of Penis,0
24731,Possibly Related to Intervention,Adult Alveolar Soft Part Sarcoma,0
24732,Type - attribute,papillary carcinoma of penis,0
24733,Speaking (activity),Kaposi's sarcoma of skin,0
24734,Kind of quantity - Consistency,Anaplastic large cell lymphoma,0
24735,Area,Bladder adenocarcinoma stage IV,0
24736,Visible,Microcystic meningioma,0
24737,Psammomatous Meningioma,Extracranial Neuroblastoma,0
24738,Adult,Basal Cell Ameloblastoma,0
24739,Slightly (qualifier value),FIGO Stage IVA Ovarian Cancer,0
24740,Vaginal mass,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24741,Biomaterial Treatment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24742,Shortened,Hereditary corneal dystrophy,0
24743,Death (finding),Malignant melanoma of eyelid,0
24744,Diagnosis Study,Botryoid-Type Embryonal Rhabdomyosarcoma,0
24745,Present,Liver Lymphangioma,0
24746,Common (qualifier value),Chest Wall Fibromatosis,0
24747,Humor therapy,Advanced Uterine Corpus Carcinosarcoma,0
24748,<3 (qualifier value),Microcystic meningioma,0
24749,MUTYH-Associate Polyposis,Grade 3a Malignant Neoplasm,0
24750,Presentation,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24751,Injury wounds,Kaposi's sarcoma of extrahepatic bile duct,0
24752,Chronic Lymphocytic Leukemia,Tumorlet,0
24753,Intestines,Cervical Squamous Intraepithelial Neoplasia,0
24754,Spinal meningocele,Metastatic Malignant Neoplasm in the Sellar Region,0
24755,Fasting,Non-Hodgkin Lymphoma During Pregnancy,0
24756,Frequently,Localized Askin Tumor,0
24757,Congenital MeSH qualifier,Benign neoplasm of thorax,0
24758,Version (morphologic abnormality),Recurrent Uveal Melanoma,0
24759,Subgroup,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24760,Negation,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
24761,Primary operation,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
24762,Eye,Small cell neuroendocrine carcinoma of bladder,0
24763,Cause of death:Find:Pt:^Patient:Nom,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24764,Five-year Survival Rate,Basal Cell Ameloblastoma,0
24765,External lower lip,Acute Undifferentiated Leukemia,0
24766,Trial Screening,Female Breast Carcinoma,0
24767,Back structure,de novo Myelodysplastic Syndrome,0
24768,Term (temporal),Thyroid Hurthle Cell Carcinoma,0
24769,Often - answer to question,Contact dermatitis due to alkali,0
24770,unknown vaccine or immune globulin,Liver Lymphangioma,0
24771,Mass,Melanomatosis,0
24772,Related personal status,Colorectal cancer,0
24773,Location of Pharyngeal Residue Following Swallowing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24774,Metastatic Neoplasm,Collecting Duct Carcinoma of the Kidney,0
24775,How Often Felt Normal question,Diffuse malignant mesothelioma,0
24776,International Classification of Diseases for Oncology,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24777,Pathology report,Intestinal Metaplasia of Bladder Urothelium,0
24778,Caucasians,Intraepithelial Melanocytic Hyperplasia,0
24779,Chronic acquired lymphedema,Stage III Cutaneous Melanoma AJCC v6,0
24780,Carcinoma,Cancer of Urinary Tract,0
24781,Means,Medulloblastoma,0
24782,Occurrence,Granular Cell Leiomyosarcoma,0
24783,Ability,Kaposi's sarcoma of skin,0
24784,Reporting,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
24785,Specimen Source Codes - Tears,Type II Endometrial Adenocarcinoma,0
24786,Visual Impairment,embryonal rhabdomyosarcoma of prostate,0
24787,Frequency of Pain Question,Cerebral Primitive Neuroectodermal Tumor,0
24788,shared attribute,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
24789,Hormonal,Adult Acute Eosinophilic Leukemia,0
24790,Pain NOS,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24791,Cells,Childhood Fibrillary Astrocytoma,0
24792,Linear,Stage III Cutaneous Melanoma AJCC v6,0
24793,Time (foundation metadata concept),Benign squamous cell tumor,0
24794,65+,Acute Undifferentiated Leukemia,0
24795,Branch of,Familial Hemophagocytic Lymphocytosis,0
24796,Medical Imaging,Giant cell angiofibroma,0
24797,Superkingdom (taxonomic category),Maxillary Sinus Adenocarcinoma,0
24798,Plain chest X-ray,ROSE Cluster 3,0
24799,Agreement,ROSE Cluster 3,0
24800,Infection,Colorectal Neuroendocrine Tumor G2,0
24801,Body structure,Ovarian Carcinoid Tumor,0
24802,Human papilloma virus infection,Chest Wall Fibromatosis,0
24803,Present,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24804,Lung,Diffuse malignant mesothelioma,0
24805,Malignant Female Reproductive System Neoplasm,Pancreatic Intraepithelial Neoplasia-3,0
24806,Percent of Bacteria,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24807,Death (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24808,Mucous Membrane,Breast Ductal Adenoma,0
24809,Study Control,Metastatic Malignant Neoplasm in the Sellar Region,0
24810,Dyspareunia (female),Thymic Atypical Carcinoid Tumor,0
24811,diagnosis aspect,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24812,Severe (severity modifier),Stage III Adult Immunoblastic Lymphoma,0
24813,Cervix carcinoma,Carcinoma of urinary bladder,0
24814,Patient Reported Outcome Stem,Mixed astrocytoma-ependymoma,0
24815,Present,Granular Cell Leiomyosarcoma,0
24816,Tissue membrane,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24817,System - kit,Pilocytic astrocytoma of cerebellum,0
24818,Negation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24819,Along edge (qualifier value),Undifferentiated Endocervical Sarcoma,0
24820,Aspects of disease screening,Recurrent Uveal Melanoma,0
24821,Deoxyribonucleic Acid Measurement,Angiosarcoma of liver,0
24822,Middle Aged,Familial Hemophagocytic Lymphocytosis,0
24823,Adult Non-Hodgkin Lymphoma,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
24824,Cancer Genus,Benign Apocrine Neoplasm,0
24825,Common (qualifier value),Childhood Choriocarcinoma,0
24826,True primary (qualifier value),Extra-abdominal fibromatosis,0
24827,Diffuse Large B-Cell Lymphoma,Vaginal Adenoma,0
24828,Tissue damage,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24829,Rose extract,Intraepithelial Melanocytic Hyperplasia,0
24830,Component (part),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24831,Endocrine,Refractory Barrett Esophagus,0
24832,Greater,Malignant neoplasm of choroid,0
24833,Corneal dystrophy,embryonal rhabdomyosarcoma of prostate,0
24834,Usual,Stage III Cutaneous Melanoma AJCC v6,0
24835,300,Adult Acute Eosinophilic Leukemia,0
24836,pharmacotherapeutic,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24837,Liquid Tumor,embryonal rhabdomyosarcoma of prostate,0
24838,radiotherapeutic,malignant lymphoma of pancreatic lymph nodes,0
24839,Diabetes,Fibroadenoma of breast,0
24840,lymph nodes,Human Papillomavirus-Related Carcinoma,0
24841,Nasal septum structure,Neonatal leukemia,0
24842,Possible,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24843,Glioblastoma Multiforme Pathway,Metaplastic carcinoma of breast,0
24844,Approximate,Cancer of Urinary Tract,0
24845,Infant,Stage 0 Penile Cancer AJCC v8,0
24846,Sarcoma,Plexosarcoma,0
24847,Science of Etiology,Recurrent Uveal Melanoma,0
24848,Tent - Recreation Equipment,Type II Endometrial Adenocarcinoma,0
24849,lymph nodes,Mixed astrocytoma-ependymoma,0
24850,Blood in stool,Stage 0 Penile Cancer AJCC v8,0
24851,Classification of information,Localized Askin Tumor,0
24852,Chemotherapy Regimen,Giant cell angiofibroma,0
24853,Disease,Endometrial Small Cell Carcinoma,0
24854,CYP19A1 protein,Testicular cancer metastatic,0
24855,Fever symptoms (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24856,QPCT wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24857,Buildup,Liver Lymphangioma,0
24858,Present,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24859,Central Nervous System Neoplasms,Type II Endometrial Adenocarcinoma,0
24860,Graph Edge,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
24861,Appearance,Diffuse malignant mesothelioma,0
24862,Dryness of eye,Metastatic Neoplasm to the Gallbladder,0
24863,Experimental Result,Cystadenocarcinoma,0
24864,blood forming organ,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24865,include - SetOperator,Endometrial Small Cell Carcinoma,0
24866,Nucleated Thrombocyte Count,Intraepithelial Melanocytic Hyperplasia,0
24867,Five,Cervical Fibroepithelial Polyp,0
24868,Congenital qualifier,Angiosarcoma of liver,0
24869,Malignant Neoplasms,Acinar cell carcinoma of pancreas,0
24870,Olfactory,Funisitis (disorder),0
24871,include - SetOperator,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24872,Post Device,Fibroadenoma of breast,0
24873,Pediatric Neoplasm,Refractory Ependymoma,0
24874,Status post,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
24875,Cancer Genus,Mixed parotid tumor,0
24876,Old,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24877,Call (Instruction),Mucinous adenocarcinoma gastric,0
24878,Usually,Mucinous adenocarcinoma gastric,0
24879,Togo,Childhood Central Nervous System Ganglioneuroblastoma,0
24880,Incidence,Recurrent Testicular Lymphoma,0
24881,Tumor size,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
24882,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Refractory Ependymoma,0
24883,Response to treatment,Childhood Anaplastic Large Cell Lymphoma,0
24884,unknown vaccine or immune globulin,Blepharal carcinoma,0
24885,Valid,Squamous cell carcinoma of lip,0
24886,Basis - conceptual entity,Methotrexate-Associated Hodgkin Lymphoma,0
24887,Intellectual scale,Recurrent Testicular Lymphoma,0
24888,Condoms,Refractory Barrett Esophagus,0
24889,Name,Metastatic Lung Small Cell Carcinoma,0
24890,Adipose tissue,Diffuse malignant mesothelioma,0
24891,Abnormal Reference Range,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24892,Femur length,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
24893,Physical findings,Pilocytic astrocytoma of cerebellum,0
24894,contextual factors,Localized Askin Tumor,0
24895,Usual,squamous cell carcinoma of the thyroid gland,0
24896,Oral region,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24897,Feature,Thymic Atypical Carcinoid Tumor,0
24898,Receptors,Undifferentiated Endocervical Sarcoma,0
24899,Vagina Carcinoma,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
24900,Ultraviolet Light Sterilization,Intraepithelial Melanocytic Hyperplasia,0
24901,risk factors,FIGO Stage IVA Ovarian Cancer,0
24902,Including (qualifier),sarcoma of spinal cord,0
24903,Purpose,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
24904,3+ Answer to Question,FIGO Stage IVA Ovarian Cancer,0
24905,Severe (severity modifier),Uterine Cancer,0
24906,Malignant neoplasm of ovary,Atypical Lobular Breast Hyperplasia,0
24907,Colon structure (body structure),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24908,year,Refractory Ependymoma,0
24909,Organ,Angiosarcoma of liver,0
24910,Case unit dose,Colorectal cancer,0
24911,Including (qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24912,Fever symptoms (finding),Acute Undifferentiated Leukemia,0
24913,Platelet Glycoprotein 4,Malignant Neoplasm of Lung - Multiple Primary Sites,0
24914,Often - answer to question,Stage IB Lung Cancer AJCC v7,0
24915,Work,Intestinal Metaplasia of Bladder Urothelium,0
24916,PREVENT (product),Bladder adenocarcinoma stage IV,0
24917,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24918,Spreading (qualifier value),Breast Ductal Adenoma,0
24919,Thin skin,Periosteal Osteosarcoma,0
24920,analysis aspect,Maxillary Sinus Adenocarcinoma,0
24921,Estrogens,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24922,Male Reproductive System Part,Undifferentiated Endocervical Sarcoma,0
24923,Histologic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24924,ESR1 gene,Acinar cell carcinoma of pancreas,0
24925,Subtype (attribute),Stage IV Colorectal Cancer AJCC v8,0
24926,Mammal liver preparation,Pancreatic Intraepithelial Neoplasia-3,0
24927,ERBB2 protein,Carcinomatosis of peritoneal cavity,0
24928,cancer risk,Lipoma of small intestine,0
24929,chance,Human Papillomavirus-Related Carcinoma,0
24930,Array Feature,Xeroderma pigmentosum,0
24931,Smear - instruction imperative,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24932,NCI CTEP SDC Salivary Gland Cancer Sub-Category Terminology,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24933,Togo,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24934,Structure of zygote,Splenic Manifestation of Hairy Cell Leukemia,0
24935,Reduced,BRCA2 Syndrome,0
24936,English [International Organization for Standardization 639-1 code en] language reference set,Type II Endometrial Adenocarcinoma,0
24937,Did not receive therapy or drug for,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24938,Etiology aspects,Chronic Myelomonocytic Leukemia-2,0
24939,Concept History,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24940,Worsening pattern,clear cell adenocarcinoma of gallbladder,0
24941,Publications,Thymic Clear Cell Carcinoma,0
24942,Malignant tumor of colon,Malignant neoplasm of choroid,0
24943,Mammary Gland Parenchyma,Pancreatic Intraepithelial Neoplasia-3,0
24944,No Application Type,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24945,Malignant Neoplasms,Chronic Myelomonocytic Leukemia-2,0
24946,Death NOS,Neonatal leukemia,0
24947,per second,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24948,Tryptophanase,Cerebral hemangioma,0
24949,Type - attribute,Cervical Fibroepithelial Polyp,0
24950,Type A,Benign Anal Granular Cell Tumor,0
24951,Thin (qualifier value),Heavy Chain Deposition Disease,0
24952,fish - non-drug agent,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24953,status - In progress,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24954,DNA Damage,Low Grade Squamous Intraepithelial Neoplasia,0
24955,General surgery specialty,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
24956,Component object,Tonsillar Carcinoma,0
24957,Invasive Lesion,Intraepithelial Melanocytic Hyperplasia,0
24958,Benign Neoplasm,GIANT PIGMENTED HAIRY NEVUS,0
24959,Less Than,Refractory Bladder Carcinoma,0
24960,Internal,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
24961,Skin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24962,Togo,Recurrent Testicular Lymphoma,0
24963,Medical,Lipoma of small intestine,0
24964,Blood Vessel,Papillary squamous cell carcinoma,0
24965,Age,Heavy Chain Deposition Disease,0
24966,Aggressive behavior,Leiomyoma of Gallbladder,0
24967,CDISC SEND Body System Terminology,Gallbladder Adenocarcinoma,0
24968,<3 (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24969,Case unit dose,Unfavorable Non-Hodgkin Lymphoma,0
24970,Wound Healing,Thyroid Hurthle Cell Carcinoma,0
24971,favor,Methotrexate-Associated Hodgkin Lymphoma,0
24972,Aggressive course,Digestive System Hodgkin Lymphoma,0
24973,>90,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
24974,Human body structure,Leptomeningeal sarcoma,0
24975,Categories,Atypical Mesothelial Hyperplasia,0
24976,Greater than one,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24977,Lymphoid Tissue,Small cell neuroendocrine carcinoma of bladder,0
24978,Out (direction),Maxillary Sinus Adenoid Cystic Carcinoma,0
24979,Age,Brain Ependymoma,0
24980,Symptoms,Xeroderma pigmentosum,0
24981,risk factors - observation list,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24982,Treating,Bladder Neuroendocrine Neoplasm,0
24983,Surgery specialty,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24984,Skin,Locally Advanced Carcinoma,0
24985,Very Much,Basal Cell Ameloblastoma,0
24986,Classification,Thyroid Hurthle Cell Carcinoma,0
24987,Retinoic Acid Response Element,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24988,Adenocarcinoma,Airway Hemangioma,0
24989,How Often Weight Loss,Cervical Fibroepithelial Polyp,0
24990,Pleomorphism (morphologic abnormality),Rhabdomyosarcoma with ganglionic differentiation,0
24991,primary tumor,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
24992,Extrinsic,Intraepithelial Melanocytic Hyperplasia,0
24993,shared attribute,Peripheral primitive neuroectodermal tumor of soft tissue,0
24994,Retinoic Acid Response Element,Type II Endometrial Adenocarcinoma,0
24995,veterans alcoholism screening test (VAST),Parathyroid Gland Adenocarcinoma,0
24996,Specimen Source Codes - Tube,Heavy Chain Deposition Disease,0
24997,Result,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24998,Adult Classical Hodgkin Lymphoma,BRCA2 Syndrome,0
24999,Pleural Effusion,Carcinoma of urinary bladder,0
25000,65,Female Breast Carcinoma,0
25001,Test Result,Maxillary Sinus Adenoid Cystic Carcinoma,0
25002,Proliferation,Airway Hemangioma,0
25003,Therapeutic radiology procedure,Endometrial Small Cell Carcinoma,0
25004,suggestion,Stage IV Penile Cancer AJCC v7,0
25005,Stem of plant,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
25006,Usually,Atypical Mesothelial Hyperplasia,0
25007,Genes,Kaposi's sarcoma of skin,0
25008,Population Group,papillary carcinoma of penis,0
25009,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Cervical Fibroepithelial Polyp,0
25010,Human body structure,benign mature teratoma of pancreas,0
25011,lymph nodes,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25012,Set of organs,Testicular cancer metastatic,0
25013,% Ercs,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25014,Obese build,Pancreatic Intraepithelial Neoplasia-3,0
25015,Epithelial cell count (procedure),Maxillary Sinus Adenoid Cystic Carcinoma,0
25016,Lymphatic System,Mixed astrocytoma-ependymoma,0
25017,Encounter due to family history of colonic polyps,Tongue Alveolar Soft Part Sarcoma,0
25018,Lymphoma,Small cell neuroendocrine carcinoma of bladder,0
25019,Complete,Thymic Clear Cell Carcinoma,0
25020,Metastatic Neoplasm,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25021,Person Observer,Tonsillar Carcinoma,0
25022,white blood cell type,Bladder squamous cell carcinoma stage I,0
25023,Lymphadenopathy,Liver Lymphangioma,0
25024,Occur (action),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25025,Screening procedure,Splenic Manifestation of Hairy Cell Leukemia,0
25026,Status post,Xeroderma pigmentosum,0
25027,Carcinoma in Situ,FIGO Stage II Ovarian Cancer,0
25028,Diagnosis,Epithelioid Sarcoma NCI Grade 3,0
25029,Time,Primary Cutaneous Plasmablastic Lymphoma,0
25030,Embryonic Development,Metastatic Lung Small Cell Carcinoma,0
25031,Skin Specimen,Chondrosarcoma,0
25032,Environmental Pollutants,Precursor B-lymphoblastic lymphoma stage II,0
25033,Common (qualifier value),Liver Cavernous Hemangioma,0
25034,Manufactured form,Benign squamous cell tumor,0
25035,Tumor Mass,Leptomeningeal sarcoma,0
25036,Time,Blepharal carcinoma,0
25037,Therapeutic radiology procedure,Airway Hemangioma,0
25038,Fibroadenoma of breast,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25039,Cardiac Lead Procedure,Trichilemmocarcinoma,0
25040,Enlarged,Plexosarcoma,0
25041,Cutaneous leiomyoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25042,Short,FIGO Stage IVA Ovarian Cancer,0
25043,Occurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25044,Liquid Tumor,Kaposi's sarcoma of extrahepatic bile duct,0
25045,Togo,Chronic Myelomonocytic Leukemia-2,0
25046,Stop (Instruction Imperative),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25047,potential,Adrenal Rest Tumor,0
25048,Cure (remedy),Cerebral Primitive Neuroectodermal Tumor,0
25049,Body tissue,Colorectal Neuroendocrine Tumor G2,0
25050,Cancer Genus,Precursor B-lymphoblastic lymphoma stage II,0
25051,South,BRCA2 Syndrome,0
25052,Germ cell tumor,Digestive System Hodgkin Lymphoma,0
25053,+2,Anterior Urethral Malignant Neoplasm,0
25054,Autosome,Cartilaginous exostosis,0
25055,Supportive assistance,adenosquamous carcinoma of breast,0
25056,Pelvic cavity structure,Unfavorable Non-Hodgkin Lymphoma,0
25057,Containing (qualifier),Placental aromatase deficiency,0
25058,Oral region,Squamous cell carcinoma of lip,0
25059,Case (situation),Microcystic meningioma,0
25060,One,Intraepithelial Melanocytic Hyperplasia,0
25061,Dilate procedure,Acute Undifferentiated Leukemia,0
25062,Hyperplastic Polyp,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25063,Trachea,Xeroderma pigmentosum,0
25064,Light Microscopy,Childhood Cerebellar Neoplasm,0
25065,Type - attribute,Benign Anal Granular Cell Tumor,0
25066,QPCT wt Allele,Benign tumor of eyelid,0
25067,Blue color,Placental aromatase deficiency,0
25068,Out (direction),Basal Cell Ameloblastoma,0
25069,Vision:-:Point in time:^Patient:-,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25070,Poor function,Recurrent Testicular Lymphoma,0
25071,Water Specimen,Carcinoma of urinary bladder,0
25072,+2,Refractory Ependymoma,0
25073,How Much Distress Itching,Maxillary Sinus Adenocarcinoma,0
25074,Malignant neoplasm of brain,Thymic Clear Cell Carcinoma,0
25075,Diet Code Specification Type - Preference,Kaposi's sarcoma of skin,0
25076,therapeutic aspects,Fibroadenoma of breast,0
25077,year,Benign squamous cell tumor,0
25078,Intracranial,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25079,Thecoma,Human Papillomavirus-Related Carcinoma,0
25080,Screening Study,Thymic Clear Cell Carcinoma,0
25081,Symptoms aspect,Familial Hemophagocytic Lymphocytosis,0
25082,primary tumor,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25083,Entity Determiner - specific,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25084,Cystic dermoid choristoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25085,Prostate,Cerebral Primitive Neuroectodermal Tumor,0
25086,Extent of disease,Stage IV Penile Cancer AJCC v7,0
25087,Cancer Genus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25088,shared attribute,Spermatocytic seminoma,0
25089,Etiology aspects,embryonal rhabdomyosarcoma of prostate,0
25090,Form:Finding:Point in time:{Setting}:Document:{Role},Mucinous adenocarcinoma gastric,0
25091,Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25092,Population Group,Liver Cavernous Hemangioma,0
25093,Presentation,Diffuse malignant mesothelioma,0
25094,Detected (finding),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
25095,Necrotic changes (finding),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25096,Disintegration (morphologic abnormality),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25097,Choroid Plexus Papilloma,Malignant Testicular Sertoli Cell Tumor,0
25098,Pancreas,Carcinoma,0
25099,Numerous,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
25100,Significant,Adult Acute Eosinophilic Leukemia,0
25101,posterior fossa,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25102,Part Dosing Unit,Pancreatic carcinoma,0
25103,Diagnosis Study,Xeroderma pigmentosum,0
25104,Term (lexical),Melanomatosis,0
25105,Increase,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25106,Physical findings,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
25107,Donor person,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25108,New Zealand,Recurrent Testicular Lymphoma,0
25109,Version,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25110,Abnormal cell,Clonal Hematopoiesis of Indeterminate Potential,0
25111,Tumor cells,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25112,Vaccinated (qualifier),Multiple Endocrine Neoplasia,0
25113,Biopsy,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25114,Proliferation,Mucinous adenocarcinoma,0
25115,Never (frequency),Recurrent Testicular Lymphoma,0
25116,Known,mucinous adenocarcinoma of gallbladder,0
25117,Primary,gliosarcoma,0
25118,Used by,Digestive System Hodgkin Lymphoma,0
25119,Aggressive behavior,ROSE Cluster 3,0
25120,adaptive,Deep Leiomyoma,0
25121,Very,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
25122,Area,Acantholytic squamous cell carcinoma,0
25123,Astrocytoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25124,User Group,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25125,Diagnosis Study,Congenital hamartoma,0
25126,Application Context,Pancreatic Intraepithelial Neoplasia-3,0
25127,Manufactured sign,Anterior Urethral Malignant Neoplasm,0
25128,70%,Microcystic meningioma,0
25129,Moved to,Basal Cell Ameloblastoma,0
25130,99,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25131,Childhood Rhabdomyosarcoma,Brain Tumor,0
25132,Nitrofurantoin,Intestinal Metaplasia of Bladder Urothelium,0
25133,Down Syndrome,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25134,Version (morphologic abnormality),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25135,Epithelium,Advanced Uterine Corpus Carcinosarcoma,0
25136,Persons,Kaposi's sarcoma of extrahepatic bile duct,0
25137,Certain (qualifier value),Adult Acute Eosinophilic Leukemia,0
25138,Central Nervous System Neoplasms,Collecting Duct Carcinoma of the Kidney,0
25139,Common (qualifier value),Benign Apocrine Neoplasm,0
25140,Biogenic Amines,Carcinomatosis of peritoneal cavity,0
25141,Pharyngeal structure,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
25142,Including (qualifier),Recurrent Testicular Lymphoma,0
25143,Breast,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
25144,Present,Type II Endometrial Adenocarcinoma,0
25145,Ankle joint structure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
25146,Then,Gallbladder Adenocarcinoma,0
25147,Rare Diseases,non-Hodgkin's lymphoma of spleen,0
25148,Code,Mucosal Melanoma,0
25149,Cessation of life,Hemangioma,0
25150,Dietary Lead,ROSE Cluster 3,0
25151,Long Term Survivorship,Testicular cancer metastatic,0
25152,Broken skin,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25153,Professional guide,Astrocytoma of brain,0
25154,Weight decreased,Unfavorable Non-Hodgkin Lymphoma,0
25155,Term Birth,Mucinous adenocarcinoma gastric,0
25156,Pressure- physical agent,Benign neoplasm of thorax,0
25157,Symptoms aspect,Uterine Cancer,0
25158,Qualitative form,Bladder squamous cell carcinoma stage I,0
25159,Cells,Ovarian Carcinoid Tumor,0
25160,Polyp of large intestine,Stage IB Lung Cancer AJCC v7,0
25161,Body part,Metastatic Ductal Breast Carcinoma,0
25162,Case (situation),Cancer of Urinary Tract,0
25163,75,Breast Apocrine Adenoma,0
25164,New,Recurrent Primary Lymphoma of Bone,0
25165,Medical Device Emits Smoke,Mixed astrocytoma-ependymoma,0
25166,Common Specifications in HL7 V3 Publishing,adenoid cystic carcinoma of lung,0
25167,Assisting (procedure),Recurrent Testicular Lymphoma,0
25168,Vagina,Lipoma of small intestine,0
25169,PSA Level Less than Five,Thymic Clear Cell Carcinoma,0
25170,Drain device,Nasal cavity carcinoma,0
25171,Tired,Type II Endometrial Adenocarcinoma,0
25172,Presentation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25173,Anterior portion of neck,mucinous adenocarcinoma of gallbladder,0
25174,Antibodies,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25175,contagion,FIGO Stage IVA Ovarian Cancer,0
25176,alone - group size,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
25177,Rapid,Anterior Urethral Malignant Neoplasm,0
25178,foreign,Localized Ewing Sarcoma,0
25179,Frequently,papillary carcinoma of penis,0
25180,Add - instruction imperative,Localized Ewing Sarcoma,0
25181,National origin,Stage 0 Penile Cancer AJCC v8,0
25182,% live,Periosteal Osteosarcoma,0
25183,Anaplastic astrocytoma,Liver Cavernous Hemangioma,0
25184,Collection (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
25185,Human body,Stage 0 Lip Carcinoma,0
25186,Percent (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25187,Worsening pattern,Intraepithelial Melanocytic Hyperplasia,0
25188,Recommendation,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25189,Show,Childhood Lung Non-Small Cell Carcinoma,0
25190,dependent,Lung Mucinous Cystadenoma,0
25191,Diffuse Large B-Cell Lymphoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25192,Orbital region,Methotrexate-Associated Hodgkin Lymphoma,0
25193,Life threatening - Event Consequence,Refractory Ependymoma,0
25194,Specimen Source Codes - tumor,Grade 1 Clear Cell Renal Cell Carcinoma,0
25195,Macrophage Activation Syndrome,Ichthyosis,0
25196,color additive,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
25197,Peritoneum,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
25198,Colloids,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
25199,Hormonal,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25200,Determined by,Locally Advanced Soft Tissue Sarcoma,0
25201,Genetic,Cervical Fibroepithelial Polyp,0
25202,Red color,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25203,Gastroesophageal reflux disease,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
25204,Etiology aspects,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25205,Symptoms aspect,Non-Metastatic Gestational Trophoblastic Tumor,0
25206,Scientific Publication,Malignant Neoplasm of Lung - Multiple Primary Sites,0
25207,Genetic,Thyroid Hurthle Cell Carcinoma,0
25208,Surface,Cerebral Primitive Neuroectodermal Tumor,0
25209,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
25210,Secondary to,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25211,Adult Lymphoma,Cerebral Primitive Neuroectodermal Tumor,0
25212,Administered Component Designation,Refractory Ependymoma,0
25213,Ultraviolet Rays,Cartilaginous exostosis,0
25214,precancerous lesions,Acantholytic squamous cell carcinoma,0
25215,Participation Type - origin,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25216,various other intestinal adsorbents in ATC,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
25217,Time (foundation metadata concept),Extracranial Neuroblastoma,0
25218,Abnormality of the face,Small intestine carcinoma,0
25219,Dental Base,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25220,Anatomic Node,Medulloblastoma,0
25221,Aspects of signs,Nasal cavity carcinoma,0
25222,Immune System Processes,Refractory Bladder Carcinoma,0
25223,Neoplasm Metastasis,Childhood Anaplastic Large Cell Lymphoma,0
25224,contextual factors,Malignant neoplasm of gallbladder,0
25225,analysis aspect,Pancreatic carcinoma,0
25226,Qualitative form,Refractory Bladder Carcinoma,0
25227,CDISC SDTM Disease Outcome Terminology,embryonal rhabdomyosarcoma of prostate,0
25228,Organ,Platinum-Resistant Lung Small Cell Carcinoma,0
25229,Silent,Fourth Ventricle and Brain Stem Ependymal Tumor,0
25230,shared attribute,Intraepithelial Melanocytic Hyperplasia,0
25231,Estrogen [EPC],Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25232,Segmental Mastectomy,Cherubism,0
25233,Rare,Multiple Skull Base Meningiomas,0
25234,Deterioration of status,Locally Advanced Soft Tissue Sarcoma,0
25235,Sacrifice,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25236,List,Tongue Alveolar Soft Part Sarcoma,0
25237,Weight Loss,Benign Anal Granular Cell Tumor,0
25238,Result,Airway Hemangioma,0
25239,Current (present time),Childhood Central Nervous System Ganglioneuroblastoma,0
25240,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Neonatal leukemia,0
25241,High Risk Acute Leukemia,Precursor B-lymphoblastic lymphoma stage II,0
25242,Name (property) (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25243,Mean Percent of Normal,Adult Alveolar Soft Part Sarcoma,0
25244,Leading,Locally Advanced Soft Tissue Sarcoma,0
25245,How Often Itching,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25246,fludarabine,Squamous cell carcinoma of lip,0
25247,3+ Score,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25248,Original Regulatory Submission,Breast Ductal Adenoma,0
25249,Dental Cavity Lining,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
25250,Have Weight Loss,Liver Lymphangioma,0
25251,Condition,Airway Hemangioma,0
25252,Shapes,Ectomesenchymal Chondromyxoid Tumor,0
25253,Histologic,Clonal Hematopoiesis of Indeterminate Potential,0
25254,Both kidneys,Digestive System Hodgkin Lymphoma,0
25255,Related personal status,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25256,Physical findings,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
25257,*Type - Kind of quantity,Uterine Cancer,0
25258,Carcinoma of lung,Small cell neuroendocrine carcinoma of bladder,0
25259,Left,Stage IB Pancreatic Cancer AJCC v8,0
25260,Unknown,Hereditary Diffuse Gastric Adenocarcinoma,0
25261,Occurrence,Refractory Barrett Esophagus,0
25262,Menopause present (finding),Nasal cavity carcinoma,0
25263,Cell Differentiation process,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25264,Occurrence,Malignant neoplasm of gallbladder,0
25265,Immune system,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25266,Well Differentiated,Gallbladder adenoma,0
25267,per day,Hemangioma,0
25268,Symptoms aspect,Female Breast Carcinoma,0
25269,cancer classification,Refractory Bladder Carcinoma,0
25270,Spreading (qualifier value),Periosteal Osteosarcoma,0
25271,teratologic,Refractory Ependymoma,0
25272,Decreased,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
25273,2+ Score,Non-Metastatic Gestational Trophoblastic Tumor,0
25274,Taxonomic,Locally Advanced Epithelioid Hemangioendothelioma,0
25275,Microvolt,Stage IB Pancreatic Cancer AJCC v8,0
25276,Approximate,non-Hodgkin's lymphoma of spleen,0
25277,Organ,Digestive System Hodgkin Lymphoma,0
25278,Base - General Qualifier,Benign Ovarian Thecoma,0
25279,Tryptophanase,Thymic Clear Cell Carcinoma,0
25280,Malignant Neoplasms,Pancreatic Endocrine Carcinoma,0
25281,Qualitative form,Benign Anal Granular Cell Tumor,0
25282,Inflammation,Grade 1 Clear Cell Renal Cell Carcinoma,0
25283,Fever,Anterior Urethral Malignant Neoplasm,0
25284,Primary malignant neoplasm,Acute Undifferentiated Leukemia,0
25285,Pediculus (eukaryote),Sarcomatoid Renal Cell Carcinoma,0
25286,Part of,Granular Cell Leiomyosarcoma,0
25287,Intraoral approach,Tongue Alveolar Soft Part Sarcoma,0
25288,Malignant Neoplasms,Benign neoplasm of thorax,0
25289,Anatomic Site,Chondrosarcoma,0
25290,Plumbum metallicum,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25291,Enlargement procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25292,Source,Acute Undifferentiated Leukemia,0
25293,Bladder Cancer Pathway,Secondary malignant neoplasm of lymph node,0
25294,Tissue damage,FIGO Stage II Ovarian Cancer,0
25295,How Often Sweats,Metastatic Lung Neuroendocrine Neoplasm,0
25296,Endocrine Cells,Splenic Manifestation of Hairy Cell Leukemia,0
25297,Present,Mucinous cystadenofibroma,0
25298,Biogenic Amines,Hyperplasia of pituitary gland,0
25299,Etiology aspects,Heavy Chain Deposition Disease,0
25300,Epstein-Barr Virus Early RNA,Locally Advanced Soft Tissue Sarcoma,0
25301,Vestibular fold,Anterior Urethral Malignant Neoplasm,0
25302,Bone Marrow Examination,Angiosarcoma of liver,0
25303,Study Site,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
25304,Excision,Undifferentiated Neuroblastoma,0
25305,Swallowing painful,Recurrent Rhabdomyosarcoma,0
25306,Increased,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25307,Human body structure,Hereditary Diffuse Gastric Adenocarcinoma,0
25308,newly,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
25309,Mutation,Endometrial Small Cell Carcinoma,0
25310,Money or percentage indicator - Percentage,Chest Wall Fibromatosis,0
25311,Significant,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25312,Relationships,Adrenal Rest Tumor,0
25313,Reported,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
25314,Specimen Source Codes - tumor,Acute Undifferentiated Leukemia,0
25315,Feelings,Human Papillomavirus-Related Carcinoma,0
25316,generic name,Pancreatic carcinoma,0
25317,Part of,FIGO Stage II Ovarian Cancer,0
25318,Syndrome,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25319,Togo,Childhood Thyroid Gland Follicular Carcinoma,0
25320,Accident due to exposure to weather conditions,Testicular cancer metastatic,0
25321,General surgery specialty,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25322,Neuropathy,embryonal rhabdomyosarcoma of prostate,0
25323,Leg,Locally Advanced Carcinoma,0
25324,Cancer Other,Cancer of Urinary Tract,0
25325,Along edge (qualifier value),Female Breast Carcinoma,0
25326,Laryngeal papillomatosis,Refractory Bladder Carcinoma,0
25327,American College of Cardiology/American Heart Association Lesion Complexity Score C,Mucinous cystadenofibroma,0
25328,Tissue Specimen Code,Angiosarcoma of liver,0
25329,Abnormal host response,Mucinous adenocarcinoma gastric,0
25330,Often - answer to question,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25331,Lymphocyte,embryonal rhabdomyosarcoma of prostate,0
25332,Foreskin of penis,Locally Advanced Soft Tissue Sarcoma,0
25333,Thyroid carcinoma,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
25334,Equilibrium,Intestinal Metaplasia of Bladder Urothelium,0
25335,Approach,Locally Advanced Carcinoma,0
25336,Percent of Abnormal Cells,Airway Hemangioma,0
25337,Classical Hodgkin's Lymphoma,Cervical Squamous Intraepithelial Neoplasia,0
25338,Usual Severity Weight Loss,Malignant neoplasm of gallbladder,0
25339,Intestines,Spongiotic dermatitis,0
25340,Secretory Vesicles,Basal Cell Ameloblastoma,0
25341,Carcinoma of bladder,Bladder squamous cell carcinoma stage I,0
25342,2+,Benign Anal Granular Cell Tumor,0
25343,Recommendation,Undifferentiated Neuroblastoma,0
25344,Value Above Reference Range,Brain Tumor,0
25345,radiotherapeutic,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25346,Count of entities,Childhood Anaplastic Large Cell Lymphoma,0
25347,include - SetOperator,Pleomorphic adenoma of parotid gland,0
25348,Adult Classical Hodgkin Lymphoma,Adult Acute Eosinophilic Leukemia,0
25349,Subject Risk,Stage III Cutaneous Melanoma AJCC v6,0
25350,Old,Refractory Ependymoma,0
25351,Ability,Hemangioma,0
25352,Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
25353,Occurrence Indicator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25354,Telephone Extension Number,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25355,Melanins,Refractory Ependymoma,0
25356,Secondary Neoplasm,Spongiotic dermatitis,0
25357,Referring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25358,Initially,Neoplasms,0
25359,Most,Extracranial Neuroblastoma,0
25360,Often - answer to question,Malignant Testicular Sertoli Cell Tumor,0
25361,Following,Lipoma of small intestine,0
25362,Sodium Chloride,Serous cystadenocarcinoma ovary,0
25363,Common Specifications in HL7 V3 Publishing,Undifferentiated Endocervical Sarcoma,0
25364,Molecular Mass,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25365,Progress,Mucinous cystadenofibroma,0
25366,Death (finding),Peripheral primitive neuroectodermal tumor of soft tissue,0
25367,Container status - Identified,Benign squamous cell tumor,0
25368,Skin,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25369,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Neonatal leukemia,0
25370,Publishing,Hodgkin lymphoma,0
25371,Biopsy,Childhood Central Nervous System Ganglioneuroblastoma,0
25372,New Zealand Rabbits,FIGO Stage IVA Ovarian Cancer,0
25373,Bothered by Night Sweats,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25374,Both ovaries,Spongiotic dermatitis,0
25375,Mucins,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25376,Order (action),Non-Hodgkin Lymphoma During Pregnancy,0
25377,Left sided,Acantholytic squamous cell carcinoma,0
25378,Type A,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
25379,Activity (animal life circumstance),Unfavorable Non-Hodgkin Lymphoma,0
25380,CD69 protein,Choroid Necrotic Melanoma,0
25381,Tract,Localized Askin Tumor,0
25382,Symptoms,Recurrent Testicular Lymphoma,0
25383,depend,Refractory Ependymoma,0
25384,Logical Condition,Mucinous neoplasm,0
25385,Cell (compartment),Localized Ewing Sarcoma,0
25386,melanotic,Hyperplasia of pituitary gland,0
25387,Lymphatic,Peripheral primitive neuroectodermal tumor of soft tissue,0
25388,described,malignant lymphoma of pancreatic lymph nodes,0
25389,Affecting,Ectomesenchymal Chondromyxoid Tumor,0
25390,treatment options,Microcystic meningioma,0
25391,Segmental Mastectomy,Thyroid Hurthle Cell Carcinoma,0
25392,Operative Surgical Procedures,Intestinal Metaplasia of Bladder Urothelium,0
25393,Skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25394,Including (qualifier),Squamous cell carcinoma of lip,0
25395,Container status - Identified,Pancreatic Intraepithelial Neoplasia-3,0
25396,Hematological Disease,Undifferentiated Endocervical Sarcoma,0
25397,Precipitating Factors,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25398,Entire great blood vessel (organ),Recurrent Uveal Melanoma,0
25399,Requirement,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25400,*Susceptibility,Endometrial Small Cell Carcinoma,0
25401,Most,Nasal cavity carcinoma,0
25402,Most,Stage IV Penile Cancer AJCC v7,0
25403,2+ Score,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25404,Characteristics,Intraepithelial Melanocytic Hyperplasia,0
25405,Communicable Diseases,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25406,Type A,Pancreatic Intraepithelial Neoplasia-3,0
25407,Abdomen distended,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25408,shared attribute,Hyperplasia of pituitary gland,0
25409,The Sun,Thymic Clear Cell Carcinoma,0
25410,Mitosis,BRCA2 Syndrome,0
25411,Decision,Mucinous adenocarcinoma gastric,0
25412,Name,Pancreatic Intraepithelial Neoplasia-3,0
25413,Time (foundation metadata concept),Metastatic Malignant Neoplasm in the Sellar Region,0
25414,Mathematical Factor,Giant cell angiofibroma,0
25415,Malignant neoplasm of kidney,Vaginal Adenoid Cystic Carcinoma,0
25416,Have Weight Loss,Bladder squamous cell carcinoma stage I,0
25417,Malignant neoplasm of breast,Precursor B-lymphoblastic lymphoma stage II,0
25418,Including (qualifier),Familial Adenomatous Polyposis Associated Medulloblastoma,0
25419,Neuroendocrine Tumors,Stage III Cutaneous Melanoma AJCC v6,0
25420,Case unit dose,Cartilaginous exostosis,0
25421,Adult Non-Hodgkin Lymphoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25422,Characteristics,Endometrial Small Cell Carcinoma,0
25423,Prognosis:Find:Pt:^Patient:Nom,Recurrent Uveal Melanoma,0
25424,Europe,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25425,Always (frequency),papillary carcinoma of penis,0
25426,parotid gland swelling,Stage III Adult Immunoblastic Lymphoma,0
25427,Measured Tumor Identification,Localized Malignant Neoplasm,0
25428,Therapeutic radiology procedure,Malignant melanoma of eyelid,0
25429,Pain management,Benign Carotid Body Paraganglioma,0
25430,Either,Localized Ewing Sarcoma,0
25431,Linear,Metaplastic carcinoma of breast,0
25432,Divide,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25433,Neoplasm Metastasis,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25434,Feelings,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
25435,various other intestinal adsorbents in ATC,Kaposi's sarcoma of skin,0
25436,1+ Score,Peripheral primitive neuroectodermal tumor of soft tissue,0
25437,Disease,Chondrosarcoma,0
25438,Reported Term,Carcinoma ex pleomorphic adenoma of parotid gland,0
25439,Occur (action),Carcinoma of urinary bladder,0
25440,Relationships,Squamous cell carcinoma of lip,0
25441,include - SetOperator,Human Papillomavirus-Related Carcinoma,0
25442,Togo,Type II Endometrial Adenocarcinoma,0
25443,Before,Benign Apocrine Neoplasm,0
25444,Mesothelial hyperplasia,Testicular cancer metastatic,0
25445,Covered (qualifier value),Pleomorphic adenoma of parotid gland,0
25446,Persons,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25447,Similarity,Thymic Atypical Carcinoid Tumor,0
25448,Case (situation),Ovarian Dermoid Cyst with Secondary Carcinoma,0
25449,Twice - dosing instruction fragment,FIGO Stage IVA Ovarian Cancer,0
25450,Call (Instruction),Botryoid-Type Embryonal Rhabdomyosarcoma,0
25451,Loss of Appetite question,Advanced Uterine Corpus Carcinosarcoma,0
25452,Squamous cell carcinoma,Granular Cell Leiomyosarcoma,0
25453,Metastatic Neoplasm,Fibroadenoma of breast,0
25454,Subtype (attribute),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25455,What subject filter - Result,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
25456,Time,Splenic Manifestation of Hairy Cell Leukemia,0
25457,Skin,Hyperplasia of pituitary gland,0
25458,Affecting,Unicystic ameloblastoma,0
25459,Cure (remedy),Malignant melanoma of eyelid,0
25460,Hematopoietic cell,Intraepithelial Melanocytic Hyperplasia,0
25461,Affecting,Primary Cutaneous Plasmablastic Lymphoma,0
25462,Does stand alone,Squamous cell carcinoma of lip,0
25463,Diffuse Large B-Cell Lymphoma,Localized Ewing Sarcoma,0
25464,Neoplasm Metastasis,Localized Askin Tumor,0
25465,Papillary thyroid carcinoma,gliosarcoma,0
25466,regional,ROSE Cluster 3,0
25467,Preventive intent,Blepharal carcinoma,0
25468,Lower (action),Endometrial Small Cell Carcinoma,0
25469,Term (temporal),Unfavorable Non-Hodgkin Lymphoma,0
25470,ano-rectal,ROSE Cluster 3,0
25471,Classification of information,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25472,Head and neck structure,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
25473,Intestinal cell,Spongiotic dermatitis,0
25474,Liquid substance,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
25475,Togo,Localized Ewing Sarcoma,0
25476,*Type - Kind of quantity,Refractory Bladder Carcinoma,0
25477,Cerebellar Hypoplasia,Low Grade Squamous Intraepithelial Neoplasia,0
25478,Part Dosing Unit,High Grade Glandular Intraepithelial Neoplasia,0
25479,Congenital MeSH qualifier,Acantholytic squamous cell carcinoma,0
25480,Eighth,Angiosarcoma of liver,0
25481,One,Malignant melanoma of eyelid,0
25482,Morning,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
25483,Left sided,Benign Anal Granular Cell Tumor,0
25484,Array Feature,Hemangioma,0
25485,Term (temporal),Secondary malignant neoplasm of lymph node,0
25486,various antiinfectives and antiseptics for local oral treatment,Parathyroid Gland Adenocarcinoma,0
25487,Primary malignant neoplasm,Bladder adenocarcinoma stage IV,0
25488,Removing (action),Malignant melanoma of eyelid,0
25489,Common wart,Bladder adenocarcinoma stage IV,0
25490,Submandibular,Squamous cell carcinoma of lip,0
25491,Usually,Benign Ovarian Thecoma,0
25492,Ischemia Procedure,Mucinous adenocarcinoma gastric,0
25493,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Peripheral primitive neuroectodermal tumor of soft tissue,0
25494,1000000,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25495,Long,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25496,Cause of death:Find:Pt:^Patient:Nom,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25497,Low Mitosis-Karyorrhexis Index,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25498,Squamous cell carcinoma,Malignant neoplasm of olfactory nerve,0
25499,N+ (tumor staging),Angiosarcoma of liver,0
25500,CYREN gene,Kaposi's sarcoma of extrahepatic bile duct,0
25501,Therapeutic procedure,Uterine Cancer,0
25502,combination - answer to question,Mixed astrocytoma-ependymoma,0
25503,Frequently,Stage IV Penile Cancer AJCC v7,0
25504,Population Group,Localized Malignant Neoplasm,0
25505,Fever,Thymic Atypical Carcinoid Tumor,0
25506,Used by,Nasal cavity carcinoma,0
25507,Malignant Neoplasms,Astrocytoma of brain,0
25508,Assortment,Thymic Atypical Carcinoid Tumor,0
25509,Benign,Stage 0 Lip Carcinoma,0
25510,pharmacotherapeutic,Adenocarcinoma,0
25511,Intraepithelial Neoplasia,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25512,Nevus,Benign neoplasm of eye,0
25513,low,Xeroderma pigmentosum,0
25514,Part of,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25515,CD69 wt Allele,Medulloblastoma,0
25516,various other nasal preparations in ATC,Carcinoma,0
25517,Common Specifications in HL7 V3 Publishing,Chest Wall Fibromatosis,0
25518,/40,Gallbladder adenoma,0
25519,Tryptophanase,Maxillary Sinus Adenoid Cystic Carcinoma,0
25520,Ultrasonography,papillary carcinoma of penis,0
25521,Line Unit of Length,Small cell neuroendocrine carcinoma of bladder,0
25522,Levator palpebrae superioris structure,Intraepithelial Melanocytic Hyperplasia,0
25523,Specimen Source Codes - Lesion,Intraepithelial Melanocytic Hyperplasia,0
25524,Breast Cancer Type 1 Susceptibility Protein Measurement,Liver Lymphangioma,0
25525,Interaction,Pancreatic Intraepithelial Neoplasia-3,0
25526,Groups,Atypical Lobular Breast Hyperplasia,0
25527,Increase,Blepharal carcinoma,0
25528,Term (lexical),Type II Endometrial Adenocarcinoma,0
25529,United States,Uterine Cancer,0
25530,bony process,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25531,Due to,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25532,diagnosis aspect,Fibroadenoma of breast,0
25533,Urine looks dark,Kaposi's sarcoma of extrahepatic bile duct,0
25534,color additive,Benign squamous cell tumor,0
25535,Nerve,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25536,Therapeutic procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25537,1+,Intraepithelial Melanocytic Hyperplasia,0
25538,analysis aspect,Localized Malignant Neoplasm,0
25539,Common Specifications in HL7 V3 Publishing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25540,Value Above Reference Range,Low Grade Squamous Intraepithelial Neoplasia,0
25541,Indexes,Digestive System Hodgkin Lymphoma,0
25542,<90,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25543,other medicated shampoos in ATC,Acantholytic squamous cell carcinoma,0
25544,Tobacco,Stage III Adult Immunoblastic Lymphoma,0
25545,Diagnosis Study,Mucinous adenocarcinoma gastric,0
25546,Characteristics,Collecting Duct Carcinoma of the Kidney,0
25547,Overall,Localized Askin Tumor,0
25548,Over (spatial),Clonal Hematopoiesis of Indeterminate Potential,0
25549,Rapid disease progression,Stage IB Pancreatic Cancer AJCC v8,0
25550,Cell Count,Blepharal carcinoma,0
25551,Secretory Vesicles,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25552,Subject Risk,Malignant Testicular Sertoli Cell Tumor,0
25553,Poor - grade value,Bladder squamous cell carcinoma stage I,0
25554,Containing (qualifier),Intestinal Metaplasia of Bladder Urothelium,0
25555,Brain Neoplasms,Gallbladder Adenocarcinoma,0
25556,Sequence Arm,Malignant neoplasm of gallbladder,0
25557,Symptoms,Localized Askin Tumor,0
25558,Diagnosis Study,Stage IB Pancreatic Cancer AJCC v8,0
25559,Adult Glioblastoma,Anaplastic large cell lymphoma,0
25560,Metastatic malignant neoplasm to brain,Anterior Urethral Malignant Neoplasm,0
25561,Morphology,Cancer of Urinary Tract,0
25562,More,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
25563,Connective Tissue,FIGO Stage IVA Ovarian Cancer,0
25564,English [International Organization for Standardization 639-1 code en] language reference set,Intraepithelial Melanocytic Hyperplasia,0
25565,Common Specifications in HL7 V3 Publishing,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25566,Adult,Colorectal High Grade B-Cell Lymphoma,0
25567,Often - answer to question,Peripheral primitive neuroectodermal tumor of soft tissue,0
25568,Kidney,Congenital hamartoma,0
25569,Combined,Carcinomatosis of peritoneal cavity,0
25570,Malignant Epithelial Cell,Chest Wall Fibromatosis,0
25571,Treating,Female Breast Carcinoma,0
25572,Common (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25573,Approximate,Benign tumor of eyelid,0
25574,Pressure (finding),Kaposi's sarcoma of extrahepatic bile duct,0
25575,SMG1 wt Allele,non-Hodgkin's lymphoma of spleen,0
25576,Fever,clear cell adenocarcinoma of gallbladder,0
25577,Decrease,Choroid Necrotic Melanoma,0
25578,Occurrence Indicator,Atypical Lobular Breast Hyperplasia,0
25579,Supportive assistance,Mucinous adenocarcinoma gastric,0
25580,Stem of plant,Angiosarcoma of liver,0
25581,Extrinsic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25582,Mixed (qualifier value),Anaplastic large cell lymphoma,0
25583,mouth swelling,Type II Endometrial Adenocarcinoma,0
25584,Body structure,Vaginal Adenoid Cystic Carcinoma,0
25585,Negation,Recurrent Testicular Lymphoma,0
25586,1+ Score,Lung squamous cell carcinoma stage I,0
25587,shared attribute,Peripheral primitive neuroectodermal tumor of soft tissue,0
25588,CDISC SEND Tumor Findings Results Terminology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25589,Detected (finding),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25590,Diagnosis,Cervical Fibroepithelial Polyp,0
25591,Usual,Childhood Central Nervous System Ganglioneuroblastoma,0
25592,Specimen Source Codes - tumor,benign mature teratoma of pancreas,0
25593,How Much Distress Weight Loss,Tongue Alveolar Soft Part Sarcoma,0
25594,Feature,Engraftment syndrome,0
25595,Rare,Splenic Manifestation of Hairy Cell Leukemia,0
25596,Chewing,ICHTHYOSIS,0
25597,Pharmacotherapy,Liver Cavernous Hemangioma,0
25598,Range of Motion,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25599,Fasting Status Indicator,Lung squamous cell carcinoma stage I,0
25600,50%,Thymic Atypical Carcinoid Tumor,0
25601,Smear - instruction imperative,Stage IB Lung Cancer AJCC v7,0
25602,GORAB gene,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25603,Sunscreening Agents,papillary carcinoma of penis,0
25604,Malignant Neoplasms,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
25605,pharmacotherapeutic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25606,Sequence Data Type,Localized Askin Tumor,0
25607,Certain (qualifier value),Lipoma of small intestine,0
25608,Primary malignant neoplasm,Engraftment syndrome,0
25609,Human body structure,Benign Anal Granular Cell Tumor,0
25610,Individual,Adult Acute Eosinophilic Leukemia,0
25611,Benign,Stage I Adult Non-Hodgkin Lymphoma,0
25612,Prior Chemotherapy,Basal Cell Ameloblastoma,0
25613,per period (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25614,900,Periosteal Osteosarcoma,0
25615,African American,Unicystic ameloblastoma,0
25616,CEL gene,Methotrexate-Associated Hodgkin Lymphoma,0
25617,shared attribute,Pancreatic Intraepithelial Neoplasia-3,0
25618,Childhood Lymphoma,Stage IB Lung Cancer AJCC v7,0
25619,Togo,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25620,Diagnosis,Intestinal Neuroendocrine Carcinoma,0
25621,+5,Blood Vessel Tumors,0
25622,Precision - second,Xeroderma pigmentosum,0
25623,Twice (Numerical Qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25624,Malignant Neoplasms,Squamous cell carcinoma of lip,0
25625,Gum of mandible,Malignant neoplasm of thalamus,0
25626,Blood,Mucinous cystadenofibroma,0
25627,Common Specifications in HL7 V3 Publishing,Fibroadenoma of breast,0
25628,Cancer Remission,Cervical Squamous Intraepithelial Neoplasia,0
25629,Lumpectomy of breast,FIGO Stage IVA Ovarian Cancer,0
25630,Infrequent,Unicystic ameloblastoma,0
25631,Cells,Multiple Skull Base Meningiomas,0
25632,Value Above Reference Range,Stage I Adult Non-Hodgkin Lymphoma,0
25633,Blood Products Laboratory Testing,Benign Carotid Body Paraganglioma,0
25634,Case (situation),Basal Cell Ameloblastoma,0
25635,Forecast of outcome,Malignant melanoma of eyelid,0
25636,Ovarian Carcinoma,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
25637,Vague,Kaposi's sarcoma of extrahepatic bile duct,0
25638,day,Recurrent Testicular Lymphoma,0
25639,Occur (action),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25640,Scar Tissue,Primary Cutaneous Plasmablastic Lymphoma,0
25641,Frequently,Metastatic Ductal Breast Carcinoma,0
25642,risk factors,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
25643,Formation,Non-Metastatic Gestational Trophoblastic Tumor,0
25644,Biomaterial Treatment,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25645,Egg of order Phthiraptera,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25646,Universal restriction modifier (core metadata concept),High Grade Glandular Intraepithelial Neoplasia,0
25647,Magnetic Resonance Imaging Study File,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25648,Code,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25649,Unlikely Related to Intervention,Small cell neuroendocrine carcinoma of bladder,0
25650,Pain,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25651,Cessation of life,Pancreatic Intraepithelial Neoplasia-3,0
25652,Offspring,embryonal rhabdomyosarcoma of prostate,0
25653,Primary malignant neoplasm,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25654,Form:Finding:Point in time:{Setting}:Document:{Role},Diffuse malignant mesothelioma,0
25655,Liver Flavor,Trabecular adenocarcinoma,0
25656,Singular,Carcinoma,0
25657,include - SetOperator,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
25658,Sneezing,ROSE Cluster 3,0
25659,removal technique,Recurrent Testicular Lymphoma,0
25660,Treatment Epoch,Type II Endometrial Adenocarcinoma,0
25661,Back Pain,Small cell neuroendocrine carcinoma of bladder,0
25662,Childhood Hodgkin Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
25663,Risk,Precursor B-lymphoblastic lymphoma stage II,0
25664,Body tissue,Hemangioma,0
25665,Age of onset of symptoms:Time:Pt:^Patient:Qn,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25666,Common (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
25667,Term (lexical),Acute Undifferentiated Leukemia,0
25668,Ovary,Splenic Manifestation of Hairy Cell Leukemia,0
25669,Tryptophanase,Multiple Skull Base Meningiomas,0
25670,Specimen Source Codes - Lesion,Vaginal Adenoid Cystic Carcinoma,0
25671,Plasma Product,Intestinal Neuroendocrine Carcinoma,0
25672,Participation Type - origin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25673,Treating,Nasal cavity carcinoma,0
25674,Suspected diagnosis,Low Grade Squamous Intraepithelial Neoplasia,0
25675,Curettage procedure,Blepharal carcinoma,0
25676,heirarchal root,Maxillary Sinus Adenoid Cystic Carcinoma,0
25677,radiotherapeutic,Papillary squamous cell carcinoma,0
25678,Analysis,clear cell adenocarcinoma of gallbladder,0
25679,Increased,Liver Lymphangioma,0
25680,Formation,Adult Alveolar Soft Part Sarcoma,0
25681,Specimen Source Codes - Lesion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25682,shared attribute,Childhood Central Nervous System Ganglioneuroblastoma,0
25683,lymph nodes,Contact dermatitis due to alkali,0
25684,Tumor site:Anat:Pt:Specimen:Nom,Undifferentiated Endocervical Sarcoma,0
25685,Type - attribute,Diffuse malignant mesothelioma,0
25686,Lymphatic Abnormalities,BRCA2 Syndrome,0
25687,Table Cell Horizontal Align - left,BRCA2 Syndrome,0
25688,survival aspects,Nasal cavity carcinoma,0
25689,Contusions,Medulloblastoma,0
25690,90%,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25691,Bone Marrow Examination,Adrenal Rest Tumor,0
25692,SLC6A2 wt Allele,Contact dermatitis due to alkali,0
25693,Case (situation),FIGO Stage IVA Ovarian Cancer,0
25694,One,Adult Fibrolamellar Carcinoma,0
25695,Use of,Acute Undifferentiated Leukemia,0
25696,Report (document),Trabecular adenocarcinoma,0
25697,Individual,Refractory Bladder Carcinoma,0
25698,Qualitative form,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25699,Urinary Bladder,Endometrial Small Cell Carcinoma,0
25700,Occur (action),Adult Hepatocellular Carcinoma,0
25701,Biopsy,Unicystic ameloblastoma,0
25702,NCI CTEP SDC Melanoma Sub-Category Terminology,Chondrosarcoma,0
25703,penis,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25704,Platelets Product,FIGO Stage II Ovarian Cancer,0
25705,Carcinoid Tumor,Astrocytoma of brain,0
25706,Squamocolumnar junction of cervix,Refractory Barrett Esophagus,0
25707,Usual,Chondrosarcoma,0
25708,Muscle (organ),Primary Cutaneous Plasmablastic Lymphoma,0
25709,Adult Diffuse Large B-Cell Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
25710,Late,Methotrexate-Associated Hodgkin Lymphoma,0
25711,Primary malignant neoplasm,Childhood Lymphoma,0
25712,Application Dosing Unit,Pancreatic carcinoma,0
25713,Reduced,Pancreatic carcinoma,0
25714,Chemotherapy,Grade 1 Clear Cell Renal Cell Carcinoma,0
25715,More,Benign Anal Granular Cell Tumor,0
25716,Skin fold,Clonal Hematopoiesis of Indeterminate Potential,0
25717,Greatly,Stage III Adult Immunoblastic Lymphoma,0
25718,Scaling,Sarcomatoid Renal Cell Carcinoma,0
25719,System (unit of presentation),Diffuse malignant mesothelioma,0
25720,Laboratory mice,Hodgkin Disease,0
25721,strategy,Xeroderma pigmentosum,0
25722,newly,Non-Metastatic Gestational Trophoblastic Tumor,0
25723,pharmacotherapeutic,Benign Anal Granular Cell Tumor,0
25724,Disease,Uterine Cancer,0
25725,Premalignant Cell,Bladder adenocarcinoma stage IV,0
25726,Examination of skin,Chronic Myelomonocytic Leukemia-2,0
25727,Biologic Development,Spindle Cell Melanoma,0
25728,Pediculus humanus capitis (eukaryote),Type II Endometrial Adenocarcinoma,0
25729,Connection,Stage IV Penile Cancer AJCC v7,0
25730,Age-Years,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25731,Mathematical Operator,Endometrial Small Cell Carcinoma,0
25732,Opening,Gallbladder Adenocarcinoma,0
25733,Myoepithelial,Anterior Urethral Malignant Neoplasm,0
25734,Needs,mucinous adenocarcinoma of gallbladder,0
25735,Recognition of Outliers by Sampling Ends,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25736,Participation Type - origin,Bladder squamous cell carcinoma stage I,0
25737,Malignant Neoplasms,Type II Endometrial Adenocarcinoma,0
25738,International Classification of Disease for Oncology,Malignant melanoma of eyelid,0
25739,Screening,Breast Ductal Adenoma,0
25740,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
25741,intent,Lung Inflammatory Myofibroblastic Tumor,0
25742,Spreading (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
25743,artesunate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25744,Ephrin Type-B Receptor 1,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25745,Improved,Stage IV Penile Cancer AJCC v7,0
25746,Bone marrow: lymphocytes (finding),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25747,Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25748,Pancreatic ductal cell,Stage IV Colorectal Cancer AJCC v8,0
25749,Coding,Advanced Uterine Corpus Carcinosarcoma,0
25750,Malignant neoplasm of thyroid,Stage IB Lung Cancer AJCC v7,0
25751,ultrasound device,Type II Endometrial Adenocarcinoma,0
25752,Often - answer to question,Melanomatosis,0
25753,Adult,Hodgkin lymphoma,0
25754,Usually,Low Grade Squamous Intraepithelial Neoplasia,0
25755,stage,Female Breast Carcinoma,0
25756,Code,Benign Carotid Body Paraganglioma,0
25757,65+,Bladder Neuroendocrine Neoplasm,0
25758,65,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25759,Staining method,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25760,Etiology aspects,Locally Advanced Carcinoma,0
25761,Only - dosing instruction fragment,Stage IV Childhood Non-Hodgkin Lymphoma,0
25762,eTMF Content Model Code,embryonal rhabdomyosarcoma of prostate,0
25763,Measles,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
25764,To,Carcinoma of urinary bladder,0
25765,contextual factors,Ichthyosis,0
25766,Cancer Genus,Tongue Alveolar Soft Part Sarcoma,0
25767,Less Than,Human Papillomavirus-Related Carcinoma,0
25768,Pediatric,Low Grade Squamous Intraepithelial Neoplasia,0
25769,Abnormal,Spongiotic dermatitis,0
25770,Continuous,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25771,Descent,Brain Tumor,0
25772,Therapeutic radiology procedure,Benign neoplasm of thorax,0
25773,Pancreatitis,Mucinous adenocarcinoma,0
25774,Feature,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25775,Tissue Specimen Code,BRCA2 Syndrome,0
25776,Cells,Recurrent Uveal Melanoma,0
25777,Multiply - dosing instruction fragment,Adult Alveolar Soft Part Sarcoma,0
25778,oncology field,Intestinal Metaplasia of Bladder Urothelium,0
25779,Active,Digestive System Hodgkin Lymphoma,0
25780,year,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
25781,Definitely Related to Intervention,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25782,Pediatrics,Childhood Fibrillary Astrocytoma,0
25783,Report (document),Pancreatic Endocrine Carcinoma,0
25784,Case (situation),Fibroadenoma of breast,0
25785,Imaging Techniques,Serous cystadenocarcinoma ovary,0
25786,Qualitative form,Mixed astrocytoma-ependymoma,0
25787,Disease,Lung Mucinous Cystadenoma,0
25788,Overall Survival,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25789,1960s,Malignant neoplasm of subglottis,0
25790,Persons,Familial Adenomatous Polyposis Associated Medulloblastoma,0
25791,Oral cavity,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25792,Mass of body structure,High Grade Glandular Intraepithelial Neoplasia,0
25793,Seizures,Pancreatic Intraepithelial Neoplasia-3,0
25794,Detection,Mucinous adenocarcinoma gastric,0
25795,Body structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
25796,Togo,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25797,Interventional procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25798,Highest,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
25799,Tryptophanase,Cervical Fibroepithelial Polyp,0
25800,Decision,Unicystic ameloblastoma,0
25801,Hip structure,Mucosal Melanoma,0
25802,eTMF Content Model Code,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25803,Thoracic spinal cord structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25804,Togo,Thymic Clear Cell Carcinoma,0
25805,Superkingdom (taxonomic category),Acantholytic squamous cell carcinoma,0
25806,Adenocarcinoma,Engraftment syndrome,0
25807,Combined,Nasal cavity carcinoma,0
25808,Blast count procedure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25809,Advanced phase,Undifferentiated Endocervical Sarcoma,0
25810,Group A (qualifier value),Squamous cell carcinoma of lip,0
25811,Detected (finding),Leptomeningeal sarcoma,0
25812,Hemangiosarcoma,Human Papillomavirus-Related Carcinoma,0
25813,Neuroblastoma,Funisitis (disorder),0
25814,Body part,Chondrosarcoma,0
25815,Renal carcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25816,Cancer Other,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25817,Nevus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25818,New,Liver Lymphangioma,0
25819,Cancer Genus,Mucosal Melanoma,0
25820,excessive growth,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25821,Due to,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
25822,Glycation End Products,FIGO Stage IVA Ovarian Cancer,0
25823,defects aspect,ROSE Cluster 3,0
25824,Including (qualifier),Trabecular adenocarcinoma,0
25825,Degree or extent,Nasal cavity carcinoma,0
25826,+2,Giant cell angiofibroma,0
25827,Obese build,Chronic Myelomonocytic Leukemia-2,0
25828,Electromagnetic Radiation,Small cell neuroendocrine carcinoma of bladder,0
25829,Evaluation procedure,Unicystic ameloblastoma,0
25830,Usually,clear cell adenocarcinoma of gallbladder,0
25831,Leads (device),Mucinous cystadenofibroma,0
25832,Consistency,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25833,Somalia,Pancreatic Intraepithelial Neoplasia-3,0
25834,Most,Carcinoma of urinary bladder,0
25835,Treating,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25836,Lead,Locally Advanced Carcinoma,0
25837,Tumor type,Refractory Bladder Carcinoma,0
25838,Diffuse Large B-Cell Lymphoma,Thyroid Hurthle Cell Carcinoma,0
25839,Metastasis,Malignant Neoplasm with Regional Lymph Node Involvement,0
25840,Intestines,Refractory Bladder Carcinoma,0
25841,depend,Stage II Carcinoma of Penis,0
25842,Frequently,Diffuse malignant mesothelioma,0
25843,Human body,Hereditary Diffuse Gastric Adenocarcinoma,0
25844,Classification,Rhabdomyosarcoma with ganglionic differentiation,0
25845,epithelial,Tonsillar Carcinoma,0
25846,Adenocarcinoma,Childhood Fibrillary Astrocytoma,0
25847,Childbirth,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25848,status - In progress,Liver Cavernous Hemangioma,0
25849,Nervous system structure,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
25850,Body structure,Cancer of Urinary Tract,0
25851,Feelings,Recurrent Primary Lymphoma of Bone,0
25852,In Blood,Intestinal Metaplasia of Bladder Urothelium,0
25853,Country,Transitional cell carcinoma,0
25854,PSA Level Less than Two,Familial Adenomatous Polyposis Associated Medulloblastoma,0
25855,respiratory,Grade 3a Malignant Neoplasm,0
25856,First (number),Noninfiltrating Intraductal Carcinoma,0
25857,Platelets Product,FIGO Stage IVA Ovarian Cancer,0
25858,Representation (action),Acute lymphadenitis,0
25859,Statistical Prevalence,Malignant melanoma of eyelid,0
25860,Progress,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25861,Geographic Locations,Childhood Extragonadal Malignant Germ Cell Tumor,0
25862,Compleat Liquid Nutrition,Undifferentiated Endocervical Sarcoma,0
25863,Trachea,Primary Cutaneous Plasmablastic Lymphoma,0
25864,Mediastinum,Angiosarcoma of liver,0
25865,Onset of (contextual qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25866,Make - Instruction Imperative,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
25867,Etiology aspects,Methotrexate-Associated Hodgkin Lymphoma,0
25868,Abnormally high,Benign Anal Granular Cell Tumor,0
25869,Condition,embryonal rhabdomyosarcoma of prostate,0
25870,Arsenic measurement,Testicular cancer metastatic,0
25871,Certainties,Adrenal Rest Tumor,0
25872,Make - Instruction Imperative,Refractory WHO Grade III Glioma,0
25873,Progress,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
25874,Intellectual scale,Granular Cell Leiomyosarcoma,0
25875,palmidrol,Lung squamous cell carcinoma stage I,0
25876,Illness: Cannot describe symptoms,Adult Alveolar Soft Part Sarcoma,0
25877,survive,Digestive System Hodgkin Lymphoma,0
25878,Lymphatic,Benign tumor of eyelid,0
25879,Brain Neoplasms,Unfavorable Non-Hodgkin Lymphoma,0
25880,Treating,Methotrexate-Associated Hodgkin Lymphoma,0
25881,Clinical Trial [Publication Type],Benign tumor of eyelid,0
25882,Treating,Cancer of Urinary Tract,0
25883,Benign neurologic neoplasms,Vaginal Adenoma,0
25884,Qualitative form,clear cell adenocarcinoma of gallbladder,0
25885,Swelling,Unicystic ameloblastoma,0
25886,DNA Microarray Chip,squamous cell carcinoma of the thyroid gland,0
25887,Worse,embryonal rhabdomyosarcoma of prostate,0
25888,survival aspects,Thymic Clear Cell Carcinoma,0
25889,Weight Loss,Extracranial Neuroblastoma,0
25890,To,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25891,Breast Feeding,Precursor B-lymphoblastic lymphoma stage II,0
25892,Medications,Stage I Colon Neuroendocrine Tumor AJCC v8,0
25893,To,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25894,Symptoms,Peripheral primitive neuroectodermal tumor of soft tissue,0
25895,Digital Content Category,Mucinous adenocarcinoma gastric,0
25896,Immunoproliferative Disorders,Xeroderma pigmentosum,0
25897,Aspects of signs,Clonal Hematopoiesis of Indeterminate Potential,0
25898,Sweating,Xeroderma pigmentosum,0
25899,Laboratory Procedures,carcinoma of middle ear,0
25900,Occurrence Indicator,Leiomyoma of Gallbladder,0
25901,Have Pain,Anterior Urethral Malignant Neoplasm,0
25902,Electrolytes,Medulloblastoma,0
25903,Homo sapiens,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25904,Attachment (action),sarcoma of spinal cord,0
25905,Side,papillary carcinoma of penis,0
25906,Body Site Modifier - Lower,Intestinal Metaplasia of Bladder Urothelium,0
25907,Raised,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
25908,Additional,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25909,<3 (qualifier value),benign mature teratoma of pancreas,0
25910,Laboratory Procedures,Type II Endometrial Adenocarcinoma,0
25911,Occurrence Indicator,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25912,Older child,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25913,Skin cell,Cerebral Primitive Neuroectodermal Tumor,0
25914,Primary malignant neoplasm,Kaposi's sarcoma of skin,0
25915,Qualitative form,Ovarian germ cell choriocarcinoma stage IV,0
25916,Teaching principal,Cancer of Urinary Tract,0
25917,Exostosis,Stage III Cutaneous Melanoma AJCC v6,0
25918,Chemotherapy,Mucosal Melanoma,0
25919,International Statistical Classification of Diseases and Related Health Problems,Localized Ewing Sarcoma,0
25920,Injury due to exposure to external cause,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25921,Common Specifications in HL7 V3 Publishing,Carcinoma of urinary bladder,0
25922,majority,Maxillary Sinus Adenoid Cystic Carcinoma,0
25923,VIPR1 wt Allele,Kaposi's sarcoma of extrahepatic bile duct,0
25924,described,Multiple Skull Base Meningiomas,0
25925,Overall Publication Type,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25926,Code,Ichthyoses,0
25927,Last,Intestinal Metaplasia of Bladder Urothelium,0
25928,*Type - Kind of quantity,Tongue Alveolar Soft Part Sarcoma,0
25929,Recurrent infections,Malignant Neoplasm of Lung - Multiple Primary Sites,0
25930,Anatomic Site,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
25931,Manufactured form,Malignant Neoplasm of Lung - Multiple Primary Sites,0
25932,Rating (action),Testicular cancer metastatic,0
25933,Usually Need Help from Another Person for Eating,Primary Cutaneous Plasmablastic Lymphoma,0
25934,Time,Cancer of Urinary Tract,0
25935,Multiple malignancy,Metaplastic carcinoma of breast,0
25936,Togo,Stage II Hepatocellular Carcinoma AJCC v8,0
25937,Seeding,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25938,MDFAttributeType - Fraction,Benign Anal Granular Cell Tumor,0
25939,Negation,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
25940,Major,Diffuse malignant mesothelioma,0
25941,Net (qualifier),clear cell adenocarcinoma of gallbladder,0
25942,Arsenic measurement,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
25943,Relationships,Digestive System Hodgkin Lymphoma,0
25944,Occurrence Indicator,Adult Hepatocellular Carcinoma,0
25945,therapeutic aspects,Childhood Lymphoma,0
25946,Chemicals,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25947,Common Specifications in HL7 V3 Publishing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25948,Including (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25949,Direct (qualifier),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25950,Rare,Adenocarcinoma of duodenum,0
25951,analysis aspect,Kaposi's sarcoma of skin,0
25952,Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
25953,More,Cervical Squamous Intraepithelial Neoplasia,0
25954,combination - answer to question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25955,Source (property) (qualifier value),Multiple Skull Base Meningiomas,0
25956,Carcinoid Tumor,Stage II Carcinoma of Penis,0
25957,South,Childhood Central Nervous System Ganglioneuroblastoma,0
25958,Well,Mucinous adenocarcinoma gastric,0
25959,Cystadenocarcinoma,Brain Tumor,0
25960,Obesity,Metastatic Malignant Neoplasm in the Sellar Region,0
25961,Five,Thyroid Hurthle Cell Carcinoma,0
25962,Usually,Angiosarcoma of liver,0
25963,Macrophage Activation Syndrome,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25964,Usual Severity Shortness of Breath,Maxillary Sinus Adenocarcinoma,0
25965,Occur (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
25966,Regular,Thymic Clear Cell Carcinoma,0
25967,Usually,non-Hodgkin's lymphoma of spleen,0
25968,gene therapy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25969,Curative - procedure intent,Unresectable Rhabdomyosarcoma,0
25970,Occurrence Indicator,Acute Undifferentiated Leukemia,0
25971,Lower (action),Low Grade Squamous Intraepithelial Neoplasia,0
25972,Poor - qualifier,Malignant Testicular Sertoli Cell Tumor,0
25973,Experimental Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25974,Referring,Diffuse malignant mesothelioma,0
25975,Description,Carcinoma of urinary bladder,0
25976,Fever symptoms (finding),Childhood Central Nervous System Ganglioneuroblastoma,0
25977,Term Birth,adenoid cystic carcinoma of lung,0
25978,Smear - instruction imperative,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25979,Greater than one,mucinous adenocarcinoma of gallbladder,0
25980,Surgical aspects,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25981,AMACR wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25982,Disease Grade 2,Cervical Fibroepithelial Polyp,0
25983,Edema,Mixed astrocytoma-ependymoma,0
25984,Lymphadenopathy,Peripheral primitive neuroectodermal tumor of soft tissue,0
25985,1950s,Pancreatic Intraepithelial Neoplasia-3,0
25986,Human Papillomavirus Positive,Melanomatosis,0
25987,Togo,Refractory Barrett Esophagus,0
25988,Wash (cleansing action),Blepharal carcinoma,0
25989,Tubal Ligation,Primary Cutaneous Plasmablastic Lymphoma,0
25990,Condition:Find:Pt:^Patient:Nom,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25991,incidence of cases,Cerebral hemangioma,0
25992,Smudge Cell Count,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25993,Due to,Astrocytoma of brain,0
25994,curettage specimen,Recurrent Uveal Melanoma,0
25995,10%,Vaginal Adenoma,0
25996,Classification,Type II Endometrial Adenocarcinoma,0
25997,per year,Vaginal Adenoid Cystic Carcinoma,0
25998,Mucinous Adenocarcinoma,Intraepithelial Melanocytic Hyperplasia,0
25999,Case unit dose,Recurrent Uveal Melanoma,0
26000,Subtype (attribute),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26001,Occurrence Indicator,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26002,Arising in,Vaginal Adenoid Cystic Carcinoma,0
26003,Including (qualifier),Basal Cell Ameloblastoma,0
26004,Face,Pancreatic carcinoma,0
26005,Females,Mucinous adenocarcinoma,0
26006,Continuance of life,Diffuse malignant mesothelioma,0
26007,Occurrence Indicator,Refractory Ependymoma,0
26008,SLC6A2 protein,Nasal cavity carcinoma,0
26009,Symptoms,mucinous adenocarcinoma of gallbladder,0
26010,Bayer Corneal Epitheliopathy Grade 3,Maxillary Sinus Adenocarcinoma,0
26011,Rare Diseases,Noninfiltrating Intraductal Carcinoma,0
26012,Specimen Source Codes - Tears,Childhood Central Nervous System Ganglioneuroblastoma,0
26013,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26014,Frequently,Refractory Glioma,0
26015,Teens,Human Papillomavirus-Related Carcinoma,0
26016,Red blood cells,Liver Cavernous Hemangioma,0
26017,65,Gallbladder Adenocarcinoma,0
26018,Keratoconjunctivitis Sicca,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26019,Hormonal Contraception,Chest Wall Fibromatosis,0
26020,United States,Stage IB Lung Cancer AJCC v7,0
26021,Red Blood Cell Count measurement,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26022,Tumor Mass,Metastatic Carcinoma in the Lung,0
26023,Cancer invasiveness,Non-Metastatic Gestational Trophoblastic Tumor,0
26024,Megakaryocytes,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
26025,Stem of Organ,Cancer of Urinary Tract,0
26026,Administration occupational activities,Stage IV Colorectal Cancer AJCC v8,0
26027,Nicotiana tabacum,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26028,1000000,sarcoma of spinal cord,0
26029,chapter,Werner Syndrome,0
26030,Process (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
26031,Treating,Carcinoma of urinary bladder,0
26032,Trauma,Stage 0 Penile Cancer AJCC v8,0
26033,More,Engraftment syndrome,0
26034,Sarcoma,Primary Cutaneous Plasmablastic Lymphoma,0
26035,Malignant - descriptor,Type II Endometrial Adenocarcinoma,0
26036,Practice Experience,Fibroadenoma of breast,0
26037,Surgery specialty,Cystadenocarcinoma,0
26038,Occur (action),Breast Ductal Adenoma,0
26039,Pleurodesis,Undifferentiated Endocervical Sarcoma,0
26040,Histologic type,Thyroid Hurthle Cell Carcinoma,0
26041,High Mitosis-Karyorrhexis Index,Stage IB Pancreatic Cancer AJCC v8,0
26042,Original Regulatory Submission,Xeroderma pigmentosum,0
26043,Act Class - review,Stage IB Lung Cancer AJCC v7,0
26044,Anatomic structures,Blood Vessel Tumors,0
26045,Parotid Gland,Brain Tumor,0
26046,Lead,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26047,Biomaterial Treatment,Chronic Myelomonocytic Leukemia-2,0
26048,Increased,Type II Endometrial Adenocarcinoma,0
26049,Qualitative form,Hereditary Diffuse Gastric Adenocarcinoma,0
26050,How Much Nausea During This Period,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26051,Average of Value Derivation Technique,Pancreatic Intraepithelial Neoplasia-3,0
26052,Usual,Carcinoma of urinary bladder,0
26053,Exposure to,Small Intestinal Villous Adenoma,0
26054,Manufactured form,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26055,shared attribute,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26056,Formation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26057,Alteration,Tonsillar Carcinoma,0
26058,West Haven Hepatic Encephalopathy Grade 3,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
26059,Carcinoma,Deep Leiomyoma,0
26060,Tumor grade G3,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26061,Removing (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26062,Common Specifications in HL7 V3 Publishing,Refractory Ependymoma,0
26063,Occur (action),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
26064,65,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26065,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26066,Malignant Vaginal Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
26067,European race,Vaginal Adenoid Cystic Carcinoma,0
26068,CD69 protein,Hereditary Diffuse Gastric Adenocarcinoma,0
26069,Contain (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26070,site-specific telomere resolvase activity,Peripheral primitive neuroectodermal tumor of soft tissue,0
26071,Benign,Fibroadenoma of breast,0
26072,Usual,Breast Ductal Adenoma,0
26073,Approach,Splenic Manifestation of Hairy Cell Leukemia,0
26074,chance,Ovarian germ cell choriocarcinoma stage IV,0
26075,Basin,Recurrent Testicular Lymphoma,0
26076,metaplastic cell transformation,Extracranial Neuroblastoma,0
26077,SHORT STATURE,Larynx carcinoma recurrent,0
26078,Body part,Nasal cavity carcinoma,0
26079,Problems - What subject filter,Parathyroid Gland Adenocarcinoma,0
26080,Publishing,Clonal Hematopoiesis of Indeterminate Potential,0
26081,Etiology aspects,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26082,Smaller,Stage IB Pancreatic Cancer AJCC v8,0
26083,Biomaterial Treatment,Metastatic Carcinoma in the Lung,0
26084,Characteristics,adenoid cystic carcinoma of lung,0
26085,General surgery specialty,Lung Inflammatory Myofibroblastic Tumor,0
26086,Benign Vascular Neoplasm,clear cell adenocarcinoma of gallbladder,0
26087,Image Feature,Medulloblastoma,0
26088,Age of Onset,Pancreatic carcinoma,0
26089,Nine,Type II Endometrial Adenocarcinoma,0
26090,Subacute,Maxillary Sinus Adenocarcinoma,0
26091,Sequence Data Type,Uterine Cancer,0
26092,Both ovaries,Localized Askin Tumor,0
26093,Human body,Refractory Ependymoma,0
26094,Given name,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26095,How Much Distress Weight Loss,Nasal cavity carcinoma,0
26096,Yellow color,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26097,Occurrence,Type II Endometrial Adenocarcinoma,0
26098,European race,Metastatic Ductal Breast Carcinoma,0
26099,Negation,embryonal rhabdomyosarcoma of prostate,0
26100,More,Stage III Cutaneous Melanoma AJCC v6,0
26101,Including (qualifier),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
26102,70%,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26103,Classification,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26104,Orbital region,Acantholytic squamous cell carcinoma,0
26105,Sex Cord-Stromal Tumor,Refractory Bladder Carcinoma,0
26106,Vomiting,Refractory Barrett Esophagus,0
26107,Specimen Source Codes - Respiratory,FIGO Stage II Ovarian Cancer,0
26108,Rest,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26109,Plasma Cells,Engraftment syndrome,0
26110,Carcinomatosis,Multiple Skull Base Meningiomas,0
26111,Process,Mastocytosis,0
26112,Mathematical Factor,Locally Advanced Soft Tissue Sarcoma,0
26113,growth aspects,Heavy Chain Deposition Disease,0
26114,Due to,Stage IB Pancreatic Cancer AJCC v8,0
26115,Formation,Benign Carotid Body Paraganglioma,0
26116,Monocyte count result,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26117,Breast collecting duct,Cancer of Urinary Tract,0
26118,Mechanism Component of Device,Breast Ductal Adenoma,0
26119,C-KIT Gene,Diffuse malignant mesothelioma,0
26120,Quantity,Intraepithelial Melanocytic Hyperplasia,0
26121,Never (frequency),Clonal Hematopoiesis of Indeterminate Potential,0
26122,Death (finding),Adenocarcinoma of the prostate metastatic,0
26123,Neoplastic disease,Keratoderma,0
26124,Country number:Find:Pt:^Patient:Nom,Childhood Thyroid Gland Follicular Carcinoma,0
26125,Include (action),Serous cystadenocarcinoma ovary,0
26126,Anemia,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26127,Base - General Qualifier,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26128,Known,Uterine Cancer,0
26129,Disease Screening,Hodgkin Disease,0
26130,Testiculo-,Unicystic ameloblastoma,0
26131,To,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26132,Asia,Localized Askin Tumor,0
26133,Cancer Genus,Malignant neoplasm of choroid,0
26134,lymph nodes,Diffuse malignant mesothelioma,0
26135,Africa,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26136,Five,Atypical Mesothelial Hyperplasia,0
26137,Mass of pancreas,Kaposi's sarcoma of extrahepatic bile duct,0
26138,Pediatric Neoplasm,embryonal rhabdomyosarcoma of prostate,0
26139,seen,Chronic Myelomonocytic Leukemia-2,0
26140,Surface,Acute Undifferentiated Leukemia,0
26141,Chest wall structure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
26142,Vascular,Gallbladder Adenocarcinoma,0
26143,Symptoms aspect,Nasal cavity carcinoma,0
26144,Study Control,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
26145,In Blood,Digestive System Hodgkin Lymphoma,0
26146,African American,Recurrent Primary Lymphoma of Bone,0
26147,More,Spongiotic dermatitis,0
26148,Tissue of central nervous system,Benign Ovarian Thecoma,0
26149,Chemotherapy,Benign tumor of eyelid,0
26150,Togo,Female Breast Carcinoma,0
26151,Labrador retriever,Malignant neoplasm of thalamus,0
26152,status - In progress,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26153,Abnormal cell,Larynx carcinoma recurrent,0
26154,Severe (severity modifier),Human Papillomavirus-Related Carcinoma,0
26155,per second,Type II Endometrial Adenocarcinoma,0
26156,Decrease,Cerebral Primitive Neuroectodermal Tumor,0
26157,Diagnostic Imaging,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26158,Slow Growing,Carcinoma of urinary bladder,0
26159,Substance amount,Pancreatic carcinoma,0
26160,Smear - instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26161,Type A,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26162,Classes - encounter,Congenital hamartoma,0
26163,Measles virus genotype D1,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26164,Spreading (qualifier value),Lipoma of small intestine,0
26165,Pharmacotherapy,Vaginal Adenoid Cystic Carcinoma,0
26166,Preventive intent,Anterior Urethral Malignant Neoplasm,0
26167,Medulloblastoma,Benign squamous cell tumor,0
26168,Age,Recurrent Uveal Melanoma,0
26169,Bothered by Nausea,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26170,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Blepharal carcinoma,0
26171,Thin skin,Cerebral hemangioma,0
26172,Junctional,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26173,Relationships,Unresectable Rhabdomyosarcoma,0
26174,Including (qualifier),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26175,Secretory Vesicles,Basal Cell Ameloblastoma,0
26176,Lymphoma,Precursor B-lymphoblastic lymphoma stage II,0
26177,depend,Stage IV Penile Cancer AJCC v7,0
26178,Squamous cell carcinoma - category,Primary Cutaneous Plasmablastic Lymphoma,0
26179,Therapeutic procedure,Stage III Cutaneous Melanoma AJCC v6,0
26180,Decreased Immunologic Activity [PE],FIGO Stage II Ovarian Cancer,0
26181,Persons,embryonal rhabdomyosarcoma of prostate,0
26182,Treating,Metaplastic carcinoma of breast,0
26183,Smear - instruction imperative,Spermatocytic seminoma,0
26184,Linear,mucinous adenocarcinoma of gallbladder,0
26185,Painless,Refractory Ependymoma,0
26186,Detection,Liver Lymphangioma,0
26187,Benign,Malignant Testicular Sertoli Cell Tumor,0
26188,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26189,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26190,Thought,Extracranial Neuroblastoma,0
26191,Increasing,Kaposi's sarcoma of extrahepatic bile duct,0
26192,Telencephalon,Stage I Colon Neuroendocrine Tumor AJCC v8,0
26193,Biopsy,BRCA2 Syndrome,0
26194,Lower Extremity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26195,Others - Allergy,Uterine Cancer,0
26196,Goblet Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26197,Compresses (device),Neonatal leukemia,0
26198,Frequently,Benign neoplasm of eye,0
26199,What subject filter - Result,Stage IB Pancreatic Cancer AJCC v8,0
26200,Blink Reflexes,Digestive System Hodgkin Lymphoma,0
26201,Image Feature,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26202,Easy,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26203,Entity Determiner - specific,Engraftment syndrome,0
26204,Melanocytic nevus,Ichthyosis,0
26205,Acute lymphocytic leukemia,Small cell neuroendocrine carcinoma of bladder,0
26206,Symptoms,Testicular cancer metastatic,0
26207,Occurrence,FIGO Stage IVA Ovarian Cancer,0
26208,Occurrence Indicator,Acute Undifferentiated Leukemia,0
26209,International Statistical Classification of Diseases and Related Health Problems,Kaposi's sarcoma of extrahepatic bile duct,0
26210,Universal HL7CMETAttribution,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26211,<2 years,sarcoma of spinal cord,0
26212,Close,Carcinoma,0
26213,Borg Category-Ratio 10 Perceived Exertion Score 5,Gallbladder Adenocarcinoma,0
26214,Three,Pancreatic Intraepithelial Neoplasia-3,0
26215,Referring,Low Grade Squamous Intraepithelial Neoplasia,0
26216,Followed by,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
26217,Advanced phase,Stage III Cutaneous Melanoma AJCC v6,0
26218,Colon <insect>,Clonal Hematopoiesis of Indeterminate Potential,0
26219,Urinary Bladder,Undifferentiated Endocervical Sarcoma,0
26220,Estimated,Stage 0 Penile Cancer AJCC v8,0
26221,Clinical Study Case,Benign Anal Granular Cell Tumor,0
26222,Drop Metastasis,Airway Hemangioma,0
26223,LINC01194 gene,Extra-abdominal fibromatosis,0
26224,Plumbum metallicum,Small cell neuroendocrine carcinoma of bladder,0
26225,National Academy of Sciences (U.S.),Kaposi's sarcoma of skin,0
26226,various antiinfectives and antiseptics for local oral treatment,Platinum-Resistant Lung Small Cell Carcinoma,0
26227,Well Differentiated,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26228,Frequently,Ichthyosis,0
26229,Adenocarcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26230,Area,Malignant Testicular Sertoli Cell Tumor,0
26231,Similarity,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26232,Others - Allergy,ROSE Cluster 3,0
26233,Bothered by Night Sweats,High Grade Glandular Intraepithelial Neoplasia,0
26234,Skin Pigmentation,ROSE Cluster 3,0
26235,Clonality,Pancreatic Intraepithelial Neoplasia-3,0
26236,Deterioration of status,Spongiotic dermatitis,0
26237,Contain (action),Non-Hodgkin Lymphoma During Pregnancy,0
26238,Surgery specialty,Type II Endometrial Adenocarcinoma,0
26239,Manufactured sign,Uterine Cancer,0
26240,To,Recurrent Uveal Melanoma,0
26241,PSA Level Less than Five,Nasal cavity carcinoma,0
26242,Abdomen,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
26243,Eczema,Plexosarcoma,0
26244,Value Above Reference Range,Chondrosarcoma,0
26245,diagnosis aspect,Maxillary Sinus Adenocarcinoma,0
26246,Including (qualifier),Carcinoma of urinary bladder,0
26247,Characterization,Adult Alveolar Soft Part Sarcoma,0
26248,Risk,Diffuse malignant mesothelioma,0
26249,Homo sapiens,ICHTHYOSIS,0
26250,Walled,Splenic Manifestation of Hairy Cell Leukemia,0
26251,Larynx,Blood Vessel Tumors,0
26252,Surrounding (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
26253,Overall Survival,Unresectable Rhabdomyosarcoma,0
26254,Blood capillaries,Lung Mucinous Cystadenoma,0
26255,Racial group,Cartilaginous exostosis,0
26256,Negation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26257,Colorectal Cancer Pathway,Stage II Hepatocellular Carcinoma AJCC v8,0
26258,Tumor type,Astrocytoma of brain,0
26259,To,Metastatic Neoplasm to the Gallbladder,0
26260,35,Childhood Central Nervous System Ganglioneuroblastoma,0
26261,Contrast Media,Malignant Testicular Sertoli Cell Tumor,0
26262,Domain (area of knowledge),Digestive System Hodgkin Lymphoma,0
26263,Links List,Heavy Chain Deposition Disease,0
26264,Slow Growing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26265,70%,Spongiotic dermatitis,0
26266,Subtype (attribute),Benign Anal Granular Cell Tumor,0
26267,Oral region,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
26268,Qualitative form,Locally Advanced Squamous Cell Carcinoma,0
26269,Ancestry-Informative Marker,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26270,List,Breast Apocrine Adenoma,0
26271,Third,Anterior Urethral Malignant Neoplasm,0
26272,Spread by direct extension,Chondrosarcoma,0
26273,Common Specifications in HL7 V3 Publishing,Squamous cell carcinoma of lip,0
26274,Neuroectodermal Tumor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26275,Replaced by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26276,50%,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26277,Serum blood tests,Urethral Carcinoma,0
26278,Application Context,Malignant neoplasm of subglottis,0
26279,Carcinoma,Refractory Glioma,0
26280,Array Feature,Colorectal Neuroendocrine Tumor G2,0
26281,High Mitosis-Karyorrhexis Index,BRCA2 Syndrome,0
26282,Swallowing:-:Point in time:^Patient:-,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26283,Primary,Basal Cell Ameloblastoma,0
26284,Initially,Fibroadenoma of breast,0
26285,Tumor Mass,FIGO Stage II Ovarian Cancer,0
26286,Overall Publication Type,Benign tumor of eyelid,0
26287,Disease Outcome,Childhood Anaplastic Large Cell Lymphoma,0
26288,Source,Childhood Lung Non-Small Cell Carcinoma,0
26289,Urinary Diversion,Childhood Central Nervous System Ganglioneuroblastoma,0
26290,/40,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
26291,Spreading (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26292,American College of Cardiology/American Heart Association Lesion Complexity Score C,Intestinal Metaplasia of Bladder Urothelium,0
26293,90%,Uterine Cancer,0
26294,Increased risk,Kaposi's sarcoma of skin,0
26295,Taken,Recurrent Uveal Melanoma,0
26296,Diagnosis,embryonal rhabdomyosarcoma of prostate,0
26297,Carcinoid Tumor,Endometrial Small Cell Carcinoma,0
26298,Genus Homo,Basal Cell Ameloblastoma,0
26299,Treatment Epoch,Colorectal High Grade B-Cell Lymphoma,0
26300,Diabetes,Primary Cutaneous Plasmablastic Lymphoma,0
26301,depend,Nasal cavity carcinoma,0
26302,Cover (physical object),Angiosarcoma of liver,0
26303,Ninein,Uterine Cancer,0
26304,Bacterial Infections,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26305,At risk of infection,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26306,depend,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26307,How Much Distress Itching,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26308,Primary malignant neoplasm of endometrium,Placental aromatase deficiency,0
26309,structure,Adenocarcinoma of duodenum,0
26310,Rate,Granular Cell Leiomyosarcoma,0
26311,Phase,Pancreatic Endocrine Carcinoma,0
26312,Vaginal intraepithelial neoplasia,Diffuse malignant mesothelioma,0
26313,Part of,Endometrial Small Cell Carcinoma,0
26314,Presentation,FIGO Stage IVA Ovarian Cancer,0
26315,Administration procedure,Localized Ewing Sarcoma,0
26316,Frequently,Refractory Bladder Carcinoma,0
26317,prior radiation therapy,Granular Cell Leiomyosarcoma,0
26318,Packaging Case,Acinar cell carcinoma of pancreas,0
26319,Cosmetics,Adenocarcinoma of the prostate metastatic,0
26320,human epidermal growth factor,High Grade Glandular Intraepithelial Neoplasia,0
26321,International Classification of Diseases for Oncology,Stage IV Penile Cancer AJCC v7,0
26322,Numbers,Acute Undifferentiated Leukemia,0
26323,Hematopoietic Neoplasms,Tonsillar Carcinoma,0
26324,Top (position),Ovarian Carcinoid Tumor,0
26325,Body part,Undifferentiated Endocervical Sarcoma,0
26326,Asia,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26327,Include (action),Intraepithelial Melanocytic Hyperplasia,0
26328,Childbirth,Endometrial Small Cell Carcinoma,0
26329,growth aspects,Malignant Testicular Sertoli Cell Tumor,0
26330,Carcinoma of lung,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26331,Pleural effusion disorder,Platinum-Resistant Lung Small Cell Carcinoma,0
26332,Esophagus,Acantholytic squamous cell carcinoma,0
26333,Pigment cell,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26334,Fasting Status Indicator,Cerebral Primitive Neuroectodermal Tumor,0
26335,Both ovaries,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
26336,2+,Airway Hemangioma,0
26337,Measurement,Angiosarcoma of liver,0
26338,Angioimmunoblastic Lymphadenopathy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26339,Fracture,Mucinous adenocarcinoma gastric,0
26340,Analysis,embryonal rhabdomyosarcoma of prostate,0
26341,1+,Benign neoplasm of eye,0
26342,combination of objects,Neonatal leukemia,0
26343,Togo,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26344,Major,Mucinous adenocarcinoma gastric,0
26345,Dorsal,Cerebral Primitive Neuroectodermal Tumor,0
26346,Source,Localized Askin Tumor,0
26347,Trial Screening,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26348,Cultured Cell Line,Stage IB Pancreatic Cancer AJCC v8,0
26349,Highest,Engraftment syndrome,0
26350,*Activity (kind of quantity),Placental aromatase deficiency,0
26351,Use of,Localized Askin Tumor,0
26352,Early,Cancer of Urinary Tract,0
26353,Body of penis,Mucinous adenocarcinoma gastric,0
26354,Qualitative form,Adult Hepatocellular Carcinoma,0
26355,Varies,Periosteal Osteosarcoma,0
26356,Syndrome,Engraftment syndrome,0
26357,include - SetOperator,Gallbladder Adenocarcinoma,0
26358,European Medicines Agency,Breast Ductal Adenoma,0
26359,Covers (device),Metaplastic carcinoma of breast,0
26360,photoreactivating enzyme activity,Cerebral Primitive Neuroectodermal Tumor,0
26361,Increased,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26362,Child,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26363,Have Weight Loss,Stage IB Lung Cancer AJCC v7,0
26364,Death Related to Adverse Event,Stage II Carcinoma of Penis,0
26365,Manufactured form,Tonsillar Carcinoma,0
26366,Body part,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26367,Male Gender,Acantholytic squamous cell carcinoma,0
26368,Thyroid Gland Follicular Adenoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
26369,Overall Survival,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26370,Internal,Unicystic ameloblastoma,0
26371,sex,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26372,Cell secretion,Stage IB Pancreatic Cancer AJCC v8,0
26373,Ovulation,Metastatic Ductal Breast Carcinoma,0
26374,Turner Syndrome,Testicular cancer metastatic,0
26375,Feel Pain,Benign tumor of eyelid,0
26376,Sunglasses (physical object),papillary carcinoma of penis,0
26377,Common (qualifier value),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
26378,Vaginal,Small cell neuroendocrine carcinoma of bladder,0
26379,Occur (action),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
26380,Cancer Genus,Ichthyosis,0
26381,Abnormal result,Cerebral Primitive Neuroectodermal Tumor,0
26382,Small cell carcinoma of lung,Carcinoma,0
26383,Often - answer to question,Malignant neoplasm of subglottis,0
26384,Frequency,Medulloblastoma,0
26385,Cause of death.underlying,Neoplasms,0
26386,Body Fluids,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26387,Mesenchymal Stem Cells,Vaginal Adenoid Cystic Carcinoma,0
26388,<90,Stage IV Penile Cancer AJCC v7,0
26389,Type - attribute,Kaposi's sarcoma of skin,0
26390,Anemia,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26391,Ivory Coast,Xeroderma pigmentosum,0
26392,Central African Republic,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26393,Only - dosing instruction fragment,Acantholytic squamous cell carcinoma,0
26394,Hair follicle structure,Ichthyosis,0
26395,Malignant tumor of cervix,Metaplastic carcinoma of breast,0
26396,removal technique,Stage 0 Lip Carcinoma,0
26397,Often - answer to question,Spermatocytic seminoma,0
26398,Numbers,Malignant neoplasm of choroid,0
26399,Body tissue,Mucinous adenocarcinoma gastric,0
26400,Distant,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26401,Occurrence,Mucosal Melanoma,0
26402,Null cell,Prostate Lymphoma,0
26403,Occurrence,Brain Tumor,0
26404,Grade,Adrenal Rest Tumor,0
26405,Version,Locally Advanced Epithelioid Hemangioendothelioma,0
26406,Affecting,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26407,What subject filter - Result,Undifferentiated Neuroblastoma,0
26408,Diagnosis,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
26409,Manufactured form,Trabecular adenocarcinoma,0
26410,Pallor of skin,Stage III Cutaneous Melanoma AJCC v6,0
26411,Magnetic Resonance Imaging,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
26412,Skin Specimen,Cancer of Urinary Tract,0
26413,Major,Tonsillar Carcinoma,0
26414,Chemotherapy,Small cell neuroendocrine carcinoma of bladder,0
26415,Cell Differentiation process,Airway Hemangioma,0
26416,What subject filter - Result,Stage III Cutaneous Melanoma AJCC v6,0
26417,Usual Severity Vomiting,Trabecular adenocarcinoma,0
26418,regional,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26419,WHO Central Nervous System Grade I,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26420,Acute monocytic leukemia,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26421,majority,Cerebral Primitive Neuroectodermal Tumor,0
26422,N not otherwise specified Antibody,FIGO Stage II Ovarian Cancer,0
26423,Aspects of disease screening,Breast Ductal Adenoma,0
26424,Usual Severity Weight Loss,Brain Ependymoma,0
26425,Ultrasonics (sound),Mucinous adenocarcinoma gastric,0
26426,Approximate,Childhood Extragonadal Malignant Germ Cell Tumor,0
26427,Computed Tomography Study File,Mucinous adenocarcinoma gastric,0
26428,BRAF gene,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26429,In Blood,Necrotizing Funisitis,0
26430,Removed,Carcinomatosis of peritoneal cavity,0
26431,treatment - ActInformationManagementReason,Intestinal Metaplasia of Bladder Urothelium,0
26432,Tired,Benign squamous cell tumor,0
26433,Extreme Response,Pancreatic Intraepithelial Neoplasia-3,0
26434,Body structure,non-Hodgkin's lymphoma of spleen,0
26435,Skin tanning,Breast Ductal Adenoma,0
26436,Geographic Locations,clear cell adenocarcinoma of gallbladder,0
26437,Prior Chemotherapy,Endometrial Small Cell Carcinoma,0
26438,Bladder Neoplasm,Pilocytic astrocytoma of cerebellum,0
26439,X-linked inheritance,Stage IV Colorectal Cancer AJCC v8,0
26440,Include (action),Adenocarcinoma,0
26441,Group A (blood group),Epithelioid Sarcoma NCI Grade 3,0
26442,BRCA2 gene,papillary carcinoma of penis,0
26443,Subgroup A Nepoviruses,Unicystic ameloblastoma,0
26444,Tryptophanase,Digestive System Hodgkin Lymphoma,0
26445,Index,benign mature teratoma of pancreas,0
26446,10 days,Cerebral Primitive Neuroectodermal Tumor,0
26447,Agent,Recurrent Testicular Lymphoma,0
26448,risk factors - observation list,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26449,Relate - vinyl resin,Localized Ewing Sarcoma,0
26450,Middle Age,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26451,Fibrosis,Melanomatosis,0
26452,Equus caballus,Refractory WHO Grade III Glioma,0
26453,Occurrence Indicator,Stage IV Colorectal Cancer AJCC v8,0
26454,Often - answer to question,Stage IB Pancreatic Cancer AJCC v8,0
26455,Part Dosing Unit,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26456,23,Peripheral primitive neuroectodermal tumor of soft tissue,0
26457,Value Above Reference Range,Astrocytoma of brain,0
26458,Form:Finding:Point in time:{Setting}:Document:{Role},Childhood Central Nervous System Ganglioneuroblastoma,0
26459,Frequently,Thymic Clear Cell Carcinoma,0
26460,Diagnosis,Advanced Lung Carcinoma,0
26461,Adult,Acute Undifferentiated Leukemia,0
26462,Known,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26463,How Much Distress Vomiting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26464,Embryonic Development,Hereditary Diffuse Gastric Adenocarcinoma,0
26465,Sharing (Social Behavior),Neoplasms,0
26466,Abnormal Reference Range,Pancreatic Endocrine Carcinoma,0
26467,Primary,Angiosarcoma of liver,0
26468,Body part,FIGO Stage II Ovarian Cancer,0
26469,High probability,Primary Cutaneous Plasmablastic Lymphoma,0
26470,Collection (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
26471,Diagnostic Neoplasm Staging,Locally Advanced Squamous Cell Carcinoma,0
26472,common types,Neoplasms,0
26473,Diagnosis Study,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26474,Gastrointestinal Neoplasms,Pancreatic Endocrine Carcinoma,0
26475,Numbers,Adult Hepatocellular Carcinoma,0
26476,seen,Blood Vessel Tumors,0
26477,Arytenoid Cartilage,Melanomatosis,0
26478,Associated with,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26479,Progress,Metastatic Kidney Carcinoma,0
26480,Cyperus papyrus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26481,Night time,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26482,Oral region,Human Papillomavirus-Related Carcinoma,0
26483,Does jump,Undifferentiated Neuroblastoma,0
26484,Contain (action),Recurrent Uveal Melanoma,0
26485,Tissue Specimen Code,Female Breast Carcinoma,0
26486,Blood,Benign neoplasm of eye,0
26487,Historical aspects qualifier,mucinous adenocarcinoma of gallbladder,0
26488,Malignant Neoplasms,Stage IB Lung Cancer AJCC v7,0
26489,Benign,Cartilaginous exostosis,0
26490,Occurrence,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26491,Present,Cervical Squamous Intraepithelial Neoplasia,0
26492,Patient Discharge,Type II Endometrial Adenocarcinoma,0
26493,Aspects of disease screening,Platinum-Resistant Lung Small Cell Carcinoma,0
26494,Removed,Papillary cystic tumor,0
26495,Personal Contact,Cancer of Urinary Tract,0
26496,Requirement,Undifferentiated Neuroblastoma,0
26497,Affecting,FIGO Stage II Ovarian Cancer,0
26498,aggressive cancer,Benign tumor of eyelid,0
26499,Increased risk,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26500,survival aspects,Maxillary Sinus Adenoid Cystic Carcinoma,0
26501,Fever symptoms (finding),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26502,Numbers,Childhood Central Nervous System Ganglioneuroblastoma,0
26503,Location,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26504,Mathematical Factor,Cervical Fibroepithelial Polyp,0
26505,status - In progress,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26506,Statistical Prevalence,Peripheral primitive neuroectodermal tumor of soft tissue,0
26507,Males,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
26508,Visual,Childhood Thyroid Gland Follicular Carcinoma,0
26509,Methods,Astrocytoma of brain,0
26510,Occurrence,Pilocytic astrocytoma of cerebellum,0
26511,Bowen's Disease,Xeroderma pigmentosum,0
26512,Low Level,FIGO Stage II Ovarian Cancer,0
26513,One,Metaplastic carcinoma of breast,0
26514,Thoracic Duct,Adenocarcinoma,0
26515,Largest,Type II Endometrial Adenocarcinoma,0
26516,NCI CTEP SDC Melanoma Sub-Category Terminology,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26517,Metastatic Neoplasm,Cerebral Primitive Neuroectodermal Tumor,0
26518,curative treatment,Human Papillomavirus-Related Carcinoma,0
26519,Sensory organ,Malignant melanoma of eyelid,0
26520,Diagnosis Study,Liver Lymphangioma,0
26521,Oral,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26522,Mantle Zone,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26523,Leads (device),Clinical Stage I Cutaneous Melanoma AJCC v8,0
26524,IgY,Cerebral hemangioma,0
26525,Vagina Carcinoma,Carcinomatosis of peritoneal cavity,0
26526,Patient need for (contextual qualifier),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26527,Northern Europe,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26528,Swollen Lymph Node,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26529,Target,Thymic Clear Cell Carcinoma,0
26530,Specific qualifier value,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26531,Egg of order Phthiraptera,Cancer of Urinary Tract,0
26532,Body tissue,Locally Advanced Carcinoma,0
26533,N not otherwise specified Antibody,FIGO Stage II Ovarian Cancer,0
26534,Discharge,Carcinoma ex pleomorphic adenoma of parotid gland,0
26535,Disease,Fibroadenoma of breast,0
26536,Limited (extensiveness),Hereditary Diffuse Gastric Adenocarcinoma,0
26537,Ulcer,Blepharal carcinoma,0
26538,Tobacco smoking behavior,Adult Alveolar Soft Part Sarcoma,0
26539,Present,Testicular cancer metastatic,0
26540,Specific qualifier value,Tonsillar Carcinoma,0
26541,Prominent,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26542,Itchiness,adenosquamous carcinoma of breast,0
26543,Malignant Neoplasms,Xeroderma pigmentosum,0
26544,Primary operation,Childhood Fibrillary Astrocytoma,0
26545,Poor - qualifier,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
26546,Proteins,Malignant melanoma of eyelid,0
26547,Blood group antibody I,Metaplastic carcinoma of breast,0
26548,Referring,Adult Acute Eosinophilic Leukemia,0
26549,Mathematical Operator,Thyroid Hurthle Cell Carcinoma,0
26550,Tryptophanase,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26551,Administrative Division,Thymic Clear Cell Carcinoma,0
26552,United States Military Commissioned Officer O4,Breast Ductal Adenoma,0
26553,Type A,Stage IB Pancreatic Cancer AJCC v8,0
26554,Extremely Agree,Urethral Carcinoma,0
26555,Africa,Gallbladder adenoma,0
26556,Bone structure of cranium,Engraftment syndrome,0
26557,Spreading (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
26558,Copy (object),Liver Lymphangioma,0
26559,Linear,Undifferentiated Neuroblastoma,0
26560,Location of Pharyngeal Residue Following Swallowing,Bladder squamous cell carcinoma stage I,0
26561,Screening Study,Intraepithelial Melanocytic Hyperplasia,0
26562,New,squamous cell carcinoma of the thyroid gland,0
26563,Very rare,Maxillary Sinus Adenocarcinoma,0
26564,Benign,Childhood Fibrillary Astrocytoma,0
26565,Large blood vessel structure,Pancreatic carcinoma,0
26566,Death (finding),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26567,Biologic Development,Childhood Lymphoma,0
26568,Buildup,Melanomatosis,0
26569,90%,Carcinoma ex pleomorphic adenoma of parotid gland,0
26570,Age at diagnosis,papillary carcinoma of penis,0
26571,Sarcoma,Intraepithelial Melanocytic Hyperplasia,0
26572,per year,Benign tumor of eyelid,0
26573,Neoplasm Metastasis,Malignant Testicular Sertoli Cell Tumor,0
26574,Catalogs,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26575,Precipitating Factors,Blood Vessel Tumors,0
26576,Metabolic Syndrome X,Pancreatic carcinoma,0
26577,Two,Cervical Fibroepithelial Polyp,0
26578,Type A,Bladder squamous cell carcinoma stage I,0
26579,Period (temporal qualifier),Peripheral primitive neuroectodermal tumor of soft tissue,0
26580,Lesion of breast,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
26581,Togo,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26582,Reduced,Recurrent Testicular Lymphoma,0
26583,High Risk Acute Leukemia,Localized Askin Tumor,0
26584,More,Vaginal Adenoma,0
26585,Synonym,Kaposi's sarcoma of extrahepatic bile duct,0
26586,Bathing,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26587,High Grade Ovarian Serous Adenocarcinoma,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26588,Histology Procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26589,Cartilaginous exostosis,Stage III Cutaneous Melanoma AJCC v6,0
26590,Targeted Therapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26591,Alternative,Adenocarcinoma of duodenum,0
26592,Beginning,Carcinoma of submandibular gland,0
26593,Base - General Qualifier,Nasal cavity carcinoma,0
26594,Pharmaceutical Preparations,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26595,Possible diagnosis,Cartilaginous exostosis,0
26596,Thickened,Bladder squamous cell carcinoma stage I,0
26597,Affecting,Testicular cancer metastatic,0
26598,Biomaterial Treatment,Cervical Squamous Intraepithelial Neoplasia,0
26599,Life Threatening or Disabling Adverse Event,Intestinal Metaplasia of Bladder Urothelium,0
26600,include - SetOperator,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26601,Taxonomic,Adrenal Rest Tumor,0
26602,Frequently,Splenic Manifestation of Hairy Cell Leukemia,0
26603,Infection,Angiosarcoma of liver,0
26604,Qualitative form,Vaginal Adenoma,0
26605,Surrounding (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26606,Pharyngeal structure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26607,Reverse,Malignant neoplasm of choroid,0
26608,Mechanism (attribute),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26609,Y protein,Childhood Lung Non-Small Cell Carcinoma,0
26610,Known,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26611,year,Stage I Adult Non-Hodgkin Lymphoma,0
26612,Low Mitosis-Karyorrhexis Index,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26613,Lacking,Low Grade Squamous Intraepithelial Neoplasia,0
26614,Negation,Vaginal Adenoma,0
26615,Contents,Liver Lymphangioma,0
26616,Histamine Release,Brain Tumor,0
26617,Lower urinary tract infectious disease,Rhabdomyosarcoma with ganglionic differentiation,0
26618,Series,Carcinoma of urinary bladder,0
26619,Secondary Neoplasm,Acute lymphadenitis,0
26620,Esophagus,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26621,How Often Weight Loss,Refractory Barrett Esophagus,0
26622,Gland,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26623,Lymphoid Tissue,Refractory Ependymoma,0
26624,Dependent for bathing,Mucinous adenocarcinoma,0
26625,Clinical Study Case,Splenic Manifestation of Hairy Cell Leukemia,0
26626,Unmarried,Localized Ewing Sarcoma,0
26627,Teratoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26628,Oxygen,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
26629,Treating,Anterior Urethral Malignant Neoplasm,0
26630,Specimen Type - Macrophages,Malignant Neoplasm of Lung - Multiple Primary Sites,0
26631,Prominent,Peripheral primitive neuroectodermal tumor of soft tissue,0
26632,Progress,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26633,Thymus Gland,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26634,Etiology aspects,Carcinomatosis of peritoneal cavity,0
26635,Hair follicle structure,Uterine Cancer,0
26636,Characteristics,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26637,Surgical service,Hyperplasia of pituitary gland,0
26638,Ultrasonography,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26639,ITGBL1 gene,Cervical Squamous Intraepithelial Neoplasia,0
26640,VARIOUS DRUG CLASSES IN ATC,Recurrent Testicular Lymphoma,0
26641,Known,Spongiotic dermatitis,0
26642,Tumor type,Heavy Chain Deposition Disease,0
26643,Pediculus (eukaryote),Childhood Fibrillary Astrocytoma,0
26644,Feature,Gallbladder Adenocarcinoma,0
26645,To,Metaplastic carcinoma of breast,0
26646,Cells,Ectomesenchymal Chondromyxoid Tumor,0
26647,Categories,Locally Advanced Squamous Cell Carcinoma,0
26648,Probably,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26649,Hematoxylin and eosin stain method,Pancreatic carcinoma,0
26650,Cancer Genus,Engraftment syndrome,0
26651,Known,Undifferentiated Neuroblastoma,0
26652,Basal Cell Carcinoma Pathway,Pilocytic astrocytoma of cerebellum,0
26653,Acid reflux SYMPTOMS,Periosteal Osteosarcoma,0
26654,Two,Astrocytoma of brain,0
26655,Primary,Cancer of Urinary Tract,0
26656,84,Cervical Squamous Intraepithelial Neoplasia,0
26657,Skeletal bone,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
26658,Rule (guideline),Hereditary Diffuse Gastric Adenocarcinoma,0
26659,Volume 2,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26660,Well Differentiated,Angiosarcoma of liver,0
26661,Symptoms aspect,Undifferentiated Endocervical Sarcoma,0
26662,1+ Score,Benign Anal Granular Cell Tumor,0
26663,To,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26664,Myelodysplastic-Myeloproliferative Diseases,Undifferentiated Endocervical Sarcoma,0
26665,Burkina Faso,Basal Cell Ameloblastoma,0
26666,Body part,Bladder squamous cell carcinoma stage I,0
26667,Anabolism,Plexosarcoma,0
26668,Rare,Refractory Ependymoma,0
26669,Cancer Genus,Intestinal Metaplasia of Bladder Urothelium,0
26670,Smear - instruction imperative,Cartilaginous exostosis,0
26671,Much,Benign Carotid Body Paraganglioma,0
26672,Common (qualifier value),Thymic Clear Cell Carcinoma,0
26673,Large,Bladder squamous cell carcinoma stage I,0
26674,include - SetOperator,adenosquamous carcinoma of breast,0
26675,Pruritus,adenoid cystic carcinoma of lung,0
26676,Drain number:ID:Pt:^Patient:Nom,Neonatal leukemia,0
26677,Africa,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26678,Term Birth,Locally Advanced Squamous Cell Carcinoma,0
26679,Use of,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26680,Young Adult,Small cell neuroendocrine carcinoma of bladder,0
26681,Different,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26682,Common Specifications in HL7 V3 Publishing,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26683,Approximate,Thymoma malignant recurrent,0
26684,100%,Intraepithelial Melanocytic Hyperplasia,0
26685,Malignant Neoplasms,Benign Anal Granular Cell Tumor,0
26686,shared attribute,Benign Apocrine Neoplasm,0
26687,Endocrine finding,Parathyroid Gland Adenocarcinoma,0
26688,Immune System Finding,Fibroadenoma of breast,0
26689,World,Epithelioid Sarcoma NCI Grade 3,0
26690,Lymphocyte,Chronic Myelomonocytic Leukemia-2,0
26691,CDISC SDTM Procedure Terminology,Cervical Fibroepithelial Polyp,0
26692,Containing (qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26693,Body part,Lipoma of small intestine,0
26694,Caucasians,Engraftment syndrome,0
26695,Term (lexical),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26696,Most,Locally Advanced Squamous Cell Carcinoma,0
26697,More,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26698,year,Pancreatic carcinoma,0
26699,Epithelial Cells,Stage IB Lung Cancer AJCC v7,0
26700,Genus Homo,Grade 3a Malignant Neoplasm,0
26701,What subject filter - Result,Metastatic Malignant Neoplasm in the Sellar Region,0
26702,Cervical lymph node group,Neonatal leukemia,0
26703,removal technique,Adult Anaplastic Oligodendroglioma,0
26704,Reduced,Advanced Uterine Corpus Carcinosarcoma,0
26705,Therapy Object (animal model),Kaposi's sarcoma of skin,0
26706,Malignant Childhood Neoplasm,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26707,Function Axis,Childhood Cerebellar Neoplasm,0
26708,Take,Cerebral Primitive Neuroectodermal Tumor,0
26709,Usual,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26710,Frequency of Pain Question,Kaposi's sarcoma of skin,0
26711,Olfactory organ,Metaplastic carcinoma of breast,0
26712,Analysis of substances,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26713,Involvement with,Blepharal carcinoma,0
26714,Enlargement procedure,Metastatic Carcinoma in the Lung,0
26715,Pelvic cavity structure,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
26716,Areas <moth>,Acantholytic squamous cell carcinoma,0
26717,Electromagnetic Radiation,Microcystic meningioma,0
26718,Diagnosis Study,Colorectal cancer,0
26719,Therapeutic radiology procedure,Ovarian Carcinoid Tumor,0
26720,Breast Feeding,Nasal cavity carcinoma,0
26721,Skin Erosion,Engraftment syndrome,0
26722,Milliampere second,Unicystic ameloblastoma,0
26723,Females,Mucinous adenocarcinoma gastric,0
26724,Provide (product),Cerebral hemangioma,0
26725,Neoplastic Glandular Cell,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26726,Urinary tract infection,Tonsillar Carcinoma,0
26727,Experimental Result,Thymic Clear Cell Carcinoma,0
26728,Human Cells,Recurrent Primary Lymphoma of Bone,0
26729,Type A,FIGO Stage IVA Ovarian Cancer,0
26730,depend,Bladder adenocarcinoma stage IV,0
26731,various antiinfectives and antiseptics for local oral treatment,Female Breast Carcinoma,0
26732,Levels (qualifier value),Localized Malignant Neoplasm,0
26733,Associated topography,Kaposi's sarcoma of extrahepatic bile duct,0
26734,Mass of body region,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26735,unknown vaccine or immune globulin,Astrocytoma of brain,0
26736,Experimental Result,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26737,combination - answer to question,Uterine Cancer,0
26738,Fever,mucinous adenocarcinoma of gallbladder,0
26739,development aspects,Adult Acute Eosinophilic Leukemia,0
26740,Epithelial ovarian cancer,Primary Cutaneous Plasmablastic Lymphoma,0
26741,Genetic Heterogeneity,Acantholytic squamous cell carcinoma,0
26742,Case unit dose,Cancer of Urinary Tract,0
26743,Death (finding),Occult Lung Adenosquamous Carcinoma,0
26744,Basis - conceptual entity,Melanomatosis,0
26745,Pediatrics,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26746,Usual,Adult Acute Eosinophilic Leukemia,0
26747,More,Pancreatic Intraepithelial Neoplasia-3,0
26748,Singular,Diffuse malignant mesothelioma,0
26749,Vision,Stage III Adult Immunoblastic Lymphoma,0
26750,Brain,Endometrial Small Cell Carcinoma,0
26751,Literature,Recurrent Uveal Melanoma,0
26752,Common Specifications in HL7 V3 Publishing,Heavy Chain Deposition Disease,0
26753,Include (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
26754,Estimated,Angiosarcoma of liver,0
26755,One,FIGO Stage II Ovarian Cancer,0
26756,Most,Benign neoplasm of thorax,0
26757,Risk,Choroid Necrotic Melanoma,0
26758,Symptom severity level,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26759,Adolescent (age group),Maxillary Sinus Adenocarcinoma,0
26760,Known,Intracortical osteosarcoma,0
26761,Organ,Familial Adenomatous Polyposis Associated Medulloblastoma,0
26762,depend,Recurrent Uveal Melanoma,0
26763,Spongiosis,Testicular cancer metastatic,0
26764,High risk of,Acute Undifferentiated Leukemia,0
26765,Benign Vascular Neoplasm,Angiosarcoma of liver,0
26766,Affecting,Xeroderma pigmentosum,0
26767,Disease,Splenic Manifestation of Hairy Cell Leukemia,0
26768,High Grade Ovarian Serous Adenocarcinoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
26769,Symptoms,Angiosarcoma of liver,0
26770,Base - General Qualifier,Werner Syndrome,0
26771,Thyroid carcinoma,Malignant neoplasm of gallbladder,0
26772,Tired,Metastatic Malignant Neoplasm in the Sellar Region,0
26773,Including (qualifier),Ovarian Dermoid Cyst with Secondary Carcinoma,0
26774,Infrequent,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
26775,Intestinal Obstruction,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
26776,Over (spatial),Mucinous adenocarcinoma gastric,0
26777,Moon,Stage III Adult Immunoblastic Lymphoma,0
26778,Cessation of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26779,Cancer Genus,Benign tumor of eyelid,0
26780,Symptoms aspect,Spindle Cell Melanoma,0
26781,Genes,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26782,Neoplasms,Squamous cell carcinoma of lip,0
26783,Architecture,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26784,35,Familial Adenomatous Polyposis Associated Medulloblastoma,0
26785,Disease,Periosteal Osteosarcoma,0
26786,Case (situation),Precursor B-lymphoblastic lymphoma stage II,0
26787,Lower lip structure,Endometrial Small Cell Carcinoma,0
26788,Smear - instruction imperative,Acantholytic squamous cell carcinoma,0
26789,Body tissue,Hyperplasia of pituitary gland,0
26790,Intestines,Ichthyosis,0
26791,Extent of disease,Adult Acute Eosinophilic Leukemia,0
26792,How Much Nausea During This Period,Fourth Ventricle and Brain Stem Ependymal Tumor,0
26793,Common Specifications in HL7 V3 Publishing,Bladder adenocarcinoma stage IV,0
26794,Treating,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26795,parent,Digestive System Hodgkin Lymphoma,0
26796,1+,Chest Wall Fibromatosis,0
26797,/40,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26798,Negative Surgical Margin,Fibroadenoma of breast,0
26799,What subject filter - Result,Malignant Testicular Sertoli Cell Tumor,0
26800,Long,Malignant melanoma of eyelid,0
26801,leukemia,Localized Malignant Neoplasm,0
26802,Spreading (qualifier value),malignant lymphoma of pancreatic lymph nodes,0
26803,Type A,Malignant neoplasm of subglottis,0
26804,alone - group size,Engraftment syndrome,0
26805,High,Fibroadenoma of breast,0
26806,Less Than,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26807,photoreactivating enzyme activity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26808,Form of uterus,Neoplasms,0
26809,Virilization,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26810,Malignant Neoplasms,Benign Anal Granular Cell Tumor,0
26811,Protein Turn,Female Breast Carcinoma,0
26812,Tumor cells,FIGO Stage II Ovarian Cancer,0
26813,Sore sensation,Metaplastic carcinoma of breast,0
26814,Reflux within Device Medical Device Problem,Liver Lymphangioma,0
26815,Persons,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26816,Epitopes,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26817,Reported Term,Bladder Neuroendocrine Neoplasm,0
26818,per year,Blepharal carcinoma,0
26819,Offspring,embryonal rhabdomyosarcoma of prostate,0
26820,Package Type Not Applicable,Liver Lymphangioma,0
26821,High risk of,Giant cell angiofibroma,0
26822,Malignant Neoplasms,Uterine Cancer,0
26823,Exposure to radiation,Recurrent Uveal Melanoma,0
26824,Vestigium,Metastatic Lung Neuroendocrine Neoplasm,0
26825,lymph nodes,Stage III Cutaneous Melanoma AJCC v6,0
26826,Measuring ruler,Refractory Barrett Esophagus,0
26827,unknown vaccine or immune globulin,Recurrent Uveal Melanoma,0
26828,Hereditary,Serous cystadenocarcinoma ovary,0
26829,Near,Splenic Manifestation of Hairy Cell Leukemia,0
26830,Tumor Mass,Serous cystadenocarcinoma ovary,0
26831,PREVENT (product),Methotrexate-Associated Hodgkin Lymphoma,0
26832,therapeutic aspects,Diffuse malignant mesothelioma,0
26833,Person Name,Neonatal leukemia,0
26834,Transection (procedure),ROSE Cluster 3,0
26835,Result,Extra-abdominal fibromatosis,0
26836,Lower - spatial qualifier,non-Hodgkin's lymphoma of spleen,0
26837,90 - 100%,Brain Ependymoma,0
26838,therapeutic aspects,Pancreatic carcinoma,0
26839,Administration occupational activities,Hodgkin Disease,0
26840,Original,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26841,Response (statement),Adult Hepatocellular Carcinoma,0
26842,Rate,Granular Cell Leiomyosarcoma,0
26843,Primary malignant neoplasm,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
26844,How Often Felt Normal question,Blood Vessel Tumors,0
26845,Fasting Status Indicator,Carcinoma ex pleomorphic adenoma of parotid gland,0
26846,Tumor site:Anat:Pt:Specimen:Nom,Hyperplasia of pituitary gland,0
26847,Circulatory Process,Unresectable Rhabdomyosarcoma,0
26848,Childhood Renal Cell Carcinoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26849,Enteral Route of Drug Administration,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
26850,Back Pain,Endometrial Small Cell Carcinoma,0
26851,Natural History,Anaplastic large cell lymphoma,0
26852,Allergen (brand of diphenylpyraline),Cervical Squamous Intraepithelial Neoplasia,0
26853,Benign Neoplasm,Precursor B-lymphoblastic lymphoma stage II,0
26854,Ultraviolet Rays,sarcoma of spinal cord,0
26855,Erythropoiesis,Medulloblastoma,0
26856,Linear,Acute Undifferentiated Leukemia,0
26857,Gastric Adenocarcinoma,Airway Hemangioma,0
26858,Study,Adult Anaplastic Oligodendroglioma,0
26859,Scientific Control,Familial Adenomatous Polyposis Associated Medulloblastoma,0
26860,Unit of radiation dose,Intraepithelial Melanocytic Hyperplasia,0
26861,Greater,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26862,treatment - ActInformationManagementReason,Familial Hemophagocytic Lymphocytosis,0
26863,prior radiation therapy,Medulloblastoma,0
26864,combination of objects,Intraepithelial Melanocytic Hyperplasia,0
26865,Recombinant Interleukins,Endometrial Small Cell Carcinoma,0
26866,therapeutic aspects,Recurrent Uveal Melanoma,0
26867,Count,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26868,Age,Blepharal carcinoma,0
26869,Etiology,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26870,Deterioration of status,Squamous cell carcinoma of lip,0
26871,National Academy of Sciences (U.S.),Vaginal Adenoid Cystic Carcinoma,0
26872,Living Alone,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26873,Others - Allergy,Stage 0 Lip Carcinoma,0
26874,North America,Acantholytic squamous cell carcinoma,0
26875,Cell Count,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26876,Classification,Digestive System Hodgkin Lymphoma,0
26877,Pressure- physical agent,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
26878,Change -- procedure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26879,Persons,FIGO Stage IVA Ovarian Cancer,0
26880,Embryonal Neoplasm,Malignant neoplasm of olfactory nerve,0
26881,Upper arm,Nasal cavity carcinoma,0
26882,Cells,Cervical Squamous Intraepithelial Neoplasia,0
26883,Devices,Type II Endometrial Adenocarcinoma,0
26884,To,Chest Wall Fibromatosis,0
26885,Common (qualifier value),Pancreatic carcinoma,0
26886,Common (qualifier value),Benign Apocrine Neoplasm,0
26887,/40,Splenic Manifestation of Hairy Cell Leukemia,0
26888,Oral cavity,Benign squamous cell tumor,0
26889,Tumor Mass,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26890,Observation of color of skin,FIGO Stage IVA Ovarian Cancer,0
26891,Negation,Colorectal Neuroendocrine Tumor G2,0
26892,Make - Instruction Imperative,Stage II Carcinoma of Penis,0
26893,Multiplicative Product,Refractory Barrett Esophagus,0
26894,Infiltration,Localized Askin Tumor,0
26895,Occurrence,Testicular cancer metastatic,0
26896,Debris,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26897,Advanced phase,Noninfiltrating Intraductal Carcinoma,0
26898,Count of entities,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
26899,Occurrence,FIGO Stage IVA Ovarian Cancer,0
26900,30%,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26901,Call (Instruction),Carcinoma of urinary bladder,0
26902,Mechanism Component of Device,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26903,CDISC SEND Body System Terminology,Cerebral Primitive Neuroectodermal Tumor,0
26904,Symptoms aspect,Intraepithelial Melanocytic Hyperplasia,0
26905,Patient Reported Outcome Stem,Xeroderma pigmentosum,0
26906,early disease,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26907,Secondary Neoplasm,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26908,Administration procedure,Vaginal Adenoma,0
26909,Body tissue,Nasal cavity carcinoma,0
26910,Administration procedure,Stage III Adult Immunoblastic Lymphoma,0
26911,Speech Disorders,Liver Lymphangioma,0
26912,Data call receiving device,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26913,Togo,Cervical Adenomyoma,0
26914,Present,Ichthyosis,0
26915,ethnic european,Neonatal leukemia,0
26916,Heart,Unfavorable Non-Hodgkin Lymphoma,0
26917,Occurrence,ICHTHYOSIS,0
26918,Occur (action),Lipoma of small intestine,0
26919,Less Than,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26920,shared attribute,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26921,First (number),Type II Endometrial Adenocarcinoma,0
26922,Histology:Find:Pt:Cancer.XXX:Nar,Mixed astrocytoma-ependymoma,0
26923,Surrounding (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26924,State,Maxillary Sinus Adenoid Cystic Carcinoma,0
26925,Neoplasm Metastasis,Hemangioma,0
26926,Genus Homo,Hodgkin lymphoma,0
26927,Chest pain:Finding:Point in time:^Patient:Ordinal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26928,More,Leiomyoma of Gallbladder,0
26929,Tryptophanase,Malignant Testicular Sertoli Cell Tumor,0
26930,Facial edema,Fibroadenoma of breast,0
26931,biopsy characteristics,Giant cell angiofibroma,0
26932,Body tissue,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
26933,Slightly Agree,Bladder adenocarcinoma stage IV,0
26934,Include (action),Childhood Anaplastic Large Cell Lymphoma,0
26935,pathologic fistula,Tongue Alveolar Soft Part Sarcoma,0
26936,Most,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26937,Glioblastoma Multiforme Pathway,Uterine Cancer,0
26938,Case (situation),Airway Hemangioma,0
26939,Well,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26940,Intravascular line,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
26941,Further,Basal Cell Ameloblastoma,0
26942,Malignant - descriptor,Female Breast Carcinoma,0
26943,Speech,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
26944,Imaging Techniques,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26945,Act Relationship Subset - previous,Stage II Carcinoma of Penis,0
26946,photograph,Heavy Chain Deposition Disease,0
26947,Head and neck structure,Extra-abdominal fibromatosis,0
26948,fibroblast proliferation,Bladder squamous cell carcinoma stage I,0
26949,immune system development,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26950,Include (action),Secondary malignant neoplasm of lymph node,0
26951,MAPK1IP1L gene,Adult Acute Eosinophilic Leukemia,0
26952,Before,Serous cystadenocarcinoma ovary,0
26953,child survival,Stage III Adult Immunoblastic Lymphoma,0
26954,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Thymic Clear Cell Carcinoma,0
26955,Simpson Grade 3,Stage III Adult Immunoblastic Lymphoma,0
26956,Egg of order Phthiraptera,Mixed astrocytoma-ependymoma,0
26957,Pancreas,Mucinous neoplasm,0
26958,Body structure,Recurrent Testicular Lymphoma,0
26959,Iodides,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
26960,Geographic Locations,Small cell neuroendocrine carcinoma of bladder,0
26961,Appearance,Giant cell angiofibroma,0
26962,Urine for culture,Stage II Carcinoma of Penis,0
26963,Due to,Clonal Hematopoiesis of Indeterminate Potential,0
26964,treatment - ActInformationManagementReason,Mastocytosis,0
26965,Aplasia Cutis Congenita,Cerebral hemangioma,0
26966,Symptoms,Digestive System Hodgkin Lymphoma,0
26967,Laminar,Acute Undifferentiated Leukemia,0
26968,history (of) disease family,Astrocytoma of brain,0
26969,Present,Adenocarcinoma,0
26970,Head and neck structure,Stage III Cutaneous Melanoma AJCC v6,0
26971,Cancer Genus,Splenic Manifestation of Hairy Cell Leukemia,0
26972,Channel,Medulloblastoma,0
26973,Infective cystitis,Malignant neoplasm of subglottis,0
26974,Ovary,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26975,Mature,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26976,Fertility,Carcinomatosis of peritoneal cavity,0
26977,Oligomeric Procyanidin Complex,Pancreatic carcinoma,0
26978,Slightly (qualifier value),Periosteal Osteosarcoma,0
26979,Tired,Human Papillomavirus-Related Carcinoma,0
26980,Two,Thymic Clear Cell Carcinoma,0
26981,Lymphocyte,Metastatic Carcinoma in the Lung,0
26982,Medical problem:Finding:Point in time:^Patient:Nominal,Microcystic meningioma,0
26983,Bone Marrow Cells,Methotrexate-Associated Hodgkin Lymphoma,0
26984,Overall,Blepharal carcinoma,0
26985,Endometrium,Clonal Hematopoiesis of Indeterminate Potential,0
26986,Persistent embryonic structure,Breast Ductal Adenoma,0
26987,Spreading (qualifier value),Gallbladder Adenocarcinoma,0
26988,Kidney,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26989,Caucasoid Race,Human Papillomavirus-Related Carcinoma,0
26990,Top (position),Thyroid Hurthle Cell Carcinoma,0
26991,Young,Brain Tumor,0
26992,World,Funisitis (disorder),0
26993,Data Transformation,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26994,Term (temporal),Liver Cavernous Hemangioma,0
26995,Thyroid Gland Follicular Cell,ROSE Cluster 3,0
26996,Tanning of leather,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26997,Communicable Diseases,Non-Hodgkin Lymphoma During Pregnancy,0
26998,Glioma,Localized Askin Tumor,0
26999,PSA Level Less than Five,Contact dermatitis due to alkali,0
27000,Metastatic Neoplasm,Refractory Bladder Carcinoma,0
27001,Abundance,Localized Malignant Neoplasm,0
27002,Immunotherapy,mucinous adenocarcinoma of gallbladder,0
27003,Linear,Acute Undifferentiated Leukemia,0
27004,newly,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27005,Symptoms,Hemangioma,0
27006,Appearance,Mucinous adenocarcinoma,0
27007,Body structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27008,Occurrence Indicator,Adult Fibrolamellar Carcinoma,0
27009,System - kit,Recurrent Primary Lymphoma of Bone,0
27010,High Mitosis-Karyorrhexis Index,Melanomatosis,0
27011,Malignant neoplasm of endometrium,Childhood Extragonadal Malignant Germ Cell Tumor,0
27012,Life threatening illness,Stage 0 Penile Cancer AJCC v8,0
27013,Pelvis+,Gallbladder Adenocarcinoma,0
27014,Rating (action),Mixed astrocytoma-ependymoma,0
27015,10%,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27016,Representation (action),Thyroid Hurthle Cell Carcinoma,0
27017,Form:Finding:Point in time:{Setting}:Document:{Role},Thymic Clear Cell Carcinoma,0
27018,Give - dosing instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27019,Males,Methotrexate-Associated Hodgkin Lymphoma,0
27020,Easy,Pilocytic astrocytoma of cerebellum,0
27021,Point Name,Chronic Myelomonocytic Leukemia-2,0
27022,Weight Loss,Gallbladder Adenocarcinoma,0
27023,therapeutic aspects,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
27024,Childbirth,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27025,More Often than Once a Day,Recurrent Uveal Melanoma,0
27026,Edit Action,Airway Hemangioma,0
27027,Infiltration (procedure),Unresectable Rhabdomyosarcoma,0
27028,Confirmed by,Blepharal carcinoma,0
27029,Leukocytes,Carcinoma of submandibular gland,0
27030,Coloring Excipient,Melanomatosis,0
27031,Persistent embryonic structure,Metastatic Carcinoma in the Lung,0
27032,Average,Benign Anal Granular Cell Tumor,0
27033,Twice - dosing instruction fragment,Extracranial Neuroblastoma,0
27034,Case (situation),gliosarcoma,0
27035,Income,Pancreatic carcinoma,0
27036,International Classification of Diseases for Oncology,Anterior Urethral Malignant Neoplasm,0
27037,biomedical tube device,Hyperplasia of pituitary gland,0
27038,Carcinoid Tumor,Ovarian Carcinoid Tumor,0
27039,IPSS Risk Category High,Adult Acute Eosinophilic Leukemia,0
27040,Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27041,unknown vaccine or immune globulin,Epithelioid Sarcoma NCI Grade 3,0
27042,Medications,High Grade Glandular Intraepithelial Neoplasia,0
27043,Spreading (qualifier value),Female Breast Carcinoma,0
27044,Age,Epithelioid Sarcoma NCI Grade 3,0
27045,Pigment cell,Acantholytic squamous cell carcinoma,0
27046,Cell Count,Cancer of Urinary Tract,0
27047,3+ Score,Pancreatic Endocrine Carcinoma,0
27048,Shapes,Tonsillar Carcinoma,0
27049,Abnormal result,Secondary malignant neoplasm of lymph node,0
27050,World,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27051,Occurrence Indicator,Squamous cell carcinoma of lip,0
27052,Major <insect>,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
27053,Cherubism,adenosquamous carcinoma of breast,0
27054,Specimen Source Codes - tumor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27055,More,Childhood Extragonadal Malignant Germ Cell Tumor,0
27056,CDISC SEND Tumor Findings Results Terminology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27057,Persons,Blepharal carcinoma,0
27058,Did not receive therapy or drug for,FIGO Stage IVA Ovarian Cancer,0
27059,History of previous events,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27060,Aim (idea),Carcinoma ex pleomorphic adenoma of parotid gland,0
27061,Acrospiroma,Grade 3a Malignant Neoplasm,0
27062,Treatment Epoch,Hereditary corneal dystrophy,0
27063,Vagina Carcinoma,Refractory Ependymoma,0
27064,Cessation of life,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27065,potential,Pancreatic carcinoma,0
27066,CDISC Relationship Class,Giant cell angiofibroma,0
27067,Abnormal Reference Range,Intraepithelial Melanocytic Hyperplasia,0
27068,Changing,Female Breast Carcinoma,0
27069,Mass of body region,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27070,Route,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27071,Neuroglia,Papillary squamous cell carcinoma,0
27072,Tryptophanase,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27073,Usual,Thyroid Hurthle Cell Carcinoma,0
27074,Intercellular edema,Extracranial Neuroblastoma,0
27075,Back Pain,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27076,Providing (action),Recurrent Primary Lymphoma of Bone,0
27077,Areas <moth>,Parathyroid Gland Adenocarcinoma,0
27078,Fatigue,squamous cell carcinoma of the thyroid gland,0
27079,Malignant Vaginal Neoplasm,Secondary malignant neoplasm of lymph node,0
27080,Hematologic Tests,Kaposi's sarcoma of skin,0
27081,Classification,Breast Ductal Adenoma,0
27082,site-specific telomere resolvase activity,Malignant Testicular Sertoli Cell Tumor,0
27083,Usually,Colorectal High Grade B-Cell Lymphoma,0
27084,Treating,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27085,100%,Spongiotic dermatitis,0
27086,Numbers,Carcinoma of submandibular gland,0
27087,Study,Cancer of Urinary Tract,0
27088,dendritic spine neck,Clonal Hematopoiesis of Indeterminate Potential,0
27089,Pharmaceutical Preparations,mucinous adenocarcinoma of gallbladder,0
27090,pharmacotherapeutic,Benign Anal Granular Cell Tumor,0
27091,Study Site,FIGO Stage II Ovarian Cancer,0
27092,Form of bone,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27093,Etiology aspects,Stage II Hepatocellular Carcinoma AJCC v8,0
27094,Vagina,FIGO Stage IVA Ovarian Cancer,0
27095,Does carry,Astrocytoma of brain,0
27096,Data (eukaryote),Sarcomatoid Renal Cell Carcinoma,0
27097,Call (Instruction),Type II Endometrial Adenocarcinoma,0
27098,Itchiness,Gallbladder Adenocarcinoma,0
27099,Similarity,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27100,Infiltration,Anterior Urethral Malignant Neoplasm,0
27101,Sequence Data Type,gliosarcoma,0
27102,Spreading (qualifier value),Neoplasms,0
27103,Patient observation,Heavy Chain Deposition Disease,0
27104,Nasal cartilage structure,Benign squamous cell tumor,0
27105,status - In progress,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27106,Treating,Human Papillomavirus-Related Carcinoma,0
27107,Frequently,Carcinomatosis of peritoneal cavity,0
27108,Glioblastoma,Hyperplasia of pituitary gland,0
27109,adnexal mass,Choroid Necrotic Melanoma,0
27110,Frequently,Cervical Squamous Intraepithelial Neoplasia,0
27111,Release - action (qualifier value),FIGO Stage IVA Ovarian Cancer,0
27112,Hematological Disease,FIGO Stage IVA Ovarian Cancer,0
27113,Prevalence aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27114,Spleen,Human Papillomavirus-Related Carcinoma,0
27115,1+,gliosarcoma,0
27116,Macrophage Activation Syndrome,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
27117,Treated with,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27118,Closed,Stage III Cutaneous Melanoma AJCC v6,0
27119,shared attribute,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27120,Cell (compartment),Ichthyoses,0
27121,Bleeding tendency,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27122,Anterior portion of neck,Carcinoma of urinary bladder,0
27123,Type - attribute,Breast Ductal Adenoma,0
27124,National origin,Female Breast Carcinoma,0
27125,Thought,Adenocarcinoma,0
27126,First sign,Recurrent Testicular Lymphoma,0
27127,Initial Usage,Squamous cell carcinoma of lip,0
27128,Anorexia,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27129,Neuroglia,Recurrent Uveal Melanoma,0
27130,Tears - SpecimenType,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27131,Human body structure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27132,Xeroderma Pigmentosum,Childhood Central Nervous System Ganglioneuroblastoma,0
27133,Cure (remedy),Mucinous adenocarcinoma gastric,0
27134,Sequence Arm,Extra-abdominal fibromatosis,0
27135,Ovulation,Diffuse malignant mesothelioma,0
27136,One,Recurrent Rhabdomyosarcoma,0
27137,*Type - Kind of quantity,Basal Cell Ameloblastoma,0
27138,Thick,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27139,Abnormal cell,Localized Malignant Neoplasm,0
27140,+2,Maxillary Sinus Adenoid Cystic Carcinoma,0
27141,Chemotherapy,Locally Advanced Carcinoma,0
27142,Type A,Malignant Testicular Sertoli Cell Tumor,0
27143,Carcinoma of lung,Engraftment syndrome,0
27144,Test Result,FIGO Stage II Ovarian Cancer,0
27145,<3 (qualifier value),Cherubism,0
27146,Patients,Human Papillomavirus-Related Carcinoma,0
27147,Leaking,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27148,Feel Tired question,Secondary malignant neoplasm of lymph node,0
27149,Malignant Vaginal Neoplasm,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27150,Increased,Bladder adenocarcinoma stage IV,0
27151,Usually,Localized Askin Tumor,0
27152,Accessory,Carcinomatosis of peritoneal cavity,0
27153,PREVENT (product),FIGO Stage IVA Ovarian Cancer,0
27154,Intermediate Soft Tissue Tumor,Medulloblastoma,0
27155,VIPR1 wt Allele,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27156,Tissue of urinary bladder,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27157,Europe,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27158,Physical shape,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27159,Physical findings,Refractory Barrett Esophagus,0
27160,Function (attribute),Stage IV Childhood Non-Hodgkin Lymphoma,0
27161,Symptoms,Melanomatosis,0
27162,Adult Lymphoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27163,Entity Determiner - specific,Malignant melanoma of eyelid,0
27164,Male Phenotype,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27165,Age,Thyroid Hurthle Cell Carcinoma,0
27166,Characterization,Atypical Lobular Breast Hyperplasia,0
27167,Myelodysplastic Syndrome,Peripheral primitive neuroectodermal tumor of soft tissue,0
27168,Morphology,Anterior Urethral Malignant Neoplasm,0
27169,Thinking,Benign Anal Granular Cell Tumor,0
27170,Central Nervous System,Chronic Myelomonocytic Leukemia-2,0
27171,Type A,Hemangioma,0
27172,Endometrial biopsy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27173,Antibiotics,Malignant neoplasm of olfactory nerve,0
27174,Malignant Neoplasms,Thyroid Hurthle Cell Carcinoma,0
27175,Three,Extracranial Neuroblastoma,0
27176,98,Atypical Lobular Breast Hyperplasia,0
27177,40%,Thymic Atypical Carcinoid Tumor,0
27178,Analysis of substances,Gastric Diffuse Large B-Cell Lymphoma,0
27179,Therapy Object (animal model),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27180,2+ Score,Giant cell angiofibroma,0
27181,Hormonal Contraception,Cartilaginous exostosis,0
27182,>90,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27183,Urinary Bladder,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
27184,Treatment Effectiveness,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27185,Negative,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27186,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
27187,Anorectal Malformations,Occult Lung Adenosquamous Carcinoma,0
27188,International Classification of Diseases for Oncology,Refractory Glioma,0
27189,treatment - ActInformationManagementReason,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27190,Commercial Lot,Recurrent Uveal Melanoma,0
27191,Throat,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
27192,ultrasound device,Recurrent Uveal Melanoma,0
27193,Skin Specimen,Gallbladder Adenocarcinoma,0
27194,Carcinoma,Peripheral primitive neuroectodermal tumor of soft tissue,0
27195,Occurrence Indicator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27196,Glioblastoma Multiforme,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27197,Set scale,Malignant neoplasm of subglottis,0
27198,Frequently,papillary carcinoma of penis,0
27199,Common Specifications in HL7 V3 Publishing,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
27200,lymph nodes,Acute Undifferentiated Leukemia,0
27201,Net (qualifier),Basal Cell Ameloblastoma,0
27202,Disease,Human Papillomavirus-Related Carcinoma,0
27203,To,Intracortical osteosarcoma,0
27204,To,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27205,Zone,Recurrent Diffuse Intrinsic Pontine Glioma,0
27206,Squamous cell carcinoma,Benign Carotid Body Paraganglioma,0
27207,Treatment intent,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27208,Type A,Colorectal High Grade B-Cell Lymphoma,0
27209,Squamous cell carcinoma - category,Carcinoma,0
27210,55,Diffuse malignant mesothelioma,0
27211,Specific qualifier value,Engraftment syndrome,0
27212,Case unit dose,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
27213,Specimen,Extra-Adrenal Paraganglioma,0
27214,Life Threatening,Mastocytosis,0
27215,Common Specifications in HL7 V3 Publishing,Choroid Epithelioid Cell Melanoma,0
27216,Smear - instruction imperative,Recurrent Rhabdomyosarcoma,0
27217,Formation,Localized Askin Tumor,0
27218,ultrasound device,sarcoma of spinal cord,0
27219,Case (situation),Benign squamous cell tumor,0
27220,Has difficulty doing (qualifier value),Refractory Barrett Esophagus,0
27221,Primary,Adenocarcinoma,0
27222,Tissue of urinary bladder,Recurrent Primary Lymphoma of Bone,0
27223,Medical,Heavy Chain Deposition Disease,0
27224,Array Feature,FIGO Stage II Ovarian Cancer,0
27225,Right lymphatic duct,Cartilaginous exostosis,0
27226,Total thymectomy,Bladder Neuroendocrine Neoplasm,0
27227,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
27228,Human body structure,Methotrexate-Associated Hodgkin Lymphoma,0
27229,Screening procedure,Endometrial Small Cell Carcinoma,0
27230,Fatigue,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27231,research subject screening,Cancer of Urinary Tract,0
27232,Hyperlink,Cartilaginous exostosis,0
27233,Negation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27234,Biomaterial Treatment,Thymic Clear Cell Carcinoma,0
27235,Within,adenosquamous carcinoma of breast,0
27236,Modify status - jump,Hereditary Diffuse Gastric Adenocarcinoma,0
27237,Upper genitourinary tract structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27238,United States,Adult Alveolar Soft Part Sarcoma,0
27239,Appearance,Parathyroid Gland Adenocarcinoma,0
27240,Tumor Mass,Xeroderma pigmentosum,0
27241,Primary malignant neoplasm,Pancreatic Endocrine Carcinoma,0
27242,Mathematical Operator,Refractory Barrett Esophagus,0
27243,Decision,Squamous cell carcinoma of lip,0
27244,Name (property) (qualifier value),Xeroderma pigmentosum,0
27245,Primary malignant neoplasm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27246,Object Class,Localized Askin Tumor,0
27247,pharmacotherapeutic,Diffuse malignant mesothelioma,0
27248,To,Intracortical osteosarcoma,0
27249,Vagina Carcinoma,Stage 0 Penile Cancer AJCC v8,0
27250,Estrogen Receptors,Refractory Barrett Esophagus,0
27251,Aim (idea),Diffuse malignant mesothelioma,0
27252,0%,Malignant neoplasm of subglottis,0
27253,Occur (action),Ovarian Carcinoid Tumor,0
27254,Including (qualifier),Anterior Urethral Malignant Neoplasm,0
27255,Act Relationship Subset - previous,Splenic Manifestation of Hairy Cell Leukemia,0
27256,Seminoma,Spindle Cell Melanoma,0
27257,Base - General Qualifier,carcinoma of middle ear,0
27258,Tryptophanase,Refractory Barrett Esophagus,0
27259,Bodily secretions,Stage IB Pancreatic Cancer AJCC v8,0
27260,Changed status,Localized Ewing Sarcoma,0
27261,Clinical Study Case,Tubal Hyperplasia,0
27262,Before values,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
27263,Specimen Source Codes - Mucosa,Low Grade Squamous Intraepithelial Neoplasia,0
27264,Breast Feeding,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27265,N not otherwise specified Antibody,Xeroderma pigmentosum,0
27266,Feelings,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27267,Weight decreased,Childhood Central Nervous System Ganglioneuroblastoma,0
27268,Negation,Malignant melanoma of eyelid,0
27269,Personal appearance,Ovarian Carcinoid Tumor,0
27270,radiotherapeutic,Tongue Alveolar Soft Part Sarcoma,0
27271,Malignant Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
27272,PODXL wt Allele,Intraepithelial Melanocytic Hyperplasia,0
27273,Aim (idea),Childhood Central Nervous System Immature Teratoma,0
27274,Togo,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27275,monoclonal,Benign Apocrine Neoplasm,0
27276,Large,benign mature teratoma of pancreas,0
27277,Sharing (Social Behavior),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
27278,Sweat,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27279,Overlap,Neoplasms,0
27280,Decision,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27281,Togo,Childhood Lung Non-Small Cell Carcinoma,0
27282,Before,Localized Ewing Sarcoma,0
27283,Two,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27284,Often - answer to question,Precursor B-lymphoblastic lymphoma stage II,0
27285,Body part,Cancer of Urinary Tract,0
27286,Case unit dose,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
27287,pump (device),adenosquamous carcinoma of breast,0
27288,Weight,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27289,Five,Localized Askin Tumor,0
27290,Capillary vessel,gliosarcoma,0
27291,Central neuroblastoma,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
27292,Laryngeal prominence,Stage I Adult Non-Hodgkin Lymphoma,0
27293,Endocrine Cells,Human Papillomavirus-Related Carcinoma,0
27294,High Level,Choroid Necrotic Melanoma,0
27295,Type - attribute,Plexosarcoma,0
27296,Common (qualifier value),Undifferentiated Endocervical Sarcoma,0
27297,1800s,Stage III Cutaneous Melanoma AJCC v6,0
27298,Malignant Neoplasms,Acute Undifferentiated Leukemia,0
27299,Genome - anatomical entity,non-Hodgkin's lymphoma of spleen,0
27300,Primary operation,clear cell adenocarcinoma of gallbladder,0
27301,Cell Device,Cherubism,0
27302,T prime,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
27303,Lymphatic duct,Gallbladder adenoma,0
27304,1000000,Human Papillomavirus-Related Carcinoma,0
27305,Determined by,Brain Ependymoma,0
27306,Carcinoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
27307,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Giant cell angiofibroma,0
27308,Screening Study,Kaposi's sarcoma of extrahepatic bile duct,0
27309,Meaning,Metastatic Lung Neuroendocrine Neoplasm,0
27310,Death (finding),Unfavorable Non-Hodgkin Lymphoma,0
27311,Colon Carcinoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27312,Improved - answer to question,Breast Ductal Adenoma,0
27313,Death NOS,Undifferentiated Endocervical Sarcoma,0
27314,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,embryonal rhabdomyosarcoma of prostate,0
27315,protein expression,Anterior Urethral Malignant Neoplasm,0
27316,Body structure,Low Grade Squamous Intraepithelial Neoplasia,0
27317,Multiplication,Astrocytoma of brain,0
27318,Increase in size since previous mammogram,Clonal Hematopoiesis of Indeterminate Potential,0
27319,Syndrome,Stage I Adult Non-Hodgkin Lymphoma,0
27320,Form:Finding:Point in time:{Setting}:Document:{Role},Choroid Necrotic Melanoma,0
27321,Western Europe,Type II Endometrial Adenocarcinoma,0
27322,Form:Finding:Point in time:{Setting}:Document:{Role},Basal Cell Ameloblastoma,0
27323,Pharmacotherapy,Non-Metastatic Gestational Trophoblastic Tumor,0
27324,Injury wounds,Xeroderma pigmentosum,0
27325,cell type,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27326,Carcinoid Tumor,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27327,Centroblast,Maxillary Sinus Adenocarcinoma,0
27328,US State,Clonal Hematopoiesis of Indeterminate Potential,0
27329,Workplace,Microcystic meningioma,0
27330,Greeks,Mucinous adenocarcinoma gastric,0
27331,Symptoms aspect,Tongue Alveolar Soft Part Sarcoma,0
27332,Human body structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27333,Symptoms aspect,Platinum-Resistant Lung Small Cell Carcinoma,0
27334,penis,Childhood Fibrillary Astrocytoma,0
27335,Left,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
27336,Exposure to radiation,Refractory Bladder Carcinoma,0
27337,Linear,Cervical Adenomyoma,0
27338,Administration procedure,Stage IB Pancreatic Cancer AJCC v8,0
27339,Central Nervous System Neoplasms,Multiple Endocrine Neoplasia,0
27340,Usual,Stage III Cutaneous Melanoma AJCC v6,0
27341,Immunotherapy,Digestive System Hodgkin Lymphoma,0
27342,History of present illness,Localized Askin Tumor,0
27343,Mutation,Childhood Fibrillary Astrocytoma,0
27344,Several,Carcinomatosis of peritoneal cavity,0
27345,Manufactured form,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
27346,Communicable Diseases,Spindle Cell Melanoma,0
27347,Distant,Pancreatic Endocrine Carcinoma,0
27348,+2,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
27349,Control function,Endometrial Small Cell Carcinoma,0
27350,High risk,Periosteal Osteosarcoma,0
27351,Respiratory distress,Anterior Urethral Malignant Neoplasm,0
27352,Nature,Occult Lung Adenosquamous Carcinoma,0
27353,epithelial,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
27354,Retinoic Acid Response Element,Digestive System Hodgkin Lymphoma,0
27355,Manufactured form,adenosquamous carcinoma of breast,0
27356,Sunscreening Agents,Clonal Hematopoiesis of Indeterminate Potential,0
27357,Genetic screening method,Benign squamous cell tumor,0
27358,Recurrent infections,Unresectable Rhabdomyosarcoma,0
27359,Brain,Squamous cell carcinoma of lip,0
27360,1000000,FIGO Stage IVA Ovarian Cancer,0
27361,Tumor cells,Microcystic meningioma,0
27362,Neoplasms,malignant lymphoma of pancreatic lymph nodes,0
27363,Etiology aspects,Colorectal High Grade B-Cell Lymphoma,0
27364,solid substance,Liver Lymphangioma,0
27365,Cartilage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27366,Leading,Grade 1 Clear Cell Renal Cell Carcinoma,0
27367,Morphology,Cervical Adenomyoma,0
27368,Fever,Hodgkin lymphoma,0
27369,Participation Type - origin,Endometrial Small Cell Carcinoma,0
27370,Classification of information,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27371,Good,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27372,Gastric Acid,Tongue Alveolar Soft Part Sarcoma,0
27373,Involvement with,Thyroid Hurthle Cell Carcinoma,0
27374,Order (document),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27375,Smooth muscle (tissue),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27376,Manufactured form,Hereditary Diffuse Gastric Adenocarcinoma,0
27377,regional,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
27378,Include (action),FIGO Stage IVA Ovarian Cancer,0
27379,Lymphoma,Adenocarcinoma,0
27380,Internal,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27381,Base - General Qualifier,Locally Advanced Carcinoma,0
27382,Formation,Carcinomatosis of peritoneal cavity,0
27383,Approximate,Acantholytic squamous cell carcinoma,0
27384,1+ Score,Brain Tumor,0
27385,Specimen Type - Serum,Angiosarcoma of liver,0
27386,Neoplasms,Extra-Adrenal Paraganglioma,0
27387,Malignant Neoplasms,Benign neoplasm of eye,0
27388,Lower - spatial qualifier,Refractory Barrett Esophagus,0
27389,control aspects,Xeroderma pigmentosum,0
27390,European race,Bladder squamous cell carcinoma stage I,0
27391,Primary malignant neoplasm,Type II Endometrial Adenocarcinoma,0
27392,Adult Classical Hodgkin Lymphoma,Breast Ductal Adenoma,0
27393,Science of Statistics,Adult Alveolar Soft Part Sarcoma,0
27394,Occurrence Indicator,Gallbladder Adenocarcinoma,0
27395,Usual,Recurrent Testicular Lymphoma,0
27396,Malignant Neoplasms,Type II Endometrial Adenocarcinoma,0
27397,Retarded,Parathyroid Gland Adenocarcinoma,0
27398,To,Adrenal Rest Tumor,0
27399,Result,Angiosarcoma of liver,0
27400,Links List,Acute Undifferentiated Leukemia,0
27401,Including (qualifier),Advanced Lung Carcinoma,0
27402,Human body,Hemangioma,0
27403,Abdomen+,benign mature teratoma of pancreas,0
27404,hiv-infection/aids,Leiomyoma of Gallbladder,0
27405,Primary malignant neoplasm,Gallbladder Adenocarcinoma,0
27406,Sequence Data Type,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27407,Stromal Cells,Unresectable Rhabdomyosarcoma,0
27408,Present,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27409,Manufactured form,Extracranial Neuroblastoma,0
27410,Radiation Ionizing Radiotherapy,Giant cell angiofibroma,0
27411,Microvolt,Unfavorable Non-Hodgkin Lymphoma,0
27412,Tobacco smoking behavior,High Grade Glandular Intraepithelial Neoplasia,0
27413,Metastatic Disease Clinical Trial Setting,Keratoderma,0
27414,stage,FIGO Stage II Ovarian Cancer,0
27415,Colloid,Stage III Cutaneous Melanoma AJCC v6,0
27416,Movement,Childhood Anaplastic Large Cell Lymphoma,0
27417,Severe (severity modifier),Choroid Necrotic Melanoma,0
27418,Tryptophanase,Atypical Mesothelial Hyperplasia,0
27419,PREVENT (product),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27420,Digital Content Category,FIGO Stage IVA Ovarian Cancer,0
27421,Operative Surgical Procedures,Mucinous adenocarcinoma gastric,0
27422,How Much Distress Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
27423,soluble,Hodgkin Disease,0
27424,Metastatic Neoplasm,benign mature teratoma of pancreas,0
27425,Make - Instruction Imperative,Mucinous adenocarcinoma,0
27426,Admission Level of Care Code - Improved,Trichilemmocarcinoma,0
27427,Carcinoma in Situ,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27428,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Transitional cell carcinoma,0
27429,Transformation,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27430,Cessation of life,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27431,Body site,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27432,Due to,Epithelioid Sarcoma NCI Grade 3,0
27433,suggestion,Occult Lung Adenosquamous Carcinoma,0
27434,Precision - second,Recurrent Testicular Lymphoma,0
27435,Current (present time),Unresectable Rhabdomyosarcoma,0
27436,Specific qualifier value,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27437,First (number),Kaposi's sarcoma of skin,0
27438,Overall Publication Type,Adult Alveolar Soft Part Sarcoma,0
27439,Childhood Hodgkin Lymphoma,Leiomyoma of Gallbladder,0
27440,Science of Etiology,Atypical Lobular Breast Hyperplasia,0
27441,suggestion,Mucinous adenocarcinoma gastric,0
27442,Diagnosis,Liver Cavernous Hemangioma,0
27443,Li-Fraumeni Syndrome,Ectomesenchymal Chondromyxoid Tumor,0
27444,Internal,Kaposi's sarcoma of skin,0
27445,Relative,Low Grade Squamous Intraepithelial Neoplasia,0
27446,Name Given at Birth,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27447,Antidepressive Agents,Deep Leiomyoma,0
27448,Fever,clear cell adenocarcinoma of gallbladder,0
27449,Myeloproliferative disease,Splenic Manifestation of Hairy Cell Leukemia,0
27450,Polypeptide Hormones,Blood Vessel Tumors,0
27451,To,Endometrial Small Cell Carcinoma,0
27452,Membrane,Adult Alveolar Soft Part Sarcoma,0
27453,Tissue Growth,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27454,SPG21 gene,Benign Ovarian Thecoma,0
27455,Tumor cells,Testicular cancer metastatic,0
27456,Unusual,Grade 3a Malignant Neoplasm,0
27457,Body tissue,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27458,Progress,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27459,radiotherapeutic,Placental aromatase deficiency,0
27460,Qualitative form,Benign neoplasm of eye,0
27461,Very Much,non-Hodgkin's lymphoma of spleen,0
27462,Epiglottis structure,Stage I Colon Neuroendocrine Tumor AJCC v8,0
27463,Involvement with,Plexosarcoma,0
27464,Median Statistical Measurement,Choroid Epithelioid Cell Melanoma,0
27465,Male population group,Endometrial Small Cell Carcinoma,0
27466,Young Adult,Metastatic Lung Neuroendocrine Neoplasm,0
27467,Allergens,High Grade Glandular Intraepithelial Neoplasia,0
27468,Cervical lymph node group,Bladder adenocarcinoma stage IV,0
27469,Biological Response Modifier Therapy,Benign squamous cell tumor,0
27470,Variable (uniformity),Periosteal Osteosarcoma,0
27471,biopsy characteristics,Localized Malignant Neoplasm,0
27472,Genus Homo,Recurrent Testicular Lymphoma,0
27473,Negative - answer,Undifferentiated Endocervical Sarcoma,0
27474,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Xeroderma pigmentosum,0
27475,point - UnitsOfMeasure,FIGO Stage IVA Ovarian Cancer,0
27476,Serum albumin level decreased below normal (finding),Stage II Fallopian Tube Cancer,0
27477,survival aspects,Acantholytic squamous cell carcinoma,0
27478,Mature Lymphocyte,Nasal cavity carcinoma,0
27479,Infrequent,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27480,Swelling,Extracranial Neuroblastoma,0
27481,Surface,Kaposi's sarcoma of skin,0
27482,Occurrence Indicator,Undifferentiated Neuroblastoma,0
27483,Cancer Genus,Mixed astrocytoma-ependymoma,0
27484,Call (Instruction),Pancreatic carcinoma,0
27485,foreign,FIGO Stage IVA Ovarian Cancer,0
27486,Mesothelium,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27487,Fatigue,Recurrent Testicular Lymphoma,0
27488,acute,Hereditary corneal dystrophy,0
27489,Location,Chronic Myelomonocytic Leukemia-2,0
27490,shared attribute,Recurrent Uveal Melanoma,0
27491,Treating,embryonal rhabdomyosarcoma of prostate,0
27492,Biopsy,Benign squamous cell tumor,0
27493,Abdominal bloating,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27494,Chemotherapy Regimen,Malignant melanoma of eyelid,0
27495,Upper urinary tract structure,Intestinal Metaplasia of Bladder Urothelium,0
27496,Death Related to Adverse Event,Benign Anal Granular Cell Tumor,0
27497,True primary (qualifier value),Breast Apocrine Adenoma,0
27498,Previously Treated Childhood Rhabdomyosarcoma,Localized Askin Tumor,0
27499,Stillbirth,Cartilaginous exostosis,0
27500,site-specific telomere resolvase activity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27501,peripheral blood,Medulloblastoma,0
27502,Blood flow,Xeroderma pigmentosum,0
27503,Personal appearance,Stage IB Lung Cancer AJCC v7,0
27504,Greasy hair,Chest Wall Fibromatosis,0
27505,Spreading (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27506,Location of Oral Residue Following Swallowing,Childhood Thyroid Gland Follicular Carcinoma,0
27507,form name,Mucinous adenocarcinoma gastric,0
27508,Diagnosis,Mucinous adenocarcinoma,0
27509,Spreading (qualifier value),Mixed parotid tumor,0
27510,>90,Intestinal Metaplasia of Bladder Urothelium,0
27511,Negation,Localized Ewing Sarcoma,0
27512,High risk of,Xeroderma pigmentosum,0
27513,Nervous system structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27514,respiratory gaseous exchange in organisms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27515,Administration procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
27516,Often - answer to question,Testicular cancer metastatic,0
27517,Percent normal,Breast Ductal Adenoma,0
27518,Interferes with,Squamous cell carcinoma of lip,0
27519,Infant,Carcinoma ex pleomorphic adenoma of parotid gland,0
27520,Ultrasonography,Benign squamous cell tumor,0
27521,Physical findings,Malignant neoplasm of subglottis,0
27522,Changing,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27523,Lesion,Mucinous adenocarcinoma gastric,0
27524,Social group,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27525,Smear - instruction imperative,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
27526,Childhood Germ Cell Tumor,Adult Anaplastic Oligodendroglioma,0
27527,Lymphatic obstruction,Papillary squamous cell carcinoma,0
27528,Qualitative form,Small Intestinal Villous Adenoma,0
27529,analysis aspect,Kaposi's sarcoma of skin,0
27530,removal technique,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27531,Gastrointestinal tract structure,embryonal rhabdomyosarcoma of prostate,0
27532,Several,Transitional cell carcinoma,0
27533,Include (action),Diffuse malignant mesothelioma,0
27534,Contrast,sarcoma of spinal cord,0
27535,Bacteria present,Refractory Barrett Esophagus,0
27536,Bladder Cancer Pathway,Childhood Central Nervous System Ganglioneuroblastoma,0
27537,To,Stage IV Penile Cancer AJCC v7,0
27538,Occur (action),Pancreatic Intraepithelial Neoplasia-3,0
27539,Two,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27540,Relationships,Cancer of Urinary Tract,0
27541,contact person,Collecting Duct Carcinoma of the Kidney,0
27542,Block Specimens,Mucinous cystadenofibroma,0
27543,Living Alone,adenosquamous carcinoma of breast,0
27544,Offspring,ROSE Cluster 3,0
27545,year,Atypical Lobular Breast Hyperplasia,0
27546,artesunate,Locally Advanced Carcinoma,0
27547,Four,Anterior Urethral Malignant Neoplasm,0
27548,Biomedicine,Lipoma of small intestine,0
27549,Frequency of Pain Question,Childhood Central Nervous System Ganglioneuroblastoma,0
27550,Child,FIGO Stage II Ovarian Cancer,0
27551,Risk,Engraftment syndrome,0
27552,>90,Recurrent Testicular Lymphoma,0
27553,Intestines,Plexosarcoma,0
27554,Heterogeneity,Clonal Hematopoiesis of Indeterminate Potential,0
27555,Abdomen+,Childhood Thyroid Gland Follicular Carcinoma,0
27556,soft tissue,Cherubism,0
27557,Mixed Salivary Gland Tumor,Thyroid Hurthle Cell Carcinoma,0
27558,Did not receive therapy or drug for,Collecting Duct Carcinoma of the Kidney,0
27559,Male,Stage III Cutaneous Melanoma AJCC v6,0
27560,Complete Pharyngeal Contraction,Adult Anaplastic Oligodendroglioma,0
27561,lymph nodes,Metastatic Malignant Neoplasm in the Sellar Region,0
27562,Often - answer to question,Breast Ductal Adenoma,0
27563,Adenocarcinoma,Refractory Ependymoma,0
27564,Blood group antibody I,Xeroderma pigmentosum,0
27565,Term (lexical),Peripheral primitive neuroectodermal tumor of soft tissue,0
27566,Esophageal pH Monitoring,Intraepithelial Melanocytic Hyperplasia,0
27567,Infrequent,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
27568,Therapeutic procedure,Medulloblastoma,0
27569,Removed,Tonsillar Carcinoma,0
27570,Aggressive behavior,Adenocarcinoma,0
27571,Immune System Processes,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27572,Sound - physical agent,gliosarcoma,0
27573,Lumen,Atypical Mesothelial Hyperplasia,0
27574,Condition:Find:Pt:^Patient:Nom,Mucinous adenocarcinoma gastric,0
27575,Skin Specimen,Type II Endometrial Adenocarcinoma,0
27576,Either,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27577,Rate,embryonal rhabdomyosarcoma of prostate,0
27578,Genes,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
27579,Assisted (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27580,Mathematical Factor,Primary Cutaneous Plasmablastic Lymphoma,0
27581,Object Class,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27582,Non-Small Cell Lung Carcinoma,Splenic Manifestation of Hairy Cell Leukemia,0
27583,Volume Measurement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27584,combination of objects,Carcinoma of urinary bladder,0
27585,Diagnosis,Kaposi's sarcoma of extrahepatic bile duct,0
27586,Square Mile,Hyperplasia of pituitary gland,0
27587,Less Than,Benign tumor of eyelid,0
27588,Chemotherapy,Congenital hamartoma,0
27589,Transurethral Resection,ROSE Cluster 3,0
27590,Pharmaceutical Preparations,Thymic Atypical Carcinoid Tumor,0
27591,Value Above Reference Range,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27592,Case (situation),Squamous cell carcinoma of lip,0
27593,Metaplasia,Stage III Adult Immunoblastic Lymphoma,0
27594,Malignant neoplasm of mouth,Cancer of Urinary Tract,0
27595,Architecture,Adult Alveolar Soft Part Sarcoma,0
27596,Occurrence,Squamous cell carcinoma of lip,0
27597,Reaching,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27598,Treatment Epoch,Kaposi's sarcoma of skin,0
27599,Togo,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
27600,Cell Device,Metastatic Neoplasm to the Gallbladder,0
27601,Lung,Tonsillar Carcinoma,0
27602,How Much Distress Nausea,Small intestine carcinoma,0
27603,Caucasians,embryonal rhabdomyosarcoma of prostate,0
27604,Anatomic Site,Intestinal Metaplasia of Bladder Urothelium,0
27605,Back structure,embryonal rhabdomyosarcoma of prostate,0
27606,Volume,Childhood Fibrillary Astrocytoma,0
27607,diagnosis aspect,FIGO Stage II Ovarian Cancer,0
27608,Smear - instruction imperative,Benign squamous cell tumor,0
27609,Neuron spine,Benign Anal Granular Cell Tumor,0
27610,Qualitative form,Diffuse malignant mesothelioma,0
27611,Malignant Squamous Cell Neoplasm,Werner Syndrome,0
27612,Tip,FIGO Stage IVA Ovarian Cancer,0
27613,Base - General Qualifier,Recurrent Testicular Lymphoma,0
27614,leukemia,Gallbladder Adenocarcinoma,0
27615,Occurrence,Undifferentiated Endocervical Sarcoma,0
27616,Sharp Edges,High Grade Glandular Intraepithelial Neoplasia,0
27617,Tissue damage,Contact dermatitis due to alkali,0
27618,Prophylactic behavior,Medulloblastoma,0
27619,Pancreatic carcinoma,Leiomyoma of Gallbladder,0
27620,Occur (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27621,month,Xeroderma pigmentosum,0
27622,Form:Finding:Point in time:{Setting}:Document:{Role},Undifferentiated Endocervical Sarcoma,0
27623,Qualitative mobility,Malignant neoplasm of thalamus,0
27624,Male population group,Plexosarcoma,0
27625,Mechanism (attribute),Thymic Clear Cell Carcinoma,0
27626,Human body structure,squamous cell carcinoma of the thyroid gland,0
27627,Young,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27628,Gender,Kaposi's sarcoma of skin,0
27629,pharmacotherapeutic,Transitional cell carcinoma,0
27630,melanoma,Stage 0 Penile Cancer AJCC v8,0
27631,Unknown (origin) (qualifier value),Cartilaginous exostosis,0
27632,Erythrocytes,Cerebral Primitive Neuroectodermal Tumor,0
27633,Colon <insect>,Bladder squamous cell carcinoma stage I,0
27634,Body tissue,Refractory Barrett Esophagus,0
27635,shared attribute,Benign Apocrine Neoplasm,0
27636,*Type - Kind of quantity,Malignant Testicular Sertoli Cell Tumor,0
27637,Common (qualifier value),Recurrent Diffuse Intrinsic Pontine Glioma,0
27638,Average,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
27639,Act Relationship Type - occurrence,Peripheral primitive neuroectodermal tumor of soft tissue,0
27640,Occurrence Indicator,Childhood Fibrillary Astrocytoma,0
27641,Surgical aspects,Activated B-cell type diffuse large B-cell lymphoma,0
27642,Complete,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27643,Portion of urine,Undifferentiated Neuroblastoma,0
27644,Negation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27645,Body Fluids,Astrocytoma of brain,0
27646,Colorectal Cancer,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27647,Common (qualifier value),Grade 1 Clear Cell Renal Cell Carcinoma,0
27648,Chemotherapy Regimen,Engraftment syndrome,0
27649,Plumbum metallicum,Stage I Colon Neuroendocrine Tumor AJCC v8,0
27650,Neoplasm Metastasis,Recurrent Testicular Lymphoma,0
27651,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Melanomatosis,0
27652,Brain,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27653,Forecast of outcome,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27654,Chemotherapy Regimen,Cervical Fibroepithelial Polyp,0
27655,metaplastic cell transformation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
27656,Abnormal Cell Count,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
27657,Wall of blood vessel,Pancreatic Intraepithelial Neoplasia-3,0
27658,Antibiotic throat preparations,Intraepithelial Melanocytic Hyperplasia,0
27659,risk factors - observation list,Placental aromatase deficiency,0
27660,Often - answer to question,Vaginal Adenoid Cystic Carcinoma,0
27661,Lifetime,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
27662,Lymphadenopathy,Squamous cell carcinoma of lip,0
27663,Affecting,Kaposi's sarcoma of skin,0
27664,Paraplegia,Ovarian Carcinoid Tumor,0
27665,United Kingdom,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27666,Crystallography,Gastric Diffuse Large B-Cell Lymphoma,0
27667,Cutaneous Melanoma,Xeroderma pigmentosum,0
27668,65,Extra-abdominal fibromatosis,0
27669,Infective cystitis,Metastatic Malignant Neoplasm in the Sellar Region,0
27670,Malignant - descriptor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27671,Cell Count,Chronic Myelomonocytic Leukemia-2,0
27672,Usual,Diffuse malignant mesothelioma,0
27673,Case (situation),Extra-abdominal fibromatosis,0
27674,shared attribute,Gallbladder Adenocarcinoma,0
27675,Widening,Malignant melanoma of eyelid,0
27676,Lung,Adenocarcinoma,0
27677,Sensation quality,Peripheral primitive neuroectodermal tumor of soft tissue,0
27678,Deterioration of status,Testicular cancer metastatic,0
27679,Disease,Benign Anal Granular Cell Tumor,0
27680,Occur (action),Spongiotic dermatitis,0
27681,Lymphatic vessel,Pancreatic carcinoma,0
27682,Reported Term,Carcinoma of urinary bladder,0
27683,Including (qualifier),ICHTHYOSIS,0
27684,include - SetOperator,Stage III Cutaneous Melanoma AJCC v6,0
27685,Logical Condition,Malignant neoplasm of gallbladder,0
27686,Subject is Randomized,Undifferentiated Endocervical Sarcoma,0
27687,Positive,gliosarcoma,0
27688,Domain (area of knowledge),Blood Vessel Tumors,0
27689,Diagnostic Imaging,Vaginal Adenoma,0
27690,Structure of posterior fossa of cranial cavity,Intestinal Metaplasia of Bladder Urothelium,0
27691,Primary malignant neoplasm,Familial Adenomatous Polyposis Associated Medulloblastoma,0
27692,include - SetOperator,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27693,Loss,Adult Brain Stem Mixed Glioma,0
27694,Infantile hemangioma,Transitional cell carcinoma,0
27695,Good,Acantholytic squamous cell carcinoma,0
27696,Various patch test substance,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27697,Formation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27698,Means,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27699,Statistical Prevalence,Thyroid Hurthle Cell Carcinoma,0
27700,low,papillary carcinoma of penis,0
27701,Scientific Publication,Congenital hamartoma,0
27702,cell growth,Undifferentiated Endocervical Sarcoma,0
27703,Include (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27704,Tissue damage,mucinous adenocarcinoma of gallbladder,0
27705,Common Specifications in HL7 V3 Publishing,Malignant neoplasm of gallbladder,0
27706,Malignant Neoplasms,Nasal cavity carcinoma,0
27707,Degree or extent,FIGO Stage II Ovarian Cancer,0
27708,Involvement with,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27709,Tissue Specimen Code,Epithelioid Sarcoma NCI Grade 3,0
27710,Study Control,Recurrent Testicular Lymphoma,0
27711,Form:Finding:Point in time:{Setting}:Document:{Role},Neonatal leukemia,0
27712,Cavitation,Metastatic Malignant Neoplasm in the Sellar Region,0
27713,Type A,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27714,diagnosis aspect,Pancreatic carcinoma,0
27715,Itchiness,FIGO Stage II Ovarian Cancer,0
27716,Only - dosing instruction fragment,Chronic Myelomonocytic Leukemia-2,0
27717,Randomization,Endometrial Small Cell Carcinoma,0
27718,disease markers,Adenocarcinoma of duodenum,0
27719,Arsenic measurement,Bladder adenocarcinoma stage IV,0
27720,Common (qualifier value),Kaposi's sarcoma of skin,0
27721,Publishing,Colorectal High Grade B-Cell Lymphoma,0
27722,General surgery specialty,Recurrent Testicular Lymphoma,0
27723,Multiplication,Mucosal Melanoma,0
27724,Coins,Anterior Urethral Malignant Neoplasm,0
27725,Reported Term,Cancer of Urinary Tract,0
27726,Both ovaries,FIGO Stage II Ovarian Cancer,0
27727,Lymphoid Cell Count,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
27728,Occur (action),Hodgkin Disease,0
27729,Smear - instruction imperative,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27730,medication - HL7 publishing domain,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27731,Cream,Cartilaginous exostosis,0
27732,Hematologist,Ectomesenchymal Chondromyxoid Tumor,0
27733,Adult human body,Adult Alveolar Soft Part Sarcoma,0
27734,Tissue sampling,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27735,encoding mental process,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
27736,% index,Adult Hepatocellular Carcinoma,0
27737,Extravasation,Recurrent Uveal Melanoma,0
27738,Sustained,Benign Anal Granular Cell Tumor,0
27739,Adult Grade III Meningioma,Bladder squamous cell carcinoma stage I,0
27740,Location,FIGO Stage IVA Ovarian Cancer,0
27741,Cavern,Childhood Anaplastic Large Cell Lymphoma,0
27742,Patient need for (contextual qualifier),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
27743,treatment - ActInformationManagementReason,Chest Wall Fibromatosis,0
27744,Immune,Locally Advanced Squamous Cell Carcinoma,0
27745,Count of entities,Endometrial Small Cell Carcinoma,0
27746,Chemotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27747,Referral placed,Melanomatosis,0
27748,majority,Neoplasms,0
27749,Fatty Liver Disease,FIGO Stage IVA Ovarian Cancer,0
27750,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27751,Third revision,Primary Cutaneous Plasmablastic Lymphoma,0
27752,Eye,Basal Cell Ameloblastoma,0
27753,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Childhood Central Nervous System Ganglioneuroblastoma,0
27754,Young,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27755,Woman,Recurrent Testicular Lymphoma,0
27756,Lighter device,Stage III Adult Immunoblastic Lymphoma,0
27757,Frequently,Locally Advanced Soft Tissue Sarcoma,0
27758,Diagnostic Neoplasm Staging,Acute Undifferentiated Leukemia,0
27759,Cellular infiltrate,Malignant melanoma of eyelid,0
27760,Hormonal,Kaposi's sarcoma of extrahepatic bile duct,0
27761,Irregular,FIGO Stage IVA Ovarian Cancer,0
27762,Relocation of home or business,Microcystic meningioma,0
27763,Problems - What subject filter,Refractory Bladder Carcinoma,0
27764,Uvea,Carcinoma ex pleomorphic adenoma of parotid gland,0
27765,Menopause present (finding),Malignant Neoplasm of Lung - Multiple Primary Sites,0
27766,diagnosis aspect,Mucinous adenocarcinoma gastric,0
27767,Acids,Digestive System Hodgkin Lymphoma,0
27768,Only - dosing instruction fragment,adenosquamous carcinoma of breast,0
27769,Reduction procedure,Stage IV Penile Cancer AJCC v7,0
27770,Sometimes,Stage III Cutaneous Melanoma AJCC v6,0
27771,High Grade Ovarian Serous Adenocarcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27772,Sexually Transmitted Diseases,Recurrent Uveal Melanoma,0
27773,Homo sapiens,Malignant neoplasm of thalamus,0
27774,Removing (action),Methotrexate-Associated Hodgkin Lymphoma,0
27775,Childhood Osteosarcoma,Uterine Cancer,0
27776,Vertebral column,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27777,Pruritus,embryonal rhabdomyosarcoma of prostate,0
27778,Sufficiently defined concept definition status (core metadata concept),Small cell neuroendocrine carcinoma of bladder,0
27779,Experimental Result,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
27780,Characteristics,Intraepithelial Melanocytic Hyperplasia,0
27781,Common Specifications in HL7 V3 Publishing,Unfavorable Non-Hodgkin Lymphoma,0
27782,Show,Melanomatosis,0
27783,Formation,Anterior Urethral Malignant Neoplasm,0
27784,respiratory,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27785,research subject screening,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27786,Name,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27787,Most,Xeroderma pigmentosum,0
27788,Breast,Pancreatic Intraepithelial Neoplasia-3,0
27789,Aspects of disease screening,Metastatic Neoplasm to the Gallbladder,0
27790,85,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27791,How Often Itching,Diffuse malignant mesothelioma,0
27792,Grade,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27793,Levels (qualifier value),Papillary squamous cell carcinoma,0
27794,Skin,Tonsillar Carcinoma,0
27795,Hodgkin Disease,Childhood Central Nervous System Ganglioneuroblastoma,0
27796,Human body structure,Adenocarcinoma of duodenum,0
27797,Measurement,FIGO Stage IVA Ovarian Cancer,0
27798,Recommendation,Metastatic Neoplasm to the Gallbladder,0
27799,Cells,Intraepithelial Melanocytic Hyperplasia,0
27800,Morphology,Ovarian germ cell choriocarcinoma stage IV,0
27801,Spherical shape,Stage III Cutaneous Melanoma AJCC v6,0
27802,Characterization,Endometrial Small Cell Carcinoma,0
27803,Anterior,Intraepithelial Melanocytic Hyperplasia,0
27804,site-specific telomere resolvase activity,Bladder adenocarcinoma stage IV,0
27805,Palpebral margin,Small cell neuroendocrine carcinoma of bladder,0
27806,Pain of lymph node,Trabecular adenocarcinoma,0
27807,Fatigue,Platinum-Resistant Lung Small Cell Carcinoma,0
27808,Individual,Pleomorphic adenoma of parotid gland,0
27809,Empty (qualifier),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27810,Estimated,Werner Syndrome,0
27811,Medical Device Emits Smoke,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27812,Malignant Neoplasms,Childhood Central Nervous System Ganglioneuroblastoma,0
27813,Occurrence,Mucinous neoplasm,0
27814,Swollen Lymph Node,gliosarcoma,0
27815,Enzyme Unit,Grade 1 Clear Cell Renal Cell Carcinoma,0
27816,Recommendation,Blepharal carcinoma,0
27817,Tube - unit dose,Undifferentiated Endocervical Sarcoma,0
27818,Primary Malignant Liver Neoplasm,Refractory Barrett Esophagus,0
27819,In Blood,Splenic Manifestation of Hairy Cell Leukemia,0
27820,Carcinoma,Intraepithelial Melanocytic Hyperplasia,0
27821,1+ Score,Intraepithelial Melanocytic Hyperplasia,0
27822,anatomical layer,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27823,Approximate,Epithelioid Sarcoma NCI Grade 3,0
27824,Sinus - general anatomical term,FIGO Stage IVA Ovarian Cancer,0
27825,Sweat,Cherubism,0
27826,VARIOUS DRUG CLASSES IN ATC,BRCA2 Syndrome,0
27827,90%,Metaplastic carcinoma of breast,0
27828,Night time,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27829,Hereditary,Localized Malignant Neoplasm,0
27830,Australia,Benign Ovarian Thecoma,0
27831,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27832,Known,Locally Advanced Soft Tissue Sarcoma,0
27833,Hemorrhage,Malignant Neoplasm with Regional Lymph Node Involvement,0
27834,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27835,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Recurrent Uveal Melanoma,0
27836,Body tissue,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
27837,Continuous,Kaposi's sarcoma of extrahepatic bile duct,0
27838,Subtype (attribute),Benign Anal Granular Cell Tumor,0
27839,Cervix carcinoma,Human Papillomavirus-Related Carcinoma,0
27840,Patient Reported Outcome Stem,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27841,Human Age Group,clear cell adenocarcinoma of gallbladder,0
27842,United States,Stage IB Pancreatic Cancer AJCC v8,0
27843,Old,Endometrial Small Cell Carcinoma,0
27844,Mechanism Component of Device,Mucinous adenocarcinoma gastric,0
27845,Name,Trichilemmocarcinoma,0
27846,Lymphocyte,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27847,Cartilage,Engraftment syndrome,0
27848,per year,Stage 0 Penile Cancer AJCC v8,0
27849,Numbers,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27850,Childhood Lymphoma,Nasal cavity carcinoma,0
27851,Within,Deep Leiomyoma,0
27852,Certain (qualifier value),Stage I Colon Neuroendocrine Tumor AJCC v8,0
27853,Include (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27854,Certainties,Intraepithelial Melanocytic Hyperplasia,0
27855,Cardiovascular system,Metastatic Neoplasm to the Gallbladder,0
27856,Angioma,Spongiotic dermatitis,0
27857,Nose,Locally Advanced Soft Tissue Sarcoma,0
27858,Symptoms,Squamous cell carcinoma of lip,0
27859,Lymphoma,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
27860,cure of disease,BRCA2 Syndrome,0
27861,Disease Management,Choroid Epithelioid Cell Melanoma,0
27862,Occurrence Indicator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27863,Removed,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27864,General Health:Find:Pt:^Patient:Ord,Tongue Alveolar Soft Part Sarcoma,0
27865,Classification,Stage 0 Penile Cancer AJCC v8,0
27866,Death (finding),adenoid cystic carcinoma of lung,0
27867,treatment - ActInformationManagementReason,Gastric Diffuse Large B-Cell Lymphoma,0
27868,Skin Specimen,Secondary malignant neoplasm of lymph node,0
27869,Able to Concentrate Question,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
27870,PSA Level Less than Two,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27871,Person Name,Recurrent Uveal Melanoma,0
27872,status - In progress,Stage IB Lung Cancer AJCC v7,0
27873,Heel Spur,Intestinal Metaplasia of Bladder Urothelium,0
27874,NBL1 wt Allele,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27875,Glandular,Pilocytic astrocytoma of cerebellum,0
27876,Retinoic Acid Response Element,High Grade Glandular Intraepithelial Neoplasia,0
27877,Life,Endometrial Small Cell Carcinoma,0
27878,Tryptophanase,Ovarian Carcinoid Tumor,0
27879,Comparison,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27880,shared attribute,embryonal rhabdomyosarcoma of prostate,0
27881,Cause of Death,Benign Anal Granular Cell Tumor,0
27882,Tumor Mass,Plexosarcoma,0
27883,Negation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27884,Have Sweats,Melanomatosis,0
27885,eTMF Content Model Code,Localized Malignant Neoplasm,0
27886,Radiation Oncology specialty,carcinoma of middle ear,0
27887,Smear - instruction imperative,Testicular cancer metastatic,0
27888,Prognosis:Find:Pt:^Patient:Nom,Papillary squamous cell carcinoma,0
27889,Presentation,Cherubism,0
27890,ACTG2 wt Allele,Testicular cancer metastatic,0
27891,Devices,Lipoma of small intestine,0
27892,High Risk Acute Leukemia,Pancreatic carcinoma,0
27893,Family member,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
27894,CYP19A1 gene,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27895,Most,Choroid Necrotic Melanoma,0
27896,Body tissue,Malignant neoplasm of thalamus,0
27897,Diagnosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27898,Small cell carcinoma of lung,Unresectable Rhabdomyosarcoma,0
27899,Main,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
27900,Microplate Well,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27901,Persons,Hodgkin lymphoma,0
27902,As Much as Desired,Adenocarcinoma of the prostate metastatic,0
27903,Social group,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27904,Numbers,Kaposi's sarcoma of extrahepatic bile duct,0
27905,SLC6A2 wt Allele,Childhood Central Nervous System Ganglioneuroblastoma,0
27906,Common (qualifier value),Undifferentiated Endocervical Sarcoma,0
27907,>5,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27908,Near,Childhood Lung Non-Small Cell Carcinoma,0
27909,Mixed Cell Morphology,Gallbladder Adenocarcinoma,0
27910,Cells,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27911,United States,FIGO Stage II Ovarian Cancer,0
27912,Occurrence Indicator,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
27913,Occur (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27914,Skin Aging,Digestive System Hodgkin Lymphoma,0
27915,Lymph,Localized Ewing Sarcoma,0
27916,Flowers,Pilocytic astrocytoma of cerebellum,0
27917,Fourth ventricle structure,Kaposi's sarcoma of skin,0
27918,Diagnosis Study,Adult Acute Eosinophilic Leukemia,0
27919,Infiltrative Growth Pattern,FIGO Stage IVA Ovarian Cancer,0
27920,Phenotype,Colorectal High Grade B-Cell Lymphoma,0
27921,Body tissue,Low Grade Squamous Intraepithelial Neoplasia,0
27922,Neoadjuvant Therapy Clinical Trial Setting,Neonatal leukemia,0
27923,Beginning,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27924,Dependent for bathing,Ovarian germ cell choriocarcinoma stage IV,0
27925,Multiple Myeloma,Maxillary Sinus Adenoid Cystic Carcinoma,0
27926,Greater,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27927,Large,Recurrent Uveal Melanoma,0
27928,Highest,Medulloblastoma,0
27929,Rare,embryonal rhabdomyosarcoma of prostate,0
27930,Biopsy,ROSE Cluster 3,0
27931,Extremely Agree,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27932,Ethanol,Locally Advanced Epithelioid Hemangioendothelioma,0
27933,include - SetOperator,Maxillary Sinus Adenocarcinoma,0
27934,Infrequent,Choroid Epithelioid Cell Melanoma,0
27935,Human papillomavirus types,Intraepithelial Melanocytic Hyperplasia,0
27936,general population,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27937,Primary malignant neoplasm,Undifferentiated Endocervical Sarcoma,0
27938,Multiple adenomatous polyps,Pancreatic carcinoma,0
27939,Vaccines,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27940,Carcinoma,Carcinoma,0
27941,Rare,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27942,Others - Allergy,Female Breast Carcinoma,0
27943,Tryptophanase,Basal Cell Ameloblastoma,0
27944,Known,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
27945,Skin,Vaginal Adenoma,0
27946,Adult,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27947,Percent normal,Clonal Hematopoiesis of Indeterminate Potential,0
27948,School Grade,Childhood Central Nervous System Ganglioneuroblastoma,0
27949,Near,Mixed astrocytoma-ependymoma,0
27950,Medicine,Stage III Adult Immunoblastic Lymphoma,0
27951,North America,Recurrent Uveal Melanoma,0
27952,Neoplasms,Vaginal Adenoma,0
27953,leukemia,Unicystic ameloblastoma,0
27954,Primary malignant neoplasm,Unicystic ameloblastoma,0
27955,Specific qualifier value,Acinar cell carcinoma of pancreas,0
27956,Occur (action),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27957,metaplastic cell transformation,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27958,Epidermal cells,Undifferentiated Neuroblastoma,0
27959,Upper arm,Giant cell angiofibroma,0
27960,Pale feces (finding),Advanced Lung Carcinoma,0
27961,Exposure to,Female Breast Carcinoma,0
27962,Unknown,Childhood Fibrillary Astrocytoma,0
27963,Adult,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27964,Monoclonal antibodies,Undifferentiated Endocervical Sarcoma,0
27965,Endothelium,Lipoma of small intestine,0
27966,Removing (action),Noninfiltrating Intraductal Carcinoma,0
27967,Death Related to Adverse Event,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27968,What subject filter - Result,Non-Metastatic Gestational Trophoblastic Tumor,0
27969,Europe,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27970,Obesity,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27971,WHO Central Nervous System Grade I,Adult Anaplastic Oligodendroglioma,0
27972,Back,Vaginal Adenoid Cystic Carcinoma,0
27973,3+ Answer to Question,Melanomatosis,0
27974,Array,Splenic Manifestation of Hairy Cell Leukemia,0
27975,Vibroacoustic Stimulation,Squamous cell carcinoma of lip,0
27976,Concept History,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27977,Numbers,Congenital hamartoma,0
27978,Interventional procedure,Vaginal Adenoid Cystic Carcinoma,0
27979,Abdomen distended,benign mature teratoma of pancreas,0
27980,High risk,Pancreatic Intraepithelial Neoplasia-3,0
27981,active (HL7 RoleLink),Congenital hamartoma,0
27982,Person Name,Adult Acute Eosinophilic Leukemia,0
27983,Cancer Other,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27984,Low Mitosis-Karyorrhexis Index,FIGO Stage II Ovarian Cancer,0
27985,per second,Recurrent Uveal Melanoma,0
27986,Canada,Digestive System Hodgkin Lymphoma,0
27987,Telencephalon,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27988,Cancer Genus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27989,Aspects of signs,Malignant melanoma of eyelid,0
27990,Free of (attribute),Intraepithelial Melanocytic Hyperplasia,0
27991,NCI CTEP SDC Astrocytoma,Precursor B-lymphoblastic lymphoma stage II,0
27992,Bladder Continence Question,Extracranial Neuroblastoma,0
27993,high - ActExposureLevelCode,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
27994,Stage,Mucinous cystadenofibroma,0
27995,Levels (qualifier value),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
27996,Increase,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27997,Polycythemia,Digestive System Hodgkin Lymphoma,0
27998,physiological aspects,Localized Ewing Sarcoma,0
27999,Qualitative form,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
28000,Cell Device,Childhood Choriocarcinoma,0
28001,Immune,Refractory Barrett Esophagus,0
28002,Form:Finding:Point in time:{Setting}:Document:{Role},Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
28003,Face (spatial concept),mucinous adenocarcinoma of gallbladder,0
28004,Benign,Stage II Carcinoma of Penis,0
28005,combination of objects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
28006,Formation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28007,Risk,Locally Advanced Squamous Cell Carcinoma,0
28008,Extension,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
28009,Dairy Cream,Heavy Chain Deposition Disease,0
28010,4+ Answer to question,Bladder squamous cell carcinoma stage I,0
28011,Vaginal (intended site),Hemangioma,0
28012,Physical Medical Procedure,Secondary malignant neoplasm of lymph node,0
28013,Biopsy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28014,Factor,ICHTHYOSIS,0
28015,Network Device,Female Breast Carcinoma,0
28016,How Often Itching,Neoplasms,0
28017,Apply (administration method),Tonsillar Carcinoma,0
28018,Palmitic Acid,Multiple Endocrine Neoplasia,0
28019,Greater than one,Neonatal leukemia,0
28020,Related personal status,Type II Endometrial Adenocarcinoma,0
28021,Further,Childhood Anaplastic Large Cell Lymphoma,0
28022,Changing,Intestinal Metaplasia of Bladder Urothelium,0
28023,seconds,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28024,Mediator brand of benfluorex hydrochloride,Recurrent Testicular Lymphoma,0
28025,Screening Study,Endometrial Small Cell Carcinoma,0
28026,Pediatric Neoplasm,Cervical Squamous Intraepithelial Neoplasia,0
28027,High Level,mucinous adenocarcinoma of gallbladder,0
28028,diagnosis aspect,Pancreatic Intraepithelial Neoplasia-3,0
28029,Treatment Epoch,Lung squamous cell carcinoma stage I,0
28030,Plasmacytoma - category,Recurrent Uveal Melanoma,0
28031,Numbers,Splenic Manifestation of Hairy Cell Leukemia,0
28032,Including (qualifier),Childhood Lymphoma,0
28033,Science of Morphology,Mucinous neoplasm,0
28034,Uveal melanoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28035,Tobacco smoking behavior,Plexosarcoma,0
28036,Adult human body,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28037,Sexual Partners,Thymoma malignant recurrent,0
28038,Ovary,Recurrent Uveal Melanoma,0
28039,Small,Childhood Lymphoma,0
28040,Therapeutic radiology procedure,Undifferentiated Endocervical Sarcoma,0
28041,Therapeutic radiology procedure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
28042,Infection,Angiosarcoma of liver,0
28043,liter,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28044,described,Transitional cell carcinoma,0
28045,Possible,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28046,Progress,Intraepithelial Melanocytic Hyperplasia,0
28047,Less often,Pleomorphic adenoma of parotid gland,0
28048,Cancer Genus,Ovarian germ cell choriocarcinoma stage IV,0
28049,Pathogenic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28050,Symptoms,Malignant Neoplasm of Lung - Multiple Primary Sites,0
28051,Visual Impairment,Kaposi's sarcoma of skin,0
28052,Thymectomy,Human Papillomavirus-Related Carcinoma,0
28053,mononuclear cells,Localized Ewing Sarcoma,0
28054,defective,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28055,Problems - What subject filter,Testicular cancer metastatic,0
28056,Therapeutic radiology procedure,malignant lymphoma of pancreatic lymph nodes,0
28057,Known,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28058,Diagnosis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28059,Array,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
28060,Immune system,Blepharal carcinoma,0
28061,Location,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28062,Surgery specialty,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28063,Negation,Serous cystadenocarcinoma ovary,0
28064,Sex Cord-Stromal Tumor,Recurrent Uveal Melanoma,0
28065,Abnormal Reference Range,Acantholytic squamous cell carcinoma,0
28066,Anabolism,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28067,Enlarged,Digestive System Hodgkin Lymphoma,0
28068,What subject filter - Result,Non-Metastatic Gestational Trophoblastic Tumor,0
28069,Doubling Time,Acantholytic squamous cell carcinoma,0
28070,40%,Childhood Anaplastic Large Cell Lymphoma,0
28071,Common (qualifier value),Angiosarcoma of liver,0
28072,Hormonal,Placental aromatase deficiency,0
28073,Occurrence Indicator,Stage III Cutaneous Melanoma AJCC v6,0
28074,Approximate,Engraftment syndrome,0
28075,Approximate,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28076,therapeutic aspects,Intraepithelial Melanocytic Hyperplasia,0
28077,site-specific telomere resolvase activity,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
28078,Anaplastic astrocytoma,Astrocytoma of brain,0
28079,<3 (qualifier value),Gallbladder adenoma,0
28080,Categories,Maxillary Sinus Adenocarcinoma,0
28081,Affect (mental function),Adenocarcinoma,0
28082,Protons,Malignant melanoma of eyelid,0
28083,Congenital anomaly of liver,Benign neoplasm of thorax,0
28084,Shortness of Breath Visual Analogue Scale,Childhood Extragonadal Malignant Germ Cell Tumor,0
28085,3+ Answer to Question,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
28086,skin color,Clonal Hematopoiesis of Indeterminate Potential,0
28087,Pickle,Recurrent Testicular Lymphoma,0
28088,Head,Chronic Myelomonocytic Leukemia-2,0
28089,Togo,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28090,Sequence Data Type,Grade 3a Malignant Neoplasm,0
28091,Visceral,Nasal cavity carcinoma,0
28092,Formation,Adenocarcinoma of duodenum,0
28093,Operative Surgical Procedures,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28094,Lymphoma,Adenocarcinoma,0
28095,month,Colorectal cancer,0
28096,Analysis of substances,Stage IV Colorectal Cancer AJCC v8,0
28097,Statistical Significance,Cerebral Primitive Neuroectodermal Tumor,0
28098,Antibiotics,Grade 3a Malignant Neoplasm,0
28099,Genus Chalazion,Mucinous adenocarcinoma gastric,0
28100,Reciprocal translocation,Intestinal Neuroendocrine Carcinoma,0
28101,PCYT1A wt Allele,Endometrial Small Cell Carcinoma,0
28102,To,Localized Askin Tumor,0
28103,Medulla,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
28104,mast cell,Adult Alveolar Soft Part Sarcoma,0
28105,Pancreas,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28106,Statistical Significance,Mucinous adenocarcinoma,0
28107,Milk - dietary,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28108,Usually,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28109,risk factors - observation list,Testicular cancer metastatic,0
28110,Methods aspects,Primary Cutaneous Plasmablastic Lymphoma,0
28111,Adverse Event by CTCAE Category,Carcinoma of submandibular gland,0
28112,peripheral blood,Choroid Necrotic Melanoma,0
28113,Giant Cells,Ovarian germ cell choriocarcinoma stage IV,0
28114,Females,Anterior Urethral Malignant Neoplasm,0
28115,radiotherapeutic,Multiple Skull Base Meningiomas,0
28116,Sublingual Gland,Pancreatic Intraepithelial Neoplasia-3,0
28117,Cellular infiltrate,Recurrent Primary Lymphoma of Bone,0
28118,Mobility aid,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28119,Lighter device,Childhood Fibrillary Astrocytoma,0
28120,Does play,Benign Carotid Body Paraganglioma,0
28121,Surgical reduction,Methotrexate-Associated Hodgkin Lymphoma,0
28122,Increased,Non-Metastatic Gestational Trophoblastic Tumor,0
28123,shared attribute,Refractory Ependymoma,0
28124,Behavior:-:Point in time:^Patient:-,Familial Adenomatous Polyposis Associated Medulloblastoma,0
28125,Symptoms,Chondrosarcoma,0
28126,Females,Hereditary Diffuse Gastric Adenocarcinoma,0
28127,80%,Recurrent Primary Lymphoma of Bone,0
28128,biopsy characteristics,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28129,Disease,Adult Acute Eosinophilic Leukemia,0
28130,Biomaterial Treatment,Cervical Fibroepithelial Polyp,0
28131,Abnormal,Fourth Ventricle and Brain Stem Ependymal Tumor,0
28132,common procedures,Unicystic ameloblastoma,0
28133,Beginning,Rhabdomyosarcoma with ganglionic differentiation,0
28134,radiotherapeutic,Stage III Cutaneous Melanoma AJCC v6,0
28135,Symptoms aspect,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28136,Formation,Pancreatic carcinoma,0
28137,Smear - instruction imperative,Hereditary Diffuse Gastric Adenocarcinoma,0
28138,Two,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28139,Status post,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
28140,common types,malignant lymphoma of pancreatic lymph nodes,0
28141,Supratentorial Embryonal Tumor,Germinoma,0
28142,Type A,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28143,Tumor Mass,Heavy Chain Deposition Disease,0
28144,List,Intraepithelial Melanocytic Hyperplasia,0
28145,Cervical lymph node group,Cervical Fibroepithelial Polyp,0
28146,Experimental Result,Tumorlet,0
28147,Frequently,Pancreatic carcinoma,0
28148,Surgical aspects,Neonatal leukemia,0
28149,Family history of leukemia,Kaposi's sarcoma of skin,0
28150,>90,Vaginal Adenoid Cystic Carcinoma,0
28151,Painless,Hemangioma,0
28152,Space - property,Leptomeningeal sarcoma,0
28153,Phrase,Rhabdomyosarcoma with ganglionic differentiation,0
28154,Operation excision,Localized Askin Tumor,0
28155,Basal Cell Cancer,Refractory Bladder Carcinoma,0
28156,How Much Distress Diarrhea,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
28157,Unknown GENC,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28158,Cells,Intraepithelial Melanocytic Hyperplasia,0
28159,Part,Giant cell angiofibroma,0
28160,Duodenum,FIGO Stage IVA Ovarian Cancer,0
28161,Out (direction),Childhood Central Nervous System Ganglioneuroblastoma,0
28162,Include (action),Brain Ependymoma,0
28163,metaplastic cell transformation,Low Grade Squamous Intraepithelial Neoplasia,0
28164,Post,Carcinoma,0
28165,Ulceration,Small Intestinal Villous Adenoma,0
28166,Diagnosis,High Grade Glandular Intraepithelial Neoplasia,0
28167,Firstly,Digestive System Hodgkin Lymphoma,0
28168,Always (frequency),adenosquamous carcinoma of breast,0
28169,Type 1,Metaplastic carcinoma of breast,0
28170,Dysuria,Refractory Bladder Carcinoma,0
28171,Fever,Malignant neoplasm of thalamus,0
28172,Neoplasms,Childhood Lung Non-Small Cell Carcinoma,0
28173,Gene Cluster Text Format,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28174,Linear,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28175,Volume (publication),Neoplasms,0
28176,Therapeutic procedure,Angiosarcoma of liver,0
28177,4+ Answer to question,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28178,Occur (action),Multiple Endocrine Neoplasia,0
28179,Surgery specialty,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28180,Mucous body substance,Female Breast Carcinoma,0
28181,Malignant neoplasm of brain,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
28182,Glandular stomach,Methotrexate-Associated Hodgkin Lymphoma,0
28183,Structure of subclavian vein,Melanomatosis,0
28184,Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28185,Neoplasms,Malignant neoplasm of gallbladder,0
28186,Parameterized Data Type - Set,Metaplastic carcinoma of breast,0
28187,Superkingdom (taxonomic category),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
28188,white blood cell type,embryonal rhabdomyosarcoma of prostate,0
28189,Immunotherapy,Adult Anaplastic Oligodendroglioma,0
28190,FAT1 wt Allele,Hereditary Diffuse Gastric Adenocarcinoma,0
28191,Five,Congenital hamartoma,0
28192,Feel Nausea,Anterior Urethral Malignant Neoplasm,0
28193,Vermilion border of lip,Malignant Testicular Sertoli Cell Tumor,0
28194,Have Been Vomiting,Xeroderma pigmentosum,0
28195,Neutral Charge,Stage III Cutaneous Melanoma AJCC v6,0
28196,Broken skin,embryonal rhabdomyosarcoma of prostate,0
28197,Formed,Locally Advanced Epithelioid Hemangioendothelioma,0
28198,Cell septum,Type II Endometrial Adenocarcinoma,0
28199,Negation,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
28200,Gram per Deciliter,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
28201,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Parathyroid Gland Adenocarcinoma,0
28202,Intact,FIGO Stage II Ovarian Cancer,0
28203,Prognosis:Find:Pt:^Patient:Nom,Bladder adenocarcinoma stage IV,0
28204,Support,Ichthyosis,0
28205,Very High Level,Bladder squamous cell carcinoma stage I,0
28206,Spreading (qualifier value),benign mature teratoma of pancreas,0
28207,Fatal,Advanced Lung Carcinoma,0
28208,Therapeutic radiology procedure,Collecting Duct Carcinoma of the Kidney,0
28209,Surrounding (qualifier value),Nasal cavity carcinoma,0
28210,Muscle Contraction,Metastatic Ductal Breast Carcinoma,0
28211,Biomaterial Treatment,Leptomeningeal sarcoma,0
28212,Occurrence Indicator,Congenital hamartoma,0
28213,MOSTLY,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28214,Involvement with,Carcinomatosis of peritoneal cavity,0
28215,Oropharyngeal,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28216,Surgical aspects,Metastatic Neoplasm to the Gallbladder,0
28217,Body tissue,Intraepithelial Melanocytic Hyperplasia,0
28218,Result,Cervical Adenomyoma,0
28219,Africa,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28220,Point Name,Brain Ependymoma,0
28221,Wound Healing,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
28222,Central Nervous System,Female Breast Carcinoma,0
28223,Sounds device,Bladder Neuroendocrine Neoplasm,0
28224,Medical service,Maxillary Sinus Adenoid Cystic Carcinoma,0
28225,Science of Statistics,Melanomatosis,0
28226,Low Level,Astrocytoma of brain,0
28227,Forecast of outcome,Extra-abdominal fibromatosis,0
28228,Childhood diseases,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
28229,Concern,sarcoma of spinal cord,0
28230,Enlarged,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28231,Benign,Precursor B-lymphoblastic lymphoma stage II,0
28232,Occur (action),Diffuse malignant mesothelioma,0
28233,Early disease stage,Spermatocytic seminoma,0
28234,Body structure,Fibroadenoma of breast,0
28235,Weight Loss,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28236,Symptoms,Melanomatosis,0
28237,Related personal status,Melanomatosis,0
28238,Most,Extracranial Neuroblastoma,0
28239,risk factors,Recurrent Testicular Lymphoma,0
28240,Embryonic tissue,Non-Metastatic Gestational Trophoblastic Tumor,0
28241,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28242,Symptoms aspect,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28243,Common (qualifier value),Acantholytic squamous cell carcinoma,0
28244,Formation,Cherubism,0
28245,Brain Neoplasms,Acantholytic squamous cell carcinoma,0
28246,Pharmacotherapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
28247,Group Object,Recurrent Rhabdomyosarcoma,0
28248,Involvement with,High Grade Glandular Intraepithelial Neoplasia,0
28249,PGR gene,Stage IB Pancreatic Cancer AJCC v8,0
28250,Weight measurement scales,Atypical Lobular Breast Hyperplasia,0
28251,Device Spring,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28252,Ependyma,FIGO Stage IVA Ovarian Cancer,0
28253,Breast tissue sample,Congenital hamartoma,0
28254,Nursing interventions,Stage IB Pancreatic Cancer AJCC v8,0
28255,error,Localized Askin Tumor,0
28256,Class,Carcinomatosis of peritoneal cavity,0
28257,*Type - Kind of quantity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
28258,Woman,Mucinous adenocarcinoma gastric,0
28259,Occur (action),Malignant melanoma of eyelid,0
28260,Eye,Cancer of Urinary Tract,0
28261,Residential flat,Recurrent Uveal Melanoma,0
28262,Genes,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
28263,Cancer stage iv,Astrocytoma of brain,0
28264,Tryptophanase,Lung squamous cell carcinoma stage I,0
28265,high - ActExposureLevelCode,Acantholytic squamous cell carcinoma,0
28266,Fibrosis,Refractory Bladder Carcinoma,0
28267,Financial Account,Platinum-Resistant Lung Small Cell Carcinoma,0
28268,Often - answer to question,Undifferentiated Endocervical Sarcoma,0
28269,High,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28270,Voice,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28271,Aggressive behavior,Recurrent Testicular Lymphoma,0
28272,Poor - grade value,Kaposi's sarcoma of extrahepatic bile duct,0
28273,Lung,Childhood Fibrillary Astrocytoma,0
28274,Pain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28275,Known,Adult Hepatocellular Carcinoma,0
28276,Mother (person),Cervical Fibroepithelial Polyp,0
28277,Operative Surgical Procedures,Platinum-Resistant Lung Small Cell Carcinoma,0
28278,Woman,Bladder adenocarcinoma stage IV,0
28279,Mammal liver preparation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28280,Pancreatic carcinoma,Neoplasms,0
28281,Common (qualifier value),Anterior Urethral Malignant Neoplasm,0
28282,Ultraviolet Rays,Low Grade Squamous Intraepithelial Neoplasia,0
28283,Ability,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28284,Body part,Acantholytic squamous cell carcinoma,0
28285,Malignant Neoplasms,Liver Cavernous Hemangioma,0
28286,Known,Melanomatosis,0
28287,various other intestinal adsorbents in ATC,Benign tumor of eyelid,0
28288,Early,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
28289,Therapeutic procedure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
28290,eTMF Content Model Code,Plexosarcoma,0
28291,Gastric Content,Tongue Alveolar Soft Part Sarcoma,0
28292,Secondary Neoplasm,Squamous cell carcinoma of lip,0
28293,Neoplasms,Kaposi's sarcoma of extrahepatic bile duct,0
28294,Completely - dosing instruction fragment,Childhood Central Nervous System Ganglioneuroblastoma,0
28295,Detached,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
28296,Consultation,Engraftment syndrome,0
28297,Function Axis,Recurrent Uveal Melanoma,0
28298,HLA Class II Histocompatibility Antigen Gamma Chain,Benign Anal Granular Cell Tumor,0
28299,Call (Instruction),Hyperplasia of pituitary gland,0
28300,Benign melanocytic nevus,Stage III Cutaneous Melanoma AJCC v6,0
28301,Lesion,Mixed parotid tumor,0
28302,factor A,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
28303,Occur (action),Adenocarcinoma of duodenum,0
28304,Possibly Related to Intervention,malignant lymphoma of pancreatic lymph nodes,0
28305,Body tissue,Bladder squamous cell carcinoma stage I,0
28306,Persons,Necrotizing Funisitis,0
28307,Laboratory Procedures,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
28308,Certain (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
28309,N not otherwise specified Antibody,Mastocytosis,0
28310,Contain (action),Benign Apocrine Neoplasm,0
28311,Identified,Mucinous adenocarcinoma gastric,0
28312,Architecture,Locally Advanced Squamous Cell Carcinoma,0
28313,Cancer Genus,Acute lymphadenitis,0
28314,Condition,Cervical Fibroepithelial Polyp,0
28315,Ultrasonography,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28316,Mass in breast,Thyroid Hurthle Cell Carcinoma,0
28317,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
28318,Back Pain,Gallbladder adenoma,0
28319,Endodermal,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28320,M NOS ANTIBODY,Kaposi's sarcoma of extrahepatic bile duct,0
28321,Location of Pharyngeal Residue Following Swallowing,Periosteal Osteosarcoma,0
28322,Parotid Neoplasms,Testicular cancer metastatic,0
28323,Ovary,Malignant melanoma of eyelid,0
28324,Cure (remedy),Childhood Choriocarcinoma,0
28325,Type - attribute,Thymoma malignant recurrent,0
28326,Either,Cancer of Urinary Tract,0
28327,Function Axis,Clonal Hematopoiesis of Indeterminate Potential,0
28328,United States,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
28329,shared attribute,ROSE Cluster 3,0
28330,Colorectal Cancer,Giant cell angiofibroma,0
28331,diagnosis aspect,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28332,Urothelial Carcinoma,Tongue Alveolar Soft Part Sarcoma,0
28333,Approximate,Astrocytoma of brain,0
28334,Disease Screening,Choroid Necrotic Melanoma,0
28335,Area,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
28336,Supernumerary,clear cell adenocarcinoma of gallbladder,0
28337,Overlap,Ampulla of Vater Tubular Adenoma,0
28338,Tumor Mass,Hemangioma,0
28339,Type A,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28340,Version,Colorectal High Grade B-Cell Lymphoma,0
28341,Etiology,Intraepithelial Melanocytic Hyperplasia,0
28342,Rare,Cartilaginous exostosis,0
28343,Insecticides,Liver Lymphangioma,0
28344,pharmacotherapeutic,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
28345,Removed,Tonsillar Carcinoma,0
28346,Major,Ovarian germ cell choriocarcinoma stage IV,0
28347,Primary malignant neoplasm,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
28348,Liver,Melanomatosis,0
28349,Symptoms,Stage III Adult Immunoblastic Lymphoma,0
28350,Europe,Vaginal Adenoid Cystic Carcinoma,0
28351,Methods aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28352,React,Occult Lung Adenosquamous Carcinoma,0
28353,Distal (qualifier value),Occult Lung Adenosquamous Carcinoma,0
28354,Rare,Undifferentiated Endocervical Sarcoma,0
28355,Bone Pain,Heavy Chain Deposition Disease,0
28356,International Classification of Disease,Mucinous adenocarcinoma gastric,0
28357,View,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28358,MOSTLY,Mucinous adenocarcinoma gastric,0
28359,Occurrence Indicator,Vaginal Adenoid Cystic Carcinoma,0
28360,Painless,Intestinal Neuroendocrine Carcinoma,0
28361,Have Nausea,malignant lymphoma of pancreatic lymph nodes,0
28362,Growth,Benign Apocrine Neoplasm,0
28363,As Much as Desired,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
28364,Abdomen+,Recurrent Testicular Lymphoma,0
28365,Cure (remedy),Botryoid-Type Embryonal Rhabdomyosarcoma,0
28366,Relocation of home or business,Refractory Bladder Carcinoma,0
28367,Fresh Specimen,Cartilaginous exostosis,0
28368,Point,Unresectable Rhabdomyosarcoma,0
28369,More,High Grade Glandular Intraepithelial Neoplasia,0
28370,Part of,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
28371,Lacrimal sac,Kaposi's sarcoma of extrahepatic bile duct,0
28372,Cover - action,Adult Alveolar Soft Part Sarcoma,0
28373,Have Weight Loss,Cancer of Urinary Tract,0
28374,Numbers,squamous cell carcinoma of the thyroid gland,0
28375,Several,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28376,Paraplegia,Hemangioma,0
28377,Age-Years,Breast Ductal Adenoma,0
28378,To,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
28379,Genitourinary system,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
28380,Experimental Result,Metastatic Lung Small Cell Carcinoma,0
28381,Study Protocol,Blepharal carcinoma,0
28382,Classification,Granular Cell Leiomyosarcoma,0
28383,Form:Finding:Point in time:{Setting}:Document:{Role},Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28384,Supraglottis (body part),BRCA2 Syndrome,0
28385,Requirement,Engraftment syndrome,0
28386,Irregular,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28387,Precision - second,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28388,Carcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28389,Persons,Unfavorable Non-Hodgkin Lymphoma,0
28390,Bladder Cancer Pathway,Xeroderma pigmentosum,0
28391,Worsening pattern,Human Papillomavirus-Related Carcinoma,0
28392,Symptoms aspect,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
28393,Variant,Blepharal carcinoma,0
28394,Various patch test substance,Adult Acute Eosinophilic Leukemia,0
28395,Oral region,Grade 3a Malignant Neoplasm,0
28396,Hodgkin Disease,BRCA2 Syndrome,0
28397,American College of Cardiology/American Heart Association Lesion Complexity Score C,Methotrexate-Associated Hodgkin Lymphoma,0
28398,*Type - Kind of quantity,BRCA2 Syndrome,0
28399,Irregular,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28400,Twice - dosing instruction fragment,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28401,Name (property) (qualifier value),Engraftment syndrome,0
28402,cancer therapy,Diffuse malignant mesothelioma,0
28403,Retinoic Acid Response Element,Recurrent Primary Lymphoma of Bone,0
28404,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
28405,Primary malignant neoplasm,Adult Hepatocellular Carcinoma,0
28406,Participation Type - origin,Localized Askin Tumor,0
28407,Diagnosis Study,Tongue Alveolar Soft Part Sarcoma,0
28408,One,Methotrexate-Associated Hodgkin Lymphoma,0
28409,First (number),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28410,Persons,Bladder adenocarcinoma stage IV,0
28411,Before,Locally Advanced Epithelioid Hemangioendothelioma,0
28412,Females,Intraepithelial Melanocytic Hyperplasia,0
28413,Device system,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28414,Contain (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
28415,50%,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28416,Probable diagnosis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28417,Malignant Neoplasms,FIGO Stage IVA Ovarian Cancer,0
28418,Small cell carcinoma of lung,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28419,To,Occult Lung Adenosquamous Carcinoma,0
28420,Spreading (qualifier value),Choroid Epithelioid Cell Melanoma,0
28421,Togo,Lung squamous cell carcinoma stage I,0
28422,Smear - instruction imperative,Acute lymphadenitis,0
28423,shared attribute,Benign neoplasm of eye,0
28424,Area,FIGO Stage IVA Ovarian Cancer,0
28425,Persons,Acantholytic squamous cell carcinoma,0
28426,Mathematical Factor,Uterine Cancer,0
28427,combination of objects,Medulloblastoma,0
28428,Meninges,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28429,Grade III Meningioma,Periosteal Osteosarcoma,0
28430,Recommendation,Testicular cancer metastatic,0
28431,diagnosis aspect,Testicular cancer metastatic,0
28432,Diagnosis,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28433,Universal restriction modifier (core metadata concept),ICHTHYOSIS,0
28434,Affect (mental function),Thyroid Hurthle Cell Carcinoma,0
28435,Mixed Tumor,Malignant neoplasm of thalamus,0
28436,Large,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28437,Salivary Gland Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
28438,Esophagus,Acute Undifferentiated Leukemia,0
28439,Condition,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28440,Extrinsic,Adenocarcinoma of duodenum,0
28441,Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28442,Cell (compartment),FIGO Stage IVA Ovarian Cancer,0
28443,Common (qualifier value),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28444,Cervical lymph node group,Spermatocytic seminoma,0
28445,Hour Times Percent,Malignant neoplasm of olfactory nerve,0
28446,3+ Score,Mucinous adenocarcinoma gastric,0
28447,Smoking,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28448,Semilunar fold of fauces,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
28449,Reduced,Hemangioma,0
28450,Malignant Neoplasms,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
28451,Lymphocyte component of blood,Stage 0 Penile Cancer AJCC v8,0
28452,Cartilage,Placental aromatase deficiency,0
28453,Approximate,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28454,appendage,Refractory Barrett Esophagus,0
28455,Cavern,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28456,SPINK5 gene,Hyperplasia of pituitary gland,0
28457,Neoplasms,Noninfiltrating Intraductal Carcinoma,0
28458,Cicatrix,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28459,Evaluation procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28460,Correlation,Bladder squamous cell carcinoma stage I,0
28461,Childhood,Adenocarcinoma,0
28462,Poor function,Stage III Cutaneous Melanoma AJCC v6,0
28463,Primary malignant neoplasm,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
28464,Concept History,Tonsillar Carcinoma,0
28465,Salivary Gland Neoplasms,Benign Anal Granular Cell Tumor,0
28466,Hematologic Tests,Stage II Carcinoma of Penis,0
28467,Free of (attribute),Digestive System Hodgkin Lymphoma,0
28468,Measures,Malignant neoplasm of choroid,0
28469,Platelets Product,Adult Alveolar Soft Part Sarcoma,0
28470,Related personal status,Giant cell angiofibroma,0
28471,status - In progress,Recurrent Testicular Lymphoma,0
28472,Fibrous connective tissue,Ovarian germ cell choriocarcinoma stage IV,0
28473,Common (qualifier value),Refractory Barrett Esophagus,0
28474,Risk,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28475,Body tissue,Benign neoplasm of eye,0
28476,General surgery specialty,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
28477,Manufactured form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28478,Manufactured form,Extra-Adrenal Paraganglioma,0
28479,Cancer/Testis Antigen,Stage IV Penile Cancer AJCC v7,0
28480,Abnormal Reference Range,Advanced Uterine Corpus Carcinosarcoma,0
28481,Form:Finding:Point in time:{Setting}:Document:{Role},Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28482,History,Familial Adenomatous Polyposis Associated Medulloblastoma,0
28483,flower allergenic extracts,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28484,Radiation,Tonsillar Carcinoma,0
28485,Sample Mean,BRCA2 Syndrome,0
28486,Acquired (qualifier value),Acute Undifferentiated Leukemia,0
28487,Term (temporal),Childhood Extragonadal Malignant Germ Cell Tumor,0
28488,Related personal status,Angiosarcoma of liver,0
28489,Bodily secretions,Thyroid Hurthle Cell Carcinoma,0
28490,Call (Instruction),Malignant Testicular Sertoli Cell Tumor,0
28491,Direct (qualifier),Hemangioma,0
28492,shared attribute,Intracortical osteosarcoma,0
28493,follow-up,Acute Undifferentiated Leukemia,0
28494,Example,Childhood Lymphoma,0
28495,3+ Score,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28496,Decision,Carcinoma of urinary bladder,0
28497,In Blood,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28498,Procedure (set of actions),Splenic Manifestation of Hairy Cell Leukemia,0
28499,Bayer Corneal Epitheliopathy Grade 3,Digestive System Hodgkin Lymphoma,0
28500,Mathematical Operator,sarcoma of spinal cord,0
28501,Characterization,Childhood Thyroid Gland Follicular Carcinoma,0
28502,Therapeutic radiology procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28503,Occurrence,Ovarian Carcinoid Tumor,0
28504,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
28505,Greater Than,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28506,Fresh Water,FIGO Stage II Ovarian Cancer,0
28507,lymph nodes,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28508,Ultrasonic Shockwave,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
28509,Table Cell Horizontal Align - left,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
28510,Colon Carcinoma,Benign Anal Granular Cell Tumor,0
28511,Genus Anemia,High Grade Glandular Intraepithelial Neoplasia,0
28512,Usually,Hemangioma,0
28513,Primary malignant neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28514,Referring,Cancer of Urinary Tract,0
28515,Microplate Well,Human Papillomavirus-Related Carcinoma,0
28516,To,Squamous cell carcinoma of lip,0
28517,Type - attribute,Malignant neoplasm of gallbladder,0
28518,Associated with,Locally Advanced Squamous Cell Carcinoma,0
28519,Elderly (population group),Mixed astrocytoma-ependymoma,0
28520,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
28521,Administration procedure,benign mature teratoma of pancreas,0
28522,Most,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28523,Usually Need Help from Another Person for Reach,Carcinoma of urinary bladder,0
28524,body system,Acute Undifferentiated Leukemia,0
28525,Fatigue,FIGO Stage II Ovarian Cancer,0
28526,Differentiation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28527,Aggressive course,Malignant melanoma of eyelid,0
28528,treatment - ActInformationManagementReason,Grade 3a Malignant Neoplasm,0
28529,Post,Anterior Urethral Malignant Neoplasm,0
28530,Symptoms aspect,Choroid Epithelioid Cell Melanoma,0
28531,Development,Acantholytic squamous cell carcinoma,0
28532,List,Benign squamous cell tumor,0
28533,Central African Republic,Mucinous adenocarcinoma gastric,0
28534,Providing (action),Small cell neuroendocrine carcinoma of bladder,0
28535,Low Grade,Malignant Testicular Sertoli Cell Tumor,0
28536,Appearance Distress Question,Giant cell angiofibroma,0
28537,per year,Kaposi's sarcoma of skin,0
28538,Triggered by,Precursor B-lymphoblastic lymphoma stage II,0
28539,Including (qualifier),Hemangioma,0
28540,brain cell,Splenic Manifestation of Hairy Cell Leukemia,0
28541,Metastatic malignant neoplasm to brain,Acantholytic squamous cell carcinoma,0
28542,Cultured Cell Line,Hodgkin Disease,0
28543,Uredinales,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28544,shared attribute,Mucinous cystadenofibroma,0
28545,melanoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
28546,System (unit of presentation),Engraftment syndrome,0
28547,Infrequent,Type II Endometrial Adenocarcinoma,0
28548,seen,Stage IB Pancreatic Cancer AJCC v8,0
28549,Renal pelvis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28550,Confirmation,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
28551,Persistent,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28552,Related personal status,Primary Cutaneous Plasmablastic Lymphoma,0
28553,Abdomen,Testicular cancer metastatic,0
28554,North America,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
28555,Cell (compartment),Unfavorable Non-Hodgkin Lymphoma,0
28556,Eye,Undifferentiated Endocervical Sarcoma,0
28557,insensitivity,Uterine Cancer,0
28558,Term (lexical),Acute lymphadenitis,0
28559,Treatment Epoch,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
28560,Oral contraception,Noninfiltrating Intraductal Carcinoma,0
28561,Set scale,Basal Cell Ameloblastoma,0
28562,Complete Pharyngeal Contraction,Uterine Cancer,0
28563,Abnormal,Mucinous adenocarcinoma,0
28564,To,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28565,Disease Screening,Spongiotic dermatitis,0
28566,Dependent for Toilet Use,Childhood Anaplastic Large Cell Lymphoma,0
28567,Living Alone,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28568,Secretory Vesicles,Localized Askin Tumor,0
28569,Part of,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28570,Negation,Thyroid Hurthle Cell Carcinoma,0
28571,PREVENT (product),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
28572,55,Bladder squamous cell carcinoma stage I,0
28573,Linear,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28574,Carcinoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
28575,Night time,embryonal rhabdomyosarcoma of prostate,0
28576,Bothered by Vomiting,Metastatic Lung Neuroendocrine Neoplasm,0
28577,Ectodermal,Vaginal Adenoid Cystic Carcinoma,0
28578,Occurrence,Bladder adenocarcinoma stage IV,0
28579,Blood,Maxillary Sinus Adenocarcinoma,0
28580,Basis - conceptual entity,Mixed astrocytoma-ependymoma,0
28581,Lung,Pancreatic carcinoma,0
28582,Classification,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28583,New,Recurrent Primary Lymphoma of Bone,0
28584,Adult Anaplastic Astrocytoma,Adenocarcinoma,0
28585,United States,Malignant neoplasm of olfactory nerve,0
28586,cancer location,Urethral Carcinoma,0
28587,3+ Score,Leiomyoma of Gallbladder,0
28588,Descending,Clonal Hematopoiesis of Indeterminate Potential,0
28589,Disease,Bladder adenocarcinoma stage IV,0
28590,intended - ParticipationSignature,Peripheral primitive neuroectodermal tumor of soft tissue,0
28591,per year,Bladder Neuroendocrine Neoplasm,0
28592,HEMOCHROMATOSIS,Kaposi's sarcoma of extrahepatic bile duct,0
28593,Known,Refractory Bladder Carcinoma,0
28594,Metastatic Neoplasm,Stage III Adult Immunoblastic Lymphoma,0
28595,prior radiation therapy,Nasal cavity carcinoma,0
28596,Affecting,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28597,Multiple Partners,Maxillary Sinus Adenoid Cystic Carcinoma,0
28598,Response process,adenoid cystic carcinoma of lung,0
28599,More,FIGO Stage II Ovarian Cancer,0
28600,Include (action),Malignant melanoma of eyelid,0
28601,Pharmacotherapy,Transitional cell carcinoma,0
28602,Optical filter,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28603,Local disease,FIGO Stage II Ovarian Cancer,0
28604,Lesion,Refractory Barrett Esophagus,0
28605,Choose (action),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28606,2+,Chondrosarcoma,0
28607,Skin,Blood Vessel Tumors,0
28608,Endocrine Cells,Childhood Central Nervous System Ganglioneuroblastoma,0
28609,Administration procedure,Chronic Myelomonocytic Leukemia-2,0
28610,Electromagnetic Radiation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28611,Liver,Localized Ewing Sarcoma,0
28612,Common (qualifier value),ROSE Cluster 3,0
28613,Preventive monitoring,Brain Tumor,0
28614,low exposure,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
28615,Pancreas,Xeroderma pigmentosum,0
28616,Persons,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
28617,Nursing interventions,embryonal rhabdomyosarcoma of prostate,0
28618,Account number:Identifier:Point in time:^Patient:Nominal,Diffuse malignant mesothelioma,0
28619,CD44 wt Allele,Engraftment syndrome,0
28620,shared attribute,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28621,Include (action),Recurrent Primary Lymphoma of Bone,0
28622,Decision,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28623,Synonym,Stage III Cutaneous Melanoma AJCC v6,0
28624,Removal of bladder,Breast Apocrine Adenoma,0
28625,Symptoms,Endometrial Small Cell Carcinoma,0
28626,Lymphatic vessel,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28627,radiotherapeutic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28628,FAT1 wt Allele,Maxillary Sinus Adenoid Cystic Carcinoma,0
28629,Pleomorphic carcinoma,Cerebral Primitive Neuroectodermal Tumor,0
28630,Adult Non-Hodgkin Lymphoma,Metaplastic carcinoma of breast,0
28631,therapeutic aspects,Congenital hamartoma,0
28632,Liquid substance,Stage III Cutaneous Melanoma AJCC v6,0
28633,1000000,clear cell adenocarcinoma of gallbladder,0
28634,Numerous,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28635,Myeloproliferation,Benign Anal Granular Cell Tumor,0
28636,Pruritus,Blepharal carcinoma,0
28637,AS virus,High Grade Glandular Intraepithelial Neoplasia,0
28638,Dietary Lead,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
28639,Present,Extra-Adrenal Paraganglioma,0
28640,History of present illness,Childhood Fibrillary Astrocytoma,0
28641,Diagnosis Study,Anaplastic large cell lymphoma,0
28642,Hormone Therapy,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
28643,Therapeutic procedure,Engraftment syndrome,0
28644,Adult,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28645,Endometrial Carcinoma,Recurrent Rhabdomyosarcoma,0
28646,X-Ray Computed Tomography,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
28647,Contact Dermatitis,Acantholytic squamous cell carcinoma,0
28648,white blood cell type,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28649,Changed status,Malignant Neoplasm with Regional Lymph Node Involvement,0
28650,70%,Deep Leiomyoma,0
28651,Thick,Carcinoma of urinary bladder,0
28652,Sometimes,Cerebral Primitive Neuroectodermal Tumor,0
28653,Occur (action),Parathyroid Gland Adenocarcinoma,0
28654,Fever,Thymic Clear Cell Carcinoma,0
28655,Night time,Lung squamous cell carcinoma stage I,0
28656,Spinal Cord,Engraftment syndrome,0
28657,European race,Cerebral Primitive Neuroectodermal Tumor,0
28658,Prevalence aspects,Liver Lymphangioma,0
28659,metastatic qualifier,Bladder adenocarcinoma stage IV,0
28660,Formation,Recurrent Rhabdomyosarcoma,0
28661,Lower (action),Blepharal carcinoma,0
28662,Malignant Neoplasms,Intestinal Neuroendocrine Carcinoma,0
28663,Open,Endometrial Small Cell Carcinoma,0
28664,Increased,Localized Malignant Neoplasm,0
28665,Classification of information,Recurrent Testicular Lymphoma,0
28666,Medical service,Intraepithelial Melanocytic Hyperplasia,0
28667,Old,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28668,Membrane Device,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28669,Basis - conceptual entity,Uterine Cancer,0
28670,Diameter (qualifier value),mucinous adenocarcinoma of gallbladder,0
28671,Communicable Diseases,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28672,20%,Locally Advanced Soft Tissue Sarcoma,0
28673,Physician:Identifier:Point in time:^Patient:Nominal,Neoplasms,0
28674,Reduction (chemical),Unfavorable Non-Hodgkin Lymphoma,0
28675,Coding,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
28676,Childhood Diffuse Large B-Cell Lymphoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28677,Antibiotics,Vaginal Adenoid Cystic Carcinoma,0
28678,associated disease,Benign squamous cell tumor,0
28679,Abdomen distended,Malignant neoplasm of subglottis,0
28680,Estimated,Congenital hamartoma,0
28681,Include (action),Stage III Cutaneous Melanoma AJCC v6,0
28682,fludarabine,Kaposi's sarcoma of skin,0
28683,Glioblastoma Multiforme Pathway,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
28684,Pediatric Neoplasm,Acantholytic squamous cell carcinoma,0
28685,Pharmacotherapy,Undifferentiated Endocervical Sarcoma,0
28686,Special,Stage I Adult Non-Hodgkin Lymphoma,0
28687,MOSTLY,Prostate Lymphoma,0
28688,Part,Carcinoma ex pleomorphic adenoma of parotid gland,0
28689,Feelings,Localized Ewing Sarcoma,0
28690,high - ActExposureLevelCode,Platinum-Resistant Lung Small Cell Carcinoma,0
28691,Development,Malignant Neoplasm of Lung - Multiple Primary Sites,0
28692,Mammary Gland Parenchyma,Metastatic Malignant Neoplasm in the Sellar Region,0
28693,include - SetOperator,Xeroderma pigmentosum,0
28694,Part of,Stage IV Childhood Non-Hodgkin Lymphoma,0
28695,Status post,Tubal Hyperplasia,0
28696,Identified,Metastatic Malignant Neoplasm in the Sellar Region,0
28697,How Often Weight Loss,Malignant melanoma of eyelid,0
28698,Operative Surgical Procedures,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28699,CD69 wt Allele,Transitional cell carcinoma,0
28700,Known,Diffuse malignant mesothelioma,0
28701,Enlarged,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28702,Treatment Effectiveness,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28703,70%,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
28704,Specimen Source Codes - tumor,Medulloblastoma,0
28705,Fasting Status Indicator,Localized Askin Tumor,0
28706,Analysis of substances,benign mature teratoma of pancreas,0
28707,Qualitative form,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
28708,Second Suffix,Stage 0 Lip Carcinoma,0
28709,various other nasal preparations in ATC,Hodgkin Disease,0
28710,Data call receiving device,Noninfiltrating Intraductal Carcinoma,0
28711,Hemopoietic tissue,Localized Askin Tumor,0
28712,IPSS Risk Category High,Diffuse malignant mesothelioma,0
28713,Pleura,Tonsillar Carcinoma,0
28714,Neoplasms,Mucinous adenocarcinoma gastric,0
28715,described,Benign Anal Granular Cell Tumor,0
28716,Clinical Study Follow-up,Cartilaginous exostosis,0
28717,European race,Non-Metastatic Gestational Trophoblastic Tumor,0
28718,Count of entities,Liver Lymphangioma,0
28719,Squamous cell carcinoma - category,non-Hodgkin's lymphoma of spleen,0
28720,Main,Acantholytic squamous cell carcinoma,0
28721,eTMF Content Model Code,Benign Carotid Body Paraganglioma,0
28722,Infrequent,Tubal Hyperplasia,0
28723,Others - Allergy,Uterine Cancer,0
28724,National origin,Childhood Central Nervous System Immature Teratoma,0
28725,Result,Mixed astrocytoma-ependymoma,0
28726,Multiplication,Refractory Ependymoma,0
28727,Necrosis,Periosteal Osteosarcoma,0
28728,Measures,Malignant Testicular Sertoli Cell Tumor,0
28729,Genetic Heterogeneity,Intestinal Metaplasia of Bladder Urothelium,0
28730,include - SetOperator,Papillary squamous cell carcinoma,0
28731,RMS,Heavy Chain Deposition Disease,0
28732,Neoplasms,Stage II Carcinoma of Penis,0
28733,Science of Etiology,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28734,Basal Cell Cancer,Tonsillar Carcinoma,0
28735,Continuance of life,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
28736,Biologist (general),Metaplastic carcinoma of breast,0
28737,Manufactured form,Benign Anal Granular Cell Tumor,0
28738,Type - attribute,Benign Anal Granular Cell Tumor,0
28739,Biopsy,Chest Wall Fibromatosis,0
28740,Pediculus humanus capitis (eukaryote),Intestinal Neuroendocrine Carcinoma,0
28741,Tissue Specimen Code,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28742,Serving,Breast Ductal Adenoma,0
28743,metaplastic cell transformation,Liver Lymphangioma,0
28744,include - SetOperator,Benign neoplasm of thorax,0
28745,Usually,Precursor B-lymphoblastic lymphoma stage II,0
28746,Affecting,Basal Cell Ameloblastoma,0
28747,Neoplasm Metastasis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28748,Molecular Mass,Localized Malignant Neoplasm,0
28749,Cough,Breast Apocrine Adenoma,0
28750,Immunotherapy,Tongue Alveolar Soft Part Sarcoma,0
28751,Characteristics,Endometrial Small Cell Carcinoma,0
28752,Benign condition,Intraepithelial Melanocytic Hyperplasia,0
28753,Tissue Specimen Code,Advanced Lung Carcinoma,0
28754,Metastatic Neoplasm,Low Grade Squamous Intraepithelial Neoplasia,0
28755,Screening Study,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28756,History of previous events,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28757,Status post,Adenocarcinoma of the prostate metastatic,0
28758,Out (direction),Medulloblastoma,0
28759,Severe (severity modifier),Thymic Atypical Carcinoid Tumor,0
28760,Liver Cirrhosis,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28761,Chemotherapy Regimen,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
28762,Tumor cells,Mucinous neoplasm,0
28763,Device system,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28764,International Classification of Diseases,Heavy Chain Deposition Disease,0
28765,Meaning,Bladder squamous cell carcinoma stage I,0
28766,Nerve injury,Childhood Central Nervous System Ganglioneuroblastoma,0
28767,Medical service,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28768,Physiology,Xeroderma pigmentosum,0
28769,10%,Xeroderma pigmentosum,0
28770,Term (temporal),Ichthyoses,0
28771,Bone structure of cranium,Small cell neuroendocrine carcinoma of bladder,0
28772,Blood group A (finding),Parathyroid Gland Adenocarcinoma,0
28773,Completely Able,Mucinous adenocarcinoma gastric,0
28774,Neuroendocrine Tumors,Locally Advanced Epithelioid Hemangioendothelioma,0
28775,shared attribute,Breast Ductal Adenoma,0
28776,Intervention regimes,Werner Syndrome,0
28777,Antibodies,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
28778,Unknown,Clonal Hematopoiesis of Indeterminate Potential,0
28779,Lung,Pancreatic carcinoma,0
28780,Exception - Property or Attribute,clear cell adenocarcinoma of gallbladder,0
28781,Testis,Vaginal Adenoma,0
28782,Science of Etiology,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
28783,Pediculus humanus capitis (eukaryote),Cancer of Urinary Tract,0
28784,Neoplasms,FIGO Stage II Ovarian Cancer,0
28785,Heart,Adenocarcinoma,0
28786,commercial,Low Grade Squamous Intraepithelial Neoplasia,0
28787,Malignant Cell Count,Adult Acute Eosinophilic Leukemia,0
28788,Experimental Result,Acantholytic squamous cell carcinoma,0
28789,biopsy characteristics,mucinous adenocarcinoma of gallbladder,0
28790,Disease,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
28791,Human Cells,Carcinoma,0
28792,Including (qualifier),Chest Wall Fibromatosis,0
28793,Skin,Stage I Adult Non-Hodgkin Lymphoma,0
28794,Contribution,Refractory WHO Grade III Glioma,0
28795,Pain NOS,Engraftment syndrome,0
28796,Containing (qualifier),benign mature teratoma of pancreas,0
28797,Manufactured form,Diffuse malignant mesothelioma,0
28798,Group Object,Secondary malignant neoplasm of lymph node,0
28799,Pure Spanish horse breed (organism),Recurrent Testicular Lymphoma,0
28800,Object Class,Human Papillomavirus-Related Carcinoma,0
28801,Present,Childhood Central Nervous System Ganglioneuroblastoma,0
28802,Reflecting,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
28803,0%,Type II Endometrial Adenocarcinoma,0
28804,Qualitative form,Bladder adenocarcinoma stage IV,0
28805,Show,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28806,Females,Benign neoplasm of thorax,0
28807,Grade IV Childhood Astrocytic Neoplasm,Diffuse malignant mesothelioma,0
28808,Sublingual Gland,Kaposi's sarcoma of skin,0
28809,Primary malignant neoplasm,Carcinomatosis of peritoneal cavity,0
28810,Malignant neoplasm of ovary,Cervical Squamous Intraepithelial Neoplasia,0
28811,Due to,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
28812,Decision,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28813,Diagnosis Study,Benign neoplasm of thorax,0
28814,Precision - characteristic,Grade 3a Malignant Neoplasm,0
28815,mucosa-associated lymphoid tissue,Extra-Adrenal Paraganglioma,0
28816,Parotid inflammation,BRCA2 Syndrome,0
28817,Sometimes,Endometrial Small Cell Carcinoma,0
28818,Social group,Grade 3a Malignant Neoplasm,0
28819,Abnormal,Cherubism,0
28820,Epithelial Cells,Acute Undifferentiated Leukemia,0
28821,Entity Determiner - specific,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
28822,Endocrine,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
28823,Due to,Localized Ewing Sarcoma,0
28824,Case (situation),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
28825,Fused structure,Familial Hemophagocytic Lymphocytosis,0
28826,Fibrous papule of nose,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28827,Abnormal,Splenic Manifestation of Hairy Cell Leukemia,0
28828,Neoplasms,FIGO Stage IVA Ovarian Cancer,0
28829,Experimental Result,Benign Apocrine Neoplasm,0
28830,eTMF Content Model Code,Adenocarcinoma of the prostate metastatic,0
28831,Immunotherapy,Maxillary Sinus Adenoid Cystic Carcinoma,0
28832,Slow,Recurrent Testicular Lymphoma,0
28833,Records,Malignant neoplasm of gallbladder,0
28834,Choriocarcinoma,Hereditary Diffuse Gastric Adenocarcinoma,0
28835,Metastasis,Trabecular adenocarcinoma,0
28836,Universal,Tonsillar Carcinoma,0
28837,Human Cells,Mucosal Melanoma,0
28838,Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28839,Specimen Source Codes - tumor,High Grade Glandular Intraepithelial Neoplasia,0
28840,History,Thymic Atypical Carcinoid Tumor,0
28841,Usual,Trabecular adenocarcinoma,0
28842,Usual Severity Pain,Trabecular adenocarcinoma,0
28843,Worsening pattern,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28844,Two,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28845,Embryonic tissue,Papillary cystic tumor,0
28846,pharmacotherapeutic,Mucinous adenocarcinoma,0
28847,Physical Examination,Malignant neoplasm of subglottis,0
28848,A Codes,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
28849,Operative Surgical Procedures,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28850,Dominant,Stage II Hepatocellular Carcinoma AJCC v8,0
28851,Vaginal Hemorrhage,Undifferentiated Endocervical Sarcoma,0
28852,Subtype (attribute),Refractory Barrett Esophagus,0
28853,Type - attribute,FIGO Stage IVA Ovarian Cancer,0
28854,Involvement with,GIANT PIGMENTED HAIRY NEVUS,0
28855,Benign melanocytic nevus,Mucinous adenocarcinoma gastric,0
28856,Plant nodule,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
28857,Stage Grouping,Recurrent Testicular Lymphoma,0
28858,Class,Leptomeningeal sarcoma,0
28859,biomedical tube device,Small cell neuroendocrine carcinoma of bladder,0
28860,Science of Anatomy,Congenital hamartoma,0
28861,Effectiveness,squamous cell carcinoma of the thyroid gland,0
28862,chance,Thymic Atypical Carcinoid Tumor,0
28863,New,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28864,Orbital region,Malignant neoplasm of olfactory nerve,0
28865,Approximate,Recurrent Uveal Melanoma,0
28866,Aggressive course,Hemangioma,0
28867,unknown vaccine or immune globulin,Airway Hemangioma,0
28868,Shortness of breath:-:Point in time:^Patient:-,Squamous cell carcinoma of lip,0
28869,English Language,Malignant neoplasm of subglottis,0
28870,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28871,Disease,Colorectal High Grade B-Cell Lymphoma,0
28872,IGHV@ gene cluster,Thymic Clear Cell Carcinoma,0
28873,Concern,Papillary squamous cell carcinoma,0
28874,Bone Marrow,clear cell adenocarcinoma of gallbladder,0
28875,Oral mucous membrane structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28876,Beginning,Stage IB Pancreatic Cancer AJCC v8,0
28877,ICD-9,Mucinous neoplasm,0
28878,Rumex,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
28879,Volume Measurement,Atypical Mesothelial Hyperplasia,0
28880,Precision - second,Malignant melanoma of eyelid,0
28881,Skin Specimen,Epithelioid Sarcoma NCI Grade 3,0
28882,Including (qualifier),Cervical Adenomyoma,0
28883,Together,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28884,Logical Condition,gliosarcoma,0
28885,Hormones,Rhabdomyosarcoma with ganglionic differentiation,0
28886,General surgery specialty,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28887,Occurrence Indicator,Squamous cell carcinoma of lip,0
28888,Have Weight Loss,Nasal cavity carcinoma,0
28889,Rubella,Stage IB Pancreatic Cancer AJCC v8,0
28890,Retained,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28891,Approximate,Familial Adenomatous Polyposis Associated Medulloblastoma,0
28892,GUCY2C protein,Human Papillomavirus-Related Carcinoma,0
28893,Methods,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28894,Age at menopause:Time:Point in time:^Patient:Quantitative,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28895,Paracel Islands,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
28896,Delta (difference),Metastatic Lung Neuroendocrine Neoplasm,0
28897,Science of Etiology,Malignant Testicular Sertoli Cell Tumor,0
28898,Then,Stage III Cutaneous Melanoma AJCC v6,0
28899,Screening,FIGO Stage II Ovarian Cancer,0
28900,Usually,Malignant Neoplasm of Lung - Multiple Primary Sites,0
28901,Further,Childhood Central Nervous System Ganglioneuroblastoma,0
28902,Activity (animal life circumstance),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
28903,Beginning,Type II Endometrial Adenocarcinoma,0
28904,Numbers,Vaginal Adenoma,0
28905,Run action,Sarcomatoid Renal Cell Carcinoma,0
28906,Eighth,Mucinous adenocarcinoma gastric,0
28907,High Grade Lymphoma (neoplasm),Acute lymphadenitis,0
28908,Personal appearance,Carcinoma ex pleomorphic adenoma of parotid gland,0
28909,Ability,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
28910,Mast/Stem Cell Growth Factor Receptor Kit,Malignant melanoma of eyelid,0
28911,High,Benign Anal Granular Cell Tumor,0
28912,Skeletal system,Atypical Lobular Breast Hyperplasia,0
28913,Magnetic Resonance Imaging Study File,Recurrent Uveal Melanoma,0
28914,Penis carcinoma,clear cell adenocarcinoma of gallbladder,0
28915,Show,Childhood Extragonadal Malignant Germ Cell Tumor,0
28916,Abnormal cellular component of blood,Bladder squamous cell carcinoma stage I,0
28917,Derived value,Mucinous adenocarcinoma gastric,0
28918,Two,Childhood Central Nervous System Ganglioneuroblastoma,0
28919,Adult Lymphoma,Vaginal Adenoma,0
28920,error,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28921,Involvement with,Digestive System Hodgkin Lymphoma,0
28922,Age-Years,Human Papillomavirus-Related Carcinoma,0
28923,Body part,Benign Anal Granular Cell Tumor,0
28924,Contain (action),Localized Malignant Neoplasm,0
28925,United States,Breast Ductal Adenoma,0
28926,Magnetic Resonance Imaging Study File,Leiomyoma of Gallbladder,0
28927,3+ Score,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
28928,0%,Carcinoma of submandibular gland,0
28929,Age,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28930,In Blood,clear cell adenocarcinoma of gallbladder,0
28931,Cause of death:Find:Pt:^Patient:Nom,Recurrent Primary Lymphoma of Bone,0
28932,Symptoms,Vaginal Adenoma,0
28933,Angiosarcoma of liver,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28934,Ovarian Carcinoma,Anterior Urethral Malignant Neoplasm,0
28935,Neoplasm Metastasis,Tonsillar Carcinoma,0
28936,seen,Keratoderma,0
28937,More Often than Once a Day,Acute lymphadenitis,0
28938,Palatine Tonsil,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
28939,Fever symptoms (finding),Ectomesenchymal Chondromyxoid Tumor,0
28940,Therapeutic procedure,Recurrent Uveal Melanoma,0
28941,Treatment Epoch,Clonal Hematopoiesis of Indeterminate Potential,0
28942,Publications,Unicystic ameloblastoma,0
28943,Glandular stomach,Neoplasms,0
28944,include - SetOperator,Mucinous adenocarcinoma gastric,0
28945,Accounting (activity),Chest Wall Fibromatosis,0
28946,Disease,Localized Malignant Neoplasm,0
28947,Fever,FIGO Stage IVA Ovarian Cancer,0
28948,Case unit dose,Stage 0 Lip Carcinoma,0
28949,Genetic Heterogeneity,Undifferentiated Endocervical Sarcoma,0
28950,To,adenoid cystic carcinoma of lung,0
28951,Benign Neoplasm,Mucinous adenocarcinoma gastric,0
28952,Adoptive Immunotherapy,Localized Ewing Sarcoma,0
28953,Cluster,Spermatocytic seminoma,0
28954,Left sided,Granular Cell Leiomyosarcoma,0
28955,External lower lip,Mixed parotid tumor,0
28956,Cell Device,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
28957,Exposure to,Mastocytosis,0
28958,Proportion,Engraftment syndrome,0
28959,Call (Instruction),Malignant Neoplasm of Lung - Multiple Primary Sites,0
28960,survival aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
28961,Homo sapiens,Low Grade Squamous Intraepithelial Neoplasia,0
28962,New,Atypical Lobular Breast Hyperplasia,0
28963,The Sun,Acantholytic squamous cell carcinoma,0
28964,Numbers,FIGO Stage II Ovarian Cancer,0
28965,diagnostic image,Recurrent Diffuse Intrinsic Pontine Glioma,0
28966,Entity Determiner - specific,Plexosarcoma,0
28967,P-Glycoprotein,embryonal rhabdomyosarcoma of prostate,0
28968,Fever symptoms (finding),Recurrent Testicular Lymphoma,0
28969,Germ cell tumor,Squamous cell carcinoma of lip,0
28970,Classification of information,Hereditary Diffuse Gastric Adenocarcinoma,0
28971,Known,FIGO Stage IVA Ovarian Cancer,0
28972,include - SetOperator,Metaplastic carcinoma of breast,0
28973,Vaginal (intended site),adenosquamous carcinoma of breast,0
28974,Present,clear cell adenocarcinoma of gallbladder,0
28975,Research Activities,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28976,Papanicolaou Test,Malignant melanoma of eyelid,0
28977,Abdomen+,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28978,Diagnosis Study,Malignant neoplasm of choroid,0
28979,90%,Benign squamous cell tumor,0
28980,Topical Cream,Tonsillar Carcinoma,0
28981,Usual Severity Cough,Childhood Anaplastic Large Cell Lymphoma,0
28982,Pain Distress Question,Childhood Anaplastic Large Cell Lymphoma,0
28983,section sample,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28984,Subject Risk,Digestive System Hodgkin Lymphoma,0
28985,Neurofibromatosis 2,BRCA2 Syndrome,0
28986,low confidentiality,Choroid Necrotic Melanoma,0
28987,Qualitative form,Childhood Anaplastic Large Cell Lymphoma,0
28988,Primary malignant neoplasm,Type II Endometrial Adenocarcinoma,0
28989,Injection Route of Drug Administration,Bladder Neuroendocrine Neoplasm,0
28990,Spreading (qualifier value),Malignant neoplasm of thalamus,0
28991,High risk,Mucinous adenocarcinoma gastric,0
28992,Blood Vessel,Metastatic Ductal Breast Carcinoma,0
28993,Most,Malignant neoplasm of choroid,0
28994,Lymphoid leukemia,Tonsillar Carcinoma,0
28995,Malignant Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
28996,Chemotherapy Regimen,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28997,Follow-up status,benign mature teratoma of pancreas,0
28998,Biopsy,Engraftment syndrome,0
28999,Person Name,Ovarian Dermoid Cyst with Secondary Carcinoma,0
29000,Location of Pharyngeal Residue Following Swallowing,Mucinous adenocarcinoma gastric,0
29001,Spread by direct extension,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29002,Togo,Intraepithelial Melanocytic Hyperplasia,0
29003,Ten,Squamous cell carcinoma of lip,0
29004,Hyperestrogenism,Testicular cancer metastatic,0
29005,Tryptophanase,Ichthyoses,0
29006,Characterization,Mucinous cystadenofibroma,0
29007,65,Anterior Urethral Malignant Neoplasm,0
29008,inflammatory,Epithelioid Sarcoma NCI Grade 3,0
29009,Occurrence Indicator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
29010,Survival Rate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29011,COL18A1 wt Allele,Extra-Adrenal Paraganglioma,0
29012,Neck,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
29013,Smear - instruction imperative,FIGO Stage IVA Ovarian Cancer,0
29014,Genital system,Pancreatic carcinoma,0
29015,Syndrome,Fibroadenoma of breast,0
29016,Reported Term,Refractory Barrett Esophagus,0
29017,Base of the Brain,Stage I Colon Neuroendocrine Tumor AJCC v8,0
29018,+5,Bladder adenocarcinoma stage IV,0
29019,Lymphocyte component of blood,Hodgkin lymphoma,0
29020,shared attribute,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
29021,English Language,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
29022,low exposure,Atypical Lobular Breast Hyperplasia,0
29023,Characterization,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
29024,Atypical Ductal Breast Hyperplasia,Blepharal carcinoma,0
29025,color additive,Multiple Endocrine Neoplasia,0
29026,Squamous cell carcinoma of skin,Recurrent Testicular Lymphoma,0
29027,Numerous,Mastocytosis,0
29028,Screening Study,Neoplasms,0
29029,Low Level,Kaposi's sarcoma of skin,0
29030,T-Cell Marker,Childhood Fibrillary Astrocytoma,0
29031,Hollow shape,Gallbladder Adenocarcinoma,0
29032,Increase in size since previous mammogram,Collecting Duct Carcinoma of the Kidney,0
29033,Forecast of outcome,Benign Carotid Body Paraganglioma,0
29034,Lymphocyte,Carcinoma of urinary bladder,0
29035,Result,Benign Anal Granular Cell Tumor,0
29036,Including (qualifier),Atypical Mesothelial Hyperplasia,0
29037,Elderly (population group),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29038,error,Undifferentiated Endocervical Sarcoma,0
29039,risk factors - observation list,Intestinal Metaplasia of Bladder Urothelium,0
29040,Disease Screening,Chest Wall Fibromatosis,0
29041,90%,Familial Adenomatous Polyposis Associated Medulloblastoma,0
29042,Central,Benign squamous cell tumor,0
29043,Sweat,Recurrent Primary Lymphoma of Bone,0
29044,Collections (publication),Kaposi's sarcoma of extrahepatic bile duct,0
29045,Most,Adult Acute Eosinophilic Leukemia,0
29046,Drain number:ID:Pt:^Patient:Nom,Acute Undifferentiated Leukemia,0
29047,10%,Metastatic Carcinoma in the Lung,0
29048,Possible diagnosis,Stage IB Lung Cancer AJCC v7,0
29049,Microplate Well,Peripheral primitive neuroectodermal tumor of soft tissue,0
29050,Gene Mutation,Airway Hemangioma,0
29051,protein expression,Nasal cavity carcinoma,0
29052,Common Specifications in HL7 V3 Publishing,Unresectable Rhabdomyosarcoma,0
29053,Primary malignant neoplasm,Mucinous adenocarcinoma gastric,0
29054,<90,Acantholytic squamous cell carcinoma,0
29055,Occurrence Indicator,Pancreatic Endocrine Carcinoma,0
29056,Involvement with,Recurrent Primary Lymphoma of Bone,0
29057,True primary (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
29058,pharmacotherapeutic,Undifferentiated Endocervical Sarcoma,0
29059,Breaking down,Keratoderma,0
29060,All,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
29061,Primary malignant neoplasm,Gallbladder Adenocarcinoma,0
29062,Colorectal Cancer Pathway,Benign tumor of eyelid,0
29063,Smear - instruction imperative,Carcinoma,0
29064,Return to (contextual qualifier) (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
29065,Body tissue,Childhood Lymphoma,0
29066,Coloring Excipient,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29067,Device system,Thymic Clear Cell Carcinoma,0
29068,low exposure,malignant lymphoma of pancreatic lymph nodes,0
29069,Decision,Intestinal Metaplasia of Bladder Urothelium,0
29070,Drug Kit,Cartilaginous exostosis,0
29071,Providing presence (regime/therapy),Metastatic Lung Neuroendocrine Neoplasm,0
29072,Universities,Placental aromatase deficiency,0
29073,Smear - instruction imperative,Cervical Fibroepithelial Polyp,0
29074,Equidae,Pancreatic Intraepithelial Neoplasia-3,0
29075,Publishing,Precursor B-lymphoblastic lymphoma stage II,0
29076,Special,Human Papillomavirus-Related Carcinoma,0
29077,Hematology (discipline),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29078,Benign Smooth Muscle Neoplasm,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
29079,Reduced,Colorectal High Grade B-Cell Lymphoma,0
29080,Unique,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
29081,Filter - medical device,Splenic Manifestation of Hairy Cell Leukemia,0
29082,Divide,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
29083,Application Context,adenoid cystic carcinoma of lung,0
29084,Therapeutic procedure,Acute Undifferentiated Leukemia,0
29085,Caucasoid Race,Refractory Ependymoma,0
29086,Disease,Adult Anaplastic Oligodendroglioma,0
29087,Group A (blood group),Cartilaginous exostosis,0
29088,Name (property) (qualifier value),adenoid cystic carcinoma of lung,0
29089,Logical Condition,Metastatic Lung Neuroendocrine Neoplasm,0
29090,Different,Recurrent Uveal Melanoma,0
29091,Include (action),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
29092,Sore Throat,Stage III Adult Immunoblastic Lymphoma,0
29093,epithelial,Bladder adenocarcinoma stage IV,0
29094,active (HL7 RoleLink),Squamous cell carcinoma of lip,0
29095,Ulcer,Unicystic ameloblastoma,0
29096,Initial (abbreviation),FIGO Stage II Ovarian Cancer,0
29097,Surrounding (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
29098,Lymphocyte component of blood,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29099,Aspects of disease screening,Cerebral Primitive Neuroectodermal Tumor,0
29100,Include (action),Blood Vessel Tumors,0
29101,cell type,mucinous adenocarcinoma of gallbladder,0
29102,Common Specifications in HL7 V3 Publishing,Undifferentiated Neuroblastoma,0
29103,Leading,Mixed parotid tumor,0
29104,Adult Anaplastic Astrocytoma,Fourth Ventricle and Brain Stem Ependymal Tumor,0
29105,Symptoms,FIGO Stage II Ovarian Cancer,0
29106,Abnormal Cell Count,Pancreatic Intraepithelial Neoplasia-3,0
29107,Numerous,Non-Metastatic Gestational Trophoblastic Tumor,0
29108,BEP regimen,Locally Advanced Epithelioid Hemangioendothelioma,0
29109,Sexual function,gliosarcoma,0
29110,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
29111,Only - dosing instruction fragment,Malignant Testicular Sertoli Cell Tumor,0
29112,Cessation of life,Recurrent Testicular Lymphoma,0
29113,Metastatic Neoplasm,BRCA2 Syndrome,0
29114,Primary malignant neoplasm,Airway Hemangioma,0
29115,Gut,Pilocytic astrocytoma of cerebellum,0
29116,epidemiologic,Pleomorphic adenoma of parotid gland,0
29117,Representation (action),Localized Askin Tumor,0
29118,Pallor,Malignant melanoma of eyelid,0
29119,Specimen Source Codes - tumor,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
29120,Nucleotide Excision Repair Pathway,Cerebral Primitive Neuroectodermal Tumor,0
29121,combination - answer to question,Refractory Ependymoma,0
29122,Glioblastoma,clear cell adenocarcinoma of gallbladder,0
29123,2+ Score,Benign Anal Granular Cell Tumor,0
29124,Most,Mixed astrocytoma-ependymoma,0
29125,Contain (action),Kaposi's sarcoma of skin,0
29126,Tobacco smoking behavior,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
29127,Neoplasms,Clinical Stage I Cutaneous Melanoma AJCC v8,0
29128,Pain of lymph node,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
29129,Class (taxonomic),Tonsillar Carcinoma,0
29130,Tryptophanase,Airway Hemangioma,0
29131,United States Military Commissioned Officer O4,Recurrent Uveal Melanoma,0
29132,Treatment intent,Benign Apocrine Neoplasm,0
29133,various antiinfectives and antiseptics for local oral treatment,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
29134,Myeloid Progenitor Cells,Refractory Barrett Esophagus,0
29135,Factor,Heavy Chain Deposition Disease,0
29136,Tissue specific,Human Papillomavirus-Related Carcinoma,0
29137,Tryptophanase,Liver Cavernous Hemangioma,0
29138,High Level,Malignant melanoma of eyelid,0
29139,Symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29140,Hematologic Tests,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
29141,Type - attribute,Kaposi's sarcoma of extrahepatic bile duct,0
29142,Targeted Therapy,Pancreatic Endocrine Carcinoma,0
29143,Papule,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
29144,Manufactured form,Stage III Cutaneous Melanoma AJCC v6,0
29145,List,Cerebral Primitive Neuroectodermal Tumor,0
29146,Twice - dosing instruction fragment,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
29147,per year,Female Breast Carcinoma,0
29148,Historical aspects qualifier,Thymic Atypical Carcinoid Tumor,0
29149,Rhabdomyosarcoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29150,radiotherapeutic,Recurrent Uveal Melanoma,0
29151,chronic,Human Papillomavirus-Related Carcinoma,0
29152,Food,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
29153,Occur (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
29154,>90,Stage IV Childhood Non-Hodgkin Lymphoma,0
29155,Primary malignant neoplasm,Xeroderma pigmentosum,0
29156,Contain (action),Stage II Carcinoma of Penis,0
29157,respiratory,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29158,Cover (physical object),Congenital hamartoma,0
29159,Cyclophosphamide,adenosquamous carcinoma of breast,0
29160,Small cell carcinoma of lung,Childhood Choriocarcinoma,0
29161,Infertility,Pancreatic Endocrine Carcinoma,0
29162,Family history,Chest Wall Fibromatosis,0
29163,Sore Throat,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
29164,error,Multiple Endocrine Neoplasia,0
29165,Specimen Source Codes - Respiratory,Undifferentiated Endocervical Sarcoma,0
29166,Transurethral Resection,Mucinous adenocarcinoma gastric,0
29167,Squamous cell carcinoma,Unicystic ameloblastoma,0
29168,Occurrence Indicator,Kaposi's sarcoma of skin,0
29169,Feelings,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
29170,Tumor type,Atypical Lobular Breast Hyperplasia,0
29171,Tonsil,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29172,List,ROSE Cluster 3,0
29173,Treating,Choroid Epithelioid Cell Melanoma,0
29174,1+ Score,Melanomatosis,0
29175,Pacemakers,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
29176,Thymoma,Astrocytoma of brain,0
29177,Requirement,Thymic Atypical Carcinoid Tumor,0
29178,Major <insect>,Adenocarcinoma of the prostate metastatic,0
29179,Secondary Neoplasm,Xeroderma pigmentosum,0
29180,Nevus,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
29181,Class (taxonomic),Carcinoma of urinary bladder,0
29182,Diagnosis Study,ROSE Cluster 3,0
29183,Locally,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
29184,Combined Modality Therapy,Benign squamous cell tumor,0
29185,High Mitosis-Karyorrhexis Index,Plexosarcoma,0
29186,Cell Differentiation process,Benign Anal Granular Cell Tumor,0
29187,Including (qualifier),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29188,Cessation of life,Basal Cell Ameloblastoma,0
29189,Empty (qualifier),Hodgkin lymphoma,0
29190,Specific qualifier value,Squamous cell carcinoma of lip,0
29191,Confirmed by,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29192,Desmoplastic fibroma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
29193,Europe,papillary carcinoma of penis,0
29194,Offspring,Malignant Testicular Sertoli Cell Tumor,0
29195,Call (Instruction),Childhood Central Nervous System Ganglioneuroblastoma,0
29196,Hematopoietic Neoplasms,Squamous cell carcinoma of lip,0
29197,body system,Adenocarcinoma,0
29198,100%,embryonal rhabdomyosarcoma of prostate,0
29199,Primary,Stage IB Lung Cancer AJCC v7,0
29200,Brain Neoplasms,Recurrent Uveal Melanoma,0
29201,Neck,Recurrent Primary Lymphoma of Bone,0
29202,Lymphocyte component of blood,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
29203,Biological Response Modifiers,Refractory Bladder Carcinoma,0
29204,Medical pathologist,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
29205,Assisted (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29206,Nephrons,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
29207,Image Feature,Endometrial Small Cell Carcinoma,0
29208,Aspects of signs,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
29209,Benign tumor of salivary gland,Localized Malignant Neoplasm,0
29210,Milliampere second,Benign Apocrine Neoplasm,0
29211,Aflatoxins,Angiosarcoma of liver,0
29212,shared attribute,Clinical Stage I Cutaneous Melanoma AJCC v8,0
29213,Gypsum,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29214,Shortened,Breast Apocrine Adenoma,0
29215,Normal hemostatic function,Squamous cell carcinoma of lip,0
29216,Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
29217,Unintentional,Digestive System Hodgkin Lymphoma,0
29218,Back structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29219,include - SetOperator,Stage IV Penile Cancer AJCC v7,0
29220,Multiply - dosing instruction fragment,Recurrent Testicular Lymphoma,0
29221,Derivative,Astrocytoma of brain,0
29222,Gait normal,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
29223,Most,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29224,Pharmacotherapy,Gallbladder Adenocarcinoma,0
29225,Reduction procedure,Small intestine carcinoma,0
29226,Unusual,Mastocytosis,0
29227,60%,Vaginal Adenoma,0
29228,Common bile duct structure,Digestive System Hodgkin Lymphoma,0
29229,Papillomaviridae,Undifferentiated Endocervical Sarcoma,0
29230,Biological Response Modifiers,Recurrent Uveal Melanoma,0
29231,Usage,Benign Anal Granular Cell Tumor,0
29232,Hematologic Tests,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29233,clinical syndromes,adenosquamous carcinoma of breast,0
29234,Diffuse Large B-Cell Lymphoma,Basal Cell Ameloblastoma,0
29235,Improved,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
29236,Severe Extremity Pain,Mucinous adenocarcinoma gastric,0
29237,Adult Anaplastic Astrocytoma,Colorectal High Grade B-Cell Lymphoma,0
29238,How Much Distress Weight Loss,Platinum-Resistant Lung Small Cell Carcinoma,0
29239,Adult Myelodysplastic Syndrome,Ovarian Dermoid Cyst with Secondary Carcinoma,0
29240,Including (qualifier),Malignant neoplasm of olfactory nerve,0
29241,Cutaneous Melanoma,Adult Acute Eosinophilic Leukemia,0
29242,Literature,Localized Ewing Sarcoma,0
29243,Body structure,Childhood Central Nervous System Ganglioneuroblastoma,0
29244,Pharmacotherapy,Ovarian Carcinoid Tumor,0
29245,Entity Determiner - specific,Werner Syndrome,0
29246,How Much Distress Pain,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29247,Usual,Gallbladder Adenocarcinoma,0
29248,Adult Germ Cell Tumor,mucinous adenocarcinoma of gallbladder,0
29249,Have Weight Loss,Atypical Lobular Breast Hyperplasia,0
29250,3+ Answer to Question,Maxillary Sinus Adenocarcinoma,0
29251,STOMACH: EXCISIONS,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29252,Slightly Agree,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
29253,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
29254,Increase,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29255,Occur (action),Stage IB Lung Cancer AJCC v7,0
29256,Time (foundation metadata concept),Pilocytic astrocytoma of cerebellum,0
29257,geographic population,Mucinous adenocarcinoma gastric,0
29258,Case (situation),Giant cell angiofibroma,0
29259,Approximate,Childhood Central Nervous System Ganglioneuroblastoma,0
29260,Cell Device,Papillary cystic tumor,0
29261,Metastasis,Low Grade Squamous Intraepithelial Neoplasia,0
29262,Ulcer,Human Papillomavirus-Related Carcinoma,0
29263,Five-year Survival Rate,Vaginal Adenoid Cystic Carcinoma,0
29264,Different,Acantholytic squamous cell carcinoma,0
29265,Anatomic Structure,Refractory Barrett Esophagus,0
29266,CDISC SEND Tumor Findings Results Terminology,FIGO Stage II Ovarian Cancer,0
29267,Interferes with,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29268,International Classification of Diseases for Oncology,Adult Acute Eosinophilic Leukemia,0
29269,Bone pain,Melanomatosis,0
29270,60%,Malignant neoplasm of thalamus,0
29271,City of Boston,Mucinous adenocarcinoma gastric,0
29272,Removed,Nasal cavity carcinoma,0
29273,Location of Pharyngeal Residue Following Swallowing,Localized Ewing Sarcoma,0
29274,Malignant Neoplasms,Refractory Ependymoma,0
29275,Psychotherapy,Stage I Adult Non-Hodgkin Lymphoma,0
29276,Occurrence Indicator,Malignant melanoma of eyelid,0
29277,Common Specifications in HL7 V3 Publishing,Benign Anal Granular Cell Tumor,0
29278,Often - answer to question,FIGO Stage II Ovarian Cancer,0
29279,High risk of,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
29280,Substance,Maxillary Sinus Adenocarcinoma,0
29281,Swollen Lymph Node,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29282,CD44 wt Allele,Adult Hepatocellular Carcinoma,0
29283,Category Type,mucinous adenocarcinoma of gallbladder,0
29284,Reported Term,Familial Adenomatous Polyposis Associated Medulloblastoma,0
29285,Malignant - descriptor,Childhood Thyroid Gland Follicular Carcinoma,0
29286,Carcinoma,Childhood Central Nervous System Ganglioneuroblastoma,0
29287,include - SetOperator,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
29288,Complete excision,Cervical Fibroepithelial Polyp,0
29289,Urinary system,Localized Askin Tumor,0
29290,Creation,Prostate Lymphoma,0
29291,Skin Pigmentation,Stage I Colon Neuroendocrine Tumor AJCC v8,0
29292,Nicotiana tabacum,Refractory Ependymoma,0
29293,UV Radiation Exposure,Endometrial Small Cell Carcinoma,0
29294,Most,Blepharal carcinoma,0
29295,inflammatory,adenoid cystic carcinoma of lung,0
29296,Asia,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
29297,Half,Bladder squamous cell carcinoma stage I,0
29298,Etiology aspects,Tumorlet,0
29299,Europe,Breast Ductal Adenoma,0
29300,*Type - Kind of quantity,Cerebral Primitive Neuroectodermal Tumor,0
29301,ovarian,Thymoma malignant recurrent,0
29302,Associated with,Adenocarcinoma of duodenum,0
29303,Behavior:-:Point in time:^Patient:-,Carcinoma of urinary bladder,0
29304,Singular,Vaginal Adenoma,0
29305,shared attribute,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
29306,Groups,Stage IV Colorectal Cancer AJCC v8,0
29307,Onset of illness,Giant cell angiofibroma,0
29308,Possible,Tubal Hyperplasia,0
29309,Death (finding),FIGO Stage IVA Ovarian Cancer,0
29310,Cell Count,BRCA2 Syndrome,0
29311,Treatment Epoch,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29312,>90,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
29313,Section (object),Tonsillar Carcinoma,0
29314,Bothered by Night Sweats,Thymic Clear Cell Carcinoma,0
29315,Contact with,Spermatocytic seminoma,0
29316,Two,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29317,Since,Lipoma of small intestine,0
29318,Recent,Extra-Adrenal Paraganglioma,0
29319,described,Pancreatic Intraepithelial Neoplasia-3,0
29320,Touch sensation,Stage II Carcinoma of Penis,0
29321,Tumor cells,Undifferentiated Endocervical Sarcoma,0
29322,Binding (Molecular Function),Medulloblastoma,0
29323,Symptoms,Tubal Hyperplasia,0
29324,Fibroid Tumor,ICHTHYOSIS,0
29325,Outer cortex of kidney,Recurrent Primary Lymphoma of Bone,0
29326,Grade IV Childhood Astrocytic Neoplasm,Carcinoma of urinary bladder,0
29327,Measurement,Pancreatic Intraepithelial Neoplasia-3,0
29328,Most,Neoplasms,0
29329,Obesity,Female Breast Carcinoma,0
29330,Various patch test substance,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
29331,Feature,Digestive System Hodgkin Lymphoma,0
29332,potential,Melanomatosis,0
29333,Approximate,Cerebral hemangioma,0
29334,algorithm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29335,Anal part of perineum,Stage 0 Penile Cancer AJCC v8,0
29336,Have Sweats,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29337,Presence (property),Clinical Stage I Cutaneous Melanoma AJCC v8,0
29338,Headache,Extra-abdominal fibromatosis,0
29339,Publications,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29340,Adult human body,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29341,1000000,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
29342,Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29343,Usual,Cancer of Urinary Tract,0
29344,British Virgin Islands,Vaginal Adenoma,0
29345,100%,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
29346,Occur (action),Female Breast Carcinoma,0
29347,Tissue of urinary bladder,Acantholytic squamous cell carcinoma,0
29348,Frequently,Malignant Neoplasm of Lung - Multiple Primary Sites,0
29349,child survival,Benign Anal Granular Cell Tumor,0
29350,Trial Screening,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
29351,Young Adult,Carcinoma of urinary bladder,0
29352,product,Recurrent Testicular Lymphoma,0
29353,Malignant Neoplasms,Peripheral primitive neuroectodermal tumor of soft tissue,0
29354,Workers,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29355,Areas <moth>,Grade 1 Clear Cell Renal Cell Carcinoma,0
29356,Neoplasms,Cherubism,0
29357,What subject filter - Result,Collecting Duct Carcinoma of the Kidney,0
29358,Primary malignant neoplasm of fallopian tube,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29359,Usual,Colorectal cancer,0
29360,Singular,Squamous cell carcinoma of lip,0
29361,Old,Kaposi's sarcoma of skin,0
29362,Symptoms aspect,Malignant neoplasm of thalamus,0
29363,Cold Sensation,Carcinoma,0
29364,Nervous system structure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29365,Genus Anemia,Metastatic Malignant Neoplasm in the Sellar Region,0
29366,Specimen Source Codes - tumor,FIGO Stage IVA Ovarian Cancer,0
29367,/hour,Cervical Adenomyoma,0
29368,Lymphoma,Heavy Chain Deposition Disease,0
29369,Layer of dermis,Intraepithelial Melanocytic Hyperplasia,0
29370,Device Plate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29371,Primary,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
29372,Females,Extra-Adrenal Paraganglioma,0
29373,Presentation,FIGO Stage IVA Ovarian Cancer,0
29374,ethnic european,Pancreatic Intraepithelial Neoplasia-3,0
29375,Set (Psychology),Childhood Choriocarcinoma,0
29376,Egg of order Phthiraptera,Recurrent Uveal Melanoma,0
29377,Test - temporal region,Papillary cystic tumor,0
29378,Make - Instruction Imperative,Pancreatic Intraepithelial Neoplasia-3,0
29379,SPINK5 gene,ALK positive large B-cell lymphoma,0
29380,Disease,squamous cell carcinoma of the thyroid gland,0
29381,subapical complex location,Adenocarcinoma,0
29382,International Classification of Diseases,Stage III Adult Immunoblastic Lymphoma,0
29383,control substance,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29384,Tissue membrane,Pleomorphic adenoma of parotid gland,0
29385,3+ Answer to Question,Precursor B-lymphoblastic lymphoma stage II,0
29386,diagnosis aspect,Stage III Cutaneous Melanoma AJCC v6,0
29387,Call (Instruction),Metastatic Carcinoma in the Lung,0
29388,Contusions,Malignant neoplasm of thalamus,0
29389,Variety (taxon),Stage IV Colorectal Cancer AJCC v8,0
29390,Less Than,Stage 0 Lip Carcinoma,0
29391,Useful,Carcinoma of urinary bladder,0
29392,Adult human body,Nasal cavity carcinoma,0
29393,Occur (action),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
29394,United States,Metaplastic carcinoma of breast,0
29395,classical example,Kaposi's sarcoma of extrahepatic bile duct,0
29396,Blood Vessel,Botryoid-Type Embryonal Rhabdomyosarcoma,0
29397,Science of Etiology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
29398,Original,Intraepithelial Melanocytic Hyperplasia,0
29399,Biospecimen,Kaposi's sarcoma of extrahepatic bile duct,0
29400,Bothered by Night Sweats,Colorectal High Grade B-Cell Lymphoma,0
29401,Vulvovaginal Region,Refractory Barrett Esophagus,0
29402,Monitoring Device,Benign Anal Granular Cell Tumor,0
29403,Malignant neoplasm of soft tissue,Cerebral hemangioma,0
29404,Cervical lymph node group,Cancer of Urinary Tract,0
29405,Usual Severity Itching,embryonal rhabdomyosarcoma of prostate,0
29406,Nausea,Acantholytic squamous cell carcinoma,0
29407,2+,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
29408,Diagnosis Study,Pancreatic Intraepithelial Neoplasia-3,0
29409,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29410,Difficult (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29411,Nasal sinus,Mastocytosis,0
29412,Mesenchymal Stem Cells,Precursor B-lymphoblastic lymphoma stage II,0
29413,Certainties,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
29414,Symptoms aspect,Kaposi's sarcoma of extrahepatic bile duct,0
29415,Oral region,Tonsillar Carcinoma,0
29416,Vital High Nitrogen Enteral Nutrition,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
29417,United States,Bladder adenocarcinoma stage IV,0
29418,Endotracheal aspiration,Breast Ductal Adenoma,0
29419,Physical findings,Squamous cell carcinoma of lip,0
29420,Complete Pharyngeal Contraction,Uterine Cancer,0
29421,Goes <invertebrate>,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
29422,Hepatitis C,Pancreatic Intraepithelial Neoplasia-3,0
29423,status - In progress,Human Papillomavirus-Related Carcinoma,0
29424,Used by,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
29425,Harbor,Acantholytic squamous cell carcinoma,0
29426,Inflammatory lesion,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
29427,Person Name,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29428,Number of birth,Ovarian Dermoid Cyst with Secondary Carcinoma,0
29429,To,Basal Cell Ameloblastoma,0
29430,Five,Chest Wall Fibromatosis,0
29431,Epithelium,Kaposi's sarcoma of extrahepatic bile duct,0
29432,Disc Shape,Botryoid-Type Embryonal Rhabdomyosarcoma,0
29433,Psychological inhibition,Recurrent Primary Lymphoma of Bone,0
29434,Set of regional lymph nodes,Stage IV Childhood Non-Hodgkin Lymphoma,0
29435,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29436,Tubal Ligation,Cerebral hemangioma,0
29437,Developing Countries,Cancer of Urinary Tract,0
29438,Adult,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29439,Lobule,Stage III Cutaneous Melanoma AJCC v6,0
29440,Non-small cell carcinoma,clear cell adenocarcinoma of gallbladder,0
29441,Concept Relationship,Papillary cystic tumor,0
29442,Include (action),Adult Alveolar Soft Part Sarcoma,0
29443,Science of Etiology,Refractory Bladder Carcinoma,0
29444,Contain (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
29445,Additional,Breast Ductal Adenoma,0
29446,System,Secondary malignant neoplasm of lymph node,0
29447,Cells,Vaginal Adenoid Cystic Carcinoma,0
29448,Prognosis:Find:Pt:^Patient:Nom,ROSE Cluster 3,0
29449,Circumscribe (action),Intestinal Metaplasia of Bladder Urothelium,0
29450,Unmarried person,Carcinomatosis of peritoneal cavity,0
29451,Death (finding),Diffuse malignant mesothelioma,0
29452,Fluid Leak,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
29453,Lymphadenopathy,Liver Cavernous Hemangioma,0
29454,Science of Etiology,Chest Wall Fibromatosis,0
29455,Elements,Non-Hodgkin Lymphoma During Pregnancy,0
29456,10%,Human Papillomavirus-Related Carcinoma,0
29457,Primary malignant neoplasm,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
29458,Bladder Cancer Pathway,Adult Brain Stem Mixed Glioma,0
29459,Skin,Engraftment syndrome,0
29460,Tumor cells,Metastatic Ductal Breast Carcinoma,0
29461,Arising,Extra-abdominal fibromatosis,0
29462,Diagnosis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29463,floor (object),Acute Undifferentiated Leukemia,0
29464,Bloating,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29465,Adult Anaplastic Large Cell Lymphoma,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
29466,Anatomic Site,Pancreatic Intraepithelial Neoplasia-3,0
29467,Result,Cerebral Primitive Neuroectodermal Tumor,0
29468,Singular,Medulloblastoma,0
29469,Classification,Hereditary Diffuse Gastric Adenocarcinoma,0
29470,Intravascular line,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
29471,Tryptophanase,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
29472,Increase in size since previous mammogram,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29473,Growth abnormality,Recurrent Testicular Lymphoma,0
29474,Often - answer to question,Hair nevus,0
29475,65,Metastatic Malignant Neoplasm in the Sellar Region,0
29476,Cervical dysplasia,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
29477,Non-Secretory Plasma Cell Myeloma,Locally Advanced Soft Tissue Sarcoma,0
29478,Firstly,Thyroid carcinoma,0
29479,Recombinant Human Chorionic Gonadotropin,Engraftment syndrome,0
29480,Thymectomy,Neoplasms,0
29481,Salivary Glands,Endometrial Small Cell Carcinoma,0
29482,Sometimes,Mixed parotid tumor,0
29483,newly,FIGO Stage II Ovarian Cancer,0
29484,Pancreatic Hormones,Botryoid-Type Embryonal Rhabdomyosarcoma,0
29485,Form:Finding:Point in time:{Setting}:Document:{Role},FIGO Stage II Ovarian Cancer,0
29486,Blood Platelets,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29487,Result,Malignant Neoplasm with Regional Lymph Node Involvement,0
29488,Known,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29489,shared attribute,papillary carcinoma of penis,0
29490,Europe,Human Papillomavirus-Related Carcinoma,0
29491,Genetic Risk,Benign Carotid Body Paraganglioma,0
29492,SLC6A2 wt Allele,Intraepithelial Melanocytic Hyperplasia,0
29493,Person 1,Adult Acute Eosinophilic Leukemia,0
29494,SLC6A2 wt Allele,Unresectable Rhabdomyosarcoma,0
29495,Special,Intracortical osteosarcoma,0
29496,Including (qualifier),Clinical Stage I Cutaneous Melanoma AJCC v8,0
29497,Drainage procedure,Lipoma of small intestine,0
29498,Base - General Qualifier,Papillary cystic tumor,0
29499,SPINK5 gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
29500,Malignant Neoplasms,Benign Anal Granular Cell Tumor,0
29501,Usual,FIGO Stage IVA Ovarian Cancer,0
29502,Edema,Acute lymphadenitis,0
29503,Cancer Remission,Squamous cell carcinoma of lip,0
29504,Rare,Nasal cavity carcinoma,0
29505,suggestion,Colorectal High Grade B-Cell Lymphoma,0
29506,Limited (extensiveness),Astrocytoma of brain,0
29507,/40,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
29508,Anatomic Site,Metastatic Lung Neuroendocrine Neoplasm,0
29509,per period (qualifier value),Unresectable Rhabdomyosarcoma,0
29510,Sharing (Social Behavior),Refractory Barrett Esophagus,0
29511,Cultured Cell Line,Leptomeningeal sarcoma,0
29512,Certain (qualifier value),embryonal rhabdomyosarcoma of prostate,0
29513,Identified,Thyroid Hurthle Cell Carcinoma,0
29514,Plant seeds,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
29515,Malignant Neoplasms,Prostate Lymphoma,0
29516,New,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
29517,Identified,Trichilemmocarcinoma,0
29518,Mutation,Metastatic Malignant Neoplasm in the Sellar Region,0
29519,Childhood Non-Hodgkin Lymphoma,Secondary malignant neoplasm of lymph node,0
29520,nonmetastatic,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
29521,95,Small Intestinal Villous Adenoma,0
29522,various other agents for local oral treatment in ATC,Gallbladder Adenocarcinoma,0
29523,site-specific telomere resolvase activity,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
29524,MOSTLY,embryonal rhabdomyosarcoma of prostate,0
29525,Group A (blood group),Hyperplasia of pituitary gland,0
29526,Tissue Specimen Code,gliosarcoma,0
29527,/40,Localized Ewing Sarcoma,0
29528,Obesity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29529,Have Weight Loss,Spermatocytic seminoma,0
29530,Magnetic Resonance Imaging,Recurrent Uveal Melanoma,0
29531,Case unit dose,Metastatic Lung Neuroendocrine Neoplasm,0
29532,risk factors - observation list,Melanomatosis,0
29533,Followed by,Cystadenocarcinoma,0
29534,Infection of kidney,Chondrosarcoma,0
29535,Abnormal Cell Count,Botryoid-Type Embryonal Rhabdomyosarcoma,0
29536,Loss of Appetite question,Mucinous adenocarcinoma gastric,0
29537,Description,Recurrent Uveal Melanoma,0
29538,3+ Answer to Question,Malignant melanoma of eyelid,0
29539,point - UnitsOfMeasure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29540,Fever,Maxillary Sinus Adenoid Cystic Carcinoma,0
29541,Call (Instruction),Thymoma malignant recurrent,0
29542,Rate,Giant cell angiofibroma,0
29543,Fever,Werner Syndrome,0
29544,Sun Exposure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
29545,Act Status - obsolete,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29546,One,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
29547,Bothered by Night Sweats,Chronic Myelomonocytic Leukemia-2,0
29548,Body Site Modifier - Lower,Recurrent Uveal Melanoma,0
29549,Ultraviolet Light Sterilization,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
29550,combination - answer to question,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29551,AKT1S1 wt Allele,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
29552,Psyche structure,Female Breast Carcinoma,0
29553,seen,Mucinous adenocarcinoma gastric,0
29554,Age of Onset,Cystadenocarcinoma,0
29555,Histocompatibility Testing,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29556,Time (foundation metadata concept),Lipoma of small intestine,0
29557,Collections (publication),Malignant neoplasm of gallbladder,0
29558,Air Conditioning,Familial Hemophagocytic Lymphocytosis,0
29559,Frequently,Thymic Clear Cell Carcinoma,0
29560,Central Nervous System Embryonal Tumor,mucinous adenocarcinoma of gallbladder,0
29561,Neuroendocrine Tumors,FIGO Stage IVA Ovarian Cancer,0
29562,Sclerotherapy,Small intestine carcinoma,0
29563,Young,Childhood Fibrillary Astrocytoma,0
29564,Prognosis:Find:Pt:^Patient:Nom,Rhabdomyosarcoma with ganglionic differentiation,0
29565,Replacement,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
29566,Heart,Low Grade Squamous Intraepithelial Neoplasia,0
29567,Disruptive,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
29568,Geographic Locations,Adenocarcinoma,0
29569,Similarity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29570,Probable diagnosis,Nasal cavity carcinoma,0
29571,Secondary Neoplasm,Serous cystadenocarcinoma ovary,0
29572,Inferior,Cervical Adenomyoma,0
29573,Malignant neoplasm of breast,Chronic Myelomonocytic Leukemia-2,0
29574,Formations,Liver Lymphangioma,0
29575,Secondary Neoplasm,Kaposi's sarcoma of skin,0
29576,*Type - Kind of quantity,Mucinous adenocarcinoma gastric,0
29577,Devices,Stage 0 Penile Cancer AJCC v8,0
29578,Never (frequency),clear cell adenocarcinoma of gallbladder,0
29579,Bacteria present,Acute Undifferentiated Leukemia,0
29580,Human body structure,Adult Hepatocellular Carcinoma,0
29581,Specimen Source Codes - tumor,Childhood Central Nervous System Ganglioneuroblastoma,0
29582,Name,Astrocytoma of brain,0
29583,Call (Instruction),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29584,Child,Recurrent Uveal Melanoma,0
29585,To,Cartilaginous exostosis,0
29586,Pylorus,Ichthyosis,0
29587,Infrequent,Acute Undifferentiated Leukemia,0
29588,Mutation,Benign squamous cell tumor,0
29589,1+,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
29590,Most,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29591,Qualitative form,Adult Acute Eosinophilic Leukemia,0
29592,Sweat,Childhood Lymphoma,0
29593,Social group,Cerebral Primitive Neuroectodermal Tumor,0
29594,More,Peripheral primitive neuroectodermal tumor of soft tissue,0
29595,Firstly,Refractory Barrett Esophagus,0
29596,Name,Brain Ependymoma,0
29597,Including (qualifier),Cerebral Primitive Neuroectodermal Tumor,0
29598,Direct (qualifier),Xeroderma pigmentosum,0
29599,Tumor cells,Nasal cavity carcinoma,0
29600,Sometimes,Lipoma of small intestine,0
29601,Biopsy,Pancreatic Endocrine Carcinoma,0
29602,Therapeutic procedure,Vaginal Adenoid Cystic Carcinoma,0
29603,Library Protocol,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29604,To,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
29605,Cell Device,Vaginal Adenoma,0
29606,Occur (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
29607,Overall,clear cell adenocarcinoma of gallbladder,0
29608,Feel Tired question,Precursor B-lymphoblastic lymphoma stage II,0
29609,Numbness,Chronic Myelomonocytic Leukemia-2,0
29610,Supportive assistance,Recurrent Testicular Lymphoma,0
29611,Pancreas,High Grade Glandular Intraepithelial Neoplasia,0
29612,Beginning,Childhood Central Nervous System Ganglioneuroblastoma,0
29613,Cover - action,Thymic Atypical Carcinoid Tumor,0
29614,Adult human body,Carcinomatosis of peritoneal cavity,0
29615,Active,Locally Advanced Carcinoma,0
29616,Adrenal Medulla,Malignant neoplasm of choroid,0
29617,Function (attribute),Splenic Manifestation of Hairy Cell Leukemia,0
29618,High Grade Ovarian Serous Adenocarcinoma,Breast Apocrine Adenoma,0
29619,Constipation,Refractory Ependymoma,0
29620,Insect Bites,Endometrial Small Cell Carcinoma,0
29621,Specimen Source Codes - tumor,Localized Askin Tumor,0
29622,Immune System Processes,Mucosal Melanoma,0
29623,Lymphocyte,Colorectal High Grade B-Cell Lymphoma,0
29624,Beginning,Bladder squamous cell carcinoma stage I,0
29625,Monoclonal Antibodies,Stage IV Childhood Non-Hodgkin Lymphoma,0
29626,Increased,Splenic Manifestation of Hairy Cell Leukemia,0
29627,Blood,embryonal rhabdomyosarcoma of prostate,0
29628,Complication,Thymic Clear Cell Carcinoma,0
29629,Blue - answer to question,Ovarian germ cell choriocarcinoma stage IV,0
29630,Thymus Neoplasms,Malignant neoplasm of choroid,0
29631,generic name,Recurrent Uveal Melanoma,0
29632,Including (qualifier),Microcystic meningioma,0
29633,Cancer Remission,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29634,Wild,Multiple Endocrine Neoplasia,0
29635,Type A,Kaposi's sarcoma of skin,0
29636,unknown vaccine or immune globulin,carcinoma of middle ear,0
29637,Medications,Cancer of Urinary Tract,0
29638,Lymphocyte component of blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29639,Various patch test substance,Collecting Duct Carcinoma of the Kidney,0
29640,Descent,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29641,High risk,Epithelioid Sarcoma NCI Grade 3,0
29642,Tissue damage,Cervical Fibroepithelial Polyp,0
29643,Concern,Peripheral primitive neuroectodermal tumor of soft tissue,0
29644,Treatment Epoch,Intraepithelial Melanocytic Hyperplasia,0
29645,Primary operation,Extra-abdominal fibromatosis,0
29646,Case unit dose,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
29647,Skeletal,Thyroid carcinoma,0
29648,Source of radiation (attribute),Gallbladder adenoma,0
29649,Entity Name Part Qualifier - birth,adenosquamous carcinoma of breast,0
29650,Lower Urinary Tract Symptoms,Neoplasms,0
29651,Primary,Hodgkin Disease,0
29652,described,Precursor B-lymphoblastic lymphoma stage II,0
29653,Type A,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29654,Occurrence Indicator,Liver Cavernous Hemangioma,0
29655,Malignant - descriptor,Intestinal Metaplasia of Bladder Urothelium,0
29656,Possible diagnosis,Angiosarcoma of liver,0
29657,Rapid,Mucinous adenocarcinoma gastric,0
29658,Similarity,Localized Ewing Sarcoma,0
29659,Body tissue,Neoplasms,0
29660,Adipose tissue,Low Grade Squamous Intraepithelial Neoplasia,0
29661,Geographic Locations,Childhood Lymphoma,0
29662,Togo,Carcinoma,0
29663,Feature,Digestive System Hodgkin Lymphoma,0
29664,Changed status,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
29665,Before,Benign neoplasm of thorax,0
29666,Progesterone Receptor Measurement,Cerebral Primitive Neuroectodermal Tumor,0
29667,Cells,Stage III Cutaneous Melanoma AJCC v6,0
29668,Pharmacotherapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
29669,Similarity,Chest Wall Fibromatosis,0
29670,Experimental Result,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
29671,Term (temporal),Cartilaginous exostosis,0
29672,Increasing,Blepharal carcinoma,0
29673,Maintenance,Thyroid Hurthle Cell Carcinoma,0
29674,Category Type,Contact dermatitis due to alkali,0
29675,False Discovery Rate,Childhood Lung Non-Small Cell Carcinoma,0
29676,Fasting Status Indicator,Tonsillar Carcinoma,0
29677,Both kidneys,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29678,Smear - instruction imperative,Brain Ependymoma,0
29679,Family member,Benign Anal Granular Cell Tumor,0
29680,SLC6A2 wt Allele,Thyroid Hurthle Cell Carcinoma,0
29681,Sharing (Social Behavior),Malignant neoplasm of gallbladder,0
29682,Reported Term,Kaposi's sarcoma of extrahepatic bile duct,0
29683,CEL gene,mucinous adenocarcinoma of gallbladder,0
29684,Primary malignant neoplasm,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29685,Smear - instruction imperative,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
29686,Transformation,Periosteal Osteosarcoma,0
29687,NIN gene,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
29688,Disease,Botryoid-Type Embryonal Rhabdomyosarcoma,0
29689,Infection,Cancer of Urinary Tract,0
29690,shared attribute,Chronic Myelomonocytic Leukemia-2,0
29691,Experimental Result,Stage I Colon Neuroendocrine Tumor AJCC v8,0
29692,Abnormal result,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29693,Bone Marrow,Acute Undifferentiated Leukemia,0
29694,Togo,Liver Lymphangioma,0
29695,survive,Female Breast Carcinoma,0
29696,Abnormal Reference Range,Noninfiltrating Intraductal Carcinoma,0
29697,Beginning,Thyroid Hurthle Cell Carcinoma,0
29698,Treatment Epoch,Stage IB Lung Cancer AJCC v7,0
29699,cell transformation,Ampulla of Vater Tubular Adenoma,0
29700,International Classification of Disease for Oncology,Extra-Adrenal Paraganglioma,0
29701,IPSS Risk Category High,Ovarian Dermoid Cyst with Secondary Carcinoma,0
29702,Primary,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29703,Fatal,Benign Apocrine Neoplasm,0
29704,Include (action),Microcystic meningioma,0
29705,Biomaterial Treatment,Diffuse malignant mesothelioma,0
29706,Bruising,Stage IV Penile Cancer AJCC v7,0
29707,American College of Cardiology/American Heart Association Lesion Complexity Score C,Intestinal Metaplasia of Bladder Urothelium,0
29708,Living Alone,Malignant neoplasm of gallbladder,0
29709,Turner Syndrome,Bladder squamous cell carcinoma stage I,0
29710,Merkel cell carcinoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29711,Reciprocal translocation,FIGO Stage IVA Ovarian Cancer,0
29712,Type A,Intraepithelial Melanocytic Hyperplasia,0
29713,Rate,Cartilaginous exostosis,0
29714,Sometimes,Stage I Colon Neuroendocrine Tumor AJCC v8,0
29715,Weight decreased,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
29716,Code,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
29717,Approximate,Blepharal carcinoma,0
29718,Mass of neck,Unicystic ameloblastoma,0
29719,English [International Organization for Standardization 639-1 code en] language reference set,Clonal Hematopoiesis of Indeterminate Potential,0
29720,Manual pelvic examination (procedure),Xeroderma pigmentosum,0
29721,Hepatoblastoma,Childhood Fibrillary Astrocytoma,0
29722,Germinoma,ROSE Cluster 3,0
29723,Primary malignant neoplasm,Astrocytoma of brain,0
29724,Coughing,Stage III Cutaneous Melanoma AJCC v6,0
29725,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Adult Alveolar Soft Part Sarcoma,0
29726,International Statistical Classification of Diseases and Related Health Problems,Unresectable Rhabdomyosarcoma,0
29727,Function (attribute),Angiosarcoma of liver,0
29728,Connect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
29729,Thick,Mucinous adenocarcinoma gastric,0
29730,Usual,Rhabdomyosarcoma with ganglionic differentiation,0
29731,Rate,Recurrent Primary Lymphoma of Bone,0
29732,Increased,Intracortical osteosarcoma,0
29733,Mutation Abnormality,Nasal cavity carcinoma,0
29734,Very,Mucinous cystadenofibroma,0
29735,Genital region,Intestinal Metaplasia of Bladder Urothelium,0
29736,depend,Cervical Adenomyoma,0
29737,Third revision,Blepharal carcinoma,0
29738,Term (temporal),Tonsillar Carcinoma,0
29739,Pluripotent,Human Papillomavirus-Related Carcinoma,0
29740,Wall of lymphatic vessel,FIGO Stage II Ovarian Cancer,0
29741,Malignant neoplasm of thyroid,Childhood Anaplastic Large Cell Lymphoma,0
29742,Urinary tract,Undifferentiated Neuroblastoma,0
29743,Orbital region,Human Papillomavirus-Related Carcinoma,0
29744,Common Specifications in HL7 V3 Publishing,Cerebral hemangioma,0
29745,Childhood Diffuse Large B-Cell Lymphoma,Human Papillomavirus-Related Carcinoma,0
29746,Childhood Leukemia,Recurrent Primary Lymphoma of Bone,0
29747,Persons,Carcinoma ex pleomorphic adenoma of parotid gland,0
29748,Present,Cerebral Primitive Neuroectodermal Tumor,0
29749,Specific qualifier value,Low Grade Squamous Intraepithelial Neoplasia,0
29750,Neuroendocrine Tumors,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29751,See,Melanomatosis,0
29752,Recommendation,non-Hodgkin's lymphoma of spleen,0
29753,Thymic Tissue,benign mature teratoma of pancreas,0
29754,Precision - temporal,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
29755,Fever,Microcystic meningioma,0
29756,MYELODYSPLASTIC SYNDROME,Adult Alveolar Soft Part Sarcoma,0
29757,shared attribute,Hereditary Diffuse Gastric Adenocarcinoma,0
29758,Therapeutic procedure,Mucosal Melanoma,0
29759,Neoplastic disease,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29760,Image Feature,Kaposi's sarcoma of extrahepatic bile duct,0
29761,General surgery specialty,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
29762,diagnosis aspect,Locally Advanced Soft Tissue Sarcoma,0
29763,Difficult (qualifier value),Carcinomatosis of peritoneal cavity,0
29764,Removed,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
29765,Males,Childhood Extragonadal Malignant Germ Cell Tumor,0
29766,Manufactured sign,Ovarian germ cell choriocarcinoma stage IV,0
29767,Cellular infiltrate,Clonal Hematopoiesis of Indeterminate Potential,0
29768,Formed,Metastatic Carcinoma in the Lung,0
29769,Age at menopause,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
29770,Adult,Blepharal carcinoma,0
29771,Cervix Uteri,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
29772,Breaking down,Intestinal Metaplasia of Bladder Urothelium,0
29773,Basis - conceptual entity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29774,Males,Undifferentiated Neuroblastoma,0
29775,Universal restriction modifier (core metadata concept),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29776,System - kit,Intraepithelial Melanocytic Hyperplasia,0
29777,Qualitative form,Diffuse malignant mesothelioma,0
29778,Liver Flavor,Malignant neoplasm of choroid,0
29779,Financial Account,Stage IB Pancreatic Cancer AJCC v8,0
29780,Communicable Diseases,Pancreatic carcinoma,0
29781,Bladder Neoplasm,Thymic Clear Cell Carcinoma,0
29782,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
29783,Therapeutic radiology procedure,Digestive System Hodgkin Lymphoma,0
29784,Benign Neoplasm,Metastatic Carcinoma in the Lung,0
29785,Pressure (property),Stage IB Pancreatic Cancer AJCC v8,0
29786,Lineage,Benign neoplasm of eye,0
29787,Therapeutic procedure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
29788,Vagina,Cerebral Primitive Neuroectodermal Tumor,0
29789,Most,Keratoderma,0
29790,Benign melanocytic nevus,Childhood Fibrillary Astrocytoma,0
29791,Menstruation,Chronic Myelomonocytic Leukemia-2,0
29792,Cells,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
29793,Appearance Distress Question,Recurrent Testicular Lymphoma,0
29794,Experimental Result,Locally Advanced Carcinoma,0
29795,More,Adult Hepatocellular Carcinoma,0
29796,Muscle Tissue,Nasal cavity carcinoma,0
29797,Placenta Specimen,Pancreatic Intraepithelial Neoplasia-3,0
29798,Twice (Numerical Qualifier),Thymic Clear Cell Carcinoma,0
29799,Therapeutic procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
29800,Surface,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
29801,Neoplasm Metastasis,Cervical Squamous Intraepithelial Neoplasia,0
29802,Congenital defects,Melanomatosis,0
29803,Tumor Mass,Cerebral hemangioma,0
29804,Mental concentration,Melanomatosis,0
29805,Malignant neoplasm of lung,Intestinal Metaplasia of Bladder Urothelium,0
29806,Therapeutic procedure,Stage IB Pancreatic Cancer AJCC v8,0
29807,Genitourinary organs,Malignant neoplasm of olfactory nerve,0
29808,Device system,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
29809,Malignant Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
29810,Case unit dose,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29811,Childhood Hodgkin Lymphoma,ROSE Cluster 3,0
29812,Funisitis (disorder),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
29813,Fordyce's disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
29814,Carrying,Undifferentiated Neuroblastoma,0
29815,Collection (action),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
29816,Head and Neck Carcinoma,Childhood Fibrillary Astrocytoma,0
29817,Diagnosis Study,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29818,Sectioning technique,Malignant neoplasm of gallbladder,0
29819,Occur (action),Thymoma malignant recurrent,0
29820,Used by,Thymic Clear Cell Carcinoma,0
29821,Resolution,Uterine Cancer,0
29822,Life Expectancy Greater than Twenty Years,Xeroderma pigmentosum,0
29823,Followed by,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29824,Type A,Grade 1 Clear Cell Renal Cell Carcinoma,0
29825,Human body structure,Thyroid Hurthle Cell Carcinoma,0
29826,Atla (fungus),Lipoma of small intestine,0
29827,Formation,Intestinal Metaplasia of Bladder Urothelium,0
29828,Telephone Extension Number,adenosquamous carcinoma of breast,0
29829,CDISC SDTM Disease Outcome Terminology,Refractory Barrett Esophagus,0
29830,year,Squamous cell carcinoma of lip,0
29831,Adolescent (age group),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
29832,Cultured Cell Line,FIGO Stage II Ovarian Cancer,0
29833,SLC6A2 wt Allele,embryonal rhabdomyosarcoma of prostate,0
29834,Breast Cancer Type 1 Susceptibility Protein Measurement,Benign Anal Granular Cell Tumor,0
29835,1960s,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29836,Chew (administration method),Vaginal Adenoid Cystic Carcinoma,0
29837,Unmarried,Botryoid-Type Embryonal Rhabdomyosarcoma,0
29838,<50,Cartilaginous exostosis,0
29839,Administration procedure,Chondrosarcoma,0
29840,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29841,Africa,Lung squamous cell carcinoma stage I,0
29842,Old,Metastatic Carcinoma in the Lung,0
29843,Approximate,Granular Cell Leiomyosarcoma,0
29844,include - SetOperator,Malignant Neoplasm of Lung - Multiple Primary Sites,0
29845,Percent (qualifier value),FIGO Stage IVA Ovarian Cancer,0
29846,Include (action),Benign Anal Granular Cell Tumor,0
29847,Telencephalon,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29848,Protein antibody,Acute lymphadenitis,0
29849,Disease Screening,Intestinal Neuroendocrine Carcinoma,0
29850,Increase,Bladder adenocarcinoma stage IV,0
29851,Treating,Benign tumor of eyelid,0
29852,Beginning,Ovarian Carcinoid Tumor,0
29853,CD44 wt Allele,Periosteal Osteosarcoma,0
29854,Moving,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
29855,Molecule,Localized Ewing Sarcoma,0
29856,diabetic,Childhood Choriocarcinoma,0
29857,Intestines,Thymic Clear Cell Carcinoma,0
29858,Increase,Stage 0 Penile Cancer AJCC v8,0
29859,Manufactured form,Intraepithelial Melanocytic Hyperplasia,0
29860,Referring,Heavy Chain Deposition Disease,0
29861,Following,Carcinomatosis of peritoneal cavity,0
29862,Chemotherapy Regimen,Angiosarcoma of liver,0
29863,Base - General Qualifier,Vaginal Adenoma,0
29864,Multiple malignancy,Digestive System Hodgkin Lymphoma,0
29865,Subtype (attribute),Stage II Carcinoma of Penis,0
29866,Africa,Benign Anal Granular Cell Tumor,0
29867,operate <remove>,Breast Ductal Adenoma,0
29868,penis,Pilocytic astrocytoma of cerebellum,0
29869,More,High Grade Glandular Intraepithelial Neoplasia,0
29870,MDFAttributeType - Fraction,Testicular cancer metastatic,0
29871,Better,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29872,Dangerousness,Angiosarcoma of liver,0
29873,melanoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
29874,Due to,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
29875,Type - attribute,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
29876,Malignant tumor of cervix,FIGO Stage IVA Ovarian Cancer,0
29877,Tryptophanase,Larynx carcinoma recurrent,0
29878,Cancer Genus,Xeroderma pigmentosum,0
29879,row - Table,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29880,Age,Cancer of Urinary Tract,0
29881,Primary malignant neoplasm,Metastatic Lung Neuroendocrine Neoplasm,0
29882,NCI CTEP SDC Mastocytosis Sub-Category Terminology,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29883,Congenital condition,Stage II Hepatocellular Carcinoma AJCC v8,0
29884,Sarcoma of soft tissue,Kaposi's sarcoma of extrahepatic bile duct,0
29885,Pharmacotherapy,Benign tumor of eyelid,0
29886,Mesenchymal Stem Cells,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
29887,Malignant neoplasm of endometrium,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
29888,Dietary Lead,Transitional cell carcinoma,0
29889,Support,Cervical Fibroepithelial Polyp,0
29890,Early,Recurrent Primary Lymphoma of Bone,0
29891,More,Xeroderma pigmentosum,0
29892,Loss of appetite (finding),Funisitis (disorder),0
29893,World,Metastatic Malignant Neoplasm in the Sellar Region,0
29894,Fluid behavior,Atypical Lobular Breast Hyperplasia,0
29895,Sequence Data Type,Type II Endometrial Adenocarcinoma,0
29896,Type A,Engraftment syndrome,0
29897,Polycythemia,Locally Advanced Soft Tissue Sarcoma,0
29898,Height / growth measure,Lipoma of small intestine,0
29899,Tongue,Platinum-Resistant Lung Small Cell Carcinoma,0
29900,3+ Score,Adult Anaplastic Oligodendroglioma,0
29901,Childhood Medulloblastoma,Vaginal Adenoid Cystic Carcinoma,0
29902,Occur (action),Hair nevus,0
29903,One,Bladder squamous cell carcinoma stage I,0
29904,Early stage,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
29905,Intestines,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29906,South East Asian,Benign Apocrine Neoplasm,0
29907,Absence (morphologic abnormality),Acinar cell carcinoma of pancreas,0
29908,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Mucosal Melanoma,0
29909,Percent (qualifier value),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
29910,Type - attribute,Localized Ewing Sarcoma,0
29911,Type - attribute,Kaposi's sarcoma of extrahepatic bile duct,0
29912,risk factors - observation list,Botryoid-Type Embryonal Rhabdomyosarcoma,0
29913,Platelets,Female Breast Carcinoma,0
29914,Neoplasms,Female Breast Carcinoma,0
29915,Body tissue,Mucinous adenocarcinoma gastric,0
29916,cancer therapy,Recurrent Testicular Lymphoma,0
29917,include - SetOperator,Unicystic ameloblastoma,0
29918,Rare Diseases,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29919,Linear,Splenic Manifestation of Hairy Cell Leukemia,0
29920,First (number),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
29921,Choroid plexus of cerebral hemisphere,Intestinal Metaplasia of Bladder Urothelium,0
29922,Definition,Epithelioid Sarcoma NCI Grade 3,0
29923,Offspring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
29924,Widening,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29925,Cell Device,Localized Askin Tumor,0
29926,Anatomic Site,Locally Advanced Squamous Cell Carcinoma,0
29927,Etiology aspects,squamous cell carcinoma of the thyroid gland,0
29928,Ability,Childhood Fibrillary Astrocytoma,0
29929,Death (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
29930,Cancer Registry,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
29931,peripheral blood,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29932,Include (action),Metastatic Neoplasm to the Gallbladder,0
29933,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29934,Sweating,Clonal Hematopoiesis of Indeterminate Potential,0
29935,800,Chondrosarcoma,0
29936,Statistical Prevalence,Pleomorphic adenoma of parotid gland,0
29937,Common (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
29938,True primary (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
29939,Government,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29940,Call (Instruction),Diffuse malignant mesothelioma,0
29941,Vaginal (intended site),Non-Metastatic Gestational Trophoblastic Tumor,0
29942,Paraplegia,Recurrent Primary Lymphoma of Bone,0
29943,Usually,Trabecular adenocarcinoma,0
29944,Head - Component of Device,Malignant neoplasm of subglottis,0
29945,Autoimmune Diseases,Mucinous adenocarcinoma gastric,0
29946,active (HL7 RoleLink),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
29947,Known,Stage IB Lung Cancer AJCC v7,0
29948,Multiple Partners,Anterior Urethral Malignant Neoplasm,0
29949,low exposure,Metastatic Ductal Breast Carcinoma,0
29950,geographic population,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
29951,Adenocarcinoma,Liver Cavernous Hemangioma,0
29952,Estimated,BRCA2 Syndrome,0
29953,Spreading (qualifier value),BRCA2 Syndrome,0
29954,Deferred,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
29955,Average,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
29956,Life Expectancy Less than Ten Years,Female Breast Carcinoma,0
29957,Early,Sarcomatoid Renal Cell Carcinoma,0
29958,Participation Type - origin,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
29959,Greater than one,Acantholytic squamous cell carcinoma,0
29960,Mastocytosis,Female Breast Carcinoma,0
29961,Percent of Abnormal Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
29962,Occur (action),Splenic Manifestation of Hairy Cell Leukemia,0
29963,Pancreas,Recurrent Testicular Lymphoma,0
29964,Involvement with,Neonatal leukemia,0
29965,examination of cervix,Childhood Fibrillary Astrocytoma,0
29966,Peripheral,benign mature teratoma of pancreas,0
29967,Update,Refractory Bladder Carcinoma,0
29968,Tumor tissue sample,Uterine Cancer,0
29969,Omphalitis,Nasal cavity carcinoma,0
29970,Beginning,Stage III Cutaneous Melanoma AJCC v6,0
29971,Taxonomic,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
29972,therapeutic aspects,Intestinal Neuroendocrine Carcinoma,0
29973,Lateral column (anatomical descriptor),Locally Advanced Epithelioid Hemangioendothelioma,0
29974,Smear - instruction imperative,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
29975,Effective,Neonatal leukemia,0
29976,Aspiration of food,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
29977,Time,Acantholytic squamous cell carcinoma,0
29978,Microorganism,Non-Metastatic Gestational Trophoblastic Tumor,0
29979,Measures,FIGO Stage IVA Ovarian Cancer,0
29980,Atypical Teratoid Rhabdoid Tumor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
29981,Array Feature,Familial Hemophagocytic Lymphocytosis,0
29982,Five,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
29983,One,Maxillary Sinus Adenocarcinoma,0
29984,Deterioration of status,Primary Cutaneous Plasmablastic Lymphoma,0
29985,Cover (physical object),Primary Cutaneous Plasmablastic Lymphoma,0
29986,Early,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
29987,Area,Epithelioid Sarcoma NCI Grade 3,0
29988,Spur (body structure),Mucinous cystadenofibroma,0
29989,Enhance (action),Grade 3a Malignant Neoplasm,0
29990,Used by,Brain Tumor,0
29991,In Blood,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
29992,radiotherapeutic,embryonal rhabdomyosarcoma of prostate,0
29993,Growth abnormality,Cervical Squamous Intraepithelial Neoplasia,0
29994,risk factors - observation list,Multiple Skull Base Meningiomas,0
29995,Exact (qualifier),Ovarian germ cell choriocarcinoma stage IV,0
29996,Histocompatibility Testing,Xeroderma pigmentosum,0
29997,shared attribute,Vaginal Adenoma,0
29998,Platelet Glycoprotein 4,Stage II Fallopian Tube Cancer,0
29999,include - SetOperator,Secondary malignant neoplasm of lymph node,0
30000,High,gliosarcoma,0
30001,Negation,embryonal rhabdomyosarcoma of prostate,0
30002,Anatomic Site,Cancer of Urinary Tract,0
30003,Prognosis:Find:Pt:^Patient:Nom,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
30004,<90,Peripheral primitive neuroectodermal tumor of soft tissue,0
30005,Lymphocyte,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
30006,Screening,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
30007,Including (qualifier),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
30008,NCI CTEP SDC Myeloma Sub-Category Terminology,Benign Apocrine Neoplasm,0
30009,Cell Shape,Small Intestinal Villous Adenoma,0
30010,Pain,sarcoma of spinal cord,0
30011,Have Shortness of Breath question,Type II Endometrial Adenocarcinoma,0
30012,uti symptoms,Small cell neuroendocrine carcinoma of bladder,0
30013,Term (lexical),Breast Ductal Adenoma,0
30014,eTMF Content Model Code,Pleomorphic adenoma of parotid gland,0
30015,Malignant Central Nervous System Neoplasm,Cherubism,0
30016,Blocking,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
30017,pharmacotherapeutic,Keratoderma,0
30018,Specimen Source Codes - tumor,Pleomorphic adenoma of parotid gland,0
30019,Process,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
30020,Money or percentage indicator - Percentage,Cancer of Urinary Tract,0
30021,Sunlight,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
30022,Carcinoma,Trabecular adenocarcinoma,0
30023,research subject screening,Malignant melanoma of eyelid,0
30024,Child,Recurrent Primary Lymphoma of Bone,0
30025,Rare,Papillary squamous cell carcinoma,0
30026,Ultrasonics (sound),Female Breast Carcinoma,0
30027,Togo,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
30028,majority,Metastatic Carcinoma in the Lung,0
30029,Environment,Spermatocytic seminoma,0
30030,Neoadjuvant Therapy Clinical Trial Setting,Recurrent Testicular Lymphoma,0
30031,Antineoplastic Chemotherapy Protocols,Bladder squamous cell carcinoma stage I,0
30032,Make - Instruction Imperative,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
30033,Type - attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
30034,Anatomic Site,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
30035,Long hair,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
30036,Study Variable,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
30037,Small,Plexosarcoma,0
30038,Hematologist,Fibroadenoma of breast,0
30039,Symptoms,Digestive System Hodgkin Lymphoma,0
30040,School Grade,Stage I Colon Neuroendocrine Tumor AJCC v8,0
30041,Unknown GENC,Stage IV Childhood Non-Hodgkin Lymphoma,0
30042,Tumor cells,Stage II Carcinoma of Penis,0
30043,Affecting,Trabecular adenocarcinoma,0
30044,Continuous,BRCA2 Syndrome,0
30045,Approximate,Unfavorable Non-Hodgkin Lymphoma,0
30046,Including (qualifier),Lipoma of small intestine,0
30047,therapeutic aspects,Acantholytic squamous cell carcinoma,0
30048,Internal,FIGO Stage II Ovarian Cancer,0
30049,Definitely Related to Intervention,embryonal rhabdomyosarcoma of prostate,0
30050,Normal hair follicles,Intraepithelial Melanocytic Hyperplasia,0
30051,Period (temporal qualifier),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
30052,Cancer Genus,Squamous cell carcinoma of lip,0
30053,Progesterone Receptor,Childhood Central Nervous System Ganglioneuroblastoma,0
30054,Biologic Development,Trabecular adenocarcinoma,0
30055,Abnormally high,Stage III Cutaneous Melanoma AJCC v6,0
30056,Retinoic Acid Response Element,Stage III Cutaneous Melanoma AJCC v6,0
30057,Patient Caretaker,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
30058,Qualitative form,Prostate Lymphoma,0
30059,Ovulation,Congenital hamartoma,0
30060,Tryptophanase,Stage IV Penile Cancer AJCC v7,0
30061,Areas <moth>,Type II Endometrial Adenocarcinoma,0
30062,peripheral blood,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
30063,Lacking,Medulloblastoma,0
30064,Involvement with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
30065,World Health Organization,Activated B-cell type diffuse large B-cell lymphoma,0
30066,Often - answer to question,Acantholytic squamous cell carcinoma,0
30067,Formation,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
30068,consider,Unfavorable Non-Hodgkin Lymphoma,0
30069,Phase,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
30070,More,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
30071,Stage Grouping,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
30072,Cessation of life,Recurrent Testicular Lymphoma,0
30073,Mass of body structure,Cherubism,0
30074,Remetinostat,Nasal cavity carcinoma,0
30075,Malignant Testicular Germ Cell Tumor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
30076,Structure of posterior spinal artery,Localized Askin Tumor,0
30077,Causing,Undifferentiated Neuroblastoma,0
30078,Large,Giant cell angiofibroma,0
30079,Administration procedure,Blood Vessel Tumors,0
30080,Often - answer to question,Stage III Adult Immunoblastic Lymphoma,0
30081,Smear - instruction imperative,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
30082,Cancer Genus,Anterior Urethral Malignant Neoplasm,0
30083,Related personal status,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
30084,Respiratory System,Stage I Adult Non-Hodgkin Lymphoma,0
30085,Nasolacrimal duct structure,Colorectal Neuroendocrine Tumor G2,0
30086,Structure of lymphatic trunk,Testicular cancer metastatic,0
30087,Thin (qualifier value),Benign Anal Granular Cell Tumor,0
30088,Microbial anatomical capsule structure,Non-Hodgkin Lymphoma During Pregnancy,0
30089,Often - answer to question,Liver Lymphangioma,0
30090,Occur (action),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
30091,Representation (action),Pancreatic Intraepithelial Neoplasia-3,0
30092,Brain,Undifferentiated Endocervical Sarcoma,0
30093,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Mixed astrocytoma-ependymoma,0
30094,Body tissue,mucinous adenocarcinoma of gallbladder,0
30095,Approximate,Placental aromatase deficiency,0
30096,Varies,Recurrent Primary Lymphoma of Bone,0
30097,Form:Finding:Point in time:{Setting}:Document:{Role},Cartilaginous exostosis,0
30098,Acquisition (action),Malignant Neoplasm of Lung - Multiple Primary Sites,0
30099,Chemotherapy,Childhood Anaplastic Large Cell Lymphoma,0
30100,Life Expectancy Greater than Twenty Years,Granular Cell Leiomyosarcoma,0
30101,Condition:Find:Pt:^Patient:Nom,Heavy Chain Deposition Disease,0
30102,Adult Medulloblastoma,Occult Lung Adenosquamous Carcinoma,0
30103,Compleat Liquid Nutrition,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
30104,Childhood,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
30105,risk factors - observation list,Benign tumor of eyelid,0
30106,Term (temporal),Locally Advanced Carcinoma,0
30107,What subject filter - Result,Mixed parotid tumor,0
30108,cell growth,embryonal rhabdomyosarcoma of prostate,0
30109,Precancerous Conditions,Pancreatic carcinoma,0
30110,Aggressive course,Splenic Manifestation of Hairy Cell Leukemia,0
30111,Parotid Neoplasms,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
30112,/mL,Cervical Fibroepithelial Polyp,0
30113,described,Undifferentiated Neuroblastoma,0
30114,bony process,Cervical Adenomyoma,0
30115,Cystoscopy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
30116,Blood Platelets,Unresectable Rhabdomyosarcoma,0
30117,radiotherapeutic,Adenocarcinoma of the prostate metastatic,0
30118,Present,Cancer of Urinary Tract,0
30119,CDISC SEND Tumor Findings Results Terminology,Medulloblastoma,0
30120,Hematuria,Acinar cell carcinoma of pancreas,0
30121,60%,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
30122,Neoplasms,FIGO Stage IVA Ovarian Cancer,0
30123,Anal sac glands,Ovarian germ cell choriocarcinoma stage IV,0
30124,Negation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
30125,Particle,Metastatic Kidney Carcinoma,0
30126,Separate,Locally Advanced Epithelioid Hemangioendothelioma,0
30127,Low Grade,Plexosarcoma,0
30128,Numbers,Benign Ovarian Thecoma,0
30129,Function Axis,Methotrexate-Associated Hodgkin Lymphoma,0
30130,Therapeutic procedure,Stage I Adult Non-Hodgkin Lymphoma,0
30131,Occurrence,Methotrexate-Associated Hodgkin Lymphoma,0
30132,SPINK5 gene,Benign neoplasm of thorax,0
30133,Histopathologic Grade differentiation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
30134,Muscle Tissue,Adult Alveolar Soft Part Sarcoma,0
30135,Cancer Genus,Carcinoma ex pleomorphic adenoma of parotid gland,0
30136,Patient Monitoring,Kaposi's sarcoma of extrahepatic bile duct,0
30137,3+ Score,Undifferentiated Endocervical Sarcoma,0
30138,Fatigue,Spongiotic dermatitis,0
30139,macrophage,Benign Anal Granular Cell Tumor,0
30140,To,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
30141,Case unit dose,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
30142,Feature,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
30143,Throat,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
30144,Not Otherwise Specified,Undifferentiated Endocervical Sarcoma,0
30145,Five-year Survival Rate,Familial Hemophagocytic Lymphocytosis,0
30146,To,Intestinal Metaplasia of Bladder Urothelium,0
30147,To,Diffuse malignant mesothelioma,0
30148,Concept model range (foundation metadata concept),Lipoma of small intestine,0
30149,PREVENT (product),Botryoid-Type Embryonal Rhabdomyosarcoma,0
30150,Pelvis,Recurrent Testicular Lymphoma,0
30151,Development,Endometrial Small Cell Carcinoma,0
30152,Response to treatment,Cancer of Urinary Tract,0
30153,Tired,Acantholytic squamous cell carcinoma,0
30154,shared attribute,BRCA2 Syndrome,0
30155,Serious,Unicystic ameloblastoma,0
30156,40%,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
30157,Leg,Transitional cell carcinoma,0
30158,Greater than one,Breast Ductal Adenoma,0
30159,Aggressive behavior,Advanced Uterine Corpus Carcinosarcoma,0
30160,Domain specific term,Pancreatic Endocrine Carcinoma,0
30161,Poor - grade value,Refractory Ependymoma,0
30162,Term (temporal),Pancreatic Intraepithelial Neoplasia-3,0
30163,set (group),Non-Metastatic Gestational Trophoblastic Tumor,0
30164,Characterization,Cartilaginous exostosis,0
30165,Specimen,Diffuse malignant mesothelioma,0
30166,Logical Condition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
30167,Occur (action),Undifferentiated Endocervical Sarcoma,0
30168,Tumor cells,Squamous cell carcinoma of lip,0
30169,Lower (action),Ichthyoses,0
30170,membrane attack complex location,Spindle Cell Melanoma,0
30171,Genetic Marker Expression,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
